Mammalian Phenotype Ontology Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

9717 genotypes with 27260 annotations displayed of selected term and subterms
Searched Term: abnormal immune system morphology
Allelic Composition (Genetic Background)	Annotated Term	Reference
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (C.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan})	abnormal CD8-positive, alpha-beta T cell differentiation	J:93488
	decreased CD8-positive, alpha-beta T cell number	J:93488
	decreased dendritic cell number	J:93488
	increased neutrophil cell number	J:194800
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (B6.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/J)	decreased dendritic cell number	J:100867, J:113232, J:96123
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (C.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/J)	decreased dendritic cell number	J:96123
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (involves: C57BL/6 * FVB/N)	abnormal alveolar macrophage morphology	J:137452
	decreased dendritic cell number	J:137452
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (NOD.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/Jdk)	decreased dendritic cell number	J:137009
	decreased macrophage cell number	J:137009
	decreased NK T cell number	J:137009
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (involves: FVB/N)	decreased gamma-delta T cell number	J:193548
	decreased leukocyte cell number	J:193548
	decreased neutrophil cell number	J:193548
	decreased T cell number	J:193548
1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/0 (B6.FVB-1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan})	decreased dendritic cell number	J:194800
	decreased neutrophil cell number	J:194800
	increased monocyte cell number	J:194800
	increased neutrophil cell number	J:194800
1700019D03Rik^{tm1.1(NCOM)Mfgc}/1700019D03Rik^{tm1.1(NCOM)Mfgc} (C57BL/6N-1700019D03Rik^{tm1.1(NCOM)Mfgc}/Tcp)	enlarged lymph nodes	J:211773
1700025G04Rik^em1(IMPC)Mbp/1700025G04Rik^em1(IMPC)Mbp (C57BL/6NCrl-1700025G04Rik^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
1700034E13Rik^em1(IMPC)Mbp/1700034E13Rik^em1(IMPC)Mbp (C57BL/6NCrl-1700034E13Rik^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
1700069L16Rik^em1(IMPC)Mbp/1700069L16Rik^em1(IMPC)Mbp (C57BL/6NCrl-1700069L16Rik^em1(IMPC)Mbp/Mmucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
2310022B05Rik^{tm1a(EUCOMM)Hmgu}/2310022B05Rik^{tm1a(EUCOMM)Hmgu} (C57BL/6N-2310022B05Rik^{tm1a(EUCOMM)Hmgu}/H)	increased B cell number	J:165965
	increased leukocyte cell number	J:165965
2810408A11Rik^{tm1a(EUCOMM)Wtsi}/2810408A11Rik^{tm1a(EUCOMM)Wtsi} (C57BL/6N-2810408A11Rik^{tm1a(EUCOMM)Wtsi}/H)	decreased NK cell number	J:165965
	increased CD4-positive, alpha-beta T cell number	J:165965
	increased NK cell number	J:165965
3425401B19Rik^{em2(IMPC)Ccpcz}/3425401B19Rik^{em2(IMPC)Ccpcz} (C57BL/6NCrl-3425401B19Rik^{em2(IMPC)Ccpcz}/Ph)	increased effector memory T-helper cell number	J:211773
	increased eosinophil cell number	J:211773
4930444P10Rik^em1(IMPC)Tcp/4930444P10Rik⁺ (C57BL/6NCrl-4930444P10Rik^em1(IMPC)Tcp/Cmmr)	decreased eosinophil cell number	J:211773
4933434E20Rik^{tm1a(EUCOMM)Wtsi}/4933434E20Rik^{tm1a(EUCOMM)Wtsi} (C57BL/6N-4933434E20Rik^{tm1a(EUCOMM)Wtsi}/Wtsi)	enlarged lymphatic vessel	J:239583
5730403I07Rik^em8Gpt/5730403I07Rik^em8Gpt (involves: C57BL/6JGpt)	abnormal T cell number	J:329871
6430548M08Rik^em1(IMPC)Mbp/6430548M08Rik^em1(IMPC)Mbp (C57BL/6N-6430548M08Rik^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
9430015G10Rik^tm1Lex/9430015G10Rik^tm1Lex (B6;129S5-9430015G10Rik^tm1Lex/Mmucd)	decreased CD4-positive, alpha-beta T cell number	J:171883
	increased B cell number	J:171883
A2ml1^em1(IMPC)Tcp/A2ml1⁺ (C57BL/6N-A2ml1^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
A2ml1^em1(IMPC)Tcp/A2ml1^em1(IMPC)Tcp (C57BL/6N-A2ml1^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
A^y/a Apoe^tm1Unc/Apoe^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J * KK/TaJcl)	increased monocyte cell number	J:177084
AA467197^em1Nyam/AA467197^em1Nyam (C57BL/6J-AA467197^em1Nyam)	abnormal thymus cortex morphology	J:347271
	abnormal thymus medulla morphology	J:347271
	decreased CD4-positive, alpha-beta T cell number	J:347271
Aadac^em1(IMPC)Mbp/Aadac^em1(IMPC)Mbp (C57BL/6NCrl-Aadac^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	small thymus	J:211773
Aadacl4^{em1(IMPC)Ccpcz}/Aadacl4^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Aadacl4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Aars2^{tm1(KOMP)Wtsi}/Aars2⁺ (C57BL/6N-Aars2^{tm1(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Aass^em1(IMPC)Tcp/Aass^em1(IMPC)Tcp (C57BL/6NCrl-Aass^em1(IMPC)Tcp/Cmmr)	enlarged lymph nodes	J:211773
Abat^{tm1c(EUCOMM)Hmgu}/Abat^{tm1c(EUCOMM)Hmgu} Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * DBA/2)	abnormal CD4-positive T cell differentiation	J:333883
	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:333883
	abnormal T-helper 1 cell differentiation	J:333883
	abnormal T-helper 17 cell differentiation	J:333883
Abca1^tm1Jdm/Abca1^tm1Jdm (DBA/1LacJ-Abca1^tm1Jdm)	enlarged spleen	J:60210
Abca1^tm1Jdm/Abca1^tm1Jdm (involves: C57BL/6 * DBA/1LacJ)	abnormal thymus morphology	J:132254
Abca1^tm1Jdm/Abca1^tm1Jdm Abcg1^tm1Dgen/Abcg1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)	decreased monocyte cell number	J:190966
	increased monocyte cell number	J:190966
	increased neutrophil cell number	J:190966
Abca1^tm1Jdm/Abca1^tm1Jdm Tgm2^tm1Gml/Tgm2^tm1Gml (involves: C57BL/6 * DBA/1LacJ)	abnormal thymus morphology	J:132254
Abca1^tm1Wpfl/Abca1^tm1Wpfl (involves: 129P2/OlaHsd * C57BL/6J)	abnormal thymus morphology	J:64390
Abca5^{em1(IMPC)Ccpcz}/Abca5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Abca5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Abcb1a^mds/Abcb1a^mds (involves: CF-1)	increased eosinophil cell number	J:64725
Abcb1a^tm1Bor/Abcb1a^tm1Bor (FVBTac.129P2-Abcb1a^tm1Bor)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:102640
Abcb1a^tm1Bor/Abcb1a^tm1Bor (FVBTac.129P2-Abcb1a^tm1Bor)	decreased gamma-delta intraepithelial T cell number	J:102640
Abcb1a^tm1Bor/Abcb1a^tm1Bor Abcb1b^tm1Bor/Abcb1b^tm1Bor (FVBTac.129P2-Abcb1b^tm1Bor Abcb1a^tm1Bor)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:102640
	decreased gamma-delta intraepithelial T cell number	J:102640
	increased double-positive T cell number	J:102640
Abcb4^em1(IMPC)H/Abcb4^em1(IMPC)H (C57BL/6NTac-Abcb4^em1(IMPC)H/H)	increased basophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Abcb4^tm1Bor/Abcb4^tm1Bor (FVB.129P2-Abcb4^tm1Bor/J)	enlarged spleen	J:217802
Abcb4^tm1Bor/Abcb4^tm1Bor (CAnNCrl.12P2(FVB)-Abcb4^tm1Bor)	enlarged spleen	J:217802
Abcb9^{tm1b(KOMP)Wtsi}/Abcb9^{tm1b(KOMP)Wtsi} (C57BL/6N-Abcb9^{tm1b(KOMP)Wtsi}/Tcp)	enlarged lymph nodes	J:211773
Abcc1^tm1Bor/Abcc1^tm1Bor Tg(Thy1-APPSw,Thy1-PSEN1L166P)21Jckr/0 (FVB.Cg-Abcc1^tm1Bor Tg(Thy1-APPSw,Thy1-PSEN1L166P)21Jckr)	microgliosis	J:178230
Abcc2^{tm2b(KOMP)Wtsi}/Abcc2^{tm2b(KOMP)Wtsi} (C57BL/6N-Abcc2^{tm2b(KOMP)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Abcc4^tm1Kruh/Abcc4^tm1Kruh (B6.129-Abcc4^tm1Kruh)	abnormal spleen B cell follicle morphology	J:117326
	abnormal spleen red pulp morphology	J:117326
	decreased spleen B cell follicle number	J:117326
	decreased spleen B cell follicle size	J:117326
	small spleen	J:117326
	thymus cortex hypoplasia	J:117326
Abcc5^em1(IMPC)H/Abcc5^em1(IMPC)H (C57BL/6N-Abcc5^em1(IMPC)H/H)	decreased eosinophil cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Abcc9^em1(IMPC)H/Abcc9⁺ (C57BL/6N-Abcc9^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
Abcc9^em1(IMPC)H/Abcc9⁺ (C57BL/6N-Abcc9^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Abcc10^tm1Eah/Abcc10^tm1Eah (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal spleen red pulp morphology	J:172648
	decreased leukocyte cell number	J:172648
	decreased spleen germinal center number	J:172648
	decreased spleen germinal center size	J:172648
	decreased spleen white pulp amount	J:172648
	small spleen	J:172648
	thymus cortex hypoplasia	J:172648
Abcd1^tm1Kds/Y (involves: 129S4/SvJae * C57BL/6J)	abnormal microglial cell morphology	J:94583
Abcd1^tm1Kds/Y Abcd2^tm1Apuj/Abcd2^tm1Apuj (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)	abnormal microglial cell morphology	J:94583
Abcd2^tm1Apuj/Abcd2^tm1Apuj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal microglial cell morphology	J:94583
Abce1^{tm1.1(KOMP)Vlcg}/Abce1⁺ (C57BL/6N-Abce1^{tm1.1(KOMP)Vlcg}/Tcp)	enlarged lymph nodes	J:211773
	increased neutrophil cell number	J:211773
Abce1^{tm1b(EUCOMM)Hmgu}/Abce1⁺ (C57BL/6N-Abce1^{tm1b(EUCOMM)Hmgu}/H)	increased large unstained cell number	J:211773
Abcg1^tm1Dgen/Abcg1^tm1Dgen (B6.129P2-Abcg1^tm1Dgen)	increased macrophage derived foam cell number	J:117028
Abcg1^tm1Dgen/Abcg1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte morphology	J:132952
	abnormal macrophage morphology	J:132952
	abnormal monocyte differentiation	J:132952
	increased B cell number	J:132952
	increased CD4-positive, alpha-beta T cell number	J:132952
	increased CD8-positive, alpha-beta T cell number	J:132952
	increased dendritic cell number	J:132952
	increased eosinophil cell number	J:132952
	increased monocyte cell number	J:132952
	increased neutrophil cell number	J:132952
Abcg5^trac/Abcg5^trac (A/J-Abcg5^trac)	abnormal neutrophil morphology	J:157223
Abcg5^trac/Abcg5^trac (A/J-Abcg5^trac)	decreased leukocyte cell number	J:157223
Abcg8^{tm1b(KOMP)Wtsi}/Abcg8^{tm1b(KOMP)Wtsi} (C57BL/6N-Abcg8^{tm1b(KOMP)Wtsi}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased B-2 B cell number	J:211773
	decreased CD4-negative NK T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased NK T cell number	J:211773
	decreased T cell number	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Abhd5^tm1.1Rze/Abhd5^tm1.1Rze (involves: 129P2/OlaHsd * C57BL/6)	abnormal granulocyte morphology	J:160725
Abhd10^em1(IMPC)Mbp/Abhd10^em1(IMPC)Mbp (C57BL/6NCrl-Abhd10^em1(IMPC)Mbp/Mmucd)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Abhd12^tm1Crv/Abhd12^tm1Crv (involves: C57BL/6)	microgliosis	J:193716
Abhd13^em1(IMPC)Mbp/Abhd13^em1(IMPC)Mbp (C57BL/6NCrl-Abhd13^em1(IMPC)Mbp/Mmucd)	decreased spleen weight	J:211773
Abhd17c^em1(IMPC)Mbp/Abhd17c^em1(IMPC)Mbp (C57BL/6N-Abhd17c^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Abl1^m1/Abl1^m1 (either: 129S/SvEv-Abl1^m1 or (involves: 129S/SvEv * CD-1) or (involves: 129S/SvEv * C57BL/6 * DBA/2))	abnormal B cell differentiation	J:14644
	abnormal immune system cell morphology	J:14644
	abnormal immune system organ morphology	J:14644
	abnormal spleen germinal center morphology	J:14644
	abnormal spleen morphology	J:14644
	abnormal spleen white pulp morphology	J:14644
	abnormal T cell number	J:14644
	abnormal thymus morphology	J:14644
	decreased immature B cell number	J:14644
	decreased pre-B cell number	J:14644
	decreased pro-B cell number	J:14644
	decreased single-positive T cell number	J:14644
	decreased thymocyte number	J:14644
	increased single-positive T cell number	J:14644
	spleen hypoplasia	J:14644
	thymus cortex hypoplasia	J:14644
	thymus hypoplasia	J:14644
Abl1^m1/Abl1^m1 (involves: 129S/SvEv)	abnormal B cell differentiation	J:28795
	abnormal immune system cell morphology	J:34903
	decreased mature B cell number	J:28795
	decreased pre-B cell number	J:28795
	decreased pro-B cell number	J:28795
Abl1^m1/Abl1^m1 (involves: 129S/SvEv * C57BL/6)	abnormal lymphopoiesis	J:148105
Abl1^m1/Abl1^m1 (involves: 129S/SvEv * C57BL/6)	decreased pro-B cell number	J:148105
Abl1^tm1Mlg/Abl1^tm1Mlg (involves: 129S/SvEv * C57BL/6J)	decreased B cell number	J:72875
	decreased lymphocyte cell number	J:72875
	decreased T cell number	J:72875
	decreased thymocyte number	J:72875
	spleen atrophy	J:72875
	thymus atrophy	J:72875
Abl1^tm1Mlg/Abl1^tm1Mlg (involves: 129S/SvEv * C57BL/6J * CBA)	abnormal spleen morphology	J:34643
Abl1^tm1Mlg/Abl1^tm1Mlg Tg(ACTB-Abl1K290R)1Spg/0 (involves: 129S/SvEv C57BL/6J * CBA)	abnormal spleen morphology	J:34643
Abl1^tm2.2Goff/Abl1^tm2.2Goff (involves: 129P2/OlaHsd * C57BL/6J * FVB/N)	spleen atrophy	J:166211
	thymus atrophy	J:166211
Ablim3^em1(IMPC)Tcp/Ablim3^em1(IMPC)Tcp (C57BL/6N-Ablim3^em1(IMPC)Tcp/Tcp)	decreased basophil cell number	J:211773
	enlarged lymph nodes	J:211773
Abraxas2^tm1.2Bwng/Abraxas2⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl)	enlarged spleen	J:245949
Abraxas2^tm1.2Bwng/Abraxas2^tm1.2Bwng (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl)	enlarged spleen	J:245949
Abtb1^{em1(IMPC)Ccpcz}/Abtb1^{em1(IMPC)Ccpcz} (C57BL/6N-Abtb1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Abtb2^{tm1a(KOMP)Wtsi}/Abtb2^{tm1a(KOMP)Wtsi} (C57BL/6N-A^tm1Brd Abtb2^{tm1a(KOMP)Wtsi}/WtsiH)	decreased leukocyte cell number	J:211773
Acaca^tm1Dejs/Acaca^tm1Dejs Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	decreased memory T cell number	J:209886
	decreased T cell number	J:209886
Acad10^em1(IMPC)Tcp/Acad10^em1(IMPC)Tcp (C57BL/6N-Acad10^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Acan^{tm1b(EUCOMM)Hmgu}/Acan⁺ (C57BL/6N-Acan^{tm1b(EUCOMM)Hmgu}/H)	increased basophil cell number	J:211773
Acbd5^{tm1a(EUCOMM)Wtsi}/Acbd5^{tm1a(EUCOMM)Wtsi} (C57BL/6N-A^tm1Brd Acbd5^{tm1a(EUCOMM)Wtsi}/WtsiCnbc)	abnormal microglial cell morphology	J:299448
Ace2^{em1(IMPC)Ccpcz}/Y (C57BL/6NCrl-Ace2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Ace2^{em1(IMPC)Ccpcz}/Ace2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ace2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Ace2^{tm1a(KOMP)Wtsi}/Y Tg(FOXJ1-cre)F26Htzm/0 (involves: C57BL/6N * C57BL/6NTac)	increased neutrophil cell number	J:282139
Ace2^{tm1a(KOMP)Wtsi}/Ace2^{tm1a(KOMP)Wtsi} Tg(FOXJ1-cre)F26Htzm/0 (involves: C57BL/6N * C57BL/6NTac)	increased neutrophil cell number	J:282139
Ace2^tm1Pngr/Y (involves: 129P2/OlaHsd)	increased neutrophil cell number	J:282139
Ace2^tm1Pngr/Ace2^tm1Pngr (involves: 129P2/OlaHsd)	increased neutrophil cell number	J:282139
Ace^{tm1.1(KOMP)Vlcg}/Ace⁺ (C57BL/6N-Ace^{tm1.1(KOMP)Vlcg}/MbpMmucd)	increased basophil cell number	J:211773
Ace^tm6Keb/Ace^tm6Keb (involves: 129 * C57BL/6)	increased T cell number	J:122178
Acer1^{tm1a(EUCOMM)Wtsi}/Acer1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Acer1^{tm1a(EUCOMM)Wtsi})	increased eosinophil cell number	J:235775
Ache^em1(IMPC)Mbp/Ache⁺ (C57BL/6N-Ache^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Ackr3^tm1.1Fma/Ackr3^tm1.1Fma (involves: BALB/cJ * C57BL/6)	decreased marginal zone B cell number	J:124878
Ackr4^tm1.1Rjbn/Ackr4^tm1.1Rjbn (B6.129S6-Ackr4^tm1.1Rjbn)	abnormal CD4-positive, alpha-beta T cell number	J:166490
	abnormal T-helper 17 cell differentiation	J:166490
	increased T-helper 17 cell number	J:166490
	spleen hyperplasia	J:166490
Acoxl^em1(IMPC)Mbp/Acoxl^em1(IMPC)Mbp (C57BL/6NCrl-Acoxl^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Acp2^{tm1a(EUCOMM)Wtsi}/Acp2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Acp2^{tm1a(EUCOMM)Wtsi}/H)	decreased CD4-positive, alpha-beta T cell number	J:165965
	decreased CD8-positive, alpha-beta T cell number	J:165965
	decreased T cell number	J:165965
	increased B cell number	J:165965
Acp2^tm1Psa/Acp2^tm1Psa (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)	abnormal microglial cell morphology	J:41986
Acsl3^{Gt(OST148301)Lex}/Acsl3^{Gt(OST148301)Lex} (B6;129S5-Acsl3^{Gt(OST148301)Lex}/Orl)	decreased B cell number	J:82809
	increased CD4-positive, alpha-beta T cell number	J:82809
Acsl5^{tm1.1(KOMP)Vlcg}/Acsl5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Acsl5^{tm1.1(KOMP)Vlcg}/Ucd)	increased spleen weight	J:211773
Acsm1^{em1(IMPC)Mhzh}/Acsm1^{em1(IMPC)Mhzh} (C57BL/6N-Acsm1^{em1(IMPC)Mhzh}/Mhzh)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Acta2^em1(IMPC)H/Acta2^em1(IMPC)H (C57BL/6NTac-Acta2^em1(IMPC)H/H)	decreased basophil cell number	J:211773
	decreased lymphocyte cell number	J:211773
Actb^{tm4(cre/ERT2)Npa}/Actb⁺ Sgpl1^tm1.1Npa/Sgpl1^tm1.1Npa (involves: BALB/cJ * C57BL/6)	abnormal lymph node morphology	J:199525
	abnormal regulatory T cell number	J:199525
	decreased follicular B cell number	J:199525
	decreased marginal zone B cell number	J:199525
	decreased single-positive T cell number	J:199525
	increased thymocyte number	J:199525
	spleen hypoplasia	J:199525
Actl6a^tm1.1Grc/Actl6a⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6J * CBA)	decreased granulocyte number	J:192124
	decreased macrophage cell number	J:192124
Actl6a^tm1.1Grc/Actl6a^tm1.1Grc Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6J * CBA)	decreased B cell number	J:192124
	decreased granulocyte number	J:192124
	decreased leukocyte cell number	J:192124
	decreased lymphocyte cell number	J:192124
	decreased macrophage cell number	J:192124
	decreased monocyte cell number	J:192124
Acvr1b^{tm1.1(KOMP)Vlcg}/Acvr1b⁺ (C57BL/6N-Acvr1b^{tm1.1(KOMP)Vlcg}/Ucd)	enlarged lymph nodes	J:211773
Acvr2a^{tm1.1(KOMP)Vlcg}/Acvr2a⁺ (C57BL/6N-Acvr2a^{tm1.1(KOMP)Vlcg}/Ucd)	decreased eosinophil cell number	J:211773
	decreased neutrophil cell number	J:211773
Acvr2b^tm1Enl/Acvr2b^tm1Enl (either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6J))	abnormal spleen morphology	J:42018
	small spleen	J:42018
Ada^tm1Mw/Ada^tm1Mw (involves: 129S7/SvEvBrd * C57BL/6)	decreased T cell number	J:25085
Ada^tm1Mw/Ada^tm1Mw (involves: 129S7/SvEvBrd)	increased dendritic cell number	J:138722
Ada^tm1Mw/Ada^tm1Mw Tg(PLADA)4118Rkmb/0 (involves: 129S7/SvEvBrd * C57BL/6)	abnormal spleen red pulp morphology	J:73418
	abnormal thymus corticomedullary boundary morphology	J:73418
	decreased double-positive T cell number	J:73418
	decreased leukocyte cell number	J:73418
	increased double-negative T cell number	J:73418
	increased eosinophil cell number	J:73418
	increased granulocyte number	J:73418
	increased macrophage cell number	J:73418
	small spleen	J:73418
	small thymus	J:73418
	spleen hypoplasia	J:73418
Adam8^tm1.1Rood/Adam8^tm1.1Rood (involves: 129/Sv * C57BL/6 * FVB/N)	abnormal osteoclast differentiation	J:172936
Adam10^tm1.1Dhc/Adam10^tm1.1Dhc Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)	abnormal B cell differentiation	J:158127
	absent marginal zone B cells	J:158127
	decreased transitional stage T2 B cell number	J:158127
	increased follicular B cell number	J:158127
	increased transitional stage T1 B cell number	J:158127
Adam10^tm1.1Khr/Adam10^tm1.1Khr Csf3r^tm1Link/Csf3r^tm1Link Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * C57BL/6N)	abnormal granulocyte differentiation	J:179060
	enlarged spleen	J:179060
	myeloid hyperplasia	J:179060
	spleen hyperplasia	J:179060
Adam10^tm1.1Khr/Adam10^tm1.1Khr Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N)	abnormal granulocyte differentiation	J:179060
	abnormal spleen morphology	J:179060
	abnormal T cell differentiation	J:179060
	decreased CD4-positive, alpha-beta T cell number	J:179060
	decreased CD8-positive, alpha-beta T cell number	J:179060
	decreased double-positive T cell number	J:179060
	decreased T cell number	J:179060
	enlarged spleen	J:179060
	increased leukocyte cell number	J:179060
	increased neutrophil cell number	J:179060
	increased spleen red pulp amount	J:179060
	increased spleen weight	J:179060
	myeloid hyperplasia	J:179060
	small thymus	J:179060
	spleen hyperplasia	J:179060
	thymus hypoplasia	J:179060
Adam10^tm1Zhu/Adam10^tm1.1Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)	abnormal T cell differentiation	J:139042
	decreased CD4-positive, alpha-beta T cell number	J:139042
	decreased double-positive T cell number	J:139042
	thymus hypoplasia	J:139042
Adam10^tm1Zhu/Adam10^tm1Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL/J)	abnormal T cell differentiation	J:139042
	decreased CD4-positive, alpha-beta T cell number	J:139042
	decreased double-positive T cell number	J:139042
	thymus hypoplasia	J:139042
Adam17^tm1.2Bbl/Adam17^tm1.2Bbl Sox9^tm3(cre)Crm/Sox9⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:144795
	decreased B cell number	J:144795
	decreased lymphocyte cell number	J:144795
	decreased T cell number	J:144795
	enlarged spleen	J:144795
	increased leukocyte cell number	J:144795
	increased macrophage cell number	J:144795
	increased neutrophil cell number	J:144795
	increased spleen red pulp amount	J:144795
Adam17^tm1.2Bbl/Adam17^tm1.2Bbl Sox9^tm3(cre)Crm/Sox9⁺ (B6.129(SJL)-Sox9^tm3(cre)Crm Adam17^tm1.2Bbl)	increased T-helper 1 cell number	J:229771
	increased T-helper 2 cell number	J:229771
	increased T-helper 17 cell number	J:229771
Adam17^{tm1a(EUCOMM)Wtsi}/Adam17⁺ (involves: C57BL/6 * C57BL/6N)	myeloid hyperplasia	J:213427
Adam28^tm1.2Dica/Adam28^tm1.2Dica (B6JRj.129-Adam28^tm1.2Dica)	abnormal alpha-beta T cell morphology	J:298188
	abnormal lymphocyte morphology	J:298188
	decreased CD8-positive, alpha-beta T cell number	J:298188
Adam28^tm1.2Dica/Adam28^tm1.2Dica (CJRj.129-Adam28^tm1.2Dica)	decreased CD8-positive, alpha-beta T cell number	J:298188
Adamdec1^tm1Dgen/Adamdec1^tm1Dgen (B6.129P2-Adamdec1^tm1Dgen)	increased neutrophil cell number	J:301741
Adamts1^em1(IMPC)Mbp/Adamts1⁺ (C57BL/6N-Adamts1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Adamts3^tm1.2Itl/Adamts3^tm1.2Itl (involves: BALB/cJ * C57BL/6NTac * SJL)	abnormal lymphangiogenesis	J:245044
	absent lymphatic vessels	J:245044
Adamts6^b2b1879.1Clo/Adamts6^b2b1879.1Clo (C57BL/6J-Adamts6^b2b1879.1Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2029Clo/Adamts6^b2b2029Clo (C57BL/6J-Adamts6^b2b2029Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2182Clo/Adamts6^b2b2182Clo (C57BL/6J-Adamts6^b2b2182Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2187.1Clo/Adamts6^b2b2187.1Clo (C57BL/6J-Adamts6^b2b2187.1Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2228Clo/Adamts6^b2b2228Clo (C57BL/6J-Adamts6^b2b2228Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2405Clo/Adamts6^b2b2405Clo (C57BL/6J-Adamts6^b2b2405Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2407Clo/Adamts6^b2b2407Clo (C57BL/6J-Adamts6^b2b2407Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2744Clo/Adamts6^b2b2744Clo (C57BL/6J-Adamts6^b2b2744Clo)	thymus hypoplasia	J:175213
Adamts6^b2b2966.2Clo/Adamts6^b2b2966.2Clo (C57BL/6J-Adamts6^b2b2966.2Clo)	thymus hypoplasia	J:175213
Adamts9^{tm1b(KOMP)Wtsi}/Adamts9⁺ (C57BL/6N-Adamts9^{tm1b(KOMP)Wtsi}/MbpMmucd)	abnormal lymph node morphology	J:211773
Adamts14^{Gt(511E11)Cmhd}/Adamts14^{Gt(511E11)Cmhd} Adamts2^tm1Prc/Adamts2^tm1Prc (involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)	cutaneous mastocytosis	J:271185
	decreased B cell number	J:271185
	decreased CD8-positive, alpha-beta T cell number	J:271185
	increased CD4-positive, alpha-beta T cell number	J:271185
Adamts16^em1(IMPC)H/Adamts16^em1(IMPC)H (C57BL/6N-Adamts16^em1(IMPC)H/H)	decreased eosinophil cell number	J:211773
	decreased neutrophil cell number	J:211773
Adamtsl3^em1(IMPC)Tcp/Adamtsl3^em1(IMPC)Tcp (C57BL/6N-Adamtsl3^em1(IMPC)Tcp/Cmmr)	enlarged lymph nodes	J:211773
	small spleen	J:211773
Adap1^{tm1a(EUCOMM)Wtsi}/Adap1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Adap1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased memory-marker NK cell number	J:211773
	increased NK cell number	J:211773
Adar^em1Stsn/Adar^tm1Olds (involves: 129S/SvEv * C57BL/6J)	abnormal spleen morphology	J:308678
Adarb2^em1(IMPC)Tcp/Adarb2^em1(IMPC)Tcp (C57BL/6NCrl-Adarb2^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Adck1^em2(IMPC)Tcp/Adck1^em2(IMPC)Tcp (C57BL/6NCrl-Adck1^em2(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Adcy1^{tm1b(EUCOMM)Wtsi}/Adcy1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Adcy1^{tm1b(EUCOMM)Wtsi}/H)	increased leukocyte cell number	J:211773
Adcyap1^tm1Clw/Adcyap1^tm1Clw (B6.129S4-Adcyap1^tm1Clw)	increased T-helper 17 cell number	J:194151
Add2^tm1Feb/Add2^tm1Feb (B6.129-Add2^tm1Feb)	increased spleen weight	J:63047
Add2^tm1Llp/Add2^tm1Llp (involves: 129S4/SvJae * C57BL/6J)	enlarged spleen	J:71029
Add2^tm1Llp/Add2^tm1Llp (involves: 129S4/SvJae * C57BL/6J)	increased spleen iron level	J:71029
Adgb^em1(IMPC)Mbp/Adgb⁺ (C57BL/6NCrl-Adgb^em1(IMPC)Mbp/Mmucd)	increased eosinophil cell number	J:211773
Adgrb1^{tm2a(EUCOMM)Wtsi}/Adgrb1⁺ (C57BL/6N-Adgrb1^{tm2a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Adgre1^m2Btlr/Adgre1^m2Btlr (C57BL/6J-Adgre1^m2Btlr)	decreased macrophage cell number	J:195410
Adgre1^m3Btlr/Adgre1^m3Btlr (C57BL/6J-Adgre1^m3Btlr)	decreased macrophage cell number	J:234244
Adgre1^M4Btlr/Adgre1⁺ (C57BL/6J-Adgre1^M4Btlr)	decreased macrophage cell number	J:255001
Adgre1^M4Btlr/Adgre1^M4Btlr (C57BL/6J-Adgre1^M4Btlr)	decreased macrophage cell number	J:255001
Adgre5^tm1.1Joha/Adgre5^tm1.1Joha (involves: 129P2/OlaHsd * C57BL/6J * FVB/N)	increased granulocyte number	J:140713
Adgre5^tm1Kake/Adgre5^tm1Kake (B6.129S6-Adgre5^tm1Kake)	increased granulocyte number	J:118705
Adgrf1^{em1(IMPC)Ccpcz}/Adgrf1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Adgrf1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Adgrf5^tm1.2Bstc/Adgrf5^tm1.2Bstc (involves: 129S4/SvJae * C57BL/6J)	increased macrophage derived foam cell number	J:196943
Adgrf5^tm1.2Jpbs/Adgrf5^tm1.2Jpbs (BALB/c-Adgrf5^tm1.2Jpbs)	abnormal alveolar macrophage morphology	J:221769
Adgrf5^{tm1b(KOMP)Wtsi}/Adgrf5^{tm1b(KOMP)Wtsi} (C57BL/6N-Adgrf5^{tm1b(KOMP)Wtsi}/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
Adgrf5^tm1Shiro/Adgrf5^tm1Shiro (B6.Cg-Adgrf5^tm1Shiro)	abnormal alveolar macrophage morphology	J:204701
Adgrf5^tm1Shiro/Adgrf5^tm1Shiro (B6.Cg-Adgrf5^tm1Shiro)	increased macrophage cell number	J:204701
Adgrg3^tm1Zgwg/Adgrg3^tm1Zgwg (involves: 129 * C57BL/6)	abnormal B cell morphology	J:222670
	abnormal immune system morphology	J:222670
	abnormal spleen B cell follicle morphology	J:222670
	abnormal spleen B cell follicle shape	J:222670
	abnormal spleen marginal zone morphology	J:222670
	abnormal spleen morphology	J:222670
	decreased follicular B cell number	J:222670
	decreased mature B cell number	J:222670
	decreased transitional stage T1 B cell number	J:222670
	increased marginal zone B cell number	J:222670
	increased transitional stage T2 B cell number	J:222670
Adgrl4^em1(IMPC)Mbp/Adgrl4^em1(IMPC)Mbp (C57BL/6N-Adgrl4^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Adip1^LG/J/? Capn10^tm1Chev/Capn10⁺ ((B6.129-Capn10^tm1Chev x LG/J)F1)	increased spleen weight	J:153477
Adipoq^tm1Chan/Adipoq⁺ (B6.129-Adipoq^tm1Chan)	increased leukocyte cell number	J:122020
Adipoq^tm1Chan/Adipoq^tm1Chan (B6.129-Adipoq^tm1Chan)	increased leukocyte cell number	J:122020
Adipoq^tm1Ish/Adipoq^tm1Ish (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal osteoclast morphology	J:199264
Adipor1^{tm1b(EUCOMM)Hmgu}/Adipor1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Adipor1^{tm1b(EUCOMM)Hmgu}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Adipor2^{tm1b(EUCOMM)Hmgu}/Adipor2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Adipor2^{tm1b(EUCOMM)Hmgu}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Adk^{em1(IMPC)Ccpcz}/Adk⁺ (C57BL/6N-Adk^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Adm2^em1Zhan/Adm2^em1Zhan (Not Specified)	increased Ly6C high monocyte number	J:266495
Adm^tm1Kmca/Adm^tm1Kmca (B6.129P2-Adm^tm1Kmca)	increased uterine NK cell number	J:201446
Adm^tm1Unc/Adm^tm1Unc (involves: 129S6/SvEvTac)	decreased uterine NK cell number	J:201446
Adm^tm1Unc/Adm^tm1Unc (129S6/SvEvTac-Adm^tm1Unc)	abnormal lymph organ development	J:130930
Adnp2^em3(IMPC)Tcp/Adnp2⁺ (C57BL/6NCrl-Adnp2^em3(IMPC)Tcp/Tcp)	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	small spleen	J:211773
Adora2a^em1(IMPC)H/Adora2a^em1(IMPC)H (C57BL/6N-Adora2a^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Adrb2^em1(IMPC)Mbp/Adrb2^em1(IMPC)Mbp (C57BL/6N-Adrb2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Adrb2^tm1Bkk/Adrb2⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast differentiation	J:97566
Adrb2^tm1Bkk/Adrb2^tm1Bkk (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast differentiation	J:97566
Adrb2^tm1Bkk/Adrb2^tm1Bkk (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast morphology	J:97566
Adrb3^em1(IMPC)Krb/Adrb3^em1(IMPC)Krb (C57BL/6NTac-Adrb3^em1(IMPC)Krb/Krb)	increased CD4-negative, CD25-positive NK T cell number	J:211773
Adrm1^{Gt(OST128063)Lex}/Adrm1^{Gt(OST128063)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal single-positive T cell number	J:166694
	enlarged thymus	J:166694
	increased CD4-positive, alpha-beta T cell number	J:166694
	increased CD8-positive, alpha-beta T cell number	J:166694
	thymus hyperplasia	J:166694
Adss2^{tm1b(EUCOMM)Wtsi}/Adss2⁺ (C57BL/6N-Adss2^{tm1b(EUCOMM)Wtsi}/Bay)	decreased eosinophil cell number	J:211773
Adtrp^tm1.1Clu/Adtrp^tm1.1Clu (involves: 129S4/SvJaeSor * C57BL/6)	increased mast cell number	J:295059
Afap1l2^{tm1b(KOMP)Wtsi}/Afap1l2^{tm1b(KOMP)Wtsi} (C57BL/6N-Afap1l2^{tm1b(KOMP)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	increased neutrophil cell number	J:211773
Afdn^em1(IMPC)Mbp/Afdn⁺ (C57BL/6N-Afdn^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Aff1^Rob/Aff1⁺ (involves: BALB/cAnNCrl * C3H/HeN)	abnormal double-negative T cell morphology	J:82265
	decreased thymus weight	J:82265
	thymus hypoplasia	J:82265
Aff1^tm1Cim/Aff1^tm1Cim (involves: 129P2/OlaHsd * BALB/c)	abnormal immune system cell morphology	J:63253
	abnormal immune system organ morphology	J:63253
	abnormal T cell differentiation	J:63253
	decreased B cell number	J:63253
	decreased double-positive T cell number	J:63253
	decreased mature B cell number	J:63253
	decreased pre-B cell number	J:63253
	decreased single-positive T cell number	J:63253
	thymus hypoplasia	J:63253
Afg3l1^tm1.1Arte/Afg3l1^tm1.1Arte Afg3l2^tm1Arte/Afg3l2^tm1Arte Tg(Plp1-cre/ERT)3Pop/0 (involves: C57BL/6J * C57BL/6N)	microgliosis	J:237410
Afg3l2^tm1Arte/Afg3l2^tm1Arte Tg(Pcp2-cre)2Mpin/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	microgliosis	J:193564
Agbl4^em1(IMPC)Mbp/Agbl4^em1(IMPC)Mbp (C57BL/6NCrl-Agbl4^em1(IMPC)Mbp/Mmucd)	increased monocyte cell number	J:211773
Agbl4^{Tn(pb-Act-RFP)1.080115015-HRAZhu}/Agbl4^{Tn(pb-Act-RFP)1.080115015-HRAZhu} (involves: FVB/N)	abnormal spleen morphology	J:233744
	increased spleen weight	J:233744
Ager^tm1.1Arnd/Ager^tm1.1Arnd (B6.129P2-Ager^tm1.1Arnd)	decreased osteoclast cell number	J:104998
Ager^tm1Arnd/Ager⁺ Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased dendritic cell number	J:194800
	decreased plasmacytoid dendritic cell number	J:194800
Agk^em1Qiz/Agk^em1Qiz (involves: C57BL/6 * DBA/2)	abnormal CD8-positive, alpha beta T cell morphology	J:282052
Agk^em1Qiz/Agk^em1Qiz (involves: C57BL/6 * DBA/2)	decreased effector memory CD8-positive, alpha-beta T cell number	J:282052
Agk^tm1.1Smoc/Agk^tm1.1Smoc (Not Specified)	decreased effector memory CD8-positive, alpha-beta T cell number	J:282052
Aglna/? (C57BL/6-Aglna/Anu)	abnormal spleen marginal zone morphology	J:169366
Aglna/? (C57BL/6-Aglna/Anu)	increased activated T cell number	J:169366
Ago2^tm1.1Tara/Ago2^tm1.1Tara Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * CBA)	enlarged spleen	J:165967
Agpat2^{em1(IMPC)Ccpcz}/Agpat2⁺ (C57BL/6NCrl-Agpat2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Agpat2^tm1Garg/Agpat2^tm1Garg (involves: 129S6/SvEvTac)	increased spleen weight	J:146649
Agpat5^{em1(IMPC)Ccpcz}/Agpat5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Agpat5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Agr2^tm1.2Erle/Agr2^tm1.2Erle (involves: 129S4/SvJae * FVB/N)	increased mast cell number	J:148339
Agr2^tm1.2Lpkn/Agr2^tm1.2Lpkn (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal Peyer's patch follicle morphology	J:156704
Agtpbp1^atms/Agtpbp1^atms (MRL/Mp-Agtpbp1^atms Fas^lpr)	decreased spleen weight	J:103944
Agtpbp1^atms/Agtpbp1^atms (MRL/Mp-Agtpbp1^atms)	abnormal lymphocyte cell number	J:103944
	abnormal spleen morphology	J:103944
	abnormal T cell differentiation	J:103944
	abnormal T cell subpopulation ratio	J:103944
	decreased B cell number	J:103944
	decreased spleen weight	J:103944
	increased CD4-positive, alpha-beta T cell number	J:103944
	increased CD8-positive, alpha-beta T cell number	J:103944
	spleen hypoplasia	J:103944
Agtpbp1^atms/Agtpbp1^atms Fas^lpr/Fas^lpr (MRL/Mp-Agtpbp1^atms Fas^lpr)	enlarged lymph nodes	J:103944
	enlarged spleen	J:103944
Agtr1a^{em1(IMPC)Rbrc}/Agtr1a^{em1(IMPC)Rbrc} (C57BL/6NJcl-Agtr1a^{em1(IMPC)Rbrc}/Rbrc)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Agtrap^em1(IMPC)Mbp/Agtrap^em1(IMPC)Mbp (C57BL/6NCrl-Agtrap^em1(IMPC)Mbp/MbpMmucd)	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Agtrap^tm1Tamk/Agtrap^tm1Tamk (involves: C57BL/6N)	abnormal macrophage morphology	J:263253
Ahcy^{tm1b(EUCOMM)Hmgu}/Ahcy⁺ (C57BL/6N-Ahcy^{tm1b(EUCOMM)Hmgu}/Tcp)	increased basophil cell number	J:211773
Ahnak^{tm1b(KOMP)Mbp}/Ahnak⁺ (C57BL/6N-Ahnak^{tm1b(KOMP)Mbp}/H)	increased large unstained cell number	J:211773
	increased monocyte cell number	J:211773
Ahr^tm1Bra/Ahr^tm1Bra (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal Langerhans cell morphology	J:148870
	decreased spleen germinal center size	J:33827
	enlarged spleen	J:33827
Ahr^tm1Gonz/Ahr^tm1Gonz (involves: 129S4/SvJae * C57BL/6N)	abnormal spleen morphology	J:44690
	abnormal spleen red pulp morphology	J:44690
	decreased spleen white pulp amount	J:44690
	enlarged spleen	J:44690
	small spleen	J:25048
	spleen hypoplasia	J:25048
Ahr^tm2Bra/Ahr^tm2Bra (involves: 129/Sv * C57BL/6)	increased spleen weight	J:83597
Ahr^tm4.1Bra/Ahr^tm4.1Bra (involves: 129/Sv * C57BL/6)	enlarged spleen	J:141978
Ahsp^tm1.1Mjwe/Ahsp^tm1.1Mjwe (involves: 129S6/SvEvTac * C57BL/6)	enlarged spleen	J:94421
Ahsp^tm1Mjwe/Ahsp^tm1Mjwe (involves: 129S6/SvEvTac * C57BL/6)	enlarged spleen	J:94421
Aicda^em1Jaych/Aicda^em1Jaych (involves: C57BL/6J)	abnormal class switch recombination	J:305843
	abnormal lymph node cell ratio	J:305843
	abnormal Peyer's patch germinal center morphology	J:305843
	abnormal splenic cell ratio	J:305843
Aicda^tm1(cre)Mnz/Aicda⁺ Gt(ROSA)26Sor^{tm2(sb11)Njen}/Gt(ROSA)26Sor⁺ TgTn(sb-T2/Onc2)6070Njen/0 (involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J)	increased T cell derived lymphoma incidence	J:153656
Aicda^tm1.1Fwa/Aicda^tm1.1Fwa (involves: 129S6/SvEvTac)	abnormal class switch recombination	J:209271
Aicda^tm1.1Fwa/Aicda^tm1.1Fwa (involves: 129S6/SvEvTac)	abnormal somatic hypermutation frequency	J:209271
Aicda^{tm1b(EUCOMM)Hmgu}/Aicda^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Aicda^{tm1b(EUCOMM)Hmgu}/Wtsi)	decreased follicular B cell number	J:211773
	decreased late germinal center B cell number	J:211773
	increased early germinal center B cell number	J:211773
	increased germinal center B cell number	J:211773
	increased leukocyte cell number	J:211773
Aicda^tm1Hon/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:136224, J:141427
Aicda^tm1Hon/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aicda^tm1Hon/Aicda^tm1.1Fwa (involves: 129S/SvEv * C57BL/6NCrlj * CBA/JNCrlj)	abnormal class switch recombination	J:209271
Aicda^tm1Hon/Aicda^tm1Hon (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427, J:73659, J:120658
	abnormal somatic hypermutation frequency	J:136224, J:141427
	increased germinal center B cell number	J:169227
Aicda^tm1Hon/Aicda^tm1Hon Bcl6^tm1.1Jwan/Bcl6^tm1.1Jwan (involves: 129S6/SvEvTac * C57BL/6NCrlj * CBA/JNCrlj)	abnormal somatic hypermutation frequency	J:190534
Aicda^tm1Hon/Aicda^tm1Hon Exo1^tm1Wed/Exo1^tm1Wed Igh^tm4.1Mnz/Igh⁺ (involves: C57BL/6 * CBA/JNCrlj * SJL)	abnormal immunoglobulin heavy chain V(D)J recombination	J:194603
Aicda^tm1Hon/Aicda^tm1Hon Exo1^tm1Wed/Exo1^tm1Wed Igh^tm4.1Mnz/Igh⁺ Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129 * C57BL/6 * CBA/JNCrlj * SJL)	abnormal immunoglobulin heavy chain V(D)J recombination	J:194603
Aicda^tm1Hon/Aicda^tm1Hon Igh^tm3Mnz/Igh^tm4.1Mnz Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129 * C57BL/6 * CBA)	abnormal class switch recombination	J:159173
Aicda^tm1Hon/Aicda^tm1Hon Igh^tm4.1Mnz/Igh⁺ (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	abnormal immunoglobulin heavy chain V(D)J recombination	J:194603
Aicda^tm1Hon/Aicda^tm1Hon Igh^tm4.1Mnz/Igh⁺ Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	abnormal immunoglobulin heavy chain V(D)J recombination	J:194603
Aicda^tm1Hon/Aicda^tm3Mnz (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427
Aicda^tm1Hon/Aicda^tm3Mnz (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aicda^tm1Hon/Aicda^tm4Mnz (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427
Aicda^tm1Hon/Aicda^tm4Mnz (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aicda^tm2.1Hon/Aicda^tm2.1Hon (C57BL/6-Aicda^tm2.1Hon)	abnormal somatic hypermutation frequency	J:169227
Aicda^tm2.1Hon/Aicda^tm2.1Hon (C57BL/6-Aicda^tm2.1Hon)	increased germinal center B cell number	J:169227
Aicda^tm2.1Hon/Aicda^tm2.1Hon (involves: BALB/c * C57BL/6)	increased germinal center B cell number	J:169227
Aicda^tm3.1Mnz/Aicda^tm3.1Mnz (involves: C57BL/6)	abnormal class switch recombination	J:147109
Aicda^tm3.1Mnz/Aicda^tm3.1Mnz (involves: C57BL/6)	abnormal somatic hypermutation frequency	J:147109
Aicda^tm3Mnz/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427
Aicda^tm3Mnz/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aicda^tm4.1Mnz/Aicda^tm4.1Mnz (involves: C57BL/6)	abnormal class switch recombination	J:147109
Aicda^tm4.1Mnz/Aicda^tm4.1Mnz (involves: C57BL/6)	abnormal somatic hypermutation frequency	J:147109
Aicda^tm4Mnz/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:141427
Aicda^tm4Mnz/Aicda⁺ (involves: C57BL/6 * CBA)	abnormal somatic hypermutation frequency	J:141427
Aif1^tm1Nsib/Aif1^tm1Nsib (involves: 129S/SvEv * C57BL/6)	decreased spleen weight	J:204462
Aif1l^{tm1b(EUCOMM)Wtsi}/Aif1l^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Aif1l^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
	small thymus	J:211773
Aim2^{em1(IMPC)Ccpcz}/Aim2^{em1(IMPC)Ccpcz} (C57BL/6N-Aim2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Aim2^{Gt(CSG445)Byg}/Aim2^{Gt(CSG445)Byg} (involves: 129P2/OlaHsd * C57BL/6)	decreased NK cell number	J:158969
Aim2^tm1.2Arte/Aim2^tm1.2Arte Dnase2a^tm1Osa/Dnase2a^tm1Osa Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129 * BALB/c * C57BL/6 * C57BL/6J)	abnormal spleen morphology	J:238323
	enlarged spleen	J:238323
	increased spleen weight	J:238323
Aimp1^em1(IMPC)Tcp/Aimp1^em1(IMPC)Tcp (C57BL/6NCrl-Aimp1^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Aire^{tm1.1(cre)Ghr}/Aire^{tm1.1(cre)Ghr} (Not Specified)	decreased dendritic cell number	J:176844
	decreased regulatory T cell number	J:176844
	increased dendritic cell number	J:176844
Aire^{tm1.1(NCOM)Mfgc}/Aire^{tm1.1(NCOM)Mfgc} (C57BL/6N-Aire^{tm1.1(NCOM)Mfgc}/Tcp)	increased monocyte cell number	J:211773
Aire^tm1.1Doi/Aire^tm1.1Doi (involves: 129S2/SvPas * C57BL/6)	abnormal thymus medulla morphology	J:83422
	increased T cell number	J:83422
Aire^tm1.1Doi/Aire^tm1.1Doi Tg(Ins2-TFRC/OVA)296Wehi/0 Tg(TcraTcrb)425Cbn/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:135154
	decreased CD4-positive, alpha-beta T cell number	J:135154
Aire^tm1Mand/Aire⁺ Tg(Ins2-TFRC/OVA)296Wehi/0 Tg(TcraTcrb)425Cbn/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:135154
Aire^tm1Mmat/Aire^tm2Mmat (involves: C57BL/6 * CBA)	abnormal thymus morphology	J:141379
Aire^tm1Mmat/Aire^tm2Mmat Tg(TcraTcrb)425Cbn/? (involves: BALB/c * C57BL/6 * CBA)	abnormal thymus morphology	J:141379
Aire^tm1Pltn/Aire^tm1Pltn (involves: 129S4/SvJae * C57BL/6)	abnormal T cell morphology	J:77873
Aire^tm1Pltn/Aire^tm1Pltn (involves: 129S4/SvJae * C57BL/6)	thymus atrophy	J:77873
Aire^tm1Pltn/Aire^tm1Pltn (B6.129S4-Aire^tm1Pltn)	abnormal metallophilic macrophage morphology	J:115076
	abnormal myelopoiesis	J:115076
	abnormal spleen marginal zone morphology	J:115076
	decreased follicular B cell number	J:115076
	enlarged spleen	J:115076
	increased B cell number	J:115076
	increased marginal zone B cell number	J:115076
	increased monocyte cell number	J:115076
	increased spleen weight	J:115076
Aire^tm1Ptsn/Aire^tm1Ptsn (C57BL/6-Aire^tm1Ptsn)	abnormal thymus medulla morphology	J:145910
Aire^tm2Mmat/Aire^tm2Mmat (involves: C57BL/6 * CBA)	abnormal thymus morphology	J:141379
Aire^tm2Mmat/Aire^tm2Mmat (involves: C57BL/6 * CBA)	absent Hassall's corpuscle	J:141379
Ajuba^em1(IMPC)H/Ajuba^em1(IMPC)H (C57BL/6N-Ajuba^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Ak7^{em1(IMPC)Ccpcz}/Ak7⁺ (C57BL/6NCrl-Ak7^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Akap9^{tm1a(KOMP)Wtsi}/Akap9⁺ (involves: C57BL/6 * C57BL/6N)	decreased B cell number	J:213427
	decreased mature B cell number	J:213427
	increased CD4-positive, alpha-beta T cell number	J:213427
	increased CD8-positive, alpha-beta T cell number	J:213427
	increased T cell number	J:213427
Akap11^{tm1b(EUCOMM)Hmgu}/Akap11^{tm1b(EUCOMM)Hmgu} (B6N(Cg)-Akap11^{tm1b(EUCOMM)Hmgu}/J)	decreased leukocyte cell number	J:211773
Akap12^tm1Ihg/Akap12^tm1Ihg (involves: 129S4/SvJae * C57BL/6)	increased spleen red pulp amount	J:138882
Akap13^em1(IMPC)Mbp/Akap13^em1(IMPC)Mbp (C57BL/6N-Akap13^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Akap13^tm1Segj/Akap13⁺ (involves: 129)	decreased B cell number	J:181088
	decreased spleen B cell follicle size	J:181088
	decreased spleen weight	J:181088
	decreased splenocyte number	J:181088
	decreased transitional stage T2 B cell number	J:181088
	increased transitional stage T1 B cell number	J:181088
	small spleen	J:181088
	spleen hypoplasia	J:181088
Akna^tm1Mak/Akna^tm1Mak (B6.129P2-Akna^tm1Mak)	increased neutrophil cell number	J:233952
Akr1a1^{Gt(OST222400)Lex}/Akr1a1^{Gt(OST222400)Lex} (B6.129S5-Akr1a1^{Gt(OST222400)Lex})	increased osteoclast cell number	J:164548
Akt1^tm1Nhy/Akt1^tm1Nhy (involves: 129/Sv * C57BL/6)	abnormal thymus morphology	J:71404
Akt1^tm1Pnt/Akt1^tm1Pnt Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Akt3^tm1Mbb/Akt3^tm1Mbb Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd)	arrested T cell differentiation	J:135903
	decreased double-positive T cell number	J:135903
	increased double-negative T cell number	J:135903
	thymus hypoplasia	J:135903
Akt1^tm1Pnt/Akt1^tm1Pnt Akt2^tm1.1Mbb/Akt2^tm1.1Mbb Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd)	arrested T cell differentiation	J:135903
	decreased double-positive T cell number	J:135903
	increased double-negative T cell number	J:135903
	thymus hypoplasia	J:135903
Akt1^tm1Pnt/Akt1^tm1Pnt Akt3^tm1Mbb/Akt3^tm1Mbb Tg(Lck-cre)1Cwi/0 (Not Specified)	decreased double-positive T cell number	J:135903
	thymus hypoplasia	J:135903
Alad^em1(IMPC)Tcp/Alad⁺ (C57BL/6NCrl-Alad^em1(IMPC)Tcp/Cmmr)	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Aldh1a2^tm1Dll/Aldh1a2^tm1Ipc (involves: CD-1)	athymia	J:81969
Aldh1a2^tm1Dll/Aldh1a2^tm1Ipc (involves: CD-1)	thymus hypoplasia	J:81969
Aldh1l2^{em1(IMPC)Kmpc}/Aldh1l2^{em1(IMPC)Kmpc} (C57BL/6NTac-Aldh1l2^{em1(IMPC)Kmpc}/Kmpc)	increased B-1a cell number	J:211773
	increased CD8-positive, CD25-positive alpha-beta T cell number	J:211773
Aldh2^tm1.1Mak/Aldh2⁺ (involves: 129S6/SvEvTac * C57BL/6J)	decreased leukocyte cell number	J:223796
Aldh2^tm1.1Mak/Aldh2^tm1.1Mak (involves: 129S6/SvEvTac * C57BL/6J)	decreased leukocyte cell number	J:223796
Aldh2^{tm1a(EUCOMM)Wtsi}/Aldh2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Aldh2^{tm1a(EUCOMM)Wtsi}/Ieg)	decreased CD4-positive, alpha-beta T cell number	J:165965
	decreased CD8-positive, alpha-beta T cell number	J:165965
	decreased T cell number	J:165965
Aldh2^{tm1a(EUCOMM)Wtsi}/Aldh2^{tm1a(EUCOMM)Wtsi} Fancd2^tm1Hou/Fancd2^tm1Hou (involves: 129S4/SvJae * C57BL/6J * C57BL/6N)	abnormal lymphopoiesis	J:193232
	abnormal spleen morphology	J:188123
	abnormal thymus morphology	J:188123
	decreased leukocyte cell number	J:188123
	enlarged spleen	J:193232
	increased CD8-positive, alpha-beta T cell number	J:193232
	increased double-positive T cell number	J:193232
	increased T cell derived lymphoma incidence	J:193232
Aldoa^{tm1.1(KOMP)Wtsi}/Aldoa⁺ (C57BL/6N-Aldoa^{tm1.1(KOMP)Wtsi}/Bay)	decreased leukocyte cell number	J:211773
Alg1^{tm1b(KOMP)Wtsi}/Alg1⁺ (C57BL/6N-Alg1^{tm1b(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Alg6^em1(IMPC)Tcp/Alg6⁺ (C57BL/6N-Alg6^em1(IMPC)Tcp/Cmmr)	enlarged lymph nodes	J:211773
Alg13^{tm1a(KOMP)Wtsi}/Alg13^{tm1a(KOMP)Wtsi} (C57BL/6N-Alg13^{tm1a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Alkbh1^{tm1b(EUCOMM)Hmgu}/Alkbh1⁺ (C57BL/6N-Alkbh1^{tm1b(EUCOMM)Hmgu}/Ieg)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
Alo1/Alo1 (involves: C3H/HeJ * C57BL/6J)	abnormal lymph node morphology	J:109802
	enlarged lymph nodes	J:109802
	enlarged spleen	J:109802
	lymph node necrosis	J:109802
Alo1/Alo1⁺ (involves: C3H/HeJ * C57BL/6J)	abnormal lymph node morphology	J:109802
	enlarged lymph nodes	J:109802
	enlarged spleen	J:109802
	lymph node necrosis	J:109802
Alo2/Alo2 (involves: C3H/HeJ * C57BL/6J)	abnormal lymph node morphology	J:109802
	enlarged lymph nodes	J:109802
	enlarged spleen	J:109802
	lymph node necrosis	J:109802
Alo2/Alo2⁺ (involves: C3H/HeJ * C57BL/6J)	abnormal lymph node morphology	J:109802
	enlarged lymph nodes	J:109802
	enlarged spleen	J:109802
	lymph node necrosis	J:109802
Alox5^{em1(IMPC)Ccpcz}/Alox5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Alox5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Alox5^tm1Fun/Alox5^tm1Fun (involves: 129S2/SvPas * C57BL/6)	small spleen	J:21372
Alox15^tm1Fun/Alox15^tm1Fun (B6.129S2-Alox15^tm1Fun/J)	abnormal lymph node morphology	J:119405
	abnormal myelopoiesis	J:119405
	abnormal spleen red pulp morphology	J:119405
	abnormal spleen white pulp morphology	J:119405
	decreased spleen B cell follicle number	J:119405
	increased basophil cell number	J:119405
	increased leukocyte cell number	J:119405
	increased spleen weight	J:119405
	intermingled spleen red and white pulp	J:119405
Aloxe3^em1(IMPC)Mbp/Aloxe3⁺ (C57BL/6N-Aloxe3^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	small spleen	J:211773
Alpl^tm1Jlm/Alpl^tm1Jlm (either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))	abnormal spleen morphology	J:39015
	abnormal thymus cortex morphology	J:39015
	decreased leukocyte cell number	J:39015
	pale spleen	J:39015
	small spleen	J:39015
Altre^tm1.1Hbgl/Altre^tm1.1Hbgl Foxp3^{tm4(YFP/icre)Ayr}/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased regulatory T cell number	J:342907
	decreased T cell number	J:342907
	increased CD8-positive, alpha-beta T cell number	J:342907
	increased memory T cell number	J:342907
Amdhd1^{tm2b(EUCOMM)Hmgu}/Amdhd1^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Amdhd1^{tm2b(EUCOMM)Hmgu}/BayMmucd)	increased lymphocyte cell number	J:211773
Amelx^{em1(IMPC)Ccpcz}/Y (C57BL/6N-Amelx^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Amelx^{em1(IMPC)Ccpcz}/Amelx⁺ (C57BL/6N-Amelx^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
Amelx^{em1(IMPC)Ccpcz}/Amelx^{em1(IMPC)Ccpcz} (C57BL/6N-Amelx^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Amer1^tm1.2Nbar/Y (involves: 129S4/SvJae * C57BL/6 * CD-1 * SJL)	spleen hypoplasia	J:173242
Amhr2^tm3(cre)Bhr/Amhr2⁺ Pten^tm1Hwu/Pten^tm1Hwu (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)	decreased uterine NK cell number	J:170203
Amotl2^em1(IMPC)Mbp/Amotl2^em1(IMPC)Mbp (C57BL/6NCrl-Amotl2^em1(IMPC)Mbp/MbpMmucd)	increased monocyte cell number	J:211773
Ampd1^{tm1b(KOMP)Wtsi}/Ampd1⁺ (C57BL/6N-Ampd1^{tm1b(KOMP)Wtsi}/Ucd)	decreased neutrophil cell number	J:211773
Ampd1^{tm1b(KOMP)Wtsi}/Ampd1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ampd1^{tm1b(KOMP)Wtsi}/Ucd)	enlarged lymph nodes	J:211773
Ampd3^tm1Tm/Ampd3^tm1Tm Pklr^slc/Pklr^slc (involves: CBA/NSlc)	enlarged spleen	J:203909
Ampd3^{tm2a(KOMP)Wtsi}/Ampd3^{tm2a(KOMP)Wtsi} (B6JTyr;B6N-Ampd3^{tm2a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:165965
Amtn^em1(IMPC)Mbp/Amtn^em1(IMPC)Mbp (C57BL/6N-Amtn^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	small spleen	J:211773
anem/anem (BALB/c-anem)	increased leukocyte cell number	J:227974
Ang^{tm1.1(KOMP)Vlcg}/Ang^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ang^{tm1.1(KOMP)Vlcg}/Ucd)	increased eosinophil cell number	J:211773
Ang^tm1Dats/Ang^tm1Dats (Not Specified)	decreased leukocyte cell number	J:236081
Ang^tm1Dats/Ang^tm1Dats (Not Specified)	increased lymphocyte cell number	J:236081
Angpt1^tm1.1Seq/Angpt1^tm1.1Seq Angpt2^{tm1c(KOMP)Seq}/Angpt2^{tm1c(KOMP)Seq} Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/? Tg(tetO-cre)1Jaw/0 (involves: 129 * C57BL/6NCr)	abnormal lymphatic vessel morphology	J:217296
Angpt2^em1(IMPC)Mbp/Angpt2⁺ (C57BL/6NCrl-Angpt2^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Angpt2^em1(IMPC)Mbp/Angpt2^em1(IMPC)Mbp (C57BL/6NCrl-Angpt2^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	small thymus	J:211773
Angpt2^tm1Gdy/Angpt2^tm1Gdy (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphatic vessel morphology	J:89618
Angptl3^{tm2b(KOMP)Wtsi}/Angptl3^{tm2b(KOMP)Wtsi} (C57BL/6N-Angptl3^{tm2b(KOMP)Wtsi}/Ccpcz)	enlarged lymph nodes	J:211773
Angptl4^{Gt(OST352973)Lex}/Angptl4^{Gt(OST352973)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal lymphatic vessel morphology	J:122968
	abnormal mesenteric lymph node morphology	J:122968
Angptl4^tm1Lex/Angptl4^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal lymphatic vessel morphology	J:122968
	abnormal mesenteric lymph node morphology	J:122968
Ank1^ity16/Ank1^ity16 (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	decreased spleen iron level	J:199427
	enlarged spleen	J:199427
	increased leukocyte cell number	J:199427
	increased lymphocyte cell number	J:199427
	increased neutrophil cell number	J:199427
Ank1^M1Btlr/Ank1^M1Btlr (C57BL/6J-Ank1^m1Btlr)	abnormal spleen morphology	J:203831
	enlarged spleen	J:203831
	increased spleen iron level	J:203831
Ank1^M1Wlst/Ank1⁺ (involves: 129S1/SvImJ * C3H/HeJ * C57BL/6)	enlarged spleen	J:170562
Ank1^M1Wlst/Ank1^M1Wlst (involves: C3H/HeJ * C57BL/6)	abnormal leukocyte cell number	J:170562
Ank1^M1Wlst/Ank1^M1Wlst (involves: 129S1/SvImJ * C3H/HeJ * C57BL/6)	abnormal myelopoiesis	J:170562
	enlarged spleen	J:170562
Ank1^MRI23420/Ank1⁺ (SJL/J-Ank1^MRI23420)	abnormal spleen morphology	J:187820
	enlarged spleen	J:187820
	increased spleen iron level	J:187820
	increased spleen weight	J:187820
Ank1^MRI23420/Ank1^MRI23420 (SJL/J-Ank1^MRI23420)	enlarged spleen	J:187820
Ank1^MRI23420/Ank1^MRI23420 (SJL/J-Ank1^MRI23420)	increased spleen weight	J:187820
Ank1^nb/Ank1^nb (either: (involves: non-inbred stock) or (involves: C57BL/6) or (involves: WB/Re))	abnormal thymus development	J:30699
	enlarged lymph nodes	J:30699
	enlarged spleen	J:30699
	increased leukocyte cell number	J:30699
Ank1^nb/Ank1^nb ((WB.Cg-Ank1^nb/BrkJ x B6.Cg-Ank1^nb/BrkJ)F1)	enlarged spleen	J:162532
Ank1^Rbc2/Ank1^Rbc2 (involves: 129S1/Sv * BALB/c)	enlarged spleen	J:148127
Ank^tm1.1Ejr/Ank⁺ (B6.129-Ank^tm1.1Ejr)	abnormal osteoclast differentiation	J:168526
Ank^tm1.1Ejr/Ank^tm1.1Ejr (B6.129-Ank^tm1.1Ejr)	abnormal osteoclast differentiation	J:168526
Ankfy1^{tm1b(KOMP)Mbp}/Ankfy1⁺ (C57BL/6N-Ankfy1^{tm1b(KOMP)Mbp}/Tcp)	increased monocyte cell number	J:211773
Ankrd11^{tm1c(EUCOMM)Wtsi}/Ankrd11^{tm1c(EUCOMM)Wtsi} E2f1^{Tg(Wnt1-cre)2Sor}/E2f1⁺ (involves: C3H * C57BL/6 * C57BL/6N)	decreased osteoclast cell number	J:306391
Ankrd11^Yod/Ankrd11⁺ (involves: BALB/cAnNCrl * C3H/HeH)	decreased osteoclast cell number	J:136455
Ankrd31^{em1(IMPC)Hmgu}/Ankrd31^{em1(IMPC)Hmgu} (C57BL/6NCrl-Ankrd31^{em1(IMPC)Hmgu}/Ieg)	abnormal spleen morphology	J:211773
Ankrd46^em1(IMPC)Mbp/Ankrd46^em1(IMPC)Mbp (C57BL/6NCrl-Ankrd46^em1(IMPC)Mbp/MbpMmucd)	increased monocyte cell number	J:211773
Ankrd52^em1(IMPC)J/Ankrd52⁺ (C57BL/6NJ-Ankrd52^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ankrd60^em1(IMPC)J/Ankrd60^em1(IMPC)J (C57BL/6NJ-Ankrd60^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Ano2^{em1(IMPC)Ccpcz}/Ano2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ano2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Ano5^em2Huyi/Ano5^em2Huyi (C57BL/6-Ano5^em2Huyi)	decreased osteoclast cell number	J:336715
Ano6^em3(IMPC)Tcp/Ano6⁺ (C57BL/6NCrl-Ano6^em3(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Anpep^tm1.1Lsha/Anpep^tm1.1Lsha (B6.Cg-Anpep^tm1.1Lsha)	increased CD4-positive, alpha-beta T cell number	J:163945
Antxr2^tm1.1Jkit/Antxr2^tm1.1Jkit (involves: 129 * C57BL/6)	lymphangiectasis	J:187210
anx/anx (B6C3Fe a/a-anx/J)	decreased spleen weight	J:7689
	increased thymus weight	J:7689
	pale spleen	J:7689
	small spleen	J:7689
anx/anx (involves: DW/J * M. m. domesticus poschiavinus * Swiss)	abnormal spleen morphology	J:13936
	small spleen	J:13936
Anxa1^{em1(IMPC)Ccpcz}/Anxa1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Anxa1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Anxa5^tm1Epo/Anxa5^tm1Epo Anxa6^tm1Moss/Anxa6^tm1Moss (involves: 129P2/OlaHsd * C57BL/6)	decreased dendritic cell number	J:193886
	increased B cell number	J:193886
Anxa5^tm1Epo/Anxa5^tm1Epo Anxa6^tm1Moss/Anxa6^tm1Moss Col10a1^tm1Ksec/Col10a1^tm1Ksec (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	decreased dendritic cell number	J:193886
	increased B cell number	J:193886
	increased T-helper cell number	J:193886
Ap1b1^b2b1660Clo/Ap1b1^b2b1660Clo (C57BL/6J-Ap1b1^b2b1660Clo)	absent spleen	J:175213
	spleen hypoplasia	J:175213
Ap1g1^tm1Schu/Ap1g1⁺ (either: (involves: 129P2/OlaHsd * 129X1/SvJ) or (involves: 129P2/OlaHsd * C57BL/6J))	decreased CD4-positive, alpha-beta T cell number	J:53252
Ap2b1^b2b2321Clo/Ap2b1^b2b2321Clo (C57BL/6J-Ap2b1^b2b2321Clo)	thymus hypoplasia	J:175213
Ap3b1^pe/Ap3b1^pe Hps1^ep/Hps1^ep (involves: C3H/He * C3HeB/FeJ * C57BL/6J)	abnormal monocyte morphology	J:85431
Ap4e1^{tm1b(KOMP)Wtsi}/Ap4e1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ap4e1^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Ap4e1^{tm1b(KOMP)Wtsi}/Ap4e1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ap4e1^{tm1b(KOMP)Wtsi}/Ucd)	enlarged lymph nodes	J:211773
Ap4e1^{tm1b(KOMP)Wtsi}/Ap4e1^{tm1b(KOMP)Wtsi} (C57BL/6N-Ap4e1^{tm1b(KOMP)Wtsi}/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Ap4m1^{tm1b(EUCOMM)Wtsi}/Ap4m1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ap4m1^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Ap5m1^em1(IMPC)Mbp/Ap5m1^em1(IMPC)Mbp (C57BL/6N-Ap5m1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Apbb1ip^{em1(IMPC)Ccpcz}/Apbb1ip^{em1(IMPC)Ccpcz} (C57BL/6N-Apbb1ip^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Apc^Min/Apc⁺ (C57BL/6J-Apc^Min)	decreased macrophage cell number	J:85142
Apc^Min/Apc⁺ (involves: 129 * C57BL/6)	decreased NK cell number	J:156864
	decreased splenocyte number	J:156864
	decreased T cell number	J:156864
Apc^Min/Apc⁺ Tg(Rorc-EGFP)1Ebe/? (involves: C57BL/6)	abnormal effector T cell morphology	J:137020
	enlarged mesenteric lymph nodes	J:137020
	lymph node hyperplasia	J:137020
Apc^tm1Kk/Apc^tm1Kk Tg(Lck-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:100461
	arrested T cell differentiation	J:100461
	increased double-negative T cell number	J:100461
	increased mast cell number	J:128606
	small thymus	J:100461
	thymus hypoplasia	J:100461
Apc^tm1Rak/Apc⁺ Smad4^E6sad/Smad4⁺ (B6.129P2-Apc^tm1Rak Smad4^E6sad/+ +)	enlarged spleen	J:107273
Apc^tm2.1Cip/Apc⁺ Atg7^tm1Tchi/Atg7^tm1Tchi Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:227287
	increased CD103-positive CD11b-low dendritic cell number	J:227287
	increased regulatory T cell number	J:227287
Apc^tm2.1Cip/Apc^tm2.1Cip Lect2^tm1Ymg/Lect2^tm1Ymg Tg(Ttr-cre/Esr1)1Vco/0 (B6.Cg-Lect2^tm1Ymg Apc^tm2.1Cip Tg(Ttr-cre/Esr1)1Vco)	increased NK T cell number	J:184496
Apc^tm2.1Cip/Apc^tm2.1Cip Tg(Ttr-cre/Esr1)1Vco/0 (B6.Cg-Apc^tm2.1Cip Tg(Ttr-cre/Esr1)1Vco)	decreased NK T cell number	J:184496
Apc^tm2Rak/Apc^tm2Rak Tg(KRT14-cre)8Brn/0 (involves: 129/Sv * C57BL/6J * FVB/N * SJL)	abnormal Hassall's corpuscle morphology	J:114152
	abnormal thymus morphology	J:114152
	decreased thymocyte number	J:114152
	small thymus	J:114152
Apcs^tm1Mpe/Apcs⁺ (B6.Cg-Apcs^tm1Mpe)	abnormal spleen red pulp morphology	J:90502
	abnormal spleen white pulp morphology	J:90502
	increased spleen white pulp amount	J:90502
Apcs^tm1Mpe/Apcs^tm1Mpe (B6.Cg-Apcs^tm1Mpe)	abnormal spleen morphology	J:90502
	abnormal spleen red pulp morphology	J:90502
	abnormal spleen white pulp morphology	J:90502
	increased spleen white pulp amount	J:90502
Apex2^em1(IMPC)H/Apex2^em1(IMPC)H (C57BL/6NTac-Apex2^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Apex2^tm1Yun/Y (B6.129S-Apex2^tm1Yun)	decreased B cell number	J:95267
	decreased leukocyte cell number	J:95267
	decreased T cell number	J:95267
	decreased thymocyte number	J:95267
	thymus atrophy	J:95267
Aplf^{Gt(RRF189)Byg}/Aplf^{Gt(RRF189)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal class switch recombination	J:168260
Apobec1^{em1(IMPC)Ccpcz}/Apobec1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Apobec1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Apoc4^{tm1.1(KOMP)Mbp}/Apoc4^{tm1.1(KOMP)Mbp} (C57BL/6N-Apoc4^{tm1.1(KOMP)Mbp}/Ieg)	increased leukocyte cell number	J:211773
Apoe^tm1.1Mae/Apoe^tm1.1Mae Tg(Fabp4-cre)1Rev/0 (B6.Cg-Apoe^tm1.1Mae Tg(Fabp4-cre)1Rev)	decreased macrophage cell number	J:219838
	increased macrophage cell number	J:219838
Apoe^tm1Bres/Apoe^tm1Bres Mapk9^tm1Flv/Mapk9^tm1Flv (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal macrophage morphology	J:94044
	increased macrophage derived foam cell number	J:94044
Apoe^tm1Unc/Apoe^tm1Unc (B6.129P2-Apoe^tm1Unc/J)	abnormal CD4-positive, alpha-beta T cell number	J:108154, J:47027
	abnormal immune system morphology	J:47027
	abnormal T cell number	J:47027
	decreased follicular B cell number	J:133606
	decreased marginal zone B cell number	J:133606
	increased B cell number	J:133606
	increased marginal zone B cell number	J:133606
	increased spleen weight	J:61564
	increased T-helper 2 cell number	J:47027
Apoe^tm1Unc/Apoe^tm1Unc (B6.129P2-Apoe^tm1Unc)	increased CD4-positive, alpha-beta T cell number	J:125366
Apoe^tm1Unc/Apoe^tm1Unc Cbs^tm1Unc/Cbs^tm1Unc Tg(Mt1-CBS)25Waku/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	increased Ly6C high monocyte number	J:168131
	increased monocyte cell number	J:168131
Apoe^tm1Unc/Apoe^tm1Unc Ccr2^tm1Ifc/Ccr2^tm1Ifc (B6.Cg-Apoe^tm1Unc Ccr2^tm1Ifc)	decreased monocyte cell number	J:153310
Apoe^tm1Unc/Apoe^tm1Unc Ccr2^tm1Ifc/Ccr2^tm1Ifc Cx3cl1^tm1Lira/Cx3cl1^tm1Lira (B6.Cg-Apoe^tm1Unc Cx3cl1^tm1Lira Ccr2^tm1Ifc)	decreased monocyte cell number	J:153310
Apoe^tm1Unc/Apoe^tm1Unc Ccr5^tm1Blck/Ccr5^tm1Blck (involves: 129P2/OlaHsd * C57BL/6)	abnormal mononuclear phagocyte morphology	J:128063
	decreased T cell number	J:128063
Apoe^tm1Unc/Apoe^tm1Unc Ccr5^tm1Kuz/Ccr5^tm1Kuz (involves: 129P2/OlaHsd * C57BL/6)	abnormal mononuclear phagocyte morphology	J:128063
	decreased T cell number	J:128063
Apoe^tm1Unc/Apoe^tm1Unc Cd36^tm1Mfe/Cd36^tm1Mfe (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	abnormal macrophage derived foam cell morphology	J:61672
Apoe^tm1Unc/Apoe^tm1Unc Cx3cl1^tm1Sgs/Cx3cl1^tm1Sgs (B6.129-Apoe^tm1Unc Cx3cl1^tm1Sgs)	increased macrophage derived foam cell number	J:95279
Apoe^tm1Unc/Apoe^tm1Unc Cxcl10^tm1Adl/Cxcl10^tm1Adl (B6.129-Cxcl10^tm1Adl Apoe^tm1Unc)	decreased CD4-positive, alpha-beta T cell number	J:166204
Apoe^tm1Unc/Apoe^tm1Unc Fas^lpr/Fas^lpr (B6.Cg-Apoe^tm1Unc Fas^lpr)	decreased CD4-positive, alpha-beta T cell number	J:121671
	decreased CD8-positive, alpha-beta T cell number	J:121671
	enlarged lymph nodes	J:121671
	enlarged spleen	J:121671
	enlarged thymus	J:121671
Apoe^tm1Unc/Apoe^tm1Unc Fasl^gld/Fasl^gld (B6.Cg-Fasl^gld Apoe^tm1Unc)	abnormal lymph node morphology	J:91058
	enlarged lymph nodes	J:200141, J:91058
	enlarged spleen	J:91058
	increased spleen weight	J:200141, J:91058
	increased T cell number	J:91058
Apoe^tm1Unc/Apoe^tm1Unc Glg1^{Gt(RST092)Byg}/Glg1⁺ (B6J.129P2-Apoe^tm1Unc Glg1^{Gt(RST092)Byg})	decreased macrophage cell number	J:226586
Apoe^tm1Unc/Apoe^tm1Unc Hsd11b1^tm1Lex/Hsd11b1^tm1Lex (B6.129-Hsd11b1^tm1Lex Apoe^tm1Unc)	abnormal macrophage derived foam cell morphology	J:199430
	decreased macrophage cell number	J:199430
Apoe^tm1Unc/Apoe^tm1Unc Klf15^tm2Jain/Klf15^tm2Jain Tg(Tagln-cre)1Jjl/0 (involves: 129P2/OlaHsd * FVB/N)	increased macrophage cell number	J:203920
Apoe^tm1Unc/Apoe^tm1Unc Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129P2/OlaHsd * 129S6/SvEvTac)	decreased macrophage cell number	J:110044
Apoe^tm1Unc/Apoe^tm1Unc Pla2g15^tm1Ytan/Pla2g15^tm1Ytan (involves: 129S/SvEv * B6.129P2-Apoe^tm1Unc/J)	abnormal macrophage morphology	J:97471
Apoe^tm1Unc/Apoe^tm1Unc Thbs4^tm1Olsa/Thbs4^tm1Olsa (involves: 129P2/OlaHsd * C57BL/6J)	increased macrophage cell number	J:345752
Apoe^{tm2(APOE3)Mae}/Apoe^{tm2(APOE3)Mae} Tg(Thy1-APPSwDutIowa)BWevn/? (involves: 129P2/OlaHsd * C57BL/6)	abnormal microglial cell morphology	J:136318
Apoe^{tm3(APOE4)Mae}/Apoe^{tm3(APOE4)Mae} Tg(Thy1-APPSwDutIowa)BWevn/? (involves: 129P2/OlaHsd * C57BL/6)	abnormal microglial cell morphology	J:136318
Apof^{tm1.1(KOMP)Vlcg}/Apof^{tm1.1(KOMP)Vlcg} (C57BL/6N-Apof^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
App^{tm1b(KOMP)Wtsi}/App⁺ (C57BL/6N-App^{tm1b(KOMP)Wtsi}/Ics)	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
App^tm1Ck/App^tm1Ck Tg(PDGFB-PSEN1M146L)2Jhd/0 (involves: 129 * Black Swiss * C57BL/6 * DBA/2 * SW)	abnormal microglial cell morphology	J:102542
App^tm2.1Tcs/App^tm2.1Tcs (involves: C57BL/6)	microgliosis	J:212758
App^tm2.1Tcs/App^tm2.1Tcs Cast^tm1Tcs/Cast^tm1Tcs (involves: 129P2/OlaHsd * C57BL/6)	microgliosis	J:212758
App^tm3.1Tcs/App^tm3.1Tcs (involves: C57BL/6)	microgliosis	J:212758
Aptx^tm1Pmc/Aptx^tm1Pmc Atm^tm2.1Mfgc/Atm^tm2.1Mfgc (involves: 129 * C57BL/6)	abnormal CD4-positive helper T cell morphology	J:316365
	abnormal T cell differentiation	J:316365
	decreased T cell number	J:316365
	increased CD8-positive, alpha-beta T cell number	J:316365
Aqp1^{tm1b(EUCOMM)Wtsi}/Aqp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Aqp1^{tm1b(EUCOMM)Wtsi}/H)	increased neutrophil cell number	J:211773
Aqp3^m1Btlr/Aqp3^m1Btlr (C57BL/6J-Aqp3^m1Btlr)	abnormal gut-associated lymphoid tissue morphology	J:153279
Aqp11^{tm1.1(KOMP)Vlcg}/Aqp11⁺ (B6N(Cg)-Aqp11^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Ar^Tfm/Y (involves: STOCK Eda^Ta Atp7a^Mo-blo)	abnormal myeloid leukocyte morphology	J:110923
Ar^Tfm/Y (involves: STOCK Eda^Ta Atp7a^Mo-blo)	increased immature B cell number	J:110923
Ar^tm1Chc/Y Tmem163^{Tg(ACTB-cre)2Mrt}/0 (involves: 129S/SvEv * C57BL/6J * FVB/N)	increased osteoclast cell number	J:81789
Ar^tm1Chc/Ar^tm1.1Chc Tmem163^{Tg(ACTB-cre)2Mrt}/0 (involves: 129S/SvEv * C57BL/6J * FVB/N)	enlarged thymus	J:87193
Araf^tm1Mmc/Y (involves: 129P2/OlaHsd * C57BL/6)	small thymus	J:33951
Araf^tm1Mmc/Araf^tm1Mmc (involves: 129P2/OlaHsd * C57BL/6)	small thymus	J:33951
Arb2a^{em2(IMPC)Ccpcz}/Arb2a^{em2(IMPC)Ccpcz} (C57BL/6NCrl-Arb2a^{em2(IMPC)Ccpcz}/Ph)	abnormal thymus morphology	J:211773
	decreased Ly6C-positive NK T cell number	J:211773
	enlarged thymus	J:211773
Arb2a^{Tg(Tyr)TpNpin}/Arb2a^{Tg(Tyr)TpNpin} (involves: FVB/N)	thymus hypoplasia	J:260599
Arf4^{tm1b(KOMP)Wtsi}/Arf4⁺ (C57BL/6N-Arf4^{tm1b(KOMP)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Arfip1^em1(IMPC)Mbp/Arfip1^em1(IMPC)Mbp (C57BL/6N-Arfip1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Arg1^tm1.1Lky/Arg1⁺ Tg(Sftpc-Chia)#Lky/0 (involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2)	decreased macrophage cell number	J:122735
Arg2^{em1(IMPC)Ccpcz}/Arg2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Arg2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Arhgap1^tm1Yizh/Arhgap1^tm1Yizh (involves: 129S6/SvEvTac)	spleen hypoplasia	J:101418
Arhgap1^tm1Yizh/Arhgap1^tm1Yizh (involves: 129S6/SvEvTac)	thymus hypoplasia	J:101418
Arhgap1^tm1Yizh/Arhgap1^tm1Yizh (involves: 129S6/SvEvTac * C57BL/6)	decreased spleen white pulp amount	J:119516
	spleen hypoplasia	J:119516
Arhgap5^tm1Jset/Arhgap5^tm1Jset (involves: 129S2/SvPas * C57BL/6J)	small thymus	J:76484
Arhgap10^em1(IMPC)Tcp/Arhgap10^em1(IMPC)Tcp (C57BL/6NCrl-Arhgap10^em1(IMPC)Tcp/Cmmr)	enlarged lymph nodes	J:211773
Arhgap15^tm1Ehi/Arhgap15^tm1Ehi (B6.129-Arhgap15^tm1Ehi)	abnormal leukocyte cell number	J:174896
	abnormal leukocyte morphology	J:174896
	abnormal macrophage morphology	J:174896
	decreased lymphocyte cell number	J:174896
	decreased macrophage cell number	J:174896
	decreased monocyte cell number	J:174896
	decreased neutrophil cell number	J:174896
Arhgap17^{tm1b(EUCOMM)Wtsi}/Arhgap17^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Arhgap17^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased B-1a cell number	J:211773
	decreased follicular B cell number	J:211773
	decreased mature B cell number	J:211773
	increased transitional stage T1 B cell number	J:211773
Arhgap21^{Gt(RRR629)Byg}/Arhgap21⁺ (B6.129P2-Arhgap21^{Gt(RRR629)Byg})	increased leukocyte cell number	J:262703
	increased neutrophil cell number	J:262703
Arhgap25^{tm1a(KOMP)Wtsi}/Arhgap25^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	increased neutrophil cell number	J:240521
Arhgap26^{tm1b(EUCOMM)Hmgu}/Arhgap26^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Arhgap26^{tm1b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Arhgap28^em1(IMPC)Mbp/Arhgap28^em1(IMPC)Mbp (C57BL/6NCrl-Arhgap28^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
Arhgap30^{tm1a(EUCOMM)Wtsi}/Arhgap30^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Arhgap30^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Arhgap45^em1Ciphe/Arhgap45^em1Ciphe (C57BL/6-Arhgap45^em1Ciphe)	decreased B cell number	J:309971
	decreased CD4-positive, alpha-beta T cell number	J:309971
	decreased CD8-positive, alpha-beta T cell number	J:309971
	decreased CD8-positive, naive alpha-beta T cell number	J:309971
	decreased DN1 thymic pro-T cell number	J:309971
	decreased naive B cell number	J:309971
	decreased T cell number	J:309971
	lymph node hypoplasia	J:309971
Arhgdia^tm1Ytk/Arhgdia^tm1Ytk (involves: 129S/SvEv * C57BL/6 * DBA)	decreased T cell number	J:140671
Arhgdia^tm1Ytk/Arhgdia^tm1Ytk Arhgdib^tm1Miyo/Arhgdib^tm1Miyo (involves: 129S/SvEv)	abnormal leukocyte cell number	J:140671
	abnormal lymph node B cell domain morphology	J:140671
	abnormal mesenteric lymph node morphology	J:140671
	abnormal thymus medulla morphology	J:140671
	decreased double-positive T cell number	J:140671
	decreased follicular B cell number	J:140671
	decreased immature B cell number	J:140671
	decreased marginal zone B cell number	J:140671
	decreased mature B cell number	J:140671
	decreased pre-B cell number	J:140671
	decreased T cell number	J:140671
	decreased transitional stage B cell number	J:140671
	disorganized spleen B cell follicle	J:140671
	increased eosinophil cell number	J:140671
	increased single-positive T cell number	J:140671
	spleen hypoplasia	J:140671
Arhgdib^tm1Miyo/Arhgdib^tm1Miyo (involves: 129S/SvEv)	decreased B cell number	J:140671
Arhgdib^tm1Miyo/Arhgdib^tm1Miyo (involves: 129S/SvEv)	decreased T cell number	J:140671
Arhgef1^tm1.1Rmt/Arhgef1^tm1.1Rmt (C57BL/6-Arhgef1^tm1.1Rmt)	decreased B cell number	J:113295
	decreased B-1 B cell number	J:113295
	decreased follicular B cell number	J:113295
	decreased marginal zone B cell number	J:113295
Arhgef1^{tm1a(EUCOMM)Wtsi}/Arhgef1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Arhgef1^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased dendritic cell number	J:211773
	decreased immature NK cell number	J:211773
	decreased Ly6C-positive immature NK cell number	J:211773
	decreased marginal zone B cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased memory-marker gamma-delta T cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta memory T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased gamma-delta T cell number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased Ly6C-positive NK T cell number	J:211773
	increased mature NK cell number	J:211773
	increased monocyte cell number	J:211773
	increased plasmacytoid dendritic cell number	J:211773
Arhgef1^tm1Djle/Arhgef1^tm1Djle (involves: 129S4/SvJae * C57BL/6)	enlarged spleen	J:129331
	increased leukocyte cell number	J:129331
Arhgef1^tm1Djle/Arhgef1^tm1Djle (involves: 129S4/SvJae)	increased germinal center B cell number	J:174313
Arhgef1^tm1Kdf/Arhgef1^tm1Kdf (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphocyte cell number	J:99463
	decreased B cell number	J:99463
	decreased marginal zone B cell number	J:99463
Arhgef2^em1(IMPC)Mbp/Arhgef2^em1(IMPC)Mbp (C57BL/6N-Arhgef2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Arhgef4^{tm1a(KOMP)Wtsi}/Arhgef4^{tm1a(KOMP)Wtsi} (C57BL/6N-Arhgef4^{tm1a(KOMP)Wtsi}/Wtsi)	decreased T cell number	J:165965
	increased mature B cell number	J:165965
Arhgef5^tm1.1Dwu/Arhgef5^tm1.1Dwu (involves: 129S1/Sv * 129S6/SvEvTac)	decreased eosinophil cell number	J:157812
Arhgef6^tm1Kdf/Arhgef6^tm1Kdf (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell number	J:137269
	decreased CD4-positive, alpha-beta T cell number	J:137269
	decreased CD8-positive, alpha-beta T cell number	J:137269
	decreased lymphocyte cell number	J:137269
	decreased mature B cell number	J:137269
Arhgef6^{tm2e.1(EUCOMM)Wtsi}/Y (C57BL/6N-Arhgef6^{tm2e.1(EUCOMM)Wtsi}/Tcp)	enlarged lymph nodes	J:211773
Arhgef6^{tm2e.1(EUCOMM)Wtsi}/Arhgef6^{tm2e.1(EUCOMM)Wtsi} (C57BL/6N-Arhgef6^{tm2e.1(EUCOMM)Wtsi}/Tcp)	decreased lymphocyte cell number	J:211773
Arhgef16^em1(IMPC)Mbp/Arhgef16^em1(IMPC)Mbp (C57BL/6NCrl-Arhgef16^em1(IMPC)Mbp/Mmucd)	increased monocyte cell number	J:211773
Arid1b^em1(IMPC)Tcp/Arid1b⁺ (C57BL/6NCrl-Arid1b^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Arid3a^tm1Pwt/Arid3a^tm1Pwt (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell differentiation	J:169178
	abnormal class switch recombination	J:169178
	decreased B cell number	J:169178
	decreased B-1 B cell number	J:169178
	decreased B-1a cell number	J:169178
	decreased B-2 B cell number	J:169178
	decreased marginal zone B cell number	J:169178
	decreased pre-B cell number	J:169178
	decreased pro-B cell number	J:169178
	decreased transitional stage B cell number	J:169178
	decreased transitional stage T1 B cell number	J:169178
	decreased transitional stage T2 B cell number	J:169178
Arid3b^{tm1c(KOMP)Wtsi}/Arid3b^{tm1c(KOMP)Wtsi} Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6N * SJL)	abnormal B cell differentiation	J:236980
	decreased B cell number	J:236980
	decreased B-1b cell number	J:236980
	decreased CD4-positive, alpha-beta T cell number	J:236980
	decreased immature B cell number	J:236980
	decreased pre-B cell number	J:236980
	decreased pre-pro B cell number	J:236980
	decreased pro-B cell number	J:236980
	decreased transitional stage B cell number	J:236980
	increased B-1a cell number	J:236980
	increased follicular B cell number	J:236980
Arid3c^em1(IMPC)J/Arid3c^em1(IMPC)J (C57BL/6NJ-Arid3c^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Arid4a^tm1Alb/Arid4a^tm1Alb (involves: 129S7/SvEvBrd)	abnormal mononuclear cell differentiation	J:141004
	decreased B cell number	J:141004
	decreased leukocyte cell number	J:141004
	decreased lymphocyte cell number	J:141004
	decreased monocyte cell number	J:141004
	decreased neutrophil cell number	J:141004
	decreased T cell number	J:141004
	enlarged spleen	J:141004
	increased leukocyte cell number	J:141004
	increased T cell number	J:141004
Arid4a^tm1Alb/Arid4a^tm1Alb Arid4b^tm1Alb/Arid4b⁺ (involves: 129S7/SvEvBrd)	abnormal leukopoiesis	J:141004
	decreased B cell number	J:141004
	decreased lymphocyte cell number	J:141004
	decreased T cell number	J:141004
	enlarged spleen	J:141004
	increased leukocyte cell number	J:141004
	increased monocyte cell number	J:141004
	increased neutrophil cell number	J:141004
	increased T cell number	J:141004
Arid5a^tm1Rnis/Arid5a^tm1Rnis (B6.Cg-Arid5a^tm1Rnis)	decreased T-helper 17 cell number	J:197418
Arid5a^tm1Rnis/Arid5a^tm1Rnis (B6.Cg-Arid5a^tm1Rnis)	increased T cell number	J:197418
Arid5b^tm1Pjh/Arid5b^tm1Pjh (involves: 129S4/SvJae * BALB/c)	abnormal immune system organ morphology	J:70658
	abnormal lymphopoiesis	J:70658
	decreased double-positive T cell number	J:70658
	decreased pro-B cell number	J:70658
	increased single-positive T cell number	J:70658
	spleen hypoplasia	J:70658
	thymus cortex hypoplasia	J:70658
	thymus hypoplasia	J:70658
Arl6ip5^tm1.2Jwzh/Arl6ip5^tm1.2Jwzh (B6.129X1-Arl6ip5^tm1.2Jwzh)	abnormal immune system organ morphology	J:187133
Arl16^{em1(IMPC)Ccpcz}/Arl16^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Arl16^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Armc2^{tm1b(EUCOMM)Hmgu}/Armc2⁺ (C57BL/6N-Armc2^{tm1b(EUCOMM)Hmgu}/H)	increased neutrophil cell number	J:211773
Armcx1^em1(IMPC)Mbp/Y (C57BL/6N-Armcx1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Armh4^em1(IMPC)H/Armh4^em1(IMPC)H (C57BL/6N-Armh4^em1(IMPC)H/H)	enlarged spleen	J:211773
Arp^BALB/c/Arp^BALB/c (involves: B10.D2 * BALB/c)	abnormal lymph node morphology	J:7273
	abnormal Peyer's patch morphology	J:6549
	lymph node hypoplasia	J:6549
	spleen hyperplasia	J:6549
	thymus hyperplasia	J:6549
Arp^BALB/c/Arp^BALB/c Lus^C57BL/10/Lus^C57BL/10 (involves: B10.D2 * BALB/c)	abnormal lymph node morphology	J:7273
Arpc1b^{tm1a(EUCOMM)Wtsi}/Arpc1b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Arpc1b^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased macrophage cell number	J:211773
	decreased marginal zone precursor B cell number	J:211773
	decreased mature NK cell number	J:211773
	decreased NK cell number	J:211773
	decreased transitional stage T2 B cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD103-positive CD11b-low dendritic cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased immature NK cell number	J:211773
	increased KLRG1+ CD4 alpha-beta T cell number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased KLRG1-positive T-helper cell number	J:211773
	increased leukocyte cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker NK cell number	J:211773
	increased plasma cell number	J:211773
Arpc4^{tm1a(EUCOMM)Wtsi}/Arpc4⁺ (B6JTyr;B6N-Arpc4^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:165965
Arrdc4^em1(IMPC)Tcp/Arrdc4^em1(IMPC)Tcp (C57BL/6NCrl-Arrdc4^em1(IMPC)Tcp/Cmmr)	enlarged lymph nodes	J:211773
	increased monocyte cell number	J:211773
Arsa^tm1Gie/Arsa^tm1Gie (involves: 129P2/OlaHsd * C57BL/6J)	abnormal microglial cell morphology	J:37978
Arsg^tm1Tdi/Arsg^tm1Tdi (involves: 129S2/SvPas * C57BL/6)	abnormal macrophage morphology	J:185592
	abnormal microglial cell morphology	J:185592
	abnormal perivascular macrophage morphology	J:185592
	microgliosis	J:185592, J:254592
Art1^{tm1b(EUCOMM)Wtsi}/Art1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Art1^{tm1b(EUCOMM)Wtsi}/Tcp)	enlarged lymph nodes	J:211773
	increased basophil cell number	J:211773
Asah1^tm1.2Geno/Asah1^tm1.2Geno (involves: C57BL/6)	abnormal lymph node morphology	J:285931
	abnormal thymus morphology	J:285931
	decreased B cell number	J:285931
	decreased CD4-positive, alpha-beta T cell number	J:285931
	decreased CD8-positive, alpha-beta T cell number	J:285931
	decreased double-positive T cell number	J:285931
	decreased leukocyte cell number	J:285931
	decreased lymphocyte cell number	J:285931
	decreased splenocyte number	J:285931
	decreased T cell number	J:285931
	enlarged spleen	J:285931
	increased granulocyte number	J:285931
	increased macrophage cell number	J:285931
	increased macrophage derived foam cell number	J:285931
	increased monocyte cell number	J:285931
Asah1^tm1Medin/Asah1^tm1Medin (involves: 129S6/SvEvTac * CD-1)	enlarged lymph nodes	J:232306
	enlarged spleen	J:232306
	enlarged thymus	J:232306
	increased eosinophil cell number	J:232306
	increased leukocyte cell number	J:232306
	increased macrophage derived foam cell number	J:232306
	increased monocyte cell number	J:232306
	increased neutrophil cell number	J:232306
	increased spleen weight	J:232306
	pale spleen	J:232306
Asb1^{em1(IMPC)Ccpcz}/Asb1^{em1(IMPC)Ccpcz} (C57BL/6N-Asb1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased CD4-positive NK T cell number	J:211773
Asb1^tm1Wehi/Asb1^tm1Wehi (involves: C57BL/6)	small spleen	J:71266
Asb1^tm1Wehi/Asb1^tm1Wehi (involves: C57BL/6)	spleen hypoplasia	J:71266
Asb2^{tm2b(KOMP)Wtsi}/Asb2⁺ (C57BL/6N-Asb2^{tm2b(KOMP)Wtsi}/Kmpc)	decreased Ly6C-positive immature NK cell number	J:211773
	increased Ly6C-positive immature NK cell number	J:211773
Asb4^{em1(IMPC)Ccpcz}/Asb4^{em1(IMPC)Ccpcz} (C57BL/6N-Asb4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Asb5^{em1(IMPC)Ccpcz}/Asb5^{em1(IMPC)Ccpcz} (C57BL/6N-Asb5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Asb7^{em1(IMPC)Ccpcz}/Asb7^{em1(IMPC)Ccpcz} (C57BL/6N-Asb7^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
Asb16^{em1(IMPC)Ccpcz}/Asb16^{em1(IMPC)Ccpcz} (C57BL/6N-Asb16^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ascc2^{tm1a(EUCOMM)Wtsi}/Ascc2⁺ (C57BL/6N-Ascc2^{tm1a(EUCOMM)Wtsi}/Bay)	enlarged spleen	J:211773
Ascl4^em1(IMPC)J/Ascl4^em1(IMPC)J (C57BL/6NJ-Ascl4^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ascl5^{em1(IMPC)Ccpcz}/Ascl5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ascl5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ash1l^{tm2b(EUCOMM)Hmgu}/Ash1l⁺ (C57BL/6N-Ash1l^{tm2b(EUCOMM)Hmgu}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Asic2^em1(IMPC)Mbp/Asic2^em1(IMPC)Mbp (C57BL/6N-Asic2^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Asic3^em1(IMPC)Mbp/Asic3^em1(IMPC)Mbp (C57BL/6NCrl-Asic3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Asl^tm1Brle/Asl^tm1Brle (involves: 129S7/SvEvBrd)	decreased lymphocyte cell number	J:180208
	decreased spleen germinal center number	J:180208
	increased macrophage cell number	J:180208
	increased spleen red pulp amount	J:180208
	thymus cortex hypoplasia	J:180208
Asphd1^{em1(IMPC)Ccpcz}/Asphd1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Asphd1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Aspscr1^em1(IMPC)Tcp/Aspscr1^em1(IMPC)Tcp (C57BL/6NCrl-Aspscr1^em1(IMPC)Tcp/Tcp)	decreased neutrophil cell number	J:211773
	enlarged lymph nodes	J:211773
	increased lymphocyte cell number	J:211773
Aste1^{tm1a(KOMP)Wtsi}/Aste1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Aste1^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Asxl1^tm1.1Iaai/Asxl1^tm1.1Iaai Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(Mx1-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * CBA)	abnormal myelopoiesis	J:208092
Asxl1^tm1.1Iaai/Asxl1^tm1.1Iaai Tg(Mx1-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * CBA)	abnormal myelopoiesis	J:208092
	decreased leukocyte cell number	J:208092
	decreased mature B cell number	J:208092
	decreased monocyte cell number	J:208092
	decreased neutrophil cell number	J:208092
Asxl1^tm1.1Iaai/Asxl1^tm1.1Iaai Tg(VAV1-cre)1Graf/0 (involves: 129S/SvEv * C57BL/6)	abnormal myelopoiesis	J:208092
	decreased leukocyte cell number	J:208092
	decreased mature B cell number	J:208092
	decreased monocyte cell number	J:208092
	decreased neutrophil cell number	J:208092
	decreased splenocyte number	J:208092
Asxl1^tm1.1Mjxu/Asxl1⁺ (involves: 129 * C57BL/6)	abnormal leukocyte morphology	J:208085
	abnormal myelopoiesis	J:208085
	abnormal neutrophil morphology	J:208085
	abnormal spleen morphology	J:208085
	decreased B cell number	J:208085
	decreased leukocyte cell number	J:208085
	decreased neutrophil cell number	J:208085
	enlarged spleen	J:208085
	increased leukocyte cell number	J:208085
	increased monocyte cell number	J:208085
Asxl1^tm1.1Mjxu/Asxl1^tm1.1Mjxu (involves: 129 * C57BL/6)	abnormal leukocyte morphology	J:208085
	abnormal neutrophil morphology	J:208085
	abnormal spleen white pulp morphology	J:208085
	decreased B cell number	J:208085
	decreased leukocyte cell number	J:208085
	decreased lymphocyte cell number	J:208085
	decreased spleen red pulp amount	J:208085
	decreased spleen weight	J:208085
	increased monocyte cell number	J:208085
	increased single-positive T cell number	J:208085
	myeloid hyperplasia	J:208085
	small spleen	J:208085
	spleen atrophy	J:208085
Asxl1^{tm1a(EUCOMM)Wtsi}/Asxl1⁺ (B6Dnk;B6Brd;B6N-Asxl1^{tm1a(EUCOMM)Wtsi} Tyr^c-Brd/WtsiH)	decreased leukocyte cell number	J:175295
Asxl1^{tm1a(EUCOMM)Wtsi}/Asxl1⁺ (C57BL/6N-Asxl1^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased B cell number	J:165965
Asxl1^tm1Bc/Asxl1^tm1Bc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal immune system cell morphology	J:155898
	abnormal immune system organ morphology	J:155898
	abnormal lymphopoiesis	J:155898
	abnormal thymus morphology	J:155898
	decreased B cell number	J:155898
	decreased CD4-positive, alpha-beta T cell number	J:155898
	decreased pre-B cell number	J:155898
	decreased T cell number	J:155898
	increased double-negative T cell number	J:155898
	spleen hyperplasia	J:155898
Atad2b^{tm1b(EUCOMM)Hmgu}/Atad2b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Atad2b^{tm1b(EUCOMM)Hmgu}/Ics)	decreased NK T cell number	J:211773
Atad5^{Gt(RRF055)Byg}/Atad5⁺ (involves: 129P2/OlaHsd)	increased T cell derived lymphoma incidence	J:176672
Atcay^ji/Atcay^ji (Not Specified)	abnormal thymus cortex morphology	J:14903
	abnormal thymus medulla morphology	J:14903
	abnormal thymus morphology	J:14903
Atf2^{Tg(Gzma-Klra1)7Wum}/Atf2⁺ (involves: C57BL/6)	decreased NK cell number	J:61178
Atf2^{Tg(Gzma-Klra1)7Wum}/Atf2⁺ (involves: C57BL/6)	decreased NK T cell number	J:61178
Atf2^{tm1b(EUCOMM)Hmgu}/Atf2⁺ (C57BL/6N-Atf2^{tm1b(EUCOMM)Hmgu}/Ccpcz)	abnormal spleen morphology	J:211773
Atf4^tm1(KOMP)Mbp/Atf4⁺ (C57BL/6NCrl-Atf4^tm1(KOMP)Mbp/MbpMmucd)	decreased monocyte cell number	J:211773
Atg3^tm1.1Ywh/Atg3^tm1.1Ywh Fnip1^m1Btlr/Fnip1^m1Btlr Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6J)	absent B cells	J:234285
Atg3^tm1.1Ywh/Atg3^tm1.1Ywh Gt(ROSA)26Sor^{tm1(cre/ERT)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJaeSor * C57BL/6)	abnormal T cell morphology	J:172749
Atg3^tm1.1Ywh/Atg3^tm1.1Ywh Tg(Lck-cre)548Jxm/0 (involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * CBA)	abnormal T cell morphology	J:172749
	decreased CD4-positive, alpha-beta T cell number	J:172749
	decreased CD8-positive, alpha-beta T cell number	J:172749
	spleen hypoplasia	J:172749
	thymus hypoplasia	J:172749
Atg4b^{tm1b(EUCOMM)Hmgu}/Atg4b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Atg4b^{tm1b(EUCOMM)Hmgu}/H)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Atg5^tm1Myok/Atg5^tm1Myok Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S/SvEv)	increased lymphocyte cell number	J:235399
	increased monocyte cell number	J:235399
	increased neutrophil cell number	J:235399
Atg5^tm1Nmz/Atg5^tm1Nmz (involves: 129 * BALB/c * C57BL/6)	abnormal thymus cortex morphology	J:140583
Atg5^tm1Nmz/Atg5^tm1Nmz Tg(CAG-EGFP/Map1lc3b)53Nmz/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal thymus morphology	J:140583
Atg5^tm1Nmz/Atg5^tm1Nmz Tg(Cd4-cre)1Cwi/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell morphology	J:211733
	abnormal T cell subpopulation ratio	J:211733
	decreased CD4-positive, alpha-beta T cell number	J:211733
	decreased CD8-positive, alpha-beta T cell number	J:211733
	decreased T cell number	J:211733
Atg7^tm1Tchi/Atg7^tm1Tchi Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)	abnormal leukocyte morphology	J:176843
	decreased B cell number	J:176843
	decreased leukocyte cell number	J:176843
	decreased NK cell number	J:176843
	decreased T cell number	J:176843
Atg7^tm1Tchi/Atg7^tm1Tchi Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)	increased lymphocyte cell number	J:235399
	increased monocyte cell number	J:235399
	increased neutrophil cell number	J:235399
Atg16l1^{tm1a(EUCOMM)Wtsi}/Atg16l1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Atg16l1^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Atg16l1^{tm1c(EUCOMM)Wtsi}/Atg16l1^{tm1c(EUCOMM)Wtsi} Tg(Vil1-cre)997Gum/? (involves: C57BL/6J * C57BL/6N * SJL)	increased macrophage cell number	J:221019
Atg16l2^m1Anu/Atg16l2^m1Anu (C57BL/6NCrlAnu-Atg16l2^m1Anu)	decreased lymphocyte cell number	J:104190
Atl2^{tm2b(EUCOMM)Hmgu}/Atl2⁺ (C57BL/6N-Atl2^{tm2b(EUCOMM)Hmgu}/H)	decreased neutrophil cell number	J:211773
	decreased spleen weight	J:211773
	increased lymphocyte cell number	J:211773
Atl3^em1(IMPC)Tcp/Atl3^em1(IMPC)Tcp (C57BL/6N-Atl3^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Atm^m1Btlr/Atm^m1Btlr (C57BL/6J-Atm^m1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265252
	decreased CD8-positive, alpha-beta T cell number	J:265252
	decreased single-positive T cell number	J:265252
	decreased T cell number	J:265252
Atm^m2Btlr/Atm^m2Btlr (C57BL/6J-Atm^m2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265253
	decreased CD8-positive, naive alpha-beta T cell number	J:265253
	decreased single-positive T cell number	J:265253
	increased central memory CD8 positive, alpha-beta T cell number	J:265253
	increased effector memory CD4-positive, alpha-beta T cell number	J:265253
Atm^m3Btlr/Atm^m3Btlr (C57BL/6J-Atm^m3Btlr)	increased B-1a cell number	J:272820
Atm^m3Btlr/Atm^m3Btlr (C57BL/6J-Atm^m3Btlr)	increased macrophage cell number	J:272820
Atm^M4Btlr/Atm^M4Btlr (C57BL/6J-Atm^M4Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272821
Atm^m5Btlr/Atm^m5Btlr (C57BL/6J-Atm^m5Btlr)	abnormal lymphocyte morphology	J:272824
Atm^m5Btlr/Atm^m5Btlr (C57BL/6J-Atm^m5Btlr)	increased B-1 B cell number	J:272824
Atm^m6Btlr/Atm^m6Btlr (C57BL/6J-Atm^m6Btlr)	abnormal CD4-positive T cell differentiation	J:274964
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274964
	abnormal T cell differentiation	J:274964
	decreased CD4-positive, alpha-beta T cell number	J:274964
	decreased CD8-positive, naive alpha-beta T cell number	J:274964
	decreased T cell number	J:274964
	increased CD8-positive, alpha-beta memory T cell number	J:274964
	increased central memory CD4-positive, alpha-beta T cell number	J:274964
	increased central memory CD8 positive, alpha-beta T cell number	J:274964
	increased effector memory CD4-positive, alpha-beta T cell number	J:274964
Atm^tm1.1Mmpl/Atm^tm1.1Mmpl (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J)	decreased T cell number	J:226414
	increased B cell number	J:226414
	increased T cell derived lymphoma incidence	J:226414
Atm^tm1Awb/Atm⁺ Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	decreased macrophage cell number	J:103922
Atm^tm1Awb/Atm^tm1Awb (either: 129S6/SvEvTac-Atm^tm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss))	decreased activated T cell number	J:34193
	decreased double-positive T cell number	J:34193
	decreased T cell number	J:34193
	increased double-positive T cell number	J:34193
	increased T cell derived lymphoma incidence	J:34193
Atm^tm1Awb/Atm^tm1Awb (involves: 129S6/SvEvTac * C57BL/6)	increased T cell derived lymphoma incidence	J:103922
Atm^tm1Awb/Atm^tm1Awb (involves: 129S6/SvEvTac)	abnormal class switch recombination	J:150435
	decreased CD4-positive, alpha-beta T cell number	J:90941
	decreased CD8-positive, alpha-beta T cell number	J:90941
	increased T cell derived lymphoma incidence	J:90941
Atm^tm1Awb/Atm^tm1Awb (CByJ.129S6-Atm^tm1Awb)	increased T cell derived lymphoma incidence	J:208539
Atm^tm1Awb/Atm^tm1Awb (129S6/SvEvTac-Atm^tm1Awb)	increased T cell derived lymphoma incidence	J:208539
Atm^tm1Awb/Atm^tm1Awb (either: (129S6/SvEvTac-Atm^tm1Awb x B6.129S6-Atm^tm1Awb)F1 or (B6.129S6-Atm^tm1Awb x 129S6/SvEvTac-Atm^tm1Awb)F1)	increased T cell derived lymphoma incidence	J:208539
Atm^tm1Awb/Atm^tm1Awb (either: (129S6/SvEvTac-Atm^tm1Awb x A.129S6-Atm^tm1Awb)F1 or (A.129S6-Atm^tm1Awb x 129S6/SvEvTac-Atm^tm1Awb)F1)	increased T cell derived lymphoma incidence	J:208539
Atm^tm1Awb/Atm^tm1Awb (129S6/SvEvTac-Atm^tm1Awb/J)	decreased single-positive T cell number	J:226414
	decreased T cell number	J:226414
	increased B cell number	J:226414
	increased double-positive T cell number	J:226414
	increased T cell derived lymphoma incidence	J:226414
Atm^tm1Awb/Atm^tm1Awb Paxx^em1Spj/Paxx^em1Spj (involves: A/J * C57BL/6NTac)	abnormal class switch recombination	J:236776
	decreased B cell number	J:236776
	decreased splenocyte number	J:236776
	decreased T cell number	J:236776
Atm^tm1Awb/Atm^tm1Awb Rad52^tm1Aps/Rad52^tm1Aps (involves: 129P2/OlaHsd * 129S6/SvEvTac)	decreased CD4-positive, alpha-beta T cell number	J:90941
	decreased CD8-positive, alpha-beta T cell number	J:90941
	increased T cell derived lymphoma incidence	J:90941
Atm^tm1Bal/Atm^tm1Bal (involves: 129S4/SvJae)	decreased pre-B cell number	J:35914
	decreased thymocyte number	J:35914
	increased T cell derived lymphoma incidence	J:35914
	small thymus	J:35914
Atm^tm1Fwa/Atm^tm1Fwa (involves: 129S4/SvJae * C57BL/6)	decreased immature B cell number	J:61201
	decreased lymphocyte cell number	J:61201
	decreased pre-B cell number	J:61201
	decreased splenocyte number	J:61201
	decreased T cell number	J:61201
	decreased thymocyte number	J:61201
	increased T cell derived lymphoma incidence	J:61201
Atm^tm1Fwa/Atm^tm1Fwa (involves: 129S4/SvJae)	abnormal class switch recombination	J:191288
Atm^tm1Led/Atm^tm1Led (involves: 129S6/SvEvTac * Black Swiss)	abnormal T cell differentiation	J:36561
	decreased CD4-positive, alpha-beta T cell number	J:36561
	increased double-positive T cell number	J:36561
	increased T cell derived lymphoma incidence	J:69726
	small thymus	J:36561
	thymus cortex hypoplasia	J:36561
Atm^tm1Mfl/Atm^tm1Mfl (involves: 129T2/SvEms * C57BL/6J)	abnormal immune system cell morphology	J:69726
	abnormal immune system organ morphology	J:69726
	abnormal T cell differentiation	J:69726
	decreased thymocyte number	J:69726
	enlarged spleen	J:69726
	increased double-negative T cell number	J:69726
	increased single-positive T cell number	J:69726
	increased T cell derived lymphoma incidence	J:69726
	small lymph nodes	J:69726
	small spleen	J:69726
	small thymus	J:69726
Atm^tm1Shzh/Atm^tm2.1Fwa Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor⁺ (involves: 129 * 129S6/SvEvTac)	abnormal class switch recombination	J:191288
Atm^tm2.1Fwa/Atm^tm2.1Fwa Tg(VAV1-cre)1Graf/0 (involves: 129S6/SvEvTac)	decreased B cell number	J:277750
	decreased T cell number	J:277750
	decreased thymocyte number	J:277750
	increased T cell derived lymphoma incidence	J:277750
Atm^tm2.1Mfgc/Atm^tm2.1Mfgc (C57BL/6-Atm^tm2.1Mfgc)	abnormal T cell differentiation	J:316365
Atm^tm2.1Mfgc/Atm^tm2.1Mfgc (C57BL/6-Atm^tm2.1Mfgc)	decreased T cell number	J:316365
Atmin^tm1.1Jhh/Atmin^tm1.1Jhh (C57BL/6-Atmin^tm1.1Jhh)	thymus hypoplasia	J:167544
Atmin^tm1.1Jhh/Atmin^tm1.1Jhh Cd79a^tm1(cre)Reth/Cd79a⁺ (B6.Cg-Cd79a^tm1(Cre)Reth Atmin^tm1.1Jhh)	decreased B cell number	J:230105
	decreased immature B cell number	J:230105
Atmin^tm1.1Jhh/Atmin^tm1.1Jhh Cd79a^tm1(cre)Reth/Cd79a⁺ Tg(IghMyc)22Bri/0 (B6.Cg-Cd79a^tm1(Cre)Reth Atmin^tm1.1Jhh Tg(IghMyc)22Bri)	decreased B cell number	J:230105
	decreased immature B cell number	J:230105
Atmin^tm1.2Jhh/Atmin^tm1.2Jhh Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S1/Sv * BALB/c * C57BL/6)	enlarged spleen	J:191832
	increased B cell number	J:191832
	increased immature B cell number	J:191832
	increased pre-B cell number	J:191832
	increased spleen weight	J:191832
Atmin^tm1.2Jhh/Atmin^tm1.2Jhh Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	abnormal B cell differentiation	J:191832
	decreased immature B cell number	J:191832
	decreased mature B cell number	J:191832
	decreased pre-B cell number	J:191832
	decreased spleen weight	J:191832
	small spleen	J:191832
Atmin^tm1.2Jhh/Atmin^tm1.2Jhh Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	decreased B cell number	J:191832
	decreased lymphocyte cell number	J:191832
	decreased mature B cell number	J:191832
	decreased pre-B cell number	J:191832
Atmin^tm1.2Jhh/Atmin^tm1.2Jhh Trp53^tm1Brn/Trp53^tm1Brn Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	decreased B cell number	J:191832
	decreased immature B cell number	J:191832
Atn1^{tm1b(EUCOMM)Wtsi}/Atn1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Atn1^{tm1b(EUCOMM)Wtsi}/Cnrm)	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Atp1a1^{em1(IMPC)Ccpcz}/Atp1a1⁺ (C57BL/6NCrl-Atp1a1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Atp1a3^Myk/Atp1a3⁺ (involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr * FVB/NCr)	microgliosis	J:151948
Atp2a2^tm1Ges/Atp2a2⁺ (involves: 129X1/SvJ)	abnormal osteoclast differentiation	J:198051
Atp2b4^tm1Ges/Atp2b4^tm1Ges (involves: 129X1/SvJ * Black Swiss)	enlarged submandibular lymph nodes	J:91844
Atp2c2^em1(IMPC)Tcp/Atp2c2^em1(IMPC)Tcp (C57BL/6NCrl-Atp2c2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Atp4a^m1Btlr/Atp4a^m1Btlr (involves: C57BL/6J)	abnormal spleen morphology	J:179090
Atp4a^m1Btlr/Atp4a^m1Btlr (involves: C57BL/6J)	enlarged spleen	J:179090
Atp5if1^em1Jpy/Atp5if1^em1Jpy (C57BL/6J-Atp5if1^em1Jpy)	decreased neutrophil cell number	J:312819
Atp5mg^{tm1b(EUCOMM)Hmgu}/Atp5mg⁺ (C57BL/6N-Atp5mg^{tm1b(EUCOMM)Hmgu}/H)	decreased eosinophil cell number	J:211773
	enlarged spleen	J:211773
Atp5mk^{tm1b(EUCOMM)Wtsi}/Atp5mk^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Atp5mk^{tm1b(EUCOMM)Wtsi}/H)	increased leukocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Atp6v0a2^tm1Kdb/Atp6v0a2^tm1Kdb Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:274048
	decreased alpha-beta T cell number	J:274048
	decreased CD4-positive, alpha-beta T cell number	J:274048
	decreased T cell number	J:274048
Atp6v0d1^{tm1b(EUCOMM)Hmgu}/Atp6v0d1⁺ (C57BL/6N-Atp6v0d1^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Atp6v0d2^tm1Ywc/Atp6v0d2^tm1Ywc (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:117744
	abnormal osteoclast morphology	J:117744
Atp6v1b2^{tm1b(KOMP)Wtsi}/Atp6v1b2⁺ (C57BL/6N-Atp6v1b2^{tm1b(KOMP)Wtsi}/Tcp)	small lymph nodes	J:211773
Atp6v1c1^{tm1b(NCOM)Mfgc}/Atp6v1c1⁺ (C57BL/6N-Atp6v1c1^{tm1b(NCOM)Mfgc}/Tcp)	increased leukocyte cell number	J:211773
Atp6v1h^em1Xhd/Atp6v1h⁺ (involves: C57BL/6)	abnormal osteoclast differentiation	J:239439
Atp7a^Mo-ml/Y (involves: C3Hf/He)	decreased spleen weight	J:12745
Atp7b^tx-J/Atp7b^tx-J (C3H/HeJ-Atp7b^tx-J/J)	increased eosinophil cell number	J:24233
Atp8b1^em1(IMPC)Tcp/Atp8b1^em1(IMPC)Tcp (C57BL/6NCrl-Atp8b1^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
	increased leukocyte cell number	J:211773
Atp11a^{tm1a(KOMP)Wtsi}/Atp11a^{tm1a(KOMP)Wtsi} (C57BL/6N-Atp11a^{tm1a(KOMP)Wtsi}/Wtsi)	abnormal thymus morphology	J:239583
Atp11c^ambr/Y (C57BL/6-Atp11c^ambr)	abnormal B cell differentiation	J:171924
	decreased B cell number	J:171924
	decreased B-1 B cell number	J:171924
	decreased B-1a cell number	J:171924
	decreased B-1b cell number	J:171924
	decreased B-2 B cell number	J:171924
	decreased follicular B cell number	J:171924
	decreased immature B cell number	J:171924
	decreased leukocyte cell number	J:171924
	decreased lymphocyte cell number	J:171924
	decreased mature B cell number	J:171924
	decreased pre-B cell number	J:171924
	decreased pro-B cell number	J:171924
	decreased T cell number	J:171924
Atp11c^ambr/Y Tg(H2-Ea-Il7)10Rhdr/0 (involves: C57BL/6 * C57BL/6JApb * DBA/2)	decreased B cell number	J:171924
Atp11c^ambr/Y Tg(IghelMD4)4Ccg/0 (involves: C57BL/6 * C57BL/6JApb)	decreased immature B cell number	J:171924
	decreased pro-B cell number	J:171924
Atp11c^ambr/Y Tg(Vav-BCL2)69Jad/0 (involves: C57BL/6 * C57BL/6J * C57BL/6JApb)	decreased B cell number	J:171924
	decreased immature B cell number	J:171924
	decreased pre-B cell number	J:171924
Atp11c^em1(IMPC)J/Y (C57BL/6NJ-Atp11c^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Atp11c^em1(IMPC)J/Atp11c^em1(IMPC)J (C57BL/6NJ-Atp11c^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Atp11c^m1Btlr/Y (involves: C57BL/6J)	absent follicular B cells	J:171925
	arrested B cell differentiation	J:171925
	decreased B cell number	J:185495, J:171925
	decreased B-1 B cell number	J:171925
	decreased B-2 B cell number	J:171925
	decreased immature B cell number	J:171925
	decreased transitional stage B cell number	J:171925
	decreased transitional stage T1 B cell number	J:171925
	decreased transitional stage T2 B cell number	J:171925
	decreased transitional stage T3 B cell number	J:171925
Atp11c^m1Btlr/Y Tg(BCL2)22Wehi/0 (involves: C57BL/6J * C57BL/6JWehi * SJL/Wehi)	decreased B cell number	J:171925
	decreased follicular B cell number	J:171925
	decreased mature B cell number	J:171925
	increased marginal zone B cell number	J:171925
Atp11c^m1Btlr/Y Tg(IghmHyHEL10,IgkHyHEL10)4Ccg/0 (involves: C57BL/6 * C57BL/6J * C57BL/6JSfdAnu)	decreased B cell number	J:171925
Atp11c^m1Btlr/Atp11c^m1Btlr (involves: C57BL/6J)	decreased B cell number	J:185495
Atp11c^m1Btlr/Atp11c^m2Btlr (involves: C57BL/6J)	decreased B cell number	J:171925
Atp11c^m2Anu/Y (C57BL/6JAnu-Atp11c^m2Anu/AnuApb)	decreased B cell number	J:171924
Atp11c^m2Btlr/Y (involves: C57BL/6J)	decreased B cell number	J:185495, J:171925
Atp11c^m2Btlr/Atp11c^m2Btlr (involves: C57BL/6J)	decreased B cell number	J:185495
Atp13a3^em1(IMPC)J/Atp13a3^em1(IMPC)J (C57BL/6NJ-Atp13a3^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Atp13a5^tm1Lex/Atp13a5^tm1Lex (B6;129S5-Atp13a5^tm1Lex/Mmucd)	decreased NK cell number	J:171883
Atr^tm1Bal/Atr^tm2Bal Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	decreased thymocyte number	J:123200
Atr^tm1Ofc/Atr^tm1Ofc (Not Specified)	decreased spleen weight	J:151542
Atr^tm1Ofc/Atr^tm1Ofc (Not Specified)	decreased thymus weight	J:151542
Auh^em1(IMPC)Tcp/Auh^em1(IMPC)Tcp (C57BL/6NCrl-Auh^em1(IMPC)Tcp/Tcp)	increased eosinophil cell number	J:211773
Aurka^{tm1b(EUCOMM)Hmgu}/Aurka⁺ (B6N(Cg)-Aurka^{tm1b(EUCOMM)Hmgu}/J)	decreased leukocyte cell number	J:211773
Avp^{tm1b(EUCOMM)Wtsi}/Avp⁺ (C57BL/6N-Avp^{tm1b(EUCOMM)Wtsi}/H)	decreased large unstained cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Avpr1a^tm1Sbhu/Avpr1a^tm1Sbhu (involves: C57BL/6)	abnormal B cell differentiation	J:105892
Avpr1a^tm1Sbhu/Avpr1a^tm1Sbhu (involves: C57BL/6)	increased B-1a cell number	J:105892
Awat2^em1(IMPC)Mbp/Y (C57BL/6NCrl-Awat2^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
Awat2^tm1.2Golc/Y (involves: 129 * C57BL/6 * C57BL/6J)	abnormal lymphangiogenesis	J:308387
Awat2^tm1.2Golc/Awat2^tm1.2Golc (involves: 129 * C57BL/6 * C57BL/6J)	abnormal lymphangiogenesis	J:308387
awg^{Tg(GBts1env)832Pkw}/awg^{Tg(GBts1env)832Pkw} (involves: C57BL/6J * SJL)	thymus atrophy	J:43273
Axl^tm1Grl/Axl^tm1Grl Mertk^tm1Grl/Mertk^tm1Grl Tyro3^tm1Grl/Tyro3^tm1Grl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	enlarged lymph nodes	J:70420
	enlarged spleen	J:54681, J:70420
	increased lymphocyte cell number	J:70420
Azgp1^tm1.1Sbah/Azgp1^tm1.1Sbah (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:118213
Azi2^tm1Aki/Azi2^tm1Aki (Not Specified)	abnormal dendritic cell differentiation	J:204786
b2b227Clo/b2b227Clo (C57BL/6J-b2b227Clo)	spleen hypoplasia	J:175213
b2b386.1Clo/b2b386.1Clo (C57BL/6J-b2b386.1Clo)	absent spleen	J:175213
b2b386Clo/b2b386Clo (C57BL/6J-b2b386Clo)	absent spleen	J:175213
b2b954Clo/b2b954Clo (C57BL/6J-b2b954Clo)	thymus hypoplasia	J:175213
b2b1249Clo/b2b1249Clo (C57BL/6J-b2b1249Clo)	thymus hypoplasia	J:175213
b2b1702Clo/b2b1702Clo (C57BL/6J-b2b1702Clo)	spleen hypoplasia	J:175213
b2b1702Clo/b2b1702Clo (C57BL/6J-b2b1702Clo)	thymus hypoplasia	J:175213
b2b1941Clo/b2b1941Clo (C57BL/6J-b2b1941Clo)	athymia	J:175213
b2b2025Clo/b2b2025Clo (C57BL/6J-b2b2025Clo)	absent spleen	J:175213
b2b2025Clo/b2b2025Clo (C57BL/6J-b2b2025Clo)	spleen hypoplasia	J:175213
b2b2059Clo/b2b2059Clo (C57BL/6J-b2b2059Clo)	spleen hypoplasia	J:175213
b2b2140Clo/b2b2140Clo (C57BL/6J-b2b2140Clo)	spleen hypoplasia	J:175213
b2b2187Clo/b2b2187Clo (C57BL/6J-b2b2187Clo)	thymus hypoplasia	J:175213
b2b2463Clo/b2b2463Clo (C57BL/6J-b2b2463Clo)	thymus hypoplasia	J:175213
b2b2588Clo/b2b2588Clo (C57BL/6J-b2b2588Clo)	thymus hypoplasia	J:175213
b2b2696.1Clo/b2b2696.1Clo (C57BL/6J-b2b2696.1Clo)	absent spleen	J:175213
b2b2696.2Clo/b2b2696.2Clo (C57BL/6J-b2b2696.2Clo)	thymus hypoplasia	J:175213
b2b2696Clo/b2b2696Clo (C57BL/6J-b2b2696Clo)	absent spleen	J:175213
b2b2736.2Clo/b2b2736.2Clo (C57BL/6J-b2b2736.2Clo)	thymus hypoplasia	J:175213
b2b2736Clo/b2b2736Clo (C57BL/6J-b2b2736Clo)	accessory spleen	J:175213
	spleen hypoplasia	J:175213
	thymus hypoplasia	J:175213
b2b2821Clo/b2b2821Clo (C57BL/6J-b2b2821Clo)	thymus hypoplasia	J:175213
b2b2966Clo/b2b2966Clo (C57BL/6J-b2b2966Clo)	thymus hypoplasia	J:175213
b2b3077.2Clo/b2b3077.2Clo (C57BL/6J-b2b3077.2Clo)	thymus hypoplasia	J:175213
b2b3077Clo/b2b3077Clo (C57BL/6J-b2b3077Clo)	thymus hypoplasia	J:175213
b2b3121Clo/b2b3121Clo (C57BL/6J-b2b3121Clo)	thymus hypoplasia	J:175213
b2b3260.2Clo/b2b3260.2Clo (C57BL/6J-b2b3260.2Clo)	abnormal thymus morphology	J:175213
b2b3260.2Clo/b2b3260.2Clo (C57BL/6J-b2b3260.2Clo)	thymus hypoplasia	J:175213
b2b3260Clo/b2b3260Clo (C57BL/6J-b2b3260Clo)	abnormal thymus morphology	J:175213
b2b3260Clo/b2b3260Clo (C57BL/6J-b2b3260Clo)	thymus hypoplasia	J:175213
B2m^tm1Jae/B2m^tm1Jae (involves: 129S2/SvPas * C57BL/6J)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:80910
	decreased CD8-positive, alpha-beta T cell number	J:80910, J:744
	increased gamma-delta intraepithelial T cell number	J:744
	increased gamma-delta T cell number	J:744
B2m^tm1Jae/B2m^tm1Jae (involves: 129S2/SvPas)	decreased CD8-positive, alpha-beta T cell number	J:166104
B2m^tm1Jae/B2m^tm1Jae Cd4^tm1Jrp/Cd4^tm1Jrp (involves: 129S2/SvPas * C57BL/6)	increased CD8-positive, alpha-beta T cell number	J:45168
B2m^tm1Jae/B2m^tm1Jae Foxp3^sf Otc^spf/Y (involves: 129/Rl * 129S2/SvPas)	abnormal immune system organ morphology	J:20865
	abnormal lymph node morphology	J:20865
	enlarged lymph nodes	J:20865
	enlarged spleen	J:20865
	increased CD4-positive, alpha-beta T cell number	J:20865
	increased plasma cell number	J:20865
B2m^tm1Jae/B2m^tm1Jae Rr94^tm3.2Litt/Rr94^tm3.2Litt (involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)	abnormal T cell differentiation	J:158962
	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
B2m^tm1Jae/B2m^tm1Jae Rr96^tm1.1Yzo/Rr96^tm1.1Yzo (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal T cell differentiation	J:130559
B2m^tm1Jae/B2m^tm1Jae Tg(H2-K-Cd86)27All/0 (involves: 129S2/SvPas * C57BL/6 * CBA)	absent B cells	J:112475
B2m^tm1Jae/B2m^tm1Jae Tg(LckNotch1)9Erob/? (involves: 129S2/SvPas * C57BL/6 * CBA)	increased CD8-positive, alpha-beta T cell number	J:93005
	lymph node hypoplasia	J:93005
B2m^tm1Jae/B2m^tm1Jae Themis^tm1Lov/Themis^tm1Lov (involves: 129)	abnormal CD8-positive, alpha-beta T cell differentiation	J:151075
B2m^tm1Jae/B2m^tm1Jae Tox^tm1.1Kay/Tox^tm1.1Kay (involves: 129S6/SvEvTac * 129S2/SvPas)	abnormal CD8-positive, alpha-beta T cell number	J:131287
B2m^tm1Jae/B2m^tm1Jae Zbtb7b^tm1Litt/Zbtb7b^tm1.2Litt (involves: 129S2/SvPas * C57BL/6)	abnormal CD8-positive, alpha-beta T cell differentiation	J:141144
	abnormal double-positive T cell morphology	J:141144
B2m^tm1Unc/B2m⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:64451
B2m^tm1Unc/B2m^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell number	J:113083
B2m^tm1Unc/B2m^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	absent CD8-positive, alpha-beta T cells	J:64451
B2m^tm1Unc/B2m^tm1Unc (NOD.129P2-B2m^tm1Unc)	absent CD8-positive, alpha-beta T cells	J:121685
B2m^tm1Unc/B2m^tm1Unc (B6.129P2-B2m^tm1Unc/DcrJ)	decreased CD8-positive, alpha-beta T cell number	J:123934
B2m^tm1Unc/B2m^tm1Unc (B6.129P2-B2m^tm1Unc/DcrJ)	increased T-helper 1 cell number	J:123934
B2m^tm1Unc/B2m^tm1Unc Ciita^tm1Ccum/Ciita^tm1Ccum (NOD.Cg-B2m^tm1Unc Ciita^tm1Ccum)	decreased single-positive T cell number	J:107051
B2m^tm1Unc/B2m^tm1Unc H2-Ab1^b-tm1Doi/H2-Ab1^b-tm1Doi Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129P2/OlaHsd * 129S2/SvPas)	absent CD4-positive, alpha-beta T cells	J:77098
	absent CD8-positive, alpha-beta T cells	J:77098
B2m^tm1Unc/B2m^tm1Unc H2-D1^b-tm1Bpe/H2-D1^b-tm1Bpe (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:41077
B2m^tm1Unc/B2m^tm1Unc Il2^tm1Hor/Il2^tm1Hor (involves: 129 * C57BL/6)	abnormal CD4-positive T cell differentiation	J:39981
	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:39981
	abnormal CD8-positive, alpha beta T cell morphology	J:51450
	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:39981
B2m^tm1Unc/B2m^tm1Unc Il2rg^tm1.1Asin/Il2rg^tm1Wjl Tg(Cd8a-cre)B8Asin/0 (involves: 129P2/OlaHsd 129S4/SvJae * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:190889
B2m^tm1Unc/B2m^tm1Unc Il7r^tm1.1Asin/Il7r^tm1Imx Tg(Cd8a-cre)B8Asin/0 (involves: 129P2/OlaHsd 129S7/SvEvBrd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:190889
B2m^tm1Unc/B2m^tm1Unc Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal immune system morphology	J:77098
B2m^tm1Unc/B2m^tm1Unc Prkdc^scid/Prkdc^scid (NOD.Cg-B2m^tm1Unc Prkdc^scid)	absent lymphocyte	J:102141
	arrested B cell differentiation	J:102141
	arrested T cell differentiation	J:102141
	increased macrophage cell number	J:102141
	increased T cell derived lymphoma incidence	J:102141
B2m^tm1Unc/B2m^tm1Unc Rr381^em2Kap/Rr381^em2Kap (involves: 129P2/OlaHsd * C57BL/6)	absent CD8-positive, alpha-beta T cells	J:333471
B2m^tm1Unc/B2m^tm1Unc Tespa1^tm1Smoc/Tespa1^tm1Smoc (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:186446
B2m^tm1Unc/B2m^tm1Unc Tg(GFAP-B2m)9Mdos/? (involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ)	absent CD8-positive, alpha-beta T cells	J:135214
B2m^tm1Unc/B2m^tm1Unc Tg(GFAP-B2m)#Mdos/? (involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ)	absent CD8-positive, alpha-beta T cells	J:135214
B2m^tm1Unc/B2m^tm1Unc Tg(HLA-A/H2-D/B2M)1Dvs/0 (NOD.Cg-B2m^tm1Unc Tg(HLA-A/H2-D/B2M)1Dvs)	decreased CD8-positive, alpha-beta T cell number	J:121685
B2m^tm1Unc/B2m^tm1Unc Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 (NOD.Cg-B2m^tm1Unc Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)	abnormal CD8-positive, alpha beta T cell morphology	J:93553
B2m^tm1Unc/B2m^tm1Unc Zbtb7b^tm4.1Itan/Zbtb7b^tm4.1Itan (involves: 129P2/OlaHsd)	increased CD8-positive, alpha-beta T cell number	J:193321
B3galt2^{tm1.1(KOMP)Vlcg}/B3galt2⁺ (C57BL/6N-B3galt2^{tm1.1(KOMP)Vlcg}/Tcp)	decreased lymphocyte cell number	J:211773
B3gnt5^tm1Big/B3gnt5^tm1Big (C57BL/6-B3gnt5^tm1Big)	abnormal spleen germinal center morphology	J:166763
	abnormal spleen morphology	J:166763
	absent spleen marginal zone	J:166763
	decreased B cell number	J:166763
	enlarged lymph nodes	J:166763
	enlarged spleen	J:166763
	increased spleen white pulp amount	J:166763
	intermingled spleen red and white pulp	J:166763
B3gnt5^tm1Nari/B3gnt5^tm1Nari (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:161366
B3gnt5^tm2.1Big/B3gnt5^tm2.1Big (involves: 129/Sv * C57BL/6 * FVB/N)	abnormal spleen germinal center morphology	J:166763
	abnormal spleen morphology	J:166763
	absent spleen marginal zone	J:166763
	decreased B cell number	J:166763
	enlarged lymph nodes	J:166763
	enlarged spleen	J:166763
	increased spleen white pulp amount	J:166763
	intermingled spleen red and white pulp	J:166763
B3gnt6^tm1Lx/B3gnt6^tm1Lx (involves: 129S1/Sv * C57BL/6J)	increased macrophage cell number	J:123826
	increased monocyte cell number	J:123826
	increased T cell number	J:123826
B3gnt7^{tm1e.1(KOMP)Wtsi}/B3gnt7^{tm1e.1(KOMP)Wtsi} (C57BL/6N-B3gnt7^{tm1e.1(KOMP)Wtsi}/Ucd)	enlarged spleen	J:211773
B4galnt1^tm1Rlp/B4galnt1^tm1Rlp Hexb^tm1Rlp/Hexb^tm1Rlp (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:53080
B4galnt2^tm1Jbl/B4galnt2^tm1Jbl (involves: 129S1/Sv)	abnormal B cell number	J:217719
B4galnt2^tm1Jbl/B4galnt2^tm1Jbl (involves: 129S1/Sv)	increased neutrophil cell number	J:217719
B4galnt3^{tm1a(EUCOMM)Wtsi}/B4galnt3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-B4galnt3^{tm1a(EUCOMM)Wtsi}/Ics)	increased CD8-positive, alpha-beta T cell number	J:165965
B4galt1^tm1Yiw/B4galt1^tm1Yiw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	enlarged spleen	J:106669
	increased leukocyte cell number	J:106669
	increased lymphocyte cell number	J:106669
	increased neutrophil cell number	J:106669
B4galt3^em1Masn/B4galt3^em1Masn (C57BL/6-B4galt3^em1Masn)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:343168
	decreased regulatory T cell number	J:343168
	increased CD8-positive, alpha-beta T cell number	J:343168
B4galt4^em1(IMPC)J/B4galt4^em1(IMPC)J (C57BL/6NJ-B4galt4^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
B4galt5^em1(IMPC)Tcp/B4galt5⁺ (C57BL/6NCrl-B4galt5^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
B4gat1^tm1Mifu/B4gat1^tm1Mifu (B6.Cg-B4gat1^tm1Mifu)	abnormal lymph node cell ratio	J:120722
B4gat1^tm1Mifu/B4gat1^tm1Mifu Gcnt1^tm1Jxm/Gcnt1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymph node cell ratio	J:120722
B9d2/Tgfb1^tm1Flv/B9d2/Tgfb1^tm1Flv Tg(CD207-cre)1Dhka/? (involves: 129S6/SvEvTac * C57BL/6J * SJL/J)	decreased Langerhans cell number	J:126147
B9d2/Tgfb1^tm1Flv/Tgfb1^tm2Flv Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)	increased regulatory T cell number	J:169839
B9d2/Tgfb1^tm1Flv/Tgfb1^tm2Flv Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:123547
	abnormal T-helper 17 cell differentiation	J:169839
B9d2/Tgfb1^tm1Flv/Tgfb1^tm2Flv Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129S6/SvEvTac * 129X1/SvJ)	abnormal T cell differentiation	J:169839
	decreased T-helper 17 cell number	J:169839
	increased regulatory T cell number	J:169839
	increased T-helper 1 cell number	J:169839
B9d2/Tgfb1^tm1Flv/B9d2/Tgfb1^tm1Flv Tg(CD207-cre)1Dhka/? (involves: 129S6/SvEvTac * C57BL/6J * SJL/J)	decreased Langerhans cell number	J:126147
B9d2/Tgfb1^tm1Flv/B9d2⁺ Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)	increased regulatory T cell number	J:169839
B9d2/Tgfb1^tm1Flv/B9d2⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T-helper 17 cell differentiation	J:169839
B9d2/Tgfb1^tm1Flv/B9d2⁺ Tg(CD207-cre)1Dhka/? (involves: 129S6/SvEvTac * C57BL/6J * SJL/J)	decreased Langerhans cell number	J:126147
B9d2/Tgfb1^tm1Flv/B9d2⁺ Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129S6/SvEvTac * 129X1/SvJ)	abnormal T cell differentiation	J:169839
	decreased T-helper 17 cell number	J:169839
	increased regulatory T cell number	J:169839
	increased T-helper 1 cell number	J:169839
B9d2^{tm1a(EUCOMM)Wtsi}/B9d2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-B9d2^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
	accessory spleen	J:239583
	enlarged lymphatic vessel	J:239583
	small spleen	J:239583
Baat^em1(IMPC)Mbp/Baat^em1(IMPC)Mbp (C57BL/6NCrl-Baat^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
Babam1^{em1(IMPC)Ccpcz}/Babam1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Babam1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased NK T cell number	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
Bach2^M1Btlr/Bach2^M1Btlr (C57BL/6J-Bach2^M1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:272023
Bach2^M1Btlr/Bach2^M1Btlr (C57BL/6J-Bach2^M1Btlr)	increased B-1 B cell number	J:272023
Bach2^m1Ccg/Bach2^m1Ccg (C57BL/6-Bach2^m1Ccg)	decreased B cell number	J:94077
	decreased marginal zone B cell number	J:94077
	myeloid hyperplasia	J:94077
Bach2^m2Anu/Bach2^m2Anu (C57BL/6NCrlAnu-Bach2^m2Anu)	decreased mature B cell number	J:104190
Bach2^m2Anu/Bach2^m2Anu (C57BL/6NCrlAnu-Bach2^m2Anu)	increased immature B cell number	J:104190
Bach2^{tm1a(EUCOMM)Wtsi}/Bach2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Bach2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased B cell number	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased CD11b-high dendritic cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased follicular B cell number	J:211773
	decreased mature B cell number	J:211773
	decreased memory-marker NK cell number	J:211773
	decreased regulatory T cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD8-positive, alpha-beta memory T cell number	J:211773
	increased CD11b-low dendritic cell number	J:211773
	increased CD103-positive CD11b-low dendritic cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased eosinophil cell number	J:211773
	increased immature B cell number	J:211773
	increased KLRG1+ CD4 alpha-beta T cell number	J:211773
	increased KLRG1+ CD8 alpha-beta T cell number	J:211773
	increased KLRG1-positive CD4-negative NK T cell number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased KLRG1-positive gamma-delta T cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased Ly6C high monocyte number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased macrophage cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker NK cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased NK cell number	J:211773
Bach2^{tm1b(EUCOMM)Wtsi}/Bach2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Bach2^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased B cell number	J:211773
	decreased B-1a cell number	J:211773
	decreased B-2 B cell number	J:211773
	decreased CD4-negative NK T cell number	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased CD11b-high dendritic cell number	J:211773
	decreased follicular B cell number	J:211773
	decreased Ly6C-positive immature NK cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased marginal zone B cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased NK T cell number	J:211773
	decreased transitional stage B cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased eosinophil cell number	J:211773
	increased granulocyte number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased monocyte cell number	J:211773
	increased NK T cell number	J:211773
Bach2^tm1Igar/Bach2^tm1Igar (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell differentiation	J:91110
	abnormal class switch recombination	J:91110
	abnormal somatic hypermutation frequency	J:91110
	absent germinal center B cells	J:91110
	decreased B cell number	J:91110
	decreased mature B cell number	J:91110
	spleen hypoplasia	J:91110
Bad^tm1Meg/Bad^tm1Meg (involves: 129S4/SvJae)	abnormal B cell differentiation	J:88139
	abnormal T cell differentiation	J:88139
	decreased mature B cell number	J:88139
	decreased pro-B cell number	J:88139
	decreased thymus weight	J:88139
	small thymus	J:88139
	thymus hypoplasia	J:88139
Bad^tm1Sjk/Bad^tm1Sjk (either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6))	abnormal immune system cell morphology	J:84987
Bag3^tm1.1Jhl/Bag3^tm1.1Jhl (B6.129S2-Bag3^tm1.1Jhl)	decreased leukocyte cell number	J:144416
	decreased lymphocyte cell number	J:144416
	decreased neutrophil cell number	J:144416
	decreased spleen weight	J:144416
	decreased thymus weight	J:144416
	spleen hypoplasia	J:144416
	thymus hypoplasia	J:144416
Bag4^tm1Yeh/Bag4^tm1Yeh (involves: 129P2/OlaHsd * C57BL/6)	spleen hypoplasia	J:83559
Bag4^tm1Yeh/Bag4^tm1Yeh (involves: 129P2/OlaHsd * C57BL/6)	thymus hypoplasia	J:83559
Bahd1^{tm2b(KOMP)Wtsi}/Bahd1⁺ (C57BL/6N-Bahd1^{tm2b(KOMP)Wtsi}/Ics)	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased CD4-negative NK T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased neutrophil cell number	J:211773
	increased NK cell number	J:211773
	increased NK T cell number	J:211773
	increased T cell number	J:211773
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm1Sjk/Bax^tm1Sjk (involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6)	abnormal B cell morphology	J:66872
	abnormal T cell morphology	J:66872
	enlarged lymph nodes	J:66872
	enlarged spleen	J:66872
	increased leukocyte cell number	J:66872
	increased lymphocyte cell number	J:66872
	increased spleen red pulp amount	J:66872
	increased spleen white pulp amount	J:66872
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm1Sjk/Bax^tm2Sjk Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal B cell number	J:100463
	decreased marginal zone B cell number	J:100463
	increased B cell number	J:100463
	increased B-2 B cell number	J:100463
	increased follicular B cell number	J:100463
	increased pre-B cell number	J:100463
	increased pro-B cell number	J:100463
	increased transitional stage B cell number	J:100463
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm1Sjk/Bax^tm2Sjk Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal T cell differentiation	J:100463
	increased B cell number	J:100463
	increased leukocyte cell number	J:100463
	increased lymphocyte cell number	J:100463
Bak1^tm1Thsn/Bak1^tm1Thsn Bax^tm2Sjk/Bax^tm2Sjk Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	increased regulatory T cell number	J:208318
Bank1^tm1Kuro/Bank1^tm1Kuro (Not Specified)	abnormal spleen germinal center morphology	J:113321
	abnormal splenic cell ratio	J:113321
	increased B-1a cell number	J:113321
	increased mature B cell number	J:113321
	increased spleen germinal center number	J:113321
	increased spleen germinal center size	J:113321
Bap1^tm1.1Geno/Bap1^tm1.1Geno Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal granulocyte morphology	J:187380
	abnormal myelopoiesis	J:187380
	abnormal neutrophil morphology	J:187380
	enlarged spleen	J:187380
	increased leukocyte cell number	J:187380
	increased monocyte cell number	J:187380
	increased neutrophil cell number	J:187380
	myeloid hyperplasia	J:187380
Batf3^tm1Kmm/Batf3^tm1Kmm (involves: 129S6/SvEvTac * BALB/cJ)	abnormal dendritic cell differentiation	J:141064
	decreased memory T cell number	J:141064
	decreased myeloid dendritic cell number	J:141064
Batf^tm1.1Ejt/Batf^tm1.1Ejt (involves: 129S/Sv * C57BL/6 * FVB/N)	abnormal class switch recombination	J:160935
	abnormal T-helper 2 cell differentiation	J:160935
	absent germinal center B cells	J:160935
	decreased CD4-positive, alpha-beta T cell number	J:160935
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:160935
	decreased T follicular helper cell number	J:160935
	decreased T-helper 17 cell number	J:160935
Batf^tm1.1Kmm/Batf^tm1.1Kmm (129S6/SvEvTac-Batf^tm1.1Kmm)	abnormal CD4-positive T cell differentiation	J:150643
Bax^tm1Sjk/Bax^tm1Sjk (involves: 129X1/SvJ)	enlarged spleen	J:29253
	increased B cell number	J:29253
	increased thymocyte number	J:29253
Baz2a^em1(IMPC)Tcp/Baz2a^em1(IMPC)Tcp (C57BL/6NCrl-Baz2a^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Baz2b^{em1(IMPC)Wtsi}/Baz2b^{em1(IMPC)Wtsi} (C57BL/6N-Baz2b^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Bbc3^tm1Ast/Bbc3^tm1Ast (involves: C57BL/6 * NZB)	abnormal splenic cell ratio	J:132819
	increased CD8-positive, alpha-beta T cell number	J:132819
	increased leukocyte cell number	J:132819
Bbc3^tm1Gpz/Bbc3^tm1Gpz Trp53^tm1Brd/Trp53^tm8Xu (involves: 129P2/OlaHsd * 129S7/SvEvBrd)	decreased thymocyte number	J:170216
Bbln^{tm1(KOMP)Wtsi}/Bbln⁺ (involves: C57BL/6N)	abnormal osteoclast differentiation	J:296689
Bbln^{tm1(KOMP)Wtsi}/Bbln^{tm1(KOMP)Wtsi} (involves: C57BL/6N)	abnormal osteoclast differentiation	J:296689
	increased osteoclast cell number	J:296689
Bbs5^{tm1b(EUCOMM)Wtsi}/Bbs5^{tm1b(EUCOMM)Wtsi} (C57BL/6NTac-Bbs5^{tm1b(EUCOMM)Wtsi}/H)	decreased spleen weight	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Bbs12^{em1(IMPC)Ccpcz}/Bbs12⁺ (C57BL/6NCrl-Bbs12^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Bcap31^tm1.1Bwang/Bcap31^tm1.1Bwang Tg(Lck-cre)548Jxm/0 (involves: C57BL/6 * CBA)	decreased CD8-positive, naive alpha-beta T cell number	J:274469
	decreased single-positive T cell number	J:274469
	decreased thymocyte number	J:274469
	decreased thymus weight	J:274469
	increased effector memory T-helper cell number	J:274469
	small thymus	J:274469
	thymus hypoplasia	J:274469
Bcar3^em1(IMPC)Mbp/Bcar3^em1(IMPC)Mbp (C57BL/6N-Bcar3^em1(IMPC)Mbp/MbpMmucd)	increased basophil cell number	J:211773
Bckdha^em1(IMPC)Tcp/Bckdha⁺ (C57BL/6NCrl-Bckdha^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Bcl2^tm1Dlo/Bcl2^tm1Dlo (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:73660
	decreased CD8-positive, alpha-beta T cell number	J:73660
	decreased lymphocyte cell number	J:73660
	decreased mature B cell number	J:73660
	decreased pre-B cell number	J:73660
	decreased thymocyte number	J:73660
Bcl2^tm1Dlo/Bcl2^tm1Dlo (B6.129P2-Bcl2^tm1Dlo)	abnormal leukopoiesis	J:73316
	decreased spleen weight	J:153846
	decreased spleen white pulp amount	J:153846
	spleen atrophy	J:153846
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm1.1Ast/Bcl2l11⁺ (B6.Cg-Bcl2^tm1Dlo Bcl2l11^tm1.1Ast)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.129-Bcl2^tm1Dlo Bcl2l11^tm1.1Ast)	abnormal leukopoiesis	J:73316
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.Cg-Bcl2^tm1Dlo Bcl2l11^tm1.1Ast)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm1.1Boui/Bcl2l11^tm2.1Boui (B6.Cg-Bcl2^tm1Dlo Bcl2l11^tm1.1Boui/Bcl2l11^tm2.1Boui)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2^tm1Dlo/Bcl2^tm1Dlo Bcl2l11^tm3.1Boui/Bcl2l11^tm3.1Boui (B6.Cg-Bcl2^tm1Dlo Bcl2l11^tm3.1Boui)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2^tm1Lbox/Bcl2^tm1Lbox (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal B cell differentiation	J:114637
	decreased B cell number	J:114637
	decreased immature B cell number	J:114637
	decreased mature B cell number	J:114637
	decreased pre-B cell number	J:114637
Bcl2^tm1Sjk/Bcl2^tm1Sjk (involves: 129S2/SvPas * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:15224
	abnormal CD8-positive, alpha beta T cell morphology	J:15224
	abnormal immune system organ morphology	J:15224
	abnormal spleen morphology	J:15224
	abnormal spleen red pulp morphology	J:15224
	abnormal spleen white pulp morphology	J:15224
	abnormal thymus morphology	J:15224
	decreased B cell number	J:15224
	decreased double-positive T cell number	J:15224
	decreased lymphocyte cell number	J:15224
	decreased T cell number	J:15224
	increased double-negative T cell number	J:15224
	small spleen	J:15224
	small thymus	J:15224
Bcl2^tm1Tsu/Bcl2^tm1Tsu (involves: 129P2/OlaHsd * ICR)	abnormal lymphocyte morphology	J:22391
	small spleen	J:22391
	small thymus	J:22391
	spleen atrophy	J:22391
	thymus atrophy	J:22391
Bcl2^tm2.1Lbox/Bcl2⁺ (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	enlarged lymph nodes	J:175730
	enlarged spleen	J:175730
	increased B cell number	J:175730
	increased immature B cell number	J:175730
	increased mature B cell number	J:175730
	increased pre-B cell number	J:175730
Bcl2^tm2.1Lbox/Bcl2^tm2.1Lbox (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	enlarged lymph nodes	J:175730
	enlarged spleen	J:175730
	increased B cell number	J:175730
	increased immature B cell number	J:175730
	increased mature B cell number	J:175730
	increased pre-B cell number	J:175730
Bcl2a1a^tm1.1Tac/Bcl2a1a^tm1.1Tac Bcl2a1b^tm1.1Tac/Bcl2a1b^tm1.1Tac Bcl2a1d^tm1.1Tac/Bcl2a1d^tm1.1Tac (involves: BALB/cJ * C57BL/6NTac)	decreased CD4-positive, alpha-beta memory T cell number	J:258915
	decreased central memory CD4-positive, alpha-beta T cell number	J:258915
	decreased dendritic cell number	J:258915
	decreased effector memory CD4-positive, alpha-beta T cell number	J:258915
	decreased gamma-delta T cell number	J:258915
	decreased regulatory T cell number	J:258915
Bcl2l1^tm1Cant/Bcl2l1^tm1Cant (involves: 129S6/SvEvTac)	decreased memory T cell number	J:77507
Bcl2l1^tm1Ywh/Bcl2l1^tm1Ywh Mcl1^tm1Ywh/Mcl1^tm1Ywh Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	absent CD4-positive, alpha-beta T cells	J:137400
	absent CD8-positive, alpha-beta T cells	J:137400
	decreased double-positive T cell number	J:137400
Bcl2l1^tm1Ywh/Bcl2l1^tm1Ywh Tg(Lck-cre)548Jxm/? (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)	decreased double-positive T cell number	J:99012
	decreased thymocyte number	J:99012
Bcl2l11^em1(IMPC)H/Bcl2l11^em1(IMPC)H (C57BL/6NTac-Bcl2l11^em1(IMPC)H/H)	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased spleen weight	J:211773
Bcl2l11^em1Flv/Bcl2l11⁺ Morrbid⁺/Morrbid^em1Flv (C57BL/6N-Bcl2l11^em1Flv +/+ Morrbid^em1Flv)	decreased eosinophil cell number	J:236609
	decreased Ly6C high monocyte number	J:236609
	decreased neutrophil cell number	J:236609
Bcl2l11^tm1.1Ast/Bcl2l11⁺ (B6.129S1-Bcl2l11^tm1.1Ast)	increased leukocyte cell number	J:153846
Bcl2l11^tm1.1Ast/Bcl2l11⁺ (B6.129S1-Bcl2l11^tm1.1Ast)	increased spleen weight	J:153846
Bcl2l11^tm1.1Ast/Bcl2l11⁺ Pten^tm1Hwu/Pten⁺ Tg(CD2-icre)4Kio/0 (involves: 129S1/Sv * 129S4/SvJae * C57BL/10 * CBA/Ca)	abnormal T cell number	J:133215
	increased germinal center B cell number	J:133215
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (involves: 129S1/Sv * C57BL/6)	abnormal plasma cell morphology	J:58641
	abnormal spleen morphology	J:58641
	abnormal splenic cell ratio	J:132217
	decreased double-positive T cell number	J:58641
	enlarged spleen	J:58641
	increased B cell number	J:58641
	increased CD4-positive, alpha-beta T cell number	J:58641
	increased CD8-positive, alpha-beta T cell number	J:58641
	increased double-negative T cell number	J:58641
	increased follicular B cell number	J:132217
	increased granulocyte number	J:58641
	increased immature B cell number	J:132217
	increased leukocyte cell number	J:58641
	increased marginal zone B cell number	J:132217
	increased monocyte cell number	J:58641
	increased splenocyte number	J:132217
	increased T cell number	J:58641
	increased transitional stage B cell number	J:132217
	spleen hyperplasia	J:58641
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.129S1-Bcl2l11^tm1.1Ast)	abnormal B cell morphology	J:133084
	abnormal leukopoiesis	J:73316
	abnormal NK cell morphology	J:123409
	increased immature B cell number	J:133084
	increased leukocyte cell number	J:153846
	increased mature B cell number	J:133084
	increased NK cell number	J:123409
	increased regulatory T cell number	J:208318
	increased spleen weight	J:153846
	increased transitional stage B cell number	J:133084
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.129-Bcl2l11^tm1.1Ast/J)	decreased lymphocyte cell number	J:137609
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (involves: 129S1/Sv)	abnormal CD4-positive, alpha-beta T cell number	J:132819
	abnormal splenic cell ratio	J:132819
	increased B cell number	J:132819
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast (B6.129S1-Bcl2l11^tm1.1Ast/J)	increased B cell number	J:153652
	increased CD4-positive, alpha-beta T cell number	J:153652
	increased CD8-positive, alpha-beta T cell number	J:153652
	increased splenocyte number	J:153652
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Bik^tm1Ast/Bik^tm1Ast (B6.Cg-Bcl2l11^tm1.1Ast Bik^tm1Ast)	abnormal B cell differentiation	J:103605
	abnormal T cell differentiation	J:103605
	decreased immature B cell number	J:103605
	decreased pre-B cell number	J:103605
	decreased pro-B cell number	J:103605
	enlarged spleen	J:103605
	increased B cell number	J:103605
	increased granulocyte number	J:103605
	increased mature B cell number	J:103605
	increased monocyte cell number	J:103605
	increased T cell number	J:103605
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Bmf^tm1Rjd/Bmf^tm1Rjd (B6.129S-Bcl2l11^tm1.1Ast Bmf^tm1Rjd)	increased B cell number	J:153652
	increased CD4-positive, alpha-beta T cell number	J:153652
	increased CD8-positive, alpha-beta T cell number	J:153652
	increased splenocyte number	J:153652
	increased thymocyte number	J:153652
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Bmf^tm2.1Rjd/Bmf^tm2.1Rjd (B6.129S-Bcl2l11^tm1.1Ast Bmf^tm2.1Rjd)	increased B cell number	J:153652
	increased CD4-positive, alpha-beta T cell number	J:153652
	increased CD8-positive, alpha-beta T cell number	J:153652
	increased splenocyte number	J:153652
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Bnip3l^{Gt(XT0573)Wtsi}/Bnip3l^{Gt(XT0573)Wtsi} (involves: 129S1/Sv * C57BL/6)	decreased lymphocyte cell number	J:137609
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Dicer1^tm1Mmk/Dicer1^tm1Mmk Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S1/Sv * BALB/c)	decreased B cell number	J:135783
	decreased mature B cell number	J:135783
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Fas^lpr/Fas^lpr (B6.Cg-Bcl2l11^tm1.1Ast Fas^lpr)	abnormal effector T cell morphology	J:132217
	abnormal lymph node cell ratio	J:132217
	abnormal splenic cell ratio	J:132217
	abnormal T cell number	J:132217
	abnormal T cell subpopulation ratio	J:132217
	decreased B cell number	J:132217
	decreased spleen red pulp amount	J:132217
	enlarged lymph nodes	J:132217
	enlarged spleen	J:132217
	increased dendritic cell number	J:132217
	increased follicular B cell number	J:132217
	increased immature B cell number	J:132217
	increased leukocyte cell number	J:132217
	increased macrophage cell number	J:132217
	increased marginal zone B cell number	J:132217
	increased memory T cell number	J:132217
	increased spleen white pulp amount	J:132217
	increased transitional stage B cell number	J:132217
	lymph node hyperplasia	J:132217
	spleen hyperplasia	J:132217
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Mirc14^tm1.2Flv/Mirc14^tm1.2Flv (involves: 129S1/Sv * C57BL/6 * C57BL/6N * FVB/N * SJL)	decreased NK T cell number	J:203157
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Pmaip1^tm1Ast/Pmaip1^tm1Ast (involves: 129S1/Sv * C57BL/6)	abnormal NK cell morphology	J:123409
Bcl2l11^tm1.1Ast/Bcl2l11^tm1.1Ast Zbtb1^m1Btlr/Zbtb1^m1Btlr (involves: 129S1/Sv * C3H/HeN * C57BL/6 * C57BL/6J)	absent T cells	J:178820
Bcl2l11^tm1.1Boui/Bcl2l11⁺ Tg(IghMyc)22Bri/0 (involves: C57BL/6 * SJL)	increased leukocyte cell number	J:186117
	increased T cell derived lymphoma incidence	J:186117
Bcl2l11^tm1.1Boui/Bcl2l11^tm1.1Boui (C57BL/6-Bcl2l11^tm1.1Boui)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2l11^tm1.1Boui/Bcl2l11^tm1.1Boui Tg(IghMyc)22Bri/0 (involves: C57BL/6 * SJL)	increased leukocyte cell number	J:186117
Bcl2l11^tm1.1Boui/Bcl2l11^tm2.1Boui (C57BL/6-Bcl2l11^tm1.1Boui/Bcl2l11^tm2.1Boui)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2l11^tm1Ast/Bcl2l11^tm1Ast Dicer1^tm1Bdh/Dicer1^tm1Bdh Aicda^tm1(cre)Njen/Aicda⁺ (involves: 129S1/Sv * C57BL/6)	abnormal B cell differentiation	J:181782
	decreased germinal center B cell number	J:181782
	decreased plasma cell number	J:181782
Bcl2l11^tm1Sjk/Bcl2l11^tm1Sjk (involves: 129X1/SvJ)	abnormal spleen marginal zone morphology	J:100463
	increased B cell number	J:100463
	increased B-2 B cell number	J:100463
	increased follicular B cell number	J:100463
	increased transitional stage B cell number	J:100463
Bcl2l11^tm2.1Boui/Bcl2l11⁺ Tg(IghMyc)22Bri/0 (involves: C57BL/6 * SJL)	increased leukocyte cell number	J:186117
Bcl2l11^tm2.1Boui/Bcl2l11^tm2.1Boui (C57BL/6-Bcl2l11^tm2.1Boui)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2l11^tm2.1Boui/Bcl2l11^tm2.1Boui Tg(IghMyc)22Bri/0 (involves: C57BL/6 * SJL)	increased leukocyte cell number	J:186117
Bcl2l11^tm3.1Boui/Bcl2l11^tm3.1Boui (C57BL/6-Bcl2l11^tm3.1Boui)	increased leukocyte cell number	J:153846
	increased spleen weight	J:153846
Bcl2l11^tm3Rjd/Bcl2l11^tm3Rjd (B6.129S6-Bcl2l11^tm3Rjd)	increased B cell number	J:153652
	increased CD4-positive, alpha-beta T cell number	J:153652
	increased CD8-positive, alpha-beta T cell number	J:153652
	increased splenocyte number	J:153652
Bcl2l11^tm3Rjd/Bcl2l11^tm3Rjd Bmf^tm3.1Rjd/Bmf^tm3.1Rjd (B6.129S6-Bcl2l11^tm3Rjd Bmf^tm3.1Rjd)	increased B cell number	J:153652
	increased CD4-positive, alpha-beta T cell number	J:153652
	increased CD8-positive, alpha-beta T cell number	J:153652
	increased splenocyte number	J:153652
Bcl2l11^tm6.1Boui/Bcl2l11^tm6.1Boui Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	increased regulatory T cell number	J:208318
Bcl2l12^{tm1.1(KOMP)Vlcg}/Bcl2l12^{tm1.1(KOMP)Vlcg} (C57BL/6N-Bcl2l12^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Bcl3^m1Btlr/Bcl3⁺ (C57BL/6J-Bcl3^m1Btlr)	decreased B cell number	J:255184
	decreased B-1b cell number	J:255184
	increased CD8-positive, alpha-beta T cell number	J:255184
	increased macrophage cell number	J:255184
Bcl3^m1Btlr/Bcl3^m1Btlr (C57BL/6J-Bcl3^m1Btlr)	decreased B cell number	J:255184
	decreased B-1b cell number	J:255184
	increased B-1 B cell number	J:255184
	increased CD8-positive, alpha-beta T cell number	J:255184
	increased central memory CD4-positive, alpha-beta T cell number	J:255184
	increased macrophage cell number	J:255184
Bcl3^m2Btlr/Bcl3^m2Btlr (C57BL/6J-Bcl3^m2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:264818
	increased B-1 B cell number	J:264818
	increased CD8-positive, alpha-beta memory T cell number	J:264818
Bcl3^m3Btlr/Bcl3^m3Btlr (C57BL/6J-Bcl3^m3Btlr)	decreased central memory CD8 positive, alpha-beta T cell number	J:274858
Bcl3^{tm1b(EUCOMM)Wtsi}/Bcl3^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Bcl3^{tm1b(EUCOMM)Wtsi}/H)	increased spleen weight	J:211773
Bcl3^tm1Rie/Bcl3^tm1Rie (involves: 129)	abnormal dendritic cell number	J:77049
	abnormal follicular dendritic cell morphology	J:77049
	abnormal myeloid dendritic cell morphology	J:77049
	abnormal Peyer's patch follicle morphology	J:77049
	abnormal Peyer's patch germinal center morphology	J:77049
	abnormal Peyer's patch morphology	J:77049
	abnormal Peyer's patch T cell area morphology	J:77049
	decreased B cell number	J:77049
	decreased Peyer's patch number	J:77049
	increased plasmacytoid dendritic cell number	J:77049
	small Peyer's patches	J:77049
Bcl3^tm1Sbn/Bcl3^tm1Sbn (involves: 129S4/SvJae * C57BL/6)	abnormal B cell differentiation	J:39747
	abnormal class switch recombination	J:39747
	abnormal lymph node B cell domain morphology	J:39747
	abnormal lymphocyte morphology	J:39747
	abnormal metallophilic macrophage morphology	J:39747
	abnormal spleen marginal zone macrophage morphology	J:39747
	absent spleen germinal center	J:39747
	decreased B cell number	J:39747
	decreased macrophage cell number	J:39747
	decreased spleen germinal center size	J:39747
	disorganized spleen B cell follicle	J:39747
	intermingled spleen red and white pulp	J:39747
	lymph node hypoplasia	J:39747
Bcl3^tm1Sbn/Bcl3^tm1Sbn (involves: 129S4/SvJae)	decreased follicular B cell number	J:207111
	decreased transitional stage T1 B cell number	J:207111
	decreased transitional stage T2 B cell number	J:207111
	increased marginal zone B cell number	J:207111
Bcl3^tm1Ver/Bcl3^tm1Ver (involves: 129P2/OlaHsd * FVB/NJ)	absent spleen germinal center	J:38092
Bcl6^tm1.1Dent/Bcl6^tm1.1Dent Tg(Cd4-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6 * DBA/2 * FVB/N)	abnormal T follicular helper cell differentiation	J:202372
	decreased germinal center B cell number	J:202372
	decreased T follicular helper cell number	J:202372
Bcl6^tm1.1Jwan/Bcl6^tm1.1Jwan (involves: 129S6/SvEvTac)	abnormal somatic hypermutation frequency	J:190534
Bcl6^tm1.1Meln/Bcl6^tm1.1Meln (involves: 129 * C57BL/6 * FVB/N)	abnormal immune system organ morphology	J:194821
	abnormal Peyer's patch germinal center morphology	J:194821
	abnormal spleen germinal center morphology	J:194821
	decreased spleen germinal center number	J:194821
	decreased T follicular helper cell number	J:194821
Bcl6^tm1.1Mtto/Bcl6^tm1.1Mtto Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6 * C57BL/6JJcl)	abnormal memory B cell morphology	J:190943
	abnormal somatic hypermutation frequency	J:190943
	decreased germinal center B cell number	J:190943
Bcl6^tm1.1Mtto/Bcl6^tm1.1Mtto Cd79a^tm1(cre)Reth/Cd79a⁺ Tg(Cd4-cre)1Cwi/0 (involves: BALB/c * C57BL/6 * C57BL/6JJcl * DBA/2)	decreased germinal center B cell number	J:190943
Bcl6^tm1.1Mtto/Bcl6^tm1.1Mtto Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JJcl)	decreased germinal center B cell number	J:190943
Bcl6^tm1.1Mtto/Bcl6^tm1.1Mtto Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6JJcl * DBA/2)	abnormal somatic hypermutation frequency	J:190943
	absent germinal center B cells	J:190943
	decreased germinal center B cell number	J:190943
	decreased T follicular helper cell number	J:190943
Bcl6^tm1.1Toka/Bcl6^tm1.1Toka (involves: C57BL/6 * NZB)	abnormal Peyer's patch morphology	J:174014
	decreased germinal center B cell number	J:174014
	decreased T follicular helper cell number	J:174014
Bcl6^tm1Htno/Bcl6^tm1Htno (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:55952
Bcl6^tm1Rdf/Bcl6^tm1Rdf (involves: 129S1/Sv)	abnormal immune system morphology	J:40769
	abnormal Peyer's patch germinal center morphology	J:40769
	absent lymph node germinal center	J:40769
	absent spleen germinal center	J:40769
	increased eosinophil cell number	J:40769
	small thymus	J:40769
	spleen hyperplasia	J:40769
Bcl6^tm1Sdt/Bcl6^tm1Sdt (involves: 129/Sv * C57BL/6)	spleen hypoplasia	J:123621
Bcl6^tm2Rdf/Bcl6^tm2Rdf (involves: 129S1/Sv)	abnormal immune system morphology	J:40769
	abnormal Peyer's patch germinal center morphology	J:40769
	absent lymph node germinal center	J:40769
	absent spleen germinal center	J:40769
	increased eosinophil cell number	J:40769
	small thymus	J:40769
	spleen hyperplasia	J:40769
Bcl6^tm2Rdf/Bcl6^tm2Rdf Ighm^tm1(Bcl6)Rdf/? (involves: 129/Sv * 129S1/Sv * C57BL/6)	abnormal immune system morphology	J:98937
	abnormal spleen germinal center morphology	J:98937
Bcl6b^tm1Dtf/Bcl6b^tm1Dtf (involves: 129P2/OlaHsd)	decreased memory T cell number	J:99818
Bcl6b^tm1Tto/Bcl6b^tm1Tto (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:93656
	abnormal CD8-positive, alpha beta T cell morphology	J:93656
Bcl6b^tm2Dent/Bcl6b^tm2Dent (involves: 129/Sv * C57BL/6)	decreased neutrophil cell number	J:123621
Bcl6b^tm2Dent/Bcl6b^tm2Dent (involves: 129/Sv * C57BL/6)	increased monocyte cell number	J:123621
Bcl6b^tm2Dent/Bcl6b^tm2Dent Rag1^tm1Mom/Rag1^tm1Mom (involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)	decreased lymphocyte cell number	J:123621
Bcl10^m1Btlr/Bcl10^m1Btlr (C57BL/6J-Bcl10^m1Btlr)	decreased B-1 B cell number	J:265122
	increased CD4-positive, alpha-beta T cell number	J:265122
	increased single-positive T cell number	J:265122
	increased T cell number	J:265122
Bcl10^tm1Mak/Bcl10^tm1Mak (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:67297
	decreased activated T cell number	J:67297
	decreased double-positive T cell number	J:67297
	decreased thymocyte number	J:67297
	increased double-negative T cell number	J:67297
Bcl10^tm1Swm/Bcl10^tm1Swm (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:85147
	decreased B cell number	J:85147
	decreased B-1 B cell number	J:85147
	decreased follicular B cell number	J:85147
	decreased marginal zone B cell number	J:85147
	decreased mature B cell number	J:85147
Bcl11a^tm1Ngc/Bcl11a⁺ (involves: 129S1/Sv)	abnormal T cell differentiation	J:194616
	decreased DN2 thymocyte number	J:194616
	decreased lymphocyte cell number	J:207383
Bcl11a^tm1Ngc/Bcl11a^tm1Ngc (involves: 129S1/Sv * C57BL/6J)	abnormal dendritic cell differentiation	J:207383
	abnormal immunoglobulin heavy chain V(D)J recombination	J:83646
	absent B cells	J:207383, J:83646
	absent CD4-positive, alpha-beta T cells	J:83646
	absent lymphocyte	J:207383
	decreased plasmacytoid dendritic cell number	J:207383
	decreased T cell number	J:83646
	increased CD8-positive, alpha-beta T cell number	J:83646
	increased double-negative T cell number	J:83646
	increased gamma-delta T cell number	J:83646
	small thymus	J:83646
	thymus hypoplasia	J:83646
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	decreased B cell number	J:207383
	decreased plasmacytoid dendritic cell number	J:207383
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal dendritic cell differentiation	J:207383
	decreased B cell number	J:207383
	decreased dendritic cell number	J:207383
	decreased plasmacytoid dendritic cell number	J:207383
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Kdm1a^tm1.1Sho/Kdm1a^tm1.1Sho Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	decreased leukocyte cell number	J:196140
Bcl11a^tm1Pwt/Bcl11a^tm1Pwt Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	decreased leukocyte cell number	J:196140
Bcl11a^tm2.1Peli/Bcl11a^tm2.1Peli Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S1/Sv)	abnormal immune system morphology	J:194616
	abnormal T cell differentiation	J:194616
	decreased B cell number	J:194616
	decreased DN2 thymocyte number	J:194616
	decreased immature B cell number	J:194616
	decreased pre-B cell number	J:194616
	decreased pro-B cell number	J:194616
Bcl11b^tm1.2Leid/Bcl11b^tm1.2Leid (involves: C57BL/6 * SJL)	absent T cells	J:147182
Bcl11b^tm1.2Leid/Bcl11b^tm1.2Leid (involves: C57BL/6 * SJL)	thymus hypoplasia	J:147182
Bcl11b^tm1Avram/Bcl11b^tm1Avram Tcra^tm1Mom/Tcra^tm1Mom Tg(Cd4-cre)1Cwi/? (involves: 129 * C57BL/6 * DBA/2)	abnormal positive T cell selection	J:128515
	decreased double-positive T cell number	J:128515
	thymus hypoplasia	J:128515
Bcl11b^tm1Avram/Bcl11b^tm1Avram Tg(Cd4-cre)1Cwi/? (involves: 129 * C57BL/6 * DBA/2)	abnormal leukocyte morphology	J:128515
	abnormal positive T cell selection	J:128515
	decreased CD4-positive, alpha-beta T cell number	J:128515
	decreased CD8-positive, alpha-beta T cell number	J:128515
	decreased double-negative T cell number	J:128515
	decreased double-positive T cell number	J:128515
	enlarged mesenteric lymph nodes	J:128515
	increased B cell number	J:128515
	increased dendritic cell number	J:128515
	increased gamma-delta T cell number	J:128515
	increased NK cell number	J:128515
	increased spleen weight	J:128515
	spleen hyperplasia	J:128515
	thymus hypoplasia	J:128515
Bcl11b^tm1Avram/Bcl11b^tm1Avram Tg(Cd4-cre)1Cwi/? Tg(LCKprBCL2)36Sjk/? (involves: 129 * C57BL/6 * DBA/2)	abnormal positive T cell selection	J:128515
	decreased CD4-positive, alpha-beta T cell number	J:128515
	decreased CD8-positive, alpha-beta T cell number	J:128515
	decreased double-positive T cell number	J:128515
	thymus hypoplasia	J:128515
Bcl11b^tm1Jpk/Bcl11b^tm1Jpk (involves: BALB/c * C57BL/6 * CBA)	abnormal T cell differentiation	J:83651
	abnormal T cell morphology	J:83651
	abnormal T cell receptor beta chain V(D)J recombination	J:83651
	abnormal thymus cortex morphology	J:83651
	abnormal thymus medulla morphology	J:83651
	absent thymus corticomedullary boundary	J:83651
	decreased double-positive T cell number	J:83651
	increased CD8-positive, alpha-beta T cell number	J:83651
	increased double-negative T cell number	J:83651
	thymus hypoplasia	J:83651
Bcl11b^tm1Peli/Bcl11b^tm1Peli Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6J)	abnormal NK cell differentiation	J:161373
Bcl11b^tm2.1Jpk/Bcl11b⁺ Tg(Lck-cre)1Jtak/0 (involves: C57BL/6)	abnormal T cell number	J:210122
	decreased CD4-positive, alpha-beta T cell number	J:210122
	decreased CD8-positive, alpha-beta T cell number	J:210122
	decreased double-positive T cell number	J:210122
	decreased thymocyte number	J:210122
	increased double-negative T cell number	J:210122
Bclaf1^tm1Raz/Bclaf1^tm1Raz (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:158087
	increased B cell number	J:158087
Bcmd2^CAST/EiJ/Bcmd2^CAST/EiJ (AW.CAST-Bcmd2)	increased mast cell number	J:75340
Bco2^tm1Dnp/Bco2^tm1Dnp (involves: 129S6/SvEvTac * C57BL/6)	enlarged spleen	J:166153
Bco2^tm1Dnp/Bco2^tm1Dnp (involves: 129S6/SvEvTac * C57BL/6)	increased spleen weight	J:166153
Bcor^tm1.1Vjba/Y Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S1/Sv * C57BL/6 * CBA/Ca)	increased neutrophil cell number	J:231455
Bcr^{tm1(BCR/ABL)Tsr}/Bcr⁺ Runx1^tm3Dow/Runx1⁺ Tg(Vav1-cre)#Cgp/0 (involves: C57BL/6)	decreased lymphocyte cell number	J:203111
	increased monocyte cell number	J:203111
	increased neutrophil cell number	J:203111
Bcr^tm1Hkp/Bcr^tm1Hkp (involves: 129S2/SvPas)	increased leukocyte cell number	J:23804
Bcr^tm1Hkp/Bcr^tm1Hkp (involves: 129S2/SvPas)	increased neutrophil cell number	J:23804
Bcs1l^tm1.1Levp/Bcs1l^tm1.1Levp (B6.129-Bcs1l^tm1.1Levp)	abnormal macrophage morphology	J:273501
	increased macrophage cell number	J:273501
	increased neutrophil cell number	J:273501
Bdp1^em1(IMPC)Tcp/Bdp1⁺ (C57BL/6N-Bdp1^em1(IMPC)Tcp/Cmmr)	abnormal spleen morphology	J:211773
	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Bean1^em1(IMPC)H/Bean1^em1(IMPC)H (C57BL/6N-Bean1^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Becn1^tm1.1Bflu/Becn1^tm1.1Bflu Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:203090
	decreased CD8-positive, alpha-beta T cell number	J:203090
Becn1^{tm1b(KOMP)Wtsi}/Becn1⁺ (C57BL/6N-Becn1^{tm1b(KOMP)Wtsi}/Ieg)	increased leukocyte cell number	J:211773
Becn1^tm1Blev/Becn1⁺ (involves: 129X1/SvJ * C57BL/6J)	abnormal immune system morphology	J:86953
	increased spleen germinal center number	J:86953
	increased spleen germinal center size	J:86953
Becn1^tm1Ebr/Becn1^tm1Ebr Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	abnormal spleen morphology	J:235399
	increased lymphocyte cell number	J:235399
	increased monocyte cell number	J:235399
	increased neutrophil cell number	J:235399
Bex2^{tm1b(EUCOMM)Hmgu}/Bex2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bex2^{tm1b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Bex6^{tm1.1(KOMP)Vlcg}/Bex6^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Bex6^{tm1.1(KOMP)Vlcg}/J)	increased leukocyte cell number	J:211773
Bhlhe40^tm1Tan/Bhlhe40^tm1Tan (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal CD4-positive T cell differentiation	J:72651
	abnormal immune system cell morphology	J:72651
	abnormal lymph node germinal center morphology	J:72651
	decreased double-positive T cell number	J:72651
	increased CD4-positive, alpha-beta T cell number	J:72651
	increased CD8-positive, alpha-beta T cell number	J:72651
	increased double-negative T cell number	J:72651
	increased spleen germinal center number	J:72651
	increased spleen white pulp amount	J:72651
	lymph node hyperplasia	J:72651
	spleen hyperplasia	J:72651
	thymus hyperplasia	J:72651
Bhlhe41^tm1.2Cdon/Bhlhe41^tm1.2Cdon (B6.129S6-Bhlhe41^tm1.2Cdon)	abnormal lymphocyte cell number	J:157740
	abnormal T-helper 2 cell differentiation	J:157740
	decreased eosinophil cell number	J:157740
	decreased macrophage cell number	J:157740
	decreased neutrophil cell number	J:157740
Bhmt^{tm1b(EUCOMM)Hmgu}/Bhmt^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bhmt^{tm1b(EUCOMM)Hmgu}/Bay)	increased spleen weight	J:211773
Bicdl1^{tm2b(EUCOMM)Wtsi}/Bicdl1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Bicdl1^{tm2b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Bicdl2^em1(IMPC)Mbp/Bicdl2^em1(IMPC)Mbp (C57BL/6N-Bicdl2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Bin3^tm1Gcp/Bin3^tm1Gcp (involves: 129 * C57BL/6)	enlarged spleen	J:133313
Birc2^tm1Jda/Birc2^tm1Jda (B6.129P2-Birc2^tm1Jda)	decreased lymphocyte cell number	J:97656
Birc2^tm1Rbr/Birc2^tm1Rbr Birc3^tm1.1Rbr/Birc3^tm1.1Rbr Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * NZB)	decreased germinal center B cell number	J:172843
	decreased spleen germinal center size	J:172843
	enlarged lymph nodes	J:172843
	enlarged spleen	J:172843
	increased B cell number	J:172843
	increased follicular B cell number	J:172843
	increased marginal zone B cell number	J:172843
Birc3^tm1Jda/Birc3^tm1Jda (B6.Cg-Birc3^tm1Jda)	abnormal gut-associated lymphoid tissue morphology	J:166899
	abnormal lymphocyte cell number	J:166899
	decreased follicular B cell number	J:166899
	decreased immature B cell number	J:166899
	enlarged mesenteric lymph nodes	J:166899
	increased B cell number	J:166899
	increased marginal zone B cell number	J:166899
	increased T cell number	J:166899
	lymph node hyperplasia	J:166899
Birc3^tm1Rgk/Birc3^tm1Rgk (B6.129X1-Birc3^tm1Rgk)	abnormal leukocyte cell number	J:144012
Birc3^tm1Rgk/Birc3^tm1Rgk (B6.129X1-Birc3^tm1Rgk)	decreased macrophage cell number	J:144012
Birc5^tm1Mak/Birc5^tm1Mak Tg(Lck-cre)I57Jxm/0 (involves: 129P2/OlaHsd)	abnormal T cell morphology	J:90892
	abnormal thymus corticomedullary boundary morphology	J:90892
	decreased double-negative T cell number	J:90892
	decreased thymocyte number	J:90892
	small thymus	J:90892
Birc5^tm1Wnt/Birc5^tm1Emc Tg(Cd4-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:87435
Birc5^tm1Wnt/Birc5^tm1Emc Tg(Lck-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6 * DBA/2)	decreased double-positive T cell number	J:87435
	decreased T cell number	J:87435
	increased double-negative T cell number	J:87435
	small lymph nodes	J:87435
	thymus hypoplasia	J:87435
Blk^tm1Tara/Blk^tm1Tara Fyn^tm1Sor/Fyn^tm1Sor Lyn^tm1Ard/Lyn^tm1Ard (either: B6.129-Lyn^tm1Ard Fyn^tm1Sor Blk^tm1Tara or (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6))	abnormal B cell differentiation	J:115080
	abnormal pro-B cell differentiation	J:115080
	arrested B cell differentiation	J:115080
	decreased B cell number	J:115080
	decreased immature B cell number	J:115080
	decreased pre-B cell number	J:115080
Blm^tm4Ches/Blm^tm4Ches Cd19^tm1(cre)Cgn/Cd19⁺ Nsmce2^tm2.1Ofc/Nsmce2^tm2.1Ofc (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)	abnormal B cell morphology	J:227197
	decreased B cell number	J:227197
	small spleen	J:227197
Blm^tm4Ches/Blm^tm4Ches Trp53bp1^tm1Jc/Trp53bp1^tm1Jc Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal class switch recombination	J:194603
Blnk^em1(IMPC)H/Blnk^em1(IMPC)H (C57BL/6N-Blnk^em1(IMPC)H/H)	decreased basophil cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
	small spleen	J:211773
Blnk^m1Btlr/Blnk^m1Btlr (C57BL/6J-Blnk^m1Btlr)	arrested B cell differentiation	J:159439
	decreased mature B cell number	J:159439
	increased CD4-positive, alpha-beta T cell number	J:159439
	increased CD8-positive, alpha-beta T cell number	J:159439
Blnk^m1Btlr/Blnk^m1Btlr (involves: C57BL/6J)	arrested B cell differentiation	J:185495
Blnk^tm1Achn/Blnk^tm1Achn (involves: 129X1/SvJ)	abnormal B cell differentiation	J:58805
	abnormal mature B cell morphology	J:58805
	absent B-1b cells	J:58805
	arrested B cell differentiation	J:58805
	decreased B-1a cell number	J:58805
	decreased mature B cell number	J:58805
	decreased splenocyte number	J:58805
	increased pro-B cell number	J:58805
Blnk^tm1Dkit/Blnk^tm1Dkit (involves: C57BL/6)	abnormal B cell differentiation	J:84040
	abnormal immature B cell morphology	J:94297
	abnormal plasma cell differentiation	J:143854
	abnormal pre-B cell morphology	J:84040
	arrested B cell differentiation	J:143854
	decreased follicular B cell number	J:143854
	decreased immature B cell number	J:84040
	decreased marginal zone B cell number	J:143854
	decreased mature B cell number	J:84040
	decreased transitional stage B cell number	J:143854
Blnk^tm1Dkit/Blnk^tm1Dkit Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn (involves: 129P2/OlaHsd * C57BL/6 * NZB)	abnormal pre-B cell morphology	J:84040
	absent immature B cells	J:84040
	absent mature B cells	J:84040
	arrested B cell differentiation	J:84040
	decreased pre-B cell number	J:84040
	enlarged lymph nodes	J:84040
	enlarged spleen	J:84040
Blnk^tm1Dkit/Blnk^tm1Dkit Igh-J^{tm1(3H9-VDJ)Mwg}/Igh-J⁺ (involves: C57BL/6 * NZB)	abnormal immature B cell morphology	J:94297
Blnk^tm1Dkit/Blnk^tm1Dkit Igh-J^{tm1(3H9-VDJ)Mwg}/Igh-J⁺ Igk-J^tm1Mwg/Igk-J⁺ (involves: C57BL/6 * NZB)	abnormal immature B cell morphology	J:94297
Blnk^tm1Dkit/Blnk^tm1Dkit Prkcd^tm1Kin/Prkcd^tm1Kin (involves: 129P2/OlaHsd * C57BL/6 * NZB)	abnormal plasma cell differentiation	J:143854
	arrested B cell differentiation	J:143854
	decreased B-1 B cell number	J:143854
	decreased B-2 B cell number	J:143854
	decreased follicular B cell number	J:143854
	decreased marginal zone B cell number	J:143854
Blnk^tm1Kplm/Blnk^tm1Kplm (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:61130, J:131161
	absent B-1a cells	J:61130
	decreased B cell number	J:61130, J:131161
	decreased immature B cell number	J:61130
	decreased mature B cell number	J:61130
	decreased pre-B cell number	J:61130, J:120460
	increased pro-B cell number	J:61130, J:131161
	spleen hypoplasia	J:131161
Blnk^tm1Kplm/Blnk^tm1Kplm Igh^tm4Cgn/Igh⁺ Igk^tm1Rsky/Igk⁺ (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:120460
	decreased B cell number	J:120460
	increased pre-B cell number	J:120460
	increased transitional stage B cell number	J:120460
Blnk^tm1Kplm/Blnk^tm1Kplm Plcg2^tm1.1Kuro/Plcg2⁺ (involves: 129P2/OlaHsd)	decreased B cell number	J:131161
Blnk^tm1Kplm/Blnk^tm1Kplm Plcg2^tm1.1Kuro/Plcg2^tm1.1Kuro (involves: 129P2/OlaHsd)	decreased B cell number	J:131161
	spleen hypoplasia	J:131161
Blnk^tm1Pjln/Blnk^tm1Pjln (involves: BALB/c)	abnormal pre-B cell morphology	J:58740
	arrested B cell differentiation	J:58740
	decreased mature B cell number	J:58740
	enlarged spleen	J:80332
	increased mature B cell number	J:157575
	increased pre-B cell number	J:58740, J:80332
Blnk^tm1Pjln/Blnk^tm1Pjln Btk^tm1Gsv/Y (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal B cell differentiation	J:94768
	decreased immature B cell number	J:94768
	decreased mature B cell number	J:94768
Blnk^tm1Pjln/Blnk^tm1Pjln Btk^tm1Gsv/Y Tg(CD19-BTKK430R)XK24Rwhe/? (involves: 129P2/OlaHsd BALB/c * C57BL/6 * FVB)	abnormal B cell differentiation	J:94768
Blnk^tm1Pjln/Blnk^tm1Pjln Btk^tm1Wk/Btk^tm1Wk (involves: 129S4/SvJae * BALB/c * C57BL/6)	arrested B cell differentiation	J:70406
Bloc1s4^em1(IMPC)Mbp/Bloc1s4^em1(IMPC)Mbp (C57BL/6NCrl-Bloc1s4^em1(IMPC)Mbp/MbpMmucd)	increased monocyte cell number	J:211773
Bloc1s6^em1(IMPC)Mbp/Bloc1s6^em1(IMPC)Mbp (C57BL/6N-Bloc1s6^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
Bmal1^tm1Bra/Bmal1^tm1Bra (B6.129-Bmal1^tm1Bra)	decreased basophil cell number	J:191844
	decreased leukocyte cell number	J:110697
	decreased lymphocyte cell number	J:110697
	decreased spleen weight	J:110697
	increased eosinophil cell number	J:191844
	increased leukocyte cell number	J:191844
	increased lymphocyte cell number	J:191844
	increased monocyte cell number	J:110697
	increased neutrophil cell number	J:110697, J:191844
Bmal1^tm1Bra/Bmal1^tm1Bra (involves: 129/Sv * C57BL/6)	abnormal B cell differentiation	J:118522
	abnormal T cell subpopulation ratio	J:118522
	decreased B cell number	J:135933, J:118522
	decreased follicular B cell number	J:118522
	decreased lymphocyte cell number	J:135933, J:118522
	decreased transitional stage B cell number	J:118522
	increased neutrophil cell number	J:135933
Bmf^tm1.1Ast/Bmf^tm1.1Ast (B6.Cg-Bmf^tm1.1Anst)	abnormal B cell morphology	J:133084
	abnormal immune system cell morphology	J:133084
	abnormal spleen morphology	J:133084
	enlarged spleen	J:133084
	increased follicular B cell number	J:133084
	increased immature B cell number	J:133084
	increased mature B cell number	J:133084
	increased pre-B cell number	J:133084
	increased T cell derived lymphoma incidence	J:133084
	increased transitional stage B cell number	J:133084
	spleen hyperplasia	J:133084
Bmf^tm1Rjd/Bmf^tm1Rjd (B6.129S6-Bmf^tm1Rjd)	enlarged spleen	J:153652
	increased B cell number	J:153652
	increased CD8-positive, alpha-beta T cell number	J:153652
	increased splenocyte number	J:153652
Bmf^tm3.1Rjd/Bmf^tm3.1Rjd (B6.129S6-Bmf^tm3.1Rjd)	decreased CD4-positive, alpha-beta T cell number	J:153652
Bmi1^tm1Brn/Bmi1^tm1Brn (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))	abnormal double-negative T cell morphology	J:17712
	abnormal spleen red pulp morphology	J:17712
	abnormal spleen white pulp morphology	J:17712
	decreased immature B cell number	J:17712
	decreased mature B cell number	J:17712
	decreased thymocyte number	J:17712
	small spleen	J:17712
	thymus cortex hypoplasia	J:17712
Bmi1^tm1Brn/Bmi1^tm1Brn (involves: 129P2/OlaHsd)	decreased double-positive T cell number	J:134271
Bmi1^tm1Brn/Bmi1^tm1Brn E2f6^tm1Lees/E2f6^tm1Lees (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	decreased double-positive T cell number	J:134271
Bmi1^tm1Sgon/Bmi1^tm1Sgon Commd10^{Tg(Vav1-icre)A2Kio}/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * CBA/Ca)	abnormal immune system cell morphology	J:221849
	abnormal immune system organ morphology	J:221849
	abnormal spleen morphology	J:221849
	abnormal spleen periarteriolar lymphoid sheath morphology	J:221849
	abnormal spleen white pulp morphology	J:221849
	abnormal thymus morphology	J:221849
	absent spleen germinal center	J:221849
	decreased B cell number	J:221849
	decreased spleen red pulp amount	J:221849
	decreased spleen white pulp amount	J:221849
	decreased T cell number	J:221849
	small spleen	J:221849
	small thymus	J:221849
	thymus atrophy	J:221849
Bmi1^tm1Sgon/Bmi1^tm1Sgon Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/? (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	decreased lymphocyte cell number	J:221849
	decreased spleen weight	J:221849
Bmp1^tm1.1Dgr/Bmp1^tm1.1Dgr Tll1^tm2.1Dgr/Tll1^tm2.1Dgr Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 * SJL)	increased osteoclast cell number	J:210366
Bmp2^tm1.1Mis/Bmp2^tm1.2Mis Tg(Col1a1-cre)1Bek/0 (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * CD-1)	decreased osteoclast cell number	J:210409
Bmp2^tm1Cjt/Bmp2^tm1Cjt Bmp4^tm1Jfm/Bmp4^tm1Jfm Tg(Prrx1-cre)1Cjt/0 (involves: 129S4/SvJaeSor * C57BL/6 * SJL)	abnormal bone marrow development	J:118257
Bmp7^{tm1a(EUCOMM)Hmgu}/Bmp7⁺ (C57BL/6N-Bmp7^{tm1a(EUCOMM)Hmgu}/H)	increased monocyte cell number	J:165965
Bmp10^b2b2711Clo/Bmp10^b2b2711Clo (C57BL/6J-Bmp10^b2b2711Clo)	thymus hypoplasia	J:175213
Bmpr1a^tm2.1Bhr/Bmpr1a^tm2.1Bhr Tg(Col1a1-cre/Esr1*)1Mis/0 (involves: 129S7/SvEvBrd)	abnormal osteoclast differentiation	J:143588
	decreased osteoclast cell number	J:143588
Bnc1^em1(IMPC)H/Bnc1^em1(IMPC)H (C57BL/6NTac-Bnc1^em1(IMPC)H/H)	abnormal spleen morphology	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Bnip1^{tm2b(KOMP)Wtsi}/Bnip1⁺ (C57BL/6N-Bnip1^{tm2b(KOMP)Wtsi}/Nju)	increased eosinophil cell number	J:211773
Bnip3l^tm1.1Gwd/Bnip3l^tm1.1Gwd (involves: 129 * C57BL/6)	abnormal spleen morphology	J:141583
	abnormal thrombopoiesis	J:141583
	enlarged spleen	J:141583
	increased spleen red pulp amount	J:141583
Bnip3l^tm1Ney/Bnip3l^tm1Ney (Not Specified)	enlarged spleen	J:141545
Bnip3l^tm1Ney/Bnip3l^tm1Ney (Not Specified)	spleen hyperplasia	J:141545
Bnip5^{tm1.1(KOMP)Vlcg}/Bnip5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Bnip5^{tm1.1(KOMP)Vlcg}/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Boc^{tm1b(KOMP)Wtsi}/Boc^{tm1b(KOMP)Wtsi} (C57BL/6N-Boc^{tm1b(KOMP)Wtsi}/H)	increased basophil cell number	J:211773
Bod1^{tm1b(KOMP)Wtsi}/Bod1⁺ (C57BL/6N-Bod1^{tm1b(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Bod1l^em1Bltn/Bod1l^em1Bltn Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6J * C57BL/6NTac)	abnormal class switch recombination	J:337726
Bok^tm1.1Ast/Bok^tm1.1Ast (involves: BALB/cJ * C57BL/6)	increased spleen weight	J:203179
Bok^tm1.1Ast/Bok^tm1.1Ast (involves: BALB/cJ * C57BL/6)	increased thymus weight	J:203179
Bok^{tm1b(EUCOMM)Hmgu}/Bok^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bok^{tm1b(EUCOMM)Hmgu}/Tcp)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Bomb1^NSF/N/Bomb1^NSF/N (involves: NFS/N * SL/Kh)	increased pre-B cell number	J:55364
Bomb1^SL/Kh/Bomb1^SL/Kh (involves: NFS/N * SL/Kh)	increased pre-B cell number	J:55364
Bpgm^m1Pgrs/Bpgm^m1Pgrs (involves: C57BL/6 * C57BL/10J)	enlarged spleen	J:301620
Bpi^tm1.1Buls/Bpi^tm1.1Buls (involves: BALB/cJ * C57BL/6J)	enlarged mesenteric lymph nodes	J:346703
Bpi^tm1.1Buls/Bpi^tm1.1Buls (involves: BALB/cJ * C57BL/6J)	increased T cell number	J:346703
Bptf^tm1.1Cwu/Bptf^tm1.1Cwu Emx1^tm1(cre)Krj/Emx1⁺ (involves: 129S1/Sv * 129S2/SvPas * C57BL/6)	microgliosis	J:334252
Braf^tm1(ARAF)Urr/Braf^tm1(ARAF)Urr (involves: 129S1/Sv * C57BL/6 * CD-1)	decreased spleen weight	J:112971
	decreased thymus weight	J:112971
Braf^tm1Bbd/Braf⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal thymus morphology	J:170095
	decreased thymocyte number	J:170095
	thymus atrophy	J:170095
Braf^tm1Bbd/Braf⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)	abnormal thymus morphology	J:170095
	decreased thymocyte number	J:170095
	thymus atrophy	J:170095
Braf^tm1Bbd/Braf⁺ (B6.129-Braf^tm1Bbd)	abnormal thymus morphology	J:170095
	decreased thymocyte number	J:170095
	thymus atrophy	J:170095
Braf^tm1Cpri/Braf⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased leukocyte cell number	J:104375
	enlarged spleen	J:104375
Braf^tm1Mmcm/Braf^tm1Mmcm Cd207^{tm2.1(cre)Bjec}/Cd207⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	increased dendritic cell number	J:211690
Braf^tm1Mmcm/Braf^tm1Mmcm Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	enlarged lymph nodes	J:211690
	hepatosplenomegaly	J:211690
	increased dendritic cell number	J:211690
Braf^tm1Tumg/Braf⁺ Tg(CAG-cre)2Osb/0 (involves: C57BL * C57BL/6J * DBA)	abnormal lymph organ development	J:216228
Braf^tm1Wds/Braf^tm1Wds Raf1^tm2Bacc/Raf1^tm2Bacc H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129P2/OlaHsd * C57BL/6J * CBA/J)	small thymus	J:144862
Braf^tm2Cpri/Braf⁺ Tg(CMV-cre)1Cgn/0 (B6.Cg-Braf^tm2Cpri Tg(CMV-cre)1Cgn)	enlarged spleen	J:187371
	increased spleen weight	J:187371
	lymphoid hyperplasia	J:187371
Brap^em1(IMPC)Mbp/Brap⁺ (C57BL/6NCrl-Brap^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Brca1^tm2.1Cxd/Brca1^tm2.1Cxd Shld1^em1Nus/Shld1^em1Nus (involves: 129S6/SvEvTac * C57BL/6NCrl)	abnormal class switch recombination	J:307190
Brca1^tm2.1Cxd/Brca1^tm2.1Cxd Trp53^tm1Brd/Trp53⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	enlarged thymus	J:81541
	increased T cell derived lymphoma incidence	J:81541
Brca1^tm2.1Cxd/Brca1^tm2.1Cxd Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	increased T cell derived lymphoma incidence	J:81541
Brca1^tm2.1Cxd/Brca1^tm2.1Cxd Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129 * 129S6/SvEvTac)	abnormal class switch recombination	J:307190
Brca1^tm2Mak/Brca1^tm2Mak Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj Tg(Lck-cre)548Jxm/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased thymocyte number	J:63282
Brca1^tm2Mak/Brca1^tm2Mak Chek2^tm1Mak/Chek2^tm1Mak Tg(Lck-cre)548Jxm/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased T cell derived lymphoma incidence	J:90512
Brca1^tm2Mak/Brca1^tm2Mak Tg(Lck-cre)548Jxm/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal immune system organ morphology	J:63282
	abnormal T cell number	J:63282
	decreased double-positive T cell number	J:63282
	decreased single-positive T cell number	J:63282
	decreased thymocyte number	J:63282
	increased double-negative T cell number	J:63282
Brca1^tm2Mak/Brca1^tm2Mak Tg(Lck-cre)548Jxm/? Tg(TcrLCMV)327Sdz/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal T cell number	J:63282
	decreased double-positive T cell number	J:63282
	decreased thymocyte number	J:63282
	increased double-negative T cell number	J:63282
Brca1^tm2Mak/Brca1^tm2Mak Tg(Lck-cre)548Jxm/? Trp53^tm1Brd/Trp53^tm1Brd (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased T cell derived lymphoma incidence	J:90512
Brca1^tm5.1Cxd/Brca1^tm5.1Cxd (involves: 129S6/SvEvTac * FVB/N)	increased T cell derived lymphoma incidence	J:155810
Brca2^tm1Cam/Brca2^tm1Cam (involves: 129S/SvEv * MF1)	increased T cell derived lymphoma incidence	J:46812
Brca2^tm1Cam/Brca2^tm1Cam (involves: 129S/SvEv * MF1)	increased thymus weight	J:46812
Brca2^tm1Cbl/Brca2^tm1Cbl (either: (involves: 129S2/SvPas * C57BL/10) or (involves: 129S2/SvPas * C57BL/6 * DBA/2))	increased T cell derived lymphoma incidence	J:44386
Brca2^tm1Kamc/Brca2^tm1Kamc (involves: 129P2/OlaHsd * BALB/c)	spleen hypoplasia	J:144998
Brca2^tm1Mak/Brca2^tm2Mak Trp53^tm1Brd/Trp53^tm1Brd Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CBA)	increased activated T cell number	J:79697
Brd2^{em1(IMPC)Wtsi}/Brd2⁺ (C57BL/6N-Brd2^{em1(IMPC)Wtsi}/WtsiIeg)	decreased CD8-positive, alpha-beta T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
Brd2^{em1(IMPC)Wtsi}/Brd2^{em1(IMPC)Wtsi} (C57BL/6N-Brd2^{em1(IMPC)Wtsi}/WtsiIeg)	abnormal thymus topology	J:239583
	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
	small thymus	J:239583
Brd9^em1(IMPC)Tcp/Brd9⁺ (C57BL/6N-Brd9^em1(IMPC)Tcp/Cmmr)	increased neutrophil cell number	J:211773
Brix1^{tm1b(KOMP)Mbp}/Brix1⁺ (C57BL/6N-Brix1^{tm1b(KOMP)Mbp}/Mhzh)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Brpf1^{tm1a(EUCOMM)Wtsi}/Brpf1⁺ (Not Specified)	decreased T cell number	J:165965
Brpf1^{tm1a(EUCOMM)Wtsi}/Brpf1⁺ (Not Specified)	increased monocyte cell number	J:165965
Brwd1^em1(IMPC)Tcp/Brwd1^em1(IMPC)Tcp (C57BL/6N-Brwd1^em1(IMPC)Tcp/Cmmr)	abnormal spleen morphology	J:211773
Bscl2^tm1.1Lchan/Bscl2^tm1.1Lchan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	enlarged spleen	J:183701
Bscl2^tm1.2Gliu/Bscl2^tm1.2Gliu (involves: 129 * 129S4/SvJaeSor * C57BL/6 * FVB/N)	enlarged spleen	J:173404
Bscl2^{tm1b(EUCOMM)Hmgu}/Bscl2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Bscl2^{tm1b(EUCOMM)Hmgu}/Ics)	increased large unstained cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Bsg^tm1.1Znc/Bsg^tm1.1Znc Tg(Lck-cre)19Hhan/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	decreased double-positive T cell number	J:207886
	decreased single-positive T cell number	J:207886
	decreased thymocyte number	J:207886
	decreased thymus weight	J:207886
Bsg^tm1Tmu/Bsg^tm1Tmu (involves: 129S2/SvPas)	increased spleen weight	J:287636
	increased splenocyte number	J:287636
	increased T-helper 17 cell number	J:287636
Bsp/Bsp (C57BL/6By)	abnormal spleen morphology	J:6856
Bsp/Bsp⁺ (C57BL/6By)	abnormal spleen morphology	J:6856
Bst1^tm1Thir/Bst1^tm1Thir (involves: 129P2/OlaHsd * C57BL/6)	decreased B-1 B cell number	J:111424
	decreased immature B cell number	J:111424
	increased B cell number	J:111424
Bst2^tm1.1Bsz/Bst2^tm1.1Bsz (involves: C57BL/6)	enlarged lymph nodes	J:180252
Bst2^tm1.1Bsz/Bst2^tm1.1Bsz (involves: C57BL/6)	enlarged spleen	J:180252
Btbd1^{tm1a(KOMP)Wtsi}/Btbd1^{tm1a(KOMP)Wtsi} (C57BL/6N-Btbd1^{tm1a(KOMP)Wtsi}/Wtsi)	increased CD4-positive NK T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
Btbd2^em1(IMPC)Mbp/Btbd2^em1(IMPC)Mbp (C57BL/6N-Btbd2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Btbd3^{tm1b(EUCOMM)Hmgu}/Btbd3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Btbd3^{tm1b(EUCOMM)Hmgu}/Ccpcz)	increased CD8-positive, CD25-positive alpha-beta T cell number	J:211773
Btbd7^{em1(IMPC)Ccpcz}/Btbd7^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Btbd7^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Btbd16^{tm2b(EUCOMM)Hmgu}/Btbd16^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Btbd16^{tm2b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Btbd18^{em1(IMPC)Ccpcz}/Btbd18^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Btbd18^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Btc^em1(IMPC)Mbp/Btc^em1(IMPC)Mbp (C57BL/6N-Btc^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
	increased neutrophil cell number	J:211773
Btf3^em1(IMPC)Tcp/Btf3⁺ (C57BL/6NCrl-Btf3^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
Btg1^em1(IMPC)Mbp/Btg1^em1(IMPC)Mbp (C57BL/6NCrl-Btg1^em1(IMPC)Mbp/Mmucd)	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Btk^m1Anu/Btk^m1Anu (involves: BXSB/MpJ * C57BL/6JAnu * SB/Le)	decreased B cell number	J:104190
Btk^m1Anu/Btk^m1Anu X/Yaa (involves: BXSB/MpJ * C57BL/6JAnu * SB/Le)	decreased B cell number	J:104190
Btk^m2Anu/Btk^m2Anu (C57BL/6NCrlAnu-Btk^m2Anu)	increased immature B cell number	J:104190
Btk^{tm1a(EUCOMM)Hmgu}/Y (C57BL/6N-Btk^{tm1a(EUCOMM)Hmgu}/Ics)	increased CD4-positive, alpha-beta T cell number	J:165965
Btk^tm1Gsv/Y (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:35769
	absent B-1a cells	J:35769
	absent mature B cells	J:35769
	decreased B cell number	J:35769
	decreased immature B cell number	J:35769
Btk^tm1Gsv/Y Tg(CD19-BTKK430R)XK24Rwhe/? (involves: 129P2/OlaHsd C57BL/6 * FVB)	abnormal lymphocyte cell number	J:120989
	abnormal pre-B cell morphology	J:120989
	absent B-1a cells	J:120989
	decreased B cell number	J:120989
Btk^tm1Gsv/Btk⁺ (involves: 129P2/OlaHsd * C57BL/6)	absent B-1a cells	J:35769
	decreased B cell number	J:35769
	decreased mature B cell number	J:35769
Btk^tm1Wk/Btk^tm1Wk (involves: 129S4/SvJae * C57BL/6)	abnormal B cell differentiation	J:28968
	abnormal lymph node germinal center morphology	J:82298
	decreased mature B cell number	J:28968, J:82298
	decreased spleen germinal center number	J:82298
	decreased spleen germinal center size	J:82298
	increased pro-B cell number	J:28968
Btk^tm1Wk/Btk^tm1Wk Cd40^tm1Geha/Cd40^tm1Geha (involves: 129S4/SvJae * C57BL/6)	absent lymph node germinal center	J:82298
	absent spleen germinal center	J:82298
	decreased B cell number	J:82298
	decreased mature B cell number	J:82298
Btk^tm1Wk/Btk^tm1Wk Tec^tm1Welm/Tec^tm1Welm (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:66080
	abnormal spleen marginal zone morphology	J:66080
	abnormal spleen morphology	J:66080
	abnormal spleen white pulp morphology	J:66080
	decreased B cell number	J:66080
	increased pre-B cell number	J:66080
Btk^vila/Btk^vila (C57BL/6JAnu-Btk^vila/AnuApb)	abnormal leukocyte morphology	J:104190
Btk^vila/Btk^vila (C57BL/6JAnu-Btk^vila/AnuApb)	decreased B cell number	J:104190
Btk^xid/Y (CBA/HN-Btk^xid)	decreased B cell number	J:81429
Btk^xid/Y (CBA/HN-Btk^xid)	decreased splenocyte number	J:81429
Btk^xid/Y (involves: CBA/HN * DBA/2N)	decreased B cell number	J:81429
Btk^xid/Y (involves: CBA/HN * DBA/2N)	spleen hypoplasia	J:81429
Btk^xid/? (involves: BALB/c * CBA/N)	decreased B-1 B cell number	J:108696
Btk^xid/? (involves: BALB/c * CBA/N)	decreased mature B cell number	J:108696
Btk^xid/Y Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129S4/SvJae * CBA/CaHN)	decreased follicular B cell number	J:69477
Btk^xid/? Tg(IGH-Btk)1Witt/0 (involves: BALB/c * C3H * C57BL/6 * CBA/N)	decreased B-1 B cell number	J:108696
Btk^xid/? Tg(IGH-Btk)1Witt/Tg(IGH-Btk)1Witt (involves: BALB/c * C3H * C57BL/6 * CBA/N)	decreased B-1 B cell number	J:108696
Btk^xid/Btk^xid (CBA/CaHN-Btk^xid/J)	decreased follicular B cell number	J:69477
	decreased neutrophil cell number	J:92639
	impaired myelopoiesis	J:92639
Btk^xid/Btk^xid (involves: CBA/HN * DBA/2N)	decreased B cell number	J:81429
Btk^xid/Btk^xid (involves: CBA/HN * DBA/2N)	spleen hypoplasia	J:81429
Btk^xid/Btk^xid (CBA/HN-Btk^xid)	abnormal lymphopoiesis	J:7981
	abnormal pre-B cell morphology	J:7981
	decreased B cell number	J:81429
	decreased splenocyte number	J:81429
Btk^xid/Btk^xid (B6.CBA-Btk^xid)	decreased transitional stage B cell number	J:145687
Btk^xid/Btk^xid Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129S4/SvJae * CBA/CaHN)	decreased follicular B cell number	J:69477
Btnl1^em1Ahay/Btnl1^em1Ahay (Not Specified)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:236526
Btnl1^em1Ahay/Btnl1^em1Ahay (Not Specified)	decreased gamma-delta intraepithelial T cell number	J:236526
Btnl1^tm1(KOMP)Mbp/Btnl1^tm1(KOMP)Mbp (C57BL/6N-Btnl1^tm1(KOMP)Mbp)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:236526
	decreased gamma-delta intraepithelial T cell number	J:236526
Btnl1^tm1(KOMP)Mbp/Btnl1^tm1(KOMP)Mbp Foxn1^nu/Foxn1^nu (involves: albino stock * C57BL/6N)	decreased gamma-delta intraepithelial T cell number	J:236526
Btnl1^tm1(KOMP)Mbp/Btnl1^tm1(KOMP)Mbp Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/0 Tg(tetO-Btnl1)#Ahay/0 (involves: 129S4/SvJae C57BL/6 * C57BL/6N)	decreased gamma-delta intraepithelial T cell number	J:236526
Btnl1^tm1(KOMP)Mbp/Btnl1^tm1(KOMP)Mbp Tg(tetO-Btnl1)#Ahay/0 Tg(Vil-rtTA2M2)1Rsmi/0 (involves: C57BL/6N FVB/N)	decreased gamma-delta intraepithelial T cell number	J:236526
Btnl2^em1Wche/Btnl2^em1Wche (C57BL/6-Btnl2^em1Wche)	abnormal gamma-delta T cell morphology	J:321348
Btnl4^em1(IMPC)Tcp/Btnl4^em1(IMPC)Tcp (C57BL/6N-Btnl4^em1(IMPC)Tcp/1Cmmr)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Btnl6^em1.1Ahay/Btnl6^em1.1Ahay (Not Specified)	decreased CD4-positive, gamma-delta intraepithelial T cell number	J:291989
Btnl6^em1Ahay/Btnl6^em1Ahay Tg(Vil1-cre)20Syr/0 (involves: C57BL/6 * DBA/2)	decreased CD4-positive, gamma-delta intraepithelial T cell number	J:291989
Btrc^{tm1b(KOMP)Wtsi}/Btrc^{tm1b(KOMP)Wtsi} (C57BL/6N-Btrc^{tm1b(KOMP)Wtsi}/H)	increased monocyte cell number	J:211773
Btrc^tm1Kin/Btrc^tm1Kin (involves: C57BL/6)	abnormal lymphocyte morphology	J:84639
Bub1^tm1.1Tvd/Bub1^tm1.1Tvd (B6.129P2-Bub1^tm1.1Tvd)	increased leukocyte cell number	J:143035
Bub1b^{Gt(neo-btk)1Dai}/Bub1b⁺ (involves: 129S4/SvJae * C57BL/6)	enlarged spleen	J:88223
Bub1b^tm1.1Hsl/Bub1b⁺ (involves: 129 * C57BL/6)	enlarged spleen	J:201641
Bub1b^tm1.1Hsl/Bub1b⁺ (involves: 129 * C57BL/6)	increased spleen white pulp amount	J:201641
Bud13^{em1(IMPC)Ccpcz}/Bud13⁺ (C57BL/6NCrl-Bud13^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
Bxs6^BXSB/MpJ/Bxs6^BXSB/MpJ X/Yaa (B10.BXSB-(D13Mit3-D13Mit78) Yaa)	enlarged spleen	J:145049
C1galt1^ptl1/C1galt1^ptl1 (C57BL/6-C1galt1^ptl1)	abnormal thrombopoiesis	J:115272
C1ql2^em1(IMPC)Mbp/C1ql2^em1(IMPC)Mbp (C57BL/6N-C1ql2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
C1ql3^em1(IMPC)H/C1ql3^em1(IMPC)H (C57BL/6NTac-C1ql3^em1(IMPC)H/H)	decreased eosinophil cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
C1ql4^tm1Lex/C1ql4^tm1Lex (B6.129S5-C1ql4^tm1Lex)	decreased leukocyte cell number	J:344722
C1ql4^tm1Lex/C1ql4^tm1Lex (B6.129S5-C1ql4^tm1Lex)	decreased lymphocyte cell number	J:344722
C1qtnf1^em1(IMPC)Mbp/C1qtnf1^em1(IMPC)Mbp (C57BL/6N-C1qtnf1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
C1qtnf4^em1Smoc/C1qtnf4^em1Smoc (C57BL/6JSmoc-C1qtnf4^em1Smoc/Smoc)	abnormal macrophage differentiation	J:302282
C1qtnf6^tm1Yiw/C1qtnf6^tm1Yiw (B6.129P2-C1qtnf6^tm1Yiw)	increased B cell number	J:227217
C1qtnf7^{tm1(KOMP)Vlcg}/C1qtnf7^{tm1(KOMP)Vlcg} (C57BL/6N-C1qtnf7^{tm1(KOMP)Vlcg})	increased macrophage cell number	J:244352
C2cd3^em1(IMPC)Tcp/C2cd3⁺ (C57BL/6N-C2cd3^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
C2cd3^em1(IMPC)Tcp/C2cd3⁺ (C57BL/6N-C2cd3^em1(IMPC)Tcp/Tcp)	increased neutrophil cell number	J:211773
C3^tm1Crr/C3^tm1Crr (involves: 129S4/SvJae * C57BL/6)	abnormal immune system morphology	J:44240
	abnormal spleen germinal center morphology	J:64282
	decreased mast cell number	J:44240
	decreased neutrophil cell number	J:44240
	decreased osteoclast cell number	J:166640
	decreased spleen germinal center number	J:64282
	decreased spleen germinal center size	J:64282
C3^tm1Crr/C3^tm1Crr (B6.129S4-C3^tm1Crr)	abnormal neutrophil morphology	J:113463
C3^tm1Crr/C3^tm1Crr C4b^tm1Crr/C4b^tm1Crr Fas^lpr/Fas^lpr (involves: 129S4/SvJae * C57BL/6 * MRL)	enlarged cervical lymph nodes	J:127292
	enlarged spleen	J:127292
C3ar1^tm1Cge/C3ar1^tm1Cge (involves: 129S4/SvJae * C57BL/6)	decreased osteoclast cell number	J:166640
C3ar1^tm1Raw/C3ar1^tm1Raw (B6.129X1(B6)-C3ar1^tm1Raw)	abnormal T-helper 2 cell differentiation	J:80071
	decreased eosinophil cell number	J:80071
	decreased lymphocyte cell number	J:80071
	decreased neutrophil cell number	J:80071
C4b^tm1Crr/C4b^tm1Crr (involves: 129S4/SvJae * C57BL/6)	abnormal spleen germinal center morphology	J:64282
	decreased spleen germinal center number	J:64282
	decreased spleen germinal center size	J:64282
C4b^tm1Crr/C4b^tm1Crr (involves: 129S4/SvJae * C57BL/6J)	increased macrophage cell number	J:111811
	increased neutrophil cell number	J:111811
	increased spleen germinal center number	J:111811
	increased spleen weight	J:111811
C4b^tm1Crr/C4b^tm1Crr Fas^lpr/Fas^lpr (involves: 129S4/SvJae * C57BL/6 * MRL)	enlarged cervical lymph nodes	J:127292
	enlarged spleen	J:127292
C5ar1^tm1Cge/C5ar1^tm1Cge (involves: 129S4/SvJae * C57BL/6)	decreased osteoclast cell number	J:166640
C5ar1^tm1Raw/C5ar1^tm1Raw (B6.Cg-C5ar1^tm1Raw)	increased spleen germinal center number	J:139786
C5ar2^em1(IMPC)H/C5ar2^em1(IMPC)H (C57BL/6NTac-C5ar2^em1(IMPC)H/H)	decreased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
C8a^{tm1b(EUCOMM)Hmgu}/C8a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-C8a^{tm1b(EUCOMM)Hmgu}/Tcp)	increased lymphocyte cell number	J:211773
C9orf72^em1Eggn/C9orf72^em1Eggn (involves: C57BL/6)	enlarged cervical lymph nodes	J:240357
C9orf72^em1Eggn/C9orf72^em1Eggn (involves: C57BL/6)	enlarged spleen	J:240357
C9orf72^em5Lutzy/C9orf72^em5Lutzy (C57BL/6-C9orf72^em5Lutzy)	enlarged lymph nodes	J:101977
	enlarged spleen	J:101977
C9orf72^{tm1.1(KOMP)Mbp}/C9orf72^{tm1.1(KOMP)Mbp} (C57BL/6N-C9orf72^{tm1.1(KOMP)Mbp}/Ucd)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
C9orf72^tm1.1Eggn/C9orf72^tm1.1Eggn (involves: C57BL/6 * C57BL/6N)	abnormal lymphocyte morphology	J:240357
	abnormal spleen morphology	J:240357
	enlarged spleen	J:240357
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:240357
	increased leukocyte cell number	J:240357
	increased neutrophil cell number	J:240357
	increased splenocyte number	J:240357
C9orf72^tm1Eggn/C9orf72^tm1Eggn (involves: C57BL/6 * C57BL/6N)	abnormal lymphocyte morphology	J:240357
	enlarged cervical lymph nodes	J:240357
	enlarged spleen	J:240357
	increased leukocyte cell number	J:240357
	increased neutrophil cell number	J:240357
C9orf72^tm1Lagi/C9orf72^tm1Lagi (involves: C57BL/6 * C57BL/6N)	abnormal celiac lymph node morphology	J:232242
	abnormal cervical lymph node morphology	J:232242
	abnormal lymph node cell ratio	J:232242
	decreased lymphocyte cell number	J:232242
	enlarged cervical lymph nodes	J:232242
	enlarged spleen	J:232242
	increased neutrophil cell number	J:232242
Cabin1^{em1(IMPC)Ccpcz}/Cabin1⁺ (C57BL/6NCrl-Cabin1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Cabp1^{tm1b(EUCOMM)Wtsi}/Cabp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cabp1^{tm1b(EUCOMM)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Cacna1a^tg-6J/Cacna1a^tg-6J (involves: BALB/cByJ * C57BL/6J)	abnormal spleen red pulp morphology	J:82238
	thymus atrophy	J:82238
Cacna1g^em1(IMPC)Mbp/Cacna1g^em1(IMPC)Mbp (C57BL/6N-Cacna1g^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
Cacna1i^{tm1b(KOMP)Wtsi}/Cacna1i^{tm1b(KOMP)Wtsi} (C57BL/6N-Cacna1i^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Cacna2d1^em1(IMPC)Mbp/Cacna2d1^em1(IMPC)Mbp (C57BL/6N-Cacna2d1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	increased monocyte cell number	J:211773
	small spleen	J:211773
Cacna2d2^em1(IMPC)Mbp/Cacna2d2⁺ (C57BL/6N-Cacna2d2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Cacna2d2^em1(IMPC)Mbp/Cacna2d2^em1(IMPC)Mbp (C57BL/6N-Cacna2d2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Cacna2d2^tm1Svi/Cacna2d2^tm1Svi (involves: 129S1/Sv * C57BL/6J)	thymus hypoplasia	J:92396
Cacnb4^lh/Cacnb4^lh (B6EiC3Sn a/A-Cacnb4^lh/J)	abnormal lymph node morphology	J:5281
	abnormal Peyer's patch germinal center morphology	J:5281
	absent thymus corticomedullary boundary	J:5281
	decreased double-positive T cell number	J:115345
	decreased lymphocyte cell number	J:5281
	decreased Peyer's patch number	J:5281
	enlarged lymph nodes	J:5281
	small Peyer's patches	J:5281
	small spleen	J:5281
	small thymus	J:5281
Cactin^{em1(IMPC)Ccpcz}/Cactin⁺ (C57BL/6NCrl-Cactin^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Cacybp^{GT(OST39970)Lex}/Cacybp^{GT(OST39970)Lex} (involves: 129S5/SvEvBrd)	abnormal spleen white pulp morphology	J:110899
	abnormal T cell morphology	J:110899
	decreased thymocyte number	J:110899
	small thymus medulla	J:110899
	spleen hypoplasia	J:110899
	thymus hypoplasia	J:110899
Cacybp^{tm1b(EUCOMM)Wtsi}/Cacybp⁺ (C57BL/6N-Cacybp^{tm1b(EUCOMM)Wtsi}/Tcp)	increased neutrophil cell number	J:211773
Cadm1^{Gt(Ayu21-W34)Imeg}/Cadm1^{Gt(Ayu21-W34)Imeg} (involves: C57BL/6 * CBA/JNCrlj)	abnormal T cell differentiation	J:178612
	abnormal T cell receptor V(D)J recombination	J:178612
	decreased CD4-positive, alpha-beta T cell number	J:178612
	decreased CD8-positive, alpha-beta T cell number	J:178612
	increased double-positive T cell number	J:178612
Cadps2^{em1(IMPC)Rbrc}/Cadps2^{em1(IMPC)Rbrc} (C57BL/6NJcl-Cadps2^{em1(IMPC)Rbrc}/Rbrc)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Calb1^{em1(IMPC)Ccpcz}/Calb1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Calb1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Calcr^tm1Dgal/Calcr⁺ Iapp^tm1Sgm/Iapp⁺ (involves: 129P2/OlaHsd)	increased osteoclast cell number	J:88964
Calcrl^tm1Kmca/Calcrl^tm1Kmca (129S6/SvEvTac-Calcrl^tm1Kmca)	abnormal lymph organ development	J:130930
Calcrl^tm1Kmca/Calcrl^tm1Kmca (involves: 129S6/SvEvTac)	decreased uterine NK cell number	J:201446
Calu^em1(IMPC)Tcp/Calu⁺ (C57BL/6N-Calu^em1(IMPC)Tcp/Tcp)	small lymph nodes	J:211773
Camk1d^em1(IMPC)Mbp/Camk1d^em1(IMPC)Mbp (C57BL/6NCrl-Camk1d^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Camk4^{em1(IMPC)Ccpcz}/Camk4^{em1(IMPC)Ccpcz} (C57BL/6N-Camk4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Camk4^tm1Tch/Camk4^tm1Tch (B6.129X1-Camk4^tm1Tch)	abnormal osteoclast differentiation	J:129599
Camk4^tm1Tch/Camk4^tm1Tch (B6.129X1-Camk4^tm1Tch)	decreased osteoclast cell number	J:129599
Caml^tm1Rjb/Caml^tm2Rjb Tg(Lck-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	decreased single-positive T cell number	J:100536
	decreased thymocyte number	J:100536
Caml^tm1Rjb/Caml^tm2Rjb Tg(Lck-cre)1Cwi/0 Tg(TcraTcrb)1100Mjb/0 (involves: 129 * C57BL/6 * DBA/2)	abnormal negative T cell selection	J:100536
	abnormal positive T cell selection	J:100536
	decreased thymocyte number	J:100536
Camp^tm1.1Jimw/Camp^tm1.1Jimw (involves: C57BL/6)	decreased dendritic cell number	J:199611
Camp^tm1Rlg/Camp^tm1Rlg (involves: 129X1/SvJ * C57BL/6)	increased neutrophil cell number	J:199719
Camsap3^{tm1a(EUCOMM)Wtsi}/Camsap3^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Camsap3^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased gamma-delta T cell number	J:211773
	increased leukocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Cand1^em1(IMPC)Mbp/Cand1⁺ (C57BL/6NCrl-Cand1^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Canx^{em1(IMPC)Ccpcz}/Canx⁺ (C57BL/6NCrl-Canx^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Canx^{em1(IMPC)Ccpcz}/Canx^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Canx^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Capza1^em1(IMPC)Tcp/Capza1^em1(IMPC)Tcp (C57BL/6NCrl-Capza1^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Car6^{em1(IMPC)Ccpcz}/Car6^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Car6^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased NK cell number	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
Car6^tm1Pwp/Car6^tm1Pwp (B6.129S6-Car6^tm1Pwp)	abnormal Peyer's patch follicle morphology	J:172854
Car9^tm1Lex/Car9^tm1Lex (B6;129S5-Car9^tm1Lex/Mmucd)	increased mature B cell number	J:171883
Card11^{em1(IMPC)Ccpcz}/Card11^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Card11^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased spleen weight	J:211773
	enlarged thymus	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased T cell number	J:211773
	increased T-helper cell number	J:211773
	small spleen	J:211773
Card11^em1Welu/Card11⁺ (involves: C57BL/6)	decreased marginal zone B cell number	J:292926
	decreased transitional stage T1 B cell number	J:292926
	decreased transitional stage T3 B cell number	J:292926
	increased transitional stage T2 B cell number	J:292926
Card11^em1Welu/Card11^em1Welu (involves: C57BL/6)	abnormal B cell differentiation	J:292926
	abnormal germinal center B cell morphology	J:292926
	abnormal plasma cell differentiation	J:292926
	decreased B-1 B cell number	J:292926
	decreased B-1a cell number	J:292926
	decreased germinal center B cell number	J:292926
	decreased marginal zone B cell number	J:292926
	decreased pre-B cell number	J:292926
	decreased transitional stage T1 B cell number	J:292926
	decreased transitional stage T3 B cell number	J:292926
	increased follicular B cell number	J:292926
	increased transitional stage T2 B cell number	J:292926
Card11^em2Welu/Card11⁺ (involves: C57BL/6)	increased B-1 B cell number	J:292926
Card11^em2Welu/Card11⁺ (involves: C57BL/6)	increased marginal zone B cell number	J:292926
Card11^em2Welu/Card11^em2Welu (involves: C57BL/6)	abnormal plasma cell differentiation	J:292926
	decreased mature B cell number	J:292926
	enlarged spleen	J:292926
	increased B-1a cell number	J:292926
	increased B-1b cell number	J:292926
	increased germinal center B cell number	J:292926
	increased marginal zone B cell number	J:292926
	increased pre-B cell number	J:292926
	increased transitional stage T2 B cell number	J:292926
Card11^em3Welu/Card11^em3Welu (Not Specified)	decreased B-1 B cell number	J:292926
Card11^em3Welu/Card11^em3Welu (Not Specified)	decreased marginal zone B cell number	J:292926
Card11^m1Btlr/Card11^m1Btlr (C57BL/6J-Card11^m1Btlr)	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:149767
	abnormal double-negative T cell morphology	J:149767, J:139069
	decreased B-1 B cell number	J:149767, J:139069
	decreased gamma-delta T cell number	J:149767, J:139069
	decreased mature B cell number	J:149767, J:139069
	decreased memory T cell number	J:149767, J:139069
	decreased NK cell number	J:149767, J:139069
	decreased NK T cell number	J:149767, J:139069
	decreased regulatory T cell number	J:149767
Card11^m3Btlr/Card11^m3Btlr (C57BL/6J-Card11^m3Btlr)	increased B-1a cell number	J:221487
Card11^M4Btlr/Card11⁺ (C57BL/6J-Card11^M4Btlr)	decreased B-1a cell number	J:254856
Card11^M4Btlr/Card11⁺ (C57BL/6J-Card11^M4Btlr)	increased B-1b cell number	J:254856
Card11^M4Btlr/Card11^M4Btlr (C57BL/6J-Card11^M4Btlr)	decreased B-1a cell number	J:254856
Card11^M4Btlr/Card11^M4Btlr (C57BL/6J-Card11^M4Btlr)	increased B-1b cell number	J:254856
Card11^M5Btlr/Card11⁺ (C57BL/6J-Card11^M5Btlr)	increased B-1 B cell number	J:254879
Card11^M5Btlr/Card11⁺ (C57BL/6J-Card11^M5Btlr)	increased B-1a cell number	J:254879
Card11^M5Btlr/Card11^M5Btlr (C57BL/6J-Card11^M5Btlr)	increased B-1 B cell number	J:254879
Card11^M5Btlr/Card11^M5Btlr (C57BL/6J-Card11^M5Btlr)	increased B-1a cell number	J:254879
Card11^M6Btlr/Card11^M6Btlr (C57BL/6J-Card11^M6Btlr)	increased alpha-beta T cell number	J:272116
Card11^M7Btlr/Card11^M7Btlr (C57BL/6J-Card11^M7Btlr)	abnormal T cell differentiation	J:274762
	decreased B cell number	J:274762
	decreased B-1 B cell number	J:274762
	decreased central memory CD4-positive, alpha-beta T cell number	J:274762
	decreased effector memory CD4-positive, alpha-beta T cell number	J:274762
	decreased effector memory CD8-positive, alpha-beta T cell number	J:274762
	increased CD4-positive, alpha-beta T cell number	J:274762
	increased CD8-positive, alpha-beta T cell number	J:274762
	increased T cell number	J:274762
Card11^m8Btlr/Card11^m8Btlr (C57BL/6J-Card11^m8Btlr)	abnormal B cell differentiation	J:274940
	decreased B cell number	J:274940
	decreased B-1a cell number	J:274940
	decreased effector memory CD8-positive, alpha-beta T cell number	J:274940
	increased B-1b cell number	J:274940
	increased CD4-positive, alpha-beta T cell number	J:274940
	increased CD8-positive, alpha-beta T cell number	J:274940
	increased NK T cell number	J:274940
	increased T cell number	J:274940
Card11^tm1Litt/Card11^tm1Litt (involves: 129P2/OlaHsd)	abnormal double-negative T cell morphology	J:89322
	abnormal T cell differentiation	J:89322
	absent B-1a cells	J:89322
Card11^tm1Pngr/Card11^tm1Pngr (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:84036
	abnormal lymphocyte morphology	J:84036
	absent B-1a cells	J:84036
	decreased NK cell number	J:84036
Card11^tm1Vmd/Card11^tm1Vmd (involves: 129S6/SvEvTac * C57BL/6N)	absent immature B cells	J:95800
Card11^tm1Xav/Card11^tm1Xav (involves: 129 * C57BL/6)	abnormal T-helper 2 cell differentiation	J:132226
	increased CD4-positive, alpha-beta T cell number	J:132226
	increased CD8-positive, alpha-beta T cell number	J:132226
Card11^unm/Card11^unm (C57BL/6JSfdAnu-Card11^unm/Anu)	abnormal B cell differentiation	J:84042
	decreased B-1 B cell number	J:84042
	lymph node hyperplasia	J:84042
	spleen hyperplasia	J:84042
Card14^em2Tshu/Card14⁺ (involves: C57BL/6)	abnormal gamma-delta T cell number	J:289239
Card14^em2Tshu/Card14⁺ (involves: C57BL/6)	increased alpha-beta T cell number	J:289239
Card19^tm1Rwen/Card19^tm1Rwen Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JSfd)	decreased B cell number	J:336763
	increased B cell number	J:336763
Carm1^{tm1b(EUCOMM)Hmgu}/Carm1⁺ (C57BL/6N-Carm1^{tm1b(EUCOMM)Hmgu}/Nju)	decreased lymphocyte cell number	J:211773
Carm1^tm1Mtb/Carm1^tm1Mtb (involves: 129S6/SvEvTac)	arrested T cell differentiation	J:159958
Carm1^tm2.1Mtb/Carm1^tm2.1Mtb (involves: 129S4/SvJaeSor * 129S6/SvEvTac * Black Swiss)	arrested T cell differentiation	J:159958
	thymus hypoplasia	J:159958
Carmil2^bas/Carmil2^bas (involves: C3HeB/FeJ * C57BL/6)	decreased regulatory T cell number	J:205441
Carmil2^bas/Carmil2^bas (involves: C3HeB/FeJ * C57BL/6)	enlarged thymus	J:205441
Carmil2^bas/Carmil2^{tm1a(KOMP)Mbp} (involves: C3HeB/FeJ * C57BL/6 * C57BL/6N)	decreased regulatory T cell number	J:205441
Carmil3^em1(IMPC)Mbp/Carmil3^em1(IMPC)Mbp (C57BL/6N-Carmil3^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Cartpt^tm1Hmh/Cartpt^tm1Hmh (Not Specified)	abnormal osteoclast morphology	J:97566
Cartpt^tm1Hmh/Cartpt^tm1Hmh (Not Specified)	increased osteoclast cell number	J:97566
Casp3^tm1Flv/Casp3^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal bone marrow development	J:94703
Casp3^tm1Flv/Casp3^tm1Flv (involves: 129S1/Sv * C57BL/6)	decreased thymocyte number	J:36821
Casp3^tm1Flv/Casp3^tm1Flv Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0 (involves: 129S1/Sv * C57BL/6 * CBA)	increased lymphocyte cell number	J:100854
	increased macrophage cell number	J:100854
	increased neutrophil cell number	J:100854
Casp3^tm1Mak/Casp3^tm1Mak Tg(TcrLCMV)327Sdz/0 (B6.Cg-Casp3^tm1Mak Tg(TcrLCMV)327Sdz)	abnormal CD8-positive, alpha beta T cell morphology	J:97650
Casp8^{em1(IMPC)Ccpcz}/Casp8⁺ (C57BL/6NCrl-Casp8^{em1(IMPC)Ccpcz}/Ccpcz)	decreased lymphocyte cell number	J:211773
Casp8^em1Hbz/Casp8^em1Hbz (involves: C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:342732
Casp8^em1Hbz/Casp8^em1Hbz (involves: C57BL/6)	enlarged spleen	J:342732
Casp8^em1Hbz/Casp8^em1Hbz Mlkl^em1Hbz/Mlkl^em1Hbz (involves: C57BL/6)	decreased B cell number	J:342732
	decreased leukocyte cell number	J:342732
	decreased lymphocyte cell number	J:342732
	decreased mature B cell number	J:342732
	decreased T cell number	J:342732
	enlarged spleen	J:342732
	increased CD11b-high dendritic cell number	J:342732
	increased granulocyte number	J:342732
	increased macrophage cell number	J:342732
Casp8^em1Hbz/Casp8^em1Hbz Ripk1^em1Hbz/Ripk1^em1Hbz Ripk3^tm1Xidw/Ripk3^tm1Xidw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased leukocyte cell number	J:342732
	decreased lymphocyte cell number	J:342732
	decreased mature B cell number	J:342732
	decreased T cell number	J:342732
Casp8^em1Hbz/Casp8^em1Hbz Ripk3^tm1Xidw/Ripk3^tm1Xidw (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased B cell number	J:342732
	decreased leukocyte cell number	J:342732
	decreased lymphocyte cell number	J:342732
	decreased mature B cell number	J:342732
	decreased T cell number	J:342732
	enlarged spleen	J:342732
	increased CD11b-high dendritic cell number	J:342732
	increased granulocyte number	J:342732
	increased macrophage cell number	J:342732
Casp8^m1Btlr/Casp8^m1Btlr (C57BL/6J-Casp8^m1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:255007
	decreased CD8-positive, naive alpha-beta T cell number	J:255007
	decreased T cell number	J:255007
	increased CD8-positive, alpha-beta T cell number	J:255007
	increased effector memory CD4-positive, alpha-beta T cell number	J:255007
Casp8^M2Btlr/Casp8^M2Btlr (C57BL/6J-Casp8^M2Btlr)	increased effector memory CD8-positive, alpha-beta T cell number	J:272851
Casp8^tm1.1Raz/Casp8^tm1.1Raz Otulin^em1Gvl/Otulin^em1Gvl Ripk3^tm1Vmd/Ripk3^tm1Vmd (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)	enlarged lymph nodes	J:312394
Casp8^tm1.1Raz/Casp8^tm1.1Raz Ripk3^tm1Vmd/Ripk3^tm1Vmd (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	enlarged axillary lymph nodes	J:170815
	enlarged cervical lymph nodes	J:170815
	enlarged lymph nodes	J:170814
	enlarged spleen	J:170815, J:170814
	enlarged thymus	J:170814
	increased B cell number	J:170815
	increased leukocyte cell number	J:170815
	increased spleen white pulp amount	J:170815
	increased T cell number	J:170815, J:170814
	large lymphoid organs	J:170814
	lymph node hyperplasia	J:170815
Casp8^tm1.1Vmd/Casp8^tm1.1Vmd Ripk3^tm2Vmd/Ripk3^tm2Vmd (involves: C57BL/6N)	enlarged lymph nodes	J:209137
	enlarged spleen	J:209137
	increased T cell number	J:209137
Casp8^tm1Hed/Casp8^tm1Hed Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	decreased B cell number	J:116713
	decreased B-1 B cell number	J:116713
	decreased marginal zone B cell number	J:116713
	spleen hypoplasia	J:116713
Casp8^tm1Hed/Casp8^tm1Hed Tg(KRT14-cre)1Efu/0 (Not Specified)	increased mast cell number	J:167299
Casp8^tm1Raz/Casp8^tm1Raz Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal lymphocyte morphology	J:107455
	abnormal T cell morphology	J:82759
	abnormal T cell subpopulation ratio	J:107455, J:82759
	decreased CD4-positive, alpha-beta T cell number	J:82759
	decreased CD8-positive, alpha-beta T cell number	J:82759
	decreased leukocyte cell number	J:107455
	decreased T cell number	J:82759
	enlarged lymph nodes	J:107455
	enlarged spleen	J:107455
	increased B cell number	J:107455
	increased lymphocyte cell number	J:107455
	increased T cell number	J:107455
	lymphoid hyperplasia	J:107455
Casp8^tm1Wll/Casp8^tm1.1Yuan Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129S1/Sv * 129X1/SvJ * MF1)	abnormal macrophage differentiation	J:92722
Casp14^{em1(IMPC)Ccpcz}/Casp14^{em1(IMPC)Ccpcz} (C57BL/6N-Casp14^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Casz1^{Gt(CJ0565)Wtsi}/Casz1^{Gt(CJ0565)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphatic vessel morphology	J:242127
	enlarged lymphatic vessel	J:242127
Cav1^tm1Mls/Cav1^tm1Mls (involves: 129/Sv * C57BL/6 * SJL)	abnormal osteoclast morphology	J:141361
Cbfa2t3^tm1.1Swh/Cbfa2t3^tm1.1Swh (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal myelopoiesis	J:140967
	decreased immature B cell number	J:140967
	enlarged spleen	J:140967
Cbfb^tm1Itan/Cbfb^tm1Itan Rr94^tm3.1Litt/Rr94^tm3.1Litt Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)	abnormal double-positive T cell morphology	J:158962
	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	decreased double-positive T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
	increased double-positive T cell number	J:158962
Cbfb^tm1Itan/Cbfb^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal CD8-positive, alpha beta T cell morphology	J:158962, J:125953
	abnormal CD8-positive, alpha-beta T cell number	J:125953
	abnormal T cell differentiation	J:125953
	abnormal T-helper 1 cell differentiation	J:125953
	decreased CD8-positive, alpha-beta T cell number	J:158962
	increased double-positive T cell number	J:158962
Cbfb^tm1Itan/Cbfb^tm1Itan Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd)	abnormal CD4-positive T cell differentiation	J:125953
	abnormal CD8-positive, alpha-beta T cell differentiation	J:125953
	abnormal double-positive T cell morphology	J:125953
	abnormal T-helper 1 cell differentiation	J:125953
	decreased thymocyte number	J:125953
Cbfb^tm1Itan/Cbfb^tm1Itan Zbtb7b^tm2Litt/Zbtb7b⁺ Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:141144
	decreased CD4-positive, alpha-beta T cell number	J:141144
Cbfb^tm1Itan/Cbfb^tm1Itan Zbtb7b^tm2Litt/Zbtb7b^tm1.2Litt Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:141144
	decreased CD4-positive, alpha-beta T cell number	J:141144
Cbfb^tm1Lhc/Cbfb^tm1Lhc Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal myelopoiesis	J:105040
	abnormal spleen morphology	J:105040
	enlarged spleen	J:105040
	increased leukocyte cell number	J:105040
Cbfb^tm1Spe/Cbfb^tm1Spe Tg(Tek-GFP/Cbfb)1Spe/0 (either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1))	abnormal myelopoiesis	J:80670
	abnormal splenic cell ratio	J:80670
	increased CD4-positive, alpha-beta T cell number	J:80670
	small thymus	J:80670
	spleen hypoplasia	J:80670
Cbfb^tm1Spe/Cbfb^tm1Spe Tg(Tek-GFP/Cbfb)2Spe/0 (either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster))	abnormal myelopoiesis	J:80670
	abnormal splenic cell ratio	J:80670
	increased CD4-positive, alpha-beta T cell number	J:80670
	small thymus	J:80670
	spleen hypoplasia	J:80670
Cbfb^tm1Spe/Cbfb^tm2.1Spe (involves: 129S4/SvJae)	abnormal splenic cell ratio	J:124224
	abnormal T cell differentiation	J:124224
	abnormal thymus cell ratio	J:124224
	abnormal thymus morphology	J:124224
	decreased double-positive T cell number	J:124224
	increased CD4-positive, alpha-beta T cell number	J:124224
	thymus hypoplasia	J:124224
Cbfb^tm1Tok/Cbfb^tm1Tok Tg(Gata1-Cbfb)1Tok/0 (involves: 129P2/OlaHsd * C57BL/6J)	absent T cells	J:80668
	decreased lymphocyte cell number	J:80668
	small spleen	J:80668
	small thymus	J:80668
Cbfb^tm2.1Spe/Cbfb^tm2.1Spe (involves: 129S4/SvJae)	abnormal splenic cell ratio	J:124224
	abnormal T cell differentiation	J:124224
	abnormal thymus cell ratio	J:124224
	abnormal thymus morphology	J:124224
	decreased double-positive T cell number	J:124224
	increased CD4-positive, alpha-beta T cell number	J:124224
	thymus hypoplasia	J:124224
Cbfb^tm2Itan/Cbfb^tm2Itan (Not Specified)	abnormal lymph organ development	J:168918
	abnormal peripheral lymph node morphology	J:168918
	absent Peyer's patches	J:168918
	decreased Peyer's patch number	J:168918
Cbfb^tm5Ppl/Cbfb⁺ (Not Specified)	abnormal mononuclear cell differentiation	J:193140
Cbfb^tm5Ppl/Cbfb⁺ (Not Specified)	myeloid hyperplasia	J:193140
Cbfb^tm6Ppl/Cbfb⁺ (involves: 129S/SvEv * C57BL/6)	decreased B cell number	J:252447
Cbl^tm1.1Hua/Cbl^tm1.1Hua Lat^tm1Les/Lat^tm1Les (involves: 129P2/OlaHsd)	abnormal thymus development	J:91369
	increased CD4-positive, alpha-beta T cell number	J:91369
	thymus hypoplasia	J:91369
Cbl^tm1.1Hua/Cbl^tm1.1Hua Lcp2^tm1Gak/Lcp2^tm1Gak (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal T cell differentiation	J:91369
	enlarged spleen	J:91369
	increased CD4-positive, alpha-beta T cell number	J:91369
Cbl^tm1.1Hua/Cbl^tm1.1Hua Lcp2^tm1Gak/Lcp2^tm1Gak Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129P2/OlaHsd * 129S/SvEv * 129S1/Sv * 129X1/SvJ)	abnormal T cell differentiation	J:91369
Cbl^tm1Ddlb/Cbl^tm1Ddlb (involves: 129S1/Sv * C57BL/6J)	abnormal lymph node cell ratio	J:76895
	abnormal spleen morphology	J:76895
	abnormal splenic cell ratio	J:76895
	abnormal thymus cell ratio	J:76895
	enlarged lymph nodes	J:76895
	enlarged spleen	J:76895
Cbl^tm1Ddlb/Cbl^tm1Ddlb (involves: 129S1/Sv)	enlarged spleen	J:81965
	increased spleen red pulp amount	J:81965
	spleen hyperplasia	J:81965
Cbl^tm1Ddlb/Cbl^tm1Ddlb (involves: 129S1/Sv * C57BL/6)	enlarged spleen	J:103366
	increased spleen red pulp amount	J:103366
	spleen hyperplasia	J:103366
Cbl^tm1Ddlb/Cbl^tm2Wlan (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal double-negative T cell morphology	J:103366
	abnormal lymph node cell ratio	J:103366
	abnormal spleen morphology	J:103366
	abnormal splenic cell ratio	J:103366
	abnormal T cell differentiation	J:103366
	abnormal thymus morphology	J:103366
	abnormal thymus size	J:103366
	decreased single-positive T cell number	J:103366
	enlarged spleen	J:103366
	increased spleen red pulp amount	J:103366
	spleen hyperplasia	J:103366
	thymus hypoplasia	J:103366
Cbl^tm1Soga/Cbl^tm1Soga (Not Specified)	enlarged spleen	J:151543
Cbl^tm1Soga/Cbl^tm1Soga Tg(Tec-BCR/ABL1)5Hhi/0 (involves: C57BL/6 * DBA/2)	enlarged lymph nodes	J:151543
Cbl^tm1Wlan/Cbl^tm1Wlan (involves: 129S1/Sv * C57BL/6)	enlarged spleen	J:81965
	increased spleen red pulp amount	J:81965
	myeloid hyperplasia	J:81965
	spleen hyperplasia	J:81965
Cbl^tm2Hua/Cbl^tm2Hua Cblb^tm1Hua/Cblb^tm1Hua Tg(Lck-cre)I57Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * ICR)	abnormal T cell morphology	J:80427
	enlarged spleen	J:80427
Cbl^tm2Wlan/Cbl^tm2Wlan (involves: 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:103366
	abnormal thymus morphology	J:103366
	abnormal thymus size	J:103366
	enlarged spleen	J:103366
	increased spleen red pulp amount	J:103366
	spleen hyperplasia	J:103366
	thymus hypoplasia	J:103366
Cblb^tm1Pngr/Cblb^tm1Pngr Itk^tm1Litt/Itk^tm1Litt (B6.129-Itk^tm1Litt Cblb^tm1Pngr)	abnormal T cell morphology	J:141390
	abnormal T-helper 2 cell differentiation	J:141390
	decreased T cell number	J:141390
Cblif^{tm1a(KOMP)Wtsi}/Cblif^{tm1a(KOMP)Wtsi} (C57BL/6N-Cblif^{tm1a(KOMP)Wtsi})	increased CD4-positive, alpha-beta T cell number	J:236022
	increased T cell number	J:236022
Cbs^tm1Unc/Cbs^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	absent uterine NK cells	J:190486
Cbs^tm1Unc/Cbs^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	decreased uterine NK cell number	J:190486
Cbs^tm1Unc/Cbs^tm1Unc Tg(Mt1-CBSS466L)EB86Waku/0 (involves: 129P2/OlaHsd C3H * C57BL/6)	increased Ly6C high monocyte number	J:168131
	increased monocyte cell number	J:168131
Cbx2^tm1Cim/Cbx2^tm1Cim (involves: 129P2/OlaHsd * BALB/c)	arrested T cell differentiation	J:38487
Cbx4^tm1.1Gxu/Cbx4^tm1.2Gxu Tg(Foxn1-cre)1Tbo/0 (involves: 129S2/SvPas * C57BL/6J)	abnormal lymphopoiesis	J:194053
	abnormal thymus development	J:194053
	decreased double-positive T cell number	J:194053
	decreased T cell number	J:194053
	thymus atrophy	J:194053
	thymus hypoplasia	J:194053
Cbx4^tm1.2Gxu/Cbx4^tm1.2Gxu (involves: 129S2/SvPas * C57BL/6J)	abnormal thymus development	J:194053
	thymus hypoplasia	J:194053
Ccbe1^tm1Lex/Ccbe1^tm1Lex (involves: 129S5/SvEvBrd)	abnormal lymphangiogenesis	J:186594
Ccbe1^tm1Lex/Ccbe1^tm1Lex (involves: 129S5/SvEvBrd)	absent lymphatic vessels	J:186594
Ccbe1^tm1Mlkn/Ccbe1^tm1Mlkn (either: B6.129-Ccbe1^tm1Mlkn or (involves: 129 * C57BL/6))	absent lymphatic vessels	J:196696
	decreased macrophage cell number	J:196696
Ccdc25^em1(IMPC)Mbp/Ccdc25⁺ (C57BL/6N-Ccdc25^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Ccdc32^em1(IMPC)J/Ccdc32⁺ (C57BL/6NJ-Ccdc32^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Ccdc39^b2b2025.1Clo/Ccdc39^b2b2025.1Clo (C57BL/6J-Ccdc39^b2b2025.1Clo)	absent spleen	J:175213
	spleen hypoplasia	J:175213
Ccdc40^em1(IMPC)J/Ccdc40^em1(IMPC)J (C57BL/6NJ-Ccdc40^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ccdc86^tm1Hfuj/Ccdc86⁺ (involves: C57BL/6NTac)	abnormal T cell morphology	J:151722
Ccdc88b^em1(IMPC)Tcp/Ccdc88b^em1(IMPC)Tcp (C57BL/6NCrl-Ccdc88b^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
Ccdc88b^m1Pgrs/Ccdc88b^m1Pgrs (involves: C57BL/6J * C57BL/10J)	decreased CD8-positive, alpha-beta T cell number	J:230618
Ccdc92^{tm1a(KOMP)Mbp}/Ccdc92^{tm1a(KOMP)Mbp} (C57BL/6N-Ccdc92^{tm1a(KOMP)Mbp})	decreased macrophage cell number	J:332421
Ccdc110^{em1(IMPC)Ccpcz}/Ccdc110^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ccdc110^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Ccdc124^{tm1b(KOMP)Wtsi}/Ccdc124^{tm1b(KOMP)Wtsi} (C57BL/6N-Ccdc124^{tm1b(KOMP)Wtsi}/Nju)	small spleen	J:211773
Ccdc127^{tm1b(EUCOMM)Wtsi}/Ccdc127^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ccdc127^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Ccdc154^ntl/Ccdc154^ntl (involves: 129S7/SvEvBrd * C57BL/6J)	enlarged spleen	J:226596
Ccdc166^em1(IMPC)J/Ccdc166^em1(IMPC)J (C57BL/6NJ-Ccdc166^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Ccdc171^m1Anu/Ccdc171⁺ (C57BL/NCrlAnu-Ccdc171^m1Anu/Anu)	decreased mature B cell number	J:104190
Ccdc171^m1Anu/Ccdc171^m1Anu (C57BL/NCrlAnu-Ccdc171^m1Anu/Anu)	decreased mature B cell number	J:104190
Ccdc183^{em1(IMPC)Hmgu}/Ccdc183^{em1(IMPC)Hmgu} (C57BL/6NCrl-Ccdc183^{em1(IMPC)Hmgu}/Ieg)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Ccdc198^{em1(IMPC)Ccpcz}/Ccdc198^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ccdc198^{em1(IMPC)Ccpcz}/Ph)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased eosinophil cell number	J:337480
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Ccl2^tm1.1Tyos/Ccl2^tm1.1Tyos (involves: 129S1/Sv)	decreased dendritic cell number	J:199611
Ccl2^tm1Rol/Ccl2⁺ Mpz^tm1Msch/Mpz⁺ (involves: 129S4/SvJae * 129S7/SvEvBrd)	abnormal macrophage derived foam cell morphology	J:133028
	decreased macrophage cell number	J:133028
Ccl2^tm1Rol/Ccl2⁺ Tg(PMP22)C61Clh/0 (involves: 129S4/SvJae * C57BL/6J * CBA/Ca)	increased macrophage cell number	J:158350
Ccl2^tm1Rol/Ccl2^tm1Rol (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)	abnormal monocyte morphology	J:45920
Ccl2^tm1Rol/Ccl2^tm1Rol (involves: 129S4/SvJae)	abnormal monocyte morphology	J:121281
	decreased lymphocyte cell number	J:147697
	decreased macrophage cell number	J:147697
Ccl2^tm1Rol/Ccl2^tm1Rol (B6.129S4-Ccl2^tm1Rol)	decreased leukocyte cell number	J:68145
	decreased macrophage cell number	J:147328
	increased CD4-positive, alpha-beta T cell number	J:68145
	increased neutrophil cell number	J:118606
	increased osteoclast cell number	J:109290
Ccl2^tm1Rol/Ccl2^tm1Rol ((129S4/SvJae x C57BL/6)F1)	decreased macrophage cell number	J:119615
Ccl2^tm1Rol/Ccl2^tm1Rol Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)	abnormal microglial cell morphology	J:200877
Ccl2^tm1Rol/Ccl2^tm1Rol Mpz^tm1Msch/Mpz⁺ (involves: 129S4/SvJae * 129S7/SvEvBrd)	decreased macrophage cell number	J:133028
	increased macrophage cell number	J:133028
Ccl2^tm1Rol/Ccl2^tm1Rol Tg(PMP22)C61Clh/0 (involves: 129S4/SvJae * C57BL/6J * CBA/Ca)	increased macrophage cell number	J:158350
Ccl3^tm1Unc/Ccl3^tm1Unc (B6.129P2-Ccl3^tm1Unc/J)	decreased neutrophil cell number	J:94599
Ccl5^tm1Hso/Ccl5^tm1Hso (involves: 129P2/OlaHsd * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:75842
Ccl7^tm1Ifc/Ccl7^tm1Ifc (involves: 129S4/SvJae)	abnormal monocyte morphology	J:121281
Ccl11^tm1Mer/Ccl11^tm1Mer (involves: 129S6/SvEvTac * NIH Black Swiss)	decreased eosinophil cell number	J:38945
Ccl11^tm1Mer/Ccl11^tm1Mer (129S.129S6-Ccl11^tm1Mer)	decreased eosinophil cell number	J:102034
Ccl11^tm1Mer/Ccl11^tm1Mer Ccl24^tm1Mer/Ccl24^tm1Mer (involves: 129S6/SvEvTac)	decreased eosinophil cell number	J:115273
Ccl17^em1(IMPC)H/Ccl17^em1(IMPC)H (C57BL/6N-Ccl17^em1(IMPC)H/H)	increased spleen weight	J:211773
Ccl17^{tm2.1(cre)Ifo}/Ccl17⁺ Hif1a^tm3Rsjo/Hif1a^tm3Rsjo (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal dendritic cell number	J:187773
Ccl19^tm1Cys/Ccl19^tm1Cys (B6.129X1-Ccl19^tm1Cys)	abnormal immune system morphology	J:126345
Ccl19^tm1Cys/Ccl19^tm1Cys (B6.129X1-Ccl19^tm1Cys)	decreased T cell number	J:126345
Ccl21a^tm1Yout/Ccl21a^tm1Yout (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal negative T cell selection	J:244640
	abnormal spleen morphology	J:244640
	decreased alpha-beta T cell number	J:244640
	decreased B cell number	J:244640
	decreased thymocyte number	J:244640
	small thymus medulla	J:244640
Ccl25^em1(IMPC)H/Ccl25^em1(IMPC)H (C57BL/6N-Ccl25^em1(IMPC)H/H)	enlarged spleen	J:211773
	increased spleen weight	J:211773
Ccl25^tm1.1Mal/Ccl25^tm1.1Mal (B6.129S2-Ccl25^tm1.1Mal)	abnormal gamma-delta T cell number	J:136944
	abnormal mesenteric lymph node morphology	J:136944
	abnormal T cell subpopulation ratio	J:136944
	decreased gamma-delta intraepithelial T cell number	J:136944
Ccl25^tm1.1Mal/Ccl25^tm1.1Mal Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:136667
	abnormal T cell subpopulation ratio	J:136667
	decreased gamma-delta intraepithelial T cell number	J:136667
Ccl27a^{tm1.1(KOMP)Vlcg}/Ccl27a^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ccl27a^{tm1.1(KOMP)Vlcg}/MbpMmucd)	decreased regulatory T cell number	J:330550
Ccl28^{em1(IMPC)Ccpcz}/Ccl28^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ccl28^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Ccl28^tm1Takna/Ccl28^tm1Takna (C57BL/6J-Ccl28^tm1Takna)	abnormal immune system cell morphology	J:256896
Ccm2^tm2.1Sbn/Ccm2^tm2.1Sbn Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	microgliosis	J:174085
Ccn3^em1(IMPC)Mbp/Ccn3^em1(IMPC)Mbp (C57BL/6N-Ccn3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Ccn3^tm1.1Ecan/Ccn3^tm1.1Ecan (B6.Cg-Ccn3^tm1.1Ecan)	abnormal osteoclast differentiation	J:158478
Ccna1^tm1Djw/Ccna1^tm1Djw Ccna2^tm1.1Pisc/Ccna2^tm1.1Pisc Tg(Mx1-cre)1Cgn/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	decreased leukocyte cell number	J:155178
Ccnb1ip1^em1(IMPC)Tcp/Ccnb1ip1^em1(IMPC)Tcp (C57BL/6NCrl-Ccnb1ip1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Ccnb2^tm1Thnt/Ccnb2^tm1Thnt (involves: 129P2/OlaHsd * C57BL/6)	increased double-negative T cell number	J:47430
	small thymus	J:47430
Ccnc^tm1.1Pisc/Ccnc^tm1.1Pisc Tg(Lck-LMO1)11Sjk/0 Tg(Mx1-cre)1Cgn/0 (Not Specified)	increased T cell derived lymphoma incidence	J:217695
Ccnd1^tm1Dsn/Ccnd1^tm1Dsn Ccnd2^tm1Wbg/Ccnd2^tm1Wbg Ccnd3^tm1Pisc/Ccnd3^tm1Pisc (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal lymphopoiesis	J:92563
Ccnd1^tm1Dsn/Ccnd1^tm1Dsn Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf (involves: 129 * C57BL/6)	enlarged spleen	J:66707
	enlarged thymus	J:66707
	thymus hyperplasia	J:66707
Ccnd3^{tm1.1(Ccnd2)Iaai}/Ccnd3^{tm1.1(Ccnd2)Iaai} (involves: 129S6/SvEvTac)	decreased double-positive T cell number	J:192031
	decreased pre-B cell number	J:192031
	small thymus	J:192031
	thymus hypoplasia	J:192031
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc (Not Specified)	decreased double-positive T cell number	J:88120, J:192031
	decreased lymphocyte cell number	J:88120
	decreased pre-B cell number	J:192031
	increased double-negative T cell number	J:88120
	small thymus	J:192031
	thymus hypoplasia	J:88120, J:192031
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf (involves: 129S4/SvJaeSor)	decreased double-positive T cell number	J:192031
	thymus hypoplasia	J:192031
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc Rb1^tm2Brn/Rb1^tm2Brn Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	decreased double-positive T cell number	J:192031
	thymus hypoplasia	J:192031
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc Tg(Lck)4220Rmp/0 (involves: C57BL/6J * DBA/2)	increased T cell derived lymphoma incidence	J:88120
Ccnd3^tm1Pisc/Ccnd3^tm1Pisc Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas)	increased T cell derived lymphoma incidence	J:88120
Ccnd3^tm2.1Pisc/Ccnd3^tm2.1Pisc Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	decreased double-positive T cell number	J:192032
	decreased leukocyte cell number	J:192032
	small thymus	J:192032
Ccne1^tm1Clur/Ccne1^tm1Clur (involves: 129S4/SvJae)	abnormal myeloid leukocyte morphology	J:136692
	abnormal spleen red pulp morphology	J:136692
	enlarged spleen	J:136692
	spleen hyperplasia	J:136692
Ccne1^tm1Jro/Ccne1^tm1Jro (either: 129-Ccne1^tm1Jro or B6.129-Ccne1^tm1Jro)	increased spleen weight	J:99695
Ccne1^tm1Pisc/Ccne1^tm1Pisc Ccne2^tm1Pisc/Ccne2^tm1Pisc (involves: 129S2/SvPas)	abnormal thrombopoiesis	J:85224
Ccnt1^em1(IMPC)J/Ccnt1⁺ (C57BL/6NJ-Ccnt1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ccnt1^em1(IMPC)J/Ccnt1^em1(IMPC)J (C57BL/6NJ-Ccnt1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ccr1^tm1Cge/Ccr1^tm1Cge (C.129S4-Ccr1^tm1Cge)	decreased CD4-positive, alpha-beta T cell number	J:95242
Ccr1^tm1Cge/Ccr1^tm1Cge (C.129S4-Ccr1^tm1Cge)	decreased CD8-positive, alpha-beta T cell number	J:95242
Ccr1^tm1Gao/Ccr1^tm1Gao (involves: C57BL/6)	decreased mast cell number	J:94599
Ccr1^tm1Gao/Ccr1^tm1Gao (involves: 129S4/SvJae)	abnormal Kupffer cell morphology	J:152548
Ccr2^em1(IMPC)H/Ccr2^em1(IMPC)H (C57BL/6N-Ccr2^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased eosinophil cell number	J:211773
Ccr2^{tm1.1(CCR2)Rodb}/Ccr2^{tm1.1(CCR2)Rodb} (involves: C57BL/6)	abnormal macrophage morphology	J:203000
Ccr2^tm1.1Dnc/Ccr2^tm1.1Dnc (Not Specified)	decreased CD11b-high dendritic cell number	J:223508
	increased CD11b-high dendritic cell number	J:223508
	increased dendritic cell number	J:223508
Ccr2^tm1.1Mpa/Ccr2^tm1.1Mpa (involves: BALB/cJ * C57BL/6)	decreased macrophage cell number	J:189044
Ccr2^tm1.1Mpa/Ccr2^tm1.1Mpa (involves: BALB/cJ * C57BL/6)	decreased monocyte cell number	J:189044
Ccr2^tm1Blck/Ccr2^tm1Blck Fas^lpr/Fas^lpr (MRL.Cg-Ccr2^tm1Blck Fas^lpr)	abnormal immune system organ morphology	J:113343
	abnormal lymphocyte cell number	J:113343
	enlarged lymph nodes	J:113343
	enlarged spleen	J:113343
Ccr2^tm1Brv/Ccr2^tm1Brv (involves: 129S1/Sv * ICR)	abnormal spleen morphology	J:111517
	enlarged spleen	J:111517
	increased eosinophil cell number	J:111517
Ccr2^tm1Ifc/Ccr2^tm1Ifc (B6.129S4-Ccr2^tm1Ifc/J)	abnormal osteoclast cell number	J:149360
	abnormal osteoclast differentiation	J:149360
	decreased osteoclast cell number	J:149360
Ccr2^tm1Ifc/Ccr2^tm1Ifc (involves: 129S4/SvJae)	abnormal monocyte morphology	J:121281
Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd * C57BL/6J)	decreased CD4-positive, alpha-beta T cell number	J:110814
	increased B cell number	J:110814
	increased CD8-positive, alpha-beta T cell number	J:110814
Ccr2^tm1Mae/Ccr2^tm1Mae (B6.129P2-Ccr2^tm1Mae)	decreased macrophage cell number	J:147328
Ccr2^tm1Mae/Ccr2^tm1Mae (involves: 129P2/OlaHsd * BALB/c)	decreased neutrophil cell number	J:162714
Ccr2^tm1Mpa/Ccr2^tm1Mpa Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased macrophage cell number	J:189044
Ccr3^{em1(IMPC)Ccpcz}/Ccr3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ccr3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Ccr3^tm1Cge/Ccr3^tm1Cge (involves: 129S4/SvJae * BALB/c)	abnormal eosinophil cell number	J:74509
	decreased eosinophil cell number	J:115273, J:74509, J:75347
	decreased monocyte cell number	J:115273
	increased eosinophil cell number	J:74509
Ccr4^tm1Pwr/Ccr4^tm1Pwr (involves: 129P2/OlaHsd * C57BL/6)	decreased eosinophil cell number	J:120221
	decreased lymphocyte cell number	J:70088
	decreased macrophage cell number	J:70088
	increased macrophage cell number	J:120221
	increased neutrophil cell number	J:120221
Ccr4^tm1Pwr/Ccr4^tm1Pwr (B6.129P2-Ccr4^tm1Pwr)	increased CD8-positive, alpha-beta T cell number	J:95239
Ccr4^tm1Pwr/Ccr4^tm1Pwr (B6.129P2-Ccr4^tm1Pwr)	increased NK T cell number	J:95239
Ccr5^tm1Kuz/Ccr5^tm1Kuz (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:110814
	abnormal CD8-positive, alpha beta T cell morphology	J:110814
	abnormal Kupffer cell morphology	J:152548
	decreased NK cell number	J:135308
	increased NK T cell number	J:110814
Ccr6^tm1(EGFP)Irw/Ccr6^tm1(EGFP)Irw (involves: 129S6/SvEvTac * C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:85086
	abnormal CD4-positive, alpha-beta intraepithelial T cell morphology	J:85086
	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:85086
	abnormal gut-associated lymphoid tissue morphology	J:113363, J:120122
	abnormal Peyer's patch morphology	J:120122
	decreased B cell number	J:120122
	decreased Peyer's patch number	J:120122
Ccr6^{tm1.1(KOMP)Vlcg}/Ccr6^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ccr6^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
Ccr6^tm1Gma/Ccr6^tm1Gma (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal myeloid dendritic cell morphology	J:68191
	abnormal Peyer's patch follicle morphology	J:68191
	abnormal Peyer's patch morphology	J:68191
	decreased leukocyte cell number	J:68191
	increased leukocyte cell number	J:68191
Ccr6^tm1Gma/Ccr6^tm1Gma Tg(Rorc-EGFP)1Ebe/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal effector T cell morphology	J:137020
Ccr6^tm1Lira/Ccr6^tm1Lira (involves: 129)	abnormal Peyer's patch T cell area morphology	J:113363
Ccr6^tm1Lira/Ccr6^tm1Lira (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:148286
	abnormal gut-associated lymphoid tissue morphology	J:76461
	abnormal intraepithelial T cell number	J:76461
	abnormal lymphocyte morphology	J:148286
	abnormal myeloid dendritic cell morphology	J:124358
	abnormal peritoneal macrophage morphology	J:124358
	abnormal Peyer's patch germinal center morphology	J:76461
	abnormal Peyer's patch morphology	J:76461
	decreased B cell number	J:148286
	decreased CD4-positive, alpha-beta T cell number	J:148286
	decreased CD8-positive, alpha-beta T cell number	J:148286
	increased activated T cell number	J:76461
	increased B-1 B cell number	J:124358
	increased double-positive T cell number	J:76461
	increased T cell number	J:76461
Ccr7^m1Btlr/Ccr7⁺ (C57BL/6J-Ccr7^m1Btlr)	decreased macrophage cell number	J:221477
Ccr7^m1Btlr/Ccr7^m1Btlr (C57BL/6J-Ccr7^m1Btlr)	decreased macrophage cell number	J:221477
Ccr7^m1Btlr/Ccr7^m1Btlr (C57BL/6J-Ccr7^m1Btlr)	increased single-positive T cell number	J:221477
Ccr7^tm1Rfor/Ccr7^tm1Rfor (involves: 129P2/OlaHsd * BALB/c)	abnormal class switch recombination	J:57976
	abnormal lymph node cortex morphology	J:57976
	abnormal lymph node germinal center morphology	J:57976
	abnormal lymph node T cell domain morphology	J:57976
	abnormal Peyer's patch T cell area morphology	J:57976
	abnormal spleen marginal sinus morphology	J:57976
	abnormal spleen periarteriolar lymphoid sheath morphology	J:57976
	abnormal spleen red pulp morphology	J:57976
	decreased CD4-positive, alpha-beta T cell number	J:57976
	decreased dendritic cell number	J:57976
	decreased T cell number	J:57976
	enlarged spleen	J:57976
	increased CD4-positive, alpha-beta T cell number	J:57976
	increased T cell number	J:57976
	small lymph nodes	J:57976
	small Peyer's patches	J:57976
Ccr7^tm1Rfor/Ccr7^tm1Rfor (B6.129P2-Ccr7^tm1Rfor)	abnormal thymus cortex morphology	J:93960
Ccr7^tm1Rfor/Ccr7^tm1Rfor (B6.129P2-Ccr7^tm1Rfor)	small thymus medulla	J:93960
Ccr7^tm1Rfor/Ccr7^tm1Rfor (involves: 129P2/OlaHsd)	decreased CD11b-high dendritic cell number	J:223508
Ccr7^tm1Rfor/Ccr7^tm1Rfor (involves: 129P2/OlaHsd)	decreased CD103-positive CD11b-low dendritic cell number	J:223508
Ccr9^tm1.1Mal/Ccr9^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	abnormal leukocyte cell number	J:72386
	abnormal T cell differentiation	J:72386
	decreased double-positive T cell number	J:72386
	decreased pro-B cell number	J:72386
	decreased T cell number	J:72386
	increased T cell number	J:72386
Ccr9^tm1.1Mal/Ccr9^tm1.1Mal (involves: 129S2/SvPas)	abnormal gamma-delta T cell number	J:136944
	abnormal mesenteric lymph node morphology	J:136944
	abnormal T cell subpopulation ratio	J:136944
	decreased gamma-delta intraepithelial T cell number	J:136944
Ccr9^tm1.1Mal/Ccr9^tm1.1Mal Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:136667
	abnormal T cell subpopulation ratio	J:136667
	decreased gamma-delta intraepithelial T cell number	J:136667
Ccr9^tm1Ccb/Ccr9^tm1Ccb (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:94596
	decreased thymocyte number	J:94596
Ccr9^tm1Lov/Ccr9^tm1Lov (involves: 129)	abnormal gamma-delta intraepithelial T cell morphology	J:110846
	decreased CD8-positive, gamma-delta intraepithelial T cell number	J:110846
	decreased lymphocyte cell number	J:110846
	increased gamma-delta T cell number	J:110846
Ccr10^tm1.1Nax/Ccr10^tm1.1Nax (B6.129S4(Cg)-Ccr10^tm1.1Nax)	decreased gamma-delta intraepithelial T cell number	J:165323
Ccr10^tm1Cge/Ccr10^tm1Cge (C.129S4-Ccr10^tm1Cge)	abnormal plasma cell morphology	J:140728
Ccrl2^tm1Ssoz/Ccrl2^tm1Ssoz (B6.129-Ccrl2^tm1Ssoz)	lymph node hypoplasia	J:165873
Cd1^tm1Gru/Cd1^tm1Gru (involves: 129S2/SvPas * BALB/c)	abnormal eosinophil cell number	J:84720
	absent NK T cells	J:47769
	decreased CD4-positive, alpha-beta T cell number	J:126220
Cd1d1^em1(IMPC)H/Cd1d1^em1(IMPC)H (C57BL/6NTac-Cd1d1^em1(IMPC)H/H)	increased basophil cell number	J:211773
Cd1d1^tm1.1Aben/Cd1d1^tm1.1Aben Tg(Cd4-cre)1Cwi/0 (B6.Cg-Cd1d1^tm1.1Aben Tg(Cd4-cre)1Cwi)	decreased NK T cell number	J:183087
Cd1d1^tm1.1Boes/Cd1d1^tm1.1Boes (involves: C57BL/6)	abnormal NK T cell morphology	J:151699
Cd1d1^tm1.1Boes/Cd1d1^tm1.1Boes (involves: C57BL/6)	decreased NK T cell number	J:151699
Cd1d1^tm1.2Aben/Cd1d1^tm1.2Aben (B6(C)-Cd1d1^tm1.2Aben/J)	abnormal CD4-positive T cell differentiation	J:177038
Cd1d1^tm1Crw/Cd1d1^tm1Crw (involves: 129S4/SvJae * C57BL/6)	decreased NK T cell number	J:76976
Cd1d1^tm1Luc/Cd1d1^tm1Luc (B6.129S6-Cd1d1^tm1Luc)	decreased regulatory T cell number	J:122245
Cd1d1^tm1Luc/Cd1d1^tm1Luc (involves: 129S6/SvEvTac * C57BL/6)	arrested T cell differentiation	J:125679
	decreased NK T cell number	J:39748
Cd1d1^tm1Luc/Cd1d1^tm1Luc Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (B6.129-Cd1d1^tm1Luc Cx3cr1^tm1Litt)	decreased NK cell number	J:129712
Cd1d1^tm2Aben/Cd1d1^tm2Aben (B6.129P2-Cd1d1^tm2Aben)	decreased NK T cell number	J:174337
Cd1d1^tm2Aben/Cd1d1^tm2Aben (involves: 129P2/OlaHsd * C57BL/6)	decreased NK T cell number	J:174337
Cd2ap^tm1Shaw/Cd2ap^tm1Shaw (involves: 129X1/SvJ)	spleen atrophy	J:57971
Cd2ap^tm1Shaw/Cd2ap^tm1Shaw (involves: 129X1/SvJ)	thymus atrophy	J:57971
Cd3d^tm1Kap/Cd3d^tm1Kap (C57BL/6-Cd3d^tm1Kap)	arrested T cell differentiation	J:39925
	decreased CD4-positive, alpha-beta T cell number	J:39925
	decreased CD8-positive, alpha-beta T cell number	J:39925
Cd3e^m1Btlr/Cd3e^m1Btlr (C57BL/6J-Cd3e^m1Btlr)	abnormal thymus morphology	J:132486
	absent T cells	J:132486
	arrested T cell differentiation	J:132486
	small thymus	J:132486
Cd3e^m1Btlr/Cd3e^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Cd3e^m2Btlr/Cd3e^m2Btlr (C57BL/6J-Cd3e^m2Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:274934
	abnormal T cell differentiation	J:274934
	decreased CD4-positive, alpha-beta T cell number	J:274934
	decreased CD8-positive, naive alpha-beta T cell number	J:274934
	increased CD8-positive, alpha-beta T cell number	J:274934
	increased central memory CD8 positive, alpha-beta T cell number	J:274934
Cd3e^tm1.1Geno/Cd3e^tm1.1Geno (involves: C57BL/6)	abnormal double-positive T cell morphology	J:192604
	abnormal T cell differentiation	J:192604
	abnormal T cell number	J:192604
	increased DN3 thymocyte number	J:192604
Cd3e^tm1.1Geno/Cd3e^tm1.1Geno Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6 * C57BL/6J * DBA/2J)	abnormal negative T cell selection	J:192604
	abnormal positive T cell selection	J:192604
	increased DN3 thymocyte number	J:192604
Cd3e^tm1.1Geno/Cd3e^tm1.1Geno Tg(TcrAND)53Hed/0 (involves: C57BL/6 * SJL)	abnormal CD4-positive T cell differentiation	J:192604
	abnormal positive T cell selection	J:192604
	increased DN3 thymocyte number	J:192604
Cd3e^tm1.1Geno/Cd3e^tm1.1Geno Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6)	abnormal positive T cell selection	J:192604
	abnormal T cell differentiation	J:192604
	abnormal thymus cell ratio	J:192604
	decreased double-positive T cell number	J:192604
	decreased T cell number	J:192604
	increased DN3 thymocyte number	J:192604
Cd3e^tm1.1Lov/Cd3e^tm1.1Lov (Not Specified)	abnormal T cell morphology	J:72144
	arrested T cell differentiation	J:72144
	decreased double-positive T cell number	J:72144
	increased double-negative T cell number	J:72144
Cd3e^tm1.1Lov/Cd3e^tm1.1Lov Trdc^tm1Mal/Trdc^tm1Mal (involves: C57BL/6)	abnormal double-negative T cell morphology	J:112658
Cd3e^tm1Cpt/Cd3e^tm1Cpt (involves: 129S4/SvJae * C57BL/6)	absent T cells	J:54756
	decreased double-positive T cell number	J:54756
	thymus hypoplasia	J:54756
Cd3e^tm1Cpt/Cd3e^tm1Cpt Tg(CD3E)26Cpt/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	decreased double-positive T cell number	J:54756
	decreased T cell number	J:54756
	thymus hypoplasia	J:54756
Cd3e^tm1Lov/Cd3e^tm1Lov (involves: 129S1/Sv * 129X1/SvJ)	abnormal T cell morphology	J:72144
	arrested T cell differentiation	J:72144
	decreased double-positive T cell number	J:72144
	increased double-negative T cell number	J:72144
Cd3e^tm1Mal/Cd3e^tm1Mal (involves: C57BL/6)	absent CD4-positive, alpha-beta T cells	J:77098
	absent CD8-positive, alpha-beta T cells	J:77098
	arrested T cell differentiation	J:77098
Cd3e^tm1Mal/Cd3e^tm1Mal (C57BL/6-Cd3e^tm1Mal)	abnormal B cell morphology	J:81133
	abnormal double-negative T cell morphology	J:81133
	absent T cells	J:131351
	arrested T cell differentiation	J:81133
Cd3e^tm1Mal/Cd3e^tm1Mal Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	absent CD4-positive, alpha-beta T cells	J:77098
	absent CD8-positive, alpha-beta T cells	J:77098
	arrested T cell differentiation	J:77098
Cd3e^tm1Mal/Cd3e^tm1Mal Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: C57BL/6)	increased neutrophil cell number	J:191055
Cd3g^tm1.1Cage/Cd3g^tm1.1Cage (B6.129P2-Cd3g^tm1.1Cage)	decreased CD8-positive, alpha-beta T cell number	J:153813
	decreased thymocyte number	J:153813
	spleen hypoplasia	J:153813
Cd3g^tm1Amk/Cd3g^tm1Amk (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:77504
	decreased thymocyte number	J:114561
	lymph node hypoplasia	J:77504
	thymus hypoplasia	J:77504
Cd3g^tm1Amk/Cd3g^tm1Amk Tg(Igh-Pim1)1Brn/0 (involves: 129P2/OlaHsd * C57BL/6LiA * CBA)	decreased thymocyte number	J:114561
Cd4^del/Cd4^del (C57BR/cdJ-Cd4^del)	abnormal immune system organ morphology	J:46692
	abnormal lymph node T cell domain morphology	J:46692
	abnormal spleen morphology	J:46692
	absent CD4-positive, alpha-beta T cells	J:46692
	increased CD8-positive, alpha-beta T cell number	J:46692
Cd4^em1Litt/Cd4^em1Litt Rr386^em1Pdi/Rr386^em1Pdi (involves: C57BL/6J)	decreased T helper 1 cell number	J:333574
Cd4^m1Btlr/Cd4^m1Btlr (C57BL/6J-Cd4^m1Btlr)	absent CD4-positive, alpha-beta T cells	J:212900
Cd4^maat/Cd4^maat (C57BL/6JAnu-Cd4^maat/Apb)	abnormal CD4-positive, alpha beta T cell morphology	J:104190
	abnormal double-positive T cell morphology	J:104190
	decreased CD4-positive, alpha-beta T cell number	J:104190
	increased CD8-positive, alpha-beta T cell number	J:104190
Cd4^sesh/Cd4^sesh (C57BL/6JAnu-Cd4^sesh/AnuApb)	abnormal CD4-positive, alpha beta T cell morphology	J:104190
	abnormal double-positive T cell morphology	J:104190
	decreased T cell number	J:104190
Cd4^thth/Cd4^thth (C57BL/6JSfdAnu-Cd4^thth)	absent CD4-positive, alpha-beta T cells	J:104190
Cd4^{tm1(cre/ERT2)Thbu}/Cd4⁺ Gfm1^{tm1c(EUCOMM)Wtsi}/Gfm1^{tm1c(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N * SJL)	abnormal T-helper 17 cell differentiation	J:302272
	increased CD8-positive, alpha-beta T cell number	J:302272
	increased single-positive T cell number	J:302272
Cd4^{tm1(cre/ERT2)Thbu}/Cd4⁺ Tgfbr2^tm1Karl/Tgfbr2^tm1Karl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased memory T cell number	J:204579
	increased regulatory T cell number	J:204579
Cd4^tm1Doi/Cd4^tm1Doi Lag3^tm1Doi/Lag3^tm1Doi (involves: 129 * C57BL/6)	increased double-negative T cell number	J:33272
Cd4^tm1Doi/Cd4^tm1Litt Lag3^tm1Doi/Lag3⁺ (involves: 129 * C57BL/6)	increased double-negative T cell number	J:33272
Cd4^tm1Jrp/Cd4^tm1Jrp (either: B6.129S2-Cd4^tm1Jrp or B10.Cg-Cd4^tm1Jrp)	abnormal T cell differentiation	J:45168
	decreased CD4-positive, alpha-beta T cell number	J:45168
	decreased double-positive T cell number	J:45168
	increased CD8-positive, alpha-beta T cell number	J:45168
Cd4^tm1Jrp/Cd4^tm1Jrp Tg(TcrAND)53Hed/0 (either: (involves: 129S2/SvPas * C57BL/6 * SJL) or (involves: 129S2/SvPas * C57BL/6 * C57BL/10 * SJL))	abnormal T cell number	J:45168
	thymus hyperplasia	J:45168
Cd4^tm1Knw/Cd4^tm1Knw (B6.129S-Cd4^tm1Knw/J)	decreased CD4-positive, alpha-beta T cell number	J:87828
Cd4^tm1Knw/Cd4^tm1Knw (B6.129S-Cd4^tm1Knw/J)	increased CD8-positive, alpha-beta T cell number	J:87828
Cd4^tm1Litt/Cd4^tm1Litt (involves: 129S2/SvPas)	absent CD4-positive, alpha-beta T cells	J:50435
	decreased CD4-positive, alpha-beta T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962, J:50435
Cd4^tm1Litt/Cd4^tm1Litt Foxp3^sf Otc^spf/Y (involves: 129/Rl * 129S2/SvPas)	abnormal CD8-positive, alpha beta T cell morphology	J:20865
	abnormal immune system organ morphology	J:20865
	enlarged lymph nodes	J:20865
Cd4^tm1Litt/Cd4^tm1Nik Tg(Lck-cre)3785Nik/0 (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:73479
	increased CD8-positive, alpha-beta T cell number	J:73479
Cd4^tm1Mak/Cd4^tm1Mak (involves: 129S2/SvPas * C57BL/6 * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:68957
Cd4^tm1Mak/Cd4^tm1Mak (B6.129S2-Cd4^tm1Mak/J)	absent plasma cells	J:133047
Cd4^tm1Mak/Cd4^tm1Mak Cd8a^tm1Mak/Cd8a^tm1Mak (involves: 129S2/SvPas * C57BL/6 * DBA/2)	abnormal double-negative T cell morphology	J:12572
	abnormal gamma-delta T cell number	J:12572
	abnormal T cell differentiation	J:12572
	abnormal T cell number	J:12572
	decreased double-positive T cell number	J:12572
	small thymus medulla	J:12572
Cd4ts1^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd4ts2^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd4ts3^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd4ts4^C3H/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd4ts5^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd4ts5^C57BL/6/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased memory T cell number	J:83220
Cd4ts6^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd4vts1^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd5^{tm1.1(KOMP)Mbp}/Cd5^{tm1.1(KOMP)Mbp} (C57BL/6N-Cd5^{tm1.1(KOMP)Mbp}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Cd5^tm1.1Chra/Cd5^tm1.1Chra (involves: C57BL/6 * FVB/N)	decreased B cell number	J:189919
	decreased CD4-positive, alpha-beta T cell number	J:189919
	decreased double-positive T cell number	J:189919
	decreased follicular B cell number	J:189919
	decreased T-helper 17 cell number	J:189919
	increased double-negative T cell number	J:189919
Cd5^tm1.1Chra/Cd5^tm1.1Chra Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: C57BL/6 * FVB/N)	decreased T helper 1 cell number	J:189919
Cd5^tm1Cgn/Cd5^tm1Cgn (B6.129P2-Cd5^tm1Cgn)	increased regulatory T cell number	J:189919
Cd5l^tm1Nto/Cd5l^tm1Nto (involves: 129P2/OlaHsd * C57BL/6)	abnormal double-positive T cell morphology	J:52195
Cd5l^tm1Nto/Cd5l^tm1Nto (involves: 129P2/OlaHsd * C57BL/6)	decreased thymocyte number	J:52195
Cd6^tm1Linf/Cd6^tm1Linf (D1.Cg-Cd6^tm1Linf)	decreased B-1 B cell number	J:238478
	decreased B-1a cell number	J:238478
	increased B-1a cell number	J:238478
	increased B-1b cell number	J:238478
Cd7^tm1Bfh/Cd7^tm1Bfh (involves: 129 * C57BL/6)	increased double-positive T cell number	J:48758
Cd7^tm1Bfh/Cd7^tm1Bfh (involves: 129 * C57BL/6)	increased thymocyte number	J:48758
Cd7^tm1Bfh/Cd7^tm1Bfh (B6.129-Cd7^tm1Bfh)	increased double-positive T cell number	J:48758
Cd7^tm1Bfh/Cd7^tm1Bfh (B6.129-Cd7^tm1Bfh)	increased thymocyte number	J:48758
Cd8a^m1Btlr/Cd8a^m1Btlr (C57BL/6J-Cd8a^m1Btlr)	abnormal CD4-positive T cell differentiation	J:221492
Cd8a^m1Btlr/Cd8a^m1Btlr (C57BL/6J-Cd8a^m1Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:221492
Cd8a^{tm1.1(cre)Koni}/Cd8a^{tm1.1(cre)Koni} (involves: C57BL/6J * C57BL/6NHsd * SJL)	decreased CD8-positive, alpha-beta T cell number	J:177182
Cd8a^tm1.1Kio/Cd8a^tm1.1Kio (involves: 129S4/SvJae * C57BL/10 * CBA/Ca)	abnormal CD4-positive T cell differentiation	J:76799
Cd8a^tm1.1Litt/Cd8a^tm1.1Litt (either: (involves: 129P2/OlaHsd * AKR) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal CD8-positive, alpha beta T cell morphology	J:50624
Cd8a^tm1Asin/Cd8a^tm1Asin (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal double-positive T cell morphology	J:126026
Cd8a^tm1Asin/Cd8a^tm1Asin Cd8b1^tm1Litt/Cd8b1^tm1Litt H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (involves: 129 * FVB/N)	decreased CD4-positive, alpha-beta T cell number	J:126026
	increased CD8-positive, alpha-beta T cell number	J:126026
Cd8a^tm1Asin/Cd8a^tm1Asin Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J)	abnormal CD8-positive, alpha beta T cell morphology	J:125259
Cd8a^tm1Asin/Cd8a^tm1Asin Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * FVB/N)	abnormal positive T cell selection	J:126026
	decreased CD4-positive, alpha-beta T cell number	J:126026
	increased CD8-positive, alpha-beta T cell number	J:126026
Cd8a^tm1Asin/Cd8a^tm1Mak (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * FVB/N)	abnormal positive T cell selection	J:126026
	abnormal T cell subpopulation ratio	J:126026
	increased CD8-positive, alpha-beta T cell number	J:126026
Cd8a^tm1Mak/Cd8a^tm1Mak (involves: 129S2/SvPas * C57BL/6 * DBA/2)	absent CD8-positive, alpha-beta T cells	J:68956
Cd8a^tm1Mak/Cd8a^tm1Mak Il15^tm1Imx/Il15^tm1Imx X/Yaa (BXSB.Cg-Cd8a^tm1Mak Il15^tm1Imx/Dcr)	abnormal spleen B cell follicle morphology	J:179430
	increased monocyte cell number	J:179430
	increased splenocyte number	J:179430
Cd8a^tm1Mak/Cd8a^tm1Mak Zbtb7b^hd/Zbtb7b^hd (involves: B6.129S2-Cd8a^tm1Mak * B6.Cg-Thpok^hd)	absent CD4-positive, alpha-beta T cells	J:95867
Cd8b1^M1Btlr/Cd8b1⁺ (C57BL/6J-Cd8b1^M1Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:255009
Cd8b1^M1Btlr/Cd8b1⁺ (C57BL/6J-Cd8b1^M1Btlr)	increased CD4-positive, alpha-beta T cell number	J:255009
Cd8b1^M1Btlr/Cd8b1^M1Btlr (C57BL/6J-Cd8b1^M1Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:255009
Cd8b1^M1Btlr/Cd8b1^M1Btlr (C57BL/6J-Cd8b1^M1Btlr)	increased CD4-positive, alpha-beta T cell number	J:255009
Cd8b1^m2Btlr/Cd8b1^m2Btlr (C57BL/6J-Cd8b1^m2Btlr)	abnormal B cell differentiation	J:274761
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274761
	decreased CD8-positive, alpha-beta T cell number	J:274761
	decreased CD8-positive, naive alpha-beta T cell number	J:274761
	decreased T cell number	J:274761
	increased CD4-positive, alpha-beta T cell number	J:274761
	increased central memory CD8 positive, alpha-beta T cell number	J:274761
	increased effector memory CD8-positive, alpha-beta T cell number	J:274761
Cd8b1^tm1Litt/Cd8b1⁺ Tg(Cd8b1)46Erob/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal T cell subpopulation ratio	J:110916
	decreased T cell number	J:110916
	decreased thymocyte number	J:110916
Cd8b1^tm1Litt/Cd8b1⁺ Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129S4/SvJae * C57BL/6J * DBA/2)	decreased double-positive T cell number	J:112551
Cd8b1^tm1Litt/Cd8b1^tm1Litt (involves: 129S4/SvJae * C57BL/6J)	abnormal T cell subpopulation ratio	J:110916
	decreased CD8-positive, alpha-beta T cell number	J:112551, J:110916
	decreased thymocyte number	J:110916
Cd8b1^tm1Litt/Cd8b1^tm1Litt Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129S4/SvJae * C57BL/6J * DBA/2)	abnormal lymph node cell ratio	J:112551
	abnormal negative T cell selection	J:112551
	abnormal positive T cell selection	J:112551
	decreased CD8-positive, alpha-beta T cell number	J:112551
	increased CD4-positive, alpha-beta T cell number	J:112551
Cd8b1^tm1Wpfl/Cd8b1^tm1Wpfl (involves: 129S2/SvPas)	abnormal CD8-positive, alpha beta T cell morphology	J:19928
	abnormal CD8-positive, alpha-beta T cell differentiation	J:19928
	abnormal T cell subpopulation ratio	J:19928
	decreased CD8-positive, alpha-beta T cell number	J:19928
	decreased thymocyte number	J:19928
Cd8mts1^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased memory T cell number	J:83220
Cd8mts2^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased memory T cell number	J:83220
Cd8mts3^C57BL/6/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased memory T cell number	J:83220
Cd8mts4^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased memory T cell number	J:83220
Cd8mts5^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd8mts5^C57BL/6/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased memory T cell number	J:83220
Cd8mts6^C3H/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:83220
Cd8ts1^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:83220
Cd8ts2^C57BL/6/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:83220
Cd8ts3^C3H/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:83220
Cd8ts3^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Cd19^em2(IMPC)Ics/Cd19^em2(IMPC)Ics (C57BL/6N-Cd19^em2(IMPC)Ics/Ics)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Cd19^tm1(cre)Cgn/? Gt(ROSA)26Sor^{tm1(HBEGF)Awai}/Gt(ROSA)26Sor^{tm1(HBEGF)Awai} (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:131076
	abnormal lymph node cell ratio	J:131076
	abnormal lymphocyte cell number	J:131076
	abnormal lymphocyte morphology	J:131076
	abnormal splenic cell ratio	J:131076
	absent immature B cells	J:131076
	absent mature B cells	J:131076
Cd19^tm1(cre)Cgn/Cd19⁺ Cxcr4^tm1Tng/Cxcr4^tm2Tng (involves: 129P2/OlaHsd * C57BL/6)	decreased plasma cell number	J:109147
Cd19^tm1(cre)Cgn/Cd19⁺ Ell2^tm1.1Cmil/Ell2^tm1.1Cmil (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased mature B cell number	J:234692
	decreased plasma cell number	J:234692
	decreased transitional stage T1 B cell number	J:234692
	decreased transitional stage T2 B cell number	J:234692
	decreased transitional stage T3 B cell number	J:234692
	increased follicular B cell number	J:234692
	increased immature B cell number	J:234692
	increased pre-B cell number	J:234692
	increased pro-B cell number	J:234692
Cd19^tm1(cre)Cgn/Cd19⁺ Ell2^tm2.1Cmil/Ell2^tm2.1Cmil (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased mature B cell number	J:234692
Cd19^tm1(cre)Cgn/Cd19⁺ Ep300^tm2Reck/Ep300⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:147840
	abnormal spleen marginal zone macrophage morphology	J:147840
	abnormal transitional stage B cell morphology	J:147840
	decreased marginal zone B cell number	J:147840
	enlarged lymph nodes	J:147840
	enlarged spleen	J:147840
	increased activated T cell number	J:147840
	increased B cell number	J:147840
	increased spleen weight	J:147840
	intermingled spleen red and white pulp	J:147840
Cd19^tm1(cre)Cgn/Cd19⁺ Fas^lpr/Fas^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6 * MRL)	enlarged lymph nodes	J:114948
	enlarged spleen	J:114948
Cd19^tm1(cre)Cgn/Cd19⁺ Fas^lpr/Fas^tm1Cgn Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * MRL)	enlarged lymph nodes	J:114948
	enlarged spleen	J:114948
	increased double-negative T cell number	J:114948
Cd19^tm1(cre)Cgn/Cd19⁺ Fas^tm1Ach/Fas^tm1Ach (involves: 129P2/OlaHsd * BALB/c)	enlarged spleen	J:123556
	increased lymphocyte cell number	J:123556
Cd19^tm1(cre)Cgn/Cd19⁺ Gna12^tm1Citb/Gna12^tm1Citb Gna13^tm2.1Soff/Gna13^tm2.1Soff (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6N)	decreased marginal zone B cell number	J:117663
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^tm1(DTA)Riet/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd)	decreased B cell number	J:92789
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm1(ITK/SYK)Jrld}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd)	enlarged spleen	J:160931
	increased T cell derived lymphoma incidence	J:160931
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm2(CARD11*L225LI)Jrld}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd)	abnormal plasmablast number	J:228288
	abnormal spleen morphology	J:228288
	enlarged lymph nodes	J:228288
	enlarged spleen	J:228288
	increased B cell number	J:228288
	increased plasma cell number	J:228288
	spleen hyperplasia	J:228288
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal splenic cell ratio	J:113365
	increased B cell number	J:113365
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm5(Map3k14)Rsky}/Gt(ROSA)26Sor^{tm5(Map3k14)Rsky} (involves: 129P2/OlaHsd * C57BL/6)	enlarged lymph nodes	J:139293
	enlarged spleen	J:139293
	increased marginal zone B cell number	J:139293
	increased mature B cell number	J:139293
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm5(Map3k14)Rsky}/Gt(ROSA)26Sor^{tm5(Map3k14)Rsky} Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (involves: 129P2/OlaHsd * C57BL/6)	decreased lymphocyte cell number	J:139293
	decreased mature B cell number	J:139293
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm6(Map3k14)Rsky}/Gt(ROSA)26Sor^{tm6(Map3k14)Rsky} (involves: 129P2/OlaHsd * C57BL/6)	abnormal Peyer's patch morphology	J:139293
	abnormal spleen B cell follicle morphology	J:139293
	decreased B-1 B cell number	J:139293
	enlarged lymph nodes	J:139293
	enlarged spleen	J:139293
	increased mature B cell number	J:139293
Cd19^tm1(cre)Cgn/Cd19⁺ Gt(ROSA)26Sor^{tm6(Map3k14)Rsky}/Gt(ROSA)26Sor^{tm6(Map3k14)Rsky} Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (involves: 129P2/OlaHsd * C57BL/6)	increased lymphocyte cell number	J:139293
	increased mature B cell number	J:139293
Cd19^tm1(cre)Cgn/Cd19⁺ Igbp1^tm1Imku/Y (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:74619
	abnormal spleen germinal center morphology	J:74619
	decreased B cell number	J:74619
	decreased follicular B cell number	J:74619
	decreased pre-B cell number	J:74619
Cd19^tm1(cre)Cgn/Cd19⁺ Ikbkb^tm1Cgn/Ikbkb^tm1.1Cgn (involves: 129P2/OlaHsd * C57BL/6)	decreased B-1 B cell number	J:79132
	decreased follicular B cell number	J:79132
	decreased immature B cell number	J:79132
	decreased marginal zone B cell number	J:79132
	decreased mature B cell number	J:79132
Cd19^tm1(cre)Cgn/Cd19⁺ Ikbkb^tm2Cgn/Ikbkb^tm2.1Cgn (involves: 129P2/OlaHsd * C57BL/6)	decreased B-1 B cell number	J:79132
	decreased follicular B cell number	J:79132
	decreased marginal zone B cell number	J:79132
	decreased mature B cell number	J:79132
Cd19^tm1(cre)Cgn/Cd19⁺ Ikbkb^tm2Mka/Ikbkb^tm2Mka (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:82995
	decreased B-1 B cell number	J:82995
	decreased marginal zone B cell number	J:82995
Cd19^tm1(cre)Cgn/Cd19⁺ Ikbkg^tm1.1Mpa/Y (involves: 129P2/OlaHsd * C57BL/6)	decreased B-1 B cell number	J:79132
	decreased follicular B cell number	J:79132
	decreased immature B cell number	J:79132
	decreased marginal zone B cell number	J:79132
	decreased mature B cell number	J:79132
Cd19^tm1(cre)Cgn/Cd19⁺ Il10^tm1Roer/Il10^tm1Roer (involves: 129P2/OlaHsd)	abnormal myeloid leukocyte morphology	J:151551
	increased B cell number	J:151551
	increased CD4-positive, alpha-beta T cell number	J:151551
	increased plasma cell number	J:151551
Cd19^tm1(cre)Cgn/Cd19⁺ Inpp5d^tm1Rav/Inpp5d^tm1Rav Pten^tm1Hwu/Pten^tm1Hwu (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal B cell morphology	J:166155
	abnormal myeloid leukocyte morphology	J:166155
	decreased B cell number	J:166155
	enlarged spleen	J:166155
	increased B cell number	J:166155
	increased spleen white pulp amount	J:166155
Cd19^tm1(cre)Cgn/Cd19⁺ Irf8^tm1.1Hm/Irf8^tm1.1Hm (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen marginal zone morphology	J:168923
	decreased follicular B cell number	J:168923
	increased B cell number	J:168923
	increased B-2 B cell number	J:168923
	increased follicular B cell number	J:168923
	increased marginal zone B cell number	J:168923
	increased transitional stage B cell number	J:168923
Cd19^tm1(cre)Cgn/Cd19⁺ Klhl6^tm2Sato/Klhl6^tm2Sato (either: (involves: 129P2/OlaHsd * 129T2/SvEms) or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * CD-1))	abnormal B cell differentiation	J:101363
	abnormal lymph node germinal center morphology	J:101363
	decreased B cell number	J:101363
Cd19^tm1(cre)Cgn/Cd19⁺ Ltb^tm1Avt/Ltb^tm1Avt (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen B cell follicle morphology	J:79129
	abnormal spleen follicular dendritic cell network	J:79129
	decreased marginal zone B cell number	J:79129
	decreased spleen germinal center number	J:79129
	decreased spleen germinal center size	J:79129
	small Peyer's patches	J:79129
Cd19^tm1(cre)Cgn/Cd19⁺ Ltb^tm1Avt/Ltb^tm1Avt Tg(Lck-cre)1Jtak/? (involves: 129P2/OlaHsd * C57BL/6)	absent follicular dendritic cells	J:79129
Cd19^tm1(cre)Cgn/Cd19⁺ Map3k7^tm1Aki/Map3k7^tm1.1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased B-1 B cell number	J:112597
Cd19^tm1(cre)Cgn/Cd19⁺ Mcl1^tm2Sjk/Mcl1^tm3Sjk (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal B cell differentiation	J:86906
	absent early pro-B cells	J:86906
	absent late pro-B cells	J:86906
	absent pre-B cells	J:86906
	arrested B cell differentiation	J:86906
	decreased B cell number	J:86906
Cd19^tm1(cre)Cgn/Cd19⁺ Mirc30^tm1.1Rdf/Mirc30^tm1.1Rdf (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	increased B cell number	J:156946
	increased B-1a cell number	J:156946
	increased spleen white pulp amount	J:156946
Cd19^tm1(cre)Cgn/Cd19⁺ Myd88^em1.1Rsky/Myd88⁺ (involves: C57BL/6NTac)	abnormal splenic cell ratio	J:308792
	enlarged spleen	J:308792
	increased germinal center B cell number	J:308792
	increased plasma cell number	J:308792
Cd19^tm1(cre)Cgn/Cd19⁺ Notch2^tm1.1Hhi/Notch2⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased marginal zone B cell number	J:83476
Cd19^tm1(cre)Cgn/Cd19⁺ Notch2^tm2Hhi/Notch2^tm1.1Hhi (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal spleen marginal zone morphology	J:83476
	absent marginal zone B cells	J:83476
	decreased transitional stage B cell number	J:83476
Cd19^tm1(cre)Cgn/Cd19⁺ Pax5^tm1Mbu/Pax5^tm3Mbu (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal B cell differentiation	J:75504
	abnormal class switch recombination	J:75504
	decreased immature B cell number	J:75504
	decreased mature B cell number	J:75504
	decreased pre-B cell number	J:75504
Cd19^tm1(cre)Cgn/Cd19⁺ Prdm1^tm1Clme/Prdm1^tm1Clme (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal B cell differentiation	J:101890
	abnormal memory B cell number	J:101890
	abnormal plasma cell differentiation	J:101890
	abnormal plasma cell morphology	J:101890, J:114881
	decreased plasma cell number	J:101890
	increased spleen germinal center number	J:101890
	increased spleen germinal center size	J:101890
Cd19^tm1(cre)Cgn/Cd19⁺ Pten^tm1Hwu/Pten^tm1Hwu (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal B cell negative selection	J:155314
	abnormal class switch recombination	J:114881
	abnormal plasma cell morphology	J:114881
	decreased spleen germinal center number	J:83213
	increased B cell number	J:83213
	increased B-1 B cell number	J:83213
	increased marginal zone B cell number	J:83213
Cd19^tm1(cre)Cgn/Cd19⁺ Ptpn6^tm1Rsky/Ptpn6^tm1Rsky (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte cell number	J:123568
	abnormal lymph organ size	J:123568
	decreased follicular B cell number	J:123568
	decreased marginal zone B cell number	J:123568
	enlarged lymph nodes	J:123568
	enlarged spleen	J:123568
	increased B cell number	J:123568
	increased B-1a cell number	J:123568
	increased granulocyte number	J:123568
	increased macrophage cell number	J:123568
	increased plasma cell number	J:123568
	increased T cell number	J:123568
Cd19^tm1(cre)Cgn/Cd19⁺ Rac1^tm1Tyb/Rac1^tm1Tyb Rac2^tm1Mddw/Rac2^tm1Mddw (involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6)	arrested B cell differentiation	J:86765
	decreased B cell number	J:86765
	decreased B-1 B cell number	J:86765
	decreased follicular B cell number	J:86765
	decreased marginal zone B cell number	J:86765
	decreased transitional stage B cell number	J:86765
Cd19^tm1(cre)Cgn/Cd19⁺ Rbpj^tm1Hon/Rbpj^tm1Hon (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:76240
	decreased marginal zone B cell number	J:121523, J:76240
	increased follicular B cell number	J:121523, J:76240
Cd19^tm1(cre)Cgn/Cd19⁺ Rbpj^tm1Hon/Rbpj^tm1Hon Spen^tm2.1Hon/Spen^tm2.1Hon (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased marginal zone B cell number	J:121523
	increased follicular B cell number	J:121523
Cd19^tm1(cre)Cgn/Cd19⁺ Slc3a2^tm1.1Mgin/Slc3a2^tm1.1Mgin (involves: 129 * C57BL/6 * SJL)	abnormal class switch recombination	J:148000
	abnormal plasma cell differentiation	J:148000
	decreased germinal center B cell number	J:148000
Cd19^tm1(cre)Cgn/Cd19⁺ Spen^tm2.1Hon/Spen^tm2.1Hon (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased follicular B cell number	J:121523
	increased marginal zone B cell number	J:121523
Cd19^tm1(cre)Cgn/Cd19⁺ Srsf3^tm1Pjln/Srsf3^tm1Pjln (involves: 129P2/OlaHsd * BALB/c)	decreased B cell number	J:113645
Cd19^tm1(cre)Cgn/Cd19⁺ Tbl1xr1^{tm1c(EUCOMM)Hmgu}/Tbl1xr1^{tm1c(EUCOMM)Hmgu} Tg(Vav-BCL2)69Jad/0 (involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)	abnormal B cell differentiation	J:292118
	abnormal lymphocyte morphology	J:292118
	abnormal spleen morphology	J:292118
Cd19^tm1(cre)Cgn/Cd19⁺ Tcf3^tm1Mbu/Tcf3^tm1.2Mbu (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased B cell number	J:137719
	decreased immature B cell number	J:137719
	decreased mature B cell number	J:137719
	decreased pre-B cell number	J:137719
	decreased pro-B cell number	J:137719
	decreased transitional stage B cell number	J:137719
Cd19^tm1(cre)Cgn/Cd19⁺ Tcf3^tm1Mbu/Tcf3^tm1.2Mbu Tg(Vav-BCL2)69Jad/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)	decreased pre-B cell number	J:137719
Cd19^tm1(cre)Cgn/Cd19⁺ Tgfbr2^tm1Roes/Tgfbr2^tm1Roes (involves: 129P2/OlaHsd * BALB/c)	abnormal B-1 B cell morphology	J:90558
	abnormal B-1 B cell number	J:90558
	absent plasma cells	J:90558
	enlarged Peyer's patches	J:90558
	increased leukocyte cell number	J:90558
Cd19^tm1(cre)Cgn/Cd19⁺ Tnfaip3^tm1.1Awai/Tnfaip3^tm1.1Awai (involves: 129P2/OlaHsd)	decreased B-1a cell number	J:175422
	decreased B-1b cell number	J:175422
	decreased marginal zone B cell number	J:175422
	decreased mature B cell number	J:175422
	enlarged spleen	J:175422
	increased B cell number	J:175422
	increased follicular B cell number	J:175422
	increased germinal center B cell number	J:175422
	increased splenocyte number	J:175422
	increased T cell number	J:175422
Cd19^tm1(cre)Cgn/Cd19⁺ Tnfaip3^tm2Ama/Tnfaip3⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased germinal center B cell number	J:163917
	increased plasma cell number	J:163917
Cd19^tm1(cre)Cgn/Cd19⁺ Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:172843
Cd19^tm1(cre)Cgn/Cd19⁺ Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc Traf2^tm1Rbr/Traf2^tm1Rbr (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	increased follicular B cell number	J:132877
	increased marginal zone B cell number	J:132877
Cd19^tm1(cre)Cgn/Cd19⁺ Traf2^tm1Rbr/Traf2^tm1Rbr (involves: 129P2/OlaHsd * C57BL/6)	increased follicular B cell number	J:132877
	increased marginal zone B cell number	J:132877
	lymph node hyperplasia	J:132877
Cd19^tm1(cre)Cgn/Cd19⁺ Traf2^tm1Rbr/Traf2^tm1Rbr Traf3^tm1Rbr/Traf3^tm1Rbr (involves: 129P2/OlaHsd * C57BL/6 * SJL)	increased marginal zone B cell number	J:132877
Cd19^tm1(cre)Cgn/Cd19⁺ Traf3^tm1Rbr/Traf3^tm1Rbr (involves: 129P2/OlaHsd * C57BL/6 * SJL)	increased follicular B cell number	J:132877
	increased marginal zone B cell number	J:132877
	lymph node hyperplasia	J:132877
Cd19^tm1(cre)Cgn/Cd19⁺ Ube2n^tm1Aki/Ube2n^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen marginal zone morphology	J:112287
	decreased B cell number	J:112287
	decreased marginal zone B cell number	J:112287
Cd19^tm1(cre)Cgn/Cd19⁺ Wac^em2Cya/Wac^em2Cya (B6.Cg-Cd19^tm1(cre)Cgn Wac^em2Cya)	abnormal plasma cell differentiation	J:345327
	decreased plasma cell number	J:345327
Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:27463
	absent spleen germinal center	J:83213, J:27463
	decreased B-1 B cell number	J:83213, J:27463
Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:155314
Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:155314
Cd19^{tm1(cre/ERT2)Rsky}/Cd19⁺ Myd88^em1.1Rsky/Myd88⁺ (involves: 129P2/OlaHsd * C57BL/6NTac)	increased plasma cell number	J:308792
Cd19^tm1Tft/Cd19^tm1Tft (Not Specified)	decreased B cell number	J:27236
Cd19^tm1Tft/Cd19^tm1Tft (Not Specified)	decreased B-1 B cell number	J:27236
Cd19^tm1Tft/Cd19^tm1Tft (involves: 129/Sv * C57BL/6)	decreased neutrophil cell number	J:66111
Cd19^tm1Tft/Cd19^tm1Tft (involves: 129 * C57BL/6)	decreased B cell number	J:71174
Cd19^tm1Tft/Cd19^tm1Tft (involves: 129 * C57BL/6)	decreased B-1 B cell number	J:71174
Cd19^tm1Tft/Cd19^tm1Tft (B6.Cg-Cd19^tm1Tft)	increased CD8-positive, alpha-beta T cell number	J:106487
Cd19^tm1Tft/Cd19^tm1Tft Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJaeSor * C57BL/6)	decreased B cell number	J:71174
	decreased B-1 B cell number	J:71174
	decreased mature B cell number	J:71174
	enlarged spleen	J:71174
Cd22^m1Anu/Cd22^m1Anu (C57BL/6JAnu-Cd22^m1Anu/AnuApb)	arrested B cell differentiation	J:104190
Cd22^m1Anu/Cd22^m1Anu (C57BL/6JAnu-Cd22^m1Anu/AnuApb)	decreased B cell number	J:104190
Cd22^m1Btlr/Cd22^m1Btlr (C57BL/6J-Cd22^m1Btlr)	abnormal B cell differentiation	J:173079
Cd22^m1Btlr/Cd22^m1Btlr (involves: C57BL/6J)	abnormal B cell differentiation	J:185495
Cd22^m2Btlr/Cd22^m2Btlr (C57BL/6J-Cd22^m2Btlr)	abnormal B cell differentiation	J:215821
Cd22^m3Btlr/Cd22^m3Btlr (C57BL/6J-Cd22^m3Btlr)	decreased B cell number	J:220066
Cd22^m3Btlr/Cd22^m3Btlr (C57BL/6J-Cd22^m3Btlr)	increased B-1a cell number	J:220066
Cd22^m4Btlr/Cd22^m4Btlr (C57BL/6J-Cd22^m4Btlr)	decreased B cell number	J:224660
	decreased B-2 B cell number	J:224660
	decreased memory B cell number	J:224660
	increased B-1a cell number	J:224660
Cd22^m5Btlr/Cd22^m5Btlr (C57BL/6J-Cd22^m5Btlr)	decreased B cell number	J:254827
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254827
	increased CD8-positive, alpha-beta memory T cell number	J:254827
Cd22^{tm1.1(CD22)Lnit}/Cd22^{tm1.1(CD22)Lnit} (involves: 129S4/SvJae)	decreased B cell number	J:189017
	decreased marginal zone B cell number	J:189017
	decreased transitional stage T1 B cell number	J:189017
	decreased transitional stage T2 B cell number	J:189017
Cd22^{tm1b(EUCOMM)Wtsi}/Cd22^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cd22^{tm1b(EUCOMM)Wtsi}/Tcp)	increased monocyte cell number	J:211773
Cd22^tm1Eac/Cd22⁺ Lyn^tm1Ard/Lyn⁺ Ptpn6^me-v/Ptpn6⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell negative selection	J:110531
	abnormal mature B cell morphology	J:110531
Cd22^tm1Eac/Cd22⁺ Lyn^tm1Ard/Lyn⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell negative selection	J:110531
	abnormal mature B cell morphology	J:110531
Cd22^tm1Eac/Cd22⁺ Ptpn6^me-v/Ptpn6⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell negative selection	J:110531
	abnormal mature B cell morphology	J:110531
Cd22^tm1Eac/Cd22⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:110531
Cd22^tm1Eac/Cd22^tm1Eac (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:37451
	abnormal transitional stage B cell morphology	J:132991
	decreased marginal zone B cell number	J:132991
	decreased mature B cell number	J:37451, J:132991
	decreased memory B cell number	J:37451
Cd22^tm1Lam/Cd22^tm1Lam (involves: 129 * C57BL/6)	decreased marginal zone B cell number	J:125719
Cd22^tm1Lam/Cd22^tm1Lam (involves: 129 * C57BL/6)	decreased mature B cell number	J:125719
Cd22^tm1Lam/Cd22^tm1Lam Igh^tm1.2Rsky/Igh⁺ (involves: 129 * BALB/c * C57BL/6)	abnormal class switch recombination	J:125719
Cd22^tm1Lam/Cd22^tm1Lam Igh^tm1.2Rsky/Igh^tm1.2Rsky (involves: 129 * BALB/c * C57BL/6)	decreased B-1a cell number	J:125719
Cd22^tm1Lnit/Cd22^tm1Lnit (involves: 129P2/OlaHsd * C57BL/6)	decreased marginal zone B cell number	J:198790
Cd22^tm1Msn/Cd22^tm1Msn (either: (involves: 129S/SvEv * BALB/c) or (involves: 129S/SvEv * C57BL/6J))	abnormal mature B cell morphology	J:76974
	increased B-1 B cell number	J:76974
Cd22^tm1Tft/Cd22^tm1Tft (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:92736
	decreased marginal zone B cell number	J:92736
	decreased mature B cell number	J:92736
Cd22^tm2Lnit/Cd22^tm2Lnit (involves: 129P2/OlaHsd * C57BL/6)	absent mature B cells	J:198790
	decreased marginal zone B cell number	J:198790
Cd22^tm2Tft/Cd22^tm2Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased B cell number	J:92736
Cd22^tm2Tft/Cd22^tm2Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased B cell number	J:208364
Cd22^tm3Lnit/Cd22^tm3Lnit (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal immune system morphology	J:198790
	absent mature B cells	J:198790
	decreased B cell number	J:198790
	decreased marginal zone B cell number	J:198790
	decreased transitional stage B cell number	J:198790
Cd22^tm3Tft/Cd22^tm3Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased B cell number	J:92736
Cd24a^tm1Pjln/Cd24a^tm1Pjln (C57BL/6-Cd24a^tm1Pjln)	abnormal B cell differentiation	J:76695
	dark spleen	J:76695
	decreased immature B cell number	J:76695
	decreased pre-B cell number	J:76695
Cd27^{em1(IMPC)Ccpcz}/Cd27^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cd27^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
Cd27^tm1Jbo/Cd27^tm1Jbo (B6.129P2-Cd27^tm1Jbo)	abnormal leukopoiesis	J:97606
	decreased regulatory T cell number	J:198200
	increased leukocyte cell number	J:97606
Cd28^tm1.1Huen/Cd28^tm1.1Huen Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	decreased regulatory T cell number	J:191101
Cd28^{tm1a(EUCOMM)Hmgu}/Cd28^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Cd28^{tm1a(EUCOMM)Hmgu}/H)	decreased T cell number	J:165965
	increased CD4-positive, alpha-beta T cell number	J:165965
	increased leukocyte cell number	J:165965
Cd28^tm1Jmg/Cd28^tm1Jmg (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal lymphopoiesis	J:124570
Cd28^tm1Jmg/Cd28^tm1Mak (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal lymphopoiesis	J:124570
Cd28^tm1Ltu/Cd28^tm1Ltu Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased regulatory T cell number	J:194503
	enlarged lymph nodes	J:194503
	enlarged spleen	J:194503
	increased activated T cell number	J:194503
	increased B cell number	J:194503
Cd28^tm1Mak/Cd28⁺ Cd5^tm1Cgn/Cd5^tm1Cgn (either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))	abnormal T cell clonal deletion	J:110925
Cd28^tm1Mak/Cd28^tm1Mak (involves: 129S2/SvPas * C57BL/6 * DBA/2)	abnormal class switch recombination	J:14194
Cd28^tm1Mak/Cd28^tm1Mak (involves: 129S2/SvPas)	abnormal class switch recombination	J:123989
	decreased regulatory T cell number	J:191101, J:205441
	decreased spleen germinal center number	J:123989
	enlarged thymus	J:205441
Cd28^tm1Mak/Cd28^tm1Mak Cd5^tm1Cgn/Cd5⁺ (either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))	abnormal T cell clonal deletion	J:110925
Cd28^tm1Mak/Cd28^tm1Mak Cd5^tm1Cgn/Cd5^tm1Cgn (either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))	abnormal T cell clonal deletion	J:110925
	increased CD4-positive, alpha-beta T cell number	J:110925
	increased CD8-positive, alpha-beta T cell number	J:110925
Cd28^tm1Mak/Cd28^tm1Mak Cd40lg^tm1Flv/Cd40lg^tm1Flv (NOD.Cg-Cd40lg^tm1Flv Cd28^tm1Mak)	decreased regulatory T cell number	J:93421
Cd28^tm1Mak/Cd28^tm1Mak Ndfip1^{Gt(RRD002)Byg}/Ndfip1^{Gt(RRD002)Byg} (involves: 129P2/OlaHsd * 129S2/SvPas)	increased eosinophil cell number	J:205692
Cd28^tm1Mak/Cd28^tm1Mak Rc3h1^san/Rc3h1⁺ (involves: 129S2/SvPas * C57BL/6 * C57BL/6JSfdAnu)	increased T cell derived lymphoma incidence	J:189087
Cd28^tm1Mak/Cd28^tm1Mak Tg(Cd4-cre)1Cwi/? Traf6^tm2Ywc/Traf6^tm2Ywc (involves: 129S2/SvPas * C57BL/6 * DBA/2)	increased activated T cell number	J:130882
	increased memory T cell number	J:130882
Cd28^tm1Mak/Cd28^tm1Mak Tg(H2-K-Cd86)7All/0 (involves: BALB/c * C57BL/6 * CBA)	abnormal T cell differentiation	J:112266
Cd28^tm1Pjl/Cd28^tm1Pjl (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:83722
Cd28^tm1Pjl/Cd28^tm1Pjl Tg(H2-K-Cd86)27All/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased B cell number	J:112475
Cd28^tm1Pjl/Cd28^tm1Pjl Tnfrsf9^tm1Byk/Tnfrsf9^tm1Byk (either: B6.Cg-Cd28^tm1Pjl Tnfrsf9^tm1Byk or C.Cg-Cd28^tm1Pjl Tnfrsf9^tm1Byk)	abnormal class switch recombination	J:83722
Cd28^tm1Shr/Cd28^tm1Shr (involves: 129S4/SvJae * BALB/c * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:68642
Cd28^tm1Shr/Cd28^tm1Shr Ctla4^tm1Shr/Ctla4⁺ (C.129S4-Cd28^tm1Shr Ctla4^tm1Shr)	abnormal CD8-positive, alpha beta T cell morphology	J:125259
Cd28^tm1Shr/Cd28^tm1Shr Ctla4^tm1Shr/Ctla4^tm1Shr (C.129S4-Cd28^tm1Shr Ctla4^tm1Shr)	decreased CD4-positive, alpha-beta T cell number	J:68642
Cd34^tm1Lal/Cd34^tm1Lal (involves: 129S2/SvPas)	decreased splenocyte number	J:30621
Cd34^tm1Szk/Cd34^tm1Szk (involves: 129P2/OlaHsd * C57BL/6J)	decreased eosinophil cell number	J:32799
Cd36^em1(IMPC)Mbp/Cd36^em1(IMPC)Mbp (C57BL/6N-Cd36^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cd36^tm1Mfe/Cd36^tm1Mfe (B6.129S1-Cd36^tm1Mfe)	abnormal B cell morphology	J:130897
	abnormal plasma cell differentiation	J:130897
	increased transitional stage B cell number	J:130897
Cd37^tm1Hor/Cd37^tm1Hor (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:63315
	abnormal lymph node germinal center morphology	J:63315
	decreased spleen germinal center number	J:63315
	decreased spleen germinal center size	J:63315
Cd38^{em1(IMPC)Ccpcz}/Cd38^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cd38^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK T cell number	J:211773
	decreased T-helper cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased NK cell number	J:211773
Cd40^tm1Arah/Cd40^tm1Arah (B6.129S1-Cd40^tm1Arah)	absent spleen germinal center	J:120512
Cd40^tm1Geha/Cd40^tm1Geha (involves: 129S4/SvJae * C57BL/6)	abnormal lymph node germinal center morphology	J:82298
	decreased spleen germinal center number	J:82298
	decreased spleen germinal center size	J:82298
Cd40^tm1Kik/Cd40⁺ Mir146^tm1.1Lfl/Mir146^tm1.1Lfl Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	increased T follicular helper cell number	J:266124
Cd40^tm1Kik/Cd40^tm1Kik (involves: 129P2/OlaHsd * C57BL/6)	absent spleen germinal center	J:25007
Cd40^tm1Kik/Cd40^tm1Kik (involves: 129P2/OlaHsd * C57BL/6)	decreased neutrophil cell number	J:25007
Cd40^tm1Kik/Cd40^tm1Kik (involves: 129P2/OlaHsd)	absent germinal center B cells	J:190943
Cd40^tm1Kik/Cd40^tm1Kik (involves: 129P2/OlaHsd)	decreased B cell number	J:190943
Cd40^tm1Kik/Cd40^tm1Kik Ltbr^tm1Mmat/Ltbr^tm1Mmat (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal thymus epithelium morphology	J:173115
	abnormal thymus medulla morphology	J:173115
Cd40^tm1Kik/Cd40^tm1Kik Tg(Tnfsf13b)1Fma/? (B6.Cg-Cd40^tm1Kik Tg(Tnfsf13b)1Fma)	abnormal class switch recombination	J:113556
	absent spleen germinal center	J:113556
	increased marginal zone B cell number	J:113556
Cd40^tm1Kik/Cd40^tm1Kik Tnfsf11^tm1Pngr/Tnfsf11^tm1Pngr (involves: 129P2/OlaHsd)	abnormal thymus epithelium morphology	J:173115
Cd40^tm1Kik/Cd40^tm1Kik Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (involves: 129 * 129P2/OlaHsd * BALB/c)	enlarged lymph nodes	J:93923
	enlarged spleen	J:93923
	increased follicular B cell number	J:138560
	increased marginal zone B cell number	J:138560
	increased transitional stage B cell number	J:138560
Cd40lg^m1Btlr/Y (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Cd40lg^m1Btlr/Cd40lg^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Cd40lg^tm1Flv/Cd40lg^tm1Flv (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:25010
	abnormal immune system morphology	J:25010
	abnormal osteoclast differentiation	J:120087
	abnormal T cell differentiation	J:25010
	absent spleen germinal center	J:25010
	decreased double-positive T cell number	J:25010
	increased CD4-positive, alpha-beta T cell number	J:25010
Cd40lg^tm1Flv/Cd40lg^tm1Flv (NOD.129S2-Cd40lg^tm1Flv)	decreased regulatory T cell number	J:93421
Cd40lg^tm1Imx/Y (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:21137
	abnormal immune system organ morphology	J:21137
	abnormal lymph node morphology	J:21137
	absent lymph node germinal center	J:21137
	absent spleen germinal center	J:21137
	lymph node hypoplasia	J:21137
Cd40lg^tm1Imx/Cd40lg^tm1Imx (involves: 129S2/SvPas * C57BL/6J * BALB/c)	abnormal T cell clonal deletion	J:110925
Cd40lg^tm1Imx/Cd40lg^tm1Imx (involves: 129S2/SvPas * C57BL/6)	microgliosis	J:115487
Cd44^M1Btlr/Cd44^M1Btlr (C57BL/6J-Cd44^M1Btlr)	decreased alpha-beta T cell number	J:267483
	decreased CD4-positive, alpha-beta T cell number	J:267483
	decreased CD8-positive, alpha-beta T cell number	J:267483
	decreased central memory CD4-positive, alpha-beta T cell number	J:267483
	decreased central memory CD8 positive, alpha-beta T cell number	J:267483
	decreased effector memory CD4-positive, alpha-beta T cell number	J:267483
Cd44^tm1Hbg/Cd44^tm1Hbg (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:68069
	abnormal CD8-positive, alpha beta T cell morphology	J:68069
Cd44^tm1Hbg/Cd44^tm1Hbg (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast differentiation	J:101563
Cd44^tm1Hbg/Cd44^tm1Hbg (B6.129-Cd44^tm1Hbg)	decreased mast cell histamine storage	J:146846
Cd44^tm1Hbg/Cd44^tm1Hbg (B6.129-Cd44^tm1Hbg)	decreased mast cell number	J:146846
Cd44^tm1Hbg/Cd44^tm1Hbg Tg(TNF)197Gkl/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal osteoclast differentiation	J:97992
	abnormal osteoclast morphology	J:97992
	increased osteoclast cell number	J:97992
Cd47^tm1Fpl/Cd47^tm1Fpl (involves: 129S7/SvEvBrd)	decreased T cell number	J:36489
Cd47^tm1Fpl/Cd47^tm1Fpl (B6.129S7-Cd47^tm1Fpl)	decreased osteoclast cell number	J:116609
Cd47^tm1Fpl/Cd47^tm1Fpl (C.129S7-Cd47^tm1Fpl)	decreased osteoclast cell number	J:116609
Cd47^tm1Fpl/Cd47^tm1Fpl (NOD.129S7-Cd47^tm1Fpl)	abnormal spleen morphology	J:76580
	abnormal splenic cell ratio	J:76580
	enlarged spleen	J:76580
Cd47^tm1Fpl/Cd47^tm1Fpl (involves: 129S7/SvEvBrd * C57BL/6)	abnormal osteoclast differentiation	J:147367
	decreased leukocyte cell number	J:134866
	decreased neutrophil cell number	J:134866
Cd48^tm1Rsr/Cd48^tm1Rsr (B6.129S4-Cd48^tm1Rsr)	increased CD4-positive, alpha-beta T cell number	J:53718
Cd52^{em1(IMPC)Ccpcz}/Cd52^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cd52^{em1(IMPC)Ccpcz}/Ccpcz)	decreased NK T cell number	J:211773
Cd59a^tm1Bpm/Cd59a^tm1Bpm (involves: 129)	increased macrophage cell number	J:148367
Cd59a^tm1Bpm/Cd59a^tm1Bpm (B6.129-Cd59a^tm1Bpm)	decreased plasma cell number	J:119703
	increased CD4-positive, alpha-beta T cell number	J:123582
	increased double-positive T cell number	J:123582
	increased neutrophil cell number	J:123582
Cd68^tm1Xfen/Cd68^tm1Xfen (C57BL/6J-Cd68^tm1Xfen)	abnormal osteoclast morphology	J:178120
Cd69^tm1Fsm/Cd69^tm1Fsm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell differentiation	J:61329
	increased immature B cell number	J:61329
	increased pre-B cell number	J:61329
Cd69^tm1Naka/Cd69^tm1Naka (B6.129P2-Cd69^tm1Naka)	decreased CD4-positive, alpha-beta T cell number	J:184704
Cd70^tm1(cre)Jbo/Cd70^tm1(cre)Jbo (B6.129P2-Cd70^tm1(cre)Jbo)	decreased regulatory T cell number	J:198200
Cd70^tm1.1Jda/Cd70^tm1.1Jda (B6.Cg-Cd70^tm1.1Jda)	decreased CD8-positive, alpha-beta T cell number	J:193042
Cd72^b/Cd72^b Fas^lpr/Fas^lpr (involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)	abnormal B cell number	J:204782
	abnormal T cell number	J:204782
	decreased spleen weight	J:204782
Cd72^c/Cd72^c Fas^lpr/Fas^lpr (involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)	abnormal B cell number	J:204782
	abnormal T cell number	J:204782
	enlarged lymph nodes	J:204782
	increased spleen weight	J:204782
Cd72^tm1Jrp/Cd72^tm1Jrp (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal B cell differentiation	J:76990
	decreased B cell number	J:76990
	decreased B-2 B cell number	J:76990
	decreased follicular B cell number	J:76990
	decreased mature B cell number	J:76990
	increased B-1 B cell number	J:76990
	increased B-1a cell number	J:76990
	increased immature B cell number	J:76990
	increased marginal zone B cell number	J:76990
	increased pre-B cell number	J:76990
	increased pro-B cell number	J:76990
Cd72^tm1Jrp/Cd72^tm1Jrp Tg(BCL2)22Wehi/0 (either: (involves: 129P2/OlaHsd * C57BL/6JWehi * SJL/JWehi) or (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JWehi * SJL/JWehi))	decreased mature B cell number	J:76990
	increased immature B cell number	J:76990
Cd72^tm1Tsub/Cd72^tm1Tsub (involves: C57BL/6J)	increased spleen weight	J:204782
Cd72^tm1Tsub/Cd72^tm1Tsub Fas^lpr/Fas^lpr (involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp)	abnormal B cell number	J:204782
	abnormal T cell number	J:204782
	enlarged lymph nodes	J:204782
	increased spleen weight	J:204782
Cd74^em1(IMPC)H/Cd74^em1(IMPC)H (C57BL/6N-Cd74^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Cd74^tm1Doi/Cd74^tm1Doi (either: (involves: 129/Sv * B10.BR) or (involves: 129/Sv * C57BL/6))	decreased CD4-positive, alpha-beta T cell number	J:4119, J:45185
	increased CD8-positive, alpha-beta T cell number	J:4119
Cd74^tm1Doi/Cd74^tm1Doi H2-DMa^tm1Doi/H2-DMa^tm1Doi (involves: 129S2/SvPas * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:42482
	increased CD8-positive, alpha-beta T cell number	J:42482
Cd74^tm1Doi/Cd74^tm1Doi Tap1^tm1Arp/Tap1^tm1Arp (involves: 129S2/SvPas * C57BL/6)	abnormal T cell number	J:113083
Cd74^tm1Eae/Cd74^tm1Eae (involves: 129S2/SvPas)	decreased CD4-positive, alpha-beta T cell number	J:113050
Cd74^tm1Eae/Cd74^tm1Eae (B6.129S2-Cd74^tm1Eae)	abnormal lymph node cell ratio	J:112084
Cd74^tm1Eae/Cd74^tm1Eae (B6.129S2-Cd74^tm1Eae)	arrested B cell differentiation	J:112084
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * C57BL/6J)	decreased CD4-positive, alpha-beta T cell number	J:65918
Cd74^tm1Liz/Cd74^tm1Liz (B6.129S-Cd74^tm1Liz)	decreased CD4-positive, alpha-beta T cell number	J:28966
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * BALB/cAn)	abnormal B cell differentiation	J:110927
	decreased CD4-positive, alpha-beta T cell number	J:110927, J:113714
	increased immature B cell number	J:110927
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * BALB/c * C57BL)	abnormal B cell differentiation	J:110927
	increased immature B cell number	J:110927
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv * C57BL * C57BL/10 * C57BR)	abnormal B cell differentiation	J:110927
	increased immature B cell number	J:110927
Cd74^tm1Liz/Cd74^tm1Liz (involves: 129S/SvEv)	abnormal positive T cell selection	J:125548
Cd74^tm1Liz/Cd74^tm1Liz (B6.129S-Cd74^tm1Liz/J)	decreased B cell number	J:194664
Cd74^tm1Liz/Cd74^tm1Liz H2-DMa^tm1Liz/H2-DMa^tm1Liz (involves: 129S/SvEv * BALB/c)	decreased CD4-positive, alpha-beta T cell number	J:113714
Cd74^tm1Liz/Cd74^tm1Liz H2-DMa^tm1Luc/H2-DMa^tm1Luc Tg(CD74)AR194Ayr/? (involves: 129S/SvEv * 129S4/SvJae * C57BL/6J * DBA/2J)	decreased CD4-positive, alpha-beta T cell number	J:88717
Cd74^tm1Liz/Cd74^tm1Liz H2-DMa^tm1Luc/H2-DMa^tm1Luc Tg(CD74)1Ayr/0 (involves: 129S/SvEv 129S4/SvJae * C57BL/6J * DBA/2J)	decreased CD4-positive, alpha-beta T cell number	J:88717
Cd74^tm1Liz/Cd74^tm1Liz Sppl2a^tm1Basc/Sppl2a^tm1Basc (B6.129-Sppl2a^tm1Basc Cd74^tm1Liz)	decreased B cell number	J:194664
	decreased Peyer's patch number	J:194664
Cd74^tm1Liz/Cd74^tm1Liz Sppl2a^tm1Dgen/Sppl2a^tm1Dgen (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	decreased follicular B cell number	J:194595
Cd79a^m1Anu/Cd79a^m1Anu (involves: C57BL/6JSfdAnu * C57BL/10Sg * C57BR/cd)	absent pre-B cells	J:104190
Cd79a^m1Anu/Cd79a^m1Anu (C57BL/6-Cd79a^m1Anu)	absent pre-B cells	J:171924
Cd79a^m1Btlr/Cd79a^m1Btlr (involves: C57BL/6J * C57BL/10J)	decreased B cell number	J:174338
Cd79a^m1Btlr/Cd79a^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Cd79a^m1Btlr/Cd79a^m1Btlr (involves: C57BL/6J)	decreased B cell number	J:185495
Cd79a^m2Btlr/Cd79a^m2Btlr (C57BL/6J-Cd79a^m2Btlr)	decreased B-1 B cell number	J:254836
Cd79a^tm1(cre)Reth/Cd79a⁺ Commd3^tm1.1Ksuz/Commd3^tm1.1Ksuz (involves: BALB/c * C57BL/6NSlc * SJL)	abnormal plasmablast number	J:278399
	abnormal spleen B cell follicle morphology	J:278399
	decreased follicular B cell number	J:278399
	decreased mature B cell number	J:278399
	decreased spleen germinal center number	J:278399
Cd79a^tm1(cre)Reth/Cd79a⁺ Commd8^tm1.1Ksuz/Commd8^tm1.1Ksuz (involves: BALB/c * C57BL/6NSlc * SJL)	abnormal plasmablast number	J:278399
	abnormal spleen B cell follicle morphology	J:278399
	decreased follicular B cell number	J:278399
	decreased mature B cell number	J:278399
	decreased spleen germinal center number	J:278399
Cd79a^tm1(cre)Reth/Cd79a⁺ Ctnnbl1^tm1.1Crad/Ctnnbl1^tm1.1Crad (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)	abnormal class switch recombination	J:232010
Cd79a^tm1(cre)Reth/Cd79a⁺ Dicer1^tm1Mmk/Dicer1^tm1Mmk Tg(BCL2)22Wehi/0 (involves: BALB/c * C57BL/6JWehi * SJL/JWehi)	decreased B cell number	J:135783
	decreased mature B cell number	J:135783
Cd79a^tm1(cre)Reth/Cd79a⁺ Dynll1^tm1.1Jhh/Dynll1^tm1.1Jhh (B6.Cg-Dynll1^tm1.1Jhh Cd79a^tm1(Cre)Reth)	abnormal B cell morphology	J:230105
	decreased immature B cell number	J:230105
	decreased mature B cell number	J:230105
	decreased pre-B cell number	J:230105
Cd79a^tm1(cre)Reth/Cd79a⁺ Dynll1^tm1.1Jhh/Dynll1^tm1.1Jhh Tg(IghMyc)22Bri/0 (B6.Cg-Dynll1^tm1.1Jhh Cd79a^tm1(Cre)Reth Tg(IghMyc)22Bri)	decreased immature B cell number	J:230105
Cd79a^tm1(cre)Reth/Cd79a⁺ Eif4a1^tm1.1Bea/Eif4a1^tm1.1Bea (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	decreased B cell number	J:344730
	decreased pro-B cell number	J:344730
Cd79a^tm1(cre)Reth/Cd79a⁺ Eif4b^tm1.1Tnr/Eif4b^tm1.1Tnr Eif4h^{tm1c(EUCOMM)Wtsi}/Eif4h^{tm1c(EUCOMM)Wtsi} (involves: BALB/c * C57BL/6 * C57BL/6N)	decreased mature B cell number	J:344730
Cd79a^tm1(cre)Reth/Cd79a⁺ Huwe1^tm1.1Mak/Y (B6.Cg-Cd79a^tm1(cre)Reth Huwe1^tm1.1Mak)	abnormal B cell differentiation	J:181705
	abnormal class switch recombination	J:181705
	absent B-1a cells	J:181705
	decreased follicular B cell number	J:181705
	decreased marginal zone B cell number	J:181705
	decreased mature B cell number	J:181705
	decreased pre-B cell number	J:181705
	decreased transitional stage B cell number	J:181705
Cd79a^tm1(cre)Reth/Cd79a⁺ Huwe1^tm1.1Mak/Y Trp53^tm1Brn/Trp53^tm1Brn (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal class switch recombination	J:181705
	absent B-1a cells	J:181705
Cd79a^tm1(cre)Reth/Cd79a⁺ Ikzf1^tm3.1Mbu/Ikzf1^tm3.1Mbu (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)	abnormal B cell differentiation	J:209928
	abnormal B cell number	J:209928
	decreased pre-B cell number	J:209928
	increased pro-B cell number	J:209928
Cd79a^tm1(cre)Reth/Cd79a⁺ Phf5a^tm1.1Oux/Phf5a^tm1.1Oux (involves: BALB/c * C57BL/6J)	abnormal B cell receptor editing	J:345807
	abnormal immunoglobulin heavy chain V(D)J recombination	J:345807
	decreased B cell number	J:345807
	decreased early pro-B cell number	J:345807
	decreased immature B cell number	J:345807
	decreased late pro-B cell number	J:345807
	decreased mature B cell number	J:345807
	decreased pre-B cell number	J:345807
	increased pre-pro B cell number	J:345807
	small spleen	J:345807
Cd79a^tm1(cre)Reth/Cd79a⁺ Phf5a^tm1.1Oux/Phf5a^tm1.1Oux Tg(IghelMD4)4Ccg/0 (involves: BALB/c * C57BL/6 * C57BL/6J)	abnormal B cell number	J:345807
Cd79a^tm1(cre)Reth/Cd79a⁺ Slc39a10^tm1.1Tfk/Slc39a10^tm1.1Tfk (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)	decreased B cell number	J:213935
	decreased pro-B cell number	J:213935
	spleen atrophy	J:213935
Cd79a^tm1(cre)Reth/Cd79a⁺ Was^tm1.1Ldn/Y (involves: BALB/c * C57BL/6)	decreased B cell number	J:182528
	decreased follicular B cell number	J:182528
	decreased marginal zone B cell number	J:182528
	decreased mature B cell number	J:182528
	increased germinal center B cell number	J:182528
	increased plasma cell number	J:182528
Cd79a^tm1(cre)Reth/Cd79a⁺ Was^tm1.1Ldn/Was⁺ (involves: BALB/c * C57BL/6)	abnormal B cell number	J:182528
Cd79a^tm1(cre)Reth/Cd79a⁺ Was^tm1.1Ldn/Was^tm1.1Ldn (involves: BALB/c * C57BL/6)	decreased B cell number	J:182528
	decreased follicular B cell number	J:182528
	decreased marginal zone B cell number	J:182528
	decreased mature B cell number	J:182528
	increased germinal center B cell number	J:182528
	increased plasma cell number	J:182528
Cd79a^tm1(cre)Reth/Cd79a^tm1(cre)Reth Mzb1^tm1.1Rug/Mzb1^tm1.1Rug (involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)	abnormal B cell number	J:211639
	decreased pre-B cell number	J:211639
	increased late pro-B cell number	J:211639
	increased pro-B cell number	J:211639
	small spleen	J:211639
Cd79a^{tm1.1(BAP31N-EGFP)Pld}/Cd79a^{tm1.1(BAP31N-EGFP)Pld} (Not Specified)	abnormal immune system cell morphology	J:75114
Cd79a^tm1.1Cgn/Cd79a⁺ Cd79b^tm1Gzmn/Cd79b^tm1Gzmn (involves: 129P2/OlaHsd)	decreased B cell number	J:179254
	decreased pre-B cell number	J:179254
	increased pro-B cell number	J:179254
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn (involves: 129P2/OlaHsd)	decreased B-1a cell number	J:124400
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn (involves: 129P2/OlaHsd * C57BL/6)	decreased B-1 B cell number	J:71100
	decreased marginal zone B cell number	J:71100
	decreased mature B cell number	J:71100
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn Cd79b^tm1Gzmn/Cd79b⁺ (involves: 129P2/OlaHsd)	decreased B cell number	J:179254
	decreased pre-B cell number	J:179254
	increased pro-B cell number	J:179254
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn Cd79b^tm1Gzmn/Cd79b^tm1Gzmn (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:124400
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn Cd79b^tm1Gzmn/Cd79b^tm1Gzmn (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:179254
	absent pre-B cells	J:179254
	decreased B cell number	J:179254
	increased pro-B cell number	J:179254
Cd79a^tm1.1Cgn/Cd79a^tm1.1Cgn Cd79b^tm2.1Mnz/Cd79b^tm2.1Mnz (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	absent mature B cells	J:71100
	arrested B cell differentiation	J:71100
Cd79a^tm1.1Rsky/Cd79a^tm1.1Rsky (involves: C57BL/6)	decreased marginal zone B cell number	J:179254
	decreased mature B cell number	J:179254
	increased immature B cell number	J:179254
	increased pre-B cell number	J:179254
	increased transitional stage B cell number	J:179254
	increased transitional stage T1 B cell number	J:179254
	increased transitional stage T2 B cell number	J:179254
	increased transitional stage T3 B cell number	J:179254
Cd79a^{tm2(cre/Esr1*)Reth}/Cd79a⁺ Rag1^tm1.1Sadu/Rag1^tm1.1Sadu (involves: BALB/c)	arrested B cell differentiation	J:155473
Cd79a^tm2Cgn/Cd79a^tm2Cgn (involves: C57BL/6 * C.B-20)	decreased B cell number	J:80885
Cd79a^tm2Cgn/Cd79a^tm2Cgn (involves: C57BL/6 * C.B-20)	decreased mature B cell number	J:80885
Cd79a^tm2Cgn/Cd79a^tm2Cgn (involves: C57BL/6)	decreased mature B cell number	J:71100, J:66840
	decreased pre-B cell number	J:71100, J:66840
	increased pro-B cell number	J:66840
Cd79a^tm2Cgn/Cd79a^tm2Cgn Cd79b^tm2.1Mnz/Cd79b^tm2.1Mnz (involves: 129/Sv * C57BL/6)	arrested B cell differentiation	J:66840
	decreased transitional stage B cell number	J:66840
Cd79a^tm2Pld/Cd79a^tm2Pld (BALB/c-Cd79a^tm2Pld)	abnormal B cell differentiation	J:87492
	abnormal T cell differentiation	J:87492
	absent mature B cells	J:87492
	decreased double-positive T cell number	J:87492
Cd79a^tm2Pld/Cd79a^tm2Pld Cd79b^tm1Mnz/Cd79b^tm1Mnz (involves: 129S1/Sv * BALB/c)	absent pre-B cells	J:87492
Cd79a^tm3Cgn/Cd79a^tm3Cgn Tg(Mx1-cre)1Cgn/? (involves: C57BL/6 * CBA)	abnormal metallophilic macrophage morphology	J:88620
	abnormal spleen marginal zone macrophage morphology	J:88620
	abnormal spleen red pulp morphology	J:88620
	decreased B cell number	J:88620
Cd79a^tm4.1Cgn/Cd79a^tm4.1Cgn (involves: C57BL/6)	abnormal B cell differentiation	J:91091
Cd79a^tm4.1Cgn/Cd79a^tm4.1Cgn Igh^tm1.2Rsky/Igh⁺ (involves: BALB/c * C57BL/6)	abnormal pro-B cell differentiation	J:125719
Cd79a^tm4Cgn/Cd79a^tm4.1Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:91091
Cd79a^tm4Cgn/Cd79a^tm4.1Cgn Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	absent immature B cells	J:91091
	arrested B cell differentiation	J:91091
	decreased B cell number	J:91091
	decreased follicular B cell number	J:91091
	decreased marginal zone B cell number	J:91091
Cd79a^tm5.1Cgn/Cd79a⁺ Igh^tm1.2Rsky/Igh⁺ (involves: 129 * BALB/c * C57BL/6)	abnormal class switch recombination	J:125719
Cd79a^tm5.1Cgn/Cd79a^tm5.1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:91091
Cd79a^tm5.1Cgn/Cd79a^tm5.1Cgn (involves: 129 * C57BL/6)	abnormal B cell morphology	J:125719
	decreased B-1a cell number	J:125719
	decreased immature B cell number	J:125719
	decreased mature B cell number	J:125719
	decreased pre-B cell number	J:125719
	decreased T cell number	J:125719
	increased pro-B cell number	J:125719
Cd79a^tm5.1Cgn/Cd79a^tm5.1Cgn Igh^tm1.2Rsky/Igh⁺ (involves: 129 * BALB/c * C57BL/6)	abnormal class switch recombination	J:125719
Cd79a^tm5.1Cgn/Cd79a^tm5.1Cgn Igh^tm1.2Rsky/Igh^tm1.2Rsky (involves: 129 * BALB/c * C57BL/6)	abnormal B cell morphology	J:125719
	abnormal class switch recombination	J:125719
	decreased immature B cell number	J:125719
	decreased mature B cell number	J:125719
	decreased pre-B cell number	J:125719
	decreased T cell number	J:125719
	increased B-1b cell number	J:125719
	increased pro-B cell number	J:125719
Cd79a^tm5Cgn/Cd79a^tm5.1Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:91091
Cd79a^tm5Cgn/Cd79a^tm5.1Cgn Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	absent immature B cells	J:91091
	arrested B cell differentiation	J:91091
	decreased B cell number	J:91091
Cd79a^tm6Cgn/Cd79a^tm6Cgn (involves: C57BL/6)	abnormal B cell number	J:113407
	decreased B-1a cell number	J:113407
	increased transitional stage B cell number	J:113407
Cd79b^m1Btlr/Cd79b^m1Btlr (C57BL/6J-Cd79b^m1Btlr)	decreased B cell number	J:267537
	decreased B-1 B cell number	J:267537
	decreased NK cell number	J:267537
	increased alpha-beta T cell number	J:267537
	increased CD4-positive, alpha-beta T cell number	J:267537
	increased CD8-positive, alpha-beta T cell number	J:267537
Cd79b^m1Ghost/Cd79b^m1Ghost (B10.Cg-Ptprc^a Cd79b^m1Ghost H2^a)	abnormal B cell differentiation	J:157450
	absent B cells	J:157450
	absent Peyer's patches	J:157450
	arrested B cell differentiation	J:157450
Cd79b^M2Btlr/Cd79b^M2Btlr (C57BL/6J-Cd79b^M2Btlr)	abnormal lymphocyte morphology	J:272863
	decreased B cell number	J:272863
	decreased B-1 B cell number	J:272863
Cd79b^tm1Gzmn/Cd79b^tm1Gzmn (involves: 129/Sv * C57BL/6)	decreased B-1a cell number	J:124400
Cd79b^tm1Mnz/Cd79b^tm1Mnz (involves: 129S1/Sv)	abnormal pro-B cell differentiation	J:78601
	abnormal pro-B cell morphology	J:78601
	arrested B cell differentiation	J:78601
Cd79b^tm1Mnz/Cd79b^tm1Mnz Tg(BCL2)22Wehi/0 Tg(IghelMD4)4Ccg/0 Tg(Rag2-Igb)1Mnz/0 (involves: 129S1/Sv * C57BL/6 * C57BL/6JWehi * SJL/JWehi)	arrested B cell differentiation	J:78601
Cd79b^tm1Mnz/Cd79b^tm1Mnz Tg(BCL2)22Wehi/0 Tg(Rag2-Igb)1Mnz/0 (involves: 129S1/Sv * C57BL/6JWehi * SJL/JWehi)	arrested B cell differentiation	J:78601
Cd79b^tm1Mnz/Cd79b^tm1Mnz Tg(IghelMD4)4Ccg/0 Tg(Rag2-Igb)1Mnz/0 (involves: 129S1/Sv * C57BL/6)	abnormal immature B cell morphology	J:78601
	arrested B cell differentiation	J:78601
Cd79b^tm1Mnz/Cd79b^tm1Mnz Tg(Rag2-Igb)1Mnz/0 (involves: 129S1/Sv)	abnormal pre-B cell morphology	J:78601
	arrested B cell differentiation	J:78601
Cd79b^tm2.1Mnz/Cd79b^tm2.1Mnz (involves: 129 * C57BL/6)	decreased mature B cell number	J:71100
Cd79b^tm2.1Mnz/Cd79b^tm2.1Mnz (involves: 129/Sv * C57BL/6)	arrested B cell differentiation	J:66840
	decreased mature B cell number	J:66840
	decreased pre-B cell number	J:66840
	decreased transitional stage B cell number	J:66840
	increased pro-B cell number	J:66840
Cd79b^tm3Mnz/Cd79b^tm3Mnz (involves: 129/Sv * C57BL/6)	abnormal immature B cell morphology	J:128768
	decreased B cell number	J:128768
	decreased B-1a cell number	J:128768
	decreased immature B cell number	J:128768
	decreased mature B cell number	J:128768
	increased marginal zone B cell number	J:128768
	increased pro-B cell number	J:128768
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr (involves: 129S4/SvJae)	abnormal lymph node B cell domain morphology	J:39089
	abnormal spleen morphology	J:39089
	decreased regulatory T cell number	J:205441, J:113109
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr (involves: 129S4/SvJae * BALB/c)	abnormal T cell number	J:112266
	decreased double-positive T cell number	J:112266
Cd80^tm1Shr/Cd80^tm1Shr Cd86^tm2Shr/Cd86^tm2Shr Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0 (involves: 129S4/SvJae * FVB/N * NOD)	decreased regulatory T cell number	J:113109
Cd81^tm1Geha/Cd81^tm1Geha (involves: 129S4/SvJae * C57BL/6)	abnormal B cell morphology	J:43975
	decreased B-1 B cell number	J:43975
	decreased B-1a cell number	J:43975
Cd81^tm1Lvy/Cd81^tm1Lvy (involves: 129S1/Sv * 129X1/SvJ)	abnormal B cell morphology	J:40394
Cd81^tm1Lvy/Cd81^tm1Lvy (either: (B6ByJ.129-Cd81^tm1Lvy x CByJ.129-Cd81^tm1Lvy)F1 or (CByJ.129-Cd81^tm1Lvy x B6ByJ.129-Cd81^tm1Lvy)F1)	abnormal microglial cell morphology	J:79426
Cd81^tm1Tmiy/Cd81^tm1Tmiy (involves: 129/Sv * C57BL/6)	abnormal B cell differentiation	J:41830
	abnormal immune system cell morphology	J:41830
	decreased B-1 B cell number	J:41830
Cd81^tm1Tmiy/Cd81^tm1Tmiy Cd9^tm1Mek/Cd9^tm1Mek (involves: 129/Sv * C57BL/6)	increased osteoclast cell number	J:83795
Cd82^tm1Kjbr/Cd82^tm1Kjbr (Not Specified)	abnormal macrophage differentiation	J:326451
	increased macrophage cell number	J:326451
	increased neutrophil cell number	J:326451
Cd83^anu/Cd83^anu (involves: C57BL/6JAnu * CBA/CaJAnu)	abnormal B cell morphology	J:104190
	abnormal dendritic cell morphology	J:104190
	decreased CD4-positive, alpha-beta T cell number	J:104190
Cd83^lcd4/Cd83^lcd4 (involves: C57BL/6J)	abnormal CD4-positive T cell differentiation	J:92721
Cd83^tm1.1Lnjt/Cd83^tm1.1Lnjt (involves: C57BL/6 * C57BL/6N)	decreased CD4-positive, alpha-beta T cell number	J:236611
Cd83^tm1.1Lnjt/Cd83^tm1.1Lnjt Marchf1^tm1.1Sish/Marchf1^tm1.1Sish (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6N)	decreased CD4-positive, alpha-beta T cell number	J:236611
Cd83^tm1Tft/Cd83^tm1Tft (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive T cell differentiation	J:75700
	arrested T cell differentiation	J:75700
	decreased CD4-positive, alpha-beta T cell number	J:75700
Cd84^tm1Pls/Cd84^tm1Pls (C57BL/6J-Cd84^tm1Pls)	abnormal long lived plasma cell morphology	J:157915
	decreased CD4-positive, alpha-beta T cell number	J:157915
	decreased germinal center B cell number	J:157915
	decreased spleen germinal center size	J:157915
Cd86^tm1Shr/Cd86^tm1Shr (NOD.129S4-Cd86^tm1Shr)	decreased regulatory T cell number	J:93421
Cd86^tm1Shr/Cd86^tm1Shr (involves: 129S4/SvJae)	absent spleen germinal center	J:39089
Cd96^{em1(IMPC)Wtsi}/Cd96^{em1(IMPC)Wtsi} (C57BL/6N-Cd96^{em1(IMPC)Wtsi}/WtsiOulu)	increased leukocyte cell number	J:211773
Cd101^tm1.1Dil/Cd101^tm1.1Dil (involves: BALB/cJ * C57BL/6 * C57BL/6NTac)	decreased granulocyte number	J:175943
Cd177^{tm1(KOMP)Vlcg}/Cd177^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased monocyte cell number	J:225335
	decreased neutrophil cell number	J:225335
Cd180^tm1Kmiy/Cd180^tm1Kmiy Fas^lpr/Fas^lpr (MRL.Cg-Cd180^tm1Kmiy Fas^lpr)	decreased B cell number	J:137066
	decreased CD8-positive, alpha-beta T cell number	J:137066
	enlarged lymph nodes	J:137066
	enlarged spleen	J:137066
	increased double-negative T cell number	J:137066
Cd200^tm1Jods/Cd200^tm1Jods (C57BL/6-Cd200^tm1Jods)	abnormal immune system organ morphology	J:65982
	abnormal lymph node morphology	J:65982
	abnormal microglial cell morphology	J:65982
	enlarged lymph nodes	J:65982
	increased macrophage cell number	J:79906, J:65982
	increased spleen red pulp amount	J:65982
Cd207^{tm1(Hbegf/EGFP)Bjec}/Cd207⁺ (involves: C57BL/6 * SJL)	absent Langerhans cell	J:137517
	decreased dendritic cell number	J:137452
Cd207^tm1.1Cfg/Cd207^tm1.1Cfg (involves: C57BL/6)	abnormal Peyer's patch morphology	J:217719
Cd207^tm1Mal/Cd207^tm1Mal (B6.129S2-Cd207^tm1Mal)	abnormal Langerhans cell morphology	J:95147
Cd207^{tm2.1(cre)Bjec}/Cd207⁺ Tgfbr1^tm1.1Karl/Tgfbr1^tm1.1Karl (involves: 129S4/SvJaeSor * C57BL/6)	decreased dendritic cell number	J:179630
Cd207^tm2.1Mal/Cd207^{tm3.1(HBEGF/EGFP)Mal} (involves: 129S2/SvPas)	abnormal Langerhans cell morphology	J:99114
	absent Langerhans cell	J:99114
	decreased Langerhans cell number	J:99114
Cd209a^tm1.1Cfg/Cd209a^tm1.1Cfg (involves: C57BL/6)	increased lymphocyte cell number	J:217719
	increased mature B cell number	J:217719
	increased monocyte cell number	J:217719
	increased plasma cell number	J:217719
	increased spleen germinal center size	J:217719
Cd209b^tm1.1Cfg/Cd209b^tm1.1Cfg (involves: C57BL/6)	decreased mature B cell number	J:217719
	increased eosinophil cell number	J:288225
	increased macrophage cell number	J:217719
Cd209c^{em1(IMPC)Ccpcz}/Cd209c^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cd209c^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cd209d^tm1.1Cfg/Cd209d^tm1.1Cfg (involves: C57BL/6)	increased B cell number	J:217719
Cd247^tm1Lov/Cd247^tm1Lov (involves: 129S4/SvJae)	abnormal single-positive T cell number	J:14170
	abnormal T-helper 1 cell morphology	J:14170
	absent gamma-delta intraepithelial T cell	J:46914
	decreased CD4-positive, alpha-beta T cell number	J:14170
	decreased double-positive T cell number	J:14170
	decreased thymocyte number	J:14170
Cd247^tm1Lov/Cd247^tm1Lov Fcer1g^tm1Rav/Fcer1g^tm1Rav (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal effector T cell morphology	J:46914
	absent gamma-delta intraepithelial T cell	J:46914
	decreased thymocyte number	J:46914
Cd247^tm1Mal/Cd247^tm1Mal (either: C57BL/6-Cd247^tm1Mal or (involves: BALB/c * C57BL/6))	abnormal intraepithelial T cell morphology	J:15272
	abnormal T cell differentiation	J:15272
	decreased CD4-positive, alpha-beta T cell number	J:15272
	decreased CD8-positive, alpha-beta T cell number	J:15272
	decreased double-positive T cell number	J:15272
	decreased single-positive T cell number	J:15272
	decreased thymocyte number	J:15272
	increased double-negative T cell number	J:15272
Cd247^tm1Mal/Cd247^tm1Mal (involves: C57BL/6)	abnormal double-negative T cell morphology	J:112990, J:110847
	abnormal T cell differentiation	J:112990
	abnormal T cell morphology	J:110847
	decreased double-positive T cell number	J:110847
Cd247^tm1Mal/Cd247^tm1Mal Lck^tm1Mak/Lck^tm1Mak (involves: 129S2/SvPas * C57BL/6)	abnormal double-negative T cell morphology	J:110847
	abnormal T cell differentiation	J:110847
	abnormal T cell morphology	J:110847
	decreased double-positive T cell number	J:110847
Cd247^tm1Mhu/Cd247^tm1Mhu (involves: 129S7/SvEvBrd * C57BL/6)	abnormal T cell differentiation	J:15579
	decreased CD4-positive, alpha-beta T cell number	J:15579
	decreased CD8-positive, alpha-beta T cell number	J:15579
	decreased double-positive T cell number	J:15579
	decreased thymocyte number	J:15579
	enlarged lymph nodes	J:15579
	enlarged spleen	J:15579
	enlarged thymus cortex	J:15579
	increased double-negative T cell number	J:15579
	small thymus	J:15579
	small thymus medulla	J:15579
	thymus hypoplasia	J:15579
Cd247^tm1Mhu/Cd247^tm1Mhu Fcer1g^tm1Rav/Fcer1g^tm1Rav (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	decreased uterine NK cell number	J:100668
Cd247^tm1Tks/Cd247^tm1Tks (involves: 129P2/OlaHsd * C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:15271
	decreased CD4-positive, alpha-beta T cell number	J:15271
	decreased CD8-positive, alpha-beta T cell number	J:15271
	decreased double-positive T cell number	J:15271
	decreased single-positive T cell number	J:15271
	decreased thymocyte number	J:15271
	small thymus medulla	J:15271
Cd247^tm1Tks/Cd247^tm1Tks (B6.129P2-Cd247^tm1Tks)	abnormal NK cell morphology	J:66403
Cd247^tm1Tks/Cd247^tm1Tks (B6.129P2-Cd247^tm1Tks)	decreased NK T cell number	J:28282
Cd247^tm2.1Lov/Cd247^tm2.1Lov (Not Specified)	abnormal gamma-delta T cell differentiation	J:192915
	abnormal NK T cell morphology	J:192915
	abnormal T cell differentiation	J:192915
	abnormal T-helper 1 cell differentiation	J:192915
	decreased CD4-positive, alpha-beta T cell number	J:192915
	decreased CD8-positive, alpha-beta T cell number	J:192915
	decreased thymocyte number	J:192915
	increased regulatory T cell number	J:192915
Cd247^tm2.1Lov/Cd247^tm2.1Lov Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:192915
Cd274^tm1.1Lex/Cd274^tm1.1Lex (involves: 129S5/SvEvBrd)	decreased CD8-positive, alpha-beta T cell number	J:126829
Cd274^tm1Lpc/Cd274^tm1Lpc (B6.129S-Cd274^tm1Lpc)	increased activated T cell number	J:89781
Cd274^tm1Lpc/Cd274^tm1Lpc (B6.129S-Cd274^tm1Lpc)	increased CD8-positive, alpha-beta T cell number	J:89781
Cd274^tm1Lpc/Cd274^tm1Lpc (involves: 129S/SvEv * C57BL/6)	abnormal T cell morphology	J:136330
	abnormal T-helper 1 cell differentiation	J:162539
	decreased T helper 1 cell number	J:162539
	increased CD8-positive, alpha-beta T cell number	J:152305
	increased T cell number	J:142815
Cd274^tm1Lpc/Cd274^tm1Lpc (C.129S-Cd274^tm1Lpc)	decreased germinal center B cell number	J:165841
	decreased plasma cell number	J:165841
	decreased T-helper 17 cell number	J:165841
Cd274^tm1Shr/Cd274^tm1Shr (involves: C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:91480
Cd274^tm1Shr/Cd274^tm1Shr (involves: C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:91480
Cd300a^{tm1b(EUCOMM)Hmgu}/Cd300a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cd300a^{tm1b(EUCOMM)Hmgu}/Bay)	decreased eosinophil cell number	J:211773
Cd300a^tm1Shib/Cd300a^tm1Shib (B6JJcl.C-Cd300a^tm1Shib)	increased neutrophil cell number	J:189144
Cd300c^{em1(IMPC)Wtsi}/Cd300c^{em1(IMPC)Wtsi} (C57BL/6N-Cd300c^{em1(IMPC)Wtsi}/WtsiOulu)	increased leukocyte cell number	J:211773
Cd302^tm1.1Dnjh/Cd302^tm1.1Dnjh (involves: C57BL/6)	decreased dendritic cell number	J:301848
Cd320^{Gt(CC0426)Wtsi}/Cd320^{Gt(CC0426)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	decreased leukocyte cell number	J:199961
Cdc7^{tm1.1(KOMP)Vlcg}/Cdc7⁺ (C57BL/6N-Cdc7^{tm1.1(KOMP)Vlcg}/Tcp)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Cdc42^{tm1b(EUCOMM)Hmgu}/Cdc42⁺ (C57BL/6N-Cdc42^{tm1b(EUCOMM)Hmgu}/H)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Cdc42ep5^{tm1(KOMP)Wtsi}/Cdc42ep5^{tm1(KOMP)Wtsi} (C57BL/6N-Cdc42ep5^{tm1(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Cdc73^tm1Btt/Cdc73^tm1Btt Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S4/SvJae C57BL/6 * CBA)	small spleen	J:135255
Cdca7l^em1(IMPC)Mbp/Cdca7l^em1(IMPC)Mbp (C57BL/6NCrl-Cdca7l^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Cdcp2^em1(IMPC)Mbp/Cdcp2^em1(IMPC)Mbp (C57BL/6N-Cdcp2^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Cdh5^{tm3(Cdh5/Ctnna1)Dvst}/Cdh5^{tm3(Cdh5/Ctnna1)Dvst} (involves: 129 * C57BL/6)	abnormal lymphatic vessel endothelial cell morphology	J:213676
	increased leukocyte cell number	J:177191
	increased neutrophil cell number	J:177191
Cdh5^{tm3(Cdh5/Ctnna1)Dvst}/Cdh5^{tm3(Cdh5/Ctnna1)Dvst} (B6.Cg-Cdh5^{tm3(Cdh5/Ctnna1)Dvst})	abnormal lymphatic vessel endothelium morphology	J:213676
	abnormal lymphatic vessel morphology	J:213676
Cdh10^{tm2b(KOMP)Wtsi}/Cdh10^{tm2b(KOMP)Wtsi} (C57BL/6N-Cdh10^{tm2b(KOMP)Wtsi}/Ucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Cdh17^tm1Ohn/Cdh17^tm1Ohn (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen marginal zone morphology	J:96738
	decreased B cell number	J:96738
	decreased B-1a cell number	J:96738
	decreased germinal center B cell number	J:96738
	decreased marginal zone B cell number	J:96738
	decreased mature B cell number	J:96738
	decreased spleen germinal center size	J:96738
	increased pre-B cell number	J:96738
	increased pro-B cell number	J:96738
Cdh23^{tm2b(EUCOMM)Wtsi}/Cdh23^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Cdh23^{tm2b(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Cdk4⁺/Cdk4⁺ Tg(Mt1-Hgf)#Lmb/0 (B6.Cg-Cdk4^tm1.1Bbd Tg(Mt1-Hgf)#Lmb)	abnormal axillary lymph node morphology	J:111992
	abnormal inguinal lymph node morphology	J:111992
Cdk4^tm1.1Bbd/Cdk4⁺ Tg(Mt1-Hgf)#Lmb/0 (B6.Cg-Cdk4^tm1.1Bbd Tg(Mt1-Hgf)#Lmb)	abnormal axillary lymph node morphology	J:111992
	abnormal inguinal lymph node morphology	J:111992
	enlarged axillary lymph nodes	J:111992
	enlarged inguinal lymph nodes	J:111992
Cdk4^tm1.1Bbd/Cdk4^tm1.1Bbd Tg(Mt1-Hgf)#Lmb/0 (B6.Cg-Cdk4^tm1.1Bbd Tg(Mt1-Hgf)#Lmb)	abnormal axillary lymph node morphology	J:111992
	abnormal inguinal lymph node morphology	J:111992
	enlarged axillary lymph nodes	J:111992
	enlarged inguinal lymph nodes	J:111992
Cdk5rap2^an/Cdk5rap2^an (Not Specified)	decreased leukocyte cell number	J:5439
Cdk5rap2^{Gt(RRO242)Byg}/Cdk5rap2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased leukocyte cell number	J:160533
Cdk5rap2^{Gt(RRO242)Byg}/Cdk5rap2^an (involves: 129P2/OlaHsd * C57BL/6J)	decreased leukocyte cell number	J:160533
Cdk5rap2^{tm1a(EUCOMM)Wtsi}/Cdk5rap2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cdk5rap2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Cdk6^tm1Bbd/Cdk6^tm1Bbd (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal spleen morphology	J:92529
	abnormal spleen red pulp morphology	J:92529
	abnormal thymus morphology	J:92529
	decreased leukocyte cell number	J:92529
	increased single-positive T cell number	J:92529
	small spleen	J:92529
	spleen hypoplasia	J:92529
	thymus cortex atrophy	J:92529
	thymus hypoplasia	J:92529
Cdk6^tm1Phin/Cdk6⁺ Tg(Lck-Akt1*E40K)E-3Pnt/0 (involves: 129S4/SvJae)	increased T cell derived lymphoma incidence	J:144975
Cdk6^tm1Phin/Cdk6^tm1Phin (involves: 129S4/SvJae)	abnormal lymphopoiesis	J:144975
	abnormal T cell differentiation	J:144975
	decreased CD8-positive, alpha-beta T cell number	J:144975
	decreased double-negative T cell number	J:144975
	decreased double-positive T cell number	J:144975
	decreased thymocyte number	J:144975
	thymus atrophy	J:144975
	thymus hypoplasia	J:144975
Cdk6^tm1Phin/Cdk6^tm1Phin (involves: 129S4/SvJae * C57BL/6)	decreased DN1 thymic pro-T cell number	J:174697
	decreased DN2 thymocyte number	J:174697
	decreased double-positive T cell number	J:174697
	increased CD4-positive, alpha-beta T cell number	J:174697
	increased CD8-positive, alpha-beta T cell number	J:174697
	increased DN3 thymocyte number	J:174697
Cdk6^tm1Phin/Cdk6^tm1Phin Tg(Lck-Akt1*E40K)E-3Pnt/0 (involves: 129S4/SvJae)	abnormal T cell differentiation	J:144975
Cdk6^tm2.1Phin/Cdk6^tm2.1Phin (involves: 129 * C57BL/6 * FVB/N)	abnormal T cell differentiation	J:174697
	decreased DN1 thymic pro-T cell number	J:174697
	decreased DN2 thymocyte number	J:174697
	decreased DN4 thymocyte number	J:174697
	decreased double-positive T cell number	J:174697
	decreased thymocyte number	J:174697
	increased CD4-positive, alpha-beta T cell number	J:174697
	increased CD8-positive, alpha-beta T cell number	J:174697
	increased DN3 thymocyte number	J:174697
	increased double-negative T cell number	J:174697
	small thymus	J:174697
Cdk6^tm2.1Phin/Cdk6^tm2.1Phin Il2ra^tm1Dw/Il2ra^tm1Dw (involves: 129S4/SvJae * C57BL/6 * FVB/N)	increased CD4-positive, alpha-beta T cell number	J:174697
	increased CD8-positive, alpha-beta T cell number	J:174697
Cdk6^tm3.1Phin/Cdk6^tm3.1Phin (involves: 129 * C57BL/6 * FVB/N)	abnormal T cell differentiation	J:174697
	enlarged thymus	J:174697
	increased CD4-positive, alpha-beta T cell number	J:174697
	increased DN1 thymic pro-T cell number	J:174697
	increased thymocyte number	J:174697
Cdk6^tm4.1Phin/Cdk6^tm4.1Phin (involves: 129 * C57BL/6 * FVB/N)	abnormal T cell differentiation	J:174697
	decreased DN1 thymic pro-T cell number	J:174697
	decreased DN2 thymocyte number	J:174697
	decreased DN4 thymocyte number	J:174697
	decreased double-positive T cell number	J:174697
	decreased thymocyte number	J:174697
	increased CD4-positive, alpha-beta T cell number	J:174697
	increased CD8-positive, alpha-beta T cell number	J:174697
	increased DN3 thymocyte number	J:174697
	small thymus	J:174697
Cdk10^tm1.2Kald/Cdk10^tm1.2Kald (involves: 129 * C57BL/6 * FVB/N)	abnormal spleen morphology	J:262333
Cdk12^em1(IMPC)Tcp/Cdk12⁺ (C57BL/6NCrl-Cdk12^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Cdkl2^{tm1b(EUCOMM)Hmgu}/Cdkl2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cdkl2^{tm1b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Cdkn1a^{tm1.1(KOMP)Vlcg}/Cdkn1a^{tm1.1(KOMP)Vlcg} (C57BL/6N-Cdkn1a^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cdkn1a^tm1Led/Cdkn1a^tm1Led Gadd45a^tm1Ajf/Gadd45a^tm1Ajf (either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))	abnormal lymphopoiesis	J:76041
	decreased basophil cell number	J:76041
	decreased eosinophil cell number	J:76041
	decreased leukocyte cell number	J:76041
	decreased lymphocyte cell number	J:76041
Cdkn1a^tm1Led/Cdkn1a^tm1Led Zbtb17^tm1Cksn/Zbtb17^tm1Cksn Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Zbtb17^tm1Cksn Cdkn1a^tm1Led Commd10^{Tg(Vav1-icre)A2Kio})	arrested T cell differentiation	J:170508
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj (B6;129S2-Cdkn1a^tm1Tyj/J)	decreased monocyte cell number	J:108569
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:60292
	enlarged cervical lymph nodes	J:60292
	enlarged lymph nodes	J:60292
	enlarged spleen	J:60292
	increased B cell number	J:60292
	increased memory T cell number	J:60292
	increased spleen weight	J:60292
	increased T cell derived lymphoma incidence	J:70894
	lymph node hyperplasia	J:60292
	spleen hyperplasia	J:60292
Cdkn1a^tm1Tyj/Cdkn1a^tm1Tyj Tg(MMTV-vHaras)SH1Led/0 (involves: 129S2/SvPas * C57BL/6J * CD-1 * FVB/N)	enlarged spleen	J:66183
Cdkn1b^tm1Ako/Cdkn1b^tm1Ako (involves: 129S1/Sv * C57BL/6)	increased spleen weight	J:33401
	increased thymocyte number	J:33401
	increased thymus weight	J:33401
Cdkn1b^tm1Ako/Cdkn1b^tm1Ako Cdkn2c^tm1Yxi/Cdkn2c^tm1Yxi (involves: 129/Sv * 129S1/Sv * C57BL/6 * DBA/2)	enlarged spleen	J:50053
	enlarged thymus	J:50053
Cdkn1b^tm1Kin/Cdkn1b^tm1Kin (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:33402
	enlarged thymus	J:33402
	increased T cell number	J:33402
	thymus hyperplasia	J:33402
Cdkn1b^tm1Mlf/Cdkn1b⁺ Crebbp^tm1Jvd/Crebbp^tm1Jvd Tg(MMTV-cre)4Mam/0 (involves: 129 * C57BL/6 * CBA * FVB)	increased T cell derived lymphoma incidence	J:88323
Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf (involves: 129S4/SvJaeSor * C57BL/6J)	abnormal spleen morphology	J:33400
	abnormal thymus morphology	J:33400
	enlarged spleen	J:33400
	enlarged thymus	J:33400
	spleen hyperplasia	J:33400
	thymus hyperplasia	J:33400
Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf (involves: 129S4/SvJaeSor)	enlarged spleen	J:107588
	enlarged thymus	J:107588
	spleen hypoplasia	J:107588
Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf Tg(KRT5-CDK4)2303Mlrp/0 (involves: 129S4/SvJae * C57BL/6 * FVB * SENCAR * SSIN)	enlarged thymus	J:107588
	thymus hyperplasia	J:107588
Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf Trp53^tm1Brd/Trp53^tm1Brd (involves: C3H * C57BL/6J * NIH)	increased T cell derived lymphoma incidence	J:87536
Cdkn1b^tm1Mlf/Cdkn1b^tm1Mlf Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J)	increased T cell derived lymphoma incidence	J:87536
Cdkn1b^tm3Jro/Cdkn1b^tm3Jro (involves: 129S4/SvJaeSor)	enlarged spleen	J:103819
Cdkn1b^tm3Jro/Cdkn1b^tm3Jro (involves: 129S4/SvJaeSor)	enlarged thymus	J:103819
Cdkn1c^tm1Kat/Cdkn1c^tm1Kat (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen white pulp morphology	J:61190
Cdkn2a^tm1Cjs/Cdkn2a^tm1Cjs (involves: 129X1/SvJ * C57BL/6)	increased T cell derived lymphoma incidence	J:44427
Cdkn2a^tm1Cjs/Cdkn2a^tm1Cjs Nop53^tm2.1Asuz/Nop53^tm2.1Asuz Tg(Lck-cre)#Jxm/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)	decreased thymocyte number	J:241062
Cdkn2a^tm1Rdp/Cdkn2a^tm1Rdp (involves: 129/Sv * C57BL/6 * SJL)	abnormal spleen morphology	J:53805
	abnormal spleen red pulp morphology	J:53805
	increased spleen white pulp amount	J:53805
Cdkn2a^tm1Rdp/Cdkn2a^tm1Rdp Rnf2^tm1Mvi/Rnf2^tm1Mvi Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * C57BL/10 * CBA * SJL)	enlarged spleen	J:130397
Cdkn2a^tm1Rdp/Cdkn2a^tm1Rdp Tg(Tyr-NRASQ61K)1Bee/? (involves: 129/Sv C57BL/6 * DBA/2 * SJL)	enlarged lymph nodes	J:98545
Cdkn2a^tm2.1Rdp/Cdkn2a^tm2.1Rdp (involves: 129S6/SvEvTac * FVB/N)	increased CD4-positive, alpha-beta T cell number	J:71394
	increased CD8-positive, alpha-beta T cell number	J:71394
	increased double-positive T cell number	J:71394
	increased thymus weight	J:71394
	thymus hyperplasia	J:71394
Cdkn2b^tm1Bbd/Cdkn2b^tm1Bbd (involves: 129S1/Sv * C57BL/6)	abnormal lymph node germinal center morphology	J:63299
	abnormal lymph node secondary follicle morphology	J:63299
	abnormal lymphocyte morphology	J:63299
	abnormal spleen marginal zone morphology	J:63299
	abnormal spleen morphology	J:63299
	increased mature B cell number	J:63299
	lymph node hyperplasia	J:63299
	lymphoid hyperplasia	J:63299
	spleen hyperplasia	J:63299
Cdkn2b^tm1Bbd/Cdkn2b^tm1Bbd Cdkn2c^tm1Bbd/Cdkn2c^tm1Bbd (involves: 129S1/Sv * C57BL/6)	abnormal Langerhans cell morphology	J:63299
	abnormal lymphocyte morphology	J:63299
	enlarged spleen	J:63299
	lymph node hyperplasia	J:63299
	lymphoid hyperplasia	J:63299
Cdkn2b^tm1Bbd/Cdkn2b^tm1Bbd Pbx1^tm1Koss/Pbx1^tm1Koss Nkx2-5^tm2(cre)Rph/Nkx2-5⁺ (involves: 129P2/OlaHsd * 129S1/Sv)	abnormal spleen mesenchyme morphology	J:184521
	abnormal spleen morphology	J:184521
Cdkn2b^tm1Wff/Cdkn2b^tm1Wff Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	increased monocyte cell number	J:163498
	myeloid hyperplasia	J:163498
Cdkn2c^tm1Bbd/Cdkn2c^tm1Bbd (involves: 129S1/Sv * C57BL/6)	abnormal lymph node medulla morphology	J:63299
	enlarged lymph nodes	J:63299
	enlarged spleen	J:63299
	increased spleen white pulp amount	J:63299
	increased T cell derived lymphoma incidence	J:63299
	lymphoid hyperplasia	J:63299
Cdkn2c^tm1Yxi/Cdkn2c^tm1Yxi (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal thymus size	J:50053
	enlarged spleen	J:50053
	increased B cell number	J:50053
	increased T cell number	J:50053
	spleen hyperplasia	J:50053
	thymus hyperplasia	J:50053
Cds2^{Gt(OST184358)Lex}/Cds2⁺ (involves: 129S5/SvEvBrd * C57BL/6J)	decreased B cell number	J:103485
	increased T cell number	J:103485
Ceacam5^{em1(IMPC)Wtsi}/Ceacam5^{em1(IMPC)Wtsi} (C57BL/6N-Ceacam5^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Cebpa^tm1Dgt/Cebpa^tm1Dgt Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal myelopoiesis	J:94682
	decreased granulocyte number	J:94682
	failure of myelopoiesis	J:94682
Cebpa^tm1Gjd/Cebpa^tm1Gjd (B6.129S7-Cebpa^tm1Gjd)	failure of myelopoiesis	J:94682
Cebpa^tm2Btp/Cebpa^tm2Btp (B6.129P2-Cebpa^tm2Btp)	abnormal myelopoiesis	J:187834
	decreased neutrophil cell number	J:187834
	enlarged spleen	J:187834
Cebpa^tm2Nerl/Cebpa^tm2Nerl (involves: 129P2/OlaHsd * C57BL/6)	abnormal granulocyte morphology	J:72330
	decreased granulocyte number	J:72330
Cebpa^tm4Nerl/Cebpa^tm4Nerl (involves: 129P2/OlaHsd * C57BL/6)	abnormal granulocyte morphology	J:72330
	decreased granulocyte number	J:72330
Cebpa^tm8.1Nerl/Cebpa^tm8.1Nerl (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal granulocyte morphology	J:136134
	abnormal leukocyte morphology	J:136134
	abnormal myeloid leukocyte morphology	J:136134
	decreased granulocyte number	J:136134
	decreased monocyte cell number	J:136134
	decreased neutrophil cell number	J:136134
	enlarged spleen	J:136134
Cebpb^tm1.1Acle/Cebpb^tm1.1Acle (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal osteoclast differentiation	J:150006
	abnormal osteoclast morphology	J:150006
Cebpb^tm1Pfj/Cebpb^tm1Pfj (involves: 129S1/Sv * C57BL/6)	abnormal osteoclast differentiation	J:150006
Cebpb^tm1Pfj/Cebpb^tm1Pfj (involves: 129S1/Sv * C57BL/6)	abnormal osteoclast morphology	J:150006
Cebpb^tm1Vpo/Cebpb^tm1Vpo (involves: 129S/SvEv * MF1)	abnormal lymph node B cell domain morphology	J:25215
	abnormal lymph node cortex morphology	J:25215
	abnormal lymph node medulla morphology	J:25215
	abnormal lymph node medullary cord morphology	J:25215
	abnormal lymph node secondary follicle morphology	J:25215
	abnormal lymph node T cell domain morphology	J:25215
	abnormal mucosa-associated lymphoid tissue morphology	J:25215
	abnormal plasma cell morphology	J:25215
	abnormal spleen red pulp morphology	J:25215
	abnormal spleen secondary B follicle morphology	J:25215
	abnormal spleen white pulp morphology	J:25215
	enlarged axillary lymph nodes	J:25215
	enlarged inguinal lymph nodes	J:25215
	enlarged lymph nodes	J:25215
	enlarged mesenteric lymph nodes	J:25215
	enlarged spleen	J:25215
	enlarged submandibular lymph nodes	J:25215
Cebpb^tm2.1Acle/Cebpb^tm2.1Acle (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal osteoclast morphology	J:155795
	decreased osteoclast cell number	J:155795
Cebpe^tm1Kgx/Cebpe^tm1Kgx (involves: 129S6/SvEvTac * NIH Black Swiss)	abnormal eosinophil differentiation	J:76024
	abnormal granulocyte differentiation	J:76024
	abnormal myelopoiesis	J:76024
	abnormal neutrophil differentiation	J:76024
	abnormal neutrophil morphology	J:76024
	decreased eosinophil cell number	J:76024
	decreased granulocyte number	J:76024
	enlarged lymph nodes	J:76024
	impaired myelopoiesis	J:76024
	increased plasma cell number	J:76024
Cebpe^tm1Kgx/Cebpe^tm1Kgx (involves: 129S6/SvEvTac)	abnormal eosinophil differentiation	J:76024
	abnormal granulocyte differentiation	J:76024
	abnormal myelopoiesis	J:76024
	abnormal neutrophil differentiation	J:76024
	abnormal neutrophil morphology	J:76024
	decreased eosinophil cell number	J:76024
	decreased granulocyte number	J:76024
	enlarged lymph nodes	J:76024
	impaired myelopoiesis	J:76024
	increased plasma cell number	J:76024
Cecr2^{tm2b(EUCOMM)Hmgu}/Cecr2⁺ (C57BL/6N-Cecr2^{tm2b(EUCOMM)Hmgu}/Tcp)	enlarged lymph nodes	J:211773
Cemip2^tm1.1Cya/Cemip2^tm1.1Cya Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6 CBA)	abnormal lymph node morphology	J:317425
Cemip^tm1.1Okda/Cemip^tm1.1Okda (involves: C57BL/6NCrlj * CBA/JNCrlj)	decreased osteoclast cell number	J:241936
Cep68^em1(IMPC)J/Cep68^em1(IMPC)J (C57BL/6NJ-Cep68^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Cep76^{tm1b(EUCOMM)Hmgu}/Cep76^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cep76^{tm1b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Cep85l^em1(IMPC)Mbp/Cep85l^em1(IMPC)Mbp (C57BL/6N-Cep85l^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Cep290^b2b1454Clo/Cep290^b2b1454Clo (C57BL/6J-Cep290^b2b1454Clo)	accessory spleen	J:175213
	spleen hypoplasia	J:175213
Cep290^b2b1752Clo/Cep290^b2b1752Clo (C57BL/6J-Cep290^b2b1752Clo)	spleen hypoplasia	J:175213
Cer1^{em1(IMPC)Ccpcz}/Cer1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cer1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Cerk^tm1Fbor/Cerk^tm1Fbor (involves: BALB/c)	decreased granulocyte number	J:131522
	decreased neutrophil cell number	J:131522
	increased leukocyte cell number	J:131522
Cers1^{tm1b(EUCOMM)Hmgu}/Cers1⁺ (C57BL/6N-Cers1^{tm1b(EUCOMM)Hmgu}/H)	increased neutrophil cell number	J:211773
Cers6^tm1.1Kwi/Cers6^tm1.1Kwi (involves: 129P2/OlaHsd * C57BL/6)	microgliosis	J:201327
Ces1c^{em1(IMPC)Ccpcz}/Ces1c^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ces1c^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Cfap20dc^em1(IMPC)J/Cfap20dc^em1(IMPC)J (C57BL/6NJ-Cfap20dc^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Cfap47^{em1(IMPC)Hmgu}/Cfap47^{em1(IMPC)Hmgu} (C57BL/6NCrl-Cfap47^{em1(IMPC)Hmgu}/Ieg)	decreased spleen weight	J:211773
Cfap53^{em1(IMPC)Wtsi}/Cfap53^{em1(IMPC)Wtsi} (C57BL/6N-Cfap53^{em1(IMPC)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
	small spleen	J:239583
Cfap161^{em1(IMPC)Ccpcz}/Cfap161^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cfap161^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cfc1^b2b2736.1Clo/Cfc1^b2b2736.1Clo (C57BL/6J-Cfc1^b2b2736.1Clo)	accessory spleen	J:175213
	spleen hypoplasia	J:175213
Cfc1^tm1Cbm/Cfc1^tm1Cbm (Not Specified)	small spleen	J:58530
Cfc1^tm1Cbm/Cfc1^tm1Cbm (Not Specified)	spleen hypoplasia	J:58530
Cfc1^tm1Mms/Cfc1^tm1Mms (either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6J))	absent spleen	J:58104
Cflar^tm1.1Pope/Cflar^tm1.2Pope Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	abnormal abdominal lymph node morphology	J:167430
	abnormal B cell number	J:167430
	abnormal CD4-positive, alpha-beta T cell number	J:167430
	abnormal CD8-positive, alpha-beta T cell number	J:167430
	abnormal lymphocyte cell number	J:167430
	abnormal myelopoiesis	J:167430
	abnormal spleen B cell follicle morphology	J:167430
	abnormal spleen marginal zone morphology	J:167430
	abnormal spleen morphology	J:167430
	abnormal spleen red pulp morphology	J:167430
	abnormal thymus corticomedullary boundary morphology	J:167430
	abnormal thymus morphology	J:167430
	decreased macrophage cell number	J:167430
	enlarged spleen	J:167430
	increased CD8-positive, alpha-beta T cell number	J:167430
	increased eosinophil cell number	J:167430
	increased granulocyte number	J:167430
	increased leukocyte cell number	J:167430
	increased monocyte cell number	J:167430
	increased neutrophil cell number	J:167430
Cflar^tm1Ywh/Cflar^tm1Ywh Tg(Lck-cre)548Jxm/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)	decreased single-positive T cell number	J:100558
Cftr^tm1Unc/Cftr^tm1Unc (involves: 129P2/OlaHsd)	spleen hyperplasia	J:2079
Cftr^tm2Mrc/Cftr^tm2Mrc (B6.129S6-Cftr^tm2Mrc)	abnormal alveolar macrophage morphology	J:112450
Cftr^tm2Mrc/Cftr^tm2Mrc (B6.129S6-Cftr^tm2Mrc)	decreased neutrophil cell number	J:112450
Cgref1^em1(IMPC)J/Cgref1^em1(IMPC)J (C57BL/6NJ-Cgref1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Cgrrf1^{tm1b(KOMP)Wtsi}/Cgrrf1^{tm1b(KOMP)Wtsi} (C57BL/6N-Cgrrf1^{tm1b(KOMP)Wtsi}/Wtsi)	increased CD5-positive gamma-delta T cell number	J:211773
	increased gamma-delta T cell number	J:211773
Chaf1b^{tm2c(EUCOMM)Hmgu}/Chaf1b⁺ Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6J * C57BL/6N * CBA/J)	increased leukocyte cell number	J:266848
Champ1^em1(IMPC)Mbp/Champ1⁺ (C57BL/6NCrl-Champ1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Chchd7^em3(IMPC)Tcp/Chchd7^em3(IMPC)Tcp (C57BL/6NCrl-Chchd7^em3(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Chd2^{Gt(RRBO46)Byg}/Chd2⁺ (involves: 129P2/OlaHsd * C57BL/6)	dark spleen	J:146743
	decreased lymphocyte cell number	J:146176
	enlarged lymph nodes	J:146743
	enlarged spleen	J:146743
	increased CD4-positive, alpha-beta T cell number	J:146176
	increased spleen red pulp amount	J:146743
	increased T cell derived lymphoma incidence	J:146176
	lymphoid hyperplasia	J:146176
Chd4^tm1.1Kge/Chd4^tm1.1Kge Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * SJL)	abnormal CD4-positive, alpha beta T cell morphology	J:109547
	arrested T cell differentiation	J:109547
	decreased double-positive T cell number	J:109547
	increased CD8-positive, alpha-beta T cell number	J:109547
	lymph node hypoplasia	J:109547
	spleen hypoplasia	J:109547
Chd4^tm1.1Kge/Chd4^tm1.2Kge Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * SJL)	thymus hypoplasia	J:109547
Chd4^tm1.2Kge/Chd4^tm1.2Kge Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal T cell differentiation	J:109547
	decreased double-positive T cell number	J:109547
	increased CD8-positive, alpha-beta T cell number	J:109547
	increased double-negative T cell number	J:109547
	thymus hypoplasia	J:109547
Chd5^em1(IMPC)Mbp/Chd5^em1(IMPC)Mbp (C57BL/6NCrl-Chd5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Chd7^{Gt(RRR136)Byg}/Chd7⁺ (involves: 129P2/OlaHsd * C57BL/6)	ectopic thymus	J:154590
	small thymus	J:154590
	thymus hypoplasia	J:154590
Chd7^Gt(XK403)Byg/Chd7⁺ Tbx1^tm1Bld/Tbx1⁺ (either: (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) or (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CD-1))	ectopic thymus	J:154590
Chd7^{tm2a(EUCOMM)Wtsi}/Chd7⁺ (involves: 129S5/SvEvBrd * C57BL/6N)	decreased leukocyte cell number	J:330596
	decreased monocyte cell number	J:330596
	increased NK T cell number	J:330596
Chd7^Whi/Chd7⁺ (C3HeB/FeJ-Chd7^Whi)	decreased monocyte cell number	J:330596
Chd7^Whi/Chd7⁺ (C3HeB/FeJ-Chd7^Whi)	increased NK T cell number	J:330596
Chd8^em1(IMPC)Mbp/Chd8⁺ (C57BL/6N-Chd8^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	increased lymphocyte cell number	J:211773
Chd9^{tm1a(EUCOMM)Wtsi}/Chd9^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Chd9^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased Langerhans cell number	J:211773
Chek2^tm1Mak/Chek2⁺ Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal pro-B cell morphology	J:103922
	decreased double-negative T cell number	J:103922
	decreased macrophage cell number	J:103922
Chfr^{tm1a(KOMP)Wtsi}/Chfr^{tm1a(KOMP)Wtsi} (C57BL/6NCrl-Chfr^{tm1a(KOMP)Wtsi}/Ccpcz)	abnormal spleen morphology	J:211773
Chi3l1^tm1Eli/Chi3l1^tm1Eli (B6.Cg-Chi3l1^tm1Eli)	abnormal macrophage morphology	J:148490
Chi3l1^tm1Eli/Chi3l1^tm1Eli (B6.Cg-Chi3l1^tm1Eli)	decreased T-helper 2 cell number	J:148490
Chi3l1^tm1Eli/Chi3l1^tm1Eli Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0 (involves: C57BL/6 * CBA)	abnormal T-helper 2 cell number	J:148490
Chia1^tm1.1Lof/Chia1^tm1.1Lof (C57BL/6-Chia1^tm1.1Lof)	increased lymphocyte cell number	J:257728
Chia1^tm1.1Lof/Chia1^tm1.1Lof (C57BL/6-Chia1^tm1.1Lof)	increased neutrophil cell number	J:257728
Chic2^{tm1b(EUCOMM)Wtsi}/Chic2⁺ (C57BL/6N-Chic2^{tm1b(EUCOMM)Wtsi}/H)	enlarged spleen	J:211773
Chmp2b^em1(IMPC)Mbp/Chmp2b⁺ (C57BL/6NCrl-Chmp2b^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Chmp4c^{tm1b(EUCOMM)Wtsi}/Chmp4c^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Chmp4c^{tm1b(EUCOMM)Wtsi}/H)	decreased basophil cell number	J:211773
Chordc1^em1(IMPC)Mbp/Chordc1⁺ (C57BL/6N-Chordc1^em1(IMPC)Mbp/MbpMmucd)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Chordc1^tm1Mbra/Chordc1⁺ (involves: 129 * C57BL/6)	abnormal myelopoiesis	J:222040
	abnormal spleen morphology	J:222040
	enlarged spleen	J:222040
	increased leukocyte cell number	J:222040
Chrd^tm1Emdr/Chrd^tm1Emdr (either: B6SJL.129-Chrd^tm1Emdr or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J))	athymia	J:83662
Chrd^tm1Emdr/Chrd^tm1Emdr (129S6.129-Chrd^tm1Emdr)	athymia	J:146769
Chrd^tm1Emdr/Chrd^tm1Emdr Tbx1^m1Jlk/Tbx1^m1Jlk (129/Sv-Tbx1^m1Jlk Chrd^tm1Emdr)	athymia	J:146769
Chrna5^em1(IMPC)H/Chrna5^em1(IMPC)H (C57BL/6N-Chrna5^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Chrna7^tm1Bay/Chrna7^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	decreased neutrophil cell number	J:140280
	increased lymphocyte cell number	J:140280
Chrnb2^tm1Jpc/Chrnb2^tm1Jpc (B6.129P2-Chrnb2^tm1Jpc)	decreased B cell number	J:112766
Chrnb2^tm1Jpc/Chrnb2^tm1Jpc (involves: 129P2/OlaHsd * C57BL/6J)	myeloid hyperplasia	J:140280
Chrnb2^tm1Jpc/Chrnb2^tm1Jpc (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:103908
Chst1^{tm1(KOMP)Vlcg}/Chst1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased B cell number	J:204813
	increased T cell number	J:204813
Chst2^em1(IMPC)Mbp/Chst2^em1(IMPC)Mbp (C57BL/6N-Chst2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Chst3^tm1Tmu/Chst3^tm1Tmu (involves: 129S2/SvPas * 129X1/SvJ)	decreased T cell number	J:73698
Chst3^tm1Tmu/Chst3^tm1Tmu (involves: 129S2/SvPas)	decreased neutrophil cell number	J:217719
Chst3^tm1Tmu/Chst3^tm1Tmu (involves: 129S2/SvPas)	lymph node hypoplasia	J:217719
Chst4^tm1Sdr/Chst4^tm1Sdr (involves: C57BL/6)	abnormal lymph node morphology	J:86759
Chst4^tm1Sdr/Chst4^tm1Sdr (involves: C57BL/6)	abnormal lymph node primary follicle morphology	J:86759
Chst10^{em1(IMPC)Hmgu}/Chst10^{em1(IMPC)Hmgu} (C57BL/6NCrl-Chst10^{em1(IMPC)Hmgu}/Ieg)	increased spleen weight	J:211773
Chst11^{tm1a(KOMP)Wtsi}/Chst11^{tm1a(KOMP)Wtsi} (C57BL/6N-Chst11^{tm1a(KOMP)Wtsi}/Wtsi)	abnormal thymus morphology	J:239583
Chst15^tm1Oh/Chst15^tm1Oh (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell morphology	J:165927
Chsy1^em1(IMPC)Mbp/Chsy1^em1(IMPC)Mbp (C57BL/6NCrl-Chsy1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Chsy1^skt/Chsy1^skt Pde6b⁺/Pde6b⁺ (mixed)	decreased macrophage cell number	J:286529
	decreased neutrophil cell number	J:286529
	microgliosis	J:286529
Chsy1^skt/Chsy1^tm1Lex (mixed)	microgliosis	J:286529
Chsy1^tm1Lex/Chsy1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	microgliosis	J:286529
Chtop^{tm1a(EUCOMM)Wtsi}/Chtop^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Chtop^{tm1a(EUCOMM)Wtsi}/Wtsi)	absent spleen	J:239583
	spleen hypoplasia	J:239583
Chuk^{em1(IMPC)Ccpcz}/Chuk⁺ (C57BL/6NCrl-Chuk^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Chuk^tm2Mka/Chuk^tm2Mka Tg(Tnfsf13b)1Fma/? (B6.Cg-Chuk^tm2Mka Tg(Tnfsf13b)1Fma)	absent spleen marginal zone	J:113556
	decreased marginal zone B cell number	J:113556
	increased transitional stage B cell number	J:113556
Chuk^tm2Yhu/Chuk^tm2Yhu Tg(Lor-CHUK)8Yhu/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	absent lymph nodes	J:197037
Chuk^tm2Yhu/Chuk^tm2Yhu Tg(Lor-CHUK)8Yhu/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	increased CD4-positive, alpha-beta T cell number	J:197037
	increased CD8-positive, alpha-beta T cell number	J:197037
	increased macrophage cell number	J:197037
	increased neutrophil cell number	J:197037
Churc1^{tm1b(EUCOMM)Wtsi}/Churc1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Churc1^{tm1b(EUCOMM)Wtsi}/Wtsi)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased effector memory T-helper cell number	J:211773
Ciao2b^{em1(IMPC)Ccpcz}/Ciao2b⁺ (C57BL/6N-Ciao2b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Cib1^{tm1b(EUCOMM)Hmgu}/Cib1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cib1^{tm1b(EUCOMM)Hmgu}/Bay)	decreased neutrophil cell number	J:211773
Cib2^{tm1b(EUCOMM)Wtsi}/Cib2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cib2^{tm1b(EUCOMM)Wtsi}/H)	increased basophil cell number	J:211773
Cibar1^{tm1b(KOMP)Wtsi}/Cibar1^{tm1b(KOMP)Wtsi} (C57BL/6N-Cibar1^{tm1b(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:274784, J:211773
Cideb^tm1Pli/Cideb^tm1Pli (Not Specified)	decreased spleen weight	J:126556
Cigs2^tm1.1Anse/Cigs2⁺ Il4^tm1(CD2)Mmrs/Il4⁺ (involves: 129 * BALB/cJ * C57BL/6)	decreased basophil cell number	J:181313
Cigs2^tm1.1Anse/Cigs2^tm1.1Anse (involves: BALB/cJ * C57BL/6)	abnormal class switch recombination	J:181313
Ciita^m1Btlr/Ciita^m1Btlr (C57BL/6J-Ciita^m1Btlr)	abnormal CD4-positive T cell differentiation	J:221483
Ciita^m1Btlr/Ciita^m1Btlr (C57BL/6J-Ciita^m1Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:221483
Ciita^tm1.1Dim/Ciita^tm1.1Dim (involves: 129S2/SvPas * C57BL/6 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:51885
	decreased dendritic cell number	J:51885
Ciita^tm1Ccum/Ciita^tm1Ccum (involves: 129S2/SvPas * C57BL/6J)	abnormal popliteal lymph node morphology	J:64283
	abnormal T cell differentiation	J:64283
	decreased CD4-positive, alpha-beta T cell number	J:31601
	increased CD4-positive, alpha-beta T cell number	J:64283
	increased CD8-positive, alpha-beta T cell number	J:64283
Ciita^tm1Ccum/Ciita^tm1Ccum (NOD.129S2(B6)-Ciita^tm1Ccum)	abnormal T cell differentiation	J:106081
	decreased CD4-positive, alpha-beta T cell number	J:106081
	increased CD8-positive, alpha-beta T cell number	J:106081
Ciita^tm1Jpyt/Ciita^tm1Jpyt (involves: 129P2/OlaHsd * C57BL/6J)	abnormal T cell subpopulation ratio	J:57100
	decreased CD4-positive, alpha-beta T cell number	J:57100
	increased CD8-positive, alpha-beta T cell number	J:57100
	increased double-positive T cell number	J:57100
Ciita^tm1Wrth/Ciita^tm1Wrth (involves: 129P2/OlaHsd * C57BL/6)	absent CD4-positive, alpha-beta T cells	J:233241
	increased osteoclast cell number	J:233241
Ciita^tm2Wrth/Ciita^tm2Wrth (involves: 129P2/OlaHsd * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:92170
Cilk1^{tm1b(KOMP)Mbp}/Cilk1^{tm1b(KOMP)Mbp} (C57BL/6N-Cilk1^{tm1b(KOMP)Mbp}/Ucd)	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Cimap1b^{em1(IMPC)Ccpcz}/Cimap1b^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cimap1b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Cimap2^Retro/Cimap2⁺ (involves: C57BL/6J)	increased CD8-positive, alpha-beta T cell number	J:223336
Cimap2^Retro/Cimap2^Retro (involves: C57BL/6J)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:223336
	increased activated T cell number	J:223336
	increased CD8-positive, alpha-beta T cell number	J:223336
	increased central memory CD8 positive, alpha-beta T cell number	J:223336
Cimap2^{tm1a(KOMP)Wtsi}/Cimap2⁺ (involves: C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:223336
Cimip2b^{tm1(KOMP)Wtsi}/Cimip2b^{tm1(KOMP)Wtsi} (C57BL/6N-Cimip2b^{tm1(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Ciroz^b2b1167Clo/Ciroz^b2b1167Clo (C57BL/6J-Ciroz^b2b1167Clo)	spleen hypoplasia	J:175213
Cish^tm1.1Cdon/Cish^tm1.1Cdon Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T-helper 2 cell differentiation	J:204829
	increased eosinophil cell number	J:204829
Cish^tm1.2Cdon/Cish^tm1.2Cdon (B6.129S6(Cg)-Cish^tm1.2Cdon)	abnormal CD4-positive T cell differentiation	J:204829
	abnormal immune system morphology	J:204829
	abnormal T-helper 2 cell differentiation	J:204829
	increased eosinophil cell number	J:204829
	increased lymphocyte cell number	J:204829
	lymph node hyperplasia	J:204829
	spleen hyperplasia	J:204829
	thymus hyperplasia	J:204829
Cited2^tm1Bha/Cited2^tm1Bha (involves: 129P2/OlaHsd * C57BL/6J)	small spleen	J:92872
Cited2^tm1Bha/Cited2^tm1Bha (B6.129P2-Cited2^tm1Bha)	small spleen	J:92872
Ciz1^{Gt(IST13830B6)Tigm}/Ciz1^{Gt(IST13830B6)Tigm} (B6J.B6N-Ciz1^{Gt(IST13830B6)Tigm})	increased monocyte cell number	J:231433
	increased neutrophil cell number	J:231433
Ciz1^tm1.1Homy/Ciz1^tm1.1Homy (involves: 129P2/OlaHsd * C57BL/6 * DBA)	enlarged spleen	J:198470
	lymph node hyperplasia	J:198470
	thymus hyperplasia	J:198470
Ckb^{tm1.1(KOMP)Wtsi}/Ckb^{tm1.1(KOMP)Wtsi} (C57BL/6N-Ckb^{tm1.1(KOMP)Wtsi}/Ucd)	increased lymphocyte cell number	J:211773
Cks1b^tm1Sir/Cks1b^tm1Sir Tg(IghMyc)22Bri/? (involves: C57BL * C57BL/6 * SJL)	decreased leukocyte cell number	J:121564
	decreased lymphocyte cell number	J:121564
	decreased spleen weight	J:121564
Clasp1^em1(IMPC)Mbp/Clasp1⁺ (C57BL/6NCrl-Clasp1^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Clca1^tm1.1Lex/Clca1^tm1.1Lex (involves: 129S/SvEvBrd)	increased neutrophil cell number	J:125158
Clcf1^{tm1.1(KOMP)Vlcg}/Clcf1⁺ (C57BL/6N-Clcf1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased leukocyte cell number	J:211773
Clcn1^em1(IMPC)Mbp/Clcn1^em1(IMPC)Mbp (C57BL/6NCrl-Clcn1^em1(IMPC)Mbp/MbpMmucd)	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Clcn7^tm1.1Lex/Clcn7^tm1.1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	microgliosis	J:186049
Clcn7^tm1.1Mawa/Clcn7⁺ (involves: C57BL/6J * C57BL/6N * CD-1)	increased osteoclast cell number	J:254787
Clcn7^tm1.1Teti/Clcn7⁺ (involves: 129S2/SvPas * C57BL/6)	increased osteoclast cell number	J:203761
Clcn7^tm1Tjj/Clcn7^tm1Tjj (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast morphology	J:67273
Clcn7^tm2Tjj/Clcn7^tm2Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast morphology	J:67273, J:217031
Clcn7^tm2Tjj/Clcn7^tm2Tjj (involves: 129S1/Sv * 129X1/SvJ)	microgliosis	J:155176
Clcn7^tm3.1Tjj/Clcn7^tm3.1Tjj Emx1^{tm1.1(cre)Ito}/Emx1⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)	microgliosis	J:155176
Clcn7^tm4.1Tjj/Clcn7^tm4.1Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast morphology	J:160702, J:217031
Clcn7^tm5.1Tjj/Clcn7^tm5.1Tjj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast morphology	J:217031
Clcnkb^em1(IMPC)Mbp/Clcnkb^em1(IMPC)Mbp (C57BL/6NCrl-Clcnkb^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Cldn3^em1(IMPC)H/Cldn3^em1(IMPC)H (C57BL/6N-Cldn3^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Cldn9^em1(IMPC)H/Cldn9^em1(IMPC)H (C57BL/6NTac-Cldn9^em1(IMPC)H/H)	increased basophil cell number	J:211773
Cldn12^{tm1.1(KOMP)Vlcg}/Cldn12^{tm1.1(KOMP)Vlcg} (B6J.B6N-Cldn12^{tm1.1(KOMP)Vlcg})	increased leukocyte cell number	J:279934
	increased spleen weight	J:279934
Cldn18^tm1Lex/Cldn18^tm1Lex (involves: 129S5/SvEvBrd)	abnormal osteoclast differentiation	J:195931
Cldn18^tm1Lex/Cldn18^tm1Lex (involves: 129S5/SvEvBrd)	increased osteoclast cell number	J:195931
Clec1b^tm1.1Arte/Clec1b^tm1.1Arte Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal lymphatic vessel endothelial cell morphology	J:181715
	abnormal lymphatic vessel morphology	J:181715
Clec1b^tm1.1Ksi/Clec1b^tm1.1Ksi (involves: C57BL/6)	abnormal lymphatic vessel morphology	J:165898
Clec1b^tm1.2Arte/Clec1b^tm1.2Arte (Not Specified)	abnormal lymphatic vessel morphology	J:181715
Clec1b^tm1.2Arte/Clec1b^tm1.2Arte (Not Specified)	decreased lymphatic vessel endothelial cell number	J:181715
Clec1b^tm1Ksi/Clec1b^tm1Ksi Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal lymphatic vessel morphology	J:187533
Clec1b^tm1Lex/Clec1b^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal mononuclear cell morphology	J:161922
Clec1b^tm1Mlkn/Clec1b^tm1Mlkn (involves: 129S4/SvJae * C57BL/6)	abnormal lymphatic vessel morphology	J:162815
Clec2d^tm1.1Mgil/Clec2d^tm1.1Mgil (C57BL/6-Clec2d^tm1.1Mgil)	abnormal osteoclast differentiation	J:143122
	increased osteoclast cell number	J:143122
Clec4a2^tm1.1Cfg/Clec4a2^tm1.1Cfg (involves: C57BL/6)	enlarged lymph nodes	J:217719
Clec4a2^tm1Yiw/Clec4a2^tm1Yiw (involves: 129P2/OlaHsd * C57BL/6J)	abnormal immune system morphology	J:217720
	increased dendritic cell number	J:217720
	increased single-positive T cell number	J:217720
Clec4d^tm1.1Cfg/Clec4d^tm1.1Cfg (involves: C57BL/6)	increased B cell number	J:217719
Clec4d^tm1.1Cfg/Clec4d^tm1.1Cfg (involves: C57BL/6)	increased mature B cell number	J:217719
Clec4d^tm1.1Shoy/Clec4d^tm1.1Shoy (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus morphology	J:203159
	decreased dendritic cell number	J:203159
Clec4e^tm1.1Cfg/Clec4e^tm1.1Cfg (B6.Cg-Clec4e^tm1.1Cfg)	decreased lymphocyte cell number	J:136334
	decreased monocyte cell number	J:136334
	decreased neutrophil cell number	J:136334
Clec4e^tm1Tks/Clec4e^tm1Tks (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased neutrophil cell number	J:172959
Clec4e^tm1Tks/Clec4e^tm1Tks (involves: 129S1/Sv * 129X1/SvJ)	decreased dendritic cell number	J:203159
Clec4g^tm1.1Cfg/Clec4g^tm1.1Cfg (involves: C57BL/6)	increased lymphocyte cell number	J:217719
Clec4g^tm1.1Cfg/Clec4g^tm1.1Cfg (involves: C57BL/6)	increased monocyte cell number	J:217719
Clec4g^tm1.1Fhe/Clec4g^tm1.1Fhe (B6.129-Clec4g^tm1.1Fhe)	abnormal immune system cell morphology	J:200968
	increased activated T cell number	J:200968
	increased CD4-positive, alpha-beta T cell number	J:200968
	increased CD8-positive, alpha-beta T cell number	J:200968, J:194891
Clec4n^tm1Yiw/Clec4n^tm1Yiw (B6.129P2-Clec4n^tm1Yiw)	abnormal CD4-positive T cell differentiation	J:160680
Clec5a^em1(IMPC)Mbp/Clec5a^em1(IMPC)Mbp (C57BL/6NCrl-Clec5a^em1(IMPC)Mbp/MbpMmucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Clec10a^m1/Clec10a^m1 (NC/Nga)	increased neutrophil cell number	J:283174
Clec10a^tm1Hed/Clec10a⁺ St3gal1^tm1Jxm/St3gal1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased CD8-positive, alpha-beta T cell number	J:78035
Clec10a^tm1Hed/Clec10a^tm1Hed (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased neutrophil cell number	J:283174
Clec10a^tm1Hed/Clec10a^tm1Hed St3gal1^tm1Jxm/St3gal1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased CD8-positive, alpha-beta T cell number	J:78035
Clic5^jbg/Clic5^jbg (involves: C3H/HeJ * C57BL/6)	decreased eosinophil cell number	J:160186
	decreased monocyte cell number	J:160186
	decreased neutrophil cell number	J:160186
Clk1^{tm1a(EUCOMM)Wtsi}/Clk1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Clk1^{tm1a(EUCOMM)Wtsi}/Ics)	decreased granulocyte number	J:165965
Cln3^tm1Nbm/Cln3^tm1Nbm (involves: 129S6/SvEvTac * C57BL/6J)	abnormal professional antigen presenting cell morphology	J:233445
Cln8^em1(IMPC)Mbp/Cln8^em1(IMPC)Mbp (C57BL/6N-Cln8^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Clnk^{em1(IMPC)Ccpcz}/Clnk^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Clnk^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Clnk^tm1Rygo/Clnk^tm1Rygo Lcp2^tm1Geha/Lcp2^tm1Geha (involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c)	increased NK cell number	J:131621
Clock^{em1(IMPC)Ccpcz}/Clock^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Clock^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased spleen weight	J:211773
	enlarged thymus	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased T-helper cell number	J:211773
Clp1^tm1.1Pngr/Clp1^tm1.1Pngr (CBA.Cg-Clp1^tm1.1Pngr)	abnormal microglial cell morphology	J:209564
Clpp^{tm1a(EUCOMM)Wtsi}/Clpp^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Clpp^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive NK T cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased gamma-delta T cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK T cell number	J:211773
	increased B cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased leukocyte cell number	J:211773
	increased Ly6C high monocyte number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased mature B cell number	J:211773
	increased monocyte cell number	J:211773
Clptm1^em1(IMPC)Tcp/Clptm1⁺ (C57BL/6N-Clptm1^em1(IMPC)Tcp/Cmmr)	enlarged lymph nodes	J:211773
	increased monocyte cell number	J:211773
Clptm1l^{tm1d(EUCOMM)Wtsi}/Clptm1l⁺ (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)	abnormal class switch recombination	J:265892
Clptq1^NZB/BlNJ/Clptq1^NZB/BlNJ (B6.NZB-(D4Mit193-D4Mit33))	enlarged spleen	J:143646
	enlarged thymus	J:143646
	increased B-1a cell number	J:143646
	increased NK T cell number	J:143646
Clrn1^{tm1.1(KOMP)Vlcg}/Clrn1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Clrn1^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
Clspn^{tm1(KOMP)Vlcg}/Clspn⁺ (C57BL/6N-Clspn^{tm1(KOMP)Vlcg})	increased B cell number	J:332163
	lymphoid hyperplasia	J:332163
Clstn1^{tm1b(EUCOMM)Hmgu}/Clstn1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Clstn1^{tm1b(EUCOMM)Hmgu}/H)	increased basophil cell number	J:211773
Clta^tm1.2Fmb/Clta^tm1.2Fmb (involves: C57BL/6)	abnormal class switch recombination	J:235591
Clta^tm1.2Fmb/Clta^tm1.2Fmb (involves: C57BL/6)	decreased germinal center B cell number	J:235591
Cluh^{em1(IMPC)Ccpcz}/Cluh⁺ (C57BL/6N-Cluh^{em1(IMPC)Ccpcz}/Ccpcz)	increased Ly6C-positive mature NK cell number	J:211773
Cmah^tm1Avrk/Cmah^tm1Avrk Dmd^mdx/Dmd^mdx (involves: 129X1/SvJ * C57BL/10ScSn)	increased macrophage cell number	J:164594
	increased monocyte cell number	J:164594
Cmah^tm1Avrk/Cmah^tm1Avrk Dock2^m1Hsd/Dock2^m1Hsd (B6NHsd.Cg-Dock2^m1Hsd Cmah^tm1Avrk)	decreased follicular B cell number	J:144035
	decreased marginal zone B cell number	J:144035
Cmah^tm1Avrk/Cmah^tm1Avrk Dock2^m1Hsd/Dock2^m1Hsd Siae^tm1.2Avrk/Siae^tm1.2Avrk (B6NHsd.Cg-Siae^tm1.2Avrk Dock2^m1Hsd Cmah^tm1Avrk)	decreased follicular B cell number	J:144035
	decreased marginal zone B cell number	J:144035
Cmip^{tm1a(EUCOMM)Wtsi}/Cmip^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cmip^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal lymphatic vessel morphology	J:239583
Cmklr1^tm1Dgen/Cmklr1^tm1Dgen (B6.Cg-Cmklr1^tm1Dgen)	abnormal alveolar macrophage morphology	J:157190
	abnormal immune system morphology	J:157190
	increased neutrophil cell number	J:157190
Cmtm4^{tm1d(EUCOMM)Wtsi}/Cmtm4^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	decreased CD8-positive, alpha-beta T cell number	J:333836
	increased B cell number	J:333836
Cmtm5^{tm1c(KOMP)Wtsi}/Cmtm5^{tm1c(KOMP)Wtsi} Cnp^tm1(cre)Kan/Cnp⁺ (B6.Cg-Cnp^tm1(cre)Kan Cmtm5^{tm1c(KOMP)Wtsi})	microgliosis	J:327261
Cmtm7^{tm2a(EUCOMM)Hmgu}/Cmtm7⁺ Rag1^tm1Fwa/Rag1^tm1Fwa (chimera involves: C57BL/6 * C57BL/6N)	abnormal B-1a B cell morphology	J:207033
	decreased B-1a cell number	J:207033
	decreased plasma cell number	J:207033
Cndp2^em1(IMPC)Mbp/Cndp2^em1(IMPC)Mbp (C57BL/6NCrl-Cndp2^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Cnga3^{tm1.1(KOMP)Vlcg}/Cnga3⁺ (C57BL/6N-Cnga3^{tm1.1(KOMP)Vlcg}/Ucd)	enlarged spleen	J:211773
Cngb3^{em1(IMPC)Ccpcz}/Cngb3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cngb3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Cnn2^tm1.2Jin/Cnn2^tm1.2Jin (B6.129X1-Cnn2^tm1.2Jin)	abnormal immune system cell morphology	J:141867
	decreased granulocyte number	J:141867
	decreased monocyte cell number	J:141867
	decreased neutrophil cell number	J:141867
	increased macrophage cell number	J:141867
Cnn2^tm1Jin/Cnn2^tm1Jin (B6.129X1-Cnn2^tm1Jin)	decreased monocyte cell number	J:141867
Cnn2^tm1Jin/Cnn2^tm1Jin (B6.129X1-Cnn2^tm1Jin)	decreased neutrophil cell number	J:141867
Cnot3^tm1.1Tya/Cnot3⁺ (B6.129P2(Cg)-Cnot3^tm1.1Tya)	abnormal osteoclast differentiation	J:206802
Cnot3^tm1.1Tya/Cnot3⁺ (B6.129P2(Cg)-Cnot3^tm1.1Tya)	increased osteoclast cell number	J:206802
Cnot4^{tm1b(EUCOMM)Wtsi}/Cnot4⁺ (C57BL/6N-Cnot4^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased KLRG1-positive NK cell number	J:211773
Cnppd1^{tm1.1(KOMP)Vlcg}/Cnppd1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cnppd1^{tm1.1(KOMP)Vlcg}/J)	increased leukocyte cell number	J:211773
Cnpy2^{em1(IMPC)Wtsi}/Cnpy2⁺ (C57BL/6N-Cnpy2^{em1(IMPC)Wtsi}/Wtsi)	increased effector memory T-helper cell number	J:211773
Cntf^tm1Mpin/Cntf^tm1Mpin (involves: 129S2/SvPas)	abnormal microglial cell morphology	J:15313
Cntn5^em1(IMPC)Mbp/Cntn5^em1(IMPC)Mbp (C57BL/6N-Cntn5^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Coasy^em1(IMPC)H/Coasy⁺ (C57BL/6NTac-Coasy^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Cobl^{em1(IMPC)Ccpcz}/Cobl^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cobl^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased effector memory T-helper cell number	J:211773
Cobll1^{em1(IMPC)Ccpcz}/Cobll1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cobll1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Cog5^{em1(IMPC)Ccpcz}/Cog5⁺ (C57BL/6NCrl-Cog5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cog6^{tm1a(EUCOMM)Wtsi}/Cog6^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cog6^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased alpha-beta T cell number	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased Ly6C-positive immature NK cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased marginal zone B cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased memory-marker gamma-delta T cell number	J:211773
	decreased memory-marker NK cell number	J:211773
	decreased NK cell number	J:211773
	decreased NK T cell number	J:211773
	decreased T cell number	J:211773
	decreased T-helper cell number	J:211773
	decreased transitional stage T2 B cell number	J:211773
	increased B-2 B cell number	J:211773
	increased CD4-negative NK T cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD5-positive gamma-delta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased eosinophil cell number	J:211773
	increased follicular B cell number	J:211773
	increased gamma-delta T cell number	J:211773
	increased granulocyte number	J:211773
	increased KLRG1+ CD4 alpha-beta T cell number	J:211773
	increased KLRG1+ CD8 alpha-beta T cell number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased KLRG1-positive T-helper cell number	J:211773
	increased leukocyte cell number	J:211773
	increased Ly6C high monocyte number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker gamma-delta T cell number	J:211773
	increased memory-marker NK cell number	J:211773
	increased monocyte cell number	J:211773
	increased plasma cell number	J:211773
Col1a1^{tm1(CAG-Ezh2)Meln}/Col1a1⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd 129S4/SvJae * C57BL/6)	increased germinal center B cell number	J:199122
	increased spleen germinal center number	J:199122
	increased spleen germinal center size	J:199122
Col1a1^{tm1(CAG-Mir22)Ppp}/Col1a1^{tm1(CAG-Mir22)Ppp} Tg(Mx1-cre)1Cgn/0 (Not Specified)	decreased leukocyte cell number	J:199366
	enlarged spleen	J:199366
	increased myeloid dendritic cell number	J:199366
	increased T cell derived lymphoma incidence	J:199366
Col1a1^{tm1(tetO-Cyp26b1)Mfra}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	abnormal lymphatic vessel morphology	J:206581
Col1a1^{tm1(tetO-Fos)Wag}/Col1a1⁺ Tg(KRT5-rtTA)T2D6Sgkd/0 (involves: 129S4/SvJae * C57BL/6 * FVB/N)	increased CD4-positive, alpha-beta T cell number	J:201145
	increased granulocyte number	J:201145
Col1a1^{tm1(tetO-GFP/RNAi:Rad21)Iaai}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	decreased B cell number	J:229031
Col1a1^{tm1(tetO-Irf4)Sing}/Col1a1^{tm1(tetO-Irf4)Sing} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ Irf4^tm1Mak/Irf4⁺ (involves: 129P2/OlaHsd 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:203903
	abnormal plasma cell differentiation	J:203903
Col1a1^{tm1(tetO-Irf4)Sing}/Col1a1^{tm1(tetO-Irf4)Sing} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ Irf4^tm1Mak/Irf4^tm1Mak (involves: 129P2/OlaHsd 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:203903
	abnormal plasma cell differentiation	J:203903
Col1a1^{tm1(tetO-RNAi:Rps19)Karl}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129S4/SvJae * C57BL/6)	decreased lymphocyte cell number	J:179085
Col1a1^{tm1(tetO-RNAi:Rps19)Karl}/Col1a1^{tm1(tetO-RNAi:Rps19)Karl} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129S4/SvJae * C57BL/6)	decreased lymphocyte cell number	J:179085
	decreased neutrophil cell number	J:179085
Col1a1^{tm2(tetO-Fosl2,-DsRed)Wag}/Col1a1⁺ Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S4/SvJae * C57BL/6 * CD-1)	abnormal osteoclast morphology	J:211215
Col1a1^{tm2(tetO-GFP/RNAi:Smc1a)Iaai}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	decreased B cell number	J:229031
	enlarged spleen	J:229031
	increased neutrophil cell number	J:229031
	increased spleen red pulp amount	J:229031
	myeloid hyperplasia	J:229031
	myeloid metaplasia	J:229031
Col1a1^{tm2(tetO-GFP/RNAi:Smc1a)Iaai}/Col1a1^{tm3(tetO-GFP/RNAi:Stag2)Iaai} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	abnormal spleen morphology	J:229031
	decreased B cell number	J:229031
	enlarged spleen	J:229031
	myeloid hyperplasia	J:229031
Col1a1^{tm2(tetO-IDH2R140Q)Ppp}/Col1a1^{tm2(tetO-IDH2R140Q)Ppp} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/? (involves: 129S4/SvJae C57BL/6)	enlarged spleen	J:210097
Col1a1^{tm2(tetO-Pou5f1)Jae}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	spleen atrophy	J:98920
	thymus atrophy	J:98920
Col1a1^{tm2(tetO-RNAi:Rps19)Karl}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129S4/SvJae * C57BL/6)	decreased lymphocyte cell number	J:179085
Col1a1^{tm2(tetO-RNAi:Rps19)Karl}/Col1a1^{tm2(tetO-RNAi:Rps19)Karl} Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129S4/SvJae * C57BL/6)	decreased lymphocyte cell number	J:179085
	decreased neutrophil cell number	J:179085
Col1a1^{tm3(tetO-Fosl1,-DsRed)Wag}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	enlarged spleen	J:213764
Col1a1^{tm3(tetO-GFP/RNAi:Apc)Slowe}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	increased T cell derived lymphoma incidence	J:171191
Col1a1^{tm3(tetO-GFP/RNAi:Stag2)Iaai}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	decreased B cell number	J:229031
Col1a1^{tm4(tetO-GFP/RNAi:Apc)Slowe}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	increased T cell derived lymphoma incidence	J:171191
Col1a1^{tm6(tetO-MSI2)Jae}/Col1a1⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae C57BL/6)	abnormal leukocyte morphology	J:163322
	abnormal myelopoiesis	J:163322
	decreased lymphocyte cell number	J:163322
	decreased neutrophil cell number	J:163322
	enlarged spleen	J:163322
	increased leukocyte cell number	J:163322
	increased spleen weight	J:163322
	spleen hyperplasia	J:163322
Col1a2^{tm1b(EUCOMM)Wtsi}/Col1a2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Col1a2^{tm1b(EUCOMM)Wtsi}/BayMmucd)	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Col3a1^m1Btlr/Col3a1^m1Btlr (C57BL/6J-Col3a1^m1Btlr)	increased alpha-beta T cell number	J:271973
	increased CD4-positive, alpha-beta T cell number	J:271973
	increased CD8-positive, alpha-beta T cell number	J:271973
Col4a2^{em1(IMPC)Wtsi}/Col4a2^{em1(IMPC)Wtsi} (C57BL/6N-Col4a2^{em1(IMPC)Wtsi}/WtsiOulu)	abnormal thymus topology	J:239583
	small thymus	J:239583
Col4a3^{tm1b(EUCOMM)Wtsi}/Col4a3^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Col4a3^{tm1b(EUCOMM)Wtsi}/H)	decreased basophil cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased large unstained cell number	J:211773
	increased neutrophil cell number	J:211773
Col4a4^m1H/Col4a4^m1H (involves: C3H/HeH * C57BL/6J)	increased leukocyte cell number	J:285510
Col4a5^{tm1b(EUCOMM)Wtsi}/Y (C57BL/6N-Col4a5^{tm1b(EUCOMM)Wtsi}/Cnrm)	increased leukocyte cell number	J:211773
Col4a5^{tm1b(EUCOMM)Wtsi}/Col4a5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Col4a5^{tm1b(EUCOMM)Wtsi}/Cnrm)	increased large unstained cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Col6a3^em1(IMPC)Tcp/Col6a3^em1(IMPC)Tcp (C57BL/6N-Col6a3^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Col7a1^em#Jtol/Col7a1^em#Jtol (involves: 129S4/SvJae * BALB/c * C57BL/Ka * NOD)	absent B cells	J:280214
	absent NK T cells	J:280214
	absent T cells	J:280214
Col9a3^em1(IMPC)Tcp/Col9a3^em1(IMPC)Tcp (C57BL/6N-Col9a3^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Col10a1^tm1.1Rpbh/Col10a1^tm1.1Rpbh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased osteoclast cell number	J:154052
Col10a1^tm1Bhr/Col10a1^tm1Bhr (involves: 129S7/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:62230
	absent lymph nodes	J:62230
	decreased B cell number	J:62230
	decreased double-positive T cell number	J:62230
	decreased spleen red pulp amount	J:62230
	decreased spleen weight	J:62230
	decreased thymocyte number	J:62230
	decreased thymus weight	J:62230
	increased CD4-positive, alpha-beta T cell number	J:62230
	increased double-negative T cell number	J:62230
	increased single-positive T cell number	J:62230
	small spleen	J:62230
	small thymus	J:62230
	spleen hypoplasia	J:62230
	thymus hypoplasia	J:62230
Col10a1^tm1Ksec/Col10a1^tm1Ksec (involves: 129S/SvEv * C57BL/6)	abnormal T-helper 2 cell differentiation	J:193886
	decreased dendritic cell number	J:193886
	increased B cell number	J:193886
	increased T-helper cell number	J:193886
Col17a1^{tm1.1(COL17A1)Zliu}/Col17a1^{tm1.1(COL17A1)Zliu} (involves: 129P2/OlaHsd * C57BL/6J)	increased neutrophil cell number	J:261781
Col17a1^tm1Tiin/Col17a1^tm1Tiin (involves: C57BL/6)	increased basophil cell number	J:220622
	increased eosinophil cell number	J:220622
	increased monocyte cell number	J:220622
	increased neutrophil cell number	J:220622
Col26a1^em3(IMPC)Tcp/Col26a1^em3(IMPC)Tcp (C57BL/6NCrl-Col26a1^em3(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Col27a1^em1(IMPC)Mbp/Col27a1⁺ (C57BL/6N-Col27a1^em1(IMPC)Mbp/MbpMmucd)	enlarged spleen	J:211773
	small spleen	J:211773
Colec12^em1(IMPC)Mbp/Colec12^em1(IMPC)Mbp (C57BL/6N-Colec12^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Colgalt2^tm1.1Hwei/Colgalt2^tm1.1Hwei (involves: C57BL/6J)	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:310468
Colgalt2^tm1.1Hwei/Colgalt2^tm1.1Hwei (involves: C57BL/6J)	abnormal regulatory T cell morphology	J:310468
Commd8^tm1.1Ksuz/Commd8^tm1.1Ksuz Igh^tm1Mnz/Igh⁺ Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6NSlc * SJL)	abnormal spleen B cell follicle morphology	J:278399
Commd9^{tm1b(KOMP)Wtsi}/Commd9⁺ (C57BL/6N-Commd9^{tm1b(KOMP)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Commd10^{Tg(Vav1-icre)A2Kio}/0 Map3k7^tm1.1Arte/Map3k7^tm1.1Arte (involves: C57BL/10 * C57BL/6J * C57BL/6NTac * CBA/Ca)	decreased macrophage cell number	J:332172
	enlarged axillary lymph nodes	J:332172
	enlarged inguinal lymph nodes	J:332172
	enlarged spleen	J:332172
	increased B cell number	J:332172
	increased lymphocyte cell number	J:332172
	increased neutrophil cell number	J:332172
	increased splenocyte number	J:332172
Commd10^{Tg(Vav1-icre)A2Kio}/0 Nfil3^tm1.2Kubo/Nfil3^tm1.2Kubo (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	decreased dendritic cell number	J:334296
Comt^tm1Kara/Comt^tm1Kara (involves: 129S4/SvJaeSor)	increased uterine NK cell number	J:137276
Cop1^{Gt(XR0653)1.1Wtsi}/Cop1^{Gt(XR0653)1.1Wtsi} (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased T cell derived lymphoma incidence	J:178271
Copa^tm1.1Shum/Copa⁺ (B6(CBA)-Copa^tm1.1Shum)	abnormal B cell morphology	J:288425
	decreased double-positive T cell number	J:288425
	increased effector memory T-helper cell number	J:288425
	increased single-positive T cell number	J:288425
Cops5^tm1Rpar/Cops5^tm1Rpar Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)	decreased double-positive T cell number	J:132114
	decreased single-positive T cell number	J:132114
	decreased thymocyte number	J:132114
	thymus medulla hypoplasia	J:132114
Cops5^tm1Rpar/Cops5^tm1Rpar Tg(Lck-cre)548Jxm/0 Tg(TcraTcrb)425Cbn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)	decreased thymocyte number	J:132114
Cops5^tm1Rpar/Cops5^tm1Rpar Tg(Lck-cre)548Jxm/0 Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129 * C57BL/6 * CBA * SJL)	decreased thymocyte number	J:132114
Cops7a^{tm1b(KOMP)Mbp}/Cops7a^{tm1b(KOMP)Mbp} (C57BL/6N-Cops7a^{tm1b(KOMP)Mbp}/Ucd)	increased monocyte cell number	J:211773
Cops8^{em1(IMPC)Ccpcz}/Cops8⁺ (C57BL/6NCrl-Cops8^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Cops8^tm1Nwe/Cops8^tm1.1Nwe Tg(Cd4-cre)1Cwi/? (involves: 129S1/Sv * C57BL/6 * DBA/2)	decreased T cell number	J:126339
Coro1a^koy/Coro1a^koy (C57BL/6-Coro1a^koy)	decreased CD4-positive, alpha-beta T cell number	J:141431
	decreased CD8-positive, alpha-beta T cell number	J:141431
	decreased thymocyte number	J:141431
Coro1a^{Lmb3-C57BL/6Scr}/Coro1a^{Lmb3-C57BL/6Scr} (MRL.Cg-Coro1a^C57BL/6Scr Fas^lpr)	decreased spleen weight	J:125557
	small lymph nodes	J:125557
Coro1a^{Lmb3-MRL/MpScr}/Coro1a^{Lmb3-MRL/MpScr} (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	enlarged lymph nodes	J:45708
	enlarged spleen	J:45708
Coro1a^{Lmb3-MRL/MpScr}/Coro1a^{Lmb3-MRL/MpScr} (B6.MRL-Coro1a^MRL/MpScr Fas^lpr)	enlarged lymph nodes	J:125557
	increased spleen weight	J:125557
Coro1a^ptcd/Coro1a^ptcd (B6.CTS-Coro1a^ptcd)	abnormal effector T cell morphology	J:141431
	decreased CD4-positive, alpha-beta T cell number	J:141431
	decreased CD8-positive, alpha-beta T cell number	J:141431
	increased thymocyte number	J:141431
Coro1a^ptcd/Coro1a^tm1Achn (B6.Cg-Coro1a^ptcd Coro1a^tm1Achn)	abnormal effector T cell morphology	J:141431
	decreased CD4-positive, alpha-beta T cell number	J:141431
	decreased CD8-positive, alpha-beta T cell number	J:141431
	increased thymocyte number	J:141431
Coro1a^tm1Achn/Coro1a^tm1Achn (involves: 129X1/SvJ * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:111593
	decreased CD8-positive, alpha-beta T cell number	J:111593
	decreased memory T cell number	J:111593
	decreased T cell number	J:111593
Coro1a^tm1Achn/Coro1a^tm1Achn (B6.129X1-Coro1a^tm1Achn)	decreased thymocyte number	J:141431
Coro1a^tm1Jpie/Coro1a^tm1Jpie (involves: 129 * C57BL/6)	decreased B cell number	J:133258
	decreased CD4-positive, alpha-beta T cell number	J:133258
	decreased CD8-positive, alpha-beta T cell number	J:133258
	decreased monocyte cell number	J:133258
Cotl1^{tm1b(EUCOMM)Hmgu}/Cotl1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cotl1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Cox6b1^em1(IMPC)Tcp/Cox6b1⁺ (C57BL/6NCrl-Cox6b1^em1(IMPC)Tcp/Tcp)	increased spleen weight	J:211773
Cox10^tm1Ctm/Cox10^tm1Ctm Slc6a3^{tm1.1(cre)Bkmn}/? (B6.Cg-Cox10^tm1Ctm Slc6a3^{tm1.1(cre)Bkmn})	microgliosis	J:231810
Cox19^{tm1b(EUCOMM)Hmgu}/Cox19⁺ (C57BL/6N-Cox19^{tm1b(EUCOMM)Hmgu}/Tcp)	enlarged lymph nodes	J:211773
Cp^tm1Hrs/Cp^tm1Hrs (involves: 129X1/SvJ * Black Swiss)	increased spleen iron level	J:57730
Cp^tm1Yos/Cp^tm1Yos (involves: 129P2/OlaHsd * BALB/c)	abnormal Kupffer cell morphology	J:79916
Cpa3^tm1Hrr/Cpa3^tm1Hrr (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell morphology	J:99367
Cpa3^tm3(icre)Hrr/Cpa3⁺ (B6.129P2-Cpa3^tm3(icre)Hrr)	absent mast cells	J:178942
Cpa3^tm3(icre)Hrr/Cpa3⁺ (B6.129P2-Cpa3^tm3(icre)Hrr)	decreased basophil cell number	J:178942
Cpa3^tm3(icre)Hrr/Cpa3⁺ Fgfr1^tm1Upir/Fgfr1^tm1Upir Fgfr2^tm1Dor/Fgfr2^tm1Dor Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)	absent mast cells	J:221184
Cpa3^tm3(icre)Hrr/Cpa3⁺ Gt(ROSA)26Sor^tm1Hjf/? Notch1^tm1Agt/Notch1^tm1Agt (involves: 129 * C57BL/6)	abnormal dendritic cell differentiation	J:143731
	abnormal T cell receptor beta chain V(D)J recombination	J:143731
Cpa3^tm3(icre)Hrr/Cpa3⁺ Notch1^tm1Agt/Notch1^tm1Agt (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:143731
	abnormal B cell morphology	J:143731
	abnormal T cell receptor beta chain V(D)J recombination	J:143731
	decreased double-negative T cell number	J:143731
	decreased double-positive T cell number	J:143731
	increased single-positive T cell number	J:143731
	thymus hypoplasia	J:143731
Cpap^{tm1a(EUCOMM)Wtsi}/Cpap^{tm1a(EUCOMM)Wtsi} (B6Brd;B6N-Tyr^c-Brd Cpap^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased CD8-positive, alpha-beta T cell number	J:194085
	increased T cell number	J:194085
Cpe^{tm1b(EUCOMM)Hmgu}/Cpe^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cpe^{tm1b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Cpgi5563^{tm1.1(NCC)Wcs}/Cpgi5563^{tm1.1(NCC)Wcs} (C57BL/6N-Cpgi5563^{tm1.1(NCC)Wcs}/Wtsi)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:277622
	decreased CD8-positive, alpha-beta T cell number	J:277622
	decreased effector memory CD4-positive, alpha-beta T cell number	J:277622
	decreased gamma-delta T cell number	J:277622
Cplane2^b2b2827Clo/Cplane2^b2b2827Clo (C57BL/6J-Cplane2^b2b2827Clo)	thymus hypoplasia	J:175213
Cpm^{em1(IMPC)Ccpcz}/Cpm^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Cpm^{em1(IMPC)Ccpcz}/Ccpcz)	decreased CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
Cpne5^{tm2b(EUCOMM)Hmgu}/Cpne5^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Cpne5^{tm2b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Cpox^Rbc16/Cpox⁺ (involves: C57BL/6)	enlarged spleen	J:244493
Cpox^Rbc16/Cpox⁺ (involves: C57BL/6)	increased spleen red pulp amount	J:244493
Cpq^em1(IMPC)Tcp/Cpq^em1(IMPC)Tcp (C57BL/6N-Cpq^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Cps1^em1(IMPC)H/Cps1⁺ (C57BL/6NTac-Cps1^em1(IMPC)H/H)	decreased neutrophil cell number	J:211773
Cps1^em1(IMPC)H/Cps1⁺ (C57BL/6NTac-Cps1^em1(IMPC)H/H)	increased lymphocyte cell number	J:211773
Cpt1c^Gt(XL823)Byg/Cpt1c⁺ Nf1^tm1Tyj/Nf1⁺ Trp53^tm1Tyj/Trp53⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	spleen hyperplasia	J:228258
Cpvl^em1(IMPC)Tcp/Cpvl^em1(IMPC)Tcp (C57BL/6NCrl-Cpvl^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Cpxm1^em1(IMPC)Tcp/Cpxm1^em1(IMPC)Tcp (C57BL/6N-Cpxm1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	increased monocyte cell number	J:211773
Cr1l^tm1.1Song/Cr1l^tm1.1Song Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:146538
	decreased CD8-positive, alpha-beta T cell number	J:146538
	decreased lymphocyte cell number	J:146538
	increased B cell number	J:146538
	lymph node hypoplasia	J:146538
Cr1l^tm1.1Song/Cr1l^tm1.1Song Tg(Lck-cre)548Jxm/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:146538
	decreased CD8-positive, alpha-beta T cell number	J:146538
	decreased lymphocyte cell number	J:146538
	increased B cell number	J:146538
	lymph node hypoplasia	J:146538
Cr1l^tm1.1Song/Cr1l^tm1.1Song Vsig4^tm1Gne/Vsig4^tm1Gne Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6N * DBA/2 * SJL)	decreased lymphocyte cell number	J:146538
Cr2^tm1.1Jhws/Cr2^tm1.1Jhws (Not Specified)	decreased B-1a cell number	J:205353
Cr2^tm1Crr/Cr2^tm1Crr (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B-1 B cell morphology	J:31942
	abnormal immune system morphology	J:69452
	abnormal spleen germinal center morphology	J:31942
	decreased B cell number	J:31942
	decreased B-1a cell number	J:69452
	decreased neutrophil cell number	J:66111
	decreased spleen germinal center number	J:31942, J:69452
	decreased spleen germinal center size	J:31942
Cr2^tm1Crr/Cr2^tm1Crr (involves: 129S7/SvEvBrd)	decreased follicular B cell number	J:69477
Cr2^tm1Crr/Cr2^tm1Crr (involves: 129S7/SvEvBrd)	increased marginal zone B cell number	J:69477
Cr2^tm1Hmo/Cr2^tm1Hmo (involves: 129S7/SvEvBrd * C57BL/6)	abnormal class switch recombination	J:151991
Cr2^tm1Hmo/Cr2^tm1Hmo (involves: 129S7/SvEvBrd * C57BL/6)	abnormal memory B cell differentiation	J:151991
Cr2^tm1Tft/Cr2^tm1Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased spleen germinal center number	J:95979
Cr2^{tm2.1(HLA-A)Crr}/Cr2^{tm2.1(HLA-A)Crr} (involves: C57BL/6)	abnormal class switch recombination	J:151991
	abnormal memory B cell differentiation	J:151991
Crabp1^{tm1b(EUCOMM)Wtsi}/Crabp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Crabp1^{tm1b(EUCOMM)Wtsi}/Tcp)	increased monocyte cell number	J:211773
Crb1^rd8+em1Boc/Crb1^rd8+em1Boc Jak3^m1J/Jak3^m1J (B6.Cg-Crb1^rd8+em1Boc Jak3^m1J/Boc)	small spleen	J:265859
	small thymus	J:265859
Crb1^rd8/Crb1^rd8 Jak3^m1J/Jak3^m1J (B6.Cg-Crb1^rd8 Jak3^m1J/BocJ)	decreased spleen weight	J:265859
	small spleen	J:265859
	small thymus	J:265859
Crbn^tm1.1Ble/Crbn^tm1.1Ble (involves: C57BL/6)	decreased B cell number	J:267091
	decreased granulocyte number	J:267091
	decreased leukocyte cell number	J:267091
	decreased T cell number	J:267091
Creb3l2^{em1(IMPC)Ccpcz}/Creb3l2⁺ (C57BL/6NCrl-Creb3l2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Crebbp^tm1Dli/Crebbp⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal granulocyte morphology	J:191503
	abnormal leukocyte morphology	J:191503
	absent pre-B cells	J:60630
	decreased B cell number	J:60630
	decreased lymphocyte cell number	J:191503
	enlarged spleen	J:191503, J:60630
	increased granulocyte number	J:191503
Crebbp^tm1Jvd/Crebbp^tm1Jvd Ep300^tm2Pkb/Ep300^tm2Pkb Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal T cell number	J:105505
	decreased double-positive T cell number	J:105505
	increased double-negative T cell number	J:105505
Crebbp^tm1Jvd/Crebbp^tm1Jvd Tg(Lck-cre)548Jxm/0 (involves: 129 * C57BL/6 * CBA)	decreased CD4-positive, alpha-beta T cell number	J:105505
	decreased T cell number	J:105505
	decreased thymocyte number	J:105505
	increased double-positive T cell number	J:105505
	increased T cell derived lymphoma incidence	J:105505
	small thymus	J:105505
Crebbp^tm1Jvd/Crebbp^tm1Jvd Tg(MMTV-cre)4Mam/0 (involves: 129 * C57BL/6 * FVB)	decreased double-positive T cell number	J:88323
	increased CD8-positive, alpha-beta T cell number	J:88323
	increased T cell derived lymphoma incidence	J:88323
Crebbp^tm1Pkb/Crebbp^tm1Pkb (involves: 129P2/OlaHsd * C57BL/6)	decreased thymocyte number	J:98329
Crh^tm1Maj/Crh^tm1Maj (involves: 129S2/SvPas * C57BL/6)	increased splenocyte number	J:98419
cri/cri (involves: DBA/2J)	decreased leukocyte cell number	J:6327
cri/cri (involves: DBA/2J)	decreased neutrophil cell number	J:6327
Crim1^{em1(IMPC)Wtsi}/Crim1^{em1(IMPC)Wtsi} (C57BL/6N-Crim1^{em1(IMPC)Wtsi}/WtsiOrl)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Crip3^tm1Mjb/Crip3^tm1Mjb (either: (involves: 129S/Sv) or (involves: 129S/Sv * C57BL/6))	decreased thymocyte number	J:72942
	small thymus	J:72942
	thymus hypoplasia	J:72942
Crispld2^tm1Lex/Crispld2^tm1Lex (B6;129S5-Crispld2^tm1Lex/Mmucd)	abnormal immune system morphology	J:171883
Crkl^tm1Imo/Crkl^tm1Imo (involves: 129S4/SvJaeSor * C57BL/6J)	abnormal thymus development	J:67826
Crlf2^em1(IMPC)Mbp/Crlf2^em1(IMPC)Mbp (C57BL/6N-Crlf2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Crlf2^tm1Wjl/Crlf2^tm1Wjl (involves: 129 * C57BL/6)	abnormal lymphopoiesis	J:108209
	decreased B cell number	J:108209
	decreased single-positive T cell number	J:108209
Crocc2^{em1(IMPC)Ccpcz}/Crocc2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Crocc2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Crppa^em1(IMPC)H/Crppa⁺ (C57BL/6NTac-Crppa^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Crtam^tm1Achn/Crtam^tm1Achn (involves: 129 * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:145314
Crtam^tm1Achn/Crtam^tm1Achn (involves: 129 * C57BL/6)	increased CD8-positive, alpha-beta T cell number	J:145314
Crx^{em1(IMPC)Ccpcz}/Crx^{em1(IMPC)Ccpcz} (C57BL/6N-Crx^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased NK cell number	J:211773
	small thymus	J:211773
Cry1^em1(IMPC)H/Cry1^em1(IMPC)H (C57BL/6N-Cry1^em1(IMPC)H/H)	increased leukocyte cell number	J:211773
Csf1^op/Csf1^op (C57BL/6J-Csf1^op)	abnormal osteoclast morphology	J:5634
	abnormal spleen red pulp morphology	J:5634
	decreased macrophage cell number	J:110981
	decreased osteoclast cell number	J:5634
Csf1^op/Csf1^op (B6C3Fe a/a-Csf1^op/J)	abnormal Kupffer cell morphology	J:26978
	abnormal Langerhans cell morphology	J:112594
	abnormal microglial cell morphology	J:49613
	abnormal osteoclast differentiation	J:19549, J:4732
	abnormal osteoclast morphology	J:26978
	abnormal perivascular macrophage morphology	J:49613
	abnormal spleen red pulp morphology	J:26978
	abnormal splenic cell ratio	J:104139
	absent Langerhans cell	J:112594
	decreased leukocyte cell number	J:104139
	decreased macrophage cell number	J:26978, J:104139
	decreased monocyte cell number	J:104139
	decreased osteoclast cell number	J:73663
	thymus cortex hypoplasia	J:26978
	thymus medulla atrophy	J:26978
Csf1^op/Csf1^op (involves: C3HeB/FeJ * C57BL/6J)	abnormal osteoclast cell number	J:33189
	abnormal osteoclast differentiation	J:38039
	decreased osteoclast cell number	J:33189
Csf1^op/Csf1^op (B6;C3Fe a/a-Csf1^op/J)	abnormal microglial cell morphology	J:170081
Csf1^op/Csf1^op (B6;C3Fe a/a-Csf1^op/J)	decreased macrophage cell number	J:30863, J:147697
Csf1^op/Csf1^op Csf2^tm1Ard/Csf2^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	decreased leukocyte cell number	J:19089
	increased neutrophil cell number	J:19089
Csf1^op/Csf1^op Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	abnormal lymph node cell ratio	J:117880
Csf1^tm1.2Sabw/Csf1^tm1.2Sabw (involves: 129S4/SvJaeSor * C57BL/6)	abnormal Kupffer cell morphology	J:180199
	abnormal myeloid leukocyte morphology	J:180199
	decreased B cell number	J:180199
	decreased lymphocyte cell number	J:180199
	decreased macrophage cell number	J:180199
	decreased monocyte cell number	J:180199
	decreased osteoclast cell number	J:180199
	decreased spleen weight	J:180199
	increased granulocyte number	J:180199
	increased T cell number	J:180199
	small spleen	J:180199
Csf1r^tm1Ers/Csf1r⁺ (B6.129X1-Csf1r^tm1Ers)	microgliosis	J:219294
Csf1r^tm1Ers/Csf1r^tm1Ers (involves: 129X1/SvJ * C3Heb/FeJ * C57BL/6J)	abnormal leukocyte cell number	J:73663
	abnormal osteoclast differentiation	J:73663
	abnormal spleen morphology	J:73663
	decreased Langerhans cell number	J:73663
	decreased lymphocyte cell number	J:73663
	decreased macrophage cell number	J:73663
	decreased monocyte cell number	J:73663
	increased granulocyte number	J:73663
	increased spleen weight	J:73663
Csf1r^tm1Ers/Csf1r^tm1Ers (FVB.129X1-Csf1r^tm1Ers)	abnormal macrophage differentiation	J:112594
	abnormal osteoclast morphology	J:111489
	absent Langerhans cell	J:112594
Csf2^tm1Ard/Csf2^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	abnormal alveolar macrophage morphology	J:18747
	abnormal spleen size	J:67766
	lymphoid hyperplasia	J:18747
Csf2^tm1Dran/Csf2^tm1Dran Ifng^tm1Ts/Ifng^tm1Ts Il3^tm1Glli/Il3^tm1Glli (involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)	increased eosinophil cell number	J:83086
Csf2^tm1Dran/Csf2^tm1Dran Il3^tm1Glli/Il3^tm1Glli (B6.129S2-Csf2^tm1Dran Il3^tm1Glli)	increased eosinophil cell number	J:67404
Csf2^tm1Dran/Csf2^tm1Dran Il3^tm1Glli/Il3^tm1Glli (C.129S2-Csf2^tm1Dran Il3^tm1Glli)	increased eosinophil cell number	J:67404
Csf2^tm1Mlg/Csf2^tm1Mlg (involves: 129S2/SvPas)	abnormal alveolar macrophage morphology	J:17978
Csf2^tm1Mlg/Csf2^tm1Mlg (involves: 129S2/SvPas)	lymphoid hyperplasia	J:17978
Csf2ra^em1Szut/Csf2ra^em1Szut (C57BL/6-Csf2ra^em1Szut)	abnormal alveolar macrophage morphology	J:322934
Csf2ra^em1Szut/Csf2ra^em1Szut (C57BL/6-Csf2ra^em1Szut)	increased lymphocyte cell number	J:322934
Csf2rb^tm1Cgb/Csf2rb^tm1Cgb (involves: 129S1/Sv * C57BL/6)	decreased eosinophil cell number	J:29737
Csf2rb^tm1Clsc/Csf2rb^tm1Clsc Csf2rb2^tm1Cgb/Csf2rb2^tm1Cgb (C.129S1-Csf2rb2^tm1Cgb Csf2rb^tm1Clsc)	lymph node hyperplasia	J:130939
Csf2rb^tm1Mur/Csf2rb^tm1Mur (involves: 129P2/OlaHsd * C57BL/6)	decreased eosinophil cell number	J:35829
Csf2rb^tm1Mur/Csf2rb^tm1Mur (involves: 129P2/OlaHsd)	decreased eosinophil cell number	J:24122
Csf2rb^tm1Mur/Csf2rb^tm1Mur Il3^tm1Tyb/Il3^tm1Tyb (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased eosinophil cell number	J:35829
Csf2rb^{tm2b(EUCOMM)Hmgu}/Csf2rb⁺ (C57BL/6N-Csf2rb^{tm2b(EUCOMM)Hmgu}/Orl)	increased eosinophil cell number	J:211773
Csf3^em1(IMPC)H/Csf3^em1(IMPC)H (C57BL/6NTac-Csf3^em1(IMPC)H/H)	decreased eosinophil cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Csf3^tm1Ard/Csf3⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased neutrophil cell number	J:20400
Csf3^tm1Ard/Csf3^tm1Ard (involves: 129P2/OlaHsd * C57BL/6)	decreased leukocyte cell number	J:20400
	decreased monocyte cell number	J:20400
	decreased neutrophil cell number	J:20400
	impaired myelopoiesis	J:20400
Csf3r^tm1Eur/Csf3r^tm1Eur (involves: 129P2/OlaHsd * C57BL/6 * FVB)	abnormal neutrophil differentiation	J:48503
	decreased neutrophil cell number	J:48503
Csf3r^tm1Link/Csf3r^tm1Link (involves: 129X1/SvJ * NIH Black Swiss)	abnormal monocyte morphology	J:37618
	decreased monocyte cell number	J:37618
	decreased neutrophil cell number	J:37618
Csf3r^tm2Eur/Csf3r^tm2Eur (involves: 129P2/OlaHsd * FVB)	decreased neutrophil cell number	J:185115
Csf3r^tm3Link/Csf3r^tm3Link (involves: 129X1/SvJ * C57BL/6)	decreased neutrophil cell number	J:67612
Csf3r^{tm4(Epor)Link}/Csf3r^{tm4(Epor)Link} (involves: 129X1/SvJ * C57BL/6)	decreased granulocyte number	J:79825
	decreased neutrophil cell number	J:79825
Csf3r^{tm4(Epor)Link}/Csf3r^{tm4(Epor)Link} (B6.129X1-Csf3r^{tm4(Epor)Link})	decreased neutrophil cell number	J:79567
Csk^tm1Sor/Csk⁺ Ptprc^ltng/Ptprc^ltng (involves: 129S7/SvEvBrd * C57BL/6)	thymus hypoplasia	J:158876
Csk^tm1Sor/Csk⁺ Ptprc^ltng/Ptprc^tm1Mak (involves: 129S7/SvEvBrd * C57BL/6)	abnormal T cell differentiation	J:158876
	thymus hypoplasia	J:158876
Csk^tm1Tara/Csk^tm1Tara Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CB20 * CBA)	abnormal CD4-positive T cell differentiation	J:49654
	absent CD8-positive, alpha-beta T cells	J:49654
	enlarged thymus	J:49654
Csk^tm1Tara/Csk^tm2Tara Elane^tm1(cre)Roes/Elane⁺ (involves: 129P2/OlaHsd * CB20 * C57BL/6)	abnormal myelopoiesis	J:89716
Csmd3^em1(IMPC)Mbp/Csmd3^em1(IMPC)Mbp (C57BL/6NCrl-Csmd3^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
Csnk1a1^{tm1c(KOMP)Wtsi}/Csnk1a1^{tm1c(KOMP)Wtsi} Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6N * CBA)	abnormal spleen red pulp morphology	J:216977
	bone marrow failure	J:216977
Csnk1g1^em1(IMPC)J/Csnk1g1^em1(IMPC)J (C57BL/6NJ-Csnk1g1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Csnk2a2^em1(IMPC)Mbp/Csnk2a2^em1(IMPC)Mbp (C57BL/6N-Csnk2a2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Cspt^C57BL/6/Cspt^C57BL/6 (involves: C57BL/6 * NOD/ShLtDoi * SJL)	increased CD8-positive, alpha-beta T cell number	J:97046
Cspt^C57BL/6/Cspt^NOD/ShiLtDoi (involves: C57BL/6 * NOD/ShLtDoi * SJL)	increased CD8-positive, alpha-beta T cell number	J:97046
Cst6^{em1(IMPC)Ccpcz}/Cst6⁺ (C57BL/6NCrl-Cst6^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Cst7^tm1.2Arte/Cst7^tm1.2Arte (involves: C57BL/6)	abnormal eosinophil morphology	J:258944
Cst7^tm1.2Arte/Cst7^tm1.2Arte (involves: C57BL/6)	decreased eosinophil cell number	J:258944
Cstb^{tm1b(EUCOMM)Wtsi}/Cstb^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cstb^{tm1b(EUCOMM)Wtsi}/Orl)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Ctbs^tm1Tbec/Ctbs^tm1Tbec (involves: 129S2/SvPas * C57BL/6N)	abnormal Kupffer cell morphology	J:185162
Ctc1^tm1.1Schg/Ctc1^tm1.1Schg (involves: 129S7/SvEvBrd * C57BL/6)	small spleen	J:184809
	small thymus	J:184809
Ctcf^tm2Gal/Ctcf⁺ Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:143271
	decreased CD8-positive, alpha-beta T cell number	J:143271
	thymus hypoplasia	J:143271
Ctcf^tm2Gal/Ctcf^tm2Gal Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * C57BL/10)	decreased double-positive T cell number	J:143271
Ctcf^tm2Gal/Ctcf^tm2Gal Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:143271
	abnormal T cell morphology	J:143271
	decreased CD4-positive, alpha-beta T cell number	J:143271
	decreased CD8-positive, alpha-beta T cell number	J:143271
	decreased double-positive T cell number	J:143271
	decreased single-positive T cell number	J:143271
	increased double-negative T cell number	J:143271
	increased single-positive T cell number	J:143271
	thymus hypoplasia	J:143271
Ctcf^tm2Gal/Ctcf^tm2Gal Tg(Lck-cre)1Cwi/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * DBA/2J)	abnormal T cell differentiation	J:143271
	decreased CD4-positive, alpha-beta T cell number	J:143271
	decreased CD8-positive, alpha-beta T cell number	J:143271
	decreased double-positive T cell number	J:143271
Ctcf^tm2Gal/Ctcf^tm2Gal Tg(Lck-cre)1Cwi/0 Tg(TcraTcrb)425Cbn/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:143271
	decreased CD4-positive, alpha-beta T cell number	J:143271
	decreased double-positive T cell number	J:143271
	decreased T cell number	J:143271
	increased double-negative T cell number	J:143271
	increased single-positive T cell number	J:143271
Ctdspl2^{tm2b(KOMP)Wtsi}/Ctdspl2⁺ (C57BL/6N-Ctdspl2^{tm2b(KOMP)Wtsi}/Bay)	increased spleen weight	J:211773
Ctla4^m1Btlr/Ctla4^m1Btlr (C57BL/6J-Ctla4^m1Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:265263
	increased effector memory CD4-positive, alpha-beta T cell number	J:265263
	increased effector memory CD8-positive, alpha-beta T cell number	J:265263
Ctla4^tm1All/Ctla4^tm1All (involves: 129S1/Sv * 129X1/SvJ)	abnormal thymus morphology	J:42481
	decreased double-positive T cell number	J:42481
	decreased T cell number	J:42481
	increased double-negative T cell number	J:42481
	lymph node hypoplasia	J:42481
Ctla4^tm1All/Ctla4^tm1All Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * NOD * SJL)	enlarged spleen	J:109887
Ctla4^tm1All/Ctla4^tm1All Tg(TcrAND)53Hed/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal lymphopoiesis	J:119845
	abnormal T cell subpopulation ratio	J:119845
	increased CD4-positive, alpha-beta T cell number	J:119845
	increased CD8-positive, alpha-beta T cell number	J:119845
Ctla4^tm1All/Ctla4^tm1All Tg(TcraTcrb)8Rest/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:140448
	increased CD4-positive, alpha-beta T cell number	J:140448
Ctla4^tm1Saka/Ctla4^tm1Saka Foxp3^tm1(cre)Saka/Y (involves: BALB/c)	abnormal splenic cell ratio	J:140085
	increased regulatory T cell number	J:140085
	lymph node hyperplasia	J:140085
	spleen hyperplasia	J:140085
Ctla4^tm1Shr/Ctla4^tm1Shr (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal lymph node cell ratio	J:30393
	abnormal splenic cell ratio	J:30393
	abnormal T cell differentiation	J:30393
	abnormal T cell morphology	J:30393
	decreased double-positive T cell number	J:30393
	enlarged lymph nodes	J:30393
	enlarged spleen	J:30393
	increased double-negative T cell number	J:30393
	increased T cell number	J:30393
Ctla4^tm1Shr/Ctla4^tm1Shr Tg(DO11.10)10Dlo/0 (involves: 129S4/SvJae * BALB/c * C3H * C57BL/6)	enlarged lymph nodes	J:57090
	enlarged spleen	J:57090
Ctnnb1^{tm1(Nfkbia)Rsu}/Ctnnb1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal cervical lymph node morphology	J:71744
	abnormal peripheral lymph node morphology	J:71744
	absent peripheral lymph nodes	J:71744
	absent Peyer's patches	J:71744
	absent popliteal lymph nodes	J:71744
	decreased Peyer's patch number	J:71744
	increased granulocyte number	J:71744
	increased leukocyte cell number	J:71744
	small axillary lymph nodes	J:71744
	small brachial lymph nodes	J:71744
	small Peyer's patches	J:71744
Ctnnb1^tm1Mmt/Ctnnb1⁺ Ctsk^tm1(cre)Ska/Ctsk⁺ (involves: 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj)	abnormal osteoclast differentiation	J:178340
Ctnnb1^tm1Mmt/Ctnnb1⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal osteoclast differentiation	J:178340
Ctnnb1^tm1Mmt/Ctnnb1⁺ Pparg^{tm1.1(tTA)Jmgr}/Pparg⁺ Tg(tetO-cre)1Jaw/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	abnormal osteoclast differentiation	J:178340
	decreased osteoclast cell number	J:178340
	increased splenocyte number	J:178340
Ctnnb1^tm1Mmt/Ctnnb1⁺ Tg(Col1a1-cre)1Kry/0 (involves: 129X1/SvJ * FVB)	decreased osteoclast cell number	J:98430
Ctnnb1^tm1Mmt/Ctnnb1⁺ Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129X1/SvJ * CD-1)	abnormal osteoclast differentiation	J:114494
Ctnnb1^{tm2(Nfkbia)Rsu}/Ctnnb1⁺ Tg(CMV-cre)1Cgn/0 (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal lymph node morphology	J:71744
	abnormal Peyer's patch morphology	J:71744
	increased granulocyte number	J:71744
	increased leukocyte cell number	J:71744
Ctnnb1^tm2Kem/Ctnnb1⁺ Ctsk^tm1(cre)Ska/Ctsk⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj)	increased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	increased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1⁺ Pparg^{tm1.1(tTA)Jmgr}/Pparg⁺ Tg(tetO-cre)1Jaw/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	increased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1⁺ Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	increased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Ctsk^tm1(cre)Ska/Ctsk⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj)	increased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	increased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Pparg^{tm1.1(tTA)Jmgr}/Pparg⁺ Tg(tetO-cre)1Jaw/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased osteoclast cell number	J:178340
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Pparg^{tm1.1(tTA)Jmgr}/Pparg⁺ Tg(tetO-cre)1Jaw/0 Tg(tetO-HIST1H2BJ/GFP)47Efu/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)	abnormal osteoclast differentiation	J:178340
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Tg(Col1a1-cre)1Kry/0 (involves: 129S1/Sv * 129X1/SvJ * FVB)	increased osteoclast cell number	J:98430
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Tg(KRT14-cre/ERT)20Efu/0 (involves: 129S1/Sv * 129X1/SvJ * CD-1)	cutaneous mastocytosis	J:204142
Ctnnb1^tm2Kem/Ctnnb1^tm2Kem Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased osteoclast cell number	J:178340
Ctnnb1^tm4Wbm/Ctnnb1^tm4Wbm Krt14^tm1(cre)Wbm/Krt14⁺ (involves: 129P2/OlaHsd)	decreased gamma-delta T cell number	J:202499
	increased neutrophil cell number	J:202499
Ctps1^em1(IMPC)Tcp/Ctps1⁺ (C57BL/6N-Ctps1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Ctps1^{tm1c(KOMP)Wtsi}/Ctps1^{tm1c(KOMP)Wtsi} Commd10^{Tg(Vav1-icre)A2Kio}/0 (B6.Cg-Ctps1^{tm1c(KOMP)Wtsi} Commd10^{Tg(Vav1-icre)A2Kio})	abnormal spleen morphology	J:348981
	decreased B cell number	J:348981
	decreased double-positive T cell number	J:348981
	decreased NK cell number	J:348981
	decreased T cell number	J:348981
	increased CD4-positive, alpha-beta T cell number	J:348981
	increased CD8-positive, alpha-beta T cell number	J:348981
	small thymus	J:348981
	thymus hypoplasia	J:348981
Ctps1^{tm1c(KOMP)Wtsi}/Ctps1^{tm1c(KOMP)Wtsi} Ctps2^{tm1c(EUCOMM)Hmgu}/Ctps2^{tm1c(EUCOMM)Hmgu} Tg(Cd4-cre)1Cwi/0 (involves: 129S/Sv * C57BL/6 * DBA/2)	decreased T cell number	J:348981
Ctps1^{tm1c(KOMP)Wtsi}/Ctps1^{tm1c(KOMP)Wtsi} Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (B6.Cg-Ctps1^{tm1c(KOMP)Wtsi} Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj})	abnormal spleen morphology	J:348981
	decreased germinal center B cell number	J:348981
	decreased lymphocyte cell number	J:348981
	decreased T follicular helper cell number	J:348981
	increased CD8-positive, alpha-beta T cell number	J:348981
	small thymus	J:348981
	thymus hypoplasia	J:348981
Ctps1^{tm1c(KOMP)Wtsi}/Ctps1^{tm1c(KOMP)Wtsi} Tg(Cd4-cre)1Cwi/0 (involves: 129S/Sv * C57BL/6 * DBA/2)	decreased effector memory T-helper cell number	J:348981
	increased CD8-positive, naive alpha-beta T cell number	J:348981
Ctps1^{tm1c(KOMP)Wtsi}/Ctps1^{tm1c(KOMP)Wtsi} Tg(Cd4-cre)1Cwi/0 Foxp3^sf/Y Rag1^tm1Mom/Rag1⁺ (mixed)	decreased regulatory T cell number	J:348981
	enlarged spleen	J:348981
	thymus hypoplasia	J:348981
Ctsa^tm1Adz/Ctsa^tm1Adz (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/NJ))	enlarged spleen	J:29674
Ctsa^{tm2b(EUCOMM)Hmgu}/Ctsa^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Ctsa^{tm2b(EUCOMM)Hmgu}/H)	enlarged spleen	J:211773
	increased monocyte cell number	J:211773
	increased spleen weight	J:211773
Ctsd^m1J/Ctsd^m1J (C3HeB/FeJ-Ctsd^m1J/GrsrJ)	thymus atrophy	J:229377
Ctsd^tm1.1Thre/Ctsd^tm1.1Thre Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: C57BL/6 * C57BL/6N * CBA * SJL)	decreased double-positive T cell number	J:227618
	microgliosis	J:227618
	thymus atrophy	J:227618
Ctsd^tm1.1Thre/Ctsd^tm1.1Thre Tg(Nes-cre)1Kln/0 (involves: C57BL/6 * C57BL/6N * SJL)	abnormal thymus morphology	J:227618
	decreased double-positive T cell number	J:227618
	microgliosis	J:227618
Ctsd^tm1Cptr/Ctsd^tm1Cptr (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd))	abnormal microglial cell morphology	J:71688
	abnormal spleen B cell follicle morphology	J:28201
	abnormal spleen white pulp morphology	J:28201
	decreased double-positive T cell number	J:28201
	decreased lymphocyte cell number	J:28201
	thymus hypoplasia	J:28201
Ctse^tm1Kjy/Ctse^tm1Kjy (involves: C57BL/6)	increased double-positive T cell number	J:108745
Ctse^tm1Kjy/Ctse^tm1Kjy (involves: C57BL/6)	increased eosinophil cell number	J:108745
Ctsg^{tm2.1(PML/RARA)Ley}/Ctsg⁺ (involves: 129X1/SvJ * C57BL/6)	abnormal myelopoiesis	J:84230, J:86458
	enlarged spleen	J:84230
	increased leukocyte cell number	J:84230
Ctsg^{tm2.1(PML/RARA)Ley}/Ctsg⁺ (involves: 129 * 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:166479
	enlarged spleen	J:166479
	increased spleen weight	J:166479
Ctsg^{tm2.1(PML/RARA)Ley}/Ctsg⁺ Elane^tm1Sds/Elane^tm1Sds (involves: 129S/SvEv * 129X1/SvJ * C57BL/6)	abnormal myelopoiesis	J:86458
Ctsg^{tm3.1(PML/RARA)Ley}/Ctsg⁺ (involves: 129 * C57BL/6)	abnormal spleen morphology	J:166479
	enlarged spleen	J:166479
	increased spleen weight	J:166479
Ctsk^tm1(cre)Ska/Ctsk⁺ Esr1^tm1Mma/Esr1^tm1Mma (involves: 129S2/SvPas * C57BL/6 * SJL)	increased osteoclast cell number	J:127179
Ctsk^tm1(cre)Ska/Ctsk⁺ Plekhm1^tm1.1Hzhao/Plekhm1^tm1.1Hzhao (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)	abnormal osteoclast morphology	J:236517
Ctsk^tm1.1Rbar/Ctsk^tm1.1Rbar Tg(Itgam-cre)AJva/0 (involves: C57BL/6)	increased osteoclast cell number	J:194492
Ctsk^tm1.1Rbar/Ctsk^tm1.1Rbar Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal osteoclast differentiation	J:194492
	increased osteoclast cell number	J:194492
Ctsk^tm1Mbs/Ctsk^tm1Mbs (B6.129-Ctsk^tm1Mbs)	increased osteoclast cell number	J:128098
Ctsk^tm1Vuo/Ctsk^tm1Vuo (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal osteoclast morphology	J:95525
	increased osteoclast cell number	J:95525
Ctsk^tm1Ypl/Ctsk^tm1Ypl (B6.129S4-Ctsk^tm1Ypl)	increased osteoclast cell number	J:117870
Ctsk^tm1Ypl/Ctsk^tm1Ypl (129S4/SvJae-Ctsk^tm1Ypl)	increased osteoclast cell number	J:117870
Ctsl^m1Btlr/Ctsl^m1Btlr (C57BL/6J-Ctsl^m1Btlr)	abnormal CD4-positive T cell differentiation	J:272869
	abnormal CD8-positive, alpha beta T cell morphology	J:272869
	abnormal CD8-positive, alpha-beta T cell differentiation	J:272869
	abnormal T cell differentiation	J:272869
	decreased alpha-beta T cell number	J:272869
	decreased CD4-positive, alpha-beta T cell number	J:272869
	increased alpha-beta T cell number	J:272869
	increased CD8-positive, alpha-beta T cell number	J:272869
	increased central memory CD4-positive, alpha-beta T cell number	J:272869
	increased central memory CD8 positive, alpha-beta T cell number	J:272869
	increased effector memory CD4-positive, alpha-beta T cell number	J:272869
Ctsl^nkt/Ctsl^nkt (either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * DBA/2))	abnormal immune system organ morphology	J:54856
	decreased CD4-positive, alpha-beta T cell number	J:54856
	lymph node hyperplasia	J:54856
	thymus atrophy	J:54856
Ctsl^nkt/Ctsl^nkt (B6.Cg-Ctsl^nkt)	enlarged lymph nodes	J:78460
Ctsl^nkt/Ctsl^nkt (C.Cg-Ctsl^nkt)	abnormal immune system organ morphology	J:78460
	abnormal leukocyte cell number	J:99009
	abnormal lymph node cortex morphology	J:99009
	abnormal lymph node morphology	J:99009
	abnormal thymus corticomedullary boundary morphology	J:99009
	abnormal thymus lobule morphology	J:99009
	abnormal thymus morphology	J:99009
	decreased CD4-positive, alpha-beta T cell number	J:99009
	dilated lymph node medullary sinus	J:99009
	enlarged lymph nodes	J:78460, J:99009
	enlarged thymus cortex	J:99009
	increased CD8-positive, alpha-beta T cell number	J:99009
Ctsl^tm1.2Thre/Ctsl^tm1.2Thre (involves: C57BL/6 * C57BL/6N)	decreased CD4-positive, alpha-beta T cell number	J:216506
Ctsl^tm1Alpk/Ctsl^tm1Alpk (involves: 129P2/OlaHsd * C57BL/6)	decreased osteoclast cell number	J:99755
Ctsl^tm1Cptr/Ctsl^tm1Cptr (involves: 129P2/OlaHsd * C57BL/6J)	increased regulatory T cell number	J:153355
Ctsl^tm1Cptr/Ctsl^tm1Cptr (NOD.129P2-Ctsl^tm1Cptr)	decreased CD4-positive, alpha-beta T cell number	J:153355
Ctsl^tm1Cptr/Ctsl^tm1Cptr (NOD.129P2-Ctsl^tm1Cptr)	increased regulatory T cell number	J:153355
Ctsl^tm1Cptr/Ctsl^tm1Cptr (involves: 129P2/OlaHsd)	decreased CD4-positive, alpha-beta T cell number	J:216506
Ctsm^{tm1(KOMP)Wtsi}/Ctsm^{tm1(KOMP)Wtsi} (C57BL/6N-Ctsm^{tm1(KOMP)Wtsi}/Nju)	increased monocyte cell number	J:211773
Ctss^em1(IMPC)H/Ctss^em1(IMPC)H (C57BL/6NTac-Ctss^em1(IMPC)H/H)	decreased spleen weight	J:211773
Ctss^tm1Hap/Ctss^tm1Hap Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0 (involves: 129S2/SvPas * C57BL/6 * CBA)	increased lymphocyte cell number	J:100854
	increased macrophage cell number	J:100854
	increased neutrophil cell number	J:100854
Cttnbp2^{tm1b(KOMP)Wtsi}/Cttnbp2^{tm1b(KOMP)Wtsi} (C57BL/6N-Cttnbp2^{tm1b(KOMP)Wtsi}/Wtsi)	decreased transitional stage T1 B cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased plasma cell number	J:211773
Ctu2^{tm1(KOMP)Wtsi}/Ctu2⁺ (C57BL/6N-Ctu2^{tm1(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Cul4a/Pcid2^tm2Ktc/Cul4a/Pcid2^tm2Ktc Tg(Mx1-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)	abnormal leukocyte morphology	J:138468
	abnormal spleen capsule morphology	J:138468
	abnormal spleen morphology	J:138468
	decreased lymphocyte cell number	J:138468
	decreased monocyte cell number	J:138468
	decreased neutrophil cell number	J:138468
	decreased spleen red pulp amount	J:138468
	decreased spleen weight	J:138468
	decreased spleen white pulp amount	J:138468
	small thymus	J:138468
	spleen hypoplasia	J:138468
Cul4a/Pcid2^tm2Ktc/Cul4a/Pcid2^tm2Ktc Tg(Mx1-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)	abnormal leukocyte morphology	J:138468
	abnormal spleen capsule morphology	J:138468
	abnormal spleen morphology	J:138468
	decreased lymphocyte cell number	J:138468
	decreased monocyte cell number	J:138468
	decreased neutrophil cell number	J:138468
	decreased spleen red pulp amount	J:138468
	decreased spleen weight	J:138468
	decreased spleen white pulp amount	J:138468
	small thymus	J:138468
	spleen hypoplasia	J:138468
Cul5^{tm1.1(KOMP)Vlcg}/Cul5⁺ (C57BL/6N-Cul5^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Cul9^{em1(IMPC)Ccpcz}/Cul9^{em1(IMPC)Ccpcz} (C57BL/6N-Cul9^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Cux1^tm1Rhsc/Cux1^tm1Rhsc (involves: 129S1/Sv * C57BL/6J)	abnormal myelopoiesis	J:100055
	abnormal T cell differentiation	J:100055
	decreased B cell number	J:100055
	decreased double-positive T cell number	J:100055
	decreased thymocyte number	J:100055
	small thymus	J:100055
	thymus cortex hypoplasia	J:100055
	thymus hypoplasia	J:100055
Cwc22^em1(IMPC)Mbp/Cwc22⁺ (C57BL/6NCrl-Cwc22^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
Cx3cl1^tm1Lira/Cx3cl1^tm1Lira (involves: C57BL/6)	decreased monocyte cell number	J:145036
Cx3cr1^tm1Litt/Cx3cr1⁺ (B6.129P2-Cx3cr1^tm1Litt)	microgliosis	J:110266
Cx3cr1^tm1Litt/Cx3cr1⁺ Psen1^tm1Mpm/Psen1^tm1Mpm Tg(APPSwe,tauP301L)1Lfa/0 Tg(Thy1-YFP)HJrs/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal microglial cell morphology	J:159680
Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (involves: 129P2/OlaHsd * C57BL/6)	decreased monocyte cell number	J:145036
Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (involves: 129P2/OlaHsd)	increased dendritic cell number	J:210086
Cx3cr1^tm1Litt/Cx3cr1^tm1Litt (B6.129P2-Cx3cr1^tm1Litt)	abnormal microglial cell morphology	J:265696
	decreased NK cell number	J:129712
	microgliosis	J:110266
Cx3cr1^{tm2.1(cre/ERT2)Litt}/Cx3cr1⁺ Vps35^{Gt(RRK261)Byg}/Vps35^{Gt(RRK261)Byg} (involves: 129P2/OlaHsd * C57BL/6)	increased macrophage cell number	J:292365
	microgliosis	J:292365
Cxadr^em1(IMPC)Mbp/Cxadr⁺ (C57BL/6N-Cxadr^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Cxadr^tm1.1Ics/Cxadr^tm1.1Ics Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S2/SvPas C57BL/6 * C57BL/6J * CBA)	enlarged thymus	J:174138
	increased thymocyte number	J:174138
Cxcl1^em1(IMPC)Mbp/Cxcl1^em1(IMPC)Mbp (C57BL/6N-Cxcl1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
	increased monocyte cell number	J:211773
Cxcl5^tm1.1Mkch/Cxcl5^tm1.1Mkch (B6.129P2-Cxcl5^tm1.1Mkch)	decreased neutrophil cell number	J:208901
Cxcl5^tm1Gscw/Cxcl5^tm1Gscw (involves: 129)	increased granulocyte number	J:162629
Cxcl9^{tm1b(EUCOMM)Wtsi}/Cxcl9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cxcl9^{tm1b(EUCOMM)Wtsi}/H)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Cxcl10^tm1Adl/Cxcl10^tm1Adl (involves: 129S4/SvJae * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:75584
Cxcl11^em1Groj/Cxcl11^em1Groj (C57BL/6J-Cxcl11^em1Groj)	abnormal B cell morphology	J:345391
Cxcl11^em1Groj/Cxcl11^em1Groj (C57BL/6J-Cxcl11^em1Groj)	increased CD8-positive, alpha-beta T cell number	J:345391
Cxcl12^tm1.1Sjm/Cxcl12^tm1.1Sjm Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/? (involves: 129S/SvEv * C57BL/6)	decreased leukocyte cell number	J:194748
	decreased lymphocyte cell number	J:194748
Cxcl12^tm1.1Sjm/Cxcl12^tm1.1Sjm Tg(Prrx1-cre)1Cjt/? (involves: C57BL/6 * SJL/J)	abnormal B cell differentiation	J:194748
Cxcl12^tm1.1Ystz/Cxcl12^tm1.2Ystz Tg(CAG-cre/Esr1)5Amc/0 (involves: 129X1/SvJ C57BL/6 * CBA * FVB/N)	decreased pro-B cell number	J:168434
	increased neutrophil cell number	J:168434
Cxcl12^tm1Tng/Cxcl12^tm1.1Link Tg(BGLAP-cre)1Clem/0 (involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac * FVB/N)	decreased B cell number	J:193594
Cxcl12^tm1Tng/Cxcl12^tm1.1Link Tg(Prrx1-cre)1Cjt/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL/J)	decreased B cell number	J:193594
	decreased pre-pro B cell number	J:193594
Cxcl12^tm1Tng/Cxcl12^tm1.1Link Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129P2/OlaHsd * C57BL/6 * CD-1 * FVB/N)	decreased B cell number	J:193594
	decreased pre-pro B cell number	J:193594
Cxcl12^tm1Tng/Cxcl12^tm1Tng (involves: 129P2/OlaHsd)	decreased pre-B cell number	J:34750
	decreased pro-B cell number	J:34750
	impaired myelopoiesis	J:49070
Cxcl12^{tm3.1(HBEGF/EGFP)Tng}/Cxcl12⁺ (B6.Cg-Cxcl12^{tm3.1(HBEGF/EGFP)Tng})	decreased pro-B cell number	J:164657
Cxcl13^em2(IMPC)H/Cxcl13^em2(IMPC)H (C57BL/6NTac-Cxcl13^em2(IMPC)H/H)	increased basophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Cxcl13^m1Btlr/Cxcl13^m1Btlr (C57BL/6J-Cxcl13^m1Btlr)	increased B-1 B cell number	J:221480
Cxcl13^tm1Cys/Cxcl13^tm1Cys (involves: 129X1/SvJ * C57BL/6)	abnormal lymph node germinal center morphology	J:78282
	abnormal Peyer's patch morphology	J:78282
	abnormal spleen B cell follicle morphology	J:78282
	abnormal spleen marginal zone morphology	J:78282
	absent axillary lymph nodes	J:78282
	absent brachial lymph nodes	J:78282
	absent follicular dendritic cells	J:78282
	absent inguinal lymph nodes	J:78282
	decreased lymph node number	J:78282
	decreased Peyer's patch number	J:78282
	decreased spleen germinal center size	J:78282
	small Peyer's patches	J:78282
Cxcl14^tm1Tha/Cxcl14^tm1Tha (involves: C57BL/6 * CBA)	decreased macrophage cell number	J:126841
Cxcl15^tm1Lira/Cxcl15^tm1Lira (involves: 129 * C57BL/6J)	decreased neutrophil cell number	J:67605
Cxcl16^tm1Syon/Cxcl16^tm1Syon (B6.129P2-Cxcl16^tm1Syon)	decreased NK T cell number	J:155199
Cxcr2^{tm1(IL8RB)Dktr}/Cxcr2^{tm1(IL8RB)Dktr} (involves: 129S2/SvPas * C57BL/6)	decreased spleen weight	J:113489
	increased granulocyte number	J:113489
	increased leukocyte cell number	J:113489
Cxcr2^{tm1a(EUCOMM)Wtsi}/Cxcr2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cxcr2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased B cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased immature B cell number	J:211773
	decreased mature B cell number	J:211773
	decreased pre-B cell number	J:211773
	decreased pre-pro B cell number	J:211773
	decreased T cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD8-positive, alpha-beta memory T cell number	J:211773
	increased CD103-positive CD11b-low dendritic cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased eosinophil cell number	J:211773
	increased gamma-delta T cell number	J:211773
	increased granulocyte number	J:211773
	increased KLRG1+ CD4 alpha-beta T cell number	J:211773
	increased KLRG1+ CD8 alpha-beta T cell number	J:211773
	increased leukocyte cell number	J:211773
	increased Ly6C high monocyte number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased memory-marker CD4-positive NK T cell number	J:211773
	increased memory-marker gamma-delta T cell number	J:211773
	increased memory-marker NK cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Cxcr2^tm1Mwm/Cxcr2^tm1Mwm (involves: 129S2/SvPas * C57BL/6J)	abnormal granulocyte differentiation	J:19570
	abnormal myelopoiesis	J:19570
	abnormal spleen white pulp morphology	J:19570
	enlarged cervical lymph nodes	J:19570
	enlarged lymph nodes	J:19570
	enlarged spleen	J:19570
	increased B cell number	J:19570
	increased neutrophil cell number	J:19570
	lymph node medullary cord hyperplasia	J:19570
	myeloid hyperplasia	J:19570
Cxcr2^tm1Mwm/Cxcr2^tm1Mwm (involves: 129S2/SvPas * BALB/c)	abnormal myelopoiesis	J:113489
	decreased thymus weight	J:113489
	increased granulocyte number	J:113489
	increased spleen weight	J:113489
Cxcr4^em1(IMPC)Mbp/Cxcr4⁺ (C57BL/6NCrl-Cxcr4^em1(IMPC)Mbp/MbpMmucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Cxcr4^tm1.1Bala/Cxcr4⁺ (B6.129S2-Cxcr4^tm1.1Bala)	abnormal CD4-positive, alpha-beta T cell number	J:186735
	abnormal immune system cell morphology	J:186735
	abnormal immune system morphology	J:186735
	abnormal immune system organ morphology	J:186735
	abnormal lymph node B cell domain morphology	J:186735
	abnormal lymph node morphology	J:186735
	abnormal neutrophil morphology	J:186735
	abnormal spleen morphology	J:186735
	abnormal spleen white pulp morphology	J:186735
	abnormal thymus morphology	J:186735
	decreased B cell number	J:186735
	decreased immature B cell number	J:186735
	decreased leukocyte cell number	J:186735
	decreased NK cell number	J:178789
	decreased spleen weight	J:186735
	decreased T cell number	J:186735
	increased mature B cell number	J:186735
	increased NK cell number	J:178789
Cxcr4^tm1Qma/Cxcr4^tm1Qma (involves: 129X1/SvJ)	decreased pro-B cell number	J:49070
Cxcr4^tm1Qma/Cxcr4^tm1Qma (involves: 129X1/SvJ)	impaired myelopoiesis	J:49070
Cxcr4^tm1Tng/Cxcr4^tm1Tng (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:69256
Cxcr4^tm1Tng/Cxcr4^tm1Tng (involves: 129P2/OlaHsd)	failure of myelopoiesis	J:69256
Cxcr4^tm1Tng/Cxcr4^tm1Tng (B6.Cg-Cxcr4^tm1Tng)	abnormal T cell differentiation	J:82996
Cxcr4^tm1Tng/Cxcr4^tm1Tng (B6.Cg-Cxcr4^tm1Tng)	decreased double-positive T cell number	J:82996
Cxcr4^tm1Yiw/Cxcr4^tm1Yiw Tg(Lck-cre)1Jtak/0 (involves: 129P2/OlaHsd)	decreased thymocyte number	J:164872
Cxcr4^tm1Yzo/Cxcr4^tm1Yzo (Not Specified)	abnormal B cell differentiation	J:167314
	abnormal leukopoiesis	J:69255
	abnormal lymphopoiesis	J:69255
	impaired myelopoiesis	J:69255
Cxcr4^tm2Yzo/Cxcr4^tm2Yzo Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:94911
	abnormal Peyer's patch follicle morphology	J:94911
	decreased B-1 B cell number	J:94911
	decreased B-2 B cell number	J:94911
	decreased mature B cell number	J:94911
	decreased plasma cell number	J:94911
Cxcr4^tm2Yzo/Cxcr4^tm2Yzo Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased lymphocyte cell number	J:217569
	increased monocyte cell number	J:217569
	increased neutrophil cell number	J:217569
Cxcr4^tm2Yzo/Cxcr4^tm2Yzo Tg(Fabp4-cre)1Rev/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage cell number	J:217569
	decreased B cell number	J:217569
	decreased CD4-positive, alpha-beta T cell number	J:217569
	increased CD8-positive, alpha-beta T cell number	J:217569
Cxcr4^tm2Yzo/Cxcr4^tm3.1Yzo Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:167314
Cxcr4^tm3.1Yzo/Cxcr4^tm3.1Yzo (Not Specified)	decreased pro-B cell number	J:167314
Cxcr4^tm3.1Yzo/Cxcr4^tm3.1Yzo (Not Specified)	impaired myelopoiesis	J:167314
Cxcr5^tm1.1Namt/Cxcr5^tm1.1Namt Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6 * C57BL/6J * CBA)	decreased follicular dendritic cell number	J:241561
Cxcr5^tm1Lipp/Cxcr5^tm1Lipp (involves: 129S2/SvPas * CD-1)	abnormal Peyer's patch morphology	J:37126
	abnormal spleen primary B follicle morphology	J:37126
	abnormal spleen secondary B follicle morphology	J:37126
	absent axillary lymph nodes	J:78282
	absent brachial lymph nodes	J:78282
	absent cervical lymph nodes	J:78282
	absent follicular dendritic cells	J:78282
	absent inguinal lymph nodes	J:78282, J:37126
	absent lymph nodes	J:78282
	absent Peyer's patches	J:37126
	absent spleen germinal center	J:37126
	increased B cell number	J:37126
Cyb5d1^{tm1.1(KOMP)Vlcg}/Cyb5d1^{tm1.1(KOMP)Vlcg} (B6N(Cg)-Cyb5d1^{tm1.1(KOMP)Vlcg}/J)	increased leukocyte cell number	J:211773
Cyb5r3^{tm1c(KOMP)Wtsi}/Cyb5r3^{tm1c(KOMP)Wtsi} Tg(Myh11-icre/ERT2)1Soff/0 (B6.Cg-Cyb5r3^{tm1c(KOMP)Wtsi} Tg(Myh11-icre/ERT2)1Soff)	decreased monocyte cell number	J:280543
Cyb561d2^{tm1b(EUCOMM)Wtsi}/Cyb561d2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cyb561d2^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Cyba^{tm1a(EUCOMM)Wtsi}/Cyba^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Cyba^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Cybb^tm1.1Abk/Cybb^tm1.1Abk Lyz2^tm1(cre)Ifo/? (B6.Cg-Lyz2^tm1(cre)Ifo Cybb^tm1.1Abk)	enlarged spleen	J:245699
Cybb^tm1Din/Cybb^tm1Din (B6.129S-Cybb^tm1Din/J)	increased lymphocyte cell number	J:235399
	increased monocyte cell number	J:235399
	increased neutrophil cell number	J:235399
Cybb^{tm2b(KOMP)Wtsi}/Cybb^{tm2b(KOMP)Wtsi} (C57BL/6N-Cybb^{tm2b(KOMP)Wtsi}/H)	increased spleen weight	J:211773
Cycs^tm1Mak/Cycs^tm1Mak (involves: C57BL/6)	absent pre-B cells	J:98949
	decreased B cell number	J:98949
	decreased leukocyte cell number	J:98949
	decreased T cell number	J:98949
	increased spleen weight	J:98949
	spleen hyperplasia	J:98949
	thymus atrophy	J:98949
	thymus hypoplasia	J:98949
Cyld^tm1.1Awai/Cyld^tm1.1Awai (Not Specified)	abnormal B cell differentiation	J:126113
	abnormal B cell morphology	J:126113
	abnormal class switch recombination	J:126113
	abnormal Peyer's patch germinal center morphology	J:126113
	abnormal spleen marginal zone morphology	J:126113
	abnormal spleen morphology	J:126113
	decreased B-1 B cell number	J:126113
	decreased immature B cell number	J:126113
	enlarged lymph nodes	J:126113
	enlarged Peyer's patches	J:126113
	enlarged spleen	J:126113
	increased B cell number	J:126113
	increased follicular B cell number	J:126113
	increased marginal zone B cell number	J:126113
	increased pro-B cell number	J:126113
Cyld^tm1Awai/Cyld^tm1Awai Tg(CD19-cre/ERT2)1Cgn/? (Not Specified)	abnormal mature B cell morphology	J:126113
	decreased B-1 B cell number	J:126113
	decreased immature B cell number	J:126113
	enlarged lymph nodes	J:126113
	enlarged Peyer's patches	J:126113
	enlarged spleen	J:126113
	increased B cell number	J:126113
Cyld^tm1Lex/Cyld^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	thymus hyperplasia	J:114972
Cyld^tm1Scs/Cyld^tm1Scs (involves: 129S1/Sv * 129X1/SvJ)	abnormal B cell differentiation	J:112392
	abnormal T cell number	J:112392
	decreased CD4-positive, alpha-beta T cell number	J:112392
	decreased CD8-positive, alpha-beta T cell number	J:112392
	increased double-positive T cell number	J:112392
Cyp1a1^tm1.1Dwn/Cyp1a1^tm1.1Dwn (B6.129P2-Cyp1a1^tm1.1Dwn)	decreased lymphocyte cell number	J:163973
	decreased spleen weight	J:163973
	decreased thymus weight	J:163973
	increased neutrophil cell number	J:163973
Cyp1a1^tm1.1Dwn/Cyp1a1^tm1.1Dwn (involves: 129P2/OlaHsd * C57BL/6)	decreased leukocyte cell number	J:122409
	small spleen	J:122409
	small thymus	J:122409
Cyp1a1^tm4.1Dwn/Cyp1a1^tm4.1Dwn (B6.129X1-Cyp1a1^tm4.1Dwn)	decreased lymphocyte cell number	J:163973
	decreased spleen weight	J:163973
	decreased thymus weight	J:163973
	increased neutrophil cell number	J:163973
Cyp1a^tm1Dwn/Cyp1a^tm1Dwn (B6.129-Cyp1a^tm1Dwn)	decreased leukocyte cell number	J:122409
	small spleen	J:122409
	small thymus	J:122409
Cyp2ab1^{tm1b(KOMP)Wtsi}/Cyp2ab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Cyp2ab1^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Cyp2c70^em1Sjka/Cyp2c70^em1Sjka (C57BL/6-Cyp2c70^em1Sjka)	increased spleen weight	J:330641
Cyp2d22^em1(IMPC)Tcp/Cyp2d22^em1(IMPC)Tcp (C57BL/6NCrl-Cyp2d22^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Cyp2f2^em1(IMPC)H/Cyp2f2^em1(IMPC)H (C57BL/6N-Cyp2f2^em1(IMPC)H/H)	enlarged spleen	J:211773
Cyp2g1^{tm1(rtTA)Lane}/Cyp2g1⁺ Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0 (involves: 129 * C57BL/6 * SJL)	increased macrophage cell number	J:157842
Cyp7a1^{tm1b(EUCOMM)Wtsi}/Cyp7a1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Cyp7a1^{tm1b(EUCOMM)Wtsi}/Ieg)	increased leukocyte cell number	J:211773
Cyp11b1^tm1Chjk/Cyp11b1^tm1Chjk (involves: 129P2/OlaHsd * C57BL/6J)	decreased thymus weight	J:147610
Cyp19a1^{tm1b(EUCOMM)Hmgu}/Cyp19a1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cyp19a1^{tm1b(EUCOMM)Hmgu}/H)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Cyp19a1^tm1Esi/Cyp19a1^tm1Esi (involves: 129S6/SvEvTac * C57BL/6)	abnormal spleen germinal center morphology	J:92438
	enlarged mesenteric lymph nodes	J:92438
	enlarged spleen	J:92438
	increased B cell number	J:92438
	increased granulocyte number	J:92438
	increased leukocyte cell number	J:92438
	increased lymphocyte cell number	J:92438
	increased mature B cell number	J:92438
	spleen hyperplasia	J:92438
Cyp19a1^tm1Sih/Cyp19a1^tm1Sih (involves: 129S/SvEv)	increased dendritic cell number	J:216958
Cyp19a1^tm1Sih/Cyp19a1^tm1Sih (involves: 129S/SvEv)	increased macrophage cell number	J:216958
Cyp19a1^tm1Toda/Cyp19a1^tm1Toda (involves: 129P2/OlaHsd * C57BL/6J)	increased osteoclast cell number	J:114305
Cyp21a1^em1(IMPC)Tcp/Cyp21a1⁺ (C57BL/6NCrl-Cyp21a1^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Cyp26b1^tm1Hmd/Cyp26b1^tm1Hmd (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphatic vessel endothelial cell morphology	J:206581
Cyp26b1^tm1Hmd/Cyp26b1^tm1Hmd Tg(Prox1-EGFP)KY221Gsat/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/NTac)	abnormal lymphatic vessel endothelial cell morphology	J:206581
	abnormal lymphatic vessel morphology	J:206581
Cyp27b1^{tm1b(EUCOMM)Hmgu}/Cyp27b1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cyp27b1^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Cyp27b1^tm1Dgo/Cyp27b1^tm1Dgo (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	decreased osteoclast cell number	J:70030
	decreased T cell number	J:70030
	enlarged lymph nodes	J:70030
Cyp51^tm1.1Bfro/Cyp51^tm1.1Bfro (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphatic vessel morphology	J:173366
	abnormal lymphatic vessel smooth muscle morphology	J:173366
Cyren^em1Vokh/Cyren^em1Vokh (C57BL/6-Cyren^em1Vokh)	abnormal class switch recombination	J:306598
Cyren^{tm1.1(KOMP)Vlcg}/Cyren^{tm1.1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal class switch recombination	J:265834
Cyrib^m1Ivdi/Cyrib^m1Ivdi (involves: 129S1/Sv * 129X1/SvJ * DBA/2J)	abnormal spleen morphology	J:282597
	abnormal spleen white pulp morphology	J:282597
	increased neutrophil cell number	J:282597
Cys1^cpk/Cys1^cpk (involves: C57BL/6J * CD-1)	spleen hypoplasia	J:33739
Cys1^cpk/Cys1^cpk (involves: C57BL/6J * CD-1)	thymus hypoplasia	J:33739
Cystm1^{tm1b(EUCOMM)Hmgu}/Cystm1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Cystm1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Cyth2^{tm1d(EUCOMM)Wtsi}/Cyth2^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased eosinophil cell number	J:307633
Cytip^tm1Tes/Cytip^tm1Tes (involves: 129S1/Sv * FVB/N)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:110320
	decreased leukocyte cell number	J:110320
	decreased lymphocyte cell number	J:110320
	lymph node hypoplasia	J:110320
D6Wsu163e^{tm1b(EUCOMM)Wtsi}/D6Wsu163e^{tm1b(EUCOMM)Wtsi} (C57BL/6N-D6Wsu163e^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased memory-marker NK cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
D630045J12Rik^{tm1b(KOMP)Wtsi}/D630045J12Rik^{tm1b(KOMP)Wtsi} (C57BL/6N-D630045J12Rik^{tm1b(KOMP)Wtsi}/Tcp)	enlarged lymph nodes	J:211773
Daam2^{tm1b(KOMP)Wtsi}/Daam2^{tm1b(KOMP)Wtsi} (C57BL/6N-Daam2^{tm1b(KOMP)Wtsi}/Wtsi)	increased large unstained cell number	J:211773
Dab1^scm-4J/Dab1^scm-4J (CBA/J-Dab1^scm-4J/GrsrJ)	thymus atrophy	J:153275
Dach2^{em1(IMPC)Ccpcz}/Dach2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Dach2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased eosinophil cell number	J:211773
	small lymph nodes	J:211773
	small spleen	J:211773
Dact2^{tm1b(EUCOMM)Wtsi}/Dact2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dact2^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Dad1^tm1Kni/Dad1⁺ (involves: 129S/SvEv)	decreased thymus weight	J:99897
Dagla^{tm1a(EUCOMM)Wtsi}/Dagla^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Dagla^{tm1a(EUCOMM)Wtsi}/Nju)	small spleen	J:211773
	small thymus	J:211773
Dapp1^tm1Mnz/Dapp1^tm1Mnz (B6.129P2-Dapp1^tm1Mnz)	decreased B-1a cell number	J:86182
Daw1^b2b1116Clo/Daw1^b2b1116Clo (C57BL/6J-Daw1^b2b1116Clo)	spleen hypoplasia	J:175213
Daw1^b2b1584Clo/Daw1^b2b1584Clo (C57BL/6J-Daw1^b2b1584Clo)	absent spleen	J:175213
Dazap1^{em1(IMPC)Ccpcz}/Dazap1⁺ (C57BL/6NCrl-Dazap1^{em1(IMPC)Ccpcz}/Ccpcz)	increased eosinophil cell number	J:211773
Dbn1^{tm1a(KOMP)Wtsi}/Dbn1⁺ (C57BL/6N-Dbn1^{tm1a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Dbn1^{tm1b(KOMP)Wtsi}/Dbn1⁺ (C57BL/6N-Dbn1^{tm1b(KOMP)Wtsi}/Wtsi)	increased CD8-positive, alpha-beta T cell number	J:211773
Dbnl^tm1Jwnd/Dbnl⁺ (involves: BALB/c)	increased spleen weight	J:109363
Dbnl^tm1Jwnd/Dbnl^tm1Jwnd (involves: BALB/c)	increased spleen weight	J:109363
Dbr1^{Gt(YTA280)Byg}/Dbr1⁺ (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:223318
Dcaf5^{em1(IMPC)Ccpcz}/Dcaf5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Dcaf5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased NK cell number	J:211773
	increased spleen weight	J:211773
	small spleen	J:211773
Dcaf8^{em1(IMPC)Ccpcz}/Dcaf8^{em1(IMPC)Ccpcz} (C57BL/6N-Dcaf8^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Dcaf12^{em1(IMPC)Ccpcz}/Dcaf12^{em1(IMPC)Ccpcz} (C57BL/6N-Dcaf12^{em1(IMPC)Ccpcz}/Ccpcz)	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased neutrophil cell number	J:211773
Dcaf15^{tm1a(EUCOMM)Hmgu}/Dcaf15^{tm1a(EUCOMM)Hmgu} (C57BL/6NCrl-Dcaf15^{tm1a(EUCOMM)Hmgu}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased spleen weight	J:211773
	enlarged thymus	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased NK cell number	J:211773
	increased T cell number	J:211773
	increased T-helper cell number	J:211773
Dcc^{Tg(H2-Kb-Jak2V617F)1Shmd}/Dcc⁺ (involves: C57BL/6 DBA/2)	abnormal neutrophil morphology	J:130189
	abnormal spleen morphology	J:130189
	decreased spleen white pulp amount	J:130189
	enlarged spleen	J:130189
	increased granulocyte number	J:130189
	increased leukocyte cell number	J:130189
	increased spleen red pulp amount	J:130189
	increased spleen weight	J:130189
	myeloid hyperplasia	J:130189
Dcc^{tm1b(NCOM)Mfgc}/Dcc⁺ (C57BL/6N-Dcc^{tm1b(NCOM)Mfgc}/Tcp)	increased neutrophil cell number	J:211773
Dck^m1Btlr/Dck⁺ (C57BL/6J-Dck^m1Btlr)	decreased B cell number	J:236696
Dck^m1Btlr/Dck^m1Btlr (C57BL/6J-Dck^m1Btlr)	decreased B cell number	J:236696
	decreased CD4-positive, alpha-beta T cell number	J:236696
	increased CD8-positive, alpha-beta T cell number	J:236696
	increased macrophage cell number	J:236696
Dck^memi/Dck^memi (C57BL/6J-Dck^memi)	abnormal myeloid leukocyte morphology	J:184080
	abnormal T cell differentiation	J:184080
	decreased B cell number	J:184080
	decreased CD4-positive, alpha-beta T cell number	J:184080
	enlarged spleen	J:184080
	increased effector memory CD4-positive, alpha-beta T cell number	J:184080
	increased effector memory CD8-positive, alpha-beta T cell number	J:184080
	small thymus	J:184080
	thymus hypoplasia	J:184080
Dck^tm1.1Radu/Dck^tm1.1Radu (involves: 129S4/SvJae * BALB/cJ * C57BL/6 * C57BL/6J)	abnormal double-negative T cell morphology	J:158373
	abnormal peripheral lymph node morphology	J:158373
	abnormal spleen morphology	J:158373
	abnormal T cell differentiation	J:158373
	abnormal thymus morphology	J:158373
	absent spleen white pulp	J:158373
	decreased B cell number	J:158373
	decreased double-positive T cell number	J:158373
	decreased pre-B cell number	J:158373
	decreased T cell number	J:158373
	increased double-negative T cell number	J:158373
	increased pro-B cell number	J:158373
	increased spleen weight	J:158373
	thymus hypoplasia	J:158373
Dclre1a^tm1Rleg/Dclre1a^tm1Rleg Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * 129S7/SvEvBrd)	increased T cell derived lymphoma incidence	J:102381
Dclre1c^m1Brck/Dclre1c^m1Brck (involves: C3H * C57BL/6)	absent B cells	J:207533
Dclre1c^m1Brck/Dclre1c^m1Brck (involves: C3H * C57BL/6)	absent T cells	J:207533
Dclre1c^m1Brck/Dclre1c^m1Brck (involves: C57BL/6)	absent B cells	J:207533
	absent CD4-positive, alpha-beta T cells	J:207533
	absent CD8-positive, alpha-beta T cells	J:207533
	decreased DN1 thymic pro-T cell number	J:207533
	decreased DN4 thymocyte number	J:207533
	decreased double-positive T cell number	J:207533
	decreased pre-B cell number	J:207533
Dclre1c^m1Btlr/Dclre1c^m1Btlr (C57BL/6J-Dclre1c^m1Btlr)	decreased B cell number	J:217790
	decreased single-positive T cell number	J:217790
	decreased T cell number	J:217790
	increased macrophage cell number	J:217790
	increased neutrophil cell number	J:217790
	increased NK cell number	J:217790
Dclre1c^M2Btlr/Dclre1c^M2Btlr (C57BL/6J-Dclre1c^M2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265131
	decreased CD8-positive, naive alpha-beta T cell number	J:265131
	decreased single-positive T cell number	J:265131
	decreased T cell number	J:265131
	increased central memory CD8 positive, alpha-beta T cell number	J:265131
	increased effector memory CD4-positive, alpha-beta T cell number	J:265131
	increased effector memory CD8-positive, alpha-beta T cell number	J:265131
Dclre1c^m3Btlr/Dclre1c^m3Btlr (C57BL/6J-Dclre1c^m3Btlr)	decreased B cell number	J:265132
	decreased B-1 B cell number	J:265132
	decreased CD4-positive, alpha-beta T cell number	J:265132
	decreased CD8-positive, alpha-beta T cell number	J:265132
	decreased CD8-positive, naive alpha-beta T cell number	J:265132
	decreased NK T cell number	J:265132
	decreased single-positive T cell number	J:265132
	decreased T cell number	J:265132
	increased central memory CD4-positive, alpha-beta T cell number	J:265132
	increased effector memory CD4-positive, alpha-beta T cell number	J:265132
	increased effector memory CD8-positive, alpha-beta T cell number	J:265132
Dclre1c^tm1.1Fwa/Dclre1c^tm1.1Fwa (involves: 129S6/SvEvTac * C57BL/6)	arrested B cell differentiation	J:80995
	arrested T cell differentiation	J:80995
Dclre1c^tm1.1Jpdv/Dclre1c^tm1.1Jpdv (involves: 129P1/ReJ)	abnormal B cell differentiation	J:137743
	abnormal T cell receptor V(D)J recombination	J:194422
	arrested T cell differentiation	J:137712
Dclre1c^tm1Fwa/Dclre1c^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6)	absent immature B cells	J:80995
	arrested B cell differentiation	J:80995
	arrested T cell differentiation	J:80995
	decreased thymocyte number	J:80995
Dclre1c^tm1Fwa/Dclre1c^tm1Fwa (involves: 129S6/SvEvTac)	abnormal T cell receptor beta chain V(D)J recombination	J:147864
	absent B cells	J:147864
	arrested B cell differentiation	J:147864
	decreased CD4-positive, alpha-beta T cell number	J:147864
	decreased CD8-positive, alpha-beta T cell number	J:147864
	decreased double-positive T cell number	J:147864
	decreased thymocyte number	J:147864
	spleen hypoplasia	J:147864
Dclre1c^tm1Jsek/Dclre1c^tm1Jsek (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immunoglobulin heavy chain V(D)J recombination	J:147864
	abnormal T cell receptor beta chain V(D)J recombination	J:147864
	decreased B cell number	J:147864
	decreased CD4-positive, alpha-beta T cell number	J:147864
	decreased CD8-positive, alpha-beta T cell number	J:147864
	decreased double-positive T cell number	J:147864
	decreased pre-B cell number	J:147864
	decreased thymocyte number	J:147864
	increased pro-B cell number	J:147864
	spleen hypoplasia	J:147864
Dclre1c^tm2.1Jpdv/Dclre1c^tm2.2Jpdv Tg(Cr2-cre)3Cgn/0 (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:153841
Dclre1c^tm2.2Jpdv/Dclre1c^tm2.2Jpdv (B6.129S2-Dclre1c^tm2.2Jpdv)	abnormal mononuclear cell morphology	J:153841
	absent immature B cells	J:153841
	arrested B cell differentiation	J:153841
	arrested T cell differentiation	J:153841
	decreased CD4-positive, alpha-beta T cell number	J:153841
	decreased CD8-positive, alpha-beta T cell number	J:153841
	decreased double-positive T cell number	J:153841
	decreased mature B cell number	J:153841
	decreased splenocyte number	J:153841
	decreased thymocyte number	J:153841
Dclre1c^tm2Mcow/Dclre1c^tm2Mcow (involves: 129/Sv * C57BL/6)	abnormal lymph node morphology	J:96535
	abnormal spleen B cell follicle morphology	J:96535
	absent thymus cortex	J:96535
	arrested B cell differentiation	J:96535
	arrested T cell differentiation	J:96535
	decreased lymphocyte cell number	J:96535
	decreased thymocyte number	J:96535
	decreased thymus weight	J:96535
	small lymph nodes	J:96535
	small spleen	J:96535
Dcn^tm1Ioz/Dcn⁺ Trp53^tm1Brd/Trp53^tm1Brd (involves: 129/Sv * Black Swiss * C57BL/6)	increased T cell derived lymphoma incidence	J:53511
Dcn^tm1Ioz/Dcn^tm1Ioz Trp53^tm1Brd/Trp53^tm1Brd (involves: 129/Sv * Black Swiss * C57BL/6)	enlarged thymus	J:53511
	increased T cell derived lymphoma incidence	J:53511
	thymus hyperplasia	J:53511
Dcstamp^tm1Suda/Dcstamp^tm1Suda (Not Specified)	abnormal osteoclast differentiation	J:100555
Dctn1^tm2.1Cai/Dctn1^tm2.1Cai Tg(Thy1-cre)1Vln/? (involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB/N)	microgliosis	J:264431
Dcun1d1^{Gt(RRR261)Byg}/Dcun1d1^{Gt(RRR261)Byg} (involves: 129P2/OlaHsd)	lymphoid hypoplasia	J:262901
	spleen hypoplasia	J:262901
Ddb1^{em1(IMPC)Ccpcz}/Ddb1⁺ (C57BL/6N-Ddb1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ddit3^tm2.1Dron/Ddit3^tm2.1Dron (B6.129S(Cg)-Ddit3^tm2.1Dron/J)	abnormal T cell morphology	J:214136
Ddost^{tm1.1(KOMP)Vlcg}/Ddost⁺ (C57BL/6N-Ddost^{tm1.1(KOMP)Vlcg}/Ucd)	enlarged lymph nodes	J:211773
	small spleen	J:211773
Ddr1^tm1Wfv/Ddr1^tm1Wfv Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)	decreased macrophage cell number	J:149015
Ddrgk1^{tm1c(EUCOMM)Hmgu}/Ddrgk1^{tm1c(EUCOMM)Hmgu} Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/6N)	decreased granulocyte number	J:231701
	decreased lymphocyte cell number	J:231701
	decreased monocyte cell number	J:231701
Ddx23^{em1(IMPC)Wtsi}/Ddx23⁺ (C57BL/6N-Ddx23^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Ddx46^em1(IMPC)Tcp/Ddx46⁺ (C57BL/6N-Ddx46^em1(IMPC)Tcp/Cmmr)	enlarged lymph nodes	J:211773
Ddx52^{tm1a(EUCOMM)Wtsi}/Ddx52⁺ (C57BL/6N-Ddx52^{tm1a(EUCOMM)Wtsi}/Ics)	decreased NK cell number	J:165965
Dedd^tm1Tmiy/Dedd^tm1Tmiy (B6.Cg-Dedd^tm1Tmiy)	decreased spleen weight	J:119734
Def6^{Gt(OST307148)Lex}/Def6^{Gt(OST307148)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal spleen germinal center morphology	J:106469
	enlarged lymph nodes	J:106469
	enlarged spleen	J:106469
	increased immature B cell number	J:106469
	increased memory T cell number	J:106469
	increased T cell number	J:106469
Defb3^tm1Xen/Defb3^tm1Xen (involves: C57BL/6)	increased neutrophil cell number	J:199719
Del(1)1Brk/Del(1)1Brk (involves: 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal spleen morphology	J:100202
	abnormal spleen white pulp morphology	J:100202
	enlarged spleen	J:100202
	increased leukocyte cell number	J:100202
	increased spleen red pulp amount	J:100202
Del(2Duoxa2-Duoxa1)1Sref/Del(2Duoxa2-Duoxa1)1Sref (involves: 129S6/SvEvTac * C57BL/6J)	decreased spleen weight	J:205165
Del(3Bglap2-Bglap)2Kry/Del(3Bglap2-Bglap)2Kry (involves: 129S7/SvEvBrd * C57BL/6)	increased osteoclast cell number	J:34440
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw (involves: 129S4/SvJae * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:174337
	decreased NK T cell number	J:112657, J:174337, J:39749, J:76976
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw Tcra^Ln1Ogu/Tcra⁺ (involves: 129/Sv * C57BL/6)	abnormal NK T cell morphology	J:152041
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw Tg(TcraAV19AJ33)1Shima/0 (involves: 129S4/SvJae * C57BL/6)	abnormal NK T cell morphology	J:112657
Del(3Cd1d2-Cd1d1)1Sbp/Del(3Cd1d2-Cd1d1)1Sbp (involves: 129S6/SvEvTac)	decreased NK T cell number	J:151699
Del(4C4-C5)1Lap/+ (involves: 129S6/SvEvTac)	enlarged spleen	J:158126
Del(4C4-C5)1Lap/Del(4C4-C5)1Lap (involves: 129S6/SvEvTac)	enlarged spleen	J:158126
Del(4D4Mit190-D4Mit51)2Aam/+ (involves: 129S7/SvEvBrd)	spleen hyperplasia	J:121726
Del(6Gimap5-Gimap3)1Yout/Del(6Gimap5-Gimap3)1Yout (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	decreased B cell number	J:209926
	decreased NK cell number	J:209926
	decreased T cell number	J:209926
Del(6Snca)1Slab/Del(6Snca)1Slab Tg(Th-SNCA)1Mgsp/0 (involves: C57BL/6J C57BL/6JOlaHsd * CBA/Ca)	abnormal microglial cell morphology	J:108310
Del(7)Tyr^c-3H/Del(7)Tyr^c-3H (involves: 101/H * C3H/HeH)	abnormal thymus morphology	J:5063
Del(8A4-B3)7H/+ (involves: 101/H * C3H/HeH)	abnormal lymphatic vessel morphology	J:123074
Del(9Apoa1-Apoa4)1Hmez/Del(9Apoa1-Apoa4)1Hmez (involves: 129P2/OlaHsd * C57BL/6)	increased macrophage derived foam cell number	J:109005
Del(9Cd3g-Cd3d)1Cpt/Del(9Cd3g-Cd3d)1Cpt (involves: 129S4/SvJae * C57BL/6)	absent gamma-delta T cells	J:76991
	arrested T cell differentiation	J:76991
	decreased alpha-beta T cell number	J:76991
	thymus hypoplasia	J:76991
Del(11Hoxb3-Hoxb4)1Karl/Del(11Hoxb3-Hoxb4)1Karl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal spleen morphology	J:83563
	decreased spleen weight	J:83563
	spleen hypoplasia	J:83563
Del(11Hoxb3-Hoxb4)1Karl/Del(11Hoxb3-Hoxb4)1Karl Hoxa9^tm1Mrc/Hoxa9^tm1Mrc (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6)	decreased spleen weight	J:126371
	spleen hypoplasia	J:126371
Del(11Jmjd6-Mettl23)1Ysfk/Del(11Jmjd6-Mettl23)1Ysfk (involves: C57BL/6)	abnormal thymus development	J:90288
	thymus hypoplasia	J:90288
Del(11Nlrp1a-Nlrp1c-ps)1Smas/Del(11Nlrp1a-Nlrp1c-ps)1Smas (Not Specified)	decreased neutrophil cell number	J:191055
Del(11Stat5a-Stat5b)1Mam/Del(11Stat5a-Stat5b)1Mam (involves: 129 * 129S6/SvEvTac * C57BL/6)	absent gamma-delta T cells	J:122463
	arrested B cell differentiation	J:122463
	decreased B cell number	J:122463
	decreased CD8-positive, alpha-beta T cell number	J:122463
	small lymph nodes	J:122463
	small spleen	J:122463
	small thymus	J:122463
Del(14Trim13-Dleu2)4Rdf/Del(14Trim13-Dleu2)4Rdf (involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	increased B cell number	J:156946
	increased B-1a cell number	J:156946
	increased spleen white pulp amount	J:156946
Del(14Trim13-Rnaseh2b)6Rdf/+ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal lymphopoiesis	J:179879
	increased B cell number	J:179879
Del(15Rr316124-Rr313939)2Fsp/+ Myc^tm1Atp/Myc⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:257739
	decreased granulocyte number	J:257739
Del(15Rr316124-Rr313939)2Fsp/+ Rr331^em1Fsp/Rr331⁺ (involves: C57BL/6)	decreased B cell number	J:257739
	increased pre-B cell number	J:257739
Del(15Rr316124-Rr313939)2Fsp/+ Rr307328^em1Fsp/Rr307328⁺ (involves: C57BL/6)	decreased B cell number	J:257739
	increased pre-B cell number	J:257739
Del(15Rr316124-Rr313939)2Fsp/Del(15Rr316124-Rr313939)2Fsp (Not Specified)	decreased B cell number	J:257739
	decreased granulocyte number	J:257739
Del(16Pi4ka-Hira)1Atai/+ (C57BL/6N-Del(16Pi4ka-Hira)1Atai)	thymus hypoplasia	J:285407
Del(17Btnl1-Btnl6)1Ahay/Del(17Btnl1-Btnl6)1Ahay (involves: BALB/c * C57BL/6J)	decreased CD4-positive, gamma-delta intraepithelial T cell number	J:291989
Del(18Pcdhg)1Xzw/Del(18Pcdhg)1Xzw (Not Specified)	microgliosis	J:188341
Dennd1b^tm1.1Achn/Dennd1b^tm1.1Achn Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	lymph node hyperplasia	J:229307
Dennd1b^tm1.2Achn/Dennd1b^tm1.2Achn (involves: C57BL/6)	abnormal T cell number	J:229307
Dennd1b^tm1.2Achn/Dennd1b^tm1.2Achn (involves: C57BL/6)	lymph node hyperplasia	J:229307
Dennd5b^em1(IMPC)Tcp/Dennd5b^em1(IMPC)Tcp (C57BL/6N-Dennd5b^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Dennd10^{em1(IMPC)Ccpcz}/Dennd10^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Dennd10^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Dffb^tm1Osa/Dffb^tm1Osa Dnase2a^tm1Osa/Dnase2a^tm1Osa (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:81474
	abnormal thymus morphology	J:81474
	decreased double-positive T cell number	J:81474
	increased double-negative T cell number	J:81474
	small thymus	J:81474
	thymus hypoplasia	J:81474
Dgcr2^{tm1b(EUCOMM)Wtsi}/Dgcr2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dgcr2^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Dgka^tm1Xpz/Dgka^tm1Xpz (involves: 129 * C57BL/6)	increased T cell number	J:113564
Dgka^tm1Xpz/Dgka^tm1Xpz Dgkz^tm1Gak/Dgkz^tm1Gak (involves: 129 * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:113564
Dgkz^tm1Gak/Dgkz^tm1Gak (involves: 129X1/SvJ * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:85149
	decreased CD8-positive, alpha-beta T cell number	J:85149
	increased B cell number	J:85149
Dgkz^tm1Gak/Dgkz^tm1Gak (B6.129X1-Dgkz^tm1Gak)	increased T cell number	J:113564
Dh/Dh (Not Specified)	absent spleen	J:152370, J:112
Dh/Dh⁺ (Not Specified)	absent spleen	J:152370, J:112
	enlarged lymph nodes	J:30753
	increased granulocyte number	J:30753
	increased lymphocyte cell number	J:30753
Dh/Dh⁺ (B6.CBA-Dh)	abnormal T cell differentiation	J:5834
Dh/Dh⁺ (B6.CBA-Dh)	absent spleen	J:5834
Dh/Dh⁺ Foxn1^nu/Foxn1^nu (involves: N:NIH(S))	abnormal Peyer's patch morphology	J:6062
	absent spleen	J:6062
	athymia	J:6062
	decreased leukocyte cell number	J:6062
Dh/Dh⁺ H2^d/H2^d (NZB.Cg-Dh)	absent spleen	J:12036
Dhcr7^em1(IMPC)Mbp/Dhcr7⁺ (C57BL/6N-Dhcr7^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Dhfr^orana/Dhfr⁺ (involves: C57BL/6JAnu)	enlarged spleen	J:236197
Dhps^{tm2c(EUCOMM)Wtsi}/Dhps^{tm2c(EUCOMM)Wtsi} Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6J C57BL/6N * CBA * SJL)	decreased spleen red pulp amount	J:236582
	spleen hypoplasia	J:236582
Dhrs7b^{Gt(OST255410)Lex}/Dhrs7b^{Gt(OST255410)Lex} (B6;129S5-Dhrs7b^{Gt(OST255410)Lex}/Mmucd)	thymus atrophy	J:171883
Dhx8^em1(IMPC)Mbp/Dhx8⁺ (C57BL/6NCrl-Dhx8^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged thymus	J:211773
Dhx9^{Tn(pb-Act-RFP)1.071225026-HRAZhu}/Dhx9⁺ Igs12^tm1Zhu/Igs12^tm1Zhu Ptprc^a/Ptprc^b Tg(Lck-cre)#Zhu/0 (involves: 129S6/SvEvTac * C57BL/6 * FVB/NJ * SJL/J)	abnormal T cell differentiation	J:207361
Dhx15^{tm1c(EUCOMM)Wtsi}/Dhx15^{tm1c(EUCOMM)Wtsi} Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C3H * C57BL/6N)	abnormal B cell differentiation	J:284624
	decreased B cell number	J:284624
	decreased pre-B cell number	J:284624
	decreased spleen weight	J:284624
	spleen hypoplasia	J:284624
Dhx15^{tm1c(EUCOMM)Wtsi}/Dhx15^{tm1c(EUCOMM)Wtsi} Tg(Cd4-cre)1Cwi/0 (involves: C3H * C57BL/6N * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:284624
	decreased CD8-positive, alpha-beta T cell number	J:284624
Dhx35^{tm1b(EUCOMM)Wtsi}/Dhx35^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dhx35^{tm1b(EUCOMM)Wtsi}/Wtsi)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Dhx36^tm1.2Pmt/Dhx36^tm1.2Pmt Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129P2/Ola * 129S4/SvJaeSor * C57BL/6 * C57BL/10 * CBA/Ca)	enlarged spleen	J:185179
	intermingled spleen red and white pulp	J:185179
	thymus hypoplasia	J:185179
Dhx36^tm1.2Pmt/Dhx36^tm1.2Pmt Tg(Mx1-cre)1Cgn/0 (involves: 129P2/Ola * 129S4/SvJaeSor * C57BL/6 * CBA)	abnormal leukopoiesis	J:185179
Dhx40^{tm1b(KOMP)Wtsi}/Dhx40^{tm1b(KOMP)Wtsi} (C57BL/6N-Dhx40^{tm1b(KOMP)Wtsi}/Wtsi)	increased spleen weight	J:211773
Diaph1^M1Btlr/Diaph1⁺ (C57BL/6J-Diaph1^M1Btlr)	abnormal CD4-positive, alpha-beta T cell number	J:254820
	abnormal CD8-positive, alpha-beta T cell number	J:254820
	increased central memory CD4-positive, alpha-beta T cell number	J:254820
	increased central memory CD8 positive, alpha-beta T cell number	J:254820
Diaph1^M1Btlr/Diaph1^M1Btlr (C57BL/6J-Diaph1^M1Btlr)	abnormal CD4-positive, alpha-beta T cell number	J:254820
	abnormal CD8-positive, alpha-beta T cell number	J:254820
	decreased effector memory CD8-positive, alpha-beta T cell number	J:254820
	increased central memory CD4-positive, alpha-beta T cell number	J:254820
	increased central memory CD8 positive, alpha-beta T cell number	J:254820
Diaph1^M2Btlr/Diaph1⁺ (C57BL/6J-Diaph1^M2Btlr)	decreased B-1 B cell number	J:254819
Diaph1^M2Btlr/Diaph1^M2Btlr (C57BL/6J-Diaph1^M2Btlr)	decreased B-1 B cell number	J:254819
Diaph1^M2Btlr/Diaph1^M2Btlr (C57BL/6J-Diaph1^M2Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:254819
Diaph1^m3Btlr/Diaph1^m3Btlr (C57BL/6J-Diaph1^m3Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254818
	decreased CD8-positive, naive alpha-beta T cell number	J:254818
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254818
	increased CD8-positive, alpha-beta memory T cell number	J:254818
	increased central memory CD4-positive, alpha-beta T cell number	J:254818
	increased central memory CD8 positive, alpha-beta T cell number	J:254818
	increased effector memory CD4-positive, alpha-beta T cell number	J:254818
	increased effector memory CD8-positive, alpha-beta T cell number	J:254818
Diaph1^tm1.1Sna/Diaph1^tm1.1Sna (B6.Cg-Diaph1^tm1.1Sna)	decreased CD4-positive, alpha-beta T cell number	J:126090
	decreased CD8-positive, alpha-beta T cell number	J:126090
	decreased T cell number	J:126090
	increased single-positive T cell number	J:126090
Diaph1^tm1Asal/Diaph1^tm1Asal (involves: 129S1/Sv * C57BL/6)	abnormal lymph node morphology	J:124319
	abnormal spleen germinal center morphology	J:124319
	abnormal spleen morphology	J:124319
	absent spleen white pulp	J:124319
	decreased lymphocyte cell number	J:124319
	increased granulocyte number	J:124319
	increased leukocyte cell number	J:124319
	increased monocyte cell number	J:124319
	increased neutrophil cell number	J:124319
	increased spleen weight	J:124319
Diaph3^tm1.1Pji/Diaph3^tm1.1Pji Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * CBA/J)	enlarged spleen	J:293763
Dicer1^m1Btlr/Dicer1^m1Btlr (C57BL/6J-Dicer1^m1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265172
	decreased CD8-positive, alpha-beta T cell number	J:265172
	decreased CD8-positive, naive alpha-beta T cell number	J:265172
	decreased single-positive T cell number	J:265172
	decreased T cell number	J:265172
	increased B-1 B cell number	J:265172
	increased central memory CD8 positive, alpha-beta T cell number	J:265172
	increased effector memory CD4-positive, alpha-beta T cell number	J:265172
	increased effector memory CD8-positive, alpha-beta T cell number	J:265172
Dicer1^{tm1b(EUCOMM)Wtsi}/Dicer1⁺ (C57BL/6N-Dicer1^{tm1b(EUCOMM)Wtsi}/H)	absent spleen	J:211773
	decreased neutrophil cell number	J:211773
	decreased spleen weight	J:211773
Dicer1^tm1Bdh/Dicer1⁺ H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129 * C57BL/6 * CBA/J)	abnormal thymus development	J:166758
Dicer1^tm1Bdh/Dicer1^tm1Bdh Aicda^tm1(cre)Njen/Aicda⁺ (involves: 129 * C57BL/6)	absent memory B cells	J:181782
	absent plasma cells	J:181782
	decreased germinal center B cell number	J:181782
Dicer1^tm1Bdh/Dicer1^tm1Bdh Foxp3^{tm4(YFP/icre)Ayr}/Y (involves: 129S1/Sv * 129X1/SvJ)	enlarged lymph nodes	J:138683
	enlarged spleen	J:138683
Dicer1^tm1Bdh/Dicer1^tm1Bdh Foxp3^{tm4(YFP/icre)Ayr}/Foxp3^{tm4(YFP/icre)Ayr} (involves: 129S1/Sv * 129X1/SvJ)	enlarged lymph nodes	J:138683
	enlarged spleen	J:138683
Dicer1^tm1Bdh/Dicer1^tm1Bdh H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129 * C57BL/6 * CBA/J)	athymia	J:166758
Dicer1^tm1Bdh/Dicer1^tm1Bdh Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	decreased regulatory T cell number	J:138683
Dicer1^tm1Bdh/Dicer1^tm1Bdh Tg(Foxp3-EGFP/icre)1aJbs/0 (involves: 129 * NOD/ShiLt)	abnormal effector T cell morphology	J:138808
	abnormal lymph node cell ratio	J:138808
	abnormal regulatory T cell morphology	J:138808
	abnormal splenic cell ratio	J:138808
	decreased regulatory T cell number	J:138808
	enlarged lymph nodes	J:138808
	enlarged spleen	J:138808
Dicer1^tm1Dli/Dicer1^tm1Dli Tg(Cd4-cre)1Cwi/? (involves: 129 * C57BL/6 * DBA/2)	decreased T cell number	J:100546
Dicer1^tm1Mmk/Dicer1^tm1.1Mmk Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c)	abnormal immunoglobulin V(D)J recombination	J:135783
	decreased B cell number	J:135783
Dicer1^tm1Mmk/Dicer1^tm1Mmk Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c)	arrested B cell differentiation	J:135783
	decreased immature B cell number	J:135783
	decreased mature B cell number	J:135783
	decreased pre-B cell number	J:135783
	increased pro-B cell number	J:135783
Dicer1^tm1Mmk/Dicer1^tm1Mmk Tg(IghelMD4)4Ccg/0 Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c)	decreased B cell number	J:135783
	decreased mature B cell number	J:135783
Dicer1^tm1Mmk/Dicer1^tm1Mmk Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased T cell number	J:98192
	decreased thymocyte number	J:98192
	increased gamma-delta T cell number	J:98192
Dicer1^tm1Mmk/Dicer1^tm1Mmk Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129 * C57BL/6 * CD-1)	abnormal granulocyte differentiation	J:158901
	abnormal myeloid leukocyte morphology	J:158901
	abnormal neutrophil morphology	J:158901
	decreased B cell number	J:158901
	decreased leukocyte cell number	J:158901
	enlarged spleen	J:158901
Dicer1^tm1Tara/Dicer1^tm1Tara Foxn1^tm3(cre)Nrm/Foxn1⁺ (involves: 129P2/OlaHsd * C57BL/6NHsd)	abnormal positive T cell selection	J:180783
	abnormal thymus cortex morphology	J:180783
	abnormal thymus epithelium morphology	J:180783
	abnormal thymus medulla morphology	J:180783
	abnormal thymus morphology	J:180783
	decreased CD4-positive, alpha-beta T cell number	J:180783
	decreased CD8-positive, alpha-beta T cell number	J:180783
Dido1^tm1Cmar/Dido1⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal splenic cell ratio	J:101201
	abnormal splenocyte morphology	J:101201
	increased granulocyte number	J:101201
	increased monocyte cell number	J:101201
	increased spleen weight	J:101201
	spleen hyperplasia	J:101201
Dido1^tm1Cmar/Dido1^tm1Cmar (involves: 129S1/Sv * 129X1/SvJ)	abnormal splenic cell ratio	J:101201
	abnormal splenocyte morphology	J:101201
	increased granulocyte number	J:101201
	increased monocyte cell number	J:101201
	increased spleen weight	J:101201
	increased spleen white pulp amount	J:101201
	spleen hyperplasia	J:101201
Dip2b^{tm1a(EUCOMM)Wtsi}/Dip2b⁺ (B6JTyr;B6N-Dip2b^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Dip2c^em1(IMPC)Tcp/Dip2c⁺ (C57BL/6N-Dip2c^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	increased monocyte cell number	J:211773
	small thymus	J:211773
Dipk2b^em1(IMPC)Mbp/Dipk2b^em1(IMPC)Mbp (C57BL/6N-Dipk2b^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Dis3^tm1.1Uba/Dis3^tm1.1Uba Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	abnormal B cell morphology	J:302856
	abnormal class switch recombination	J:302856
Dis3l^{em1(IMPC)Ccpcz}/Dis3l⁺ (C57BL/6NCrl-Dis3l^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Disc1^em1(IMPC)Mbp/Disc1^em1(IMPC)Mbp (C57BL/6N-Disc1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Disp3^em1(IMPC)Mbp/Disp3^em1(IMPC)Mbp (C57BL/6N-Disp3^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Dkc1^tm1.1Pjma/Y (B6.129X1(FVB)-Dkc1^tm1.1Pjma)	decreased B cell number	J:217050
Dkc1^tm1.1Pjma/Y (B6.129X1(FVB)-Dkc1^tm1.1Pjma)	decreased T cell number	J:217050
Dkc1^tm1Ppp/Y (involves: 129S1/Sv)	abnormal spleen morphology	J:81054
	decreased B cell number	J:81054
	decreased leukocyte cell number	J:81054
	decreased lymphocyte cell number	J:81054
	decreased pre-B cell number	J:81054
	decreased spleen red pulp amount	J:81054
	decreased spleen white pulp amount	J:81054
	enlarged spleen	J:81054
Dkc1^tm1Ppp/Dkc1⁺ (involves: 129S1/Sv)	abnormal immune system cell morphology	J:81054
Dkc1^tm1Ppp/Dkc1⁺ (involves: 129S1/Sv)	abnormal immune system organ morphology	J:81054
Dkk2^tm1Dwu/Dkk2^tm1Dwu (involves: 129)	abnormal osteoclast differentiation	J:100858
Dkk2^tm1Dwu/Dkk2^tm1Dwu (involves: 129)	increased osteoclast cell number	J:100858
Dkk3^tm1Cni/Dkk3^tm1Cni (involves: 129X1/SvJ * C57BL/6)	decreased NK cell number	J:106922
Dlgap2^{em1(IMPC)Mhzh}/Dlgap2^{em1(IMPC)Mhzh} (C57BL/6N-Dlgap2^{em1(IMPC)Mhzh}/Mhzh)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Dlk1^tm1Srba/Dlk1^tm1Srba (involves: 129X1/SvJ * C57BL/6)	abnormal B cell number	J:145076
	abnormal spleen B cell follicle morphology	J:145076
	abnormal spleen marginal zone morphology	J:145076
	decreased immature B cell number	J:145076
	decreased mature B cell number	J:145076
	increased immature B cell number	J:145076
	increased marginal zone B cell number	J:145076
	increased transitional stage B cell number	J:145076
Dll1^tm1Gos/Dll1⁺ (C3Fe.129-Dll1^tm1Gos)	decreased B-1 B cell number	J:150183
	decreased CD4-positive, alpha-beta T cell number	J:150183
	decreased CD8-positive, alpha-beta T cell number	J:150183
	increased B cell number	J:150183
	increased CD8-positive, alpha-beta T cell number	J:150183
Dll1^tm1Gos/Dll1⁺ (involves: 129S1/Sv * 129X1/SvJ)	decreased CD4-positive, alpha-beta T cell number	J:150183
Dll1^tm1Gos/Dll1⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased B cell number	J:150183
Dll1^tm1Mjo/Dll1^tm1Mjo Tg(Mx1-cre)1Cgn/? (involves: 129 * C57BL/6 * CBA)	absent marginal zone B cells	J:90630
Dll4^tm1Frad/Dll4^tm1Frad Foxn1^tm3(cre)Nrm/Foxn1⁺ (B6.Cg-Dll4^tm1Frad Foxn1^tm3(cre)Nrm)	abnormal T cell differentiation	J:143472
	abnormal thymus cell ratio	J:143472
	decreased CD4-positive, alpha-beta T cell number	J:143472
	decreased CD8-positive, alpha-beta T cell number	J:143472
	decreased double-positive T cell number	J:143472
	decreased thymocyte number	J:143472
	increased immature B cell number	J:143472
Dll4^tm1Kaho/Dll4^tm1Kaho Tg(Foxn1-cre)8Ghr/0 (involves: C57BL/6 * DBA/2)	abnormal lymphopoiesis	J:143473
	absent CD4-positive, alpha-beta T cells	J:143473
	absent CD8-positive, alpha-beta T cells	J:143473
	decreased double-positive T cell number	J:143473
	thymus hypoplasia	J:143473
Dmd^em1Wehi/Y (BALB/c-Dmd^em1Wehi)	enlarged spleen	J:353371
Dmd^mdx/Y Spp1^tm1Blh/Spp1^tm1Blh (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)	decreased granulocyte number	J:150572
	decreased neutrophil cell number	J:150572
	decreased T cell number	J:150572
	increased regulatory T cell number	J:150572
	increased T cell number	J:150572
Dmd^mdx/Dmd^mdx Mmp9^tm1Tvu/Mmp9⁺ (B10.Cg-Mmp9^tm1Tvu Dmd^mdx)	decreased macrophage cell number	J:150030
Dmd^mdx/Dmd^mdx Mmp9^tm1Tvu/Mmp9^tm1Tvu (B10.Cg-Mmp9^tm1Tvu Dmd^mdx)	decreased macrophage cell number	J:150030
Dmd^mdx/Dmd^mdx Prkdc^scid/Prkdc^scid (involves: BALB/c * C57BL/10ScSn * C57BL/Ka)	absent CD4-positive, alpha-beta T cells	J:125527
	absent CD8-positive, alpha-beta T cells	J:125527
	decreased B cell number	J:125527
Dmd^mdx/Dmd^mdx Spp1^tm1Blh/Spp1^tm1Blh (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)	decreased granulocyte number	J:150572
	decreased neutrophil cell number	J:150572
	decreased T cell number	J:150572
	increased regulatory T cell number	J:150572
	increased T cell number	J:150572
Dmp1^tm1Mis/Dmp1^tm1Mis (involves: 129S7/SvEvBrd * CD-1)	abnormal bone marrow development	J:184352
Dmp1^tm1Mis/Dmp1^tm1Mis (involves: 129S7/SvEvBrd * CD-1)	decreased osteoclast cell number	J:184352
Dmtf1^tm1Cjs/Dmtf1⁺ Kras^tm2Tyj/Kras⁺ (involves: 129S2/SvPas * C57BL/6)	increased T cell derived lymphoma incidence	J:126002
Dmtf1^tm1Cjs/Dmtf1⁺ Kras^tm3Tyj/Kras⁺ (involves: 129S4/SvJae * C57BL/6)	increased T cell derived lymphoma incidence	J:126002
Dmtf1^tm1Cjs/Dmtf1^tm1Cjs (involves: 129/Sv * C57BL/6)	decreased thymocyte number	J:63444
Dmtf1^tm1Cjs/Dmtf1^tm1Cjs Kras^tm2Tyj/Kras⁺ (involves: 129S2/SvPas * C57BL/6)	increased T cell derived lymphoma incidence	J:126002
Dmtf1^tm1Cjs/Dmtf1^tm1Cjs Kras^tm3Tyj/Kras⁺ (involves: 129S4/SvJae * C57BL/6)	increased T cell derived lymphoma incidence	J:126002
Dnaaf4^b2b811.1Clo/Dnaaf4^b2b811.1Clo (C57BL/6J-Dnaaf4^b2b811.1Clo)	abnormal spleen morphology	J:205312
Dnaaf4^tm1.2Jjlo/Dnaaf4^tm1.2Jjlo (involves: 129S1/Sv * 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J)	abnormal spleen morphology	J:205312
Dnaaf9^{tm1b(EUCOMM)Hmgu}/Dnaaf9^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Dnaaf9^{tm1b(EUCOMM)Hmgu}/Tcp)	increased neutrophil cell number	J:211773
Dnah2^em1(IMPC)Tcp/Dnah2^em1(IMPC)Tcp (C57BL/6N-Dnah2^em1(IMPC)Tcp/Tcp)	abnormal lymph node morphology	J:211773
Dnah5^b2b2451Clo/Dnah5^b2b2451Clo (C57BL/6J-Dnah5^b2b2451Clo)	abnormal spleen morphology	J:175213
Dnah5^b2b2925Clo/Dnah5^b2b2925Clo (C57BL/6J-Dnah5^b2b2925Clo)	absent spleen	J:175213
Dnah5^hlb612/Dnah5^hlb612 (involves: C57BL/6J)	abnormal spleen morphology	J:130755
Dnah5^hlb612/Dnah5^hlb612 (involves: C57BL/6J)	absent spleen	J:130755
Dnah11^b2b1289Clo/Dnah11^b2b1289Clo (C57BL/6J-Dnah11^b2b1289Clo)	accessory spleen	J:175213
Dnah11^b2b1727Clo/Dnah11^b2b1727Clo (C57BL/6J-Dnah11^b2b1727Clo)	spleen hypoplasia	J:175213
Dnah11^b2b1775Clo/Dnah11^b2b1775Clo (C57BL/6J-Dnah11^b2b1775Clo)	spleen hypoplasia	J:175213
Dnah11^iv/Dnah11^iv (SI/Col Tyrp1^b Dnah11^iv/J)	abnormal spleen morphology	J:4058
Dnai1^b2b1526Clo/Dnai1^b2b1526Clo (C57BL/6J-Dnai1^b2b1526Clo)	spleen hypoplasia	J:175213
Dnai2^em1(IMPC)Tcp/Dnai2⁺ (C57BL/6NCrl-Dnai2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Dnajc2^em1(IMPC)J/Dnajc2⁺ (C57BL/6NJ-Dnajc2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Dnajc3^m1Btlr/Dnajc3^m1Btlr (C57BL/6J-Dnajc3^m1Btlr)	increased CD4-positive, alpha-beta T cell number	J:265248
	increased CD8-positive, alpha-beta memory T cell number	J:265248
	increased single-positive T cell number	J:265248
	increased T cell number	J:265248
Dnajc11^spc/Dnajc11^spc (B6.Cg-Dnajc11^spc)	decreased B cell number	J:221543
	decreased double-positive T cell number	J:221543
	decreased leukocyte cell number	J:221543
	decreased thymus weight	J:221543
	enlarged thymus medulla	J:221543
	increased CD4-positive, alpha-beta T cell number	J:221543
	increased CD8-positive, alpha-beta T cell number	J:221543
	increased DN1 thymic pro-T cell number	J:221543
	increased double-negative T cell number	J:221543
	spleen hypoplasia	J:221543
	thymus cortex atrophy	J:221543
	thymus hypoplasia	J:221543
Dnajc15^{Gt(RRN226)Byg}/Dnajc15^{Gt(RRN226)Byg} (B6.129P2-Dnajc15^{Gt(RRN226)Byg})	abnormal CD8-positive, alpha beta T cell morphology	J:204025
Dnajc15^{tm1b(KOMP)Wtsi}/Dnajc15^{tm1b(KOMP)Wtsi} (C57BL/6N-Dnajc15^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Dnal1^{tm1.1(KOMP)Vlcg}/Dnal1⁺ (C57BL/6N-Dnal1^{tm1.1(KOMP)Vlcg}/Ucd)	decreased eosinophil cell number	J:211773
Dnase1^tm1Tmo/Dnase1⁺ (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:62549
Dnase1^tm1Tmo/Dnase1^tm1Tmo (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:62549
Dnase1l2^em1(IMPC)Bay/Dnase1l2^em1(IMPC)Bay (C57BL/6N-Dnase1l2^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Dnase1l2^{tm1.1(KOMP)Wtsi}/Dnase1l2^{tm1.1(KOMP)Wtsi} (C57BL/6N-Dnase1l2^{tm1.1(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Dnase1l3^em1(IMPC)Mbp/Dnase1l3^em1(IMPC)Mbp (C57BL/6NCrl-Dnase1l3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Dnase2a^tm1Osa/Dnase2a^tm1Osa (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal thymus morphology	J:81474
	small thymus	J:81474
	thymus hypoplasia	J:81474
Dnase2a^tm1Osa/Dnase2a^tm1Osa Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)	abnormal macrophage morphology	J:114982
	abnormal spleen morphology	J:238323
	enlarged spleen	J:238323, J:114982
	increased spleen red pulp amount	J:114982
	increased spleen weight	J:238323
Dnase2a^tm1Osa/Dnase2a^tm2Osa Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA)	abnormal macrophage morphology	J:114982
Dnm2^tm2.1Ics/Dnm2⁺ (involves: C57BL/6J)	increased macrophage cell number	J:288372
Dnmbp^em1(IMPC)Mbp/Dnmbp^em1(IMPC)Mbp (C57BL/6N-Dnmbp^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Dnmt1^{tm1(tetO-BCL2)Sjk}/Dnmt1⁺ Tg(IghMyc)22Bri/0 Tg(MMTVtTA)1Mam/0 (involves: 129S4/SvJae * C57BL/6)	enlarged spleen	J:93549
Dnmt1^tm2Jae/Dnmt1^tm2Jae Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S4/SvJae * BALB/c * C57BL/6)	abnormal B cell differentiation	J:113645
	decreased pro-B cell number	J:113645
Dnmt3b^tm1Enl/Dnmt3b^tm6Enl (involves: 129S4/SvJae * C57BL/6)	decreased thymocyte number	J:106540
	small thymus	J:106540
Dnmt3b^tm1Enl/Dnmt3b^tm7Enl (involves: 129S4/SvJae * C57BL/6)	decreased double-positive T cell number	J:106540
	decreased thymocyte number	J:106540
	increased double-negative T cell number	J:106540
	small thymus	J:106540
Dnmt3b^tm6Enl/Dnmt3b^tm6Enl (involves: 129S4/SvJae * C57BL/6)	decreased thymocyte number	J:106540
	small thymus	J:106540
Dnmt3b^tm6Enl/Dnmt3b^tm7Enl (involves: 129S4/SvJae * C57BL/6)	decreased thymocyte number	J:106540
Dnmt3b^tm7Enl/Dnmt3b^tm7Enl (involves: 129S4/SvJae * C57BL/6)	decreased thymocyte number	J:106540
	small thymus	J:106540
Dntt^tm1Fwa/Dntt^tm1Fwa (chimera involves: 129S/SvEv)	abnormal immune system morphology	J:75921
Dntt^tm1Gfn/Dntt^tm1Gfn Polm^tm1Crey/Polm^tm1Crey (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal immunoglobulin light chain V-J recombination	J:113406
Dntt^tm1Tok/Dntt^tm1Tok (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphocyte cell number	J:61801
	abnormal T cell morphology	J:61801
	decreased gamma-delta T cell number	J:61801
Dock1^b2b3190Clo/Dock1^b2b3190Clo (C57BL/6J-Dock1^b2b3190Clo)	thymus hypoplasia	J:175213
Dock2^m1Anu/Dock2^m1Anu (C57BL/6JAnu-Dock2^m1Anu)	decreased B cell number	J:104190
Dock2^m1Anu/Dock2^m1Anu (C57BL/6JAnu-Dock2^m1Anu)	decreased T cell number	J:104190
Dock2^m1Btlr/Dock2^m1Btlr (involves: C57BL/6J)	abnormal B cell differentiation	J:173592
	abnormal class switch recombination	J:185495
	decreased B cell number	J:185495
	decreased T cell number	J:185495
Dock2^m1Hsd/Dock2^m1Hsd Irf5^tm1Ttg/Irf5^tm1Ttg (B6NHsd.Cg-Irf5^tm1Ttg Dock2^m1Hsd)	abnormal B cell differentiation	J:182658
	absent marginal zone B cells	J:182658
	decreased follicular B cell number	J:182658
	decreased plasmacytoid dendritic cell number	J:182658
	decreased splenocyte number	J:182658
	increased B cell number	J:182658
	increased immature B cell number	J:182658
	increased plasmacytoid dendritic cell number	J:182658
Dock2^m1Hsd/Dock2^m1Hsd Siae^tm1.2Avrk/Siae^tm1.2Avrk (B6NHsd.Cg-Siae^tm1.2Avrk Dock2^m1Hsd)	decreased B-1a cell number	J:144035
	decreased follicular B cell number	J:144035
	decreased marginal zone B cell number	J:231437, J:144035
	decreased T cell number	J:144035
	increased B-1b cell number	J:144035
	increased CD4-positive, alpha-beta memory T cell number	J:231437
	spleen hypoplasia	J:144035
Dock2^m2Anu/Dock2^m2Anu (C57BL/6JAnu-Dock2^m2Anu)	abnormal T cell morphology	J:104190
	decreased mature B cell number	J:104190
	decreased T cell number	J:104190
Dock2^m2Btlr/Dock2^m2Btlr (C57BL/6J-Dock2^m2Btlr)	decreased B cell number	J:173670
	decreased CD4-positive, alpha-beta T cell number	J:173670
	decreased CD8-positive, alpha-beta T cell number	J:173670
Dock2^m2Btlr/Dock2^m2Btlr (involves: C57BL/6J)	abnormal B cell differentiation	J:185495
	abnormal class switch recombination	J:185495
	decreased B cell number	J:185495
	decreased T cell number	J:185495
Dock2^m3Anu/Dock2^m3Anu (C57BL/6NCrlAnu-Dock2^m3Anu)	abnormal CD4-positive, alpha beta T cell morphology	J:104190
	abnormal CD8-positive, alpha beta T cell morphology	J:104190
	decreased CD4-positive, alpha-beta T cell number	J:104190
Dock2^m3Btlr/Dock2^m3Btlr (C57BL/6J-Dock2^m3Btlr)	abnormal CD4-positive T cell differentiation	J:191187
	abnormal CD8-positive, alpha-beta T cell differentiation	J:191187
	decreased CD4-positive, alpha-beta T cell number	J:191187
	decreased CD8-positive, alpha-beta T cell number	J:191187
Dock2^m4Btlr/Dock2^m4Btlr (C57BL/6J-Dock2^m4Btlr)	abnormal B cell differentiation	J:221486
	abnormal CD4-positive T cell differentiation	J:221486
	abnormal CD8-positive, alpha-beta T cell differentiation	J:221486
Dock2^m5Btlr/Dock2⁺ (C57BL/6J-Dock2^m5Btlr)	abnormal CD4-positive T cell differentiation	J:225938
	abnormal CD8-positive, alpha-beta T cell differentiation	J:225938
	decreased CD4-positive, alpha-beta T cell number	J:225938
	decreased single-positive T cell number	J:225938
	increased CD8-positive, alpha-beta T cell number	J:225938
	increased single-positive T cell number	J:225938
Dock2^m5Btlr/Dock2^m5Btlr (C57BL/6J-Dock2^m5Btlr)	abnormal B cell differentiation	J:225938
	abnormal CD4-positive T cell differentiation	J:225938
	abnormal CD8-positive, alpha-beta T cell differentiation	J:225938
	decreased CD4-positive, alpha-beta T cell number	J:225938
	decreased single-positive T cell number	J:225938
	increased B cell number	J:225938
	increased CD8-positive, alpha-beta T cell number	J:225938
	increased single-positive T cell number	J:225938
Dock2^m7Btlr/Dock2⁺ (C57BL/6J-Dock2^m7Btlr)	decreased B cell number	J:255181
	increased macrophage cell number	J:255181
	increased neutrophil cell number	J:255181
Dock2^m7Btlr/Dock2^m7Btlr (C57BL/6J-Dock2^m7Btlr)	decreased B cell number	J:255181
	increased macrophage cell number	J:255181
	increased neutrophil cell number	J:255181
	increased NK cell number	J:255181
Dock2^m8Btlr/Dock2^m8Btlr (C57BL/6J-Dock2^m8Btlr)	decreased CD4-positive, alpha-beta T cell number	J:272402
Dock2^m8Btlr/Dock2^m8Btlr (C57BL/6J-Dock2^m8Btlr)	increased CD8-positive, alpha-beta T cell number	J:272402
Dock2^M9Btlr/Dock2^M9Btlr (C57BL/6J-Dock2^M9Btlr)	increased CD8-positive, alpha-beta T cell number	J:272403
Dock2^m10Btlr/Dock2^m10Btlr (C57BL/6J-Dock2^m10Btlr)	decreased B-1b cell number	J:272404
Dock2^m10Btlr/Dock2^m10Btlr (C57BL/6J-Dock2^m10Btlr)	increased NK cell number	J:272404
Dock2^m11Btlr/Dock2^m11Btlr (C57BL/6J-Dock2^m11Btlr)	abnormal B cell differentiation	J:272405
	abnormal CD4-positive T cell differentiation	J:272405
	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:272405
	decreased B cell number	J:272405
	decreased CD4-positive, alpha-beta T cell number	J:272405
	decreased CD8-positive, naive alpha-beta T cell number	J:272405
	decreased NK cell number	J:272405
	increased B-1 B cell number	J:272405
	increased CD8-positive, alpha-beta T cell number	J:272405
	increased central memory CD4-positive, alpha-beta T cell number	J:272405
	increased central memory CD8 positive, alpha-beta T cell number	J:272405
	increased effector memory CD4-positive, alpha-beta T cell number	J:272405
Dock2^M12Btlr/Dock2^M12Btlr (C57BL/6J-Dock2^M12Btlr)	decreased B-1a cell number	J:272406
Dock2^m13Btlr/Dock2^m13Btlr (C57BL/6J-Dock2^m13Btlr)	increased alpha-beta T cell number	J:272437
Dock2^m13Btlr/Dock2^m13Btlr (C57BL/6J-Dock2^m13Btlr)	increased CD8-positive, alpha-beta T cell number	J:272437
Dock2^M14Btlr/Dock2^M14Btlr (C57BL/6J-Dock2^M14Btlr)	abnormal lymphocyte morphology	J:272438
Dock2^M14Btlr/Dock2^M14Btlr (C57BL/6J-Dock2^M14Btlr)	increased CD8-positive, alpha-beta T cell number	J:272438
Dock2^m15Btlr/Dock2^m15Btlr (C57BL/6J-Dock2^m15Btlr)	decreased B cell number	J:274942
	decreased CD4-positive, alpha-beta T cell number	J:274942
	decreased CD8-positive, naive alpha-beta T cell number	J:274942
	decreased T cell number	J:274942
	increased B-1 B cell number	J:274942
	increased CD8-positive, alpha-beta T cell number	J:274942
	increased central memory CD8 positive, alpha-beta T cell number	J:274942
	increased NK cell number	J:274942
Dock2^M16Btlr/Dock2^M16Btlr (C57BL/6J-Dock2^M16Btlr)	abnormal CD8-positive, alpha-beta T cell number	J:274971
Dock2^{tm1b(EUCOMM)Wtsi}/Dock2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dock2^{tm1b(EUCOMM)Wtsi}/BayMmucd)	increased spleen weight	J:211773
Dock2^tm1Tsas/Dock2^tm1Tsas (involves: C57BL/6)	abnormal immune system morphology	J:71005
	abnormal Peyer's patch morphology	J:71005
	abnormal spleen morphology	J:71005
	abnormal spleen white pulp morphology	J:71005
	decreased marginal zone B cell number	J:71005
	lymph node hypoplasia	J:71005
	spleen hypoplasia	J:71005
Dock2^tm1Tsas/Dock2^tm1Tsas (B6.Cg-Dock2^tm1Tsas)	decreased lymphocyte cell number	J:130919
	decreased mature B cell number	J:130919
	decreased T cell number	J:130919
Dock2^tm1Tsas/Dock2^tm1Tsas Tg(Tcra2B4)1Mmd/? Tg(Tcrb2B4)1Mmd/? (involves: C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:84581
	decreased double-positive T cell number	J:84581
Dock8^cpm/Dock8^cpm (C57BL/6JSfdAnu-Dock8^cpm)	decreased marginal zone B cell number	J:155516
	decreased spleen germinal center size	J:155516
	decreased T cell number	J:155516
Dock8^cpm/Dock8^pri (C57BL/6J-Dock8^cpm/Dock8^pri)	decreased marginal zone B cell number	J:155516
Dock8^cpm/Dock8^pri (C57BL/6J-Dock8^cpm/Dock8^pri)	decreased T cell number	J:155516
Dock8^m1Anu/Dock8^m1Anu (C57BL/6NCrlAnu-Dock8^m1Anu)	decreased activated T cell number	J:104190
Dock8^m1Anu/Dock8^m1Anu (C57BL/6NCrlAnu-Dock8^m1Anu)	decreased T cell number	J:104190
Dock8^m2Anu/Dock8^m2Anu (C57BL/6NCrlAnu-Dock8^m2Anu)	absent marginal zone B cells	J:104190
	decreased activated T cell number	J:104190
	decreased T cell number	J:104190
Dock8^M2Btlr/Dock8^M2Btlr (C57BL/6J-Dock8^M2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:272530
Dock8^m4Btlr/Dock8^m4Btlr (C57BL/6J-Dock8^m4Btlr)	abnormal B cell differentiation	J:274856
	abnormal CD4-positive T cell differentiation	J:274856
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274856
	abnormal T cell differentiation	J:274856
	decreased B-1 B cell number	J:274856
	decreased CD4-positive, alpha-beta T cell number	J:274856
	decreased CD8-positive, alpha-beta T cell number	J:274856
	decreased CD8-positive, naive alpha-beta T cell number	J:274856
	decreased T cell number	J:274856
	increased CD4-positive, alpha-beta T cell number	J:274856
	increased central memory CD4-positive, alpha-beta T cell number	J:274856
	increased central memory CD8 positive, alpha-beta T cell number	J:274856
	increased effector memory CD4-positive, alpha-beta T cell number	J:274856
	increased effector memory CD8-positive, alpha-beta T cell number	J:274856
Dock8^pri/Dock8^pri (C57BL/6JAnu-Dock8^pri)	decreased B-1 B cell number	J:155516
	decreased germinal center B cell number	J:155516
	decreased marginal zone B cell number	J:155516
	decreased spleen germinal center size	J:155516
	decreased T cell number	J:155516
Dock8^tm1Ysfk/Dock8^tm1Ysfk (B6.Cg-Dock8^tm1Ysfk)	decreased CD4-positive, alpha-beta T cell number	J:185165
	decreased CD8-positive, alpha-beta T cell number	J:185165
	decreased follicular dendritic cell number	J:185165
	decreased marginal zone B cell number	J:185165
Dock10^{tm1a(EUCOMM)Hmgu}/Dock10^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Dock10^{tm1a(EUCOMM)Hmgu}/Ieg)	abnormal spleen marginal zone morphology	J:238172
	abnormal thymus cell ratio	J:238172
	arrested B cell differentiation	J:236911
	decreased B cell number	J:236911
	decreased follicular B cell number	J:236911
	decreased marginal zone B cell number	J:236911
	increased single-positive T cell number	J:236911
	increased T cell number	J:236911
Dock10^tm1Thar/Dock10^tm1Thar (involves: C57BL/6)	decreased B cell number	J:300632
Dock11^tm1.1Mmar/Dock11^tm1.1Mmar (Not Specified)	abnormal metallophilic macrophage morphology	J:238172
	abnormal spleen marginal zone morphology	J:238172
	abnormal thymus cell ratio	J:238172
	decreased marginal zone B cell number	J:238172
Dohh^tm1.2Sbal/Dohh⁺ (B6.129(Cg)-Dohh^tm1.2Sbal)	abnormal spleen morphology	J:214321
Dok1^tm1Ppp/Dok1^tm1Ppp Dok2^tm1Ppp/Dok2^tm1Ppp (129S1/Sv-Dok1^tm1Ppp Dok2^tm1Ppp)	enlarged spleen	J:95334
	increased leukocyte cell number	J:95334
	increased monocyte cell number	J:95334
	increased neutrophil cell number	J:95334
Dok1^tm1Ppp/Dok1^tm1Ppp Dok2^tm1Ppp/Dok2^tm1Ppp Dok3^tm1Ppp/Dok3^tm1Ppp (129S1/Sv-Dok1^tm1Ppp Dok2^tm1Ppp Dok3^tm1Ppp)	increased leukocyte cell number	J:158011
Dok1^tm1Yyam/Dok1^tm1Yyam Dok2^tm1Yyam/Dok2^tm1Yyam (B6.129-Dok1^tm1Yyam Dok2^tm1Yyam)	abnormal myelopoiesis	J:95335
	enlarged spleen	J:95335
	increased leukocyte cell number	J:95335
	increased monocyte cell number	J:95335
	increased neutrophil cell number	J:95335
Dok1^tm1Yyam/Dok1^tm1Yyam Dok2^tm1Yyam/Dok2^tm1Yyam Dok3^tm1Brs/Dok3^tm1Brs (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	increased macrophage cell number	J:163407
Dok1^tm1Yyam/Dok1^tm1Yyam Dok2^tm1Yyam/Dok2^tm1Yyam Tg(Tec-BCR/ABL1)5Hhi/0 (involves: C57BL/6)	enlarged lymph nodes	J:95335
	enlarged thymus	J:95335
Dok1^tm1Yyam/Dok1^tm1Yyam Tg(Tec-BCR/ABL1)5Hhi/0 (involves: C57BL/6)	enlarged lymph nodes	J:95335
	enlarged thymus	J:95335
Dok2^tm1Yyam/Dok2^tm1Yyam Tg(Tec-BCR/ABL1)5Hhi/0 (involves: C57BL/6)	enlarged lymph nodes	J:95335
	enlarged thymus	J:95335
Dok3^tm1Brs/Dok3^tm1Brs (involves: C57BL/6)	increased macrophage cell number	J:163407
Dok7^{tm1.1(KOMP)Vlcg}/Dok7⁺ (C57BL/6N-Dok7^{tm1.1(KOMP)Vlcg}/Ucd)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Dop1b^{tm1a(EUCOMM)Wtsi}/Dop1b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Dop1b^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Dot1l^tm1.1Saam/Dot1l^tm1.1Saam Tg(VAV1-cre)1Graf/0 (involves: 129S1/Sv * C57BL/6)	abnormal leukopoiesis	J:193161
	decreased lymphocyte cell number	J:193161
	decreased neutrophil cell number	J:193161
Dp(11Cops3-Rnf112)1Jrl/0 (involves: 129S7/SvEvBrd * C57BL/6)	decreased spleen weight	J:83302
Dp(16Cbr1-Fam3b)1Rhr/0 Gata1^tm8.2Sho/Y (involves: 129S1/Sv * 129S6/SvEvTac)	enlarged spleen	J:184564
	increased monocyte cell number	J:184564
Dph6^{tm1a(KOMP)Wtsi}/Dph6^{tm1a(KOMP)Wtsi} (C57BL/6N-Dph6^{tm1a(KOMP)Wtsi}/Wtsi)	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased mature B cell number	J:211773
	decreased NK T cell number	J:211773
	decreased T-helper cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD5-positive gamma-delta T cell number	J:211773
	increased CD11b-low dendritic cell number	J:211773
	increased dendritic cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased gamma-delta T cell number	J:211773
	increased granulocyte number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased KLRG1-positive T-helper cell number	J:211773
	increased marginal zone B cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker gamma-delta T cell number	J:211773
	increased monocyte cell number	J:211773
	increased plasma cell number	J:211773
	increased plasmacytoid dendritic cell number	J:211773
Dpp3^{tm1d(EUCOMM)Hmgu}/Dpp3^{tm1d(EUCOMM)Hmgu} (involves: BALB/c * C57BL/6 * C57BL/6J * C57BL/6N * SJL)	increased osteoclast cell number	J:294242
Dpp4^em1Rba/Dpp4^em1Rba (C57BL/6J-Dpp4^em1Rba)	decreased lymphocyte cell number	J:279723
	increased monocyte cell number	J:279723
	increased neutrophil cell number	J:279723
Dpp4^{tm1(DPP4)Vlcg}/? (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	increased CD4-positive, alpha-beta T cell number	J:238079
	increased CD8-positive, alpha-beta T cell number	J:238079
	increased macrophage cell number	J:238079
	increased neutrophil cell number	J:238079
Dpp4^{tm1b(EUCOMM)Wtsi}/Dpp4^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Dpp4^{tm1b(EUCOMM)Wtsi}/Ics)	decreased lymphocyte cell number	J:211773
Dpp9^{em1(IMPC)Ccpcz}/Dpp9⁺ (C57BL/6NCrl-Dpp9^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Dppa1^{tm1b(KOMP)Wtsi}/Dppa1⁺ (C57BL/6N-Dppa1^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Drc1^b2b1654Clo/Drc1^b2b1654Clo (C57BL/6J-Drc1^b2b1654Clo)	absent spleen	J:175213
Drd2^tm1Low/Drd2^tm1Low (B6.129S2-Drd2^tm1Low/J)	decreased spleen weight	J:106832
Drd2^tm1Low/Drd2^tm1Low (B6.129S2-Drd2^tm1Low/J)	microgliosis	J:194407
Drd3^em1(IMPC)Mbp/Drd3^em1(IMPC)Mbp (C57BL/6N-Drd3^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Drgx^em1(IMPC)Mbp/Drgx⁺ (C57BL/6N-Drgx^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Drosha^tm1Litt/Drosha^tm1.1Litt Foxp3^{tm4(YFP/icre)Ayr}/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	enlarged lymph nodes	J:138683
	enlarged spleen	J:138683
	increased CD8-positive, alpha-beta T cell number	J:138683
	increased leukocyte cell number	J:138683
Drosha^tm1Litt/Drosha^tm1.1Litt Foxp3^{tm4(YFP/icre)Ayr}/Foxp3^{tm4(YFP/icre)Ayr} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal regulatory T cell morphology	J:138683
	enlarged lymph nodes	J:138683
	enlarged spleen	J:138683
	increased CD8-positive, alpha-beta T cell number	J:138683
	increased leukocyte cell number	J:138683
Drosha^tm1Litt/Drosha^tm1.1Litt Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)	decreased CD8-positive, alpha-beta T cell number	J:138683
	decreased double-positive T cell number	J:138683
	decreased lymphocyte cell number	J:138683
	decreased regulatory T cell number	J:138683
	decreased thymocyte number	J:138683
	increased activated T cell number	J:138683
	increased gamma-delta T cell number	J:138683
	increased granulocyte number	J:138683
Dsg3^bal/Dsg3^bal (C57BL/6J-Dsg3^bal/J)	cutaneous mastocytosis	J:18223
Dsg3^sqk/Dsg3^sqk (C57BL/6-Dsg3^sqk)	decreased B cell number	J:219200
	decreased double-positive T cell number	J:219200
	decreased immature B cell number	J:219200
	decreased lymphocyte cell number	J:219200
	decreased pre-B cell number	J:219200
	decreased single-positive T cell number	J:219200
	decreased transitional stage B cell number	J:219200
	increased neutrophil cell number	J:219200
Dsg4^hage/Dsg4^hage Fas^lpr/Fas^lpr X/Yaa (EOD-Dsg4^hage)	abnormal effector T cell morphology	J:140028
Dsg4^hage/Dsg4^hage Fas^lpr/Fas^lpr X/Yaa (EOD-Dsg4^hage)	abnormal mast cell morphology	J:140028
Dsg4^lah-J/Dsg4^lah-J (involves: DBA/1LacJ)	abnormal peripheral lymph node morphology	J:83117
Dsp^em1(IMPC)Mbp/Dsp⁺ (C57BL/6N-Dsp^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
Dsp^em1(IMPC)Mbp/Dsp⁺ (C57BL/6N-Dsp^em1(IMPC)Mbp/MbpMmucd)	enlarged lymph nodes	J:211773
Dstn^corn1/Dstn^corn1 (A.BY-H2^bc H2-T18^f/SnJ)	abnormal lymphangiogenesis	J:98465
Dtnbp1^{tm1b(EUCOMM)Hmgu}/Dtnbp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Dtnbp1^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased lymphocyte cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Dtx1^tm1.2Mzl/Dtx1^tm1.2Mzl (B6.129-Dtx1^tm1.2Mzl)	abnormal lymphocyte morphology	J:151605
	decreased marginal zone B cell number	J:151605
	spleen hyperplasia	J:151605
Dtx4^{em1(IMPC)Ccpcz}/Dtx4⁺ (C57BL/6N-Dtx4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Duox2^em1(IMPC)Mbp/Duox2^em1(IMPC)Mbp (C57BL/6N-Duox2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
	small spleen	J:211773
Duoxa2^{tm1b(KOMP)Wtsi}/Duoxa2^{tm1b(KOMP)Wtsi} (C57BL/6N-Duoxa2^{tm1b(KOMP)Wtsi}/Wtsi)	decreased B cell number	J:211773
	decreased B-2 B cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased CD11b-high dendritic cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased follicular B cell number	J:211773
	decreased immature B cell number	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased Ly6C low monocyte number	J:211773
	decreased mature B cell number	J:211773
	decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	decreased memory-marker gamma-delta T cell number	J:211773
	decreased NK cell number	J:211773
	decreased transitional stage T1 B cell number	J:211773
	increased alpha-beta T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased neutrophil cell number	J:211773
	increased plasmacytoid dendritic cell number	J:211773
	increased T cell number	J:211773
	increased T-helper cell number	J:211773
Dusp1^tm1Brv/Dusp1^tm1Brv (C3.129S2-Dusp1^tm1Brv)	increased granulocyte number	J:164929
Dusp4^Gt(XG164)Byg/Dusp4^Gt(XG164)Byg (B6.129P2-Dusp4^Gt(XG164)Byg)	increased CD4-positive, alpha-beta T cell number	J:180366
Dusp5^tm1.1Achn/Dusp5^tm1.1Achn (involves: C57BL/6NCrl)	increased thymocyte number	J:218203
Dusp5^tm1.1Achn/Dusp5^tm1.1Achn Rag2^tm1.1Cgn/Rag2^tm1.1Cgn (involves: C57BL/6NCrl)	increased eosinophil cell number	J:218203
Dusp5^{tm1a(KOMP)Wtsi}/Dusp5^{tm1a(KOMP)Wtsi} (C57BL/6-Dusp5^{tm1a(KOMP)Wtsi})	abnormal CD8-positive, alpha beta T cell morphology	J:240637
	increased effector memory CD8-positive, alpha-beta T cell number	J:240637
Dusp6^tm1Jmol/Dusp6^tm1Jmol (involves: 129 * C57BL/6)	increased spleen weight	J:142966
Dusp10^tm1Flv/Dusp10^tm1Flv (involves: 129S6/SvEvTac)	increased activated T cell number	J:92104
Dusp14^{Gt(OST210117)Lex}/Dusp14^{Gt(OST210117)Lex} (B6.129S5-Dusp14^{Gt(OST210117)Lex})	increased T-helper 1 cell number	J:209403
	increased T-helper 17 cell number	J:209403
Dusp16^em1(IMPC)Tcp/Dusp16^em1(IMPC)Tcp (C57BL/6NCrl-Dusp16^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Dusp22^tm1Tht/Dusp22^tm1Tht (B6.129S7-Dusp22^tm1Tht)	enlarged spleen	J:213253
Dusp22^tm1Tht/Dusp22^tm1Tht (B6.129S7-Dusp22^tm1Tht)	increased spleen white pulp amount	J:213253
Dvl3^b2b2866Clo/Dvl3^b2b2866Clo (C57BL/6J-Dvl3^b2b2866Clo)	thymus hypoplasia	J:175213
Dync1li1^em1(IMPC)Tcp/Dync1li1⁺ (C57BL/6NCrl-Dync1li1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Dyrk1a^tm1Jdc/Dyrk1a^tm1Jdc Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6J * C57BL/6NTac * CBA/J)	decreased B cell number	J:223138
	decreased double-positive T cell number	J:223138
	decreased immature B cell number	J:223138
	decreased mature B cell number	J:223138
	decreased pre-B cell number	J:223138
	decreased thymocyte number	J:223138
Dyrk1b^{tm1b(EUCOMM)Wtsi}/Dyrk1b⁺ (C57BL/6N-Dyrk1b^{tm1b(EUCOMM)Wtsi}/Ics)	decreased large unstained cell number	J:211773
	decreased lymphocyte cell number	J:211773
Dyrk2^em1(IMPC)Ics/Dyrk2⁺ (C57BL/6N-Dyrk2^em1(IMPC)Ics/Ics)	decreased large unstained cell number	J:211773
Dytn^em1(IMPC)J/Dytn^em1(IMPC)J (C57BL/6NJ-Dytn^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
E2f1^{Tg(Wnt1-cre)2Sor}/E2f1⁺ Snrpb^em1Lajm/Snrpb⁺ (involves: C3H * C57BL/6 * C57BL/6J * CD1)	athymia	J:326544
E2f1^tm1Meg/E2f1^tm1Meg (either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))	abnormal double-positive T cell morphology	J:33100
	enlarged thymus	J:33100
	increased CD4-positive, alpha-beta T cell number	J:33100
	increased CD8-positive, alpha-beta T cell number	J:33100
	increased T cell derived lymphoma incidence	J:33100
	increased thymocyte number	J:33100
	increased thymus weight	J:33100
E2f1^tm1Meg/E2f1^tm1Meg (NOD.Cg-E2f1^tm1Meg)	abnormal CD4-positive, alpha beta T cell morphology	J:93708
	abnormal CD8-positive, alpha beta T cell morphology	J:93708
	abnormal double-positive T cell morphology	J:93708
	decreased double-positive T cell number	J:93708
	decreased regulatory T cell number	J:93708
	enlarged thymus	J:93708
	increased T cell number	J:93708
	increased thymocyte number	J:93708
E2f2^tm1Zubi/E2f2^tm1Zubi (involves: 129S1/Sv * C57BL/6)	abnormal immune system morphology	J:76318
	abnormal spleen white pulp morphology	J:76318
	abnormal T cell differentiation	J:76318
	abnormal T cell subpopulation ratio	J:76318
	enlarged spleen	J:76318
	increased memory T cell number	J:76318
	increased spleen weight	J:76318
E2f2^tm1Zubi/E2f2^tm1Zubi Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J)	abnormal immune system morphology	J:76318
	enlarged spleen	J:76318
	increased CD8-positive, alpha-beta T cell number	J:76318
	thymus hypoplasia	J:76318
E2f4^tm1Jrn/E2f4^tm1Jrn (involves: 129P2/OlaHsd * C57BL/6)	abnormal granulocyte morphology	J:64192
	decreased double-positive T cell number	J:64192
	decreased granulocyte number	J:64192
	decreased thymocyte number	J:64192
	increased double-negative T cell number	J:64192
	increased NK cell number	J:64192
	thymus hypoplasia	J:64192
Ebag9^tm1Rehm/Ebag9^tm1Rehm (either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal CD8-positive, alpha beta T cell morphology	J:152534
Ebf1^em1(IMPC)Mbp/Ebf1⁺ (C57BL/6N-Ebf1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
Ebf1^m1Btlr/Ebf1^m1Btlr (C57BL/6J-Ebf1^m1Btlr)	decreased B cell number	J:265157
	increased CD4-positive, alpha-beta T cell number	J:265157
	increased single-positive T cell number	J:265157
	increased T cell number	J:265157
Ebf1^m2Btlr/Ebf1^m2Btlr (C57BL/6J-Ebf1^m2Btlr)	decreased B cell number	J:265158
	decreased B-1 B cell number	J:265158
	decreased B-2 B cell number	J:265158
	increased B-1a cell number	J:265158
	increased B-1b cell number	J:265158
	increased CD4-positive, alpha-beta T cell number	J:265158
	increased single-positive T cell number	J:265158
	increased T cell number	J:265158
Ebf1^M3Btlr/Ebf1^M3Btlr (C57BL/6J-Ebf1^M3Btlr)	decreased B-1 B cell number	J:265160
	increased CD4-positive, alpha-beta T cell number	J:265160
	increased single-positive T cell number	J:265160
	increased T cell number	J:265160
Ebf1^M4Btlr/Ebf1^M4Btlr (C57BL/6J-Ebf1^M4Btlr)	decreased B cell number	J:267560
	decreased NK cell number	J:267560
	increased alpha-beta T cell number	J:267560
	increased CD4-positive, alpha-beta T cell number	J:267560
	increased CD8-positive, alpha-beta T cell number	J:267560
Ebf1^M5Btlr/Ebf1^M5Btlr (C57BL/6J-Ebf1^M5Btlr)	abnormal lymphocyte morphology	J:272841
	decreased B cell number	J:272841
	decreased B-1 B cell number	J:272841
Ebf1^m6Btlr/Ebf1^m6Btlr (C57BL/6J-Ebf1^m6Btlr)	abnormal lymphocyte morphology	J:272842
	decreased B cell number	J:272842
	decreased B-1 B cell number	J:272842
	decreased effector memory CD4-positive, alpha-beta T cell number	J:272842
	increased alpha-beta T cell number	J:272842
	increased CD4-positive, alpha-beta T cell number	J:272842
	increased CD8-positive, alpha-beta T cell number	J:272842
Ebf1^Serv/Ebf1⁺ (C57BL/6JAnu-Ebf1^Serv)	decreased B cell number	J:104190
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased B-1 B cell number	J:182210
	decreased marginal zone B cell number	J:182210
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6 * SJL)	arrested B cell differentiation	J:182210
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	decreased germinal center B cell number	J:182210
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ (involves: C57BL/6 * SJL)	arrested B cell differentiation	J:182210
	decreased germinal center B cell number	J:182210
	decreased immature B cell number	J:182210
	decreased marginal zone B cell number	J:182210
	decreased pre-B cell number	J:182210
	decreased spleen germinal center number	J:182210
	decreased transitional stage B cell number	J:182210
	increased B cell number	J:182210
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ Tg(BCL2)#Wehi/0 (involves: C57BL/6 * C57BL/6JWehi * SJL * SJL/JWehi)	decreased immature B cell number	J:182210
	decreased pre-B cell number	J:182210
Ebf1^tm1.1Rug/Ebf1^tm1.1Rug Tg(Cr2-cre)3Cgn/0 (involves: C57BL/6 * SJL)	decreased B-1 B cell number	J:182210
	decreased marginal zone B cell number	J:182210
Ebf1^tm1Rug/Ebf1^tm1Rug (involves: 129S2/SvPas)	abnormal B cell morphology	J:52607
	absent B-1 B cells	J:52607
	absent mature B cells	J:52607
	arrested B cell differentiation	J:52607
	decreased pro-B cell number	J:52607
Ebf1^tm1Rug/Ebf1^tm1Rug (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	increased osteoclast cell number	J:147179
Ebf2^em1(IMPC)Mbp/Ebf2⁺ (C57BL/6N-Ebf2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Ebi3^Gt716Lex/Ebi3^Gt716Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal CD4-positive, alpha-beta T cell number	J:286951
	increased CD8-positive, alpha-beta T cell number	J:286951
	increased macrophage cell number	J:286951
Ebi3^Gt716Lex/Ebi3^Gt716Lex Tg(DO11.10)10Dlo/0 (involves: 129S5/SvEvBrd * BALB/c * C3H * C57BL/6)	abnormal T cell differentiation	J:134148
Ebi3^tm1Rsb/Ebi3^tm1Rsb (involves: 129X1/SvJ * C57BL/6)	abnormal immune system morphology	J:81014
	abnormal T-helper 1 cell morphology	J:97822
	abnormal T-helper 2 cell morphology	J:97822
	decreased NK cell number	J:81014
	decreased T-helper 2 cell number	J:81014
Ebna1bp2^em1(IMPC)Tcp/Ebna1bp2⁺ (C57BL/6N-Ebna1bp2^em1(IMPC)Tcp/Cmmr)	enlarged spleen	J:211773
Ece1^tm1Reh/Ece1^tm1Reh (involves: 129S6/SvEvTac * C57BL/6)	persistent cervical thymus	J:46640
Ecm1^{tm1b(EUCOMM)Hmgu}/Ecm1⁺ (C57BL/6N-Ecm1^{tm1b(EUCOMM)Hmgu}/H)	decreased neutrophil cell number	J:211773
Ecrg4^{tm1b(EUCOMM)Hmgu}/Ecrg4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ecrg4^{tm1b(EUCOMM)Hmgu}/Orl)	decreased large unstained cell number	J:211773
Ecscr^{tm1.1(KOMP)Vlcg}/Ecscr^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ecscr^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal thymus morphology	J:211773
	small thymus	J:211773
Edc3^em1(IMPC)Tcp/Edc3⁺ (C57BL/6NCrl-Edc3^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Edc3^em1(IMPC)Tcp/Edc3^em1(IMPC)Tcp (C57BL/6NCrl-Edc3^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Eddm3b^{tm1b(KOMP)Wtsi}/Eddm3b^{tm1b(KOMP)Wtsi} (C57BL/6N-Eddm3b^{tm1b(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Ednra^tm1Ywa/Ednra^tm1Ywa (129S/SvEv-Ednra^tm1Ywa)	ectopic thymus	J:46639
Ednra^tm1Ywa/Ednra^tm1Ywa (129S/SvEv-Ednra^tm1Ywa)	thymus hypoplasia	J:46639
Ednrb^tm1Nrd/Ednrb^tm1Nrd Gt(ROSA)26Sor^{tm14(CAG-tdTomato)Hze}/Gt(ROSA)26Sor⁺ H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * CBA/J)	abnormal mature B cell number	J:233811
	abnormal Peyer's patch morphology	J:233811
	abnormal spleen morphology	J:233811
	abnormal splenic cell ratio	J:233811
	decreased B cell number	J:233811
	decreased germinal center B cell number	J:233811
	decreased marginal zone B cell number	J:233811
	decreased spleen red pulp amount	J:233811
	decreased spleen weight	J:233811
	decreased spleen white pulp amount	J:233811
	small Peyer's patches	J:233811
	small spleen	J:233811
Eef1a1^tm2Arge/Eef1a1⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal double-positive T cell morphology	J:197167
Eef1a2^wst/Eef1a2^wst (B6C3Fe a/a-Eef1a2^wst/J)	decreased plasma cell number	J:7903
	decreased spleen weight	J:6766
	decreased thymus weight	J:6766
	lymphoid hypoplasia	J:6766
	small lymph nodes	J:6766
Eef1a2^wst/Eef1a2^wst (Not Specified)	thymus atrophy	J:50410
Eef1d^em1(IMPC)Mbp/Eef1d⁺ (C57BL/6NCrl-Eef1d^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Efemp1^tm2Lmar/Efemp1^tm2Lmar (involves: 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:132043
	decreased spleen weight	J:132043
Efhd2^{tm1(KOMP)Vlcg}/Efhd2^{tm1(KOMP)Vlcg} (C57BL/6-Efhd2^{tm1(KOMP)Vlcg})	increased germinal center B cell number	J:228565
	increased plasma cell number	J:228565
	increased spleen germinal center size	J:228565
Efnb1^tm1.1Jwu/Efnb1^tm1.1Jwu Efnb2^tm1.1Jwu/Efnb2^tm1.1Jwu Tg(Lck-cre)I540Jxm/0 (B6.Cg-Efnb2^tm1.1Jwu Efnb1^tm1.1Jwu Tg(Lck-cre)I540Jxm)	abnormal T cell differentiation	J:178148
	abnormal T-helper 1 cell differentiation	J:178148
	abnormal T-helper 17 cell differentiation	J:178148
	decreased CD4-positive, alpha-beta T cell number	J:178148
	decreased CD8-positive, alpha-beta T cell number	J:178148
	decreased DN4 thymocyte number	J:178148
	decreased double-positive T cell number	J:178148
	decreased spleen weight	J:178148
	decreased T cell number	J:178148
	decreased thymus weight	J:178148
	increased DN3 thymocyte number	J:178148
	increased double-negative T cell number	J:178148
	small spleen	J:178148
	small thymus	J:178148
	spleen hypoplasia	J:178148
	thymus hypoplasia	J:178148
Efnb2^tm5.1Kln/Efnb2^tm5.1Kln (involves: C57BL/6)	abnormal afferent lymphatic vessel morphology	J:95885
Efnb2^tm5.1Kln/Efnb2^tm5.1Kln (involves: C57BL/6)	abnormal lymphatic vessel morphology	J:95885
Efnb2^tm5.1Kln/Efnb2^tm5.1Kln (involves: CD-1)	abnormal lymphatic vessel morphology	J:95885
Efnb2^tm5.1Kln/Efnb2^tm5.1Kln Flt4^tm1Ali/Flt4⁺ (involves: C57BL/6)	abnormal afferent lymphatic vessel morphology	J:95885
	abnormal lymphatic vessel morphology	J:95885
Efnb2^tm6Kln/Efnb2^tm6Kln (involves: C57BL/6)	abnormal lymphatic vessel morphology	J:95885
Eftud2^{tm1b(KOMP)Wtsi}/Eftud2⁺ (C57BL/6N-Eftud2^{tm1b(KOMP)Wtsi}/Ics)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Egfr^{tm1a(EUCOMM)Wtsi}/Egfr⁺ (C57BL/6N-Egfr^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Egfr^tm1Dwt/Egfr^tm1Dwt Sox9^tm3(cre)Crm/Sox9⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	increased T-helper 1 cell number	J:229771
	increased T-helper 2 cell number	J:229771
	increased T-helper 17 cell number	J:229771
Egln1^tm1.1Brei/Egln1^tm1.1Brei Tg(CD68-icre)1Bwlx/0 (involves: C57BL/6)	abnormal lymphocyte cell number	J:194598
	abnormal spleen morphology	J:194598
	enlarged spleen	J:194598
	increased spleen weight	J:194598
Egln1^tm1.1Fsl/Egln1⁺ (C57BL/6-Egln1^tm1.1Fsl)	increased spleen weight	J:202737
Egln1^tm1Fong/Egln1^tm1Fong (involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL)	abnormal lymph organ development	J:114669
Egln1^tm2.1Fsl/Egln1^tm2.1Fsl Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} Egln1^tm2.1Fsl)	increased spleen weight	J:202737
Egln1^tm2.1Fsl/Egln1^tm2.1Fsl Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Hif1a^tm3Rsjo/Hif1a^tm3Rsjo (B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} Egln1^tm2.1Fsl Hif1a^tm3Rsjo)	increased spleen weight	J:202737
Egln1^tm2.1Fsl/Egln1^tm2.1Fsl Pax3^tm1(cre)Joe/Pax3⁺ (involves: 129 * C57BL/6)	increased spleen weight	J:202737
Egln1^tm2.2Fsl/Egln1⁺ (B6.Cg-Egln1^tm2.2Fsl)	increased spleen weight	J:202737
Egln1^tm2Fong/Egln1^tm2Fong Gt(ROSA)26Sor^{tm1(cre/ERT2)Alj}/Gt(ROSA)26Sor⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal splenic cell ratio	J:132720
	enlarged spleen	J:132720
	increased leukocyte cell number	J:132720
Egln2^tm1Fong/Egln2^tm1Fong Egln3^tm1Fong/Egln3^tm1Fong (involves: 129S6/SvEvTac * C57BL/6)	abnormal splenic cell ratio	J:132720
	enlarged spleen	J:132720
Egr1^{tm1b(NCOM)Mfgc}/Egr1⁺ (C57BL/6N-Egr1^{tm1b(NCOM)Mfgc}/Tcp)	increased lymphocyte cell number	J:211773
Egr1^tm1Jmi/Egr1^tm1Jmi (B6.129-Egr1^tm1Jmi)	increased osteoclast cell number	J:51107
Egr1^tm1Jmi/Egr1^tm1Jmi (involves: 129 * C57BL/6)	abnormal leukocyte cell number	J:123870
	abnormal leukocyte morphology	J:123870
	abnormal neutrophil morphology	J:123870
	increased lymphocyte cell number	J:123870
	increased spleen weight	J:123870
	increased T cell derived lymphoma incidence	J:123870
Ehmt1^{tm1b(EUCOMM)Hmgu}/Ehmt1⁺ (C57BL/6N-Ehmt1^{tm1b(EUCOMM)Hmgu}/Nju)	increased neutrophil cell number	J:211773
Eid2b^em1(IMPC)J/Eid2b⁺ (C57BL/6NJ-Eid2b^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Eif1ad^{tm1b(EUCOMM)Hmgu}/Eif1ad⁺ (C57BL/6N-Eif1ad^{tm1b(EUCOMM)Hmgu}/Bay)	increased large unstained cell number	J:211773
Eif2a^em1(IMPC)Mbp/Eif2a^em1(IMPC)Mbp (C57BL/6N-Eif2a^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Eif2ak1^em1(IMPC)Bay/Eif2ak1^em1(IMPC)Bay (C57BL/6N-Eif2ak1^em1(IMPC)Bay/BayMmucd)	increased spleen weight	J:211773
Eif2ak2^em1(IMPC)Mbp/Eif2ak2^em1(IMPC)Mbp (C57BL/6N-Eif2ak2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Eif2ak2^em1Btlr/Eif2ak2^em1Btlr Zfp574^em1Btlr/Zfp574^em1Btlr (C57BL/6J-Zfp574^em1Btlr Eif2ak2^em1Btlr)	abnormal class switch recombination	J:354285
	decreased lymphocyte cell number	J:354285
Eif2d^em1(IMPC)Mbp/Eif2d^em1(IMPC)Mbp (C57BL/6N-Eif2d^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Eif2s2^em3(IMPC)Bay/Eif2s2⁺ (C57BL/6N-Eif2s2^em3(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Eif4a1^tm1.1Bea/Eif4a1^tm1.1Bea Tg(Fcer2a-cre)5Mbu/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased germinal center B cell number	J:344730
Eif4b^tm1.1Smoc/Eif4b^tm1.1Smoc Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ (involves: 129 * C57BL/6)	decreased leukocyte cell number	J:311140
	decreased lymphocyte cell number	J:311140
	decreased NK cell number	J:311140
	increased macrophage cell number	J:311140
	increased neutrophil cell number	J:311140
	small spleen	J:311140
	small thymus	J:311140
Eif4g1^{em1(IMPC)Hmgu}/Eif4g1⁺ (C57BL/6NCrl-Eif4g1^{em1(IMPC)Hmgu}/Ieg)	decreased spleen weight	J:211773
Elapor1^{tm1b(EUCOMM)Hmgu}/Elapor1⁺ (C57BL/6N-Elapor1^{tm1b(EUCOMM)Hmgu}/Ics)	decreased lymphocyte cell number	J:211773
Elavl1^tm1.1Atas/Elavl1^tm1.1Atas Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129X1/SvJ * C57BL/6)	decreased T-helper 17 cell number	J:207013
Elavl1^tm1.1Dkon/Elavl1^tm1.1Dkon Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6.129P2-Elavl1^tm1.1Dkon Lyz2^tm1(cre)Ifo)	increased macrophage cell number	J:184388
	increased monocyte cell number	J:184388
Elavl1^tm1.1Thla/Elavl1⁺ (involves: 129S1/Sv)	spleen hypoplasia	J:155109
Elavl1^tm1.1Thla/Elavl1⁺ (involves: 129S1/Sv)	thymus hypoplasia	J:155109
Elavl1^tm1Dkon/Elavl1^tm1Dkon Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal spleen development	J:149149
	absent spleen	J:149149
Elavl1^tm1Dkon/Elavl1^tm1Dkon Tg(Lck-cre)I57Jxm/0 (B6.Cg-Elavl1^tm1Dkon Tg(Lck-cre)I57Jxm)	abnormal positive T cell selection	J:148866
	decreased CD4-positive, alpha-beta T cell number	J:148866
	decreased CD8-positive, alpha-beta T cell number	J:148866
	increased double-negative T cell number	J:148866
	increased double-positive T cell number	J:148866
	increased single-positive T cell number	J:148866
Elavl1^tm1Dkon/Elavl1^tm1Dkon Tg(Lck-cre)I57Jxm/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/? (B6.Cg-Elavl1^tm1Dkon Tg(Lck-cre)I57Jxm Tg(TcraH-Y,TcrbH-Y)71Vbo)	abnormal negative T cell selection	J:148866
	increased thymocyte number	J:148866
Elavl1^tm1Thla/Elavl1^tm1Thla Gt(ROSA)26Sor^{tm1(cre/ERT2)Alj}/Gt(ROSA)26Sor⁺ (involves: 129)	abnormal myeloid leukocyte morphology	J:155109
	decreased double-positive T cell number	J:155109
	decreased granulocyte number	J:155109
	decreased leukocyte cell number	J:155109
	increased granulocyte number	J:155109
	lymph node hypoplasia	J:155109
	spleen hypoplasia	J:155109
	thymus hypoplasia	J:155109
Elf1^tm1Jml/Elf1^tm1Jml (Not Specified)	abnormal B cell differentiation	J:100734
Elf4^em1Hdu/Elf4^em1Hdu (C57BL/6-Elf4^em1Hdu)	abnormal CD4-positive T cell differentiation	J:328935
Elf4^tm1Nim/Elf4^tm1Nim (B6.129S1-Elf4^tm1Nim)	abnormal lymphocyte morphology	J:79568
	abnormal T cell differentiation	J:79568
	decreased NK cell number	J:79568
	decreased NK T cell number	J:79568
	increased B cell number	J:79568
	large lymphoid organs	J:79568
Elfn2^{tm1.1(KOMP)Vlcg}/Elfn2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Elfn2^{tm1.1(KOMP)Vlcg}/Ucd)	increased eosinophil cell number	J:211773
Elk3^tm1Wlyk/Elk3^tm1Wlyk (either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))	lymphangiectasis	J:71816
Elk4^{tm1a(EUCOMM)Wtsi}/Elk4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Elk4^{tm1a(EUCOMM)Wtsi}/H)	decreased CD4-positive, alpha-beta T cell number	J:165965
	decreased CD8-positive, alpha-beta T cell number	J:165965
	decreased mature B cell number	J:165965
	decreased T cell number	J:165965
	increased B cell number	J:165965
	increased T cell number	J:165965
Elk4^tm1Rtr/Elk4^tm1Rtr (either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))	abnormal positive T cell selection	J:88515
	abnormal T cell selection	J:88515
	decreased CD4-positive, alpha-beta T cell number	J:88515
	decreased CD8-positive, alpha-beta T cell number	J:88515
	decreased single-positive T cell number	J:88515
	decreased T cell number	J:88515
	decreased thymocyte number	J:88515
Elk4^tm1Rtr/Elk4^tm1Rtr Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129/Sv * C57BL/6 * DBA/2J)	abnormal positive T cell selection	J:88515
	decreased CD8-positive, alpha-beta T cell number	J:88515
Elk4^tm1Rtr/Elk4^tm1Rtr Tg(TcraTcrb)425Cbn/? (involves: 129/Sv * C57BL/6)	abnormal positive T cell selection	J:88515
	abnormal splenic cell ratio	J:88515
	decreased CD4-positive, alpha-beta T cell number	J:88515
Elk4^tm1Rtr/Elk4^tm1Rtr Tg(TcrLCMV)327Sdz/? (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal positive T cell selection	J:88515
	decreased CD8-positive, alpha-beta T cell number	J:88515
Elmo1^M1Btlr/Elmo1^M1Btlr (C57BL/6J-Elmo1^M1Btlr)	decreased B cell number	J:265231
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:265231
	increased B-1 B cell number	J:265231
	increased CD8-positive, alpha-beta memory T cell number	J:265231
Elmo1^m2Btlr/Elmo1^m2Btlr (C57BL/6J-Elmo1^m2Btlr)	decreased B cell number	J:265232
Elmo1^m3Btlr/Elmo1^m3Btlr (C57BL/6J-Elmo1^m3Btlr)	decreased central memory CD8 positive, alpha-beta T cell number	J:271894
	decreased NK cell number	J:271894
	increased CD8-positive, alpha-beta T cell number	J:271894
Elmo1^M4Btlr/Elmo1^M4Btlr (C57BL/6J-Elmo1^M4Btlr)	abnormal B cell morphology	J:271969
	abnormal T cell morphology	J:271969
	decreased CD4-positive, alpha-beta T cell number	J:271969
	increased B-1 B cell number	J:271969
	increased CD8-positive, alpha-beta T cell number	J:271969
Elmo1^{tm1a(EUCOMM)Wtsi}/Elmo1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Elmo1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Elmod1^{tm1a(EUCOMM)Hmgu}/Elmod1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Elmod1^{tm1a(EUCOMM)Hmgu}/H)	decreased B cell number	J:165965
	decreased leukocyte cell number	J:165965
Elmod1^{tm1b(EUCOMM)Hmgu}/Elmod1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Elmod1^{tm1b(EUCOMM)Hmgu}/H)	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Emc4^{tm1(KOMP)Wtsi}/Emc4⁺ (C57BL/6N-Emc4^{tm1(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Emc8^{tm1b(EUCOMM)Hmgu}/Emc8⁺ (C57BL/6N-Emc8^{tm1b(EUCOMM)Hmgu}/H)	increased neutrophil cell number	J:211773
Eme1^{tm1.1(KOMP)Wtsi}/Eme1^{tm1.1(KOMP)Wtsi} (C57BL/6N-Eme1^{tm1.1(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Eml3^em1(IMPC)J/Eml3⁺ (C57BL/6NJ-Eml3^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Emp2^tm1.1Tac/Emp2^tm1.1Tac Tg(Zp3-cre)93Knw/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N)	increased leukocyte cell number	J:243365
	increased uterine NK cell number	J:243365
Emsy^{em1(IMPC)Ccpcz}/Emsy⁺ (C57BL/6NCrl-Emsy^{em1(IMPC)Ccpcz}/Ccpcz)	increased NK cell number	J:211773
Emv30^b/Emv30^b Prkdc^scid/Prkdc^scid (NOD.Cg-Emv30^b Prkdc^scid/Dvs)	increased T cell derived lymphoma incidence	J:29951
Emv72^b/Emv72^b (CAnNCr.B6NCr-Emv72^b)	abnormal T cell morphology	J:194735
En1^tm1(Tnf)Fpit/En1^tm1(Tnf)Fpit (involves: C57BL/6)	increased monocyte cell number	J:170743
En1^tm1(Tnf)Fpit/En1^tm1(Tnf)Fpit (involves: C57BL/6)	microgliosis	J:170743
Eng^em1(IMPC)Mbp/Eng⁺ (C57BL/6N-Eng^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Enkur^tm1Hmf/Enkur^tm1Hmf (involves: 129 * C57BL/6J)	abnormal spleen morphology	J:253966
Enkur^tm1Hmf/Enkur^tm1Hmf (involves: 129 * C57BL/6J)	absent spleen	J:253966
Enpp1^{em1(IMPC)Ccpcz}/Enpp1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Enpp1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	small thymus	J:211773
Enpp3^tm1Ktak/Enpp3^tm1Ktak (either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c * C57BL/6))	increased basophil cell number	J:223825
	increased mast cell number	J:223825
Enpp3^tm1Ktak/Enpp3^tm1Ktak P2rx7^tm1Gab/P2rx7^tm1Gab (either: (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) or (involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6))	increased basophil cell number	J:223825
	increased mast cell number	J:223825
Entpd1^{tm1a(EUCOMM)Wtsi}/Entpd1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Entpd1^{tm1a(EUCOMM)Wtsi}/Ieg)	increased T cell number	J:165965
Entpd1^tm1Rdr/Entpd1^tm1Rdr (involves: 129S2/SvPas)	spleen fibrosis	J:57505
Entpd5^tm1Rre/Entpd5^tm1Rre (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal Kupffer cell morphology	J:163795
Entpd7^tm1Ktak/Entpd7^tm1Ktak (B6.Cg-Entpd7^tm1Ktak)	abnormal CD4-positive, alpha-beta T cell number	J:191188
Entpd7^tm1Ktak/Entpd7^tm1Ktak (B6.Cg-Entpd7^tm1Ktak)	increased T-helper 17 cell number	J:191188
Eomes^tm1.1Bflu/Eomes^tm1.1Bflu Tbx21^tm1Glm/Tbx21^tm1Glm Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:163822
	decreased CD8-positive, alpha-beta T cell number	J:163822
	decreased memory T cell number	J:163822
Eomes^tm1.1Bflu/Eomes^tm1.1Bflu Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	decreased memory T cell number	J:163822
Eomes^tm1.1Twa/? Il15^tm1Imx/Il15^tm1Imx (involves: C57BL/6 * C57BL/6N)	abnormal NK cell differentiation	J:210160
Eomes^tm1.1Twa/? Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac * C57BL/6N)	abnormal NK cell differentiation	J:210160
Eomes^tm1.1Twa/? Tg(CD2-Tbx21)#Staka/? (involves: C57BL/6N)	abnormal NK cell differentiation	J:210160
Eomes^tm1.1Twa/? Tg(Itgax-TGFBR2)1Flv/? (involves: C3H * C57BL/6 * C57BL/6N)	abnormal NK cell differentiation	J:210160
Eomes^tm1Apr/Eomes⁺ (involves: C57BL/6)	decreased memory T cell number	J:112679
Eomes^tm1Apr/Eomes⁺ (involves: C57BL/6)	decreased NK cell number	J:112679
Eomes^tm1Apr/Eomes⁺ Tbx21^tm1Srnr/Tbx21^tm1Srnr (involves: C57BL/6)	decreased memory T cell number	J:112679
	decreased NK cell number	J:112679
	decreased NK T cell number	J:112679
Eomes^tm1Srnr/Eomes^tm1Srnr Tbx21^tm1Srnr/Tbx21^tm1Srnr Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD8-positive, alpha-beta T cell differentiation	J:137655
	abnormal T cell morphology	J:137655
	decreased CD8-positive, alpha-beta T cell number	J:137655
	decreased memory T cell number	J:137655
	increased neutrophil cell number	J:137655
Eomes^tm1Srnr/Eomes^tm1Srnr Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	decreased memory T cell number	J:137655
Ep300^Plt6/Ep300⁺ Mpl^tm1Wsa/Mpl^tm1Wsa (involves: 129S1/Sv * C57BL/6)	increased eosinophil cell number	J:140200
Ep300^Plt6/Ep300^Plt6 (involves: 129S1/Sv * C57BL/6)	decreased B cell number	J:140200
	decreased eosinophil cell number	J:140200
	decreased leukocyte cell number	J:140200
	decreased lymphocyte cell number	J:140200
Ep300^tm1Pkb/Ep300⁺ Myb^tm1Ssp/Myb⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased thymocyte number	J:98329
Ep300^tm1Pkb/Ep300^tm1Pkb (involves: 129P2/OlaHsd * C57BL/6)	decreased thymocyte number	J:98329
Ep300^tm2Pkb/Ep300^tm2Pkb Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased single-positive T cell number	J:105505
	decreased thymocyte number	J:105505
	increased double-positive T cell number	J:105505
	small thymus	J:105505
Epas1^tm1.1Fsl/Epas1⁺ (involves: C57BL/6 * C57BL/6NTac)	increased leukocyte cell number	J:199595
	increased lymphocyte cell number	J:199595
	increased monocyte cell number	J:199595
Epas1^tm1.1Fsl/Epas1^tm1.1Fsl (involves: C57BL/6 * C57BL/6NTac)	increased leukocyte cell number	J:199595
	increased monocyte cell number	J:199595
	increased spleen weight	J:199595
Epas1^tm1Mcs/Epas1^tm1.1Mcs Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129X1/SvJ * FVB/N)	enlarged spleen	J:119731
Epb41^tm1Cnby/Epb41^tm1Cnby (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ)	decreased spleen iron level	J:77852
	enlarged spleen	J:77852
	increased spleen red pulp amount	J:77852
Epb42^tm1Llp/Epb42^tm1Llp (involves: 129P2/OlaHsd * C57BL/6J)	increased spleen iron level	J:67412
	increased spleen weight	J:67412
Epc1^{tm1a(EUCOMM)Wtsi}/Epc1⁺ (Not Specified)	decreased leukocyte cell number	J:175295
Epcam^tm1.1Mcu/Epcam^tm1.1Mcu Tg(CD207-cre)1Dhka/0 (involves: 129 * C57BL/6 * C57BL/6J * SJL/J)	abnormal Langerhans cell morphology	J:182665
Epdr1^{tm1b(NCOM)Mfgc}/Epdr1^{tm1b(NCOM)Mfgc} (C57BL/6N-Epdr1^{tm1b(NCOM)Mfgc}/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Epg5^em1(IMPC)H/Epg5^em1(IMPC)H (C57BL/6NTac-Epg5^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Epg5^tm1Ygz/Epg5^tm1Ygz (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	microgliosis	J:196603
Epgn^tm1.1Msdr/Epgn^tm1.1Msdr (involves: 129P2/OlaHsd * C57BL/6N)	increased spleen weight	J:194427
Epha2^em1(IMPC)Mbp/Epha2^em1(IMPC)Mbp (C57BL/6N-Epha2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Epha3^em1(IMPC)Mbp/Epha3^em1(IMPC)Mbp (C57BL/6N-Epha3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Epha6^{tm1b(KOMP)Wtsi}/Epha6^{tm1b(KOMP)Wtsi} (C57BL/6N-Epha6^{tm1b(KOMP)Wtsi}/Tcp)	abnormal spleen morphology	J:211773
Ephb1^em1(IMPC)Mbp/Ephb1^em1(IMPC)Mbp (C57BL/6N-Ephb1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Ephb2^em1(IMPC)Mbp/Ephb2^em1(IMPC)Mbp (C57BL/6N-Ephb2^em1(IMPC)Mbp/MbpMmucd)	enlarged spleen	J:211773
	small spleen	J:211773
epi/? (involves: CBA/J)	decreased leukocyte cell number	J:27487
	decreased lymphocyte cell number	J:27487
	increased neutrophil cell number	J:27487
Epm2a^{Tg(TcraK,TcrbK)TG-BFlv}/Epm2a⁺ (involves: C57BL/6J * CBA/J)	increased CD8-positive, alpha-beta T cell number	J:107545
Epm2a^{Tg(TcraK,TcrbK)TG-BFlv}/Epm2a⁺ (involves: C57BL/6 * C57BL/10 * C57BR/cd * CBA/J)	increased T cell derived lymphoma incidence	J:112696
Epo^{Tg(TAg/Epo)134.3LCPjr}/Epo^{Tg(TAg/Epo)134.3LCPjr} (involves: C57BL/6 * CBA)	increased spleen weight	J:79374
Epor^tm1.2Jtp/Epor^tm1.2Jtp (involves: 129P2/OlaHsd * C57BL/6)	decreased spleen weight	J:67205
Eppin^em1(IMPC)Mbp/Eppin^em1(IMPC)Mbp (C57BL/6N-Eppin^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Eps8l2^{tm1b(EUCOMM)Wtsi}/Eps8l2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Eps8l2^{tm1b(EUCOMM)Wtsi}/H)	increased basophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased monocyte cell number	J:211773
Eps15^{tm1a(KOMP)Wtsi}/Eps15^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Eps15^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:165965
Eps15^tm1Noff/Eps15^tm1Noff (B6.129-Eps15^tm1Noff)	abnormal spleen B cell follicle morphology	J:195689
	abnormal spleen marginal zone morphology	J:195689
	abnormal spleen white pulp morphology	J:195689
	decreased B cell number	J:195689
	decreased leukocyte cell number	J:195689
	decreased lymphocyte cell number	J:195689
	increased marginal zone B cell number	J:195689
Eps15^tm1Noff/Eps15^tm1Noff (involves: 129 * C57BL/6)	abnormal marginal zone B cell morphology	J:195689
	increased marginal zone B cell number	J:195689
	increased transitional stage T1 B cell number	J:195689
Epsti1^em1Mjnh/Epsti1^em1Mjnh (Not Specified)	abnormal macrophage differentiation	J:272013
Epsti1^em1Mjnh/Epsti1^em1Mjnh (Not Specified)	decreased macrophage cell number	J:272013
Epx^{tm1.1(cre)Jlee}/Epx⁺ Gt(ROSA)26Sor^tm1(DTA)Lky/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased eosinophil cell number	J:198489
Epx^{tm1b(EUCOMM)Wtsi}/Epx^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Epx^{tm1b(EUCOMM)Wtsi}/Orl)	increased monocyte cell number	J:211773
Epx^tm1Nal/Epx^tm1Nal (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal eosinophil morphology	J:70567
Erap1^tm1Dgen/Erap1^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:101679
	thymus hyperplasia	J:101679
Erbb4^tm1Grl/Erbb4^tm1Grl Tg(Myh6-ERBB4)HT2Gass/0 (involves: 129S1/Sv * 129X1/SvJ)	increased granulocyte number	J:132190
Ercc1^tm1Jhjh/Ercc1^tm1Jhjh (involves: C57BL/6 * FVB/N)	abnormal class switch recombination	J:92471
Ercc1^tm1Jhjh/Ercc1^tm1Jhjh (involves: C57BL/6 * FVB/N)	spleen hypoplasia	J:92471
Ercc1^tm2Jhjh/Ercc1^tm2Jhjh (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:41161
Ercc2^{tm2(ERCC2)Jhjh}/Ercc2^{tm2(ERCC2)Jhjh} (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:76608
Ercc2^tm3Jhjh/Ercc2^tm3Jhjh (involves: 129 * C57BL/6J)	microgliosis	J:179808
Ercc5^tm1Shm/Ercc5^tm1Shm (involves: 129S2/SvPas * C57BL/6J)	decreased spleen weight	J:53756
Ercc6^tm1Gvh/Ercc6^tm1Gvh (involves: 129P2/OlaHsd * C57BL/6J)	microgliosis	J:179808
Ercc6^tm1Gvh/Ercc6^tm1Gvh Xpa^tm1Gvh/Xpa^tm1Hvs Tg(Camk2a-cre)1Szi/0 (involves: 129P2/OlaHsd * C57BL/6J * CBA)	microgliosis	J:179808
Ercc6^tm1Gvh/Ercc6^tm1Gvh Xpa^tm1Gvh/Xpa^tm1Hvs Tg(Pcp2-cre)2Mpin/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)	microgliosis	J:179808
Ercc6l2^em1Mengf/Ercc6l2^em1Mengf (Not Specified)	abnormal class switch recombination	J:311900
Ercc6l2^em1Mengf/Ercc6l2^em1Mengf (Not Specified)	decreased T cell number	J:311900
Ercc6l2^em1Mengf/Ercc6l2^em1Mengf Nhej1^em1Mengf/Nhej1^em1Mengf (Not Specified)	abnormal T cell receptor V(D)J recombination	J:311900
Ercc6l2^em2Mengf/Ercc6l2^em2Mengf (Not Specified)	abnormal class switch recombination	J:311900
Ercc8^tm1Jhjh/Ercc8^tm1Jhjh (involves: 129P2/OlaHsd * C57BL/6J)	microgliosis	J:179808
Erg^em1(IMPC)Bay/Erg⁺ (C57BL/6N-Erg^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Erg^em1(IMPC)Bay/Erg⁺ (C57BL/6N-Erg^em1(IMPC)Bay/Bay)	decreased leukocyte cell number	J:211773
Erg^mld2/Erg⁺ (involves: 129S1/Sv * C57BL/6)	decreased transitional stage B cell number	J:137835
Erg^mld2/Erg⁺ Mpl^tm1Wsa/Mpl^tm1Wsa (B6.Cg-Mpl^tm1Wsa Erg^mld2)	decreased leukocyte cell number	J:137835
Erlec1^em1(IMPC)Mbp/Erlec1^em1(IMPC)Mbp (C57BL/6N-Erlec1^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Erlin1^em1(IMPC)Tcp/Erlin1^em1(IMPC)Tcp (C57BL/6N-Erlin1^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
Ern1^tm1Rjk/Ern1^tm1Rjk (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal pro-B cell morphology	J:106975
Errfi1^tm1Gvw/Errfi1^tm1Gvw (Not Specified)	enlarged thymus	J:100927
Espl1^Gt(XL058)Byg/Espl1⁺ Trp53^tm1Tyj/Trp53^tm1Tyj (B6.129-Trp53^tm1Tyj Espl1^Gt(XL058)Byg)	abnormal splenocyte morphology	J:174926
Esr1^tm1.1Scma/Esr1^tm1.1Scma Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	increased osteoclast cell number	J:156947
Esr1^tm1Arnal/Esr1^tm1Arnal (involves: C57BL/6)	increased osteoclast cell number	J:171276
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell number	J:82423
	abnormal class switch recombination	J:82423
	abnormal lymph node cell ratio	J:88156
	decreased CD4-positive, alpha-beta T cell number	J:110416
	decreased CD8-positive, alpha-beta T cell number	J:110416
	increased double-positive T cell number	J:110416
	increased plasma cell number	J:88156
	increased spleen germinal center number	J:88156
	thymus hypoplasia	J:110416
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd)	decreased immature B cell number	J:110923
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd)	decreased mature B cell number	J:110923
Esr1^tm1Ksk/Esr1^tm1Ksk (involves: 129P2/OlaHsd * C57BL/6N)	abnormal B cell differentiation	J:63462
	decreased B cell number	J:63462
	decreased immature B cell number	J:63462
	decreased mature B cell number	J:63462
	decreased thymocyte number	J:111590
	decreased thymus weight	J:111590
Esr1^tm1Ksk/Esr1^tm1Ksk Esr2^tm1Unc/Esr2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell number	J:82423
	abnormal class switch recombination	J:82423
	decreased CD4-positive, alpha-beta T cell number	J:110416
	decreased CD8-positive, alpha-beta T cell number	J:110416
	decreased spleen weight	J:110416
	increased double-positive T cell number	J:110416
	thymus hypoplasia	J:110416
Esr2^tm1Mma/Esr2^tm1Mma (involves: 129S2/SvPas)	increased neutrophil cell number	J:165719
Esr2^tm1Unc/Esr2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell number	J:82423
	abnormal leukopoiesis	J:83617
	abnormal lymphopoiesis	J:83617
	enlarged lymph nodes	J:83617
	enlarged spleen	J:83617
	increased granulocyte number	J:83617
	increased leukocyte cell number	J:83617
	increased monocyte cell number	J:83617
	increased neutrophil cell number	J:83617
	increased pre-B cell number	J:83617
	increased pro-B cell number	J:83617
	spleen hyperplasia	J:83617
	spleen hypoplasia	J:110416
Esrp2^em1(IMPC)Tcp/Esrp2^em1(IMPC)Tcp (C57BL/6NCrl-Esrp2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Esrra^tm1Vgi/Esrra^tm1Vgi (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast differentiation	J:160910
	decreased osteoclast cell number	J:160910
	increased splenocyte number	J:160910
Ess2^tm1.1Nbioc/Ess2^tm1.1Nbioc Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6N * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:339504
	decreased CD8-positive, alpha-beta T cell number	J:339504
	decreased CD8-positive, naive alpha-beta T cell number	J:339504
	decreased memory T cell number	J:339504
	increased gamma-delta T cell number	J:339504
	increased NK T cell number	J:339504
Esyt2^{tm2b(KOMP)Wtsi}/Esyt2⁺ (C57BL/6N-Esyt2^{tm2b(KOMP)Wtsi}/Bay)	enlarged spleen	J:211773
Etfb^{em1(IMPC)Hmgu}/Etfb⁺ (C57BL/6NCrl-Etfb^{em1(IMPC)Hmgu}/Ieg)	increased spleen weight	J:211773
Etnk1^{tm1b(EUCOMM)Wtsi}/Etnk1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Etnk1^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Ets1^tm1.1Dds/Ets1⁺ (129S6/SvEvTac-Ets1^tm1.1Dds)	abnormal thymus morphology	J:121460
	decreased memory T cell number	J:121460
	enlarged thymus	J:121460
	increased thymus weight	J:121460
Ets1^tm1.1Dds/Ets1^tm1.1Dds (129S6/SvEvTac-Ets1^tm1.1Dds)	abnormal CD8-positive, alpha beta T cell morphology	J:121460
	abnormal lymphopoiesis	J:121460
	abnormal spleen morphology	J:121460
	abnormal spleen red pulp morphology	J:121460
	abnormal thymus cortex morphology	J:121460
	abnormal thymus morphology	J:121460
	abnormal thymus subcapsular epithelium morphology	J:121460
	decreased B cell number	J:121460
	decreased CD4-positive, alpha-beta T cell number	J:121460
	decreased leukocyte cell number	J:121460
	decreased memory T cell number	J:121460
	decreased spleen weight	J:121460
	enlarged thymus	J:121460
	increased double-positive T cell number	J:121460
	increased thymus weight	J:121460
	small spleen	J:121460
Ets1^tm1Fwa/Ets1^tm1Fwa (B6.129S4-Ets1^tm1Fwa)	abnormal B cell differentiation	J:93845
	absent B-1a cells	J:93845
	decreased B cell number	J:93845
	decreased mature B cell number	J:93845
	decreased pro-B cell number	J:93845
	increased pro-B cell number	J:93845
Ets1^tm1Jml/Ets1^tm1Jml (involves: 129S/SvEv * C57BL/6)	abnormal CD8-positive, alpha-beta T cell differentiation	J:125056
	decreased CD4-positive, alpha-beta T cell number	J:125056
	decreased CD8-positive, alpha-beta T cell number	J:125056
	increased double-negative T cell number	J:125056
	thymus hypoplasia	J:125056
Ets1^tm1Jml/Ets1^tm1Jml Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6J * DBA/2J)	decreased CD8-positive, alpha-beta T cell number	J:125056
	increased double-negative T cell number	J:125056
Ets1^tm2Jml/Ets1^tm2Jml (involves: 129X1/SvJ * C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:50627
	decreased NK cell number	J:50627
	decreased T cell number	J:50627
	decreased thymocyte number	J:50627
	increased plasma cell number	J:50627
Etv2^tm1Dlim/Etv2^tm2.1Dlim Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJaeSor * C57BL/6 * CBA)	decreased leukocyte cell number	J:172687
	impaired myelopoiesis	J:172687
	spleen hypoplasia	J:172687
Etv6^{em1(IMPC)Rbrc}/Etv6⁺ (C57BL/6NJcl-Etv6^{em1(IMPC)Rbrc}/Rbrc)	increased large unstained cell number	J:211773
	increased spleen weight	J:211773
Etv6^em3Knic/Etv6⁺ (involves: C57BL/6J)	abnormal B cell number	J:342774
Etv6^{tm1(RUNX1)Haho}/Etv6⁺ Tg(Gata1-cre)1Sho/0 (involves: 129S1/Sv * C57BL/6 * CD-1 * Swiss Webster)	abnormal B cell differentiation	J:151639
Etv6^{tm1(RUNX1)Haho}/Etv6⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal lymphopoiesis	J:151639
	decreased B cell number	J:151639
	decreased lymphocyte cell number	J:151639
	decreased neutrophil cell number	J:151639
	myeloid hyperplasia	J:151639
Etv6^{tm1(RUNX1)Haho}/Etv6⁺ Tg(VAV1-cre)1Graf/0 (involves: 129S1/Sv * C57BL/6)	arrested B cell differentiation	J:151639
	decreased B cell number	J:151639
	decreased pre-B cell number	J:151639
	decreased pro-B cell number	J:151639
Etv6^tm2Sho/Etv6^tm2Sho Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * C57BL/6 * CBA)	decreased neutrophil cell number	J:93052
Evc2^em1(IMPC)Mbp/Evc2^em1(IMPC)Mbp (C57BL/6N-Evc2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Ewsr1^tm1(ERG)Thr/Ewsr1⁺ Rag1^tm1(cre)Thr/Rag1⁺ (involves: 129S/SvEv)	increased lymphocyte cell number	J:98679
	increased T cell derived lymphoma incidence	J:98679
Ewsr1^{tm1b(EUCOMM)Wtsi}/Ewsr1⁺ (C57BL/6N-Ewsr1^{tm1b(EUCOMM)Wtsi}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Ewsr1^tm1Sblee/Ewsr1^tm1Sblee (involves: 129S6/SvEvTac * Black Swiss)	decreased double-positive T cell number	J:122058
	decreased immature B cell number	J:122058
	decreased leukocyte cell number	J:122058
	decreased mature B cell number	J:122058
	decreased pre-B cell number	J:122058
	spleen hypoplasia	J:122058
	thymus hypoplasia	J:122058
Exo1^tm2Wed/Exo1^tm2Wed (involves: 129 * C57BL/6)	abnormal class switch recombination	J:198719
Exo1^tm2Wed/Exo1^tm2Wed (involves: 129 * C57BL/6)	abnormal somatic hypermutation frequency	J:198719
Exoc6^hbd/Exoc6^hbd (AB.Cg-Exoc6^hbd)	decreased spleen iron level	J:8251
Exoc6^hbd/Exoc6^hbd (AB.Cg-Exoc6^hbd)	enlarged spleen	J:8251
Extl1^em1Caox/Extl1^em1Caox Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6 * CBA)	abnormal regulatory T cell morphology	J:333437
	decreased dendritic cell number	J:333437
	decreased T helper 1 cell number	J:333437
	enlarged lymph nodes	J:333437
	enlarged spleen	J:333437
	increased B cell number	J:333437
	increased Ly6C high monocyte number	J:333437
	increased T cell number	J:333437
	increased T-helper 17 cell number	J:333437
Extl3^em1(IMPC)Mbp/Extl3⁺ (C57BL/6N-Extl3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Eya1^tm1Rilm/Eya1^tm1Rilm (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	athymia	J:79848, J:57313
Eya2^em1(IMPC)Mbp/Eya2^em1(IMPC)Mbp (C57BL/6N-Eya2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Eya2^tm2Px/Eya2^tm2Px (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	small thymus	J:311538
Ezh1^tm1Sgon/Ezh1^tm1Sgon Tg(VAV1-cre)1Graf/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal myeloid leukocyte morphology	J:193722
	absent spleen germinal center	J:193722
	decreased B cell number	J:193722
	decreased immature B cell number	J:193722
	decreased pro-B cell number	J:193722
	decreased spleen red pulp amount	J:193722
	decreased spleen white pulp amount	J:193722
	lymphoid hypoplasia	J:193722
	small spleen	J:193722
Ezh2^em1Jbn/Ezh2⁺ (C57BL/6J-Ezh2^em1Jbn)	increased spleen weight	J:267184
Ezh2^tm1.1Nesh/Ezh2⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:239472
	abnormal spleen white pulp morphology	J:239472
	enlarged lymph nodes	J:239472
	enlarged spleen	J:239472
Ezh2^tm1.1Nesh/Ezh2^tm1.1Nesh Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129 * 129P2/OlaHsd * C57BL/6)	enlarged lymph nodes	J:239472
	enlarged spleen	J:239472
Ezh2^tm1Tara/Ezh2^tm1Tara Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd)	decreased germinal center B cell number	J:199122
	decreased spleen germinal center number	J:199122
	decreased spleen germinal center size	J:199122
Ezh2^tm1Tara/Ezh2^tm1Tara Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal B cell differentiation	J:83216
	abnormal immunoglobulin V(D)J recombination	J:83216
	abnormal pro-B cell morphology	J:83216
	decreased immature B cell number	J:83216
	decreased pre-B cell number	J:83216
Ezh2^tm2Sho/Ezh2^tm2.1Sho Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	decreased double-positive T cell number	J:182211
	decreased thymocyte number	J:182211
	enlarged lymph nodes	J:182211
	enlarged spleen	J:182211
	increased double-negative T cell number	J:182211
Ezh2^tm2Sho/Ezh2^tm2Sho Pgr^tm2(cre)Lyd/Pgr⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased uterine NK cell number	J:290765
Ezh2^tm2Sho/Ezh2^tm2Sho Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	decreased double-positive T cell number	J:182211
	decreased thymocyte number	J:182211
	enlarged lymph nodes	J:182211
	enlarged spleen	J:182211
	increased double-negative T cell number	J:182211
F2r^tm1Pago/F2r^tm1Pago (involves: 129P2/OlaHsd)	abnormal lymph node morphology	J:133917
F2r^tm1Pago/F2r^tm1Pago (involves: 129P2/OlaHsd)	enlarged mesenteric lymph nodes	J:133917
F2rl1^tm1Cgh/F2rl1^tm1Cgh (B6.129S4-F2rl1^tm1Cgh)	decreased dendritic cell number	J:113591
F3^tm1.1Dwr/F3^tm1.1Dwr (involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)	decreased B cell number	J:91165
	decreased leukocyte cell number	J:91165
	decreased neutrophil cell number	J:91165
F9^tm1Dws/Y (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:44497
F11^tm1Gjb/F11^tm1Gjb Proc^tm1Fjc/Proc^tm1Fjc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymph node cortex morphology	J:67398
	abnormal lymph node morphology	J:67398
	abnormal neutrophil morphology	J:67398
	decreased leukocyte cell number	J:67398
	decreased neutrophil cell number	J:67398
	enlarged lymph nodes	J:67398
Fa2h^em1(IMPC)Mbp/Fa2h^em1(IMPC)Mbp (C57BL/6NCrl-Fa2h^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Fabp1^{tm1b(EUCOMM)Hmgu}/Fabp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fabp1^{tm1b(EUCOMM)Hmgu}/Cnrm)	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
Fabp2^{em1(IMPC)Hmgu}/Fabp2^{em1(IMPC)Hmgu} (C57BL/6N-Fabp2^{em1(IMPC)Hmgu}/Ieg)	enlarged lymph nodes	J:211773
Fadd^tm1Wnt/Fadd^tm1Wnt Tg(Fadd)33Wnt/0 Tg(Lck-cre)I57Jxm/0 (involves: 129S4/SvJae * C57BL/6 * CBA * ICR)	abnormal T cell differentiation	J:69617
	decreased CD4-positive, alpha-beta T cell number	J:69617
	decreased CD8-positive, alpha-beta T cell number	J:69617
	decreased double-positive T cell number	J:69617
	increased B cell number	J:69617
	increased double-negative T cell number	J:69617
	thymus hypoplasia	J:69617
Fadd^tm1Wnt/Fadd^tm1Wnt Tg(Fadd)33Wnt/0 Tg(Lck-cre)I57Jxm/0 Tg(Tcra2C,Tcrb2C)1Dlo/0 (involves: 129S4/SvJae * C57BL/6 * C57L * CBA * ICR * SJL)	increased double-negative T cell number	J:69617
	thymus hypoplasia	J:69617
Fadd^tm1Wnt/Fadd^tm1Wnt Tg(Fadd/EGFP)#Jizh/? Tg(Cd4-cre)1Cwi/? (involves: 129S4/SvJae * C57BL/6 * DBA/2)	decreased activated T cell number	J:113207
	decreased single-positive T cell number	J:113207
	increased B cell number	J:113207
Fadd^tm1Wnt/Fadd^tm1Wnt Tg(Fadd/EGFP)#Jizh/? Tg(Lck-cre)1Cwi/? (involves: 129S4/SvJae)	decreased activated T cell number	J:113207
	decreased single-positive T cell number	J:113207
	increased B cell number	J:113207
Fadd^tm1Wnt/Fadd^tm1Wnt Tg(Fadd/EGFP)#Jizh/? Tg(Mx1-cre)1Cgn/? (involves: 129S4/SvJae * C57BL/6 * CBA)	spleen hypoplasia	J:168722
	thymus hypoplasia	J:168722
Fadd^tm2.1Wnt/Fadd^tm2.1Wnt Tg(Cd4-cre)1Cwi/? (B6.Cg-Tg(Cd4-cre)1Cwi Fadd^tm2.1Wnt)	abnormal T cell subpopulation ratio	J:162312
	enlarged lymph nodes	J:162312
	enlarged spleen	J:162312
	increased B cell number	J:162312
Fads1^{Gt(IST11525H2)Tigm}/Fads1^{Gt(IST11525H2)Tigm} (C57BL/6-Fads1^{Gt(IST11525H2)Tigm})	abnormal mononuclear cell morphology	J:186265
	decreased regulatory T cell number	J:186265
Fads2^tm1Mtna/Fads2^tm1Mtna (involves: 129S6/SvEvTac * C57BL/6J)	abnormal spleen white pulp morphology	J:153293
	abnormal thymus cortex morphology	J:153293
	enlarged spleen	J:153293
	increased spleen red pulp amount	J:153293
	lymphoid hypoplasia	J:153293
	small thymus	J:153293
Fah^em1(IMPC)Mbp/Fah⁺ (C57BL/6N-Fah^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Fah^em1(IMPC)Mbp/Fah⁺ (C57BL/6N-Fah^em1(IMPC)Mbp/MbpMmucd)	enlarged spleen	J:211773
Faim2^{em1(IMPC)Ccpcz}/Faim2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Faim2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Fam3a^em1Cya/Fam3a^em1Cya (involves: C57BL/6)	increased macrophage cell number	J:295206
	increased NK T cell number	J:295206
	increased T cell number	J:295206
Fam3d^em1Wko/Fam3d^em1Wko (C57BL/6-Fam3d^em1Wko)	decreased Ly6C high monocyte number	J:304594
	decreased macrophage cell number	J:304594
	decreased neutrophil cell number	J:304594
	enlarged spleen	J:300819
	increased leukocyte cell number	J:300819
	increased neutrophil cell number	J:304594, J:300819
Fam53a^{em1(IMPC)Ccpcz}/Fam53a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam53a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Fam72a^{tm1.1(KOMP)Vlcg}/Fam72a^{tm1.1(KOMP)Vlcg} (C57BL/6NTac-Fam72a^{tm1.1(KOMP)Vlcg})	abnormal class switch recombination	J:326431
	abnormal somatic hypermutation frequency	J:326431
	increased germinal center B cell number	J:326431
Fam72a^{tm1.1(KOMP)Vlcg}/Fam72a^{tm1.1(KOMP)Vlcg} Msh2^tm1Mak/Msh2^tm1Mak (C57BL/6NTac-Fam72a^{tm1.1(KOMP)Vlcg} Msh2^tm1Mak)	abnormal class switch recombination	J:326431
	abnormal somatic hypermutation frequency	J:326431
Fam76b^{Gt(IST14004H1)Tigm}/Fam76b^{Gt(IST14004H1)Tigm} (C57BL/6-Fam76b^{Gt(IST14004H1)Tigm})	abnormal spleen germinal center morphology	J:358021
	abnormal spleen white pulp morphology	J:358021
	abnormal splenic cell ratio	J:358021
	decreased B cell number	J:358021
	enlarged spleen	J:358021
	increased spleen weight	J:358021
	microgliosis	J:358021
Fam81a^{em1(IMPC)Ccpcz}/Fam81a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam81a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fam83d^{em1(IMPC)Ccpcz}/Fam83d^{em1(IMPC)Ccpcz} (C57BL/6N-Fam83d^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Fam83h^{em1(IMPC)Ccpcz}/Fam83h^{em1(IMPC)Ccpcz} (C57BL/6N-Fam83h^{em1(IMPC)Ccpcz}/Ccpcz)	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
Fam83h^{em2(IMPC)Ccpcz}/Fam83h⁺ (C57BL/6NCrl-Fam83h^{em2(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Fam110b^{tm1a(EUCOMM)Wtsi}/Fam110b⁺ (C57BL/6N-Fam110b^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased mature B cell number	J:165965
	increased leukocyte cell number	J:165965
Fam120c^{em1(IMPC)Ccpcz}/Fam120c^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fam120c^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fam124a^{em1(IMPC)Ccpcz}/Fam124a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam124a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fam151b^{tm1b(EUCOMM)Hmgu}/Fam151b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fam151b^{tm1b(EUCOMM)Hmgu}/H)	increased neutrophil cell number	J:211773
Fam161a^{Gt(462E7)Cmhd}/Fam161a^{Gt(462E7)Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	microgliosis	J:214319
Fam161b^{em1(IMPC)Ccpcz}/Fam161b^{em1(IMPC)Ccpcz} (C57BL/6N-Fam161b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fam163a^{tm2b(KOMP)Wtsi}/Fam163a^{tm2b(KOMP)Wtsi} (C57BL/6N-Fam163a^{tm2b(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Fam167a^{em1(IMPC)Ccpcz}/Fam167a^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fam167a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fam185a^{em1(IMPC)Ccpcz}/Fam185a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam185a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Fam209^{tm1b(KOMP)Wtsi}/Fam209^{tm1b(KOMP)Wtsi} (C57BL/6N-Fam209^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Fam210a^{tm1b(EUCOMM)Wtsi}/Fam210a⁺ (involves: BALB/cJ * C57BL/6N)	increased osteoclast cell number	J:261817
Fam210a^{tm1c(EUCOMM)Wtsi}/Fam210a^{tm1c(EUCOMM)Wtsi} Tg(ACTA1-cre/Esr1)2Kesr/0 (involves: C3H C57BL/6N * SJL)	increased osteoclast cell number	J:261817
Fam210a^{tm1c(EUCOMM)Wtsi}/Fam210a^{tm1c(EUCOMM)Wtsi} Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6N CBA * SJL)	increased osteoclast cell number	J:261817
Fam210b^em1Cya/Fam210b^em1Cya (involves: C57BL/6N)	enlarged spleen	J:351618
Fam210b^em1Cya/Fam210b^em1Cya (involves: C57BL/6N)	increased splenocyte number	J:351618
Fam210b^{tm1b(KOMP)Mbp}/Fam210b^{tm1b(KOMP)Mbp} (C57BL/6N-Fam210b^{tm1b(KOMP)Mbp}/Ucd)	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Fam219a^{em1(IMPC)Ccpcz}/Fam219a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam219a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Fam221a^{em1(IMPC)Ccpcz}/Fam221a^{em1(IMPC)Ccpcz} (C57BL/6N-Fam221a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased neutrophil cell number	J:211773
Fam227b^{em1(IMPC)Ccpcz}/Fam227b^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fam227b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fam229b^em1(IMPC)Mbp/Fam229b^em1(IMPC)Mbp (C57BL/6NCrl-Fam229b^em1(IMPC)Mbp/MbpMmucd)	increased basophil cell number	J:211773
Fam234b^{tm1a(EUCOMM)Wtsi}/Fam234b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fam234b^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased CD8-positive, alpha-beta T cell number	J:165965
Fancc^tm1Mab/Fancc^tm1Mab Sod1^tm1Cep/Sod1^tm1Cep (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphocyte morphology	J:71134
	decreased leukocyte cell number	J:71134
	decreased lymphocyte cell number	J:71134
	decreased neutrophil cell number	J:71134
Fancd2^em1Tzh/Fancd2^em1Tzh (C57BL/6-Fancd2^em1Tzh)	enlarged spleen	J:284566
Fancl^{tm1b(EUCOMM)Hmgu}/Fancl^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fancl^{tm1b(EUCOMM)Hmgu}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Farp2^tm1Akum/Farp2^tm1Akum (B6.Cg-Farp2^tm1Akum)	decreased osteoclast cell number	J:166376
Farp2^tm1Akum/Farp2^tm1Akum (B6.Cg-Farp2^tm1Akum)	increased osteoclast cell number	J:166376
Farsa^{tm2a(EUCOMM)Wtsi}/Farsa⁺ (C57BL/6N-Farsa^{tm2a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Fas^lpr-cg/Fas^lpr-cg (CBA/KlJms-Fas^lpr-cg/J)	abnormal lymph organ size	J:24805
	abnormal T cell differentiation	J:24805
	enlarged lymph nodes	J:24805, J:81770
	enlarged spleen	J:24805
	increased spleen weight	J:81770
Fas^lpr/Fas^lpr (MRL/Mp-Fas^lpr)	abnormal B cell morphology	J:108760
	abnormal B cell receptor editing	J:131138
	abnormal immune system organ morphology	J:28885
	abnormal lymph node cell ratio	J:6257
	abnormal lymph node morphology	J:27634
	abnormal marginal zone B cell morphology	J:131138
	abnormal T cell morphology	J:108760, J:8267
	abnormal thymus medulla morphology	J:28885
	enlarged lymph nodes	J:27634, J:108760, J:13757, J:28885
	enlarged Peyer's patches	J:28885
	enlarged spleen	J:28885
	enlarged thymus	J:13757
	increased thymus weight	J:28885
	lymph node hyperplasia	J:27634
	lymph node necrosis	J:27634
	thymus atrophy	J:27634
	thymus cortex atrophy	J:13757, J:28885
Fas^lpr/Fas^lpr (MRL/Mp-Agtpbp1^atms Fas^lpr)	enlarged lymph nodes	J:103944
	enlarged spleen	J:103944
	enlarged thymus	J:103944
Fas^lpr/Fas^lpr (MRL/MpJ-Fas^lpr/J)	decreased immature B cell number	J:122315
	decreased marginal zone B cell number	J:122315
	decreased mature B cell number	J:122315
	decreased spleen germinal center number	J:122315
	decreased transitional stage B cell number	J:122315
	enlarged lymph nodes	J:92084, J:7454
	increased neutrophil cell number	J:127199
	increased plasma cell number	J:122315
	lymph node necrosis	J:7454
Fas^lpr/Fas^lpr (involves: C3H * MRL/Mp)	increased spleen weight	J:34296
Fas^lpr/Fas^lpr (B6.MRL-Fas^lpr/J)	abnormal splenic cell ratio	J:132217
	enlarged lymph nodes	J:119584
	increased follicular B cell number	J:132217
	increased immature B cell number	J:132217
	increased marginal zone B cell number	J:132217
	increased splenocyte number	J:132217
	increased transitional stage B cell number	J:132217
	lymph node hyperplasia	J:132217
Fas^lpr/Fas^lpr (MRL-Fas^lpr)	enlarged lymph nodes	J:126261
Fas^lpr/Fas^lpr (MRL-Fas^lpr)	increased spleen weight	J:126261
Fas^lpr/Fas^lpr (C3.MRL-Fas^lpr/J)	abnormal T cell morphology	J:7454
	decreased eosinophil cell number	J:106288
	enlarged lymph nodes	J:7454
	lymph node hyperplasia	J:7454
	lymph node necrosis	J:7454
Fas^lpr/Fas^lpr (B6.MRL-Fas^lpr)	enlarged lymph nodes	J:6638, J:135036, J:7454
	enlarged spleen	J:135036
	increased double-negative T cell number	J:135036
	lymph node necrosis	J:7454
Fas^lpr/Fas^lpr (AK.MRL-Fas^lpr)	enlarged lymph nodes	J:7454
Fas^lpr/Fas^lpr (AK.MRL-Fas^lpr)	lymph node necrosis	J:7454
Fas^lpr/Fas^lpr (C3.MRL-Fas^lpr)	abnormal T cell morphology	J:8267
Fas^lpr/Fas^lpr (MRL/MpJ-Fas^lpr)	abnormal leukocyte morphology	J:126009
	decreased activated T cell number	J:137066
	decreased B cell number	J:137066
	decreased CD4-positive, alpha-beta T cell number	J:137066
	decreased CD8-positive, alpha-beta T cell number	J:137066
	enlarged lymph nodes	J:137066
	enlarged spleen	J:137066
	increased double-negative T cell number	J:137066
Fas^lpr/Fas^lpr (involves: C57BL/6 * MRL/Mp)	enlarged spleen	J:73396
Fas^lpr/Fas^lpr (involves: C57BL/6 * MRL/Mp)	lymph node hyperplasia	J:73396
Fas^lpr/Fas^lpr (involves: 129P2/OlaHsd * MRL)	enlarged lymph nodes	J:26250
	increased double-negative T cell number	J:26250
	increased gamma-delta T cell number	J:26250
Fas^lpr/Fas^lpr Fcer1g^tm1Tks/Fcer1g^tm1Tks (MRL.Cg-Fcer1g^tm1Tks Fas^lpr)	increased double-negative T cell number	J:106188
	increased spleen weight	J:106188
Fas^lpr/Fas^lpr Havcr1^tm1Kuch/Havcr1^tm1Kuch (B6.Cg-Havcr1^tm1Kuch Fas^lpr)	enlarged lymph nodes	J:186484
	enlarged spleen	J:186484
	increased activated T cell number	J:186484
	increased B cell number	J:186484
	increased CD4-positive, alpha-beta T cell number	J:186484
	increased CD8-positive, alpha-beta T cell number	J:186484
	increased double-negative T cell number	J:186484
	increased T cell number	J:186484
Fas^lpr/Fas^lpr Ifnar1^tm1Agt/Ifnar1^tm1Agt (MRL.Cg-Ifnar1^tm1Agt Fas^lpr)	enlarged lymph nodes	J:92084
Fas^lpr/Fas^lpr Ifnar1^tm1Agt/Ifnar1^tm1Agt Ifngr1^tm1Agt/Ifngr1^tm1Agt (MRL.Cg-Ifngr1^tm1Agt Ifnar1^tm1Agt Fas^lpr)	small lymph nodes	J:92084
Fas^lpr/Fas^lpr Ifng^tm1Ts/Ifng^tm1Ts (involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)	abnormal lymph node size	J:39600
	abnormal spleen size	J:39600
	decreased double-negative T cell number	J:39600
	enlarged lymph nodes	J:39600
	enlarged spleen	J:39600
Fas^lpr/Fas^lpr Ifngr1^tm1Agt/Ifngr1^tm1Agt (MRL.Cg-Ifngr1^tm1Agt Fas^lpr)	small lymph nodes	J:92084
Fas^lpr/Fas^lpr Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (MRL.Cg-Fas^lpr Igh-J^{tm2(3H9-VDJ)Mwg})	abnormal B cell receptor editing	J:131138
	abnormal marginal zone B cell morphology	J:131138
Fas^lpr/Fas^lpr Ighm^tm1Cgn/Ighm^tm1Cgn (involves: 129S2/SvPas * C57BL/6 * MRL/Mp)	arrested B cell differentiation	J:119584
	decreased mature B cell number	J:119584
	enlarged lymph nodes	J:119584
	increased T cell number	J:119584
Fas^lpr/Fas^lpr Il2ra^tm1Dw/Il2ra^tm1Dw Tg(CD2-Ccdc86)1Hfuj/? (B6.Cg-Il2ra^tm1Dw Fas^lpr Tg(CD2-Ccdc86)1Hfuj)	enlarged spleen	J:151722
Fas^lpr/Fas^lpr Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp)	abnormal lymph node size	J:39600
	abnormal spleen size	J:39600
	enlarged spleen	J:39600
	increased spleen weight	J:39600
	spleen hyperplasia	J:39600
Fas^lpr/Fas^lpr Irf1^tm1Mak/Irf1⁺ (MRL.Cg-Irf1^tm1Mak Fas^lpr)	increased CD4-positive, alpha-beta T cell number	J:114771
Fas^lpr/Fas^lpr Irf1^tm1Mak/Irf1^tm1Mak (MRL.Cg-Irf1^tm1Mak Fas^lpr)	increased CD4-positive, alpha-beta T cell number	J:114771
Fas^lpr/Fas^lpr Itfg2^{Gt(OST215121)Lex}/Itfg2^{Gt(OST215121)Lex} (involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp)	decreased B cell number	J:205951
	enlarged lymph nodes	J:205951
	enlarged spleen	J:205951
	increased double-negative T cell number	J:205951
Fas^lpr/Fas^lpr Pou2af1^tm1Pmt/Pou2af1^tm1Pmt (involves: 129P2/OlaHsd * C57BL/6 * MRL)	abnormal T cell number	J:125114
	decreased plasma cell number	J:125114
	increased B cell number	J:125114
Fas^lpr/Fas^lpr Selp^tm1Bay/Selp^tm1Bay (MRL.Cg-Selp^tm1Bay Fas^lpr)	increased neutrophil cell number	J:127199
Fas^lpr/Fas^lpr Spp1^tm1Rit/Spp1^tm1Rit (involves: 129S7/SvEvBrd * C57BL/6 * MRL/Mp)	enlarged spleen	J:73396
	lymph node hyperplasia	J:73396
Fas^lpr/Fas^lpr Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * MRL)	increased gamma-delta intraepithelial T cell number	J:26250
	increased gamma-delta T cell number	J:26250
	increased T cell number	J:26250
Fas^lpr/Fas^lpr Tg(CD2-Foxj1)#Stlp/0 (MRL.Cg-Fas^lpr Tg(CD2-Foxj1)#Stlp)	decreased CD4-positive, alpha-beta T cell number	J:122222
	enlarged lymph nodes	J:122222
	enlarged spleen	J:122222
	increased double-negative T cell number	J:122222
Fas^lpr/Fas^lpr Tg(H2-K-Cd86)27All/0 (involves: C57BL/6 * CBA * MRL/MpJ)	decreased B cell number	J:112475
Fas^lpr/Fas^lpr Tlr7^tm1Flv/Y (involves: 129S1/Sv * C57BL/6 * MRL/Mp)	abnormal CD4-positive, alpha beta T cell morphology	J:113557
	abnormal lymph node size	J:113557
	decreased double-negative T cell number	J:113557
	decreased spleen weight	J:113557
Fas^lpr/Fas^lpr Tlr9^tm1Aki/Tlr9^tm1Aki (B6.Cg-Tlr9^tm1Aki Fas^lpr)	enlarged lymph nodes	J:135036
	enlarged spleen	J:135036
	increased double-negative T cell number	J:135036
Fas^lpr/Fas^lpr Tlr9^tm1Aki/Tlr9^tm1Aki (MRL.Cg-Tlr9^tm1Aki Fas^lpr)	enlarged lymph nodes	J:113557
	enlarged spleen	J:113557
	increased CD4-positive, alpha-beta T cell number	J:113557
	increased double-negative T cell number	J:113557
Fas^lpr/Fas^lpr Tnfrsf9^tm1Byk/Tnfrsf9^tm1Byk (MRL.Cg-Tnfrsf9^tm1Byk Fas^lpr)	enlarged lymph nodes	J:127197
	enlarged spleen	J:127197
	increased B-1 B cell number	J:127197
	increased B-2 B cell number	J:127197
	increased CD4-positive, alpha-beta T cell number	J:127197, J:126929
	increased double-negative T cell number	J:127197, J:126929
	increased spleen germinal center number	J:127197
Fas^lpr/Fas^lpr Tnfrsf13c^Bcmd1/Tnfrsf13c⁺ (MRL.Cg-Tnfrsf13c^Bcmd1 Fas^lpr)	decreased B cell number	J:122315
	decreased marginal zone B cell number	J:122315
Fas^lpr/Fas^tm1.1Cgn (involves: C57BL/6 * MRL)	abnormal immune system morphology	J:114948
	enlarged lymph nodes	J:114948
	enlarged spleen	J:114948
Fas^lpr/Fas^tm1Cgn Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * MRL)	enlarged lymph nodes	J:114948
	enlarged spleen	J:114948
	increased double-negative T cell number	J:114948
Fas^m1Btlr/Fas^m1Btlr (C57BL/6J-Fas^m1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:216052
	decreased CD8-positive, alpha-beta T cell number	J:216052
	increased neutrophil cell number	J:216052
	increased NK cell number	J:216052
Fas^m2Btlr/Fas^m2Btlr (C57BL/6J-Fas^m2Btlr)	increased central memory CD4-positive, alpha-beta T cell number	J:271891
Fas^m2Btlr/Fas^m2Btlr (C57BL/6J-Fas^m2Btlr)	increased effector memory CD4-positive, alpha-beta T cell number	J:271891
Fas^theo/Fas^theo (either: (involves: C57BL/6JAnu * C57BL/10SnSg * C57BR/cd) or (involves: C57BL/6JAnu * C57BL/10SnSg * C57BR/cd * CBA/CaJAnu))	enlarged lymph nodes	J:104190
Fas^tm1.1Cgn/Fas^tm1.1Cgn (involves: C57BL/6)	abnormal immune system morphology	J:114948
	enlarged lymph nodes	J:114948
	enlarged spleen	J:114948
Fas^tm1Ach/Fas^tm1Ach Tg(GZMB-cre)1Jcb/? (involves: C57BL/6 * FVB/N)	increased double-positive T cell number	J:123556
Fas^tm1Ach/Fas^tm1Ach Tg(Itgax-cre,-EGFP)4097Ach/? (Not Specified)	abnormal spleen morphology	J:123556
	abnormal spleen periarteriolar lymphoid sheath morphology	J:123556
	enlarged spleen	J:123556
	increased dendritic cell number	J:123556
Fas^tm1Ach/Fas^tm1Ach Tg(Lck-cre)548Jxm/? (involves: C57BL/6 * CBA)	increased double-positive T cell number	J:123556
Fas^tm1Cgn/Fas^tm1Cgn Tg(Cd4-cre)1Cwi/0 (B6.Cg-Tg(Cd4-cre)1Cwi Fas^tm1Cgn)	abnormal immune system cell morphology	J:114948
	abnormal immune system organ morphology	J:114948
	decreased B cell number	J:114948
	decreased T cell number	J:114948
	enlarged spleen	J:114948
	increased activated T cell number	J:114948
	increased double-negative T cell number	J:114948
	increased memory T cell number	J:114948
	lymph node hypoplasia	J:114948
	spleen hypoplasia	J:114948
Fas^tm1Cgn/Fas^tm1Cgn Tg(Lck-cre)I57Jxm/0 (B6.Cg-Fas^tm1Cgn Tg(Lck-cre)I57Jxm)	lymph node hypoplasia	J:114948
Fas^tm1Cgn/Fas^tm1Cgn Tg(Mx1-cre)1Cgn/0 (B6.Cg-Fas^tm1Cgn Tg(Mx1-cre)1Cgn)	abnormal immune system morphology	J:114948
	enlarged lymph nodes	J:114948
	enlarged spleen	J:114948
Fas^tm1Dlo/Fas^tm1Dlo (involves: 129P2/OlaHsd * C57BL/6)	enlarged lymph nodes	J:31847
Fas^tm1Dlo/Fas^tm1Dlo (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:31847
Fas^tm1Osa/Fas^tm1Osa (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymph organ size	J:64296
	abnormal T cell clonal deletion	J:32125
	enlarged lymph nodes	J:64296, J:32125
	enlarged spleen	J:64296, J:32125
	increased B cell number	J:32125
	increased leukocyte cell number	J:32125
	increased lymphocyte cell number	J:64296, J:32125
	lymphoid hyperplasia	J:64296
Fasl^del1Hong/Fasl^del1Hong (either: (involves: 129 * BALB/c * C57BL/6) or (involves: 129X1/SvJ * C3H/HeJ * C57BL/6))	abnormal thymus cell ratio	J:112563
	enlarged lymph nodes	J:112563
	enlarged spleen	J:112563
	enlarged thymus	J:112563
Fasl^gld/Fasl^gld (C3H/HeJ-Fasl^gld/J)	abnormal lymph node morphology	J:7306
	abnormal T cell differentiation	J:12002, J:8267
	decreased B cell number	J:29572
	enlarged lymph nodes	J:7306, J:29572
	enlarged spleen	J:7306, J:29572
	increased leukocyte cell number	J:7306
	increased lymphocyte cell number	J:7306, J:29572
	increased neutrophil cell number	J:7306
	increased T cell number	J:29572
Fasl^gld/Fasl^gld (B6Smn.C3-Fasl^gld/J)	decreased granulocyte number	J:136745
Fasl^gld/Fasl^gld (C3H/HeJ-Fasl^gld)	abnormal T cell morphology	J:8267
Fasl^gld/Fasl^gld (involves: C3H/HeJ * C57BL/6)	enlarged lymph nodes	J:153501
	enlarged spleen	J:153501
	increased T cell number	J:153501
Fasl^gld/Fasl^gld (involves: C3H/HeJ)	enlarged lymph nodes	J:171440
	enlarged spleen	J:171440
	increased spleen weight	J:171440
Fasl^gld/Fasl^gld (B6.C3-Fasl^gld)	abnormal lymph node morphology	J:91058
	enlarged lymph nodes	J:91058
	enlarged spleen	J:91058
	increased spleen weight	J:91058
Fasl^tm1.1Ast/Fasl^tm1.1Ast (involves: BALB/cJ * C57BL/6)	enlarged lymph nodes	J:153501
Fasl^tm1.1Ast/Fasl^tm1.1Ast (involves: BALB/cJ * C57BL/6)	enlarged spleen	J:153501
Fasl^tm1.1Bksa/Fasl^tm1.1Bksa (involves: 129)	enlarged lymph nodes	J:171440
	enlarged spleen	J:171440
	increased spleen weight	J:171440
Fasl^tm1.1Cgm/Fasl^tm1.1Cgm (involves: 129S2/SvPas * C57BL/6 * C57BL/6N)	increased germinal center B cell number	J:168406
	increased plasma cell number	J:168406
Fasl^tm1.1Lest/Fasl^tm1.1Lest (involves: 129 * C57BL/6)	abnormal double-negative T cell morphology	J:87990
	abnormal lymph node morphology	J:87990
	enlarged lymph nodes	J:87990
	enlarged spleen	J:87990
	lymphoid hyperplasia	J:87990
Fastk^tm1.1Andp/Fastk^tm1.1Andp (B6.129S6-Fastk^tm1.1Andp)	decreased neutrophil cell number	J:160443
Fastkd2^{tm1b(EUCOMM)Wtsi}/Fastkd2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Fastkd2^{tm1b(EUCOMM)Wtsi}/Bay)	decreased spleen weight	J:211773
Fat1^{Gt(KST249)Byg}/Fat1^{Gt(KST249)Byg} Tg(Myl1-lacZ)1Ibdml/0 (involves: 129P2/OlaHsd)	lymphangiectasis	J:199157
Fat3^{em1(IMPC)Ccpcz}/Fat3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fat3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fbf1^{tm1a(EUCOMM)Wtsi}/Fbf1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fbf1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Fblim1^tm1.1Chen/Fblim1^tm1.1Chen (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	abnormal osteoclast differentiation	J:186501
	increased osteoclast cell number	J:186501
Fbln1^{Gt(XST011)Byg}/Fbln1^{Gt(XST011)Byg} (involves: 129P2/OlaHsd * C57BL/6)	thymus hypoplasia	J:137690
Fbln1^tm1Tmpl/Fbln1^tm1Tmpl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	thymus hypoplasia	J:137690
Fbn1^em1(IMPC)H/Fbn1⁺ (C57BL/6NTac-Fbn1^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Fbn1^tm2.1Hcd/Fbn1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal T-helper 1 cell morphology	J:206074
	increased B cell number	J:206074
	increased plasma cell number	J:206074
Fbn1^tm3.1Hcd/Fbn1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal T-helper 1 cell morphology	J:206074
	increased B cell number	J:206074
	increased plasma cell number	J:206074
Fbn1^Tsk/Fbn1⁺ (B6.Cg-Fbn1^Tsk)	abnormal uterine NK cell morphology	J:1377
Fbn1^Tsk/Fbn1⁺ (B6.Cg-Fbn1^Tsk)	increased mast cell number	J:8047
Fbn1^Tsk/Fbn1⁺ Kit^W/Kit^W-v (involves: C57BL/6 * C57BL/10 * DBA/2 * WB/ReJ)	absent mast cells	J:24076
Fbp2^{tm2b(EUCOMM)Hmgu}/Fbp2⁺ (C57BL/6N-Fbp2^{tm2b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Fbrsl1^em1(IMPC)Tcp/Fbrsl1^em1(IMPC)Tcp (C57BL/6N-Fbrsl1^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
	small thymus	J:211773
Fbxl3^{em1(IMPC)Ccpcz}/Fbxl3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fbxl3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased spleen weight	J:211773
Fbxl5^{Gt(OST386421)Lex}/Fbxl5⁺ (involves: 129S5/SvEvBrd * C57BL/6)	increased spleen iron level	J:193752
Fbxl18^{tm1b(EUCOMM)Hmgu}/Fbxl18^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fbxl18^{tm1b(EUCOMM)Hmgu}/Mhzh)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Fbxl19^{tm1b(EUCOMM)Wtsi}/Fbxl19⁺ (C57BL/6N-Fbxl19^{tm1b(EUCOMM)Wtsi}/Nju)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Fbxo4^tm1.1Jadi/Fbxo4⁺ (Not Specified)	myeloid hyperplasia	J:178645
Fbxo4^tm1.1Jadi/Fbxo4^tm1.1Jadi (Not Specified)	myeloid hyperplasia	J:178645
Fbxo7^{tm1a(EUCOMM)Hmgu}/Fbxo7^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	increased pro-B cell number	J:183053
Fbxo7^{tm1a(EUCOMM)Wtsi}/Fbxo7^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fbxo7^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Fbxo7^{tm1a(EUCOMM)Wtsi}/Fbxo7^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal effector T cell number	J:272313
	abnormal T cell differentiation	J:272313
	decreased CD4-positive, alpha-beta T cell number	J:272313
	decreased CD8-positive, alpha-beta T cell number	J:272313
	decreased T cell number	J:272313
	enlarged spleen	J:272313
	increased activated T cell number	J:272313
	increased double-negative T cell number	J:272313
	increased effector memory CD4-positive, alpha-beta T cell number	J:272313
	increased effector memory CD8-positive, alpha-beta T cell number	J:272313
	increased memory T cell number	J:272313
	increased spleen weight	J:272313
	thymus atrophy	J:272313
	thymus hypoplasia	J:272313
Fbxo7^{tm1c(EUCOMM)Wtsi}/Fbxo7^{tm1c(EUCOMM)Wtsi} Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6J * C57BL/6N)	decreased CD8-positive, alpha-beta T cell number	J:272313
	decreased T cell number	J:272313
Fbxo9^{tm1b(EUCOMM)Hmgu}/Fbxo9^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fbxo9^{tm1b(EUCOMM)Hmgu}/Tcp)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Fbxo10^{tm1b(KOMP)Wtsi}/Fbxo10^{tm1b(KOMP)Wtsi} (C57BL/6N-Fbxo10^{tm1b(KOMP)Wtsi}/Nju)	decreased neutrophil cell number	J:211773
Fbxo21^em1Smbk/Fbxo21^em1Smbk Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Fbxo21^em1Smbk Commd10^{Tg(Vav1-icre)A2Kio})	decreased spleen weight	J:333469
	increased T cell number	J:333469
Fbxo25^{em1(IMPC)Ccpcz}/Fbxo25^{em1(IMPC)Ccpcz} (C57BL/6N-Fbxo25^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fbxo28^{em1(IMPC)Mhzh}/Fbxo28⁺ (C57BL/6N-Fbxo28^{em1(IMPC)Mhzh}/Mhzh)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Fbxo36^{tm1b(KOMP)Wtsi}/Fbxo36^{tm1b(KOMP)Wtsi} (C57BL/6N-Fbxo36^{tm1b(KOMP)Wtsi}/Nju)	decreased monocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Fbxw2^{tm1b(EUCOMM)Hmgu}/Fbxw2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fbxw2^{tm1b(EUCOMM)Hmgu}/Nju)	increased basophil cell number	J:211773
Fbxw7^tm1Iaai/Fbxw7^tm1Iaai Tg(Lck-cre)1Cwi/0 (involves: 129/Sv * C57BL/6)	increased T cell derived lymphoma incidence	J:137138
Fbxw7^tm1Iaai/Fbxw7^tm1Iaai Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * CBA)	abnormal T cell differentiation	J:137138
	decreased double-negative T cell number	J:137138
	thymus hypoplasia	J:137138
Fbxw7^tm1Iaai/Fbxw7^tm1Iaai Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	abnormal T cell differentiation	J:200006
Fbxw7^tm1Kei/Fbxw7^tm1Kei Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	increased double-positive T cell number	J:128523
Fbxw7^tm1Kei/Fbxw7^tm1Kei Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6)	increased double-positive T cell number	J:128523
Fbxw7^tm1Kei/Fbxw7^tm1Kei Tg(Lck-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6)	arrested T cell differentiation	J:128523
	decreased single-positive T cell number	J:128523
	enlarged thymus	J:128523
	increased double-positive T cell number	J:128523
Fbxw7^tm1Kei/Fbxw7^tm1Kei Trp53^tm1Tyj/Trp53^tm1Tyj Tg(Lck-cre)1Cwi/? (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	increased T cell derived lymphoma incidence	J:128523
Fbxw8^{tm1b(EUCOMM)Hmgu}/Fbxw8⁺ (C57BL/6N-Fbxw8^{tm1b(EUCOMM)Hmgu}/Nju)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Fbxw9^{tm1a(EUCOMM)Wtsi}/Fbxw9⁺ (C57BL/6N-Fbxw9^{tm1a(EUCOMM)Wtsi}/Bay)	absent spleen	J:211773
Fbxw9^{tm1a(EUCOMM)Wtsi}/Fbxw9^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Fbxw9^{tm1a(EUCOMM)Wtsi}/Bay)	absent lymph nodes	J:211773
Fbxw9^{tm1b(EUCOMM)Wtsi}/Fbxw9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Fbxw9^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Fbxw10^em1(IMPC)Tcp/Fbxw10^em1(IMPC)Tcp (C57BL/6N-Fbxw10^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Fbxw16^{em1(IMPC)Ccpcz}/Fbxw16⁺ (C57BL/6N-Fbxw16^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	small thymus	J:211773
Fbxw18^{em1(IMPC)Ccpcz}/Fbxw18⁺ (C57BL/6N-Fbxw18^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Fbxw20^{em1(IMPC)Ccpcz}/Fbxw20^{em1(IMPC)Ccpcz} (C57BL/6N-Fbxw20^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fbxw25^{em1(IMPC)Ccpcz}/Fbxw25^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fbxw25^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Fbxw26^{tm1b(KOMP)Wtsi}/Fbxw26^{tm1b(KOMP)Wtsi} (C57BL/6N-Fbxw26^{tm1b(KOMP)Wtsi}/Wtsi)	decreased memory-marker NK cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased NK cell number	J:211773
Fcamr^tm1Shib/Fcamr^tm1Shib (involves: 129P2/OlaHsd * C57BL/6)	abnormal memory B cell differentiation	J:150824
	abnormal somatic hypermutation frequency	J:150824
	abnormal spleen germinal center morphology	J:150824
	increased spleen germinal center number	J:150824
	increased spleen germinal center size	J:150824
Fcamr^tm2Shib/Fcamr^tm2Shib (BALB/c-Fcamr^tm2Shib)	increased spleen germinal center number	J:150824
Fcamr^tm2Shib/Fcamr^tm2Shib (BALB/c-Fcamr^tm2Shib)	increased spleen germinal center size	J:150824
Fcer1a^tm1Ftl/Fcer1a^tm1Ftl (CBy.129S2-Fcer1a^tm1Ftl)	decreased eosinophil cell number	J:120702
Fcer1g^tm1Rav/Fcer1g^tm1Rav Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (involves: 129P2/OlaHsd * C57BL/6)	decreased uterine NK cell number	J:100668
Fcer1g^tm1Rav/Fcer1g^tm1Rav Tyrobp^tm1Lll/Tyrobp^tm1Lll (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:89583
Fcer1g^tm1Tks/Fcer1g^tm1Tks (involves: C57BL/6J)	decreased dendritic cell number	J:203159
Fcgr1^tm1Jgjw/Fcgr1^tm1Jgjw (involves: 129 * C57BL/6)	abnormal dendritic cell differentiation	J:112436
Fcgr2b^tm1.2Jsv/Fcgr2b⁺ X/Yaa (involves: C57BL/6 * FVB/N * SB/Le)	enlarged spleen	J:179175
	increased monocyte cell number	J:179175
Fcgr2b^tm1Kgcs/Fcgr2b⁺ (involves: C57BL/6)	increased germinal center B cell number	J:190890
Fcgr2b^tm1Ttk/Fcgr2b⁺ X/Yaa (involves: 129S4/SvJae * C57BL/6 * SB/Le)	increased monocyte cell number	J:129409
Fcgr2b^tm1Ttk/Fcgr2b^tm1.2Jsv Sle21^129P2/Ola/Sle21^C57BL/6 (involves: 129P2/Ola * 129S4/SvJae * C57BL/6 * FVB/N)	enlarged spleen	J:179175
	increased spleen weight	J:179175
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk (B6.129S4-Fcgr2b^tm1Ttk)	enlarged lymph nodes	J:64152
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk (B6.129S4-Fcgr2b^tm1Ttk)	enlarged spleen	J:64152
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Il17a^tm1Yiw/Il17a⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	increased plasma cell number	J:191090
	increased spleen germinal center number	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	increased double-negative T cell number	J:191090
	increased plasma cell number	J:191090
	increased spleen germinal center number	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Sle21^129P2/Ola/Sle21^129P2/Ola (B6.129S4-Fcgr2b^tm1Ttk)	enlarged spleen	J:179175
	increased spleen weight	J:179175
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Tlr7^tm1Flv/Y X/Yaa (B6.Cg-Fcgr2b^tm1Ttk Tlr7^tm1Flv Yaa)	enlarged spleen	J:127600
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Traf3ip2^tm1Sbn/Traf3ip2⁺ (involves: 129 * 129S4/SvJae * C57BL/6)	abnormal neutrophil morphology	J:191090
	abnormal T cell morphology	J:191090
	increased double-negative T cell number	J:191090
	increased memory T cell number	J:191090
	increased monocyte cell number	J:191090
	increased myeloid dendritic cell number	J:191090
	increased neutrophil cell number	J:191090
	increased plasma cell number	J:191090
	increased plasmacytoid dendritic cell number	J:191090
	increased single-positive T cell number	J:191090
	increased spleen germinal center number	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Traf3ip2^tm1Sbn/Traf3ip2^tm1Sbn (involves: 129 * 129S4/SvJae * C57BL/6)	abnormal T cell morphology	J:191090
	increased double-negative T cell number	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Traf3ip2^tm2Sbn/Traf3ip2⁺ (involves: 129S4/SvJae * BALB/c * C57BL/6)	enlarged spleen	J:191090
	increased germinal center B cell number	J:191090
	increased plasma cell number	J:191090
	increased spleen weight	J:191090
	spleen hyperplasia	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk Traf3ip2^tm2Sbn/Traf3ip2^tm2Sbn Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S4/SvJae * BALB/c * C57BL/6)	increased germinal center B cell number	J:191090
	increased plasma cell number	J:191090
Fcgr2b^tm1Ttk/Fcgr2b^tm1Ttk X/Yaa (B6.Cg-Fcgr2b^tm1Ttk Yaa)	enlarged spleen	J:127600
Fcgr3^tm1Jsv/Fcgr3^tm1Jsv (B6.129P2-Fcgr3^tm1Jsv/J)	abnormal leukocyte cell number	J:78297
Fcgr3^tm1Jsv/Fcgr3^tm1Jsv (B6.129P2-Fcgr3^tm1Jsv/J)	increased neutrophil cell number	J:78297
Fcgr3^tm1Jsv/Fcgr3^tm1Jsv Sle21^129P2/Ola/Sle21^129P2/Ola (B6.129P2-Fcgr3^tm1Jsv)	enlarged spleen	J:179175
	increased activated T cell number	J:179175
	increased B cell number	J:179175
	increased spleen weight	J:179175
Fcgr4^tm1Rav/Fcgr4^tm1Rav Tg(Ctsk-cre)1Rda/0 (involves: C57BL/6)	decreased osteoclast cell number	J:197378
Fcmr^tm1.2Khl/Fcmr^tm1.2Khl (involves: C57BL/6)	decreased B cell number	J:174871
Fcmr^tm1Ohno/Fcmr^tm1Ohno (B6.129-Fcmr^tm1Ohno)	abnormal B cell morphology	J:190117
	decreased marginal zone B cell number	J:190117
	increased B-1 B cell number	J:190117
	increased T cell number	J:190117
Fcrl2^tm1Lex/Fcrl2^tm1Lex (B6;129S5-Fcrl2^tm1Lex/Mmucd)	decreased CD8-positive, alpha-beta T cell number	J:171883
Fcrla^{tm1b(KOMP)Wtsi}/Fcrla^{tm1b(KOMP)Wtsi} (C57BL/6N-Fcrla^{tm1b(KOMP)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Fdx2^{em1(IMPC)Rbrc}/Fdx2^{em1(IMPC)Rbrc} (C57BL/6NJcl-Fdx2^{em1(IMPC)Rbrc}/Rbrc)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased large unstained cell number	J:211773
	increased spleen weight	J:211773
Fdxr^tm1Xch/Fdxr⁺ (B6.Cg-Fdxr^tm1Xch)	increased T cell derived lymphoma incidence	J:244082
Fech^m1Pas/Fech^m1Pas (involves: 129/Sv * BALB/c)	increased spleen weight	J:2021
Fech^m1Pas/Fech^{tm1.1(FECH)Emi} (involves: 129 BALB/cJ * C57BL/6J)	decreased eosinophil cell number	J:239515
	enlarged spleen	J:239515
Fen1^tm1Bhsh/Fen1^tm1Bhsh (involves: 129S1/Sv)	pale spleen	J:121378
Fen1^tm1Rak/Fen1⁺ (involves: 129/Sv * C57BL/6 * SJL/J)	thymus atrophy	J:77962
Fen1^tm2.1Bhsh/Fen1^tm2.1Bhsh (involves: 129S1/Sv)	increased thymus tumor incidence	J:218627
Fen1^tm2Klng/Fen1^tm2Klng (involves: 129X1/SvJ * C57BL/6)	abnormal spleen B cell follicle morphology	J:138901
	abnormal spleen marginal zone morphology	J:138901
	enlarged spleen	J:138901
	increased spleen B cell follicle number	J:138901
	increased spleen B cell follicle size	J:138901
	lymphoid hyperplasia	J:138901
Fen1^tm3.1Bhsh/Fen1⁺ (Not Specified)	enlarged spleen	J:231218
	increased plasma cell number	J:231218
	lymphoid hyperplasia	J:231218
Fen1^tm3.1Bhsh/Fen1^tm3.1Bhsh (Not Specified)	enlarged spleen	J:231218
	increased plasma cell number	J:231218
	lymphoid hyperplasia	J:231218
Fer^em1(IMPC)Tcp/Fer⁺ (C57BL/6N-Fer^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Fer^em1(IMPC)Tcp/Fer⁺ (C57BL/6N-Fer^em1(IMPC)Tcp/Tcp)	increased spleen weight	J:211773
Fer^em1(IMPC)Tcp/Fer^em1(IMPC)Tcp (C57BL/6N-Fer^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Fermt3^tm1.1Efp/Fermt3^tm1.1Efp (involves: C57BL/6)	increased leukocyte cell number	J:227094
Fermt3^tm2.1Ref/Fermt3^tm2.1Ref Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal effector T cell morphology	J:203436
Fes^tm1Mcs/Fes^tm1Mcs (involves: 129X1/SvJ)	abnormal leukocyte cell number	J:64748
	decreased B cell number	J:64748
	increased granulocyte number	J:64748
	increased monocyte cell number	J:64748
	increased neutrophil cell number	J:64748
	thymus hypoplasia	J:64748
Fes^tm2Pag/Fes^tm2Pag (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal myelopoiesis	J:98590
	decreased B cell number	J:98590
	increased pre-B cell number	J:98590
	increased pro-B cell number	J:98590
Ffar2^tm1Dgen/Ffar2^tm1Dgen (involves: C57BL/6)	increased T cell number	J:153951
Ffar2^tm2Lex/Ffar2^tm2Lex (involves: 129S7/SvEvBrd * C57BL/6)	abnormal neutrophil morphology	J:157383
Fgd1^em1(IMPC)Tcp/Fgd1⁺ (C57BL/6NCrl-Fgd1^em1(IMPC)Tcp/Tcp)	enlarged thymus	J:211773
Fgd3^{em1(IMPC)Ccpcz}/Fgd3^{em1(IMPC)Ccpcz} (C57BL/6N-Fgd3^{em1(IMPC)Ccpcz}/Ccpcz)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Fgd5^em1(IMPC)Mbp/Fgd5⁺ (C57BL/6NCrl-Fgd5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Fgf3^{tm4b(EUCOMM)Hmgu}/Fgf3⁺ (C57BL/6N-Fgf3^{tm4b(EUCOMM)Hmgu}/Bay)	enlarged lymph nodes	J:211773
Fgf7^tm1Efu/Fgf7^tm1Efu (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	spleen hypoplasia	J:129368
Fgf8^tm1.3Mrt/Fgf8^tm1.4Mrt Tg(Tbx1-cre)1Joe/0 (involves: 129P2/OlaHsd)	abnormal thymus morphology	J:88814
	small thymus	J:88814
Fgf8^tm1.4Mrt/Fgf8⁺ Tbx1^tm1Bld/Tbx1⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * ICR)	thymus hypoplasia	J:78686
Fgf8^tm1Mrc/Fgf8^tm1Moon Hoxa3^tm1(cre)Moon/Hoxa3⁺ (involves: 129/Sv * C57BL/6)	ectopic thymus	J:87304
	thymus hypoplasia	J:87304
Fgf8^tm1Mrc/Fgf8^tm2Mrc Hoxa3^tm1(cre)Moon/Hoxa3⁺ (involves: 129/Sv * C57BL/6)	ectopic thymus	J:87304
	thymus hypoplasia	J:87304
Fgf9^{tm1b(KOMP)Wtsi}/Fgf9⁺ (C57BL/6N-Fgf9^{tm1b(KOMP)Wtsi}/H)	decreased spleen weight	J:211773
Fgf10^{tm1b(EUCOMM)Wtsi}/Fgf10⁺ (C57BL/6N-Fgf10^{tm1b(EUCOMM)Wtsi}/H)	decreased leukocyte cell number	J:211773
Fgf10^tm1Ska/Fgf10^tm1Ska (involves: C57BL/6 * CBA)	small thymus	J:114183
Fgf14^{em1(IMPC)Ccpcz}/Fgf14^{em1(IMPC)Ccpcz} (C57BL/6N-Fgf14^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Fgf20^{em1(IMPC)Ccpcz}/Fgf20^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fgf20^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fgf23^tm1Blan/Fgf23^tm1Blan (involves: 129/Sv * C57BL/6)	small spleen	J:121006
Fgf23^tm1Tyam/Fgf23^tm1Tyam (involves: C57BL/6 * CBA)	decreased lymphocyte cell number	J:88172
	spleen hypoplasia	J:88172
	thymus atrophy	J:88172
Fgfbp3^{tm1.1(KOMP)Wtsi}/Fgfbp3^{tm1.1(KOMP)Wtsi} (C57BL/6N-Fgfbp3^{tm1.1(KOMP)Wtsi}/Ucd)	increased neutrophil cell number	J:211773
Fgfr1^tm1Upir/Fgfr1^tm1Upir Fgfr2^tm1Dor/Fgfr2^tm1Dor Tg(KRT5-cre)5132Jlj/0 (involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)	abnormal mast cell morphology	J:221184
	increased mast cell number	J:221184
Fgfr2^tm1Dor/Fgfr2^tm1.1Dor Twist2^tm1(cre)Dor/Twist2⁺ (involves: 129X1/SvJ)	abnormal osteoclast differentiation	J:90391
Fgfr2^tm1Dsn/Fgfr2^tm1Dsn Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	increased gamma-delta T cell number	J:119723
Fgfr2^tm1Ewj/Fgfr2⁺ Tg(EIIa-cre)C5379Lmgd/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)	abnormal thymus morphology	J:101174
	decreased osteoclast cell number	J:101174
Fgfr2^tm3Dsn/Fgfr2^tm3Dsn (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus development	J:67731
Fgfr3^{tm1.1(FGFR3*)Ytc}/Fgfr3⁺ (involves: 129)	decreased osteoclast cell number	J:287271
Fgfr3^{tm1.1(FGFR3)Ytc}/Fgfr3^{tm1.1(FGFR3)Ytc} (involves: 129)	decreased osteoclast cell number	J:287271
Fgfr3^tm1Led/Fgfr3^tm1Led (involves: 129S6/SvEvTac)	increased osteoclast cell number	J:32105
Fgfr3^tm2Llm/Fgfr3⁺ Tg(CMV-cre)1Ipc/? (involves: 129S2/SvPas * C57BL/6 * SJL)	increased osteoclast cell number	J:183772
Fgfr3^tm2Llm/Fgfr3⁺ Tg(Col2a1-cre)1Bhr/? (involves: 129S2/SvPas * C57BL/6 * SJL)	increased osteoclast cell number	J:183772
Fgfr4^M1Btlr/Fgfr4^M1Btlr (C57BL/6J-Fgfr4^M1Btlr)	decreased B-1a cell number	J:265097
Fgg^tm1Lord/Fgg^tm1Lord (involves: 129P2/OlaHsd * C57BL/6)	increased leukocyte cell number	J:129828
Fgl1^{tm1b(EUCOMM)Hmgu}/Fgl1^{tm1b(EUCOMM)Hmgu} (involves: BALB/cJ * C57BL/6N)	decreased B cell number	J:269578
	increased central memory CD8 positive, alpha-beta T cell number	J:269578
Fgl2^tm1Pam/Fgl2^tm1Pam (B6.129X1-Fgl2^tm1Pam)	abnormal Peyer's patch follicle morphology	J:130895
	decreased Peyer's patch number	J:130895
	enlarged spleen	J:130895
	increased dendritic cell number	J:130895
	increased regulatory T cell number	J:130895
Fgr^tm1Hev/Fgr^tm1Hev Hck^tm1Hev/Hck^tm1Hev (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal macrophage morphology	J:59037
Fhip1b^em1(IMPC)Tcp/Fhip1b^em1(IMPC)Tcp (C57BL/6NCrl-Fhip1b^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Fhip2b^{em1(IMPC)Ccpcz}/Fhip2b^{em1(IMPC)Ccpcz} (C57BL/6N-Fhip2b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fhip2b^em1Wwan/Fhip2b^em1Wwan (involves: C57BL/6)	enlarged spleen	J:285283
Fhip2b^em1Wwan/Fhip2b^em1Wwan (involves: C57BL/6)	increased leukocyte cell number	J:285283
Fhit^tm1Hbn/Fhit⁺ (involves: 129X1/SvJ * C57BL/6)	decreased granulocyte number	J:71303
Fhit^tm1Hbn/Fhit^tm1Hbn (involves: 129X1/SvJ * C57BL/6)	decreased granulocyte number	J:71303
Fibcd1^tm1Spte/Fibcd1^tm1Spte (B6.129S1-Fibcd1^tm1Spte)	decreased lymphocyte cell number	J:340107
Fig4^plt1/Fig4^plt1 (involves: 129P2/OlaHsd * C3H * C57BL/6 * CAST/Ei * SJL)	spleen hypoplasia	J:122737
Fkbp4^em1(IMPC)Mbp/Fkbp4^em1(IMPC)Mbp (C57BL/6N-Fkbp4^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Fkbp5^{tm1b(KOMP)Wtsi}/Fkbp5^{tm1b(KOMP)Wtsi} (C57BL/6N-Fkbp5^{tm1b(KOMP)Wtsi}/MbpMmucd)	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Fkbp11^em1(IMPC)Mbp/Fkbp11^em1(IMPC)Mbp (C57BL/6N-Fkbp11^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	small spleen	J:211773
Flcn^tm1Baba/Flcn^tm1.1Lss Tg(CAG-cre/Esr1)1Lbe/0 (involves: 129S1/Sv 129X1/SvJ)	arrested B cell differentiation	J:189078
	decreased B cell number	J:189078
Fli1^tm1.1Dkw/Fli1⁺ (B6.129S6-Fli1^tm1.1Dkw)	decreased B cell number	J:137876
Fli1^tm1.1Dkw/Fli1^tm1.1Dkw (B6.129S6-Fli1^tm1.1Dkw)	abnormal B cell differentiation	J:137876
	abnormal class switch recombination	J:137876
	abnormal splenic cell ratio	J:137876
	decreased B cell number	J:137876
	decreased follicular B cell number	J:137876
	increased marginal zone B cell number	J:137876
	increased transitional stage B cell number	J:137876
	spleen hyperplasia	J:137876
Fli1^tm1Ber/Fli1^tm1Ber (either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1))	decreased thymocyte number	J:33052
Fli1^tm1Ber/Fli1^tm1Ber (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)	enlarged spleen	J:33052
Fli1^tm1Morl/Fli1^tm1Morl Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * CBA)	abnormal leukocyte morphology	J:167426
	abnormal thrombopoiesis	J:167426
	decreased granulocyte number	J:167426
	increased monocyte cell number	J:167426
	increased NK cell number	J:167426
Flna^tm1.2Caw/Flna⁺ (involves: 129S4/SvJae * C57BL/6)	increased leukocyte cell number	J:118252
Flnb^{tm1b(KOMP)Wtsi}/Flnb⁺ (C57BL/6N-Flnb^{tm1b(KOMP)Wtsi}/H)	decreased neutrophil cell number	J:211773
Flt1^tm1.1Fong/Flt1^tm1.1Fong Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor⁺ (involves: 129S6/SvEvTac * C57BL/6NCr * CD-1)	increased macrophage cell number	J:202202
Flt3^{em1(IMPC)Ccpcz}/Flt3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Flt3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased NK cell number	J:211773
Flt3^m1Btlr/Flt3^m1Btlr (C57BL/6J-Flt3^m1Btlr)	decreased dendritic cell number	J:159599
	decreased NK cell number	J:159599
	decreased plasmacytoid dendritic cell number	J:159599
	decreased splenocyte number	J:159599
	small lymph nodes	J:159599
Flt3^tm1.1Dosm/Flt3⁺ (B6.129(C)-Flt3^tm1.1Dosm)	abnormal spleen morphology	J:205200
	arrested B cell differentiation	J:205200
	enlarged spleen	J:205200
	increased spleen white pulp amount	J:205200
Flt3^tm1Dgg/Flt3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell differentiation	J:126003
	decreased B cell number	J:126003
	decreased mature B cell number	J:126003
	decreased T cell number	J:126003
	enlarged spleen	J:126003
	increased granulocyte number	J:126003
	increased leukocyte cell number	J:126003
	increased monocyte cell number	J:126003
	increased spleen red pulp amount	J:126003
	increased spleen white pulp amount	J:126003
Flt3^tm1Dgg/Flt3⁺ Kmt2a^tm1Clgr/Kmt2a⁺ (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)	enlarged spleen	J:189096
	increased leukocyte cell number	J:189096
Flt3^tm1Dgg/Flt3^tm1Dgg (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell differentiation	J:126003
	decreased B cell number	J:126003
	decreased mature B cell number	J:126003
	decreased T cell number	J:126003
	enlarged spleen	J:126003
	increased granulocyte number	J:126003
	increased leukocyte cell number	J:126003
	increased monocyte cell number	J:126003
	increased spleen red pulp amount	J:126003
	increased spleen white pulp amount	J:126003
Flt3^tm1Dgg/Flt3^tm1Dgg Kmt2a^tm1Clgr/Kmt2a⁺ (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)	enlarged spleen	J:189096
	increased leukocyte cell number	J:189096
Flt3^tm1Dosm/Flt3⁺ Tg(Mx1-cre)1Cgn/0 (B6.Cg-Flt3^tm1Dosm Tg(Mx1-cre)1Cgn)	abnormal spleen white pulp morphology	J:133528
	arrested B cell differentiation	J:133528
	decreased B cell number	J:133528
	decreased leukocyte cell number	J:133528
	decreased lymphocyte cell number	J:133528
	decreased neutrophil cell number	J:133528
	decreased pre-B cell number	J:133528
	enlarged spleen	J:133528
	increased dendritic cell number	J:133528
	increased granulocyte number	J:133528
	increased leukocyte cell number	J:133528
	increased monocyte cell number	J:133528
	increased neutrophil cell number	J:133528
	increased pro-B cell number	J:133528
	intermingled spleen red and white pulp	J:133528
Flt3^tm1Irl/Flt3^tm1Irl (either: 129S/SvEv-Flt3^tm1Irl or (involves: 129S/SvEv * C57BL/6J))	abnormal B cell differentiation	J:27238, J:99149
	decreased pre-B cell number	J:27238
	decreased pro-B cell number	J:27238
Flt3^tm1Irl/Flt3^tm1Irl Kit^W/Kit^W-v (involves: 129S/SvEv * C57BL/6)	abnormal leukocyte morphology	J:27238
	abnormal myelopoiesis	J:27238
	abnormal T cell number	J:27238
	decreased B cell number	J:27238
	decreased double-negative T cell number	J:27238
	decreased double-positive T cell number	J:27238
	decreased lymphocyte cell number	J:27238
	decreased pre-B cell number	J:27238
	decreased pro-B cell number	J:27238
	thymus hypoplasia	J:27238
Flt3^tm2.1Dosm/Flt3⁺ (B6.129(C)-Flt3^tm2.1Dosm)	abnormal B cell morphology	J:205200
	abnormal myelopoiesis	J:205200
	abnormal spleen morphology	J:205200
	enlarged spleen	J:205200
	increased leukocyte cell number	J:205200
	increased pre-pro B cell number	J:205200
	increased pro-B cell number	J:205200
	increased spleen white pulp amount	J:205200
	intermingled spleen red and white pulp	J:205200
	myeloid hyperplasia	J:205200
Flt3l^tm1Imx/Flt3l^tm1Imx (C57BL/6-Flt3l^tm1Imx)	abnormal dendritic cell morphology	J:62536, J:89868
	abnormal immature B cell morphology	J:62536
	abnormal immune system cell morphology	J:62536
	abnormal immune system organ morphology	J:62536
	abnormal leukocyte morphology	J:62536
	decreased B cell number	J:79569
	decreased double-negative T cell number	J:79569
	decreased leukocyte cell number	J:62536
	decreased lymphocyte cell number	J:62536
	decreased myeloid dendritic cell number	J:62536, J:89868
	decreased NK cell number	J:62536
	decreased plasmacytoid dendritic cell number	J:62536, J:89868
	decreased pre-B cell number	J:79569
	decreased pro-B cell number	J:79569, J:62536
	impaired myelopoiesis	J:62536
	increased neutrophil cell number	J:62536
	lymph node hypoplasia	J:62536
	spleen hypoplasia	J:62536
Flt3l^tm1Imx/Flt3l^tm1Imx (involves: C57BL/6)	decreased CD11b-high dendritic cell number	J:223508
	decreased CD103-positive CD11b-low dendritic cell number	J:223508
	decreased dendritic cell number	J:189122
	decreased macrophage cell number	J:189122
	decreased monocyte cell number	J:189122
	decreased NK cell number	J:189122
	decreased plasmacytoid dendritic cell number	J:189122
	increased neutrophil cell number	J:189122
Flt4^Chy/Flt4⁺ (involves: C3H)	abnormal lymphangiogenesis	J:177405
Flt4^Chy/Flt4⁺ (involves: C3H)	abnormal lymphatic vessel morphology	J:72387
Flt4^Chy/Flt4^Chy (involves: C3H)	abnormal lymphangiogenesis	J:177405
Flt4^Chy/Flt4^Chy (involves: C3H)	absent lymphatic vessels	J:177405
Flt4^tm1.1Ichi/Flt4⁺ Kras^tm1Mok/Kras⁺ (involves: 129S/SvEv * C57BL/6)	lymphatic vessel hypoplasia	J:159024
Flt4^tm1.1Ichi/Flt4⁺ Kras^tm1Mok/Kras⁺ Tg(HRAS)2Jic/0 (involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2)	lymphatic vessel hypoplasia	J:159024
Flt4^tm1.2Yhe/Flt4^tm1.2Yhe (involves: 129/Sv * C57BL/6J * FVB/N)	abnormal lymphangiogenesis	J:177405
	absent lymphatic vessels	J:177405
Flt4^tm1Ali/Flt4⁺ Nrp2^tm1Ddg/Nrp2⁺ (involves: C57BL/6)	abnormal lymphangiogenesis	J:156869
Flt4^tm1Ali/Flt4⁺ Nrp2^tm1Ddg/Nrp2^tm1Ddg (involves: C57BL/6)	abnormal lymphangiogenesis	J:156869
Flt4^tm1Ali/Flt4⁺ Tmem204^tm1.1Ali/Tmem204^tm1.1Ali (involves: BALB/c * C57BL/6)	abnormal lymphatic vessel smooth muscle morphology	J:159519
	enlarged lymphatic vessel	J:159519
Flt4^tm1Ali/Flt4^tm2Ali (involves: 129S1/Sv * 129X1/SvJ * ICR)	absent lymphatic vessels	J:137909
Flt4^tm2Ali/Flt4⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal lymphatic vessel morphology	J:137909
Flt4^tm2Ali/Flt4^tm2Ali (involves: 129S1/Sv * 129X1/SvJ * ICR)	absent lymphatic vessels	J:137909
Flvcr1^tm1.1Jlab/Flvcr1^tm1.1Jlab (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal spleen morphology	J:132057
	enlarged spleen	J:132057
fm/fm (involves: CBA/H)	abnormal lymph node morphology	J:275
	abnormal Peyer's patch morphology	J:275
	abnormal spleen morphology	J:5417, J:275
	abnormal thymus morphology	J:275
Fmnl1^tm1.2Sdb/Fmnl1^tm1.2Sdb Lyz2^tm1(cre)Ifo/Lyz2^tm1(cre)Ifo (involves: C3H * C57BL/6 * FVB/N)	abnormal Kupffer cell morphology	J:250144
	abnormal macrophage morphology	J:250144
	decreased macrophage cell number	J:250144
Fmo3^em1(IMPC)Mbp/Fmo3^em1(IMPC)Mbp (C57BL/6N-Fmo3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Fmo5^em1(IMPC)Mbp/Fmo5^em1(IMPC)Mbp (C57BL/6N-Fmo5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Fndc3a^em1(IMPC)Tcp/Fndc3a^em1(IMPC)Tcp (C57BL/6N-Fndc3a^em1(IMPC)Tcp/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Fndc9^{tm1.1(KOMP)Vlcg}/Fndc9^{tm1.1(KOMP)Vlcg} (C57BL/6N-Fndc9^{tm1.1(KOMP)Vlcg}/Ucd)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Fnip1^{em1(IMPC)Ccpcz}/Fnip1⁺ (C57BL/6NCrl-Fnip1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	small thymus	J:211773
Fnip1^{em1(IMPC)Ccpcz}/Fnip1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Fnip1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	enlarged thymus	J:211773
	increased neutrophil cell number	J:211773
	small spleen	J:211773
Fnip1^{Gt(RRM154)Byg}/Fnip1^{Gt(RRM154)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	absent B cells	J:189078
	absent B-2 B cells	J:189078
	arrested B cell differentiation	J:189078
	decreased B cell number	J:189078
	decreased B-1 B cell number	J:189078
	decreased mature B cell number	J:189078
	decreased pre-B cell number	J:189078
	decreased transitional stage B cell number	J:189078
	increased pro-B cell number	J:189078
	small spleen	J:189078
Fnip1^{Gt(RRM154)Byg}/Fnip1^{Gt(RRM154)Byg} Igh^tm2Cgn/Igh^tm2Cgn (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	absent B cells	J:189078
	absent B-2 B cells	J:189078
	decreased B-1 B cell number	J:189078
Fnip1^{Gt(RRM154)Byg}/Fnip1^{Gt(RRM154)Byg} Tg(BCL2)22Wehi/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	increased B cell number	J:189078
Fnip1^{Gt(RRM154)Byg}/Fnip1^{Gt(RRM154)Byg} Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	absent B cells	J:189078
	absent B-2 B cells	J:189078
	decreased B-1 B cell number	J:189078
	increased immature B cell number	J:189078
Fnip1^LPAB.1/Fnip1^LPAB.1 (C57BL/6J-Fnip1^LPAB.1)	absent B cells	J:187318
	arrested B cell differentiation	J:187318
	decreased B-1 B cell number	J:187318
Fnip1^m1Btlr/Fnip1^m1Btlr (C57BL/6J-Fnip1^m1Btlr)	abnormal splenocyte morphology	J:234285
	absent B cells	J:234285
	decreased marginal zone B cell number	J:234285
Fnip1^m2Btlr/Fnip1^m2Btlr (C57BL/6J-Fnip1^m2Btlr)	decreased B cell number	J:265134
	increased B-1 B cell number	J:265134
	increased CD4-positive, alpha-beta T cell number	J:265134
	increased single-positive T cell number	J:265134
	increased T cell number	J:265134
Fnip1^M3Btlr/Fnip1^M3Btlr (C57BL/6J-Fnip1^M3Btlr)	abnormal B cell differentiation	J:272802
Fnip1^tm1.2Baba/Fnip1^tm1.2Baba (involves: C57BL/6 * C57BL/6J * FVB/N * SJL)	absent B cells	J:189078
	absent B-2 B cells	J:189078
	arrested B cell differentiation	J:189078
	decreased B cell number	J:189078
	decreased B-1 B cell number	J:189078
	decreased mature B cell number	J:189078
	decreased pre-B cell number	J:189078
	decreased transitional stage B cell number	J:189078
	increased pro-B cell number	J:189078
	small spleen	J:189078
Fnip1^tm1.2Baba/Fnip1^tm1.2Baba Igh^tm2Cgn/Igh^tm2Cgn (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	absent B cells	J:189078
	absent B-2 B cells	J:189078
	decreased B-1 B cell number	J:189078
Fnip1^tm1.2Baba/Fnip1^tm1.2Baba Tg(BCL2)22Wehi/0 (involves: C57BL/6 * FVB/N * SJL)	increased B cell number	J:189078
Fnip1^tm1.2Baba/Fnip1^tm1.2Baba Tg(IghelMD4)4Ccg/0 (involves: C57BL/6 * C57BL/6J * FVB/N * SJL)	absent B cells	J:189078
	absent B-2 B cells	J:189078
	decreased B-1 B cell number	J:189078
	increased immature B cell number	J:189078
Fntb^tm1Bbd/Fntb^tm1.1Bbd Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)	small spleen	J:98944
Fntb^tm1Bbd/Fntb^tm1Bbd Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a^{tm1(cre/ERT2)Bbd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)	small spleen	J:98944
Focad^em1(IMPC)Bay/Focad⁺ (C57BL/6N-Focad^em1(IMPC)Bay/BayMmucd)	decreased spleen weight	J:211773
Fos^tm1Pa/Fos^tm1Pa (involves: 129X1/SvJ * C57BL/6J)	abnormal lymphopoiesis	J:3233
Fos^tm1Wag/Fos^tm1Wag (involves: 129S2/SvPas)	decreased osteoclast cell number	J:65766
Fos^tm1Wag/Fos^tm1Wag (involves: 129S2/SvPas * C57BL/6)	abnormal spleen morphology	J:3493
	abnormal spleen white pulp morphology	J:3493
	abnormal thymus size	J:3493
	decreased B cell number	J:3493
	decreased double-positive T cell number	J:3493
	decreased splenocyte number	J:3493
	decreased thymocyte number	J:3493
	increased T cell number	J:3493
Fos^tm1Wag/Fos^{tm2(Fosl1)Wag} (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	decreased osteoclast cell number	J:65766
Fos^tm5.1Wag/Fos^tm5.1Wag (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal osteoclast differentiation	J:175064
	decreased osteoclast cell number	J:175064
Fos^tm6.1Wag/Fos^tm6.1Wag (involves: 129P2/OlaHsd * C57BL/6 * SJL)	abnormal osteoclast differentiation	J:175064
Fos^tm7Wag/Fos^tm7Wag Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:190150
Fosl2^tm2.1Wag/Fosl2^tm2.1Wag (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:137646
	abnormal osteoclast morphology	J:137646
	increased osteoclast cell number	J:137646
Fosl2^tm2Wag/Fosl2^tm2Wag Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:137646
Fosl2^tm2Wag/Fosl2^tm2Wag Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	abnormal osteoclast morphology	J:211215
Foxa2^tm1Khk/Foxa2^tm1Khk Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0 (involves: 129 * 129P2/OlaHsd * C57BL/6)	increased macrophage cell number	J:88601
	increased neutrophil cell number	J:88601
Foxc2^tm1.1Miu/Foxc2^tm1.1Miu Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * C57BL/6J * SJL)	abnormal lymphatic vessel morphology	J:316530
Foxc2^tm1Miu/Foxc2⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)	abnormal thoracic duct morphology	J:83436
	enlarged lymph nodes	J:83436
	increased lymph node number	J:83436
	lymphangiectasis	J:83436
	lymphatic vessel hyperplasia	J:83436
Foxh1^b2b2662Clo/Foxh1^b2b2662Clo (C57BL/6J-Foxh1^b2b2662Clo)	absent spleen	J:175213
	thymus hypoplasia	J:175213
Foxh1^tm1Hmd/Foxh1^tm1.1Hmd Tg(Leftb-cre)1Hmd/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6Cr)	spleen hypoplasia	J:82311
Foxi3^em3Akg/Foxi3^tm1.2Akg (involves: 129X1/SvJ * C57BL/6)	athymia	J:336768
Foxj3^{tm1b(EUCOMM)Wtsi}/Foxj3⁺ (C57BL/6N-Foxj3^{tm1b(EUCOMM)Wtsi}/Bay)	increased leukocyte cell number	J:211773
Foxn1^nu-2J/Foxn1^nu-2J (B6(SJL)-Foxn1^nu-2J/GrsrJ)	athymia	J:192383
Foxn1^nu-StL/Foxn1^nu-StL (involves: C57BL/6)	absent T cells	J:63313
Foxn1^nu-StL/Foxn1^nu-StL (involves: C57BL/6)	athymia	J:63313
Foxn1^nu-StL/Foxn1^tm1Tbo (involves: 129S1/Sv * C57BL/6)	abnormal thymus development	J:63313
Foxn1^nu-StL/Foxn1^tm1Tbo (involves: 129S1/Sv * C57BL/6)	athymia	J:63313
Foxn1^nu-str/Foxn1^nu-str (AKR/J-Foxn1^nu-str/J)	abnormal immune system cell morphology	J:30715
	abnormal immune system morphology	J:24755
	abnormal immune system organ morphology	J:30715
	abnormal Peyer's patch germinal center morphology	J:30715
	abnormal Peyer's patch morphology	J:30715
	athymia	J:24755
	decreased lymphocyte cell number	J:30715
	decreased T cell number	J:30715
	increased eosinophil cell number	J:30715
	increased granulocyte number	J:30715
	increased neutrophil cell number	J:30715
	lymph node hypoplasia	J:30715
	spleen hypoplasia	J:30715
Foxn1^nu-Y/Foxn1^nu-Y (101/HY-Foxn1^nu-Y)	abnormal thymus development	J:4060
	absent T cells	J:4060
	athymia	J:4060, J:29022
Foxn1^nu/Foxn1⁺ (C.Cg-Foxn1^nu)	small thymus	J:7330
Foxn1^nu/Foxn1⁺ (NFS.Cg-Foxn1^nu)	abnormal thymus morphology	J:7330
Foxn1^nu/Foxn1⁺ (NFS.Cg-Foxn1^nu)	small thymus	J:7330
Foxn1^nu/Foxn1⁺ (B6N.Cg-Foxn1^nu)	small thymus	J:7330
Foxn1^nu/Foxn1⁺ (C3N.Cg-Foxn1^nu)	small thymus	J:7330
Foxn1^nu/Foxn1^nu (involves: NMRI)	abnormal thymus development	J:6363
Foxn1^nu/Foxn1^nu (Not Specified)	abnormal lymph node T cell domain morphology	J:202296
	abnormal Peyer's patch germinal center morphology	J:202296
	abnormal spleen morphology	J:202296
	abnormal splenic cell ratio	J:202296
	abnormal thymus morphology	J:202297
	athymia	J:202296, J:5059
	decreased leukocyte cell number	J:5059
	small spleen	J:202296
Foxn1^nu/Foxn1^nu (involves: C57BL/10Sn * C57BR/cd)	abnormal thymus development	J:7898
Foxn1^nu/Foxn1^nu (involves: CD-1)	athymia	J:106251
Foxn1^nu/Foxn1^nu (involves: CBA)	abnormal lymph node morphology	J:202808
	decreased leukocyte cell number	J:202299
	decreased lymphocyte cell number	J:202299
	decreased T cell number	J:202808
Foxn1^nu/Foxn1^nu Map3k14^aly/Map3k14^aly (involves: BALB/cAJcl * C57BL/6J)	absent B cells	J:96579
	absent lymph nodes	J:96579
	absent Peyer's patches	J:96579
	athymia	J:96579
	decreased gamma-delta intraepithelial T cell number	J:96579
	decreased T cell number	J:96579
Foxn1^nu/Foxn1^nu Tg(Foxn1)E1Hon/0 (involves: CD-1)	athymia	J:33866
Foxn1^nu/Foxn1^tm1.1Dmsu Tg(CAG-cre/Esr1)5Amc/0 (involves: 129/Sv C57BL/6 * CBA * SJL)	abnormal thymus epithelium morphology	J:159773
	decreased thymocyte number	J:159773
Foxn1^sepe/Foxn1^sepe (BALB/c-Foxn1^sepe)	athymia	J:227974
Foxn1^{tm1.1(KOMP)Vlcg}/Foxn1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Foxn1^{tm1.1(KOMP)Vlcg}/Tcp)	abnormal thymus morphology	J:211773
	athymia	J:211773
Foxn1^tm1.1Cbln/Foxn1⁺ (involves: 129P2/OlaHsd * C57BL/6)	thymus hyperplasia	J:177992
Foxn1^tm1.1Cbln/Foxn1^tm1.1Cbln (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphocyte cell number	J:177992
	decreased single-positive T cell number	J:177992
	increased DN1 thymic pro-T cell number	J:177992
	increased double-positive T cell number	J:177992
	thymus hypoplasia	J:177992
Foxn1^tm1.1Cbln/Foxn1^tm1Tbo (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	absent T cells	J:177992
	small thymus	J:177992
Foxn1^tm1.1Dmsu/Foxn1^tm1.1Dmsu Tg(CAG-cre/Esr1)5Amc/0 (involves: 129/Sv C57BL/6 * CBA * SJL)	abnormal thymus morphology	J:159773
	decreased double-positive T cell number	J:159773
	decreased thymocyte number	J:159773
	small thymus	J:159773
	thymus atrophy	J:159773
Foxn1^tm1.1Dmsu/Foxn1^tm1.1Dmsu Tg(KRT5-cre/ERT2)2Ipc/0 (involves: 129/Sv * C57BL/6 * SJL)	abnormal thymus corticomedullary boundary morphology	J:159773
	abnormal thymus medulla morphology	J:159773
	decreased thymocyte number	J:159773
	small thymus	J:159773
	thymus atrophy	J:159773
Foxn1^tm1Dmsu/Foxn1^tm1Dmsu (involves: 129/Sv * C57BL/6)	athymia	J:159773
Foxn1^tm1Nrm/Foxn1^tm1Nrm (involves: 129X1/SvJ * C57BL/6J)	abnormal CD4-positive, alpha beta T cell morphology	J:86255
	abnormal CD8-positive, alpha beta T cell morphology	J:86255
	abnormal T cell differentiation	J:86255
	abnormal thymus development	J:86255
	abnormal thymus epithelium morphology	J:86255
	absent thymus cortex	J:86255
	absent thymus medulla	J:86255
	decreased CD4-positive, alpha-beta T cell number	J:86255
	decreased double-negative T cell number	J:86255
	decreased double-positive T cell number	J:86255
	decreased T cell number	J:86255
	decreased thymocyte number	J:86255
	small thymus	J:86255
	thymus cyst	J:86255
Foxn1^tm1Tbo/Foxn1^tm1Tbo (involves: 129S1/Sv)	abnormal leukocyte cell number	J:33796
	abnormal thymus development	J:33796
	abnormal thymus epithelium morphology	J:177992
	abnormal thymus morphology	J:33796
	absent T cells	J:33796
	athymia	J:33796
	increased B cell number	J:33796
Foxn1^tm2Tbo/Foxn1^tm2Tbo Tg(KRT14-cre/ERT2)1Ipc/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased T cell number	J:110046
Foxn1^tm3(cre)Nrm/Foxn1⁺ Gt(ROSA)26Sor^{tm1(Tbx1)Rche}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NHsd)	abnormal thymus development	J:214094
	abnormal thymus epithelium morphology	J:214094
	decreased thymocyte number	J:214094
	thymus hypoplasia	J:214094
Foxn1^tm3(cre)Nrm/Foxn1⁺ Mir205hg^tm1Oers/Mir205hg^tm1Oers (B6(Cg)-Mir205hg^tm1Oers Foxn1^tm3(cre)Nrm)	decreased thymocyte number	J:278363
	decreased thymus weight	J:278363
	thymus hypoplasia	J:278363
Foxn4^{em1(IMPC)Ccpcz}/Foxn4⁺ (C57BL/6NCrl-Foxn4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
Foxo1^tm1.1Rdp/Foxo1⁺ Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * 129S1/Sv)	increased B cell number	J:157297
Foxo1^tm1.1Stlp/Foxo1^tm1.1Stlp Tg(Lck-cre)1Cwi/0 (involves: 129S4/SvJae)	abnormal single-positive T cell number	J:154205
	decreased CD8-positive, alpha-beta T cell number	J:154205
	decreased double-positive T cell number	J:154205
	decreased T cell number	J:154205
	increased CD4-positive, alpha-beta T cell number	J:154205
	increased CD8-positive, alpha-beta T cell number	J:154205
	small lymphoid organs	J:154205
	small spleen	J:154205
Foxo1^tm1Flv/Foxo1^tm1Flv Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)	enlarged lymph nodes	J:189962
	enlarged spleen	J:189962
	increased CD4-positive, alpha-beta T cell number	J:189962
	increased CD8-positive, alpha-beta T cell number	J:189962
	increased regulatory T cell number	J:189962
	increased T cell number	J:189962
Foxo1^tm1Flv/Foxo1^tm1Flv Ifng^tm1Ts/Ifng^tm1Ts Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129S6/SvEvTac * 129S7/SvEvBrd * 129X1/SvJ)	increased CD4-positive, alpha-beta T cell number	J:189962
	increased CD8-positive, alpha-beta T cell number	J:189962
Foxo1^tm1Flv/Foxo1^tm1Flv Rag1^tm1Mom/Rag1^tm1Mom Tg(CD2-Il7r)1Asin/? Tg(Cd4-cre)1Cwi/? Tg(TcraTcrb)425Cbn/? (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * DBA/2)	decreased T cell number	J:147057
Foxo1^tm1Flv/Foxo1^tm1Flv Rag1^tm1Mom/Rag1^tm1Mom Tg(Cd4-cre)1Cwi/? Tg(TcraTcrb)425Cbn/? (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * DBA/2)	decreased T cell number	J:147057
Foxo1^tm1Flv/Foxo1^tm1Flv Tg(Cd4-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	enlarged lymph nodes	J:147057
	increased single-positive T cell number	J:147057
Foxo1^tm1Rdp/Foxo1^tm1.1Rdp Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * 129S1/Sv)	absent marginal zone B cells	J:157297
	increased B cell number	J:157297
Foxo1^tm1Rdp/Foxo1^tm1Rdp Foxo3^tm1Rdp/Foxo3^tm1Rdp Foxo4^tm1Rdp/Foxo4^tm1Rdp Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N)	increased T cell derived lymphoma incidence	J:118179
Foxo3^Gt(XAO26)Byg/Foxo3^Gt(XAO26)Byg (involves: 129P2/OlaHsd)	abnormal immune system organ morphology	J:93593
	enlarged lymph nodes	J:93593
	enlarged spleen	J:93593
	lymphoid hyperplasia	J:93593
	spleen hyperplasia	J:93593
Foxo3^tm1Nmt/Foxo3^tm1Nmt (B6.Cg-Foxo3^tm1Nmt)	abnormal NK cell morphology	J:123409
Foxo3^tm1Nmt/Foxo3^tm1Nmt (B6.Cg-Foxo3^tm1Nmt)	increased NK cell number	J:123409
Foxo6^{tm1(KOMP)Vlcg}/Foxo6^{tm1(KOMP)Vlcg} (B6J.B6NTac-Foxo6^{tm1(KOMP)Vlcg})	abnormal Kupffer cell morphology	J:236585
Foxp1^tm1.1Pwt/Foxp1^tm1.1Pwt Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:156832
	decreased CD8-positive, alpha-beta T cell number	J:156832
Foxp1^tm1Rao/Foxp1^tm1Rao (B6.129-Foxp1^tm1Rao)	abnormal B cell differentiation	J:112644
	arrested B cell differentiation	J:112644
	decreased mature B cell number	J:112644
Foxp2^tm2.2Woen/Foxp2⁺ (involves: C57BL/6 * C57BL/6J)	increased CD4-positive, alpha-beta T cell number	J:150425
Foxp2^tm2.2Woen/Foxp2⁺ (involves: C57BL/6 * C57BL/6J)	increased CD8-positive, alpha-beta T cell number	J:150425
Foxp3^sf/Y (either: 129Rl.Cg-Foxp3^sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))	abnormal lymph node B cell domain morphology	J:11262
	abnormal lymph node medullary cord morphology	J:11262
	abnormal lymph node morphology	J:11262
	abnormal lymph node T cell domain morphology	J:11262
	abnormal lymphocyte morphology	J:11262
	abnormal macrophage morphology	J:11262
	abnormal spleen morphology	J:11262
	abnormal spleen white pulp morphology	J:11262
	abnormal thymus cortex morphology	J:11262
	abnormal thymus morphology	J:11262
	absent spleen marginal zone	J:11262
	decreased spleen B cell follicle number	J:11262
	enlarged lymph nodes	J:11262
	increased leukocyte cell number	J:11262
	increased spleen red pulp amount	J:11262
	increased spleen weight	J:11262
	small thymus	J:11262
Foxp3^sf/Y (involves: 101/H * C3H/HeH * STOCK MR)	abnormal spleen morphology	J:10398
	increased leukocyte cell number	J:10398
	increased spleen red pulp amount	J:10398
	increased spleen weight	J:10398
	increased spleen white pulp amount	J:10398
	intermingled spleen red and white pulp	J:10398
Foxp3^sf/Y (B6.Cg-Foxp3^sf)	abnormal CD4-positive, alpha beta T cell morphology	J:82560
Foxp3^sf/Y (B6.Cg-Foxp3^sf)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:82560
Foxp3^sf Otc^spf/Y (involves: 129/Rl)	enlarged lymph nodes	J:20865
	enlarged spleen	J:20865
	increased CD4-positive, alpha-beta T cell number	J:20865
Foxp3^sf/Foxp3^sf Tg(Rorc-EGFP)1Ebe/? (involves: C57BL/6)	abnormal effector T cell morphology	J:137020
Foxp3^{tm1(CD2/CD52)Shori}/Foxp3^{tm1(CD2/CD52)Shori} (involves: C57BL/6)	decreased regulatory T cell number	J:171378
Foxp3^tm1.1Ayr/Y (involves: 129S1/Sv * 129X1/SvJ)	abnormal CD4-positive, alpha beta T cell morphology	J:82560
	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:82560
	enlarged lymph nodes	J:82560
	enlarged spleen	J:82560
Foxp3^tm1.1Ayr/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	enlarged spleen	J:117743
Foxp3^tm1.1Ayr/Foxp3^tm1.1Ayr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:125405
	decreased double-positive T cell number	J:125405
	enlarged spleen	J:117743
	thymus hypoplasia	J:125405
Foxp3^tm1.1Ayr/Foxp3^tm1.1Ayr Mir146^tm1.1Bal/Mir146^tm1.1Bal (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased regulatory T cell number	J:167922
Foxp3^tm1.1Mal/Foxp3^tm1.1Mal Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	decreased regulatory T cell number	J:131351
	thymus hypoplasia	J:131351
Foxp3^tm1Ayr/Y Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	enlarged lymph nodes	J:97029
	enlarged spleen	J:97029
Foxp3^tm1Ayr/Foxp3^tm1Ayr Tg(Cd4-cre)1Cwi/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:125405
	decreased double-positive T cell number	J:125405
	thymus hypoplasia	J:125405
Foxp3^tm1Flv/Foxp3⁺ B9d2/Tgfb1^tm1Flv/Tgfb1^tm2Flv Tg(Cd4-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	increased regulatory T cell number	J:123547
Foxp3^tm1Kuch/? Il6^tm1Kopf/Il6^tm1Kopf (involves: 129S2/SvPas * C57BL/6)	abnormal CD4-positive T cell differentiation	J:123352
	increased regulatory T cell number	J:123352
Foxp3^tm1Tch/Y (C.129X1-Foxp3^tm1Tch)	absent regulatory T cells	J:117165
	enlarged spleen	J:117165
	increased activated T cell number	J:117165
	increased CD4-positive, alpha-beta T cell number	J:117165
	increased CD8-positive, alpha-beta T cell number	J:117165
	increased eosinophil cell number	J:117165
	increased leukocyte cell number	J:117165
	increased lymphocyte cell number	J:117165
	increased monocyte cell number	J:117165
Foxp3^tm1Tch/Y (B6.129X1-Foxp3^tm1Tch)	increased eosinophil cell number	J:117165
	increased leukocyte cell number	J:117165
	increased lymphocyte cell number	J:117165
	increased monocyte cell number	J:117165
Foxp3^tm1Tch/Y Stat6^tm1Gru/Stat6^tm1Gru (C.129-Stat6^tm1Gru Foxp3^tm1Tch)	increased eosinophil cell number	J:117165
Foxp3^{tm2.1(EGFP/cre)Shori}/Y (involves: 129 * C57BL/6)	decreased regulatory T cell number	J:234397
Foxp3^{tm2.1(EGFP/cre)Shori}/Y Pdcd1^tm1Hon/Pdcd1^tm1Hon (involves: 129 * 129S2/SvPas * C57BL/6)	enlarged lymph nodes	J:234397
	enlarged spleen	J:234397
	increased effector memory T-helper cell number	J:234397
	lymph node hyperplasia	J:234397
	spleen hyperplasia	J:234397
Foxp3^tm2Ayr/? Zap70^rps/Zap70^rps (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:211510
	abnormal double-positive T cell morphology	J:211510
	abnormal regulatory T cell number	J:211510
	abnormal T cell differentiation	J:211510
	decreased CD4-positive, alpha-beta T cell number	J:211510
	decreased CD8-positive, alpha-beta T cell number	J:211510
Foxp3^tm2Flv/Y (involves: C57BL/6)	enlarged lymph nodes	J:118631
Foxp3^tm2Flv/Y (involves: C57BL/6)	enlarged spleen	J:118631
Foxp3^{tm3(HBEGF/GFP)Ayr}/Foxp3^{tm3(HBEGF/GFP)Ayr} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased T cell number	J:117743
	enlarged spleen	J:117743
	increased dendritic cell number	J:117743
Foxp3^tm3Tch/Y (C.129X1-Foxp3^tm3Tch)	abnormal CD4-positive, alpha beta T cell morphology	J:120636
	abnormal immune system organ morphology	J:120636
	abnormal T cell subpopulation ratio	J:120636
	enlarged lymph nodes	J:120636
	enlarged spleen	J:120636
	thymus hypoplasia	J:120636
Foxp3^tm3Tch/Foxp3⁺ (C.129X1-Foxp3^tm3Tch)	decreased T cell number	J:120636
Foxp3^tm3Tch/Foxp3⁺ (C.129X1-Foxp3^tm3Tch)	decreased thymocyte number	J:120636
Foxp3^{tm4(YFP/icre)Ayr}/Y Zfp91^tm1Smoc/Zfp91^tm1Smoc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased regulatory T cell number	J:306129
	increased CD8-positive, alpha-beta T cell number	J:306129
Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn (involves: 129S1/Sv * 129X1/SvJ)	abnormal regulatory T cell morphology	J:205658
Foxp3^{tm4(YFP/icre)Ayr}/Foxp3^{tm4(YFP/icre)Ayr} Ikzf4^tm1Djr/Ikzf4^tm1Djr (involves: 129S1/Sv * 129X1/SvJ)	decreased regulatory T cell number	J:294549
	enlarged lymph nodes	J:294549
	enlarged spleen	J:294549
	increased germinal center B cell number	J:294549
	increased spleen B cell follicle number	J:294549
	increased spleen germinal center number	J:294549
	increased T cell number	J:294549
	increased T follicular helper cell number	J:294549
Foxp3^tm5.2Ayr/Foxp3^tm5.2Ayr (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)	abnormal gut-associated lymphoid tissue morphology	J:156942
	abnormal intraepithelial T cell morphology	J:156942
	abnormal mesenteric lymph node morphology	J:156942
	abnormal Peyer's patch morphology	J:156942
	abnormal T cell differentiation	J:156942
	decreased regulatory T cell number	J:156942
	increased T cell number	J:156942
Foxp3^tm6.2Ayr/Foxp3^tm6.2Ayr (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)	decreased regulatory T cell number	J:156942
Foxp3^tm7.2Ayr/Foxp3⁺ (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)	decreased regulatory T cell number	J:156942
Foxp3^tm7.2Ayr/Foxp3^tm7.2Ayr (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)	abnormal regulatory T cell morphology	J:156942
	decreased regulatory T cell number	J:156942
Foxp3^{tm9(EGFP/cre/ERT2)Ayr}/Foxp3⁺ Il1r2^tm1.1Mchc/Il1r2^tm1.1Mchc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6NTac)	abnormal alpha-beta T cell number	J:347877
	increased CD4-positive, alpha-beta T cell number	J:347877
	increased spleen germinal center size	J:347877
	increased T follicular helper cell number	J:347877
Foxq1^sa-e1/Foxq1^sa-e1 (involves: 101/Rl * C3H/Rl)	abnormal lymphocyte cell number	J:75422
Foxq1^sa/Foxq1^sa Lyst^bg/Lyst^bg (involves: 101/Rl * C3H/Rl * C57BL/6J * C57BL10/Rl)	enlarged lymph nodes	J:5311
Foxq1^sa/Foxq1^sa Lyst^bg/Lyst^bg (involves: 101/Rl * C3H/Rl * C57BL10/Rl)	enlarged spleen	J:5311
Foxr1^em1(IMPC)Tcp/Foxr1⁺ (C57BL/6NCrl-Foxr1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	small spleen	J:211773
Foxr1^em1(IMPC)Tcp/Foxr1^em1(IMPC)Tcp (C57BL/6NCrl-Foxr1^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
Foxred1^em1(IMPC)Bay/Foxred1⁺ (C57BL/6N-Foxred1^em1(IMPC)Bay/Bay)	increased spleen weight	J:211773
Fpr2^tm1.2Jimw/Fpr2^tm1.2Jimw (B6.129X1-Fpr2^tm1.2Jimw)	decreased dendritic cell number	J:160074
Fpr2^tm1.2Jimw/Fpr2^tm1.2Jimw (B6.129X1-Fpr2^tm1.2Jimw)	small lymph nodes	J:160074
Fpr2^tm1.2Jimw/Fpr2^tm1.2Jimw (involves: 129X1/SvJ)	decreased dendritic cell number	J:199611
Fras1^{em1(IMPC)Ccpcz}/Fras1⁺ (C57BL/6NCrl-Fras1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Frmd3^em1(IMPC)J/Frmd3^em1(IMPC)J (C57BL/6NJ-Frmd3^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Frmd8^em2Smoc/Frmd8^em2Smoc Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * SJL)	increased spleen weight	J:338904
Fsd2^em1(IMPC)Mbp/Fsd2^em1(IMPC)Mbp (C57BL/6N-Fsd2^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Fshr^tm1Saco/Fshr^tm1Saco (involves: 129)	enlarged spleen	J:70933
Fshr^tm1Saco/Fshr^tm1Saco (involves: 129)	increased pre-B cell number	J:65577
Fstl1^{tm1b(EUCOMM)Hmgu}/Fstl1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Fstl1^{tm1b(EUCOMM)Hmgu}/H)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Fth1^tm1.1Lck/Fth1^tm1.1Lck Tg(Mx1-cre)1Cgn/0 (B6.Cg-Fth1^tm1.1Lck Tg(Mx1-cre)1Cgn)	decreased spleen iron level	J:166515
Ftl1^tm1.1Ruvi/Ftl1^tm1.1Ruvi (involves: 129 * C57BL/6)	abnormal mononuclear phagocyte morphology	J:244236
Fts/Fts⁺ (involves: C57BL/6 * SJL)	thymus hyperplasia	J:20159
Fts/Fts⁺ (B6.Cg-Fts)	abnormal CD4-positive T cell differentiation	J:108193
	abnormal T cell morphology	J:108193
	increased thymocyte number	J:108193
	thymus hyperplasia	J:108193
Fubp1^em1(IMPC)Mbp/Fubp1⁺ (C57BL/6N-Fubp1^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
Fubp1^em1(IMPC)Mbp/Fubp1⁺ (C57BL/6N-Fubp1^em1(IMPC)Mbp/Ucd)	enlarged lymph nodes	J:211773
Fubp1^tm1.1Dlev/Fubp1^tm1.1Dlev (involves: 129 * C57BL/6)	decreased B cell number	J:229985
	lymphoid hypoplasia	J:229985
	spleen hypoplasia	J:229985
	thymus hypoplasia	J:229985
Fus^{Gt(U3NeoSV1)HO14Ggh}/Fus^{Gt(U3NeoSV1)HO14Ggh} (B6.129S2-Fus^{Gt(U3NeoSV1)HO14Ggh})	decreased B cell number	J:60213
	decreased lymphocyte cell number	J:60213
	lymphoid hypoplasia	J:60213
	small thymus	J:60213
Fut4^tm1Jbl/Fut4^tm1Jbl (B6.129S2-Fut4^tm1Jbl)	increased eosinophil cell number	J:79397
	increased granulocyte number	J:79397
	increased monocyte cell number	J:79397
	increased neutrophil cell number	J:79397
Fut4^tm1Jbl/Fut4^tm1Jbl Fut7^tm1Jbl/Fut7^tm1Jbl (B6.129S2-Fut7^tm1Jbl Fut4^tm1Jbl)	abnormal immune system organ morphology	J:79397
	abnormal lymph node primary follicle morphology	J:79397
	increased leukocyte cell number	J:79397
	increased neutrophil cell number	J:79397
	lymph node hypoplasia	J:79388, J:79397
	small lymph nodes	J:79397
Fut7^tm1Jbl/Fut7^tm1Jbl (involves: 129S2/SvPas * C57BL/6J * DBA/2J)	abnormal lymph node primary follicle morphology	J:35023
Fxr1^tm1Dln/Fxr1^tm1Dln (involves: 129P2/OlaHsd * C57BL/6)	small spleen	J:91191
Fyb1^tm1Gak/Fyb1^tm1Gak (involves: 129S1/Sv * 129X1/SvJ)	decreased thymocyte number	J:111368
Fyn^tm1Rmp/Fyn^tm1Rmp (involves: 129S2/SvPas)	decreased gamma-delta T cell number	J:37062
Fyn^tm1Rmp/Fyn^tm1Rmp (involves: 129S2/SvPas)	decreased T cell number	J:37062
Fyn^tm1Rmp/Fyn^tm1Rmp Lck^tm1Mak/Lck^tm1Mak (involves: 129S2/SvPas)	abnormal alpha-beta intraepithelial T cell morphology	J:112977
	abnormal NK T cell number	J:37940
	absent CD4-positive, alpha-beta T cells	J:37940
	absent CD8-positive, alpha-beta T cells	J:37940
	absent T cells	J:37062
	arrested T cell differentiation	J:37062, J:37940
	decreased double-positive T cell number	J:37940
	decreased gamma-delta intraepithelial T cell number	J:112977, J:37940
	thymus hypoplasia	J:37062, J:37940
Fyn^tm1Sor/Fyn^tm1Sor (either: 129S7/SvEvBrd-Fyn^tm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))	abnormal T cell clonal deletion	J:2242
Fyn^tm1Sor/Fyn^tm1Sor Lck^tm1Litt/Lck^tm1.1Litt Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129S7/SvEvBrd * 129X1/SvJ)	decreased regulatory T cell number	J:152472
	enlarged lymph nodes	J:152472
	increased regulatory T cell number	J:152472
	increased T cell number	J:152472
Fyn^tm1Sor/Fyn^tm1Sor Yes1^tm1Sor/Yes1^tm1Sor (involves: 129S7/SvEvBrd)	enlarged spleen	J:20346
	increased spleen white pulp amount	J:20346
	myeloid hyperplasia	J:20346
Fyn^tm1Yik/Fyn^tm1Yik Ptk2^tm1Lfr/Ptk2⁺ (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal T cell differentiation	J:110771
	decreased double-positive T cell number	J:110771
	decreased thymocyte number	J:110771
	thymus cortex atrophy	J:110771
Fzd1^em1(IMPC)Mbp/Fzd1^em1(IMPC)Mbp (C57BL/6N-Fzd1^em1(IMPC)Mbp/MbpMmucd)	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Fzd9^tm1Uta/Fzd9^tm1Uta (involves: 129S6/SvEvTac * 129X1/SvJ)	abnormal lymph node medullary cord morphology	J:98133
	abnormal lymph node morphology	J:98133
	abnormal spleen marginal zone morphology	J:98133
	abnormal spleen red pulp morphology	J:98133
	decreased B cell number	J:98133
	decreased pre-B cell number	J:98133
	decreased pro-B cell number	J:98133
	enlarged lymph nodes	J:98133
	enlarged spleen	J:98133
	increased eosinophil cell number	J:98133
	increased leukocyte cell number	J:98133
	increased monocyte cell number	J:98133
	increased neutrophil cell number	J:98133
	thymus atrophy	J:98133
G2e3^em1(IMPC)Tcp/G2e3^em1(IMPC)Tcp (C57BL/6NCrl-G2e3^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
G6pc2^tm1.1Pesa/G6pc2^tm1.1Pesa (NOD.129S2-G6pc2^tm1.1Pesa)	abnormal CD8-positive, alpha beta T cell morphology	J:160286
G6pc3^tm1Jyc/G6pc3^tm1Jyc (involves: 129S4/SvJae * C57BL/6)	decreased neutrophil cell number	J:120741
G6pc3^tm1Jyc/G6pc3^tm1Jyc (involves: 129S4/SvJae * C57BL/6)	increased granulocyte number	J:120741
G6pd2^em1(IMPC)Tcp/G6pd2^em1(IMPC)Tcp (C57BL/6NCrl-G6pd2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Gab2^tm1Hhg/Gab2^tm1Hhg (involves: 129S4/SvJae)	decreased mast cell number	J:70424
Gab2^tm1Pngr/Gab2^tm1Pngr (B6.Cg-Gab2^tm1Pngr)	abnormal osteoclast differentiation	J:97515
	abnormal osteoclast morphology	J:97515
	decreased osteoclast cell number	J:97515
Gab2^tm1Thir/Gab2^tm1Thir (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal mast cell differentiation	J:75092
	decreased mast cell number	J:75092
Gab2^tm3.1Thir/Gab2^tm3.1Thir (involves: 129T/SvJcl * C57BL/6Jcl)	decreased mast cell number	J:178045
Gab2^tm4.1Thir/Gab2^tm4.1Thir (involves: 129T/SvJcl * C57BL/6Jcl)	decreased mast cell number	J:178045
Gab3^em1Khoe/Gab3^em1Khoe (C57BL/6-Gab3^em1Khoe)	abnormal mature NK cell morphology	J:291290
	abnormal uterine NK cell morphology	J:291290
	decreased NK cell number	J:291290
Gab3^m1Khoe/Gab3^m1Khoe (C57BL/6-Gab3^m1Khoe)	abnormal mature NK cell morphology	J:291290
	abnormal uterine NK cell morphology	J:291290
	decreased NK cell number	J:291290
Gabarapl2^{tm1b(EUCOMM)Hmgu}/Gabarapl2⁺ (C57BL/6N-Gabarapl2^{tm1b(EUCOMM)Hmgu}/H)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Gabpa^Gt(XH074)Byg/Gabpa^Gt(XH074)Byg (involves: 129P2/OlaHsd * C57BL/6)	decreased thymocyte number	J:92671
	small thymus	J:92671
Gabpb2^{Gt(RRJ488)Byg}/Gabpb2^{Gt(RRJ488)Byg} (involves: 129P2/OlaHsd)	increased spleen germinal center number	J:141846
Gabra5^{em1(IMPC)Ccpcz}/Gabra5^{em1(IMPC)Ccpcz} (C57BL/6N-Gabra5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Gabrb3^tm2.1Geh/Gabrb3^tm2.1Geh Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive T cell differentiation	J:333883
	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:333883
	abnormal T-helper 17 cell differentiation	J:333883
Gadd45a^tm1Ajf/Gadd45a^tm1Ajf (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))	abnormal lymphopoiesis	J:76041
	decreased basophil cell number	J:76041
	decreased eosinophil cell number	J:76041
	decreased leukocyte cell number	J:76041
	decreased lymphocyte cell number	J:76041
	increased T cell number	J:76041
	increased thymocyte number	J:57882
	increased thymus weight	J:57882
Gadd45b^tm1Flv/Gadd45b^tm1Flv (involves: 129S6/SvEvTac)	abnormal T-helper 1 cell differentiation	J:87396
Gadd45b^tm1Flv/Gadd45b^tm1Flv (B6.129S6-Gadd45b^tm1Flv)	spleen hyperplasia	J:118837
Gadd45b^tm1Flv/Gadd45b^tm1Flv Gadd45g^tm1Flv/Gadd45g^tm1Flv (involves: 129S1/Sv * 129S6/SvEvTac)	abnormal T-helper 1 cell differentiation	J:87396
Gadd45b^tm1Flv/Gadd45b^tm1Flv Gadd45g^tm1Flv/Gadd45g^tm1Flv (involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)	increased mature B cell number	J:118837
	increased memory T cell number	J:118837
	spleen hyperplasia	J:118837
Gadd45g^tm1Flv/Gadd45g^tm1Flv (involves: 129S1/Sv)	abnormal T-helper 1 cell differentiation	J:87396
Gak^{em1(IMPC)Ccpcz}/Gak⁺ (C57BL/6NCrl-Gak^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Galc^twi-5J/Galc^twi-5J (BXD32/TyJ-Galc^twi-5J/J)	abnormal leukocyte morphology	J:199132
Galc^twi/Galc^twi (B6.CE-Galc^twi/J)	abnormal microglial cell morphology	J:108359
Galc^twi/Galc^twi (involves: C57BL/6J * CE/J)	abnormal macrophage morphology	J:6390
Galc^twi/Galc^twi Glb1^tm1Adz/Glb1^tm1Adz (involves: 129P2/OlaHsd * C57BL/6J * CE/J)	enlarged spleen	J:63197
Galnt1^tm1.1Jxm/Galnt1^tm1.1Jxm (B6NHsd.Cg-Galnt1^tm1.1Jxm)	decreased B cell number	J:128982
	decreased basophil cell number	J:128982
	decreased eosinophil cell number	J:128982
	decreased germinal center B cell number	J:128982
	decreased leukocyte cell number	J:128982
	decreased plasma cell number	J:128982
	decreased spleen germinal center number	J:128982
	decreased T cell number	J:128982
	increased lymphocyte cell number	J:128982
	lymph node hypoplasia	J:128982
Galnt3^tm1.1Cfg/Galnt3^tm1.1Cfg (involves: C57BL/6)	decreased monocyte cell number	J:217719
Galnt13^em1(IMPC)Mbp/Galnt13^em1(IMPC)Mbp (C57BL/6N-Galnt13^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Galnt18^{tm1b(KOMP)Wtsi}/Galnt18^{tm1b(KOMP)Wtsi} (C57BL/6N-Galnt18^{tm1b(KOMP)Wtsi}/Wtsi)	increased NK cell number	J:211773
Galr1^em1(IMPC)H/Galr1^em1(IMPC)H (C57BL/6N-Galr1^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased eosinophil cell number	J:211773
Galr2^{Gt(OST105469)Lex}/Galr2^{Gt(OST105469)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	decreased B cell number	J:103485
	increased T cell number	J:103485
Gapt^tm1.1Wz/Gapt^tm1.1Wz (Not Specified)	increased marginal zone B cell number	J:138146
Gapvd1^em1(IMPC)Mbp/Gapvd1⁺ (C57BL/6N-Gapvd1^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Garem1^em1(IMPC)Mbp/Garem1^em1(IMPC)Mbp (C57BL/6N-Garem1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Garin1a^{em1(IMPC)Ccpcz}/Garin1a^{em1(IMPC)Ccpcz} (C57BL/6N-Garin1a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Garin1b^{em1(IMPC)Ccpcz}/Garin1b^{em1(IMPC)Ccpcz} (C57BL/6N-Garin1b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Garin2^{em1(IMPC)Ccpcz}/Garin2^{em1(IMPC)Ccpcz} (C57BL/6N-Garin2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Gars1^em1(IMPC)Tcp/Gars1⁺ (C57BL/6NCrl-Gars1^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Gas2l2^{tm1a(KOMP)Wtsi}/Gas2l2^{tm1a(KOMP)Wtsi} (C57BL/6N-Gas2l2^{tm1a(KOMP)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
Gata1^Plt13/Gata1⁺ (BALB/c-Gata1^Plt13)	abnormal myelopoiesis	J:113720
	abnormal thrombopoiesis	J:113720
	enlarged spleen	J:113720
	increased spleen weight	J:113720
Gata1^tm1Mym/Y Tg(Gata1)#Mym/0 (involves: 129P2/OlaHsd C57BL/6 * DBA/2J)	increased leukocyte cell number	J:158252
Gata1^tm1Mym/Y Tg(Gata1V205G)1Mym/0 (involves: C57BL/6 DBA/2)	abnormal mononuclear cell morphology	J:89054
	abnormal thrombopoiesis	J:89054
Gata1^tm1Mym/Gata1⁺ (involves: 129P2/OlaHsd)	decreased spleen red pulp amount	J:88685
	decreased spleen white pulp amount	J:88685
	enlarged spleen	J:88685
	pale spleen	J:88685
Gata1^tm1Mym/Gata1^tm1Mym Tg(Gata1)#Mym/0 (involves: 129P2/OlaHsd C57BL/6 * DBA/2J)	increased leukocyte cell number	J:158252
Gata1^tm1Sho/Y Tg(Gata1)#Mym/0 (involves: 129S4/SvJae C57BL/6 * DBA/2J)	increased leukocyte cell number	J:158252
Gata1^tm1Sho/Gata1⁺ (involves: 129S4/SvJae * C57BL/6)	decreased eosinophil cell number	J:88711
Gata1^tm1Sho/Gata1^tm1Sho Tg(Gata1)#Mym/0 (involves: 129S4/SvJae C57BL/6 * DBA/2J)	increased leukocyte cell number	J:158252
Gata1^tm2Sho/Y (involves: 129S4/SvJae * C57BL/6 * CD-1)	abnormal spleen morphology	J:78348
	abnormal spleen red pulp morphology	J:78540
	decreased lymphocyte cell number	J:78348
	enlarged spleen	J:78348, J:78540
	increased neutrophil cell number	J:78348
	increased splenocyte number	J:78540
Gata1^tm2Sho/Gata1^tm2Sho (involves: 129S4/SvJae * C57BL/6 * CD-1)	abnormal spleen morphology	J:78348
	abnormal spleen red pulp morphology	J:78540
	decreased lymphocyte cell number	J:78348
	enlarged spleen	J:78348, J:78540
	increased neutrophil cell number	J:78348
	increased splenocyte number	J:78540
Gata1^tm2Sho/Gata1^tm2Sho (involves: 129S4/SvJae)	increased osteoclast cell number	J:111270
Gata1^tm6Sho/Y (involves: 129S1/Sv)	decreased eosinophil cell number	J:88711
Gata1^tm6Sho/Y (involves: 129S1/Sv)	enlarged spleen	J:88711
Gata1^tm6Sho/Gata1^tm6Sho (involves: 129S1/Sv)	decreased eosinophil cell number	J:88711
Gata1^tm6Sho/Gata1^tm6Sho (involves: 129S1/Sv * BALB/c)	abnormal leukocyte cell number	J:115273
	decreased eosinophil cell number	J:115273
	decreased lymphocyte cell number	J:115273
	increased neutrophil cell number	J:115273
Gata3^tm1Iho/Gata3^tm1Iho Il13^{tm1(YFP/cre)Lky}/Il13⁺ (involves: 129S4/SvJae)	decreased eosinophil cell number	J:178986
Gata3^tm1Iho/Gata3^tm1Iho Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal T cell differentiation	J:86996
	decreased CD4-positive, alpha-beta T cell number	J:86996
Gata3^tm1Iho/Gata3^tm1Iho Tg(Cd4-cre)1Cwi/0 Tg(DO11.10)10Dlo/0 (involves: BALB/c * C3H * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:86996
Gata3^tm1Iho/Gata3^tm1Iho Tg(DO11.10)10Dlo/0 Tg(Lck-cre)1Cwi/0 (involves: BALB/c * C3H * C57BL/6)	arrested T cell differentiation	J:86996
	decreased CD4-positive, alpha-beta T cell number	J:86996
	decreased CD8-positive, alpha-beta T cell number	J:86996
	decreased double-positive T cell number	J:86996
	small thymus	J:86996
Gata3^tm1Iho/Gata3^tm1Iho Tg(Lck-cre)1Cwi/0 (involves: BALB/c)	abnormal CD8-positive, alpha-beta T cell number	J:86996
	abnormal T cell subpopulation ratio	J:86996
	arrested T cell differentiation	J:86996
	decreased CD4-positive, alpha-beta T cell number	J:86996
	decreased double-positive T cell number	J:86996
	decreased thymocyte number	J:86996
	small thymus	J:86996
Gata3^tm1Jeng/Gata3^tm1Jeng (involves: 129S7/SvEvBrd)	abnormal immune system organ morphology	J:62552
Gata3^tm1Jfz/Gata3^tm1Jfz Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Cd4-cre)1Cwi/0 Tg(Tcra5CC7,Tcrb5CC7)IWep/0 (involves: 129S/SvEv * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:141145
Gata3^tm1Jfz/Gata3^tm1Jfz Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:93538
	abnormal T cell differentiation	J:141145
	decreased CD4-positive, alpha-beta T cell number	J:141145
Gata3^tm1Jfz/Gata3^tm1Jfz Tg(Tnfrsf4-cre)1Nik/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:93538
	decreased T-helper 2 cell number	J:93538
	increased T-helper 1 cell number	J:93538
Gata3^tm1Jml/Gata3^tm1Jml (involves: 129S/SvEv * C57BL/6)	abnormal immune system cell morphology	J:37093
Gata3^tm2Jeng/Gata3^tm2Jeng (Not Specified)	abnormal double-positive T cell morphology	J:155686
	abnormal T cell differentiation	J:155686
	abnormal T cell number	J:155686
	decreased double-negative T cell number	J:155686
	decreased gamma-delta T cell number	J:155686
	decreased thymocyte number	J:155686
Gata3^tm3Gsv/Gata3^tm3Gsv Tg(KRT14-cre)8Brn/0 (involves: 129P2/OlaHsd * FVB/N)	decreased T cell number	J:117058
Gatad2b^{tm1b(EUCOMM)Hmgu}/Gatad2b⁺ (C57BL/6N-Gatad2b^{tm1b(EUCOMM)Hmgu}/Ics)	increased monocyte cell number	J:211773
Gba1^tm1.1Pmis/Gba1^tm1.1Pmis Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal T cell differentiation	J:167081
	abnormal thymus morphology	J:167081
	decreased double-positive T cell number	J:167081
	enlarged spleen	J:167081
	spleen hyperplasia	J:167081
Gba1^tm1.1Pmis/Gba1^tm1.2Pmis Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal T cell differentiation	J:167081
	abnormal thymus morphology	J:167081
	decreased double-positive T cell number	J:167081
	enlarged spleen	J:167081
	spleen hyperplasia	J:167081
Gba1^tm1Clk/Gba1^tm1.1Clk Tg(Tek-cre)12Flv/0 (involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6J)	abnormal macrophage morphology	J:117763
	abnormal spleen morphology	J:117763
	increased spleen weight	J:117763
Gba1^tm1Karl/Gba1^tm1.1Karl Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal immune system organ morphology	J:113751
	abnormal spleen morphology	J:113751
	enlarged spleen	J:113751
	intermingled spleen red and white pulp	J:113751
Gba1^tm1Karl/Gba1^tm1Karl Tg(Nes-cre)1Kln/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal microglial cell morphology	J:127108
Gba1^tm1Nsb/Gba1^tm1Nsb (involves: 129S/SvEv * C57BL/6)	abnormal macrophage morphology	J:1100
Gba1^tm1Rlp/Gba1^tm1Rlp (involves: 129S4/SvJae * C57BL/6)	abnormal Kupffer cell morphology	J:76409
	abnormal lymph node morphology	J:76409
	abnormal macrophage morphology	J:76409
	decreased leukocyte cell number	J:76409
	increased spleen weight	J:76409
Gba1^tm2Ggb/Gba1^tm1Nsb (involves: 129S/SvEv * 129S5/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:86334
Gba1^tm2Ggb/Gba1^tm2Ggb (involves: 129S5/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:86334
Gba1^tm2Karl/Gba1^tm2Karl Tg(KRT14-cre)8Brn/? (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal macrophage morphology	J:127108
Gba1^tm3Ggb/Gba1^tm1Nsb (involves: 129S/SvEv * 129S5/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:86334
Gba1^tm3Ggb/Gba1^tm3Ggb (involves: 129S5/SvEvBrd)	abnormal spleen morphology	J:86334
Gba1^tm4Ggb/Gba1^tm1Nsb (involves: 129S/SvEv * 129S5/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:86334
Gba1^tm4Ggb/Gba1^tm4Ggb (involves: 129S5/SvEvBrd * C57BL/6)	abnormal spleen morphology	J:86334
Gbx2^tm1.1Mrt/Gbx2^tm1.1Mrt Fgf8^tm1.4Mrt/Fgf8⁺ (B6.129-Gbx2^tm1.1Mrt Fgf8^tm1.4Mrt)	abnormal thymus development	J:100584
Gcnt1^tm1Jxm/Gcnt1^tm1Jxm (involves: 129/Sv * C57BL/6)	abnormal B cell differentiation	J:86387
	abnormal immune system cell morphology	J:86387
	increased leukocyte cell number	J:86387
	increased neutrophil cell number	J:86387
Gcnt2^tm1Tmu/Gcnt2^tm1Tmu (involves: 129S2/SvPas * C57BL/6)	decreased B cell number	J:100533
Gcnt4^tm1.1Jxm/Gcnt4^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased neutrophil cell number	J:149909
Gcsam^tm1.1Rsky/Gcsam^tm1.1Rsky (involves: BALB/cJ * C57BL/6)	decreased Peyer's patch number	J:125784
	small Peyer's patches	J:125784
Gcsfis^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	enlarged spleen	J:61462
Gcsfis^C57BL/6J/Gcsfis^C57BL/6J (B6.SJL-Ptprc^a Pepc^b/BoyJ)	enlarged spleen	J:61462
Gcsh^em1(IMPC)H/Gcsh⁺ (C57BL/6N-Gcsh^em1(IMPC)H/H)	increased basophil cell number	J:211773
Gda^{tm1a(KOMP)Wtsi}/Gda^{tm1a(KOMP)Wtsi} (C57BL/6N-Gda^{tm1a(KOMP)Wtsi}/Wtsi)	decreased T-helper cell number	J:211773
	increased effector memory T-helper cell number	J:211773
Gdap1^{tm2b(KOMP)Wtsi}/Gdap1^{tm2b(KOMP)Wtsi} (C57BL/6N-Gdap1^{tm2b(KOMP)Wtsi}/Ucd)	abnormal thymus morphology	J:211773
	small thymus	J:211773
Gdf1^tm1Sjl/Gdf1^tm1Sjl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:60755
Gdf2^tm1Lex/Gdf2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal lymphatic vessel morphology	J:222016
Gdf2^tm1Lex/Gdf2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	lymphangiectasis	J:222016
Gdf5^em1(IMPC)H/Gdf5^em1(IMPC)H (C57BL/6NTac-Gdf5^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
Gdf6^{em1(IMPC)Ccpcz}/Gdf6⁺ (C57BL/6NCrl-Gdf6^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Gdf11^tm1Sjl/Gdf11^tm1Sjl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal spleen morphology	J:94455
Gdnf^tm1Rosl/Gdnf^tm1Rosl (involves: 129S2/SvPas)	abnormal spleen red pulp morphology	J:33808
Gdpd5^{tm1b(EUCOMM)Hmgu}/Gdpd5⁺ (C57BL/6N-Gdpd5^{tm1b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Gfi1^Gen/Gfi1⁺ (C57BL/6J-Gfi1^Gen)	abnormal myelopoiesis	J:182679
	abnormal NK cell differentiation	J:182679
	absent neutrophils	J:182679
Gfi1^tm1.1Wep/Gfi1^tm1.1Wep (B6.129-Gfi1^tm1.1Wep)	arrested T cell differentiation	J:117105
	decreased B cell number	J:117105
	small thymus	J:117105
	thymus hypoplasia	J:117105
Gfi1^tm1Tmo/Gfi1^tm1Tmo (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal granulocyte differentiation	J:75143
	abnormal monocyte differentiation	J:75143
	abnormal myelopoiesis	J:75143
	abnormal T cell differentiation	J:75143
	decreased B cell number	J:75143
	decreased granulocyte number	J:75143
	decreased lymphocyte cell number	J:75143
	decreased neutrophil cell number	J:75143
	decreased T cell number	J:75143
	decreased thymocyte number	J:75143
Gfi1^tm1Tmo/Gfi1^tm1Tmo (involves: 129S1/Sv * 129X1/SvJ)	decreased B cell number	J:192927
	decreased granulocyte number	J:192927
	decreased neutrophil cell number	J:192927
	decreased thymocyte number	J:192927
	increased monocyte cell number	J:192927
Gfi1^tm1Wep/Gfi1^tm1Wep Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell subpopulation ratio	J:117105
Gfi1^tm2Tmo/Gfi1^tm2Tmo (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:93337
	decreased neutrophil cell number	J:93337
	decreased thymocyte number	J:93337
Gfi1^{tm3(Gfib1)Tmo}/Gfi1^{tm3(Gfib1)Tmo} (involves: 129S1/Sv * 129X1/SvJ)	abnormal monocyte morphology	J:116870
	decreased granulocyte number	J:116870
Gfi1^tm4Tmo/Gfi1^tm4Tmo (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphopoiesis	J:116870
	abnormal monocyte morphology	J:116870
	abnormal neutrophil morphology	J:116870
	abnormal T cell differentiation	J:116870
	decreased double-negative T cell number	J:116870
	decreased lymphocyte cell number	J:116870
	decreased neutrophil cell number	J:116870
	decreased thymocyte number	J:116870
Gfi1^{tm5.1(GFI1)Tmo}/Gfi1⁺ Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)	myeloid hyperplasia	J:192927
Gfi1^{tm5.1(GFI1)Tmo}/Gfi1^{tm5.1(GFI1)Tmo} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased monocyte cell number	J:192927
Gfi1^{tm5.1(GFI1)Tmo}/Gfi1^{tm5.1(GFI1)Tmo} Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)	myeloid hyperplasia	J:192927
Gfi1^{tm6.1(GFI1)Tmo}/Gfi1^{tm6.1(GFI1)Tmo} Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)	myeloid hyperplasia	J:192927
Gfi1b^{tm1b(EUCOMM)Hmgu}/Gfi1b⁺ (C57BL/6N-Gfi1b^{tm1b(EUCOMM)Hmgu}/H)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Gfi1b^tm2Tmo/Gfi1b^tm2Tmo Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	increased splenocyte number	J:167416
Gfra1^tm1Rosl/Gfra1^tm1Rosl (either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))	decreased Peyer's patch number	J:120816
Gfus^tm1Jbl/Gfus^tm1Jbl (involves: 129S2/SvPas * C57BL/6J)	increased leukocyte cell number	J:82239
Gfus^tm1Jbl/Gfus^tm1Jbl (involves: 129S2/SvPas * C57BL/6J)	increased neutrophil cell number	J:82239
Ggct^em1.2Smoc/Ggct^em1.2Smoc (involves: C57BL/6J)	enlarged spleen	J:322242
Ggct^em1.2Smoc/Ggct^em1.2Smoc (involves: C57BL/6J)	increased spleen red pulp amount	J:322242
Ggh^em1(IMPC)Tcp/Ggh^em1(IMPC)Tcp (C57BL/6N-Ggh^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Ggps1^{tm1b(EUCOMM)Wtsi}/Ggps1⁺ (C57BL/6N-Ggps1^{tm1b(EUCOMM)Wtsi}/Ieg)	increased leukocyte cell number	J:211773
Ggt1^dwg/Ggt1^dwg ((STOCK Pou1f1^dw x T(8;16)17H)F1)	decreased spleen red pulp amount	J:14281
Ggt1^dwg/Ggt1^dwg ((STOCK Pou1f1^dw x T(8;16)17H)F1)	increased osteoclast cell number	J:14281
Ggta1^tm1Jbl/Ggta1⁺ Igh^tm1Jiac/Igh⁺ Igk^tm1Jiac/Igk^tm1Jiac (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	decreased mature B cell number	J:133032
Ggta1^tm1Jbl/Ggta1⁺ Igh^tm1Jiac/Igh^tm1Jiac Igk^tm1Jiac/Igk⁺ (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	decreased mature B cell number	J:133032
Ggta1^tm1Jbl/Ggta1⁺ Igh^tm1Jiac/Igh^tm1Jiac Igk^tm1Jiac/Igk^tm1Jiac (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	abnormal B cell selection	J:133032
	decreased mature B cell number	J:133032
Gh^{tm1.1(KOMP)Vlcg}/Gh^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gh^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	decreased spleen weight	J:211773
	small spleen	J:211773
Ghr^tm1Arge/Ghr^tm1Arge (involves: 129S/SvEv * C57BL/6J)	small spleen	J:66913
Ghr^{tm1c(KOMP)Wtsi}/Ghr^{tm1c(KOMP)Wtsi} Tg(Fabp4-cre)1Rev/0 (involves: C57BL/6N)	decreased spleen weight	J:206358
Ghr^tm1Jjk/Ghr^tm1Jjk (involves: 129P2/OlaHsd * BALB/c)	decreased spleen weight	J:60207
Ghr^tm2Mwat/Ghr^tm2Mwat (involves: 129X1/SvJ * C57BL)	small spleen	J:95149
Gigyf2^{tm1b(EUCOMM)Wtsi}/Gigyf2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Gigyf2^{tm1b(EUCOMM)Wtsi}/Bay)	decreased eosinophil cell number	J:211773
	increased spleen weight	J:211773
Gimap1^m1Btlr/Gimap1^m1Btlr (C57BL/6J-Gimap1^m1Btlr)	decreased B cell number	J:267546
	decreased B-1 B cell number	J:267546
	decreased CD8-positive, alpha-beta T cell number	J:267546
	increased CD4-positive, alpha-beta T cell number	J:267546
Gimap1^tm1.1Gwb/Gimap1^tm1.1Gwb Tg(CD2-icre)4Kio/0 (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	decreased B cell number	J:160782
	decreased B-1a cell number	J:160782
	decreased B-1b cell number	J:160782
	decreased B-2 B cell number	J:160782
	decreased CD4-positive, alpha-beta T cell number	J:160782
	decreased CD8-positive, alpha-beta T cell number	J:160782
	decreased follicular B cell number	J:160782
	decreased lymphocyte cell number	J:160782
	decreased marginal zone B cell number	J:160782
	decreased T cell number	J:160782
	decreased thymocyte number	J:160782
	decreased transitional stage T2 B cell number	J:160782
Gimap3^tm1.1Yout/Gimap3^tm1.1Yout (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	decreased T cell number	J:209926
	decreased thymocyte number	J:209926
Gimap5^m1Btlr/Gimap5^m1Btlr (involves: C57BL/6J)	abnormal spleen B cell follicle morphology	J:160090
	decreased B cell number	J:160090
	decreased B-1 B cell number	J:160090
	decreased CD8-positive, alpha-beta T cell number	J:160090
	decreased lymphocyte cell number	J:160090
	decreased mature B cell number	J:160090
	decreased NK cell number	J:160090
	decreased NK T cell number	J:160090
	decreased spleen B cell follicle number	J:160090
	decreased spleen B cell follicle size	J:160090
	increased granulocyte number	J:160090
	increased neutrophil cell number	J:160090
	thymus atrophy	J:160090
Gimap5^m1Btlr/Gimap5^m1Btlr Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6J * DBA/2J)	decreased CD8-positive, alpha-beta T cell number	J:160090
	decreased thymocyte number	J:160090
Gimap5^tm1Wlr/Gimap5^tm1Wlr (either: B6.129-Gimap5^tm1Wlr or C.129-Gimap5^tm1Wlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:143620
	abnormal leukocyte morphology	J:143620
	abnormal lymphocyte cell number	J:143620
	abnormal spleen morphology	J:143620
	decreased B cell number	J:143620
	decreased CD4-positive, alpha-beta T cell number	J:143620
	decreased CD8-positive, alpha-beta T cell number	J:143620
	decreased NK cell number	J:143620
	decreased NK T cell number	J:143620
	decreased T cell number	J:143620
	increased granulocyte number	J:143620
	small lymph nodes	J:143620
	spleen hypoplasia	J:143620
Gimap5^tm1Yout/Gimap5^tm1Yout (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	decreased T cell number	J:209926
Gimap6^tm1.1Gwb/Gimap6^tm1.1Gwb Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal leukocyte morphology	J:262059
	decreased B cell number	J:262059
	decreased T cell number	J:262059
	increased B cell number	J:262059
Gimap6^{tm1a(KOMP)Wtsi}/Gimap6^{tm1a(KOMP)Wtsi} (C57BL/6N-Gimap6^{tm1a(KOMP)Wtsi}/Wtsi)	decreased CD4-negative NK T cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased monocyte cell number	J:211773
Gin1^em1(IMPC)Mbp/Gin1^em1(IMPC)Mbp (C57BL/6N-Gin1^em1(IMPC)Mbp/MbpMmucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Git2^Gt(XG510)Byg/Git2^Gt(XG510)Byg (B6.129P2-Git2^Gt(XG510)Byg)	decreased marginal zone B cell number	J:160613
Git2^Gt(XG510)Byg/Git2^Gt(XG510)Byg (C.129P2-Git2^Gt(XG510)Byg)	decreased marginal zone B cell number	J:160613
Git2^Gt(XG510)Byg/Git2^Gt(XG510)Byg Tg(DO11.10)10Dlo/0 (involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:160613
Git2^Gt(XG510)Byg/Git2^Gt(XG510)Byg Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129 * C57BL/6J * DBA/2J)	abnormal positive T cell selection	J:160613
	decreased CD8-positive, alpha-beta T cell number	J:160613
Git2^Gt(XG510)Byg/Git2^Gt(XG510)Byg Tg(TcraTcrb)425Cbn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:160613
Git2^tm1Hsb/Git2^tm1Hsb (involves: C57BL/6 * CBA)	abnormal neutrophil differentiation	J:112663
Git2^tm1Hsb/Git2^tm1Hsb (involves: C57BL/6 * CBA)	enlarged spleen	J:112663
Gja1^tm1Kwi/Gja1⁺ Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal lymphatic vessel morphology	J:188626
	absent lymphatic vessels	J:188626
Gjb1^tm1Kwi/Y Gjc2^tm1(EGFP)Kwi/Gjc2^tm1(EGFP)Kwi (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	microgliosis	J:219594
Gjb2^{tm3.1(Gjb1)Kwi}/Gjb2⁺ Tg(KRT5-cre)5132Jlj/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2J * SJL)	abnormal lymphatic vessel morphology	J:188626
Gjb2^{tm3.2(Gjb1)Kwi}/Gjb2⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)	abnormal lymphatic vessel morphology	J:188626
	absent lymphatic vessels	J:188626
Gjb4^{tm1.1(KOMP)Vlcg}/Gjb4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gjb4^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Gjc2^tm1(EGFP)Kwi/Gjc2^tm1(EGFP)Kwi (involves: 129P2/OlaHsd * C57BL/6)	microgliosis	J:174197
Gjc2^tm1(EGFP)Kwi/Gjc2^tm1(EGFP)Kwi Gjb1^tm1Kwi/Gjb1^tm1Kwi (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	microgliosis	J:219594
Gjc2^tm2.1Kwi/Gjc2⁺ (involves: C57BL/6 * SJL)	microgliosis	J:174197
Gjc2^tm2.1Kwi/Gjc2^tm2.1Kwi (involves: C57BL/6 * SJL)	microgliosis	J:174197
Gjd4^tm1.1Malt/Gjd4^tm1.1Malt (involves: 129S2/SvPas * C57BL/6 * SJL)	decreased macrophage cell number	J:172698
Gk5^m5Btlr/Gk5^m5Btlr (C57BL/6J-Gk5^m5Btlr)	increased alpha-beta T cell number	J:265118
	increased CD8-positive, alpha-beta memory T cell number	J:265118
	increased central memory CD8 positive, alpha-beta T cell number	J:265118
Glb1^tm1Jmat/Glb1^tm1Jmat (involves: C57BL/6 * CBA * ICR)	abnormal lymphopoiesis	J:43534
Glb1^tm1Jmat/Glb1^tm1Jmat (involves: C57BL/6 * CBA * ICR)	small spleen	J:43534
Glb1l2^tm1Lex/Glb1l2^tm1Lex (B6;129S5-Glb1l2^tm1Lex/Mmucd)	decreased leukocyte cell number	J:171883
	decreased lymphocyte cell number	J:171883
	decreased NK cell number	J:171883
Glmp^{Gt(P084H04)Wrst}/Glmp^{Gt(P084H04)Wrst} (involves: 129S2/SvPas * C57BL/6)	abnormal Kupffer cell morphology	J:208774
	increased spleen weight	J:208774
Glra1^nmf11/Glra1^nmf11 (C57BL/6J-Glra1^nmf11/J)	small spleen	J:78134
Glra1^nmf11/Glra1^nmf11 (C57BL/6J-Glra1^nmf11/J)	thymus atrophy	J:78134
Glra2^{tm1b(KOMP)Wtsi}/Y (C57BL/6N-Glra2^{tm1b(KOMP)Wtsi}/H)	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Glrb^em1(IMPC)Tcp/Glrb⁺ (C57BL/6NCrl-Glrb^em1(IMPC)Tcp/Tcp)	increased neutrophil cell number	J:211773
Glrb^em1(IMPC)Tcp/Glrb⁺ (C57BL/6NCrl-Glrb^em1(IMPC)Tcp/Tcp)	increased spleen weight	J:211773
Gls2^em1(IMPC)Tcp/Gls2^em1(IMPC)Tcp (C57BL/6N-Gls2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Glyr1^em1(IMPC)Tcp/Glyr1^em1(IMPC)Tcp (C57BL/6N-Glyr1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Gm4922^em1(IMPC)Tcp/Gm4922^em1(IMPC)Tcp (C57BL/6NCrl-Gm4922^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Gm5148^{em1(IMPC)Ccpcz}/Gm5148⁺ (C57BL/6NCrl-Gm5148^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Gm5148^{em1(IMPC)Ccpcz}/Gm5148^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Gm5148^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Gm5544^{tm1a(KOMP)Wtsi}/Gm5544⁺ (C57BL/6N-Gm5544^{tm1a(KOMP)Wtsi}/Wtsi)	decreased marginal zone B cell number	J:211773
Gm7694^em1(IMPC)J/Gm7694^em1(IMPC)J (C57BL/6NJ-Gm7694^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Gm10800^em1(IMPC)Mbp/Gm10800^em1(IMPC)Mbp (C57BL/6N-Gm10800^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Gm26330^em1Liuq/Gm26330^em1Liuq (C57BL/6-Gm26330^em1Liuq)	decreased NK cell number	J:341056
Gm36723^em1Flv/Gm36723^em1Flv (C57BL/6-Gm36723^em1Flv)	abnormal lymphopoiesis	J:258967
	decreased lymphocyte cell number	J:258967
	decreased mature NK cell number	J:258967
	decreased NK cell number	J:258967
	increased immature NK cell number	J:258967
Gm36723^em3Flv/Gm36723^em3Flv (C57BL/6-Gm36723^em3Flv)	decreased mature NK cell number	J:258967
Gm40600^em1Cya/Gm40600^em1Cya (C57BL/6-Gm40600^em1Cya)	abnormal plasmablast number	J:311878
	decreased B cell number	J:311878
	decreased plasma cell number	J:311878
	increased B cell number	J:311878
	increased plasma cell number	J:311878
Gmds^{tm1a(KOMP)Wtsi}/Gmds^{tm1a(KOMP)Wtsi} (C57BL/6N-Gmds^{tm1a(KOMP)Wtsi}/Wtsi)	decreased alpha-beta T cell number	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	decreased dendritic cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased KLRG1+ CD8 alpha-beta T cell number	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased macrophage cell number	J:211773
	decreased mature NK cell number	J:211773
	decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK cell number	J:211773
	decreased plasmacytoid dendritic cell number	J:211773
	decreased regulatory T cell number	J:211773
	decreased T-helper cell number	J:211773
	decreased transitional stage T2 B cell number	J:211773
	increased CD4-negative NK T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased gamma-delta T cell number	J:211773
	increased granulocyte number	J:211773
	increased immature NK cell number	J:211773
	increased leukocyte cell number	J:211773
	increased Ly6C-positive NK T cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker NK cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased NK T cell number	J:211773
Gmnn^tm1.1Kio/Gmnn^tm1.2Kio Tg(CD2-icre)4Kio/0 (involves: 129S4/SvJae * C57BL/10 * CBA/Ca)	decreased CD4-positive, alpha-beta T cell number	J:159657
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:159657
	decreased CD8-positive, alpha-beta T cell number	J:159657
	decreased DN1 thymic pro-T cell number	J:159657
	decreased DN4 thymocyte number	J:159657
	decreased double-positive T cell number	J:159657
	decreased memory T cell number	J:159657
	decreased thymocyte number	J:159657
Gmnn^tm1Tjm/Gmnn^tm1Tjm Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * C57BL/6J * CBA)	abnormal spleen red pulp morphology	J:171741
	decreased granulocyte number	J:171741
	decreased leukocyte cell number	J:171741
	decreased neutrophil cell number	J:171741
Gmppa^em1(IMPC)Tcp/Gmppa^em1(IMPC)Tcp (C57BL/6N-Gmppa^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Gmps^em1(IMPC)Tcp/Gmps⁺ (C57BL/6NCrl-Gmps^em1(IMPC)Tcp/Tcp)	increased leukocyte cell number	J:211773
Gmps^em1(IMPC)Tcp/Gmps⁺ (C57BL/6NCrl-Gmps^em1(IMPC)Tcp/Tcp)	increased lymphocyte cell number	J:211773
Gna12^tm1.1Cgh/Gna12^tm1.1Cgh Gna13^tm2Cgh/Gna13^tm2Cgh Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal germinal center B cell morphology	J:174313
	increased germinal center B cell number	J:174313
Gna12^tm1Citb/Gna12^tm1Citb Gna13^tm2.1Soff/Gna13^tm2.1Soff Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * C57BL/6 * CBA)	increased CD4-positive, alpha-beta T cell number	J:149560
	increased CD8-positive, alpha-beta T cell number	J:149560
	lymph node hyperplasia	J:149560
	thymus hyperplasia	J:149560
Gnai1^{tm1b(EUCOMM)Wtsi}/Gnai1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Gnai1^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Gnai2^tm1Lbi/Gnai2^tm1Lbi (involves: 129S7/SvEvBrd)	abnormal immune system morphology	J:30507
	increased granulocyte number	J:30507
	increased single-positive T cell number	J:30507
	increased T cell number	J:30507
Gnai2^tm1Lbi/Gnai2^tm1Lbi (either: 129 or (involves: 129S7/SvEvBrd * C57BL/6J))	increased granulocyte number	J:24434
	increased thymocyte number	J:24434
Gnai2^tm1Lbi/Gnai2^tm1Lbi (B6.129S7-Gnai2^tm1Lbi)	abnormal leukocyte cell number	J:121161
	decreased eosinophil cell number	J:120069
	increased eosinophil cell number	J:120069
	increased lymphocyte cell number	J:120069
	increased monocyte cell number	J:120069
	increased neutrophil cell number	J:120069
Gnai2^tm2.1Lbi/Gnai2^tm2.1Lbi Tg(Cd4-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA)	decreased T-helper 17 cell number	J:194587
Gnao1^{tm1b(EUCOMM)Hmgu}/Gnao1⁺ (C57BL/6N-Gnao1^{tm1b(EUCOMM)Hmgu}/H)	decreased eosinophil cell number	J:211773
Gnas^tm1Lsw/Gnas⁺ (involves: 129S4/SvJae * CD-1)	thymus cortex atrophy	J:49340
Gnb1l^{Gt(OST35527)Lex}/Gnb1l⁺ (B6;129S5-Gnb1l^{Gt(OST35527)Lex}/Orl)	abnormal spleen B cell follicle morphology	J:82809
Gnb2^em1(IMPC)J/Gnb2^em1(IMPC)J (C57BL/6NJ-Gnb2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Gnb4^em1(IMPC)H/Gnb4^em1(IMPC)H (C57BL/6NTac-Gnb4^em1(IMPC)H/H)	enlarged spleen	J:211773
Gngt2^em1(IMPC)Bay/Gngt2^em1(IMPC)Bay (C57BL/6N-Gngt2^em1(IMPC)Bay/BayMmucd)	increased spleen weight	J:211773
Gnl2^{em1(IMPC)Ccpcz}/Gnl2⁺ (C57BL/6NCrl-Gnl2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Gnmt^tm1Ymac/Gnmt^tm1Ymac (involves: 129 * C57BL/6)	decreased leukocyte cell number	J:147857
	decreased monocyte cell number	J:147857
	decreased neutrophil cell number	J:147857
Gnpda1^{tm1b(KOMP)Mbp}/Gnpda1⁺ (C57BL/6N-Gnpda1^{tm1b(KOMP)Mbp}/Tcp)	increased neutrophil cell number	J:211773
Gnptab^em1(IMPC)Mbp/Gnptab⁺ (C57BL/6N-Gnptab^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Gnptab^tm1Kkol/Gnptab^tm1Kkol (involves: 129 * C57BL/6)	increased osteoclast cell number	J:202751
Gnrh1^hpg/Gnrh1^hpg (HPG/BmJ)	abnormal splenic cell ratio	J:19436
	increased B cell number	J:19436
	increased immature B cell number	J:19436
	increased mature B cell number	J:19436
Gns^{tm1e(EUCOMM)Hmgu}/Gns^{tm1e(EUCOMM)Hmgu} (C57BL/6N-A^tm1Brd Gns^{tm1e(EUCOMM)Hmgu})	microgliosis	J:242250
Golga2^{tm1(KOMP)Vlcg}/Golga2^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	increased alveolar macrophage number	J:270564
Golph3^em1(IMPC)Tcp/Golph3⁺ (C57BL/6NCrl-Golph3^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Golph3^em1(IMPC)Tcp/Golph3^em1(IMPC)Tcp (C57BL/6NCrl-Golph3^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	enlarged thymus	J:211773
Golt1b^{tm1b(EUCOMM)Wtsi}/Golt1b^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Golt1b^{tm1b(EUCOMM)Wtsi}/Ieg)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Gon4l^justy/Gon4l^justy (C3HeB/FeJ-Gon4l^justy)	absent B cells	J:163412
	arrested B cell differentiation	J:163412
	decreased B cell number	J:163412
	decreased immature B cell number	J:163412
	decreased pro-B cell number	J:163412
	decreased spleen white pulp amount	J:163412
	decreased T cell number	J:163412
	small spleen	J:163412
	spleen hypoplasia	J:163412
Got1^{tm1b(EUCOMM)Hmgu}/Got1⁺ (C57BL/6N-Got1^{tm1b(EUCOMM)Hmgu}/H)	decreased basophil cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Got2^em1(IMPC)Mbp/Got2⁺ (C57BL/6N-Got2^em1(IMPC)Mbp/MbpMmucd)	enlarged spleen	J:211773
	small spleen	J:211773
Gp2^em1(IMPC)Mbp/Gp2^em1(IMPC)Mbp (C57BL/6N-Gp2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Gp6^tm1Beni/Gp6^tm1Beni Clec1b^tm1.1Arte/Clec1b^tm1.1Arte Tg(Pf4-icre)Q3Rsko/0 (involves: 129 * C57BL/6)	abnormal lymphatic vessel morphology	J:217963
Gp6^{tm2b(EUCOMM)Hmgu}/Gp6^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Gp6^{tm2b(EUCOMM)Hmgu}/Orl)	increased lymphocyte cell number	J:211773
Gp9^{tm1.1(KOMP)Vlcg}/Gp9^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gp9^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
Gpa33^tm1Jkhh/Gpa33^tm1Jkhh (B6.129-Gpa33^tm1Jkhh)	increased dendritic cell number	J:224768
Gpatch2^em1Boui/Gpatch2^em1Boui (C57BL/6-Gpatch2^em1Boui)	decreased B cell number	J:336774
Gpatch3^em1(IMPC)Mbp/Gpatch3^em1(IMPC)Mbp (C57BL/6N-Gpatch3^em1(IMPC)Mbp/MbpMmucd)	enlarged lymph nodes	J:211773
	small spleen	J:211773
Gpatch4^{em1(IMPC)Ccpcz}/Gpatch4^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Gpatch4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	small spleen	J:211773
Gpbar1^{tm1.1(KOMP)Vlcg}/Gpbar1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gpbar1^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal lymph node morphology	J:211773
Gpc1^em1(IMPC)Mbp/Gpc1^em1(IMPC)Mbp (C57BL/6N-Gpc1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Gpc3^tm1Arge/Y (either: (involves: 129S/SvEv * 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J))	decreased spleen weight	J:75054
	increased spleen B cell follicle size	J:75054
	small spleen	J:75054
Gpc3^tm1Snd/Y (involves: 129X1/SvJ * C57BL/6)	abnormal osteoclast differentiation	J:104555
Gpcpd1^em1(IMPC)Tcp/Gpcpd1⁺ (C57BL/6N-Gpcpd1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Gper1^tm1Dgen/Gper1^tm1Dgen (B6.129-Gper1^tm1Dgen)	decreased CD4-positive, alpha-beta T cell number	J:151816
	decreased CD8-positive, alpha-beta T cell number	J:151816
	decreased T cell number	J:151816
Gpi1^b-m1Neu/Gpi1^b-m1Neu (C3.Cg-Gpi1^b-m1Neu)	increased spleen weight	J:35956
Gpi1^b-m2Neu/Gpi1^b-m2Neu (C3.Cg-Gpi1^b-m2Neu)	increased spleen weight	J:35956
Gpld1^{tm1.1(KOMP)Vlcg}/Gpld1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gpld1^{tm1.1(KOMP)Vlcg}/Ucd)	increased spleen weight	J:211773
Gpm6b^tm1Kan Plp1^tm1Kan/Y (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	microgliosis	J:193310
Gpr15^tm1.1Litt/Gpr15^tm1.1Litt (B6.129P2-Gpr15^tm1.1Litt)	decreased CD4-positive, alpha-beta T cell number	J:199126
	decreased double-negative T cell number	J:199126
	decreased regulatory T cell number	J:199126
	increased CD8-positive, alpha-beta T cell number	J:199126
Gpr15^tm1.1Litt/Gpr15^tm1.1Litt (involves: 129P2/OlaHsd * C57BL/6)	decreased regulatory T cell number	J:199126
Gpr17^{tm1b(KOMP)Mbp}/Gpr17^{tm1b(KOMP)Mbp} (C57BL/6N-Gpr17^{tm1b(KOMP)Mbp}/Tcp)	increased neutrophil cell number	J:211773
Gpr18^tm1.1Cys/Gpr18^tm1.1Cys (involves: C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:219661
Gpr18^tm1.1Cys/Gpr18^tm1.1Cys (involves: C57BL/6)	decreased CD8-positive, gamma-delta intraepithelial T cell number	J:219661
Gpr55^tm1.1Mijr/Gpr55^tm1.1Mijr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast differentiation	J:153225
	abnormal osteoclast morphology	J:153225
	decreased osteoclast cell number	J:153225
	increased osteoclast cell number	J:153225
Gpr68^tm1.1Yaxu/Gpr68^tm1.1Yaxu (B6.Cg-Gpr68^tm1.1Yaxu)	abnormal osteoclast differentiation	J:149315
Gpr68^tm1.1Yaxu/Gpr68^tm1.1Yaxu (involves: 129S4/SvJae * C57BL/6 * FVB/N)	abnormal osteoclast differentiation	J:149315
	decreased macrophage cell number	J:149315
	increased monocyte cell number	J:149315
Gpr68^tm1Yaxu/Gpr68^tm1Yaxu (involves: C57BL/6)	abnormal osteoclast differentiation	J:149315
Gpr68^tm1Yaxu/Gpr68^tm1Yaxu (involves: C57BL/6)	decreased monocyte cell number	J:149315
Gpr83^{em1(IMPC)Ccpcz}/Gpr83^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Gpr83^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK T cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Gpr83^tm1.1Fpow/Gpr83^tm1.1Fpow (C.129-Gpr83^tm1.1Fpow)	decreased CD4-positive, alpha-beta T cell number	J:144445
Gpr83^tm1.1Fpow/Gpr83^tm1.1Fpow (C.129-Gpr83^tm1.1Fpow)	spleen hyperplasia	J:144445
Gpr89^ex/Gpr89^ex (C57BL/6J-Gpr89^ex)	abnormal T cell morphology	J:287198
Gpr89^ex/Gpr89^ex (C57BL/6J-Gpr89^ex)	abnormal T cell number	J:287198
Gpr101^em7036Tac/Y (C57BL/6NTac-Gpr101^em7036Tac)	abnormal microglial cell morphology	J:347398
Gpr101^em7036Tac/Y (C57BL/6NTac-Gpr101^em7036Tac)	increased monocyte cell number	J:347398
Gpr132^tm1Witt/Gpr132^tm1Witt (involves: 129X1/SvJ * BALB/c)	abnormal immune system organ morphology	J:69473
	abnormal lymph node morphology	J:69473
	enlarged inguinal lymph nodes	J:69473
	enlarged spleen	J:69473
Gpr137b^{tm1b(KOMP)Wtsi}/Gpr137b^{tm1b(KOMP)Wtsi} (C57BL/6N-Gpr137b^{tm1b(KOMP)Wtsi}/H)	increased neutrophil cell number	J:211773
Gpr146^em1(IMPC)H/Gpr146^em1(IMPC)H (C57BL/6NTac-Gpr146^em1(IMPC)H/H)	increased spleen weight	J:211773
Gpr155^em1(IMPC)Mbp/Gpr155^em1(IMPC)Mbp (C57BL/6N-Gpr155^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Gpr174^tm1Cys/Y (B6.129-Gpr174^tm1Cys)	abnormal T-helper 1 cell differentiation	J:222307
Gpr174^tm1Cys/Y (B6.129-Gpr174^tm1Cys)	increased single-positive T cell number	J:222307
Gpr182^{tm2b(KOMP)Wtsi}/Gpr182^{tm2b(KOMP)Wtsi} (C57BL/6N-Gpr182^{tm2b(KOMP)Wtsi}/Ucd)	increased spleen weight	J:211773
Gpr182^{tm2c(KOMP)Wtsi}/Gpr182^{tm2c(KOMP)Wtsi} Tg(Cdh5-cre/ERT2)1Rha/0 (B6.Cg-Gpr182^{tm2c(KOMP)Wtsi} Tg(Cdh5-cre/ERT2)1Rha)	increased monocyte cell number	J:305796
	increased neutrophil cell number	J:305796
Gpr183^tm1.2Rbr/Gpr183^tm1.2Rbr (involves: C57BL/6 * FVB/N * SJL)	decreased plasma cell number	J:151883
Gpr183^tm1.2Rbr/Gpr183^tm1.2Rbr Igh^tm1Rbr/Igh^tm1Rbr Tg(IgkHyHEL10)1Rbr/0 (involves: C57BL/6 * FVB/N * SJL)	decreased B cell number	J:151883
	decreased plasma cell number	J:151883
Gpr183^tm1Lex/Gpr183^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased myeloid dendritic cell number	J:211122
	decreased plasmacytoid dendritic cell number	J:211122
Gprc5c^tm1Yhir/Gprc5c^tm1Yhir (B6.Cg-Gprc5c^tm1Yhir)	increased basophil cell number	J:176063
Gprc6a^{tm1.1(KOMP)Vlcg}/Gprc6a^{tm1.1(KOMP)Vlcg} (C57BL/6N-Gprc6a^{tm1.1(KOMP)Vlcg}/Ucd)	increased thymus weight	J:211773
Gpsm3^{Gt(IST12408A1)Tigm}/Gpsm3^{Gt(IST12408A1)Tigm} (involves: C57BL/6N)	decreased monocyte cell number	J:193270
Gpx7^tm1Whle/Gpx7^tm1Whle (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:193993
Gramd2a^em1(IMPC)Tcp/Gramd2a^em1(IMPC)Tcp (C57BL/6NCrl-Gramd2a^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Grap2^tm1Amch/Grap2^tm1Amch (involves: 129S1/Sv * 129X1/SvJ)	arrested T cell differentiation	J:76696
	decreased CD4-positive, alpha-beta T cell number	J:76696
	decreased CD8-positive, alpha-beta T cell number	J:76696
	decreased thymocyte number	J:76696
	increased double-negative T cell number	J:76696
Grap2^tm1Amch/Grap2^tm1Amch Lcp2^tm1.1Wz/Lcp2^tm1.1Wz (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:150304
	decreased CD4-positive, alpha-beta T cell number	J:150304
	decreased CD8-positive, alpha-beta T cell number	J:150304
	decreased double-positive T cell number	J:150304
	decreased single-positive T cell number	J:150304
Grap2^tm1Eac/Grap2^tm1Eac (involves: C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:92023
	abnormal double-negative T cell morphology	J:92023
	decreased T cell number	J:92023
	decreased thymocyte number	J:92023
	increased activated T cell number	J:92023
	increased memory T cell number	J:92023
Grap^tm1Gsf/Grap^tm1Gsf (B6.129-Grap^tm1Gsf)	increased CD4-positive, alpha-beta T cell number	J:76243
Grb2^tm1.1Hua/Grb2^tm1.1Hua Tg(DO11.10)10Dlo/0 Tg(Lck-cre)1Jtak/0 (involves: 129 * BALB/c * C3H * C57BL/6)	abnormal T cell differentiation	J:161294
	decreased CD4-positive, alpha-beta T cell number	J:161294
Grb2^tm1.1Hua/Grb2^tm1.1Hua Tg(Lck-cre)1Jtak/0 (involves: 129 * C57BL/6)	abnormal T cell differentiation	J:161294
	decreased CD4-positive, alpha-beta T cell number	J:161294
	decreased CD8-positive, alpha-beta T cell number	J:161294
	decreased double-positive T cell number	J:161294
	decreased thymocyte number	J:161294
Grb2^tm1.1Hua/Grb2^tm1.1Hua Tg(Lck-cre)1Jtak/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:161294
	decreased CD4-positive, alpha-beta T cell number	J:161294
	decreased CD8-positive, alpha-beta T cell number	J:161294
	increased CD8-positive, alpha-beta T cell number	J:161294
	increased double-positive T cell number	J:161294
Grb2^tm1Lnit/Grb2^tm1Lnit Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * BALB/cJ)	abnormal B cell differentiation	J:171222
	decreased B cell number	J:171222
	decreased follicular B cell number	J:171222
	decreased mature B cell number	J:171222
	decreased spleen germinal center number	J:171222
	decreased spleen germinal center size	J:171222
	decreased transitional stage T1 B cell number	J:171222
	decreased transitional stage T2 B cell number	J:171222
	increased plasma cell number	J:171222
Grb2^tm1Paw/Grb2⁺ Pten^tm2Mak/Pten^tm2Mak Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased T cell derived lymphoma incidence	J:93530
Grb14^tm1Daly/Grb14^tm1Daly (involves: 129X1/SvJ * C57BL/6)	decreased spleen weight	J:87892
Grem2^tm1Akh/Grem2^tm1Akh (involves: 129/Sv * C57BL/6)	increased leukocyte cell number	J:250034
Grik3^em1(IMPC)Mbp/Grik3^em1(IMPC)Mbp (C57BL/6N-Grik3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Grk2^tm1Gwd/Grk2^tm1Gwd Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129 * BALB/c * C57BL/6)	decreased B cell number	J:176118
	increased B cell number	J:176118
	increased CD4-positive, alpha-beta T cell number	J:176118
	increased CD8-positive, alpha-beta T cell number	J:176118
	increased follicular B cell number	J:176118
	increased marginal zone B cell number	J:176118
Grk2^tm1Gwd/Grk2^tm1Mca Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:176118
	decreased CD8-positive, alpha-beta T cell number	J:176118
	decreased T cell number	J:176118
	increased B cell number	J:176118
Grk6^tm1.1Mca/Grk6^tm1.1Mca (B6.129S4-Grk6^tm1.1Mca)	abnormal T cell subpopulation ratio	J:225063
	decreased CD8-positive, alpha-beta T cell number	J:225063
	decreased CD8-positive, naive alpha-beta T cell number	J:225063
	enlarged spleen	J:225063
	increased memory T cell number	J:225063
	increased spleen iron level	J:225063
	increased spleen weight	J:225063
	increased spleen white pulp amount	J:225063
	increased splenocyte number	J:225063
Grn^tm1.1Aidi/Grn^tm1.1Aidi (involves: C57BL/6 * C57BL/6J)	microgliosis	J:156824
Grn^tm1.1Far/Grn^tm1.1Far (involves: 129S4/SvJae * C57BL/6J * FVB/N)	microgliosis	J:188324
Grn^tm1.1Geno/Grn^tm1.1Geno (involves: 129 * C57BL/6J)	microgliosis	J:188420
Grn^tm1Blrl/Grn^tm1Blrl (involves: C57BL/6J)	microgliosis	J:182051
Grn^tm1Far/Grn^tm1Far Tg(ITGAM-cre)2781Gkl/0 (involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N)	microgliosis	J:188324
Grn^tm2.1Far/Grn^tm2.1Far (involves: 129S4/SvJae * C57BL/6)	microgliosis	J:259651
Grp^em1(IMPC)H/Grp^em1(IMPC)H (C57BL/6NTac-Grp^em1(IMPC)H/H)	decreased monocyte cell number	J:211773
Grsf1^{tm1b(EUCOMM)Wtsi}/Grsf1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Grsf1^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Gsdma3^Ae/Gsdma3⁺ (involves: C57BL/6J * CAST/Ei)	enlarged lymph nodes	J:180149
	enlarged spleen	J:180149
	enlarged thymus	J:180149
Gsdma3^{tm1(KOMP)Vlcg}/Gsdma3^{tm1(KOMP)Vlcg} (C57BL/6N-Gsdma3^{tm1(KOMP)Vlcg}/Nju)	increased lymphocyte cell number	J:211773
Gsdmc^em1(IMPC)Tcp/Gsdmc^em1(IMPC)Tcp (C57BL/6NCrl-Gsdmc^em1(IMPC)Tcp/TcpMmucd)	enlarged lymph nodes	J:211773
	increased monocyte cell number	J:211773
Gsn^tm1Djk/Gsn^tm1Djk (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	abnormal osteoclast differentiation	J:60625
	increased leukocyte cell number	J:24346
	increased neutrophil cell number	J:24346
Gsta4^tm1Pzim/Gsta4^tm1Pzim (involves: 129S1/Sv * 129S6/SvEvTac)	abnormal bone marrow development	J:87983
Gstcd^{tm1b(EUCOMM)Wtsi}/Gstcd^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Gstcd^{tm1b(EUCOMM)Wtsi}/Bay)	enlarged spleen	J:211773
Gstk1^tm1Pgb/Gstk1^tm1Pgb (BALB/c-Gstk1^tm1Pgb)	decreased spleen red pulp amount	J:177201
Gstk1^tm1Pgb/Gstk1^tm1Pgb (BALB/c-Gstk1^tm1Pgb)	decreased spleen weight	J:177201
Gstm4^{tm2b(EUCOMM)Hmgu}/Gstm4^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Gstm4^{tm2b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Gstz1^tm1Pgb/Gstz1^tm1Pgb (BALB/c-Gstz1^tm1Pgb/AnuApb)	decreased leukocyte cell number	J:91519
Gstz1^tm1Pgb/Gstz1^tm1Pgb (BALB/c-Gstz1^tm1Pgb/AnuApb)	decreased spleen weight	J:91519
Gsx1^tm1Ssp/Gsx1^tm1Ssp (involves: 129P2/OlaHsd)	decreased leukocyte cell number	J:31764
	decreased lymphocyte cell number	J:31764
	decreased neutrophil cell number	J:31764
Gt(ROSA)26Sor^{tm1(CAG-Bcl3,-EGFP)Hoev}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:208980
	abnormal B-2 B cell morphology	J:208980
	abnormal class switch recombination	J:208980
	abnormal follicular B cell morphology	J:208980
	abnormal Peyer's patch germinal center morphology	J:208980
	abnormal transitional stage T3 B cell morphology	J:208980
	absent marginal zone B cells	J:208980
	decreased B-1 B cell number	J:208980
	decreased B-1a cell number	J:208980
	decreased immature B cell number	J:208980
	decreased marginal zone B cell number	J:208980
	decreased transitional stage T1 B cell number	J:208980
	enlarged spleen	J:208980
	increased lymphocyte cell number	J:208980
Gt(ROSA)26Sor^{tm1(CAG-Foxn1/ERT2,-GFP)Cbln}/Gt(ROSA)26Sor⁺ Foxn1^tm3(cre)Nrm/Foxn1⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased T cell number	J:208852
Gt(ROSA)26Sor^{tm1(CAG-NPM1)Geno}/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	enlarged spleen	J:196690
	myeloid hyperplasia	J:196690
Gt(ROSA)26Sor^{tm1(CAG-NPM1)Geno}/Gt(ROSA)26Sor^{tm1(CAG-NPM1)Geno} Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	enlarged spleen	J:196690
Gt(ROSA)26Sor^{tm1(CAG-Slc39a14*L438R)Wvh}/Gt(ROSA)26Sor⁺ Tg(Runx2-icre)1Jtuc/0 (involves: FVB/N)	increased osteoclast cell number	J:261326
Gt(ROSA)26Sor^{tm1(CARD14)Ribt}/Gt(ROSA)26Sor⁺ Malt1^{tm1c(EUCOMM)Hmgu}/Malt1^{tm1c(EUCOMM)Hmgu} Tg(KRT14-cre/ERT)20Efu/0 (involves: 129S6/SvEvTac C57BL/6NCrl * CD-1)	increased dendritic cell number	J:292094
	increased neutrophil cell number	J:292094
Gt(ROSA)26Sor^{tm1(CARD14)Ribt}/Gt(ROSA)26Sor⁺ Tg(KRT14-cre/ERT)20Efu/0 (involves: 129S6/SvEvTac C57BL/6NCrl * CD-1)	increased dendritic cell number	J:292094
	increased neutrophil cell number	J:292094
Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor^{tm1(Tcfe2a/Tal1)Xhsu} (involves: 129/Sv * C57BL/6)	abnormal lymphopoiesis	J:144569
	abnormal myelopoiesis	J:144569
Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ Tacc3^tm1.1Tno/Tacc3⁺ Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	increased T cell derived lymphoma incidence	J:179414
Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ Tacc3^tm1.1Tno/Tacc3^tm1.2Tno Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	increased T cell derived lymphoma incidence	J:179414
Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor^tm1(Pyy)Paba (involves: 129S4/SvJae)	abnormal osteoclast morphology	J:189512
	increased osteoclast cell number	J:189512
Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ Il1r2^tm1.1Mchc/Il1r2^tm1.1Mchc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6NTac)	increased spleen germinal center size	J:347877
	increased T follicular helper cell number	J:347877
Gt(ROSA)26Sor^{tm1(cre/ERT)Nat}/Gt(ROSA)26Sor⁺ Pten^tm1Hwu/Pten^tm1Hwu (involves: 129 * 129S4/SvJae * BALB/c * C57BL/6)	increased T cell derived lymphoma incidence	J:130367
Gt(ROSA)26Sor^{tm1(CTNNB1)Nerl}/Gt(ROSA)26Sor^{tm1(CTNNB1)Nerl} Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)	arrested T cell differentiation	J:112660
	decreased double-negative T cell number	J:112660
	decreased granulocyte number	J:112660
	decreased leukocyte cell number	J:112660
	impaired myelopoiesis	J:112660
	thymus hypoplasia	J:112660
Gt(ROSA)26Sor^tm1(DTA)Jpmb/Gt(ROSA)26Sor⁺ Tg(Plp1-cre/ERT)3Pop/0 (involves: 129S/SvEv * C57BL/6 * DBA/2)	increased activated T cell number	J:234435
Gt(ROSA)26Sor^tm1(DTA)Lky/Gt(ROSA)26Sor⁺ Il13^{tm1(YFP/cre)Lky}/Il13^{tm1(YFP/cre)Lky} (involves: 129P2/OlaHsd * 129S4/SvJae)	decreased eosinophil cell number	J:178986
Gt(ROSA)26Sor^tm1(DTA)Lky/Gt(ROSA)26Sor^tm1(DTA)Lky Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal CD8-positive, alpha-beta T cell differentiation	J:133382
	abnormal lymph node T cell domain morphology	J:133382
	abnormal spleen morphology	J:133382
	abnormal T cell receptor V(D)J recombination	J:133382
	decreased CD4-positive, alpha-beta T cell number	J:133382
	decreased CD8-positive, alpha-beta T cell number	J:133382
	decreased double-positive T cell number	J:133382
	decreased lymphocyte cell number	J:133382
	decreased NK T cell number	J:133382
	decreased regulatory T cell number	J:133382
Gt(ROSA)26Sor^tm1(DTA)Riet/Gt(ROSA)26Sor^tm1(DTA)Riet Tg(Rorc-cre)1Litt/? (involves: 129P2/OlaHsd)	abnormal effector T cell morphology	J:137020
Gt(ROSA)26Sor^{tm1(ETV6/SYK)Hjum}/Gt(ROSA)26Sor⁺ Cd79a^{tm3(cre/ERT2)Reth}/Cd79a⁺ (involves: 129S6/SvEvTac * BALB/c)	abnormal plasma cell differentiation	J:208904
	enlarged lymph nodes	J:208904
	enlarged spleen	J:208904
	increased B cell number	J:208904
Gt(ROSA)26Sor^{tm1(ETV6/SYK)Hjum}/Gt(ROSA)26Sor⁺ Cd79a^{tm3(cre/ERT2)Reth}/Cd79a⁺ Tg(BCL2)22Wehi/0 (involves: 129S6/SvEvTac * BALB/c * C57BL/6JWehi * SJL/JWehi)	abnormal plasma cell differentiation	J:208904
	enlarged lymph nodes	J:208904
	enlarged spleen	J:208904
Gt(ROSA)26Sor^{tm1(EWSR1/FLI1)Sbk}/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal lymph node B cell domain morphology	J:129039
	abnormal myelopoiesis	J:129039
	enlarged spleen	J:129039
	increased leukocyte cell number	J:129039
	increased spleen red pulp amount	J:129039
Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ Prdm1^tm2Masu/Prdm1^tm2Masu (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal plasma cell differentiation	J:167612
	enlarged lymph nodes	J:167612
	enlarged spleen	J:167612
	increased germinal center B cell number	J:167612
Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	abnormal CD4-positive T cell differentiation	J:157757
	abnormal CD8-positive, alpha-beta T cell differentiation	J:157757
	decreased CD4-positive, alpha-beta T cell number	J:157757
	decreased CD8-positive, alpha-beta T cell number	J:157757
	decreased single-positive T cell number	J:157757
	decreased T cell number	J:157757
	increased double-positive T cell number	J:157757
Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ Rev3l^tm1.1Diaz/Rev3l^tm1.1Diaz (involves: 129P2/OlaHsd * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6NTac)	abnormal class switch recombination	J:188723
	abnormal somatic hypermutation frequency	J:188723
Gt(ROSA)26Sor^{tm1(GNAQ)Cvrk}/Gt(ROSA)26Sor⁺ Tg(Mitf-cre)7114Gsb/0 (C3FeJ.Cg-Gt(ROSA)26Sor^{tm1(GNAQ)Cvkr} Tg(Mitf-cre)7114Gsb/Cvrk)	enlarged lymph nodes	J:225597
Gt(ROSA)26Sor^{tm1(gp80,EGFP)Eces}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))	abnormal class switch recombination	J:172031
	absent spleen germinal center	J:172031
	decreased B cell number	J:172031
	decreased germinal center B cell number	J:172031
	decreased plasma cell number	J:172031
	enlarged spleen	J:172031
	increased B cell number	J:172031
	increased macrophage cell number	J:172031
	increased marginal zone B cell number	J:172031
	increased spleen weight	J:172031
	increased T cell number	J:172031
Gt(ROSA)26Sor^{tm1(gp80,EGFP)Eces}/Gt(ROSA)26Sor⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ (either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))	abnormal class switch recombination	J:172031
	absent spleen germinal center	J:172031
	decreased B cell number	J:172031
	decreased follicular B cell number	J:172031
	decreased germinal center B cell number	J:172031
	decreased plasma cell number	J:172031
	enlarged spleen	J:172031
	increased B cell number	J:172031
	increased macrophage cell number	J:172031
	increased marginal zone B cell number	J:172031
	increased spleen weight	J:172031
Gt(ROSA)26Sor^{tm1(H1/tetO-RNAi:Pdpk1)Mrl}/Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} Pten^tm1Hwu/Pten^tm1Hwu (involves: 129S4/SvJae * C57BL/6)	decreased B cell number	J:170965
	enlarged lymph nodes	J:170965
	enlarged spleen	J:170965
	increased memory B cell number	J:170965
	increased spleen weight	J:170965
Gt(ROSA)26Sor^{tm1(HBEGF)Awai}/Gt(ROSA)26Sor^{tm1(HBEGF)Awai} Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal lymphocyte cell number	J:131076
	decreased single-positive T cell number	J:131076
Gt(ROSA)26Sor^{tm1(ITK/SYK)Jrld}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal spleen morphology	J:160931
	abnormal T cell differentiation	J:160931
	decreased double-positive T cell number	J:160931
	decreased single-positive T cell number	J:160931
	decreased T cell number	J:160931
	enlarged spleen	J:160931
	increased T cell derived lymphoma incidence	J:160931
Gt(ROSA)26Sor^{tm1(Mirn155)Rsky}/Gt(ROSA)26Sor^{tm1(Mirn155)Rsky} (involves: BALB/c * C57BL/6)	increased germinal center B cell number	J:121084
Gt(ROSA)26Sor^{tm1(Notch1)Dam}/Gt(ROSA)26Sor⁺ Hes1^tm1.1Frad/Hes1^tm1.1Frad Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJaeSor * C57BL/6 * CBA)	decreased B cell number	J:167000
Gt(ROSA)26Sor^{tm1(Notch1)Dam}/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJaeSor * C57BL/6 * CBA)	decreased B cell number	J:167000
	enlarged spleen	J:167000
	increased leukocyte cell number	J:167000
Gt(ROSA)26Sor^{tm1(NOTCH1/GFP)Xhsu}/Gt(ROSA)26Sor⁺ Tg(Lck-cre)548Jxm/0 (B6.Cg-Gt(ROSA)26Sor^{tm1(NOTCH1/GFP)Xhsu} Tg(Lck-cre)548Jxm)	increased T cell derived lymphoma incidence	J:185287
Gt(ROSA)26Sor^tm1(Ntn4)Dyl/Gt(ROSA)26Sor⁺ Tg(KRT14-cre)1Amc/0 (involves: 129/Sv * C57BL/6 * CBA)	abnormal lymphangiogenesis	J:162807
	abnormal lymphatic vessel morphology	J:162807
	lymphatic vessel hyperplasia	J:162807
Gt(ROSA)26Sor^{tm1(OVAL/fla,GFP)Vnce}/Gt(ROSA)26Sor⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	decreased B cell number	J:260047
	decreased lymphocyte cell number	J:260047
	enlarged lymph nodes	J:260047
	enlarged spleen	J:260047
	increased monocyte cell number	J:260047
	increased neutrophil cell number	J:260047
	increased T cell number	J:260047
Gt(ROSA)26Sor^{tm1(OVAL/fla,GFP)Vnce}/Gt(ROSA)26Sor⁺ Tg(Itgax-cre)1-1Reiz/0 (involves: C3H * C57BL/6 * C57BL/6J)	increased monocyte cell number	J:260047
	increased neutrophil cell number	J:260047
Gt(ROSA)26Sor^{tm1(OVAL/fla,GFP)Vnce}/Gt(ROSA)26Sor⁺ Tg(S100A8-cre,-EGFP)1Ilw/0 (involves: C3H * C57BL/6 * C57BL/6J)	increased monocyte cell number	J:260047
	increased neutrophil cell number	J:260047
Gt(ROSA)26Sor^{tm1(Pik3caH1047R)Egan}/Gt(ROSA)26Sor⁺ Tg(MMTV-cre)#Tfln/0 Trp53^tm1Brn/Trp53⁺ (involves: 129P2/OlaHsd 129S6/SvEvTac)	increased T cell derived lymphoma incidence	J:170898
Gt(ROSA)26Sor^{tm1(Pik3caH1047R)Egan}/Gt(ROSA)26Sor⁺ Trp53^tm1Brn/Trp53^tm1Brn Tg(MMTV-cre)#Tfln/0 (involves: 129P2/OlaHsd 129S6/SvEvTac)	increased T cell derived lymphoma incidence	J:170898
Gt(ROSA)26Sor^{tm1(Ptpn22)Draw}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd C57BL/6)	enlarged spleen	J:201448
	increased B cell number	J:201448
	increased germinal center B cell number	J:201448
	spleen hyperplasia	J:201448
Gt(ROSA)26Sor^{tm1(RNAi:Bmpr2)Dliu}/Gt(ROSA)26Sor⁺ (involves: 129 * C57BL/6J)	abnormal spleen morphology	J:145514
	abnormal spleen white pulp morphology	J:145514
	enlarged spleen	J:145514
Gt(ROSA)26Sor^tm1(rtTA)Awu/Gt(ROSA)26Sor^tm1(rtTA)Awu Xist^tm1Awu/Y (involves: 129S4/SvJae)	abnormal B cell differentiation	J:112954
	abnormal myelopoiesis	J:112954
	abnormal T cell differentiation	J:112954
	abnormal thymus morphology	J:112954
	absent pre-B cells	J:112954
	decreased double-positive T cell number	J:112954
	decreased granulocyte number	J:112954
	decreased immature B cell number	J:112954
	decreased macrophage cell number	J:112954
	decreased pro-B cell number	J:112954
	decreased thymocyte number	J:112954
	small thymus	J:112954
	thymus hypoplasia	J:112954
Gt(ROSA)26Sor^tm1(rtTA)Awu/Gt(ROSA)26Sor^tm1(rtTA)Awu Xist^tm1Awu/Xist^tm1Awu (involves: 129S4/SvJae)	small thymus	J:112954
Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/Gt(ROSA)26Sor⁺ Tg(CAG-cre)1Nagy/0 Tg(tetO-Vegfa)90Ala/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR)	enlarged lymph nodes	J:99607
	thymus atrophy	J:99607
Gt(ROSA)26Sor^{tm1(rtTA,EGFP)Nagy}/Gt(ROSA)26Sor⁺ Tg(Col2a1-cre)1Bhr/0 Tg(tetO-Vegfa)90Ala/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N * SJL)	decreased osteoclast cell number	J:156474
	enlarged spleen	J:156474
Gt(ROSA)26Sor^{tm1(sb11)Njen}/Gt(ROSA)26Sor⁺ TgTn(sb-T2/Onc2)6057Njen/0 (involves: C3H * C57BL/6)	increased T cell derived lymphoma incidence	J:102234
Gt(ROSA)26Sor^{tm1(sb11)Njen}/Gt(ROSA)26Sor⁺ TgTn(sb-T2/Onc2)6070Njen/0 (involves: C3H * C57BL/6)	increased T cell derived lymphoma incidence	J:102234
Gt(ROSA)26Sor^{tm1(sb11)Njen}/Gt(ROSA)26Sor⁺ TgTn(sb-T2/Onc2)6113Njen/0 (involves: C3H * C57BL/6)	increased T cell derived lymphoma incidence	J:102234
Gt(ROSA)26Sor^{tm1(sb11)Njen}/Gt(ROSA)26Sor⁺ TgTn(sb-T2/Onc3)12740Njen/0 (involves: C3H * C57BL/6J)	increased T cell derived lymphoma incidence	J:153656
Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv}/Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv} (involves: C57BL/6)	abnormal T-helper 17 cell differentiation	J:205858
Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv}/Gt(ROSA)26Sor^{tm1(Stat3A661CN663C)Sbkv} Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased regulatory T cell number	J:205858
	increased T-helper 1 cell number	J:205858
	increased T-helper 17 cell number	J:205858
Gt(ROSA)26Sor^{tm1(Tbx1/GFP)Bem}/Gt(ROSA)26Sor⁺ Foxg1^tm1(cre)Skm/Foxg1⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	athymia	J:204435
Gt(ROSA)26Sor^{tm1(tTA,tetO-Mir21)Fjsl}/Gt(ROSA)26Sor⁺ Tg(Nes-cre)1Wmz/0 (involves: C57BL/6 * C57BL/6J * SJL/J)	abnormal spleen morphology	J:163919
	abnormal thymus corticomedullary boundary morphology	J:163919
	abnormal thymus morphology	J:163919
	decreased leukocyte cell number	J:163919
	enlarged lymph nodes	J:163919
	enlarged spleen	J:163919
	enlarged thymus	J:163919
	intermingled spleen red and white pulp	J:163919
Gt(ROSA)26Sor^{tm1(tTA,tetO-Mir155)Fjsl}/Gt(ROSA)26Sor⁺ Tg(Nes-cre)1Wmz/0 (involves: 129 * C57BL/6 * FVB/N * SJL/J)	abnormal immune system morphology	J:185598
	enlarged lymph nodes	J:185598
	enlarged spleen	J:185598
	increased spleen weight	J:185598
	increased spleen white pulp amount	J:185598
	thymus hyperplasia	J:185598
Gt(ROSA)26Sor^{tm1.1(Aco1)Mwh}/Gt(ROSA)26Sor^{tm1.1(Aco1)Mwh} (B6.129P2(129S1)-Gt(ROSA)26Sor^{tm1.1(Aco1*)Mwh})	increased spleen iron level	J:196374
Gt(ROSA)26Sor^{tm1.1(DUX4)Plj}/Gt(ROSA)26Sor⁺ (B6(Cg)-Gt(ROSA)26Sor^{tm1.1(DUX4)Plj})	enlarged lymph nodes	J:256652
	enlarged popliteal lymph nodes	J:256652
Gt(ROSA)26Sor^{tm1.1(DUX4)Plj}/Gt(ROSA)26Sor⁺ Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/0 (involves: 129S/SvEv C57BL/6)	enlarged lymph nodes	J:256652
	enlarged popliteal lymph nodes	J:256652
Gt(ROSA)26Sor^{tm1.1(Ubc-BCL3)Sbn}/Gt(ROSA)26Sor⁺ Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	decreased follicular B cell number	J:207111
	decreased marginal zone B cell number	J:207111
	increased follicular B cell number	J:207111
Gt(ROSA)26Sor^{tm1.1(Wls/YFP)Mbtr}/Gt(ROSA)26Sor⁺ (involves: C57BL/6)	decreased neutrophil cell number	J:202499
Gt(ROSA)26Sor^{tm1.2(CAG-PLS3,-GFP)Bwir}/Gt(ROSA)26Sor⁺ (B6N.Cg-Gt(ROSA)26Sor^{tm1.1(CAG-PLS3,-GFP)Bwir})	decreased osteoclast cell number	J:267292
Gt(ROSA)26Sor^tm1Fia/Gt(ROSA)26Sor⁺ Nf1^tm1Fcr/Nf1^tm1Par Tg(Tek-cre)1Ywa/0 (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal spleen morphology	J:114455
Gt(ROSA)26Sor^tm1Jus/Gt(ROSA)26Sor⁺ Tg(MMTV-cre)4Mam/0 (involves: C57BL/6J * C57BL/6N * FVB/N)	abnormal leukocyte morphology	J:202090
	arrested B cell differentiation	J:202090
	decreased B cell number	J:202090
	decreased double-positive T cell number	J:202090
	decreased mature B cell number	J:202090
	decreased pre-B cell number	J:202090
	decreased pro-B cell number	J:202090
	enlarged lymph nodes	J:202090
	enlarged spleen	J:202090
	enlarged thymus	J:202090
	increased CD8-positive, alpha-beta T cell number	J:202090
	increased large unstained cell number	J:202090
	increased leukocyte cell number	J:202090
	increased single-positive T cell number	J:202090
	intermingled spleen red and white pulp	J:202090
Gt(ROSA)26Sor^tm1Jus/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)	abnormal leukocyte morphology	J:202090
	arrested B cell differentiation	J:202090
	decreased B cell number	J:202090
	decreased double-positive T cell number	J:202090
	decreased mature B cell number	J:202090
	decreased pre-B cell number	J:202090
	decreased pro-B cell number	J:202090
	enlarged lymph nodes	J:202090
	enlarged spleen	J:202090
	enlarged thymus	J:202090
	increased CD8-positive, alpha-beta T cell number	J:202090
	increased large unstained cell number	J:202090
	increased leukocyte cell number	J:202090
	increased single-positive T cell number	J:202090
	intermingled spleen red and white pulp	J:202090
Gt(ROSA)26Sor^tm1Sor/Gt(ROSA)26Sor⁺ Id3^tm2.1Zhu/Id3^tm2.1Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * SJL)	decreased T cell number	J:172701
Gt(ROSA)26Sor^tm1Sor/Gt(ROSA)26Sor⁺ Nr2f2^tm2.1Tsa/Nr2f2^tm2.1Tsa Prox1^{tm3(cre/ERT2)Gco}/Prox1⁺ (involves: 129S1/Sv * 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6)	abnormal lymphatic vessel morphology	J:158959
Gt(ROSA)26Sor^tm1Sor/Gt(ROSA)26Sor⁺ Tbx1^tm3.1Bld/Tbx1^tm6(cre)Bld (involves: 129S4/SvJaeSor * 129S7/SvEvBrd)	abnormal lymphatic vessel morphology	J:159824
Gt(ROSA)26Sor^{tm2(CAG-Notch2)Uzs}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd 129S6/SvEvTac * C57BL/6J)	abnormal B cell differentiation	J:179036
	abnormal spleen marginal zone morphology	J:179036
	decreased B cell number	J:179036
	decreased B-1a cell number	J:179036
	decreased B-2 B cell number	J:179036
	decreased follicular B cell number	J:179036
	decreased spleen B cell follicle size	J:179036
	decreased spleen germinal center number	J:179036
	decreased transitional stage T2 B cell number	J:179036
	increased marginal zone B cell number	J:179036
	increased spleen weight	J:179036
	increased T cell number	J:179036
	increased transitional stage T1 B cell number	J:179036
Gt(ROSA)26Sor^{tm2(CAG-Notch2)Uzs}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19^tm1(cre)Cgn (involves: 129P2/OlaHsd 129S6/SvEvTac * C57BL/6J)	abnormal B cell differentiation	J:179036
	abnormal spleen marginal zone morphology	J:179036
	decreased follicular B cell number	J:179036
	decreased mature B cell number	J:179036
	decreased pre-B cell number	J:179036
	decreased transitional stage T2 B cell number	J:179036
	increased marginal zone B cell number	J:179036
	increased transitional stage T1 B cell number	J:179036
Gt(ROSA)26Sor^{tm2(CAG-Notch2)Uzs}/Gt(ROSA)26Sor⁺ Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S6/SvEvTac BALB/c * C57BL/6J)	arrested B cell differentiation	J:179036
	decreased B cell number	J:179036
	decreased splenocyte number	J:179036
	increased T cell number	J:179036
Gt(ROSA)26Sor^{tm2(H1/tetO-RNAi:Kdm1a)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6)	abnormal granulocyte differentiation	J:192055
	abnormal monocyte differentiation	J:192055
	enlarged spleen	J:192055
	increased leukocyte cell number	J:192055
Gt(ROSA)26Sor^{tm2(ITK/Syk)Hjum}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal spleen morphology	J:207306
	enlarged spleen	J:207306
	increased activated T cell number	J:207306
	increased CD4-positive, alpha-beta T cell number	J:207306
	increased mature B cell number	J:207306
	increased plasma cell number	J:207306
Gt(ROSA)26Sor^{tm2(ITK/Syk)Hjum}/Gt(ROSA)26Sor⁺ Tg(Lck-cre)I57Jxm/0 (involves: 129S6/SvEvTac * ICR)	abnormal spleen morphology	J:207306
	enlarged spleen	J:207306
	increased activated T cell number	J:207306
	increased CD4-positive, alpha-beta T cell number	J:207306
	increased mature B cell number	J:207306
	increased plasma cell number	J:207306
Gt(ROSA)26Sor^{tm2(Lmp1/CD40)Uzs}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal class switch recombination	J:137122
	enlarged inguinal lymph nodes	J:137122
	enlarged spleen	J:137122
	increased B cell number	J:137122
	increased follicular B cell number	J:137122
	increased marginal zone B cell number	J:137122
	increased spleen B cell follicle size	J:137122
	increased spleen weight	J:137122
	increased T cell number	J:137122
Gt(ROSA)26Sor^{tm2(Lmp1/CD40)Uzs}/Gt(ROSA)26Sor⁺ Tg(Cr2-cre)3Cgn/0 (involves: BALB/c * C57BL/6)	abnormal immune system morphology	J:137122
Gt(ROSA)26Sor^{tm2(Mirn150)Rsky}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * SJL/J)	decreased mature B cell number	J:127234
Gt(ROSA)26Sor^{tm2(Mirn150)Rsky}/Gt(ROSA)26Sor^{tm2(Mirn150)Rsky} (involves: C57BL/6 * SJL/J)	decreased B-1 B cell number	J:127234
	decreased B-2 B cell number	J:127234
	decreased CD4-positive, alpha-beta T cell number	J:127234
	decreased CD8-positive, alpha-beta T cell number	J:127234
Gt(ROSA)26Sor^{tm2.1(Mirn150)Rsky}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * SJL/J)	decreased mature B cell number	J:127234
Gt(ROSA)26Sor^{tm2.1(Mirn150)Rsky}/Gt(ROSA)26Sor^{tm2.1(Mirn150)Rsky} (involves: C57BL/6 * SJL/J)	arrested B cell differentiation	J:127234
	arrested T cell differentiation	J:127234
	decreased B-1 B cell number	J:127234
	decreased B-2 B cell number	J:127234
	decreased lymphocyte cell number	J:127234
Gt(ROSA)26Sor^{tm2.1(sb11)Njen}/Gt(ROSA)26Sor⁺ TgTn(sb-T2/Onc2)6070Njen/0 (involves: 129 * C57BL/6 * C57BL/6J)	increased T cell derived lymphoma incidence	J:153656
Gt(ROSA)26Sor^tm2Sho/Gt(ROSA)26Sor⁺ Lef1^tm1Hhx/Lef1^tm1Hhx Tg(GZMB-cre)1Jcb/0 (involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)	decreased CD8-positive, alpha-beta T cell number	J:189838
Gt(ROSA)26Sor^{tm3(CAG-EYFP)Hze}/Gt(ROSA)26Sor⁺ Stat5a^tm2Mam Stat5b^tm1Mam/Del(11Stat5a-Stat5b)1Mam Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * CBA)	abnormal CD4-positive T cell differentiation	J:204829
Gt(ROSA)26Sor^{tm3(CAG-Il17a)Awai}/Gt(ROSA)26Sor⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased granulocyte number	J:144710
Gt(ROSA)26Sor^{tm3(CAG-MIR17-92,-EGFP)Rsky}/Gt(ROSA)26Sor⁺ Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	decreased marginal zone B cell number	J:133215
	increased B-1a cell number	J:133215
Gt(ROSA)26Sor^{tm3(CAG-MIR17-92,-EGFP)Rsky}/Gt(ROSA)26Sor^{tm3(CAG-MIR17-92,-EGFP)Rsky} Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal B cell morphology	J:133215
	abnormal CD4-positive, alpha beta T cell morphology	J:133215
	abnormal immune system morphology	J:133215
	abnormal spleen marginal zone morphology	J:133215
	abnormal T cell differentiation	J:133215
	decreased marginal zone B cell number	J:133215
	decreased spleen red pulp amount	J:133215
	enlarged lymph nodes	J:133215
	increased B cell number	J:133215
	increased B-1a cell number	J:133215
	increased CD4-positive, alpha-beta T cell number	J:133215
	increased CD8-positive, alpha-beta T cell number	J:133215
	increased germinal center B cell number	J:133215
	increased lymphocyte cell number	J:133215
	increased spleen weight	J:133215
	increased spleen white pulp amount	J:133215
	intermingled spleen red and white pulp	J:133215
	lymph node hyperplasia	J:133215
	spleen hyperplasia	J:133215
Gt(ROSA)26Sor^{tm3.1(CAG-Il17a)Awai}/Gt(ROSA)26Sor⁺ (involves: BALB/c * C57BL/6)	increased granulocyte number	J:144710
Gt(ROSA)26Sor^{tm4(ACTB-tdTomato,-EGFP)Luo}/Gt(ROSA)26Sor⁺ Hnrnpl^tm1.1Tmo/Hnrnpl^tm1.1Tmo Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal T cell differentiation	J:188749
Gt(ROSA)26Sor^{tm4(CAG-hsb5)Nki}/Gt(ROSA)26Sor⁺ Tg(Mx1-cre)1Cgn/0 Tg(Tal1-tTA)19Dgt/0 Tg(tetO-BCR/ABL1)2Dgt/0 TgTn(pb-sb-GrOnc)#aGsva/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA/J * DBA/2 * FVB/N)	increased basophil cell number	J:227558
	increased granulocyte number	J:227558
	increased leukocyte cell number	J:227558
	increased spleen weight	J:227558
Gt(ROSA)26Sor^{tm4(H1/tetO-RNAi:Ezh2)Arte}/Gt(ROSA)26Sor⁺ (C57BL/6-Gt(ROSA)26Sor^{tm4(H1/tetO-RNAi:Ezh2)Arte})	small lymph nodes	J:202724
Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/Gt(ROSA)26Sor⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:167612
	decreased germinal center B cell number	J:167612
	enlarged spleen	J:167612
	increased B cell number	J:167612
	increased plasma cell number	J:167612
Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/Gt(ROSA)26Sor⁺ Ighg1^tm1(cre)Cgn/Ighg1⁺ Prdm1^tm2Masu/Prdm1^tm2Masu (involves: 129P2/OlaHsd * C57BL/6)	abnormal plasma cell differentiation	J:167612
	increased germinal center B cell number	J:167612
Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky} Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	increased B cell number	J:157297
Gt(ROSA)26Sor^{tm4(Wnt7b)Flng}/Gt(ROSA)26Sor⁺ Tg(Col1a1-cre)1Ack/0 (involves: FVB/N)	decreased osteoclast cell number	J:208766
	enlarged spleen	J:208766
	increased spleen weight	J:208766
Gt(ROSA)26Sor^{tm4(Wnt7b)Flng}/Gt(ROSA)26Sor⁺ Tg(Runx2-rtTAM2)#Flng/0 Tg(tetO-cre)1Jaw/0 (involves: 129 C57BL/6)	decreased osteoclast cell number	J:208766
Gt(ROSA)26Sor^{tm5(H1/tetO-RNAi:Ezh2)Arte}/Gt(ROSA)26Sor⁺ (C57BL/6-Gt(ROSA)26Sor^{tm5(H1/tetO-RNAi:Ezh2)Arte})	small lymph nodes	J:202724
Gt(ROSA)26Sor^{tm7(Pik3ca,EGFP)Rsky}/Gt(ROSA)26Sor⁺ Tg(CAG-cre/Esr1)5Amc/0 (B6.Cg-Gt(ROSA)26Sor^{tm7(Pik3ca,EGFP)Rsky} Tg(CAG-cre/Esr1)5Amc)	abnormal spleen morphology	J:264410
	enlarged lymphatic vessel	J:264410
Gt(ROSA)26Sor^{tm7(Pik3ca,EGFP)Rsky}/Gt(ROSA)26Sor^{tm13(CAG-MYC,-CD2)Rsky} Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:191824
	increased germinal center B cell number	J:191824
Gt(ROSA)26Sor^{tm8(Map2k1,EGFP)Rsky}/Gt(ROSA)26Sor^{tm8(Map2k1,EGFP)Rsky} Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased mature B cell number	J:157297
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/? Tnfaip3^tm1Homy/Tnfaip3^tm1Homy (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)	pale spleen	J:212681
	thymus atrophy	J:212681
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Map3k14^tm1.1Gne/Map3k14^tm1.1Gne (B6(Cg)-Map3k14^tm1.1Gne Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte})	decreased B cell number	J:240453
	decreased germinal center B cell number	J:240453
	decreased Peyer's patch number	J:240453
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Pten^tm1Hwu/Pten^tm1Hwu (involves: 129S4/SvJae * C57BL/6)	enlarged lymph nodes	J:170965
	enlarged spleen	J:170965
	increased spleen weight	J:170965
Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ Ripk3^tm1Arte/Ripk3^tm1Arte (involves: C57BL/6NTac)	abnormal lymphocyte morphology	J:209137
	thymus atrophy	J:209137
Gt(ROSA)26Sor^{tm9(Rac1,EGFP)Rsky}/Gt(ROSA)26Sor^{tm9(Rac1,EGFP)Rsky} Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased mature B cell number	J:157297
Gt(ROSA)26Sor^{tm10(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ (involves: BALB/cJ)	abnormal B cell morphology	J:181546
Gt(ROSA)26Sor^{tm10(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * BALB/cJ)	abnormal B cell differentiation	J:181546
	decreased B cell number	J:181546
	decreased mature B cell number	J:181546
	decreased pre-B cell number	J:181546
	enlarged spleen	J:181546
	increased B cell number	J:181546
	increased CD4-positive, alpha-beta T cell number	J:181546
	increased CD8-positive, alpha-beta T cell number	J:181546
	increased pro-B cell number	J:181546
Gt(ROSA)26Sor^{tm10(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Tcrb^tm1Mom/Tcrb⁺ Tcrd^tm1Mom/Tcrd^tm1Mom Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ)	enlarged spleen	J:181546
	increased B cell number	J:181546
Gt(ROSA)26Sor^{tm10(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/cJ)	enlarged spleen	J:181546
	increased B cell number	J:181546
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ (involves: C57BL/6)	abnormal B cell morphology	J:181546
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:181546
	decreased B cell number	J:181546
	decreased mature B cell number	J:181546
	decreased pre-B cell number	J:181546
	enlarged spleen	J:181546
	increased B cell number	J:181546
	increased CD4-positive, alpha-beta T cell number	J:181546
	increased CD8-positive, alpha-beta T cell number	J:181546
	increased pro-B cell number	J:181546
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Cd19^{tm1(cre/ERT2)Rsky}/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6J)	enlarged spleen	J:217520
	increased activated T cell number	J:217520
	increased B cell number	J:217520
	increased CD4-positive, alpha-beta T cell number	J:217520
	increased CD8-positive, alpha-beta T cell number	J:217520
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Tcrb^tm1Mom/Tcrb⁺ Tcrd^tm1Mom/Tcrd^tm1Mom Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	enlarged spleen	J:181546
	increased B cell number	J:181546
Gt(ROSA)26Sor^{tm11(Lmp1)Rsky}/Gt(ROSA)26Sor⁺ Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	enlarged spleen	J:181546
	increased B cell number	J:181546
Gt(ROSA)26Sor^{tm12(CD2)Rsky}/Gt(ROSA)26Sor⁺ Myc^tm2Fwa/Myc^tm2Fwa Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd 129S6/SvEvTac * C57BL/6)	decreased spleen germinal center size	J:188564
Gt(ROSA)26Sor^{tm18(Zeb2)Jhai}/Gt(ROSA)26Sor⁺ Tg(Tek-cre)1Ywa/0 Trp53^tm1Brn/Trp53^tm1Brn (involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL)	increased T cell derived lymphoma incidence	J:263520
Gt(ROSA)26Sor^{tm18(Zeb2)Jhai}/Gt(ROSA)26Sor^{tm18(Zeb2)Jhai} Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * CD-1 * SJL)	increased thymus tumor incidence	J:263520
Gt(ROSA)26Sor^{tm18(Zeb2)Jhai}/Gt(ROSA)26Sor^{tm18(Zeb2)Jhai} Tg(Tek-cre)1Ywa/0 Trp53^tm1Brn/Trp53^tm1Brn (involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL)	increased T cell derived lymphoma incidence	J:263520
Gtf2a1l^em1(IMPC)J/Gtf2a1l^em1(IMPC)J (C57BL/6NJ-Gtf2a1l^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Gtpbp2^{tm1b(KOMP)Mbp}/Gtpbp2⁺ (C57BL/6N-Gtpbp2^{tm1b(KOMP)Mbp}/Ucd)	enlarged lymph nodes	J:211773
Gtpbp2^{tm1b(KOMP)Mbp}/Gtpbp2^{tm1b(KOMP)Mbp} (C57BL/6N-Gtpbp2^{tm1b(KOMP)Mbp}/Ucd)	enlarged lymph nodes	J:211773
Gtsf1l^em1(IMPC)J/Gtsf1l^em1(IMPC)J (C57BL/6NJ-Gtsf1l^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Guca2a^em1(IMPC)Mbp/Guca2a^em1(IMPC)Mbp (C57BL/6N-Guca2a^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Guk1^em1(IMPC)J/Guk1⁺ (C57BL/6NJ-Guk1^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Gulo^{em1(IMPC)Ccpcz}/Gulo^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Gulo^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Gulo^sfx/Gulo^sfx (BALB/cBy-Gulo^sfx/J)	abnormal osteoclast differentiation	J:66648
	small spleen	J:66648
	small thymus	J:66648
Gulp1^tm1.2Kimj/Gulp1^tm1.2Kimj (involves: 129S4/SvJae * C57BL/6 * SJL)	abnormal osteoclast differentiation	J:340688
	abnormal osteoclast morphology	J:340688
	increased osteoclast cell number	J:340688
Gzmb^tm1Ley/Gzmb^tm1Ley Serpinb9^tm1Arp/Serpinb9^tm1Arp (involves: 129S2/SvPas * C57BL/6)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:113349
H1f0^tm1Ais/H1f0^tm1Ais H1f2^tm2Ais/H1f2^tm2Ais H1f4^tm2Ais/H1f4^tm2Ais (involves: 129/Sv * C57BL/6 * SJL)	small thymus	J:83954
H1f2^tm2Ais/H1f2^tm2Ais H1f3^tm2Ais/H1f3⁺ H1f4^tm2Ais/H1f4^tm2Ais (involves: 129/Sv * C57BL/6 * SJL)	small thymus	J:83954
H2-Aa^b-tm1Blt/H2-Aa^b-tm1Blt (C57BL/6-H2-Aa^b-tm1Blt)	abnormal T cell morphology	J:16372
	decreased CD4-positive, alpha-beta T cell number	J:16372
	enlarged lymph nodes	J:16372
	enlarged thymus	J:16372
	increased CD8-positive, alpha-beta T cell number	J:16372
	thymus hyperplasia	J:16372
H2-Ab1^b-tm1.1Jssh/H2-Ab1^b-tm1.1Jssh (C57BL/6-H2-Ab1^b-tm1.1Jssh)	abnormal T cell differentiation	J:201198
	decreased regulatory T cell number	J:201198
H2-Ab1^b-tm1Doi/H2-Ab1^b-tm1Doi (involves: 129S2/SvPas * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:65736
	abnormal immune system cell morphology	J:65736
	abnormal immune system morphology	J:65736
	abnormal immune system organ morphology	J:65736
	abnormal lymph node cell ratio	J:65736
	abnormal spleen B cell follicle morphology	J:65736
	abnormal spleen marginal zone morphology	J:65736
	abnormal spleen morphology	J:65736
	abnormal spleen periarteriolar lymphoid sheath morphology	J:65736
	absent spleen germinal center	J:65736
	decreased CD4-positive, alpha-beta T cell number	J:51885, J:65736
	increased CD4-positive, alpha-beta T cell number	J:64283
	increased CD8-positive, alpha-beta T cell number	J:65736, J:64283
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (involves: 129S2/SvPas * C57BL/6J)	decreased CD4-positive, alpha-beta T cell number	J:74418
	increased CD8-positive, alpha-beta T cell number	J:74418
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (B6.129S2-H2-Ab1^b-tm1Gru)	decreased CD4-positive, alpha-beta T cell number	J:91341
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (involves: 129S2/SvPas * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:67941
	decreased single-positive T cell number	J:67941
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Runx1^tm1Toku/Runx1^tm1Toku Runx3^tm1Itan/Runx3^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/2)	increased CD4-positive, alpha-beta T cell number	J:131081
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tespa1^tm1Smoc/Tespa1^tm1Smoc (involves: 129 * 129S2/SvPas * C57BL/6)	absent CD4-positive, alpha-beta T cells	J:186446
	decreased CD8-positive, alpha-beta T cell number	J:186446
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(Ab1TL)1Gru/0 (B6.Cg-H2-Ab1^b-tm1Gru Tg(Ab1TL)1Gru)	abnormal CD4-positive T cell differentiation	J:91341
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(HLA-DRB1)31Dmz/0 Tg(Ins2-CD80)3B7Flv/0 (involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA * SJL)	abnormal CD4-positive, alpha beta T cell morphology	J:68641
	abnormal CD8-positive, alpha beta T cell morphology	J:68641
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Tg(HLA-DRB1)31Dmz/0 Tg(Ins2-CD80)3B7Flv/0 (involves: 129S2/SvPas * C57BL/6 * CBA * SJL)	abnormal CD4-positive, alpha beta T cell morphology	J:68641
	abnormal CD8-positive, alpha beta T cell morphology	J:68641
H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru Themis^tm1Lov/Themis^tm1Lov (involves: 129)	abnormal negative T cell selection	J:151075
H2-Ab1^b-tm1Koni/H2-Ab1^b-tm1.1Koni Tg(Tek-cre)12Flv/0 (involves: 129X1/SvJ * C3H * C57BL/6 * C57BL/6J)	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:131774
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:131774
	increased CD4-positive, alpha-beta T cell number	J:131774
H2-Ab1^b-tm1Wug/H2-Ab1^b-tm1Wug (involves: C57BL/6)	absent CD4-positive, alpha-beta T cells	J:204951
H2-Ab1^bm12/H2-Ab1^bm12 (NZB.B6(C)-H2-Ab1^bm12)	decreased CD8-positive, alpha-beta T cell number	J:4554
	increased B cell number	J:104189
	increased CD4-positive, alpha-beta T cell number	J:4554
	increased double-negative T cell number	J:4554
H2-Ab1^g7-em1Dvs/H2-Ab1^g7-em1Dvs H2-D1^b-em5Dvs/H2-D1^b-em5Dvs H2-K1^d-em1Dvs/H2-K1^d-em1Dvs (NOD/ShiLtDvs-H2-K1^d-em1Dvs H2-Ab1^g7-em1Dvs H2-D1^em5Dvs/Dvs)	abnormal T cell subpopulation ratio	J:257229
	decreased alpha-beta T cell number	J:257229
	decreased CD4-positive, alpha-beta T cell number	J:257229
H2-Ab1^g7-em1Ygch/H2-Ab1^g7-em1Ygch (NOD/ShiLtJ-H2-Ab1^g7-em1Ygch)	decreased CD4-positive, alpha-beta T cell number	J:101977
H2-D1^b-em5Dvs/H2-D1^b-em5Dvs H2-K1^d-em1Dvs/H2-K1^d-em1Dvs (NOD/ShiLtDvs-H2-K1^d-em1Dvs H2-D1^b-em5Dvs/Dvs)	abnormal T cell subpopulation ratio	J:257229
H2-D1^b-tm1Bpe/H2-D1^b-tm1Bpe H2-K1^b-tm1Bpe/H2-K1^b-tm1Bpe (involves: 129P2/OlaHsd * C57BL/6)	absent CD8-positive, alpha-beta T cells	J:57703
	decreased CD8-positive, alpha-beta T cell number	J:54709
	increased CD4-positive, alpha-beta T cell number	J:54709
H2-DMa^tm1Liz/H2-DMa^tm1Liz (involves: BALB/cJ)	abnormal CD4-positive, alpha beta T cell morphology	J:113714
H2-DMa^tm1Lkrl/H2-DMa^tm1Lkrl (involves: 129P2/OlaHsd)	abnormal positive T cell selection	J:31786
H2-DMa^tm1Lkrl/H2-DMa^tm1Lkrl (involves: 129P2/OlaHsd)	decreased CD4-positive, alpha-beta T cell number	J:31786
H2-DMa^tm1Luc/H2-DMa^tm1Luc (involves: 129S4/SvJae)	abnormal positive T cell selection	J:125548
H2-DMa^tm1Luc/H2-DMa^tm1Luc (involves: 129S4/SvJae)	decreased CD4-positive, alpha-beta T cell number	J:31625, J:45185
H2-K1^b-tm1Bpe/H2-K1^b-tm1Bpe (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:54709
	increased CD4-positive, alpha-beta T cell number	J:54709
H2-K^bm1/H2-K^bm1 Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6)	abnormal positive T cell selection	J:92867
H2-K^bm5/H2-K^bm5 Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6)	abnormal positive T cell selection	J:133645
H2-M3^tm1Crw/H2-M3^tm1Crw (B6.129-H2-M3^tm1Crw)	abnormal CD8-positive, alpha beta T cell morphology	J:118960
H2-M3^tm1Crw/H2-M3^tm1Crw (B6.129-H2-M3^tm1Crw)	decreased activated T cell number	J:118960
H2-Oa^tm1Dma/H2-Oa^tm1Dma (involves: 129/Sv * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:65235
H2-Q10^{tm1.1(KOMP)Mbp}/H2-Q10^{tm1.1(KOMP)Mbp} (involves: C57BL/6 * C57BL/6N)	decreased gamma-delta T cell number	J:294888
	decreased immature NK cell number	J:294888
	decreased mature NK cell number	J:294888
	decreased NK cell number	J:294888
	increased NK cell number	J:294888
H2-T18^b/H2-T18^b H2-T3^tm1Luc/H2-T3^tm1Luc (C57BL/6-H2-T3^tm1Luc)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:142515
	abnormal CD8-positive, gamma-delta intraepithelial T cell morphology	J:142515
	abnormal intraepithelial T cell morphology	J:142515
H2-T18^b/H2-T18^b H2-T3^tm1Luc/H2-T3^tm1Luc Tcra^tm1Mom/Tcra^tm1Mom (B6.Cg-Tcra^tm1Mom H2-T3^tm1Luc)	abnormal intraepithelial T cell number	J:142515
	enlarged mesenteric lymph nodes	J:142515
H2-T24^{em1(IMPC)Wtsi}/H2-T24^{em1(IMPC)Wtsi} (C57BL/6N-H2-T24^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
H2^b/H2^b Itk^tm1Ljb/Itk^tm1Ljb Tg(TcrAND)53Hed/? (involves: C3H/HeJ * C57BL/6 * C57BL/10)	abnormal positive T cell selection	J:123795
	decreased CD4-positive, alpha-beta T cell number	J:123795
H2^b/H2^b Ptcra^tm1Vbo/Ptcra^tm1Vbo (involves: 129P2/OlaHsd)	decreased double-positive T cell number	J:131357
	decreased thymocyte number	J:131357
	spleen hypoplasia	J:131357
H2^b/H2^b Ptcra^tm1Vbo/Ptcra^tm1Vbo Tcra^tm1Mom/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:131357
	decreased thymocyte number	J:131357
H2^b/H2^b Ptcra^tm1Vbo/Ptcra^tm1Vbo Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:131357
H2^b/H2^b Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/? (involves: 129S/SvEv * C57BL/6)	arrested T cell differentiation	J:133112
	decreased CD4-positive, alpha-beta T cell number	J:133112
	increased CD8-positive, alpha-beta T cell number	J:133112
H2^b/H2^b Tcra/Tcrd^{tm1.1(Tcra)Rsky}/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal negative T cell selection	J:81564
	abnormal T cell differentiation	J:81564
H2^b/H2^b Tcra/Tcrd^{tm1.1(Tcra)Rsky}/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal negative T cell selection	J:81564
	abnormal T cell differentiation	J:81564
H2^b/H2^b Tcra^tm1Mom/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal double-negative T cell morphology	J:131357
	abnormal double-positive T cell morphology	J:81564
	abnormal negative T cell selection	J:81564
	abnormal T cell differentiation	J:81564
	decreased double-positive T cell number	J:131357
	decreased thymocyte number	J:131357
H2^b/H2^d ((C57BL/6 x DBA/2)F1)	abnormal T cell differentiation	J:106141
H2^b/H2^d Tg(TcraTcrb)1100Mjb/? (involves: BALB/c * C57BL/6)	abnormal negative T cell selection	J:133645
	decreased CD8-positive, alpha-beta T cell number	J:133645
	small thymus	J:133645
H2^b/H2^d Themis^tm1Gasc/Themis^tm1Gasc (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * DBA/2)	abnormal negative T cell selection	J:151074
H2^b/H2^k Itk^tm1Ljb/Itk^tm1Ljb Tg(TcrAND)53Hed/? (involves: C3H/HeJ * C57BL/6 * C57BL/10)	abnormal positive T cell selection	J:123795
	decreased CD4-positive, alpha-beta T cell number	J:123795
H2^b/H2^k Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6 * C57BL/10Sg * C57BR/c)	abnormal negative T cell selection	J:133645
	decreased CD8-positive, alpha-beta T cell number	J:133645
	small thymus	J:133645
H2^b/H2^s Tg(TcraTcrb)1100Mjb/? (involves: A/WySn * C57BL/6 * C57BL/10Sg * Swiss)	abnormal negative T cell selection	J:133645
	decreased CD8-positive, alpha-beta T cell number	J:133645
	small thymus	J:133645
H2^d/H2^d (DBA/2)	abnormal T cell differentiation	J:106141
H2^d/H2^d Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/? (involves: 129S/SvEv * C57BL/6)	arrested T cell differentiation	J:133112
	decreased CD4-positive, alpha-beta T cell number	J:133112
	decreased CD8-positive, alpha-beta T cell number	J:133112
H2^d/H2^d Tcra/Tcrd^{tm1.1(Tcra)Rsky}/Tcra/Tcrd^{tm1.1(Tcra)Rsky} Tg(Tcrb)93Vbo/0 (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:131357
	decreased thymocyte number	J:131357
H2^d/H2^d Tg(TcraP1.5,TcrbP1.5)29Amsv/0 Trap1a^tm1.1Jvde/Y (involves: 129 * BALB/cJ * C57BL/10 * DBA/2)	abnormal T cell clonal deletion	J:180807
H2^dlAb1-Ea/H2^dlAb1-Ea (involves: 129S2/SvPas * C57BL/6)	abnormal T cell number	J:57484
	decreased CD4-positive, alpha-beta T cell number	J:57484
	increased CD8-positive, alpha-beta T cell number	J:57484
H2^dlAb1-Ea/H2^dlAb1-Ea Psmb11^{tm1(Psmb8)Khog}/Psmb11^{tm1(Psmb8)Khog} (involves: 129S2/SvPas * C57BL/6)	abnormal T cell differentiation	J:196156
	decreased CD8-positive, alpha-beta T cell number	J:196156
H2^dlAb1-Ea/H2^dlAb1-Ea Rr381^em2Kap/Rr381^em2Kap (involves: 129S2/SvPas * C57BL/6)	absent CD4-positive, alpha-beta T cells	J:333471
H2^dlAb1-Ea/H2^dlAb1-Ea Rr381^em4Kap/Rr381^em4Kap (involves: 129S2/SvPas * C57BL/6)	absent CD8-positive, alpha-beta T cells	J:333471
H2^dlAb1-Ea/H2^dlAb1-Ea Rr381^em5Kap/Rr381^em5Kap (involves: 129S2/SvPas * C57BL/6)	absent CD8-positive, alpha-beta T cells	J:333471
H2^dlAb1-Ea/H2^dlAb1-Ea Tg(HLA-DRA,HLA-DRB50101)hiKito/0 Tg(TRATL3A6,TRBTL3A6)#Kito/0 (involves: 129S2/SvPas C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:189816
	increased T-helper 1 cell number	J:189816
	increased T-helper 17 cell number	J:189816
H2^g7/H2^g7 Tg(Ins2-Vtcn1)#Xxz/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: C57BL/6 * NOD * SJL)	decreased regulatory T cell number	J:177612
H2^k/H2^k Tg(TcraTcrbAD10)1Hed/? (involves: C57BL/6 * SJL)	increased CD4-positive, alpha-beta T cell number	J:124701
H2^u/H2^u Tg(TCRA)B1Jg/0 (B10.PL-H2^u H2-T18^a/(73NS)Sn-Tg(TCRA)B1Jg/J)	abnormal thymus cell ratio	J:92992
	decreased CD4-positive, alpha-beta T cell number	J:92992
	decreased double-positive T cell number	J:92992
	decreased thymocyte number	J:92992
	increased double-negative T cell number	J:92992
	increased T cell derived lymphoma incidence	J:92992
H2^u/H2^u Tg(TCRA)B1Jg/? Tg(TCRB)C14Jg/? (involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J)	abnormal effector T cell morphology	J:92991
	decreased CD8-positive, alpha-beta T cell number	J:92991
	decreased double-positive T cell number	J:92991
	increased CD4-positive, alpha-beta T cell number	J:92991
H2^u/H2^u Tg(TCRA)B1Jg/0 Tg(TCRB)C14Jg/0 (B10.PL-H2^u H2-T18^a/(73NS)Sn-Tg(TCRA)B1Jg Tg(TCRB)C14Jg)	abnormal double-negative T cell morphology	J:92992
	abnormal double-positive T cell morphology	J:92992
	abnormal thymus cell ratio	J:92992
	absent gamma-delta T cells	J:92992
	decreased double-positive T cell number	J:92992
	increased CD4-positive, alpha-beta T cell number	J:92992
	increased double-negative T cell number	J:92992
	increased T cell derived lymphoma incidence	J:92992
H2^u/H2^u Tg(TCRB)C14Jg/0 (B10.PL-H2^u H2-T18^a/(73NS)Sn-Tg(TCRB)C14Jg/J)	abnormal double-negative T cell morphology	J:92992
	abnormal double-positive T cell morphology	J:92992
	absent gamma-delta T cells	J:92992
H2ax^tm1Fwa/H2ax⁺ Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	increased T cell derived lymphoma incidence	J:84879
H2ax^tm1Fwa/H2ax^tm1Fwa (involves: 129S6/SvEvTac)	abnormal class switch recombination	J:84879
	decreased lymphocyte cell number	J:84879
	increased T cell derived lymphoma incidence	J:84879
H2ax^tm1Fwa/H2ax^tm1Fwa Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	increased T cell derived lymphoma incidence	J:84879
H2ax^tm1Nus/H2ax^tm1Nus (Not Specified)	abnormal class switch recombination	J:194603, J:120658
	decreased B cell number	J:76360
	decreased T cell number	J:76360
H2bc4^em1(IMPC)Tcp/H2bc4^em1(IMPC)Tcp (C57BL/6N-H2bc4^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
H4c16^em1(IMPC)Mbp/H4c16^em1(IMPC)Mbp (C57BL/6N-H4c16^em1(IMPC)Mbp/MbpMmucd)	enlarged thymus	J:211773
H13^{tm1b(KOMP)Wtsi}/H13^{tm1b(KOMP)Wtsi} (C57BL/6N-H13^{tm1b(KOMP)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
Hace1^tm1Pngr/Hace1^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6)	increased T cell derived lymphoma incidence	J:125183
Hamp^tm1Svl/Hamp^tm1Svl (involves: 129S2/SvPas * C57BL/6)	decreased spleen iron level	J:119004
Hand2^tm1Cse/Hand2⁺ H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S1/Sv * C57BL/6J * CBA/J)	abnormal thymus development	J:155265
Has1^{tm1b(KOMP)Wtsi}/Has1^{tm1b(KOMP)Wtsi} (C57BL/6N-Has1^{tm1b(KOMP)Wtsi}/H)	decreased eosinophil cell number	J:211773
	increased basophil cell number	J:211773
Havcr1^tm1Kuch/Havcr1^tm1Kuch (B6.Cg-Havcr1^tm1Kuch)	abnormal T cell differentiation	J:186484
	enlarged spleen	J:186484
	increased activated T cell number	J:186484
	increased CD4-positive, alpha-beta T cell number	J:186484
	increased CD8-positive, alpha-beta T cell number	J:186484
	increased double-negative T cell number	J:186484
	increased T cell number	J:186484
Havcr2^{tm1b(KOMP)Wtsi}/Havcr2^{tm1b(KOMP)Wtsi} (C57BL/6N-Havcr2^{tm1b(KOMP)Wtsi}/Ucd)	increased spleen weight	J:211773
Havcr2^tm1Vlcg/Havcr2^tm1Vlcg (B6.129-Havcr2^tm1Vlcg)	decreased T cell number	J:209885
Havcr2^tm1Vlcg/Havcr2^tm1Vlcg Tg(TcraTcrb)1100Mjb/? (B6.Cg-Havcr2^tm1Vlcg Tg(TcraTcrb)1100Mjb)	decreased T cell number	J:209885
Hax1^tm1.1Gach/Hax1^tm1.1Gach (involves: BALB/c)	abnormal B cell number	J:174159
	abnormal lymphocyte morphology	J:174159
	abnormal T cell number	J:174159
	decreased B cell number	J:174159
	decreased B-1a cell number	J:174159
	decreased CD4-positive, alpha-beta T cell number	J:174159
	decreased CD8-positive, alpha-beta T cell number	J:174159
	decreased double-positive T cell number	J:174159
	decreased immature B cell number	J:174159
	decreased marginal zone B cell number	J:174159
	decreased mature B cell number	J:174159
	decreased pre-B cell number	J:174159
	decreased pro-B cell number	J:174159
	decreased thymocyte number	J:174159
	decreased transitional stage T1 B cell number	J:174159
	decreased transitional stage T2 B cell number	J:174159
	increased follicular B cell number	J:174159
	spleen hypoplasia	J:174159
	thymus hypoplasia	J:174159
Hax1^tm1Jni/Hax1^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	decreased double-positive T cell number	J:132627
	decreased immature B cell number	J:132627
	decreased leukocyte cell number	J:132627
	decreased lymphocyte cell number	J:132627
	decreased neutrophil cell number	J:132627
	decreased single-positive T cell number	J:132627
	decreased T cell number	J:132627
Hba^b2(th)/Hba⁺ (either: (involves: 101 * SEC) or (involves: 101 * C57BL * SEC))	increased leukocyte cell number	J:123943
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBB)Tow}/Hbb^{tm2(HBG1,HBB)Tow} (Not Specified)	abnormal Kupffer cell morphology	J:134980
	abnormal spleen white pulp morphology	J:134980
	enlarged spleen	J:134980
	increased spleen red pulp amount	J:134980
	spleen vascular congestion	J:134980
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBB)Tow}/Hbb^{tm2(HBG1,HBB)Tow} Slc12a4^Rbc10/Slc12a4⁺ (involves: 129 * BALB/c * C57BL/6J)	enlarged spleen	J:227339
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBD,HBB)Ryan}/Hbb^{tm2(HBG1,HBD,HBB)Ryan} (Not Specified)	intermingled spleen red and white pulp	J:148521
	spleen hyperplasia	J:148521
Hba^tm1(HBA)Tow/Hba^tm1(HBA)Tow Hbb^{tm2(HBG1,HBD,HBB*)Ryan}/Hbb^{tm3(HBG1,HBB)Tow} (Not Specified)	spleen hyperplasia	J:148521
Hba^tm1Paz/Hba^tm1Paz Hbb^tm1Tow/Hbb^tm1Tow Tg(HBA-HBBs)41Paz/? (involves: 129S2/SvPas * 129S7/SvEvBrd * Black Swiss * C57BL/6 * DBA/2* FVB/N)	increased spleen weight	J:44161
	spleen vascular congestion	J:44161
Hbb-b1^MommeD7/Hbb-b1⁺ (involves: FVB/N)	enlarged spleen	J:142335, J:190446
Hbb-b1^MommeD7/Hbb-b1⁺ (involves: FVB/N)	increased spleen red pulp amount	J:190446
Hbb-b1^Rbc13/Hbb-b1⁺ (involves: BALB/c * C57BL/6)	enlarged spleen	J:190446
Hbb-b1^Rbc13/Hbb-b1⁺ (involves: BALB/c * C57BL/6)	increased spleen red pulp amount	J:190446
Hbb-b1^tm1Shs/Hbb-b1^tm1Shs (involves: C57BL/6)	enlarged spleen	J:78271
Hbb-b1^tm1Shs/Hbb-b1^tm1Shs (involves: C57BL/6)	increased spleen iron level	J:78271
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal spleen morphology	J:88672, J:30155
	decreased spleen white pulp amount	J:30155
	increased spleen weight	J:30155
	intermingled spleen red and white pulp	J:30155
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd * C57BL/6N)	enlarged spleen	J:185154
	increased spleen iron level	J:185154
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (B6;129-Hbb-b1^tm1Unc Hbb-b2^tm1Unc/J)	abnormal spleen morphology	J:211331
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ (involves: 129P2/OlaHsd)	enlarged spleen	J:97548
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ Tg(HBB)L2Pai/0 (involves: 129P2/OlaHsd C57BL/6)	enlarged spleen	J:97548
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ Tmprss6^tm1Otin/Tmprss6⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	abnormal spleen iron level	J:185154
	abnormal spleen size	J:185154
Hbb-b1^tm1Unc/Hbb-b1⁺ Hbb-b2^tm1Unc/Hbb-b2⁺ Tmprss6^tm1Otin/Tmprss6^tm1Otin (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	abnormal spleen size	J:185154
Hbb^d3th/Hbb⁺ Tg(LCR-HBA1,LCR-HBB)1Tow/0 (involves: C57BL/6 DBA/2J * SJL)	enlarged spleen	J:127701
Hbb^d3th/Hbb⁺ Tg(LCR-HBA2,LCR-HBB)1Cos/0 (involves: C57BL/6J CBA/J * DBA/2J)	enlarged spleen	J:94193
Hbb^d3th/Hbb^d3th Tg(HBB-AR-HBA2,-HBB)58Rub/0 Tg(LCR-HBA2,LCR-HBB)11Cos/0 (involves: FVB/N Swiss Webster)	abnormal spleen morphology	J:94190
	enlarged spleen	J:94190
	increased spleen red pulp amount	J:94190
	spleen fibrosis	J:94190
	spleen vascular congestion	J:94190
Hbb^d4/Hbb^d4 (involves: 101/H)	abnormal macrophage morphology	J:7972
	enlarged spleen	J:7972
	increased spleen red pulp amount	J:7972
Hbb^{tm1.1(HBG1,HBB*)Ryan}/Hbb⁺ (involves: C57BL/6J)	abnormal spleen morphology	J:147906
	enlarged spleen	J:147906
	increased spleen iron level	J:147906
	increased spleen red pulp amount	J:147906
	intermingled spleen red and white pulp	J:147906
Hbb^tm1Tow/Hbb⁺ (involves: 129S2/SvPas * C57BL/6)	enlarged spleen	J:29087
Hbb^tm1Tow/Hbb⁺ (involves: 129S2/SvPas * C57BL/6)	increased spleen weight	J:29087
Hbb^tm2Unc/Hbb⁺ (involves: 129P2/OlaHsd * C57BL/6J)	enlarged spleen	J:64295
Hbb^tm2Unc/Hbb⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased spleen iron level	J:64295
Hbs1l^{tm1a(KOMP)Wtsi}/Hbs1l^{tm1a(KOMP)Wtsi} (C57BL/6N-Hbs1l^{tm1a(KOMP)Wtsi}/Wtsi)	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased Langerhans cell number	J:211773
	decreased mature B cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased monocyte cell number	J:211773
	decreased T-helper cell number	J:211773
	increased CD4-positive, alpha-beta memory T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD5-positive gamma-delta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased leukocyte cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased regulatory T cell number	J:211773
Hcar1^{em1(IMPC)Ccpcz}/Hcar1^{em1(IMPC)Ccpcz} (C57BL/6N-Hcar1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased effector memory T-helper cell number	J:211773
Hck^tm1Ern/Hck^tm1Ern (involves: 129S1/Sv * C57BL/6)	abnormal alveolar macrophage morphology	J:111432
Hck^tm1Ern/Hck^tm1Ern (involves: 129S1/Sv * C57BL/6)	increased eosinophil cell number	J:111432
Hck^tm1Hev/Hck^tm1Hev Src^tm1Sor/Src^tm1Sor (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal immune system organ morphology	J:31647
	abnormal spleen germinal center morphology	J:31647
	abnormal spleen morphology	J:31647
	abnormal splenic cell ratio	J:31647
	decreased leukocyte cell number	J:31647
	increased macrophage cell number	J:31647
	lymph node hypoplasia	J:31647
	thymus hypoplasia	J:31647
Hcls1^{em1(IMPC)Ccpcz}/Hcls1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Hcls1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Hcls1^tm1Wtn/Hcls1^tm1Wtn (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:28146
Hcls1^tm1Wtn/Hcls1^tm1Wtn Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal negative T cell selection	J:28146
	decreased double-positive T cell number	J:28146
Hcls1^tm2Wtn/Hcls1^tm2Wtn (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:28146
Hcn2^m1Btlr/Hcn2^m1Btlr (C57BL/6J-Hcn2^m1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:255187
Hcn2^m1Btlr/Hcn2^m1Btlr (C57BL/6J-Hcn2^m1Btlr)	increased CD4-positive, alpha-beta T cell number	J:255187
Hcrt^{tm1.1(KOMP)Vlcg}/Hcrt^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hcrt^{tm1.1(KOMP)Vlcg}/Ucd)	increased lymphocyte cell number	J:211773
Hcst^tm1.1Cln/Hcst^tm1.1Cln (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:80426
Hcst^tm1.1Cln/Hcst^tm1.1Cln (involves: 129P2/OlaHsd * C57BL/6)	decreased uterine NK cell number	J:100668
Hcst^tm1.1Cln/Hcst^tm1.1Cln (B6.129P2-Hcst^tm1.1Cln)	abnormal osteoclast differentiation	J:147155
Hcst^tm1.1Cln/Hcst^tm1.1Cln (B6.129P2-Hcst^tm1.1Cln)	decreased osteoclast cell number	J:147155
Hcst^tm1.1Dnax/Hcst^tm1.1Dnax (involves: C57BL/6)	increased spleen weight	J:148086
Hdac1^tm1.1Pmt/Hdac1^tm1.1Pmt Hdac2^tm1.1Pmt/Hdac2^tm1.1Pmt Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB/N)	abnormal spleen morphology	J:157903
	arrested B cell differentiation	J:157903
	decreased B cell number	J:157903
	decreased pre-B cell number	J:157903
	decreased pro-B cell number	J:157903
Hdac1^tm1.1Shmc/Hdac1^tm1.1Shmc Hdac2^tm1.1Shmc/Hdac2⁺ Tg(Lck-cre)1Cwi/0 (involves: 129S7/SvEvBrd)	arrested T cell differentiation	J:194769
	decreased CD4-positive, alpha-beta T cell number	J:194769
	decreased CD8-positive, alpha-beta T cell number	J:194769
	decreased double-positive T cell number	J:194769
	enlarged spleen	J:194769
	enlarged thymus	J:194769
	increased double-negative T cell number	J:194769
	increased double-positive T cell number	J:194769
	increased single-positive T cell number	J:194769
	thymus hypoplasia	J:194769
Hdac1^tm1.1Shmc/Hdac1^tm1.1Shmc Hdac2^tm1.1Shmc/Hdac2^tm1.1Shmc Tg(Lck-cre)1Cwi/0 (involves: 129S7/SvEvBrd)	abnormal thymus corticomedullary boundary morphology	J:194769
	arrested T cell differentiation	J:194769
	decreased double-positive T cell number	J:194769
	decreased thymocyte number	J:194769
	enlarged spleen	J:194769
	enlarged thymus	J:194769
	increased double-positive T cell number	J:194769
	increased single-positive T cell number	J:194769
	increased T cell derived lymphoma incidence	J:194769
	increased thymocyte number	J:194769
Hdac4^{em1(IMPC)Ccpcz}/Hdac4⁺ (C57BL/6N-Hdac4^{em1(IMPC)Ccpcz}/Ccpcz)	increased NK cell number	J:211773
Hdc^tm1Nagy/Hdc^tm1Nagy (involves: 129S1/Sv * 129X1/SvJ)	abnormal mast cell morphology	J:70702
	decreased mast cell histamine storage	J:70702
	decreased mast cell number	J:70702
	decreased mast cell protease storage	J:70702
Hddc2^em1(IMPC)H/Hddc2^em1(IMPC)H (C57BL/6NTac-Hddc2^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Hddc3^{tm1.1(KOMP)Vlcg}/Hddc3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Hddc3^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Hectd1^{tm1b(EUCOMM)Hmgu}/Hectd1⁺ (C57BL/6N-Hectd1^{tm1b(EUCOMM)Hmgu}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Hectd3^{tm1(NCOM)Cmhd}/Hectd3^{tm1(NCOM)Cmhd} (C57BL/6N-Hectd3^{tm1(NCOM)Cmhd}/Nju)	small spleen	J:211773
	small thymus	J:211773
Heg1^tm1Mlkn/Heg1^tm1Mlkn (either: B6.129-Heg1^tm1Mlkn or (involves: 129 * C57BL/6))	abnormal lymphatic vessel endothelium morphology	J:146528
	lymphangiectasis	J:146528
Hells^{tm1a(EUCOMM)Wtsi}/Hells^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Hells^{tm1a(EUCOMM)Wtsi}/Ieg)	decreased granulocyte number	J:165965
Hells^tm1Kmu/Hells^tm1Kmu (involves: 129S1/Sv)	decreased B cell number	J:61948
	increased CD8-positive, alpha-beta T cell number	J:61948
	increased double-negative T cell number	J:61948
	small spleen	J:61948
	small thymus	J:61948
Hells^tm1Rarc/Hells^tm1Rarc (involves: 129X1/SvJ * C57BL/6J)	small thymus	J:107145
	thymus hypoplasia	J:107145
hem1/hem1 (Not Specified)	decreased leukocyte cell number	J:85113
hem2/hem2 (Not Specified)	decreased leukocyte cell number	J:85113
Heph^{em1(IMPC)Ccpcz}/Y (C57BL/6NCrl-Heph^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Heph^{em1(IMPC)Ccpcz}/Heph^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Heph^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Hephl1^cw/Hephl1^cw (CWD/LeJ)	abnormal immune system morphology	J:24875
	abnormal lymph node morphology	J:24875
	abnormal spleen morphology	J:24875
	enlarged spleen	J:24875
	enlarged thymus	J:24875
Herc1^{em3(IMPC)Wtsi}/Herc1^{em3(IMPC)Wtsi} (C57BL/6N-Herc1^{em3(IMPC)Wtsi}/Wtsi)	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased Ly6C high monocyte number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased monocyte cell number	J:211773
Herc4^{tm1b(KOMP)Wtsi}/Herc4^{tm1b(KOMP)Wtsi} (C57BL/6N-Herc4^{tm1b(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Herc6^{tm1b(EUCOMM)Hmgu}/Herc6^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Herc6^{tm1b(EUCOMM)Hmgu}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Hes1^tm1.1Frad/Hes1^tm1.1Frad Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal T cell differentiation	J:167000
	decreased DN1 thymic pro-T cell number	J:167000
	decreased DN2 thymocyte number	J:167000
	decreased DN3 thymocyte number	J:167000
	decreased DN4 thymocyte number	J:167000
	decreased double-positive T cell number	J:167000
	decreased gamma-delta T cell number	J:167000
	increased DN1 thymic pro-T cell number	J:167000
	increased immature B cell number	J:167000
	thymus hypoplasia	J:167000
Hexb^{tm1b(EUCOMM)Hmgu}/Hexb^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Hexb^{tm1b(EUCOMM)Hmgu}/H)	increased monocyte cell number	J:211773
Hexb^tm1Rlp/Hexb^tm1Rlp Tg(Hexb-tTA2S,tetO-Hexb)#Tjsa/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	microgliosis	J:190450
Hexb^tm1Rlp/Hexb^tm1Rlp Tg(SYN1-tTA2S,tetO-Hexb)#Tjsa/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	microgliosis	J:190450
Hfe^tm1.1Wsr/Hfe^tm1.1Wsr (involves: 129P2/OlaHsd * C57BL/6)	decreased spleen iron level	J:132134
Hfe^tm1Gfn/Hfe^tm1Gfn (involves: 129P2/OlaHsd * C57BL/6)	increased osteoclast cell number	J:262906
Hfe^tm1Gfn/Hfe^tm1Gfn (involves: 129P2/OlaHsd * C57BL/6)	increased spleen iron level	J:68025
Hfe^tm1Wsr/Hfe^tm1Wsr Tg(Alb1-cre)7Gsc/? (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	decreased spleen iron level	J:132134
Hfe^tm2Nca/Hfe^tm2Nca (involves: 129S6/SvEvTac)	decreased spleen iron level	J:78536
Hfe^tm2Nca/Hfe^tm2Nca (involves: 129S6/SvEvTac * C57BL/6J)	decreased spleen iron level	J:78536
Hfgi1^C57BL/6Ola/? (involves: C57BL/6Ola * BALB/cOla)	abnormal lymphopoiesis	J:123483
Hfgi2^C57BL/6Ola/? (involves: C57BL/6Ola * BALB/cOla)	abnormal lymphopoiesis	J:123483
Hgsnat^em4(IMPC)Tcp/Hgsnat^em4(IMPC)Tcp (C57BL/6NCrl-Hgsnat^em4(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Hgsnat^{tm1a(EUCOMM)Wtsi}/Hgsnat^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N * C57BL/6NTac)	abnormal Kupffer cell morphology	J:235361
	enlarged spleen	J:235361
	increased spleen weight	J:235361
	microgliosis	J:235361
Hhat^{em1(IMPC)Ccpcz}/Hhat⁺ (C57BL/6NCrl-Hhat^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased memory-marker CD4-positive NK T cell number	J:211773
Hhex^tm1Ngu/Hhex^tm1Ngu (involves: 129/Sv * C57BL/6)	abnormal monocyte differentiation	J:65105
Hhip^tm1Amc/Hhip^tm1Amc (involves: 129S1/Sv * 129X1/SvJ)	abnormal spleen morphology	J:85472
Hhip^tm1Amc/Hhip^tm1Amc (involves: 129S1/Sv * 129X1/SvJ)	small spleen	J:85472
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Itgax-cre)1-1Reiz/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal dendritic cell number	J:187773
Hif1a^tm3Rsjo/Hif1a^tm3Rsjo Tg(Tal1-cre/ERT)42-056Jrg/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell differentiation	J:192126
	abnormal T cell differentiation	J:192126
Hif1an^em1(IMPC)Mbp/Hif1an^em1(IMPC)Mbp (C57BL/6N-Hif1an^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Hip1^tm4Tsr/Hip1⁺ Runx1^tm3Dow/Runx1⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal myelopoiesis	J:151974
	abnormal spleen B cell follicle morphology	J:151974
	abnormal spleen morphology	J:151974
	enlarged spleen	J:151974
	increased granulocyte number	J:151974
	increased leukocyte cell number	J:151974
	increased neutrophil cell number	J:151974
	increased spleen red pulp amount	J:151974
	increased spleen weight	J:151974
	spleen hyperplasia	J:151974
Hip1^tm4Tsr/Hip1⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal myelopoiesis	J:151974
	abnormal spleen morphology	J:151974
	enlarged spleen	J:151974
	increased spleen red pulp amount	J:151974
	increased T cell derived lymphoma incidence	J:151974
Hira^{tm1a(EUCOMM)Wtsi}/Hira⁺ (C57BL/6N-Hira^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Hirip3^{tm1.1(KOMP)Mbp}/Hirip3^{tm1.1(KOMP)Mbp} (C57BL/6N-Hirip3^{tm1.1(KOMP)Mbp}/Ucd)	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Hivep1^tm1(KOMP)Mbp/Hivep1⁺ (C57BL/6N-Hivep1^tm1(KOMP)Mbp/MbpMmucd)	increased basophil cell number	J:211773
Hivep2^tm1Sis/Hivep2⁺ (involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj)	decreased CD8-positive, alpha-beta T cell number	J:72249
	decreased single-positive T cell number	J:72249
Hivep2^tm1Sis/Hivep2^tm1Sis (involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj)	abnormal immune system cell morphology	J:72249
	abnormal thymus cortex morphology	J:72249
	abnormal thymus lobule morphology	J:72249
	abnormal thymus medulla morphology	J:72249
	decreased single-positive T cell number	J:72249
	enlarged thymus cortex	J:72249
Hivep2^tm1Sis/Hivep2^tm1Sis (C.Cg-Hivep2^tm1Sis)	abnormal T-helper 2 cell morphology	J:96024
Hivep2^tm1Sis/Hivep2^tm1Sis Tg(DO11.10)10Dlo/? (involves: BALB/cA * C3H * C57BL/6NCrlj * CBA/JNCrlj)	abnormal positive T cell selection	J:96024
	abnormal T-helper 2 cell morphology	J:96024
	decreased single-positive T cell number	J:72249
Hivep3^tm1Glm/Hivep3^tm1Glm (Not Specified)	abnormal osteoclast differentiation	J:184764
Hivep3^tm1Glm/Hivep3^tm1Glm (Not Specified)	decreased osteoclast cell number	J:184764
Hivep3^tm1Lcw/Hivep3^tm1Lcw (chimera involves: 129S/SvEv * 129X1/SvJ)	decreased double-positive T cell number	J:79652
Hjv^tm1Arbr/Hjv^tm1Arbr (involves: 129S4/SvJae * 129X1/SvJ)	decreased spleen iron level	J:100173
Hjv^tm1Kpan/Hjv^tm1Kpan Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:231428
	decreased spleen iron level	J:231428
Hjv^tm1Nca/Hjv^tm1Nca (involves: 129S4/SvJae * 129S6/SvEvTac)	decreased spleen iron level	J:100178
Hjv^tm1Nca/Hjv^tm1Nca (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:160248
	decreased spleen iron level	J:160248
Hjv^tm1Nca/Hjv^tm1Nca Tmprss6^tm1Dgen/Tmprss6⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:160248
	decreased spleen iron level	J:160248
Hjv^tm1Nca/Hjv^tm1Nca Tmprss6^tm1Dgen/Tmprss6^tm1Dgen (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:160248
	decreased spleen iron level	J:160248
Hk1^dea/Hk1^dea (A/J-Hk1^dea/J)	abnormal spleen morphology	J:72146
	increased spleen red pulp amount	J:72146
	increased spleen weight	J:72146
Hk3^em1(IMPC)Tcp/Hk3^em1(IMPC)Tcp (C57BL/6N-Hk3^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Hlb18/? (C57BL/6J-Hlb18)	increased leukocyte cell number	J:82961
Hlb95/? (C57BL/6J-Hlb95)	increased leukocyte cell number	J:82961
Hlb141/? (C57BL/6J-Hlb141)	decreased leukocyte cell number	J:82961
Hlb141/? (C57BL/6J-Hlb141)	decreased neutrophil cell number	J:82961
hlb145/? (C57BL/6J-hlb145/J)	decreased leukocyte cell number	J:82961
hlb156/? (C57BL/6J-hlb156/J)	decreased neutrophil cell number	J:82961
hlb385/? (C57BL/6J-hlb385/J)	decreased leukocyte cell number	J:82961
Hmbox1^em1(IMPC)Tcp/Hmbox1^em1(IMPC)Tcp (C57BL/6N-Hmbox1^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
Hmga1^tm1Afus/Hmga1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	enlarged spleen	J:106702
Hmga1^tm1Afus/Hmga1^tm1Afus (involves: 129S7/SvEvBrd * C57BL/6)	enlarged spleen	J:106702
	lymphoid hyperplasia	J:106702
	myeloid hyperplasia	J:106702
Hmgb1^tm1.1Ttg/Hmgb1^tm1.1Ttg Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	decreased macrophage cell number	J:205499
Hmgb3^tm1Dmb/Y (involves: 129S6/SvEvTac * 129X1/SvJ)	abnormal leukopoiesis	J:96514
Hmgn5^tm1.2Mbus/Y (involves: 129S4/SvJae * C57BL/6J)	decreased granulocyte number	J:199604
Hmgn5^tm1.2Mbus/Y (involves: 129S4/SvJae * C57BL/6J)	increased CD8-positive, alpha-beta T cell number	J:199604
Hmgn5^tm1.2Mbus/Hmgn5^tm1.2Mbus (involves: 129S4/SvJae * C57BL/6J)	decreased granulocyte number	J:199604
	increased CD8-positive, alpha-beta T cell number	J:199604
Hmox1^tm1.1Gkl/Hmox1^tm1.1Gkl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6)	increased B cell number	J:148498
	increased CD4-positive, alpha-beta T cell number	J:148498
	increased CD8-positive, alpha-beta T cell number	J:148498
	increased granulocyte number	J:148498
	increased macrophage cell number	J:148498
Hmox1^tm1.2Gkl/Hmox1^tm1.2Gkl (involves: 129 * BALB/cJ * C57BL/6)	enlarged spleen	J:148498
Hmox1^tm1Poss/Hmox1⁺ Slc48a1^em1Ih/Slc48a1^em1Ih (involves: 129 * 129S2/SvPas * C57BL/6J)	decreased macrophage cell number	J:282829
Hmox1^tm1Poss/Hmox1^tm1Poss (involves: 129S2/SvPas * C57BL/6)	abnormal leukocyte cell number	J:79254
	abnormal lymph node cell ratio	J:79254
	abnormal splenic cell ratio	J:79254
	enlarged lymph nodes	J:79254
	enlarged spleen	J:79254
	spleen hyperplasia	J:79254
Hmox1^tm1Poss/Hmox1^tm1Poss (involves: 129 * 129S2/SvPas * C57BL/6J)	decreased macrophage cell number	J:282829
Hmox1^tm1Poss/Hmox1^tm1Poss Slc48a1^em1Ih/Slc48a1^em1Ih (involves: 129 * 129S2/SvPas * C57BL/6J)	decreased macrophage cell number	J:282829
Hmox1^tm1Poss/Hmox1^tm1Poss Spic^tm2Kmm/Spic^tm2Kmm (involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * FVB/N)	decreased macrophage cell number	J:210804
Hmox2^{tm1b(EUCOMM)Hmgu}/Hmox2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Hmox2^{tm1b(EUCOMM)Hmgu}/H)	decreased monocyte cell number	J:211773
	increased spleen weight	J:211773
Hnrnpd^{tm1b(KOMP)Wtsi}/Hnrnpd⁺ (C57BL/6N-Hnrnpd^{tm1b(KOMP)Wtsi}/Nju)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Hnrnph1^{tm1b(KOMP)Wtsi}/Hnrnph1⁺ (C57BL/6N-Hnrnph1^{tm1b(KOMP)Wtsi}/Nju)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Hnrnpl^tm1.1Tmo/Hnrnpl^tm1.1Tmo Tg(Lck-cre)548Jxm/0 (B6.Cg-Hnrnpl^tm1.1Tmo Tg(Lck-cre)548Jxm)	abnormal T cell differentiation	J:188749
	decreased CD4-positive, alpha-beta T cell number	J:188749
	decreased CD8-positive, alpha-beta T cell number	J:188749
	decreased double-positive T cell number	J:188749
	decreased T cell number	J:188749
	increased double-negative T cell number	J:188749
	thymus hypoplasia	J:188749
Hnrnpll^thdr/Hnrnpll^thdr (C57BL/6JSfdAnu-Hnrnpll^thdr/Anu)	abnormal memory T cell morphology	J:142641
	abnormal T cell differentiation	J:142641
	decreased CD4-positive, alpha-beta T cell number	J:142641
Hook1^em1(IMPC)Tcp/Hook1^em1(IMPC)Tcp (C57BL/6NCrl-Hook1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	small spleen	J:211773
Hook2^em1(IMPC)Tcp/Hook2^em1(IMPC)Tcp (C57BL/6N-Hook2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Hook3^{tm1b(NCOM)Mfgc}/Hook3^{tm1b(NCOM)Mfgc} (C57BL/6N-Hook3^{tm1b(NCOM)Mfgc}/Tcp)	increased basophil cell number	J:211773
Hormad2^{em1(IMPC)Ccpcz}/Hormad2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Hormad2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Hoxa1^tm3.1Mrc/Hoxa1^tm3.1Mrc (involves: 129S1/Sv * 129X1/SvJ)	thymus hypoplasia	J:178887
Hoxa1^tm3.1Mrc/Hoxa1^tm3.1Mrc Hoxb1^tm3Mrc/Hoxb1⁺ (involves: 129S1/Sv * 129X1/SvJ)	small thymus	J:41540
Hoxa1^tm3.1Mrc/Hoxa1^tm3.1Mrc Hoxb1^tm3Mrc/Hoxb1^tm3Mrc (involves: 129S1/Sv * 129X1/SvJ)	athymia	J:41540
Hoxa3^tm1Kth/Hoxa3^tm1Kth (involves: 129S1/Sv * 129X1/SvJ)	athymia	J:60296
Hoxa3^tm1Kth/Hoxa3^tm1Kth Hoxd3^{tm3(Hoxa3)Mrc}/Hoxd3⁺ (involves: 129S1/Sv * 129X1/SvJ)	athymia	J:60296
Hoxa3^tm1Mrc/Hoxa3⁺ Hoxb3^tm1Mrc/Hoxb3^tm1Mrc (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J)	ectopic thymus	J:46523
Hoxa3^tm1Mrc/Hoxa3⁺ Hoxd3^tm1Mrc/Hoxd3^tm1Mrc (involves: 129S7/SvEvBrd * C57BL/6J)	ectopic thymus	J:46523
Hoxa3^tm1Mrc/Hoxa3^tm1Mrc (involves: 129S7/SvEvBrd)	athymia	J:17753, J:161296
Hoxa3^tm1Mrc/Hoxa3^tm1Mrc Hoxd3^tm1Mrc/Hoxd3^tm1Mrc (involves: 129S7/SvEvBrd * C57BL/6J)	athymia	J:19447
Hoxa3^tm1Mrc/Hoxa3^tm2Nrm (involves: 129S7/SvEvBrd * C3H * C57BL/6 * C57BL/6NHsd)	athymia	J:161296
Hoxa3^tm1Mrc/Hoxa3^tm3.1Nrm H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S7/SvEvBrd * C57BL/6J * CBA/J)	ectopic thymus	J:161296
Hoxa3^tm1Nrm/Hoxa3^tm1Mrc (involves: 129S7/SvEvBrd * C3H * C57BL/6 * C57BL/6NHsd)	athymia	J:161296
Hoxa3^tm1Nrm/Hoxa3^tm1Nrm (involves: C3H * C57BL/6 * C57BL/6NHsd)	athymia	J:161296
Hoxa3^tm2Nrm/Hoxa3^tm2Nrm (involves: C3H * C57BL/6 * C57BL/6NHsd)	athymia	J:161296
Hoxa3^tm2Nrm/Hoxa3^tm3.1Nrm H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: C3H * C57BL/6 * CBA/J)	ectopic thymus	J:161296
Hoxa5^tm1Rob/Hoxa5^tm1Rob (involves: 129S/SvEv * C57BL/6 * MF1)	abnormal alveolar macrophage morphology	J:113378
Hoxa7^tm1Mrc/Hoxa7^tm1Mrc Hoxb7^tm1Mrc/Hoxb7^tm1Mrc (involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)	small thymus	J:50942
Hoxa9^tm1Mrc/Hoxa9^tm1Mrc (B6.129S7-Hoxa9^tm1Mrc)	decreased spleen weight	J:126371
Hoxa9^tm1Mrc/Hoxa9^tm1Mrc (B6.129S7-Hoxa9^tm1Mrc)	spleen hypoplasia	J:126371
Hoxb4^tm1.1Karl/Hoxb4^tm1.1Karl (involves: 129 * C57BL/6J)	spleen hypoplasia	J:90976
Hoxb8^tm1.1Mrc/Hoxb8^tm1.1Mrc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal microglial cell morphology	J:162102
Hoxb9^tm1Mrc/Hoxb9^tm1Mrc (involves: 129S7/SvEvBrd)	small thymus	J:37847
Hoxc4^tm2.1Mrc/Hoxc4^tm2.1Mrc (involves: 129S/SvEv * C57BL/6)	abnormal class switch recombination	J:148278
	abnormal somatic hypermutation frequency	J:148278
Hp^tm1Skl/Hp^tm1Skl Hpx^tm1Altr/Hpx^tm1Altr (involves: 129/Sv * 129P2/OlaHsd * C57BL/6J)	enlarged spleen	J:80539
	increased spleen red pulp amount	J:80539
Hpgds^tm1Urad/Hpgds^tm1Urad (B6.129-Hpgds^tm1Urad)	abnormal lymph node morphology	J:107651
Hprt1^b-m3/Y Impdh1^tm1Bmi/Impdh1^tm1Bmi (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymphopoiesis	J:85443
Hprt1^b-m3/Y Impdh2^tm1Bmi/Impdh2⁺ (involves: 129P2/OlaHsd)	abnormal lymphocyte cell number	J:86045
Hprt1^{tm1(CUX1)Anep}/Hprt1⁺ (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * FVB))	abnormal spleen white pulp morphology	J:113393
	abnormal splenic cell ratio	J:113393
	decreased B cell number	J:113393
	enlarged lymph nodes	J:113393
	enlarged spleen	J:113393
	increased leukocyte cell number	J:113393
	increased neutrophil cell number	J:113393
	myeloid hyperplasia	J:113393
	spleen hyperplasia	J:113393
Hps6^em1(IMPC)Tcp/Hps6^em1(IMPC)Tcp (C57BL/6N-Hps6^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
	small thymus	J:211773
Hpse^tm1.2Mdh/Hpse^tm1.2Mdh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal Langerhans cell morphology	J:209913
	decreased leukocyte cell number	J:209913
	increased eosinophil cell number	J:209913
Hr^em1(IMPC)H/Hr^em1(IMPC)H (C57BL/6NTac-Hr^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
Hr^em1(IMPC)H/Hr^em1(IMPC)H (C57BL/6NTac-Hr^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Hr^hr/Hr^hr (HRS/J)	decreased T cell number	J:6087
Hr^hr/Hr^hr (HRS/J)	increased macrophage cell number	J:150402
Hr^rh-R/Hr^rh-R (involves: 101 * C3H/Rl * C57BL/RlEl * C57BL/10Rl * SEC/El)	decreased thymus weight	J:156542
Hr^rh/Hr^rh (RHJ/LeJ)	thymus atrophy	J:57947
Hr^rhsl/Hr^rhsl (involves: BALB/c)	thymus atrophy	J:98859
Hr^USP/Hr^USP (either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2))	abnormal lymph node secondary follicle morphology	J:21316
	enlarged inguinal lymph nodes	J:21316
	enlarged popliteal lymph nodes	J:21316
	lymph node medullary cord hyperplasia	J:21316
	thymus cortex atrophy	J:21316
Hrg^tm1Wja/Hrg^tm1Wja (involves: 129P2/OlaHsd * C57BL/6)	increased monocyte cell number	J:134621
Hrh1^tm1Wtn/Hrh1^tm1Wtn (involves: 129P2/OlaHsd * C57BL/6)	decreased T cell number	J:111704
Hs1bp3^em1(IMPC)J/Hs1bp3^em1(IMPC)J (C57BL/6NJ-Hs1bp3^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Hs3st3b1^em2(IMPC)Mbp/Hs3st3b1^em2(IMPC)Mbp (C57BL/6N-Hs3st3b1^em2(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Hsd17b3^tm1.2Mpo/Hsd17b3^tm1.2Mpo (involves: 129S6/SvEvTac * C57BL/6N * C57BL/6NCrl)	increased spleen weight	J:301756
Hsd17b4^em1(IMPC)Tcp/Hsd17b4^em1(IMPC)Tcp (C57BL/6NCrl-Hsd17b4^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Hsd17b4^tm1Baes/Hsd17b4^tm1Baes (involves: 129S1/Sv * 129X1/SvJ)	microgliosis	J:201698
Hsd17b4^tm2Baes/Hsd17b4^tm2Baes Tg(Nes-cre)1Kln/0 (involves: 129 * C57BL/6 * SJL)	microgliosis	J:201698
Hsd17b11^{Gt(OST237628)Lex}/Hsd17b11^{Gt(OST237628)Lex} (B6;129S5-Hsd17b11^{Gt(OST237628)Lex}/Mmucd)	increased immature B cell number	J:171883
Hsf2bp^{tm1b(EUCOMM)Hmgu}/Hsf2bp^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Hsf2bp^{tm1b(EUCOMM)Hmgu}/Ieg)	enlarged lymph nodes	J:211773
Hsfy2^em1(IMPC)J/Hsfy2^em1(IMPC)J (C57BL/6NJ-Hsfy2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Hsh2d^tm1Viss/Hsh2d^tm1Viss (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased spleen weight	J:111408
Hspa9^{Gt(IST14901H6)Tigm}/Hspa9⁺ (involves: C57BL/6N)	decreased pre-B cell number	J:227164
Hspa12a^tm1.1Zdi/Hspa12a^tm1.1Zdi (involves: 129 * C57BL/6)	abnormal macrophage morphology	J:302786
Hspa13^tm1.1Smoc/Hspa13^tm1.1Smoc Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S * C57BL/6)	abnormal class switch recombination	J:303927
	abnormal plasmablast number	J:303927
	abnormal somatic hypermutation frequency	J:303927
	decreased plasma cell number	J:303927
Hspb8^em1(IMPC)J/Hspb8^em1(IMPC)J (C57BL/6NJ-Hspb8^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Hspbap1^{tm1b(EUCOMM)Hmgu}/Hspbap1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Hspbap1^{tm1b(EUCOMM)Hmgu}/Bay)	increased spleen weight	J:211773
Hspg2^tm1Rdgr/Hspg2^tm1Rdgr (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast morphology	J:121855
	increased osteoclast cell number	J:121855
Htr3a^tm1Ckn/Htr3a^tm1Ckn (involves: 129S1/Sv * C57BL/6J * DBA/2)	decreased lymphocyte cell number	J:90942
Htra2^mnd2/Htra2^mnd2 (involves: C3H/HeJ * C57BL/6J * CAST/Ei)	abnormal thymus morphology	J:12780
	spleen atrophy	J:12780
Htra2^mnd2/Htra2^mnd2 (involves: C57BL/6J)	abnormal immune system morphology	J:132627
	decreased double-positive T cell number	J:132627
	decreased pre-B cell number	J:132627
	decreased pro-B cell number	J:132627
	decreased single-positive T cell number	J:132627
Htra2^tm1.1Hohj/Htra2^tm1.1Hohj Tg(Nes-cre)1Kln/0 (involves: C57BL/6J)	spleen atrophy	J:225666
	thymus atrophy	J:225666
Htra2^tm1.2Hohj/Htra2^tm1.2Hohj (involves: C57BL/6 * C57BL/6J)	decreased lymphocyte cell number	J:225666
	spleen atrophy	J:225666
	thymus atrophy	J:225666
Htra2^tm1Jdo/Htra2^tm1Jdo (involves: 129P/Ola * C57BL/6)	small spleen	J:94227
Htra2^tm1Jdo/Htra2^tm1Jdo (involves: 129P/Ola * C57BL/6)	small thymus	J:94227
Htt^tm2Detl/Htt⁺ (B6J.129P2-Htt^tm2Detl)	microgliosis	J:220868
hubb/hubb (involves: ICR)	increased spleen weight	J:8170
Hyal2^tm1.1Bfla/Hyal2^tm1.1Bfla (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	increased spleen iron level	J:146040
Hycc1^{em1(IMPC)Ccpcz}/Hycc1^{em1(IMPC)Ccpcz} (C57BL/6N-Hycc1^{em1(IMPC)Ccpcz}/Ccpcz)	enlarged thymus	J:211773
	increased monocyte cell number	J:211773
Hydin^hyrh/Hydin^hyrh (involves: C57BL/6J * C57BL/10J * RIII)	thymus atrophy	J:137815
Iapp^tm1Sgm/Iapp⁺ (involves: 129P2/OlaHsd)	increased osteoclast cell number	J:88964
Iapp^tm1Sgm/Iapp^tm1Sgm (involves: 129P2/OlaHsd)	increased osteoclast cell number	J:88964
Ibsp^tm1Jeau/Ibsp^tm1Jeau (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal osteoclast morphology	J:228156, J:136223
	decreased osteoclast cell number	J:136223
	increased osteoclast cell number	J:228156
Ica1^{tm1b(EUCOMM)Wtsi}/Ica1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ica1^{tm1b(EUCOMM)Wtsi}/Tcp)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Icam1^tm1Alb/Icam1^tm1Alb (B6.Cg-Icam1^tm1Alb)	increased leukocyte cell number	J:100242
Icam1^tm1Alb/Icam1^tm1Alb (B6.Cg-Icam1^tm1Alb)	increased neutrophil cell number	J:100242
Icam1^tm1Bay/Icam1^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	increased neutrophil cell number	J:14565
Icam1^tm1Bay/Icam1^tm1Bay (B6.129S7-Icam1^tm1Bay)	increased eosinophil cell number	J:48271
	increased lymphocyte cell number	J:48271
	increased monocyte cell number	J:48271
	increased neutrophil cell number	J:48271, J:24239
Icam1^tm1Bay/Icam1^tm1Bay (either: B6.129S7-Icam1^tm1Bay or (involves: 129S7/SvEvBrd * C57BL/6))	increased leukocyte cell number	J:31374
Icam1^tm1Bay/Icam1^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	increased neutrophil cell number	J:112286
Icam1^tm1Bay/Icam1^tm1Bay Sele^tm2Alb/Sele^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	increased neutrophil cell number	J:112286
Icam1^tm1Bay/Icam1^tm1Bay Sell^tm1Tft/Sell^tm1Tft (B6.129-Sell^tm1Tft Icam1^tm1Bay)	increased eosinophil cell number	J:48271
	increased lymphocyte cell number	J:48271
	increased monocyte cell number	J:48271
	increased neutrophil cell number	J:48271
Icam1^tm1Bay/Icam1^tm1Bay Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	increased neutrophil cell number	J:24239
Icam1^tm1Cws/Icam1^tm1Cws (involves: C57BL/6)	abnormal macrophage morphology	J:100353
Icam1^tm1Jcgr/Icam1^tm1Jcgr (involves: 129S4/SvJae * C57BL/6 * DBA/2)	increased lymphocyte cell number	J:18743
	increased neutrophil cell number	J:18743
Icam1^tm1Jcgr/Icam1^tm1Jcgr Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S4/SvJae * 129S7/SvEvBrd)	increased neutrophil cell number	J:69597
Icam1^tm1Jcgr/Icam1^tm1Jcgr Ldlr^tm1Her/Ldlr^tm1Her Vcam1^tm1Dmil/Vcam1^tm1Dmil (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)	increased leukocyte cell number	J:69597
	increased lymphocyte cell number	J:69597
	increased monocyte cell number	J:69597
	increased neutrophil cell number	J:69597
Icos^tm1.1Wks/Icos^tm1.1Wks (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell number	J:155586
	abnormal B cell selection	J:155586
	abnormal class switch recombination	J:155586
	abnormal Peyer's patch germinal center morphology	J:155586
	abnormal spleen morphology	J:155586
	decreased CD4-positive, alpha-beta T cell number	J:155586
	decreased spleen germinal center number	J:155586
	small Peyer's patches	J:155586
Icos^tm1Dgry/Icos^tm1Dgry (B6.129P2-Icos^tm1Dgry)	abnormal leukocyte cell number	J:123477
	abnormal memory B cell number	J:123477
	decreased germinal center B cell number	J:123477
	decreased plasma cell number	J:123477
	increased plasma cell number	J:123477
Icos^tm1Flv/Icos^tm1Flv (involves: 129/Sv * C57BL/6)	small lymph nodes	J:87123
Icos^tm1Flv/Icos^tm1Flv (NOD.129S1-Icos^tm1Flv)	decreased T cell number	J:131529
Icos^tm1Flv/Icos^tm1Flv Rc3h1^san/Rc3h1⁺ (involves: 129S1/Sv * C57BL/6 * C57BL/6JSfdAnu)	increased T cell derived lymphoma incidence	J:189087
Icos^tm1Mak/Icos^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell number	J:155586
	abnormal class switch recombination	J:66702
	abnormal Peyer's patch germinal center morphology	J:155586
	abnormal spleen morphology	J:66702
	decreased CD4-positive, alpha-beta T cell number	J:155586
	decreased spleen germinal center number	J:66702, J:155586
	decreased spleen germinal center size	J:66702
	small Peyer's patches	J:155586
Icos^tm1Shr/Icos^tm1Shr (Not Specified)	abnormal spleen germinal center morphology	J:87124
Icos^tm1Shr/Icos^tm1Shr (Not Specified)	abnormal T cell differentiation	J:87124
Icos^tm1Tkan/Icos^tm1Tkan (involves: 129S7/SvEvBrd * C57BL/6)	abnormal Peyer's patch germinal center morphology	J:95728
	small Peyer's patches	J:95728
Icosl^tm1Cdon/Icosl^tm1Cdon (involves: 129S6/SvEvTac)	abnormal T cell differentiation	J:86697
Icosl^tm1Cdon/Icosl^tm1Cdon (involves: 129S6/SvEvTac)	small spleen	J:86697
Icosl^tm1Kplm/Icosl^tm1Kplm (involves: 129P2/OlaHsd)	abnormal spleen germinal center morphology	J:84893
Icosl^tm1Mak/Icosl^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:84668
	abnormal spleen morphology	J:84668
	abnormal T-helper 2 cell differentiation	J:84668
	decreased spleen germinal center number	J:84668
	decreased spleen germinal center size	J:84668
Id1^tm1Zhu/Id1^tm1Zhu (involves: 129S1/Sv * C57BL/6)	abnormal myelopoiesis	J:155384
	abnormal osteoclast differentiation	J:155384
	decreased lymphocyte cell number	J:119519
	increased monocyte cell number	J:155384
	increased neutrophil cell number	J:155384
	increased osteoclast cell number	J:155384
	myeloid hyperplasia	J:155384
Id1^tm1Zhu/Id1^tm1Zhu Tcf3^tm1Wein/Tcf3^tm1Wein (involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal thymus corticomedullary boundary morphology	J:44278
	absent B cells	J:44278
	arrested B cell differentiation	J:44278
	decreased lymphocyte cell number	J:44278
	increased T cell derived lymphoma incidence	J:44278
	intermingled spleen red and white pulp	J:44278
Id2^tm1Ago/Id2^tm1Ago (B6.129-Id2^tm1Ago)	absent lymph nodes	J:116119
	absent NK cells	J:116119
	decreased CD8-positive, alpha-beta T cell number	J:116119
Id2^tm1Yyk/Id2^tm1Yyk (involves: 129S1/Sv * 129X1/SvJ)	abnormal oropharyngeal lymphoid tissue morphology	J:78101
	absent Peyer's patches	J:53267
	decreased lymph node number	J:53267
	decreased NK cell number	J:53267
Id2^tm1Yyk/Id2^tm1Yyk (involves: 129S1/Sv * 129X1/SvJ * NMRI)	abnormal oropharyngeal lymphoid tissue morphology	J:78101
	absent Peyer's patches	J:53267
	decreased lymph node number	J:53267
	decreased NK cell number	J:53267
Id2^tm1Yyk/Id2^tm1Yyk (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * FVB/NJ))	absent lymph nodes	J:125739
	absent Peyer's patches	J:125739
	decreased NK T cell number	J:125739
Id2^tm1Yyk/Id2^tm1Yyk Rorc^tm2Litt/Rorc⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	abnormal gut-associated lymphoid tissue morphology	J:87395
	abnormal immune system cell morphology	J:87395
	abnormal lymph organ development	J:87395
Id2^tm1Yyk/Id2^tm1Yyk Tcf3^tm1Cmu/Tcf3⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	absent axillary lymph nodes	J:125739
	absent brachial lymph nodes	J:125739
	absent inguinal lymph nodes	J:125739
	decreased NK T cell number	J:125739
Id2^tm1Yyk/Id2^tm1Yyk Tcf3^tm1Cmu/Tcf3^tm1Cmu (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)	decreased B cell number	J:125739
	decreased NK T cell number	J:125739
	small lymph nodes	J:125739
Id3^em1(IMPC)Mbp/Id3^em1(IMPC)Mbp (C57BL/6N-Id3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Id3^tm1Cmu/Id3^tm1Cmu (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal double-positive T cell morphology	J:59969
	abnormal T cell differentiation	J:59969
Id3^tm1Zhu/Id3^tm1Zhu (involves: 129S4/SvJaeSor * C57BL/6)	abnormal T cell differentiation	J:144696
Id3^tm2.1Cmu/Id3^tm2.1Cmu (Not Specified)	decreased thymocyte number	J:176462
	increased B cell number	J:176462
	increased gamma-delta T cell number	J:176462
	increased T follicular helper cell number	J:176462
Id3^tm2.1Cmu/Id3^tm2.1Cmu Tcf3^tm4Zhu/Tcf3^tm4Zhu Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJaeSor * C57BL/6 * DBA/2)	decreased thymocyte number	J:176462
Id3^tm2.1Zhu/Id3^tm2.1Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)	abnormal T cell differentiation	J:172701
	decreased CD4-positive, alpha-beta T cell number	J:172701
	decreased CD8-positive, alpha-beta T cell number	J:172701
	decreased T cell number	J:172701
	increased CD4-positive, alpha-beta memory T cell number	J:172701
	increased CD8-positive, alpha-beta memory T cell number	J:172701
	increased gamma-delta T cell number	J:172701
Idd1^NOD/Uf/Idd1^NOD/Uf (B6.NOD-(D17Mit164-D17Mit152))	increased CD4-positive, alpha-beta T cell number	J:92304
Idd2^NOD/Smrf/Idd2^NOD/Smrf (involves: NON/Lt * NOD/Smrf)	increased CD4-positive, alpha-beta T cell number	J:30526
Idd4^NOD/Idd4^NOD (B6.NOD-Idd4)	decreased NK T cell number	J:85823
Idd6.2^C3H/HeJ/Idd6.2^C3H/HeJ (NOD.C3-Idd6.2^C3H/HeJ)	decreased NK cell number	J:137837
Idd6.2^NOD/Idd6.2^NOD (B6.NOD-(D6Mit259-D6Mit304))	abnormal T cell differentiation	J:120148
Idd6^C3H/HeJ/Idd6^C3H/HeJ (NOD.C3-Idd6^C3H/HeJ)	decreased NK cell number	J:137837
Idd7^NOD/ShiLt/Idd7^NOD/ShiLt (involves: C57BL/6 * NOD/ShiLt)	abnormal T cell clonal deletion	J:131557
Idd9.1^C57BL/10SnJ/Idd9.1^C57BL/10SnJ (NOD.B10-Idd9.1^C57BL/10SnJ)	increased NK T cell number	J:85823
Idh1^tm1Mak/Idh1^tm1Mak Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:186700
	decreased B cell number	J:186700
	decreased CD4-positive, alpha-beta T cell number	J:186700
	decreased CD8-positive, alpha-beta T cell number	J:186700
	enlarged spleen	J:186700
	increased CD4-positive, alpha-beta T cell number	J:186700
Idh1^tm2Mak/Idh1^tm2Mak Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:186700
	decreased B cell number	J:186700
	decreased CD4-positive, alpha-beta T cell number	J:186700
	decreased CD8-positive, alpha-beta T cell number	J:186700
	enlarged spleen	J:186700
	increased CD4-positive, alpha-beta T cell number	J:186700
Idh2^tm1Jwpk/Idh2^tm1Jwpk (involves: 129S4/SvJae * C57BL/6)	increased osteoclast cell number	J:272241
Idh3g^em1(IMPC)Bay/Idh3g^em1(IMPC)Bay (C57BL/6N-Idh3g^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * BALB/c)	decreased leukocyte cell number	J:170565
Ido1^tm1Alm/Ido1^tm1Alm (involves: 129X1/SvJ * C57BL/6J)	abnormal macrophage morphology	J:282516
Ids^tm1Muen/Y (Not Specified)	abnormal lymph node morphology	J:108761
Ids^tm1Muen/Y (involves: C57BL/6)	increased spleen weight	J:259752
Idua^{em1(IMPC)Hmgu}/Idua^{em1(IMPC)Hmgu} (C57BL/6NCrl-Idua^{em1(IMPC)Hmgu}/Ieg)	increased spleen weight	J:211773
Idua^tm1Efn/Idua^tm1Efn (involves: C57BL/6)	abnormal microglial cell morphology	J:81974
Ier3^tm1Mxw/Ier3^tm1Mxw (involves: 129 * C57BL/6)	decreased regulatory T cell number	J:157504
	increased granulocyte number	J:157504
	increased neutrophil cell number	J:157504
Ier3^tm1Mxw/Ier3^tm1Mxw (involves: C57BL/6)	increased T-helper 17 cell number	J:194587
Ifi44^{tm1b(KOMP)Wtsi}/Ifi44^{tm1b(KOMP)Wtsi} (C57BL/6N-Ifi44^{tm1b(KOMP)Wtsi}/Tcp)	enlarged lymph nodes	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Ifi44^{tm1b(KOMP)Wtsi}/Ifi44^{tm1b(KOMP)Wtsi} (involves: C57BL/6N)	increased CD8-positive, alpha-beta T cell number	J:297991
Ifi208^em1(IMPC)Mbp/Ifi208^em1(IMPC)Mbp (C57BL/6N-Ifi208^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Ifih1^Rgsc422/Ifih1⁺ (D2JJcl.B6JJcl-Ifih1^Rgsc422)	abnormal leukocyte cell number	J:209917
	increased dendritic cell number	J:209917
	increased granulocyte number	J:209917
	increased macrophage cell number	J:209917
	increased plasma cell number	J:209917
Ifitm1^tm1.1Ieg/Ifitm1^tm1.1Ieg (B6.129P2-Ifitm1^tm1.1Ieg)	decreased granulocyte number	J:192287
Ifitm1^tm1.1Ieg/Ifitm1^tm1.1Ieg (B6.129P2-Ifitm1^tm1.1Ieg)	decreased T cell number	J:192287
Ifitm5^em1Pmof/Ifitm5⁺ (involves: CD-1)	abnormal osteoclast morphology	J:255349
Ifna6^tm1Aki/Ifna6⁺ Myd88^tm1Aki/Myd88^tm1Aki (involves: 129P2/OlaHsd)	abnormal plasmacytoid dendritic cell morphology	J:124340
Ifnar1^tm1Agt/Ifnar1^tm1Agt (B6.129S2-Ifnar1^tm1Agt)	abnormal osteoclast morphology	J:76097
Ifnar1^tm1Agt/Ifnar1^tm1Agt (involves: 129S2/SvPas * BALB/c)	abnormal mononuclear phagocyte morphology	J:291874
	decreased Ly6C high monocyte number	J:291874
	increased CD4-positive, alpha-beta T cell number	J:291874
	increased CD8-positive, alpha-beta T cell number	J:291874
Ifnar1^tm1Agt/Ifnar1^tm1Agt Slamf1^tm1Oono/Slamf1^tm1Oono (B6.129-Slamf1^tm1Oono Ifnar1^tm1Agt)	abnormal lymphopoiesis	J:117810
Ifnar1^tm1Pjh/Ifnar1^tm1Pjh (involves: 129S2/SvPas * BALB/c)	increased leukocyte cell number	J:36004
Ifnar1^tm1Pjh/Ifnar1^tm1Pjh (B6.129S2-Ifnar1^tm1Pjh)	decreased NK cell number	J:125812
Ifnar2^tm1Pjh/Ifnar2^tm1Pjh (B6.Cg-Ifnar2^tm1Pjh)	decreased NK cell number	J:125812
Ifnb1^tm1Acgp/Ifnb1^tm1Acgp (involves: 129P2/OlaHsd)	abnormal spleen primary B follicle morphology	J:86527
	decreased macrophage cell number	J:86527
	decreased mature B cell number	J:86527
	decreased monocyte cell number	J:86527
	decreased neutrophil cell number	J:86527
	decreased pro-B cell number	J:86527
Ifnb1^tm1Ttg/Ifnb1^tm1Ttg (B6.Cg-Ifnb1^tm1Ttg)	abnormal osteoclast morphology	J:76097
Ifne^tm1.2Pjh/Ifne^tm1.2Pjh (involves: C57BL/6)	decreased NK cell number	J:197569
Ifng^tm1.1Hayg/Ifng^tm1.1Hayg (involves: 129S4/SvJae * C57BL/6J)	abnormal B cell differentiation	J:220784
	abnormal lymph node morphology	J:220784
	decreased leukocyte cell number	J:220784
	decreased mature B cell number	J:220784
	decreased pre-B cell number	J:220784
	increased T cell number	J:220784
	spleen atrophy	J:220784
	thymus atrophy	J:220784
Ifng^tm1Ts/Ifng^tm1Ts (B6.129S7-Ifng^tm1Ts/J)	abnormal spleen morphology	J:47459
	abnormal spleen red pulp morphology	J:47459
	abnormal spleen white pulp morphology	J:47459
	enlarged mesenteric lymph nodes	J:50832
	enlarged spleen	J:47459
	increased granulocyte number	J:47459
	increased leukocyte cell number	J:47459
	increased monocyte cell number	J:47459
	increased NK T cell number	J:122801
	pale spleen	J:47459
Ifng^tm1Ts/Ifng^tm1Ts (B6.129S7-Ifng^tm1Ts)	abnormal lymph node cell ratio	J:112084
	increased CD8-positive, alpha-beta T cell number	J:112048
	increased T cell derived lymphoma incidence	J:77491
Ifng^tm1Ts/Ifng^tm1Ts (C.129S7(B6)-Ifng^tm1Ts/J)	abnormal spleen morphology	J:115144
	abnormal spleen red pulp morphology	J:47459
	abnormal spleen white pulp morphology	J:47459
	abnormal uterine NK cell morphology	J:56503
	enlarged spleen	J:47459
	increased granulocyte number	J:47459
	increased leukocyte cell number	J:47459
	increased monocyte cell number	J:47459
	increased uterine NK cell number	J:56503
	pale spleen	J:47459
Ifng^tm1Ts/Ifng^tm1Ts Ldlr^tm1Her/Ldlr^tm1Her (B6.129S7-Ldlr^tm1Her Ifng^tm1Ts)	increased T cell number	J:103072
Ifng^tm1Ts/Ifng^tm1Ts Pld4^tm1.2Nemz/Pld4^tm1.2Nemz (involves: 129 * 129S7/SvEvBrd * C57BL/6J * FVB/N)	decreased NK T cell number	J:281205
Ifng^tm1Ts/Ifng^tm1Ts Socs1^tm1Wehi/Socs1^tm1Wehi (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)	enlarged thymus medulla	J:57474
Ifng^tm1Ts/Ifng^tm1Ts Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129P2/OlaHsd * 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)	abnormal lymph node cortex morphology	J:119206
	abnormal lymph node primary follicle morphology	J:119206
	abnormal lymph node secondary follicle morphology	J:119206
	absent lymph node germinal center	J:119206
	absent spleen germinal center	J:119206
	increased eosinophil cell number	J:119206
	increased leukocyte cell number	J:119206
	increased lymphocyte cell number	J:119206
	small Peyer's patches	J:119206
Ifngr1^m1Btlr/Ifngr1^m1Btlr (C57BL/6J-Ifngr1^m1Btlr)	decreased macrophage cell number	J:236694
Ifngr1^m1Btlr/Ifngr1^m1Btlr (C57BL/6J-Ifngr1^m1Btlr)	increased B cell number	J:236694
Ifngr1^tm1Agt/Ifngr1^tm1Agt (involves: 129S7/SvEvBrd)	abnormal uterine NK cell morphology	J:56503
Ifngr1^tm1Agt/Ifngr1^tm1Agt (involves: 129S7/SvEvBrd)	increased uterine NK cell number	J:56503
Ifngr1^tm1Agt/Ifngr1^tm1Agt (B6.129S7-Ifngr1^tm1Agt/J)	abnormal lymphopoiesis	J:138728
	abnormal osteoclast differentiation	J:233116
	decreased CD4-positive, alpha-beta T cell number	J:138728
	decreased CD8-positive, alpha-beta T cell number	J:138728
	decreased lymphocyte cell number	J:138728
	spleen hypoplasia	J:138728
Ifngr1^tm1Agt/Ifngr1^tm1Agt Tg(GZMB-Tax)#Lera/0 (involves: 129S7/SvEvBrd * C57BL/6)	abnormal osteoclast differentiation	J:147601
	increased osteoclast cell number	J:147601
Ifngr2^tm1Pbro/Ifngr2^tm1Pbro (involves: 129S1/Sv)	abnormal class switch recombination	J:48016
Ifngr2^tm1Pbro/Ifngr2^tm1Pbro (involves: 129S1/Sv)	abnormal T-helper 1 cell differentiation	J:48016
Ifnk^{tm1.1(KOMP)Vlcg}/Ifnk^{tm1.1(KOMP)Vlcg} (C57BL/6NTac-Ifnk^{tm1.1(KOMP)Vlcg})	enlarged spleen	J:322130
Ift70b^em1(IMPC)Bay/Ift70b^em1(IMPC)Bay (C57BL/6N-Ift70b^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Ift140^b2b1283Clo/Ift140^b2b1283Clo (C57BL/6J-Ift140^b2b1283Clo)	absent spleen	J:175213
Igbp1^tm1Cbt/Y Tg(Lck-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	decreased thymocyte number	J:93221
Igbp1^tm1Cbt/Igbp1⁺ Tg(Lck-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	decreased thymocyte number	J:93221
Igbp1^tm1Imku/Y Tg(Lck-cre)I57Jxm/? (involves: 129P2/OlaHsd * ICR)	abnormal thymus cortex morphology	J:84395
	abnormal thymus corticomedullary boundary morphology	J:84395
	decreased double-negative T cell number	J:84395
	decreased T cell number	J:84395
	decreased thymocyte number	J:84395
Igf1^tm1.1Dlr/Igf1^tm1.1Dlr Tg(Ttr-IGF1)1Sykr/0 (FVB.Cg-Igf1^tm1.1Dlr Tg(Ttr-IGF1)1Sykr)	increased spleen weight	J:157350
Igf1r^tm2Arge/Igf1r^tm2Arge Tg(BGLAP-cre)1Clem/0 (involves: 129 * FVB/N)	decreased osteoclast cell number	J:80190
Igf1sl2^C3H/HeJ/Igf1sl2^C3H/HeJ (B6.C3H-Igf1sl2^C3H/HeJ)	increased osteoclast cell number	J:111677
Igf2^tm1Snha/Igf2⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal osteoclast differentiation	J:167738
Igf2bp1^{Gt(OST33739)Lex}/Igf2bp1^{Gt(OST33739)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	spleen hypoplasia	J:89882
Igfbp2^tm1Jep/Igfbp2^tm1Jep (either: (involves: 129P1/ReJ * 129S/SvEv) or (involves: 129S/SvEv * C57BL/6))	small spleen	J:64338
Igh-7^tm1.1Lam/Igh-7^tm1.1Lam (involves: BALB/c)	decreased mature B cell number	J:146733
Igh-7^tm1Gach/Igh-7^tm1Gach (BALB/c-Igh-7^tm1Gach)	abnormal B cell number	J:143266
	increased memory B cell number	J:143266
	increased plasma cell number	J:143266
Igh-7^tm1Lam/Igh-7^tm1Lam (involves: BALB/c)	decreased mature B cell number	J:146733
Igh-7^tm1Lcwu/Igh-7^tm1Lcwu (involves: C57BL/6)	decreased mature B cell number	J:161452
Igh-7^tm1Led/Igh-7^tm1Led Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd * 129S4/SvJae)	decreased B cell number	J:161523
	increased basophil cell number	J:161523
Igh-8^tm1.1Aak/Igh-8^tm1.1Aak (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:171251
Igh-8^tm1Aak/Igh-8^tm1Aak (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:107063
Igh-8^{tm2(Ighg1)Aak}/Igh-8^{tm2(Ighg1)Aak} (involves: 129S2/SvPas)	abnormal class switch recombination	J:130574
Igh-J^{tm1(3H9-VDJ)Mwg}/Igh-J^{tm1(3H9-VDJ)Mwg} (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal B cell receptor editing	J:126940
Igh-J^{tm1(CB20)Riho}/Igh-J⁺ (involves: C57BL/10 * DBA/1)	abnormal B cell differentiation	J:179456
	decreased pre-B cell number	J:179456
	increased immature B cell number	J:179456
	increased marginal zone B cell number	J:179456
	increased mature B cell number	J:179456
Igh-J^{tm1(CB20)Riho}/Igh-J^{tm1(CB20)Riho} (involves: C57BL/10 * DBA/1)	abnormal B cell differentiation	J:179456
	decreased pre-B cell number	J:179456
	increased immature B cell number	J:179456
	increased marginal zone B cell number	J:179456
	increased mature B cell number	J:179456
Igh-J^tm1.1Lave/Igh-J⁺ (Not Specified)	abnormal B cell differentiation	J:155798
	decreased B cell number	J:155798
	decreased immature B cell number	J:155798
	decreased mature B cell number	J:155798
	decreased spleen weight	J:155798
	decreased T cell number	J:155798
	decreased transitional stage B cell number	J:155798
	decreased transitional stage T1 B cell number	J:155798
	decreased transitional stage T2 B cell number	J:155798
	increased pre-B cell number	J:155798
	increased pro-B cell number	J:155798
Igh-J^tm1.1Lave/Igh-J^tm1.1Lave (Not Specified)	abnormal B cell differentiation	J:155798
	arrested B cell differentiation	J:179317
	decreased B cell number	J:155798, J:179317
	decreased immature B cell number	J:155798
	decreased mature B cell number	J:155798
	decreased spleen weight	J:155798
	decreased T cell number	J:155798
	decreased transitional stage B cell number	J:155798
	decreased transitional stage T1 B cell number	J:155798
	decreased transitional stage T2 B cell number	J:155798
	increased pre-B cell number	J:155798
	increased pro-B cell number	J:155798
Igh-J^tm1.1Lave/Igh-J^tm1.1Lave Igk-J^tm1.1Lave/Igk-J^tm1.1Lave (Not Specified)	abnormal B cell clonal deletion	J:179317
	abnormal B cell differentiation	J:205708
	arrested B cell differentiation	J:205708, J:179317
	decreased B cell number	J:205708, J:179317
	decreased immature B cell number	J:205708
	decreased mature B cell number	J:205708
Igh-J^tm1.1Lave/Igh-J^tm1.1Lave Igk-J^tm1.1Lave/Igk-J^tm1.1Lave Tg(BCL2)22Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	abnormal B cell differentiation	J:179317
Igh-J^tm1Aigl/Igh-J⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell morphology	J:111543
	decreased B cell number	J:111543
	decreased B-1 B cell number	J:111543
Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (Not Specified)	decreased B cell number	J:79299
	decreased follicular B cell number	J:79299
	decreased marginal zone B cell number	J:79299
Igh-J^tm1Cgn/Igh^tm4Cgn Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd)	decreased mature B cell number	J:157297
Igh-J^tm1Cgn/Igh^tm11.1Cgn (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:113434
Igh-J^tm1Cgn/Igh-J⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:64285
Igh-J^tm1Cgn/Igh^tm1Leck (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin light chain V-J recombination	J:144033
Igh-J^tm1Cgn/Igh-J^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	absent mature B cells	J:64285
	arrested B cell differentiation	J:64285
Igh-J^tm1Dhu/Igh^tm3Tim (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:102308
Igh-J^tm1Dhu/Igh^tm3Tim (involves: 129 * C57BL/6)	decreased B cell number	J:102308
Igh-J^tm1Dhu/Igh^tm1Tim (involves: 129X1/SvJ * C57BL/6)	abnormal B cell differentiation	J:88410
	abnormal B cell morphology	J:87624
	abnormal immune system organ morphology	J:87624
	abnormal spleen marginal zone morphology	J:87624
	abnormal spleen morphology	J:87624
Igh-J^tm1Dhu/Igh^tm2Tim (involves: 129X1/SvJ * C57BL/6)	abnormal lymph node morphology	J:87624
	abnormal spleen morphology	J:87624
	decreased marginal zone B cell number	J:87624
Igh-J^tm1Dhu/Igh-J⁺ Il2^tm1Hor/Il2^tm1Hor (involves: 129/Sv * C57BL/6)	enlarged mesenteric lymph nodes	J:29999
Igh-J^tm1Dhu/Igh-J^{tm1(VDJ-17.2.25)Wabl} Igk^tm1Dhu/Igk^tm1Dhu (Not Specified)	abnormal B cell differentiation	J:33628
	abnormal immature B cell morphology	J:89757
Igh-J^tm1Dhu/Igh-J^tm1Dhu Il2^tm1Hor/Il2^tm1Hor (involves: 129/Sv * C57BL/6)	enlarged mesenteric lymph nodes	J:29999
Igh-J^tm1Dim/Igh-J⁺ Igk-J^tm1Dim/Igk-J⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal B cell differentiation	J:107241
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell number	J:113083
	absent B cells	J:70038
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv (involves: 129P2/OlaHsd)	absent mature B cells	J:137738
	arrested B cell differentiation	J:137738
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv (involves: 129P2/OlaHsd)	absent B cells	J:23827
	absent mature B cells	J:137738, J:70620
	arrested B cell differentiation	J:137738, J:23827
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH1)2BJkbv/0 Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:23827
	increased mature B cell number	J:23827
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH1)2BJkbv/0 Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	decreased pre-B cell number	J:137738
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	decreased pre-B cell number	J:137738
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	decreased pre-B cell number	J:137738
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH2)J9.2Jkbv/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell morphology	J:70620
	abnormal immunoglobulin heavy chain V(D)J recombination	J:70620
	abnormal immunoglobulin light chain V-J recombination	J:70620
	increased mature B cell number	J:70620
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH2)J9.2Jkbv/0 Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv (involves: 129P2/OlaHsd)	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH2BM)7Amgn/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	decreased B cell number	J:139792
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGH@yH2CM)2Amgn/0 Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	decreased B cell number	J:139792
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@*)SALed/0 (involves: 129P2/OlaHsd)	decreased mature B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@yH1)2BJkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:137738
	decreased mature B cell number	J:137738
	decreased pre-B cell number	J:137738
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@yH1)2BJkbv/0 Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:23827
	increased late pro-B cell number	J:23827
	increased mature B cell number	J:23827
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	decreased pre-B cell number	J:137738
	increased late pro-B cell number	J:137738
Igh-J^tm1Jkbv/Igh-J^tm1Jkbv Tg(IGH@yH2)J9.2Jkbv/0 (involves: 129P2/OlaHsd)	decreased mature B cell number	J:137738
Igh-J^tm1Khyk/Igh-J⁺ (CB17.129X1-Igh-J^tm1Khyk)	increased B-1 B cell number	J:109979
Igh-J^tm1Mcdl/Igh-J^tm1Mcdl Igk-J^tm1Mcdl/Igk-J^tm1Mcdl Rag1^tm1Mom/Rag1^tm1Mom Tg(DO11.10)10Dlo/? (involves: 129S/Sv * BALB/c * C3H * C57BL/6)	abnormal spleen germinal center morphology	J:100072
	abnormal T cell differentiation	J:100072
Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (involves: 129P2/OlaHsd BALB/c * C57BL/6)	abnormal B cell receptor editing	J:126940
Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (involves: 129P2/OlaHsd BALB/c)	abnormal B cell receptor editing	J:131138
	abnormal marginal zone B cell morphology	J:131138
Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (B6.129P2-Igh-J^{tm2(3H9-VDJ)Mwg})	decreased B cell number	J:142389
	increased marginal zone B cell number	J:142389
	spleen hypoplasia	J:142389
Igh-J^{tm2.1(4E10)Lave}/Igh-J^{tm2.1(4E10)Lave} (involves: C57BL/6)	arrested B cell differentiation	J:205708
	decreased B-1a cell number	J:205708
Igh-J^{tm2.1(4E10)Lave}/Igh-J^{tm2.1(4E10)Lave} Igk-J^{tm2.1(4E10)Lave}/Igk-J^{tm2.1(4E10)Lave} (involves: C57BL/6)	abnormal B cell differentiation	J:205708
	arrested B cell differentiation	J:205708
	decreased immature B cell number	J:205708
	decreased mature B cell number	J:205708
Igh-J^{tm3(3H9-VDJ)Mwg}/Igh-J^{tm3(3H9-VDJ)Mwg} (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal B cell receptor editing	J:126940
Igh-J^{tm3.1(48d)Lave}/Igh-J^{tm3.1(48d)Lave} (involves: C57BL/6)	decreased B-1a cell number	J:205708
Igh-V^{tm1(Igh-Vx24)Hmb}/Igh-V^{tm1(Igh-Vx24)Hmb} (involves: 129/Sv * C57BL/6)	increased T cell derived lymphoma incidence	J:54380
Igh^deltaD/Igh⁺ (involves: C57BL/6 * DBA/2)	abnormal B cell differentiation	J:95981
Igh^deltaD/Igh⁺ (involves: C57BL/6 * DBA/2)	decreased B cell number	J:95981
Igh^deltaD/Igh^deltaD (involves: C57BL/6 * DBA/2)	abnormal B cell differentiation	J:95981
	abnormal spleen morphology	J:95981
	arrested B cell differentiation	J:95981
	decreased B cell number	J:95981
	decreased follicular B cell number	J:95981
	increased marginal zone B cell number	J:95981
Igh^deltaD/Igh^tm11.1Cgn (involves: C57BL/6 * DBA/2)	abnormal B cell differentiation	J:113434
Igh^tm1(Myc)Janz/Igh⁺ (involves: 129X1/SvJ * C57BL/6)	enlarged lymph nodes	J:96785
	enlarged spleen	J:96785
	lymphoid hyperplasia	J:96785
Igh^tm1(Myc)Janz/Igh⁺ Mdm4^tm1.1Wahl/Mdm4^tm1.1Wahl (involves: 129S/Sv * C57BL/6)	enlarged lymph nodes	J:150341
	enlarged spleen	J:150341
Igh^tm1(PAX5)Mbu/Igh⁺ (B6.Cg-Igh^tm1(PAX5)Mbu)	abnormal lymph node morphology	J:118111
	abnormal spleen morphology	J:118111
	abnormal T cell differentiation	J:118111
	abnormal thymus morphology	J:118111
	decreased double-negative T cell number	J:118111
	decreased double-positive T cell number	J:118111
	enlarged lymph nodes	J:118111
	enlarged spleen	J:118111
	enlarged thymus	J:118111
	increased pro-B cell number	J:118111
	increased T cell derived lymphoma incidence	J:118111
	thymus hypoplasia	J:118111
Igh^tm1(PAX5)Mbu/Igh⁺ Pax5^tm1Mbu/Pax5^tm1Mbu (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)	abnormal B cell differentiation	J:118111
	decreased B cell number	J:118111
Igh^tm1(PAX5)Mbu/Igh^tm1(PAX5)Mbu (B6.Cg-Igh^tm1(PAX5)Mbu)	abnormal lymph node morphology	J:118111
	abnormal spleen morphology	J:118111
	abnormal T cell differentiation	J:118111
	abnormal thymus morphology	J:118111
	decreased double-negative T cell number	J:118111
	decreased double-positive T cell number	J:118111
	enlarged lymph nodes	J:118111
	enlarged spleen	J:118111
	enlarged thymus	J:118111
	increased pro-B cell number	J:118111
	increased T cell derived lymphoma incidence	J:118111
	thymus hypoplasia	J:118111
Igh^{tm1(VH558)Mss}/Igh⁺ (involves: FVB/N)	abnormal B cell differentiation	J:130421
Igh^{tm1(VH558)Mss}/Igh^{tm1(VH558)Mss} (involves: FVB/N)	abnormal B cell differentiation	J:130421
Igh^{tm1.1(b12)Nemz}/Igh^{tm1.1(b12)Nemz} (involves: C57BL/6N * FVB/N)	decreased immature B cell number	J:205766
	increased B cell number	J:205766
Igh^{tm1.1(b12)Nemz}/Igh^{tm1.1(b12)Nemz} Igk^{tm1.1(b12)Nemz}/Igk^{tm1.1(b12)Nemz} (involves: C57BL/6N * C57BL/6NTac * FVB/N)	decreased immature B cell number	J:205766
	increased B cell number	J:205766
Igh^{tm1.1(Rr361-HBB)Aak}/Igh^{tm1.1(Rr361-HBB)Aak} (129.129S2(Cg)-Igh^{tm1.1(Rr361-HBB)Aak})	abnormal class switch recombination	J:333279
Igh^{tm1.1(Tag)Rwhe}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:150315
	enlarged spleen	J:150315
	increased B cell number	J:150315
	lymph node hyperplasia	J:150315
Igh^tm1.1Hmj/Igh^tm1.1Hmj (involves: 129S6/SvEvTac * C57BL/6J * FVB/N)	abnormal B cell differentiation	J:140486
	abnormal immunoglobulin heavy chain V(D)J recombination	J:140486
	decreased mature B cell number	J:140486
	spleen hypoplasia	J:140486
Igh^tm1.1Hws/Igh^tm1.1Hws (BALB/cJ-Igh^tm1.1Hws)	decreased immature B cell number	J:119391
	decreased pre-B cell number	J:119391
	increased late pro-B cell number	J:119391
Igh^tm1.1Hws/Igh^tm1.1Hws (involves: BALB/c)	decreased immature B cell number	J:142069
	decreased late pro-B cell number	J:142069
	increased early pro-B cell number	J:142069
Igh^tm1.1Lnit/Igh⁺ (involves: BALB/c * C57BL/6)	abnormal B cell differentiation	J:119484
Igh^tm1.1Rsky/Igh^tm1.1Rsky (BALB/c-Igh^tm1.1Rsky)	abnormal class switch recombination	J:125719
Igh^tm1.1Twin/Igh⁺ (involves: 129 * 129S4/SvJae * C57BL/6)	decreased pre-B cell number	J:174233
Igh^tm1.1Twin/Igh⁺ (involves: 129 * 129S4/SvJae * C57BL/6)	increased pro-B cell number	J:174233
Igh^tm1.1Twin/Igh^tm1.1Twin (involves: 129 * 129S4/SvJae * C57BL/6)	abnormal B cell differentiation	J:174233
	abnormal B cell morphology	J:174233
	abnormal B cell number	J:174233
	abnormal marginal zone B cell morphology	J:174233
	absent plasma cells	J:174233
	decreased B cell number	J:174233
	decreased B-1a cell number	J:174233
	decreased follicular B cell number	J:174233
	decreased immature B cell number	J:174233
	decreased mature B cell number	J:174233
	decreased transitional stage T2 B cell number	J:174233
Igh^tm1.1Twin/Igh^tm1.1Twin Plcg2^Ali5/Plcg2⁺ (involves: 129 * 129S4/SvJae * C3HeB/FeJ * C57BL/6)	increased B-1a cell number	J:174233
Igh^tm1.1Vmd/Igh⁺ (involves: C57BL/6)	abnormal class switch recombination	J:201147
Igh^tm1.1Vmd/Igh^tm1.1Vmd (involves: C57BL/6)	abnormal class switch recombination	J:201147
Igh^tm1.2Rsky/Igh⁺ Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (involves: BALB/c * C57BL/6)	decreased mature B cell number	J:125719
Igh^tm1.2Rsky/Igh^tm1.2Rsky (BALB/c-Igh^tm1.2Rsky)	abnormal B cell morphology	J:125719
	abnormal mature B cell morphology	J:125719
	decreased B-1a cell number	J:125719
	decreased pre-B cell number	J:125719
	decreased transitional stage B cell number	J:125719
	increased marginal zone B cell number	J:125719
	increased pro-B cell number	J:125719
Igh^tm1.2Rsky/Igh^tm1.2Rsky Tg(CD19-cre/ERT2)1Cgn/? (involves: BALB/c)	abnormal class switch recombination	J:125719
Igh^tm1Aak/Igh^tm1Aak (Not Specified)	abnormal B cell differentiation	J:158402
	decreased B cell number	J:158402
	decreased pre-B cell number	J:158402
	increased pro-B cell number	J:158402
Igh^tm1Cgn/Igh⁺ (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:79556
Igh^tm1Cgn/Igh^tm2Cgn (involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)	abnormal B cell differentiation	J:79556
Igh^tm1Cog/Igh^tm1Cog (involves: 129S2/SvPas * C57BL/6)	abnormal immunoglobulin heavy chain V(D)J recombination	J:80654
	absent B cells	J:80654
	arrested B cell differentiation	J:80654
Igh^tm1Kplm/Igh⁺ (involves: A/WySnJ * BALB/c)	abnormal B-1 B cell morphology	J:115788
Igh^tm1Kplm/Igh⁺ (Not Specified)	abnormal B cell differentiation	J:115292
Igh^tm1Kplm/Igh⁺ (Not Specified)	increased B cell number	J:115292
Igh^tm1Kplm/Igh⁺ Tg(Igk-V4CH27)1-2Shc/0 (involves: C57BL/6 * SJL)	increased B cell number	J:115292
Igh^tm1Kplm/Igh^tm3Cgn (involves: C57BL/6)	abnormal B cell differentiation	J:115292
Igh^tm1Kplm/Igh^tm3Cgn (involves: C57BL/6)	abnormal B cell number	J:115292
Igh^tm1Kplm/Igh^tm4Cgn (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:115292
	abnormal B cell number	J:115292
	abnormal B-1 B cell morphology	J:115292
Igh^tm1Kplm/Igh^tm4Cgn Tg(Igk-V4CH27)1-2Shc/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	increased B cell number	J:115292
Igh^tm1Ktom/Igh^tm1Ktom (involves: ICR)	absent mature B cells	J:178635
Igh^tm1Leck/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:144033
	abnormal B-1a B cell morphology	J:144033
	abnormal immature B cell morphology	J:144033
	abnormal immunoglobulin light chain V-J recombination	J:144033
	abnormal mature B cell morphology	J:144033
Igh^tm1Leck/Igh^tm1Leck (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:144033
Igh^tm1Mnz/Igh^tm1Mnz Dis3^tm1.1Uba/Dis3^tm1.1Uba Aicda^tm1(cre)Uba/Aicda⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal somatic hypermutation frequency	J:302856
Igh^tm1Rbr/Igh⁺ (C57BL/6-Igh^tm1Rbr)	abnormal B cell morphology	J:132538
Igh^tm1Rbr/Igh⁺ Tg(IgkHyHEL10)1Rbr/0 (involves: C57BL/6)	abnormal B cell morphology	J:132538
	abnormal B-2 B cell morphology	J:132538
	increased immature B cell number	J:132538
Igh^tm1Rbr/Igh⁺ Tg(IgkHyHEL10)1Rbr/0 Tg(ML5sHEL)5Ccg/0 (involves: C57BL/6 * C57BL/6JSfd)	abnormal B cell morphology	J:132538
	decreased follicular B cell number	J:132538
	decreased marginal zone B cell number	J:132538
	increased immature B cell number	J:132538
Igh^{tm2.1(4E10)Nemz}/Igh^{tm2.1(4E10)Nemz} Igk^{tm2.1(4E10)Nemz}/Igk^{tm2.1(4E10)Nemz} (involves: C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N)	decreased B cell number	J:101977
Igh^{tm2.1(Tag)Rwhe}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:150315
	enlarged spleen	J:150315
	increased B cell number	J:150315
	lymph node hyperplasia	J:150315
Igh^tm2.1Fwa/Igh^tm2.1Fwa (involves: 129S/SvEv * C57BL/6)	abnormal class switch recombination	J:161437
	abnormal somatic hypermutation frequency	J:161437
	decreased mature B cell number	J:161437
Igh^tm2.1Hws/Igh^tm2.1Hws (involves: BALB/c * C57BL/6NCrl * DBA/2NCrl)	decreased B cell number	J:124421
	decreased B-1a cell number	J:124421
	decreased B-1b cell number	J:124421
	decreased follicular B cell number	J:124421
	decreased pre-B cell number	J:124421
	decreased transitional stage B cell number	J:124421
	increased early pro-B cell number	J:124421
	increased marginal zone B cell number	J:124421
Igh^tm2.1Hws/Igh^tm2.1Hws (involves: BALB/c)	abnormal B cell differentiation	J:142069
	decreased B-1a cell number	J:142069
	decreased follicular B cell number	J:142069
	decreased immature B cell number	J:142069
	decreased late pro-B cell number	J:142069
	decreased mature B cell number	J:142069
	decreased transitional stage B cell number	J:142069
	increased early pro-B cell number	J:142069
	increased marginal zone B cell number	J:142069
Igh^tm2Cgn/Igh⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)	abnormal B cell differentiation	J:79556
Igh^tm2Cgn/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal immunoglobulin light chain V-J recombination	J:144033
Igh^tm2Cgn/Igh⁺ Igk^tm1Rsky/Igk⁺ (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))	abnormal B cell differentiation	J:111431
	absent pre-B cells	J:111431
Igh^tm2Cgn/Igh⁺ Igk^tm2Rsky/Igk⁺ (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:150435
Igh^tm2Cgn/Igh⁺ Igk^tm2Rsky/Igk⁺ Prkdc^scid/Prkdc^scid (involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)	abnormal class switch recombination	J:150435
Igh^tm2Cgn/Igh⁺ Xrcc6^tm1Fwa/Xrcc6^tm1Fwa (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal B cell differentiation	J:44361
Igh^tm2Cgn/Igh^tm2Cgn Igk^tm1Rsky/Igk^tm1Rsky Lig4^tm1Fwa/Lig4^tm1Fwa Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)	abnormal class switch recombination	J:126758
Igh^tm2Cgn/Igh^tm2Cgn Igk^tm1Rsky/Igk^tm1Rsky Trp53^tm1Tyj/Trp53^tm1Tyj Xrcc4^tm1Fwa/Xrcc4^tm1Fwa (involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)	abnormal class switch recombination	J:126758
Igh^tm2Cgn/Igh^tm3Cgn (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * C57BL/Ka)	abnormal B cell differentiation	J:79556
Igh^tm2Cgn/Igh^tm4.1Fwa (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal immunoglobulin V(D)J recombination	J:176649
Igh^tm2Emo/Igh^tm2Emo (involves: 129S1/Sv * C57BL/6 * FVB/N)	abnormal B cell differentiation	J:108098
	absent pre-B cells	J:108098
Igh^tm2Rsky/Igh⁺ Igk^tm1Rsky/Igk⁺ (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))	abnormal B cell differentiation	J:111431
Igh^tm2Rsky/Igh⁺ Igk^tm2Rsky/Igk⁺ (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))	abnormal B cell differentiation	J:111431
Igh^tm3.1Tim/Igh⁺ (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:102308
Igh^tm3.1Tim/Igh⁺ (involves: 129 * C57BL/6)	abnormal spleen B cell follicle morphology	J:102308
Igh^tm3Cgn/Igh⁺ (involves: C57BL/6)	abnormal B cell differentiation	J:79556, J:115292
Igh^tm3Cgn/Igh^tm3Cgn (involves: C57BL/6)	decreased immature B cell number	J:76117
Igh^tm3Hws/Igh^tm3Hws (BALB/c-Igh^tm3Hws)	abnormal immunoglobulin heavy chain V(D)J recombination	J:142068
Igh^tm3Hws/Igh^tm3Hws (involves: BALB/c)	decreased B cell number	J:142069
	decreased follicular B cell number	J:142069
	decreased immature B cell number	J:142069
	decreased late pro-B cell number	J:142069
	decreased mature B cell number	J:142069
	decreased transitional stage B cell number	J:142069
	spleen hypoplasia	J:142069
Igh^tm3Tim/Igh⁺ (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:102308
Igh^tm3Tim/Igh⁺ (involves: 129 * C57BL/6)	abnormal spleen B cell follicle morphology	J:102308
Igh^tm4.1Cog/Igh^tm4.1Cog (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal class switch recombination	J:184094
Igh^tm4.1Fwa/Igh⁺ (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:176649
Igh^tm4.1Fwa/Igh⁺ (involves: 129S6/SvEvTac)	abnormal immunoglobulin V(D)J recombination	J:176649
Igh^tm4.1Fwa/Igh^tm4.1Fwa (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:176649
Igh^tm4.1Fwa/Igh^tm4.1Fwa (involves: 129S6/SvEvTac)	abnormal immunoglobulin V(D)J recombination	J:176649
Igh^tm4Cgn/Igh⁺ (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:115292
Igh^tm4Cog/Igh^tm4Cog (involves: 129S2/SvPas * C57BL/6)	absent Peyer's patches	J:109988
	absent spleen germinal center	J:109988
	small spleen	J:109988
Igh^tm5.1Cgn/Igh^tm5.1Cgn (BALB/c-Igh^tm5.1Cgn)	abnormal B cell differentiation	J:88472
	abnormal gut-associated lymphoid tissue morphology	J:88472
	abnormal lymph node germinal center morphology	J:88472
	abnormal mature B cell morphology	J:88472
	abnormal Peyer's patch germinal center morphology	J:88472
	absent B-1 B cells	J:88472
	absent B-1a cells	J:88472
	absent B-1b cells	J:88472
	absent spleen germinal center	J:88472
	decreased B cell number	J:88472
	decreased immature B cell number	J:88472
	decreased marginal zone B cell number	J:88472
	increased pro-B cell number	J:88472
Igh^tm5.1Fwa/Igh⁺ (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:176649
Igh^tm5.1Fwa/Igh⁺ (involves: 129S6/SvEvTac)	decreased pre-B cell number	J:176649
Igh^tm5.1Fwa/Igh^tm5.1Fwa (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:176649
Igh^tm5.1Fwa/Igh^tm5.1Fwa (involves: 129S6/SvEvTac)	decreased pre-B cell number	J:176649
Igh^tm5Cgn/Igh^tm5Cgn (involves: BALB/c)	absent B cells	J:88472
Igh^tm5Cgn/Igh^tm5Cgn (involves: BALB/c)	arrested B cell differentiation	J:88472
Igh^tm5Cgn/Igh^tm5Cgn Tg(CD19-cre/ERT2)1Cgn/0 (C.Cg-Igh^tm5Cgn Tg(CD19-cre/ERT2)1Cgn)	abnormal B cell differentiation	J:88472
	abnormal mature B cell morphology	J:88472
	abnormal Peyer's patch germinal center morphology	J:88472
	absent follicular B cells	J:88472
	absent marginal zone B cells	J:88472
	increased B cell number	J:88472
	increased pro-B cell number	J:88472
Igh^{tm7(VHB1-8)Cgn}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:48835
Igh^{tm8(VHB1-8)Cgn}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:48835
Igh^{tm9(VHB1-8)Cgn}/Igh⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:48835
Igh^tm11.1Cgn/Igh^tm11.1Cgn (Not Specified)	abnormal B cell differentiation	J:113434
	decreased B cell number	J:113434
	decreased immature B cell number	J:113434
	decreased mature B cell number	J:113434
	increased pro-B cell number	J:113434
Igh^tm12Cgn/Igh^tm12Cgn (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:66031
Igha^tm1(Myc)Janz/Igha⁺ (involves: 129S1/Sv * C57BL/6)	increased plasma cell number	J:90901
Igha^tm1(Myc)Janz/Igha⁺ Tg(Igk-V21-Bax)1967Bvn/0 (involves: 129S1/Sv * C57BL/6 * FVB/N)	abnormal plasma cell morphology	J:90901
	enlarged spleen	J:90901
	increased plasma cell number	J:90901
Igha^tm1(Myc)Janz/Igha⁺ Tg(Tnfsf13b)1Fma/0 (involves: 129S1/Sv * C57BL/6 * DBA/2J)	enlarged spleen	J:166158
	increased B cell number	J:166158
	increased lymphocyte cell number	J:166158
	increased mature B cell number	J:166158
	increased spleen white pulp amount	J:166158
Igha^tm2Grh/Igha^tm2Grh (involves: 129S7/SvEvBrd * C57BL/6)	abnormal class switch recombination	J:72521
Ighd^M1Btlr/Ighd⁺ (C57BL/6J-Ighd^M1Btlr)	decreased B cell number	J:255202
Ighd^M1Btlr/Ighd^M1Btlr (C57BL/6J-Ighd^M1Btlr)	decreased B cell number	J:255202
Ighd^m2Btlr/Ighd⁺ (C57BL/6J-Ighd^m2Btlr)	decreased B cell number	J:255203
Ighd^m2Btlr/Ighd^m2Btlr (C57BL/6J-Ighd^m2Btlr)	decreased B cell number	J:255203
Ighd^tm1Lam/Ighd⁺ (involves: 129S2/SvPas * C57BL/6)	decreased B cell number	J:111020
Ighd^tm1Lam/Ighd^tm1Lam (involves: 129S2/SvPas * C57BL/6)	abnormal leukopoiesis	J:111020
Ighg1^em1Wliu/Ighg1^em1Wliu (C57BL/6-Ighg1^em1Wliu)	abnormal plasma cell differentiation	J:266937
	increased germinal center B cell number	J:266937
	increased plasma cell number	J:266937
Ighg1^tm1(cre)Cgn/0 Mef2b^tm1.1Rdf/Mef2b⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased germinal center B cell number	J:265465
Ighg1^tm1(cre)Cgn/0 Mef2b^tm1.1Rdf/Mef2b^tm1.1Rdf (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:265465
	decreased germinal center B cell number	J:265465
Ighg1^tm1(cre)Cgn/0 Mef2b^tm1.1Rdf/Mef2b^tm1.1Rdf Mef2c^tm2Eno/Mef2c^tm2Eno (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	decreased germinal center B cell number	J:265465
Ighg1^tm1(cre)Cgn/0 Mef2b^tm2Rdf/Mef2b⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:265465
	increased germinal center B cell number	J:265465
Ighg1^tm1(cre)Cgn/0 Mef2b^tm2Rdf/Mef2b^tm1.1Rdf (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:265465
	increased germinal center B cell number	J:265465
Ighg1^tm1(cre)Cgn/0 Mef2c^tm2Eno/Mef2c^tm2Eno (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	decreased germinal center B cell number	J:265465
Ighg1^tm1(cre)Cgn/Ighg1⁺ Irf4^tm1Rdf/Irf4^tm1.1Rdf (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal class switch recombination	J:112643
	abnormal memory B cell morphology	J:112643
	absent plasma cells	J:112643
Ighg1^tm1(cre)Cgn/Ighg1⁺ Myd88^em1.1Rsky/Myd88⁺ (involves: 129P2/OlaHsd * C57BL/6NTac)	abnormal somatic hypermutation frequency	J:308792
	abnormal splenic cell ratio	J:308792
	increased germinal center B cell number	J:308792
	increased plasma cell number	J:308792
Ighg1^tm1(cre)Cgn/Ighg1⁺ Tbl1xr1^tm1.1Meln/Tbl1xr1⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell differentiation	J:292118
	abnormal spleen morphology	J:292118
Ighg1^tm1(cre)Cgn/Ighg1⁺ Tbl1xr1^{tm1c(EUCOMM)Hmgu}/Tbl1xr1^{tm1c(EUCOMM)Hmgu} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell differentiation	J:292118
	abnormal spleen morphology	J:292118
Ighg1^tm1Ksho/Ighg1^tm1Ksho (involves: 129P2/OlaHsd * C57BL/6)	absent memory B cells	J:39568
Ighg1^tm2Cgn/Ighg1⁺ ((C57BL/6 x 129P2/OlaHsd)F1)	abnormal class switch recombination	J:146428
Ighg1^tm3Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal class switch recombination	J:166887
Ighg2c^em1Wliu/Ighg2c^em1Wliu (C57BL/6J-Ighg2c^em1Wliu)	abnormal plasma cell differentiation	J:322180
	increased CD8-positive, alpha-beta T cell number	J:322180
	increased CD103-positive CD11b-low dendritic cell number	J:322180
	increased effector memory CD8-positive, alpha-beta T cell number	J:322180
	increased germinal center B cell number	J:322180
	increased memory B cell number	J:322180
Ighg2c^em2Wliu/Ighg2c^em2Wliu (C57BL/6J-Ighg2c^em2Wliu)	abnormal plasma cell differentiation	J:322180
	decreased germinal center B cell number	J:322180
	decreased memory B cell number	J:322180
Ighm^tm1(Bcl6)Rdf/? (involves: 129/Sv * C57BL/6)	abnormal spleen B cell follicle morphology	J:98937
	abnormal spleen morphology	J:98937
	decreased plasma cell number	J:98937
	enlarged spleen	J:98937
	increased spleen germinal center number	J:98937
	increased spleen white pulp amount	J:98937
Ighm^{tm1.1(IGH-2)Cog}/Ighm^{tm1.1(IGH-2)Cog} (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal B cell differentiation	J:157575
	abnormal plasma cell differentiation	J:157575
	decreased B cell number	J:157575
	decreased B-1 B cell number	J:157575
	decreased follicular B cell number	J:157575
	decreased marginal zone B cell number	J:157575
	decreased mature B cell number	J:157575
	decreased Peyer's patch number	J:157575
	decreased pre-B cell number	J:157575
	decreased transitional stage B cell number	J:157575
	increased B cell number	J:157575
	increased plasma cell number	J:157575
	increased pro-B cell number	J:157575
	small lymph nodes	J:157575
	small Peyer's patches	J:157575
Ighm^tm1.1Aak/Ighm^tm1.1Aak (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:171251
	decreased B cell number	J:171251
	decreased pre-B cell number	J:171251
	increased pro-B cell number	J:171251
Ighm^tm1Cgn/Igh^tm3Tim (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:102308
Ighm^tm1Cgn/Igh^tm3Tim (involves: 129 * C57BL/6)	decreased B cell number	J:102308
Ighm^tm1Cgn/Ighm⁺ (involves: 129S2/SvPas * C57BL/6)	arrested B cell differentiation	J:70398
Ighm^tm1Cgn/Ighm⁺ Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * C57BL/6 * CF-1)	thymus hypoplasia	J:99033
Ighm^tm1Cgn/Ighm^tm1Cgn (involves: 129S2/SvPas * C57BL/6)	abnormal B cell differentiation	J:64298, J:70398
	abnormal lymphatic vessel morphology	J:119344
	absent immature B cells	J:64298
	absent mature B cells	J:64298
	arrested B cell differentiation	J:64298
Ighm^tm1Cgn/Ighm^tm1Cgn (B6.129S2-Ighm^tm1Cgn/J)	abnormal spleen morphology	J:73100
	arrested B cell differentiation	J:119584
	decreased CD4-positive, alpha-beta T cell number	J:73100, J:118565
	decreased CD8-positive, alpha-beta T cell number	J:73100
	decreased dendritic cell number	J:73100
	decreased spleen weight	J:73100
Ighm^tm1Cgn/Ighm^tm1Cgn (involves: 129S2/SvPas)	abnormal metallophilic macrophage morphology	J:88620
	abnormal spleen marginal sinus morphology	J:88620
	abnormal spleen marginal zone macrophage morphology	J:88620
	absent follicular dendritic cells	J:88620
	absent mature B cells	J:118453
	arrested B cell differentiation	J:118453
	increased osteoclast cell number	J:157619
Ighm^tm1Cgn/Ighm^tm1Cgn (B6.129S2-Ighm^tm1Cgn)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:126867
Ighm^tm1Cgn/Ighm^tm1Cgn (NOD.129S2-Ighm^tm1Cgn/DvsJ)	abnormal T cell number	J:80859
	absent B cells	J:80859
	decreased spleen B cell follicle number	J:80859
Ighm^tm1Cgn/Ighm^tm1Cgn Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg (NOD.Cg-Ighm^tm1Cgn Tg(IghelMD4)4Ccg/DvsJ)	abnormal mature B cell morphology	J:80859
	decreased CD8-positive, alpha-beta T cell number	J:80859
Ighm^tm1Cgn/Ighm^tm1Cgn Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * C57BL/6 * CF-1)	thymus hypoplasia	J:99033
Ighm^tm1Che/Ighm^tm1Che (involves: 129S4/SvJae * C57BL/6)	abnormal metallophilic macrophage morphology	J:125338
	abnormal spleen B cell follicle morphology	J:125338
	abnormal spleen germinal center morphology	J:47425
	abnormal spleen marginal zone morphology	J:125338
	abnormal spleen morphology	J:125338
	abnormal spleen periarteriolar lymphoid sheath morphology	J:125338
	abnormal spleen white pulp morphology	J:125338
	increased B-1 B cell number	J:47425
Ighm^tm1Msn/Ighm^tm1Msn (involves: 129S/SvEv)	abnormal B-1a B cell morphology	J:49405
	abnormal immature B cell morphology	J:49405
	abnormal mature B cell morphology	J:49405
Ighm^tm1Msn/Ighm^tm1Msn (B6.129S-Ighm^tm1Msn)	abnormal B-1a B cell morphology	J:80656
	abnormal splenic cell ratio	J:80656
	decreased follicular B cell number	J:80656
	increased marginal zone B cell number	J:80656
Ighm^tm1Msn/Ighm^tm1Msn Tg(Igh-6)1Msn/? (B6.129S-Ighm^tm1Msn)	abnormal B-1a B cell morphology	J:80656
	abnormal splenic cell ratio	J:80656
	decreased follicular B cell number	J:80656
	increased marginal zone B cell number	J:80656
Ighm^tm1Sls/Ighm^tm1Sls (Not Specified)	abnormal class switch recombination	J:99465
Ighm^tm2.1Bgmn/Ighm^tm2.1Bgmn (involves: 129/Sv * C57BL/6 * CBA)	absent mature B cells	J:118453
	arrested B cell differentiation	J:118453
Ighm^tm3Bgmn/Ighm^tm3Bgmn (involves: 129)	decreased immature B cell number	J:131633
	decreased mature B cell number	J:131633
	increased B-1 B cell number	J:131633
Ighm^tm3Bgmn/Ighm^tm3Bgmn Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm2.1Bgmn/Igl^tm2.1Bgmn (involves: 129P2/OlaHsd * 129/Sv)	abnormal B cell differentiation	J:130864
Ighm^tm4Bgmn/Ighm^tm4Bgmn (involves: 129)	decreased immature B cell number	J:131633
	decreased mature B cell number	J:131633
	increased B-1 B cell number	J:131633
Igk-J^tm1Cog/Igk-J^tm1.1Cog (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell number	J:110100
	abnormal plasma cell morphology	J:110100
	decreased B cell number	J:110100
	decreased naive B cell number	J:110100
	increased plasma cell number	J:110100
	increased pre-B cell number	J:110100
Igk-J^tm1Cog/Igk-J^tm1Cog (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:110100
Igk^tm1Dhu/Igk^tm1Dhu Iglc1^tm1.1Ust/Iglc1⁺ (involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)	decreased B cell number	J:68144
Igk^tm1Dhu/Igk^tm1Dhu Iglc1^tm1.1Ust/Iglc1^tm1.1Ust (involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)	decreased B cell number	J:68144
Igk^tm1Dhu/Igk^tm1Dhu Iglc1^tm1Ust/Iglc1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B cell differentiation	J:68144
	increased B cell number	J:68144
Igk^tm1Dhu/Igk^tm1Dhu Iglc1^tm1Ust/Iglc1^tm1Ust (involves: 129S7/SvEvBrd * C57BL/6)	increased B cell number	J:68144
Igk^tm1Dhu/Igk^tm1Dhu Iglc1^tm2Ust/Iglc1^tm2Ust (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal B cell differentiation	J:74717
	decreased B cell number	J:74717
	decreased immature B cell number	J:74717
	decreased marginal zone B cell number	J:74717
	decreased mature B cell number	J:74717
	decreased transitional stage T1 B cell number	J:74717
	decreased transitional stage T2 B cell number	J:74717
Igk^tm1Dhu/Igk^tm1Dhu Iglc1^tm2Ust/Iglc1^tm2Ust (involves: 129S7/SvEvBrd)	increased B-1a cell number	J:113218
Igk^tm1Dhu/Igk^tm1Dhu Tg(H2-Ea-HA)HACIIAjca/0 Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0 (C.Cg-Igk^tm1Dhu Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)	abnormal CD4-positive, alpha beta T cell morphology	J:209872
	abnormal lymph node morphology	J:209872
	abnormal spleen morphology	J:209872
	absent B cells	J:209872
	increased CD4-positive, alpha-beta T cell number	J:209872
Igk^tm1Rsky/Igk⁺ Igll1^tm1Cgn/Igll1^tm1Cgn (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6)	abnormal B cell differentiation	J:35357
	decreased B cell number	J:35357
	decreased immature B cell number	J:35357
	decreased mature B cell number	J:35357
	decreased pre-B cell number	J:35357
Igk^tm2Ybgn/Igk^tm2Ybgn (Not Specified)	decreased pre-B cell number	J:123344
Igk^tm2Ybgn/Igk^tm2Ybgn (Not Specified)	increased immature B cell number	J:123344
Igkc^tm1(IGKC)Mnz/Igkc⁺ Igk-J^tm1(CD4*)Mss/Igk-J⁺ (involves: 129S4/SvJae)	abnormal immunoglobulin light chain V-J recombination	J:143876
Igkc^tm1(IGKC)Mnz/Igkc⁺ Rr158^tm1(Igh)Xu/Rr158⁺ (Not Specified)	abnormal immune system morphology	J:124407
	decreased B cell number	J:124407
Igkc^tm1Bgmn/Igkc^tm1Bgmn (involves: 129P2/OlaHsd)	abnormal B cell number	J:28868, J:118712
	abnormal Peyer's patch germinal center morphology	J:28868
	abnormal Peyer's patch morphology	J:28868
Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm1.1Bgmn/Igl^tm1.1Bgmn (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)	abnormal immature B cell morphology	J:118712
	absent B cells	J:118712
	absent B-1 B cells	J:118712
	absent B-2 B cells	J:118712
	decreased B cell number	J:118712
	spleen hypoplasia	J:118712
Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm1Bgmn/Igl^tm1Bgmn (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)	abnormal immature B cell morphology	J:118712
	absent B-1 B cells	J:118712
	absent B-2 B cells	J:118712
	absent mature B cells	J:118712
	decreased B cell number	J:118712
	spleen hypoplasia	J:118712
Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm2.1Bgmn/Igl^tm2.1Bgmn (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)	absent B cells	J:118712
	arrested B cell differentiation	J:118712
Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm2.1Bgmn/Igl^tm2.1Bgmn (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:130864
	abnormal immunoglobulin heavy chain V(D)J recombination	J:130864
	abnormal plasma cell morphology	J:130864
Igkc^tm1Bgmn/Igkc^tm1Bgmn Igl^tm2Bgmn/Igl^tm2Bgmn (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)	absent B cells	J:118712
	arrested B cell differentiation	J:118712
Igkc^tm1Cgn/Igkc⁺ (involves: C57BL/6)	increased mature B cell number	J:64287
Igkc^tm1Cgn/Igkc^tm1Cgn (involves: C57BL/6)	abnormal B cell differentiation	J:64287
	decreased mature B cell number	J:64287
	increased immature B cell number	J:64287
	increased mature B cell number	J:64287
	spleen hypoplasia	J:64287
Igkc^tm1Jkbv/Igkc^tm1Jkbv (Not Specified)	abnormal B cell differentiation	J:137738
	abnormal immunoglobulin light chain V-J recombination	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	increased pre-B cell number	J:137738
Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	increased pre-B cell number	J:137738
Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:137738
	decreased immature B cell number	J:137738
	decreased mature B cell number	J:137738
	increased pre-B cell number	J:137738
Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGK@yK2)J23.1Jkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:137738
Igkc^tm1Jkbv/Igkc^tm1Jkbv Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:137738
Igkc^tm2(IGKC)Cgn/Igkc^tm2(IGKC)Cgn (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:113008
Igkrs^tm1Nemz/Igkrs^tm1Nemz (B6.129-Igkrs^tm1Nemz)	abnormal immunoglobulin light chain V-J recombination	J:132125
	decreased immature B cell number	J:132125
	decreased mature B cell number	J:132125
Igkrs^tm1Nemz/Igkrs^tm1Nemz Tg(UBC-scFv)2Nemz/? (involves: 129 * C57BL/6 * DBA/2)	abnormal B cell clonal deletion	J:132125
	decreased immature B cell number	J:132125
	decreased mature B cell number	J:132125
Iglc1^tm1Ust/Iglc1^tm1Ust (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B cell number	J:68144
	increased lymphocyte cell number	J:68144
Iglc1^tm2Ust/Iglc1⁺ (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal immunoglobulin light chain V-J recombination	J:74717
Iglc1^tm2Ust/Iglc1^tm2Ust (involves: 129S7/SvEvBrd)	decreased B cell number	J:113218
Iglc1^tm2Ust/Iglc1^tm2Ust Ptpn6^me-v/Ptpn6^me-v (involves: 129S7/SvEvBrd * C57BL/6J)	decreased B cell number	J:113218
Igll1^tm1Cgn/Igll1^tm1Cgn (involves: 129S2/SvPas * C57BL/6)	abnormal B cell morphology	J:64284
	abnormal B-1 B cell number	J:64284
	abnormal lymphopoiesis	J:64284
	abnormal pre-B cell morphology	J:64284
	decreased B cell number	J:64284, J:35357
	increased pro-B cell number	J:64284
	spleen hypoplasia	J:64284
Igll1^tm1Cgn/Igll1^tm1Cgn Tg(Igk-V4CH27)1-2Shc/0 (involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)	abnormal B cell differentiation	J:35357
	decreased pre-B cell number	J:35357
Igll1^tm1Shim/Igll1^tm1Shim Vpreb1a^tm1Shim/Vpreb1a^tm1Shim Vpreb1b^tm1Shim/Vpreb1b^tm1Shim (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:76947
	decreased B cell number	J:76947
	decreased B-1a cell number	J:76947
	decreased immature B cell number	J:76947
	decreased mature B cell number	J:76947
	decreased pre-B cell number	J:76947
	increased late pro-B cell number	J:76947
Iglon5^em1(IMPC)Mbp/Iglon5^em1(IMPC)Mbp (C57BL/6NCrl-Iglon5^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Igs2^{em1(Alb-Golm1)Jdon}/Igs2⁺ (involves: C57BL/6N)	decreased CD8-positive, alpha-beta T cell number	J:306528
Iigp1c^{em1(IMPC)Hmgu}/Iigp1c^{em1(IMPC)Hmgu} (C57BL/6N-Iigp1c^{em1(IMPC)Hmgu}/Ieg)	abnormal lymph node morphology	J:211773
Ikbkb^em1Macc/Ikbkb⁺ (involves: C57BL/6NCrl)	abnormal effector T cell number	J:290616
	decreased B cell number	J:290616
	decreased CD4-positive, alpha-beta T cell number	J:290616
	decreased CD8-positive, alpha-beta T cell number	J:290616
	decreased memory B cell number	J:290616
	decreased T cell number	J:290616
	increased regulatory T cell number	J:290616
Ikbkb^em1Macc/Ikbkb^em1Macc (involves: C57BL/6NCrl)	abnormal effector T cell number	J:290616
	decreased B cell number	J:290616
	decreased CD4-positive, alpha-beta T cell number	J:290616
	decreased CD8-positive, alpha-beta T cell number	J:290616
	decreased memory B cell number	J:290616
	decreased T cell number	J:290616
	increased regulatory T cell number	J:290616
Ikbkb^em1Smoc/Ikbkb^em1Smoc (C57BL/6J-Ikbkb^em1Smoc)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:309163
Ikbkb^M1Btlr/Ikbkb⁺ (C57BL/6J-Ikbkb^M1Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:225271
Ikbkb^M1Btlr/Ikbkb^M1Btlr (C57BL/6J-Ikbkb^M1Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:225271
Ikbkb^M2Btlr/Ikbkb^M2Btlr (C57BL/6J-Ikbkb^M2Btlr)	decreased central memory CD4-positive, alpha-beta T cell number	J:274802
Ikbkb^tm1Cgn/Ikbkb^tm1.1Cgn Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:85810
	decreased CD8-positive, alpha-beta T cell number	J:85810
	decreased single-positive T cell number	J:85810
	decreased T cell number	J:85810
Ikbkb^tm1Cgn/Ikbkb^tm1Cgn Tg(Lck-cre)I57Jxm/0 (involves: C57BL/6 * ICR)	decreased CD4-positive, alpha-beta T cell number	J:85810
	decreased CD8-positive, alpha-beta T cell number	J:85810
Ikbkb^tm2Cgn/Ikbkb^tm2.1Cgn Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:85810
	decreased CD8-positive, alpha-beta T cell number	J:85810
Ikbkb^tm2Cgn/Ikbkb^tm2Cgn Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:85810
	decreased memory T cell number	J:85810
	decreased regulatory T cell number	J:85810
Ikbkg^m1Btlr/Y (C57BL/6J-Ikbkg^m1Btlr)	decreased regulatory T cell number	J:139558
Ikbkg^tm1.1Chtr/Y Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N * SJL)	decreased NK cell number	J:151485
	decreased NK T cell number	J:151485
Ikbkg^tm1.1Chtr/Ikbkg^tm1.1Chtr Tg(Alb1-cre)7Gsc/0 (involves: C57BL/6 * FVB/N * SJL)	decreased NK cell number	J:151485
	decreased NK T cell number	J:151485
Ikbkg^tm1.1Dwat/Ikbkg⁺ (B6.Cg-Ikbkg^tm1.1Dwat)	decreased B cell number	J:202106
Ikbkg^tm1.1Dwat/Ikbkg⁺ (B6.Cg-Ikbkg^tm1.1Dwat)	enlarged spleen	J:202106
Ikbkg^tm1.1Mpa/Y Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:85810
	decreased CD8-positive, alpha-beta T cell number	J:85810
	decreased single-positive T cell number	J:85810
	decreased T cell number	J:85810
Ikbkg^tm1.1Mpa/Ikbkg^tm1.1Mpa Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	abnormal B cell differentiation	J:113365
	decreased B cell number	J:113365
	decreased mature B cell number	J:113365
Ikbkg^tm1Mka/Ikbkg⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	small spleen	J:63054
	small thymus	J:63054
Ikzf1^m1Btlr/Ikzf1^m1Btlr (C57BL/6J-Ikzf1^m1Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:265249
	decreased CD8-positive, naive alpha-beta T cell number	J:265249
	increased B-1 B cell number	J:265249
	increased CD4-positive, alpha-beta T cell number	J:265249
	increased CD8-positive, alpha-beta T cell number	J:265249
	increased central memory CD4-positive, alpha-beta T cell number	J:265249
	increased central memory CD8 positive, alpha-beta T cell number	J:265249
	increased effector memory CD4-positive, alpha-beta T cell number	J:265249
	increased single-positive T cell number	J:265249
	increased T cell number	J:265249
Ikzf1^m2Btlr/Ikzf1^m2Btlr (C57BL/6J-Ikzf1^m2Btlr)	decreased B cell number	J:265250
	decreased CD4-positive, alpha-beta T cell number	J:265250
	decreased CD8-positive, naive alpha-beta T cell number	J:265250
	decreased single-positive T cell number	J:265250
	decreased T cell number	J:265250
	increased CD8-positive, alpha-beta T cell number	J:265250
	increased central memory CD4-positive, alpha-beta T cell number	J:265250
	increased central memory CD8 positive, alpha-beta T cell number	J:265250
	increased effector memory CD4-positive, alpha-beta T cell number	J:265250
	increased effector memory CD8-positive, alpha-beta T cell number	J:265250
	increased single-positive T cell number	J:265250
Ikzf1^m3Btlr/Ikzf1^m3Btlr (C57BL/6J-Ikzf1^m3Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265251
	increased B-1 B cell number	J:265251
	increased CD8-positive, alpha-beta T cell number	J:265251
	increased single-positive T cell number	J:265251
	increased T cell number	J:265251
Ikzf1^plstc/Ikzf1⁺ (C57BL/6JSfdAnu-Ikzf1^plstc)	abnormal B cell differentiation	J:84569
	abnormal lymphopoiesis	J:84569
	abnormal T cell differentiation	J:84569
	decreased double-negative T cell number	J:84569
	decreased double-positive T cell number	J:84569
	decreased mature B cell number	J:84569
	decreased pre-B cell number	J:84569
	decreased thymocyte number	J:84569
	increased pro-B cell number	J:84569
	increased T cell derived lymphoma incidence	J:84569
	myeloid hyperplasia	J:84569
Ikzf1^plstc/Ikzf1^plstc (C57BL/6JSfdAnu-Ikzf1^plstc)	abnormal granulocyte differentiation	J:84569
	abnormal lymphopoiesis	J:84569
	abnormal macrophage differentiation	J:84569
	abnormal myelopoiesis	J:84569
	absent pro-B cells	J:84569
	absent T cells	J:84569
	arrested B cell differentiation	J:84569
	decreased granulocyte number	J:84569
	increased macrophage cell number	J:84569
	thymus hypoplasia	J:84569
Ikzf1^tm1(Pax5)Mbu/Ikzf1⁺ Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6)	increased T cell derived lymphoma incidence	J:118111
Ikzf1^tm1(Pax5)Mbu/Ikzf1^tm1(Pax5)Mbu (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell number	J:80815
	abnormal dendritic cell morphology	J:80815
	abnormal T cell differentiation	J:80815
Ikzf1^tm1(Pax5)Mbu/Ikzf1^tm1(Pax5)Mbu Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal T cell differentiation	J:80815
	arrested T cell differentiation	J:80815
	increased B cell number	J:80815
	increased early pro-B cell number	J:80815
	thymus hypoplasia	J:80815
Ikzf1^{tm1.1(Pax5)Mbu}/Ikzf1⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:80815
	decreased double-positive T cell number	J:118111
	enlarged lymph nodes	J:118111
	enlarged spleen	J:118111
	enlarged thymus	J:118111
	increased B cell number	J:80815
	increased pro-B cell number	J:80815
	increased T cell derived lymphoma incidence	J:118111
	thymus hypoplasia	J:118111
Ikzf1^{tm1.1(Pax5)Mbu}/Ikzf1⁺ Tcf3^tm1Mbu/Tcf3^tm1Mbu Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca)	abnormal immunoglobulin heavy chain V(D)J recombination	J:137719
Ikzf1^tm1.1Smale/Ikzf1^tm1.1Smale (B6.Cg-Ikzf1^tm1.1Smale)	decreased B cell number	J:208211
	decreased B-1a cell number	J:208211
	decreased B-1b cell number	J:208211
	decreased DN1 thymic pro-T cell number	J:208211
	decreased immature B cell number	J:208211
	decreased mature B cell number	J:208211
	decreased pre-B cell number	J:208211
	thymus hypoplasia	J:208211
Ikzf1^tm1Kast/Ikzf1^tm1Kast (involves: 129S2/SvPas)	abnormal B cell differentiation	J:82813
	decreased B cell number	J:82813
	decreased B-1a cell number	J:82813
	decreased B-1b cell number	J:82813
	decreased spleen germinal center number	J:82813
Ikzf1^tm1Kge/Ikzf1⁺ (involves: 129S4/SvJae * C57BL/6)	abnormal lymph node cortex morphology	J:29355
	abnormal lymph node medulla morphology	J:29355
	abnormal T cell differentiation	J:29355
	abnormal thymus lobule morphology	J:29355
	abnormal thymus medulla morphology	J:29355
	decreased spleen red pulp amount	J:29355
	enlarged cervical lymph nodes	J:29355
	enlarged mesenteric lymph nodes	J:29355
	enlarged thymus	J:29355
	increased spleen white pulp amount	J:29355
	lymph node hyperplasia	J:29355
	spleen hyperplasia	J:29355
	thymus cortex hypoplasia	J:29355
Ikzf1^tm1Kge/Ikzf1⁺ (involves: 129S4/SvJae * BALB/c)	abnormal lymph node cortex morphology	J:29355
	abnormal lymph node medulla morphology	J:29355
	abnormal T cell differentiation	J:29355
	abnormal thymus lobule morphology	J:29355
	abnormal thymus medulla morphology	J:29355
	decreased spleen red pulp amount	J:29355
	enlarged cervical lymph nodes	J:29355
	enlarged mesenteric lymph nodes	J:29355
	enlarged thymus	J:29355
	increased spleen white pulp amount	J:29355
	lymph node hyperplasia	J:29355
	spleen hyperplasia	J:29355
	thymus cortex hypoplasia	J:29355
Ikzf1^tm1Kge/Ikzf1^tm1Kge (involves: 129S4/SvJae * C57BL/6)	abnormal eosinophil morphology	J:20671
	abnormal immune system organ morphology	J:20671
	abnormal NK cell morphology	J:20671
	abnormal spleen morphology	J:20671
	abnormal thymus cortex morphology	J:20671
	abnormal thymus morphology	J:20671
	absent axillary lymph nodes	J:20671
	absent B cells	J:20671
	absent cervical lymph nodes	J:20671
	absent inguinal lymph nodes	J:20671
	absent mesenteric lymph nodes	J:20671
	absent Peyer's patches	J:20671
	absent pre-B cells	J:20671
	arrested T cell differentiation	J:20671
	decreased gamma-delta intraepithelial T cell number	J:20671
	enlarged spleen	J:20671
	increased basophil cell number	J:20671
	intermingled spleen red and white pulp	J:20671
	thymus hypoplasia	J:20671
Ikzf1^tm1Kge/Ikzf1^tm1Kge (involves: 129S4/SvJae * BALB/c)	abnormal eosinophil morphology	J:20671
	abnormal immune system organ morphology	J:20671
	abnormal NK cell morphology	J:20671
	abnormal spleen morphology	J:20671
	abnormal thymus cortex morphology	J:20671
	abnormal thymus morphology	J:20671
	absent axillary lymph nodes	J:20671
	absent B cells	J:20671
	absent cervical lymph nodes	J:20671
	absent inguinal lymph nodes	J:20671
	absent mesenteric lymph nodes	J:20671
	absent Peyer's patches	J:20671
	absent pre-B cells	J:20671
	arrested T cell differentiation	J:20671
	decreased gamma-delta intraepithelial T cell number	J:20671
	enlarged spleen	J:20671
	increased basophil cell number	J:20671
	intermingled spleen red and white pulp	J:20671
	thymus hypoplasia	J:20671
Ikzf1^tm2.1Smale/Ikzf1^tm2.1Smale (B6.Cg-Ikzf1^tm2.1Smale)	abnormal lymphopoiesis	J:208211
	abnormal peripheral lymph node morphology	J:208211
	abnormal T cell differentiation	J:208211
	absent inguinal lymph nodes	J:208211
	absent NK cells	J:208211
	absent Peyer's patches	J:208211
	decreased B cell number	J:208211
	decreased DN2 thymocyte number	J:208211
	decreased DN3 thymocyte number	J:208211
	decreased double-negative T cell number	J:208211
	decreased double-positive T cell number	J:208211
	decreased immature B cell number	J:208211
	decreased mature B cell number	J:208211
	decreased plasmacytoid dendritic cell number	J:208211
	decreased pre-pro B cell number	J:208211
	increased gamma-delta T cell number	J:208211
	increased pre-B cell number	J:208211
	thymus cortex hypoplasia	J:208211
	thymus hypoplasia	J:208211
Ikzf1^tm2Kge/Ikzf1^tm2Kge (involves: 129S4/SvJae)	abnormal dendritic cell number	J:37317
	abnormal splenic cell ratio	J:37317
	abnormal T cell differentiation	J:208211, J:37317
	abnormal thymus development	J:37317
	absent axillary lymph nodes	J:37317
	absent B cells	J:208211, J:37317
	absent B-1a cells	J:37317
	absent cervical lymph nodes	J:37317
	absent inguinal lymph nodes	J:37317
	absent mesenteric lymph nodes	J:37317
	absent NK cells	J:208211, J:37317
	absent Peyer's patches	J:37317
	absent pre-B cells	J:37317
	absent pro-B cells	J:37317
	decreased double-positive T cell number	J:37317
	decreased gamma-delta intraepithelial T cell number	J:37317
	decreased granulocyte number	J:37317
	decreased mature gamma-delta T cell number	J:37317
	decreased plasmacytoid dendritic cell number	J:208211
	decreased splenocyte number	J:37317
	thymus hypoplasia	J:37317
Ikzf1^tm3.1Mbu/Ikzf1^tm3.1Mbu Cd79a^tm1(cre)Reth/Cd79a⁺ Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129P2/OlaHsd * 129S/SvEv * BALB/c * C57BL/6 * SJL)	decreased pro-B cell number	J:209928
Ikzf1^tm3.1Mbu/Ikzf1^tm3.1Mbu Il7r^{tm1.1(icre)Hrr}/Il7r⁺ (involves: 129P2/OlaHsd * C57BL/6 * SJL)	increased T cell derived lymphoma incidence	J:209928
Ikzf1^tm3Kge/Ikzf1^tm3Kge Tg(CD2-icre)4Kio/? (involves: C57BL/10 * CBA/Ca)	increased T cell derived lymphoma incidence	J:209927
Ikzf1^tm3Kge/Ikzf1^tm3Kge Tg(CD19-cre/ERT2)1Cgn/? (Not Specified)	absent pre-B cells	J:209927
	decreased pre-B cell number	J:209927
Ikzf3^{tm1(KOMP)Vlcg}/Ikzf3^{tm1(KOMP)Vlcg} (C57BL/6N-Ikzf3^{tm1(KOMP)Vlcg}/Rbrc)	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129S4/SvJae * C57BL/6)	abnormal B cell differentiation	J:50626
	abnormal spleen marginal zone morphology	J:50626
	decreased B cell number	J:81805
	decreased naive B cell number	J:81805
	enlarged spleen	J:50626
	increased pre-B cell number	J:50626
	increased spleen germinal center number	J:50626
Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129S4/SvJae)	decreased marginal zone B cell number	J:69477
Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129S4/SvJae)	increased follicular B cell number	J:69477
Ikzf5^{tm1(KOMP)Wtsi}/Ikzf5^{tm1(KOMP)Wtsi} (C57BL/6N-Ikzf5^{tm1(KOMP)Wtsi}/Rbrc)	increased large unstained cell number	J:211773
Il1a^tm1Yiw/Il1a^tm1Yiw Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased neutrophil cell number	J:191055
Il1r1^{em1(IMPC)Ccpcz}/Il1r1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Il1r1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Il1r1^tm1Imx/Il1r1^tm1Imx Vsig4^tm1Gne/Vsig4^tm1Gne (B6.Cg-Il1r1^tm1Imx Vsig4^tm1Gne)	decreased T helper 1 cell number	J:281762
	decreased T-helper 17 cell number	J:281762
Il1r1^tm1Roml/Il1r1^tm1Roml (C.Cg-Il1r1^tm1Roml)	decreased eosinophil cell number	J:82863
Il1r1^tm1Roml/Il1r1^tm1Roml (C.Cg-Il1r1^tm1Roml)	decreased T cell number	J:82863
Il1r1^tm1Roml/Il1r1^tm1Roml (involves: 129S1/Sv)	decreased neutrophil cell number	J:193548
Il1r1^tm1Roml/Il1r1^tm1Roml Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: 129S1/Sv * C57BL/6)	abnormal leukocyte cell number	J:191055
	abnormal leukopoiesis	J:191055
	decreased eosinophil cell number	J:191055
	decreased lymphocyte cell number	J:191055
	decreased monocyte cell number	J:191055
Il1r2^tm1.2Mchc/Il1r2^tm1.2Mchc (involves: BALB/cJ * C57BL/6J * C57BL/6NTac)	abnormal CD8-positive, alpha-beta T cell number	J:347877
	increased CD4-positive, alpha-beta T cell number	J:347877
Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd)	decreased eosinophil cell number	J:159464
Il1rl1^tm1Brl/Il1rl1^tm1Brl (involves: 129S/SvEv * C57BL/6)	increased eosinophil cell number	J:63507
Il1rl2^tm1Hblu/Il1rl2^tm1Hblu (involves: 129)	abnormal lymph node morphology	J:193548
	decreased gamma-delta T cell number	J:193548
	decreased leukocyte cell number	J:193548
	decreased macrophage cell number	J:193548
	decreased neutrophil cell number	J:193548
	increased regulatory T cell number	J:256437
Il1rn^tm1Sush/Il1rn^tm1Sush (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:97684
	abnormal dendritic cell differentiation	J:97684
	abnormal dendritic cell number	J:97684
	abnormal immune system organ morphology	J:97684
	abnormal T-helper 1 cell morphology	J:97684
	abnormal T-helper 2 cell morphology	J:97684
Il2^tm1Hor/Il2^tm1Hor (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:39981, J:15223
	abnormal class switch recombination	J:15573
	abnormal gamma-delta intraepithelial T cell morphology	J:15223
	abnormal lymphocyte cell number	J:15223
	abnormal lymphocyte morphology	J:37220
	abnormal T-helper 1 cell differentiation	J:37220
	decreased double-negative T cell number	J:15223
	decreased double-positive T cell number	J:37220
	enlarged lymph nodes	J:15223
	enlarged mesenteric lymph nodes	J:29999
	enlarged spleen	J:15223
	increased double-negative T cell number	J:37220
	increased pre-B cell number	J:16662
	increased pro-B cell number	J:16662
	increased single-positive T cell number	J:37220
	lymph node hyperplasia	J:16662
Il2^tm1Hor/Il2^tm1Hor (C.129P2-Il2^tm1Hor)	abnormal lymphocyte morphology	J:29799
	abnormal spleen morphology	J:29799
	enlarged lymph nodes	J:29799
	increased germinal center B cell number	J:29799
	increased plasma cell number	J:29799
	increased spleen red pulp amount	J:29799
	spleen hyperplasia	J:29799
Il2^tm1Hor/Il2^tm1Hor (B6.129P2-Il2^tm1Hor)	increased activated T cell number	J:28924
	increased CD4-positive, alpha-beta T cell number	J:28924
	increased CD8-positive, alpha-beta T cell number	J:28924
	increased T cell number	J:125748
Il2^tm1Hor/Il2^tm1Hor (C3.129P2-Il2^tm1Hor)	increased CD4-positive, alpha-beta T cell number	J:28924
Il2^tm1Hor/Il2^tm1Hor (C3.129P2-Il2^tm1Hor)	increased CD8-positive, alpha-beta T cell number	J:28924
Il2^tm1Hor/Il2^tm1Hor (B6.129P2-Il2^tm1Hor/J)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:131774
	decreased regulatory T cell number	J:113547
	enlarged lymph nodes	J:113547
	increased CD4-positive, alpha-beta T cell number	J:131774
	increased splenocyte number	J:131774
Il2^tm1Hor/Il2^tm1Hor (involves: 129P2/OlaHsd)	increased regulatory T cell number	J:208318
Il2^tm1Hor/Il2^tm1Hor (involves: 129P2/OlaHsd * C57BL/6J)	increased T-helper 17 cell number	J:120176
Il2^tm1Hor/Il2^tm1Hor Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	increased pre-B cell number	J:16662
	increased pro-B cell number	J:16662
Il2^tm1Hor/Il2^tm1Hor Rag2^tm1Fwa/Rag2⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	enlarged mesenteric lymph nodes	J:29999
Il2^tm1Hor/Il2^tm1Hor Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Tcra5CC7,Tcrb5CC7)IWep/0 (involves: 129P2/OlaHsd * C57BL/10)	abnormal T cell number	J:120176
	increased T-helper 17 cell number	J:120176
Il2^tm1Hor/Il2^tm1Hor Tg(DO11.10)10Dlo/? (C.Cg-Il2^tm1Hor Tg(DO11.10)10Dlo)	increased activated T cell number	J:88349
Il2^tm1Hor/Il2^tm1Hor Tg(Pgk1-HA)1.1Vbo/? Tg(Tcra/Tcrb)1Vbo/? (C.Cg-Il2^tm1Hor Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)	decreased regulatory T cell number	J:112603
	increased regulatory T cell number	J:112603
Il2ra^{tm1b(EUCOMM)Wtsi}/Il2ra^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Il2ra^{tm1b(EUCOMM)Wtsi}/Orl)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	increased large unstained cell number	J:211773
	increased neutrophil cell number	J:211773
Il2ra^tm1Dw/Il2ra^tm1Dw (involves: 129S4/SvJae * C57BL/6)	abnormal lymph organ size	J:64279
	abnormal T cell morphology	J:64279
	enlarged lymph nodes	J:64279
	enlarged spleen	J:64279
	increased lymphocyte cell number	J:64279
	increased memory T cell number	J:64279
Il2ra^tm1Dw/Il2ra^tm1Dw (B6.129S4-Il2ra^tm1Dw)	lymphoid hyperplasia	J:125748
Il2ra^tm1Dw/Il2ra^tm1Dw Tg(CD2-Ccdc86)1Hfuj/? (B6.Cg-Il2ra^tm1Dw Tg(CD2-Ccdc86)1Hfuj)	increased activated T cell number	J:151722
Il2ra^tm1Dw/Il2ra^tm1Dw Tg(Pgk1-HA)1.1Vbo/? Tg(Tcra/Tcrb)1Vbo/? (C.Cg-Il2ra^tm1Dw Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)	decreased regulatory T cell number	J:112603
	increased regulatory T cell number	J:112603
Il2rb^m1Btlr/Il2rb^m1Btlr (C57BL/6J-Il2rb^m1Btlr)	decreased B cell number	J:267694
	decreased CD4-positive, alpha-beta T cell number	J:267694
	decreased CD8-positive, naive alpha-beta T cell number	J:267694
	increased effector memory CD4-positive, alpha-beta T cell number	J:267694
	increased effector memory CD8-positive, alpha-beta T cell number	J:267694
Il2rb^M3Btlr/Il2rb^M3Btlr (C57BL/6J-Il2rb^M3Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272833
	abnormal T cell morphology	J:272833
	decreased CD8-positive, alpha-beta T cell number	J:272833
	decreased central memory CD8 positive, alpha-beta T cell number	J:272833
	decreased NK cell number	J:272833
	decreased NK T cell number	J:272833
	increased CD4-positive, alpha-beta T cell number	J:272833
Il2rb^tm1Mak/Il2rb^tm1Mak (either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas))	abnormal mononuclear cell morphology	J:25940
	decreased B cell number	J:25940
	decreased double-positive T cell number	J:25940
	decreased memory T cell number	J:25940
	enlarged lymph nodes	J:25940
	enlarged spleen	J:25940
	increased activated T cell number	J:25940
	increased CD4-positive, alpha-beta T cell number	J:25940
	increased CD8-positive, alpha-beta T cell number	J:25940
	increased granulocyte number	J:25940
	increased neutrophil cell number	J:25940
	increased plasma cell number	J:25940
	thymus hypoplasia	J:25940
Il2rb^tm1Mak/Il2rb^tm1Mak (B6.129-Il2rb^tm1Mak)	abnormal lymphocyte morphology	J:113547
	abnormal spleen periarteriolar lymphoid sheath morphology	J:113547
	decreased regulatory T cell number	J:113547
	enlarged lymph nodes	J:113547
	enlarged spleen	J:113547
Il2rb^tm1Mak/Il2rb^tm1Mak (C.129-Il2rb^tm1Mak)	abnormal immune system organ morphology	J:113547
	abnormal lymphocyte morphology	J:113547
	abnormal marginal zone B cell morphology	J:113547
	abnormal spleen periarteriolar lymphoid sheath morphology	J:113547
	abnormal T cell clonal deletion	J:113547
	decreased CD8-positive, alpha-beta T cell number	J:113547
	enlarged lymph nodes	J:113547
	enlarged spleen	J:113547
Il2rb^tm1Mak/Il2rb^tm1Mak (D2.129-Il2rb^tm1Mak)	abnormal T cell clonal deletion	J:113547
Il2rb^tm1Mak/Il2rb^tm1Mak Lck^tm1Mak/Lck^tm1Mak (involves: 129)	absent uterine NK cells	J:134589
Il2rb^tm1Mak/Il2rb^tm1Mak Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129 * 129S/SvEv)	decreased NK cell number	J:142654
Il2rg^tm1.1Asin/Il2rg^tm1Wjl Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:190889
	decreased CD8-positive, alpha-beta T cell number	J:190889
Il2rg^tm1.1Asin/Il2rg^tm1Wjl Tg(Cd8a-cre)B8Asin/0 (involves: 129S4/SvJae C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:190889
	decreased CD8-positive, alpha-beta T cell number	J:190889
	decreased NK T cell number	J:190889
	decreased regulatory T cell number	J:190889
Il2rg^tm1.1Asin/Il2rg^tm1Wjl Tg(Cd8a-cre)B8Asin/0 Tg(LCKprBCL2)36Sjk/0 (involves: 129S4/SvJae C57BL/6)	decreased NK T cell number	J:190889
Il2rg^tm1Cgn/Y (involves: 129 * CB20)	abnormal alpha-beta intraepithelial T cell morphology	J:22521
	abnormal class switch recombination	J:22521
	abnormal gamma-delta T cell differentiation	J:111821
	abnormal leukocyte morphology	J:22521
	absent gamma-delta intraepithelial T cell	J:111821
	absent gamma-delta T cells	J:111821
	absent NK cells	J:22521
	absent Peyer's patches	J:22521
	absent spleen germinal center	J:22521
	decreased mature B cell number	J:22521
	decreased plasma cell number	J:22521
	decreased pre-B cell number	J:22521
	decreased spleen white pulp amount	J:22521
	decreased T cell number	J:22521
	spleen hypoplasia	J:22521
	thymus hypoplasia	J:111821, J:22521
Il2rg^tm1Cgn/Y Rag2^tm1Fwa/Rag2^tm1Fwa (B6.129-Rag2^tm1Fwa Il2rg^tm1Cgn)	absent B cells	J:132257
	absent NK cells	J:132257
	absent T cells	J:132257
Il2rg^tm1Cgn/Il2rg^tm1Cgn (involves: 129 * CB20)	abnormal alpha-beta intraepithelial T cell morphology	J:22521
	abnormal class switch recombination	J:22521
	abnormal leukocyte morphology	J:22521
	absent NK cells	J:22521
	absent Peyer's patches	J:22521
	absent spleen germinal center	J:22521
	decreased mature B cell number	J:22521
	decreased plasma cell number	J:22521
	decreased pre-B cell number	J:22521
	decreased spleen white pulp amount	J:22521
	decreased T cell number	J:22521
	spleen hypoplasia	J:22521
	thymus hypoplasia	J:22521
Il2rg^tm1Cgn/Il2rg^tm1Cgn Kit^tm1.1Bsm/Kit^tm1.1Bsm (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	arrested T cell differentiation	J:90485
Il2rg^tm1Cgn/Il2rg^tm1Cgn Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129P2/OlaHsd * 129S/SvEv)	decreased NK cell number	J:142654
Il2rg^tm1Krf/Il2rg^tm1Krf (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))	decreased thymocyte number	J:114561
Il2rg^tm1Krf/Il2rg^tm1Krf Tg(BCL2/IGH)1Tjd/0 (either: (involves: 129P2/OlaHsd * C3H/He * C57BL/6) or (involves: 129P2/OlaHsd * C3H/He * C57BL/6 * FVB/N))	decreased thymocyte number	J:114561
Il2rg^tm1Krf/Il2rg^tm1Krf Tg(Igh-Pim1)1Brn/0 (either: (involves: 129P2/OlaHsd * C57BL/6 * CBA) or (involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N))	decreased thymocyte number	J:114561
Il2rg^tm1Sug/Y (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S6/SvEvTac * C57BL/6))	abnormal immune system cell morphology	J:31167
	abnormal immune system organ morphology	J:31167
	abnormal myelopoiesis	J:31167
	abnormal splenic cell ratio	J:31167
	absent NK cells	J:31167
	absent spleen white pulp	J:31167
	arrested B cell differentiation	J:31167
	decreased lymphocyte cell number	J:31167
	decreased T cell number	J:31167
	decreased thymocyte number	J:31167
	enlarged Peyer's patches	J:31167
	enlarged spleen	J:31167
	increased macrophage cell number	J:31167
	increased monocyte cell number	J:31167
	increased neutrophil cell number	J:31167
	small lymph nodes	J:31167
	small thymus	J:31167
	thymus cortex hypoplasia	J:31167
	thymus hypoplasia	J:31167
Il2rg^tm1Sug/Il2rg^tm1Sug (B6.129-Il2rg^tm1Sug)	absent uterine NK cells	J:116952
Il2rg^tm1Wjl/Y (involves: 129S4/SvJae * C57BL/6)	abnormal B cell number	J:108209
	abnormal CD4-positive, alpha beta T cell morphology	J:108209
	abnormal gut-associated lymphoid tissue morphology	J:24117
	abnormal immune system organ morphology	J:108209
	abnormal lymphocyte morphology	J:108209
	abnormal mesenteric lymph node morphology	J:24117
	absent gamma-delta intraepithelial T cell	J:24117
	absent gamma-delta T cells	J:24117
	absent NK cells	J:24117
	decreased CD8-positive, alpha-beta T cell number	J:24117
	decreased double-negative T cell number	J:24117
	decreased double-positive T cell number	J:24117
	decreased immature B cell number	J:24117
	decreased single-positive T cell number	J:24117
	small lymph nodes	J:24117
	small thymus	J:24117
	small thymus cortex	J:24117
	spleen hyperplasia	J:24117
	spleen hypoplasia	J:24117
	thymus hyperplasia	J:108209
Il2rg^tm1Wjl/Y Crlf2^tm1Wjl/Crlf2^tm1Wjl (involves: 129S4/SvJae * C57BL/6)	thymus hypoplasia	J:108209
Il2rg^tm1Wjl/Y Prkdc^scid/Prkdc^scid (NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/Sz)	abnormal immune system organ morphology	J:109833
	abnormal splenic cell ratio	J:109833
	abnormal thymus morphology	J:109833
	decreased CD4-positive, alpha-beta T cell number	J:109833
	decreased CD8-positive, alpha-beta T cell number	J:109833
	decreased immature B cell number	J:109833
	decreased leukocyte cell number	J:109833
	decreased mature B cell number	J:109833
	decreased NK cell number	J:109833
	decreased spleen B cell follicle number	J:109833
	lymph node hypoplasia	J:109833
	small lymph nodes	J:109833
Il2rg^tm1Wjl/Y Rag1^tm1Mom/Rag1^tm1Mom (NOD.Cg-Rag1^tm1Mom Il2rg^tm1Wjl/SzJ)	abnormal spleen morphology	J:140388
	abnormal thymus morphology	J:140388
	absent NK T cells	J:140388
	absent thymus cortex	J:140388
	absent thymus medulla	J:140388
	decreased macrophage cell number	J:140388
	decreased spleen B cell follicle number	J:140388
	thymus cyst	J:140388
Il2rg^tm1Wjl/Il2rg^tm1Wjl (B6.129S4-Il2rg^tm1Wjl/J)	abnormal splenic cell ratio	J:123902
Il2rg^tm1Wjl/Il2rg^tm1Wjl (B6.129S4-Il2rg^tm1Wjl/J)	decreased myeloid dendritic cell number	J:123902
Il2rg^tm1Wjl/Il2rg^tm1Wjl Prkdc^scid/Prkdc^scid (NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/Sz)	abnormal immune system organ morphology	J:109833
	abnormal splenic cell ratio	J:109833
	abnormal thymus morphology	J:109833
	decreased CD4-positive, alpha-beta T cell number	J:109833
	decreased CD8-positive, alpha-beta T cell number	J:109833
	decreased immature B cell number	J:109833
	decreased leukocyte cell number	J:109833
	decreased mature B cell number	J:109833
	decreased NK cell number	J:109833
	decreased spleen B cell follicle number	J:109833
	lymph node hypoplasia	J:109833
	small lymph nodes	J:109833
	thymus cyst	J:109833
Il2rg^tm1Wjl/Il2rg^tm1Wjl Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * 129S4/SvJae)	absent NK cells	J:140483
	absent T cells	J:140483
Il2rg^tm1Wjl/Il2rg^tm1Wjl Tg(CD2-Ccdc86)1Hfuj/? (B6.Cg-Il2rg^tm1Wjl Tg(CD2-Ccdc86)1Hfuj)	decreased CD4-positive, alpha-beta T cell number	J:151722
	decreased CD8-positive, alpha-beta T cell number	J:151722
	decreased regulatory T cell number	J:151722
	decreased splenocyte number	J:151722
Il2rg^tm2Cgn/Y Tg(Mx1-cre)1Cgn/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased NK cell number	J:132257
Il3^tm1Glli/Il3^tm1Glli (either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6))	abnormal mast cell differentiation	J:80500
Il3ra^m1/Il3ra^m1 (A/J)	abnormal leukopoiesis	J:23971
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (involves: 129P2/OlaHsd * C57BL/6)	increased eosinophil cell number	J:113543
Il4/Il13^tm3Anjm/Il4/Il13^tm3Anjm (involves: 129P2/OlaHsd * C57BL/6)	increased eosinophil cell number	J:113543
Il4^tm1(CD2)Mmrs/Il4^tm1(CD2)Mmrs (involves: 129)	decreased basophil cell number	J:181313
Il4^tm1.1Wep/Il4⁺ Stat6^tm1Gru/Stat6^tm1Gru (C.129-Stat6^tm1Gru Il4^tm1.1Wep)	abnormal T-helper 2 cell differentiation	J:138827
Il4^tm1.1Wep/Il4^tm1.1Wep (C.129P2-Il4^tm1.1Wep)	abnormal T-helper 2 cell differentiation	J:138827
Il4^tm1.1Wep/Il4^tm1.1Wep Stat6^tm1Gru/Stat6^tm1Gru (C.129-Stat6^tm1Gru Il4^tm1.1Wep)	abnormal T-helper 2 cell differentiation	J:138827
Il4^tm1Cgn/Il4^tm1Cgn Ndfip1^{Gt(RRD002)Byg}/Ndfip1^{Gt(RRD002)Byg} (involves: 129P2/OlaHsd)	increased CD4-positive, alpha-beta T cell number	J:205692
	increased eosinophil cell number	J:205692
	increased neutrophil cell number	J:205692
	increased T cell number	J:205692
Il4^tm1Kopf/Il4^tm1Kopf (involves: 129S2/SvPas)	decreased eosinophil cell number	J:113065
Il4^tm1Kopf/Il4^tm1Kopf Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd * 129S2/SvPas)	decreased B cell number	J:161523
	increased basophil cell number	J:161523
	increased mast cell number	J:161523
Il4^tm1Nnt/Il4^tm1Nnt (C57BL/6-Il4^tm1Nnt/J)	abnormal microglial cell morphology	J:125605
Il4^tm2Nnt/Il4^tm2Nnt (BALB/c-Il4^tm2Nnt/J)	abnormal dendritic cell differentiation	J:141937
Il4ra^tm1Fbb/Il4ra^tm1Fbb (involves: BALB/cJ)	decreased T-helper 2 cell number	J:172134
Il4ra^tm1Sz/Il4ra^tm1Sz (BALB/c-Il4ra^tm1Sz/J)	abnormal microglial cell morphology	J:125605
Il4ra^tm1Sz/Il4ra^tm1Sz Il7r^tm1.1Asin/Il7r^tm1Imx Tg(Cd8a-cre)B8Asin/0 (involves: 129S7/SvEvBrd BALB/cJ * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:190889
Il4ra^tm1Tch/Il4ra^tm1Tch (involves: 129X1/SvJ * BALB/c)	abnormal T-helper 2 cell morphology	J:86215
Il4ra^tm2Tch/Il4ra^tm2Tch (C.129X1-Il4ra^tm2Tch)	increased eosinophil cell number	J:152376
Il4ra^tm2Tch/Il4ra^tm2Tch (C.129X1-Il4ra^tm2Tch)	increased monocyte cell number	J:152376
Il4ra^tm2Tch/Il4ra^tm2Tch Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/? (B6.Cg-Il4ra^tm2Tch Tg(Scgb1a1-rtTA,tetO-IL13)1Eli)	increased eosinophil cell number	J:152376
Il5^tm1Anjm/Il5^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell morphology	J:113543
Il5^tm1Anjm/Il5^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	decreased eosinophil cell number	J:113543
Il5^tm1Anjm/Il5^tm1Anjm Il9^tm1Anjm/Il9^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell morphology	J:113543
	decreased eosinophil cell number	J:113543
Il5^tm1Kopf/Il5^tm1Kopf (C57BL/6-Il5^tm1Kopf/J)	increased eosinophil cell number	J:30867
Il5^tm1Kopf/Il5^tm1Kopf (C57BL/6-Il5^tm1Kopf)	increased lymphocyte cell number	J:30641
Il5^tm1Kopf/Il5^tm1Kopf (C57BL/6-Il5^tm1Kopf)	increased neutrophil cell number	J:30641
Il5^tm1Ktk/Il5^tm1Ktk (B6.129S4-Il5^tm1Ktk)	abnormal B-1 B cell morphology	J:180790
Il5^tm2Anjm/Il5^tm2Anjm Il9^tm1Anjm/Il9^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	increased eosinophil cell number	J:113543
Il5ra^tm1Ktk/Il5ra^tm1Ktk (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:33140
	abnormal eosinophil cell number	J:33140
	abnormal lymphopoiesis	J:33140
	abnormal T cell differentiation	J:33140
	decreased CD4-positive, alpha-beta T cell number	J:33140
Il5ra^tm1Ktk/Il5ra^tm1Ktk (B6.129P2-Il5ra^tm1Ktk)	abnormal B-1 B cell morphology	J:89849
Il5ra^tm1Ktk/Il5ra^tm1Ktk (B6.129P2-Il5ra^tm1Ktk)	decreased B-1 B cell number	J:89849
Il5ra^tm1Ktk/Il5ra^tm1Ktk Lyn^tm1Tya/Lyn^tm1Tya (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune system organ morphology	J:91089
	abnormal spleen B cell corona morphology	J:91089
	abnormal spleen white pulp morphology	J:91089
	decreased B-1 B cell number	J:91089
	enlarged lymph nodes	J:91089
	enlarged spleen	J:91089
Il6^tm1.1Jho/Il6^tm1.1Jho Tg(GFAP-cre)8Gtm/0 (involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * CBA)	microgliosis	J:211914
Il6^tm1Kopf/Il6^tm1Kopf (involves: 129S2/SvPas * C57BL/6)	abnormal microglial cell morphology	J:79142
	abnormal T cell differentiation	J:17360
	decreased T cell number	J:17360
Il6^tm1Kopf/Il6^tm1Kopf (B6.129S2-Il6^tm1Kopf/J)	decreased pro-B cell number	J:117320
Il6^tm1Kopf/Il6^tm1Kopf Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129 * C57BL/6)	abnormal lymphopoiesis	J:117320
	abnormal myelopoiesis	J:117320
	decreased pro-B cell number	J:117320
Il6^tm1Kopf/Il6^tm1Kopf Tg(Rorc-EGFP)1Ebe/? (involves: 129S2/SvPas * C57BL/6)	abnormal effector T cell morphology	J:137020
Il6^tm1Mur/Il6^tm1Mur (involves: 129/Sv * C57BL/6)	abnormal lymphocyte cell number	J:40579
Il6^tm1Mur/Il6^tm1Mur (involves: 129/Sv * C57BL/6)	absent NK cells	J:40579
Il6^tm1Mur/Il6^tm1Mur (B6.129P2(B6)-Il6^tm1Mur)	abnormal microglial cell morphology	J:85581
Il6^tm1Mur/Il6^tm1Mur (B6.129P2(B6)-Il6^tm1Mur)	abnormal osteoclast differentiation	J:65093
Il6^tm1Poli/Il6^tm1Poli (involves: 129S/SvEv * MF1)	abnormal T-helper 1 cell morphology	J:79314
Il6ra^{tm1.1(IL6R)Csk}/Il6ra^{tm1.1(IL6R)Csk} Tg(H2-L-IL6)40Csk/0 (involves: 129S6/SvEvTac * C57BL/6)	enlarged lymph nodes	J:207264
	enlarged spleen	J:207264
	increased plasma cell number	J:207264
	increased spleen weight	J:207264
	increased spleen white pulp amount	J:207264
Il6st^tm1Ard/Il6st^tm1Ard (involves: 129S1/Sv * C57BL/6)	abnormal leukocyte cell number	J:110742
Il6st^tm1Ard/Il6st^tm1Ard (involves: 129S1/Sv * C57BL/6)	abnormal thrombopoiesis	J:110742
Il6st^tm1Ern/Il6st^tm1Ern (involves: 129S1/Sv * C57BL/6)	enlarged spleen	J:79073
Il6st^tm1Ern/Il6st^tm1Ern (involves: 129S1/Sv * C57BL/6)	increased osteoclast cell number	J:87612
Il6st^tm1Ern/Il6st^tm1Ern (involves: 129S1/Sv)	increased neutrophil cell number	J:168781
Il6st^tm1Ern/Il6st^tm1Ern Tg(RP11-H2112)5Trme/0 (involves: 129S1/Sv * C57BL/6J * DBA/2J)	abnormal spleen size	J:234656
Il6st^tm1Ern/Il6st^tm1Ern Tg(RP11-H2112)9Trme/0 (involves: 129S1/Sv * C57BL/6J * DBA/2J)	abnormal spleen size	J:234656
Il6st^tm1Kish/Il6st^tm1Kish (involves: 129P2/OlaHsd * C57BL/6)	thymus hypoplasia	J:75419
Il6st^tm1Kish/Il6st^tm1Kish (involves: 129P2/OlaHsd * CD-1)	abnormal bone marrow development	J:88710
	abnormal osteoclast differentiation	J:88710
	abnormal osteoclast morphology	J:88710
	increased osteoclast cell number	J:88710
Il6st^tm1Thir/Il6st^tm1Thir (Not Specified)	enlarged axillary lymph nodes	J:59922
	enlarged cervical lymph nodes	J:59922
	enlarged inguinal lymph nodes	J:59922
	enlarged mesenteric lymph nodes	J:59922
	increased B cell number	J:59922
	increased CD4-positive, alpha-beta T cell number	J:59922
	increased CD8-positive, alpha-beta T cell number	J:59922
	lymph node hyperplasia	J:59922
	spleen hyperplasia	J:59922
Il6st^tm1Thir/Il6st^tm1Thir (involves: 129 * C57BL/6)	abnormal T cell clonal deletion	J:133059
	decreased double-positive T cell number	J:133059
	increased activated T cell number	J:133059
	increased double-negative T cell number	J:133059
	increased neutrophil cell number	J:133059
	increased single-positive T cell number	J:133059
Il6st^tm1Thir/Il6st^tm1Thir Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129 * C57BL/6 * DBA)	abnormal negative T cell selection	J:133059
Il6st^tm1Wme/Il6st^tm1Wme (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:67677
	abnormal thrombopoiesis	J:67677
	decreased thymocyte number	J:67677
	increased leukocyte cell number	J:67677
Il6st^tm2Thir/Il6st^tm2Thir (Not Specified)	decreased B-1a cell number	J:59922
Il7^hlb368/Il7^hlb368 (C57BL/6J-Il7^hlb368/J)	abnormal T cell subpopulation ratio	J:118450
	absent axillary lymph nodes	J:118450
	absent cervical lymph nodes	J:118450
	absent mesenteric lymph nodes	J:118450
	absent Peyer's patches	J:118450
	absent popliteal lymph nodes	J:118450
	decreased leukocyte cell number	J:82961, J:118450
	decreased T cell number	J:118450
	small inguinal lymph nodes	J:118450
	small spleen	J:118450
	small thymus	J:118450
	spleen hypoplasia	J:118450
	thymus hypoplasia	J:118450
Il7^m1Jyen/Il7^m1Jyen (involves: C3H * C57BL/6)	abnormal myeloid leukocyte morphology	J:136470
	decreased B cell number	J:136470
	decreased single-positive T cell number	J:136470
	lymph node hypoplasia	J:136470
	spleen hypoplasia	J:136470
	thymus hypoplasia	J:136470
Il7^tm1.1Mysl/Il7⁺ (B6.129P2(Cg)-Il7^tm1.1Mysl)	decreased T cell number	J:200544
Il7^tm1.1Mysl/Il7⁺ (B6.129P2(Cg)-Il7^tm1.1Mysl)	small lymph nodes	J:200544
Il7^tm1.1Mysl/Il7^tm1.1Mysl (B6.129P2(Cg)-Il7^tm1.1Mysl)	abnormal mesenteric lymph node morphology	J:200544
	arrested B cell differentiation	J:200544
	decreased T cell number	J:200544
	decreased thymocyte number	J:200544
	small lymph nodes	J:200544
	thymus hypoplasia	J:200544
Il7^tm1Dnax/Il7^tm1Dnax (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:125259
	absent lymph nodes	J:24165
	absent Peyer's patches	J:24165
	arrested B cell differentiation	J:24165
	decreased lymphocyte cell number	J:24165
	decreased spleen weight	J:24165
	decreased thymus weight	J:24165
	small spleen	J:24165
	small thymus	J:24165
	spleen hypoplasia	J:24165
	thymus hypoplasia	J:24165
Il7^tm1Dnax/Il7^tm1Dnax (involves: 129P2/OlaHsd)	decreased thymocyte number	J:64861
Il7^tm1Dnax/Il7^tm1Dnax Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129P2/OlaHsd * 129S/SvEv)	decreased NK cell number	J:132257
Il7^tm1Hms/Il7^tm1Hms (involves: 129S6/SvEvTac)	spleen hypoplasia	J:43971
Il7^tm1Hms/Il7^tm1Hms (involves: 129S6/SvEvTac)	thymus hypoplasia	J:43971
Il7^tm2.1Iku/Il7^tm2.1Iku Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)	abnormal B cell differentiation	J:190615
	decreased B cell number	J:190615
	decreased double-negative T cell number	J:190615
	decreased lymphocyte cell number	J:190615
	decreased NK T cell number	J:190615
	decreased T cell number	J:190615
Il7r^tm1.1Asin/Il7r^tm1Imx Tg(Cd4-cre)1Cwi/0 (involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:190889
Il7r^tm1.1Asin/Il7r^tm1Imx Tg(Cd8a-cre)B8Asin/0 (involves: 129S7/SvEvBrd C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:190889
Il7r^tm1Abra/Il7r^tm1Abra (B6.129S4-Il7r^tm1Abra)	abnormal T cell differentiation	J:125360
	decreased B cell number	J:125360
	decreased CD4-positive, alpha-beta T cell number	J:125360
	decreased CD8-positive, alpha-beta T cell number	J:125360
	decreased memory T cell number	J:125360
	decreased thymocyte number	J:125360
	increased double-positive T cell number	J:125360
Il7r^tm1Iku/Il7r^tm1Iku (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell differentiation	J:34658
	abnormal gamma-delta T cell differentiation	J:34658
	abnormal T cell subpopulation ratio	J:34658
	absent mature gamma-delta T cells	J:34658
	absent Peyer's patches	J:45633
	decreased B-1 B cell number	J:34658
	decreased double-positive T cell number	J:34658
	decreased immature B cell number	J:34658
	decreased leukocyte cell number	J:34658
	decreased lymphocyte cell number	J:34658
	decreased mature B cell number	J:34658
	decreased T cell number	J:34658
	increased double-negative T cell number	J:34658
	small thymus	J:34658
	spleen hypoplasia	J:34658
	thymus hypoplasia	J:34658
Il7r^tm1Imx/Il7r^tm1Imx (involves: 129P3/J * 129S7/SvEvBrd)	arrested B cell differentiation	J:21135
	arrested T cell differentiation	J:21135
	decreased B cell number	J:21135
	decreased T cell number	J:21135
	lymph node hypoplasia	J:21135
	spleen hypoplasia	J:21135
	thymus hypoplasia	J:21135
Il7r^tm1Imx/Il7r^tm1Imx (B6.129S7-Il7r^tm1Imx)	abnormal T cell differentiation	J:125360
	decreased double-positive T cell number	J:125360
	decreased thymocyte number	J:125360
Il7r^tm1Imx/Il7r^tm1Imx (involves: 129S7/SvEvBrd)	decreased thymocyte number	J:64861
Il7r^tm1Imx/Il7r^tm1Imx Tg(Lck-Il7r)1676Trma/? (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	decreased thymocyte number	J:66400
Il7r^tm2Iku/Il7r^tm2Iku Tg(Cd4-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal CD4-positive T cell differentiation	J:193283
	abnormal CD8-positive, alpha-beta T cell differentiation	J:193283
	abnormal T cell morphology	J:193283
	decreased NK T cell number	J:193283
	increased B cell number	J:193283
	increased gamma-delta T cell number	J:193283
	increased thymocyte number	J:193283
Il9^tm1Anjm/Il9^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell morphology	J:82881
Il9r^tm1Jcrd/Il9r^tm1Jcrd (involves: C57BL/6)	increased T-helper 1 cell number	J:151907
Il10^tm1.1Roer/Il10^tm1.1Roer (involves: 129P2/OlaHsd)	abnormal myeloid leukocyte morphology	J:151551
	increased B cell number	J:151551
	increased myeloid dendritic cell number	J:151551
	increased plasma cell number	J:151551
	increased T cell number	J:151551
	spleen hyperplasia	J:151551
Il10^tm1Cgn/Il10^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal leukocyte morphology	J:35020
	abnormal lymphocyte cell number	J:35020
	abnormal myelopoiesis	J:15222
	decreased spleen iron level	J:15222
	decreased spleen red pulp amount	J:15222
	increased CD4-positive, alpha-beta T cell number	J:35020
	increased granulocyte number	J:35020, J:15222
	increased thymus weight	J:107077
	thymus hyperplasia	J:107077
Il10^tm1Cgn/Il10^tm1Cgn Il4^tm1Cgn/Il4^tm1Cgn (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 1 cell differentiation	J:111712
Il10^tm1Cgn/Il10^tm1Cgn Il12b^tm1Jm/Il12b^tm1Jm (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	abnormal T-helper 2 cell differentiation	J:111712
Il10^tm1Cgn/Il10^tm1Cgn Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal lymph node cell ratio	J:107077
	abnormal splenic cell ratio	J:107077
	abnormal thymus corticomedullary boundary morphology	J:107077
	absent spleen white pulp	J:107077
	decreased lymphocyte cell number	J:107077
	enlarged mesenteric lymph nodes	J:107077
	enlarged spleen	J:107077
	increased macrophage cell number	J:107077
	increased neutrophil cell number	J:107077
	increased spleen red pulp amount	J:107077
	thymus hypoplasia	J:107077
Il10^tm1Roer/Il10^tm1Roer Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal lymph node morphology	J:94537
Il10ra^tm1.1Tlg/Il10ra^tm1.1Tlg Tg(Cd4-cre)1Cwi/? (B6.Cg-Tg(Cd4-cre)1Cwi Il10ra^tm1.1Tlg)	abnormal lymphocyte cell number	J:189797
	abnormal regulatory T cell number	J:189797
	decreased T cell number	J:189797
Il10ra^{tm1b(KOMP)Wtsi}/Il10ra^{tm1b(KOMP)Wtsi} (C57BL/6N-Il10ra^{tm1b(KOMP)Wtsi}/Orl)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Il10rb^tm1Agt/Il10rb^tm1Agt (involves: 129S2/SvPas * C57BL/6)	abnormal granulocyte differentiation	J:45917
	abnormal lymph node medullary cord morphology	J:45917
	abnormal mesenteric lymph node morphology	J:45917
	abnormal spleen morphology	J:45917
	increased leukocyte cell number	J:45917
	increased spleen weight	J:45917
	spleen hyperplasia	J:45917
Il11ra1^tm1Gos/Il11ra1^tm1Gos (involves: 129S2/SvPas * C57BL/6J * CD-1)	abnormal NK cell differentiation	J:93811
	abnormal uterine NK cell morphology	J:93811
Il12rb1^tm1Jm/Il12rb1^tm1Jm Tg(Rorc-EGFP)1Ebe/? (involves: 129S1/Sv * C57BL/6)	abnormal effector T cell morphology	J:137020
Il12rb2^tm1Jm/Il12rb2^tm1Jm (B6;129S1-Il12rb2^tm1Jm/J)	lymphoid hyperplasia	J:106805
Il13^{tm1(YFP/cre)Lky}/Il13⁺ Il4^tm1(CD2)Mmrs/Il4⁺ Gt(ROSA)26Sor^tm1(DTA)Lky/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S4/SvJae)	decreased eosinophil cell number	J:178986
Il13^tm1.1Anjm/Il13^tm1.1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 2 cell differentiation	J:67965
	decreased T-helper 2 cell number	J:67965
Il13^tm1.1Anjm/Il13^tm1.1Anjm (C.129P2-Il13^tm1.1Anjm)	abnormal dendritic cell differentiation	J:141937
Il13^tm1Anjm/Il13^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	decreased eosinophil cell number	J:82881
Il13^tm2Anjm/Il13^tm2Anjm (involves: 129)	abnormal T-helper 2 cell differentiation	J:67965
Il13^tm2Anjm/Il13^tm2Anjm (involves: 129)	decreased T-helper 2 cell number	J:67965
Il13^tm2Anjm/Il13^tm2Anjm (B6.129P2-Il13^tm2Anjm)	decreased macrophage cell number	J:131969
Il13^tm3.1Anjm/Il13⁺ Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd * BALB/c)	decreased eosinophil cell number	J:159464
Il13^tm3.1Anjm/Il13⁺ Il17rb^tm1Anjm/Il17rb^tm1Anjm (involves: BALB/c * C57BL/6)	decreased eosinophil cell number	J:159464
Il13^tm3.1Anjm/Il13⁺ Il17rb^tm1Anjm/Il17rb^tm1Anjm Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd * BALB/c)	decreased eosinophil cell number	J:159464
Il13ra1^tm1Twy/Y (C.Cg-Il13ra1^tm1Twy)	increased CD4-positive, alpha-beta T cell number	J:130488
	increased eosinophil cell number	J:130488
	increased T-helper 2 cell number	J:130488
Il13ra1^tm1Zagh/Il13ra1^tm1Zagh (involves: BALB/c * C57BL/6)	abnormal thymus development	J:183111
	impaired myelopoiesis	J:183111
Il15^m1Hwata/Il15^m1Hwata (Not Specified)	abnormal NK T cell number	J:184570
	decreased NK cell number	J:184570
	decreased NK T cell number	J:184570
Il15^tm1Imx/Il15⁺ Myc^tm1Atp/Myc⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased memory T cell number	J:132730
Il15^tm1Imx/Il15^tm1Imx (involves: C57BL/6)	abnormal immune system morphology	J:60915
	abnormal lymphocyte morphology	J:60915
	absent uterine NK cells	J:84009
	decreased CD8-positive, alpha-beta T cell number	J:113408, J:60915
	decreased CD8-positive, gamma-delta intraepithelial T cell number	J:155298
	decreased dendritic cell number	J:97620
	decreased memory T cell number	J:132730
	decreased NK cell number	J:132730, J:142654, J:60915
	decreased regulatory T cell number	J:208318
	small lymph nodes	J:60915
Il15^tm1Imx/Il15^tm1Imx (C57BL/6-Il15^tm1Imx/Tac)	abnormal CD8-positive, alpha-beta T cell differentiation	J:111786
	abnormal thymus cell ratio	J:111786
	decreased CD8-positive, alpha-beta T cell number	J:111786
Il15^tm1Imx/Il15^tm1Imx Il7r^tm1.1Asin/Il7r^tm1Imx Tg(Cd8a-cre)B8Asin/0 (involves: 129S7/SvEvBrd C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:190889
Il15^tm1Imx/Il15^tm1Imx Itk^tm1Litt/Itk^tm1Litt (involves: 129S4/SvJae * C57BL/6)	abnormal thymus cell ratio	J:111786
Il15^tm1Imx/Il15^tm1Imx Itk^tm1Ljb/Itk^tm1Ljb (involves: 129 * C57BL/6 * C57BL/10)	decreased CD8-positive, alpha-beta T cell number	J:113408
Il15^tm1Imx/Il15^tm1Imx Myc^tm1Atp/Myc⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased memory T cell number	J:132730
	decreased NK cell number	J:132730
Il15^tm1Imx/Il15^tm1Imx Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * C57BL/6)	decreased NK cell number	J:132257
Il15ra^tm1.1Nsl/Il15ra^tm1.1Nsl (involves: 129X1/SvJ * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:73738
	decreased memory T cell number	J:73738
	decreased NK cell number	J:73738
	decreased NK T cell number	J:73738
	decreased single-positive T cell number	J:73738
	increased CD4-positive, alpha-beta T cell number	J:73738
	lymph node hypoplasia	J:73738
Il15ra^tm1Ama/Il15ra^tm1Ama (involves: 129X1/SvJ)	decreased CD8-positive, alpha-beta T cell number	J:142570
	decreased CD8-positive, gamma-delta intraepithelial T cell number	J:155298
	decreased memory T cell number	J:142570
	decreased NK cell number	J:119213, J:142570
	decreased NK T cell number	J:142570
Il15ra^tm1Ama/Il15ra^tm2.1Ama Lyz2^tm1(cre)Ifo/0 Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)	decreased CD8-positive, alpha-beta T cell number	J:155298
	decreased memory T cell number	J:155298
	decreased NK cell number	J:155298
Il15ra^tm1Ama/Il15ra^tm2.1Ama Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)	abnormal NK cell differentiation	J:155298
	decreased CD8-positive, alpha-beta T cell number	J:155298
	decreased memory T cell number	J:155298
	decreased NK cell number	J:155298
Il15ra^tm1Ama/Il15ra^tm2.1Ama Tg(Itgax-cre)1-1Reiz/0 (involves: 129X1/SvJ * C57BL/6J * CBA)	abnormal NK cell differentiation	J:155298
	abnormal T cell subpopulation ratio	J:155298
	decreased CD8-positive, alpha-beta T cell number	J:155298
	decreased memory T cell number	J:155298
	decreased NK cell number	J:155298
Il15ra^tm1Ama/Il15ra^tm2.1Ama Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * SJL)	decreased CD8-positive, gamma-delta intraepithelial T cell number	J:155298
Il15ra^tm1Wjl/Il15ra^tm1Wjl (involves: 129 * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:142570
	decreased memory T cell number	J:142570
	decreased NK cell number	J:142570
	decreased NK T cell number	J:142570
Il17a/Il17f^tm1.1Impr/Il17a/Il17f^tm1.1Impr (involves: C57BL/6)	abnormal effector T cell morphology	J:187400
	absent gamma-delta T cells	J:187400
	increased gamma-delta T cell number	J:187400
Il17a/Il17f^tm1.1Impr/Il17a/Il17f^tm1.1Impr (involves: C57BL/6)	abnormal effector T cell morphology	J:187400
	absent gamma-delta T cells	J:187400
	increased gamma-delta T cell number	J:187400
Il17a^em1(IMPC)Mbp/Il17a^em1(IMPC)Mbp (C57BL/6N-Il17a^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Il17a^tm1Cdon/Il17a^tm1Cdon (involves: C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:136279
Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd)	decreased neutrophil cell number	J:193548
Il17a^tm1Yiw/Il17a^tm1Yiw (involves: 129P2/OlaHsd)	increased gamma-delta T cell number	J:193548
Il17a^tm1Yiw/Il17a^tm1Yiw Il17f^tm2Yiw/Il17f^tm2Yiw (involves: 129P2/OlaHsd * BALB/c)	enlarged submandibular lymph nodes	J:143719
Il17a^tm1Yiw/Il17a^tm1Yiw Il17f^tm2Yiw/Il17f^tm2Yiw (B6.129P2-Il17a^tm1Yiw Il17f^tm2Yiw)	enlarged submandibular lymph nodes	J:143719
Il17b^em1Cya/Il17b^em1Cya (C57BL/6-Il17b^em1Cya)	increased neutrophil cell number	J:339366
Il17b^{Gt(371C12)Cmhd}/Il17b^{Gt(371C12)Cmhd} (B6.129-Il17b^{Gt(371C12)Cmhd})	increased eosinophil cell number	J:229778
	increased T-helper 2 cell number	J:229778
Il17c^tm1.1Cdon/Il17c^tm1.1Cdon (involves: 129S6/SvEvTac)	decreased CD4-positive, alpha-beta T cell number	J:177650
Il17ra^tm1.2Kurs/Il17ra^tm1.2Kurs (involves: 129S4/SvJae * BALB/cJ * C57BL/6 * SJL)	increased CD4-positive, alpha-beta T cell number	J:196483
	increased gamma-delta T cell number	J:196483
	increased T-helper 17 cell number	J:196483
Il17ra^tm1Koll/Il17ra^tm1Koll (involves: 129 * C57BL/6)	abnormal granulocyte differentiation	J:71097
Il17ra^tm1Koll/Il17ra^tm1Koll (involves: 129 * C57BL/6)	decreased neutrophil cell number	J:71097
Il17ra^tm1Koll/Il17ra^tm1Koll (involves: 129)	abnormal T-helper 2 cell differentiation	J:158594
Il17rb^tm1Anjm/Il17rb^tm1Anjm (BALB/c-Il17rb^tm1Anjm)	decreased eosinophil cell number	J:159464
Il17rb^tm1Anjm/Il17rb^tm1Anjm Il1rl1^tm1Anjm/Il1rl1^tm1Anjm (involves: 129P2/OlaHsd * BALB/c)	decreased eosinophil cell number	J:159464
Il17rb^tm1Lex/Il17rb^tm1Lex (C.129-Il17rb^tm1Lex)	abnormal osteoclast differentiation	J:159874
Il17rb^tm1Tgi/Il17rb^tm1Tgi (B6.Cg-Il17rb^tm1Tgi)	decreased NK T cell number	J:184570
Il17rc^em1(IMPC)Mbp/Il17rc^em1(IMPC)Mbp (C57BL/6NCrl-Il17rc^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Il18^tm1Aki/Il18^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	abnormal microglial cell morphology	J:122031
Il18^tm1Aki/Il18^tm1Aki Nlrp1a^Neut1/Nlrp1a^Neut1 (involves: 129P2/OlaHsd * C57BL/6)	increased neutrophil cell number	J:191055
Il18^tm1Khe/Il18^tm1Khe (involves: 129P2/OlaHsd)	abnormal T cell morphology	J:62263
Il18^tm1Khe/Il18^tm1Khe (B6.129P2-Il18^tm1Khe)	increased dendritic cell number	J:138759
	increased macrophage cell number	J:138759
	increased NK cell number	J:138759
Il18bp^{tm1(KOMP)Vlcg}/Il18bp^{tm1(KOMP)Vlcg} (C57BL/6-Il18bp^{tm1(KOMP)Vlcg})	abnormal NK cell differentiation	J:255309
	decreased KLRG1-positive NK cell number	J:255309
	decreased mature NK cell number	J:255309
	decreased NK cell number	J:255309
	increased immature NK cell number	J:255309
Il18bp^{tm1.1(KOMP)Vlcg}/Il18bp^{tm1.1(KOMP)Vlcg} (involves: C57BL/6N)	abnormal lymph node morphology	J:261967
	abnormal phagocyte morphology	J:261967
	abnormal spleen morphology	J:261967
	enlarged spleen	J:261967
	increased B cell number	J:261967
	increased macrophage cell number	J:261967
	increased monocyte cell number	J:261967
Il20ra^tm1.1Misc/Il20ra^tm1.1Misc (involves: C57BL/6)	abnormal osteoclast differentiation	J:177783
Il20rb^tm1Uwe/Il20rb^tm1Uwe (B6.129P2-Il20rb^tm1Uwe)	increased memory T cell number	J:143497
Il21^tm1Lex/Il21^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal gamma-delta T cell morphology	J:123351
	abnormal T cell differentiation	J:123351
	decreased CD4-positive, alpha-beta T cell number	J:123351
Il21^tm1Lex/Il21^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:137867
	abnormal spleen germinal center morphology	J:137867
	decreased germinal center B cell number	J:137867
	decreased spleen germinal center number	J:137867
Il21^tm1Llit/Il21^tm1Llit (involves: 129 * C57BL/6J)	abnormal class switch recombination	J:114783
Il21r^tm1Day/Il21r^tm1Day (involves: BALB/c * C57BL/6)	abnormal CD4-positive T cell differentiation	J:136955, J:123352
Il21r^tm1Day/Il21r^tm1Day (involves: BALB/c * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:123352
Il21r^tm1Kopf/Il21r^tm1Kopf (B6.129-Il21r^tm1Kopf)	abnormal immune system morphology	J:137508
	decreased basophil cell number	J:137508
	decreased eosinophil cell number	J:137508
	decreased granulocyte number	J:137508
Il21r^tm1Wjl/Il21r^tm1Wjl (NOD.Cg-Il21r^tm1Wjl)	abnormal CD4-positive T cell differentiation	J:139075
Il21r^tm1Wjl/Il21r^tm1Wjl Il4^tm1Cgn/Il4^tm1Cgn (involves: 129 * C57BL/6)	abnormal lymph node germinal center morphology	J:80474
Il22^tm1Jcrd/Il22^tm1Jcrd (Not Specified)	decreased neutrophil cell number	J:193548
Il23a^tm1Dnax/Il23a^tm1Dnax (Not Specified)	decreased gamma-delta T cell number	J:193548
	decreased leukocyte cell number	J:193548
	decreased neutrophil cell number	J:193548
	decreased T cell number	J:193548
Il23a^tm1Ngh/Il23a^tm1Ngh (involves: 129S/SvEv * C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:88235
Il23a^tm1Ngh/Il23a^tm1Ngh (involves: 129 * C57BL/6)	decreased activated T cell number	J:120806
Il23r^tm1Kuch/Il23r^tm1Kuch (C57BL/6-Il23r^tm1Kuch)	abnormal CD4-positive T cell differentiation	J:148248
Il25^tm1.1Cdon/Il25^tm1.1Cdon (involves: 129S6/SvEvTac)	decreased eosinophil cell number	J:229778
Il25^tm1.1Cdon/Il25^tm1.1Cdon (involves: 129S6/SvEvTac)	decreased T-helper 2 cell number	J:229778
Il25^tm1Anjm/Il25^tm1Anjm (involves: 129P2/OlaHsd * C57BL/6)	abnormal mesenteric lymph node morphology	J:123748
	decreased eosinophil cell number	J:123748
Il25^tm1Dart/Il25^tm1Dart (involves: C57BL/6)	increased T cell number	J:125296
Il27^{tm1b(EUCOMM)Wtsi}/Il27^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Il27^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive, alpha-beta memory T cell number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
Il27^tm1Cua/Il27^tm1Cua (C57BL/6-Il27^tm1Cua)	abnormal CD4-positive T cell differentiation	J:147706
Il27ra^tm1Fjs/Il27ra^tm1Fjs (B6.Cg-Il27ra^tm1Fjs)	increased lymphocyte cell number	J:94856
Il31ra^tm1Ngh/Il31ra^tm1Ngh (C57BL/6-Il31ra^tm1Ngh)	spleen hypoplasia	J:123111
Il33^tm1Aki/Il33^tm1Aki (involves: 129X1/SvJ * C57BL/6)	decreased eosinophil cell number	J:182160
Il33^tm1Amgn/Il33^tm1Amgn (B6.129-Il33^tm1Amgn)	decreased lymphocyte cell number	J:192531
Il34^{tm1b(EUCOMM)Wtsi}/Il34^{tm1b(EUCOMM)Wtsi} (involves: BALB/cJ * C57BL/6N)	abnormal microglial cell morphology	J:187643
	absent Langerhans cell	J:187643
	decreased dendritic cell number	J:187643
	decreased Langerhans cell number	J:187643
	lymph node hypoplasia	J:187643
Il36g^tm1Lex/Il36g^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal macrophage morphology	J:264077
	decreased alveolar macrophage number	J:264077
	increased CD11b-high dendritic cell number	J:264077
Il36g^tm1Lex/Il36g^tm1Lex (involves: 129S5/SvEvBrd)	decreased CD4-positive, alpha-beta T cell number	J:256437
	increased CD4-positive, alpha-beta T cell number	J:256437
	increased regulatory T cell number	J:256437
Il36rn^tm1Kopf/Il36rn^tm1Kopf (B6.129S5-Il36rn^tm1Kopf)	increased leukocyte cell number	J:193548
Il36rn^tm1Kopf/Il36rn^tm1Kopf (B6.129S5-Il36rn^tm1Kopf)	increased neutrophil cell number	J:193548
Ilk^tm1Star/Ilk^tm2Star Tg(Acp5-cre)1Star/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased osteoclast cell number	J:197593
Imebt1^DU6/? (involves: DU6 * DUKs)	increased spleen weight	J:99475
Immp2l^{Tg(HLA-A/H2-D)2Enge}/? ((C57BL/6 x CBA)F1)	abnormal negative T cell selection	J:31937
Immp2l^{Tg(HLA-A/H2-D)2Enge}/? ((C57BL/6 x CBA)F1)	abnormal positive T cell selection	J:31937
Impact^{em1(IMPC)Ccpcz}/Impact^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Impact^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Impdh1^tm1Bmi/Impdh1^tm1Bmi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immune system cell morphology	J:85443
Impdh1^tm1Bmi/Impdh1^tm1Bmi Impdh2^tm1Bmi/Impdh2⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immune system cell morphology	J:85443
	abnormal lymphopoiesis	J:85443
Impdh2^tm1Bmi/Impdh2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymphocyte cell number	J:86045
Impg1^em1Visu/Impg1^em1Visu Impg2^em1Visu/Impg2^em1Visu (involves: C57BL/6J * DBA/2)	microgliosis	J:288311
Impg2^em1Visu/Impg2^em1Visu (involves: C57BL/6J * DBA/2)	microgliosis	J:288311
In(2a;Itch)18H/In(2a;Itch)18H (involves: 101/H * C3H/HeH)	abnormal alveolar macrophage morphology	J:24934
	increased spleen red pulp amount	J:24934
	lymph node hyperplasia	J:24934
Inca1^tm1Cmt/Inca1^tm1Cmt (involves: 129 * C57BL/6N)	abnormal spleen B cell follicle morphology	J:175667
	abnormal spleen morphology	J:175667
	abnormal spleen white pulp morphology	J:175667
Ing1^{Gt(OST206270)Lex}/Ing1^{Gt(OST206270)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	decreased thymocyte number	J:118602
Ing1^tm1Avg/Ing1^tm1Avg (involves: 129S1/Sv * C57BL/6)	enlarged spleen	J:105658
Ing2^tm1.1Ccha/Ing2^tm1.1Ccha (involves: 129 * C57BL/6J * FVB/N)	spleen hyperplasia	J:167311
Ing4^em1(IMPC)Tcp/Ing4^em1(IMPC)Tcp (C57BL/6NCrl-Ing4^em2(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Ing5^tm1.1Avo/Ing5^tm1.1Avo (B6.Cg-Ing5^tm1.1Avo)	spleen hypoplasia	J:345308
Inmt^em1(IMPC)Mbp/Inmt^em1(IMPC)Mbp (C57BL/6N-Inmt^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Ino80^tm1.1Schg/Ino80⁺ Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6J)	increased T cell derived lymphoma incidence	J:221224
Inpp4b^tm1.1Jva/Inpp4b^tm1.1Jva (B6.129-Inpp4b^tm1.1Jva)	abnormal osteoclast differentiation	J:177648
	abnormal osteoclast morphology	J:177648
	increased osteoclast cell number	J:177648
Inpp5d^el20/Inpp5d^el20 (B6.129-Inpp5d^el20)	abnormal lymphocyte cell number	J:173266
	decreased lymphocyte cell number	J:173266
	decreased pre-B cell number	J:173266
	decreased thymocyte number	J:173266
	enlarged spleen	J:173266
	increased macrophage cell number	J:173266
	small thymus	J:173266
Inpp5d^m1Btlr/Inpp5d^m1Btlr (C57BL/6J-Inpp5d^m1Btlr)	abnormal B cell differentiation	J:140987
	enlarged spleen	J:140987
	enlarged thymus	J:140987
Inpp5d^m2Btlr/Inpp5d^m2Btlr (C57BL/6J-Inpp5d^m2Btlr)	decreased B cell number	J:216053
Inpp5d^M3Btlr/Inpp5d⁺ (C57BL/6J-Inpp5d^M3Btlr)	decreased NK cell number	J:254907
Inpp5d^m5Btlr/Inpp5d^m5Btlr (C57BL/6J-Inpp5d^m5Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272856
	abnormal lymphocyte morphology	J:272856
	abnormal T cell differentiation	J:272856
	decreased alpha-beta T cell number	J:272856
	decreased B cell number	J:272856
	decreased CD4-positive, alpha-beta T cell number	J:272856
	decreased CD8-positive, alpha-beta T cell number	J:272856
	decreased CD8-positive, naive alpha-beta T cell number	J:272856
	decreased NK cell number	J:272856
	increased B-1 B cell number	J:272856
	increased CD8-positive, alpha-beta T cell number	J:272856
	increased central memory CD8 positive, alpha-beta T cell number	J:272856
	increased effector memory CD4-positive, alpha-beta T cell number	J:272856
	increased effector memory CD8-positive, alpha-beta T cell number	J:272856
Inpp5d^tm1.1Wgk/Inpp5d^tm1.1Wgk (involves: 129S6/SvEvTac * C57BL/6J)	abnormal mononuclear cell differentiation	J:94861
	abnormal NK cell morphology	J:95215
	increased dendritic cell number	J:94861
	increased monocyte cell number	J:94861
	increased NK cell number	J:95215
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt (involves: 129P2/OlaHsd)	decreased B cell number	J:77739
	enlarged lymph nodes	J:77739
	enlarged spleen	J:77739
	increased leukocyte cell number	J:77739
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt (B6.129P2/OlaHsd-Inpp5d^tm1Dmt)	decreased lymphocyte cell number	J:173266
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt (B6.129P2/OlaHsd-Inpp5d^tm1Dmt)	decreased pre-B cell number	J:173266
Inpp5d^tm1Rav/Inpp5d^tm1.1Rav Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen marginal zone macrophage morphology	J:119256
	absent marginal zone B cells	J:119256
	enlarged spleen	J:119256
Inpp5d^tm1Rav/Inpp5d^tm1Rav Cd79a^tm1(cre)Reth/Cd79a⁺ Tg(IghAb36-65)1Wys/0 (involves: 129 * BALB/c * C57BL/6 * FVB/N)	abnormal B cell negative selection	J:178833
	decreased B cell number	J:178833
	increased plasma cell number	J:178833
Inpp5d^tm1Rav/Inpp5d^tm1Rav Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	abnormal lymph node germinal center morphology	J:122796
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal granulocyte differentiation	J:48193
	abnormal lymphopoiesis	J:48193
	abnormal monocyte differentiation	J:48193
	decreased lymphocyte cell number	J:48193
	increased monocyte cell number	J:48193
	increased neutrophil cell number	J:48193
	increased spleen weight	J:48193
	spleen hyperplasia	J:48193
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal myelopoiesis	J:117320
	decreased pro-B cell number	J:117320
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh (involves: 129S1/Sv * 129X1/SvJ)	abnormal osteoclast differentiation	J:78771
	abnormal osteoclast morphology	J:78771
	increased osteoclast cell number	J:78771
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh Rag1^tm1(GFP)Imku/Rag1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal lymphopoiesis	J:117320
Inpp5d^tm1Wgk/Inpp5d^tm1.1Wgk Tg(Mx1-cre)1Cgn/0 (B6.Cg-Inpp5d^tm1Wgk/Inpp5d^tm1.1Wgk Tg(Mx1-cre)1Cgn)	abnormal myeloid leukocyte morphology	J:144110
Inpp5k^em1(IMPC)H/Inpp5k⁺ (C57BL/6NTac-Inpp5k^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Ins2^Akita/Ins2⁺ (C57BL/6-Ins2^Akita/J)	abnormal microglial cell morphology	J:99412
Ins2^Akita/Ins2⁺ (C57BL/6-Ins2^Akita/J)	increased leukocyte cell number	J:99412
Ins2^Akita/Ins2⁺ Prf1^tm1Sdz/Prf1^tm1Sdz Rag1^tm1Mom/Rag1^tm1Mom (NOD.Cg-Rag1^tm1Mom Ins2^Akita Prf1^tm1Sdz)	absent mature B cells	J:138005
	absent T cells	J:138005
	increased granulocyte number	J:138005
	increased macrophage cell number	J:138005
	increased monocyte cell number	J:138005
Insyn2b^em1(IMPC)J/Insyn2b^em1(IMPC)J (C57BL/6NJ-Insyn2b^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Invs^inv/Invs^inv (FVB/N-Invs^inv)	abnormal spleen morphology	J:48533
Invs^inv/Invs^inv (FVB/N-Invs^inv)	spleen hypoplasia	J:48533
Ipo7^em1(IMPC)Mbp/Ipo7⁺ (C57BL/6N-Ipo7^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Ipp^{tm1.1(KOMP)Vlcg}/Ipp^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ipp^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Iqce^{tm1b(EUCOMM)Hmgu}/Iqce^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Iqce^{tm1b(EUCOMM)Hmgu}/Ics)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Iqcm^em1(IMPC)Tcp/Iqcm⁺ (C57BL/6NCrl-Iqcm^em1(IMPC)Tcp/Cmmr)	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Iqcm^em1(IMPC)Tcp/Iqcm^em1(IMPC)Tcp (C57BL/6NCrl-Iqcm^em1(IMPC)Tcp/Cmmr)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased monocyte cell number	J:211773
Iqgap1^{tm1b(EUCOMM)Wtsi}/Iqgap1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Iqgap1^{tm1b(EUCOMM)Wtsi}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Irag1^{em1(IMPC)Ccpcz}/Irag1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Irag1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Irak3^tm1Flv/Irak3^tm1Flv (involves: 129S1/Sv * C57BL/6)	abnormal immune system morphology	J:78189
	abnormal Peyer's patch morphology	J:78189
	enlarged Peyer's patches	J:78189
	increased neutrophil cell number	J:78189
	increased osteoclast cell number	J:98035
Irak3^tm1Flv/Irak3^tm1Flv (NOD.129S1(B6)-Irak3^tm1Flv)	abnormal T cell differentiation	J:229884
Irak3^tm1Flv/Irak3^tm1Flv (NOD.129S1(B6)-Irak3^tm1Flv)	increased effector memory T-helper cell number	J:229884
Irak4^{em1(IMPC)Ccpcz}/Irak4^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Irak4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ireb2^tm1.2Mwh/Ireb2^tm1.2Mwh (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)	decreased spleen iron level	J:103414
Ireb2^tm1Mwh/Ireb2^tm1Mwh (involves: 129P2/OlaHsd * C57BL/6J)	decreased spleen iron level	J:105124
Ireb2^tm1Roua/Ireb2^tm1Roua (B6.Cg-Ireb2^tm1Roua)	decreased spleen iron level	J:176655
Irf1^M1Btlr/Irf1⁺ (C57BL/6J-Irf1^M1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:162995
Irf1^M1Btlr/Irf1⁺ (C57BL/6J-Irf1^M1Btlr)	decreased NK cell number	J:162995
Irf1^M1Btlr/Irf1^M1Btlr (C57BL/6J-Irf1^M1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:162995
Irf1^M1Btlr/Irf1^M1Btlr (C57BL/6J-Irf1^M1Btlr)	decreased NK cell number	J:162995
Irf1^m2Btlr/Irf1^m2Btlr (C57BL/6J-Irf1^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:267675
	decreased NK cell number	J:267675
	increased B-1 B cell number	J:267675
	increased CD4-positive, alpha-beta T cell number	J:267675
Irf1^M3Btlr/Irf1^M3Btlr (C57BL/6J-Irf1^M3Btlr)	decreased CD8-positive, alpha-beta T cell number	J:267677
Irf1^M3Btlr/Irf1^M3Btlr (C57BL/6J-Irf1^M3Btlr)	increased CD4-positive, alpha-beta T cell number	J:267677
Irf1^tm1Cwe/Irf1^tm1Cwe (involves: 129/Sv * C57BL/6)	abnormal immune system morphology	J:21235
	abnormal splenocyte morphology	J:21235
	abnormal T cell morphology	J:21235, J:36025
	abnormal thymus cell ratio	J:36025
	decreased CD8-positive, alpha-beta T cell number	J:21235
	increased T-helper 2 cell number	J:110672
Irf1^tm1Mak/Irf1^tm1Mak (either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))	abnormal T cell number	J:64286
	decreased CD8-positive, alpha-beta T cell number	J:64286
	increased CD4-positive, alpha-beta T cell number	J:64286
	increased double-positive T cell number	J:64286
Irf2^tm1Mak/Irf2^tm1Mak (either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))	decreased mature B cell number	J:64286
	decreased T cell number	J:64286
Irf2^tm1Mak/Irf2^tm1Mak (involves: 129S2/SvPas * C57BL/6)	enlarged inguinal lymph nodes	J:66034
	increased memory T cell number	J:66034
	lymph node hyperplasia	J:66034
Irf3^em1(IMPC)Mbp/Irf3^em1(IMPC)Mbp (C57BL/6N-Irf3^em1(IMPC)Mbp/MbpMmucd)	enlarged lymph nodes	J:211773
Irf3^tm1Ttg/Irf3^tm1Ttg Sting1^em1Jmin/Sting1^em1Jmin (involves: 129S/SvEv * C57BL/6N)	decreased single-positive T cell number	J:251372
Irf4^em1(IMPC)Mbp/Irf4^em1(IMPC)Mbp (C57BL/6N-Irf4^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Irf4^m1Btlr/Irf4^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Irf4^tm1.1Rdf/Irf4^tm1.1Rdf (involves: 129S1/Sv * 129S4/SvJae * C57BL/6)	abnormal B cell differentiation	J:112643
	absent spleen germinal center	J:112643
Irf4^tm1Mak/Irf4^tm1Mak (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:42683
	abnormal immune system cell morphology	J:42683
	abnormal lymph node morphology	J:42683
	abnormal spleen morphology	J:42683
	absent lymph node germinal center	J:42683
	absent plasma cells	J:42683
	absent spleen germinal center	J:42683
	arrested B cell differentiation	J:42683
	decreased dendritic cell number	J:91043
	enlarged lymph nodes	J:42683
	enlarged spleen	J:42683
	increased lymphocyte cell number	J:42683
Irf4^tm1Mak/Irf4^tm1Mak (B6.129P2-Irf4^tm1Mak)	abnormal CD4-positive, alpha beta T cell morphology	J:78909
Irf4^tm1Mak/Irf4^tm1Mak (B6.129P2-Irf4^tm1Mak)	abnormal T-helper 1 cell differentiation	J:78909
Irf4^tm1Mak/Irf4^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	decreased plasmacytoid dendritic cell number	J:97716
Irf5^{tm1e(EUCOMM)Wtsi}/Irf5^{tm1e(EUCOMM)Wtsi} (C57BL/6N-Irf5^{tm1e(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive, alpha-beta memory T cell number	J:211773
	decreased leukocyte cell number	J:211773
Irf8^M1Btlr/Irf8^M1Btlr (C57BL/6J-Irf8^M1Btlr)	decreased macrophage cell number	J:166600
	decreased monocyte cell number	J:166600
	increased neutrophil cell number	J:166600
Irf8^m2Btlr/Irf8^m2Btlr (C57BL/6J-Irf8^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:274937
Irf8^m2Btlr/Irf8^m2Btlr (C57BL/6J-Irf8^m2Btlr)	increased CD4-positive, alpha-beta T cell number	J:274937
Irf8^myls/Irf8⁺ (involves: BXH2/TyJ * C57BL/6)	increased B cell number	J:168923
	increased B-1b cell number	J:168923
	increased follicular B cell number	J:168923
	increased transitional stage B cell number	J:168923
Irf8^myls/Irf8^myls (involves: BALB/cJ * BXH2/TyJ-Irf8^myls)	abnormal myelopoiesis	J:97931
	enlarged spleen	J:97931
Irf8^myls/Irf8^myls Slc11a1^r/Slc11a1^r (BXH2/TyJ)	abnormal myelopoiesis	J:97931
Irf8^myls/Irf8^myls Slc11a1^r/Slc11a1^r (BXH2/TyJ)	enlarged spleen	J:97931
Irf8^myls/Irf8^myls Slc11a1^r/Slc11a1^r (involves: BXH2/TyJ * C3H/HeJ)	enlarged spleen	J:97931
Irf8^tm1Hor/Irf8^tm1Hor (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal plasma cell number	J:36038
	decreased B cell number	J:36038
	decreased lymphocyte cell number	J:36038
	decreased T cell number	J:36038
	enlarged lymph nodes	J:36038
	hepatosplenomegaly	J:36038
	increased B cell number	J:36038
	increased granulocyte number	J:36038
	increased leukocyte cell number	J:36038
	increased lymphocyte cell number	J:36038
	increased macrophage cell number	J:36038
	increased mature B cell number	J:36038
	increased spleen red pulp amount	J:36038
	increased spleen weight	J:36038
	spleen hyperplasia	J:36038
Irf8^tm1Hor/Irf8^tm1Hor (B6.129P2-Irf8^tm1Hor)	decreased follicular B cell number	J:168923
	increased B-1b cell number	J:168923
	increased marginal zone B cell number	J:168923
Irf8^tm1Hor/Irf8^tm1Hor Irf4^tm1Mak/Irf4^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:84577
	abnormal pre-B cell morphology	J:84577
	absent B cells	J:84577
	arrested B cell differentiation	J:84577
	decreased dendritic cell number	J:97716
	decreased lymphocyte cell number	J:84577
	decreased plasmacytoid dendritic cell number	J:97716
	decreased T cell number	J:84577
	increased pre-B cell number	J:84577
Irgc^em1(IMPC)Tcp/Irgc^em1(IMPC)Tcp (C57BL/6N-Irgc^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
Irs1^Sml/Irs1^Sml (C3.Cg-Irs1^Sml H2^b/GrsrJ)	increased osteoclast cell number	J:163661
Irs1^tm1Tka/Irs1^tm1Tka (involves: C57BL/6 * CBA)	abnormal osteoclast differentiation	J:61479
Is(14)1Rdf Is(14)2Rdf/Del(14Trim13-Dleu2)4Rdf Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	increased B cell number	J:156946
	increased B-1a cell number	J:156946
	increased spleen white pulp amount	J:156946
Is(14)1Rdf Is(14)5Rdf/Del(14Trim13-Rnaseh2b)6Rdf Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal lymphopoiesis	J:179879
	increased B cell number	J:179879
Is(14)1Rdf/Is(14)1Rdf Is(14)5Rdf/Is(14)5Rdf Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	abnormal lymphopoiesis	J:179879
	increased B cell number	J:179879
Isl1^tm1(cre)Sev/Isl1⁺ Pax9^tm1Rbal/Pax9^tm1.1Hpt (involves: 129 * C57BL/6J)	ectopic thymus	J:311535
	thymus hypoplasia	J:311535
Ism1^{em1(IMPC)Ccpcz}/Ism1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ism1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Isy1^em1(IMPC)J/Isy1⁺ (C57BL/6NJ-Isy1^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Itch^tm1.1Alta/Itch^tm1.1Alta Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymph organ size	J:204685
	abnormal lymphopoiesis	J:204685
	abnormal T-helper 2 cell differentiation	J:204685
	decreased CD4-positive, alpha-beta T cell number	J:204685
	enlarged lymph nodes	J:204685
	enlarged spleen	J:204685
	increased CD4-positive, alpha-beta T cell number	J:204685
	increased CD8-positive, alpha-beta T cell number	J:204685
	increased eosinophil cell number	J:204685
	increased leukocyte cell number	J:204685
	increased regulatory T cell number	J:204685
Itch^{tm1b(EUCOMM)Hmgu}/Itch^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Itch^{tm1b(EUCOMM)Hmgu}/H)	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Itfg2^{Gt(OST215121)Lex}/Itfg2^{Gt(OST215121)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	decreased B cell number	J:205951
	decreased lymphocyte cell number	J:205951
	decreased spleen germinal center number	J:205951
	decreased T follicular helper cell number	J:205951
	increased B cell number	J:205951
	spleen hyperplasia	J:205951
Itga2b^tm1Tlr/Itga2b^tm1Tlr (either: (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	enlarged spleen	J:63961
Itga4^tm1Mgin/Itga4^tm1Mgin (B6.129-Itga4^tm1Mgin)	decreased monocyte cell number	J:106471
Itga4^tm1Mgin/Itga4^tm1Mgin (B6.129-Itga4^tm1Mgin)	decreased Peyer's patch number	J:106471
Itga4^tm1Mshi/Itga4^tm1Mshi (C57BL/6-Itga4^tm1Mshi)	abnormal mononuclear cell morphology	J:144092
	decreased B cell number	J:144092
	decreased lymphocyte cell number	J:144092
	decreased T cell number	J:144092
	small Peyer's patches	J:144092
Itga4^tm1Tpa/Itga4^tm1Tpa Tg(Mx1-cre)1Cgn/? (involves: 129S4/SvJaeSor * C57BL/6 * CBA)	abnormal B cell differentiation	J:86861
	decreased CD4-positive, alpha-beta T cell number	J:86861
	increased leukocyte cell number	J:86861
Itga6^tm1Son/Itga6^tm1Son (involves: 129P2/OlaHsd * FVB)	abnormal lymph node morphology	J:50235
Itga6^tm1Son/Itga6^tm1Son (involves: 129P2/OlaHsd * FVB)	decreased T cell number	J:50235
Itgad^tm1.1Zimm/Itgad^tm1.1Zimm (involves: 129S6/SvEvTac * C57BL/6)	increased spleen weight	J:130908
Itgad^tm1Bll/Itgad^tm1Bll (B6.129S7-Itgad^tm1Bll)	abnormal lymphocyte cell number	J:90954
	abnormal T cell subpopulation ratio	J:90954
	decreased CD4-positive, alpha-beta T cell number	J:90954
	increased CD8-positive, alpha-beta T cell number	J:90954
Itgae^{tm1b(EUCOMM)Wtsi}/Itgae^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Itgae^{tm1b(EUCOMM)Wtsi}/H)	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
Itgae^tm1Cmp/Itgae^tm1Cmp (involves: 129S2/SvPas * BALB/c)	decreased lymphocyte cell number	J:55333
Itgae^tm1Cmp/Itgae^tm1Cmp (involves: 129S2/SvPas * BALB/c)	decreased T cell number	J:55333
Itgal^em1(IMPC)H/Itgal^em1(IMPC)H (C57BL/6NTac-Itgal^em1(IMPC)H/H)	increased spleen weight	J:211773
Itgal^tm1.1Mshi/Itgal^tm1.1Mshi (involves: C57BL/6)	decreased lymphocyte cell number	J:168533
Itgal^tm1.1Mshi/Itgal^tm1.1Mshi (involves: C57BL/6)	small lymph nodes	J:168533
Itgal^tm1Bll/Itgal^tm1Bll (involves: 129S7/SvEvBrd * C57BL/6J)	increased eosinophil cell number	J:83226
	increased leukocyte cell number	J:83226
	increased monocyte cell number	J:83226
	increased neutrophil cell number	J:83226
Itgal^tm1Bll/Itgal^tm1Bll (B6.129S7-Itgal^tm1Bll)	increased leukocyte cell number	J:100242
Itgal^tm1Bll/Itgal^tm1Bll (B6.129S7-Itgal^tm1Bll)	increased neutrophil cell number	J:100242
Itgal^tm1Hlz/Itgal^tm1Hlz (involves: 129P2/OlaHsd)	decreased lymphocyte cell number	J:99286
	decreased neutrophil cell number	J:99286
	spleen hyperplasia	J:99286
Itgal^tm1Hogg/Itgal^tm1Hogg (involves: 129P2/OlaHsd)	abnormal lymph node morphology	J:82587
	decreased B cell number	J:82587
	decreased CD4-positive, alpha-beta T cell number	J:82587
	decreased CD8-positive, alpha-beta T cell number	J:82587
	decreased lymphocyte cell number	J:82587
	enlarged spleen	J:82587
	increased CD4-positive, alpha-beta T cell number	J:82587
	increased CD8-positive, alpha-beta T cell number	J:82587
	small lymph nodes	J:82587
Itgal^tm1Wpfl/Itgal^tm1Wpfl (involves: 129)	lymph node hyperplasia	J:37160
Itgam^m1Btlr/Itgam⁺ (C57BL/6J-Itgam^m1Btlr)	abnormal dendritic cell number	J:236681
	decreased macrophage cell number	J:236681
	decreased neutrophil cell number	J:236681
	increased plasmacytoid dendritic cell number	J:236681
Itgam^m1Btlr/Itgam^m1Btlr (C57BL/6J-Itgam^m1Btlr)	abnormal dendritic cell number	J:236681
	decreased macrophage cell number	J:236681
	decreased neutrophil cell number	J:236681
	increased plasmacytoid dendritic cell number	J:236681
Itgam^m2Btlr/Itgam^m2Btlr (C57BL/6J-Itgam^m2Btlr)	decreased CD11b-high dendritic cell number	J:272532
Itgam^m3Btlr/Itgam^m3Btlr (C57BL/6J-Itgam^m3Btlr)	decreased CD11b-high dendritic cell number	J:272533
Itgam^tm1Bll/Itgam^tm1Bll (B6.129S7-Itgam^tm1Bll)	abnormal lymphocyte cell number	J:90954
	abnormal T cell subpopulation ratio	J:90954
	decreased CD4-positive, alpha-beta T cell number	J:90954
	increased CD8-positive, alpha-beta T cell number	J:90954
	increased leukocyte cell number	J:100242
	increased neutrophil cell number	J:100242
Itgam^tm1Bll/Itgam^tm1Bll (involves: 129S7/SvEvBrd * C57BL/6J)	decreased eosinophil cell number	J:83226
Itgam^tm1Myd/Itgam^tm1Myd (involves: 129S4/SvJae * BALB/c * C57BL/6)	increased eosinophil cell number	J:38052
	increased neutrophil cell number	J:38052
Itgam^tm1Myd/Itgam^tm1Myd (involves: 129S4/SvJae * C57BL/6)	decreased neutrophil cell number	J:103873
Itgam^tm1Myd/Itgam^tm1Myd (B6.129S4-Itgam^tm1Myd)	abnormal neutrophil morphology	J:113463
Itgav^tm2Hyn/Itgav^tm2.1Hyn Tg(Tek-cre)1Ywa/? (involves: 129S2/SvPas * C57BL/6 * FVB * SJL)	abnormal dendritic cell differentiation	J:125508
	abnormal immune system morphology	J:125508
	abnormal leukocyte morphology	J:125508
	decreased regulatory T cell number	J:125508
	enlarged mesenteric lymph nodes	J:125508
	enlarged Peyer's patches	J:125508
	increased regulatory T cell number	J:125508
Itgax^M1Btlr/Itgax⁺ (C57BL/6J-Itgax^M1Btlr)	decreased dendritic cell number	J:236684
Itgax^M1Btlr/Itgax⁺ (C57BL/6J-Itgax^M1Btlr)	increased plasmacytoid dendritic cell number	J:236684
Itgax^M1Btlr/Itgax^M1Btlr (C57BL/6J-Itgax^M1Btlr)	decreased dendritic cell number	J:236684
Itgax^M1Btlr/Itgax^M1Btlr (C57BL/6J-Itgax^M1Btlr)	increased plasmacytoid dendritic cell number	J:236684
Itgb2^M1Btlr/Itgb2^M1Btlr (C57BL/6J-Itgb2^M1Btlr)	abnormal NK cell differentiation	J:139559
Itgb2^m3Btlr/Itgb2^m3Btlr (C57BL/6J-Itgb2^m3Btlr)	decreased B cell number	J:265126
	decreased CD4-positive, alpha-beta T cell number	J:265126
	decreased CD8-positive, alpha-beta T cell number	J:265126
	decreased dendritic cell number	J:265126
	decreased macrophage cell number	J:265126
	decreased neutrophil cell number	J:265126
	decreased single-positive T cell number	J:265126
	increased dendritic cell number	J:265126
	increased effector memory CD4-positive, alpha-beta T cell number	J:265126
	increased NK T cell number	J:265126
Itgb2^M4Btlr/Itgb2^M4Btlr (C57BL/6J-Itgb2^M4Btlr)	abnormal T cell differentiation	J:272843
Itgb2^M4Btlr/Itgb2^M4Btlr (C57BL/6J-Itgb2^M4Btlr)	increased effector memory CD4-positive, alpha-beta T cell number	J:272843
Itgb2^m5Btlr/Itgb2^m5Btlr (C57BL/6J-Itgb2^m5Btlr)	increased B-1b cell number	J:272844
Itgb2^tm1.1Arte/Itgb2^tm1.1Arte (involves: C57BL/6NTac)	enlarged spleen	J:202261
	increased B cell number	J:202261
	increased dendritic cell number	J:202261
	increased neutrophil cell number	J:202261
	increased T cell number	J:202261
	lymph node hypoplasia	J:202261
Itgb2^tm1Bay/Itgb2^tm1Bay (involves: 129S7/SvEvBrd)	increased granulocyte number	J:13599
	increased leukocyte cell number	J:13599, J:32126
	increased lymphocyte cell number	J:13599
Itgb2^tm1Bay/Itgb2^tm1Bay (involves: 129S7/SvEvBrd * PL/J)	abnormal spleen morphology	J:32126
	enlarged lymph nodes	J:32126
	increased basophil cell number	J:32126
	increased eosinophil cell number	J:32126
	increased leukocyte cell number	J:32126
	increased lymphocyte cell number	J:32126
	increased monocyte cell number	J:32126
	increased neutrophil cell number	J:32126
	increased T cell number	J:109598
	increased T-helper 1 cell number	J:109598
	myeloid hyperplasia	J:32126
Itgb2^tm1Bay/Itgb2^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal spleen red pulp morphology	J:13599
	myeloid hyperplasia	J:13599
Itgb2^tm2Bay/Itgb2^tm2Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal immune system cell morphology	J:48542
	abnormal lymph organ size	J:48542
	abnormal neutrophil morphology	J:48542
	enlarged lymph nodes	J:48542
	enlarged spleen	J:48542
	increased leukocyte cell number	J:48542
	increased lymphocyte cell number	J:48542
	increased monocyte cell number	J:48542
	increased neutrophil cell number	J:48542
	myeloid hyperplasia	J:48542
Itgb2^tm2Bay/Itgb2^tm2Bay (B6.129S7-Itgb2^tm2Bay)	increased eosinophil cell number	J:83226
	increased leukocyte cell number	J:83226
	increased lymphocyte cell number	J:83226
	increased monocyte cell number	J:83226
	increased neutrophil cell number	J:83226
Itgb2^tm2Bay/Itgb2^tm2Bay (involves: 129S7/SvEvBrd * C57BL/6)	increased neutrophil cell number	J:112286
Itgb3^tm1Hyn/Itgb3^tm1.1Wlbcr Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal osteoclast differentiation	J:224675
	abnormal osteoclast morphology	J:224675
	decreased osteoclast cell number	J:224675
Itgb3^tm1Hyn/Itgb3^tm1.1Wlbcr Tg(Pf4-icre)Q3Rsko/0 (involves: 129S2/SvPas * C57BL/6)	enlarged spleen	J:224675
Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	enlarged spleen	J:52262
Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	increased monocyte cell number	J:119666
Itgb3^tm1Hyn/Itgb3^tm1Hyn (involves: 129S2/SvPas)	abnormal osteoclast morphology	J:60672
	decreased macrophage cell number	J:96049
	increased osteoclast cell number	J:60672
Itgb5^{tm1a(EUCOMM)Wtsi}/Itgb5^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Itgb5^{tm1a(EUCOMM)Wtsi}/Ics)	increased leukocyte cell number	J:165965
Itgb6^{em1(IMPC)Ccpcz}/Itgb6^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Itgb6^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Itgb6^tm1Des/Itgb6^tm1Des (involves: 129S4/SvJae)	absent Langerhans cell	J:120085
Itgb6^tm1Des/Itgb6^tm1Des (involves: 129S4/SvJae)	decreased Langerhans cell number	J:120085
Itgb7^tm1Cgn/Itgb7^tm1Cgn (involves: C57BL/6)	abnormal gut-associated lymphoid tissue morphology	J:34306
	abnormal immune system morphology	J:34306
	abnormal Peyer's patch follicle morphology	J:34306
	abnormal uterine NK cell morphology	J:44813
	decreased B cell number	J:34306
	decreased CD4-positive, alpha-beta T cell number	J:34306
	decreased eosinophil cell number	J:62733
	decreased mast cell number	J:62733
	increased uterine NK cell number	J:44813
	small Peyer's patches	J:34306
Itgb7^tm1Mshi/Itgb7^tm1Mshi (involves: C57BL/6)	small Peyer's patches	J:127413
Itk^m2Btlr/Itk^m2Btlr (C57BL/6J-Itk^m2Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254826
	decreased CD8-positive, alpha-beta memory T cell number	J:254826
	decreased CD8-positive, naive alpha-beta T cell number	J:254826
	increased B cell number	J:254826
	increased central memory CD4-positive, alpha-beta T cell number	J:254826
	increased central memory CD8 positive, alpha-beta T cell number	J:254826
	increased effector memory CD4-positive, alpha-beta T cell number	J:254826
Itk^tm1Lex/Itk^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased CD4-positive, alpha-beta T cell number	J:103485
	decreased CD8-positive, alpha-beta T cell number	J:103485
	increased B cell number	J:103485
Itk^tm1Litt/Itk^tm1Litt (involves: 129S4/SvJae * C57BL/6J)	decreased B cell number	J:31230
	decreased CD4-positive, alpha-beta T cell number	J:31230
	decreased T cell number	J:31230
Itk^tm1Litt/Itk^tm1Litt (involves: 129S4/SvJae * C57BL/6)	abnormal CD8-positive, alpha-beta T cell differentiation	J:111786
	abnormal thymus cell ratio	J:111786
	decreased CD8-positive, alpha-beta T cell number	J:111786
Itk^tm1Litt/Itk^tm1Litt (B6.129S4-Itk^tm1Litt)	abnormal positive T cell selection	J:141390
	abnormal T cell morphology	J:141390
	decreased T cell number	J:141390
	increased double-negative T cell number	J:141390
Itk^tm1Litt/Itk^tm1Litt Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2J)	abnormal positive T cell selection	J:31230
	decreased CD4-positive, alpha-beta T cell number	J:31230
	increased double-positive T cell number	J:31230
Itk^tm1Litt/Itk^tm1Litt Tg(TcrAND)53Hed/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	abnormal lymphocyte morphology	J:31230
	decreased CD4-positive, alpha-beta T cell number	J:31230
	increased double-negative T cell number	J:31230
Itk^tm1Litt/Itk^tm1Litt Txk^tm1Pls/Txk^tm1Pls (involves: 129S4/SvJae * 129S6/SvEvTac)	decreased CD4-positive, alpha-beta T cell number	J:54449
	decreased single-positive T cell number	J:54449
Itk^tm1Litt/Itk^tm1Litt Vav1^tm2Bbd/Vav1^tm2Bbd (B6.129-Itk^tm1Litt Vav1^tm2Bbd)	abnormal CD4-positive T cell differentiation	J:141390
	abnormal CD8-positive, alpha-beta T cell differentiation	J:141390
	abnormal positive T cell selection	J:141390
	abnormal T cell morphology	J:141390
	decreased CD4-positive, alpha-beta T cell number	J:141390
	decreased CD8-positive, alpha-beta T cell number	J:141390
	decreased double-positive T cell number	J:141390
	decreased T cell number	J:141390
	decreased thymocyte number	J:141390
	increased B cell number	J:141390
Itk^tm1Ljb/Itk^tm1Ljb (B6.129-Itk^tm1Ljb)	abnormal NK T cell morphology	J:120689
Itk^tm1Ljb/Itk^tm1Ljb (B6.129-Itk^tm1Ljb)	decreased NK T cell number	J:120689
Itk^tm1Ljb/Itk^tm1Ljb (involves: 129 * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:48231
Itk^tm1Ljb/Itk^tm1Ljb (B10.129-Itk^tm1Ljb)	abnormal CD8-positive, alpha-beta T cell differentiation	J:113408
	abnormal gamma-delta T cell morphology	J:148531
	decreased CD4-positive, alpha-beta T cell number	J:123795
	increased CD8-positive, alpha-beta T cell number	J:113408, J:123795
	increased germinal center B cell number	J:148531
	increased mature gamma-delta T cell number	J:148531
	increased memory T cell number	J:113408
Itk^tm1Ljb/Itk^tm1Ljb Rag1^tm1Mom/Rag1^tm1Mom Tg(Tcra5CC7,Tcrb5CC7)IWep/? (involves: 129 * C57BL/10)	abnormal CD4-positive T cell differentiation	J:93606
Itk^tm1Ljb/Itk^tm1Ljb Tg(Tcra2B4)1Mmd/? Tg(Tcrb2B4)1Mmd/? (involves: C3H/HeJ * C57BL/6 * C57BL/10)	decreased CD4-positive, alpha-beta T cell number	J:123795
Itk^tm1Ljb/Itk^tm1Ljb Tg(Tcra5CC7,Tcrb5CC7)IWep/? (involves: 129 * C57BL/10)	decreased CD4-positive, alpha-beta T cell number	J:123795
Itk^tm1Ljb/Itk^tm1Ljb Txk^tm1Pls/Txk^tm1Pls (B6.129-Txk^tm1Pls Itk^tm1Ljb)	increased CD8-positive, alpha-beta T cell number	J:113408
	increased memory T cell number	J:113408
Itln1^em1Cya/Itln1^em1Cya (involves: C57BL/6)	increased osteoclast cell number	J:282124
Itpkb^T-less/Itpkb^T-less (C57BL/6-Itpkb^T-less)	arrested T cell differentiation	J:89286
Itpkb^tm1Ssch/Itpkb^tm1Ssch (involves: 129S1/Sv * 129X1/SvJ * CD-1)	absent CD4-positive, alpha-beta T cells	J:86257
	absent CD8-positive, alpha-beta T cells	J:86257
	absent T cells	J:86257
	absent thymus medulla	J:86257
	arrested T cell differentiation	J:86257
	increased double-positive T cell number	J:86257
Itpkb^tm1Ssch/Itpkb^tm1Ssch Itpkc^tm1Ssch/Itpkc^tm1Ssch (involves: 129S1/Sv * 129X1/SvJ * CD-1)	absent CD4-positive, alpha-beta T cells	J:86257
	absent CD8-positive, alpha-beta T cells	J:86257
	arrested T cell differentiation	J:86257
Jade2^em1(IMPC)Tcp/Jade2^em1(IMPC)Tcp (C57BL/6N-Jade2^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Jag2^tm1Grid/Jag2^tm1Grid (involves: 129S1/Sv * C57BL/6J)	abnormal gamma-delta T cell differentiation	J:46930
	abnormal thymus medulla morphology	J:46930
	abnormal thymus morphology	J:46930
	decreased gamma-delta T cell number	J:46930
Jagn1^{tm1c(EUCOMM)Hmgu}/Jagn1^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6N * C57BL/10 * CBA/Ca)	abnormal neutrophil morphology	J:214828
Jak1^M1Mhda/Jak1⁺ (C3HeB/FeJ-Jak1^M1Mhda)	abnormal plasma cell morphology	J:199153
	enlarged spleen	J:199153
	increased plasma cell number	J:199153
Jak1^tm1Rds/Jak1^tm1Rds (involves: 129)	abnormal B cell differentiation	J:47300
	abnormal lymphopoiesis	J:47300
	abnormal T cell differentiation	J:47300
	arrested B cell differentiation	J:47300
	decreased B cell number	J:47300
	decreased thymocyte number	J:47300
	increased double-negative T cell number	J:47300
	small thymus	J:47300
Jak2^{tm1(JAK2)Argr}/Jak2⁺ Dppa3^tm1(cre)Peli/Dppa3⁺ (involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6)	increased leukocyte cell number	J:233169
	increased spleen weight	J:233169
Jak2^{tm1(JAK2)Argr}/Jak2⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	decreased leukocyte cell number	J:164539
	enlarged spleen	J:164539
	increased leukocyte cell number	J:164539
Jak2^tm1.1Ble/Jak2⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	enlarged spleen	J:257910
	increased granulocyte number	J:257910
	increased leukocyte cell number	J:257910
	increased neutrophil cell number	J:257910
Jak2^tm1.1Jlvl/Jak2^tm1.1Jlvl (involves: 129S2/SvPas * C57BL/6)	abnormal spleen morphology	J:163497
	decreased spleen white pulp amount	J:163497
	enlarged spleen	J:163497
	increased granulocyte number	J:163497
	increased leukocyte cell number	J:163497
	increased lymphocyte cell number	J:163497
	increased monocyte cell number	J:163497
	increased spleen red pulp amount	J:163497
Jak2^tm1.2Ble/Jak2⁺ (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal spleen morphology	J:160883
	abnormal spleen red pulp morphology	J:160883
	enlarged spleen	J:160883
	increased leukocyte cell number	J:160883
Jak2^tm1.2Ble/Jak2⁺ Picalm^tm1.1Tmae/Picalm^tm1.1Tmae Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)	decreased CD4-positive, alpha-beta T cell number	J:220728
	decreased CD8-positive, alpha-beta T cell number	J:220728
Jak2^tm1Mohi/Jak2⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal spleen red pulp morphology	J:183821
	abnormal spleen white pulp morphology	J:183821
	decreased B cell number	J:183821
	enlarged spleen	J:183821
	increased leukocyte cell number	J:183821
	increased neutrophil cell number	J:183821
	increased spleen red pulp amount	J:183821
	increased spleen weight	J:183821
	myeloid hyperplasia	J:183821
	spleen fibrosis	J:183821
Jak2^tm1Mohi/Jak2^tm1Mohi Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal spleen red pulp morphology	J:183821
	abnormal spleen white pulp morphology	J:183821
	decreased B cell number	J:183821
	decreased spleen white pulp amount	J:183821
	enlarged spleen	J:183821
	increased leukocyte cell number	J:183821
	increased neutrophil cell number	J:183821
	increased spleen red pulp amount	J:183821
	increased spleen weight	J:183821
	myeloid hyperplasia	J:183821
	spleen fibrosis	J:183821
Jak2^tm2.1Jlvl/Jak2⁺ Tg(Vav1-cre)#Cgp/0 (involves: 129S2/SvPas * C57BL/6NTac)	abnormal myelopoiesis	J:202234
	decreased B cell number	J:202234
	enlarged spleen	J:202234
	increased granulocyte number	J:202234
	increased leukocyte cell number	J:202234
	increased spleen weight	J:202234
	myeloid hyperplasia	J:202234
	spleen fibrosis	J:202234
Jak2^tm2.2Jlvl/Jak2⁺ (involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac * SJL)	enlarged spleen	J:202234
	increased leukocyte cell number	J:202234
Jak3^bfy/Jak3^bfy (C57BL/6JSfdAnu-Jak3^bfy/AnuApb)	abnormal lymphopoiesis	J:104190
	abnormal T cell subpopulation ratio	J:104190
	decreased B cell number	J:104190
	decreased lymphocyte cell number	J:104190
	decreased T cell number	J:104190
	decreased thymocyte number	J:104190
	small thymus	J:104190
Jak3^em1(IMPC)Mbp/Jak3⁺ (C57BL/6N-Jak3^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Jak3^m1Btlr/Jak3^m1Btlr (C57BL/6J-Jak3^m1Btlr)	abnormal T cell subpopulation ratio	J:217795
	decreased NK cell number	J:217795
	decreased single-positive T cell number	J:217795
	decreased T cell number	J:217795
	increased effector memory CD4-positive, alpha-beta T cell number	J:217795
	increased effector memory CD8-positive, alpha-beta T cell number	J:217795
	increased neutrophil cell number	J:217795
	increased single-positive T cell number	J:217795
Jak3^m1J/Jak3^m1J (B6.Cg-Crb1⁺ Jak3^m1J/Boc)	decreased spleen weight	J:265859
	decreased thymus weight	J:265859
	small spleen	J:265859
	small thymus	J:265859
Jak3^M1Pgrs/Jak3^M1Pgrs (involves: C57BL/6J * C57BL/10J)	absent B cells	J:185217
	decreased B cell number	J:185217
	decreased NK cell number	J:185217
	enlarged spleen	J:185217
	increased CD4-positive, alpha-beta T cell number	J:185217
	increased CD8-positive, alpha-beta T cell number	J:185217
	small thymus	J:185217
Jak3^m2Btlr/Jak3^m2Btlr (C57BL/6J-Jak3^m2Btlr)	increased B cell number	J:217796
Jak3^m2Btlr/Jak3^m2Btlr (C57BL/6J-Jak3^m2Btlr)	increased memory B cell number	J:217796
Jak3^m3Btlr/Jak3^m3Btlr (C57BL/6J-Jak3^m3Btlr)	abnormal T cell subpopulation ratio	J:225935
	decreased B cell number	J:225935
	decreased B-1 B cell number	J:225935
	decreased immature B cell number	J:225935
	decreased mature B cell number	J:225935
	decreased memory B cell number	J:225935
	decreased NK cell number	J:225935
	decreased single-positive T cell number	J:225935
	decreased T cell number	J:225935
	increased effector memory CD8-positive, alpha-beta T cell number	J:225935
	increased macrophage cell number	J:225935
	increased myeloid dendritic cell number	J:225935
Jak3^m4Btlr/Jak3^m4Btlr (C57BL/6J-Jak3^m4Btlr)	increased CD4-positive, alpha-beta T cell number	J:272398
Jak3^M5Btlr/Jak3^M5Btlr (C57BL/6J-Jak3^M5Btlr)	decreased NK T cell number	J:272399
Jak3^m6Btlr/Jak3^m6Btlr (C57BL/6J-Jak3^m6Btlr)	decreased CD8-positive, alpha-beta T cell number	J:272400
Jak3^m6Btlr/Jak3^m6Btlr (C57BL/6J-Jak3^m6Btlr)	increased CD4-positive, alpha-beta T cell number	J:272400
Jak3^M7Btlr/Jak3^M7Btlr (C57BL/6J-Jak3^M7Btlr)	abnormal CD4-positive T cell differentiation	J:272401
Jak3^m8Btlr/Jak3^m8Btlr (C57BL/6J-Jak3^m8Btlr)	decreased B cell number	J:274939
	decreased B-1 B cell number	J:274939
	decreased B-2 B cell number	J:274939
	decreased CD4-positive, alpha-beta T cell number	J:274939
	decreased CD8-positive, alpha-beta T cell number	J:274939
	decreased CD8-positive, naive alpha-beta T cell number	J:274939
	decreased dendritic cell number	J:274939
	decreased T cell number	J:274939
	increased B-1b cell number	J:274939
	increased effector memory CD4-positive, alpha-beta T cell number	J:274939
Jak3^tm1Flv/Jak3^tm1Flv (involves: 129S1/Sv)	arrested B cell differentiation	J:95794
	decreased CD8-positive, alpha-beta T cell number	J:95794
	enlarged spleen	J:95794
	increased CD4-positive, alpha-beta T cell number	J:95794
	small lymph nodes	J:95794
	thymus hypoplasia	J:95794
Jak3^tm1Jni/Jak3^tm1Jni Crlf2^tm1Jni/Crlf2^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:89031
	decreased B cell number	J:89031
Jak3^tm1Ljb/Jak3⁺ (involves: 129S4/SvJae)	abnormal leukocyte morphology	J:56629
	decreased lymphocyte cell number	J:56629
	increased leukocyte cell number	J:56629
	increased monocyte cell number	J:56629
	increased neutrophil cell number	J:56629
Jak3^tm1Ljb/Jak3^tm1Ljb (involves: 129S4/SvJae * C57BL/6)	abnormal B cell morphology	J:29722
	abnormal splenic cell ratio	J:29722
	arrested B cell differentiation	J:29722
	decreased immature B cell number	J:29722
	decreased mature B cell number	J:29722
	lymph node hypoplasia	J:29722
	small lymph nodes	J:29722
	small Peyer's patches	J:29722
	small thymus	J:29722
	spleen hypoplasia	J:29722
	thymus hypoplasia	J:29722
Jak3^tm1Ljb/Jak3^tm1Ljb (involves: 129S4/SvJae)	abnormal leukocyte morphology	J:56629
	abnormal myelopoiesis	J:56629
	abnormal spleen morphology	J:56629
	abnormal spleen white pulp morphology	J:56629
	abnormal T cell differentiation	J:64861
	abnormal thymus cell ratio	J:128694
	absent B cells	J:128694
	absent lymph nodes	J:128694
	decreased lymphocyte cell number	J:56629
	decreased thymocyte number	J:64861
	enlarged spleen	J:56629
	increased leukocyte cell number	J:56629
	increased monocyte cell number	J:56629
	increased neutrophil cell number	J:56629
	thymus hypoplasia	J:128694
Jak3^tm1Ljb/Jak3^tm1Ljb (B6;129S4-Jak3^tm1Ljb/J)	abnormal dendritic cell differentiation	J:123902
	abnormal dendritic cell morphology	J:123902
	abnormal splenic cell ratio	J:123902
	decreased CD4-positive, alpha-beta T cell number	J:123902
	decreased CD8-positive, alpha-beta T cell number	J:123902
	decreased myeloid dendritic cell number	J:123902
Jak3^tm1Ljb/Jak3^tm1Ljb Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S4/SvJae * 129S7/SvEvBrd)	abnormal splenic cell ratio	J:56629
Jak3^tm1Ljb/Jak3^tm1Ljb Tg(Lck-Jak3)1Ljb/0 (involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)	absent B cells	J:128694
	absent lymph nodes	J:128694
Jak3^tm1Ljb/Jak3^tm1Ljb Tg(Lck-Jak3)2Ljb/0 (involves: 129S4/SvJae * C3H * C57BL/6)	enlarged spleen	J:56629
	increased leukocyte cell number	J:56629
Jak3^tm1Ljb/Jak3^tm1Ljb Tg(Lck-Jak3)2Ljb/0 (involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)	absent B cells	J:128694
	absent lymph nodes	J:128694
Jak3^tm1Tks/Jak3^tm1Tks (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:31231
	abnormal CD4-positive, alpha beta T cell morphology	J:31231
	abnormal lymphopoiesis	J:31231
	abnormal mesenteric lymph node morphology	J:31231
	abnormal spleen periarteriolar lymphoid sheath morphology	J:31231
	abnormal spleen white pulp morphology	J:31231
	abnormal T cell morphology	J:31231
	abnormal T cell number	J:31231
	abnormal thymus cortex morphology	J:31231
	abnormal thymus corticomedullary boundary morphology	J:31231
	abnormal thymus medulla morphology	J:31231
	absent Hassall's corpuscle	J:31231
	absent lymph nodes	J:31231
	absent NK cells	J:31231
	decreased B cell number	J:31231
	decreased pre-B cell number	J:31231
	decreased thymocyte number	J:31231
	small spleen	J:31231
	small thymus medulla	J:31231
	spleen hypoplasia	J:31231
	thymus cortex hypoplasia	J:31231
	thymus hypoplasia	J:31231
Jak3^wil/Jak3^wil (C57BL/6JSfdAnu-Jak3^wil/Anu)	arrested B cell differentiation	J:104190
	decreased CD8-positive, alpha-beta T cell number	J:104190
	decreased leukocyte cell number	J:104190
Jak3^X887Y/Jak3^X887Y (Not Specified)	abnormal immune system organ morphology	J:112658
	abnormal lymph node morphology	J:112658
	abnormal lymphocyte morphology	J:112658
	abnormal spleen morphology	J:112658
	abnormal thymus morphology	J:112658
Jakmip2^em1(IMPC)J/Jakmip2^em1(IMPC)J (C57BL/6NJ-Jakmip2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Jam3^tm1Lex/Jam3^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased neutrophil cell number	J:145994
Jam3^tm1Lex/Jam3^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	increased granulocyte number	J:145994
Jam3^tm1Rha/Jam3^tm1Rha (involves: 129P2/OlaHsd * C57BL/6)	increased granulocyte number	J:121841
Jarid2^jumonji/Jarid2^jumonji (C.129P2-Jarid2^jumonji)	abnormal splenic cell ratio	J:42772
	abnormal thymus cell ratio	J:42772
	spleen hypoplasia	J:42772
	thymus hypoplasia	J:42772
Jarid2^jumonji/Jarid2^jumonji (either: B6.129P2-Jarid2^jumonji or D2.129P2-Jarid2^jumonji)	spleen hypoplasia	J:42772
	thymus hypoplasia	J:42772
Jchain^tm3Tl/Jchain⁺ (involves: 129P2/OlaHsd)	decreased plasma cell number	J:49168
Jchain^tm3Tl/Jchain^tm3Tl (involves: 129P2/OlaHsd)	decreased plasma cell number	J:49168, J:56158
Jdp2^tm1Aki/Jdp2^tm1Aki (Not Specified)	abnormal osteoclast differentiation	J:191061
Jdp2^tm1Aki/Jdp2^tm1Aki (Not Specified)	abnormal osteoclast morphology	J:191061
Jmjd4^{em1(IMPC)Wtsi}/Jmjd4^{em1(IMPC)Wtsi} (C57BL/6N-Jmjd4^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Jmjd6^tm1Gbf/Jmjd6^tm1Gbf (C57BL/6-Ptdsr^tm1Gbf)	small thymus	J:102098
Jmjd6^tm1Gbf/Jmjd6^tm1Gbf (C57BL/6-Ptdsr^tm1Gbf)	thymus hypoplasia	J:102098
Jun^em1(IMPC)Mbp/Jun⁺ (C57BL/6N-Jun^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
Jun^em1(IMPC)Mbp/Jun⁺ (C57BL/6N-Jun^em1(IMPC)Mbp/MbpMmucd)	enlarged lymph nodes	J:211773
Junb^{tm1b(EUCOMM)Hmgu}/Junb⁺ (C57BL/6N-Junb^{tm1b(EUCOMM)Hmgu}/Bay)	increased spleen weight	J:211773
Junb^tm3Wag/Junb^tm3Wag Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast morphology	J:88126
Junb^tm3Wag/Junb^tm3Wag Meox2^tm1(cre)Sor/Meox2⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)	abnormal osteoclast differentiation	J:88126
	decreased osteoclast cell number	J:88126
Junb^tm3Wag/Junb^tm3Wag Tg(KRT5-cre)1Tak/0 (involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)	increased plasma cell number	J:155575
Kash5^em1(IMPC)J/Kash5^em1(IMPC)J (C57BL/6NJ-Kash5^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Kat6a^tm1.1Glac/Kat6a^tm1.1Glac (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:148955
	decreased immature B cell number	J:148955
	decreased pre-B cell number	J:148955
	decreased pro-B cell number	J:148955
	decreased spleen weight	J:148955
	decreased thymus weight	J:148955
	spleen hypoplasia	J:148955
	thymus hypoplasia	J:148955
Kat6a^tm1Avo/Kat6a⁺ (involves: 129 * BALB/c * FVB/N)	small thymus	J:188772
Kat6a^tm1Avo/Kat6a^tm1Avo (involves: 129/Sv * BALB/c * FVB/N)	abnormal thymus development	J:108453
	absent spleen	J:108453
	athymia	J:188772
	decreased double-negative T cell number	J:108453
	small thymus	J:108453, J:188772
	thymus hypoplasia	J:108453
Kat6a^tm1Iki/Kat6a^tm1Iki (Not Specified)	abnormal myelopoiesis	J:108699
Kat6a^tm1Iki/Kat6a^tm1Iki (Not Specified)	decreased B cell number	J:108699
Kat6a^tm2.2Avo/Kat6a⁺ Tbx1^tm1Bld/Tbx1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	small thymus	J:188772
Kat8^em1(IMPC)Mbp/Kat8⁺ (C57BL/6N-Kat8^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Katnal1^em1(IMPC)Tcp/Katnal1⁺ (C57BL/6NCrl-Katnal1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Katnal1^em1(IMPC)Tcp/Katnal1^em1(IMPC)Tcp (C57BL/6NCrl-Katnal1^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Katnal2^em1(IMPC)Tcp/Katnal2^em1(IMPC)Tcp (C57BL/6N-Katnal2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased monocyte cell number	J:211773
	small spleen	J:211773
Kbtbd3^{em1(IMPC)Ccpcz}/Kbtbd3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Kbtbd3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased neutrophil cell number	J:211773
Kbtbd11^{em1(IMPC)Wtsi}/Kbtbd11^{em1(IMPC)Wtsi} (C57BL/6N-Kbtbd11^{em1(IMPC)Wtsi}/Wtsi)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Kcna5^tm1Hket/Kcna5^tm1Hket (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	abnormal microglial cell morphology	J:116545
Kcna10^em3(IMPC)Mbp/Kcna10⁺ (C57BL/6N-Kcna10^em3(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Kcnab2^em1(IMPC)Mbp/Kcnab2^em1(IMPC)Mbp (C57BL/6NCrl-Kcnab2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Kcne1^{tm1b(EUCOMM)Hmgu}/Kcne1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Kcne1^{tm1b(EUCOMM)Hmgu}/Ics)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Kcne2^{tm1a(EUCOMM)Wtsi}/Kcne2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Kcne2^{tm1a(EUCOMM)Wtsi})	decreased spleen iron level	J:230226
Kcng3^em1(IMPC)Mbp/Kcng3^em1(IMPC)Mbp (C57BL/6NCrl-Kcng3^em1(IMPC)Mbp/MbpMmucd)	increased monocyte cell number	J:211773
Kcnh8^em1(IMPC)Mbp/Kcnh8^em1(IMPC)Mbp (C57BL/6N-Kcnh8^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Kcnip1^em1(IMPC)H/Kcnip1^em1(IMPC)H (C57BL/6N-Kcnip1^em1(IMPC)H/H)	increased eosinophil cell number	J:211773
Kcnj9^{tm1b(EUCOMM)Hmgu}/Kcnj9^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Kcnj9^{tm1b(EUCOMM)Hmgu}/H)	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Kcnj10^{tm1b(KOMP)Wtsi}/Kcnj10⁺ (C57BL/6N-Kcnj10^{tm1b(KOMP)Wtsi}/H)	decreased basophil cell number	J:211773
Kcnk13^em1(IMPC)H/Kcnk13^em1(IMPC)H (involves: C57BL/6NTac)	abnormal microglial cell morphology	J:256020
Kcnk13^em1(IMPC)H/Kcnk13^em1(IMPC)H (C57BL/6N-Kcnk13^em1(IMPC)H/H)	increased basophil cell number	J:211773
	increased monocyte cell number	J:211773
Kcnmb4^em1(IMPC)Mbp/Kcnmb4^em1(IMPC)Mbp (C57BL/6N-Kcnmb4^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Kcnn4^{em1(IMPC)Ccpcz}/Kcnn4^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Kcnn4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small thymus	J:211773
Kcnn4^tm1Rklr/Kcnn4^tm1Rklr (involves: 129S/SvEv * C57BL/6)	enlarged spleen	J:148910
	increased spleen iron level	J:148910
	increased spleen weight	J:148910
Kcnt1^em1(IMPC)Mbp/Kcnt1^em1(IMPC)Mbp (C57BL/6N-Kcnt1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Kcnt2^em1(IMPC)Mbp/Kcnt2^em1(IMPC)Mbp (C57BL/6N-Kcnt2^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Kctd1^em1(IMPC)J/Kctd1^em1(IMPC)J (C57BL/6NJ-Kctd1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Kctd9^em1Beij/Kctd9^em1Beij (BALB/c-Kctd9^em1Beij)	abnormal immature NK cell morphology	J:281803
	abnormal NK cell differentiation	J:281803
	decreased mature NK cell number	J:281803
	increased immature NK cell number	J:281803
	increased NK cell number	J:281803
Kdelr1^em1Btlr/Kdelr1^em1Btlr (involves: C57BL/6J * C57BL/6JJcl)	decreased lymphocyte cell number	J:224970
Kdelr1^em1Btlr/Kdelr1^em1Btlr Tg(Gt(ROSA)26Sor-Kdelr1)#Btlr/0 (C57BL/6J-Kdelr1^em1Btlr Tg(Gt(ROSA)26Sor-Kdelr1)#Btlr)	abnormal lymphocyte morphology	J:224970
Kdelr1^m1Btlr/Kdelr1^m1Btlr (C57BL/6J-Kdelr1^m1Btlr)	abnormal lymphocyte morphology	J:224970
	abnormal T cell differentiation	J:224970
	absent NK T cells	J:224970
	decreased B cell number	J:224970
	decreased CD4-positive, alpha-beta T cell number	J:224970, J:158794
	decreased CD8-positive, alpha-beta T cell number	J:224970, J:158794
	decreased follicular B cell number	J:224970
	decreased lymphocyte cell number	J:224970
	decreased transitional stage T1 B cell number	J:224970
	decreased transitional stage T2 B cell number	J:224970
	increased marginal zone B cell number	J:224970
	thymus hypoplasia	J:158794
Kdm1a^{tm1(NCOM)Mfgc}/Kdm1a⁺ (C57BL/6N-Kdm1a^{tm1(NCOM)Mfgc}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	small spleen	J:211773
Kdm1a^tm1.1Sho/Kdm1a^tm1.1Sho Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	decreased leukocyte cell number	J:201572
Kdm1a^tm1.1Sho/Kdm1a^tm1.1Sho Tg(Mx1-cre)1Cgn/? (involves: 129 * C57BL/6 * CBA/Ca)	decreased granulocyte number	J:201572
	decreased neutrophil cell number	J:201572
Kdm3a^em1(IMPC)Mbp/Kdm3a^em1(IMPC)Mbp (C57BL/6N-Kdm3a^em1(IMPC)Mbp/MbpMmucd)	enlarged spleen	J:211773
	small spleen	J:211773
Kdm4c^{tm1a(KOMP)Wtsi}/Kdm4c⁺ (C57BL/6N-Kdm4c^{tm1a(KOMP)Wtsi}/Wtsi)	increased B cell number	J:165965
Kdm5a^tm1.1Kael/Kdm5a^tm1.1Kael (involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)	increased neutrophil cell number	J:137185
Kdm6a^tm1.1Afst/Kdm6a^tm1.1Afst Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6NTac)	abnormal granulocyte morphology	J:196401
	decreased leukocyte cell number	J:196401
	enlarged spleen	J:196401
	increased B cell number	J:196401
	increased spleen weight	J:196401
Kdm6a^tm1Cdcn/Y Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6J CBA)	enlarged spleen	J:263565
	increased granulocyte number	J:263565
	increased monocyte cell number	J:263565
	increased neutrophil cell number	J:263565
Kdm6a^tm1Cdcn/Y Tg(CAG-cre/Esr1)5Amc/0 Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas C57BL/6J * CBA * FVB/N)	enlarged spleen	J:263565
	increased monocyte cell number	J:263565
	increased neutrophil cell number	J:263565
Kdm6a^tm1Cdcn/Kdm6a^tm1Cdcn Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6J CBA)	enlarged spleen	J:263565
	increased granulocyte number	J:263565
	increased monocyte cell number	J:263565
	increased neutrophil cell number	J:263565
Kdm8^{tm1a(EUCOMM)Wtsi}/Kdm8⁺ (C57BL/6N-Kdm8^{tm1a(EUCOMM)Wtsi}/Ics)	increased B cell number	J:165965
Kdr^tm1.1Jamb/Kdr^tm1.1Jamb (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal lymphangiogenesis	J:154336
	lymphatic vessel hyperplasia	J:154336
Kdr^tm1.1Jamb/Kdr^tm1.1Jamb Tg(KRT14-cre)1Efu/0 (involves: 129S1/Sv * 129X1/SvJ * ICR)	lymphatic vessel hyperplasia	J:154336
Kdr^tm1.1Jamb/Kdr^tm1.1Jamb Tg(Pax6-cre,GFP)1Pgr/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR)	abnormal lymphatic vessel morphology	J:154336
	lymphatic vessel hyperplasia	J:154336
Kdr^tm1Jrt/Kdr⁺ Tmem204^tm1.1Ali/Tmem204^tm1.1Ali (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)	abnormal lymphatic vessel smooth muscle morphology	J:159519
	enlarged lymphatic vessel	J:159519
Kdr^tm1Ykub/Kdr^tm1Ykub (Not Specified)	enlarged lymphatic vessel	J:217533
Kdr^tm1Ykub/Kdr^tm1Ykub (Not Specified)	lymphatic vessel hyperplasia	J:217533
Kera^tm1Cyl/Kera^tm1Cyl (involves: 129S6/SvEvTac)	decreased neutrophil cell number	J:128992
Khdrbs1^tm1Rchd/Khdrbs1^tm1Rchd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal bone marrow development	J:115775
Kif5c^tm1dIcs/Kif5c⁺ (C57BL/6N-Kif5c^tm1dIcs/Ics)	decreased lymphocyte cell number	J:211773
Kif5c^tm1dIcs/Kif5c⁺ (C57BL/6N-Kif5c^tm1dIcs/Ics)	increased eosinophil cell number	J:211773
Kif9^em1(IMPC)Mbp/Kif9^em1(IMPC)Mbp (C57BL/6N-Kif9^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Kif13b^{tm1b(EUCOMM)Wtsi}/Kif13b^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Kif13b^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Kif15^em1Lium/Kif15^em1Lium (C57BL/6-Kif15^em1Lium)	decreased spleen white pulp amount	J:336767
	increased CD8-positive, alpha-beta T cell number	J:336767
	increased spleen red pulp amount	J:336767
	increased spleen weight	J:336767
	intermingled spleen red and white pulp	J:336767
Kif16b^{em1(IMPC)Ccpcz}/Kif16b^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Kif16b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Kiss1r^{tm1.1(KOMP)Vlcg}/Kiss1r^{tm1.1(KOMP)Vlcg} (C57BL/6N-Kiss1r^{tm1.1(KOMP)Vlcg}/Ucd)	increased spleen weight	J:211773
	increased thymus weight	J:211773
Kiss1r^tm1.1Lex/Kiss1r⁺ (involves: 129S4/SvJae)	decreased eosinophil cell number	J:181650
Kiss1r^tm1.1Lex/Kiss1r⁺ (involves: 129S4/SvJae)	decreased lymphocyte cell number	J:181650
Kiss1r^tm1.1Lex/Kiss1r^tm1.1Lex (involves: 129S4/SvJae)	decreased basophil cell number	J:181650
	decreased lymphocyte cell number	J:181650
	decreased monocyte cell number	J:181650
	decreased neutrophil cell number	J:181650
	increased spleen weight	J:181650
	increased thymus weight	J:181650
Kiss1r^tm1Gstn/Kiss1r^tm1Gstn (involves: 129P2/OlaHsd)	increased thymus weight	J:102113
Kit^tm1.1Bsm/Kit^tm1.1Bsm (involves: 129S1/Sv * BALB/c * C57BL/6J * FVB/N)	decreased mast cell number	J:61141
Kit^tm1Ber/Kit^tm1Ber (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased mast cell number	J:89602
Kit^tm1Bpr/Kit^tm1Bpr (either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))	decreased mast cell number	J:100778
Kit^tm1Bsm/Kit^tm1Bsm (involves: 129S1/Sv * C57BL/6J)	decreased mast cell number	J:61141
Kit^tm2Ber/Kit^tm2Ber (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased mast cell number	J:89602
Kit^tm2Bsm/Kit⁺ (involves: 129X1/SvJ * C57BL/6J)	increased mast cell number	J:83616
Kit^tm3.1Bsm/Kit^tm3.1Bsm (involves: 129S1/Sv * C57BL/6)	abnormal B cell differentiation	J:90485
	abnormal T cell differentiation	J:90485
	decreased B cell number	J:90485
	decreased mast cell number	J:90485
Kit^tm3.1Bsm/Kit^tm3.1Bsm (B6.129S1-Kit^tm3.1Bsm)	spleen hypoplasia	J:146561
Kit^tm3Ber/Kit^tm3Ber (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	arrested B cell differentiation	J:89602
	decreased mast cell number	J:89602
	enlarged spleen	J:89602
	increased B cell number	J:89602
	spleen hyperplasia	J:89602
Kit^tm4.1Bsm/Kit⁺ (involves: 129S1/Sv * C57BL/6J * FVB/N)	enlarged spleen	J:188434
	increased mast cell number	J:188434
	spleen hyperplasia	J:188434
Kit^W-37J/Kit⁺ (involves: C57BL/6 * C57BL/6J)	decreased mast cell number	J:27513
Kit^W-37J/Kit^W (involves: C57BL/6 * C57BL/6J * WB)	decreased mast cell number	J:27513
Kit^W-42J/Kit⁺ (involves: C57BL/6 * C57BL/6J * WB)	decreased mast cell number	J:27513
Kit^W-42J/Kit^W (involves: C57BL/6 * C57BL/6J * WB)	decreased mast cell number	J:27513
Kit^W-Btlr/Kit^W-Btlr (C57BL/6J-Kit^W-Btlr)	decreased mast cell number	J:133270
Kit^W-f/Kit^W-f (involves: C3H/HePas)	decreased mast cell number	J:27513
Kit^W-Jic/Kit⁺ (involves: C57BL/6)	decreased mast cell number	J:27513
Kit^W-Jic/Kit^W (involves: C57BL/6 * WB)	decreased mast cell number	J:27513
Kit^W-n/Kit^W-n (Not Specified)	decreased mast cell number	J:12107
Kit^W-n/Kit^W (involves: WB)	decreased mast cell number	J:27513
Kit^W-sh/Kit^W-sh (involves: 101/H * C3H/HeH)	decreased mast cell number	J:145444
Kit^W-sh/Kit^W-sh Lyn^tm1Ard/Lyn^tm1Ard (involves: 101 * 129P2/OlaHsd * C3H/HeH)	decreased B cell number	J:161523
	increased basophil cell number	J:161523
Kit^W-v/Kit⁺ (involves: C57BL * C57BL/6)	decreased mast cell number	J:27513
Kit^W-vkd/Kit^W-vkd (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * WB)	abnormal B cell differentiation	J:79128
	abnormal T cell differentiation	J:79128
	decreased B cell number	J:79128
	decreased thymocyte number	J:79128
Kit^W/Kit⁺ Tg(PGK1-KITLG*220)441Daw/0 (involves: C3H/HeJ)	decreased mast cell number	J:32600
Kit^W/Kit^W-v (involves: C57BL/6)	decreased basophil cell number	J:178942
Kit^W/Kit^W-v (involves: C57BL/6)	decreased mast cell number	J:178942
Kit^W/Kit^W Tg(PDGFB-EPO)321Zbz/? (involves: C3H * C57BL/6)	abnormal B cell differentiation	J:79128
	abnormal T cell differentiation	J:79128
	decreased B cell number	J:79128
	decreased thymocyte number	J:79128
Kit^Wads/Kit^Wads (C57BL/6J-Kit^Wads)	decreased mast cell number	J:96391
Kitl^Sl-con/Kitl^Sl-con (either: (involves: C3H/HeJ) or (involves: C3H/HeN))	increased mast cell number	J:23593
Kitl^Sl-d/Kitl⁺ (either: (involves: C57BL/6 * DBA/2J) or (involves: C3H * C57BL/6 * DBA/2J * WC))	decreased mast cell number	J:6084
Kitl^Sl/Kitl⁺ (either: (involves: C3H * WC) or (involves: C3H * C57BL/6 * DBA/2J * WC))	decreased mast cell number	J:6084
Kitl^Sl/Kitl⁺ Tg(PGK1-KITLG*220)441Daw/0 (involves: C3H)	decreased mast cell number	J:32600
Kitl^Sl/Kitl^Sl-d (involves: C57BL/6 * WC)	thymus atrophy	J:5758
Kitl^Sl/Kitl^Sl-d (involves: C3H * C57BL/6 * DBA/2J * WC)	decreased mast cell number	J:6084
Kitl^Sl/Kitl^Sl-d ((WC/ReJ Kitl^Sl x B6.D2-Kitl^Sl-d/J)F1-Kitl^Sl/Kitl^Sl-d/J)	abnormal osteoclast morphology	J:111273
Kitl^tm1.1Sjm/Kitl^tm2.1Sjm Lepr^tm2(cre)Rck/Lepr⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/Ka * SJL)	enlarged spleen	J:180431
	spleen hyperplasia	J:180431
Kitl^tm1.1Sjm/Kitl^tm2.1Sjm Lepr^tm2(cre)Rck/Lepr⁺ Tg(Tek-cre)12Flv/0 (involves: 129S6/SvEvTac * C3H * C57BL/6 * C57BL/Ka * SJL)	spleen hyperplasia	J:180431
Kitl^tm1Pbes/Kitl^tm1Pbes (involves: 129S1/Sv * C57BL/6J)	decreased mast cell number	J:50150
Kitl^tm2.1Pbes/Kitl^tm2.1Pbes (involves: 129S1/Sv * C57BL/6J * FVB/N)	increased mast cell number	J:157170
Kitl^tm3.1Pbes/Kitl^tm3.1Pbes (involves: 129S1/Sv * C57BL/6J * FVB/N)	decreased double-negative T cell number	J:157170
	decreased double-positive T cell number	J:157170
	decreased mast cell number	J:157170
	decreased T cell number	J:157170
	decreased thymocyte number	J:157170
Kl^kl/Kl^kl (either: C.Cg-Kl^kl or (involves: C3H/HeJ * C57BL/6J))	abnormal leukocyte cell number	J:44109
	decreased osteoclast cell number	J:44109
	thymus atrophy	J:44109
Kl^kl/Kl^kl (involves: C3H/HeJ * C57BL/6J)	decreased B cell number	J:80503
Kl^kl/Kl^kl (involves: C3H/HeJ * C57BL/6J)	decreased osteoclast cell number	J:80503
Kl^kl/Kl^kl (involves: C3H/J * C57BL/6J)	abnormal osteoclast morphology	J:56666
Kl^kl/Kl^kl Tnfrsf11b^tm1Khs/Tnfrsf11b⁺ (involves: 129P2/OlaHsd * C3H * C57BL/6)	decreased B cell number	J:80503
Kl^m1Anu/Kl^m1Anu (C57BL/6NCrlAnu-Kl^m1Anu)	abnormal spleen morphology	J:104190
Kl^m1Anu/Kl^m1Anu (C57BL/6NCrlAnu-Kl^m1Anu)	small spleen	J:104190
Klf1^Nan/Klf1⁺ (either: B6.Cg-Klf1^Nan or WB.Cg-Klf1^Nan)	increased spleen weight	J:162530
Klf1^Nan/Klf1⁺ (involves: 101/H * C3H/HeH * PT)	enlarged spleen	J:13933
Klf1^Nan/Klf1⁺ (involves: 101/H * C3H/HeH * PT)	increased spleen iron level	J:13933
Klf2^tm1Mlkn/Klf2^tm1Mlkn Tg(VAV1-cre)1Graf/0 (Not Specified)	absent T cells	J:127228
Klf2^tm2Ling/Klf2^tm2Ling Lyz2^tm1(cre)Ifo/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac)	decreased Ly6C low monocyte number	J:239509
Klf2^tm2Ling/Klf2^tm2Ling Tg(Cd4-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:151604
	decreased T cell number	J:151604
	increased single-positive T cell number	J:151604
Klf3^{Gt(CH0516)Wtsi}/Klf3^{Gt(CH0516)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	increased leukocyte cell number	J:206507
	increased spleen weight	J:206507
Klf3^{Gt(XS0187)Wtsi}/Klf3^{Gt(XS0187)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	increased leukocyte cell number	J:206507
	increased spleen weight	J:206507
Klf3^m1Cmhd/Klf3⁺ (involves: C3H/HeJ * C57BL/6J)	increased spleen weight	J:206507
Klf4^tm1Khk/Klf4^tm1Khk Lyz2^tm1(cre)Ifo/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac)	decreased Ly6C low monocyte number	J:239509
Klf13^tm1Coll/Klf13^tm1Coll (involves: 129S/SvEv)	decreased leukocyte cell number	J:136545
	decreased lymphocyte cell number	J:136545
	enlarged spleen	J:136545
	spleen hyperplasia	J:136545
Klf13^tm1Kren/Klf13^tm1Kren (B6.129-Klf13^tm1Kren)	abnormal immune system cell morphology	J:145839
	abnormal immune system organ morphology	J:145839
	abnormal spleen morphology	J:145839
	abnormal T cell number	J:145839
	decreased thymocyte number	J:145839
	increased double-positive T cell number	J:145839
	increased splenocyte number	J:145839
	increased thymocyte number	J:145839
	spleen hyperplasia	J:145839
	thymus hyperplasia	J:145839
Klf15^tm1Jain/Klf15^tm1Jain (involves: 129X1/SvJ)	increased macrophage cell number	J:203920
Klf16^em1(IMPC)J/Klf16⁺ (C57BL/6NJ-Klf16^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Klhdc2^{tm1b(EUCOMM)Hmgu}/Klhdc2⁺ (C57BL/6N-Klhdc2^{tm1b(EUCOMM)Hmgu}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Klhdc7b^em1(IMPC)H/Klhdc7b^em1(IMPC)H (C57BL/6N-Klhdc7b^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Klhl1^{em1(IMPC)Ccpcz}/Klhl1^{em1(IMPC)Ccpcz} (C57BL/6N-Klhl1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Klhl6^{em1(IMPC)Ccpcz}/Klhl6^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Klhl6^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased effector memory T-helper cell number	J:211773
	enlarged thymus	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased T cell number	J:211773
	increased T-helper cell number	J:211773
	small spleen	J:211773
Klhl6^m1Anu/Klhl6^m1Anu (C57BL/6JAnu-Klhl6^m1Anu)	decreased B cell number	J:104190
	decreased mature B cell number	J:104190
	increased immature B cell number	J:104190
Klhl6^m1Btlr/Klhl6^m1Btlr (C57BL/6J-Klhl6^m1Btlr)	decreased B cell number	J:265167
	decreased central memory CD4-positive, alpha-beta T cell number	J:265167
	increased B-1b cell number	J:265167
	increased CD4-positive, alpha-beta T cell number	J:265167
	increased single-positive T cell number	J:265167
	increased T cell number	J:265167
Klhl6^m2Btlr/Klhl6^m2Btlr (C57BL/6J-Klhl6^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:265168
	increased CD4-positive, alpha-beta T cell number	J:265168
	increased single-positive T cell number	J:265168
	increased T cell number	J:265168
Klhl6^M3Btlr/Klhl6^M3Btlr (C57BL/6J-Klhl6^M3Btlr)	increased alpha-beta T cell number	J:267699
	increased B-1a cell number	J:267699
	increased CD4-positive, alpha-beta T cell number	J:267699
	increased CD8-positive, alpha-beta T cell number	J:267699
Klhl6^m4Btlr/Klhl6^m4Btlr (C57BL/6J-Klhl6^m4Btlr)	increased B-1 B cell number	J:272394
Klhl6^M5Btlr/Klhl6^M5Btlr (C57BL/6J-Klhl6^M5Btlr)	increased B-1 B cell number	J:272395
Klhl6^m6Btlr/Klhl6^m6Btlr (C57BL/6J-Klhl6^m6Btlr)	increased alpha-beta T cell number	J:272396
Klhl6^m6Btlr/Klhl6^m6Btlr (C57BL/6J-Klhl6^m6Btlr)	increased CD4-positive, alpha-beta T cell number	J:272396
Klhl6^M7Btlr/Klhl6^M7Btlr (C57BL/6J-Klhl6^M7Btlr)	abnormal B cell differentiation	J:272397
Klhl6^M8Btlr/Klhl6^M8Btlr (C57BL/6J-Klhl6^M8Btlr)	decreased B cell number	J:274963
	increased CD4-positive, alpha-beta T cell number	J:274963
	increased T cell number	J:274963
Klhl6^tm1Sato/Klhl6^tm1Sato (either: (involves: 129T2/SvEms) or (involves: BALB/c) or (involves: CD-1))	abnormal B cell differentiation	J:101363
	abnormal lymph node germinal center morphology	J:101363
	abnormal spleen morphology	J:101363
	decreased B cell number	J:101363
	decreased follicular B cell number	J:101363
	decreased spleen weight	J:101363
	spleen hypoplasia	J:101363
Klhl14^tm1.1Jyw/Klhl14⁺ (involves: C57BL/6)	decreased B-1a cell number	J:263511
Klhl14^tm1.1Jyw/Klhl14⁺ (involves: C57BL/6)	increased B-1b cell number	J:263511
Klhl29^{tm1b(EUCOMM)Hmgu}/Klhl29⁺ (C57BL/6N-Klhl29^{tm1b(EUCOMM)Hmgu}/Ics)	increased large unstained cell number	J:211773
Klk4^{tm1.1(KOMP)Vlcg}/Klk4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Klk4^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Klk8^{em1(IMPC)Ccpcz}/Klk8^{em1(IMPC)Ccpcz} (C57BL/6N-Klk8^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
Klk10^{em1(IMPC)Ccpcz}/Klk10^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Klk10^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	enlarged thymus	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
Klk11^{em1(IMPC)Ccpcz}/Klk11^{em1(IMPC)Ccpcz} (C57BL/6N-Klk11^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Klra17^tm1.1Apma/Klra17^tm1.1Apma (involves: 129S1/Sv * 129X1/SvJ)	increased plasmacytoid dendritic cell number	J:152288
Klrb1^{tm1b(EUCOMM)Wtsi}/Klrb1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Klrb1^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased leukocyte cell number	J:211773
	increased follicular B cell number	J:211773
Klrc1^tm1Mmka/Klrc1^tm1Mmka (B6.129-Klrc1^tm1Mmka)	decreased CD8-positive, alpha-beta T cell number	J:222503
Klrg2^em1(IMPC)H/Klrg2^em1(IMPC)H (C57BL/6NTac-Klrg2^em1(IMPC)H/H)	enlarged spleen	J:211773
Klrk1^em1(IMPC)Mbp/Klrk1^em1(IMPC)Mbp (C57BL/6NCrl-Klrk1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Klrk1^tm1.1Bpol/Klrk1^tm1.1Bpol (C57BL/6-Klrk1^tm1.1Bpol)	abnormal NK cell differentiation	J:151878
	decreased B cell number	J:151878
	decreased T cell number	J:151878
	spleen hypoplasia	J:151878
Klrk1^tm2.1Bpol/Klrk1^tm2.1Bpol (Not Specified)	abnormal NK cell differentiation	J:215590
Kmt2a^tm1(AFF1)Ksy/Kmt2a⁺ (involves: 129S1/Sv * C57BL/6 * FVB)	abnormal lymphocyte morphology	J:110241
	enlarged spleen	J:110241
	increased leukocyte cell number	J:110241
	increased monocyte cell number	J:110241
	increased neutrophil cell number	J:110241
	increased pro-B cell number	J:110241
	lymphoid hyperplasia	J:110241
	myeloid hyperplasia	J:110241
Kmt2a^{tm1(MLL1/ERT)Divo}/? (involves: 129S4/SvJae * C57BL/6)	enlarged spleen	J:189329
	myeloid hyperplasia	J:189329
Kmt2a^{tm1.1(Sh3gl1)Lcc}/Kmt2a⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	enlarged lymph nodes	J:205605
	enlarged spleen	J:205605
	myeloid hyperplasia	J:205605
Kmt2a^tm1Brad/Kmt2a^tm1Brad Commd10^{Tg(Vav1-icre)A2Kio}/? (involves: 129S4/SvJae * C57BL/6 * C57BL/10 * CBA/Ca)	decreased pre-B cell number	J:149811
Kmt2a^tm1Clgr/Kmt2a⁺ (B6.129-Kmt2a^tm1Clgr)	abnormal myelopoiesis	J:115001
Kmt2a^tm1Sjk/Kmt2a⁺ (involves: 129S2/SvPas * C3H * C57BL/6)	decreased B cell number	J:29958
Kmt2a^tm1Thr/Kmt2a⁺ Mllt3^tm2Thr/Mllt3⁺ Tg(Lck-cre)1Thr/? (involves: 129S/SvEv)	abnormal spleen red pulp morphology	J:100794
	abnormal spleen white pulp morphology	J:100794
	enlarged spleen	J:100794
	increased T cell derived lymphoma incidence	J:100794
Kmt2a^{tm2(MLLT3)Thr}/Kmt2a⁺ (involves: 129P2/OlaHsd)	enlarged spleen	J:56340
Kmt2a^{tm2(MLLT3)Thr}/Kmt2a^{tm2(MLLT3)Thr} (involves: 129P2/OlaHsd * C57BL/6 * FVB)	increased leukocyte cell number	J:110241
	increased neutrophil cell number	J:110241
	increased pro-B cell number	J:110241
Kmt2a^tm2Sjk/Kmt2a⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	abnormal spleen morphology	J:95914
	enlarged spleen	J:95914
	increased leukocyte cell number	J:95914
	increased spleen red pulp amount	J:95914
	myeloid hyperplasia	J:95914
Kmt2d^tm1.1Kaig/Kmt2d⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased germinal center B cell number	J:228913
	increased spleen germinal center size	J:228913
Kmt2d^tm1.1Kaig/Kmt2d^tm1.1Kaig Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:228913
	decreased B cell number	J:228913
	decreased follicular B cell number	J:228913
	decreased mature B cell number	J:228913
	increased germinal center B cell number	J:228913
	increased spleen germinal center number	J:228913
	increased spleen germinal center size	J:228913
Kmt2e^tm1.1Hjf/Kmt2e⁺ (B6.129P2-Kmte^tm1.1Hjf)	decreased thymocyte number	J:145579
	spleen hypoplasia	J:145579
	thymus hypoplasia	J:145579
Kmt2e^tm1.1Hjf/Kmt2e^tm1.1Hjf (B6.129P2-Kmte^tm1.1Hjf)	abnormal lymphopoiesis	J:145579
	decreased B cell number	J:145579
	decreased double-negative T cell number	J:145579
	decreased double-positive T cell number	J:145579
	decreased leukocyte cell number	J:145579
	decreased macrophage cell number	J:145579
	decreased pre-B cell number	J:145579
	decreased pro-B cell number	J:145579
	decreased T cell number	J:145579
	decreased thymocyte number	J:145579
	small lymph nodes	J:145579
	small spleen	J:145579
	small thymus	J:145579
	spleen hypoplasia	J:145579
	thymus hypoplasia	J:145579
Kmt2e^tm1Apa/Kmt2e^tm1Apa (129S6/SvEvTac-Kmt2e^tm1Apa)	abnormal granulocyte differentiation	J:145445
Kmt2e^tm1Apa/Kmt2e^tm1Apa (129S6/SvEvTac-Kmt2e^tm1Apa)	abnormal neutrophil differentiation	J:145445
Kmt2e^tm1Nik/Kmt2e^tm1Nik (B6.Cg-Kmte^tm1Nik)	decreased NK cell number	J:145449
	decreased NK T cell number	J:145449
	increased neutrophil cell number	J:145449
Kmt5b^tm1Jnw/Kmt5b^tm1Jnw Kmt5c^tm1.1Jnw/Kmt5c^tm1.1Jnw Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129/Sv * C57BL/6J * C57BL/10 * CBA/Ca)	abnormal class switch recombination	J:139510
	abnormal lymphopoiesis	J:139510
	decreased B cell number	J:139510
	decreased double-positive T cell number	J:139510
Knl1^{tm1c(EUCOMM)Hmgu}/Knl1^{tm1c(EUCOMM)Hmgu} Tg(GFAP-cre)25Mes/0 (involves: 129S4/SvJaeSor * C57BL/6N * FVB/N)	microgliosis	J:278483
Knop1^{tm1b(EUCOMM)Wtsi}/Knop1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Knop1^{tm1b(EUCOMM)Wtsi}/Bay)	increased spleen weight	J:211773
Kpna2^em1(IMPC)Mbp/Kpna2⁺ (C57BL/6N-Kpna2^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
Kras^tm1.1Khai/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA/J)	enlarged spleen	J:276349
	increased leukocyte cell number	J:276349
Kras^tm1Mok/Kras⁺ Nras^tm1Mok/Nras⁺ (involves: 129S/SvEv * C57BL/6 * DBA/2)	abnormal lymphatic vessel morphology	J:159024
Kras^tm2Tyj/Kras⁺ (involves: 129S2/SvPas * C57BL/6)	increased T cell derived lymphoma incidence	J:68981
Kras^tm2Tyj/Kras⁺ (involves: 129S2/SvPas)	increased T cell derived lymphoma incidence	J:68981
Kras^tm2Tyj/Kras⁺ Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C57BL/6)	increased T cell derived lymphoma incidence	J:68981
Kras^tm2Tyj/Kras⁺ Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	increased T cell derived lymphoma incidence	J:68981
Kras^tm3Tyj/Kras⁺ (involves: 129S4/SvJae * C57BL/6)	increased T cell derived lymphoma incidence	J:68981
Kras^tm3Tyj/Kras⁺ (involves: 129S4/SvJae)	increased T cell derived lymphoma incidence	J:68981
Kras^tm3Tyj/Kras⁺ Mir21a^tm1.1Eno/Mir21a^tm1.1Eno (involves: 129S/SvEv * 129S4/SvJae * C57BL/6)	increased T cell derived lymphoma incidence	J:164198
Kras^tm3Tyj/Kras^tm3Tyj (involves: 129S4/SvJae)	increased T cell derived lymphoma incidence	J:237900
Kras^tm4.1Bbd/Kras⁺ (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N)	enlarged spleen	J:223433
Kras^tm4.1Bbd/Kras^tm4.1Bbd (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N)	decreased CD8-positive, alpha-beta T cell number	J:223433
	enlarged spleen	J:223433
	increased basophil cell number	J:223433
	increased eosinophil cell number	J:223433
	increased leukocyte cell number	J:223433
	increased neutrophil cell number	J:223433
	spleen vascular congestion	J:223433
Kras^tm4Tyj/Kras⁺ (involves: 129S4/SvJae)	increased regulatory T cell number	J:154046
Kras^tm4Tyj/Kras⁺ Gt(ROSA)26Sor^{tm4(ACTB-tdTomato,-EGFP)Luo}/Gt(ROSA)26Sor⁺ Tg(Flt3-cre)#Ccb/0 (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)	decreased B cell number	J:247853
	decreased double-negative T cell number	J:247853
	decreased double-positive T cell number	J:247853
	decreased T cell number	J:247853
	hepatosplenomegaly	J:247853
	increased dendritic cell number	J:247853
	increased leukocyte cell number	J:247853
	increased monocyte cell number	J:247853
	thymus atrophy	J:247853
Kras^tm4Tyj/Kras⁺ Lrrc17^tm1Nik/Lrrc17⁺ Srpk2^tm1Nik/Srpk2⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA)	increased leukocyte cell number	J:161558
Kras^tm4Tyj/Kras⁺ Pggt1b^tm1Mbrg/Pggt1b⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:122107
	decreased lymphocyte cell number	J:122107
	increased neutrophil cell number	J:122107
Kras^tm4Tyj/Kras⁺ Stk11^tm1.2Rdp/Stk11^tm1.2Rdp (involves: 129S4/SvJae * 129S6/SvEvTac)	increased macrophage cell number	J:197037
Kras^tm4Tyj/Kras⁺ Tg(MUC1)79.24Gend/0 (involves: 129S4/SvJae * C57BL/6)	increased regulatory T cell number	J:154046
Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA)	abnormal myelopoiesis	J:88163
	enlarged spleen	J:88163
	increased granulocyte number	J:88163
	increased leukocyte cell number	J:88163
	increased lymphoblastic lymphoma incidence	J:88163
	increased spleen red pulp amount	J:88163
	lymphoid hyperplasia	J:88163
	myeloid hyperplasia	J:88163
Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal myelopoiesis	J:87429
	enlarged spleen	J:87429, J:115071
	increased leukocyte cell number	J:87429
	increased monocyte cell number	J:87429
	myeloid hyperplasia	J:87429
Kras^tm4Tyj/Kras⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA/J)	enlarged spleen	J:276349
Kras^tm4Tyj/Kras⁺ Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm (B6.129-Kras^tm4Tyj Tgfbr2^tm1.2Hlm)	abnormal myeloid leukocyte morphology	J:177379
	increased B cell number	J:177379
	increased T cell number	J:177379
Kras^tm4Tyj/Kras⁺ Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Ptf1a^{tm1.1(cre)Cvw}/Ptf1a⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2)	enlarged spleen	J:116129
Kras^tm4Tyj/Kras⁺ Trp53^tm2Tyj/Trp53⁺ Tg(Pdx1-cre)6Tuv/0 (involves: 129S4/SvJae * C57BL/6 * FVB/N)	increased T cell derived lymphoma incidence	J:98936
Krt1^{em1(IMPC)Ccpcz}/Krt1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Krt1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased NK cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
Krt5^{tm1.1(KOMP)Vlcg}/Krt5⁺ (C57BL/6N-Krt5^{tm1.1(KOMP)Vlcg}/Tcp)	abnormal lymph node morphology	J:211773
Krt8^{tm1b(EUCOMM)Hmgu}/Krt8⁺ (C57BL/6N-Krt8^{tm1b(EUCOMM)Hmgu}/Ics)	increased neutrophil cell number	J:211773
Krt8^tm1Rgo/Krt8^tm1Rgo (involves: 129S2/SvPas * C57BL/6 * FVB/N)	enlarged spleen	J:22116
Krt27^{em1(IMPC)Ccpcz}/Krt27^{em1(IMPC)Ccpcz} (C57BL/6N-Krt27^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Krt28^{em1(IMPC)Ccpcz}/Krt28^{em1(IMPC)Ccpcz} (C57BL/6N-Krt28^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Krt33a^{em1(IMPC)Ccpcz}/Krt33a^{em1(IMPC)Ccpcz} (C57BL/6N-Krt33a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Krt33b^{em1(IMPC)Ccpcz}/Krt33b^{em1(IMPC)Ccpcz} (C57BL/6N-Krt33b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
Krt34^{em1(IMPC)Ccpcz}/Krt34^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Krt34^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Krt72^{em1(IMPC)Ccpcz}/Krt72^{em1(IMPC)Ccpcz} (C57BL/6N-Krt72^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Krtap7-1^{em1(IMPC)Ccpcz}/Krtap7-1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Krtap7-1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Krtap8-1^{em1(IMPC)Ccpcz}/Krtap8-1^{em1(IMPC)Ccpcz} (C57BL/6N-Krtap8-1^{em1(IMPC)Ccpcz}/Ccpcz)	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased NK T cell number	J:211773
	decreased T-helper cell number	J:211773
Krtap9-5^{em1(IMPC)Ccpcz}/Krtap9-5^{em1(IMPC)Ccpcz} (C57BL/6N-Krtap9-5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ksr1^tm1Shaw/Ksr1^tm1Shaw Tg(DO11.10)10Dlo/0 (involves: BALB/c * C3H * C57BL/6)	abnormal CD4-positive T cell differentiation	J:75739
Ky^em1(IMPC)J/Ky⁺ (C57BL/6NJ-Ky^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Lacc1^{tm1a(KOMP)Wtsi}/Lacc1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N * C57BL/6NTac)	abnormal macrophage morphology	J:244365
Lag3^tm1Daav/Lag3^tm1Daav Tg(Foxp3-EGFP/cre)1cJbs/0 (NOD.Cg-Lag3^tm1Daav Tg(Foxp3-EGFP/cre)1cJbs)	abnormal effector T cell number	J:260063
Lag3^tm1Doi/Lag3^tm1Doi (involves: 129S2/SvPas * C57BL/6)	enlarged spleen	J:89653
	increased CD4-positive, alpha-beta T cell number	J:89653
	increased CD8-positive, alpha-beta T cell number	J:89653
	increased single-positive T cell number	J:89653
Lage3^em1(IMPC)Tcp/Lage3^em1(IMPC)Tcp (C57BL/6N-Lage3^em1(IMPC)Tcp/Tcp)	increased neutrophil cell number	J:211773
Lair1^tm1.1Jco/Lair1^tm1.1Jco (involves: C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:180203
	decreased CD8-positive, alpha-beta T cell number	J:180203
	decreased thymocyte number	J:180203
	increased activated T cell number	J:180203
	increased B cell number	J:180203
	increased CD4-positive, alpha-beta memory T cell number	J:180203
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:180203
	increased CD8-positive, alpha-beta memory T cell number	J:180203
	increased dendritic cell number	J:180203
	increased eosinophil cell number	J:180203
	increased marginal zone B cell number	J:180203
Lama2^tm1Stk/Lama2^tm1Stk (involves: 129P2/OlaHsd * BALB/c)	abnormal thymus corticomedullary boundary morphology	J:61802
	decreased double-positive T cell number	J:61802
	decreased T cell number	J:61802
	thymus cortex hypoplasia	J:61802
Lama3^tm1.1Grsb/Lama3^tm1.1Grsb (involves: C57BL/6)	increased alveolar macrophage number	J:235712
Lama4^{tm1.1(KOMP)Vlcg}/Lama4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Lama4^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
Lama5^b2b2966.1Clo/Lama5^b2b2966.1Clo (C57BL/6J-Lama5^b2b2966.1Clo)	thymus hypoplasia	J:175213
Lama5^tm1Lsor/Lama5^tm1Lsor Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * SJL)	decreased marginal zone B cell number	J:198783
	decreased transitional stage T2 B cell number	J:198783
	increased B cell number	J:198783
	increased transitional stage T1 B cell number	J:198783
Lamp1^em1(IMPC)Mbp/Lamp1^em1(IMPC)Mbp (C57BL/6N-Lamp1^em1(IMPC)Mbp/MbpMmucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	small spleen	J:211773
Lamp2^tm1Psa/Lamp2^tm1Psa (either: (involves: 129P2/OlaHsd * 129/Sv * C57BL/6J) or (involves: 129P2/OlaHsd * 129/Sv))	abnormal thymus morphology	J:64151
	intermingled spleen red and white pulp	J:64151
Lamp3^em1(IMPC)Tcp/Lamp3^em1(IMPC)Tcp (C57BL/6N-Lamp3^em1(IMPC)Tcp/Tcp)	abnormal lymph node morphology	J:211773
Lamp3^em1Damme/Lamp3^em1Damme (involves: C57BL/6N)	increased macrophage cell number	J:324174
Lancl2^{tm2a(KOMP)Wtsi}/Lancl2^{tm2a(KOMP)Wtsi} (involves: C57BL/6N)	decreased macrophage cell number	J:250673
	decreased regulatory T cell number	J:250673
Lancl2^{tm2c(KOMP)Wtsi}/Lancl2^{tm2c(KOMP)Wtsi} Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: C57BL/6N)	decreased macrophage cell number	J:250673
	decreased regulatory T cell number	J:250673
Larp1^em1(IMPC)Mbp/Larp1⁺ (C57BL/6N-Larp1^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
Larp1^em1(IMPC)Mbp/Larp1⁺ (C57BL/6N-Larp1^em1(IMPC)Mbp/Ucd)	enlarged spleen	J:211773
Lat2^tm1Wz/Lat2^tm1Wz (B6.Cg-Lat2^tm1Wz)	spleen hyperplasia	J:116157
Lat2^tm2Wz/Lat2^tm2Wz Tg(Lck-cre)548Jxm/0 (involves: C57BL/6)	enlarged spleen	J:116157
	increased activated T cell number	J:116157
Lat2^tm3.1Wz/Lat2^tm3.1Wz (B6.Cg-Lat2^tm3.1Wz)	enlarged spleen	J:181866
Lat2^tm3.1Wz/Lat2^tm3.1Wz (B6.Cg-Lat2^tm3.1Wz)	increased memory T cell number	J:181866
Lat^tm1.1Lov/Lat^tm1.1Lov (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:116157, J:77099
	abnormal CD8-positive, alpha beta T cell morphology	J:77099
	abnormal double-negative T cell morphology	J:77099
	abnormal lymph organ size	J:77099
	abnormal T cell differentiation	J:77099
	decreased double-positive T cell number	J:77099
	decreased thymocyte number	J:77099
	enlarged lymph nodes	J:116157, J:77099
	enlarged spleen	J:116157, J:77099
	increased activated T cell number	J:77099
	small thymus	J:77099
	spleen hyperplasia	J:116157
Lat^tm1.1Lov/Lat^tm1.1Lov Lat2^tm1Wz/Lat2^tm1Wz (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:116157
	enlarged lymph nodes	J:116157
	enlarged spleen	J:116157
	spleen hyperplasia	J:116157
Lat^tm1.1Mal/Lat^tm1.1Mal (involves: 129S2/SvPas)	abnormal gamma-delta T cell differentiation	J:77098
	abnormal immune system organ morphology	J:77098
	abnormal lymph node germinal center morphology	J:125722
	abnormal lymph node secondary follicle morphology	J:125722
	abnormal lymphocyte morphology	J:77098
	abnormal spleen periarteriolar lymphoid sheath morphology	J:125722
	abnormal T cell selection	J:77098
	abnormal T cell subpopulation ratio	J:77098
	decreased double-positive T cell number	J:77098
	enlarged lymph nodes	J:77098
	enlarged spleen	J:77098
	increased B cell number	J:77098
	increased CD4-positive, alpha-beta T cell number	J:125722, J:77098
	increased eosinophil cell number	J:77098
	increased memory T cell number	J:77098
	increased plasma cell number	J:125722
	increased spleen germinal center number	J:125722
	increased spleen weight	J:262891
	increased T-helper 2 cell number	J:77098
	spleen hyperplasia	J:77098
	thymus hypoplasia	J:77098
Lat^tm1Bpay/Lat^tm1Bpay (involves: 129S2/SvPas)	abnormal T cell differentiation	J:103904
	arrested T cell differentiation	J:103904
	decreased double-negative T cell number	J:103904
	decreased T cell number	J:103904
	decreased thymocyte number	J:103904
	small thymus	J:103904
Lat^tm1Les/Lat^tm1.1Wz (involves: C57BL/6)	abnormal effector T cell morphology	J:147946
Lat^tm1Les/Lat^tm1.1Wz Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal effector T cell morphology	J:147946
	abnormal T cell differentiation	J:147946
	decreased CD4-positive, alpha-beta T cell number	J:147946
	decreased CD8-positive, alpha-beta T cell number	J:147946
	decreased regulatory T cell number	J:147946
	decreased thymocyte number	J:147946
	increased double-positive T cell number	J:147946
	increased gamma-delta T cell number	J:147946
	small thymus	J:147946
Lat^tm1Les/Lat^tm1.2Wz (involves: C57BL/6 * FVB/N)	absent T cells	J:147946
Lat^tm1Les/Lat^tm1.2Wz (involves: C57BL/6 * FVB/N)	arrested T cell differentiation	J:147946
Lat^tm1Les/Lat^tm1Les (Not Specified)	abnormal T cell morphology	J:54059
	arrested T cell differentiation	J:116964, J:54059
	decreased double-negative T cell number	J:54059
	decreased T cell number	J:54059
	decreased thymocyte number	J:54059
	small thymus	J:54059
Lat^tm1Les/Lat^tm1Les Lcp2^{tm5(Lat/Lcp2)Gak}/Lcp2^{tm5(Lat/Lcp2)Gak} (involves: 129S1/Sv * 129X1/SvJ)	arrested T cell differentiation	J:147721
	decreased double-positive T cell number	J:147721
Lat^tm1Les/Lat^tm1Les Tg(CD2-LAT2)1Wz/0 (Not Specified)	abnormal single-positive T cell number	J:116964
	abnormal spleen periarteriolar lymphoid sheath morphology	J:116964
	abnormal T cell differentiation	J:116964
	decreased double-positive T cell number	J:116964
	enlarged spleen	J:116964
	small thymus	J:116964
	spleen hyperplasia	J:116964
Lat^tm2.1Lov/Lat^tm2.1Lov (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal T cell differentiation	J:77695
	decreased T cell number	J:77695
	small thymus	J:77695
Lat^tm2.1Mal/Lat^tm2.1Mal (involves: 129S2/SvPas)	abnormal B cell differentiation	J:94074
	abnormal gamma-delta T cell differentiation	J:94074
	abnormal immune system organ morphology	J:94074
	abnormal lymphocyte morphology	J:94074
	abnormal lymphopoiesis	J:94074
	abnormal mature gamma-delta T cell morphology	J:94074
	abnormal plasma cell morphology	J:94074
	abnormal spleen morphology	J:94074
	abnormal spleen periarteriolar lymphoid sheath morphology	J:94074
	abnormal spleen white pulp morphology	J:94074
	abnormal T-helper 2 cell morphology	J:94074
	absent CD4-positive, alpha-beta T cells	J:94074
	absent CD8-positive, alpha-beta T cells	J:94074
	arrested T cell differentiation	J:94074
	decreased double-positive T cell number	J:94074
	enlarged lymph nodes	J:94074
	enlarged spleen	J:94074
	increased B cell number	J:94074
	increased mature gamma-delta T cell number	J:94074
	thymus hypoplasia	J:94074
Lat^tm3.1Mal/Lat^tm3.1Mal (involves: 129S2/SvPas)	abnormal gamma-delta T cell differentiation	J:94074
	abnormal lymph node cell ratio	J:94074
	abnormal splenic cell ratio	J:94074
	abnormal thymus cell ratio	J:94074
	absent CD4-positive, alpha-beta T cells	J:94074
	absent CD8-positive, alpha-beta T cells	J:94074
	absent mature gamma-delta T cells	J:94074
	arrested T cell differentiation	J:94074
	decreased double-positive T cell number	J:94074
	decreased T cell number	J:94074
	increased T cell number	J:94074
Lat^tm4.1Mal/Lat^tm4.1Mal (involves: 129P2/OlaHsd)	abnormal gamma-delta T cell differentiation	J:94074
	abnormal lymph node cell ratio	J:94074
	abnormal lymphocyte morphology	J:94074
	abnormal splenic cell ratio	J:94074
	abnormal thymus cell ratio	J:94074
	absent CD4-positive, alpha-beta T cells	J:94074
	absent CD8-positive, alpha-beta T cells	J:94074
	absent mature gamma-delta T cells	J:94074
	arrested T cell differentiation	J:94074
	decreased double-positive T cell number	J:94074
	decreased T cell number	J:94074
Lat^tm4.1Mal/Lat^tm4.1Mal Tg(LckF505)3073Rmp/? (involves: 129P2/OlaHsd C57BL/6 * DBA/2)	increased CD4-positive, alpha-beta T cell number	J:151840
	spleen hyperplasia	J:151840
Lat^tm4.1Mal/Lat^tm4.1Mal Trdc^tm1Mal/Trdc^tm1Mal (involves: 129P2/OlaHsd * C57BL/6)	abnormal double-negative T cell morphology	J:112658
Lat^tm5.1Mal/Lat^tm5.1Mal (involves: C57BL/6)	arrested T cell differentiation	J:152363
Lat^{tm8.1(CD2,-ECFP)Mal}/Lat^{tm8.1(CD2,-ECFP)Mal} (involves: 129S2/SvPas * C57BL/6)	abnormal lymphocyte morphology	J:152149
	abnormal T cell receptor delta chain V(D)J recombination	J:152149
	abnormal T cell receptor gamma chain V-J recombination	J:152149
	arrested T cell differentiation	J:152149
	increased double-negative T cell number	J:152149
Lat^tm9Mal/Lat^tm9Mal (involves: C57BL/6)	abnormal B cell number	J:205441
	abnormal immune system morphology	J:205441
	abnormal lymphopoiesis	J:205441
	increased T-helper 2 cell number	J:205441
Lats1^em1(IMPC)H/Lats1^em1(IMPC)H (C57BL/6NTac-Lats1^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Lax1^tm1Wz/Lax1^tm1Wz (involves: C57BL/6)	abnormal spleen germinal center morphology	J:98403
Lax1^tm1Wz/Lax1^tm1Wz (involves: C57BL/6)	abnormal splenic cell ratio	J:98403
Lbp^{tm1b(EUCOMM)Hmgu}/Lbp^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lbp^{tm1b(EUCOMM)Hmgu}/H)	decreased eosinophil cell number	J:211773
	increased spleen weight	J:211773
Lbr^em1(IMPC)Tcp/Lbr^em1(IMPC)Tcp (C57BL/6N-Lbr^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Lbr^Gt(XE569)Byg/Lbr^Gt(XE569)Byg (involves: 129P2/OlaHsd * C57BL/6Cr)	abnormal granulocyte differentiation	J:138854
	abnormal granulocyte morphology	J:138854
	abnormal lymphocyte morphology	J:138854
	abnormal neutrophil morphology	J:138854
	enlarged lymph nodes	J:138854
Lbr^ic-2J/Lbr^ic-2J (involves: A/J)	abnormal immune system cell morphology	J:80915
Lbr^ic-3J/Lbr^ic-3J (involves: A/J)	abnormal immune system cell morphology	J:80915
Lbr^ic-J/Lbr⁺ (C57BL/6J-Lbr^ic-J)	abnormal granulocyte morphology	J:80915
Lbr^ic-J/Lbr⁺ ((NZW/LacJ x C57BL/6J-Lbr^ic-J/J)F1)	abnormal neutrophil morphology	J:234168
Lbr^ic-J/Lbr⁺ ((NZW/LacJ x C57BL/6J-Lbr^ic-J/J)F1)	enlarged spleen	J:234168
Lbr^ic-J/Lbr⁺ Tm7sf2^tm1Fdp/Tm7sf2^tm1Fdp (involves: 129S4/SvJae * C57BL/6)	abnormal spleen morphology	J:143838
Lbr^ic-J/Lbr^ic-J (C57BL/6J-Lbr^ic-J)	abnormal eosinophil morphology	J:80915
	abnormal lymphocyte morphology	J:80915
	abnormal neutrophil morphology	J:80915
Lbr^ic-J/Lbr^ic-J (involves: 129S4/SvJae * C57BL/6)	abnormal neutrophil differentiation	J:143838
Lbr^ic-J/Lbr^ic-J (involves: 129S4/SvJae * C57BL/6)	abnormal spleen morphology	J:143838
Lbr^ic-J/Lbr^lym3 (C57BL/6-Lbr^ic-J/Lbr^lym3)	decreased leukocyte cell number	J:180355
Lbr^ic-J/Lbr^lym3 (C57BL/6-Lbr^ic-J/Lbr^lym3)	decreased lymphocyte cell number	J:180355
Lbr^lym3/Lbr⁺ (C57BL/6-Lbr^lym3)	abnormal neutrophil morphology	J:180355
Lbr^lym3/Lbr^lym3 (C57BL/6-Lbr^lym3)	abnormal lymphocyte cell number	J:180355
	abnormal lymphocyte morphology	J:180355
	abnormal neutrophil morphology	J:180355
	decreased B cell number	J:180355
	decreased CD4-positive, alpha-beta T cell number	J:180355
	decreased CD8-positive, alpha-beta T cell number	J:180355
	decreased leukocyte cell number	J:180355
	decreased lymphocyte cell number	J:180355
	decreased T cell number	J:180355
	lymph node hypoplasia	J:180355
	spleen hypoplasia	J:180355
	thymus hypoplasia	J:180355
Lbw2^NZB/BlScr/Lbw2^NZB/BlScr (involves: NZB * NZW)	increased spleen weight	J:98150
Lck^m1Btlr/Lck^m1Btlr (C57BL/6J-Lck^m1Btlr)	abnormal CD4-positive T cell differentiation	J:144695
	abnormal CD8-positive, alpha-beta T cell differentiation	J:144695
	decreased CD4-positive, alpha-beta T cell number	J:144695
	decreased CD8-positive, alpha-beta T cell number	J:144695
	thymus atrophy	J:144695
	thymus hypoplasia	J:144695
Lck^m2Btlr/Lck^m2Btlr (C57BL/6J-Lck^m2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:203759
Lck^m2Btlr/Lck^m2Btlr (C57BL/6J-Lck^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:203759
Lck^m3Btlr/Lck^m3Btlr (C57BL/6J-Lck^m3Btlr)	abnormal T cell subpopulation ratio	J:217863
	decreased single-positive T cell number	J:217863
	increased activated T cell number	J:217863
	increased single-positive T cell number	J:217863
Lck^tm1.1Litt/Lck^tm1.1Litt (Not Specified)	abnormal lymphocyte morphology	J:152472
Lck^tm1.1Litt/Lck^tm1.1Litt (Not Specified)	abnormal thymus morphology	J:152472
Lck^tm1Dbs/Lck^tm1Dbs (involves: C3H * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:114660
	abnormal CD8-positive, alpha beta T cell morphology	J:114660
	abnormal double-negative T cell morphology	J:114660
	abnormal T cell differentiation	J:114660
	decreased T cell number	J:114660
	decreased thymocyte number	J:114660
Lck^tm1Dbs/Lck^tm1Dbs Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C3H * C57BL/6 * DBA/2J)	abnormal positive T cell selection	J:114660
	abnormal T cell differentiation	J:114660
	arrested T cell differentiation	J:114660
Lck^tm1Dbs/Lck^tm1Dbs Tg(TcraTcrb)425Cbn/0 (involves: C3H * C57BL/6)	abnormal positive T cell selection	J:114660
	arrested T cell differentiation	J:114660
Lck^tm1Dbs/Lck^tm1Dbs Tg(TcraTcrb)1100Mjb/0 (involves: C3H * C57BL/6)	abnormal positive T cell selection	J:114660
Lck^tm1Litt/Lck^tm1.1Litt Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129X1/SvJ)	decreased regulatory T cell number	J:152472
	enlarged lymph nodes	J:152472
	increased regulatory T cell number	J:152472
	increased T cell number	J:152472
Lck^tm1Mak/Lck^tm1Mak (involves: 129S2/SvPas)	abnormal alpha-beta intraepithelial T cell morphology	J:112977
	abnormal double-negative T cell morphology	J:110847
	abnormal lymphocyte morphology	J:1119
	abnormal single-positive T cell number	J:37062
	abnormal T cell morphology	J:110847
	decreased CD4-positive, alpha-beta T cell number	J:37940
	decreased CD8-positive, alpha-beta T cell number	J:37940
	decreased double-positive T cell number	J:1119, J:110847
	decreased gamma-delta intraepithelial T cell number	J:112977, J:37940
	decreased gamma-delta T cell number	J:37062
	decreased T cell number	J:1119, J:37062
	decreased thymocyte number	J:1119
	thymus atrophy	J:1119
	thymus hypoplasia	J:37062, J:37940
Lck^tm1Mak/Lck^tm1Mak (B6.129S2-Lck^tm1Mak)	abnormal intraepithelial T cell morphology	J:111646
	abnormal intraepithelial T cell number	J:111646
	abnormal T cell differentiation	J:111646
	decreased gamma-delta intraepithelial T cell number	J:111646
Lck^tm1Mak/Lck^tm1Mak Rag1^tm1Mom/Rag1⁺ Tg(Lck-FynY528F)5525Cjg/0 (involves: 129S2/SvPas 129S7/SvEvBrd * C57BL/6)	abnormal T cell differentiation	J:37062
	decreased T cell number	J:37062
Lcmt1^{em1(IMPC)Rbrc}/Lcmt1⁺ (C57BL/6NJcl-Lcmt1^{em1(IMPC)Rbrc}/Rbrc)	increased large unstained cell number	J:211773
	increased spleen weight	J:211773
Lcn2^tm1Aade/Lcn2^tm1Aade (B6.129P2-Lcn2^tm1Aade)	increased spleen weight	J:169355
Lcn2^tm1Mrgr/Lcn2^tm1Mrgr (129(B6)-Lcn2^tm1Mrgr)	abnormal myelopoiesis	J:173490
	increased B cell number	J:173490
	increased leukocyte cell number	J:173490
	increased lymphocyte cell number	J:173490
	increased macrophage cell number	J:173490
	increased monocyte cell number	J:173490
	increased neutrophil cell number	J:173490
	increased splenocyte number	J:173490
	myeloid hyperplasia	J:173490
	spleen hyperplasia	J:173490
	thymus hyperplasia	J:173490
Lcp2^tm1.1Wz/Lcp2^tm1.1Wz (B6.Cg-Lcp2^tm1.1Wz)	abnormal effector T cell morphology	J:150304
	abnormal T cell differentiation	J:150304
	abnormal T cell subpopulation ratio	J:150304
	decreased CD4-positive, alpha-beta T cell number	J:150304
	decreased CD8-positive, alpha-beta T cell number	J:150304
	decreased double-negative T cell number	J:150304
	decreased T cell number	J:150304
	decreased thymocyte number	J:150304
	increased double-negative T cell number	J:150304
	lymph node hypoplasia	J:150304
	small thymus	J:150304
Lcp2^tm1.1Wz/Lcp2^tm1.1Wz Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6 * C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:150304
Lcp2^tm1Gak/Lcp2^tm2Gak Tg(Pf4-icre)Q3Rsko/0 Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymphatic vessel morphology	J:162815
	abnormal Peyer's patch morphology	J:162815
Lcp2^tm1Gak/Lcp2^tm2Gak Tg(VAV1-cre)1Graf/0 Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphatic vessel morphology	J:162815
Lcp2^tm1Geha/Lcp2^tm1Geha (involves: 129S4/SvJae)	increased NK cell number	J:131621
Lcp2^tm2Gak/Lcp2^tm2Gak Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:107467
	increased CD8-positive, alpha-beta T cell number	J:107467
	increased gamma-delta T cell number	J:107467
	thymus hypoplasia	J:107467
Lcp2^tm3Gak/Lcp2^tm3Gak (involves: 129S6/SvEvTac * C57BL/6)	abnormal double-negative T cell morphology	J:132995
	abnormal negative T cell selection	J:132995
	abnormal T cell subpopulation ratio	J:132995
	decreased NK T cell number	J:132995
Lcp2^tm3Gak/Lcp2^tm3Gak (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	abnormal negative T cell selection	J:132995
Lcp2^tm3Gak/Lcp2^tm3Gak Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S6/SvEvTac * C57BL/6 * DBA/2J)	abnormal negative T cell selection	J:132995
	increased CD8-positive, alpha-beta T cell number	J:132995
	increased double-positive T cell number	J:132995
Lcp2^tm3Gak/Lcp2^tm3Gak Tg(TcrAND)53Hed/? (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal positive T cell selection	J:132995
Lcp2^tm4Gak/Lcp2^tm4Gak (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal double-negative T cell morphology	J:132995
	abnormal negative T cell selection	J:132995
	abnormal T cell subpopulation ratio	J:132995
	decreased NK T cell number	J:132995
Lcp2^tm4Gak/Lcp2^tm4Gak (involves: 129S6/SvEvTac * BALB/c * C57BL/6)	abnormal negative T cell selection	J:132995
Lcp2^tm4Gak/Lcp2^tm4Gak Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)	abnormal negative T cell selection	J:132995
	increased double-positive T cell number	J:132995
Lcp2^tm4Gak/Lcp2^tm4Gak Tg(TcrAND)53Hed/? (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal positive T cell selection	J:132995
Lcp2^{tm5(Lat/Lcp2)Gak}/Lcp2^{tm5(Lat/Lcp2)Gak} (involves: 129S1/Sv * 129X1/SvJ)	arrested T cell differentiation	J:147721
	decreased double-positive T cell number	J:147721
	decreased single-positive T cell number	J:147721
	thymus hypoplasia	J:147721
Lcp2^twm/Lcp2^twm (C57BL/6JSfdAnu-Lcp2^twm/Anu)	abnormal double-positive T cell morphology	J:104190
	abnormal negative T cell selection	J:104190
	abnormal positive T cell selection	J:104190
	arrested T cell differentiation	J:104190
	decreased T cell number	J:104190
	decreased thymocyte number	J:104190
Lctlp1^DBA/1J/Lctlp1^DBA/1J (involves: DBA/1J * FVB/NJ)	increased CD8-positive, alpha-beta T cell number	J:122919
Lctlp1^DBA/1J/Lctlp1^FVB/NJ (involves: DBA/1J * FVB/NJ)	increased CD8-positive, alpha-beta T cell number	J:122919
Lctlp2^DBA/1J/Lctlp2^DBA/1J (involves: DBA/1J * FVB/NJ)	increased CD8-positive, alpha-beta T cell number	J:122919
Lctlp2^DBA/1J/Lctlp2^FVB/NJ (involves: DBA/1J * FVB/NJ)	increased CD8-positive, alpha-beta T cell number	J:122919
Ldb3^{tm2b(EUCOMM)Hmgu}/Ldb3⁺ (C57BL/6N-Ldb3^{tm2b(EUCOMM)Hmgu}/Bay)	increased basophil cell number	J:211773
	increased large unstained cell number	J:211773
Ldha^a-m1Neu/Ldha^a-m1Neu (involves: 101/El * C3H/El)	abnormal leukocyte morphology	J:132674
	increased neutrophil cell number	J:132674
	increased spleen weight	J:132674
	spleen hyperplasia	J:132674
Ldlr^Hlb301/Ldlr⁺ (C57BL/6J-Ldlr^Hlb301/J)	increased macrophage derived foam cell number	J:82961
Ldlr^Hlb301/Ldlr^Hlb301 (C57BL/6J-Ldlr^Hlb301/J)	increased macrophage derived foam cell number	J:82961
Ldlr^tm1Her/Ldlr^tm1Her (involves: 129S7/SvEvBrd * C57BL/6)	abnormal microglial cell morphology	J:116493
Ldlr^tm1Her/Ldlr^tm1Her (B6.129S7-Ldlr^tm1Her)	abnormal microglial cell morphology	J:137264
Ldlr^tm1Her/Ldlr^tm1Her Mapkapk2^tm1Mgl/Mapkapk2^tm1Mgl (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal macrophage derived foam cell morphology	J:142788
	decreased macrophage cell number	J:142788
Ldlrad4^{tm1b(EUCOMM)Wtsi}/Ldlrad4^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ldlrad4^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased monocyte cell number	J:211773
Lect2^tm1Ymg/Lect2^tm1Ymg (involves: 129P2/OlaHsd * C57BL/6J)	increased T cell number	J:90961
Lef1^{tm1.1(KOMP)Vlcg}/Lef1⁺ (C57BL/6N-Lef1^{tm1.1(KOMP)Vlcg}/Ucd)	increased monocyte cell number	J:211773
Lef1^tm1Hhx/Lef1^tm1Hhx Tcf7^tm1Cle/Tcf7^tm1Cle Gt(ROSA)26Sor^tm2Sho/Gt(ROSA)26Sor⁺ Tg(GZMB-cre)1Jcb/0 (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)	decreased CD8-positive, alpha-beta T cell number	J:189838
Lefty2^tm2Hmd/Lefty2^tm2Hmd (involves: 129P2/OlaHsd * C57BL/6)	accessory spleen	J:70483
Lemd2^em1(IMPC)Bay/Lemd2⁺ (C57BL/6N-Lemd2^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Lep^m1Yst/Lep^m1Yst (C57BL/6J-Lep^m1Yst)	increased macrophage cell number	J:167736
Lep^ob/Lep^ob (involves: C57BL/6J)	abnormal osteoclast differentiation	J:60001
Lep^ob/Lep^ob (B6.Cg-Lep^ob/J)	decreased NK cell number	J:117826
Lep^ob/Lep^ob (involves: C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:164339
Lep^ob/Lep^ob (involves: C57BL/6)	decreased splenocyte number	J:164339
Lep^{tm1b(EUCOMM)Hmgu}/Lep^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lep^{tm1b(EUCOMM)Hmgu}/Bay)	decreased spleen weight	J:211773
Lepr^db-5J/Lepr^db-5J (NOD/ShiLt-Lepr^db-5J)	abnormal CD4-positive, alpha beta T cell morphology	J:118304
Lepr^db-5J/Lepr^db-5J (NOD/ShiLt-Lepr^db-5J)	abnormal CD8-positive, alpha beta T cell morphology	J:118304
Lepr^db-Pas/Lepr^db-Pas (involves: DW/Pas)	enlarged spleen	J:174584
Lepr^db/Lepr^db (B6.Cg-Dock7^m +/+ Lepr^db/J)	abnormal leukocyte morphology	J:115772
	decreased leukocyte cell number	J:115772
	increased neutrophil cell number	J:115772
Lepr^db/Lepr^db (involves: C57BL/6)	abnormal osteoclast differentiation	J:60001
Lepr^m8Btlr/Lepr^m8Btlr (C57BL/6J-Lepr^m8Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:267679
	increased effector memory CD4-positive, alpha-beta T cell number	J:267679
	increased effector memory CD8-positive, alpha-beta T cell number	J:267679
Lepr^{tm1b(EUCOMM)Wtsi}/Lepr^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Lepr^{tm1b(EUCOMM)Wtsi}/H)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	increased eosinophil cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Lepr^tm4Mgmj/Lepr^tm4Mgmj (B6.Cg-Lepr^tm4Mgmj)	decreased CD4-positive, alpha-beta T cell number	J:164339
Lepr^tm4Mgmj/Lepr^tm4Mgmj (B6.Cg-Lepr^tm4Mgmj)	decreased splenocyte number	J:164339
Lgals2^tm1.1Cfg/Lgals2^tm1.1Cfg (involves: C57BL/6)	decreased neutrophil cell number	J:217719
	increased CD4-positive, alpha-beta T cell number	J:217719
	increased CD8-positive, alpha-beta T cell number	J:217719
	increased leukocyte cell number	J:217719
	increased lymphocyte cell number	J:217719
	increased spleen red pulp amount	J:217719
	increased T cell number	J:217719
Lgals3^tm1Ftl/Lgals3^tm1Ftl (B6.129S2-Lgals3^tm1Ftl)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:109126
Lgals3^tm1Ftl/Lgals3^tm1Ftl (B6.129S2-Lgals3^tm1Ftl)	decreased macrophage cell number	J:109126
Lgals3^tm1Ftl/Lgals3^tm1Ftl (involves: 129S2/SvPas * C57BL/6)	abnormal monocyte morphology	J:60741
	decreased lymphocyte cell number	J:60741
	decreased macrophage cell number	J:313172, J:60741
	decreased monocyte cell number	J:60741
	increased eosinophil cell number	J:60741
Lgals3^tm1Poi/Lgals3^tm1Poi (involves: 129/Sv * C57BL/6 * MF1 * SJL)	decreased granulocyte number	J:110422
Lgals8^{tm1(KOMP)Vlcg}/Lgals8^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal lymphangiogenesis	J:235778
Lgals9^tm1.1Cfg/Lgals9^tm1.1Cfg (involves: C57BL/6)	abnormal lymph node germinal center morphology	J:217719
	abnormal Peyer's patch morphology	J:217719
	increased lymphocyte cell number	J:217719
	increased neutrophil cell number	J:217719
	increased spleen germinal center size	J:217719
	lymph node hyperplasia	J:217719
	spleen hyperplasia	J:217719
	thymus hyperplasia	J:217719
Lgals9^tm1Glp/Lgals9^tm1Glp (B6.129S6-Lgals9^tm1Glp)	decreased regulatory T cell number	J:132889
Lgals9^tm1Glp/Lgals9^tm1Glp (B6.129S6-Lgals9^tm1Glp)	increased T-helper 1 cell number	J:132889
Lgmn^tm1Cptr/Lgmn^tm1Cptr (B6.129S6-Lgmn^tm1Cptr)	enlarged spleen	J:172774
Lgmn^tm1Ihn/Lgmn^tm1Ihn (involves: 129P2/OlaHsd * C57BL/6)	dark spleen	J:143886
	increased lymphocyte cell number	J:143886
	increased spleen weight	J:143886
Lgr5^{em1(IMPC)Kmpc}/Lgr5⁺ (C57BL/6NTac-Lgr5^{em1(IMPC)Kmpc}/Kmpc)	increased CD8-positive, CD25-positive alpha-beta T cell number	J:211773
	increased CD11b-high dendritic cell number	J:211773
Lgr6^{em1(IMPC)Ccpcz}/Lgr6^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Lgr6^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Lhcgr^{tm1(KOMP)Vlcg}/Lhcgr^{tm1(KOMP)Vlcg} (C57BL/6N-Lhcgr^{tm1(KOMP)Vlcg}/Nju)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	small spleen	J:211773
	small thymus	J:211773
Lhcgr^tm1Hht/Lhcgr^tm1Hht (involves: 129S7/SvEvBrd * C57BL/6J)	enlarged spleen	J:105533
Lhx5^{em1(IMPC)Ccpcz}/Lhx5⁺ (C57BL/6N-Lhx5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased leukocyte cell number	J:211773
Lif^tm1Cgre/Lif^tm1Cgre (involves: MF1)	abnormal macrophage morphology	J:96965
	increased eosinophil cell number	J:96965
	increased uterine NK cell number	J:96965
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * BALB/c)	decreased leukocyte cell number	J:136940
Lif^tm1Stw/Lif^tm1Stw (involves: 129S1/Sv * MF1)	abnormal osteoclast differentiation	J:137646
	abnormal osteoclast morphology	J:137646
	increased osteoclast cell number	J:137646
Lifr^tm1Imx/Lifr^tm1Imx (involves: 129P3/J * 129S7/SvEvBrd * C57BL/6)	increased osteoclast cell number	J:25253
Lig1^tm1Dwm/Lig1^tm1Dwm (involves: 129P2/OlaHsd)	enlarged spleen	J:75962
Lig1^tm3Dwm/Lig1^tm3Dwm (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:77902
Lig4^m1Btlr/Lig4^m1Btlr (C57BL/6J-Lig4^m1Btlr)	decreased B cell number	J:267684
	decreased CD4-positive, alpha-beta T cell number	J:267684
	decreased CD8-positive, naive alpha-beta T cell number	J:267684
	increased CD8-positive, alpha-beta T cell number	J:267684
	increased central memory CD8 positive, alpha-beta T cell number	J:267684
	increased effector memory CD4-positive, alpha-beta T cell number	J:267684
	increased NK cell number	J:267684
Lig4^m2Btlr/Lig4^m2Btlr (C57BL/6J-Lig4^m2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:267692
Lig4^m2Btlr/Lig4^m2Btlr (C57BL/6J-Lig4^m2Btlr)	increased effector memory CD4-positive, alpha-beta T cell number	J:267692
Lig4^tiny/Lig4^tiny (C57BL/6-Lig4^tiny)	absent CD8-positive, alpha-beta T cells	J:104190
	decreased B cell number	J:122725
	decreased lymphocyte cell number	J:122725
Lig4^tm1Fwa/Lig4^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell differentiation	J:50865
	abnormal lymphopoiesis	J:50865
	abnormal T cell differentiation	J:63078
	arrested B cell differentiation	J:63078
	arrested T cell differentiation	J:50865
	decreased thymocyte number	J:63078
	small thymus	J:50865
Lig4^tm1Fwa/Lig4^tm1Fwa Tg(Cr2-cre)3Cgn/0 Xrcc4^tm2Fwa/Xrcc4^tm2Fwa (involves: 129S6/SvEvTac)	abnormal class switch recombination	J:126758
Lig4^tm1Fwa/Lig4^tm1Fwa Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S6/SvEvTac * 129S7/SvEvBrd)	decreased thymocyte number	J:63078
	increased B cell number	J:63078
Lig4^tm2.1Fwa/Lig4^tm2.1Fwa (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:157574
	abnormal immune system cell morphology	J:157574
	abnormal immune system morphology	J:157574
	abnormal immune system organ morphology	J:157574
	abnormal lymphocyte cell number	J:157574
	abnormal regulatory T cell morphology	J:157574
	abnormal T cell differentiation	J:157574
	abnormal T cell receptor beta chain V(D)J recombination	J:157574
	abnormal T cell receptor V(D)J recombination	J:157574
	abnormal thymus morphology	J:157574
	decreased B cell number	J:157574
	decreased CD4-positive, alpha-beta T cell number	J:157574
	decreased CD8-positive, alpha-beta T cell number	J:157574
	decreased double-negative T cell number	J:157574
	decreased double-positive T cell number	J:157574
	decreased spleen weight	J:157574
	decreased splenocyte number	J:157574
	decreased thymocyte number	J:157574
	decreased thymus weight	J:157574
	increased T cell derived lymphoma incidence	J:157574
	small spleen	J:157574
	small thymus	J:157574
Lig4^tm3.1Fwa/Lig4^tm3.1Fwa Tg(Cr2-cre)3Cgn/0 (Not Specified)	abnormal class switch recombination	J:157537
Lilrb4a^tm1Eol/Lilrb4a^tm1Eol (B6.129P2-Lilrb4a^tm1Eol)	abnormal immune system cell morphology	J:129969
	increased macrophage cell number	J:129969
	increased plasma cell number	J:129969
Limd1^em1(IMPC)H/Limd1^em1(IMPC)H (C57BL/6NTac-Limd1^em1(IMPC)H/H)	increased basophil cell number	J:211773
Limd1^tm1Gdl/Limd1^tm1Gdl (involves: 129X1/SvJ)	abnormal osteoclast cell number	J:118130
Lime1^tm1.1Mal/Lime1^tm1.1Mal Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)1Pas/? (B6.Cg-Rag2^tm1Fwa Lime1^tm1.1Mal Tg(TcraH-Y,TcrbH-Y)1Pas)	abnormal CD4-positive T cell differentiation	J:126321
	increased CD4-positive, alpha-beta T cell number	J:126321
Lipa^tm1Hodu/Lipa^tm1Hodu (involves: 129P2/OlaHsd * CF-1)	abnormal alveolar macrophage morphology	J:101217
	abnormal Kupffer cell morphology	J:68812
	abnormal spleen morphology	J:49674, J:68812
	enlarged mesenteric lymph nodes	J:68812
	enlarged spleen	J:68812
	hepatosplenomegaly	J:68812
	increased spleen weight	J:49674, J:68812
Lipt1^em1(IMPC)Bay/Lipt1⁺ (C57BL/6N-Lipt1^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Litaf^tm1.1Ics/Litaf^tm1.1Ics (Not Specified)	increased macrophage cell number	J:186411
ll/ll X/Yaa (BXSB/MpJScr-ll)	abnormal monocyte morphology	J:10973
	decreased CD4-positive, alpha-beta T cell number	J:10973
	increased T cell derived lymphoma incidence	J:10973
Lmb1^C57BL/6Scr/Lmb1^C57BL/6Scr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	enlarged lymph nodes	J:45708
	enlarged spleen	J:45708
Lmb1^C57BL/6Scr/Lmb1^C57BL/6Scr (MRL.Cg-Lmb1^C57BL/6Scr Fas^lpr)	increased CD8-positive, alpha-beta T cell number	J:125557
	increased double-negative T cell number	J:125557
	increased spleen weight	J:125557
Lmb1^C57BL/6Scr/Lmb1^MRL/MpScr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	enlarged lymph nodes	J:45708
	enlarged spleen	J:45708
Lmb1^MRL/MpScr/Lmb1^MRL/MpScr (B6.MRL-Lmb1^MRL/MpScr Fas^lpr)	enlarged lymph nodes	J:125557
Lmb2^C57BL/6Scr/Lmb2^MRL/MpScr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	enlarged lymph nodes	J:45708
	enlarged spleen	J:45708
Lmb2^MRL/MpScr/Lmb2^MRL/MpScr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	enlarged lymph nodes	J:45708
	enlarged spleen	J:45708
Lmb2^MRL/MpScr/Lmb2^MRL/MpScr (B6.MRL-Lmb2^MRL/MpScr Fas^lpr)	decreased double-negative T cell number	J:125557
Lmb4^MRL/MpScr/Lmb4^MRL/MpScr (involves: C57BL/6-Fas^lpr * MRL-Fas^lpr)	enlarged lymph nodes	J:45708
	enlarged spleen	J:45708
Lmb4^MRL/MpScr/Lmb4^MRL/MpScr (B6.MRL-Lmb4^MRL/MpScr Fas^lpr)	enlarged lymph nodes	J:125557
Lmbr1l^em1Btlr/Lmbr1l^em1Btlr (C57BL/6J-Lmbr1l^em1Btlr)	abnormal alpha-beta T cell morphology	J:274568
	abnormal B cell differentiation	J:274568
	abnormal lymphocyte morphology	J:274568
	decreased CD4-positive, alpha-beta T cell number	J:274568
	decreased leukocyte cell number	J:274568
	decreased lymphocyte cell number	J:274568
	decreased monocyte cell number	J:274568
	decreased T cell number	J:274568
Lmbr1l^m1Btlr/Lmbr1l^m1Btlr (C57BL/6J-Lmbr1l^m1Btlr)	abnormal CD4-positive T cell differentiation	J:274568
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274568
	abnormal T cell differentiation	J:274568
	decreased CD4-positive, alpha-beta T cell number	J:274568
	decreased CD8-positive, alpha-beta T cell number	J:274568
	decreased CD8-positive, naive alpha-beta T cell number	J:274568
	decreased dendritic cell number	J:274568
	decreased NK cell number	J:274568
	decreased NK T cell number	J:274568
	decreased T cell number	J:274568
	increased B-1 B cell number	J:274568
	increased central memory CD8 positive, alpha-beta T cell number	J:274568
	increased effector memory CD4-positive, alpha-beta T cell number	J:274568
	increased macrophage cell number	J:274568
	increased neutrophil cell number	J:274568
Lmbr1l^m2Btlr/Lmbr1l^m2Btlr (C57BL/6J-Lmbr1l^m2Btlr)	increased central memory CD4-positive, alpha-beta T cell number	J:274857
Lmna^Dhe/Lmna⁺ (B6(D2)-Lmna^Dhe/TyGrsrJ)	abnormal peritoneal macrophage morphology	J:188496
Lmna^tm1.1Otin/Lmna^tm1.1Otin (involves: 129P2/OlaHsd * C57BL/6)	small spleen	J:177632
	small thymus	J:177632
Lmna^tm1Stw/Lmna^tm1Stw (involves: 129S1/Sv)	small spleen	J:58702
Lmna^tm1Stw/Lmna^tm1Stw (involves: 129S1/Sv)	thymus atrophy	J:58702
Lmo2^tm2(cre)Thr/Lmo2⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased granulocyte number	J:155870
Lmo2^tm2(cre)Thr/Lmo2⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased monocyte cell number	J:155870
Lmo2^tm2(cre)Thr/Lmo2⁺ Kmt2a^tm1Thr/Kmt2a⁺ Mllt1^tm1Thr/Mllt1⁺ (involves: 129S/SvEv)	abnormal spleen red pulp morphology	J:100794
	abnormal spleen white pulp morphology	J:100794
	enlarged spleen	J:84518, J:100794
Lmo4^tm1Slp/Lmo4^tm1Slp Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal gut-associated lymphoid tissue morphology	J:282740
	abnormal lymphopoiesis	J:282740
	decreased Peyer's patch number	J:282740
Lmo4^tm1Slp/Lmo4^tm1Slp Yeats4^em1Zfa/Yeats4^em1Zfa Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal lymphopoiesis	J:282740
Lmod3^em1(IMPC)Mbp/Lmod3⁺ (C57BL/6N-Lmod3^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
Lmod3^em1(IMPC)Mbp/Lmod3⁺ (C57BL/6N-Lmod3^em1(IMPC)Mbp/Ucd)	enlarged spleen	J:211773
Lmod3^em1(IMPC)Mbp/Lmod3^em1(IMPC)Mbp (C57BL/6N-Lmod3^em1(IMPC)Mbp/Ucd)	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased neutrophil cell number	J:211773
Lmr3^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	enlarged spleen	J:82715
Lmr3^BALB/cHeA/Lmr3^BALB/cHeA (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr3^BALB/cHeA/Lmr3^CcS5/Dem (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr7^CcS5/Dem/? (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:82715
Lmr8^BALB/cHeA/Lmr8^BALB/cHeA (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr8^BALB/cHeA/Lmr8^CcS20/Dem (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr12^CcS16/Dem/Lmr12^CcS16/Dem Lmr19^BALB/cHeA/Lmr19^BALB/cHeA (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr14^BALB/cHeA/? (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lmr14^CcS16/Dem/? (involves: BALB/cHeA * STS/A)	enlarged spleen	J:82716
Lmr16^STS/A/Lmr16^STS/A Lmr18^BALB/cHeA/Lmr18^BALB/cHeA (involves: BALB/cHeA * STS/A)	spleen hyperplasia	J:108764
Lnx1^tm1Lex/Lnx1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased B-1b cell number	J:171883
Loricrin^{tm1.1(KOMP)Vlcg}/Loricrin⁺ (C57BL/6N-Loricrin^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Loricrin^{tm1.1(KOMP)Vlcg}/Loricrin^{tm1.1(KOMP)Vlcg} (C57BL/6N-Loricrin^{tm1.1(KOMP)Vlcg}/Ucd)	increased spleen weight	J:211773
Lox^tm1.1Khki/Lox^tm1.1Khki (involves: C57BL/6)	increased lymphocyte cell number	J:264295
Lpar4^tm1Sati/Y (involves: C57BL/6)	lymphangiectasis	J:167262
Lpar4^tm1Sati/Lpar4^tm1Sati (involves: C57BL/6)	lymphangiectasis	J:167262
Lpin2^{tm1b(KOMP)Wtsi}/Lpin2^{tm1b(KOMP)Wtsi} (C57BL/6N-Lpin2^{tm1b(KOMP)Wtsi}/Tcp)	enlarged lymph nodes	J:211773
Lpin3^{tm1b(KOMP)Wtsi}/Lpin3^{tm1b(KOMP)Wtsi} (C57BL/6N-Lpin3^{tm1b(KOMP)Wtsi}/Ucd)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Lprm4^MRL/MpJ/Lprm4^MRL/MpJ (involves: C3H/HeJ-Fas^lpr * MRL/MpJ-Fas^lpr)	enlarged spleen	J:44625
Lpxn^{tm1b(EUCOMM)Hmgu}/Lpxn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lpxn^{tm1b(EUCOMM)Hmgu}/Wtsi)	abnormal plasma cell differentiation	J:305662
Lratd2^{em1(IMPC)Ccpcz}/Lratd2^{em1(IMPC)Ccpcz} (C57BL/6N-Lratd2^{em1(IMPC)Ccpcz}/Ccpcz)	decreased eosinophil cell number	J:211773
	increased B-2 B cell number	J:211773
Lrba^{Gt(OST69142)Lex}/Lrba^{Gt(OST69142)Lex} (involves: 129 * 129S5/SvEvBrd)	increased regulatory T cell number	J:237187
Lrfn2^{Tg(CD2-Myb/en)5Kmw}/Lrfn2⁺ (involves: C57BL/10 * CBA)	abnormal lymph node morphology	J:125805
	decreased T cell number	J:126456
Lrfn2^{Tg(CD2-Myb/en)5Kmw}/Lrfn2⁺ Tg(H2-K-Myc)1Brn/? (involves: C57BL/10 * CBA * FVB/N)	abnormal lymph node morphology	J:125805
	enlarged lymph nodes	J:125805
	enlarged spleen	J:125805
	lymph node necrosis	J:125805
	spleen hyperplasia	J:125805
Lrfn2^{Tg(CD2-Myb/en)5Kmw}/Lrfn2^{Tg(CD2-Myb/en)5Kmw} (involves: C57BL/10 * CBA)	abnormal thymus cortex morphology	J:126456
	abnormal thymus medulla morphology	J:126456
	decreased CD8-positive, alpha-beta T cell number	J:126456
	decreased double-negative T cell number	J:126456
	decreased T cell number	J:126456
	small spleen	J:126456
	small thymus	J:126456
Lrfn2^tm1.1Jaru/Lrfn2^tm1.1Jaru (B6.129P2(Cg)-Lrfn2^tm1.1Jaru)	decreased granulocyte number	J:301285
	decreased leukocyte cell number	J:301285
	decreased lymphocyte cell number	J:301285
Lrfn5^em1(IMPC)Tcp/Lrfn5^em1(IMPC)Tcp (C57BL/6NCrl-Lrfn5^em1(IMPC)Tcp/Tcp)	decreased neutrophil cell number	J:211773
Lrig3^{em1(IMPC)Ccpcz}/Lrig3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Lrig3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Lrp2^b2b2671Clo/Lrp2^b2b2671Clo (C57BL/6J-Lrp2^b2b2671Clo)	thymus hypoplasia	J:175213
Lrp5^tm1Grw/Lrp5^tm1Grw (involves: 129S1/Sv * 129X1/SvJ)	decreased osteoclast cell number	J:104382
Lrp12^em1Gpt/Lrp12^em1Gpt Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6JGpt * DBA/2)	increased T cell number	J:338432
Lrrc3^{tm1b(EUCOMM)Hmgu}/Lrrc3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lrrc3^{tm1b(EUCOMM)Hmgu}/Ics)	decreased lymphocyte cell number	J:211773
Lrrc8a^tm1.1Geha/Lrrc8a^tm1.1Geha (B6.129S1(Cg)-Lrrc8a^tm1.1Geha)	abnormal B cell differentiation	J:211308
	abnormal T cell differentiation	J:211308
	abnormal T cell selection	J:211308
	abnormal thymus medulla morphology	J:211308
	abnormal thymus morphology	J:211308
	absent thymus corticomedullary boundary	J:211308
	decreased B cell number	J:211308
	decreased CD4-positive, alpha-beta T cell number	J:211308
	decreased CD8-positive, alpha-beta T cell number	J:211308
	decreased DN2 thymocyte number	J:211308
	decreased DN3 thymocyte number	J:211308
	decreased DN4 thymocyte number	J:211308
	decreased double-negative T cell number	J:211308
	decreased double-positive T cell number	J:211308
	decreased immature B cell number	J:211308
	decreased marginal zone B cell number	J:211308
	decreased pre-B cell number	J:211308
	decreased T cell number	J:211308
	decreased thymocyte number	J:211308
	decreased transitional stage B cell number	J:211308
	increased pro-B cell number	J:211308
	increased regulatory T cell number	J:211308
	small spleen	J:211308
	small thymus	J:211308
	small thymus cortex	J:211308
	thymus hypoplasia	J:211308
Lrrc8c^em1(IMPC)Mbp/Lrrc8c^em1(IMPC)Mbp (C57BL/6N-Lrrc8c^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Lrrc17^{em1(IMPC)Ccpcz}/Lrrc17^{em1(IMPC)Ccpcz} (C57BL/6N-Lrrc17^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Lrrc17^tm1Nik/Lrrc17⁺ Nf1^tm1Par/Nf1^tm1Par Srpk2^tm1Nik/Srpk2⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	increased leukocyte cell number	J:161558
Lrrc30^{em1(IMPC)Rbrc}/Lrrc30^{em1(IMPC)Rbrc} (C57BL/6NJcl-Lrrc30^{em1(IMPC)Rbrc}/Rbrc)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Lrrc56^em1(IMPC)Tcp/Lrrc56^em1(IMPC)Tcp (C57BL/6N-Lrrc56^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Lrrk1^tm1.1Smo/Lrrk1^tm1.1Smo (involves: 129S/Sv)	increased osteoclast cell number	J:208677
Lrrk1^{tm1b(KOMP)Wtsi}/Lrrk1^{tm1b(KOMP)Wtsi} (C57BL/6N-Lrrk1^{tm1b(KOMP)Wtsi}/H)	decreased eosinophil cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Lrrk2^tm1.1Cai/Lrrk2⁺ Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-SNCAA53T)E2Cai/0 (involves: 129X1/SvJ C57BL/6)	microgliosis	J:156512
Lrrk2^tm1.1Cai/Lrrk2^tm1.1Cai (involves: 129X1/SvJ * C57BL/6)	microgliosis	J:156512
Lrrtm2^em1(IMPC)Mbp/Lrrtm2^em1(IMPC)Mbp (C57BL/6N-Lrrtm2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Lsm8^em1(IMPC)Mbp/Lsm8⁺ (C57BL/6N-Lsm8^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Lsm14a^{tm1b(KOMP)Wtsi}/Lsm14a⁺ (C57BL/6N-Lsm14a^{tm1b(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
Lsp1^tm1Jejb/Lsp1^tm1Jejb (involves: 129S1/Sv * 129X1/SvJ)	abnormal immune system morphology	J:64219
	abnormal lymphopoiesis	J:64219
	increased macrophage cell number	J:64219
Lss^{tm1b(KOMP)Wtsi}/Lss⁺ (C57BL/6N-Lss^{tm1b(KOMP)Wtsi}/Ieg)	increased leukocyte cell number	J:211773
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129)	abnormal spleen marginal zone morphology	J:31129
	abnormal spleen morphology	J:31129
	absent lymph nodes	J:31129
	absent Peyer's patches	J:31129
	decreased T cell number	J:31129
	increased B cell number	J:31129
	increased leukocyte cell number	J:31129
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129 * C57BL/6J)	increased spleen weight	J:112797
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129)	abnormal spleen marginal zone morphology	J:31129
	abnormal spleen morphology	J:31129
	absent lymph nodes	J:31129
	absent Peyer's patches	J:31129
	decreased T cell number	J:31129
	increased B cell number	J:31129
	increased leukocyte cell number	J:31129
Lta/Tnf^tm1Eug/Lta/Tnf^tm1Eug (involves: 129 * C57BL/6J)	increased spleen weight	J:112797
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (C57BL/6J-Lta/Tnf^tm1Jods)	abnormal spleen morphology	J:43602
	abnormal spleen white pulp morphology	J:43602
	absent lymph nodes	J:43602
	absent Peyer's patches	J:43602
	enlarged spleen	J:43602
	increased leukocyte cell number	J:43602
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (C57BL/6-Lta/Tnf^tm1Jods)	abnormal spleen white pulp morphology	J:78229
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (involves: C57BL/6)	abnormal gamma-delta T cell morphology	J:169863
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (C57BL/6J-Lta/Tnf^tm1Jods)	abnormal spleen morphology	J:43602
	absent lymph nodes	J:43602
	absent Peyer's patches	J:43602
	enlarged spleen	J:43602
	increased leukocyte cell number	J:43602
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (C57BL/6-Lta/Tnf^tm1Jods)	abnormal spleen white pulp morphology	J:78229
Lta/Tnf^tm1Jods/Lta/Tnf^tm1Jods (involves: C57BL/6)	abnormal gamma-delta T cell morphology	J:169863
Lta^hlb382/Lta^hlb382 (C57BL/6J-Lta^hlb382/J)	abnormal immune system organ morphology	J:134498
	absent lymph nodes	J:134498
	absent marginal zone B cells	J:134498
	absent mesenteric lymph nodes	J:134498
	absent Peyer's patches	J:134498
	absent spleen germinal center	J:134498
	absent spleen marginal zone	J:134498
	decreased NK cell number	J:134498
	decreased transitional stage B cell number	J:134498
	increased B-1b cell number	J:134498
	increased leukocyte cell number	J:82961
Lta^{tm1.1(KOMP)Vlcg}/Lta^{tm1.1(KOMP)Vlcg} (C57BL/6N-Lta^{tm1.1(KOMP)Vlcg}/Ucd)	decreased monocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Lta^tm1.1Sned/Lta^tm1.1Sned (B6.129-Lta^tm1.1Sned)	abnormal class switch recombination	J:109621
	abnormal immune system morphology	J:109621
	abnormal lymphopoiesis	J:109621
	absent Peyer's patches	J:109621
	decreased spleen white pulp amount	J:109621
	enlarged spleen	J:109621
Lta^tm1Dch/Lta^tm1Dch (B6.129S2-Lta^tm1Dch)	abnormal class switch recombination	J:80616
	abnormal mucosa-associated lymphoid tissue morphology	J:95222
	abnormal spleen morphology	J:80616
	absent Peyer's patches	J:80616
	absent spleen germinal center	J:80616
	absent spleen marginal zone	J:80616
	decreased spleen B cell follicle number	J:80616
	decreased spleen white pulp amount	J:80616
	increased leukocyte cell number	J:80616
Lta^tm1Dch/Lta^tm1Dch (involves: 129S2/SvPas * C57BL/6)	abnormal class switch recombination	J:109621
	abnormal leukocyte cell number	J:17976
	abnormal lymph node morphology	J:17976
	abnormal lymph node primary follicle morphology	J:109621
	abnormal spleen morphology	J:17976, J:39746
	abnormal spleen periarteriolar lymphoid sheath morphology	J:17976
	absent axillary lymph nodes	J:17976
	absent cervical lymph nodes	J:17976
	absent inguinal lymph nodes	J:17976
	absent mesenteric lymph nodes	J:17976, J:39746
	absent Peyer's patches	J:17976
	absent popliteal lymph nodes	J:17976
	absent spleen marginal zone	J:17976
	decreased spleen white pulp amount	J:109621
	decreased T cell number	J:17976
	increased B cell number	J:17976
	increased leukocyte cell number	J:17976
Lta^tm1Dch/Lta^tm1Dch (B6.129S2-Lta^tm1Dch/J)	abnormal lymph organ development	J:73100
Lta^tm1Dch/Lta^tm1Dch (involves: 129S2/SvPas)	abnormal lymphocyte morphology	J:173115
	abnormal thymus epithelium morphology	J:173115
	abnormal thymus medulla morphology	J:173115
	small thymus medulla	J:173115
Lta^tm1Dch/Lta^tm1Dch Rorc^tm2Litt/Rorc⁺ (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal gut-associated lymphoid tissue morphology	J:91566
Lta^tm1Dch/Lta^tm1Dch Tg(Igk-Lta/Ltb)4Cys/0 (involves: 129S2/SvPas * C57BL/6J * DBA/2J)	abnormal lymph organ development	J:73100
	abnormal spleen morphology	J:73100
Lta^tm1Dch/Lta^tm1Dch Tnfsf14^tm1Lpc/Tnfsf14^tm1Lpc (involves: 129S2/SvPas * 129X1/SvJ)	abnormal lymphocyte morphology	J:173115
	abnormal thymus epithelium morphology	J:173115
	small thymus medulla	J:173115
Lta^tm1Jods/Lta^tm1Jods (C57BL/6-Lta^tm1Jods)	abnormal immune system organ morphology	J:47428
	abnormal spleen morphology	J:47428
	abnormal spleen white pulp morphology	J:78229
	absent peripheral lymph nodes	J:47428
	absent Peyer's patches	J:47428
	increased lymphocyte cell number	J:47428
Lta^tm1Jods/Lta^tm1Jods (involves: C57BL/6)	abnormal thymus epithelium morphology	J:125864
Lta^tm1Tab/Lta^tm1Tab (either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * CF-1))	absent lymph nodes	J:28061
	absent Peyer's patches	J:28061
	absent spleen marginal zone	J:28061
	decreased spleen white pulp amount	J:28061
	increased leukocyte cell number	J:28061
	increased spleen weight	J:28061
Ltb4r1^tm1Tksh/Ltb4r1^tm1Tksh (B6.Cg-Ltb4r1^tm1Tksh)	decreased eosinophil cell number	J:118995
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (involves: C57BL/6)	decreased spleen white pulp amount	J:109621
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (B6.Cg-Ltb/Tnf/Lta^tm1Dvk)	abnormal class switch recombination	J:80616
	abnormal spleen morphology	J:80616
	absent axillary lymph nodes	J:80616
	absent brachial lymph nodes	J:80616
	absent inguinal lymph nodes	J:80616
	absent lymph nodes	J:80616
	absent mesenteric lymph nodes	J:80616
	absent Peyer's patches	J:80616
	absent popliteal lymph nodes	J:80616
	absent spleen germinal center	J:80616
	absent spleen marginal zone	J:80616
	decreased spleen B cell follicle number	J:80616
	decreased spleen white pulp amount	J:80616
	increased leukocyte cell number	J:80616
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (involves: C57BL/6)	decreased spleen white pulp amount	J:109621
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (B6.Cg-Ltb/Tnf/Lta^tm1Dvk)	abnormal class switch recombination	J:80616
	abnormal spleen morphology	J:80616
	absent axillary lymph nodes	J:80616
	absent brachial lymph nodes	J:80616
	absent inguinal lymph nodes	J:80616
	absent lymph nodes	J:80616
	absent mesenteric lymph nodes	J:80616
	absent Peyer's patches	J:80616
	absent popliteal lymph nodes	J:80616
	absent spleen germinal center	J:80616
	absent spleen marginal zone	J:80616
	decreased spleen B cell follicle number	J:80616
	decreased spleen white pulp amount	J:80616
	increased leukocyte cell number	J:80616
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (involves: C57BL/6)	decreased spleen white pulp amount	J:109621
Ltb/Tnf/Lta^tm1Dvk/Ltb/Tnf/Lta^tm1Dvk (B6.Cg-Ltb/Tnf/Lta^tm1Dvk)	abnormal class switch recombination	J:80616
	abnormal spleen morphology	J:80616
	absent axillary lymph nodes	J:80616
	absent brachial lymph nodes	J:80616
	absent inguinal lymph nodes	J:80616
	absent lymph nodes	J:80616
	absent mesenteric lymph nodes	J:80616
	absent Peyer's patches	J:80616
	absent popliteal lymph nodes	J:80616
	absent spleen germinal center	J:80616
	absent spleen marginal zone	J:80616
	decreased spleen B cell follicle number	J:80616
	decreased spleen white pulp amount	J:80616
	increased leukocyte cell number	J:80616
Ltb/Tnf^tm1.1Dvk/Ltb/Tnf^tm1.1Dvk (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal mesenteric lymph node morphology	J:58981
	abnormal spleen morphology	J:58981
	absent axillary lymph nodes	J:58981
	absent brachial lymph nodes	J:58981
	absent cervical lymph nodes	J:58981
	absent follicular dendritic cells	J:58981
	absent germinal center B cells	J:58981
	absent inguinal lymph nodes	J:58981
	absent peripheral lymph nodes	J:58981
	absent Peyer's patches	J:58981
	absent popliteal lymph nodes	J:58981
	absent spleen marginal zone	J:58981
	intermingled spleen red and white pulp	J:58981
Ltb/Tnf^tm1.1Dvk/Ltb/Tnf^tm1.1Dvk (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal mesenteric lymph node morphology	J:58981
	abnormal spleen morphology	J:58981
	absent axillary lymph nodes	J:58981
	absent brachial lymph nodes	J:58981
	absent cervical lymph nodes	J:58981
	absent follicular dendritic cells	J:58981
	absent germinal center B cells	J:58981
	absent inguinal lymph nodes	J:58981
	absent peripheral lymph nodes	J:58981
	absent Peyer's patches	J:58981
	absent popliteal lymph nodes	J:58981
	absent spleen marginal zone	J:58981
	intermingled spleen red and white pulp	J:58981
Ltb^tm1Flv/Ltb^tm1Flv (involves: 129S1/Sv * C57BL/6J)	abnormal mesenteric lymph node morphology	J:39746
	abnormal spleen morphology	J:39746
	abnormal spleen red pulp morphology	J:39746
	abnormal spleen white pulp morphology	J:39746
	absent peripheral lymph nodes	J:39746
	absent Peyer's patches	J:39746
Ltb^tm1Kpf/Ltb^tm1Kpf (B6.129P2-Ltb^tm1Kpf)	abnormal class switch recombination	J:80616
	abnormal spleen morphology	J:80616
	absent spleen marginal zone	J:80616
	decreased spleen B cell follicle number	J:80616
	decreased spleen white pulp amount	J:80616
	increased leukocyte cell number	J:80616
Ltb^tm1Kpf/Ltb^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6)	abnormal mesenteric lymph node morphology	J:58981, J:42508
	abnormal spleen follicular dendritic cell network	J:42508
	abnormal spleen germinal center morphology	J:42508
	abnormal spleen marginal zone morphology	J:42508
	abnormal spleen morphology	J:58981, J:42508
	abnormal spleen red pulp morphology	J:42508
	absent axillary lymph nodes	J:42508
	absent brachial lymph nodes	J:42508
	absent cervical lymph nodes	J:58981
	absent follicular dendritic cells	J:58981
	absent inguinal lymph nodes	J:42508
	absent Peyer's patches	J:42508
	absent popliteal lymph nodes	J:42508
	absent spleen marginal zone	J:58981
	decreased spleen white pulp amount	J:109621
	increased lymphocyte cell number	J:42508
Ltb^tm1Kpf/Ltb^tm1Kpf Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6)	abnormal mesenteric lymph node morphology	J:77250
	abnormal spleen morphology	J:77250
	absent axillary lymph nodes	J:77250
	absent brachial lymph nodes	J:77250
	absent inguinal lymph nodes	J:77250
	absent lymph nodes	J:77250
	absent Peyer's patches	J:77250
	absent popliteal lymph nodes	J:77250
Ltb^tm1Krn/Ltb^tm1Krn (C57BL/6-Ltb^tm1Krn)	abnormal mesenteric lymph node morphology	J:78229
	abnormal spleen morphology	J:78229
	absent cervical lymph nodes	J:78229
	absent peripheral lymph nodes	J:78229
	absent Peyer's patches	J:78229
	spleen hyperplasia	J:78229
Ltbp1^{tm1a(EUCOMM)Wtsi}/Ltbp1⁺ (B6JTyr;B6N-Ltbp1^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:175295
Ltbp3^{em1(IMPC)Ccpcz}/Ltbp3⁺ (C57BL/6NCrl-Ltbp3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased spleen weight	J:211773
Ltbp4^em1(IMPC)Tcp/Ltbp4^em1(IMPC)Tcp (C57BL/6NCrl-Ltbp4^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Ltbp4^{Gt(U3Cre)1Vmel}/Ltbp4^{Gt(U3Cre)1Vmel} (B6.129S2-Ltbp4^{Gt(U3Cre)1Vmel})	enlarged spleen	J:78819
Ltbr^m3Btlr/Ltbr^m3Btlr (C57BL/6J-Ltbr^m3Btlr)	increased NK T cell number	J:264642
Ltbr^m4Btlr/Ltbr^m4Btlr (C57BL/6J-Ltbr^m4Btlr)	decreased alpha-beta T cell number	J:264820
	decreased CD4-positive, alpha-beta T cell number	J:264820
	decreased CD8-positive, alpha-beta T cell number	J:264820
	decreased NK cell number	J:264820
	decreased single-positive T cell number	J:264820
	increased B cell number	J:264820
	increased B-1 B cell number	J:264820
Ltbr^tm1Avt/Ltbr^tm1Avt Tg(Rorc-cre)1Litt/0 (Not Specified)	decreased neutrophil cell number	J:158663
Ltbr^tm1Avt/Ltbr^tm1Avt Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * SJL)	decreased neutrophil cell number	J:158663
Ltbr^tm1Kpf/Ltbr^tm1Kpf (involves: 129P2/OlaHsd)	abnormal gamma-delta T cell morphology	J:169863
	abnormal immune system morphology	J:48837
	abnormal immune system organ morphology	J:48837
	abnormal spleen B cell follicle morphology	J:48837
	abnormal spleen morphology	J:48837
	abnormal spleen periarteriolar lymphoid sheath morphology	J:48837
	absent marginal zone B cells	J:48837
	absent peripheral lymph nodes	J:48837
	absent Peyer's patches	J:48837
	enlarged spleen	J:48837
	increased B cell number	J:48837
	increased lymphocyte cell number	J:48837
	increased T cell number	J:48837
Ltbr^tm1Kpf/Ltbr^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6)	decreased spleen white pulp amount	J:109621
Ltbr^tm1Kpf/Ltbr^tm1Kpf (B6.129P2-Ltbr^tm1Kpf)	decreased neutrophil cell number	J:158663
Ltbr^tm1Mmat/Ltbr^tm1Mmat (involves: C57BL/6 * CBA)	abnormal lymphocyte morphology	J:173115
	abnormal spleen morphology	J:173115
	abnormal thymus epithelium morphology	J:173115
	abnormal thymus medulla morphology	J:173115
	absent follicular dendritic cells	J:173115
	absent mesenteric lymph nodes	J:173115
	absent spleen germinal center	J:173115
	small thymus medulla	J:173115
Ltbr^tm1Mmat/Ltbr^tm1Mmat Tnfsf11^tm1Pngr/Tnfsf11^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal thymus epithelium morphology	J:173115
Ltf^tm1Omc/Ltf^tm1Omc (either: 129S/SvEv or (involves: 129S/SvEv * C57BL/6))	decreased spleen iron level	J:81005
Ltn1^{tm1b(EUCOMM)Hmgu}/Ltn1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ltn1^{tm1b(EUCOMM)Hmgu}/Ccpcz)	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
Ltv1^em1(IMPC)J/Ltv1⁺ (C57BL/6NJ-Ltv1^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Luc7l^em1(IMPC)Mbp/Luc7l^em1(IMPC)Mbp (C57BL/6N-Luc7l^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Lum^tm1Wwk/Lum^tm1Wwk (involves: 129P2/OlaHsd)	decreased neutrophil cell number	J:128992
Lxw5^BXSB/Scr/Lxw5^BXSB/Scr (involves: BXSB/Scr * NZW/LacScr)	enlarged spleen	J:86924
Lxw5^NZW/LacScr/Lxw5^BXSB/Scr (involves: BXSB/Scr * NZW/LacScr)	enlarged spleen	J:86924
Lxw6^NZW/LacScr/Lxw6^NZW/LacScr (involves: BXSB/Scr * NZW/LacScr)	enlarged spleen	J:86924
Ly6a^tm1Pmf/Ly6a^tm1Pmf (B6.129P2-Ly6a^tm1Pmf)	abnormal myeloid leukocyte morphology	J:81387
	decreased granulocyte number	J:81387
	decreased monocyte cell number	J:81387
	increased lymphocyte cell number	J:81387
Ly6a^tm1Pmf/Ly6a^tm1Pmf (C.129P2-Ly6a^tm1Pmf)	abnormal osteoclast differentiation	J:83409
Ly6a^tm1Pmf/Ly6a^tm1Pmf (C.129P2-Ly6a^tm1Pmf)	decreased osteoclast cell number	J:83409
Ly6a^{tm2(RUNX1)Grau}/Ly6a⁺ (involves: 129X1/SvJ * C57BL/6J)	abnormal spleen B cell follicle morphology	J:93408
	enlarged spleen	J:93408
	increased leukocyte cell number	J:93408
	increased neutrophil cell number	J:93408
	myeloid hyperplasia	J:93408
Ly6e^{tm1c(EUCOMM)Hmgu}/Ly6e^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Ly6e^{tm1c(EUCOMM)Hmgu} Commd10^{Tg(Vav1-icre)A2Kio})	abnormal mononuclear cell morphology	J:291868
	decreased B cell number	J:291868
	decreased CD4-positive, alpha-beta T cell number	J:291868
	decreased dendritic cell number	J:291868
	decreased macrophage cell number	J:291868
	decreased neutrophil cell number	J:291868
	decreased NK cell number	J:291868
Ly9^tm1Mckn/Ly9^tm1Mckn (involves: 129/Sv * C57BL/6)	abnormal T-helper 2 cell morphology	J:105482
Ly75^tm1Mnz/Ly75^tm1Mnz (Not Specified)	abnormal CD8-positive, alpha beta T cell morphology	J:97290
Ly86^{tm1a(KOMP)Wtsi}/Ly86⁺ (C57BL/6N-Ly86^{tm1a(KOMP)Wtsi}/MbpMmucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Ly86^{tm1a(KOMP)Wtsi}/Ly86^{tm1a(KOMP)Wtsi} (C57BL/6N-Ly86^{tm1a(KOMP)Wtsi}/MbpMmucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Lyar^{Gt(RRG292)Byg}/Lyar^{Gt(RRG292)Byg} Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	increased T cell derived lymphoma incidence	J:263530
Lyg1^{tm1(KOMP)Vlcg}/Lyg1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased CD4-positive, alpha-beta T cell number	J:256594
	decreased CD8-positive, alpha-beta T cell number	J:256594
Lyl1^tm1Fsky/Lyl1^tm1Fsky (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:116300
	arrested B cell differentiation	J:116300
	decreased B cell number	J:116300
	decreased pro-B cell number	J:116300
Lyn^m1Anu/Lyn^m1Anu (C57BL/6JAnu-Lyn^m1Anu)	decreased B cell number	J:195155
Lyn^M1Btlr/Lyn⁺ (C57BL/6J-Lyn^M1Btlr)	decreased B cell number	J:214511
Lyn^M1Btlr/Lyn⁺ (C57BL/6J-Lyn^M1Btlr)	increased neutrophil cell number	J:214511
Lyn^M1Btlr/Lyn^M1Btlr (C57BL/6J-Lyn^M1Btlr)	decreased B cell number	J:214511
Lyn^M1Btlr/Lyn^M1Btlr (C57BL/6J-Lyn^M1Btlr)	increased neutrophil cell number	J:214511
Lyn^m2Anu/Lyn^m2Anu (C57B/6JAnu-Lyn^m2Anu/AnuApb)	decreased mature B cell number	J:104190
Lyn^m2Anu/Lyn^m2Anu (C57B/6JAnu-Lyn^m2Anu/AnuApb)	increased immature B cell number	J:104190
Lyn^M3Btlr/Lyn⁺ (C57BL/6J-Lyn^M3Btlr)	decreased T cell number	J:236679
	increased B-1 B cell number	J:236679
	increased dendritic cell number	J:236679
	increased macrophage cell number	J:236679
Lyn^M3Btlr/Lyn^M3Btlr (C57BL/6J-Lyn^M3Btlr)	decreased T cell number	J:236679
	increased B-1 B cell number	J:236679
	increased dendritic cell number	J:236679
	increased macrophage cell number	J:236679
Lyn^mld4/Lyn^mld4 (involves: C57BL/6)	abnormal B cell morphology	J:144799
	abnormal myelopoiesis	J:144799
	decreased follicular B cell number	J:144799
	decreased marginal zone B cell number	J:144799
	decreased transitional stage B cell number	J:144799
	increased macrophage cell number	J:144799
	increased neutrophil cell number	J:144799
	increased T cell number	J:144799
	spleen hypoplasia	J:144799
Lyn^mld4/Lyn^mld4 Mpl^tm1Wsa/Mpl^tm1Wsa (B6.129S1-Mpl^tm1Wsa)	decreased leukocyte cell number	J:144799
Lyn^tm1.1Calo/Lyn^tm1.1Calo Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	enlarged lymph nodes	J:200745
	enlarged spleen	J:200745
	increased activated T cell number	J:200745
	increased dendritic cell number	J:200745
	increased granulocyte number	J:200745
	increased leukocyte cell number	J:200745
	increased monocyte cell number	J:200745
	increased plasma cell number	J:200745
	increased T cell number	J:200745
	lymph node hyperplasia	J:200745
	myeloid hyperplasia	J:200745
Lyn^tm1Ard/Lyn⁺ Ptpn6^me-v/Ptpn6⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:110531
Lyn^tm1Ard/Lyn⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:110531
Lyn^tm1Ard/Lyn^tm1Ard (involves: 129P2/OlaHsd)	decreased spleen red pulp amount	J:72269
	decreased spleen white pulp amount	J:72269
	enlarged spleen	J:72269
	increased basophil cell number	J:161523
	increased mast cell number	J:161523
	increased neutrophil cell number	J:72269
Lyn^tm1Ard/Lyn^tm1Ard (B6.129P2-Lyn^tm1Ard)	abnormal B cell morphology	J:144799
	abnormal myelopoiesis	J:144799
	decreased follicular B cell number	J:144799
	decreased marginal zone B cell number	J:144799
	decreased transitional stage B cell number	J:144799
	increased T cell number	J:144799
	spleen hypoplasia	J:144799
Lyn^tm1Ard/Lyn^tm1Ard Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell negative selection	J:110531
	abnormal mature B cell morphology	J:110531
	absent B-1 B cells	J:110531
Lyn^{tm1b(EUCOMM)Hmgu}/Lyn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Lyn^{tm1b(EUCOMM)Hmgu}/H)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased eosinophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
	small thymus	J:211773
Lyn^tm1Mhi/Lyn^tm1Mhi (involves: 129S1/Sv)	decreased spleen weight	J:72269
Lyn^tm1Mhi/Lyn^tm1Mhi (involves: 129S1/Sv)	increased neutrophil cell number	J:72269
Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJae)	decreased B cell number	J:42037
	decreased mature B cell number	J:42037
	enlarged lymph nodes	J:42037
	enlarged spleen	J:42037
Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJaeSor)	decreased B cell number	J:200745
	decreased follicular B cell number	J:146161
	decreased marginal zone B cell number	J:146161
	decreased mature B cell number	J:146161
	decreased transitional stage B cell number	J:146161
	increased plasma cell number	J:200745
	myeloid hyperplasia	J:146161
	spleen hyperplasia	J:146161
Lyn^tm1Sor/Lyn^tm1Sor (involves: 129S4/SvJaeSor * C57BL/6)	decreased B cell number	J:71174
	decreased B-1 B cell number	J:71174
	decreased mature B cell number	J:71174
	enlarged spleen	J:71174
Lyn^tm1Tya/Lyn^tm1Tya (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:29751
	abnormal spleen morphology	J:29751
	decreased B cell number	J:29751
	decreased lymphocyte cell number	J:29751
	enlarged lymph nodes	J:29751
	enlarged spleen	J:29751
	increased spleen white pulp amount	J:29751
	small Peyer's patches	J:29751
Lyn^weeb/Lyn^weeb (C57BL/6-Lyn^weeb)	decreased follicular B cell number	J:146161
	decreased marginal zone B cell number	J:146161
	decreased mature B cell number	J:146161
	decreased transitional stage B cell number	J:146161
	disorganized spleen B cell follicle	J:146161
	spleen hyperplasia	J:146161
Lyst^bg-grey/Lyst^bg-grey (C57BL/6-Lyst^bg-grey)	abnormal dermal mast cell morphology	J:106442
Lyst^bg-J/Lyst^bg-J (C57BL/6J-Lyst^bg-J/J)	abnormal granulocyte morphology	J:34814
	abnormal neutrophil morphology	J:34814
	decreased macrophage cell number	J:34814
Lyst^bg-J/Lyst^bg-J Prkdc^scid/Prkdc^scid (B6.Cg-Lyst^bg-J Prkdc^scid/Sz)	abnormal granulocyte morphology	J:34814
	abnormal lymph node morphology	J:34814
	abnormal neutrophil morphology	J:34814
	abnormal Peyer's patch morphology	J:34814
	abnormal spleen white pulp morphology	J:34814
	abnormal thymus morphology	J:34814
	decreased B cell number	J:34814
	decreased CD4-positive, alpha-beta T cell number	J:34814
	decreased CD8-positive, alpha-beta T cell number	J:34814
	decreased lymphocyte cell number	J:34814
	decreased pre-B cell number	J:34814
	decreased T cell number	J:34814
	increased eosinophil cell number	J:34814
	increased granulocyte number	J:34814
	increased macrophage cell number	J:34814
	increased monocyte cell number	J:34814
	increased neutrophil cell number	J:34814
	increased NK cell number	J:34814
	small Peyer's patches	J:34814
	small thymus	J:34814
	spleen hypoplasia	J:34814
	thymus cyst	J:34814
Lyst^bg-Lac/Lyst^bg-Lac (CBA/CaLac-Lyst^bg-Lac)	absent NK T cells	J:29745
Lyst^bg/Lyst^bg (B6.C3Rl-Lyst^bg)	abnormal eosinophil morphology	J:5078
	abnormal lymphocyte morphology	J:5078
	abnormal neutrophil morphology	J:5078
Lyve1^{tm1.1(EGFP/cre)Cys}/Lyve1⁺ Sphk1^tm2Cgh/Sphk1^tm2Cgh Sphk2^tm1.1Cgh/Sphk2^tm1.1Cgh (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal lymph node morphology	J:156826
	abnormal lymphatic vessel morphology	J:156826
	abnormal lymphocyte cell number	J:156826
	abnormal Peyer's patch T cell area morphology	J:156826
	decreased B cell number	J:156826
	decreased splenocyte number	J:156826
	decreased T cell number	J:156826
Lyve1^tm1Lhua/Lyve1^tm1Lhua (B6.129S1-Lyve1^tm1Lhua)	lymphangiectasis	J:117713
Lyz2^tm1(cre)Ifo/0 Nup85^tm1.1Yter/Nup85^tm1.1Yter (involves: 129P2/OlaHsd * C57BL/6)	decreased macrophage cell number	J:292726
Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:172024
Lyz2^tm1(cre)Ifo/Lyz2⁺ Pdcd10^tm1Wami/Pdcd10^tm1Wami (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal neutrophil morphology	J:256076
Lyz2^tm1(cre)Ifo/Lyz2⁺ Pikfyve^{tm1b(EUCOMM)Hmgu}/Pikfyve^{tm1b(EUCOMM)Hmgu} (involves: 129P2/OlaHsd * C57BL/6N)	abnormal alveolar macrophage morphology	J:244776
	decreased alveolar macrophage number	J:244776
	decreased regulatory T cell number	J:244776
	increased eosinophil cell number	J:244776
Lyz2^tm1(cre)Ifo/Lyz2⁺ Rnf217^tm1.1Fudi/Rnf217^tm1.1Fudi (involves: 129P2/OlaHsd)	decreased spleen iron level	J:315675
Lyz2^tm1(cre)Ifo/Lyz2⁺ Selenow^{tm1c(EUCOMM)Wtsi}/Selenow^{tm1c(EUCOMM)Wtsi} (B6.Cg-Selenow^{tm1c(EUCOMM)Wtsi} Lyz2^tm1(cre)Ifo)	abnormal osteoclast differentiation	J:317012
Lyz2^{tm1(HBEGF)Mtka}/Lyz2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal alveolar macrophage morphology	J:145285
Lztr1^em2Tumg/Lztr1⁺ (C57BL/6J-Lztr1^em2Tumg)	abnormal lymphatic vessel morphology	J:361054
Lztr1^em2Tumg/Lztr1⁺ (C57BL/6J-Lztr1^em2Tumg)	enlarged spleen	J:361054
Lztr1^em2Tumg/Lztr1^em2Tumg (C57BL/6J-Lztr1^em2Tumg)	abnormal lymphatic vessel morphology	J:361054
m1Hefl/m1Hefl (C3HeB/FeJ-m1Hefl)	decreased B cell number	J:137446
X/m1Nish (involves: BALB/c * C57BL/6N)	absent B cells	J:204833
	absent Peyer's patches	J:204833
	decreased NK cell number	J:204833
X/m1Nish (involves: C57BL/6N)	abnormal B cell differentiation	J:204833
	abnormal NK cell differentiation	J:204833
	absent B cells	J:204833
	absent B-1 B cells	J:204833
	absent B-2 B cells	J:204833
	absent Peyer's patches	J:204833
	decreased B cell number	J:204833
	decreased B-1 B cell number	J:204833
	decreased immature B cell number	J:204833
	decreased NK cell number	J:204833
	small lymph nodes	J:204833
m2Hefl/m2Hefl (C3HeB/FeJ-m2Hefl)	absent B cells	J:137446
m2Hefl/m2Hefl (C3HeB/FeJ-m2Hefl)	absent T cells	J:137446
m3Hefl/m3Hefl (C3HeB/FeJ-m3Hefl)	decreased CD8-positive, alpha-beta T cell number	J:137446
m3Hefl/m3Hefl (C3HeB/FeJ-m3Hefl)	decreased NK cell number	J:137446
m4Hefl/m4Hefl (C3HeB/FeJ-m4Hefl)	decreased T cell number	J:137446
m5Hefl/m5Hefl (C3HeB/FeJ-m5Hefl)	decreased T cell number	J:137446
M6pr^em1(IMPC)Mbp/M6pr^em1(IMPC)Mbp (C57BL/6N-M6pr^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
M7321Wlst/M7321Wlst⁺ (involves: 129S1/SvImJ * C57BL/6J)	abnormal thrombopoiesis	J:189491
M7324Wlst/M7324Wlst⁺ (involves: 129S1/SvImJ * C57BL/6J)	abnormal thrombopoiesis	J:189491
M7325Wlst/M7325Wlst⁺ (involves: 129S1/SvImJ * C57BL/6J)	abnormal thrombopoiesis	J:189491
m12137Asr/m12137Asr⁺ (C57BL/6J-m12137Asr)	decreased osteoclast cell number	J:132290
Macroh2a1^tm1.1Oxbo/Macroh2a1^tm1.1Oxbo (B6.Cg-Macroh2a1^tm1.1Oxbo)	decreased B cell number	J:293382
	decreased neutrophil cell number	J:293382
	increased eosinophil cell number	J:293382
	increased lymphocyte cell number	J:293382
Macroh2a2^{em1(IMPC)Hmgu}/Macroh2a2^{em1(IMPC)Hmgu} (C57BL/6NCrl-Macroh2a2^{em1(IMPC)Hmgu}/Ieg)	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Mad2l1^tm1Sorg/Mad2l1⁺ (involves: 129S2/SvPas * C57BL/6)	increased spleen germinal center number	J:62829
Madcam1^tm1.2Nwag/Madcam1^tm1.2Nwag (B6.129P2-Madcam1^tm1.2Nwag)	decreased B cell number	J:169739
	decreased plasma cell number	J:169739
	increased plasma cell number	J:169739
	small Peyer's patches	J:169739
Maea^Gt(XG702)Byg/Maea^Gt(XG702)Byg (involves: 129P2/OlaHsd * C57BL/6J)	decreased macrophage cell number	J:114865
Maf^em1(IMPC)Mbp/Maf⁺ (C57BL/6N-Maf^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Mafg^tm1Jeng/Mafg^tm1Jeng Mafk^tm1Jeng/Mafk^tm1Jeng (involves: 129S1/Sv * 129X1/SvJ)	enlarged spleen	J:61142
Mag^{tm1.1(KOMP)Vlcg}/Mag^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mag^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Magix^{em1(IMPC)Hmgu}/Y (C57BL/6NCrl-Magix^{em1(IMPC)Hmgu}/Ieg)	decreased leukocyte cell number	J:211773
Magt1^{Gt(IST13422E1)Tigm}/Y (involves: C57BL/6N)	abnormal B cell morphology	J:260923
	decreased plasma cell number	J:260923
	decreased T cell number	J:260923
	increased B cell number	J:260923
	increased marginal zone B cell number	J:260923
Malt1^tm1Vmd/Malt1^tm1Vmd (involves: C57BL/6N)	abnormal B cell differentiation	J:86770
	abnormal double-negative T cell morphology	J:86770
	abnormal immune system morphology	J:86770
	abnormal spleen marginal zone morphology	J:86770
	abnormal T cell differentiation	J:86770
	absent B-1a cells	J:86770
Maml1^tm1Mkit/Maml1^tm1Mkit (involves: 129P2/OlaHsd * C57BL/6)	decreased marginal zone B cell number	J:122286
	decreased thymocyte number	J:122286
	increased double-negative T cell number	J:122286
Mamld1^{tm1.1(NCOM)Mfgc}/Y (C57BL/6N-Mamld1^{tm1.1(NCOM)Mfgc}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Man2a1^tm1Jxm/Man2a1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:74579
	enlarged spleen	J:41621
	increased memory T cell number	J:74579
Man2b1^tm1Psa/Man2b1^tm1Psa (involves: 129 * C57BL/6J)	abnormal Kupffer cell morphology	J:56659
Man2b1^tm1Psa/Man2b1^tm1Psa (involves: 129 * C57BL/6J)	abnormal spleen red pulp morphology	J:56659
Man2b2^{tm1b(KOMP)Wtsi}/Man2b2^{tm1b(KOMP)Wtsi} (C57BL/6N-Man2b2^{tm1b(KOMP)Wtsi}/Tcp)	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Manba^tm1Khf/Manba^tm1Khf (B6.129-Manba^tm1Khf)	abnormal Kupffer cell morphology	J:105427
Map2k6^tm1Ina/Map2k6^tm1Ina Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal thymus cell ratio	J:100093
Map3k3^tm1Bisu/Map3k3^tm2Bisu Tg(Lck-cre)548Jxm/0 (involves: C57BL/6 * CBA)	decreased CD4-positive, alpha-beta T cell number	J:145923
	decreased CD8-positive, alpha-beta T cell number	J:145923
	spleen hypoplasia	J:145923
Map3k3^tm1Kuro/Map3k3^tm1Kuro Tg(Lck-cre)1Jtak/0 (involves: C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:147103
	decreased CD8-positive, alpha-beta T cell number	J:147103
	decreased double-positive T cell number	J:147103
	decreased single-positive T cell number	J:147103
	decreased thymocyte number	J:147103
	increased double-negative T cell number	J:147103
Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Lck-cre)1Jtak/0 (involves: 129P2/OlaHsd)	abnormal spleen morphology	J:112837
	absent regulatory T cells	J:112837
	decreased CD4-positive, alpha-beta T cell number	J:112837
	decreased CD8-positive, alpha-beta T cell number	J:112837
	decreased single-positive T cell number	J:112837
	decreased T cell number	J:112837
	enlarged lymph nodes	J:112837
	enlarged spleen	J:112837
	increased memory T cell number	J:112837
	spleen hyperplasia	J:112837
Map3k7^tm1Aki/Map3k7^tm1Aki Tg(Lck-cre)1Jtak/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:238318
	abnormal intraepithelial T cell number	J:238318
	abnormal regulatory T cell number	J:238318
	abnormal T cell morphology	J:238318
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:238318
	decreased NK T cell number	J:238318
	increased CD4-positive, alpha-beta T cell number	J:238318
	increased gamma-delta intraepithelial T cell number	J:238318
Map3k7^tm1Zjc/Map3k7^tm1Zjc Tg(Lck-cre)548Jxm/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	decreased CD4-positive, alpha-beta T cell number	J:111794
	decreased CD8-positive, alpha-beta T cell number	J:111794
	decreased T cell number	J:111794
Map3k8^tm1Pnt/Map3k8^tm1Pnt Tnf^tm2Gkl/Tnf⁺ (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)	increased CD8-positive, alpha-beta T cell number	J:108572
	increased single-positive T cell number	J:108572
Map3k9^em1(IMPC)Mbp/Map3k9^em1(IMPC)Mbp (C57BL/6N-Map3k9^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Map3k14^aly/Map3k14⁺ Relb^{Tg(H2-K1/GH1)106Bri}/Relb⁺ (involves: C57BL/6 * C57BL/6J)	decreased NK T cell number	J:120659
	decreased Peyer's patch number	J:120659
	small Peyer's patches	J:120659
Map3k14^aly/Map3k14^aly (involves: C57BL/6J)	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:87993, J:128211
	abnormal immune system morphology	J:147681
	abnormal NK T cell morphology	J:120659
	abnormal thymus corticomedullary boundary morphology	J:87993
	abnormal thymus medulla morphology	J:87993
	absent Peyer's patches	J:120659
	decreased dendritic cell number	J:128211
	decreased mast cell number	J:135748
	decreased NK T cell number	J:120659
	decreased regulatory T cell number	J:128211
	increased eosinophil cell number	J:135748
	small thymus	J:147681
	thymus cyst	J:147681
Map3k14^aly/Map3k14^aly (involves: AEJ/GnRk * C57BL/6J)	abnormal immune system morphology	J:54529
	abnormal lymphocyte morphology	J:16865
	abnormal lymphopoiesis	J:16865
	abnormal spleen primary B follicle morphology	J:54529
	absent follicular dendritic cells	J:54529
	absent lymph nodes	J:16865, J:54529
	absent Peyer's patches	J:16865, J:54529
	absent spleen marginal zone	J:54529
	absent thymus corticomedullary boundary	J:16865, J:54529
	decreased B cell number	J:54529
	decreased spleen B cell follicle number	J:16865
Map3k14^aly/Map3k14^aly (C57BL/6J-Map3k14^aly)	absent lymph nodes	J:16865
Map3k14^m1Btlr/Map3k14^m1Btlr (C57BL/6J-Map3k14^m1Btlr)	absent lymph nodes	J:152065
	arrested B cell differentiation	J:152065
	decreased B cell number	J:152065
Map3k14^m1Btlr/Map3k14^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Map3k14^m1Btlr/Map3k14^m1Btlr (involves: C57BL/6J)	arrested B cell differentiation	J:185495
Map3k14^tm1.1Gne/Map3k14^tm1.1Gne Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NTac)	decreased B cell number	J:280549
Map3k14^tm1.2Gne/Map3k14^tm1.2Gne (B6(Cg)-Map3k14^tm1.2Gne)	abnormal spleen marginal zone morphology	J:240453
	abnormal thymus cell ratio	J:240453
	absent inguinal lymph nodes	J:240453
	absent Peyer's patches	J:240453
	absent popliteal lymph nodes	J:240453
	decreased B cell number	J:240453
	decreased B-2 B cell number	J:240453
	decreased follicular B cell number	J:240453
	decreased germinal center B cell number	J:240453
	decreased marginal zone B cell number	J:240453
	decreased transitional stage T1 B cell number	J:240453
	decreased transitional stage T2 B cell number	J:240453
	small axillary lymph nodes	J:240453
	small brachial lymph nodes	J:240453
Map3k14^tm1Rds/Map3k14^tm1Rds (involves: 129/Sv * C57BL/6)	abnormal spleen morphology	J:68125
	abnormal thymus morphology	J:68125
	absent axillary lymph nodes	J:68125
	absent cervical lymph nodes	J:68125
	absent inguinal lymph nodes	J:68125
	absent lymph nodes	J:68125
	absent mesenteric lymph nodes	J:68125
	absent Peyer's patches	J:68125
	absent popliteal lymph nodes	J:68125
Map3k14^tm1Rds/Map3k14^tm1Rds (involves: 129)	abnormal class switch recombination	J:188560
Map4k3^{Gt(RRO270)Byg}/Map4k3^{Gt(RRO270)Byg} (involves: 129P2/OlaHsd)	abnormal T-helper 1 cell differentiation	J:177642
	abnormal T-helper 2 cell differentiation	J:177642
	abnormal T-helper 17 cell differentiation	J:177642
Map4k5^{Gt(OST218153)Lex}/Map4k5^{Gt(OST218153)Lex} (B6;129S5-Map4k5^{Gt(OST218153)Lex}/Ieg)	increased CD4-positive, alpha-beta T cell number	J:82809
Mapk1^tm1.1Hed/Mapk1^tm1.1Hed Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal T cell subpopulation ratio	J:113280
	decreased CD4-positive, alpha-beta T cell number	J:113280
	decreased CD8-positive, alpha-beta T cell number	J:113280
Mapk1^tm1Gela/Mapk1^tm1Gela H2az2^{Tg(Wnt1-cre)11Rth}/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)	abnormal thymus morphology	J:144862
Mapk1^tm1Gela/Mapk1^tm1Gela Mapk3^tm1Gela/Mapk3⁺ H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)	abnormal thymus morphology	J:144862
Mapk1^tm1Gela/Mapk1^tm1Gela Mapk3^tm1Gela/Mapk3^tm1Gela H2az2^{Tg(Wnt1-cre)11Rth}/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)	athymia	J:144862
Mapk1^tm1Hed/Mapk1^tm1Hed Mapk3^tm1Gpg/Mapk3^tm1Gpg Tg(Cd4-cre)1Cwi/0 (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal positive T cell selection	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Mapk3^tm1Gpg/Mapk3^tm1Gpg Tg(Cd4-cre)1Cwi/0 Tg(TcrAND)53Hed/0 (involves: 129/Sv * C57BL/6 * DBA/2 * SJL)	abnormal positive T cell selection	J:113280
	abnormal T cell subpopulation ratio	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Mapk3^tm1Gpg/Mapk3^tm1Gpg Tg(Lck-cre)1Cwi/0 (involves: 129/Sv * C57BL/6 * DBA/2)	decreased thymocyte number	J:113280
	increased double-positive T cell number	J:113280
	small thymus	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Mapk3^tm1Gpg/Mapk3^tm1Gpg Tg(TcraTcrb)1100Mjb/0 (involves: 129/Sv * C57BL/6)	decreased thymocyte number	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal positive T cell selection	J:113280
	decreased CD4-positive, alpha-beta T cell number	J:113280
	decreased CD8-positive, alpha-beta T cell number	J:113280
	increased double-positive T cell number	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal T cell subpopulation ratio	J:113280
	decreased double-positive T cell number	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Tg(Lck-cre)1Cwi/0 Tg(TcrAND)53Hed/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal positive T cell selection	J:113280
	abnormal T cell subpopulation ratio	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Tg(TcrAND)53Hed/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal double-positive T cell morphology	J:113280
	abnormal positive T cell selection	J:113280
Mapk1^tm1Hed/Mapk1^tm1Hed Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6)	decreased thymocyte number	J:113280
Mapk1^tm2Moga/Mapk1^tm2Moga Mapk3^tm1Gpg/Mapk3^tm1Gpg Tg(Mx1-cre)1Cgn/? (involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * CBA)	abnormal pro-B cell differentiation	J:134528
	abnormal pro-B cell morphology	J:134528
	decreased pre-B cell number	J:134528
Mapk3^tm1Gpg/Mapk3^tm1Gpg (involves: 129)	decreased T cell number	J:58468
Mapk8^tm1Flv/Mapk8^tm1Flv (involves: 129S1/Sv)	abnormal T-helper 1 cell differentiation	J:51510
Mapk8^tm1Rjd/Mapk8^tm1Rjd Mapk9^tm2.1Rjd/Mapk9^tm2.1Rjd Lyz2^tm1(cre)Ifo/Lyz2⁺ (B6J.Cg-Lyz2^tm1(cre)Ifo Mapk9^tm2.1Rjd Mapk8^tm1Rjd)	abnormal macrophage differentiation	J:192551
	decreased macrophage cell number	J:192551
Mapk9^tm1Flv/Mapk9^tm1Flv (involves: 129S2/SvPas)	abnormal T-helper 1 cell differentiation	J:50628
Mapk11^tm1Jda/Mapk11^tm1Jda Mapk14^tm1Jda/Mapk14^tm1Jda (involves: 129 * C57BL/6)	abnormal T-helper 1 cell differentiation	J:165966
	abnormal T-helper 2 cell differentiation	J:165966
	abnormal T-helper 17 cell differentiation	J:165966
Mapk14^tm1Jda/Mapk14^tm1Jda (B6.Cg-Mapk14^tm1Jda)	increased double-negative T cell number	J:146088
Mapkapk2^{tm1b(EUCOMM)Hmgu}/Mapkapk2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mapkapk2^{tm1b(EUCOMM)Hmgu}/H)	increased eosinophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
Mapkapk2^tm1Mgl/Mapkapk2^tm1Mgl (involves: 129P2/OlaHsd * C57BL/6J)	abnormal macrophage derived foam cell morphology	J:142788
	increased spleen germinal center size	J:59678
Mapkapk3^{em1(IMPC)Ccpcz}/Mapkapk3^{em1(IMPC)Ccpcz} (C57BL/6N-Mapkapk3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Mapkbp1^{tm1b(EUCOMM)Hmgu}/Mapkbp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mapkbp1^{tm1b(EUCOMM)Hmgu}/H)	increased spleen weight	J:211773
Mapt^tm1(EGFP)Klt/Mapt^tm1(EGFP)Klt Tg(MAPT)8cPdav/? (involves: 129S4/SvJae * C57BL/6 * Swiss Webster)	abnormal spleen B cell follicle morphology	J:174270
	abnormal spleen B cell follicle shape	J:174270
	abnormal spleen red pulp morphology	J:174270
	increased spleen B cell follicle size	J:174270
Mapt^{tm2.1(FUS)Neas}/Mapt⁺ (B6J.129P2(129S)-Mapt^{tm2.1(FUS)Neas})	microgliosis	J:232167
Mapt^{tm3.1(FUS)Neas}/Mapt⁺ (B6J.129P2(129S)-Mapt^{tm3.1(FUS)Neas})	microgliosis	J:232167
Mar1^tm1Wtg/Mar1⁺ (involves: 129S6/SvEvTac * C57BL/6)	abnormal somatic hypermutation frequency	J:68024
Mar1^tm1Wtg/Mar1^tm1Wtg (involves: 129S6/SvEvTac * C57BL/6)	abnormal somatic hypermutation frequency	J:68024
Marchf1^tm1.1Sish/Marchf1^tm1.1Sish (involves: 129S1/Sv * 129X1/SvJ)	abnormal dendritic cell morphology	J:119918
	abnormal T cell differentiation	J:201198
	decreased regulatory T cell number	J:201198
Marchf3^{tm1b(EUCOMM)Hmgu}/Marchf3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Marchf3^{tm1b(EUCOMM)Hmgu}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Marchf6^{tm1b(EUCOMM)Hmgu}/Marchf6^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Marchf6^{tm1b(EUCOMM)Hmgu}/Ccpcz)	decreased CD4-positive, alpha-beta T cell number	J:211773
Marchf8^{em2(IMPC)Ccpcz}/Marchf8^{em2(IMPC)Ccpcz} (C57BL/6N-Marchf8^{em2(IMPC)Ccpcz}/Ccpcz)	decreased eosinophil cell number	J:211773
Marchf9^{tm1a(EUCOMM)Wtsi}/Marchf9^{tm1a(EUCOMM)Wtsi} (Not Specified)	decreased B cell number	J:165965
Marco^tm1Ktry/Marco^tm1Ktry (B6.129S6-Marco^tm1Ktry)	abnormal spleen marginal zone morphology	J:122271
Marco^tm1Ktry/Marco^tm1Ktry Msr1^tm1Csk/Msr1^tm1Csk (B6.129-Marco^tm1Ktry Msr1^tm1Csk)	abnormal spleen marginal zone morphology	J:122271
Mark2^tm1Hpw/Mark2^tm1Hpw (involves: 129X1/SvJ * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:68830
	abnormal spleen B cell follicle morphology	J:68830
	enlarged lymph nodes	J:68830
	enlarged spleen	J:68830
	increased B cell number	J:68830
	increased spleen weight	J:68830
	lymph node hyperplasia	J:68830
	spleen hyperplasia	J:68830
Mark4^em1(IMPC)Mbp/Mark4^em1(IMPC)Mbp (C57BL/6N-Mark4^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Marveld2^tm1.1Sria/Marveld2^tm1.1Sria (involves: 129X1/SvJ * C57BL/6J)	increased spleen weight	J:201580
Marveld3^{em1(IMPC)Ccpcz}/Marveld3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Marveld3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Matn1^tm1Ref/Matn1^tm1Ref Matn2^tm1Asz/Matn2^tm1Asz Matn3^tm1Asz/Matn3^tm1Asz Matn4^tm1.1Asz/Matn4^tm1.1Asz (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased double-positive T cell number	J:237230
	increased granulocyte number	J:237230
Mavs^tm1Aki/Mavs^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:130954
Mavs^tm1Aki/Mavs^tm1Aki (involves: 129S/SvEv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:162888
	decreased CD8-positive, alpha-beta T cell number	J:162888
	enlarged spleen	J:162888
	increased dendritic cell number	J:162888
Mavs^tm1Aki/Mavs^tm1Aki Ifna6^tm1Aki/Ifna6⁺ (involves: 129P2/OlaHsd)	abnormal alveolar macrophage morphology	J:124340
	abnormal macrophage morphology	J:124340
	abnormal myeloid dendritic cell morphology	J:124340
Mavs^tm1Aki/Mavs^tm1Aki Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:130954
Mb21d2^em1(IMPC)Mbp/Mb21d2^em1(IMPC)Mbp (C57BL/6N-Mb21d2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Mbd2^tm1Bh/Mbd2^tm1Bh (NOD.129P2(B6)-Mbd2^tm1Bh)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:323838
	abnormal effector T cell morphology	J:323838
	enlarged lymph nodes	J:323838
	enlarged spleen	J:323838
	increased T-helper 1 cell number	J:323838
	increased T-helper 2 cell number	J:323838
Mbd5^{tm1b(EUCOMM)Wtsi}/Mbd5⁺ (C57BL/6N-Mbd5^{tm1b(EUCOMM)Wtsi}/Ics)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Mbip^em1(IMPC)J/Mbip⁺ (C57BL/6NJ-Mbip^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Mbl1^tm1Kata/Mbl1^tm1Kata Mbl2^tm1Kata/Mbl2^tm1Kata (involves: 129 * C57BL/6)	abnormal B cell number	J:97686
	decreased germinal center B cell number	J:97686
	decreased macrophage cell number	J:98124
	decreased monocyte cell number	J:98124
	increased B-1 B cell number	J:97686
Mboat2^em1(IMPC)Mbp/Mboat2^em1(IMPC)Mbp (C57BL/6N-Mboat2^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Mboat7^{tm1b(KOMP)Wtsi}/Mboat7⁺ (C57BL/6N-Mboat7^{tm1b(KOMP)Wtsi}/H)	increased lymphocyte cell number	J:211773
Mc2r^tm1Dchi/Mc2r^tm1Dchi (B6.129P2-Mc2r^tm1Dchi)	increased spleen weight	J:127445
Mc2r^tm1Dchi/Mc2r^tm1Dchi (B6.129P2-Mc2r^tm1Dchi)	increased thymus weight	J:127445
Mc4r^tm1Dhu/Mc4r^tm1Dhu (involves: 129S4/SvJae * C57BL/6J)	decreased osteoclast cell number	J:97566
Mcat^tm1.1Ssmi/Mcat^tm1.1Ssmi Tg(CAG-cre/Esr1)5Amc/0 (involves: 129P2/OlaHsd C57BL/6 * C57BL/6J * CBA)	abnormal immune system organ morphology	J:192213
	abnormal myelopoiesis	J:192213
	decreased leukocyte cell number	J:192213
	decreased lymphocyte cell number	J:192213
	enlarged spleen	J:192213
Mcemp1^em1Jngj/Mcemp1^em1Jngj (C57BL/6-Mcemp1^em1Jngj)	abnormal mast cell differentiation	J:335318
Mcidas^em2(IMPC)Tcp/Mcidas^em2(IMPC)Tcp (C57BL/6NCrl-Mcidas^em2(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	increased leukocyte cell number	J:211773
Mcl1^em1(IMPC)Mbp/Mcl1⁺ (C57BL/6N-Mcl1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
	small spleen	J:211773
Mcl1^tm1Dmta/Mcl1⁺ Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (B6.Cg-Mcl1^tm1Dmta Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte})	decreased germinal center B cell number	J:166069
	decreased memory B cell number	J:166069
Mcl1^tm1Dmta/Mcl1⁺ Tg(Aicda-cre)9Mbu/0 (B6.Cg-Mcl1^tm1Dmta Tg(Aicda-cre)9Mbu)	decreased germinal center B cell number	J:166069
	decreased memory B cell number	J:166069
Mcl1^tm1Dmta/Mcl1^tm1Dmta Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (B6.Cg-Mcl1^tm1Dmta Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte})	abnormal B cell differentiation	J:166069
	absent germinal center B cells	J:166069
	absent memory B cells	J:166069
	decreased naive B cell number	J:166069
Mcl1^tm1Dmta/Mcl1^tm1Dmta Tg(Aicda-cre)9Mbu/0 (B6.Cg-Mcl1^tm1Dmta Tg(Aicda-cre)9Mbu)	absent germinal center B cells	J:166069
	absent memory B cells	J:166069
Mcl1^tm1Yen/Mcl1^tm1Yen (B6.129-Mcl1^tm1Yen)	abnormal double-positive T cell morphology	J:146246
	decreased CD8-positive, alpha-beta T cell number	J:146246
	decreased double-negative T cell number	J:146246
	decreased single-positive T cell number	J:146246
Mcl1^tm1Yen/Mcl1^tm1Yen Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal double-positive T cell morphology	J:146246
	decreased CD8-positive, alpha-beta T cell number	J:146246
Mcl1^tm1Yen/Mcl1^tm1Yen Tg(TcraTcrb)425Cbn/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal double-positive T cell morphology	J:146246
	decreased CD4-positive, alpha-beta T cell number	J:146246
Mcl1^tm1Ywh/Mcl1^tm1Ywh Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	decreased granulocyte number	J:137502
	decreased neutrophil cell number	J:137502
	increased eosinophil cell number	J:137502
Mcl1^tm1Ywh/Mcl1^tm1Ywh Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:137400
	decreased CD8-positive, alpha-beta T cell number	J:137400
	decreased T cell number	J:137400
	increased double-positive T cell number	J:137400
Mcl1^tm1Ywh/Mcl1^tm1Ywh Tg(Lck-cre)548Jxm/0 (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA)	abnormal T cell differentiation	J:137400
	decreased CD4-positive, alpha-beta T cell number	J:137400
	decreased CD8-positive, alpha-beta T cell number	J:137400
	decreased double-negative T cell number	J:137400
	decreased double-positive T cell number	J:137400
	decreased T cell number	J:137400
	thymus hypoplasia	J:137400
Mcl1^tm2Sjk/Mcl1^tm3Sjk Tg(Lck-cre)1Cwi/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	arrested T cell differentiation	J:86906
	decreased double-negative T cell number	J:86906
	decreased double-positive T cell number	J:86906
	decreased T cell number	J:86906
	decreased thymocyte number	J:86906
Mcl1^tm2Sjk/Mcl1^tm3Sjk Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	decreased B cell number	J:86906
	decreased T cell number	J:86906
Mcl1^tm3Sjk/Mcl1^tm3Sjk Tg(Cpa3-cre)3Glli/0 (involves: 129X1/Sv * C57BL/6)	decreased basophil cell number	J:179080
	decreased mast cell number	J:179080
Mclr^RF/J/Mclr^SWR/J (involves: RF/J * SWR/J)	increased T cell derived lymphoma incidence	J:9614
Mclr^SWR/J/Mclr^SWR/J (involves: RF/J * SWR/J)	increased T cell derived lymphoma incidence	J:9614
Mcm2^{Gt(AB0178)Wtsi}/Mcm2⁺ Mcm4^chaos3/Mcm4^chaos3 (involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)	increased T cell derived lymphoma incidence	J:165667
Mcm2^{tm1(cre/ERT2)Scpr}/Mcm2^{tm1(cre/ERT2)Scpr} (involves: 129S6/SvEvTac)	enlarged spleen	J:141493
Mcm3ap^tm1Imku/Mcm3ap^tm1Imku Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal memory B cell number	J:88276
	abnormal spleen germinal center morphology	J:88276
	decreased B cell number	J:88276
	decreased germinal center B cell number	J:88276
Mcm4^chaos3/Mcm4^chaos3 (involves: C57BL/6J)	increased T cell derived lymphoma incidence	J:165667
Mcm4^Sdla/Mcm4⁺ (involves: C57BL/6)	decreased DN1 thymic pro-T cell number	J:194117
	enlarged lymph nodes	J:194117
	enlarged spleen	J:194117
Mcph1^{tm1a(EUCOMM)Wtsi}/Mcph1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased B cell number	J:213427
Mcpt1^tm1Hrpm/Mcpt1^tm1Hrpm (involves: 129P2/OlaHsd * MF1)	abnormal mast cell morphology	J:93795
Mcpt8^{tm1.1(HBEGF)Hkar}/Mcpt8^{tm1.1(HBEGF)Hkar} (B6.Cg-Mcpt8^{tm1.1(HBEGF)Hkar})	decreased basophil cell number	J:163761
Mcr^C57BL/10J/Mcr^NC (involves: C57BL/10J * NC)	cutaneous mastocytosis	J:8804
Mcr^NC/Mcr^NC (involves: C57BL/10J * NC)	cutaneous mastocytosis	J:8804
Mcts1^em1(IMPC)Mbp/Y (C57BL/6N-Mcts1^em1(IMPC)Mbp/Ucd)	enlarged spleen	J:211773
Mdc1^{Gt(OST441263)Lex}/Mdc1^{Gt(OST441263)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	abnormal class switch recombination	J:137341
	small spleen	J:137341
	small thymus	J:137341
Mdfic^em1Nlh/Mdfic^em2Nlh (C57BL/6J-Mdfic^em1Nlh/Mdfic^em2Nlh)	abnormal lymphatic vessel morphology	J:326462
Mdga2^{Tg(Prnp-PFN1*G118V)838Kiaei}/Mdga2⁺ (involves: C57BL/6N)	microgliosis	J:241428
Mdk^tm1Tmu/Mdk^tm1Tmu (B6.129S2-Mdk^tm1Tmu)	decreased macrophage cell number	J:102069
Mdm2^tm1.1Ypz/Mdm2^tm1.1Ypz Tg(IghMyc)22Bri/0 (B6.Cg-Mdm2^tm1.1Ypz Tg(IghMyc)22Bri)	enlarged lymph nodes	J:164200
	enlarged Peyer's patches	J:164200
	enlarged thymus	J:164200
	spleen hyperplasia	J:164200
Mdm2^tm1Bay/Mdm2^tm1Mep (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B cell differentiation	J:81065
	decreased double-negative T cell number	J:81065
	decreased double-positive T cell number	J:81065
	decreased granulocyte number	J:81065
	decreased immature B cell number	J:81065
	decreased leukocyte cell number	J:81065
	decreased lymphocyte cell number	J:81065
	decreased neutrophil cell number	J:81065
	decreased spleen weight	J:81065
	decreased T cell number	J:81065
	decreased thymocyte number	J:81065
	decreased thymus weight	J:81065
	spleen hypoplasia	J:81065
	thymus hypoplasia	J:81065
Mdm2^tm1Glo/Mdm2⁺ Mdm4^tm1Glo/Mdm4⁺ (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	decreased leukocyte cell number	J:123661
	spleen atrophy	J:123661
	spleen hypoplasia	J:123661
	thymus atrophy	J:123661
	thymus hypoplasia	J:123661
Mdm2^tm1Glo/Mdm2⁺ Trp53^tm2Wahl/Trp53^tm2Wahl (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)	decreased leukocyte cell number	J:174375
	small thymus	J:174375
	spleen atrophy	J:174375
Mdm2^tm1Mep/Mdm2^tm1.1Mep (involves: 129S7/SvEvBrd * C57BL/6 * FVB)	decreased spleen weight	J:81065
	decreased thymus weight	J:81065
Mdm2^tm2.1Snj/Mdm2^tm2.1Snj (involves: 129S4/SvJae * C57BL/6)	enlarged spleen	J:189297
	increased T cell derived lymphoma incidence	J:189297
Mdm4^m1Btlr/Mdm4^m1Btlr (C57BL/6J-Mdm4^m1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:265262
	decreased single-positive T cell number	J:265262
	increased CD4-positive, alpha-beta T cell number	J:265262
	increased single-positive T cell number	J:265262
Mdm4^m2Btlr/Mdm4^m2Btlr (C57BL/6J-Mdm4^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:272830
Mdm4^m2Btlr/Mdm4^m2Btlr (C57BL/6J-Mdm4^m2Btlr)	increased CD4-positive, alpha-beta T cell number	J:272830
Mdm4^tm1.1Wahl/Mdm4^tm1.1Wahl (involves: 129S/Sv * C57BL/6)	increased leukocyte cell number	J:150341
Me1^em1(IMPC)Tcp/Me1^em1(IMPC)Tcp (C57BL/6NCrl-Me1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Mecom^Jbo/Mecom⁺ (C3N.C-Mecom^Jbo)	abnormal neutrophil differentiation	J:113445
Mecom^tm1Aspe/Mecom^tm1Aspe (involves: 129S6/SvEvTac * C57BL/6)	increased leukocyte cell number	J:178429
Mecom^tm2.2Aspe/Mecom^tm2.2Aspe (involves: 129 * C57BL/6J * FVB/N)	abnormal immune system organ morphology	J:213829
	decreased B cell number	J:213829
	decreased leukocyte cell number	J:213829
Med18^{tm1a(EUCOMM)Wtsi}/Med18⁺ (C57BL/6N-Med18^{tm1a(EUCOMM)Wtsi}/H)	decreased leukocyte cell number	J:165965
Med20^em1(IMPC)J/Med20⁺ (C57BL/6NJ-Med20^em1(IMPC)J/J)	decreased leukocyte cell number	J:211773
Med28^{tm1.1(KOMP)Vlcg}/Med28⁺ (C57BL/6N-Med28^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Mef2b^tm2Rdf/Mef2b⁺ Tg(Cr2-cre)3Cgn/0 (involves: C57BL/6)	abnormal mature B cell morphology	J:265465
	enlarged lymph nodes	J:265465
	enlarged mesenteric lymph nodes	J:265465
	enlarged spleen	J:265465
	increased germinal center B cell number	J:265465
Mef2c^tm1Jjs/Mef2c^tm1Jjs Mir223^tm1Fcam/Mir223^tm1Fcam Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6)	abnormal neutrophil differentiation	J:140009
	increased neutrophil cell number	J:140009
Mefv^{tm3.1(MEFV)Chae}/Mefv^{tm3.1(MEFV)Chae} (B6.129S6-Mefv^{tm3.1(MEFV)Chae})	increased leukocyte cell number	J:172117
Mefv^{tm4.1(MEFV)Chae}/Mefv^{tm4.1(MEFV)Chae} (B6.129S6-Mefv^{tm4.1(MEFV)Chae})	increased leukocyte cell number	J:172117
Mefv^{tm5.1(MEFV)Chae}/Mefv^{tm5.1(MEFV)Chae} (B6.129S6-Mefv^{tm5.1(MEFV)Chae})	abnormal spleen germinal center morphology	J:172117
	decreased B cell number	J:172117
	decreased lymphocyte cell number	J:172117
	decreased T cell number	J:172117
	enlarged lymph nodes	J:172117
	enlarged spleen	J:172117
	increased granulocyte number	J:172117
	increased leukocyte cell number	J:172117
	increased macrophage cell number	J:172117
	increased monocyte cell number	J:172117
	increased neutrophil cell number	J:172117
Megf8^b2b1702.2Clo/Megf8^b2b1702.2Clo (C57BL/6J-Megf8^b2b1702.2Clo)	spleen hypoplasia	J:175213
	thymus hypoplasia	J:175213
Megf8^hlb611/Megf8^hlb611 (involves: C57BL/6J)	absent spleen	J:146805
Megf8^hlb611/Megf8^hlb611 (involves: C57BL/6J)	accessory spleen	J:146805
Megf8^hlb611/Megf8^hlb611 (involves: C57BL/6J * C3H/HeJ)	absent spleen	J:146957
Megf8^hlb611/Megf8^hlb611 (involves: C57BL/6J * C3H/HeJ)	accessory spleen	J:146957
Meis3^{tm1b(EUCOMM)Hmgu}/Meis3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Meis3^{tm1b(EUCOMM)Hmgu}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Men1^tm1.2Zqw/Men1^tm1.2Zqw Pgr^tm2(cre)Lyd/Pgr⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased uterine NK cell number	J:322043
Meox2^tm1(cre)Sor/Meox2⁺ Slc40a1^tm2Nca/Slc40a1^tm2Nca (involves: 129S4/SvJae * 129S6/SvEvTac)	increased spleen iron level	J:129846
Meox2^tm1(cre)Sor/Meox2⁺ Tg(CAG-lacZ,-FUSR521G,-EGFP)682Gyu/0 (involves: 129S4/SvJaeSor C57BL/6)	microgliosis	J:216672
Meox2^tm1(cre)Sor/Meox2⁺ Tg(CAG-lacZ,-FUS,-EGFP)629Gyu/0 (involves: 129S4/SvJaeSor * C57BL/6)	microgliosis	J:216672
Mepe^tm1Tbrw/Mepe^tm1Tbrw (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast morphology	J:81218
Mertk^tm1Gkm/Mertk^tm1Gkm (NOD.129P2-Mertk^tm1Gkm)	abnormal mononuclear cell morphology	J:147153
Mertk^tm1Gkm/Mertk^tm1Gkm (NOD.129P2-Mertk^tm1Gkm)	decreased T cell number	J:147153
Mertk^tm1Gkm/Mertk^tm1Gkm Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (NOD.Cg-Mertk^tm1Gkm Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)	decreased double-positive T cell number	J:147153
	increased CD8-positive, alpha-beta T cell number	J:147153
Mertk^tm1Grl/Mertk^tm1Grl (involves: 129P2/OlaHsd)	enlarged spleen	J:54681
Mesp1^tm2(cre)Ysa/Mesp1⁺ Tbx1^tm1Bld/Tbx1^tm3Bld (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	athymia	J:112457
	thymus hypoplasia	J:112457
Mesp1^tm2(cre)Ysa/Mesp1⁺ Tbx1^tm1Bld/Tbx1^tm5Bld (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	athymia	J:112457
Metap1^em1(IMPC)Tcp/Metap1⁺ (C57BL/6NCrl-Metap1^em1(IMPC)Tcp/Cmmr)	small spleen	J:211773
Metrn^em1(IMPC)Mbp/Metrn^em1(IMPC)Mbp (C57BL/6NCrl-Metrn^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Mettl4^em1Dfel/Mettl4^em1Dfel (involves: 129/Sv * C57BL/6N)	decreased leukocyte cell number	J:278437
Mettl4^em1Dfel/Mettl4^em1Dfel (involves: 129/Sv * C57BL/6N)	enlarged spleen	J:278437
Mettl5^{em1(IMPC)Hmgu}/Mettl5^{em1(IMPC)Hmgu} (C57BL/6N-Mettl5^{em1(IMPC)Hmgu}/Ieg)	increased spleen weight	J:211773
Mettl14^em1(IMPC)Tcp/Mettl14⁺ (C57BL/6NCrl-Mettl14^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Mettl23^{em1(IMPC)Hmgu}/Mettl23^{em1(IMPC)Hmgu} (C57BL/6NCrl-Mettl23^{em1(IMPC)Hmgu}/Ieg)	enlarged spleen	J:211773
	increased spleen weight	J:211773
Mettl25^em1(IMPC)Bay/Mettl25^em1(IMPC)Bay (C57BL/6N-Mettl25^em1(IMPC)Bay/BayMmucd)	increased spleen weight	J:211773
Mex3b^{tm1b(KOMP)Wtsi}/Mex3b^{tm1b(KOMP)Wtsi} (C57BL/6N-Mex3b^{tm1b(KOMP)Wtsi}/Ccpcz)	increased eosinophil cell number	J:211773
Mexis^tm1.1Pton/Mexis^tm1.1Pton (involves: C57BL/6)	increased macrophage derived foam cell number	J:264834
Mfap2^{tm1a(KOMP)Wtsi}/Mfap2^{tm1a(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	decreased B cell number	J:236092
	decreased leukocyte cell number	J:236092
	decreased neutrophil cell number	J:236092
	increased B cell number	J:236092
	increased macrophage cell number	J:236092
	increased monocyte cell number	J:236092
	increased myeloid dendritic cell number	J:236092
	increased splenocyte number	J:236092
Mfap2^tm1Mech/Mfap2^tm1Mech (involves: 129X1/SvJ)	decreased macrophage cell number	J:203960
Mfap2^tm1Mech/Mfap2^tm1Mech (involves: 129X1/SvJ)	decreased monocyte cell number	J:203960
Mfap2^tm1Mech/Mfap2^tm1Mech Mfap5^tm1Mech/Mfap5^tm1Mech (involves: 129X1/SvJ)	decreased monocyte cell number	J:203960
	decreased neutrophil cell number	J:203960
Mfap4^{tm1b(NCOM)Mfgc}/Mfap4^{tm1b(NCOM)Mfgc} (C57BL/6N-Mfap4^{tm1b(NCOM)Mfgc}/Tcp)	enlarged lymph nodes	J:211773
Mfap5^tm1Mech/Mfap5^tm1Mech (Not Specified)	decreased neutrophil cell number	J:203960
Mfge8^{Gt(KST227)Byg}/Mfge8^{Gt(KST227)Byg} (B6.129P2-Mfge8^{Gt(KST227)Byg})	enlarged spleen	J:98314
Mfge8^{Gt(KST227)Byg}/Mfge8^{Gt(KST227)Byg} (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:107106
Mfge8^tm1Mcu/Mfge8^tm1Mcu (involves: 129X1/SvJ * C57BL/6NCr)	enlarged spleen	J:123138
Mfge8^tm1Mcu/Mfge8^tm1Mcu Tg(RIP1-Tag)2Dh/? (involves: 129X1/SvJ * C57BL/6J * C57BL/6NCr * DBA/2J)	decreased Langerhans cell number	J:123138
Mfge8^tm1Osa/Mfge8^tm1Osa (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:90633
	enlarged spleen	J:90633
	increased spleen B cell follicle size	J:90633
	increased spleen weight	J:90633
	increased spleen white pulp amount	J:90633
	spleen hyperplasia	J:90633
Mfng^{em1(IMPC)Ccpcz}/Mfng^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Mfng^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased NK T cell number	J:211773
	enlarged thymus	J:211773
Mfng^tm1.1Cfg/Mfng^tm1.1Cfg (involves: C57BL/6)	decreased macrophage cell number	J:217719
	decreased mature B cell number	J:217719
	decreased neutrophil cell number	J:217719
	increased B cell number	J:217719
	increased lymphocyte cell number	J:217719
Mfng^tm1Cjg/Mfng^tm1Cjg (B6.Cg-Mfng^tm1Cjg)	abnormal marginal zone B cell morphology	J:146621
Mfsd1^em1(IMPC)Tcp/Mfsd1⁺ (C57BL/6N-Mfsd1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Mfsd1^em1(IMPC)Tcp/Mfsd1^em1(IMPC)Tcp (C57BL/6N-Mfsd1^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Mfsd1^{tm1a(KOMP)Wtsi}/Mfsd1^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	enlarged spleen	J:280713
Mfsd2b^{tm1a(KOMP)Wtsi}/Mfsd2b^{tm1a(KOMP)Wtsi} (C57BL/6-Mfsd2b^{tm1a(KOMP)Wtsi})	decreased B cell number	J:250123
	decreased leukocyte cell number	J:250123
	decreased T cell number	J:250123
	enlarged spleen	J:250123
Mfsd8^{tm1a(EUCOMM)Hmgu}/Mfsd8^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	abnormal spleen morphology	J:211608
	microgliosis	J:211608
Mfsd10^{tm1.1(KOMP)Vlcg}/Mfsd10^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mfsd10^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Mgat2^tm1.1Jxm/Mgat2^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal B cell differentiation	J:80661
	decreased T cell number	J:80661
	enlarged lymph nodes	J:80661
	enlarged spleen	J:80661
Mgat4b^tm1.1Jxm/Mgat4b^tm1.1Jxm (B6.129-Mgat4b^tm1.1Jxm)	decreased neutrophil cell number	J:212313
Mgat4b^tm1.1Jxm/Mgat4b^tm1.1Jxm (B6.129-Mgat4b^tm1.1Jxm)	increased leukocyte cell number	J:212313
Mgat4d^{tm1b(KOMP)Wtsi}/Mgat4d^{tm1b(KOMP)Wtsi} (C57BL/6N-Mgat4d^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Mgat5b^tm1.1Cfg/Mgat5b^tm1.1Cfg (involves: 129S6/SvEvTac)	decreased pre-B cell number	J:217719
Mgl2^{tm1.1(HBEGF/EGFP)Aiwsk}/Mgl2⁺ (involves: C57BL/6 * FVB/N)	abnormal lymph node size	J:201044
	abnormal T-helper 2 cell morphology	J:201044
	decreased B cell number	J:201044
	decreased CD4-positive, alpha-beta T cell number	J:201044
	decreased CD8-positive, alpha-beta T cell number	J:201044
	decreased dendritic cell number	J:201044
	decreased Langerhans cell number	J:201044
Mgmt^tm1Mse/Mgmt^tm1Mse (involves: 129S/SvEv)	increased T cell derived lymphoma incidence	J:47642
Mgmt^tm1Mse/Mgmt^tm1Mse Mlh1^tm1Mse/Mlh1^tm1Mse (involves: 129S/SvEv)	increased T cell derived lymphoma incidence	J:47642
Mgrn1^em1(IMPC)Tcp/Mgrn1⁺ (C57BL/6NCrl-Mgrn1^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Mgrn1^em1(IMPC)Tcp/Mgrn1^em1(IMPC)Tcp (C57BL/6NCrl-Mgrn1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Mgst2^em1(IMPC)Mbp/Mgst2^em1(IMPC)Mbp (C57BL/6N-Mgst2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Mical2^em1(IMPC)Tcp/Mical2^em1(IMPC)Tcp (C57BL/6NCrl-Mical2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Mical3^em1(IMPC)J/Mical3^em1(IMPC)J (C57BL/6NJ-Mical3^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Micu1^em#Fink/Micu1^em#Fink (C57BL/6N-Micu1^em#Fink)	decreased B cell number	J:238984
Micu1^em#Fink/Micu1^em#Fink (C57BL/6N-Micu1^em#Fink)	decreased follicular B cell number	J:238984
Micu1^em#Fink/Micu1^em#Fink Smdt1^em1Fink/Smdt1⁺ (involves: C57BL/6J * C57BL/6N * CBA)	decreased B cell number	J:238984
Micu1^tm1bNarl/Micu1⁺ (C57BL/6N-Micu1^tm1bNarl/Narl)	decreased monocyte cell number	J:211773
Mid2^{tm1b(KOMP)Wtsi}/Y (C57BL/6N-Mid2^{tm1b(KOMP)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Mif^tm1Mky/Mif^tm1Mky (C.129-Mif^tm1Mky)	decreased eosinophil cell number	J:106380
Miga2^{tm1a(KOMP)Wtsi}/Miga2^{tm1a(KOMP)Wtsi} (C57BL/6N-Miga2^{tm1a(KOMP)Wtsi}/Mmucd)	abnormal CD4-positive, alpha beta T cell morphology	J:339075
Miga2^{tm1c(KOMP)Wtsi}/Miga2^{tm1c(KOMP)Wtsi} Tg(Cd4-cre)1Cwi/0 (B6.Cg-Miga2^{tm1c(KOMP)Wtsi} Tg(Cd4-cre)1Cwi)	abnormal immune system morphology	J:339075
Minar1^em1(IMPC)Tcp/Minar1^em1(IMPC)Tcp (C57BL/6NCrl-Minar1^em1(IMPC)Tcp/Tcp)	abnormal thymus morphology	J:211773
Mink1^em1(IMPC)Tcp/Mink1^em1(IMPC)Tcp (C57BL/6N-Mink1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Mir34a^tm1.2Arte/Mir34a^tm1.2Arte (involves: C57BL/6N)	abnormal immune system cell morphology	J:221990
Mir34a^tm1.2Arte/Mir34a^tm1.2Arte (involves: C57BL/6N)	increased B cell number	J:221990
Mir122^tm1.1Apts/Mir122^tm1.1Apts (involves: 129 * C57BL/6)	increased macrophage cell number	J:190066
Mir122^tm1.1Apts/Mir122^tm1.1Apts (involves: 129 * C57BL/6)	increased monocyte cell number	J:190066
Mir122^tm1.2Kgh/Mir122^tm1.2Kgh Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)	increased monocyte cell number	J:190067
	increased neutrophil cell number	J:190067
Mir125a^tm1Smoc/Mir125a^tm1Smoc (involves: C57BL/6)	decreased regulatory T cell number	J:224880
Mir126a^tm2.1Smoc/Mir126a^tm2.1Smoc Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6J * C57BL/6N * DBA/2)	decreased T-helper 2 cell number	J:355195
	enlarged spleen	J:355195
	increased T-helper 1 cell number	J:355195
	increased T-helper 17 cell number	J:355195
Mir142^tm1.1Sbel/Mir142^tm1.1Sbel (involves: C57BL/6N)	decreased eosinophil cell number	J:227228
	decreased leukocyte cell number	J:227228
	decreased lymphocyte cell number	J:227228
	decreased monocyte cell number	J:227228
Mir142hg^{Gt(IST11580H2)Tigm}/Mir142hg^{Gt(IST11580H2)Tigm} (involves: C57BL/6N)	abnormal dendritic cell differentiation	J:207516
	abnormal dendritic cell morphology	J:207516
	decreased dendritic cell number	J:207516
	enlarged spleen	J:207516
	increased dendritic cell number	J:207516
	increased neutrophil cell number	J:207516
Mir144/Mir451a^tm1.1Mjwe/Mir144/Mir451a^tm1.1Mjwe (Not Specified)	increased spleen weight	J:163250
	spleen hyperplasia	J:163250
Mir144/Mir451a^tm1.1Mjwe/Mir144/Mir451a^tm1.1Mjwe (Not Specified)	increased spleen weight	J:163250
	spleen hyperplasia	J:163250
Mir144/Mir451a^tm1.2Doca/Mir144/Mir451a^tm1.2Doca (involves: 129P2/OlaHsd * 129S4/SvJaeSor * BALB/cJ)	enlarged spleen	J:163418
Mir144/Mir451a^tm1.2Doca/Mir144/Mir451a^tm1.2Doca (involves: 129P2/OlaHsd * 129S4/SvJaeSor * BALB/cJ)	enlarged spleen	J:163418
Mir146^tm1.1Bal/Mir146^tm1.1Bal (involves: C57BL/6)	abnormal lymphopoiesis	J:167922
	decreased leukocyte cell number	J:173230
	decreased lymphocyte cell number	J:173230
	decreased monocyte cell number	J:173230
	enlarged spleen	J:173230
	increased regulatory T cell number	J:167922
	increased spleen weight	J:173230
	increased T cell derived lymphoma incidence	J:173230
	myeloid hyperplasia	J:167922, J:173230
Mir146^tm1.1Bal/Mir146^tm1.1Bal (involves: C57BL/6 * FVB/N)	myeloid hyperplasia	J:173671
Mir146^tm1.1Bal/Mir146^tm1.1Bal Tifab^tm1.1Dsta/Tifab^tm1.1Dsta (involves: 129 * C57BL/6 * C57BL/6J)	decreased lymphocyte cell number	J:229024
	decreased neutrophil cell number	J:229024
Mir146^tm1.1Lfl/Mir146^tm1.1Lfl Ighg1^tm1(cre)Cgn/Ighg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased germinal center B cell number	J:266124
	increased T follicular helper cell number	J:266124
Mir146^tm1.1Lfl/Mir146^tm1.1Lfl Mir146b^tm1.1Lfl/Mir146b^tm1.1Lfl Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased germinal center B cell number	J:266124
	increased T follicular helper cell number	J:266124
Mir146^tm1.1Lfl/Mir146^tm1.1Lfl Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	increased germinal center B cell number	J:266124
	increased T follicular helper cell number	J:266124
Mir146^tm1.1Lfl/Mir146^tm1.1Lfl Tg(Cr2-cre)3Cgn/0 (involves: C57BL/6)	increased germinal center B cell number	J:266124
	increased plasma cell number	J:266124
	increased T follicular helper cell number	J:266124
Mir146^tm2.1Bal/Mir146^tm2.1Bal (involves: 129S1/Sv * C57BL/6 * FVB/N)	abnormal spleen B cell follicle morphology	J:173671
	decreased lymphocyte cell number	J:173671
	decreased monocyte cell number	J:173671
	enlarged lymph nodes	J:173671
	enlarged spleen	J:173671
	increased spleen germinal center number	J:173671
	increased spleen germinal center size	J:173671
	increased spleen weight	J:173671
	myeloid hyperplasia	J:173671
Mir148a^tm2942.1Arte/Mir148a^tm2942.1Arte Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal plasmablast number	J:307366
	decreased plasma cell number	J:307366
	increased memory B cell number	J:307366
Mir148a^tm2942.1Arte/Mir148a^tm2942.1Arte Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal plasmablast number	J:307366
	decreased plasma cell number	J:307366
	increased plasma cell number	J:307366
Mir148a^tm2942.2Arte/Mir148a^tm2942.2Arte (involves: C57BL/6 * FVB/N)	decreased plasma cell number	J:307366
Mir150^tm1Rsky/Mir150^tm1Rsky (involves: C57BL/6)	decreased B-2 B cell number	J:127234
Mir150^tm1Rsky/Mir150^tm1Rsky (involves: C57BL/6)	increased B-1 B cell number	J:127234
Mir155^tm1.1Brd/Mir155^tm1.1Brd (B6.Cg-Mir155^tm1.1Brd Tyr^c-Brd)	abnormal CD4-positive, alpha beta T cell morphology	J:121095
	abnormal T-helper 1 cell morphology	J:121095
	increased T-helper 2 cell number	J:121095
Mir155^tm1.1Brd/Mir155^tm1.1Brd (B6.129S7-Mir155^tm1.1Brd)	decreased regulatory T cell number	J:146268
Mir155^tm1.1Rsky/Mir155^tm1.1Rsky (involves: 129 * C57BL/6)	decreased germinal center B cell number	J:121084
Mir155^tm1.1Rsky/Mir155^tm1.1Rsky (B6.Cg-Mir155^tm1Rsky/J)	abnormal T-helper 17 cell differentiation	J:226678
	decreased effector memory T-helper cell number	J:226678
	decreased regulatory T cell number	J:226678
	decreased T-helper 17 cell number	J:226678
Mir155^tm1Brd/Mir155^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6)	abnormal class switch recombination	J:121095
Mir155^tm1Rsky/Mir155^tm1Rsky (involves: 129/Sv * C57BL/6)	abnormal gut-associated lymphoid tissue morphology	J:121084
	abnormal immune system morphology	J:121084
	abnormal Peyer's patch germinal center morphology	J:121084
	decreased spleen germinal center number	J:121084
	decreased spleen germinal center size	J:121084
Mir155^tm1Rsky/Mir155^tm1Rsky (involves: 129 * C57BL/6)	abnormal class switch recombination	J:136224
Mir181d^tm1.1Oers/Mir181d^tm1.1Oers (involves: C57BL/6)	increased T cell number	J:212571
Mir205hg^tm1.1Oers/Mir205hg^tm1.1Oers (B6(Cg)-Mir205hg^tm1.1Oers)	small thymus	J:278363
Mir210^tm1.1Wtsi/Mir210^tm1.1Wtsi (involves: C57BL/6J * C57BL/6N)	decreased germinal center B cell number	J:205868
Mir223^tm1Fcam/Mir223^tm1Fcam (involves: 129S4/SvJae * C57BL/6)	abnormal neutrophil differentiation	J:140009
	increased granulocyte number	J:140009
	increased neutrophil cell number	J:140009
Mir338^em1Zchn/Mir338^em1Zchn (C57BL/6-Mir338^em1Zchn)	decreased osteoclast cell number	J:285968
Mir451a^tm1.2Doca/Mir451a^tm1.2Doca (involves: 129P2/OlaHsd * 129S4/SvJaeSor * BALB/cJ)	enlarged spleen	J:163418
Mir451a^tm1Eno/Mir451a^tm1Eno (involves: C57BL/6)	enlarged spleen	J:163251
Mir592^em1Jzhan/Mir592^em1Jzhan (Not Specified)	abnormal microglial cell morphology	J:323615
Mirc1^tm1.1Aven/Mirc1^tm1.1Aven (involves: 129S4/SvJae * C57BL/6 * SJL/J)	decreased alpha-beta T cell number	J:223213
	decreased B cell number	J:223213
	decreased pre-B cell number	J:223213
	decreased pro-B cell number	J:223213
	small spleen	J:223213
Mirc1^tm1.2Tyj/Mirc1^tm1.2Tyj (involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL)	abnormal B cell differentiation	J:134861
	decreased pre-B cell number	J:134861
Mirc1^tm1.3Tyj/Mirc1^tm1.3Tyj (involves: 129S4/SvJae * C57BL/6 * FVB/N)	abnormal B cell differentiation	J:134861
	decreased pre-B cell number	J:134861
Mirc1^tm1Tyj/Mirc1^tm1Tyj Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA * SJL)	abnormal immunoglobulin heavy chain V(D)J recombination	J:134861
	decreased pre-B cell number	J:134861
Mirc1^tm2.1Aven/Mirc1^tm2.1Aven (involves: 129S4/SvJae * C57BL/6 * SJL/J)	decreased B cell number	J:223213
Mirc1^tm2.1Aven/Mirc1^tm2.1Aven Tg(IghMyc)22Bri/? (involves: 129S4/SvJae * C57BL/6 * SJL/J)	abnormal pre-B cell morphology	J:223213
Mirc1^tm3.1Aven/Mirc1^tm3.1Aven (involves: 129S4/SvJae * C57BL/6 * SJL/J)	decreased alpha-beta T cell number	J:223213
	decreased B cell number	J:223213
	decreased pre-B cell number	J:223213
	decreased pro-B cell number	J:223213
	small spleen	J:223213
Mirc11^tm1Rdhl/Mirc11^tm1Rdhl (B6.129-Mirc11^tm1Rdhl)	abnormal B cell differentiation	J:243248
	impaired myelopoiesis	J:243248
	increased B cell number	J:243248
	increased follicular B cell number	J:243248
	increased immature B cell number	J:243248
	increased mature B cell number	J:243248
	increased plasma cell number	J:243248
	increased pre-pro B cell number	J:243248
	increased pro-B cell number	J:243248
	increased transitional stage T1 B cell number	J:243248
Mirc14^tm1.1Ankr/Mirc14^tm1.1Ankr (involves: C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:196134
	abnormal NK T cell morphology	J:196134
	abnormal T cell differentiation	J:196134
	decreased double-positive T cell number	J:196134
	decreased NK T cell number	J:196134
	increased CD4-positive, alpha-beta T cell number	J:196134
Mirc14^tm1.1Czc/Mirc14^tm1.1Czc Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (either: (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor * C57BL/6))	decreased double-positive T cell number	J:188125
	thymus hypoplasia	J:188125
Mirc14^tm1.1Flv/Mirc14^tm1.1Flv Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6N * DBA/2 * SJL)	decreased NK T cell number	J:203157
Mirc14^tm1.2Czc/Mirc14^tm1.2Czc (either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6))	decreased B cell number	J:188125
	decreased DN3 thymocyte number	J:188125
	decreased double-positive T cell number	J:188125
	decreased germinal center B cell number	J:188125
	decreased thymocyte number	J:188125
	increased CD4-positive, alpha-beta T cell number	J:188125
	increased marginal zone B cell number	J:188125
Mirc14^tm1.2Flv/Mirc14^tm1.2Flv (involves: C57BL/6 * C57BL/6N * FVB/N * SJL)	abnormal T cell differentiation	J:203157
	abnormal T cell receptor V(D)J recombination	J:203157
	decreased B cell number	J:203157
	decreased CD4-positive, alpha-beta T cell number	J:203157
	decreased CD8-positive, alpha-beta T cell number	J:203157
	decreased DN1 thymic pro-T cell number	J:203157
	decreased double-positive T cell number	J:203157
	decreased NK T cell number	J:203157
	decreased thymocyte number	J:203157
Mirc14^tm1.2Flv/Mirc14^tm1.2Flv Mirc15^tm1.2Flv/Mirc15^tm1.2Flv (involves: C57BL/6 * C57BL/6N * FVB/N * SJL)	decreased B cell number	J:203157
	decreased immature B cell number	J:203157
	decreased pre-B cell number	J:203157
	increased pro-B cell number	J:203157
Mirc14^tm1.2Flv/Mirc14^tm1.2Flv Tg(Cd4-TcraDN32D3)1Aben/0 (involves: C57BL/6 * C57BL/6N * FVB/N * SJL)	decreased NK T cell number	J:203157
Mirc14^tm1.2Flv/Mirc14^tm1.2Flv Tg(LCKprBCL2L1)12Sjk/0 (involves: C57BL/6 * C57BL/6N * FVB/N * SJL)	decreased NK T cell number	J:203157
Mirc16^tm1.2Czc/Mirc16^tm1.2Czc (either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6))	increased CD8-positive, alpha-beta T cell number	J:188125
Mirc30^em1Hhzg/Mirc30^em1Hhzg Tg(Vav1-cre)#Cgp/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/6NRj)	abnormal NK cell morphology	J:320883
	increased B cell number	J:320883
	increased pre-B cell number	J:320883
	increased pro-B cell number	J:320883
	increased spleen weight	J:320883
Mirc30^tm1.2Rdf/Mirc30^tm1.2Rdf (involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)	increased B cell number	J:156946
	increased B-1a cell number	J:156946
	increased spleen white pulp amount	J:156946
Mirc33^tm1.1Cwh/Mirc33^tm1.1Cwh (involves: 129X1/SvJ)	abnormal T cell morphology	J:189763
	increased T-helper 1 cell number	J:189763
	lymph node hypoplasia	J:189763
	lymphoid hypoplasia	J:189763
	spleen hypoplasia	J:189763
	thymus hypoplasia	J:189763
Mitf^mi-di/Mitf^mi-di ((PT x C3H/HeH)F1)	abnormal spleen germinal center morphology	J:8196
	abnormal spleen morphology	J:8196
	abnormal spleen red pulp morphology	J:8196
	abnormal spleen white pulp morphology	J:8196
Mitf^mi-ew/Mitf^mi-ew Tfe3^tm1Est/Tfe3^tm1Est (either: (involves: 129/Sv * 129S1/Sv * C57BL/6Bn * NAW) or (involves: 129S1/Sv * C57BL/6Bn * C57BL/6J * NAW))	abnormal osteoclast morphology	J:89821
Mitf^Mi-Or/Mitf^Mi-Or (involves: 101/Rl * C3H/Rl)	abnormal osteoclast morphology	J:30149
	decreased osteoclast cell number	J:30149
	increased osteoclast cell number	J:30149
Mitf^mi-vga9/Mitf^mi-vga9 Tfe3^tm1Est/Tfe3^tm1Est (either: (involves: 129/Sv * 129S1/Sv * C57BL/6 * CBA) or (involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA))	abnormal osteoclast morphology	J:89821
Mitf^Mi/Mitf^Mi (Not Specified)	abnormal osteoclast morphology	J:5046
	decreased mast cell number	J:6889
	increased osteoclast cell number	J:5046
Mitf^Mi/Mitf^Mi (involves: C57BL/6J)	abnormal osteoclast morphology	J:89821
Mitf^Mi/Mitf^Mi Tfe3^tm1Est/Tfe3^tm1Est (either: (involves: 129/Sv * 129S1/Sv * C57BL/6J) or (involves: 129S1/Sv * C57BL/6J))	abnormal osteoclast morphology	J:89821
Mki67^em1(IMPC)Mbp/Mki67^em1(IMPC)Mbp (C57BL/6NCrl-Mki67^em1(IMPC)Mbp/MbpMmucd)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Mkrn2^{tm1b(KOMP)Wtsi}/Mkrn2^{tm1b(KOMP)Wtsi} (C57BL/6N-Mkrn2^{tm1b(KOMP)Wtsi}/Wtsi)	decreased dendritic epidermal T cell number	J:211773
Mks1^hlb614/Mks1^hlb614 (involves: C3H * C57BL/6)	absent spleen	J:167534
Mks1^hlb614/Mks1^hlb614 (involves: C3H * C57BL/6)	accessory spleen	J:167534
Mlf1^tm1Swm/Mlf1^tm1Swm (involves: 129 * C57BL/6)	increased B cell number	J:266833
Mlh1^{tm1b(EUCOMM)Hmgu}/Mlh1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mlh1^{tm1b(EUCOMM)Hmgu}/H)	increased spleen weight	J:211773
Mlh1^tm1Mse/Mlh1^tm1Mse (involves: 129S/SvEv)	increased T cell derived lymphoma incidence	J:47642
Mlh1^tm1Rak/Mlh1⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased T cell derived lymphoma incidence	J:53451
Mlh1^tm1Rak/Mlh1^tm1Rak (involves: 129P2/OlaHsd * C57BL/6)	increased T cell derived lymphoma incidence	J:53451
Mlh1^tm1Rak/Mlh1^tm1Rak (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)	increased T cell derived lymphoma incidence	J:153684
Mlkl^{em1(IMPC)Ccpcz}/Mlkl^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Mlkl^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Mllt6^em1(IMPC)Tcp/Mllt6^em1(IMPC)Tcp (C57BL/6NCrl-Mllt6^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Mllt10^em1(IMPC)Mbp/Mllt10⁺ (C57BL/6N-Mllt10^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Mmab^{em1(IMPC)Hmgu}/Mmab⁺ (C57BL/6NCrl-Mmab^{em1(IMPC)Hmgu}/Ieg)	abnormal spleen morphology	J:211773
Mmachc^{tm1.1(NCOM)Mfgc}/Mmachc⁺ (C57BL/6N-Mmachc^{tm1.1(NCOM)Mfgc}/Tcp)	enlarged lymph nodes	J:211773
Mmd^tm1Beij/Mmd^tm1Beij (Not Specified)	abnormal macrophage differentiation	J:304637
Mmd^tm1Beij/Mmd^tm1Beij (Not Specified)	small inguinal lymph nodes	J:304637
Mmgt2^{tm1b(EUCOMM)Wtsi}/Mmgt2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Mmgt2^{tm1b(EUCOMM)Wtsi}/Bay)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
Mmp2^em1(IMPC)Mbp/Mmp2^em1(IMPC)Mbp (C57BL/6N-Mmp2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Mmp2^tm1Ito/Mmp2^tm1Ito (involves: 129P2/OlaHsd)	decreased osteoclast cell number	J:121780
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129S6/SvEvTac)	decreased dendritic cell number	J:84293
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129S6/SvEvTac * CD-1)	impaired myelopoiesis	J:149957
Mmp9^tm1Tvu/Mmp9^tm1Tvu (involves: 129S6/SvEvTac * C57BL/6)	abnormal leukocyte morphology	J:88065
	increased eosinophil cell number	J:88065
	increased lymphocyte cell number	J:88065
	increased macrophage cell number	J:88065
	increased monocyte cell number	J:88065
	increased T-helper 2 cell number	J:88065
Mmp11^{tm1b(EUCOMM)Hmgu}/Mmp11^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mmp11^{tm1b(EUCOMM)Hmgu}/Ics)	increased monocyte cell number	J:211773
Mmp13^{em1(IMPC)Ccpcz}/Mmp13^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Mmp13^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Mmp15^{tm1b(KOMP)Wtsi}/Mmp15^{tm1b(KOMP)Wtsi} (C57BL/6N-Mmp15^{tm1b(KOMP)Wtsi}/Bay)	absent lymph nodes	J:211773
	athymia	J:211773
	enlarged spleen	J:211773
Mmp19^tm1Rase/Mmp19^tm1Rase (B6.129P2-Mmp19^tm1Rase)	abnormal T cell differentiation	J:137128
	decreased CD4-positive, alpha-beta T cell number	J:137128
	decreased CD8-positive, alpha-beta T cell number	J:137128
	increased double-positive T cell number	J:137128
Mmp20^{em1(IMPC)Ccpcz}/Mmp20^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Mmp20^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
Mmp25^em1(IMPC)J/Mmp25^em1(IMPC)J (C57BL/6NJ-Mmp25^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Mmrn1^{tm1b(EUCOMM)Hmgu}/Mmrn1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mmrn1^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased large unstained cell number	J:211773
Mogs^{tm1(KOMP)Vlcg}/Mogs⁺ (C57BL/6N-Mogs^{tm1(KOMP)Vlcg}/Bay)	absent lymph nodes	J:211773
	enlarged thymus	J:211773
Morc2a^{em1(IMPC)Wtsi}/Morc2a^{em1(IMPC)Wtsi} (C57BL/6N-Morc2a^{em1(IMPC)Wtsi}/WtsiOulu)	abnormal thymus topology	J:239583
	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
	athymia	J:239583
	small thymus	J:239583
Morc3^{tm1b(EUCOMM)Hmgu}/Morc3⁺ (C57BL/6N-Morc3^{tm1b(EUCOMM)Hmgu}/Ics)	decreased lymphocyte cell number	J:211773
	increased large unstained cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Morc4^em1(IMPC)Mbp/Y (C57BL/6N-Morc4^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
Morc4^em1(IMPC)Mbp/Y (C57BL/6N-Morc4^em1(IMPC)Mbp/MbpMmucd)	enlarged lymph nodes	J:211773
Morc4^em1(IMPC)Mbp/Morc4^em1(IMPC)Mbp (C57BL/6N-Morc4^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Morf4l1^tm1Kto/Morf4l1^tm1Kto (involves: 129S7/SvEvBrd)	spleen vascular congestion	J:97640
Morrbid^em1Flv/Morrbid⁺ (C57BL/6N-Morrbid^em1Flv)	decreased eosinophil cell number	J:236609
	decreased Ly6C high monocyte number	J:236609
	decreased neutrophil cell number	J:236609
Morrbid^em1Flv/Morrbid^em1Flv (C57BL/6N-Morrbid^em1Flv)	abnormal myelopoiesis	J:236609
	decreased eosinophil cell number	J:236609
	decreased Ly6C high monocyte number	J:236609
	decreased Ly6C low monocyte number	J:236609
	decreased neutrophil cell number	J:236609
Mpg^tm1Rhe/Mpg^tm1Rhe (involves: 129P2/OlaHsd * C57BL/6J)	increased CD4-positive, alpha-beta T cell number	J:70603
Mpig6b^{tm1.1(KOMP)Vlcg}/Mpig6b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Mpig6b^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Mpig6b^tm1.1Arte/Mpig6b^tm1.1Arte (involves: C57BL/6NTac)	abnormal spleen red pulp morphology	J:201266
	enlarged spleen	J:201266
	spleen fibrosis	J:201266
Mpl^{em1(IMPC)Ccpcz}/Mpl⁺ (C57BL/6NCrl-Mpl^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Mpl^{em1(IMPC)Ccpcz}/Mpl^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Mpl^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Mpl^hlb219/Mpl^hlb219 (C57BL/6J-Mpl^hlb219/J)	decreased leukocyte cell number	J:146577
Mpl^hlb219/Mpl^hlb219 (C57BL/6J-Mpl^hlb219/J)	enlarged spleen	J:146577
Mpl^tm1Wsa/Mpl^tm1Wsa Myb^Plt3/Myb⁺ (involves: 129S1/Sv * C57BL/6)	abnormal thrombopoiesis	J:89601
Mpl^tm1Wsa/Mpl^tm1Wsa Myb^Plt3/Myb^Plt3 (involves: 129S1/Sv * C57BL/6)	abnormal B cell differentiation	J:89601
	abnormal spleen morphology	J:89601
	abnormal thrombopoiesis	J:89601
	decreased spleen B cell follicle size	J:89601
	increased spleen red pulp amount	J:89601
Mpl^tm1Wsa/Mpl^tm1Wsa Myb^Plt4/Myb⁺ (involves: 129S1/Sv * C57BL/6)	abnormal thrombopoiesis	J:89601
Mpl^tm1Wsa/Mpl^tm1Wsa Myb^Plt4/Myb^Plt4 (involves: 129S1/Sv * C57BL/6)	abnormal spleen morphology	J:89601
	abnormal thrombopoiesis	J:89601
	decreased leukocyte cell number	J:89601
	decreased spleen B cell follicle size	J:89601
	increased spleen red pulp amount	J:89601
Mpl^tm1Wsa/Mpl^tm1Wsa Suz12^{Gt(Betageo)1Khe}/Suz12⁺ (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	abnormal thrombopoiesis	J:136262
	increased leukocyte cell number	J:136262
	increased lymphocyte cell number	J:136262
Mpl^tm1Wsa/Mpl^tm1Wsa Suz12^Plt8/Suz12⁺ (B6.Cg-Mpl^tm1Wsa Suz12^Plt8)	abnormal thrombopoiesis	J:136262
	increased leukocyte cell number	J:136262
	increased lymphocyte cell number	J:136262
Mpl^tm2.1Wsa/Mpl^tm2.1Wsa Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	enlarged spleen	J:208120
Mpnd^em1(IMPC)J/Mpnd^em1(IMPC)J (C57BL/6NJ-Mpnd^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Mpo^tm1Lus/Mpo^tm1Lus (involves: 129X1/SvJ * C57BL/6J)	increased monocyte cell number	J:67586
Mpp1^{em1(IMPC)Ccpcz}/Mpp1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Mpp1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	decreased effector memory T-helper cell number	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased T-helper cell number	J:211773
Mpped2^em1(IMPC)J/Mpped2^em1(IMPC)J (C57BL/6NJ-Mpped2^em1(IMPC)J/J)	increased leukocyte cell number	J:211773
Mpv17l2^{tm1.1(KOMP)Mbp}/Mpv17l2^{tm1.1(KOMP)Mbp} (C57BL/6N-Mpv17l2^{tm1.1(KOMP)Mbp}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Mpz^tm1Msch/Mpz⁺ (involves: 129S7/SvEvBrd * C57BL/6)	increased monocyte cell number	J:82432
Mpz^tm1Msch/Mpz⁺ (involves: 129S7/SvEvBrd)	increased macrophage cell number	J:133028
Mpz^tm1Msch/Mpz⁺ Rag1^tm1Mom/Rag1^tm1Mom (B6.129S7-Mpz^tm1Msch Rag1^tm1Mom)	absent CD4-positive, alpha-beta T cells	J:59319
	absent CD8-positive, alpha-beta T cells	J:59319
Mpz^tm1Msch/Mpz⁺ Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * 129S7/SvEvBrd * BALB/c * C57BL/6)	decreased T cell number	J:59319
Mpzl2^tm1Lex/Mpzl2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased B cell number	J:171883
	increased CD8-positive, alpha-beta T cell number	J:171883
Mpzl3^rc/Mpzl3^rc (C57BL/6J-Mpzl3^rc/J)	abnormal spleen morphology	J:93038
Mr1^tm1Gfn/Mr1^tm1Gfn (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal T cell number	J:113083
Mras^{Gt(OST108223)Lex}/Mras^{Gt(OST108223)Lex} (B6;129S5-Mras^{Gt(OST108223)Lex}/Ieg)	decreased B cell number	J:82809
Mrc1^tm1Mnz/Mrc1^tm1Mnz (B6.129P2-Mrc1^tm1Mnz)	decreased T cell number	J:194065
Mrc1^tm1Mnz/Mrc1^tm1Mnz (B6.129P2-Mrc1^tm1Mnz)	increased granulocyte number	J:194065
Mre11a^tm1.1Rchd/Mre11a^tm1.1Rchd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:184053
Mreg^{tm1b(EUCOMM)Hmgu}/Mreg^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Mreg^{tm1b(EUCOMM)Hmgu}/Kmpc)	abnormal lymph node morphology	J:211773
Mrgprb2^em1(IMPC)Tcp/Mrgprb2^em1(IMPC)Tcp (C57BL/6NCrl-Mrgprb2^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Mri1^em1(IMPC)Bay/Mri1^em1(IMPC)Bay (C57BL/6N-Mri1^em1(IMPC)Bay/BayMmucd)	increased spleen weight	J:211773
Mroh8^{em1(IMPC)Ccpcz}/Mroh8^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Mroh8^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Mrpl12^em1(IMPC)Tcp/Mrpl12⁺ (C57BL/6NCrl-Mrpl12^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Mrps22^{tm1.1(KOMP)Vlcg}/Mrps22⁺ (B6N(Cg)-Mrps22^{tm1.1(KOMP)Vlcg}/J)	increased leukocyte cell number	J:211773
Ms4a1^tm1Tft/Ms4a1^tm1Tft (involves: 129 * C57BL/6)	abnormal B cell number	J:88933
	decreased B-1 B cell number	J:88933
	increased transitional stage B cell number	J:88933
Ms4a4a^em1Wwz/Ms4a4a^em1Wwz (C57BL/6NCrl-Ms4a4a^em1Wwz)	decreased eosinophil cell number	J:296429
Ms4a7^em1.1Jddl/Ms4a7^em1.1Jddl (B6.Cg-Ms4a7^em1.1Jddl)	decreased macrophage cell number	J:347975
Ms4a12^em1(IMPC)Mbp/Ms4a12^em1(IMPC)Mbp (C57BL/6N-Ms4a12^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Msantd3^em1(IMPC)J/Msantd3^em1(IMPC)J (C57BL/6NJ-Msantd3^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Msh2^tm1Htr/Msh2^tm1Htr (either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))	increased T cell derived lymphoma incidence	J:27469
Msh2^tm1Htr/Msh2^tm1Htr (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:80893
	abnormal somatic hypermutation frequency	J:155454
	increased T cell derived lymphoma incidence	J:45433
Msh2^tm1Htr/Msh2^tm1Htr (involves: 129P2/OlaHsd * FVB)	increased T cell derived lymphoma incidence	J:45433
Msh2^tm1Htr/Msh2^tm1Htr Pcna^tm1Jcbs/Pcna^tm1Jcbs (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:155454
Msh2^tm1Mak/Msh2^tm1Mak (C57BL/6NTac-Msh2^tm1Mak)	abnormal class switch recombination	J:326431
Msh2^tm1Mak/Msh2^tm1Mak (C57BL/6NTac-Msh2^tm1Mak)	abnormal somatic hypermutation frequency	J:326431
Msh2^tm1Rak/Msh2^tm1Rak (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:56764
Msh2^tm1Rak/Msh2^tm1Rak (involves: 129P2/OlaHsd)	decreased mature B cell number	J:56764
Msh2^tm1Wed/Msh2^tm1Wed (involves: C57BL/6)	abnormal class switch recombination	J:86278
Msh2^tm1Whl/Msh2^tm1Whl (involves: 129P2/OlaHsd * C57BL/6J)	increased lymphoblastic lymphoma incidence	J:79016
Msh2^tm1Whl/Msh2^tm1Whl Rb1^tm1Brd/Rb1⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)	increased lymphoblastic lymphoma incidence	J:79016
Msh5^{tm1b(EUCOMM)Wtsi}/Msh5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Msh5^{tm1b(EUCOMM)Wtsi}/Ieg)	increased leukocyte cell number	J:211773
Msi2^em1(IMPC)Mbp/Msi2^em1(IMPC)Mbp (C57BL/6N-Msi2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	small spleen	J:211773
Msi2^{Gt(E035H03)Wrst}/Msi2^{Gt(E035H03)Wrst} (B6.129P2-Msi2^{Gt(E035H03)Wrst})	abnormal myeloid leukocyte morphology	J:174870
	decreased B cell number	J:174870
	decreased CD4-positive, alpha-beta T cell number	J:174870
	decreased CD8-positive, alpha-beta T cell number	J:174870
	decreased DN2 thymocyte number	J:174870
	decreased DN3 thymocyte number	J:174870
	decreased double-negative T cell number	J:174870
	decreased double-positive T cell number	J:174870
	decreased granulocyte number	J:174870
	decreased immature B cell number	J:174870
	decreased leukocyte cell number	J:174870
	decreased macrophage cell number	J:174870
	decreased mature B cell number	J:174870
	decreased pre-B cell number	J:174870
	small spleen	J:174870
	small thymus	J:174870
	spleen hypoplasia	J:174870
	thymus hypoplasia	J:174870
Msi2^tm1.1Cjl/Msi2^tm1.1Cjl Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	decreased spleen weight	J:208349
	spleen hypoplasia	J:208349
Mslnl^{tm1b(EUCOMM)Wtsi}/Mslnl^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Mslnl^{tm1b(EUCOMM)Wtsi}/BayMmucd)	decreased monocyte cell number	J:211773
Msmb^tm1Xuan/Msmb^tm1Xuan (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))	enlarged lymph nodes	J:96884
Msmp^em1Jzx/Msmp^em1Jzx (C57BL/6-Msmp^em1Jzx)	abnormal macrophage differentiation	J:311042
Msn^{tm1b(EUCOMM)Hmgu}/Msn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Msn^{tm1b(EUCOMM)Hmgu}/J)	decreased leukocyte cell number	J:211773
Msn^tm1Sts/Y (involves: 129S4/SvJae * C57BL/6)	decreased B cell number	J:189837
	decreased CD4-positive, alpha-beta T cell number	J:189837
	decreased eosinophil cell number	J:189837
	decreased lymphocyte cell number	J:189837
	decreased neutrophil cell number	J:189837
Mst1r^Fv2-s/Mst1r^Fv2-s (B6.DDD-Mst1r^Fv2-s)	enlarged spleen	J:5120
Mst1r^Fv2-s/Mst1r^Fv2-s (either: BALB/cCrgl or DBA/2Crgl or Swiss)	enlarged spleen	J:167666
Mst1r^{tm2(Mst1r)Sew}/Mst1r^{tm2(Mst1r)Sew} (involves: 129P2/OlaHsd * Black Swiss * FVB/N)	decreased spleen weight	J:215969
Msto1^em1(IMPC)Tcp/Msto1⁺ (C57BL/6N-Msto1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Msto1^em1(IMPC)Tcp/Msto1⁺ (C57BL/6N-Msto1^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Msx1^tm1Rilm/Msx1⁺ Pax9^tm1Rbal/Pax9^tm1Rbal (involves: 129 * CD-1)	ectopic thymus	J:311535
	thymus hypoplasia	J:311535
Msx2^tm1Rilm/Msx2^tm1Rilm (either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6J))	decreased osteoclast cell number	J:61509
Mt1^tm1Bri/Mt1^tm1Bri Mt2^tm1Bri/Mt2^tm1Bri (involves: 129S7/SvEvBrd)	abnormal microglial cell morphology	J:103102, J:53929
	increased macrophage cell number	J:53929
Mt1^tm1Bri/Mt1^tm1Bri Mt2^tm1Bri/Mt2^tm1Bri (129S7/SvEvBrd-Mt1^tm1Bri Mt2^tm1Bri/J)	abnormal microglial cell morphology	J:89429
	decreased B cell number	J:110643
	decreased T cell number	J:110643
	enlarged spleen	J:110643
	increased CD4-positive, alpha-beta T cell number	J:110643
	increased CD8-positive, alpha-beta T cell number	J:110643
	increased lymphocyte cell number	J:110643
	increased neutrophil cell number	J:120196
	increased plasma cell number	J:110643
	increased spleen weight	J:110643
	spleen hyperplasia	J:110643
Mtap^em1(IMPC)Mbp/Mtap⁺ (C57BL/6N-Mtap^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Mtarc1^em1(IMPC)H/Mtarc1^em1(IMPC)H (C57BL/6NTac-Mtarc1^em1(IMPC)H/H)	increased spleen weight	J:211773
Mtbcq2^NMRI8/Fbn/? (involves: DBA/2OlaHsd * NMRI8/Fbn)	increased spleen weight	J:122125
Mtch2^{tm1b(EUCOMM)Hmgu}/Mtch2⁺ (C57BL/6N-Mtch2^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased monocyte cell number	J:211773
Mtf1^Thyls-BALB/c/Mtf1^Thyls-BALB/c (involves: BALB/c * MSM)	increased T cell derived lymphoma incidence	J:71358
Mtf1^Thyls-BALB/c/Mtf1^Thyls-MSM (involves: BALB/c * MSM)	increased T cell derived lymphoma incidence	J:85264, J:71358
Mtf1^tm1Wsc/Mtf1^tm1Wsc Tg(Mx1-cre)1Cgn/0 Tg(UBC-Mtf1)1Wsc/0 (involves: 129/Sv * C57BL/6 * CBA)	decreased leukocyte cell number	J:91119
	decreased lymphocyte cell number	J:91119
Mtgq4^NMRI8/Fbn/? (involves: DBA/2OlaHsd * NMRI8/Fbn)	increased spleen weight	J:122125
Mthfd1^tm1.1Rzn/Mthfd1⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	decreased leukocyte cell number	J:199578
	decreased neutrophil cell number	J:199578
Mtmr11^em1(IMPC)Tcp/Mtmr11^em1(IMPC)Tcp (C57BL/6NCrl-Mtmr11^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Mtor^chino/Mtor^chino (involves: C57BL/6JAnu)	decreased CD4-positive, alpha-beta T cell number	J:207898
Mtor^chino/Mtor^chino (involves: C57BL/6JAnu)	decreased splenocyte number	J:207898
Mtor^tm1.2Koz/Mtor^tm1.2Koz Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:150108
	abnormal T cell subpopulation ratio	J:150108
	abnormal thymus cell ratio	J:150108
	increased regulatory T cell number	J:150108
Mtor^tm1Lgm/Mtor^tm1Lgm (involves: 129S1/Sv * C57BL/6)	abnormal T cell morphology	J:168600
	decreased B cell number	J:168600
	decreased double-positive T cell number	J:168600
	decreased follicular B cell number	J:168600
	decreased marginal zone B cell number	J:168600
	decreased monocyte cell number	J:168600
	decreased neutrophil cell number	J:168600
	decreased plasma cell number	J:168600
	decreased thymocyte number	J:168600
	decreased transitional stage T1 B cell number	J:168600
	increased CD4-positive, alpha-beta T cell number	J:168600
	increased CD8-positive, alpha-beta T cell number	J:168600
	small spleen	J:168600
Mtss1^{Gt(CSC156)Byg}/Mtss1^{Gt(CSC156)Byg} (B6.129P2-Mtss1^{Gt(CSC156)Byg})	abnormal B cell differentiation	J:186118
	abnormal B cell number	J:186118
	decreased immature B cell number	J:186118
	enlarged spleen	J:186118
	increased leukocyte cell number	J:186118
	increased pre-B cell number	J:186118
Mtus1^{Gt(RRA048)Byg}/Mtus1^{Gt(RRA048)Byg} (involves: 129P2/OlaHsd * C57BL/6)	increased leukocyte cell number	J:212144
	increased lymphocyte cell number	J:212144
	lymphoid hyperplasia	J:212144
Mtx2^em1(IMPC)J/Mtx2⁺ (C57BL/6NJ-Mtx2^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Muc2^eey/Muc2^eey (C57BL/6-Muc2^eey)	increased leukocyte cell number	J:194148
Muc2^keny/Muc2^keny (C57BL/6JAnu-Muc2^keny/AnuApb)	enlarged lymph nodes	J:104190
Muc2^wnn/Muc2^wnn (C57BL/6-Muc2^wnn)	increased leukocyte cell number	J:194148
Muc2^wnn/Muc2^wnn (C57BL/6-Muc2^wnn)	increased lymphocyte cell number	J:194148
Mug1^tm2Vln/Mug1^tm2Vln Pzp^tm1Vln/Pzp^tm1Vln (B.129P2-Pzp^tm1Vln Mug1^tm2Vln)	abnormal uterine NK cell morphology	J:117841
Mx1^s1/Mx1^s1 (C57BL/6)	abnormal peritoneal macrophage morphology	J:23752
Mxd1^tm1Rne/Mxd1^tm1Rne (involves: 129S4/SvJaeSor * C57BL/6)	abnormal myeloid leukocyte morphology	J:45945
	increased granulocyte number	J:45945
Mxd4^em1(IMPC)J/Mxd4^em1(IMPC)J (C57BL/6NJ-Mxd4^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Mxi1^tm1Rdp/Mxi1^tm1Rdp (involves: 129/Sv * C57BL/6J * SJL)	abnormal lymphocyte morphology	J:48236
	enlarged spleen	J:48236
	increased spleen white pulp amount	J:48236
Myb^boo/Myb^boo (involves: C57BL/6)	abnormal B cell differentiation	J:167270
	abnormal leukocyte morphology	J:167270
	abnormal spleen morphology	J:167270
	decreased neutrophil cell number	J:167270
	decreased spleen white pulp amount	J:167270
	enlarged spleen	J:167270
	increased spleen red pulp amount	J:167270
Myb^M303V/Myb^M303V (involves: 129S1/SvlmJ * C57BL/6)	arrested B cell differentiation	J:96507
	arrested T cell differentiation	J:96507
	decreased B cell number	J:96507
	decreased eosinophil cell number	J:96507
	decreased single-positive T cell number	J:96507
	decreased thymocyte number	J:96507
Myb^tm1.1Cgn/Myb⁺ (involves: 129P2/OlaHsd * C57BL/6)	arrested B cell differentiation	J:127234
	decreased B-1 B cell number	J:127234
	decreased mature B cell number	J:127234
	decreased pre-B cell number	J:127234
Myb^tm1Cgn/Myb^tm1.1Cgn Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:91122
	decreased double-positive T cell number	J:91122
	thymus hypoplasia	J:91122
Myb^tm1Cgn/Myb^tm1Cgn Tg(Lck-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	arrested T cell differentiation	J:91122
	decreased CD4-positive, alpha-beta T cell number	J:91122
	decreased CD8-positive, alpha-beta T cell number	J:91122
	decreased double-negative T cell number	J:91122
	decreased double-positive T cell number	J:91122
	decreased gamma-delta T cell number	J:91122
	thymus hypoplasia	J:91122
Myb^tm1Cgn/Myb^tm1Cgn Tg(Lck-cre)548Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:91122
	decreased double-positive T cell number	J:91122
	thymus hypoplasia	J:91122
Myb^tm1Epr/Myb^tm1Epr Tg(Cd4-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:93481
	decreased CD4-positive, alpha-beta T cell number	J:93481
	decreased double-positive T cell number	J:93481
	increased CD8-positive, alpha-beta T cell number	J:93481
	thymus hypoplasia	J:93481
Myb^tm1Epr/Myb^tm1Epr Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal double-negative T cell morphology	J:93481
	abnormal T cell differentiation	J:93481
	decreased double-positive T cell number	J:93481
	thymus hypoplasia	J:93481
Myb^tm1Jof/Myb^tm1Jof (involves: 129/Sv * C57BL/6)	abnormal B cell differentiation	J:85344
	abnormal double-negative T cell morphology	J:85344
	abnormal T cell differentiation	J:85344
	decreased thymocyte number	J:85344
Myb^tm1Jof/Myb^tm1Ssp (involves: 129/Sv * C57BL/6)	abnormal T cell differentiation	J:85344
Myb^tm1Jof/Myb^tm1Ssp (involves: 129/Sv * C57BL/6)	decreased thymocyte number	J:85344
Mybl1^tm1Epr/Mybl1^tm1Epr (involves: 129 * C57BL/6)	abnormal spleen B cell follicle morphology	J:67604
	abnormal spleen marginal zone morphology	J:67604
	decreased B cell number	J:67604
	decreased spleen germinal center number	J:67604
	increased spleen red pulp amount	J:67604
	small spleen	J:67604
	spleen hypoplasia	J:67604
Mybl2^tm1.1Epr/Mybl2^tm1.1Epr Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)	abnormal myelopoiesis	J:206816
	decreased B cell number	J:206816
	decreased leukocyte cell number	J:206816
	decreased lymphocyte cell number	J:206816
	decreased neutrophil cell number	J:206816
	decreased splenocyte number	J:206816
	decreased T cell number	J:206816
Mybl2^tm1.1Jof/Mybl2⁺ Tg(Zp3-cre)3Mrt/0 (involves: 129S2/SvPas * C57BL/6 * FVB/N)	abnormal myelopoiesis	J:196804
	decreased leukocyte cell number	J:196804
	decreased neutrophil cell number	J:196804
	enlarged spleen	J:196804
	increased granulocyte number	J:196804
	increased leukocyte cell number	J:196804
	increased monocyte cell number	J:196804
	myeloid hyperplasia	J:196804
Mybphl^{tm1b(KOMP)Wtsi}/Mybphl^{tm1b(KOMP)Wtsi} (C57BL/6N-Mybphl^{tm1b(KOMP)Wtsi}/Wtsi)	abnormal thymus morphology	J:239583
Myc^tm1Atp/Myc⁺ (involves: 129P2/OlaHsd * FVB/N)	lymph node hypoplasia	J:73369
	lymphoid hypoplasia	J:73369
	small lymphoid organs	J:73369
	spleen hypoplasia	J:73369
Myc^tm1Atp/Myc⁺ (B6.129P2-Myc^tm1Atp)	decreased memory T cell number	J:132730
Myc^tm1Atp/Myc^tm2.1Atp (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	lymph node hypoplasia	J:73369
	spleen hypoplasia	J:73369
Myc^tm1Lbox/Myc⁺ (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	enlarged lymph nodes	J:97900
	enlarged spleen	J:97900
	increased B cell number	J:97900
	increased spleen weight	J:97900
Myc^tm1Lbox/Myc^tm1Lbox (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	decreased T cell number	J:97900
	enlarged lymph nodes	J:97900
	enlarged spleen	J:97900
	increased B cell number	J:97900
	increased spleen weight	J:97900
Myc^tm3(Tcrb)Fwa/Myc⁺ (involves: 129)	abnormal T cell receptor beta chain V(D)J recombination	J:131995
Mycl^tm1.1Kmm/Mycl^tm1.1Kmm (B6.129S6(C)-Mycl^tm1.1Kmm)	decreased dendritic cell number	J:206430
Myct1^em1(IMPC)Mbp/Myct1^em1(IMPC)Mbp (C57BL/6N-Myct1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Myct1^em1Choi/Myct1^em1Choi (involves: C57BL/6)	abnormal macrophage cell number	J:303692
	decreased regulatory T cell number	J:303692
	increased CD8-positive, alpha-beta T cell number	J:303692
Myd88^tm1.1Defr/Myd88^tm1.1Defr (B6.129P2(SJL)-Myd88^tm1.1Defr)	decreased effector memory CD4-positive, alpha-beta T cell number	J:224849
	decreased leukocyte cell number	J:224849
	decreased macrophage cell number	J:224849
	decreased monocyte cell number	J:224849
	decreased neutrophil cell number	J:224849
Myd88^tm1Aki/Myd88^tm1Aki (B6.129P2-Myd88^tm1Aki)	abnormal dendritic cell differentiation	J:139001
Myd88^tm1Aki/Myd88^tm1Aki (B6.129P2-Myd88^tm1Aki)	increased dendritic cell number	J:116763
Myd88^tm1Aki/Myd88^tm1Aki Tg(IghelMD4)4Ccg/0 Tg(KLK4mHEL)6Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased mature B cell number	J:115059
	increased B-1 B cell number	J:115059
Myd88^tm1Defr/Myd88^tm1Defr Tg(Itgax-cre)1-1Reiz/0 (B6.Cg-Myd88^tm1Defr Tg(Itgax-cre)1-1Reiz)	abnormal dendritic cell differentiation	J:139001
	abnormal T-helper 1 cell differentiation	J:139001
Myd88^tm1Hlz/Myd88^tm1Hlz (B6.129P2-Myd88^tm1Hlz)	decreased neutrophil cell number	J:188968
Myh1^{tm1b(KOMP)Wtsi}/Myh1^{tm1b(KOMP)Wtsi} (C57BL/6N-Myh1^{tm1b(KOMP)Wtsi}/J)	decreased leukocyte cell number	J:211773
Myh9^tm1.1Dash/Myh9⁺ (involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)	abnormal thrombopoiesis	J:204923
Myh9^tm1.1Mjk/Myh9⁺ (B6.129-Myh9^tm1.1Mjk)	abnormal neutrophil morphology	J:175367
Myh9^tm1.1Mjk/Myh9^tm1.1Mjk (B6.129-Myh9^tm1.1Mjk)	abnormal neutrophil morphology	J:175367
Myh9^tm5Rsad/Myh9^tm5Rsad Tg(Lck-cre)#Nik/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)	abnormal lymph node cell ratio	J:164684
	decreased CD8-positive, alpha-beta T cell number	J:164684
Myh9^{tm6.1(EGFP/MYH9)Rsad}/Myh9⁺ (involves: 129S4/SvJae BALB/cJ * C57BL/6)	abnormal neutrophil morphology	J:175367
Myh9^tm7.1Rsad/Myh9⁺ (involves: BALB/cJ)	abnormal neutrophil morphology	J:175367
Myh9^tm7.1Rsad/Myh9^tm7.1Rsad (involves: BALB/cJ)	abnormal neutrophil morphology	J:175367
Myh15^em1(IMPC)J/Myh15^em1(IMPC)J (C57BL/6NJ-Myh15^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Myo1g^tm1.2Mfk/Myo1g^tm1.2Mfk (Not Specified)	decreased B cell number	J:209304
Myo1g^tm1.2Mfk/Myo1g^tm1.2Mfk (Not Specified)	increased B cell number	J:209304
Myo3b^{tm1b(EUCOMM)Hmgu}/Myo3b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Myo3b^{tm1b(EUCOMM)Hmgu}/J)	decreased leukocyte cell number	J:211773
Myo6^em1(IMPC)Tcp/Myo6^em1(IMPC)Tcp (C57BL/6N-Myo6^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
Myo9b^tm1.2Bah/Myo9b^tm1.2Bah (B6.Cg-Myo9b^tm1.2Bah)	decreased leukocyte cell number	J:162326
Myoz1^{tm1b(EUCOMM)Hmgu}/Myoz1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Myoz1^{tm1b(EUCOMM)Hmgu}/Ieg)	increased marginal zone B cell number	J:211773
Mypn^em1(IMPC)J/Mypn^em1(IMPC)J (C57BL/6NJ-Mypn^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Mysm1^{tm1a(KOMP)Wtsi}/Mysm1^{tm1a(KOMP)Wtsi} (Not Specified)	decreased B cell number	J:165965
	decreased leukocyte cell number	J:165965
	decreased mature B cell number	J:165965
	increased granulocyte number	J:165965
	increased T cell number	J:165965
Mysm1^{tm1b(KOMP)Wtsi}/Mysm1^{tm1b(KOMP)Wtsi} Tg(MMTV-cre)4Mam/0 (involves: 129 * C57BL/6N * FVB/N)	abnormal T cell differentiation	J:179287
	arrested B cell differentiation	J:179287
	decreased B cell number	J:179287
	decreased immature B cell number	J:179287
	decreased pre-B cell number	J:179287
	decreased pro-B cell number	J:179287
Mzb1^tm1.2Rug/Mzb1^tm1.2Rug (involves: 129S2/SvPas * BALB/cJ * C57BL/6 * SJL)	decreased pre-B cell number	J:211639
	increased pro-B cell number	J:211639
Mzf1^tm1Ppp/Mzf1^tm1Ppp (involves: 129)	abnormal bone marrow development	J:70407
Mzf1^tm1Ppp/Mzf1^tm1Ppp (involves: 129)	abnormal myelopoiesis	J:70407
N4bp1^tm1.2Vmd/N4bp1^tm1.2Vmd (involves: C57BL/6)	increased activated T cell number	J:297419
	increased germinal center B cell number	J:297419
	increased Ly6C high monocyte number	J:297419
Naa10^em1(IMPC)Mbp/Y (C57BL/6NCrl-Naa10^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	small spleen	J:211773
Naa10^em1(IMPC)Mbp/Naa10^em1(IMPC)Mbp (C57BL/6NCrl-Naa10^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Naa16^em1(IMPC)J/Naa16^em1(IMPC)J (C57BL/6NJ-Naa16^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Naa25^em1(IMPC)Tcp/Naa25⁺ (C57BL/6NCrl-Naa25^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Naa35^em1(IMPC)J/Naa35⁺ (C57BL/6NJ-Naa35^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Naa38^{em1(IMPC)Ccpcz}/Naa38⁺ (C57BL/6N-Naa38^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Nabp2^tm1.1Kkha/Nabp2^tm1.1Kkha Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	increased T cell derived lymphoma incidence	J:195140
Nabp2^tm1Schg/Nabp2^tm1Schg (involves: 129S7/SvEvBrd * C57BL/6)	increased spleen red pulp amount	J:228558
nad/nad (C(D2)-nad)	abnormal bronchus-associated lymphoid tissue morphology	J:156089
Nadsyn1^{tm1b(KOMP)Wtsi}/Nadsyn1^{tm1b(KOMP)Wtsi} (C57BL/6N-Nadsyn1^{tm1b(KOMP)Wtsi}/Ucd)	enlarged spleen	J:211773
Nagk^{tm1b(EUCOMM)Hmgu}/Nagk^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nagk^{tm1b(EUCOMM)Hmgu}/H)	increased neutrophil cell number	J:211773
Naglu^tm1Efn/Naglu^tm1Efn (either: (involves: 129S/SvEv * C57BL/6) or (involves: C57BL/6))	abnormal Kupffer cell morphology	J:58950
	abnormal macrophage morphology	J:58950
Nalcn^em1(IMPC)Mbp/Nalcn⁺ (C57BL/6N-Nalcn^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Nampt^{Gt(RRR084)Byg}/Nampt⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased neutrophil cell number	J:194883
Nampt^tm1Oleo/Nampt^tm1Oleo Tg(CD2-icre)4Kio/0 (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/10 * CBA/Ca)	decreased B cell number	J:141448
	decreased double-negative T cell number	J:141448
	decreased T cell number	J:141448
	thymus hypoplasia	J:141448
Napa^{em1(IMPC)Ccpcz}/Napa⁺ (C57BL/6NCrl-Napa^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Nat8f2^{tm1.1(KOMP)Vlcg}/Nat8f2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nat8f2^{tm1.1(KOMP)Vlcg}/J)	enlarged lymph nodes	J:211773
Nav1^em1(IMPC)Mbp/Nav1^em1(IMPC)Mbp (C57BL/6N-Nav1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Nav2^em1(IMPC)Tcp/Nav2^em1(IMPC)Tcp (C57BL/6NCrl-Nav2^em1(IMPC)Tcp/Tcp)	increased neutrophil cell number	J:211773
Naxe^{tm1b(EUCOMM)Hmgu}/Naxe^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Naxe^{tm1b(EUCOMM)Hmgu}/Bay)	increased spleen weight	J:211773
Nba10^NZB/Nba10^NZB Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6 * DBA/2J * NZB)	increased B cell number	J:134128
	increased marginal zone B cell number	J:134128
Nba10^NZB/Nba10^NZB Tlr7^tm1Aki/Y X/Yaa (B6.Cg-Nba10^NZB Tlr7^tm1Aki Yaa)	increased monocyte cell number	J:137656
Nba10^NZB/Nba10^NZB X/Yaa (C57BL/6-Nba2 Yaa)	increased monocyte cell number	J:137656, J:129409
Nbeal2^gps/Nbeal2^gps (129S1/SvImJ-Nbeal2^gps)	decreased neutrophil cell number	J:236370
Nbeal2^{tm1a(EUCOMM)Wtsi}/Nbeal2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Nbeal2^{tm1a(EUCOMM)Wtsi}/Wtsi)	enlarged spleen	J:220801
	increased leukocyte cell number	J:211773
Nbeal2^tm1Lex/Nbeal2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	enlarged spleen	J:201413
Nbn^em7Jpt/Nbn^tm2Zqw Tg(VAV1-cre)1Graf/0 (involves: 129P2/OlaHsd)	abnormal T cell morphology	J:277750
	absent mature B cells	J:277750
	decreased B cell number	J:277750
	decreased leukocyte cell number	J:277750
	decreased T cell number	J:277750
	decreased thymocyte number	J:277750
	increased CD8-positive, alpha-beta T cell number	J:277750
	increased pro-B cell number	J:277750
	increased T cell derived lymphoma incidence	J:277750
Nbn^tm1Xu/Nbn^tm1Xu (Not Specified)	decreased CD4-positive, alpha-beta T cell number	J:75272
	decreased mature B cell number	J:75272
	decreased pre-B cell number	J:75272
	decreased T cell number	J:75272
	increased T cell derived lymphoma incidence	J:75272
	thymus hypoplasia	J:75272
Nbn^tm1Zqw/Nbn⁺ (involves: 129S2/SvPas * C57BL/6)	increased T cell derived lymphoma incidence	J:86563
Nbn^tm2Zqw/Nbn^tm2Zqw Tg(VAV1-cre)1Graf/0 (involves: 129P2/OlaHsd)	abnormal bone marrow development	J:251434
	decreased leukocyte cell number	J:251434
Nbr1^tm1.1Jmos/Nbr1^tm1.1Jmos Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129X1/SvJ * C57BL/6J)	abnormal T-helper 1 cell differentiation	J:165438
	abnormal T-helper 2 cell differentiation	J:165438
Ncam2^{tm1b(EUCOMM)Hmgu}/Ncam2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ncam2^{tm1b(EUCOMM)Hmgu}/Orl)	increased eosinophil cell number	J:211773
Ncaph2^nes/Ncaph2^nes (C57BL/6JSfdAnu-Ncaph2^nes/Anu)	abnormal double-negative T cell morphology	J:123300
	abnormal splenic cell ratio	J:123300
	abnormal T cell morphology	J:123300
	abnormal thymus cell ratio	J:123300
	abnormal thymus cortex morphology	J:123300
	abnormal thymus corticomedullary boundary morphology	J:123300
	decreased CD8-positive, alpha-beta T cell number	J:123300
	decreased double-negative T cell number	J:123300
	decreased double-positive T cell number	J:123300
	decreased T cell number	J:123300
	decreased thymocyte number	J:123300
	thymus hypoplasia	J:123300
Ncaph2^nes/Ncaph2^nes Tg(TcrHEL3A9)1Mmd/0 (C57BL/6-Ncaph2^nes Tg(TcrHEL3A9)1Mmd)	abnormal double-negative T cell morphology	J:123300
	abnormal thymus cell ratio	J:123300
	decreased double-positive T cell number	J:123300
Ncf1^em1(IMPC)Mbp/Ncf1^em1(IMPC)Mbp (C57BL/6N-Ncf1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Ncf2^{tm1a(EUCOMM)Wtsi}/Ncf2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ncf2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased alpha-beta T cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased NK cell number	J:211773
	decreased NK T cell number	J:211773
	decreased regulatory T cell number	J:211773
	decreased T cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
Ncf2^{tm1b(EUCOMM)Wtsi}/Ncf2⁺ (NZM2328.B6(Cg)-Ncf2^{tm1b(EUCOMM)Wtsi})	abnormal spleen germinal center morphology	J:260777
	increased activated T cell number	J:260777
	increased B cell number	J:260777
	increased CD4-positive, alpha-beta memory T cell number	J:260777
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:260777
	increased CD8-positive, alpha-beta T cell number	J:260777
	increased follicular B cell number	J:260777
	increased germinal center B cell number	J:260777
	increased T cell number	J:260777
Ncf2^{tm1b(EUCOMM)Wtsi}/Ncf2^{tm1b(EUCOMM)Wtsi} (B6(Cg)-Ncf2^{tm1b(EUCOMM)Wtsi})	decreased CD8-positive, alpha-beta T cell number	J:260777
Ncf2^{tm1b(EUCOMM)Wtsi}/Ncf2^{tm1b(EUCOMM)Wtsi} (NZM2328.B6(Cg)-Ncf2^{tm1b(EUCOMM)Wtsi})	abnormal spleen germinal center morphology	J:260777
	increased activated T cell number	J:260777
	increased B cell number	J:260777
	increased follicular B cell number	J:260777
	increased germinal center B cell number	J:260777
	increased T cell number	J:260777
Nckap1l^m1Btlr/Nckap1l^m1Btlr (C57BL/6J-Nckap1l^m1Btlr)	decreased alpha-beta T cell number	J:272079
	decreased B cell number	J:272079
	decreased CD4-positive, alpha-beta T cell number	J:272079
	decreased CD8-positive, alpha-beta T cell number	J:272079
	decreased CD8-positive, naive alpha-beta T cell number	J:272079
	decreased central memory CD8 positive, alpha-beta T cell number	J:272079
	decreased NK cell number	J:272079
	increased alpha-beta T cell number	J:272079
	increased CD8-positive, alpha-beta T cell number	J:272079
	increased effector memory CD4-positive, alpha-beta T cell number	J:272079
	increased effector memory CD8-positive, alpha-beta T cell number	J:272079
Nckap1l^m1Iri/Nckap1l^m1Iri (involves: C57BL/6)	abnormal CD4-positive T cell differentiation	J:141377
	abnormal immune system organ morphology	J:141377
	abnormal lymphopoiesis	J:141377
	abnormal regulatory T cell number	J:141377
	abnormal thymus lobule morphology	J:141377
	decreased CD4-positive, alpha-beta T cell number	J:141377
	decreased CD8-positive, alpha-beta T cell number	J:141377
	decreased double-positive T cell number	J:141377
	decreased lymphocyte cell number	J:141377
	decreased mature B cell number	J:141377
	decreased mature gamma-delta T cell number	J:141377
	increased double-negative T cell number	J:141377
	increased leukocyte cell number	J:141377
	increased neutrophil cell number	J:141377
	lymph node hypoplasia	J:141377
	spleen hyperplasia	J:141377
	thymus hypoplasia	J:141377
Ncoa2^em1(IMPC)Mbp/Ncoa2⁺ (C57BL/6N-Ncoa2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Ncoa3^tm1Jxu/Ncoa3^tm1Jxu (involves: 129S6/SvEvTac * C57BL/6J)	abnormal B cell morphology	J:109522
	abnormal lymphopoiesis	J:109522
	abnormal spleen red pulp morphology	J:109522
	enlarged spleen	J:109522
	increased B cell number	J:109522
	increased CD4-positive, alpha-beta T cell number	J:109522
	increased CD8-positive, alpha-beta T cell number	J:109522
	increased leukocyte cell number	J:109522
	increased lymphocyte cell number	J:109522
	increased spleen germinal center size	J:109522
Ncoa5^{tm1.1(KOMP)Mbp}/Ncoa5⁺ (C57BL/6N-Ncoa5^{tm1.1(KOMP)Mbp}/Tcp)	increased eosinophil cell number	J:211773
Ncor1^tm1Rsd/Ncor1^tm1Rsd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	arrested T cell differentiation	J:65417
	small thymus	J:65417
Ncor2^tm1Rev/Ncor2^tm1Rev (involves: 129/Sv * C57BL/6)	abnormal spleen morphology	J:202976
	enlarged spleen	J:202976
	increased osteoclast cell number	J:202976
Ncr1^noe/Ncr1^noe (involves: C57BL/6J)	decreased CD4-positive, alpha-beta T cell number	J:179728
	decreased CD8-positive, alpha-beta memory T cell number	J:179728
	decreased CD8-positive, alpha-beta T cell number	J:179728
	increased NK cell number	J:179728
Ncr1^tm1Oman/Ncr1^tm1Oman (involves: 129S1/Sv * 129X1/SvJ)	decreased NK cell number	J:112394
Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(VAV1-cre)1Graf/0 (involves: 129S/SvEv * C57BL/6)	enlarged spleen	J:196407
	increased leukocyte cell number	J:196407
	myeloid hyperplasia	J:196407
Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA * SJL)	abnormal spleen morphology	J:172442
	enlarged spleen	J:172442
	increased leukocyte cell number	J:172442
	increased monocyte cell number	J:172442
	increased spleen red pulp amount	J:172442
Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(VAV1-cre)1Graf/0 (involves: 129 * C57BL/6 * SJL)	abnormal spleen morphology	J:172442
	enlarged spleen	J:172442
	increased leukocyte cell number	J:172442
	increased monocyte cell number	J:172442
	increased spleen red pulp amount	J:172442
Ncstn^tm1.1Akli/Ncstn^tm1.1Akli Tg(VAV1-cre)1Graf/0 (involves: 129)	enlarged spleen	J:196407
Ndfip1^{Gt(RRD002)Byg}/Ndfip1^{Gt(RRD002)Byg} (involves: 129P2/OlaHsd * C57BL/6)	increased activated T cell number	J:116617
	increased spleen weight	J:116617
Ndfip1^{Gt(RRD002)Byg}/Ndfip1^{Gt(RRD002)Byg} (involves: 129P2/OlaHsd)	increased activated T cell number	J:205692
Ndfip1^kru/Ndfip1^kru (involves: C57BL/6JSfdAnu)	increased T-helper 2 cell number	J:188722
Ndfip1^tm1.1Pmo/Ndfip1^tm1.1Pmo Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	increased activated T cell number	J:205692
	increased eosinophil cell number	J:205692
Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ Rnpc3^{tm1c(EUCOMM)Wtsi}/Rnpc3^{tm1c(EUCOMM)Wtsi} (involves: 129S/SvEv * C57BL/6 * C57BL/6N)	decreased leukocyte cell number	J:267519
	decreased lymphocyte cell number	J:267519
	decreased monocyte cell number	J:267519
	decreased thymus weight	J:267519
	thymus atrophy	J:267519
	thymus cortex atrophy	J:267519
	thymus medulla atrophy	J:267519
Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ Rraga^tm2Dmsa/Rraga^tm2Dmsa (involves: 129S/SvEv * 129S4/SvJae * C57BL/6)	decreased B cell number	J:213516
	enlarged spleen	J:213516
	increased monocyte cell number	J:213516
	myeloid hyperplasia	J:213516
Ndrg2^tm1Kmori/Ndrg2⁺ (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	increased T cell derived lymphoma incidence	J:210264
Ndrg2^tm1Kmori/Ndrg2^tm1Kmori (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)	increased T cell derived lymphoma incidence	J:210264
Ndrg3^em1(IMPC)Mbp/Ndrg3⁺ (C57BL/6NCrl-Ndrg3^em1(IMPC)Mbp/Mmucd)	enlarged spleen	J:211773
Ndst1^b2b2230Clo/Ndst1^b2b2230Clo (C57BL/6J-Ndst1^b2b2230Clo)	thymus hypoplasia	J:175213
Ndst2^tm1Lkj/Ndst2^tm1Lkj (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal mast cell morphology	J:57121
	decreased mast cell histamine storage	J:57121
	decreased mast cell number	J:57121
	decreased mast cell protease storage	J:57121
Ndst2^tm1Rls/Ndst2^tm1Rls (Not Specified)	decreased mast cell histamine storage	J:57120
Ndst2^tm1Rls/Ndst2^tm1Rls (Not Specified)	decreased mast cell protease storage	J:57120
Ndst2^tm1Rls/Ndst2^tm1Rls (B6.Cg-Ndst2^tm1Rls)	abnormal mast cell differentiation	J:142880
Ndst3^tm1.1Grob/Ndst3^tm1.1Grob (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	decreased CD8-positive, alpha-beta T cell number	J:138557
	decreased lymphocyte cell number	J:138557
Ndufs4^tm1.1Rpa/Ndufs4^tm1.1Rpa (involves: 129S4/SvJaeSor)	microgliosis	J:161393
Ndufs4^tm1.1Rpa/Ndufs4^tm1.1Rpa (B6.129S4-Ndufs4^tm1.1Rpa)	microgliosis	J:190475
Ndufs4^tm1Rpa/Ndufs4^tm1Rpa (B6.129S4-Ndufs4^tm1Rpa)	microgliosis	J:190475
Ndufs4^tm1Rpa/Ndufs4^tm1Rpa Tg(Nes-cre)1Kln/0 (involves: 129S4/SvJaeSor * C57BL/6 * SJL)	microgliosis	J:161393
Ndufs4^tm1Rpa/Ndufs4^tm1Rpa Tg(Nes-cre)1Kln/0 (B6.Cg-Tg(Nes-cre)1Kln Ndufs4^tm1Rpa)	microgliosis	J:190475
Nedd1^em1(IMPC)H/Nedd1⁺ (C57BL/6NTac-Nedd1^em1(IMPC)H/H)	increased eosinophil cell number	J:211773
Nedd4^Gt(XA209)Byg/Nedd4^Gt(XA209)Byg (involves: 129P2/OlaHsd)	decreased B cell number	J:143560
	increased CD4-positive, alpha-beta T cell number	J:143560
	increased CD8-positive, alpha-beta T cell number	J:143560
	increased T cell number	J:143560
Nedd4^Gt(XB398)Byg/Nedd4^Gt(XB398)Byg (involves: 129P2/OlaHsd)	decreased B cell number	J:143560
	increased CD4-positive, alpha-beta T cell number	J:143560
	increased CD8-positive, alpha-beta T cell number	J:143560
	increased T cell number	J:143560
Nedd4^{tm2b(EUCOMM)Hmgu}/Nedd4⁺ (C57BL/6N-Nedd4^{tm2b(EUCOMM)Hmgu}/H)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Nedd4l^tm1Shkr/Nedd4l^tm1Shkr (involves: C57BL/6 * C57BL/6J)	increased neutrophil cell number	J:205657
Nedd9^m1Btlr/Nedd9^m1Btlr (C57BL/6J-Nedd9^m1Btlr)	decreased B-1a cell number	J:267702
Nedd9^m1Btlr/Nedd9^m1Btlr (C57BL/6J-Nedd9^m1Btlr)	decreased B-1b cell number	J:267702
Nedd9^tm1Miku/Nedd9^tm1Miku (B6.CBA-Nedd9^tm1Miku)	abnormal B cell number	J:116716
	decreased lymphocyte cell number	J:116716
	decreased marginal zone B cell number	J:116716
	increased follicular B cell number	J:116716
	lymph node hypoplasia	J:116716
	spleen hypoplasia	J:116716
Neil2^tm1.1Tkhz/Neil2^tm1.1Tkhz (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)	increased neutrophil cell number	J:225791
Nek2^em1(IMPC)Tcp/Nek2^em1(IMPC)Tcp (C57BL/6NCrl-Nek2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Nek8^m1Btlr/Nek8^m1Btlr (C57BL/6J-Nek8^m1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:267544
	decreased effector memory CD4-positive, alpha-beta T cell number	J:267544
	decreased effector memory CD8-positive, alpha-beta T cell number	J:267544
	increased CD4-positive, alpha-beta T cell number	J:267544
Nek9^{tm1a(EUCOMM)Wtsi}/Nek9⁺ (C57BL/6N-Nek9^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Nelfa^em1(IMPC)Tcp/Nelfa⁺ (C57BL/6NCrl-Nelfa^em1(IMPC)Tcp/Tcp)	increased spleen weight	J:211773
Nell1^em1(IMPC)Mbp/Nell1^em1(IMPC)Mbp (C57BL/6N-Nell1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
Nemp1^em1(IMPC)Mbp/Nemp1^em1(IMPC)Mbp (C57BL/6NCrl-Nemp1^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Nemp2^em1(IMPC)Tcp/Nemp2^em1(IMPC)Tcp (C57BL/6N-Nemp2^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Neu1^a/Neu1^a (SM/J)	abnormal Kupffer cell morphology	J:147881
Neu1^tm1Adz/Neu1^tm1Adz (either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI))	abnormal Kupffer cell morphology	J:76937
	abnormal microglial cell morphology	J:76937
	enlarged spleen	J:76937
	spleen hyperplasia	J:76937
Neurl2^{tm1.1(KOMP)Vlcg}/Neurl2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Neurl2^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Neurl4^em1(IMPC)Mbp/Neurl4^em1(IMPC)Mbp (C57BL/6NCrl-Neurl4^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	decreased leukocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Nexmif^em1(IMPC)Tcp/Y (C57BL/6N-Nexmif^em1(IMPC)Tcp/Tcp)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased monocyte cell number	J:211773
	small spleen	J:211773
Nexmif^em1(IMPC)Tcp/Nexmif⁺ (C57BL/6N-Nexmif^em1(IMPC)Tcp/Tcp)	increased neutrophil cell number	J:211773
Nf1^tm1Fcr/Nf1⁺ Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (B6.Cg-Tg(Mx1-cre)1Cgn Nf1^tm1Fcr Pten^tm1Hwu)	abnormal spleen morphology	J:232645
	decreased B cell number	J:232645
	decreased lymphocyte cell number	J:232645
	decreased T cell number	J:232645
	enlarged spleen	J:232645
	increased granulocyte number	J:232645
	increased leukocyte cell number	J:232645
	increased macrophage cell number	J:232645
	increased monocyte cell number	J:232645
	increased spleen weight	J:232645
Nf1^tm1Fcr/Nf1^tm1Fcr (either: (involves: 129S/SvEv) or (involves: 129S/SvEv * C57BL/6J))	abnormal lymphatic vessel morphology	J:18048
Nf1^tm1Fcr/Nf1^tm1Par Tg(Tek-cre)1Ywa/0 (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	abnormal spleen morphology	J:114455
	absent spleen germinal center	J:114455
	enlarged spleen	J:114455
	spleen fibrosis	J:114455
Nf1^tm1Par/Nf1^tm1Fcr Tg(GFAP-cre)#Gtm/0 (involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal microglial cell morphology	J:165209
Nf1^tm1Par/Nf1^tm1Par Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal myeloid leukocyte morphology	J:90973
	abnormal myelopoiesis	J:90973
	abnormal spleen morphology	J:90973
	enlarged spleen	J:90973
	increased granulocyte number	J:90973
	increased leukocyte cell number	J:90973
	increased lymphocyte cell number	J:90973
	increased monocyte cell number	J:90973
	increased neutrophil cell number	J:90973
Nf1^tm1Par/Nf1^tm1Par Tg(Prrx1-cre)1Cjt/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N * SJL/J)	increased osteoclast cell number	J:193350
Nf1^tm1Tyj/Nf1⁺ Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C57BL/6)	spleen hyperplasia	J:228258
Nf2^tm2Gth/Nf2^tm2Gth Trp53^tm1Brn/Trp53^tm1Brn (involves: 129P2/OlaHsd * 129S7/SvEvBrd)	increased T cell derived lymphoma incidence	J:132943
Nfam1^{em1(IMPC)Ccpcz}/Nfam1^{em1(IMPC)Ccpcz} (C57BL/6N-Nfam1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Nfat5^tm1.1Itl/Nfat5^tm1.1Itl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NTac * FVB/N)	abnormal lymphatic vessel morphology	J:201429
Nfat5^tm1Snh/Nfat5⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	spleen hypoplasia	J:91482
	thymus hypoplasia	J:91482
Nfatc1^tm1.1Fbs/Nfatc1^tm1.1Fbs (C57BL/6-Nfatc1^tm1.1Fbs)	increased regulatory T cell number	J:305649
Nfatc1^tm1Glm/Nfatc1^tm2Glm (chimera involves: 129S2/SvPas)	abnormal lymphocyte cell number	J:78376
	decreased double-positive T cell number	J:78376
	decreased lymphocyte cell number	J:78376
	increased double-negative T cell number	J:78376
Nfatc1^tm1Rao/Nfatc1^tm1Rao Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c)	abnormal class switch recombination	J:177319
	decreased B cell number	J:177319
	decreased B-1a cell number	J:177319
Nfatc1^tm1Rao/Nfatc1^tm1Rao Tg(Fcer2a-cre)5Mbu/0 (involves: C57BL/6 * CBA)	abnormal class switch recombination	J:177319
Nfatc1^tm3Glm/Nfatc1^tm3Glm Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal osteoclast differentiation	J:144598
	decreased osteoclast cell number	J:144598
Nfatc1^tm3Glm/Nfatc1^tm3Glm Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal osteoclast differentiation	J:144598
	decreased osteoclast cell number	J:144598
Nfatc2^tm1Glm/Nfatc2^tm1Glm Nfatc3^tm1Glm/Nfatc3^tm1Glm (involves: 129S2/SvPas)	abnormal lymph node morphology	J:51339
	abnormal lymphocyte cell number	J:51339
	decreased T cell number	J:51339
	enlarged spleen	J:51339
	increased B cell number	J:51339
	increased T cell number	J:51339
Nfatc2^tm1Rao/Nfatc2^tm1Rao Nfatc3^tm1Grc/Nfatc3^tm1Grc Tg(Lck-cre)I57Jxm/0 (involves: ICR)	abnormal double-negative T cell morphology	J:141917
	abnormal T cell differentiation	J:141917
Nfatc2^tm1Srf/Nfatc2^tm1Srf (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell number	J:110686
	abnormal lymph node B cell domain morphology	J:110686
	abnormal spleen germinal center morphology	J:110686
	enlarged spleen	J:110686
	enlarged thymus	J:110686
	increased activated T cell number	J:110686
	thymus hyperplasia	J:110686
Nfatc2^tm1Srf/Nfatc2^tm1Srf (involves: 129P2/OlaHsd)	abnormal immune system organ morphology	J:45252
	abnormal lymph node morphology	J:45252
	enlarged lymph nodes	J:45252
	enlarged spleen	J:45252
	increased B cell number	J:45252
	increased lymphocyte cell number	J:45252
	increased T cell number	J:45252
	lymph node hyperplasia	J:45252
Nfatc2ip^em1(IMPC)Ics/Nfatc2ip^em1(IMPC)Ics (C57BL/6N-Nfatc2ip^em1(IMPC)Ics/Ics)	increased eosinophil cell number	J:211773
Nfatc2ip^tm1.1Glm/Nfatc2ip^tm1.1Glm (either: B6.129-Nfatc2ip^tm1.1Glm or C.129-Nfatc2ip^tm1.1Glm)	abnormal leukocyte morphology	J:157559
	decreased mast cell number	J:157559
	decreased T-helper 2 cell number	J:157559
Nfatc3^tm1.1Grc/Nfatc3^tm1.1Grc (involves: C57BL/6)	lymph node hypoplasia	J:141917
Nfatc3^tm1Glm/Nfatc3^tm1Glm Tg(DO11.10)10Dlo/? (involves: 129S2/SvPas * BALB/c * C3H * C57BL/6)	decreased double-positive T cell number	J:50124
	increased double-negative T cell number	J:50124
	small thymus	J:50124
Nfatc3^tm1Grc/Nfatc3^tm1Grc Tg(Lck-cre)I57Jxm/0 (involves: ICR)	abnormal T cell differentiation	J:141917
	decreased CD4-positive, alpha-beta T cell number	J:141917
	decreased CD8-positive, alpha-beta T cell number	J:141917
	decreased thymocyte number	J:141917
	increased double-negative T cell number	J:141917
	lymph node hypoplasia	J:141917
	thymus hypoplasia	J:141917
Nfe2^{em1(IMPC)Ccpcz}/Nfe2⁺ (C57BL/6NCrl-Nfe2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Nfe2^tm1Sho/Nfe2⁺ (C.129S4-Nfe2^tm1Sho)	enlarged spleen	J:125982
Nfe2^tm1Sho/Nfe2^tm1Sho (involves: 129/Sv * 129S4/SvJae)	increased osteoclast cell number	J:111270
Nfe2l2^{em1(IMPC)Ccpcz}/Nfe2l2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Nfe2l2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Nfe2l2^tm1Mym/Nfe2l2^tm1Mym (involves: 129P2/OlaHsd * ICR)	decreased CD4-positive, alpha-beta T cell number	J:104016
	decreased T cell number	J:104016
	enlarged lymph nodes	J:104016
	increased spleen weight	J:104016
Nfe2l2^tm1Ywk/Nfe2l2^tm1Ywk (involves: 129X1/SvJ)	enlarged spleen	J:91407
	increased macrophage cell number	J:100106
	increased spleen weight	J:91407
Nfil3^{tm1.1(KOMP)Vlcg}/Nfil3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nfil3^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
	small thymus	J:211773
Nfil3^tm1.1Brad/Nfil3⁺ (B6.Cg-Nfil3^tm1.1Brad)	decreased NK cell number	J:152774
Nfil3^tm1.1Brad/Nfil3^tm1.1Brad (B6.Cg-Nfil3^tm1.1Brad)	abnormal NK cell differentiation	J:152774
	decreased NK cell number	J:152774
	increased memory T cell number	J:152774
	increased NK T cell number	J:152774
Nfil3^tm1Look/Nfil3^tm1Look (B6.129X1-Nfil3^tm1Look)	abnormal NK cell differentiation	J:155677
Nfil3^tm1Look/Nfil3^tm1Look (B6.129X1-Nfil3^tm1Look)	decreased NK cell number	J:155677
Nfil3^tm1Pbro/Nfil3^tm1Pbro (involves: 129S6/SvEvTac * C57BL/6)	abnormal class switch recombination	J:156521
Nfil3^tm1Pbro/Nfil3^tm1Pbro (B6.129S6-Nfil3^tm1Pbro)	abnormal leukocyte morphology	J:209365
	abnormal plasma cell morphology	J:209365
	decreased NK cell number	J:209365
	increased T-helper 17 cell number	J:209365
Nfkb1^m2Btlr/Nfkb1⁺ (C57BL/6J-Nfkb1^m2Btlr)	decreased central memory CD4-positive, alpha-beta T cell number	J:254822
Nfkb1^m2Btlr/Nfkb1⁺ (C57BL/6J-Nfkb1^m2Btlr)	decreased effector memory CD4-positive, alpha-beta T cell number	J:254822
Nfkb1^m2Btlr/Nfkb1^m2Btlr (C57BL/6J-Nfkb1^m2Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:254822
	decreased central memory CD4-positive, alpha-beta T cell number	J:254822
	decreased effector memory CD4-positive, alpha-beta T cell number	J:254822
	increased central memory CD8 positive, alpha-beta T cell number	J:254822
Nfkb1^M3Btlr/Nfkb1⁺ (C57BL/6J-Nfkb1^M3Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:254821
Nfkb1^M3Btlr/Nfkb1^M3Btlr (C57BL/6J-Nfkb1^M3Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:254821
Nfkb1^M4Btlr/Nfkb1^M4Btlr (C57BL/6J-Nfkb1^M4Btlr)	decreased B-1 B cell number	J:265169
Nfkb1^M5Btlr/Nfkb1^M5Btlr (C57BL/6J-Nfkb1^M5Btlr)	decreased B-1a cell number	J:272117
Nfkb1^{tm1a(KOMP)Wtsi}/Nfkb1^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Nfkb1^{tm1a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:175295, J:165965
Nfkb1^{tm1a(KOMP)Wtsi}/Nfkb1^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased NK cell number	J:213427
	decreased regulatory T cell number	J:213427
	increased leukocyte cell number	J:213427
	lymphoid hyperplasia	J:213427
Nfkb1^tm1Bal/Nfkb1^tm1Bal (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:30268
	abnormal Peyer's patch follicle morphology	J:77049
	abnormal Peyer's patch germinal center morphology	J:77049
	abnormal Peyer's patch T cell area morphology	J:77049
	decreased myeloid dendritic cell number	J:77049
	decreased Peyer's patch number	J:77049
	small Peyer's patches	J:77049
Nfkb1^tm1Bal/Nfkb1^tm1Bal (involves: 129P2/OlaHsd)	decreased marginal zone B cell number	J:65246
Nfkb1^tm1Bal/Nfkb1^tm1Bal Nfkb2^tm1Sbn/Nfkb2^tm1Sbn (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal immune system organ morphology	J:45119
	abnormal osteoclast differentiation	J:45119
	abnormal spleen morphology	J:45119
	abnormal thymus cortex morphology	J:45119
	abnormal thymus medulla morphology	J:45119
	absent lymph nodes	J:45119
	absent spleen white pulp	J:45119
	arrested B cell differentiation	J:45119
	decreased B cell number	J:45119
	decreased CD4-positive, alpha-beta T cell number	J:45119
	decreased CD8-positive, alpha-beta T cell number	J:45119
	decreased dendritic cell number	J:45119
	decreased double-positive T cell number	J:45119
	decreased mature B cell number	J:45119
	decreased osteoclast cell number	J:45119
	decreased single-positive T cell number	J:45119
	decreased T cell number	J:45119
	increased granulocyte number	J:45119
	increased macrophage cell number	J:45119
	thymus hypoplasia	J:45119
Nfkb1^tm1Bal/Nfkb1^tm1Bal Rela^tm1Bal/Rela^tm1Bal (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal dendritic cell differentiation	J:113514
	decreased dendritic cell number	J:113514
Nfkb1^tm1Bal/Nfkb1^tm1Bal Tg(Tnfsf13b)1Fma/? (B6.Cg-Nfkb1^tm1Bal Tg(Tnfsf13b)1Fma)	abnormal class switch recombination	J:113556
	decreased marginal zone B cell number	J:113556
	increased transitional stage B cell number	J:113556
Nfkb1^tm1Brv/Nfkb1^tm1Brv (involves: 129S1/Sv)	abnormal lymph organ size	J:46912
	decreased single-positive T cell number	J:46912
	enlarged lymph nodes	J:46912
	enlarged spleen	J:46912
	myeloid hyperplasia	J:46912
Nfkb1^tm1Brv/Nfkb1^tm1Brv (involves: 129S1/Sv * C57BL/6)	decreased osteoclast cell number	J:44112
Nfkb1^tm1Brv/Nfkb1^tm1Brv Nfkb2^tm1Brv/Nfkb2⁺ (involves: 129S1/Sv * C57BL/6)	abnormal osteoclast differentiation	J:44112
	decreased osteoclast cell number	J:44112
Nfkb1^tm1Brv/Nfkb1^tm1Brv Nfkb2^tm1Brv/Nfkb2^tm1Brv (involves: 129S1/Sv * C57BL/6)	abnormal osteoclast differentiation	J:44112
	decreased osteoclast cell number	J:44112
	increased macrophage cell number	J:44112
Nfkb1^tm1Sley/Nfkb1^tm1Sley (involves: 129S4/SvJae * 129S8/SvEv)	abnormal inguinal lymph node morphology	J:142340
	absent inguinal lymph nodes	J:142340
	decreased memory T cell number	J:142340
	decreased regulatory T cell number	J:142340
	small inguinal lymph nodes	J:142340
Nfkb1^tm1Sley/Nfkb1^tm1Sley (involves: 129S4/SvJae * 129S8/SvEv * C57BL/6)	decreased memory T cell number	J:142340
	decreased NK T cell number	J:142340
	decreased regulatory T cell number	J:142340
Nfkb2^Lym1/Nfkb2⁺ (BALB/c-Nfkb2^Lym1)	abnormal lymph node morphology	J:154812
	abnormal mesenteric lymph node morphology	J:154812
	abnormal spleen white pulp morphology	J:154812
	absent axillary lymph nodes	J:154812
	absent brachial lymph nodes	J:154812
	absent cervical lymph nodes	J:154812
	absent inguinal lymph nodes	J:154812
	absent Peyer's patches	J:154812
	decreased lymph node number	J:154812
	increased lymphocyte cell number	J:154812
Nfkb2^Lym1/Nfkb2⁺ (involves: BALB/c)	abnormal B cell differentiation	J:188560
Nfkb2^Lym1/Nfkb2^Lym1 (involves: BALB/c)	abnormal class switch recombination	J:154812
	abnormal lymph node morphology	J:154812
	abnormal osteoclast differentiation	J:154812
	abnormal peripheral lymph node morphology	J:154812
	abnormal plasma cell differentiation	J:154812
	abnormal spleen follicular dendritic cell network	J:154812
	abnormal spleen periarteriolar lymphoid sheath morphology	J:154812
	abnormal spleen primary B follicle morphology	J:154812
	abnormal spleen white pulp morphology	J:154812
	abnormal T cell differentiation	J:154812
	abnormal thymus cell ratio	J:154812
	abnormal thymus size	J:154812
	absent axillary lymph nodes	J:154812
	absent brachial lymph nodes	J:154812
	absent cervical lymph nodes	J:154812
	absent inguinal lymph nodes	J:154812
	absent mesenteric lymph nodes	J:154812
	absent Peyer's patches	J:154812
	decreased follicular B cell number	J:154812
	decreased lymph node number	J:154812
	decreased marginal zone B cell number	J:154812
	decreased mature B cell number	J:154812
	decreased transitional stage B cell number	J:154812
	enlarged spleen	J:154812
	increased CD4-positive, alpha-beta T cell number	J:154812
	increased CD8-positive, alpha-beta T cell number	J:154812
	increased double-negative T cell number	J:154812
	increased double-positive T cell number	J:154812
	increased spleen red pulp amount	J:154812
	increased spleen weight	J:154812
	increased transitional stage B cell number	J:154812
Nfkb2^m2Btlr/Nfkb2^m2Btlr (C57BL/6J-Nfkb2^m2Btlr)	increased B-1a cell number	J:221493
Nfkb2^m3Btlr/Nfkb2^m3Btlr (C57BL/6J-Nfkb2^m3Btlr)	abnormal B cell differentiation	J:274960
	abnormal CD4-positive T cell differentiation	J:274960
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274960
	abnormal T cell differentiation	J:274960
	decreased B cell number	J:274960
	decreased CD4-positive, alpha-beta T cell number	J:274960
	decreased effector memory CD8-positive, alpha-beta T cell number	J:274960
	decreased NK cell number	J:274960
	increased B-1 B cell number	J:274960
	increased CD4-positive, alpha-beta T cell number	J:274960
	increased CD8-positive, alpha-beta T cell number	J:274960
	increased CD8-positive, naive alpha-beta T cell number	J:274960
	increased T cell number	J:274960
Nfkb2^M4Btlr/Nfkb2^M4Btlr (C57BL/6J-Nfkb2^M4Btlr)	increased CD4-positive, alpha-beta T cell number	J:274961
	increased CD8-positive, alpha-beta T cell number	J:274961
	increased T cell number	J:274961
Nfkb2^m5Btlr/Nfkb2^m5Btlr (C57BL/6J-Nfkb2^m5Btlr)	increased B-1 B cell number	J:274962
Nfkb2^tm1Brv/Nfkb2^tm1Brv (involves: 129S1/Sv * C57BL/6)	abnormal lymph node B cell domain morphology	J:43469
	abnormal lymph node cortex morphology	J:43469
	abnormal lymphocyte cell number	J:43469
	abnormal T cell number	J:43469
	abnormal T cell subpopulation ratio	J:43469
	abnormal thymus corticomedullary boundary morphology	J:43469
	decreased double-positive T cell number	J:43469
	decreased spleen weight	J:43469
	enlarged lymph nodes	J:43469
	increased granulocyte number	J:43469
	intermingled spleen red and white pulp	J:43469
	spleen atrophy	J:43469
	spleen hypoplasia	J:43469
	thymus atrophy	J:43469
Nfkb2^tm1Rsch/Nfkb2^tm1Rsch (involves: 129P2/OlaHsd)	abnormal myeloid dendritic cell morphology	J:77049
	abnormal Peyer's patch follicle morphology	J:77049
	abnormal Peyer's patch germinal center morphology	J:77049
	abnormal Peyer's patch morphology	J:77049
	abnormal Peyer's patch T cell area morphology	J:77049
	decreased B cell number	J:77049
	decreased dendritic cell number	J:77049
	decreased myeloid dendritic cell number	J:77049
	increased plasmacytoid dendritic cell number	J:77049
	small Peyer's patches	J:77049
Nfkb2^tm1Sbn/Nfkb2^tm1Sbn (involves: 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:45437
	abnormal lymphocyte cell number	J:45437
	abnormal metallophilic macrophage morphology	J:45437
	abnormal spleen B cell follicle morphology	J:45437
	abnormal spleen marginal zone macrophage morphology	J:45437
	abnormal spleen marginal zone morphology	J:45437
	abnormal spleen white pulp morphology	J:45437
	absent spleen germinal center	J:45437
	decreased B cell number	J:45437
	increased T cell number	J:45437
Nfkb2^tm2Brv/Nfkb2^tm2Brv (involves: 129S1/Sv * C57BL/6)	abnormal lymph node morphology	J:76380
	abnormal metallophilic macrophage morphology	J:76380
	abnormal spleen morphology	J:76380
	absent lymph node germinal center	J:76380
	absent spleen germinal center	J:76380
	absent spleen marginal zone	J:76380
	decreased B cell number	J:76380
	increased CD4-positive, alpha-beta T cell number	J:76380
	increased CD8-positive, alpha-beta T cell number	J:76380
Nfkb2^tm2Brv/Nfkb2^tm2Brv (involves: 129S1/Sv)	abnormal gamma-delta T cell morphology	J:169863
Nfkb2^tm2Brv/Nfkb2^tm2Brv (involves: 129S1/Sv)	decreased gamma-delta T cell number	J:169863
Nfkb2^tm2Brv/Nfkb2^tm2Brv Tg(Tnfsf13b)1Fma/? (B6.Cg-Nfkb2^tm2Brv Tg(Tnfsf13b)1Fma)	absent spleen marginal zone	J:113556
	decreased marginal zone B cell number	J:113556
Nfkb2^xdr/Nfkb2^xdr (C57BL/6JSfdAnu-Nfkb2^xdr/Anu)	abnormal metallophilic macrophage morphology	J:79725
	abnormal peripheral lymph node morphology	J:79725
	abnormal spleen follicular dendritic cell network	J:79725
	abnormal spleen morphology	J:79725
	abnormal spleen secondary B follicle morphology	J:79725
	decreased B-2 B cell number	J:79725
	decreased follicular B cell number	J:79725
	decreased marginal zone B cell number	J:79725
	decreased mature B cell number	J:79725
	decreased transitional stage T2 B cell number	J:79725
	increased B-1 B cell number	J:79725
Nfkb2^xdr/Nfkb2^xdr (involves: C57BL/6JSfdAnu * C57BL/10Sg * C57BR/cd * NOD)	decreased B cell number	J:79725
Nfkbia^tm1.1Kbp/Nfkbia^tm1.1Kbp (involves: 129P2/OlaHsd * C57BL/6)	abnormal granulocyte morphology	J:97945
	increased granulocyte number	J:97945
Nfkbia^tm1.1Pjc/Nfkbia^tm1.1Pjc (involves: C57BL/6)	abnormal T cell number	J:163686
	decreased CD4-positive, alpha-beta T cell number	J:163686
	decreased CD8-positive, alpha-beta T cell number	J:163686
	increased activated T cell number	J:163686
	increased double-positive T cell number	J:163686
	increased memory T cell number	J:163686
	increased thymocyte number	J:163686
Nfkbia^tm1.1Smiy/Nfkbia⁺ (B6.129-Nfkbia^tm1.1Smiy)	decreased B cell number	J:168977
	decreased follicular B cell number	J:168977
	decreased marginal zone B cell number	J:168977
	decreased transitional stage T2 B cell number	J:168977
	increased pro-B cell number	J:168977
	small Peyer's patches	J:168977
Nfkbia^tm1.1Smiy/Nfkbia^tm1.1Smiy (B6.129-Nfkbia^tm1.1Smiy)	abnormal B cell differentiation	J:168977
	abnormal marginal zone B cell morphology	J:168977
	decreased B cell number	J:168977
	decreased B-2 B cell number	J:168977
	decreased CD4-positive, alpha-beta memory T cell number	J:168977
	decreased follicular B cell number	J:168977
	decreased marginal zone B cell number	J:168977
	decreased mature B cell number	J:168977
	decreased Peyer's patch number	J:168977
	decreased regulatory T cell number	J:168977
	decreased transitional stage T2 B cell number	J:168977
	increased immature B cell number	J:168977
	increased pre-B cell number	J:168977
	increased pro-B cell number	J:168977
	small Peyer's patches	J:168977
Nfkbia^tm1Bal/Nfkbia^tm1Bal (involves: 129S4/SvJae * C57BL/6J)	abnormal granulocyte differentiation	J:30058
	decreased double-positive T cell number	J:30058
	increased leukocyte cell number	J:30058
	spleen atrophy	J:30058
	thymus atrophy	J:30058
Nfkbia^tm1Bal/Nfkbia^tm1Bal Nfkbie^tm1Syme/Nfkbie^tm1Syme (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2)	abnormal B cell differentiation	J:88142
	abnormal T cell differentiation	J:88142
	decreased immature B cell number	J:88142
	decreased pre-B cell number	J:88142
Nfkbia^tm1Fey/Nfkbia^tm1Fey (involves: 129S6/SvEvTac * C57BL/6)	abnormal B cell differentiation	J:110817
	absent spleen germinal center	J:110817
	decreased double-negative T cell number	J:110817
	decreased thymocyte number	J:110817
	increased single-positive T cell number	J:110817
	small spleen	J:110817
	thymus atrophy	J:110817
Nfkbia^tm1Stw/Nfkbia^tm1Stw (involves: 129S1/Sv)	abnormal myelopoiesis	J:32527
	increased macrophage cell number	J:32527
	increased monocyte cell number	J:32527
Nfkbib^tm1.2Rsch/Nfkbib^tm1.2Rsch (B6.129P2-Nfkbib^tm1.2Rsch)	abnormal immune system morphology	J:176877
	decreased B cell number	J:176877
	increased macrophage cell number	J:176877
	increased marginal zone B cell number	J:176877
	increased memory T cell number	J:176877
Nfkbid^m1Btlr/Nfkbid^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	absent marginal zone B cells	J:185495
	decreased B-1 B cell number	J:185495
	decreased B-1a cell number	J:185495
Nfkbid^{tm1a(EUCOMM)Wtsi}/Nfkbid⁺ (C57BL/6N-Nfkbid^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased B cell number	J:165965
Nfkbid^{tm1a(EUCOMM)Wtsi}/Nfkbid^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal class switch recombination	J:185495
Nfkbie^tm1Syme/Nfkbie^tm1Syme (either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal double-negative T cell morphology	J:88538
Nfkbiz^tm1Aki/Nfkbiz^tm1Aki (involves: 129P2/OlaHsd)	abnormal immune system organ morphology	J:194832
	abnormal lymph node cell ratio	J:194832
	abnormal lymphocyte morphology	J:194832
	abnormal T-helper 1 cell morphology	J:194832
	enlarged lymph nodes	J:194832
	enlarged spleen	J:194832
Ngfr^tm1Jae/Ngfr^tm1Jae (B6.129S4-Ngfr^tm1Jae)	abnormal Kupffer cell morphology	J:120368
Ngp^{tm1b(KOMP)Wtsi}/Ngp^{tm1b(KOMP)Wtsi} (C57BL/6N-Ngp^{tm1b(KOMP)Wtsi}/Bay)	increased spleen weight	J:211773
Nhej1^tm1.1Ics/Nhej1⁺ (involves: 129 * C57BL/6)	decreased thymocyte number	J:194422
Nhej1^tm1.1Ics/Nhej1^tm1.1Ics (involves: 129 * C57BL/6)	abnormal T cell receptor V(D)J recombination	J:194422
	decreased lymphocyte cell number	J:194422
	decreased NK T cell number	J:194422
	decreased thymocyte number	J:194422
Nhej1^tm1.1Ics/Nhej1^tm1.1Ics Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	abnormal T cell receptor V(D)J recombination	J:194422
	decreased NK T cell number	J:194422
Nhej1^tm1Fwa/Nhej1^tm1Fwa (involves: 129)	abnormal class switch recombination	J:138774
	spleen hypoplasia	J:138774
	thymus hypoplasia	J:138774
Nhej1^tm1Fwa/Nhej1^tm1Fwa Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129)	increased T cell derived lymphoma incidence	J:138774
Nhej1^tm1Fwa/Nhej1^tm1Fwa Xrcc5^tm1Nus/Xrcc5^tm1Nus (involves: 129S6/SvEvTac * C57BL/6)	athymia	J:236776
	small spleen	J:236776
Nherf1^em1(IMPC)H/Nherf1^em1(IMPC)H (C57BL/6NTac-Nherf1^em1(IMPC)H/H)	increased basophil cell number	J:211773
	increased leukocyte cell number	J:211773
Nhlh1^{tm1b(KOMP)Wtsi}/Nhlh1⁺ (C57BL/6N-Nhlh1^{tm1b(KOMP)Wtsi}/Tcp)	enlarged lymph nodes	J:211773
Nhlh2^{tm1b(KOMP)Mbp}/Nhlh2^{tm1b(KOMP)Mbp} (C57BL/6N-Nhlh2^{tm1b(KOMP)Mbp}/Tcp)	increased spleen weight	J:211773
Nhsl2^em1(IMPC)Tcp/Y (C57BL/6N-Nhsl2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Nhsl2^em1(IMPC)Tcp/Y (C57BL/6N-Nhsl2^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Nhsl2^em1(IMPC)Tcp/Nhsl2^em1(IMPC)Tcp (C57BL/6N-Nhsl2^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
Niban1^{em1(IMPC)Ccpcz}/Niban1^{em1(IMPC)Ccpcz} (C57BL/6N-Niban1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Niban3^em1(IMPC)Mbp/Niban3^em1(IMPC)Mbp (C57BL/6N-Niban3^em1(IMPC)Mbp/MbpMmucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Niban3^tm1Jyw/Niban3^tm1Jyw (B6.Cg-Niban3^tm1Jyw)	abnormal B cell differentiation	J:282961
	abnormal class switch recombination	J:282961
	abnormal transitional stage B cell morphology	J:282961
	decreased B-1a cell number	J:282961
	increased B cell number	J:282961
	increased follicular B cell number	J:282961
	increased transitional stage T2 B cell number	J:282961
Nipal3^tm1Pbfd/Nipal3^tm1Pbfd (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	decreased NK cell number	J:152829
Nipsnap3a^{tm1b(KOMP)Wtsi}/Nipsnap3a^{tm1b(KOMP)Wtsi} (C57BL/6N-Nipsnap3a^{tm1b(KOMP)Wtsi}/Wtsi)	increased effector memory T-helper cell number	J:211773
Nipsnap3b^em1(IMPC)J/Nipsnap3b^em1(IMPC)J (C57BL/6NJ-Nipsnap3b^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Nkap^tm1.1Viss/Y Tg(Lck-cre)1Cwi/0 (involves: 129S1/Sv * 129X1/SvJ)	arrested T cell differentiation	J:165961
	decreased CD4-positive, alpha-beta T cell number	J:165961
	decreased CD8-positive, alpha-beta T cell number	J:165961
	decreased DN4 thymocyte number	J:165961
	decreased double-positive T cell number	J:165961
	decreased thymocyte number	J:165961
	increased DN3 thymocyte number	J:165961
	thymus hypoplasia	J:165961
Nkg7^{tm1.1(KOMP)Vlcg}/Nkg7^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nkg7^{tm1.1(KOMP)Vlcg}/Ucd)	increased eosinophil cell number	J:211773
Nkg7^{tm1.1(KOMP)Vlcg}/Nkg7^{tm1.1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:301637
	abnormal mononuclear cell morphology	J:301637
	decreased CD4-positive, alpha-beta T cell number	J:301637
	decreased T helper 1 cell number	J:301637
Nktcn1^C57BL/6J/Nktcn1^C57BL/6J (involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))	increased NK T cell number	J:85376
Nktcn1^C57BL/6J/Nktcn1^C57BL/6J (NOD.B6-(D1Mit369-D1Mit155)(D6Mit105-D6Mit135))	abnormal T cell differentiation	J:137521
	increased NK T cell number	J:137521
Nktcn1^C57BL/6J/Nktcn1^NOD/ShiLt (involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))	increased NK T cell number	J:85376
Nktcn2^C57BL/6J/Nktcn2^C57BL/6J (involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))	increased NK T cell number	J:85376
Nktcn2^C57BL/6J/Nktcn2^NOD/ShiLt (involves: C57BL/6J * NOD.B6-(D6Mit105-D6Mit135))	increased NK T cell number	J:85376
Nkx2-3^tm1Hha/Nkx2-3^tm1Hha (involves: 129S4/SvJae * C57BL/6)	abnormal spleen primary B follicle morphology	J:54198
	abnormal splenic cell ratio	J:54198
	absent spleen	J:54198
	absent spleen marginal zone	J:54198
	decreased spleen white pulp amount	J:54198
	small spleen	J:54198
Nkx2-3^tm1Hha/Nkx2-3^tm1Hha (involves: 129S4/SvJae)	abnormal marginal zone B cell morphology	J:62129
	abnormal mesenteric lymph node morphology	J:62129
	abnormal metallophilic macrophage morphology	J:62129
	abnormal Peyer's patch follicle morphology	J:62129
	abnormal spleen marginal sinus morphology	J:62129
	abnormal spleen marginal zone macrophage morphology	J:62129
	abnormal spleen morphology	J:62129
	abnormal spleen periarteriolar lymphoid sheath morphology	J:62129
	absent marginal zone B cells	J:62129
	absent spleen marginal zone	J:62129
	decreased B cell number	J:62129
	decreased lymphocyte cell number	J:62129
	decreased Peyer's patch number	J:62129
	decreased spleen weight	J:62129
	decreased spleen white pulp amount	J:62129
	decreased T cell number	J:62129
	intermingled spleen red and white pulp	J:62129
	small Peyer's patches	J:62129
	small spleen	J:62129
Nkx2-3^tm1Rph/Nkx2-3^tm1Rph (involves: 129S1/Sv * C57BL/6)	abnormal gut-associated lymphoid tissue morphology	J:64018
	abnormal mesenteric lymph node morphology	J:64018
	abnormal metallophilic macrophage morphology	J:64018
	abnormal spleen B cell follicle morphology	J:64018
	abnormal spleen periarteriolar lymphoid sheath morphology	J:64018
	abnormal spleen red pulp morphology	J:64018
	absent spleen	J:64018
	absent spleen marginal zone	J:64018
	decreased CD4-positive, alpha-beta T cell number	J:64018
	decreased Peyer's patch number	J:64018
	decreased plasma cell number	J:64018
	increased leukocyte cell number	J:64018
	small Peyer's patches	J:64018
	small spleen	J:64018
	spleen atrophy	J:64018
Nkx2-5^tm1(cre)Rjs/Nkx2-5⁺ Tbx1^tm1Bld/Tbx1^tm3Bld (involves: 129S7/SvEvBrd * C57BL/6)	small thymus	J:91013
Nkx2-5^tm1Wehi/Nkx2-5⁺ (involves: 129P2/OlaHsd)	spleen hypoplasia	J:184521
Nkx2-5^tm2(cre)Rph/Nkx2-5⁺ Pbx1^tm1.1Koss/Pbx1^tm1.1Koss (involves: 129P2/OlaHsd * 129S1/Sv)	abnormal spleen morphology	J:184521
	spleen hypoplasia	J:184521
Nkx2-5^tm2(cre)Rph/Nkx2-5^tm4Rph (involves: 129S1/Sv)	spleen hypoplasia	J:184521
Nkx3-2^tm1.1Tlu/Nkx3-2^tm1.1Tlu (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	absent spleen	J:55583
Nkx3-2^tm1Bobh/Nkx3-2^tm1Bobh (involves: 129P2/OlaHsd * C57BL/6)	absent spleen	J:57112
Nkx3-2^tm1Tlu/Nkx3-2^tm1Tlu (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	absent spleen	J:55583
Nkx3-2^tm1Tno/Nkx3-2^tm1Tno (involves: 129S4/SvJae * C57BL/6J)	absent spleen	J:77612
Nle1^tm1Cba/Nle1^tm1.1Cota Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal immune system organ morphology	J:204063
	decreased granulocyte number	J:204063
	decreased macrophage cell number	J:204063
	decreased NK cell number	J:204063
	decreased T cell number	J:204063
	spleen hypoplasia	J:204063
	thymus hypoplasia	J:204063
Nlgn3^{em1(IMPC)Rbrc}/Y (C57BL/6NJcl-Nlgn3^{em1(IMPC)Rbrc}/Rbrc)	increased eosinophil cell number	J:211773
Nlk^tm1Tbo/Nlk^tm1Tbo (129S1/Sv-Nlk^tm1Tbo)	abnormal bone marrow development	J:73353
	abnormal immune system organ morphology	J:73353
	decreased double-positive T cell number	J:73353
	decreased gamma-delta T cell number	J:73353
	decreased lymphocyte cell number	J:73353
	decreased NK cell number	J:73353
	decreased pro-B cell number	J:73353
	decreased thymocyte number	J:73353
	impaired myelopoiesis	J:73353
	small lymph nodes	J:73353
	spleen hypoplasia	J:73353
	thymus hypoplasia	J:73353
Nlrc3^tm1Bhk/Nlrc3^tm1Bhk (B6.129S6-Nlrc3^tm1Bhk)	increased monocyte cell number	J:187586
Nlrc5^tm1.1Ggaur/Nlrc5^tm1.1Ggaur (involves: BALB/cJ)	decreased CD8-positive, alpha-beta T cell number	J:184076
Nlrc5^tm1.1Ggaur/Nlrc5^tm1.1Ggaur (involves: BALB/cJ)	enlarged spleen	J:184076
Nlrp1a^m1Btlr/Nlrp1a^m1Btlr (C57BL/6J-Nlrp1a^m1Btlr)	decreased B cell number	J:265173
	decreased B-1 B cell number	J:265173
	decreased B-1b cell number	J:265173
	decreased B-2 B cell number	J:265173
	decreased CD8-positive, alpha-beta T cell number	J:265173
	decreased central memory CD8 positive, alpha-beta T cell number	J:265173
	decreased NK cell number	J:265173
	decreased single-positive T cell number	J:265173
	decreased T cell number	J:265173
	increased effector memory CD8-positive, alpha-beta T cell number	J:265173
Nlrp1a^m2Btlr/Nlrp1a^m2Btlr (C57BL/6J-Nlrp1a^m2Btlr)	decreased B cell number	J:265174
	decreased NK cell number	J:265174
	increased dendritic cell number	J:265174
	increased neutrophil cell number	J:265174
Nlrp1a^Neut1/Nlrp1a^Neut1 (C.B6-Nlrp1a^Neut1)	decreased lymphocyte cell number	J:191055
	decreased macrophage cell number	J:191055
	enlarged spleen	J:191055
	increased neutrophil cell number	J:191055
Nlrp1a^Neut1/Nlrp1a^Neut1 Pycard^tm1Vmd/Pycard^tm1Vmd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased neutrophil cell number	J:191055
Nlrp3^tm1Hhf/Nlrp3⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	increased leukocyte cell number	J:150054
	increased neutrophil cell number	J:150054
Nlrp3^tm1Hhf/Nlrp3⁺ Rag1^tm1Mom/Rag1^tm1Mom Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	absent B cells	J:150054
	absent T cells	J:150054
Nlrp3^tm1Hhf/Nlrp3⁺ Tg(Zp3-cre)3Mrt/? (involves: 129/Sv * FVB/N)	increased leukocyte cell number	J:150054
	increased neutrophil cell number	J:150054
Nlrp3^tm1Wstr/Nlrp3⁺ (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell number	J:150053
	abnormal lymph node morphology	J:150053
	abnormal spleen red pulp morphology	J:150053
	enlarged lymph nodes	J:150053
	enlarged spleen	J:150053
	increased activated T cell number	J:150053
	increased leukocyte cell number	J:150053
	increased T-helper 1 cell number	J:150053
Nlrp3^tm3.1Hhf/Nlrp3⁺ (involves: 129)	abnormal osteoclast differentiation	J:202147
	decreased lymphocyte cell number	J:202147
	increased granulocyte number	J:202147
	increased lymphocyte cell number	J:202147
	increased monocyte cell number	J:202147
	increased neutrophil cell number	J:202147
	increased osteoclast cell number	J:202147
Nlrp6^tm1Flv/Nlrp6^tm1Flv (B6.Cg-Nlrp6^tm1Flv)	enlarged Peyer's patches	J:173245
	increased B cell number	J:173245
	increased leukocyte cell number	J:173245
Nlrp9b^{tm1b(KOMP)Wtsi}/Nlrp9b^{tm1b(KOMP)Wtsi} (C57BL/6N-Nlrp9b^{tm1b(KOMP)Wtsi}/H)	enlarged spleen	J:211773
Nlrp10^tm1Seis/Nlrp10^tm1Seis (B6.Cg-Nlrp10^tm1Seis)	decreased dendritic cell number	J:183989
Nlrp12^tm1Jpyt/Nlrp12^tm1Jpyt (B6.Cg-Nlrp12^tm1Jpyt)	decreased neutrophil cell number	J:164725
Nlrp12^tm1Tdk/Nlrp12^tm1Tdk (B6.Cg-Nlrp12^tm1Tdk)	enlarged spleen	J:178951
Nlrx1^em1(IMPC)Mbp/Nlrx1^em1(IMPC)Mbp (C57BL/6N-Nlrx1^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
nmf4/nmf4 (C57BL/6J-nmf4/J)	small spleen	J:78134
nmf4/nmf4 (C57BL/6J-nmf4/J)	thymus cortex atrophy	J:78134
nmf356/nmf356 (C57BL/6J-nmf356/J)	thymus atrophy	J:87349
Nmnat2^em1(IMPC)Mbp/Nmnat2⁺ (C57BL/6N-Nmnat2^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Nmnat3^Gt(3020)Tgen/Nmnat3^Gt(3020)Tgen (involves: C57BL/6NCrlj * CBA/JNCrlj)	enlarged spleen	J:214107
	increased spleen iron level	J:214107
	increased spleen red pulp amount	J:214107
	increased spleen weight	J:214107
Nmt1^tm1.1Poru/Nmt1^tm1.1Poru Nmt2^tm1.1Poru/Nmt2^tm1.1Poru Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal CD4-positive, alpha beta T cell morphology	J:226234
	abnormal CD8-positive, alpha beta T cell morphology	J:226234
	decreased DN4 thymocyte number	J:226234
	decreased double-positive T cell number	J:226234
	decreased single-positive T cell number	J:226234
	decreased T cell number	J:226234
	increased double-negative T cell number	J:226234
	increased gamma-delta T cell number	J:226234
	small thymus medulla	J:226234
Nmt1^tm1.1Poru/Nmt1^tm1.1Poru Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal CD4-positive, alpha beta T cell morphology	J:226234
	abnormal CD8-positive, alpha beta T cell morphology	J:226234
	decreased double-positive T cell number	J:226234
	decreased single-positive T cell number	J:226234
	decreased T cell number	J:226234
Nmt2^tm1.1Poru/Nmt2^tm1.1Poru Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	decreased double-positive T cell number	J:226234
	decreased single-positive T cell number	J:226234
	decreased T cell number	J:226234
Nnat^em1(IMPC)Mbp/Nnat^em1(IMPC)Mbp (C57BL/6NCrl-Nnat^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Nnmt^em1(IMPC)Mbp/Nnmt^em1(IMPC)Mbp (C57BL/6NCrl-Nnmt^em1(IMPC)Mbp/Mmucd)	enlarged spleen	J:211773
Noa/Noa⁺ (NOA)	cutaneous mastocytosis	J:43274
Noc2l^tm1.1Arte/Noc2l^tm1.1Arte Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal B cell morphology	J:216490
	abnormal T cell morphology	J:216490
	abnormal thymus cell ratio	J:216490
	abnormal thymus morphology	J:216490
	absent T cells	J:216490
	arrested T cell differentiation	J:216490
	decreased alpha-beta T cell number	J:216490
	decreased DN3 thymocyte number	J:216490
	decreased DN4 thymocyte number	J:216490
	decreased double-positive T cell number	J:216490
	decreased immature B cell number	J:216490
	decreased mature B cell number	J:216490
	decreased pre-B cell number	J:216490
	decreased pro-B cell number	J:216490
	decreased single-positive T cell number	J:216490
	small thymus	J:216490
	spleen hypoplasia	J:216490
	thymus hypoplasia	J:216490
Noc2l^tm1.1Arte/Noc2l^tm1.1Arte Trp53^tm1Brn/Trp53^tm1Brn Tg(CD2-icre)4Kio/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * CBA/Ca)	decreased pre-B cell number	J:216490
Nod2^em1(IMPC)Mbp/Nod2^em1(IMPC)Mbp (C57BL/6N-Nod2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Nod2^tm1Flv/Nod2^tm1Flv (involves: 129S1/Sv)	increased leukocyte cell number	J:147177
Nod2^tm1Flv/Nod2^tm1Flv (involves: 129S1/Sv)	increased neutrophil cell number	J:147177
Nod2^tm1Jhgt/Nod2^tm1Jhgt (B6.Cg-Nod2^tm1Jhgt)	abnormal immune system morphology	J:124575
	abnormal lymph node B cell domain morphology	J:124575
	abnormal Peyer's patch morphology	J:124575
	enlarged Peyer's patches	J:124575
	increased CD4-positive, alpha-beta T cell number	J:124575
	increased double-negative T cell number	J:124575
	increased Peyer's patch number	J:124575
Nod2^tm1Mka/Nod2^tm1Mka (involves: C57BL/6)	abnormal macrophage morphology	J:96128
Nodal^tm1.1Mku/Nodal^tm2Mku Tg(T-cre)1Lwd/0 (involves: 129S1/Sv * C3H * C57BL/6)	absent spleen	J:142430
	small spleen	J:142430
Nodal^tm1.2Rob/Nodal^tm3Rob (involves: 129S/SvEv * MF1)	small spleen	J:79098
Nodal^tm1Hmd/Nodal⁺ Tg(Rr443-Lefty1,-lacZ)36Hmd/0 (either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) or (involves: 129S1/Sv * 129T2/SvEms * 129X1/SvJ))	small spleen	J:82703
Nodal^tm1Hmd/Nodal^tm1Hmd (either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N) or (involves: 129S1/Sv * 129T2/SvEms * 129X1/SvJ))	abnormal spleen morphology	J:82703
	spleen hypoplasia	J:82703
Nol3^em1(IMPC)Mbp/Nol3^em1(IMPC)Mbp (C57BL/6N-Nol3^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Nop53^tm2.1Asuz/Nop53^tm2.1Asuz Tg(Lck-cre)#Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased thymocyte number	J:241062
Nop53^tm2.1Asuz/Nop53^tm2.1Asuz Trp53^tm1Tyj/Trp53^tm1Tyj Tg(Lck-cre)#Jxm/0 (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)	decreased thymocyte number	J:241062
Nos1^tm1Plh/Nos1^tm1Plh (B6;129S4-Nos1^tm1Plh/J)	abnormal osteoclast differentiation	J:105612
Nos1^tm1Plh/Nos1^tm1Plh Nos2^tm1Mrl/Nos2^tm1Mrl Nos3^tm1Plh/Nos3^tm1Plh (involves: 129S4/SvJae * 129S7/SvEvBrd)	increased osteoclast cell number	J:150159
Nos2^tm1Lau/Nos2^tm1Lau (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune system morphology	J:90903
	enlarged inguinal lymph nodes	J:90903
	increased single-positive T cell number	J:90903
Nos2^tm1Lau/Nos2^tm1Lau (B6.129P2-Nos2^tm1Lau)	abnormal osteoclast morphology	J:112399
Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S7/SvEvBrd)	abnormal eosinophil cell number	J:51635
Nos2^tm1Mrl/Nos2^tm1Mrl (involves: 129S7/SvEvBrd)	decreased eosinophil cell number	J:51635
Nos2^tm1Mrl/Nos2^tm1Mrl (B6.129S7-Nos2^tm1Mrl)	abnormal osteoclast differentiation	J:98070
	abnormal osteoclast morphology	J:98070
	decreased osteoclast cell number	J:98070
Nos3^em1(IMPC)Mbp/Nos3^em1(IMPC)Mbp (C57BL/6N-Nos3^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Notch1^tm1Agt/Notch1^tm1Agt Notch2^tm1Frad/Notch2^tm1Frad Tg(Mx1-cre)1Cgn/0 (involves: 129 * BALB/c * C57BL/6 * CBA)	abnormal T cell differentiation	J:125373
	arrested T cell differentiation	J:125373
Notch1^tm1Agt/Notch1^tm1Agt Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	abnormal B cell differentiation	J:125373
	abnormal T cell differentiation	J:125373, J:55400
	abnormal thymus cell ratio	J:55400, J:143472
	abnormal thymus morphology	J:55400
	decreased CD4-positive, alpha-beta T cell number	J:55400
	decreased CD8-positive, alpha-beta T cell number	J:55400
	decreased double-negative T cell number	J:55400
	decreased double-positive T cell number	J:55400
	decreased single-positive T cell number	J:55400
	decreased thymocyte number	J:55400
	increased immature B cell number	J:143472
	small thymus	J:55400
Notch1^tm2Pst/Notch1^tm2Pst (B6.Cg-Notch1^tm2Pst)	abnormal T cell differentiation	J:131563
	decreased double-negative T cell number	J:131563
	decreased T cell number	J:131563
	decreased thymocyte number	J:131563
Notch1^tm2Rko/Notch1^tm2Rko Notch2^tm1Rko/Notch2^tm1Rko Notch3^{Gt(PST033)Byg}/Notch3⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)	abnormal spleen morphology	J:172442
	enlarged spleen	J:172442
	increased spleen red pulp amount	J:172442
Notch1^tm2Rko/Notch1^tm2Rko Notch2^tm1Rko/Notch2^tm1Rko Notch3^{Gt(PST033)Byg}/Notch3^{Gt(PST033)Byg} Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)	abnormal spleen morphology	J:172442
	enlarged spleen	J:172442
	increased spleen red pulp amount	J:172442
Notch1^tm2Rko/Notch1^tm3(cre)Rko (involves: 129X1/SvJ * C57BL/6)	abnormal spleen morphology	J:171829
	enlarged spleen	J:171829
Notch2^{Gt(betageo)1Byg}/Notch2⁺ (B6.129P2-Notch2^{Gt(betageo)1Byg})	decreased marginal zone B cell number	J:146621
Notch2^tm1.1Ecan/Notch2⁺ (involves: 129 * 129S1/Sv * C57BL/6J)	abnormal osteoclast differentiation	J:230045
	abnormal osteoclast morphology	J:230045
	increased osteoclast cell number	J:230045
Notch2^tm1.1Hhtg/Notch2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal osteoclast differentiation	J:311038
	increased osteoclast cell number	J:311038
Notch2^tm1Frad/Notch2^tm1Frad Tg(Mx1-cre)1Cgn/0 (involves: BALB/c * C57BL/6 * CBA)	abnormal B cell differentiation	J:125373
	absent marginal zone B cells	J:125373
Notch2^tm1Yha/Notch2⁺ (B6.129-Notch2^tm1Yha)	abnormal spleen marginal zone morphology	J:85379
	decreased B-1 B cell number	J:85379
	decreased marginal zone B cell number	J:85379
Notch2^tm2.1Ecan/Notch2^tm2.1Ecan Tg(BGLAP-cre)1Clem/0 (involves: C57BL/6J * FVB/NJ)	increased osteoclast cell number	J:246017
Notch2^tm2Hhi/Notch2^tm1.1Hhi Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	decreased marginal zone B cell number	J:83476
Notch3^em1Ecan/Notch3⁺ (C57BL/6J-Notch3^em1Ecan)	abnormal osteoclast differentiation	J:270682
Notch3^em1Ecan/Notch3⁺ (C57BL/6J-Notch3^em1Ecan)	increased osteoclast cell number	J:270682
Notch3^{tm1.1(KOMP)Vlcg}/Notch3^{tm1.1(KOMP)Vlcg} (C57BL/6N-Notch3^{tm1.1(KOMP)Vlcg}/Ucd)	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Notch3^tm1Khan/Notch3^tm1Khan (involves: C57BL/6 * CBA)	decreased thymocyte number	J:98284
Notch3^tm1Khan/Notch3^tm1Khan (involves: C57BL/6 * CBA)	small thymus	J:98284
Notum^em1(IMPC)Tcp/Notum⁺ (C57BL/6NCrl-Notum^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Notum^{Gt(OST172035)Lex}/Notum^{Gt(OST172035)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	increased leukocyte cell number	J:274615
Nox4^em1(IMPC)Mbp/Nox4^em1(IMPC)Mbp (C57BL/6N-Nox4^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Noxa1^{em1(IMPC)Ccpcz}/Noxa1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Noxa1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Npas2^em1(IMPC)Mbp/Npas2^em1(IMPC)Mbp (C57BL/6N-Npas2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	increased neutrophil cell number	J:211773
Npc1^m1N/Npc1^m1N (involves: BALB/c)	abnormal alveolar macrophage morphology	J:204311
Npc1^m1N/Npc1^m1N (involves: BALB/c)	enlarged spleen	J:76733
Npc1^m1N/Npc1^m1N (BALB/cNctr-Npc1^m1N/J)	enlarged spleen	J:179744
Npc1^m1N/Npc1^m1N (BALB/cNctr-Npc1^m1N/J)	microgliosis	J:209834
Npc1^m1N/Npc1^m1N (B6.C-Npc1^m1N)	microgliosis	J:157113
Npc1^m1N/Npc1^m1N (BALB/c-Npc1^m1N)	abnormal macrophage morphology	J:221855
Npc1^m1N/Npc1^m1N (BALB/c-Npc1^m1N)	increased macrophage derived foam cell number	J:221855
Npc1^m1N/Npc1^m1N (involves: BALB/c * C3H/HeJ * C57BL/6J)	microgliosis	J:188345
Npc1^m1N/Npc1^m1N Tg(PRNP-APPSweInd)8Dwst/0 (involves: BALB/c * C3H/HeJ * C57BL/6J)	microgliosis	J:188345
Npc1^m1N/Npc1^tm1.1Apl Tg(CAG-cre/Esr1)5Amc/0 (B6J.Cg-Npc1^m1N/Npc1^tm1.1Apl Tg(CAG-cre/Esr1)5Amc)	microgliosis	J:176888
Npc1^m1N/Npc1^tm1.1Apl Tg(Syn1-cre)671Jxm/0 (B6J.Cg-Npc1^m1N/Npc1^tm1.1Apl Tg(Syn1-cre)671Jxm)	microgliosis	J:176888
Npc1^m1N/Npc1^tm1.2Apl (B6.Cg-Npc1^m1N/Npc1^tm1.2Apl)	microgliosis	J:157113
Npc1^nmf164/Npc1^nmf164 (C57BL/6J-Npc1^nmf164/J)	enlarged spleen	J:179744
Npc1^nmf164/Npc1^nmf164 (C57BL/6J-Npc1^nmf164/J)	increased macrophage derived foam cell number	J:179744
Npc1^spm/Npc1^spm (C57BLKS/J-Npc1^spm/J)	enlarged spleen	J:7245
Npc1^spm/Npc1^spm (C57BLKS/J-Npc1^spm/J)	increased macrophage derived foam cell number	J:7245
Npc1^tm1.1Apl/Npc1^tm1.2Apl Tg(Pcp2-cre)2Mpin/0 (B6.Cg-Npc1^tm1.1Apl/Npc1^tm1.2Apl Tg(Pcp2-cre)2Mpin)	microgliosis	J:157113
Npc1^tm1.1Dso/Npc1^tm1.1Dso (B6.129-Npc1^tm1.1Dso)	abnormal macrophage morphology	J:221855
	increased macrophage cell number	J:221855
	increased macrophage derived foam cell number	J:221855
	microgliosis	J:221855
Npc2^{Gt(LST105)Byg}/Npc2^{Gt(LST105)Byg} (B6.129P2-Npc2^{Gt(LST105)Byg})	abnormal immune system morphology	J:125609
Npc2^tm1Plob/Npc2^tm1Plob (involves: 129S1/Sv * C57BL/6)	decreased NK cell number	J:125609
Npc2^tm1Plob/Npc2^tm1Plob (C.129S1-Npc2^tm1Plob)	decreased NK cell number	J:125609
Npc2^tm1Plob/Npc2^tm1Plob (involves: 129S1/Sv * BALB/c)	abnormal alveolar macrophage morphology	J:204311
Npffr2^tm1.2Ics/Npffr2^tm1.2Ics (involves: C57BL/6N)	decreased macrophage cell number	J:245025
Npm1^tm1Gsva/Npm1⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	decreased B cell number	J:172071
	enlarged spleen	J:172071
	increased granulocyte number	J:172071
	increased leukocyte cell number	J:172071
	increased spleen weight	J:172071
Npm1^tm1Hft/Npm1⁺ (involves: 129)	abnormal granulocyte differentiation	J:194999
	abnormal spleen B cell follicle morphology	J:194999
	enlarged spleen	J:194999
	increased granulocyte number	J:194999
	increased leukocyte cell number	J:194999
	increased monocyte cell number	J:194999
	increased spleen weight	J:194999
	myeloid hyperplasia	J:194999
Npm1^tm1Ppp/Npm1⁺ (involves: 129S1/Sv * C57BL/6)	abnormal thrombopoiesis	J:101494
Npr2^cn/Npr2^cn (AKR/J)	small spleen	J:5109
Npr3^tm1Unc/Npr3^tm1Unc (involves: 129 * C57BL/6)	abnormal osteoclast morphology	J:56058
Nprl3^tm1.1Drhi/Nprl3^tm1.1Drhi (involves: 129P2/OlaHsd)	abnormal lymph organ development	J:183988
Npsr1^{tm1b(KOMP)Wtsi}/Npsr1^{tm1b(KOMP)Wtsi} (C57BL/6N-Npsr1^{tm1b(KOMP)Wtsi}/Rbrc)	increased eosinophil cell number	J:211773
Npy1r^tm1.1Wpg/Npy1r^tm1.1Wpg (involves: 129X1/SvJ * C57BL/6)	abnormal immune system organ morphology	J:118850
	abnormal lymph node cell ratio	J:118850
	abnormal spleen morphology	J:118850
	abnormal splenic cell ratio	J:118850
	abnormal T cell number	J:118850
	decreased B cell number	J:118850
	decreased CD8-positive, alpha-beta T cell number	J:118850
	decreased marginal zone B cell number	J:118850
	decreased mature B cell number	J:118850
	decreased transitional stage B cell number	J:118850
	increased CD4-positive, alpha-beta T cell number	J:118850
	increased CD8-positive, alpha-beta T cell number	J:118850
	increased single-positive T cell number	J:118850
	small spleen	J:118850
Npy2r^em1(IMPC)H/Npy2r^em1(IMPC)H (C57BL/6N-Npy2r^em1(IMPC)H/H)	enlarged spleen	J:211773
	increased spleen weight	J:211773
Npy2r^tm1.1Hhz/Npy2r^tm1.1Hhz (involves: 129X1/SvJ * BALB/cJ * C57BL/6)	decreased osteoclast cell number	J:84570
Npy2r^tm1Hhz/Npy2r^tm1Hhz (involves: 129X1/SvJ * C57BL/6)	decreased osteoclast cell number	J:97455
Nqo2^tm1Akj/Nqo2^tm1Akj (Not Specified)	abnormal lymphopoiesis	J:80549
Nqo2^tm1Akj/Nqo2^tm1Akj (Not Specified)	increased granulocyte number	J:80549
Nr1d1^{tm1(KOMP)Vlcg}/Nr1d1^{tm1(KOMP)Vlcg} (C57BL/6N-Nr1d1^{tm1(KOMP)Vlcg}/Bay)	decreased NK cell number	J:211773
Nr1h2^tm1.1Gstr/Nr1h2^tm1.1Gstr Nr1h3^tm1.1Gstr/Nr1h3^tm1.1Gstr (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased macrophage derived foam cell number	J:81790, J:234268
Nr1h2^tm1Djm/Nr1h2^tm1Djm Nr1h3^tm1Djm/Nr1h3^tm1Djm (involves: 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:125452
Nr1h4^tm1.1Mbj/Nr1h4^tm1.1Mbj (B6N.B6-Nr1h4^tm1.1Mbj)	increased spleen weight	J:200842
Nr2f2^tm2.1Tsa/Nr2f2^tm2.1Tsa Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6 * SJL)	decreased lymphatic vessel endothelial cell number	J:158959
Nr2f2^tm2.1Tsa/Nr2f2^tm2.1Tsa Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6 * SJL)	decreased lymphatic vessel endothelial cell number	J:158959
Nr3c1^tm1.1Jda/Nr3c1^tm1.1Jda Rag2^tm1.1Cgn/Rag2^tm1.1Cgn Tg(Lck-cre)548Jxm/0 Tg(TcrAND)53Hed/0 (B6.Cg-Rag2^tm1.1Cgn Nr3c1^tm1.1Jda Tg(Lck-cre)548Jxm Tg(TcrAND)53Hed)	decreased double-positive T cell number	J:189951
Nr3c1^tm1.1Jda/Nr3c1^tm1.1Jda Tcra^tm1Mom/Tcra^tm1Mom Tg(Lck-cre)548Jxm/0 (B6.Cg-Tcra^tm1Mom Nr3c1^tm1.1Jda Tg(Lck-cre)548Jxm)	decreased double-positive T cell number	J:189951
Nr3c1^tm1.1Jda/Nr3c1^tm1.1Jda Tg(Lck-cre)548Jxm/0 (B6.Cg-Nr3c1^tm1.1Jda Tg(Lck-cre)548Jxm)	decreased CD4-positive, alpha-beta T cell number	J:189951
	decreased CD8-positive, alpha-beta T cell number	J:189951
	decreased double-positive T cell number	J:189951
	decreased single-positive T cell number	J:189951
	thymus hypoplasia	J:189951
Nr3c1^tm1Dage/Nr3c1⁺ (involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)	decreased B cell number	J:147914
Nr3c1^tm1Dage/Nr3c1^tm1Dage (involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)	decreased B cell number	J:147914
	decreased CD4-positive, alpha-beta T cell number	J:147914
	decreased CD8-positive, alpha-beta T cell number	J:147914
	decreased macrophage cell number	J:147914
Nr3c1^tm2.1Ljm/Nr3c1^tm2.1Ljm Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal monocyte cell number	J:197150
Nr4a1^tm1Jmi/Nr4a1^tm1Jmi (involves: 129S2/SvPas * C57BL/6)	decreased Ly6C low monocyte number	J:239509
Nr4a1^tm1Jmi/Nr4a1^tm1Jmi Nr4a3^tm1Omc/Nr4a3^tm1Omc (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal leukopoiesis	J:121903
	abnormal myelopoiesis	J:121903
	abnormal spleen morphology	J:121903
	abnormal thymus morphology	J:121903
	decreased lymphocyte cell number	J:121903
	enlarged lymph nodes	J:121903
	enlarged spleen	J:121903
	increased eosinophil cell number	J:121903
	increased granulocyte number	J:121903
	increased leukocyte cell number	J:121903
	increased neutrophil cell number	J:121903
Nr4a2^tm1.1Pcn/Nr4a2⁺ Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ)	abnormal regulatory T cell morphology	J:205658
Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal regulatory T cell morphology	J:205658
	abnormal T-helper 1 cell differentiation	J:205658
	abnormal T-helper 17 cell differentiation	J:205658
Nr4a2^tm1.1Pcn/Nr4a2^tm1.1Pcn Tg(Lck-cre)1Jtak/0 (Not Specified)	abnormal regulatory T cell morphology	J:205658
	abnormal T-helper 1 cell differentiation	J:205658
	abnormal T-helper 17 cell differentiation	J:205658
	decreased regulatory T cell number	J:205658
	increased CD4-positive, alpha-beta T cell number	J:205658
	increased T-helper 1 cell number	J:205658
Nras^tm1.1Emfu/Nras^tm1.1Emfu (involves: 129S1/Sv * FVB/N)	abnormal granulocyte differentiation	J:189834
	abnormal leukocyte cell number	J:189834
	abnormal thymus morphology	J:189834
	decreased monocyte cell number	J:189834
	decreased spleen weight	J:189834
	increased granulocyte number	J:189834
	increased T cell number	J:189834
Nras^tm1Tyj/Nras^tm1Tyj Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal myelopoiesis	J:174880
	enlarged spleen	J:204263, J:174880
	increased leukocyte cell number	J:204263
	increased monocyte cell number	J:204263
	increased neutrophil cell number	J:204263
	myeloid hyperplasia	J:204263
Nrbp1^{tm3b(EUCOMM)Wtsi}/Nrbp1⁺ (C57BL/6N-Nrbp1^{tm3b(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
Nrp2^tm1.2Mom/Nrp2⁺ Sema3f^tm1.2Ddg/Sema3f⁺ (involves: 129P2/OlaHsd)	abnormal lymphatic vessel endothelial cell morphology	J:226501
Nrp2^tm1.2Mom/Nrp2^tm1.2Mom (involves: 129P2/OlaHsd)	abnormal lymphatic vessel endothelial cell morphology	J:226501
	abnormal lymphatic vessel morphology	J:226501
	lymphatic vessel hyperplasia	J:226501
Nrp2^tm1Ddg/Nrp2^tm1Ddg (involves: C57BL/6)	abnormal lymphangiogenesis	J:156869
Nrsn2^{em1(IMPC)Kmpc}/Nrsn2^{em1(IMPC)Kmpc} (C57BL/6NTac-Nrsn2^{em1(IMPC)Kmpc}/Kmpc)	abnormal lymph node morphology	J:211773
Nrxn1^{tm1b(KOMP)Wtsi}/Nrxn1⁺ (C57BL/6N-Nrxn1^{tm1b(KOMP)Wtsi}/H)	increased neutrophil cell number	J:211773
Nrxn1^{tm1b(KOMP)Wtsi}/Nrxn1^{tm1b(KOMP)Wtsi} (C57BL/6N-Nrxn1^{tm1b(KOMP)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Nsd3^{tm1b(EUCOMM)Hmgu}/Nsd3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nsd3^{tm1b(EUCOMM)Hmgu}/H)	small spleen	J:211773
Nsg1^{tm1.1(KOMP)Vlcg}/Nsg1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Nsg1^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Nsl1^em1(IMPC)J/Nsl1⁺ (C57BL/6NJ-Nsl1^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Nsmce1^{em1(IMPC)Wtsi}/Nsmce1⁺ (C57BL/6N-Nsmce1^{em1(IMPC)Wtsi}/Wtsi)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Nsrp1^tm1.1Cdj/Nsrp1^tm1.1Cdj Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal T cell number	J:306261
	decreased CD4-positive, alpha-beta T cell number	J:306261
	decreased CD8-positive, alpha-beta T cell number	J:306261
	increased memory T cell number	J:306261
Nsun2^{tm1a(EUCOMM)Wtsi}/Nsun2^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Nsun2^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal thymus capsule morphology	J:239583
Nsun5^{tm2b(EUCOMM)Wtsi}/Nsun5^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Nsun5^{tm2b(EUCOMM)Wtsi}/J)	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	increased neutrophil cell number	J:211773
Nt5c3^em1(IMPC)Tcp/Nt5c3^em1(IMPC)Tcp (C57BL/6NCrl-Nt5c3^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Nt5e^em1(IMPC)Mbp/Nt5e^em1(IMPC)Mbp (C57BL/6NCrl-Nt5e^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Ntaq1^{tm1.1(KOMP)Vlcg}/Ntaq1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ntaq1^{tm1.1(KOMP)Vlcg}/J)	increased leukocyte cell number	J:211773
Ntn4^{tm1b(KOMP)Wtsi}/Ntn4^{tm1b(KOMP)Wtsi} (C57BL/6N-Ntn4^{tm1b(KOMP)Wtsi}/Wtsi)	abnormal spleen morphology	J:211773
Ntrk1^{tm1b(EUCOMM)Wtsi}/Ntrk1⁺ (C57BL/6N-Ntrk1^{tm1b(EUCOMM)Wtsi}/H)	increased basophil cell number	J:211773
Ntrk1^tm1Tes/Ntrk1^tm1Tes Tg(Tuba1-cre)1Tes/0 (involves: 129S1/Sv)	increased B-1 B cell number	J:93578
Nub1^{tm1b(EUCOMM)Hmgu}/Nub1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nub1^{tm1b(EUCOMM)Hmgu}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased CD4-negative NK T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased CD5-positive Ly6C-positive T cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased CD11b-high dendritic cell number	J:211773
	decreased Ly6C-positive NK T cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased NK cell number	J:211773
	decreased NK T cell number	J:211773
	enlarged spleen	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased Ly6C-positive NK T cell number	J:211773
Nucb1^em1(IMPC)Mbp/Nucb1^em1(IMPC)Mbp (C57BL/6NCrl-Nucb1^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Nucks1^{tm1b(EUCOMM)Hmgu}/Nucks1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Nucks1^{tm1b(EUCOMM)Hmgu}/Ieg)	enlarged lymph nodes	J:211773
	increased leukocyte cell number	J:211773
Nudcd3^{em1(IMPC)Wtsi}/Nudcd3^{em1(IMPC)Wtsi} (C57BL/6N-Nudcd3^{em1(IMPC)Wtsi}/Wtsi)	abnormal immunoglobulin light chain V-J recombination	J:351330
	abnormal T cell differentiation	J:351330
	abnormal T cell receptor V(D)J recombination	J:351330
	decreased NK T cell number	J:351330
	increased DN3 thymocyte number	J:351330
	increased double-negative T cell number	J:351330
	increased double-positive T cell number	J:351330
	increased memory T cell number	J:351330
	increased pre-B cell number	J:351330
	thymus hypoplasia	J:351330
Nudt1^tm1Tts/Nudt1^tm1Tts Ogg1^tm1Yun/Ogg1^tm1Yun (involves: 129S/SvEv * C57BL/6JJcl)	microgliosis	J:193978
Nudt15^em1Maska/Nudt15⁺ (C57BL/6-Nudt15^em1Maska)	decreased neutrophil cell number	J:285800
Nudt15^em1Maska/Nudt15^em1Maska (C57BL/6-Nudt15^em1Maska)	decreased neutrophil cell number	J:285800
Nuggc^{em1(IMPC)Ccpcz}/Nuggc^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Nuggc^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Nuggc^tm1Diaz/Nuggc^tm1Diaz Edil3^{Tg(Sox2-cre)1Amc}/Edil3⁺ (involves: C57BL/6 * C57BL/6J * CBA)	abnormal somatic hypermutation frequency	J:190402
Nup35^m1Apb/Nup35^m1Apb (involves: C57BL/6N)	abnormal macrophage morphology	J:235141
Nup62cl^em1(IMPC)J/Y (C57BL/6NJ-Nup62cl^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Nup85^tm1.1Yter/Nup85^tm1.1Yter Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6 CBA)	decreased Ly6C high monocyte number	J:292726
	decreased Ly6C low monocyte number	J:292726
	decreased macrophage cell number	J:292726
Nup98^tm1Bmaf/Nup98⁺ (involves: 129S6/SvEvTac * C57BL/6)	decreased B cell number	J:110907
Nup98^tm1Bmaf/Nup98⁺ (involves: 129S6/SvEvTac * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:110907
Nup155^em1(IMPC)Mbp/Nup155⁺ (C57BL/6NCrl-Nup155^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Nup210^enuI476T/Nup210^enuI476T (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal alpha-beta T cell morphology	J:266693
	decreased CD4-positive, alpha-beta T cell number	J:266693
Nup210^enuI476T/Nup210^{tm1a(EUCOMM)Hmgu} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	decreased CD4-positive, alpha-beta T cell number	J:266693
Nup210^tm1.1Mdan/Nup210^tm1.1Mdan (B6.Cg-Nup210^tm1.1Mdan)	abnormal CD4-positive, alpha-beta T cell number	J:282451
	abnormal lymphocyte morphology	J:282451
	decreased CD4-positive, alpha-beta T cell number	J:282451
	decreased leukocyte cell number	J:282451
	increased effector memory T-helper cell number	J:282451
Nup210^{tm1b(EUCOMM)Hmgu}/Nup210^{tm1b(EUCOMM)Hmgu} (involves: C57BL/6N)	decreased alpha-beta T cell number	J:266693
	decreased CD4-positive, alpha-beta T cell number	J:266693
	decreased CD8-positive, alpha-beta T cell number	J:266693
	decreased T cell number	J:266693
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:266693
	increased CD8-positive, alpha-beta T cell number	J:266693
	increased central memory CD8 positive, alpha-beta T cell number	J:266693
	increased T-helper 1 cell number	J:266693
Nus1^tm1Wcsa/Nus1^tm1Wcsa Tg(Cdh5-cre/ERT2)1Rha/0 (Not Specified)	abnormal jugular lymph sac morphology	J:230506
Nwd2^{em1(IMPC)Ccpcz}/Nwd2^{em1(IMPC)Ccpcz} (C57BL/6N-Nwd2^{em1(IMPC)Ccpcz}/Ccpcz)	decreased CD8-positive, naive alpha-beta T cell number	J:211773
Nxn^{tm1b(EUCOMM)Wtsi}/Nxn⁺ (C57BL/6N-Nxn^{tm1b(EUCOMM)Wtsi}/Ccpcz)	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
Nxnl1^tm1.2Tlev/Nxnl1^tm1.2Tlev (involves: BALB/c * BALB/cJ * C57BL/6)	microgliosis	J:186370
Nxnl2^{em1(IMPC)Ccpcz}/Nxnl2⁺ (C57BL/6NCrl-Nxnl2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Nxnl2^{em1(IMPC)Ccpcz}/Nxnl2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Nxnl2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Oas1c^{em1(IMPC)Ccpcz}/Oas1c^{em1(IMPC)Ccpcz} (C57BL/6N-Oas1c^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Obp2b^{em1(IMPC)Kmpc}/Obp2b^{em1(IMPC)Kmpc} (C57BL/6NTac-Obp2b^{em1(IMPC)Kmpc}/Kmpc)	abnormal lymph node morphology	J:211773
Oca2^p-23DFiOD/Oca2^p-x (Not Specified)	increased spleen weight	J:66645
Oca2^p-30PUb/Oca2^p-x (Not Specified)	increased spleen weight	J:89922
Ociad1^em1(IMPC)J/Ociad1^em1(IMPC)J (C57BL/6NJ-Ociad1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ociad1^tm1.1Msin/Ociad1^tm1.1Msin (involves: BALB/cJ * C57BL/6NCrlj * CBA/JNCrlj)	decreased B cell number	J:279239
	decreased T cell number	J:279239
	enlarged spleen	J:279239
	increased granulocyte number	J:279239
	increased macrophage cell number	J:279239
	increased monocyte cell number	J:279239
	increased neutrophil cell number	J:279239
	increased spleen germinal center size	J:279239
Ocstamp^{tm2a(KOMP)Wtsi}/Ocstamp^{tm2a(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	abnormal osteoclast morphology	J:233553
Odad2^b2b227.1Clo/Odad2^b2b227.1Clo (C57BL/6J-Odad2^b2b227.1Clo)	spleen hypoplasia	J:175213
Odad2^em1(IMPC)Mbp/Odad2^em1(IMPC)Mbp (C57BL/6N-Odad2^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Odad3^b2b1885Clo/Odad3^b2b1885Clo (C57BL/6J-Odad3^b2b1885Clo)	spleen hypoplasia	J:175213
Odad3^{tm1b(EUCOMM)Hmgu}/Odad3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Odad3^{tm1b(EUCOMM)Hmgu}/Cnrm)	abnormal spleen morphology	J:278798
	absent spleen	J:278798
	enlarged spleen	J:278798
Odaph^{em1(IMPC)Ccpcz}/Odaph^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Odaph^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
oed/oed (STOCK pc-oed)	increased granulocyte number	J:5609
oed/oed (STOCK pc-oed)	increased leukocyte cell number	J:5609
Ogg1^tm1Yun/Ogg1^tm1Yun (involves: 129S/SvEv * C57BL/6JJcl)	microgliosis	J:193978
Ogn^{tm1b(KOMP)Wtsi}/Ogn^{tm1b(KOMP)Wtsi} (C57BL/6N-Ogn^{tm1b(KOMP)Wtsi}/J)	decreased leukocyte cell number	J:211773
Ogt^tm1Gwh/Y Tg(Lck-cre)548Jxm/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	decreased CD4-positive, alpha-beta T cell number	J:93112
	decreased CD8-positive, alpha-beta T cell number	J:93112
	decreased double-positive T cell number	J:93112
	decreased T cell number	J:93112
	decreased thymocyte number	J:93112
oh/oh (Not Specified)	increased macrophage cell number	J:5300
Olah^em1Kedk/Olah^em1Kedk (involves: C57BL/6)	abnormal macrophage morphology	J:353571
Olah^em1Kedk/Olah^em1Kedk (involves: C57BL/6)	spleen hyperplasia	J:353571
Opn3^em1(IMPC)Mbp/Opn3^em1(IMPC)Mbp (C57BL/6NCrl-Opn3^em1(IMPC)Mbp/Mmucd)	decreased leukocyte cell number	J:211773
	increased basophil cell number	J:211773
Oprl1^em1(IMPC)Mbp/Oprl1^em1(IMPC)Mbp (C57BL/6N-Oprl1^em1(IMPC)Mbp/MbpMmucd)	enlarged spleen	J:211773
Or1e1c^em1(IMPC)Mbp/Or1e1c^em1(IMPC)Mbp (C57BL/6NCrl-Or1e1c^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Or1e32^em1(IMPC)Mbp/Or1e32^em1(IMPC)Mbp (C57BL/6NCrl-Or1e32^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Or9g4^em1(IMPC)Mbp/Or9g4^em1(IMPC)Mbp (C57BL/6N-Or9g4^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Orai1^tm1.1Hjm/Orai1^tm1.1Hjm Orai2^{tm1.1(KOMP)Vlcg}/Orai2^{tm1.1(KOMP)Vlcg} Tg(Cd4-cre)1Cwi/0 (B6.Cg-Tg(Cd4-cre)1Cwi Orai1^tm1.1Hjm Orai2^{tm1.1(KOMP)Vlcg})	abnormal CD4-positive helper T cell morphology	J:241365
	decreased germinal center B cell number	J:241365
	decreased regulatory T cell number	J:241365
	decreased single-positive T cell number	J:241365
	lymph node hyperplasia	J:241365
	spleen hyperplasia	J:241365
Orgwq1^M16i/? (involves: CAST/Ei * M16i)	increased spleen weight	J:78471
Orgwq2^M16i/? (involves: CAST/Ei * M16i)	increased spleen weight	J:78471
Orgwq6^M16i/? (involves: CAST/Ei * M16i)	increased spleen weight	J:78471
Orgwq7^M16i/? (involves: CAST/Ei * M16i)	increased spleen weight	J:78471
Orgwq8^M16i/? (involves: CAST/Ei * M16i)	increased spleen weight	J:78471
Ormdl3^em1Quli/Ormdl3^em1Quli (Not Specified)	abnormal spleen morphology	J:251260
	abnormal splenic cell ratio	J:251260
	small spleen	J:251260
Osbp^em1(IMPC)Tcp/Osbp⁺ (C57BL/6NCrl-Osbp^em1(IMPC)Tcp/Cmmr)	enlarged lymph nodes	J:211773
Oscar^tm1Ywc/Oscar^tm1Ywc (involves: 129P2/OlaHsd)	abnormal osteoclast differentiation	J:178250
Oscar^tm1Ywc/Oscar^tm1Ywc Tyrobp^tm1Ttk/Tyrobp^tm1Ttk (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:178250
	abnormal osteoclast morphology	J:178250
	decreased osteoclast cell number	J:178250
Otc^em1(IMPC)Tcp/Otc⁺ (C57BL/6NCrl-Otc^em1(IMPC)Tcp/Tcp)	enlarged thymus	J:211773
Otop1^{em1(IMPC)Ccpcz}/Otop1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Otop1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Otub1^{tm1c(EUCOMM)Hmgu}/Otub1^{tm1c(EUCOMM)Hmgu} Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	abnormal follicular B cell morphology	J:280549
	decreased B-1 B cell number	J:280549
	decreased immature B cell number	J:280549
	decreased T cell number	J:280549
	enlarged spleen	J:280549
	increased B cell number	J:280549
	increased B-2 B cell number	J:280549
	increased marginal zone B cell number	J:280549
	increased mature B cell number	J:280549
Otud5^tm1Vmd/Otud5^tm1Vmd Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal T-helper 17 cell differentiation	J:219495
	decreased regulatory T cell number	J:219495
	decreased thymocyte number	J:219495
Otud5^tm1Vmd/Otud5^tm1Vmd Tg(Vav1-cre)#Cgp/0 (involves: C57BL/6)	abnormal T-helper 17 cell differentiation	J:219495
Otud6a^{tm1(KOMP)Vlcg}/Otud6a^{tm1(KOMP)Vlcg} (C57BL/6N-Otud6a^{tm1(KOMP)Vlcg}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Otud6b^{tm1b(EUCOMM)Wtsi}/Otud6b⁺ (C57BL/6N-Otud6b^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased basophil cell number	J:211773
Otud7b^tm1Dgen/Otud7b^tm1Dgen (involves: 129 * C57BL/6)	increased B cell number	J:194553
Otud7b^tm1Dgen/Otud7b^tm1Dgen (involves: 129 * C57BL/6)	lymphoid hyperplasia	J:194553
Otulin^em1(IMPC)Bay/Otulin⁺ (C57BL/6N-Otulin^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Oxsr1^tm1.1Arte/Oxsr1⁺ (involves: 129S/SvEvBrd)	abnormal dendritic cell morphology	J:191351
P2rx5^tm1Lex/P2rx5^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased CD8-positive, alpha-beta T cell number	J:82809
	increased NK cell number	J:82809
P2rx7^tm1Gab/P2rx7^tm1Gab (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))	increased osteoclast cell number	J:84145
P2ry6^tm1Jabo/P2ry6^tm1Jabo Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: 129 * C57BL/6 * C57BL/6NTac)	increased eosinophil cell number	J:179177
	increased neutrophil cell number	J:179177
P2ry6^tm1Jabo/P2ry6^tm1Jabo Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (B6.Cg-Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte} P2ry6^tm1Jabo)	increased eosinophil cell number	J:179177
	increased neutrophil cell number	J:179177
P2ry14^tm1.1Shbg/P2ry14^tm1.1Shbg (involves: 129S6/SvEvTac * C57BL/6)	increased spleen weight	J:223427
P4hb^tm1.1Geno/P4hb^tm1.2Geno Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd)	decreased neutrophil cell number	J:197556
p23-ST1/p23-ST1 (C57BL/6J-p23-ST1)	microgliosis	J:158278
Pabir2^{em1(IMPC)Ccpcz}/Y (C57BL/6NCrl-Pabir2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Pabir2^{em1(IMPC)Ccpcz}/Pabir2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Pabir2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Padi4^em1(IMPC)Mbp/Padi4^em1(IMPC)Mbp (C57BL/6N-Padi4^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Pag1^tm1Kplm/Pag1^tm1Kplm (involves: 129P2/OlaHsd * C57BL/6)	increased thymocyte number	J:101365
Pah^em1(IMPC)Tcp/Pah⁺ (C57BL/6NCrl-Pah^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Paip1^em1(IMPC)Tcp/Paip1^em1(IMPC)Tcp (C57BL/6NCrl-Paip1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Pak5^em1(IMPC)Mbp/Pak5^em1(IMPC)Mbp (C57BL/6N-Pak5^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Palm^tm1.2Kili/Palm^tm1.2Kili Tg(Ins2-VEGFC)#Pepr/0 (involves: C57BL/6N)	abnormal lymphangiogenesis	J:237034
Palm^tm1.2Kili/Palm^tm1.2Kili Tg(RIP1-Tag)2Dh/0 Tg(Ins2-VEGFC)#Pepr/0 (involves: C57BL/6J * C57BL/6N * DBA/2J)	abnormal lymphangiogenesis	J:237034
Pals1^tm1Caw/Pals1^tm1Caw Tg(rx3-icre)1Mjam/0 (Not Specified)	microgliosis	J:184469
Pals2^{em1(IMPC)Rbrc}/Pals2^{em1(IMPC)Rbrc} (C57BL/6NJcl-Pals2^{em1(IMPC)Rbrc}/Rbrc)	abnormal spleen morphology	J:211773
Pan2^{tm1b(KOMP)Wtsi}/Pan2^{tm1b(KOMP)Wtsi} (C57BL/6N-Pan2^{tm1b(KOMP)Wtsi}/Mhzh)	increased eosinophil cell number	J:211773
Pan3^em1(IMPC)Tcp/Pan3⁺ (C57BL/6N-Pan3^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Pank1^tm1.1Suja/Pank1^tm1.1Suja Pank2^tm1.1Suja/Pank2^tm1.1Suja (involves: 129S/SvEv * C57BL/6J * FVB/N)	decreased spleen weight	J:189609
	small spleen	J:189609
Pank2^{em1(IMPC)Ccpcz}/Pank2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Pank2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
Pank3^{tm1b(KOMP)Mbp}/Pank3^{tm1b(KOMP)Mbp} (C57BL/6N-Pank3^{tm1b(KOMP)Mbp}/Bay)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Panx2^{tm1b(KOMP)Wtsi}/Panx2^{tm1b(KOMP)Wtsi} (C57BL/6N-Panx2^{tm1b(KOMP)Wtsi}/Ucd)	increased spleen weight	J:211773
Pappa2^tm1Lex/Pappa2^tm1Lex (C57BL/6-Pappa2^tm1Lex)	increased spleen weight	J:174887
Pard3^{tm1b(KOMP)Wtsi}/Pard3⁺ (C57BL/6N-Pard3^{tm1b(KOMP)Wtsi}/H)	decreased basophil cell number	J:211773
Parg^{tm2b(KOMP)Mbp}/Parg⁺ (C57BL/6N-Parg^{tm2b(KOMP)Mbp}/J)	decreased leukocyte cell number	J:211773
Parl^tm1.1Bdes/Parl^tm1.1Bdes (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell morphology	J:116017
	decreased B cell number	J:116017
	decreased double-positive T cell number	J:116017
	decreased lymphocyte cell number	J:116017
	spleen atrophy	J:116017
	thymus atrophy	J:116017
Parl^tm1.1Bdes/Parl^tm1.1Bdes (involves: 129P2/OlaHsd)	microgliosis	J:269785
	spleen atrophy	J:269785
	thymus atrophy	J:269785
Parl^tm1Bdes/Parl^tm1Bdes Tg(Nes-cre)1Kln/0 (involves: 129P2/OlaHsd * C57BL/6 * SJL)	spleen atrophy	J:269785
	thymus atrophy	J:269785
Parp1^{em1(IMPC)Ccpcz}/Parp1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Parp1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Parp1^{tm1b(EUCOMM)Hmgu}/Parp1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Parp1^{tm1b(EUCOMM)Hmgu}/Ics)	decreased NK cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
Parp12^{tm1.1(KOMP)Vlcg}/Parp12^{tm1.1(KOMP)Vlcg} (C57BL/6N-Parp12^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Parp14^{Gt(OST415485)Lex}/Parp14^{Gt(OST415485)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	decreased marginal zone B cell number	J:146533
	increased follicular B cell number	J:146533
Parva^{em1(IMPC)Ccpcz}/Parva⁺ (C57BL/6NCrl-Parva^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Parvb^{tm1a(EUCOMM)Wtsi}/Parvb^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Parvb^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased mature B cell number	J:165965
	decreased NK cell number	J:165965
	decreased T cell number	J:165965
Patz1^tm1.1Welm/Patz1^tm1.1Welm (involves: 129P2/OlaHsd)	abnormal T cell subpopulation ratio	J:158947
	decreased splenocyte number	J:158947
	decreased thymocyte number	J:158947
Patz1^tm1.1Welm/Patz1^tm1.1Welm Tg(TcraTcrb)425Cbn/0 (involves: C57BL/6)	abnormal T cell subpopulation ratio	J:158947
	decreased CD8-positive, alpha-beta T cell number	J:158947
	increased CD4-positive, alpha-beta T cell number	J:158947
Patz1^tm1.1Welm/Patz1^tm1.1Welm Tg(TcraTcrb)1100Mjb/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell subpopulation ratio	J:158947
	decreased CD8-positive, alpha-beta T cell number	J:158947
	increased CD4-positive, alpha-beta T cell number	J:158947
Patz1^tm1.2Welm/Patz1^tm1.2Welm Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Patz1^tm1.2Welm Commd10^{Tg(Vav1-icre)A2Kio})	abnormal mast cell differentiation	J:209168
Pawr^tm1Jmos/Pawr^tm1Jmos (involves: 129/Sv * CD-1)	enlarged spleen	J:85495
	increased lymphocyte cell number	J:85495
	spleen hyperplasia	J:85495
Pax1^un-i/Pax1⁺ (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	decreased CD4-positive, alpha-beta T cell number	J:100951
	decreased CD8-positive, alpha-beta T cell number	J:100951
	decreased thymocyte number	J:100951
Pax1^un-i/Pax1^un-i (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))	decreased CD4-positive, alpha-beta T cell number	J:100951
	decreased CD8-positive, alpha-beta T cell number	J:100951
	decreased double-negative T cell number	J:100951
	decreased double-positive T cell number	J:100951
	decreased thymocyte number	J:100951
	increased double-negative T cell number	J:100951
Pax1^un/Pax1⁺ Tcf3^tm1Cmu/Tcf3^tm1Cmu (involves: 129P2/OlaHsd * C3H * C57BL/6)	abnormal T cell differentiation	J:103567
	abnormal T cell subpopulation ratio	J:103567
Pax3^Sp-1H/Pax3^Sp-1H (involves: 101/H * C3H/HeH * C57BL/6)	abnormal thymus morphology	J:88412
Pax3^{tm1(FOXO1A)Gcg}/Pax3⁺ (either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * NMRI))	abnormal thymus lobule morphology	J:79365
	ectopic thymus	J:79365
Pax5^m1Btlr/Pax5^m1Btlr (C57BL/6J-Pax5^m1Btlr)	decreased B cell number	J:220072
	increased macrophage cell number	J:220072
	increased monocyte cell number	J:220072
	increased single-positive T cell number	J:220072
	increased T cell number	J:220072
Pax5^m2Btlr/Pax5⁺ (C57BL/6J-Pax5^m2Btlr)	decreased B-1b cell number	J:254824
Pax5^m2Btlr/Pax5^m2Btlr (C57BL/6J-Pax5^m2Btlr)	decreased B-1b cell number	J:254824
Pax5^m2Btlr/Pax5^m2Btlr (C57BL/6J-Pax5^m2Btlr)	increased B-1 B cell number	J:254824
Pax5^m3Btlr/Pax5⁺ (C57BL/6J-Pax5^m3Btlr)	decreased B cell number	J:254825
Pax5^m3Btlr/Pax5^m3Btlr (C57BL/6J-Pax5^m3Btlr)	decreased B cell number	J:254825
	decreased B-1 B cell number	J:254825
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254825
	increased CD8-positive, alpha-beta memory T cell number	J:254825
Pax5^{tm1b(EUCOMM)Wtsi}/Pax5⁺ (C57BL/6N-Pax5^{tm1b(EUCOMM)Wtsi}/Ieg)	decreased leukocyte cell number	J:211773
	increased CD4-positive NK T cell number	J:211773
	increased memory-marker CD4-positive NK T cell number	J:211773
Pax5^tm1Mbu/Pax5^tm1Mbu (involves: 129S2/SvPas * C57BL/6)	abnormal B cell differentiation	J:38813
	abnormal lymphopoiesis	J:38813
	absent B-2 B cells	J:113076
	absent mature B cells	J:113076
	arrested B cell differentiation	J:113076
	decreased B cell number	J:113076
	decreased B-1 B cell number	J:113076
	decreased immature B cell number	J:113076
	increased T cell number	J:113076
Pax5^tm1Mbu/Pax5^tm1Mbu (involves: 129S2/SvPas)	abnormal immunoglobulin heavy chain V(D)J recombination	J:139510
Pax5^tm1Mbu/Pax5^tm1Mbu (involves: 129S2/SvPas)	arrested B cell differentiation	J:75504
Pax5^tm1Mbu/Pax5^tm1Mbu (either: 129 or (involves: 129S2/SvPas * C57BL/6J))	abnormal late pro-B cell	J:21935
	abnormal lymphopoiesis	J:21935
	absent late pro-B cells	J:21935
	arrested B cell differentiation	J:21935
Pax5^tm1Mbu/Pax5^tm3Mbu Tg(Mx1-cre)1Cgn/? (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)	decreased mature B cell number	J:75504
Pax5^tm3.1Mbu/Pax5^tm3.1Mbu (involves: 129P2/OlaHsd * C57BL/6)	arrested B cell differentiation	J:75504
Pax5^tm3Mbu/Pax5⁺ Tcf3^tm1(PBX1)Mlc/Tcf3⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal pro-B cell morphology	J:226241
	arrested B cell differentiation	J:226241
	decreased immature B cell number	J:226241
Pax9^tm1.1Hpt/Pax9^tm1.1Hpt Tg(Pgk1-cre)1Lni/? (involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)	abnormal thymus lobule morphology	J:125026
Pax9^tm1Rbal/Pax9^tm1Rbal (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	athymia	J:49857
Pax9^tm1Rbal/Pax9^tm1Rbal (involves: 129S1/Sv * 129X1/SvJ * CD-1)	ectopic thymus	J:311535
	thymus hypoplasia	J:311535
Paxx^em1(IMPC)Mbp/Paxx^em1(IMPC)Mbp (C57BL/6NCrl-Paxx^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Paxx^em1Spj/Paxx^em1Spj (C57BL/6NTac-Paxx^em1Spj)	decreased B cell number	J:236776
	decreased CD4-positive, alpha-beta T cell number	J:236776
	decreased CD8-positive, alpha-beta T cell number	J:236776
	decreased follicular B cell number	J:236776
	decreased splenocyte number	J:236776
	decreased T cell number	J:236776
	decreased transitional stage B cell number	J:236776
	increased mature B cell number	J:236776
Paxx^em1Spj/Paxx^em1Spj Nhej1^tm1Fwa/Nhej1^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6NTac)	absent lymphocyte	J:236776
	athymia	J:236776
	decreased spleen weight	J:236776
	decreased splenocyte number	J:236776
	small spleen	J:236776
Pbbcp1^C57BL/6J/? (involves: C57BL/6J * DBA/2J)	increased B cell number	J:74270
Pbrm1^tm1Zhwa/Pbrm1^tm1Zhwa Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal T-helper 2 cell differentiation	J:236906
Pbwg1.9^{M. m. castaneus}/? (involves: C57BL/6J * M. m. castaneus)	increased spleen weight	J:121981
Pbx1^em1Dunw/Pbx1^em1Dunw (C57BL/6J-Pbx1^em1Dunw)	ectopic thymus	J:320934
	spleen hypoplasia	J:320934
	thymus hypoplasia	J:320934
Pbx1^tm1.1Koss/Pbx1^tm1.1Koss Tg(WT1-cre)AG11Dbdr/0 (involves: 129P2/OlaHsd * C57BL/6)	spleen hypoplasia	J:184521
Pbx1^tm1.1Koss/Pbx1^tm1.2Koss Tmem163^{Tg(ACTB-cre)2Mrt}/0 (involves: 129P2/OlaHsd * FVB/N)	absent spleen	J:184521
Pbx1^tm1Koss/Pbx1^tm1Koss Nkx2-5^tm2(cre)Rph/Nkx2-5⁺ (involves: 129P2/OlaHsd * 129S1/Sv)	abnormal spleen mesenchyme morphology	J:184521
	abnormal spleen morphology	J:184521
	spleen hypoplasia	J:184521
Pbx1^tm1Koss/Pbx1^tm1Koss Pbx2^tm1Mlc/Pbx2⁺ Nkx2-5^tm2(cre)Rph/Nkx2-5⁺ (involves: 129P2/OlaHsd * 129S/Sv * 129S1/Sv)	abnormal spleen morphology	J:184521
	spleen hypoplasia	J:184521
Pbx1^tm1Mlc/Pbx1^tm1Mlc (involves: 129S6/SvEvTac * C57BL/6)	absent spleen	J:71996, J:70684
Pbx1^tm1Mlc/Pbx1^tm1Mlc (involves: 129S6/SvEvTac * C57BL/6)	ectopic thymus	J:71996
Pbx1^tm1Mlc/Pbx1^tm2.1Mlc (involves: 129S6/SvEvTac)	abnormal lymph node primary follicle morphology	J:132963
	decreased CD4-positive, alpha-beta T cell number	J:132963
	decreased CD8-positive, alpha-beta T cell number	J:132963
	decreased mature B cell number	J:132963
Pbx1^tm1Mlc/Pbx1^tm3.1Mlc Tg(Tek-cre)1Ywa/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal spleen morphology	J:149799
	abnormal thymus morphology	J:149799
	decreased B cell number	J:149799
	decreased double-negative T cell number	J:149799
	decreased pre-B cell number	J:149799
	decreased pro-B cell number	J:149799
	decreased T cell number	J:149799
	small spleen	J:149799
	small thymus	J:149799
	spleen hypoplasia	J:149799
	thymus hypoplasia	J:149799
Pbx4^em2Hncs/Pbx4^em2Hncs (involves: C57BL/6J * DBA * ICR)	decreased lymphocyte cell number	J:349843
Pbx4^em2Hncs/Pbx4^em2Hncs (involves: C57BL/6J * DBA * ICR)	increased neutrophil cell number	J:349843
Pcd4ts1^DBA/2/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Pcd4ts2^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Pcd4ts3^BALB/c/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:83220
Pcd8ts1^C57BL/6/? (involves: BALB/c * C3H * C57BL/6 * DBA/2)	increased CD8-positive, alpha-beta T cell number	J:83220
Pcdh7^em1Ywc/Pcdh7^em1Ywc (Not Specified)	decreased osteoclast cell number	J:298915
Pcdha2^em1(IMPC)Tcp/Pcdha2^em1(IMPC)Tcp (C57BL/6N-Pcdha2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Pcdhb13^em1(IMPC)Tcp/Pcdhb13^em1(IMPC)Tcp (C57BL/6N-Pcdhb13^em1(IMPC)Tcp/Tcp)	decreased basophil cell number	J:211773
	enlarged lymph nodes	J:211773
Pcdhg^em5Rwb/Pcdhg^em5Rwb (C57BL/6J-Pcdhg^em5Rwb/Rwb)	microgliosis	J:285314
Pcdhg^em41Rwb/Pcdhg^em41Rwb (C57BL/6J-Pcdhg^em41Rwb/Rwb)	microgliosis	J:285314
Pcdhg^tm1.1Tman/Pcdhg^tm1.1Tman (involves: 129S4/SvJae * C57BL/6)	microgliosis	J:188341
Pcgf2^{tm1b(KOMP)Mbp}/Pcgf2⁺ (C57BL/6N-Pcgf2^{tm1b(KOMP)Mbp}/Tcp)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Pcgf2^tm1Hko/Pcgf2^tm1Hko (involves: BALB/c * C57BL/6)	decreased lymphocyte cell number	J:71268
Pcgf2^tm1Hko/Pcgf2^tm1Hko (involves: BALB/c * C57BL/6)	decreased thymocyte number	J:71268
Pcgf3^{TgTn(sb-cHS4,Tyr)2349AOve}/Pcgf3^{TgTn(sb-cHS4,Tyr)2349AOve} (FVB/N-Pcgf3^{TgTn(sb-cHS4,Tyr)2349AOve})	absent spleen	J:175597
Pcid2^tm1Imku/Pcid2^tm1Imku Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal spleen B cell follicle morphology	J:166080
	decreased follicular B cell number	J:166080
	decreased marginal zone B cell number	J:166080
	decreased mature B cell number	J:166080
Pck2^em1(IMPC)Tcp/Pck2^em1(IMPC)Tcp (C57BL/6N-Pck2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Pclaf^tm1.1Lkd/Pclaf^tm1.1Lkd (involves: C57BL/6)	decreased leukocyte cell number	J:177782
	spleen hypoplasia	J:177782
	thymus hypoplasia	J:177782
Pclaf^{tm1a(EUCOMM)Wtsi}/Pclaf^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pclaf^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased CD11b-high dendritic cell number	J:211773
	decreased dendritic cell number	J:211773
	decreased immature NK cell number	J:211773
	decreased plasmacytoid dendritic cell number	J:211773
	decreased regulatory T cell number	J:211773
	decreased T cell number	J:211773
	increased CD11b-low dendritic cell number	J:211773
	increased dendritic cell number	J:211773
	increased mature NK cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased pro-B cell number	J:211773
Pcm1^em1(IMPC)Tcp/Pcm1^em1(IMPC)Tcp (C57BL/6NCrl-Pcm1^em1(IMPC)Tcp/Tcp)	decreased spleen weight	J:211773
	small spleen	J:211773
Pcmt1^tm1Shs/Pcmt1^tm1Shs (involves: 129P2/OlaHsd * C57BL/6)	small spleen	J:46228
Pcna^tm1.1Mdsc/Pcna^tm1.1Mdsc Tg(Pcna*K164R)1Mdsc/0 (involves: FVB/N)	abnormal class switch recombination	J:141098
	abnormal somatic hypermutation frequency	J:141098
Pcna^tm1Jcbs/Pcna^tm1Jcbs (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:125916
Pcna^tm1Jcbs/Pcna^tm1Jcbs (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:155454, J:177630
Pcna^tm1Jcbs/Pcna^tm1Jcbs Ung^tm1Tld/Ung^tm1Tld (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:155454
Pcsk1^tm1Dfs/Pcsk1^tm1Dfs (involves: 129 * C57BL/6J)	abnormal peritoneal macrophage morphology	J:184882
	abnormal spleen marginal zone morphology	J:184882
	abnormal spleen white pulp morphology	J:184882
	abnormal T-helper 1 cell differentiation	J:184882
	decreased follicular dendritic cell number	J:184882
	decreased NK T cell number	J:184882
	decreased T cell number	J:184882
	enlarged spleen	J:184882
	increased lymphocyte cell number	J:184882
	intermingled spleen red and white pulp	J:184882
Pcsk5^vcc/Pcsk5^vcc (involves: C57BL/6J)	abnormal thymus lobule morphology	J:136243
Pcsk5^vcc/Pcsk5^vcc (involves: C57BL/6J)	small thymus	J:136243
Pdap1^em1Rkuhn/Pdap1^em1Rkuhn Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	abnormal class switch recombination	J:298705
	abnormal somatic hypermutation frequency	J:298705
	decreased germinal center B cell number	J:298705
	decreased mature B cell number	J:298705
Pdcd1^tm1.1Liux/Pdcd1^tm1.1Liux (involves: C57BL/6)	decreased regulatory T cell number	J:190150
Pdcd1^tm1.1Liux/Pdcd1^tm1.1Liux (involves: C57BL/6)	increased T-helper 1 cell number	J:190150
Pdcd1^tm1.1Liux/Pdcd1^tm1.1Liux Tg(MMTV-PyVT)634Mul/0 (involves: C57BL/6 * FVB/N)	decreased regulatory T cell number	J:190150
	decreased T-helper 2 cell number	J:190150
	decreased T-helper 17 cell number	J:190150
	increased T-helper 1 cell number	J:190150
Pdcd1^tm1.1Shr/Pdcd1^tm1.1Shr (involves: C57BL/6)	decreased B-1 B cell number	J:153040
Pdcd1^tm1.1Shr/Pdcd1^tm1.1Shr (involves: C57BL/6)	increased regulatory T cell number	J:153040
Pdcd1^tm1Hon/Pdcd1^tm1Hon (involves: 129S2/SvPas * C57BL/6)	abnormal leukopoiesis	J:50688
	abnormal myelopoiesis	J:50688
	enlarged spleen	J:50688
	increased B cell number	J:50688
	increased B-1 B cell number	J:50688
	increased lymphocyte cell number	J:50688
Pdcd1^tm1Llc/Pdcd1^tm1Llc (involves: 129S5/SvEvBrd)	decreased CD8-positive, alpha-beta T cell number	J:126829
Pdcd1lg2^tm1.1Lex/Pdcd1lg2^tm1.1Lex (involves: 129S5/SvEvBrd)	decreased CD8-positive, alpha-beta T cell number	J:126829
Pdcd1lg2^tm3Shr/Pdcd1lg2^tm3Shr (involves: C57BL/6 * NOD/MrkTac)	increased CD4-positive, alpha-beta T cell number	J:123785
	increased CD8-positive, alpha-beta T cell number	J:123785
	lymph node hyperplasia	J:123785
Pdcd6ip^{em1(IMPC)Hmgu}/Pdcd6ip^{em1(IMPC)Hmgu} (C57BL/6N-Pdcd6ip^{em1(IMPC)Hmgu}/Ieg)	enlarged lymph nodes	J:211773
Pdcd6ip^em1(IMPC)Mbp/Pdcd6ip^em1(IMPC)Mbp (C57BL/6NCrl-Pdcd6ip^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Pde2a^em1(IMPC)H/Pde2a⁺ (C57BL/6NTac-Pde2a^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Pdgfb^tm1Cbet/Pdgfb^tm2Cbet Tg(Tie1-cre)9Ref/0 (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal microglial cell morphology	J:89186
Pdgfc^{tm1b(EUCOMM)Hmgu}/Pdgfc⁺ (C57BL/6N-Pdgfc^{tm1b(EUCOMM)Hmgu}/Ieg)	enlarged spleen	J:211773
	increased CD4-negative, CD25-positive NK T cell number	J:211773
	increased granulocyte number	J:211773
	increased monocyte cell number	J:211773
Pdgfra^tm8Sor/Pdgfra^tm8Sor H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (Not Specified)	small thymus	J:81153
Pdgfra^tm8Sor/Pdgfra^tm8Sor Pdgfrb^tm1Mdt/Pdgfrb^tm1Mdt H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: C57BL/6 * CBA)	abnormal thymus development	J:122584
	thymus hypoplasia	J:122584
Pdgfra^tm12.1Sor/Pdgfra⁺ (involves: 129 * C57BL/6)	abnormal immune system organ morphology	J:146617
Pdgfrb^b2b2903Clo/Pdgfrb^b2b2903Clo (C57BL/6J-Pdgfrb^b2b2903Clo)	thymus hypoplasia	J:175213
Pdha2^em1(IMPC)Bay/Pdha2^em1(IMPC)Bay (C57BL/6N-Pdha2^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Pdia6^em1Btlr/Pdia6^m1Btlr (involves: C57BL/6J)	decreased B cell number	J:288824
	decreased double-negative T cell number	J:288824
	decreased double-positive T cell number	J:288824
	decreased follicular B cell number	J:288824
	decreased leukocyte cell number	J:288824
	decreased lymphocyte cell number	J:288824
	decreased monocyte cell number	J:288824
	decreased NK T cell number	J:288824
	decreased pre-B cell number	J:288824
	decreased transitional stage B cell number	J:288824
	increased marginal zone B cell number	J:288824
	increased marginal zone precursor B cell number	J:288824
	increased mature B cell number	J:288824
	spleen hypoplasia	J:288824
	thymus hypoplasia	J:288824
Pdia6^{tm1b(EUCOMM)Hmgu}/Pdia6⁺ (C57BL/6N-Pdia6^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased CD4-positive NK T cell number	J:211773
	enlarged lymph nodes	J:211773
Pdik1l^em1(IMPC)Mbp/Pdik1l^em1(IMPC)Mbp (C57BL/6NCrl-Pdik1l^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Pdk2^em1(IMPC)Mbp/Pdk2^em1(IMPC)Mbp (C57BL/6N-Pdk2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Pdk4^tm1Tok/Pdk4^tm1Tok (B6.129P2-Pdk4^tm1Tok)	abnormal osteoclast cell number	J:179789
	abnormal osteoclast differentiation	J:179789
	abnormal osteoclast morphology	J:179789
Pdlim7^em1(IMPC)Mbp/Pdlim7^em1(IMPC)Mbp (C57BL/6N-Pdlim7^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Pdlim7^{Gt(OST445990)Lex}/Pdlim7^{Gt(OST445990)Lex} (B6.129S5-Pdlim7^{Gt(OST445990)Lex})	increased lymphocyte cell number	J:209780
	increased monocyte cell number	J:209780
Pdpk1^tm1.1Mlw/Pdpk1^tm1.1Mlw Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor⁺ (involves: 129X1/SvJ * C57BL/6)	abnormal regulatory T cell number	J:226194
	enlarged lymph nodes	J:226194
	enlarged spleen	J:226194
Pdpk1^tm1Dral/Pdpk1^tm1Dral (B6.129P2-Pdpk1^tm1Dral)	small spleen	J:136089
Pdpk1^tm1Mlw/Pdpk1^tm1.1Daca Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * BALB/c * C57BL/6 * DBA/2)	abnormal CD8-positive, alpha beta T cell morphology	J:165626
	decreased NK T cell number	J:165626
	decreased T cell number	J:165626
Pdpk1^tm1Mlw/Pdpk1^tm1Mlw Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal CD8-positive, alpha beta T cell morphology	J:165626
	abnormal NK T cell morphology	J:165626
	abnormal T cell differentiation	J:165626
	absent NK T cells	J:165626
	decreased NK T cell number	J:165626
	decreased T cell number	J:165626
Pdpn^tm1(cre)Mlkn/Pdpn^tm1(cre)Mlkn (involves: 129S4/SvJae * C57BL/6)	abnormal lymphatic vessel morphology	J:162815
Pdpn^tm1Mcws/Pdpn⁺ (involves: 129S6/SvEvTac)	abnormal lymphatic vessel morphology	J:94978
Pdpn^tm1Mcws/Pdpn⁺ (involves: 129S6/SvEvTac)	lymphangiectasis	J:94978
Pdpn^tm1Mcws/Pdpn^tm1Mcws (involves: 129S6/SvEvTac)	abnormal lymphatic vessel morphology	J:94978
Pdpn^tm1Mcws/Pdpn^tm1Mcws (involves: 129S6/SvEvTac)	lymphangiectasis	J:94978
Pdpn^tm2.1Mlkn/Pdpn^tm2.1Mlkn Rag1^tm1Mom/Rag1^tm1Mom Tg(Pdgfrb-cre)9Rha/0 (involves: 129S7/SvEvBrd * C57BL/6)	absent lymphocyte	J:205423
Pdpn^tm2.1Mlkn/Pdpn^tm2.1Mlkn Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6 CBA)	abnormal lymph node morphology	J:205423
	absent peripheral lymph nodes	J:205423
Pdpn^tm2.1Mlkn/Pdpn^tm2.1Mlkn Tg(CAG-cre/Esr1)5Amc/0 (involves: 129 C57BL/6)	abnormal lymphangiogenesis	J:235778
Pdpr^{tm1b(EUCOMM)Wtsi}/Pdpr^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pdpr^{tm1b(EUCOMM)Wtsi}/Ics)	decreased large unstained cell number	J:211773
Pdxp^em1(IMPC)J/Pdxp^em1(IMPC)J (C57BL/6NJ-Pdxp^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Pdzd8^{tm1b(EUCOMM)Wtsi}/Pdzd8⁺ (C57BL/6N-Pdzd8^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased large unstained cell number	J:211773
Pdzk1^{tm2b(EUCOMM)Wtsi}/Pdzk1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Pdzk1^{tm2b(EUCOMM)Wtsi}/Wtsi)	abnormal lymphatic vessel morphology	J:239583
	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Pebp1^em1(IMPC)Tcp/Pebp1^em1(IMPC)Tcp (C57BL/6NCrl-Pebp1^em1(IMPC)Tcp/Tcp)	decreased eosinophil cell number	J:211773
	enlarged lymph nodes	J:211773
	small spleen	J:211773
Pecam1^tm1Mak/Pecam1^tm1Mak (B6.129P2-Pecam1^tm1Mak)	spleen vascular congestion	J:95226
Peli1^tm1.1Arte/Peli1^tm1.1Arte (involves: C57BL/6N)	abnormal peripheral lymph node morphology	J:191578
	enlarged lymph nodes	J:191578
	lymphoid hyperplasia	J:191578
Peli1^{tm1b(EUCOMM)Wtsi}/Peli1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Peli1^{tm1b(EUCOMM)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Penk-rs^tm1Pig/Penk-rs^tm1Pig (B6.129-Penk-rs^tm1Pig)	decreased T-helper 2 cell number	J:62435
Pepd^{tm1a(KOMP)Wtsi}/Pepd^{tm1a(KOMP)Wtsi} (C57BL/6N-Pepd^{tm1a(KOMP)Wtsi}/Ucd)	decreased immature B cell number	J:211773
	decreased Ly6C-positive NK T cell number	J:211773
	decreased transitional stage T1 B cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased leukocyte cell number	J:211773
	increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker NK cell number	J:211773
Pepd^{tm1b(KOMP)Wtsi}/Pepd^{tm1b(KOMP)Wtsi} (C57BL/6N-Pepd^{tm1b(KOMP)Wtsi}/Ieg)	decreased B cell number	J:211773
	decreased B-2 B cell number	J:211773
	decreased CD5-positive Ly6C-positive T cell number	J:211773
	decreased follicular B cell number	J:211773
	enlarged lymph nodes	J:211773
Pex5^tm1Pec/Pex5^tm1Pec Cnp^tm1(cre)Kan/Cnp⁺ (involves: 129S1/Sv * 129X1/SvJ)	microgliosis	J:123503
Pex7^tm1Rjaw/Pex7^tm1Rjaw (Swiss)	abnormal osteoclast morphology	J:92346
Pex26^{tm1.1(KOMP)Vlcg}/Pex26⁺ (C57BL/6N-Pex26^{tm1.1(KOMP)Vlcg}/Ucd)	enlarged spleen	J:211773
Pfas^Sofa-2J/Pfas⁺ (B6(Cg)-Pfas^Sofa-2J/GrsrJ)	abnormal transitional stage B cell morphology	J:223062
Pfdn1^{Gt(GTR1.3)1Rul}/Pfdn1^{Gt(GTR1.3)1Rul} (involves: 129)	abnormal B cell differentiation	J:137415
	abnormal B cell morphology	J:137415
	abnormal neutrophil morphology	J:137415
	abnormal spleen morphology	J:137415
	abnormal spleen red pulp morphology	J:137415
	abnormal spleen white pulp morphology	J:137415
	abnormal splenic cell ratio	J:137415
	abnormal thymus cell ratio	J:137415
	abnormal thymus morphology	J:137415
	decreased B-1 B cell number	J:137415
	decreased B-2 B cell number	J:137415
	decreased pre-B cell number	J:137415
	decreased thymus weight	J:137415
	small spleen	J:137415
	spleen hypoplasia	J:137415
	thymus hypoplasia	J:137415
Pfkfb2^{tm1b(KOMP)Wtsi}/Pfkfb2^{tm1b(KOMP)Wtsi} (C57BL/6N-Pfkfb2^{tm1b(KOMP)Wtsi}/Nju)	decreased neutrophil cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Pfkfb3^tm1.1Pec/Pfkfb3^tm1.1Pec Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)	abnormal macrophage morphology	J:296552
Pfkm^tm1Fbos/Pfkm^tm1Fbos (involves: 129S6/SvEvTac * C57BL/6J)	enlarged spleen	J:152153
	increased spleen weight	J:152153
Pgam1^tm1.1Hiko/Pgam1^tm1.1Hiko Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal CD4-positive T cell differentiation	J:293746
	abnormal CD8-positive, alpha-beta T cell differentiation	J:293746
	abnormal effector T cell number	J:293746
	decreased CD4-positive, alpha-beta T cell number	J:293746
	decreased CD8-positive, alpha-beta T cell number	J:293746
	decreased NK T cell number	J:293746
	decreased T-helper 2 cell number	J:293746
	decreased T-helper 17 cell number	J:293746
Pgap3^tm1.1Ymra/Pgap3^tm1.1Ymra (involves: 129 * C57BL/6)	abnormal T cell morphology	J:181221
Pgap3^tm1.1Ymra/Pgap3^tm1.1Ymra (B6.Cg-Pgap3^tm1.1Ymra)	abnormal T-helper 2 cell differentiation	J:203443
Pgap3^tm1.1Ymra/Pgap3^tm1.1Ymra (B6.Cg-Pgap3^tm1.1Ymra)	increased spleen germinal center number	J:203443
Pgap4^em1Osbir/Pgap4^em1Osbir (involves: C57BL/6NSlc)	increased Ly6C-positive immature NK cell number	J:333707
Pgbd1^em1(IMPC)Tcp/Pgbd1^em1(IMPC)Tcp (C57BL/6NCrl-Pgbd1^em1(IMPC)Tcp/Tcp)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Pgc^{em1(IMPC)Ccpcz}/Pgc^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Pgc^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Pgd^tm1.1Pse/Pgd^tm1.1Pse Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal CD4-positive helper T cell morphology	J:313817
	enlarged lymph nodes	J:313817
	enlarged spleen	J:313817
	increased T cell number	J:313817
Pgd^tm1.1Pse/Pgd^tm1.1Pse Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal alpha-beta T cell morphology	J:306553
	abnormal CD8-positive, alpha beta T cell morphology	J:306553
	abnormal T cell differentiation	J:306553
	decreased CD4-positive, alpha-beta T cell number	J:306553
	decreased CD8-positive, alpha-beta T cell number	J:306553
Pgf^{em1(IMPC)Ccpcz}/Pgf^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Pgf^{em1(IMPC)Ccpcz}/Ccpcz)	decreased NK cell number	J:211773
Pglyrp4^{em1(IMPC)Ccpcz}/Pglyrp4^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Pglyrp4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small thymus	J:211773
Pgm3^{Gt(W037B08)Wrst}/Pgm3^mld1 (involves: 129S1/Sv * C57BL/6)	abnormal T cell differentiation	J:125094
	absent follicular B cells	J:125094
	decreased B cell number	J:125094
	decreased leukocyte cell number	J:125094
	decreased T cell number	J:125094
	increased pro-B cell number	J:125094
	increased spleen red pulp amount	J:125094
Pgm3^mld1/Pgm3^mld1 (C57BL/6-Pgm3^mld1)	abnormal thrombopoiesis	J:125094
	absent follicular B cells	J:125094
	decreased B cell number	J:125094
	decreased leukocyte cell number	J:125094
	increased pro-B cell number	J:125094
	increased spleen red pulp amount	J:125094
	increased spleen weight	J:125094
Pgr^tm1Bwo/Pgr^tm1Bwo (involves: 129S7/SvEvBrd)	abnormal osteoclast morphology	J:145383
Pgrmc2^tm1.1Jjp/Pgrmc2^tm1.1Jjp Pgr^tm2(cre)Lyd/Pgr⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	decreased uterine NK cell number	J:247103
Phactr1^em1(IMPC)Mbp/Phactr1^em1(IMPC)Mbp (C57BL/6NCrl-Phactr1^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	decreased leukocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Phb1^em1(IMPC)H/Phb1⁺ (C57BL/6NTac-Phb1^em1(IMPC)H/H)	increased large unstained cell number	J:211773
Phc1^tm1Os/Phc1^tm1Os (involves: 129S2/SvPas * C57BL/6)	abnormal B cell differentiation	J:75707
	decreased spleen weight	J:43764
	decreased thymus weight	J:43764
Phf6^em1Wencc/Y Tg(Vav1-cre)#Cgp/0 (Not Specified)	abnormal effector T cell number	J:278804
	abnormal splenic cell ratio	J:278804
	abnormal thymus cell ratio	J:278804
	decreased CD4-positive, alpha-beta T cell number	J:278804
	decreased CD8-positive, alpha-beta T cell number	J:278804
	decreased double-negative T cell number	J:278804
	decreased lymphocyte cell number	J:278804
	enlarged spleen	J:278804
	increased B cell number	J:278804
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:278804
	increased pro-B cell number	J:278804
Phf6^em1Wencc/Phf6^em1Wencc Tg(Vav1-cre)#Cgp/0 (Not Specified)	abnormal effector T cell number	J:278804
	abnormal splenic cell ratio	J:278804
	abnormal thymus cell ratio	J:278804
	decreased CD4-positive, alpha-beta T cell number	J:278804
	decreased CD8-positive, alpha-beta T cell number	J:278804
	decreased double-negative T cell number	J:278804
	decreased lymphocyte cell number	J:278804
	enlarged spleen	J:278804
	increased B cell number	J:278804
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:278804
	increased leukocyte cell number	J:278804
	increased pro-B cell number	J:278804
Phf6^tm1.1Avo/Y Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * SJL)	abnormal T cell differentiation	J:276228
	decreased DN2 thymocyte number	J:276228
	increased plasmacytoid dendritic cell number	J:276228
Phf8^tm1dIcs/Phf8^tm1dIcs (C57BL/6N-Phf8^tm1dIcs/Ics)	decreased lymphocyte cell number	J:211773
Phf8^tm1dIcs/Phf8^tm1dIcs (C57BL/6N-Phf8^tm1dIcs/Ics)	increased neutrophil cell number	J:211773
Phf19^tm1.1Ldc/Phf19^tm1.1Ldc (Not Specified)	enlarged spleen	J:313068
Phf20^Gt(XN131)Byg/Phf20^Gt(XN131)Byg (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:228714
	decreased double-positive T cell number	J:228714
	decreased thymocyte number	J:228714
	increased double-negative T cell number	J:228714
	intermingled spleen red and white pulp	J:228714
	small spleen	J:228714
	small thymus	J:228714
	thymus hypoplasia	J:228714
Phf20l1^em1(IMPC)Tcp/Phf20l1^em1(IMPC)Tcp (C57BL/6N-Phf20l1^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	increased spleen weight	J:211773
Phip^{em1(IMPC)Wtsi}/Phip⁺ (C57BL/6N-Phip^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Phka1^em1(IMPC)Tcp/Y (C57BL/6N-Phka1^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Phldb2^em1(IMPC)H/Phldb2^em1(IMPC)H (C57BL/6NTac-Phldb2^em1(IMPC)H/H)	increased basophil cell number	J:211773
Phrf1^em1(IMPC)Tcp/Phrf1^em1(IMPC)Tcp (C57BL/6N-Phrf1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	small spleen	J:211773
Phyh^{tm1b(EUCOMM)Wtsi}/Phyh^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Phyh^{tm1b(EUCOMM)Wtsi}/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Pi4ka^m2Btlr/Pi4ka^m2Btlr (C57BL/6J-Pi4ka^m2Btlr)	increased alpha-beta T cell number	J:272852
	increased CD4-positive, alpha-beta T cell number	J:272852
	increased central memory CD4-positive, alpha-beta T cell number	J:272852
Pi4ka^{tm1b(EUCOMM)Wtsi}/Pi4ka⁺ (C57BL/6N-Pi4ka^{tm1b(EUCOMM)Wtsi}/Tcp)	increased monocyte cell number	J:211773
Pi4ka^tm2.1Arte/Pi4ka⁺ Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6NTac)	abnormal spleen morphology	J:188779
Pi16^{Gt(OST292194)Lex}/Pi16^{Gt(OST292194)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal lymph node B cell domain morphology	J:94077
	abnormal spleen germinal center morphology	J:94077
	increased regulatory T cell number	J:94077
Pias4^tm1Rug/Pias4^tm1Rug (involves: 129S2/SvPas * C57BL/6)	abnormal myelopoiesis	J:94291
Picalm^tm1.1Tmae/Picalm^tm1.1Tmae Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)	decreased CD4-positive, alpha-beta T cell number	J:220728
	decreased CD8-positive, alpha-beta T cell number	J:220728
Picalm^tm1.1Tmae/Picalm^tm1.1Tmae Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA * SJL)	decreased CD4-positive, alpha-beta T cell number	J:220728
	decreased CD8-positive, alpha-beta T cell number	J:220728
	enlarged spleen	J:220728
Picalm^tm1Towa/Picalm^tm1Towa (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)	abnormal B cell differentiation	J:185312
	decreased spleen B cell follicle number	J:185312
	enlarged spleen	J:185312
Pierce1^{Gt(OST3440)Lex}/Pierce1^{Gt(OST3440)Lex} (either: (involves: 129S5/SvEvBrd * C57BL/6J) or (involves: 129S5/SvEvBrd * C57BL/6J * FVB/N))	abnormal spleen morphology	J:252050
Piezo1^tm2.1Apat/Piezo1^tm2.1Apat Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA)	abnormal splenic cell ratio	J:229436
	dark spleen	J:229436
Piga^tm1Tak/Piga^tm1Tak Tg(FES-cre)31Bsl/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/Ca)	abnormal T cell morphology	J:162065
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:162065
Pigr^tm1Ohw/Pigr^tm1Ohw (B6.129X1-Pigr^tm1Ohw)	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:97824
Pigr^tm1Ohw/Pigr^tm1Ohw (B6.129X1-Pigr^tm1Ohw)	abnormal intraepithelial T cell number	J:97824
Pigr^tm1Ohw/Pigr^tm1Ohw Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)	decreased lymphocyte cell number	J:97824
Pigr^tm1Rast/Pigr^tm1Rast (C57BL/6-Pigr^tm1Rast)	abnormal immune system cell morphology	J:81984
Pigv^b2b2859Clo/Pigv^b2b2859Clo (C57BL/6J-Pigv^b2b2859Clo)	thymus hypoplasia	J:175213
Pik3ap1^m1Btlr/Pik3ap1^m1Btlr (involves: C57BL/6J)	arrested B cell differentiation	J:185495
Pik3ap1^m2Btlr/Pik3ap1^m2Btlr (C57BL/6J-Pik3ap1^m2Btlr)	decreased B-1a cell number	J:255271
Pik3ap1^m2Btlr/Pik3ap1^m2Btlr (C57BL/6J-Pik3ap1^m2Btlr)	increased B-1b cell number	J:255271
Pik3ap1^M3Btlr/Pik3ap1^M3Btlr (C57BL/6J-Pik3ap1^M3Btlr)	decreased B-1 B cell number	J:272019
Pik3ap1^{tm1b(KOMP)Wtsi}/Pik3ap1^{tm1b(KOMP)Wtsi} (C57BL/6N-Pik3ap1^{tm1b(KOMP)Wtsi}/Orl)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Pik3ap1^tm1Kuro/Pik3ap1^tm1Kuro (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:75075
	absent B-1a cells	J:84669
	decreased B cell number	J:84669
	decreased follicular B cell number	J:84669
	decreased pre-B cell number	J:75075
	spleen hypoplasia	J:75075
Pik3c2a^{Gt(OST288105)Lex}/Pik3c2a^{Gt(OST288105)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	enlarged spleen	J:169710
	increased B cell number	J:169710
	increased CD4-positive, alpha-beta T cell number	J:169710
	increased CD8-positive, alpha-beta T cell number	J:169710
	increased granulocyte number	J:169710
	increased leukocyte cell number	J:169710
	increased monocyte cell number	J:169710
	increased neutrophil cell number	J:169710
Pik3c2a^{tm1b(EUCOMM)Hmgu}/Pik3c2a⁺ (C57BL/6N-Pik3c2a^{tm1b(EUCOMM)Hmgu}/Tcp)	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	increased neutrophil cell number	J:211773
Pik3c2a^tm1Bvan/Pik3c2a⁺ (involves: C57BL/6)	abnormal thrombopoiesis	J:226344
Pik3c3^tm1.1Flv/Pik3c3^tm1.1Flv Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	abnormal T cell number	J:184753
	decreased CD4-positive, alpha-beta T cell number	J:184753
	decreased CD8-positive, alpha-beta T cell number	J:184753
Pik3c3^tm1.1Flv/Pik3c3^tm1.1Flv Tg(Cd8a-cre)1Itan/0 (involves: C57BL/6 * C57BL/6N)	abnormal CD4-positive, alpha beta T cell morphology	J:184753
	abnormal CD8-positive, alpha beta T cell morphology	J:184753
	decreased CD4-positive, alpha-beta T cell number	J:184753
	decreased CD8-positive, alpha-beta T cell number	J:184753
	decreased lymphocyte cell number	J:184753
Pik3ca^tm1Jdo/Pik3ca^tm1Jdo (B6.129S7(Cg)-Pik3ca^tm1Jdo)	abnormal lymphangiogenesis	J:122866
Pik3ca^tm1Jdo/Pik3ca^tm1Jdo (B6.129S7(Cg)-Pik3ca^tm1Jdo)	abnormal lymphatic vessel morphology	J:122866
Pik3cd^{Gt(OST451938)Lex}/Pik3cd^{Gt(OST451938)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	increased leukocyte cell number	J:103485
	increased lymphocyte cell number	J:103485
Pik3cd^m2Btlr/Pik3cd⁺ (C57BL/6J-Pik3cd^m2Btlr)	decreased B-1 B cell number	J:236693
Pik3cd^m2Btlr/Pik3cd^m2Btlr (C57BL/6J-Pik3cd^m2Btlr)	decreased B-1 B cell number	J:236693
Pik3cd^m2Btlr/Pik3cd^m2Btlr (C57BL/6J-Pik3cd^m2Btlr)	decreased B-1a cell number	J:236693
Pik3cd^tm1.1Bvan/Pik3cd^tm1.1Bvan (involves: 129P2/OlaHsd * BALB/c)	abnormal B cell differentiation	J:78412
	abnormal Peyer's patch germinal center morphology	J:78412
	absent spleen germinal center	J:78412
	decreased B-1 B cell number	J:78412
	increased neutrophil cell number	J:78412
	spleen hypoplasia	J:78412
Pik3cd^tm1Jni/Pik3cd^tm1Jni (involves: 129P2/OlaHsd)	absent B-1 B cells	J:80614
	absent spleen germinal center	J:80614
	decreased B cell number	J:80614
	decreased mature B cell number	J:80614
	small lymph nodes	J:80614
	small spleen	J:80614
Pik3cd^tm1Jni/Pik3cd^tm1Jni Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6)	abnormal NK cell differentiation	J:124330
	decreased NK cell number	J:124330
	decreased T cell number	J:124330
	spleen hypoplasia	J:124330
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr (involves: 129S4/SvJae)	decreased B cell number	J:79133
	decreased B-1 B cell number	J:79133
	decreased B-2 B cell number	J:79133
	decreased marginal zone B cell number	J:79133
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal T cell differentiation	J:125791
	abnormal thymus lobule morphology	J:125791
	decreased CD4-positive, alpha-beta T cell number	J:125791
	decreased CD8-positive, alpha-beta T cell number	J:125791
	decreased double-positive T cell number	J:125791
	decreased lymphocyte cell number	J:125791
	decreased T cell number	J:125791
	small thymus	J:125791
	thymus hypoplasia	J:125791
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr Pten^tm2.1Ppp/Pten^tm2.1Ppp Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae * C57BL/6)	abnormal class switch recombination	J:130950
	increased marginal zone B cell number	J:130950
Pik3cd^tm1Tnr/Pik3cd^tm1Tnr Tg(BCL2)36Wehi/0 (involves: 129S4/SvJae * C57BL/6JWehi * SJL/JWehi)	decreased follicular B cell number	J:130950
Pik3cd^tm2.1Tnr/Pik3cd^tm2.1Tnr Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:164283
	decreased CD8-positive, alpha-beta T cell number	J:164283
	decreased germinal center B cell number	J:164283
	decreased spleen germinal center number	J:164283
	decreased spleen germinal center size	J:164283
	decreased T cell number	J:164283
	decreased T follicular helper cell number	J:164283
Pik3cd^tm2.1Tnr/Pik3cd^tm2.1Tnr Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	decreased germinal center B cell number	J:164283
	decreased spleen germinal center number	J:164283
	decreased T follicular helper cell number	J:164283
Pik3cg^tm1Dwu/Pik3cg^tm1Dwu (B6.Cg-Pik3cg^tm1Dwu)	decreased CD8-positive, alpha-beta T cell number	J:131923
Pik3cg^tm1Pngr/Pik3cg^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6)	abnormal NK cell differentiation	J:124330
	abnormal T cell differentiation	J:60347
	decreased CD4-positive, alpha-beta T cell number	J:60347
	decreased thymocyte number	J:60347
	increased eosinophil cell number	J:60347
	increased monocyte cell number	J:60347
	increased neutrophil cell number	J:60347
	thymus hypoplasia	J:60347
Pik3cg^tm1Wym/Pik3cg^tm1Wym (either: 129/Sv-Pik3cg^tm1Wym or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	increased neutrophil cell number	J:60349
Pik3cg^tm2Ehi/Pik3cg^tm2Ehi (Not Specified)	decreased macrophage cell number	J:124856
	decreased neutrophil cell number	J:124856
	increased leukocyte cell number	J:124856
Pik3r1^m1Btlr/Pik3r1^m1Btlr (C57BL/6J-Pik3r1^m1Btlr)	decreased B cell number	J:254890
	decreased B-1a cell number	J:254890
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254890
	increased CD8-positive, alpha-beta memory T cell number	J:254890
Pik3r1^M2Btlr/Pik3r1⁺ (C57BL/6J-Pik3r1^M2Btlr)	decreased B-1 B cell number	J:254892
	decreased B-1a cell number	J:254892
	decreased B-1b cell number	J:254892
	decreased B-2 B cell number	J:254892
	decreased NK T cell number	J:254892
	increased B-1b cell number	J:254892
Pik3r1^m3Btlr/Pik3r1^m3Btlr (C57BL/6J-Pik3r1^m3Btlr)	increased B-1b cell number	J:272853
Pik3r1^tm1Dfr/Pik3r1^tm1Dfr (involves: 129S6/SvEvTac * C57BL/6)	arrested B cell differentiation	J:52229
	decreased mature B cell number	J:52229
Pik3r1^tm1Dfr/Pik3r1^tm1Dfr (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:104166
	decreased immature B cell number	J:104166
	decreased mature B cell number	J:104166
	decreased pre-B cell number	J:104166
	increased pro-B cell number	J:104166
Pik3r1^tm1Dfr/Pik3r1^tm1Dfr Plcg2^tm1Jni/Plcg2^tm1Jni (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal B cell differentiation	J:104166
	arrested B cell differentiation	J:104166
	decreased immature B cell number	J:104166
	decreased mature B cell number	J:104166
	decreased pre-B cell number	J:104166
Pik3r1^tm1Tka/Pik3r1^tm1Tka (involves: C57BL/6 * CBA)	decreased B cell number	J:52228
	decreased mature B cell number	J:52228
	decreased pre-B cell number	J:52228
	decreased pro-B cell number	J:52228
Pik3r1^tm2Dfr/Pik3r1^tm2Dfr (either: C.129S6-Pik3r1^tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6))	abnormal B cell differentiation	J:94077
Pik3r5^tm1Lste/Pik3r5^tm1Lste (involves: 129P2/OlaHsd)	increased neutrophil cell number	J:238900
Pik3r6^tm1.1Lste/Pik3r6^tm1.1Lste (Not Specified)	decreased granulocyte number	J:238900
	decreased lymphocyte cell number	J:238900
	increased neutrophil cell number	J:238900
Pikfyve^{Gt(AT0926)Wtsi}/Pikfyve^{Gt(AT0926)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:190368
	abnormal thymus morphology	J:190368
	spleen hypoplasia	J:190368
	thymus hypoplasia	J:190368
Pilra^tm1Osb/Pilra^tm1Osb (B6.129-Pilra^tm1Osb)	increased neutrophil cell number	J:191085
Pim1^tm1Pwl/Pim1^tm1Pwl Pim2^tm1Brn/Pim2^tm1Brn Pim3^tm1Brn/Pim3^tm1Brn (involves: 129P/Ola * FVB/N)	decreased B cell number	J:91592
	decreased pre-B cell number	J:91592
	decreased pro-B cell number	J:91592
	increased early pro-B cell number	J:91592
Pip4k2c^{tm1b(KOMP)Wtsi}/Pip4k2c^{tm1b(KOMP)Wtsi} (involves: C57BL/6J * C57BL/6N)	decreased regulatory T cell number	J:234283
	increased CD4-positive, alpha-beta T cell number	J:234283
	increased CD8-positive, alpha-beta T cell number	J:234283
	increased T-helper cell number	J:234283
Pip4p1^{em1(IMPC)Ccpcz}/Pip4p1^{em1(IMPC)Ccpcz} (C57BL/6N-Pip4p1^{em1(IMPC)Ccpcz}/Ccpcz)	increased CD4-negative, CD25-positive NK T cell number	J:211773
Pip5k1c^tm1.2Ref/Pip5k1c^tm1.2Ref Tg(TcraTcrb)425Cbn/0 (involves: BALB/c * C57BL/6)	decreased B cell number	J:164732
	decreased dendritic cell number	J:164732
Pip^tm1Myal/Pip^tm1Myal (involves: 129S/SvEv * C57BL/6)	abnormal thymus corticomedullary boundary morphology	J:202016
	enlarged submandibular lymph nodes	J:202016
	enlarged thymus	J:202016
	enlarged thymus medulla	J:202016
Pirb^tm1Ttk/Pirb^tm1Ttk (involves: 129X1/SvJ)	abnormal dendritic cell differentiation	J:76770
	abnormal immune system cell morphology	J:76770
	increased B-1 B cell number	J:76770
Pitpnm1^{tm1a(EUCOMM)Wtsi}/Pitpnm1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	decreased leukocyte cell number	J:207051
Pitx2^tm1Hmd/Pitx2^tm1Hmd (involves: C3H * C57BL/6 * C57BL/6J)	small spleen	J:128475
Pitx2^tm1Jfm/Pitx2^tm1Jfm (involves: 129S4/SvJaeSor)	spleen hypoplasia	J:57674
Pitx2^tm1Rsd/Pitx2^tm1Rsd (involves: 129S1/Sv * 129X1/SvJ)	abnormal spleen morphology	J:57673
Pitx2^tm3.1Jfm/Pitx2^tm3.1Jfm (involves: 129S4/SvJaeSor)	small spleen	J:92872
Pitx3^eyl/Pitx3^eyl (involves: C3H/He * C57BL/6)	decreased leukocyte cell number	J:156878
	increased CD4-positive, alpha-beta T cell number	J:156878
	increased CD8-positive, alpha-beta T cell number	J:156878
	increased granulocyte number	J:156878
Pitx3^tm1.1Cai/Pitx3⁺ Tg(tetO-SNCAA53T)E2Cai/0 (involves: 129 C57BL/6J * FVB/N)	microgliosis	J:185958
Pja2^{tm1b(EUCOMM)Wtsi}/Pja2⁺ (C57BL/6N-Pja2^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Pja2^{tm1b(EUCOMM)Wtsi}/Pja2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pja2^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Pkd1^{tm1b(EUCOMM)Hmgu}/Pkd1⁺ (C57BL/6N-Pkd1^{tm1b(EUCOMM)Hmgu}/Bay)	increased neutrophil cell number	J:211773
Pkd2^tm1Dwo/Pkd2^tm1Dwo (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	absent spleen	J:77401
Pkhd1^tm1Som/Pkhd1^tm1Som (involves: 129S/SvEv * C57BL/6)	enlarged spleen	J:131370
Pkhd1l1^em1(IMPC)H/Pkhd1l1^em1(IMPC)H (C57BL/6N-Pkhd1l1^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased leukocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Pklr^char4/Pklr^char4 (involves: A/J * C57BL/6)	enlarged spleen	J:86735
Pklr^slc/Pklr^slc (CBA/NSlc-Pklr^slc)	enlarged spleen	J:30035
Pkn1^{tm1b(KOMP)Wtsi}/Pkn1^{tm1b(KOMP)Wtsi} (C57BL/6N-Pkn1^{tm1b(KOMP)Wtsi}/H)	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
Pkn1^tm1Kik/Pkn1^tm1Kik (B6.129P2-Pkn1^tm1Kik)	abnormal somatic hypermutation frequency	J:193187
	increased germinal center B cell number	J:193187
	increased spleen germinal center size	J:193187
	increased splenocyte number	J:193187
Pkn3^tm1.1Mrl/Pkn3⁺ Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA/J)	enlarged spleen	J:216983
	enlarged thymus	J:216983
Pkn3^tm1.1Mrl/Pkn3^tm1.1Mrl Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA/J)	enlarged spleen	J:216983
	enlarged thymus	J:216983
Pknox1^{Gt(OST71835)Lex}/Pknox1^{Gt(OST71835)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	decreased single-positive T cell number	J:103769
	increased double-negative T cell number	J:103769
	thymus hypoplasia	J:103769
Pknox1^tm2.1Fbla/Pknox1^tm2.1Fbla Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd)	decreased pre-B cell number	J:192251
	increased pro-B cell number	J:192251
Pknox2^{em1(IMPC)Ccpcz}/Pknox2^{em1(IMPC)Ccpcz} (C57BL/6N-Pknox2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Pkp3^tm1.1Fvr/Pkp3^tm1.1Fvr (involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL)	enlarged lymph nodes	J:136451
Pla1a^em1(IMPC)J/Pla1a^em1(IMPC)J (C57BL/6NJ-Pla1a^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Pla1a^em1Appsc/Pla1a^em1Appsc (C57BL/6J-Pla1a^em1Appsc)	increased lymphocyte cell number	J:333902
Pla2g2d^{tm1.1(KOMP)Vlcg}/Pla2g2d^{tm1.1(KOMP)Vlcg} (C57BL/6N-Pla2g2d^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Pla2g2d^tm1.1Mhg/Pla2g2d^tm1.1Mhg (B6NCrSlc.Cg-Pla2g2d^tm1.1Mhg)	abnormal effector T cell morphology	J:201008
	increased CD4-positive, alpha-beta T cell number	J:229035, J:201008
	increased CD8-positive, alpha-beta T cell number	J:229035
	increased dendritic cell number	J:201008
Pla2g3^tm1Murm/Pla2g3^tm1Murm (involves: 129S/SvEv * C57BL/6)	abnormal mast cell differentiation	J:197334
	abnormal mast cell morphology	J:197334
Pla2g4a^tm1Jvb/Pla2g4a^tm1Jvb (involves: 129S4/SvJae)	abnormal mast cell differentiation	J:54619
Pla2g5^{em1(IMPC)Ccpcz}/Pla2g5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Pla2g5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
Pla2g6^m1Sein/Pla2g6^m1Sein (C57BL/6JJcl-Pla2g6^m1Sein)	decreased double-positive T cell number	J:155328
Pla2g10^Gt712Lex/Pla2g10^Gt712Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased CD4-positive, alpha-beta T cell number	J:125607
	decreased CD8-positive, alpha-beta T cell number	J:125607
	decreased eosinophil cell number	J:125607
	decreased T cell number	J:125607
Pla2g10^tm1Kiku/Pla2g10^tm1Kiku (B6.129P2-Pla2g10^tm1Kiku)	decreased neutrophil cell number	J:155082
Pla2g15^tm1.1Jash/Pla2g15^tm1.1Jash (involves: 129S1/Sv * C57BL/6)	abnormal macrophage morphology	J:111561
	abnormal spleen morphology	J:111561
	increased macrophage cell number	J:111561
	increased macrophage derived foam cell number	J:111561
	increased spleen weight	J:111561
Plaat3^em1(IMPC)Tcp/Plaat3^em1(IMPC)Tcp (C57BL/6NCrl-Plaat3^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Plaat5^em1(IMPC)Tcp/Plaat5^em1(IMPC)Tcp (C57BL/6N-Plaat5^em1(IMPC)Tcp/Tcp)	increased eosinophil cell number	J:211773
Plac8^tm1Bhk/Plac8^tm1Bhk (129S/SvEv-Plac8^tm1Bhk)	increased leukocyte cell number	J:145277
Plac8^tm1Bhk/Plac8^tm1Bhk (129S/SvEv-Plac8^tm1Bhk)	increased neutrophil cell number	J:145277
Plac9^{tm1b(EUCOMM)Hmgu}/Plac9^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Plac9^{tm1b(EUCOMM)Hmgu}/H)	decreased neutrophil cell number	J:211773
Plag1^{em1(IMPC)Hmgu}/Plag1^{em1(IMPC)Hmgu} (C57BL/6N-Plag1^{em1(IMPC)Hmgu}/Ieg)	decreased CD8-positive, naive alpha-beta T cell number	J:211773
Plat^tm1Mlg/Plat^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	increased macrophage cell number	J:63134
Plau^{tm1b(EUCOMM)Wtsi}/Plau^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Plau^{tm1b(EUCOMM)Wtsi}/H)	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Plau^tm1Mlg/Plau^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	increased lymphocyte cell number	J:63134
Plcb1^em1(IMPC)Mbp/Plcb1⁺ (C57BL/6N-Plcb1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Plcb2^{tm1b(KOMP)Wtsi}/Plcb2^{tm1b(KOMP)Wtsi} (C57BL/6N-Plcb2^{tm1b(KOMP)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Plcd1^tm1.1Kfu/Plcd1^tm1.1Kfu Tg(KRT14-cre)1Amc/0 (involves: C57BL/6 * C57BL/6JJcl * CBA)	decreased B cell number	J:205633
	enlarged inguinal lymph nodes	J:205633
	increased granulocyte number	J:205633
	increased NK T cell number	J:205633
Plcd1^tm1Tta/Plcd1^tm1Tta (involves: 129P2/OlaHsd)	abnormal granulocyte differentiation	J:205633
	decreased B cell number	J:205633
	enlarged axillary lymph nodes	J:205633
	enlarged inguinal lymph nodes	J:205633
	enlarged lymph nodes	J:205633
	enlarged spleen	J:205633
	increased granulocyte number	J:205633
	increased leukocyte cell number	J:205633
Plce1^em1(IMPC)Mbp/Plce1^em1(IMPC)Mbp (C57BL/6N-Plce1^em1(IMPC)Mbp/MbpMmucd)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0 (either: B6.Cg-Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2))	decreased regulatory T cell number	J:157757
	decreased T cell number	J:157757
	increased CD4-positive, alpha-beta T cell number	J:157757
Plcg1^tm1Gcrp/Plcg1^tm1Rwen Tg(Cd4-cre)1Cwi/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129X1/SvJ * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:157757
	decreased double-negative T cell number	J:157757
	increased CD8-positive, alpha-beta T cell number	J:157757
	increased double-positive T cell number	J:157757
	thymus hyperplasia	J:157757
Plcg2^al/Plcg2^al (involves: 129 * C57BL/6)	abnormal lymphatic vessel morphology	J:143529
Plcg2^Ali5/Plcg2⁺ (C3HeB/FeJ-Plcg2^Ali5)	decreased B-2 B cell number	J:97930
Plcg2^Ali5/Plcg2^Ali5 (involves: C57BL/6J * C3HeB/FeJ-Plcg2^Ali5)	decreased mature B cell number	J:97930
	decreased transitional stage B cell number	J:97930
Plcg2^m1Btlr/Plcg2^m1Btlr (involves: C57BL/6J)	abnormal B cell differentiation	J:185495
Plcg2^M3Btlr/Plcg2^M3Btlr (C57BL/6J-Plcg2^M3Btlr)	decreased B-1a cell number	J:265101
Plcg2^m4Btlr/Plcg2^m4Btlr (C57BL/6J-Plcg2^m4Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:272862
Plcg2^m4Btlr/Plcg2^m4Btlr (C57BL/6J-Plcg2^m4Btlr)	increased effector memory CD8-positive, alpha-beta T cell number	J:272862
Plcg2^tm1.1Kuro/Plcg2^tm1.1Kuro (Not Specified)	abnormal B cell differentiation	J:131161
	increased pro-B cell number	J:131161
	spleen hyperplasia	J:131161
Plcg2^tm1Ichi/Plcg2^tm1Ichi (involves: 129 * C57BL/6)	abnormal lymphatic vessel morphology	J:143529
Plcg2^tm1Jni/Plcg2^tm1Jni (involves: 129P2/OlaHsd)	abnormal dendritic cell morphology	J:157619
	arrested B cell differentiation	J:86373
	decreased follicular B cell number	J:86373
	decreased mature B cell number	J:104166
	increased pro-B cell number	J:104166
	increased transitional stage T2 B cell number	J:86373
Plcg2^tm1Jni/Plcg2^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:117023
	abnormal osteoclast differentiation	J:114607
	decreased osteoclast cell number	J:114607
	increased pre-B cell number	J:117023
Plcg2^tm1Jni/Plcg2^tm1Jni Tg(IghMyc)22Bri/0 (involves: 129P2/OlaHsd * C57BL * C57BL/6 * SJL)	enlarged lymph nodes	J:117023
Plcg2^tm1Kuro/Plcg2^tm1Kuro Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	decreased mature B cell number	J:63744
	decreased pre-B cell number	J:63744
	increased B-1a cell number	J:63744
	increased immature B cell number	J:63744
	increased pro-B cell number	J:63744
Plcl2^tm1Tta/Plcl2^tm1Tta (involves: 129P2/OlaHsd)	decreased B-1a cell number	J:85960
Plcl2^tm1Tta/Plcl2^tm1Tta (involves: 129P2/OlaHsd)	decreased mature B cell number	J:85960
Pld4^em1(IMPC)Mbp/Pld4^em1(IMPC)Mbp (C57BL/6N-Pld4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased spleen weight	J:211773
Pld4^thss/Pld4^thss (BALB/cJ-Pld4^thss/GrsrJ)	abnormal alpha-beta T cell morphology	J:278304
	enlarged lymph nodes	J:278304
	enlarged spleen	J:278304
	increased macrophage cell number	J:278304
	increased marginal zone B cell number	J:278304
	increased plasma cell number	J:278304
	increased plasmacytoid dendritic cell number	J:278304
	increased spleen germinal center number	J:278304
	lymph node hyperplasia	J:278304
	spleen hyperplasia	J:278304
Pld4^tm1.1Nemz/Pld4^tm1.1Nemz Tg(Itgax-cre)1-1Reiz/0 (involves: 129 * C57BL/6 * C57BL/6J * CBA)	abnormal peritoneal macrophage morphology	J:281205
Pld4^tm1.2Nemz/Pld4^tm1.2Nemz (B6.129(Cg)-Pld4^tm1.1Nemz)	abnormal leukocyte cell number	J:281205
	abnormal peritoneal macrophage morphology	J:281205
	decreased B-1 B cell number	J:281205
	decreased NK T cell number	J:281205
	enlarged spleen	J:281205
	increased marginal zone B cell number	J:281205
	increased monocyte cell number	J:281205
Pld4^tm1.2Nemz/Pld4^tm1.2Nemz Rag1^tm1Mom/Rag1^tm1Mom (involves: 129 * 129S7/SvEvBrd * C57BL/6J * FVB/N)	abnormal peritoneal macrophage morphology	J:281205
	decreased NK T cell number	J:281205
Plek2^tm1Pji/Plek2^tm1Pji (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal granulocyte differentiation	J:257910
	enlarged spleen	J:257910
Plek2^tm1Pji/Plek2^tm1Pji Jak2^tm1.1Ble/Jak2⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal granulocyte differentiation	J:257910
Plekha5^em1(IMPC)Tcp/Plekha5^em1(IMPC)Tcp (C57BL/6NCrl-Plekha5^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	increased spleen weight	J:211773
Plekhf2^{em1(IMPC)Wtsi}/Plekhf2^{em1(IMPC)Wtsi} (C57BL/6NCrl-Plekhf2^{em1(IMPC)Wtsi}/Wtsi)	increased eosinophil cell number	J:211773
Plekhg2^em1(IMPC)J/Plekhg2^em1(IMPC)J (C57BL/6NJ-Plekhg2^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Plekhm1^tm1.2Hzhao/Plekhm1^tm1.2Hzhao (involves: 129S1/Sv * C57BL/6J)	abnormal osteoclast morphology	J:236517
Plekhm2^{tm1a(EUCOMM)Wtsi}/Plekhm2^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Plekhm2^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:165965
Plekhm2^{tm1a(EUCOMM)Wtsi}/Plekhm2^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6J * C57BL/6N)	increased leukocyte cell number	J:233985
Plekho2^em1Lzhn/Plekho2^em1Lzhn (C57BL/6-Plekho2^em1Lzhn)	decreased macrophage cell number	J:270531
Plet1^tm1Cupe/Plet1^tm1Cupe (Not Specified)	abnormal dendritic cell number	J:271548
Plet1^tm1Cupe/Plet1^tm1Cupe (Not Specified)	increased dendritic cell number	J:271548
Plg^tm1.1Fjc/Plg^tm1.1Fjc (involves: C57BL/6 * C57BL/6JJcl)	enlarged lymph nodes	J:210802
Plg^tm1Dco/Plg^tm1Dco (involves: 129S2/SvPas)	enlarged lymph nodes	J:210802
Plp1^jp-rsh/Plp1⁺ (either: STOCK Rb(1.3)1Bnr or (involves: BALB/c * DBA/2 * STOCK Rb(1.3)1Bnr))	abnormal microglial cell morphology	J:604
Plp1^{tm1c(EUCOMM)Wtsi}/Y Cnp^tm1(cre)Kan/Cnp⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	increased T cell number	J:245100
	microgliosis	J:245100
Plp1^tm1Kan/Y (involves: 129S1/Sv * 129X1/SvJ)	abnormal microglial cell morphology	J:48031
Plp1^tm1Kan/Y (involves: 129S1/Sv * 129X1/SvJ)	microgliosis	J:245100
Plp1^tm1Kan/Y (B6.129-Plp1^tm1Kan)	microgliosis	J:201143
Plp1^tm1Kan/Y Cnp^tm1(cre)Kan/Cnp⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased T cell number	J:245100
	microgliosis	J:245100
Plp1^tm1Kan/Y Tspan2^tm1Hbw/Tspan2^tm1Hbw (B6.Cg-Tspan2^tm1Hbw Plp1^tm1Kan)	microgliosis	J:201143
Plppr5^{em1(IMPC)Ccpcz}/Plppr5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Plppr5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Plscr1^tm1Lex/Plscr1^tm1Lex (129S/SvEvBrd-Plscr1^tm1Lex)	abnormal granulocyte differentiation	J:76790
	abnormal myelopoiesis	J:76790
	abnormal neutrophil differentiation	J:76790
	decreased granulocyte number	J:76790
	decreased neutrophil cell number	J:76790
Plscr1^tm1Lex/Plscr1^tm1Lex Plscr3^tm1Sims/Plscr3^tm1Sims (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal myelopoiesis	J:92404
plt/plt (involves: DDD/1)	abnormal immune system organ morphology	J:47819
	abnormal leukocyte cell number	J:47819
	abnormal lymph node T cell domain morphology	J:47819, J:47460
	abnormal peripheral lymph node morphology	J:47819
	abnormal spleen red pulp morphology	J:47460
	abnormal spleen white pulp morphology	J:47460
	decreased single-positive T cell number	J:15290
	decreased T cell number	J:47819
	increased memory T cell number	J:47460
	increased T cell number	J:47819
	lymph node hypoplasia	J:15290, J:47460
	small Peyer's patches	J:47460
plt/plt (C.DDD-plt)	decreased single-positive T cell number	J:119345
plt/plt (B6.DDD-plt)	abnormal thymus cortex morphology	J:93960
plt/plt (B6.DDD-plt)	small thymus medulla	J:93960
Plvap^{tm1e(EUCOMM)Hmgu}/Plvap^{tm1e(EUCOMM)Hmgu} Tg(TIE2GFP)287Sato/0 (involves: C57BL/6N * FVB/N)	small spleen	J:203907
Plxna1^tm1Tmj/Plxna1^tm1Tmj (involves: 129S/SvEv)	abnormal lymphatic vessel endothelial cell morphology	J:226501
Plxna1^tm1Tmj/Plxna1^tm1Tmj (involves: 129S/SvEv)	abnormal lymphatic vessel morphology	J:226501
Plxna2^tm1Hfu/Plxna2^tm1Hfu (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal lymphatic vessel morphology	J:226501
Plxna4^em1(IMPC)Mbp/Plxna4^em1(IMPC)Mbp (C57BL/6NCrl-Plxna4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Plxnc1^em1(IMPC)Mbp/Plxnc1^em1(IMPC)Mbp (C57BL/6N-Plxnc1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Plxnd1^b2b1863Clo/Plxnd1^b2b1863Clo (C57BL/6J-Plxnd1^b2b1863Clo)	thymus hypoplasia	J:175213
Plxnd1^b2b3150Clo/Plxnd1^b2b3150Clo (C57BL/6J-Plxnd1^b2b3150Clo)	thymus hypoplasia	J:175213
Pmaip1^tm1Ast/Pmaip1^tm1Ast (C57BL/6-Pmaip1^tm1Ast)	abnormal NK cell morphology	J:123409
Pmepa1^em1Akt/Pmepa1^em1Akt (C57BL/6N-Pmepa1^em1Akt)	abnormal osteoclast differentiation	J:329578
Pmepa1^em1Akt/Pmepa1^em1Akt (C57BL/6N-Pmepa1^em1Akt)	decreased osteoclast cell number	J:329578
Pml^{tm1(PML/RARA)Ley}/Pml⁺ Tg(CAG-cre/Esr1)5Amc/0 (involves: BALB/cJ C57BL/6 * CBA)	enlarged spleen	J:172024
Pml^tm1.1Ews/Pml^tm1.1Ews (involves: 129 * 129P2/OlaHsd)	increased T cell derived lymphoma incidence	J:262172
Pml^tm1.1Ews/Pml^tm1.1Ews Tg(PML-RARA)556Kog/0 (FVB.Cg-Pml^tm1.1Ews Tg(PML-RARA)556Kog)	enlarged spleen	J:262172
	increased leukocyte cell number	J:262172
Pml^tm1Ppp/Pml⁺ Trp53^tm3.1Glo/Trp53⁺ (B6.129S7(Cg)-Pml^tm1Ppp Trp53^tm3.1Glo)	hepatosplenomegaly	J:317504
	increased T cell derived lymphoma incidence	J:317504
Pml^tm1Ppp/Pml^tm1Ppp (involves: 129S7/SvEvBrd)	abnormal immune system cell morphology	J:46381
	abnormal myelopoiesis	J:46381
	decreased granulocyte number	J:46381
	decreased leukocyte cell number	J:46381
Pml^tm1Ppp/Pml^tm1Ppp Trp53^tm3.1Glo/Trp53⁺ (B6.129S7(Cg)-Pml^tm1Ppp Trp53^tm3.1Glo)	hepatosplenomegaly	J:317504
	increased T cell derived lymphoma incidence	J:317504
Pmm2^{tm1b(EUCOMM)Hmgu}/Pmm2⁺ (C57BL/6N-Pmm2^{tm1b(EUCOMM)Hmgu}/Tcp)	enlarged lymph nodes	J:211773
Pms2^tm1.1Wed/Pms2^tm1.1Wed (involves: 129S6/SvEvTac * C57BL/6NCr)	abnormal class switch recombination	J:162378
	increased T cell derived lymphoma incidence	J:162378
Pms2^tm1Lisk/Pms2^tm1Lisk (involves: 129S2/SvPas)	abnormal class switch recombination	J:162378
Pnp^bata/Pnp^bata (C57BL/6JSfdAnu-Pnp^bata)	decreased marginal zone B cell number	J:104190
Pnp^bata/Pnp^bata (C57BL/6JSfdAnu-Pnp^bata)	increased T follicular helper cell number	J:104190
Pnp^e/Pnp^e (C57BL/6J-Pnp^e)	thymus hypoplasia	J:39328
Pnp^f/Pnp^f (involves: C3H/HeHa * C57BL/6J)	increased double-negative T cell number	J:522
Pnp^f/Pnp^f (C57BL/6J-Pnp^f)	abnormal leukocyte cell number	J:39328
	decreased CD8-positive, alpha-beta T cell number	J:39328
	decreased double-positive T cell number	J:39328
	thymus hypoplasia	J:39328
Pnp^g/Pnp^g (involves: C57BL/6 * DBA/2J)	abnormal leukocyte cell number	J:39328
	decreased CD8-positive, alpha-beta T cell number	J:39328
	decreased double-positive T cell number	J:39328
	increased double-negative T cell number	J:39328
	thymus hypoplasia	J:39328
Pnp^m2Btlr/Pnp^m2Btlr (C57BL/6J-Pnp^m2Btlr)	decreased B-1a cell number	J:265150
	decreased B-2 B cell number	J:265150
	decreased CD4-positive, alpha-beta T cell number	J:265150
	decreased CD8-positive, naive alpha-beta T cell number	J:265150
	decreased T cell number	J:265150
	increased B-1b cell number	J:265150
	increased CD8-positive, alpha-beta memory T cell number	J:265150
	increased central memory CD4-positive, alpha-beta T cell number	J:265150
	increased central memory CD8 positive, alpha-beta T cell number	J:265150
	increased effector memory CD4-positive, alpha-beta T cell number	J:265150
	increased effector memory CD8-positive, alpha-beta T cell number	J:265150
Pnp^tm1Cmr/Pnp^tm1Cmr (involves: 129)	abnormal myelopoiesis	J:62870
	decreased CD4-positive, alpha-beta T cell number	J:62870
	decreased CD8-positive, alpha-beta T cell number	J:62870
	decreased double-positive T cell number	J:62870
	decreased single-positive T cell number	J:62870
	increased double-negative T cell number	J:62870
	increased pre-B cell number	J:62870
Pnpla5^em1(IMPC)Mbp/Pnpla5^em1(IMPC)Mbp (C57BL/6N-Pnpla5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Podxl2^{tm1.1(KOMP)Vlcg}/Podxl2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Podxl2^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Polb^tm1.1Jbsw/Polb⁺ (involves: 129/Sv * C57BL/6)	enlarged cervical lymph nodes	J:206872
Polb^tm1.1Jbsw/Polb^tm1.1Jbsw (involves: 129/Sv * C57BL/6)	abnormal immunoglobulin heavy chain V(D)J recombination	J:206872
	abnormal somatic hypermutation frequency	J:206872
	abnormal spleen germinal center morphology	J:206872
	enlarged cervical lymph nodes	J:206872
	increased germinal center B cell number	J:206872
	increased spleen germinal center number	J:206872
	increased T-helper 2 cell number	J:206872
Polb^{tm1a(KOMP)Wtsi}/Polb^{tm1a(KOMP)Wtsi} (C57BL/6N-Polb^{tm1a(KOMP)Wtsi}/Wtsi)	abnormal lymphatic vessel topology	J:239583
Pold1^tm1.1Bdp/Pold1^tm1.1Bdp (B6.129-Pold1^tm1.1Bdp)	increased T cell derived lymphoma incidence	J:153684
Pold1^tm1.1Bdp/Pold1^tm1.1Bdp Pole^tm1.1Bdp/Pole^tm1.1Bdp (B6.129-Pole^tm1.1Bdp Pold1^tm1.1Bdp)	increased T cell derived lymphoma incidence	J:153684
Pold1^tm1.1Uchi/Pold1^tm1.1Uchi (C57BL/6-Pold1^tm1.1Uchi)	enlarged thymus	J:144992
Pold1^tm1Bdp/Pold1^tm1Bdp (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	increased T cell derived lymphoma incidence	J:100685
Pold1^tm1Uchi/Pold1^tm1.1Uchi (C57BL/6-Pold1^tm1Uchi/Pold1^tm1.1Uchi)	enlarged thymus	J:144992
Pold4^em1(IMPC)J/Pold4^em1(IMPC)J (C57BL/6NJ-Pold4^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Pole2^em1(IMPC)Mbp/Pole2⁺ (C57BL/6NCrl-Pole2^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Pole3^em1Tbo/Pole3^em1Tbo (FVB-Pole3^em1Tbo)	decreased B cell number	J:298827
	decreased lymphocyte cell number	J:298827
	decreased splenocyte number	J:298827
	decreased thymocyte number	J:298827
Pole3^em2Tbo/Pole3^em2Tbo (FVB-Pole3^em2Tbo)	decreased B cell number	J:298827
	decreased lymphocyte cell number	J:298827
	decreased splenocyte number	J:298827
	decreased thymocyte number	J:298827
Pole3^em3Tbo/Pole3^em3Tbo (FVB-Pole3^em3Tbo)	decreased B cell number	J:298827
	decreased DN4 thymocyte number	J:298827
	decreased double-positive T cell number	J:298827
	decreased gamma-delta T cell number	J:298827
	decreased immature B cell number	J:298827
	decreased lymphocyte cell number	J:298827
	decreased pre-B cell number	J:298827
	decreased splenocyte number	J:298827
	decreased thymocyte number	J:298827
	increased DN3 thymocyte number	J:298827
	small spleen	J:298827
	small thymus	J:298827
Pole3^em4Tbo/Pole3^em4Tbo (FVB-Pole3^em4Tbo)	decreased B cell number	J:298827
	decreased DN4 thymocyte number	J:298827
	decreased immature B cell number	J:298827
	decreased lymphocyte cell number	J:298827
	decreased pre-B cell number	J:298827
	decreased splenocyte number	J:298827
	decreased thymocyte number	J:298827
	increased DN3 thymocyte number	J:298827
Pole3^{tm1(KOMP)Vlcg}/Pole3^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac * FVB)	decreased DN4 thymocyte number	J:298827
	increased DN3 thymocyte number	J:298827
Pole4^{tm1(KOMP)Vlcg}/Pole4^{tm1(KOMP)Vlcg} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N)	abnormal B cell differentiation	J:261973
	abnormal mesenteric lymph node morphology	J:261973
	abnormal spleen B cell follicle morphology	J:261973
	abnormal T cell differentiation	J:261973
	abnormal thymus morphology	J:261973
	absent thymus cortex	J:261973
	arrested B cell differentiation	J:261973
	athymia	J:261973
	decreased B cell number	J:261973
	decreased leukocyte cell number	J:261973
	decreased lymphocyte cell number	J:261973
	decreased single-positive T cell number	J:261973
	decreased spleen weight	J:261973
	increased double-negative T cell number	J:261973
	increased granulocyte number	J:261973
	increased monocyte cell number	J:261973
	increased T cell derived lymphoma incidence	J:261973
	small spleen	J:261973
Pole4^{tm1(KOMP)Vlcg}/Pole4^{tm1(KOMP)Vlcg} Trp53^tm1Brd/Trp53⁺ (involves: C57BL/6J * C57BL/6NTac)	decreased leukocyte cell number	J:261973
	decreased lymphocyte cell number	J:261973
	increased granulocyte number	J:261973
	increased monocyte cell number	J:261973
	increased T cell derived lymphoma incidence	J:261973
Pole^tm1.1Bdp/Pole^tm1.1Bdp (B6.129-Pole^tm1.1Bdp)	enlarged spleen	J:153684
Polg^tm1Prol/Polg^tm1Prol (B6J.129S7-Polg^tm1Prol)	abnormal lymphopoiesis	J:154187
	decreased double-positive T cell number	J:154187
	decreased immature B cell number	J:154187
	decreased lymphocyte cell number	J:154187
	decreased mature B cell number	J:154187
	decreased pre-B cell number	J:154187
	decreased pro-B cell number	J:154187
	decreased thymocyte number	J:154187
Poll^tm1Crey/Poll^tm1Crey (involves: 129P2/OlaHsd)	abnormal immunoglobulin heavy chain V(D)J recombination	J:113406
Poll^tm1Crey/Poll^tm1Crey Polm^tm1Crey/Polm^tm1Crey (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:113406
	abnormal immunoglobulin heavy chain V(D)J recombination	J:113406
	abnormal immunoglobulin light chain V-J recombination	J:113406
	decreased B cell number	J:113406
Polm^m1Btlr/Polm^m1Btlr (C57BL/6J-Polm^m1Btlr)	decreased B cell number	J:272866
Polm^m2Btlr/Polm^m2Btlr (C57BL/6J-Polm^m2Btlr)	abnormal lymphocyte morphology	J:272867
Polm^m2Btlr/Polm^m2Btlr (C57BL/6J-Polm^m2Btlr)	decreased B cell number	J:272867
Polm^tm1Abnd/Polm^tm1Abnd (involves: 129/Sv * BALB/c)	abnormal B cell number	J:97782
Polm^tm1Crey/Polm^tm1Crey (involves: 129P2/OlaHsd * C57BL/6)	abnormal Peyer's patch morphology	J:85190
	decreased B cell number	J:75927, J:85190
	lymphoid hypoplasia	J:85190
Polm^tm1Crey/Polm^tm1Crey (involves: 129P2/OlaHsd)	abnormal immunoglobulin light chain V-J recombination	J:113406
Polq^em1(IMPC)Mbp/Polq^em1(IMPC)Mbp (C57BL/6N-Polq^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Polq^tm1Jcs/Polq^tm1Jcs (involves: 129S4/SvJae * C57BL/6J)	abnormal somatic hypermutation frequency	J:103365
Polq^tm1Jow/Polq^tm1Jow (involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)	abnormal somatic hypermutation frequency	J:101409
Polq^tm2Jow/Polq^tm2Jow (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal somatic hypermutation frequency	J:115989
Polr1b^em1(IMPC)Tcp/Polr1b⁺ (C57BL/6NCrl-Polr1b^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Polr2a^{tm1(cre/ERT2)Bbd}/Polr2a⁺ Rnf2^tm1Mvi/Rnf2^tm1Mvi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10 * SJL)	decreased B cell number	J:130397
Polr3a^em2(IMPC)Tcp/Polr3a⁺ (C57BL/6NCrl-Polr3a^em2(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Polrmt^em1(IMPC)Mbp/Polrmt⁺ (C57BL/6N-Polrmt^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Pomc^{em1(IMPC)Rbrc}/Pomc⁺ (C57BL/6NJcl-Pomc^{em1(IMPC)Rbrc}/Rbrc)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Pomk^{em1(IMPC)Hmgu}/Pomk⁺ (C57BL/6NCrl-Pomk^{em1(IMPC)Hmgu}/Ieg)	increased spleen weight	J:211773
Pomt1^{Gt(OST194127)Lex}/Pomt1⁺ (involves: 129S5/SvEvBrd * C57BL/6J)	increased neutrophil cell number	J:103485
Postn^tm1Sjc/Postn^tm1Sjc (B6.Cg-Postn^tm1Sjc)	increased osteoclast cell number	J:200192
Pot1b^tm1.1Schg/Pot1b^tm1.1Schg Terc^tm1Rdp/Terc⁺ (involves: 129/Sv * 129S6/SvEvTac * C57BL/6 * SJL)	abnormal granulocyte morphology	J:144553
	decreased granulocyte number	J:144553
	decreased leukocyte cell number	J:144553
Pot1b^tm1.1Schg/Pot1b^tm1.1Schg Terc^tm1Rdp/Terc^tm1Rdp (involves: 129/Sv * 129S6/SvEvTac * C57BL/6 * SJL)	abnormal granulocyte morphology	J:144553
Pou1f1^dw/Pou1f1^dw (DW/J Pou1f1^dw)	decreased B cell number	J:110683
Pou2af1^{tm1b(KOMP)Wtsi}/Pou2af1^{tm1b(KOMP)Wtsi} (C57BL/6N-Pou2af1^{tm1b(KOMP)Wtsi}/Ucd)	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	increased neutrophil cell number	J:211773
Pou2af1^tm1Pjln/Pou2af1^tm1Pjln (C57BL/6-Pou2af1^tm1Pjln)	absent spleen germinal center	J:37085
	decreased B cell number	J:37085
	spleen hypoplasia	J:37085
Pou2af1^tm1Pjln/Pou2af1^tm1Pjln (involves: C57BL/6)	abnormal B cell differentiation	J:67362
	decreased B cell number	J:123039, J:67362
	decreased immature B cell number	J:67362
	decreased mature B cell number	J:67362
	decreased T cell number	J:123039
Pou2af1^tm1Pjln/Pou2af1^tm1Pjln Tg(tetO-Pou2af1)1Pjln/0 Tg(tTA)1Pjln/0 (involves: C57BL/6)	decreased B cell number	J:67362
	decreased mature B cell number	J:67362
Pou2af1^tm1Pmt/Pou2af1^tm1Pmt Ikzf3^tm1Kge/Ikzf3^tm1Kge (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	absent spleen germinal center	J:81805
	arrested B cell differentiation	J:81805
Pou2af1^tm1Rgr/Pou2af1^tm1Rgr (either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv))	abnormal B cell differentiation	J:114816, J:35785
	abnormal Peyer's patch germinal center morphology	J:35785
	abnormal pre-B cell morphology	J:114816
	absent lymph node germinal center	J:35785
	absent spleen germinal center	J:35785
	arrested B cell differentiation	J:114816
	decreased B cell number	J:114816
Pou2af3^{tm1b(NCOM)Mfgc}/Pou2af3^{tm1b(NCOM)Mfgc} (C57BL/6N-Pou2af3^{tm1b(NCOM)Mfgc}/Tcp)	decreased lymphocyte cell number	J:211773
	increased leukocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Pou2f2^tm1Bal/Pou2f2⁺ (involves: 129S2/SvPas)	decreased mature B cell number	J:4555
Pou2f2^tm1Bal/Pou2f2^tm1Bal (involves: 129S2/SvPas * C57BL/6)	arrested B cell differentiation	J:88240
	decreased B cell number	J:88240
Pou2f2^tm1Bal/Pou2f2^tm1Bal (involves: 129S2/SvPas)	decreased mature B cell number	J:4555
Pou2f2^tm1Lmc/Pou2f2^tm1Lmc (involves: C57BL/6)	arrested B cell differentiation	J:88240
	decreased B cell number	J:88240
	decreased B-1 B cell number	J:88240
Ppard^tm1Dsvg/Ppard^tm1Dsvg (involves: 129S2/SvPas * C57BL/6)	increased osteoclast cell number	J:219677
Pparg^tm1.1Gonz/Pparg^tm1.1Gonz Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)	abnormal peritoneal macrophage morphology	J:168799
Pparg^tm1Tka/Pparg⁺ (involves: C57BL/6 * CBA)	abnormal bone marrow development	J:89250
Pparg^tm2Rev/Pparg^tm2Rev Tg(Cd4-cre)1Cwi/? (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal T-helper 17 cell differentiation	J:153358
Pparg^tm2Rev/Pparg^tm2Rev Tg(Tek-cre)1Ywa/? (involves: 129S4/SvJae * C57BL/6 * SJL)	abnormal osteoclast differentiation	J:160910
	abnormal osteoclast morphology	J:130475
	abnormal spleen morphology	J:130475
	abnormal splenocyte morphology	J:130475
	decreased osteoclast cell number	J:130475
	enlarged spleen	J:130475
	increased splenocyte number	J:130475
Pparg^tm2Rev/Pparg^tm2Rev Tg(Tek-cre)12Flv/? (B6.Cg-Pparg^tm2Rev Tg(Tek-cre)12Flv)	enlarged spleen	J:154216
Ppargc1a^tm1Aztc/Ppargc1a⁺ (C57BL/6-Ppargc1a^tm1Aztc)	increased thymus weight	J:82809
Ppargc1b^tm1.2Rev/Ppargc1b^tm1.2Rev Tg(Tek-cre)1Ywa/0 (involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)	abnormal osteoclast differentiation	J:160910
Ppbp^{tm1.1(KOMP)Vlcg}/Ppbp^{tm1.1(KOMP)Vlcg} (C57BL/6N-Ppbp^{tm1.1(KOMP)Vlcg}/Ucd)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Ppfibp2^em1(IMPC)Tcp/Ppfibp2^em1(IMPC)Tcp (C57BL/6NCrl-Ppfibp2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Ppia^em1(IMPC)Mbp/Ppia^em1(IMPC)Mbp (C57BL/6NCrl-Ppia^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Ppia^tm1Lubn/Ppia^tm1Lubn (129S6.129P2-Ppia^tm1Lubn)	increased T cell number	J:93591
Ppia^tm1Lubn/Ppia^tm1Lubn (129S6.129P2-Ppia^tm1Lubn)	spleen hyperplasia	J:93591
Ppic^em1Igc/Ppic^em1Igc (C57BL/6-Ppic^em1Igc)	decreased NK cell number	J:321155
	increased transitional stage T1 B cell number	J:321155
	increased transitional stage T2 B cell number	J:321155
Ppil1^em1(IMPC)Mbp/Ppil1⁺ (C57BL/6N-Ppil1^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Ppl^{tm1b(KOMP)Wtsi}/Ppl^{tm1b(KOMP)Wtsi} (C57BL/6N-Ppl^{tm1b(KOMP)Wtsi}/Tcp)	enlarged lymph nodes	J:211773
Ppm1d^tm1Lad/Ppm1d^tm1Lad (involves: 129S7/SvEvBrd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:74284
	enlarged spleen	J:74284
	increased CD4-positive, alpha-beta T cell number	J:74284
	lymphoid hyperplasia	J:74284
	myeloid hyperplasia	J:74284
	small thymus	J:74284
	spleen hyperplasia	J:74284
Ppm1m^{tm2b(EUCOMM)Hmgu}/Ppm1m^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Ppm1m^{tm2b(EUCOMM)Hmgu}/Bay)	decreased large unstained cell number	J:211773
Ppm1n^em1(IMPC)Mbp/Ppm1n^em1(IMPC)Mbp (C57BL/6N-Ppm1n^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Ppp1r13b^tm1Suda/Ppp1r13b^tm1Suda (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal lymphatic vessel morphology	J:135686
Ppp1r13b^tm1Suda/Ppp1r13b^tm1Suda Trp53^tm1Sia/Trp53^tm1Sia (involves: various)	abnormal lymphatic vessel morphology	J:135686
Ppp1r15a^tm1.1Ajf/Ppp1r15a^tm1.1Ajf (involves: 129 * C57BL/6)	abnormal splenic cell ratio	J:106905
	increased spleen weight	J:106905
Ppp1r17^em1(IMPC)H/Ppp1r17^em1(IMPC)H (C57BL/6NTac-Ppp1r17^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Ppp1r18^em1Mgin/Ppp1r18^em1Mgin (B6J.B6N-Ppp1r18^em1Mgin)	decreased B cell number	J:331428
	decreased T cell number	J:331428
	increased leukocyte cell number	J:331428
	increased neutrophil cell number	J:331428
	small spleen	J:331428
	spleen hypoplasia	J:331428
Ppp1r18^em3Mgin/Ppp1r18^em3Mgin (B6J.B6N-Ppp1r18^em3Mgin)	decreased B cell number	J:331428
	decreased T cell number	J:331428
	increased leukocyte cell number	J:331428
	increased neutrophil cell number	J:331428
	small spleen	J:331428
	spleen hypoplasia	J:331428
Ppp2r1b^{tm1b(EUCOMM)Wtsi}/Ppp2r1b^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ppp2r1b^{tm1b(EUCOMM)Wtsi}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Ppp2r2b^{tm1b(KOMP)Wtsi}/Ppp2r2b^{tm1b(KOMP)Wtsi} (C57BL/6N-Ppp2r2b^{tm1b(KOMP)Wtsi}/Tcp)	increased leukocyte cell number	J:211773
	increased monocyte cell number	J:211773
Ppp2r2d^em1(IMPC)Mbp/Ppp2r2d^em1(IMPC)Mbp (C57BL/6N-Ppp2r2d^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Ppp2r3c^tm1Imku/Ppp2r3c^tm1Imku Tg(CD19-cre/ERT2)1Cgn/? (involves: C57BL/6)	decreased B cell number	J:100706
	decreased B-1a cell number	J:100706
	decreased follicular B cell number	J:100706
	decreased immature B cell number	J:100706
	decreased mature B cell number	J:100706
	decreased pre-B cell number	J:100706
	decreased spleen germinal center size	J:100706
	decreased transitional stage B cell number	J:100706
	increased pro-B cell number	J:100706
	increased T cell number	J:100706
	increased transitional stage B cell number	J:100706
	small spleen	J:100706
Ppp2r5a^em1(IMPC)Mbp/Ppp2r5a^em1(IMPC)Mbp (C57BL/6N-Ppp2r5a^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Ppp2r5a^{Gt(IST13127C10)Tigm}/Ppp2r5a^{Gt(IST13127C10)Tigm} (C57BL/6N-Ppp2r5a^{Gt(IST13127C10)Tigm})	enlarged mesenteric lymph nodes	J:254808
	enlarged spleen	J:254808
Ppp2r5c^em1(IMPC)Mbp/Ppp2r5c^em1(IMPC)Mbp (C57BL/6N-Ppp2r5c^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Ppp3cb^{em1(IMPC)Ccpcz}/Ppp3cb^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ppp3cb^{em1(IMPC)Ccpcz}/Ccpcz)	decreased CD4-positive NK T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK T cell number	J:211773
	decreased T-helper cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
Ppp3cb^M3Btlr/Ppp3cb⁺ (C57BL/6J-Ppp3cb^M3Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:254889
Ppp3cb^M3Btlr/Ppp3cb⁺ (C57BL/6J-Ppp3cb^M3Btlr)	increased central memory CD4-positive, alpha-beta T cell number	J:254889
Ppp3cb^M3Btlr/Ppp3cb^M3Btlr (C57BL/6J-Ppp3cb^M3Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:254889
	decreased CD8-positive, naive alpha-beta T cell number	J:254889
	increased central memory CD4-positive, alpha-beta T cell number	J:254889
	increased central memory CD8 positive, alpha-beta T cell number	J:254889
Ppp3cb^M4Btlr/Ppp3cb⁺ (C57BL/6J-Ppp3cb^M4Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:254905
Ppp3cb^M4Btlr/Ppp3cb⁺ (C57BL/6J-Ppp3cb^M4Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:254905
Ppp3cb^M4Btlr/Ppp3cb^M4Btlr (C57BL/6J-Ppp3cb^M4Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:254905
Ppp3cb^M4Btlr/Ppp3cb^M4Btlr (C57BL/6J-Ppp3cb^M4Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:254905
Ppp3cb^m5Btlr/Ppp3cb^m5Btlr (C57BL/6J-Ppp3cb^m5Btlr)	abnormal T cell morphology	J:272839
Ppp3cb^m5Btlr/Ppp3cb^m5Btlr (C57BL/6J-Ppp3cb^m5Btlr)	decreased CD8-positive, alpha-beta T cell number	J:272839
Ppp3cb^M6Btlr/Ppp3cb^M6Btlr (C57BL/6J-Ppp3cb^M6Btlr)	abnormal lymphocyte morphology	J:272840
	decreased alpha-beta T cell number	J:272840
	decreased CD4-positive, alpha-beta T cell number	J:272840
	decreased CD8-positive, alpha-beta T cell number	J:272840
Ppp3cb^tm1Jmk/Ppp3cb^tm1Jmk (involves: 129S6/SvEvTac * C57BL/6)	abnormal T cell differentiation	J:77729
	decreased single-positive T cell number	J:77729
	decreased T cell number	J:77729
	decreased thymus weight	J:75775
	thymus hypoplasia	J:77729
Ppp3r1^tm2Grc/Ppp3r1^tm2.1Grc Tg(Lck-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal lymph node cell ratio	J:89771
	abnormal positive T cell selection	J:89771
	abnormal splenic cell ratio	J:89771
Ppp3r1^tm2Grc/Ppp3r1^tm2Grc Tg(Lck-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	decreased thymocyte number	J:89771
	thymus hypoplasia	J:89771
Ppp4c^tm1Tht/Ppp4c^tm1Tht Tg(Lck-cre)548Jxm/0 (involves: C57BL/6 * CBA)	abnormal positive T cell selection	J:117684
	abnormal T cell differentiation	J:117684
	decreased CD4-positive, alpha-beta T cell number	J:117684
	decreased CD8-positive, alpha-beta T cell number	J:117684
	decreased double-positive T cell number	J:117684
	decreased single-positive T cell number	J:117684
	increased double-negative T cell number	J:117684
Ppp4c^tm1Tht/Ppp4c^tm1Tht Tg(Lck-cre)548Jxm/0 Tg(TcraTcrb)425Cbn/0 (involves: BALB/c * C57BL/6 * CBA)	abnormal positive T cell selection	J:117684
	decreased double-positive T cell number	J:117684
	decreased single-positive T cell number	J:117684
Ppp4r3b^{tm1b(EUCOMM)Hmgu}/Ppp4r3b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ppp4r3b^{tm1b(EUCOMM)Hmgu}/Ieg)	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Ppp5c^tm1.2Rhon/Ppp5c^tm1.2Rhon (B6.129X1-Ppp5c^tm1.2Rhon)	enlarged spleen	J:178164
Ppp5c^{tm1a(EUCOMM)Wtsi}/Ppp5c^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased CD4-positive, alpha-beta T cell number	J:213427
	increased CD8-positive, alpha-beta T cell number	J:213427
	increased T cell number	J:213427
	lymphoid hyperplasia	J:213427
Ppt1^tm1Aj/Ppt1^tm1Aj (involves: 129S4/SvJae * C57BL/6)	abnormal spleen morphology	J:95522
Ppt1^tm1Hof/Ppt1^tm1Hof (involves: 129S6/SvEvTac * C57BL/6J)	microgliosis	J:280337
Ppt2^tm1Hof/Ppt2^tm1Hof (involves: 129S6/SvEvTac * C57BL/6J)	abnormal spleen morphology	J:86202
	decreased spleen B cell follicle number	J:86202
	enlarged spleen	J:86202
	increased macrophage cell number	J:86202
	increased spleen weight	J:86202
Pramel1^em1(IMPC)Tcp/Pramel1^em1(IMPC)Tcp (C57BL/6NCrl-Pramel1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Pramel12^em1(IMPC)Mbp/Pramel12^em1(IMPC)Mbp (C57BL/6N-Pramel12^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Prdm1^tm1.1Liz/Prdm1^tm1.1Liz (involves: 129S/SvEv)	absent plasma cells	J:196531
Prdm1^tm1Clme/Prdm1^tm1Clme Tg(Itgax-cre)1-1Reiz/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	abnormal T follicular helper cell differentiation	J:178876
	increased germinal center B cell number	J:178876
	increased spleen germinal center number	J:178876
	increased splenocyte number	J:178876
	increased T follicular helper cell number	J:178876
Prdm4^{tm1b(EUCOMM)Hmgu}/Prdm4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Prdm4^{tm1b(EUCOMM)Hmgu}/H)	absent spleen	J:211773
Prdm8^{em1(IMPC)Wtsi}/Prdm8⁺ (C57BL/6N-Prdm8^{em1(IMPC)Wtsi}/Wtsi)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Prdm8^{em1(IMPC)Wtsi}/Prdm8^{em1(IMPC)Wtsi} (C57BL/6N-Prdm8^{em1(IMPC)Wtsi}/Wtsi)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Prdm11^tm1.1Ahl/Prdm11^tm1.1Ahl (B6.129(C)-Prdm11^tm1.1Ahl)	decreased CD4-positive, alpha-beta T cell number	J:233986
	decreased neutrophil cell number	J:233986
	increased B cell number	J:233986
Prdm13^em1(IMPC)Tcp/Prdm13^em1(IMPC)Tcp (C57BL/6NCrl-Prdm13^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	increased spleen weight	J:211773
Prdm14^{tm1a(EUCOMM)Wtsi}/Prdm14^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Prdm14^{tm1a(EUCOMM)Wtsi}/Bay)	increased effector memory T-helper cell number	J:211773
Prdm16^{Gt(OST67423)Lex}/Prdm16⁺ (involves: 129S5/SvEvBrd * C57BL/6J)	increased leukocyte cell number	J:103485
Prdm16^tm1.1Brsp/Prdm16^tm1.1Brsp Tg(Adipoq-cre)1Evdr/0 (involves: 129/Sv * C57BL/6 * FVB/N)	increased macrophage cell number	J:208683
Prdx1^flro/Prdx1^flro (C57BL/10JAnu-Prdx1^flro/AnuApb)	abnormal lymphocyte morphology	J:104190
Prdx1^tm1Rave/Prdx1^tm1Rave (involves: 129S6/SvEvTac * C57BL/6)	abnormal NK T cell number	J:84677
	abnormal spleen morphology	J:84677
	enlarged spleen	J:84677
	increased spleen weight	J:84677
	increased T cell derived lymphoma incidence	J:84677
Prdx2^tm1Yu/Prdx2^tm1Yu (involves: 129S4/SvJae)	enlarged spleen	J:84271
	increased spleen red pulp amount	J:84271
	increased spleen weight	J:84271
Prep^{Gt(RRM213)Byg}/Prep⁺ (B6.129P2-Prep^{Gt(RRM213)Byg})	increased spleen weight	J:151643
Prex1^tm1Hcew/Prex1^tm1Hcew (involves: 129P2/OlaHsd * C57BL/6)	increased neutrophil cell number	J:102214
Prf1^tm1Clrk/Prf1^tm1Clrk (C.129S7(B6)-Prf1^tm1Clrk)	increased activated T cell number	J:71576
Prf1^tm1Sdz/Prf1^tm1Sdz (C57BL/6-Prf1^tm1Sdz/J)	abnormal lymph node morphology	J:92260
	abnormal spleen white pulp morphology	J:92260
	decreased leukocyte cell number	J:193137
	decreased neutrophil cell number	J:193137
	increased spleen red pulp amount	J:92260
	lymph node necrosis	J:92260
Prf1^tm1Sdz/Prf1^tm1Sdz (C.B6-Prf1^tm1Sdz)	increased T cell derived lymphoma incidence	J:77491
Prg2^tm1Nal/Prg2^tm1Nal (involves: 129P2/OlaHsd * 129X1/SvJ)	abnormal eosinophil morphology	J:65655
Primpol^em1Nki/Primpol^em1Nki (C57BL/6-Primpol^em1Nki)	abnormal somatic hypermutation frequency	J:242620
Prkaa1^tm1Sbj/Prkaa1^tm1Sbj (involves: 129)	increased spleen weight	J:147215
Prkaa2^{tm1b(EUCOMM)Hmgu}/Prkaa2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Prkaa2^{tm1b(EUCOMM)Hmgu}/H)	enlarged spleen	J:211773
Prkab1^em1(IMPC)Bay/Prkab1^em1(IMPC)Bay (C57BL/6N-Prkab1^em1(IMPC)Bay/Bay)	increased spleen weight	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1⁺ (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Ccpcz)	decreased Ly6C-positive mature NK cell number	J:211773
	decreased lymphocyte cell number	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Wtsi)	increased memory-marker CD4-negative NK T cell number	J:211773
	increased memory-marker gamma-delta T cell number	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Bay)	increased spleen weight	J:211773
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (involves: C57BL/6N)	enlarged spleen	J:236972
	increased spleen iron level	J:236972
	increased spleen red pulp amount	J:236972
	increased spleen weight	J:236972
Prkab1^{tm1b(KOMP)Wtsi}/Prkab1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkab1^{tm1b(KOMP)Wtsi}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Prkab2^{tm1b(EUCOMM)Hmgu}/Prkab2⁺ (C57BL/6N-Prkab2^{tm1b(EUCOMM)Hmgu}/H)	increased eosinophil cell number	J:211773
Prkag1^tm1.2Mfor/Prkag1^tm1.2Mfor (involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac * FVB/N)	abnormal Kupffer cell morphology	J:167779
	enlarged spleen	J:167779
	increased spleen iron level	J:167779
	increased spleen red pulp amount	J:167779
Prkar1a^tm2Gsm/Prkar1a^tm2Gsm Tg(Cr2-cre)3Cgn/0 (involves: 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:147785
Prkcb^M4Btlr/Prkcb^M4Btlr (C57BL/6J-Prkcb^M4Btlr)	decreased B-1 B cell number	J:274860
	increased CD4-positive, alpha-beta T cell number	J:274860
	increased CD8-positive, alpha-beta T cell number	J:274860
	increased T cell number	J:274860
Prkcb^M6Btlr/Prkcb^M6Btlr (C57BL/6J-Prkcb^M6Btlr)	decreased B-1 B cell number	J:274862
Prkcb^tilc/Prkcb^tilc (involves: C57BL/6JSfdAnu)	decreased B-1a cell number	J:221236
Prkcb^tm1Tara/Prkcb^tm1Tara (involves: 129)	decreased B cell number	J:34818
	decreased B-1 B cell number	J:34818
	decreased B-1a cell number	J:34818
Prkcd^m2Btlr/Prkcd^m2Btlr (C57BL/6J-Prkcd^m2Btlr)	increased NK cell number	J:265146
Prkcd^tm1Kin/Prkcd^tm1Kin (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymph node germinal center morphology	J:76135
	abnormal Peyer's patch germinal center morphology	J:76135
	abnormal plasma cell differentiation	J:143854
	enlarged lymph nodes	J:76135
	enlarged spleen	J:76135
	increased B cell number	J:76135
	increased follicular B cell number	J:143854
	increased marginal zone B cell number	J:143854
	increased spleen germinal center number	J:76135
	increased transitional stage B cell number	J:143854
Prkcd^tm1Msg/Prkcd^tm1Msg (involves: 129X1/SvJ * C57BL/6J)	decreased neutrophil cell number	J:91377
Prkcd^tm1Qxu/Prkcd^tm1Qxu (involves: 129P2/OlaHsd * C57BL/6)	enlarged lymph nodes	J:76134
	enlarged spleen	J:76134
	increased B cell number	J:76134
Prkcd^tm1Qxu/Prkcd^tm1Qxu Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen primary B follicle morphology	J:76134
	decreased B cell number	J:76134
	increased spleen germinal center number	J:76134
Prkce^m1Btlr/Prkce^m1Btlr (C57BL/6J-Prkce^m1Btlr)	decreased dendritic cell number	J:267703
Prkce^m1Btlr/Prkce^m1Btlr (C57BL/6J-Prkce^m1Btlr)	decreased NK cell number	J:267703
Prkch^tm1.2Gasc/Prkch^tm1.2Gasc (involves: C57BL/6 * FVB/N * SJL)	abnormal brachial lymph node morphology	J:186080
	abnormal cervical lymph node morphology	J:186080
	abnormal effector T cell morphology	J:186080
	abnormal lymph node morphology	J:186080
	decreased B cell number	J:186080
	decreased CD4-positive, alpha-beta T cell number	J:186080
	decreased CD8-positive, alpha-beta T cell number	J:186080
	decreased DN1 thymic pro-T cell number	J:186080
	decreased DN4 thymocyte number	J:186080
	decreased double-positive T cell number	J:186080
	decreased lymphocyte cell number	J:186080
	decreased T cell number	J:186080
	enlarged axillary lymph nodes	J:186080
	enlarged cervical lymph nodes	J:186080
	enlarged inguinal lymph nodes	J:186080
	enlarged lymph nodes	J:186080
	increased B cell number	J:186080
	increased CD4-positive, alpha-beta T cell number	J:186080
	increased CD8-positive, alpha-beta T cell number	J:186080
	increased memory T cell number	J:186080
	increased T cell number	J:186080
	thymus hypoplasia	J:186080
Prkch^tm1.2Gasc/Prkch^tm1.2Gasc Prkcq^tm1Litt/Prkcq^tm1Litt (involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)	abnormal positive T cell selection	J:186080
	decreased CD4-positive, alpha-beta T cell number	J:186080
	decreased CD8-positive, alpha-beta T cell number	J:186080
	decreased DN1 thymic pro-T cell number	J:186080
	decreased DN4 thymocyte number	J:186080
	decreased double-negative T cell number	J:186080
	decreased double-positive T cell number	J:186080
Prkcq^tm1Litt/Prkcq^tm1Litt (B6.129P2-Prkcq^tm1Litt)	abnormal T-helper 1 cell differentiation	J:94285
Prkcq^tm1Litt/Prkcq^tm1Litt (involves: 129P2/OlaHsd * C57BL/6)	abnormal effector T cell morphology	J:186080
	abnormal positive T cell selection	J:186080
	decreased CD4-positive, alpha-beta T cell number	J:186080
	decreased CD8-positive, alpha-beta T cell number	J:186080
	decreased DN1 thymic pro-T cell number	J:186080
	decreased NK T cell number	J:141128
Prkcq^tm1Litt/Prkcq^tm1Litt Tg(Lck-Notch3)#Issc/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	enlarged spleen	J:96010
	increased spleen weight	J:96010
Prkcq^tm1Litt/Prkcq^tm1Litt Tg(LCKprBCL2L1)12Sjk/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased NK T cell number	J:141128
Prkcz^tm1Jmos/Prkcz^tm1Jmos (involves: 129P2/OlaHsd * 129/Sv)	abnormal Peyer's patch follicle morphology	J:72720
	abnormal Peyer's patch morphology	J:72720
	abnormal spleen marginal zone morphology	J:72720
	decreased B cell number	J:72720
	decreased spleen B cell follicle size	J:72720
	small Peyer's patches	J:72720
Prkd1^{em2(IMPC)Wtsi}/Prkd1⁺ (C57BL/6N-Prkd1^{em2(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Prkd2^tm1.1Shoy/Prkd2^tm1.1Shoy Prkd3^tm1.1Shoy/Prkd3^tm1.1Shoy Tg(BCL2)25Wehi/0 Tg(Lck-cre)1Jtak/0 (involves: 129 * C57BL/6 * C57BL/6JWehi * SJL/JWehi)	decreased thymocyte number	J:236298
Prkd2^tm1.1Shoy/Prkd2^tm1.1Shoy Prkd3^tm1.1Shoy/Prkd3^tm1.1Shoy Tg(Lck-cre)1Jtak/0 (involves: 129 * C57BL/6)	decreased thymocyte number	J:236298
	small thymus medulla	J:236298
Prkd2^tm1.1Shoy/Prkd2^tm1.1Shoy Prkd3^tm1.1Shoy/Prkd3^tm1.1Shoy Tg(Lck-cre)1Jtak/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)	decreased thymocyte number	J:236298
	increased double-positive T cell number	J:236298
Prkd2^tm1.1Shoy/Prkd2^tm1.1Shoy Prkd3^tm1.1Shoy/Prkd3^tm1.1Shoy Tg(Lck-cre)1Jtak/0 Tg(TcraTcrb)425Cbn/0 (involves: 129 * BALB/c * C57BL/6)	decreased thymocyte number	J:236298
Prkd2^tm1.1Shoy/Prkd2^tm1.1Shoy Prkd3^tm1.1Shoy/Prkd3^tm1.1Shoy Tg(Lck-cre)1Jtak/0 Tg(TcraTcrb)1100Mjb/0 (involves: 129 * C57BL/6)	decreased thymocyte number	J:236298
Prkdc^berty/Prkdc^berty (C57BL/6JAnu-Prkdc^berty)	absent B cells	J:104190
Prkdc^berty/Prkdc^berty (C57BL/6JAnu-Prkdc^berty)	absent T cells	J:104190
Prkdc^em2(IMPC)Ics/Prkdc^em2(IMPC)Ics (C57BL/6N-Prkdc^em2(IMPC)Ics/Ics)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Prkdc^hanky/Prkdc^hanky (either: C57BL/6JAnu or (involves: C57BL/6JAnu * CBA/CaJ))	decreased lymphocyte cell number	J:104190
	enlarged mesenteric lymph nodes	J:104190
	increased plasma cell number	J:104190
	lymph node hyperplasia	J:104190
	myeloid hyperplasia	J:104190
Prkdc^m1Anu/Prkdc^m1Anu (C57BL/6JAnu-Prkdc^m1Anu)	abnormal lymphocyte morphology	J:104190
Prkdc^m1Btlr/Prkdc^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
Prkdc^m1Btlr/Prkdc^m1Btlr (involves: C57BL/6J)	decreased B cell number	J:185495
Prkdc^m2Btlr/Prkdc^m2Btlr (C57BL/6J-Prkdc^m2Btlr)	decreased B cell number	J:204502
	decreased CD4-positive, alpha-beta T cell number	J:204502
	decreased CD8-positive, alpha-beta T cell number	J:204502
Prkdc^m4Btlr/Prkdc^m4Btlr (C57BL/6J-Prkdc^m4Btlr)	decreased B cell number	J:255217
	increased B-1b cell number	J:255217
	increased neutrophil cell number	J:255217
Prkdc^m5Btlr/Prkdc^m5Btlr (C57BL/6J-Prkdc^m5Btlr)	increased alpha-beta T cell number	J:255220
Prkdc^m5Btlr/Prkdc^m5Btlr (C57BL/6J-Prkdc^m5Btlr)	increased CD4-positive, alpha-beta T cell number	J:255220
Prkdc^m6Btlr/Prkdc^m6Btlr (C57BL/6J-Prkdc^m6Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:255221
	increased alpha-beta T cell number	J:255221
	increased CD4-positive, alpha-beta T cell number	J:255221
	increased CD8-positive, alpha-beta T cell number	J:255221
Prkdc^m7Btlr/Prkdc^m7Btlr (C57BL/6J-Prkdc^m7Btlr)	increased effector memory CD4-positive, alpha-beta T cell number	J:255223
Prkdc^M8Btlr/Prkdc⁺ (C57BL/6J-Prkdc^M8Btlr)	decreased CD8-positive, alpha-beta T cell number	J:255224
Prkdc^M8Btlr/Prkdc^M8Btlr (C57BL/6J-Prkdc^M8Btlr)	decreased CD8-positive, alpha-beta T cell number	J:255224
	increased CD4-positive, alpha-beta T cell number	J:255224
	increased plasmacytoid dendritic cell number	J:255224
Prkdc^M9Btlr/Prkdc⁺ (C57BL/6J-Prkdc^M9Btlr)	decreased B-1a cell number	J:255268
	decreased effector memory CD4-positive, alpha-beta T cell number	J:255268
	increased B cell number	J:255268
	increased B-1b cell number	J:255268
Prkdc^M9Btlr/Prkdc^M9Btlr (C57BL/6J-Prkdc^M9Btlr)	decreased B-1a cell number	J:255268
	decreased effector memory CD4-positive, alpha-beta T cell number	J:255268
	increased B cell number	J:255268
	increased B-1b cell number	J:255268
Prkdc^M10Btlr/Prkdc⁺ (C57BL/6J-Prkdc^M10Btlr)	decreased CD8-positive, alpha-beta T cell number	J:255269
Prkdc^M10Btlr/Prkdc^M10Btlr (C57BL/6J-Prkdc^M10Btlr)	decreased CD8-positive, alpha-beta T cell number	J:255269
Prkdc^m12Btlr/Prkdc^m12Btlr (C57BL/6J-Prkdc^m12Btlr)	decreased B cell number	J:264708
	decreased B-1 B cell number	J:264708
	decreased CD4-positive, alpha-beta T cell number	J:264708
	decreased CD8-positive, alpha-beta T cell number	J:264708
	decreased CD8-positive, naive alpha-beta T cell number	J:264708
	decreased NK T cell number	J:264708
	decreased single-positive T cell number	J:264708
	decreased T cell number	J:264708
	increased central memory CD4-positive, alpha-beta T cell number	J:264708
	increased central memory CD8 positive, alpha-beta T cell number	J:264708
	increased effector memory CD4-positive, alpha-beta T cell number	J:264708
	increased NK cell number	J:264708
Prkdc^m13Btlr/Prkdc^m13Btlr (C57BL/6J-Prkdc^m13Btlr)	increased effector memory CD4-positive, alpha-beta T cell number	J:272441
Prkdc^m14Btlr/Prkdc^m14Btlr (C57BL/6J-Prkdc^m14Btlr)	abnormal CD4-positive T cell differentiation	J:272442
Prkdc^M15Btlr/Prkdc^M15Btlr (C57BL/6J-Prkdc^M15Btlr)	decreased B-1 B cell number	J:272445
Prkdc^M16Btlr/Prkdc^M16Btlr (C57BL/6J-Prkdc^M16Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272520
Prkdc^m17Btlr/Prkdc^m17Btlr (C57BL/6J-Prkdc^m17Btlr)	increased plasmacytoid dendritic cell number	J:272521
Prkdc^m18Btlr/Prkdc^m18Btlr (C57BL/6J-Prkdc^m18Btlr)	abnormal B cell differentiation	J:274730
	abnormal CD4-positive T cell differentiation	J:274730
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274730
	abnormal T cell differentiation	J:274730
	decreased alpha-beta T cell number	J:274730
	decreased B cell number	J:274730
	decreased B-1 B cell number	J:274730
	decreased CD4-positive, alpha-beta T cell number	J:274730
	decreased CD8-positive, alpha-beta T cell number	J:274730
	decreased CD8-positive, naive alpha-beta T cell number	J:274730
	increased CD4-positive, alpha-beta T cell number	J:274730
	increased CD8-positive, alpha-beta T cell number	J:274730
	increased central memory CD4-positive, alpha-beta T cell number	J:274730
	increased central memory CD8 positive, alpha-beta T cell number	J:274730
	increased effector memory CD4-positive, alpha-beta T cell number	J:274730
	increased effector memory CD8-positive, alpha-beta T cell number	J:274730
	increased T cell number	J:274730
Prkdc^m19Btlr/Prkdc^m19Btlr (C57BL/6J-Prkdc^m19Btlr)	abnormal B cell differentiation	J:274763
	abnormal CD4-positive T cell differentiation	J:274763
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274763
	abnormal T cell differentiation	J:274763
	decreased B cell number	J:274763
	decreased B-1 B cell number	J:274763
	decreased CD4-positive, alpha-beta T cell number	J:274763
	decreased CD8-positive, alpha-beta T cell number	J:274763
	decreased CD8-positive, naive alpha-beta T cell number	J:274763
	decreased T cell number	J:274763
	increased central memory CD4-positive, alpha-beta T cell number	J:274763
	increased central memory CD8 positive, alpha-beta T cell number	J:274763
	increased effector memory CD4-positive, alpha-beta T cell number	J:274763
	increased effector memory CD8-positive, alpha-beta T cell number	J:274763
	increased NK cell number	J:274763
Prkdc^scid/Prkdc^scid (C.BKa-Prkdc^scid)	abnormal spleen white pulp morphology	J:6958
	abnormal thymus morphology	J:6958
	absent B cells	J:6958
	absent Peyer's patches	J:6958
	absent pre-B cells	J:6958
	absent thymus cortex	J:6958
	decreased leukocyte cell number	J:6958
	increased T cell derived lymphoma incidence	J:6958
	lymph node hypoplasia	J:6958
	lymphoid hypoplasia	J:6958
	small lymphoid organs	J:6958
	small thymus	J:6958
	thymus cyst	J:6958
Prkdc^scid/Prkdc^scid (NOD.Cg-Prkdc^scid)	abnormal lymph node morphology	J:109833, J:22026
	abnormal spleen white pulp morphology	J:109833, J:22026
	abnormal thymus corticomedullary boundary morphology	J:22026
	abnormal thymus lobule morphology	J:22026
	decreased B cell number	J:22026
	decreased CD4-positive, alpha-beta T cell number	J:109833, J:22026
	decreased CD8-positive, alpha-beta T cell number	J:109833, J:22026
	decreased lymphocyte cell number	J:22026
	decreased mature B cell number	J:109833
	decreased NK cell number	J:22026
	decreased pre-B cell number	J:22026
	decreased T cell number	J:22026
	increased granulocyte number	J:22026
	increased macrophage cell number	J:22026
	increased T cell derived lymphoma incidence	J:109833, J:22026
	spleen hypoplasia	J:109833, J:22026
	thymus cyst	J:22026
Prkdc^scid/Prkdc^scid (B6.Cg-Prkdc^scid/Sz)	abnormal lymph node B cell domain morphology	J:34814
	abnormal Peyer's patch morphology	J:34814
	abnormal spleen white pulp morphology	J:34814
	abnormal thymus morphology	J:34814
	decreased B cell number	J:34814
	decreased CD4-positive, alpha-beta T cell number	J:34814
	decreased CD8-positive, alpha-beta T cell number	J:34814
	decreased lymphocyte cell number	J:34814
	decreased pre-B cell number	J:34814
	decreased T cell number	J:34814
	increased eosinophil cell number	J:34814
	increased granulocyte number	J:34814
	increased macrophage cell number	J:34814
	increased monocyte cell number	J:34814
	increased neutrophil cell number	J:34814
	increased NK cell number	J:34814
	small Peyer's patches	J:34814
	small thymus	J:34814
	spleen hypoplasia	J:34814
	thymus cyst	J:34814
Prkdc^scid/Prkdc^scid Mcph1^{Tg(HLA-A2.1)1Enge}/Mcph1⁺ (NOD.Cg-Mcph1^{Tg(HLA-A2.1)1Enge} Prkdc^scid/Dvs)	abnormal splenocyte morphology	J:91764
Prkdc^scid/Prkdc^scid Rasa3^scat/Rasa3^scat (involves: BALB/c * BALB/cBy * C57BL)	abnormal immune system morphology	J:186485
Prkdc^scid/Prkdc^scid Tg(HLA-DRA0101,HLA-DRB10101)1Dmz/Tg(HLA-DRA0101,HLA-DRB10101)1Dmz (NOD.Cg-Tg(HLA-DRA0101,HLA-DRB10101)1Dmz Prkdc^scid/Gck)	abnormal professional antigen presenting cell morphology	J:126700
	absent T cells	J:126700
Prkdc^scid/Prkdc^scid Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 (NOD.Cg-Prkdc^scid Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)	abnormal CD4-positive, alpha beta T cell morphology	J:93553
Prkdc^scid/Prkdc^scid Tg(Tcrb)93Vbo/0 (involves: Balb/c * C57BL/Ka * C57BL/Lia * CBA/BrA)	abnormal CD4-positive, alpha beta T cell morphology	J:111476
	abnormal CD8-positive, alpha beta T cell morphology	J:111476
	abnormal double-positive T cell morphology	J:111476
	abnormal single-positive T cell number	J:111476
	abnormal T cell differentiation	J:111476
Prkdc^scid/Prkdc^scid Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129 * C3H * CF-1)	decreased spleen weight	J:129629
Prkdc^{Tg(INS-PDE2)5-1Lmb}/? (involves: FVB/N)	abnormal thymus morphology	J:108405
Prkdc^tm1.1Bpcc/Prkdc^tm1.1Bpcc (involves: 129 * C57BL/6)	abnormal immunoglobulin V(D)J recombination	J:171351
	arrested B cell differentiation	J:171351
	decreased CD4-positive, alpha-beta T cell number	J:171351
	decreased CD8-positive, alpha-beta T cell number	J:171351
	decreased double-negative T cell number	J:171351
	decreased double-positive T cell number	J:171351
	decreased gamma-delta T cell number	J:171351
	decreased granulocyte number	J:171351
	decreased leukocyte cell number	J:171351
	decreased lymphocyte cell number	J:171351
	decreased macrophage cell number	J:171351
	decreased mature B cell number	J:171351
	decreased T cell number	J:171351
	small lymphoid organs	J:171351
Prkdc^tm1Fwa/Prkdc^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6)	abnormal T cell receptor beta chain V(D)J recombination	J:50221
	abnormal T cell receptor V(D)J recombination	J:50221
	absent pre-B cells	J:50221
	arrested B cell differentiation	J:50221
	arrested T cell differentiation	J:50221
	decreased double-positive T cell number	J:50221
	decreased thymocyte number	J:50221
Prkdc^tm1Fwa/Prkdc^tm1Fwa (involves: 129S6/SvEvTac)	decreased splenocyte number	J:306598
Prkdc^tm1Gcl/Prkdc^tm1Gcl (involves: 129S1/Sv * C57BL/6)	abnormal immunoglobulin heavy chain V(D)J recombination	J:53765
	abnormal lymph node morphology	J:53765
	abnormal spleen morphology	J:53765
	abnormal T cell receptor beta chain V(D)J recombination	J:53765
	abnormal T cell receptor delta chain V(D)J recombination	J:53765
	absent mature B cells	J:53765
	absent Peyer's patches	J:53765
	absent thymus corticomedullary boundary	J:53765
	arrested B cell differentiation	J:53765
	increased T cell derived lymphoma incidence	J:53765
	small lymph nodes	J:53765
	small Peyer's patches	J:53765
	small spleen	J:53765
	small thymus	J:53765
	thymus hypoplasia	J:53765
Prkdc^tm1Get/Prkdc^tm1Get (involves: 129S4/SvJae * Black Swiss)	abnormal B cell differentiation	J:50222
	abnormal immunoglobulin heavy chain V(D)J recombination	J:50222
	abnormal immunoglobulin light chain V-J recombination	J:50222
	abnormal T cell differentiation	J:50222
	abnormal T cell number	J:50222
	abnormal T cell receptor alpha chain V-J recombination	J:50222
	abnormal T cell receptor beta chain V(D)J recombination	J:50222
	abnormal T cell receptor delta chain V(D)J recombination	J:50222
	abnormal thymus corticomedullary boundary morphology	J:50222
	arrested B cell differentiation	J:50222
	arrested T cell differentiation	J:50222
	decreased single-positive T cell number	J:50222
	decreased spleen white pulp amount	J:50222
	increased double-negative T cell number	J:50222
	increased double-positive T cell number	J:50222
	increased NK cell number	J:50222
	small lymph nodes	J:50222
	spleen hypoplasia	J:50222
	thymus hypoplasia	J:50222
Prkg1^{tm1b(KOMP)Wtsi}/Prkg1^{tm1b(KOMP)Wtsi} (C57BL/6N-Prkg1^{tm1b(KOMP)Wtsi}/H)	enlarged spleen	J:211773
Prkg1^tm2.1Naw/Prkg1^tm2.1Naw (involves: 129S1/Sv * 129X1/SvJ)	enlarged spleen	J:134639
Prl7d1^em1(IMPC)Tcp/Prl7d1^em1(IMPC)Tcp (C57BL/6NCrl-Prl7d1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Prl7d1^em1Liga/Prl7d1^em1Liga (involves: C57BL/6)	increased uterine NK cell number	J:288761
Prmt3^{tm1a(EUCOMM)Wtsi}/Prmt3^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased CD4-positive, alpha-beta T cell number	J:213427
	increased CD8-positive, alpha-beta T cell number	J:213427
	increased T cell number	J:213427
Prmt7^{tm1a(EUCOMM)Wtsi}/Prmt7^{tm1a(EUCOMM)Wtsi} (B6JTyr;B6N-Prmt7^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal thymus topology	J:239583
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Lck-Prnp)33Cwe/0 (involves: 129S7/SvEvBrd * C57BL/6)	increased CD8-positive, alpha-beta T cell number	J:129512
	increased gamma-delta T cell number	J:129512
	thymus hypoplasia	J:129512
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(Prnp)a20Cwe/0 (involves: 129S7/SvEvBrd * C57BL/6)	abnormal B cell morphology	J:129512
	abnormal T cell differentiation	J:129512
	decreased CD4-positive, alpha-beta T cell number	J:129512
	decreased CD8-positive, alpha-beta T cell number	J:129512
	decreased DN2 thymocyte number	J:129512
	decreased DN4 thymocyte number	J:129512
	decreased double-positive T cell number	J:129512
	decreased thymocyte number	J:129512
	increased DN3 thymocyte number	J:129512
	increased double-negative T cell number	J:129512
	increased gamma-delta T cell number	J:129512
	thymus atrophy	J:129512
Prnp^tm1Cwe/Prnp^tm1Cwe Tg(PrnpS170NN174T)1020Aag/0 (involves: 129S7/SvEvBrd * C57BL/6)	microgliosis	J:143528
Prnp^{tm3(PRNP129V)Tkit}/Prnp^{tm3(PRNP129V)Tkit} (Not Specified)	abnormal spleen morphology	J:126777
Procr^tm1.1Pcl/Procr^tm1.1Pcl (involves: 129S2/SvPas * C57BL/6)	bone marrow failure	J:225914
	enlarged spleen	J:225914
	increased spleen red pulp amount	J:225914
	increased spleen weight	J:225914
	increased splenocyte number	J:225914
Proser2^{em1(IMPC)Ccpcz}/Proser2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Proser2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Prox1^tm1Gco/Prox1⁺ (involves: 129S1/Sv * 129X1/SvJ * NMRI)	abnormal lymphatic vessel morphology	J:102652
Prox1^tm1Gco/Prox1⁺ (involves: 129S1/Sv * 129X1/SvJ * NMRI)	increased macrophage cell number	J:102652
Prox1^tm1Gco/Prox1^tm1Gco (involves: 129S1/Sv * 129X1/SvJ * NMRI)	abnormal lymph organ development	J:57646
Prox1^tm1Gco/Prox1^tm2Gco Tg(Tek-cre)1Ywa/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	absent lymphatic vessels	J:125507
Prox1^tm1Gco/Prox1^{tm5(GFP/cre)Gco} (involves: 129S1/Sv * 129X1/SvJ * NMRI)	decreased lymphatic vessel endothelial cell number	J:158959
Prox1^tm2Gco/Prox1⁺ Tg(Tek-cre)1Ywa/0 (involves: 129S1/Sv * C57BL/6 * NMRI * SJL)	abnormal lymphatic vessel morphology	J:102652
Prox1^tm4.1Gco/Prox1^tm4.1Gco (involves: 129S1/Sv * C57BL/10 * CBA/Ca)	decreased lymphatic vessel endothelial cell number	J:158959
Prpf3^{tm1b(KOMP)Wtsi}/Prpf3⁺ (C57BL/6N-Prpf3^{tm1b(KOMP)Wtsi}/Bay)	increased neutrophil cell number	J:211773
Prph2^Rd2/Prph2^Rd2 (O20/A-Prph2^Rd2)	abnormal macrophage morphology	J:6432
Prr7^{tm1(KOMP)Vlcg}/Prr7^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	decreased CD4-positive, alpha-beta T cell number	J:237776
Prr30^em1(IMPC)J/Prr30^em1(IMPC)J (C57BL/6NJ-Prr30^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Prrg4^em1(IMPC)Mbp/Prrg4^em1(IMPC)Mbp (C57BL/6NCrl-Prrg4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Prss8^tm1.1Hum/Prss8^tm1.2Hum Tg(KRT14-cre)1Ipc/0 (involves: 129/Sv * C57BL/6 * FVB/N * SJL)	thymus medulla hypoplasia	J:100139
Prss12^{em1(IMPC)Ccpcz}/Prss12^{em1(IMPC)Ccpcz} (C57BL/6N-Prss12^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Prss16^tm1.1Mal/Prss16⁺ Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)1Pas/? (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal positive T cell selection	J:148034
	decreased CD4-positive, alpha-beta T cell number	J:148034
	decreased single-positive T cell number	J:148034
	lymph node hypoplasia	J:148034
Prss16^tm1.1Mal/Prss16^tm1.1Mal (involves: 129S2/SvPas * C57BL/6)	abnormal professional antigen presenting cell morphology	J:148034
	abnormal thymus cortex morphology	J:148034
Prss16^tm1.1Mal/Prss16^tm1.1Mal Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)1Pas/? (involves: 129S/SvEv * 129S2/SvPas * C57BL/6)	abnormal positive T cell selection	J:148034
	decreased CD4-positive, alpha-beta T cell number	J:148034
	decreased double-positive T cell number	J:148034
	decreased single-positive T cell number	J:148034
	lymph node hypoplasia	J:148034
	spleen hypoplasia	J:148034
	thymus hypoplasia	J:148034
Prss21^{em1(IMPC)Ccpcz}/Prss21⁺ (C57BL/6N-Prss21^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Prss27^{tm1.1(NCOM)Mfgc}/Prss27^{tm1.1(NCOM)Mfgc} (C57BL/6N-Prss27^{tm1.1(NCOM)Mfgc}/Tcp)	decreased monocyte cell number	J:211773
Prss33^{em1(IMPC)Ccpcz}/Prss33^{em1(IMPC)Ccpcz} (C57BL/6N-Prss33^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	small spleen	J:211773
Prss35^{em1(IMPC)Ccpcz}/Prss35^{em1(IMPC)Ccpcz} (C57BL/6N-Prss35^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Prss47^{em1(IMPC)Ccpcz}/Prss47^{em1(IMPC)Ccpcz} (C57BL/6N-Prss47^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Prss48^{em1(IMPC)Ccpcz}/Prss48^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Prss48^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Prss50^{tm1a(EUCOMM)Hmgu}/Prss50^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Prss50^{tm1a(EUCOMM)Hmgu}/H)	decreased CD8-positive, alpha-beta T cell number	J:165965
	decreased T cell number	J:165965
Prss53^{em3(IMPC)Wtsi}/Prss53^{em3(IMPC)Wtsi} (C57BL/6N-Prss53^{em3(IMPC)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Prss54^{em1(IMPC)Ccpcz}/Prss54^{em1(IMPC)Ccpcz} (C57BL/6N-Prss54^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK T cell number	J:211773
	enlarged thymus	J:211773
Prss55^{em1(IMPC)Ccpcz}/Prss55^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Prss55^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Prss56^em1(IMPC)J/Prss56^em1(IMPC)J (C57BL/6NJ-Prss56^em1(IMPC)J/J)	decreased leukocyte cell number	J:211773
Prss57^{em1(IMPC)Ccpcz}/Prss57^{em1(IMPC)Ccpcz} (C57BL/6N-Prss57^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased NK T cell number	J:211773
	enlarged thymus	J:211773
Prss57^tm1.1Gne/Prss57^tm1.1Gne (C57BL/6N-Prss57^tm1.1Gne)	abnormal mast cell morphology	J:301479
Prss57^tm1.1Gne/Prss57^tm1.1Gne (C57BL/6N-Prss57^tm1.1Gne)	decreased mast cell histamine storage	J:301479
Prtn3^tm1.1Hrlu/Prtn3^tm1.1Hrlu (involves: C57BL/6)	increased neutrophil cell number	J:217636
Psap^tm1Ggb/Psap^tm1Ggb (involves: 129S/SvEv * C57BL/6J)	dark spleen	J:121761
Psap^tm1Suz/Psap^tm1Suz (involves: 129P2/OlaHsd)	abnormal macrophage morphology	J:113052
Psap^tm1Suz/Psap^tm1Suz (involves: 129P2/OlaHsd)	decreased spleen weight	J:106511
Psap^tm2Ggb/Psap^tm2Ggb (involves: 129S/SvEv * C57BL/6J)	microgliosis	J:198242
Psap^tm2Suz/Psap^tm2Suz (involves: 129S/SvEv * C57BL/6J)	abnormal macrophage morphology	J:78223
Psap^tm2Suz/Psap^tm2Suz (involves: 129S/SvEv * C57BL/6J)	microgliosis	J:198242
Psap^tm4.1Ggb/Psap^tm4.1Ggb (involves: 129S/SvEv * C57BL/6J)	microgliosis	J:198242
Psca^{tm1b(EUCOMM)Hmgu}/Psca^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Psca^{tm1b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Psd^em1(IMPC)Mbp/Psd^em1(IMPC)Mbp (C57BL/6NCrl-Psd^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Psen1^tm1.1Ruvi/Psen1^tm1.1Ruvi Tg(APP)8.9Btla/0 (involves: 129S2/SvPas * C57BL/6J)	microgliosis	J:187475
Psen1^tm1Bdes/Psen1⁺ Psen2^tm1Bdes/Psen2^tm1Bdes (involves: 129P2/OlaHsd)	abnormal T cell subpopulation ratio	J:91235
	enlarged lymph nodes	J:91235
	enlarged spleen	J:91235
	increased leukocyte cell number	J:91235
Psen1^tm2Shn/Psen1^tm4.1Shn Psen2^tm1Haa/Psen2^tm1Haa Tg(Camk2a-cre)1Shn/0 (involves: 129 * 129S4/SvJae * C57BL/6 * C57BL/6J * CBA)	microgliosis	J:219929
Psen2^{em1(IMPC)Ccpcz}/Psen2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Psen2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Psip1^{Gt(betageo)1Hgs}/Psip1^{Gt(betageo)1Hgs} (B6.129P2-Psip1^{Gt(betageo)1Hgs})	spleen atrophy	J:112975
Psip1^{Gt(betageo)1Hgs}/Psip1^{Gt(betageo)1Hgs} (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * MF1))	spleen atrophy	J:112975
Psma8^em1(IMPC)Tcp/Psma8^em1(IMPC)Tcp (C57BL/6N-Psma8^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
	small thymus	J:211773
Psmb8^tm1Hjf/Psmb8^tm1Hjf Tg(TcraTcrb)1100Mjb/? (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:107657
Psmb9^tm1Stl/Psmb9^tm1Stl (involves: 129P2/OlaHsd * C57BL/6)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:21549
	decreased CD8-positive, alpha-beta T cell number	J:21549
Psmb10^tm1Mgro/Psmb10^tm1Mgro (involves: 129S2/SvPas * C57BL/6)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:125058
	decreased CD8-positive, alpha-beta T cell number	J:125058
Psmb10^tm1Mgro/Psmb10^tm1Mgro Psmb9/Psmb8^tm1Klr/Psmb9/Psmb8^tm1Klr (B6.129-Psmb10^tm1Mgro Psmb9/Psmb8^tm1Klr)	decreased CD8-positive, alpha-beta T cell number	J:180765
Psmb10^tm1Mgro/Psmb10^tm1Mgro Psmb9/Psmb8^tm1Klr/Psmb9/Psmb8^tm1Klr (B6.129-Psmb10^tm1Mgro Psmb9/Psmb8^tm1Klr)	decreased CD8-positive, alpha-beta T cell number	J:180765
Psmb10^tm1Mgro/Psmb10^Tub6 (involves: 129S2/SvPas * C3HeB/FeJ)	decreased NK cell number	J:261081
	decreased T cell number	J:261081
	increased granulocyte number	J:261081
Psmb10^Tub6/Psmb10⁺ (C3HeB/FeJ-Psmb10^Tub6)	decreased CD4-positive, alpha-beta T cell number	J:261081
	decreased CD8-positive, alpha-beta T cell number	J:261081
	decreased T cell number	J:261081
Psmb10^Tub6/Psmb10^Tub6 (C3HeB/FeJ-Psmb10^Tub6)	absent lymph nodes	J:261081
	absent spleen white pulp	J:261081
	athymia	J:261081
	decreased B cell number	J:261081
	decreased leukocyte cell number	J:261081
	decreased NK cell number	J:261081
	decreased spleen red pulp amount	J:261081
	decreased T cell number	J:261081
	increased granulocyte number	J:261081
Psmb10^Tub6/Psmb10^Tub6 (B6.C3Fe-Psmb10^Tub6)	increased granulocyte number	J:261081
Psmb10^Tub6/Psmb10^Tub6 (C.C3Fe-Psmb10^Tub6)	increased granulocyte number	J:261081
Psmb11^{em1(IMPC)Ccpcz}/Psmb11^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Psmb11^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased CD4-positive NK T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased memory-marker CD4-positive NK T cell number	J:211773
	increased NK T cell number	J:211773
	increased T-helper cell number	J:211773
Psmb11^{tm1(Psmb8)Khog}/Psmb11⁺ (involves: C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:196156
Psmb11^{tm1(Psmb8)Khog}/Psmb11^{tm1(Psmb8)Khog} (involves: C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:196156
	abnormal T cell differentiation	J:196156
	abnormal T cell receptor V(D)J recombination	J:196156
	decreased CD8-positive, alpha-beta T cell number	J:196156
	decreased memory T cell number	J:196156
Psmb11^{tm1(Psmb8)Khog}/Psmb11^{tm1(Psmb8)Khog} Psmb8^tm1Hjf/Psmb8^tm1Hjf (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:196156
Psmb11^{tm1.1(Psmb8)Khog}/Psmb11^{tm1.1(Psmb8)Khog} Psmb8^tm1Hjf/Psmb8^tm1Hjf (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NTac)	abnormal T cell receptor V(D)J recombination	J:196156
	decreased CD8-positive, alpha-beta T cell number	J:196156
Psmb11^tm1Smta/Psmb11^tm1Smta (involves: C57BL/6 * CBA)	decreased CD8-positive, alpha-beta T cell number	J:121869
Psmc4^tm1.1Ryot/Psmc4^tm1.2Ryot Tg(SLC18A3-cre)KMisa/0 (involves: C57BL/6 * C57BL/6N)	microgliosis	J:193770
Psme3^tm1Jjm/Psme3^tm1Jjm (B6.129X1-Psme3^tm1Jjm)	decreased double-positive T cell number	J:88626
Psme4^b2b1508Clo/Psme4^b2b1508Clo (C57BL/6J-Psme4^b2b1508Clo)	thymus hypoplasia	J:175213
Psmf1^{tm1c(EUCOMM)Hmgu}/Psmf1^{tm1c(EUCOMM)Hmgu} Tg(Pcp2-cre)GN135Gsat/0 (involves: C57BL/6J * C57BL/6N * FVB/N)	microgliosis	J:282431
Pspc1^em1(IMPC)Mbp/Pspc1^em1(IMPC)Mbp (C57BL/6N-Pspc1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Psph^{tm1a(EUCOMM)Hmgu}/Psph^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Psph^{tm1a(EUCOMM)Hmgu}/Wtsi)	abnormal thymus morphology	J:239583
	abnormal thymus topology	J:239583
	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
	athymia	J:239583
	spleen hypoplasia	J:239583
Pstpip1^{em1(IMPC)Ccpcz}/Pstpip1^{em1(IMPC)Ccpcz} (C57BL/6N-Pstpip1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased T-helper cell number	J:211773
Pstpip1^tm1Spg/Pstpip1^tm1Spg (involves: 129S/SvEv * C57BL/6)	abnormal immune system cell morphology	J:101977
Pstpip2^cmo/Pstpip2^cmo (C.Cg-Pstpip2^cmo/J)	abnormal lymph node morphology	J:104476
Pstpip2^cmo/Pstpip2^cmo (C.Cg-Pstpip2^cmo/J)	enlarged spleen	J:104476
Pstpip2^em1(IMPC)Tcp/Pstpip2^em1(IMPC)Tcp (C57BL/6NCrl-Pstpip2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Pstpip2^m1Bcs/Pstpip2^m1Bcs (involves: C57BL/6)	abnormal microglial cell morphology	J:196534
pta/pta (C57BL/6J-pta)	thymus hypoplasia	J:94456
Ptch1^tm1Bjw/Ptch1^tm1Bjw Tg(KRT14-cre)8Brn/0 (involves: 129T2/SvEms * FVB/N)	thymus hypoplasia	J:231264
Ptch1^tm1Hahn/Ptch1^tm1Hahn Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal double-negative T cell morphology	J:127207
	abnormal thymus lobule morphology	J:127207
	decreased B cell number	J:127207
	decreased double-positive T cell number	J:127207
	decreased immature B cell number	J:127207
	decreased lymphocyte cell number	J:127207
	decreased pre-B cell number	J:127207
	decreased transitional stage B cell number	J:127207
	increased B cell number	J:127207
	increased double-negative T cell number	J:127207
	increased mature B cell number	J:127207
	increased neutrophil cell number	J:127207
	increased single-positive T cell number	J:127207
	thymus hypoplasia	J:127207
Ptch2^tm1Dgen/Ptch2^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:101679
	increased neutrophil cell number	J:101679
Ptch2^{tm3b(EUCOMM)Hmgu}/Ptch2^{tm3b(EUCOMM)Hmgu} (C57BL/6N-Ptch2^{tm3b(EUCOMM)Hmgu}/Bay)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Ptchd1^{tm1b(KOMP)IcsOrl}/Y (C57BL/6N-Ptchd1^{tm1b(KOMP)IcsOrl}/Ics)	abnormal spleen morphology	J:211773
Ptcra^tm1(icre)Hjf/Ptcra^tm1(icre)Hjf (B6.129P2-Ptcra^tm1(icre)Hjf)	decreased DN4 thymocyte number	J:197923
	decreased double-positive T cell number	J:197923
	decreased thymocyte number	J:197923
Ptcra^tm1.1Shoy/Ptcra^tm1.1Shoy (involves: C57BL/6)	decreased double-positive T cell number	J:166147
	decreased T cell number	J:166147
	decreased thymocyte number	J:166147
	increased DN3 thymocyte number	J:166147
	increased gamma-delta T cell number	J:166147
	increased T cell number	J:166147
Ptcra^tm1Bjf/Ptcra⁺ (involves: 129X1/SvJ)	abnormal T cell differentiation	J:94338
	decreased double-negative T cell number	J:94338
	decreased single-positive T cell number	J:94338
Ptcra^tm1Vbo/Ptcra^tm1Vbo (involves: 129P2/OlaHsd * C57BL/6)	arrested T cell differentiation	J:91542
	increased double-negative T cell number	J:91542
Ptcra^tm1Vbo/Ptcra^tm1Vbo (involves: 129P2/OlaHsd)	abnormal double-positive T cell morphology	J:123569
	decreased DN4 thymocyte number	J:123569
	increased DN3 thymocyte number	J:123569
	thymus hypoplasia	J:123569
Ptdss1^{tm1b(EUCOMM)Hmgu}/Ptdss1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ptdss1^{tm1b(EUCOMM)Hmgu}/Ics)	decreased large unstained cell number	J:211773
Pten^tm1.1Gle/Pten⁺ (involves: 129S6/SvEvTac * Black Swiss * FVB/N)	increased T cell derived lymphoma incidence	J:158751
Pten^tm1.1Hwu/Pten⁺ (involves: 129S4/SvJae * BALB/c)	lymphoid hyperplasia	J:110567
Pten^tm1.2Mwst/Pten⁺ (involves: 129S6/SvEvTac * Black Swiss * FVB/N)	increased T cell derived lymphoma incidence	J:158751
Pten^tm1Hwu/Pten^tm1Hwu Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae)	abnormal alveolar macrophage morphology	J:148947
Pten^tm1Hwu/Pten^tm1Hwu Rps6kb1^tm1Gtho/Rps6kb1^tm1Gtho Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA)	enlarged spleen	J:169097
	enlarged thymus	J:169097
Pten^tm1Hwu/Pten^tm1Hwu Tg(CD2-icre)4Kio/0 (involves: 129S4/SvJae * C57BL/6 * C57BL/10 * CBA/Ca)	enlarged thymus	J:216983
Pten^tm1Hwu/Pten^tm1Hwu Tg(Cdh5-cre)7Mlia/0 (involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N)	enlarged lymph nodes	J:135172
	enlarged spleen	J:135172
	enlarged thymus	J:135172
	increased leukocyte cell number	J:135172
	increased neutrophil cell number	J:135172
Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	enlarged spleen	J:169097
	enlarged thymus	J:169097
Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (BKS.Cg-Ptprc^b Thy1^a Tg(Mx1-cre)1Cgn Pten^tm1Hwu)	enlarged thymus	J:109085
	spleen hyperplasia	J:109085
Pten^tm1Hwu/Pten^tm1Hwu Tg(Mx1-cre)1Cgn/0 (B6.Cg-Tg(Mx1-cre)1Cgn Pten^tm1Hwu)	decreased B cell number	J:232645
	decreased lymphocyte cell number	J:232645
	decreased T cell number	J:232645
	enlarged spleen	J:232645
	increased granulocyte number	J:232645
	increased macrophage cell number	J:232645
	increased monocyte cell number	J:232645
	increased spleen weight	J:232645
Pten^tm1Mak/Pten⁺ (involves: 129P2/OlaHsd * C57BL/6J)	enlarged Peyer's patches	J:63478
Pten^tm1Mak/Pten⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased T cell derived lymphoma incidence	J:50437
Pten^tm1Rps/Pten⁺ (involves: 129S1/Sv * C57BL/6J)	abnormal lymph node B cell domain morphology	J:53065
	enlarged spleen	J:53065
	enlarged thymus	J:53065
	lymph node hyperplasia	J:53065
Pten^tm2.1Gle/Pten⁺ (involves: 129S6/SvEvTac * Black Swiss * FVB/N)	increased T cell derived lymphoma incidence	J:158751
Pten^tm2.1Ppp/Pten^tm2.1Ppp Tnfrsf4^tm2(cre)Nik/Tnfrsf4⁺ (involves: 129S1/Sv * 129X1/SvJ)	increased germinal center B cell number	J:164283
	increased T follicular helper cell number	J:164283
Ptf1a^tm1Pkwe/Ptf1a^tm1Pkwe (involves: 129P2/OlaHsd * C57BL/6)	abnormal spleen morphology	J:51571
Ptgdr2^tm1Byl/Ptgdr2^tm1Byl (involves: C57BL/6J)	increased eosinophil cell number	J:107519
Ptgdr^tm1Sna/Ptgdr^tm1Sna (involves: 129P2/OlaHsd * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:243958
	increased regulatory T cell number	J:243958
Ptgdr^tm1Sna/Ptgdr^tm1Sna (B6.129P2-Ptgdr^tm1Sna/Sna)	abnormal dermal mast cell morphology	J:197334
Ptgdr^tm1Sna/Ptgdr^tm1Sna (B6.129P2-Ptgdr^tm1Sna/Sna)	decreased mast cell histamine storage	J:197334
Ptgds^tm1Ohy/Ptgds^tm1Ohy (B6.129P2-Ptgds^tm1Ohy)	abnormal dermal mast cell morphology	J:197334
Ptgds^tm1Ohy/Ptgds^tm1Ohy (B6.129P2-Ptgds^tm1Ohy)	decreased mast cell histamine storage	J:197334
Ptger1^tm1Sna/Ptger1^tm1Sna (B6CrSlc.129P2-Ptger1^tm1Sna/Sna)	abnormal CD8-positive, alpha-beta T cell differentiation	J:128435
	abnormal cervical lymph node morphology	J:128435
	abnormal lymph node morphology	J:128435
	abnormal T-helper 1 cell differentiation	J:128435
Ptger2^tm1Rsz/Ptger2^tm1Rsz (involves: 129S6/SvEvTac * C57BL/6)	abnormal osteoclast differentiation	J:77408
Ptger4^tm1Bhk/Ptger4^tm1Bhk (involves: 129P2/OlaHsd * 129S/SvEv)	lymphangiectasis	J:44108
Ptger4^tm1Sna/Ptger4^tm1Sna (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:63070
Ptges^tm1.1Gaf/Ptges^tm1.1Gaf Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129 * C57BL/6)	increased leukocyte cell number	J:210141
Ptgis^em1(IMPC)Mbp/Ptgis^em1(IMPC)Mbp (C57BL/6N-Ptgis^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Ptgs1^tm1Unc/Ptgs1^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:60668
Ptgs2^tm1Unc/Ptgs2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:124756
Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6J)	abnormal mesenteric lymph node morphology	J:29510
	spleen hyperplasia	J:29510
Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:124756
Ptgs2^tm1Unc/Ptgs2^tm1Unc (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:60668
	increased leukocyte cell number	J:60668
Ptgs2^tm1Unc/Ptgs2^tm1Unc (B6.129P2-Ptgs2^tm1Unc)	abnormal class switch recombination	J:140698
Ptgs2^tm1Unc/Ptgs2^tm1Unc (B6.129P2-Ptgs2^tm1Unc)	abnormal memory B cell differentiation	J:140698
Ptgs2os^tm1Scrp/Ptgs2os^tm1Scrp (Not Specified)	decreased neutrophil cell number	J:325487
Pth1r^{tm1a(EUCOMM)Hmgu}/Pth1r^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Pth1r^{tm1a(EUCOMM)Hmgu}/Wtsi)	abnormal thymus morphology	J:239583
	enlarged lymphatic vessel	J:239583
Pth^tm1Dgo/Pth^tm1Dgo (involves: 129S2/SvPas * C57BL/6J)	abnormal osteoclast morphology	J:76407
Pth^tm1Dgo/Pth^tm1Dgo (involves: 129S2/SvPas * C57BL/6J)	decreased osteoclast cell number	J:76407
Pth^tm1Dgo/Pth^tm1Dgo Pthlh^tm1Hmk/Pthlh^tm1Hmk (involves: 129S2/SvPas * C57BL/6J)	abnormal osteoclast morphology	J:76407
	decreased osteoclast cell number	J:76407
Pthlh^tm1Ack/Pthlh^tm1Ack Tg(Col1a1-cre)1Ack/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal osteoclast morphology	J:100918
	decreased osteoclast cell number	J:100918
Pthlh^tm1Ack/Pthlh^tm1Hmk Tg(LGB-cre)74Acl/0 (involves: 129 * C57BL/6 * CBA)	abnormal osteoclast morphology	J:86536
Pthlh^tm1Hmk/Pthlh⁺ (involves: 129S2/SvPas)	abnormal osteoclast morphology	J:100918
Pthlh^tm1Hmk/Pthlh^tm1Hmk (involves: 129S2/SvPas * C57BL/6J)	abnormal osteoclast morphology	J:76407
	decreased osteoclast cell number	J:76407
Pthlh^tm1Hmk/Pthlh^tm1Hmk Pth1r^tm1Hmk/Pth1r^tm2Hmk Tg(Col2a1-PTHLH)1Ecw/0 (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * SJL)	abnormal bone marrow development	J:99641
Pthlh^tm2Ack/Pthlh^tm2Ack (involves: 129S2/SvPas * C57BL/6)	decreased osteoclast cell number	J:142669
Ptn^tm1Tmu/Ptn^tm1Tmu (B6.Cg-Ptn^tm1Tmu)	decreased macrophage cell number	J:102069
Ptp4a1^em2(IMPC)Tcp/Ptp4a1^em2(IMPC)Tcp (C57BL/6NCrl-Ptp4a1^em2(IMPC)Tcp/Tcp)	small spleen	J:211773
Ptp4a2^em1(IMPC)Tcp/Ptp4a2^em1(IMPC)Tcp (C57BL/6N-Ptp4a2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Ptp4a2^{Gt(AQ0673)Wtsi}/Ptp4a2^{Gt(AQ0673)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	decreased spleen weight	J:190411
Ptp4a3^em1(IMPC)Mbp/Ptp4a3^em1(IMPC)Mbp (C57BL/6N-Ptp4a3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Ptpmt1^tm2.1Ckq/Ptpmt1^tm2.1Ckq Tg(VAV1-cre)1Graf/0 (involves: 129S6/SvEvTac * C57BL/6J * SJL)	small spleen	J:194929
	small thymus	J:194929
Ptpn2^tm1.1Kry/Ptpn2^tm1.1Kry Tg(Col1a1-cre)1Kry/0 (involves: 129 * C57BL/6J * FVB)	abnormal osteoclast differentiation	J:183709
Ptpn2^tm1Mtr/Ptpn2^tm1Mtr (involves: 129S4/SvJae * BALB/c)	abnormal B cell number	J:42595
	abnormal spleen morphology	J:42595
	decreased B cell number	J:42595
	decreased double-positive T cell number	J:42595
	enlarged lymph nodes	J:42595
	enlarged spleen	J:42595
	increased B cell number	J:42595
	increased macrophage cell number	J:42595
	increased mature B cell number	J:42595
	increased pre-B cell number	J:42595
	increased spleen red pulp amount	J:42595
	lymph node hyperplasia	J:42595
	spleen hyperplasia	J:42595
Ptpn2^tm1Mtr/Ptpn2^tm1Mtr (C.129S4-Ptpn2^tm1Mtr)	abnormal lymph node morphology	J:186843
	abnormal negative T cell selection	J:186843
	abnormal positive T cell selection	J:186843
	abnormal T cell differentiation	J:186843
	abnormal T cell subpopulation ratio	J:186843
	decreased B cell number	J:186843
	decreased B-1 B cell number	J:186843
	decreased CD4-positive, alpha-beta T cell number	J:186843
	decreased double-positive T cell number	J:186843
	decreased follicular B cell number	J:186843
	decreased immature B cell number	J:186843
	decreased marginal zone B cell number	J:186843
	decreased mature B cell number	J:186843
	decreased single-positive T cell number	J:186843
	decreased T cell number	J:186843
	decreased thymocyte number	J:186843
	enlarged spleen	J:186843
	increased splenocyte number	J:186843
	thymus atrophy	J:186843
Ptpn2^tm1Mtr/Ptpn2^tm1Mtr (B6.129S4(C)-Ptpn2^tm1Mtr)	abnormal lymph node morphology	J:186843
	decreased B cell number	J:186843
	decreased B-1 B cell number	J:186843
	decreased CD4-positive, alpha-beta T cell number	J:186843
	decreased double-positive T cell number	J:186843
	decreased follicular B cell number	J:186843
	decreased immature B cell number	J:186843
	decreased marginal zone B cell number	J:186843
	decreased mature B cell number	J:186843
	decreased single-positive T cell number	J:186843
	decreased T cell number	J:186843
	decreased thymocyte number	J:186843
	thymus atrophy	J:186843
Ptpn2^tm2.1Ttig/Ptpn2^tm2.1Ttig (B6.Cg-Ptpn2^tm2.1Ttig)	abnormal negative T cell selection	J:186843
	abnormal positive T cell selection	J:186843
	abnormal T cell differentiation	J:186843
	abnormal T cell subpopulation ratio	J:186843
	decreased B cell number	J:186843
	decreased B-1 B cell number	J:186843
	decreased CD4-positive, alpha-beta T cell number	J:186843
	decreased double-positive T cell number	J:186843
	decreased follicular B cell number	J:186843
	decreased immature B cell number	J:186843
	decreased marginal zone B cell number	J:186843
	decreased mature B cell number	J:186843
	decreased single-positive T cell number	J:186843
	decreased thymocyte number	J:186843
	enlarged lymph nodes	J:186843
	thymus atrophy	J:186843
Ptpn6^em1.1Shoy/Ptpn6^em1.1Shoy (involves: C57BL/6)	decreased thymocyte number	J:236298
Ptpn6^m1Btlr/Ptpn6^m1Btlr (C57BL/6J-Ptpn6^m1Btlr/Mmucd)	abnormal myeloid leukocyte morphology	J:142845
	decreased mature B cell number	J:142845
	enlarged spleen	J:94077, J:142845
	increased neutrophil cell number	J:142845
Ptpn6^m3Btlr/Ptpn6⁺ (C57BL/6J-Ptpn6^m3Btlr)	abnormal CD8-positive, alpha beta T cell morphology	J:234259
	decreased B cell number	J:234259
	decreased B-2 B cell number	J:234259
	decreased immature B cell number	J:234259
	decreased mature B cell number	J:234259
	increased B-1 B cell number	J:234259
	increased B-1a cell number	J:234259
	increased dendritic cell number	J:234259
	increased macrophage cell number	J:234259
Ptpn6^m3Btlr/Ptpn6^m3Btlr (C57BL/6J-Ptpn6^m3Btlr)	abnormal CD8-positive, alpha beta T cell morphology	J:234259
	decreased B cell number	J:234259
	decreased B-2 B cell number	J:234259
	decreased immature B cell number	J:234259
	decreased mature B cell number	J:234259
	increased B-1 B cell number	J:234259
	increased B-1b cell number	J:234259
	increased dendritic cell number	J:234259
	increased macrophage cell number	J:234259
Ptpn6^m4Btlr/Ptpn6^m4Btlr (C57BL/6J-Ptpn6^m4Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:264807
	decreased CD8-positive, naive alpha-beta T cell number	J:264807
	increased B-1 B cell number	J:264807
	increased CD8-positive, alpha-beta memory T cell number	J:264807
	increased central memory CD8 positive, alpha-beta T cell number	J:264807
	increased effector memory CD4-positive, alpha-beta T cell number	J:264807
	increased effector memory CD8-positive, alpha-beta T cell number	J:264807
Ptpn6^M5Btlr/Ptpn6^M5Btlr (C57BL/6J-Ptpn6^M5Btlr)	decreased B cell number	J:265075
	decreased B-1 B cell number	J:265075
	decreased CD8-positive, naive alpha-beta T cell number	J:265075
	increased central memory CD8 positive, alpha-beta T cell number	J:265075
Ptpn6^m6Btlr/Ptpn6^m6Btlr (C57BL/6J-Ptpn6^m6Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272439
Ptpn6^m6Btlr/Ptpn6^m6Btlr (C57BL/6J-Ptpn6^m6Btlr)	abnormal T cell differentiation	J:272439
Ptpn6^m7Btlr/Ptpn6^m7Btlr (C57BL/6J-Ptpn6^m7Btlr)	abnormal T cell differentiation	J:272440
Ptpn6^me-B2/Ptpn6^me-B2 (involves: BALB/c)	increased neutrophil cell number	J:169850
Ptpn6^me-B2/Ptpn6^me-B2 (involves: BALB/c)	small thymus	J:169850
Ptpn6^me-v/Ptpn6⁺ Tg(IghelMD4)4Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal mature B cell morphology	J:110531
Ptpn6^me-v/Ptpn6^me-v (C57BL/6J-Ptpn6^me-v)	abnormal plasma cell morphology	J:14936
	abnormal thymus development	J:16613
	decreased B cell number	J:113218
	decreased mature B cell number	J:7905
	increased plasma cell number	J:7905
Ptpn6^me/Ptpn6^me (C57BL/6J-Ptpn6^me/J)	abnormal granulocyte morphology	J:5579
	abnormal immune system cell morphology	J:5579
	abnormal leukocyte cell number	J:5579
	abnormal Peyer's patch morphology	J:5579
	abnormal thymus morphology	J:5579
	enlarged spleen	J:5579
	increased granulocyte number	J:5579
	increased leukocyte cell number	J:5579
	increased monocyte cell number	J:5579
	small thymus	J:5579
Ptpn6^me/Ptpn6^me (involves: C3HeB/FeJ * C57BL/6)	abnormal microglial cell morphology	J:72655
Ptpn6^me/Ptpn6^me (either: (involves: C3H * C57BL/6J) or (involves: C57BL/6J * C57BL/6N))	thymus atrophy	J:5999
Ptpn9^tm1Dny/Ptpn9^tm1Dny (B6.129-Ptpn9^tm1Dny)	abnormal T cell differentiation	J:118880
Ptpn11^tm1.1Ics/Ptpn11⁺ (involves: 129S2/SvPas * C57BL/6 * FVB/N)	enlarged spleen	J:216593
Ptpn11^tm1Bgn/Ptpn11⁺ (involves: 129S4/SvJae * C57BL/6J)	enlarged spleen	J:91609
	increased leukocyte cell number	J:91609
	increased lymphocyte cell number	J:91609
	increased neutrophil cell number	J:91609
	myeloid hyperplasia	J:91609
Ptpn11^tm1Ckq/Ptpn11⁺ Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)	myeloid hyperplasia	J:177285
Ptpn11^tm1Ckq/Ptpn11⁺ Tg(Lck-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6J)	increased lymphoblastic lymphoma incidence	J:177285
Ptpn11^tm1Ckq/Ptpn11⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA)	arrested B cell differentiation	J:177285
	enlarged spleen	J:177285
	increased leukocyte cell number	J:177285
	increased lymphoblastic lymphoma incidence	J:177285
	increased neutrophil cell number	J:177285
	increased spleen weight	J:177285
	myeloid hyperplasia	J:177285
Ptpn11^tm6Bgn/Ptpn11⁺ Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S6/SvEvTac C57BL/6 * CBA)	abnormal leukopoiesis	J:148430
Ptpn11^tm6Bgn/Ptpn11⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal leukopoiesis	J:148430
	abnormal splenic cell ratio	J:148430
	enlarged spleen	J:148430
	increased granulocyte number	J:148430
	increased leukocyte cell number	J:148430
	increased monocyte cell number	J:148430
	intermingled spleen red and white pulp	J:148430
Ptpn13^tm1Wjh/Ptpn13^tm1Wjh (involves: 129P2/OlaHsd * C57BL/6)	increased T-helper 2 cell number	J:144351
Ptpn14^{Gt(RRR484)Byg}/Ptpn14^{Gt(RRR484)Byg} (involves: 129P2/OlaHsd)	lymphatic vessel hyperplasia	J:169186
Ptpn18^em1(IMPC)J/Ptpn18^em1(IMPC)J (C57BL/6NJ-Ptpn18^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ptpn22^tm1.1Draw/Ptpn22⁺ (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:201448
	abnormal B cell morphology	J:201448
	abnormal B cell number	J:201448
	abnormal T cell morphology	J:201448
	abnormal T cell number	J:201448
	abnormal thymus morphology	J:201448
	decreased follicular B cell number	J:201448
	decreased mature B cell number	J:201448
	enlarged spleen	J:201448
	increased B cell number	J:201448
	increased CD4-positive, alpha-beta memory T cell number	J:201448
	increased double-positive T cell number	J:201448
	increased germinal center B cell number	J:201448
	increased regulatory T cell number	J:201448
	increased spleen germinal center size	J:201448
	increased transitional stage T1 B cell number	J:201448
	spleen hyperplasia	J:201448
	thymus hyperplasia	J:201448
Ptpn22^tm1.1Draw/Ptpn22^tm1.1Draw (involves: 129 * C57BL/6)	abnormal B cell differentiation	J:201448
	abnormal B cell morphology	J:201448
	abnormal T cell differentiation	J:201448
	abnormal T cell morphology	J:201448
	abnormal thymus morphology	J:201448
	decreased follicular B cell number	J:201448
	decreased mature B cell number	J:201448
	enlarged spleen	J:201448
	increased B cell number	J:201448
	increased double-positive T cell number	J:201448
	increased effector memory CD4-positive, alpha-beta T cell number	J:201448
	increased effector memory CD8-positive, alpha-beta T cell number	J:201448
	increased germinal center B cell number	J:201448
	increased regulatory T cell number	J:201448
	increased spleen germinal center size	J:201448
	increased transitional stage T1 B cell number	J:201448
	spleen hyperplasia	J:201448
	thymus hyperplasia	J:201448
Ptpn22^tm1.1Kas/Ptpn22^tm1.1Kas (involves: C57BL/6)	enlarged spleen	J:176519
	enlarged thymus	J:176519
	increased CD4-positive, alpha-beta T cell number	J:176519
	increased CD8-positive, alpha-beta T cell number	J:176519
	increased dendritic cell number	J:176519
	increased spleen germinal center number	J:176519
	increased spleen germinal center size	J:176519
	increased T cell number	J:176519
Ptpn22^tm1.1Kas/Ptpn22^tm1.1Kas Tg(TcraTcrb)425Cbn/0 (involves: BALB/c * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:176519
Ptpn22^tm1Achn/Ptpn22^tm1Achn (involves: C57BL/6)	abnormal Peyer's patch germinal center morphology	J:90029
	enlarged lymph nodes	J:90029
	enlarged spleen	J:90029
	increased B cell number	J:90029
	increased follicular B cell number	J:90029
	increased spleen germinal center number	J:90029
Ptpn22^tm2Achn/Ptpn22^tm2Achn (involves: C57BL/6)	abnormal Peyer's patch germinal center morphology	J:90029
	enlarged lymph nodes	J:90029
	enlarged spleen	J:90029
	increased B cell number	J:90029
	increased follicular B cell number	J:90029
	increased spleen germinal center number	J:90029
Ptpn22^tm2Achn/Ptpn22^tm2Achn (B6.Cg-Ptpn22^tm2Achn)	abnormal double-positive T cell morphology	J:147129
	abnormal T cell subpopulation ratio	J:147129
	enlarged lymph nodes	J:147129
	increased memory T cell number	J:147129
Ptpn22^tm2Achn/Ptpn22^tm2Achn Ptprc^tm1Weis/Ptprc^tm1Weis (B6.Cg-Ptprc^tm1Weis Ptpn22^tm2Achn)	abnormal double-positive T cell morphology	J:147129
	abnormal lymphocyte cell number	J:147129
	abnormal T cell subpopulation ratio	J:147129
	decreased follicular B cell number	J:147129
	enlarged lymph nodes	J:147129
	increased memory T cell number	J:147129
	increased plasma cell number	J:147129
	increased transitional stage B cell number	J:147129
Ptprc^loc/Ptprc^loc (C57BL/6JSfdAnu-Ptprc^loc/AnuApb)	abnormal B cell number	J:104190
	abnormal double-positive T cell morphology	J:104190
	abnormal memory T cell number	J:104190
	abnormal T cell morphology	J:104190
	abnormal T cell selection	J:104190
	arrested T cell differentiation	J:104190
	decreased CD4-positive, alpha-beta T cell number	J:104190
	decreased CD8-positive, alpha-beta T cell number	J:104190
	decreased double-positive T cell number	J:104190
	decreased T cell number	J:104190
Ptprc^ltng/Ptprc^ltng (C57BL/6-Ptprc^ltng)	abnormal T cell differentiation	J:158876
	decreased CD4-positive, alpha-beta T cell number	J:158876
	decreased double-positive T cell number	J:158876
	thymus hypoplasia	J:158876
Ptprc^ltng/Ptprc^tm1Mak (involves: 129/Sv * C57BL/6)	abnormal T cell differentiation	J:158876
	decreased CD4-positive, alpha-beta T cell number	J:158876
	decreased double-positive T cell number	J:158876
	thymus hypoplasia	J:158876
Ptprc^ltng/Ptprc^tm1Mak Tg(TcraTcrb)425Cbn/0 (involves: 129/Sv * BALB/c * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:158876
	thymus hypoplasia	J:158876
Ptprc^m1Btlr/Ptprc^m1Btlr (involves: C57BL/6J)	absent T cells	J:152064
Ptprc^m1Smv/Ptprc^m1Smv (involves: C57BL/6J * C57BL/10J)	abnormal CD4-positive T cell differentiation	J:214487
	abnormal CD8-positive, alpha-beta T cell differentiation	J:214487
	abnormal immune system cell morphology	J:214487
	decreased DN4 thymocyte number	J:214487
	increased DN3 thymocyte number	J:214487
	increased double-negative T cell number	J:214487
Ptprc^m2Btlr/Ptprc^m2Btlr (C57BL/6J-Ptprc^m2Btlr)	decreased B-1a cell number	J:216796
	decreased B-2 B cell number	J:216796
	decreased CD4-positive, alpha-beta memory T cell number	J:216796
	decreased CD8-positive, alpha-beta memory T cell number	J:216796
	decreased mature B cell number	J:216796
	decreased memory B cell number	J:216796
	decreased memory T cell number	J:216796
	decreased single-positive T cell number	J:216796
	increased B-1 B cell number	J:216796
	increased B-1b cell number	J:216796
	increased dendritic cell number	J:216796
	increased neutrophil cell number	J:216796
	increased single-positive T cell number	J:216796
Ptprc^m3Btlr/Ptprc^m3Btlr (C57BL/6J-Ptprc^m3Btlr)	decreased B cell number	J:254899
	decreased B-1a cell number	J:254899
	decreased B-2 B cell number	J:254899
	decreased CD8-positive, alpha-beta T cell number	J:254899
	increased B-1b cell number	J:254899
Ptprc^m4Btlr/Ptprc^m4Btlr (C57BL/6J-Ptprc^m4Btlr)	decreased B cell number	J:264808
	decreased CD4-positive, alpha-beta T cell number	J:264808
	decreased CD8-positive, alpha-beta T cell number	J:264808
	decreased CD8-positive, naive alpha-beta T cell number	J:264808
	decreased single-positive T cell number	J:264808
	decreased T cell number	J:264808
	increased B-1 B cell number	J:264808
	increased central memory CD4-positive, alpha-beta T cell number	J:264808
	increased central memory CD8 positive, alpha-beta T cell number	J:264808
	increased effector memory CD4-positive, alpha-beta T cell number	J:264808
	increased effector memory CD8-positive, alpha-beta T cell number	J:264808
Ptprc^M5Btlr/Ptprc^M5Btlr (C57BL/6J-Ptprc^M5Btlr)	increased alpha-beta T cell number	J:265143
Ptprc^M6Btlr/Ptprc^M6Btlr (C57BL/6J-Ptprc^M6Btlr)	decreased B-1a cell number	J:265186
	decreased B-1b cell number	J:265186
	decreased CD8-positive, naive alpha-beta T cell number	J:265186
	increased B-1 B cell number	J:265186
Ptprc^m7Btlr/Ptprc^m7Btlr (C57BL/6J-Ptprc^m7Btlr)	decreased alpha-beta T cell number	J:267486
	decreased B cell number	J:267486
	decreased CD4-positive, alpha-beta T cell number	J:267486
	decreased CD8-positive, alpha-beta T cell number	J:267486
	decreased CD8-positive, naive alpha-beta T cell number	J:267486
	decreased NK T cell number	J:267486
	increased B-1 B cell number	J:267486
	increased central memory CD4-positive, alpha-beta T cell number	J:267486
	increased central memory CD8 positive, alpha-beta T cell number	J:267486
	increased effector memory CD4-positive, alpha-beta T cell number	J:267486
	increased effector memory CD8-positive, alpha-beta T cell number	J:267486
Ptprc^M8Btlr/Ptprc^M8Btlr (C57BL/6J-Ptprc^M8Btlr)	increased B-1 B cell number	J:267487
Ptprc^M8Btlr/Ptprc^M8Btlr (C57BL/6J-Ptprc^M8Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:267487
Ptprc^M9Btlr/Ptprc^M9Btlr (C57BL/6J-Ptprc^M9Btlr)	abnormal B cell differentiation	J:272745
	abnormal CD8-positive, alpha beta T cell morphology	J:272745
	abnormal lymphocyte morphology	J:272745
	decreased B cell number	J:272745
	decreased NK cell number	J:272745
	increased CD8-positive, alpha-beta T cell number	J:272745
	increased effector memory CD4-positive, alpha-beta T cell number	J:272745
Ptprc^M10Btlr/Ptprc^M10Btlr (C57BL/6J-Ptprc^M10Btlr)	decreased B-1b cell number	J:272777
Ptprc^M11Btlr/Ptprc^M11Btlr (C57BL/6J-Ptprc^M11Btlr)	abnormal B cell differentiation	J:274863
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274863
	increased B-1 B cell number	J:274863
Ptprc^m12Btlr/Ptprc^m12Btlr (C57BL/6J-Ptprc^m12Btlr)	decreased B cell number	J:274972
	decreased CD4-positive, alpha-beta T cell number	J:274972
	decreased CD8-positive, alpha-beta T cell number	J:274972
	decreased CD8-positive, naive alpha-beta T cell number	J:274972
	decreased central memory CD8 positive, alpha-beta T cell number	J:274972
	decreased effector memory CD4-positive, alpha-beta T cell number	J:274972
	decreased T cell number	J:274972
	increased B-1 B cell number	J:274972
Ptprc^nim/Ptprc^nim (C57BL/6JAnu-Ptprc^nim)	decreased B cell number	J:225105
	decreased leukocyte cell number	J:225105
	decreased T cell number	J:225105
Ptprc^rain/Ptprc^rain (C57BL/6JAnu-Ptprc^rain/AnuApb)	abnormal leukocyte morphology	J:104190
Ptprc^strm/Ptprc^strm (C57BL/6JAnu-Ptprc^strm/AnuApb)	decreased B cell number	J:104190
Ptprc^strm/Ptprc^strm (C57BL/6JAnu-Ptprc^strm/AnuApb)	decreased T cell number	J:104190
Ptprc^tm1Holm/Ptprc^tm1Holm (involves: 129/Sv * C57BL/6)	abnormal B cell number	J:33466
	abnormal lymphopoiesis	J:33466
	abnormal T cell differentiation	J:33466
	decreased CD4-positive, alpha-beta T cell number	J:33466
	decreased CD8-positive, alpha-beta T cell number	J:33466
	decreased double-positive T cell number	J:33466
	decreased T cell number	J:33466
	decreased thymocyte number	J:33466
	increased double-negative T cell number	J:33466
	spleen hyperplasia	J:33466
Ptprc^tm1Holm/Ptprc^tm1Holm Tg(LckF505)2964Rmp/? (involves: 129/Sv C57BL/6 * DBA/2)	increased T cell derived lymphoma incidence	J:64671
	thymus hyperplasia	J:64671
Ptprc^tm1Holm/Ptprc^tm1Holm Tg(LckF505)3073Rmp/? (involves: 129/Sv C57BL/6 * DBA/2)	increased T cell derived lymphoma incidence	J:64671
	thymus hyperplasia	J:64671
Ptprc^tm1Mak/Ptprc^tm1Mak (involves: 129/Sv * C57BL/6)	abnormal T cell subpopulation ratio	J:13163
	arrested T cell differentiation	J:158876
	decreased CD4-positive, alpha-beta T cell number	J:13163
	decreased CD8-positive, alpha-beta T cell number	J:13163
	decreased T cell number	J:13163
	decreased thymocyte number	J:13163
	increased double-negative T cell number	J:13163
Ptprc^tm1Mak/Ptprc^tm1Mak (involves: 129)	abnormal osteoclast morphology	J:141275
Ptprc^tm1Mak/Ptprc^tm1Mak (B6.Cg-Ptprc^tm1Mak)	abnormal CD4-positive, alpha-beta intraepithelial T cell morphology	J:111646
	abnormal intraepithelial T cell morphology	J:111646
	abnormal intraepithelial T cell number	J:111646
	abnormal T cell differentiation	J:111646
	decreased gamma-delta intraepithelial T cell number	J:111646
Ptprc^tm1Mak/Ptprc^tm1Mak Ptprj^tm1.2Weis/Ptprj^tm1.2Weis (involves: 129/Sv * 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal follicular B cell morphology	J:131736
	abnormal myelopoiesis	J:131736
	decreased B cell number	J:131736
Ptprc^tm1Mak/Ptprc^tm1Mak Ptprj^tm1.2Weis/Ptprj^tm1.2Weis (B6.Cg-Ptprc^tm1Mak Ptprj^tm1.2Weis)	abnormal B cell differentiation	J:131736
	abnormal follicular B cell morphology	J:131736
	abnormal myelopoiesis	J:131736
	abnormal spleen morphology	J:131736
	abnormal transitional stage B cell morphology	J:131736
	decreased B cell number	J:131736
	decreased immature B cell number	J:131736
	decreased mature B cell number	J:131736
Ptprc^tm1Mak/Ptprc^tm1Mak Tg(TcraTcrb)425Cbn/0 (involves: 129/Sv * BALB/c * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:158876
Ptprc^tm1Tyb/Ptprc^tm1Tyb (C.129S2-Ptprc^tm1Tyb)	abnormal positive T cell selection	J:57681
	abnormal T cell differentiation	J:57681
	decreased CD4-positive, alpha-beta T cell number	J:57681
	decreased CD8-positive, alpha-beta T cell number	J:57681
	decreased double-positive T cell number	J:57681
	enlarged spleen	J:57681
	increased double-negative T cell number	J:57681
	thymus hypoplasia	J:57681
Ptprc^tm1Tyb/Ptprc^tm1Tyb (B6.129S2-Ptprc^tm1Tyb)	increased NK cell number	J:98190
Ptprc^tm1Weis/Ptprc^tm1Weis (involves: 129X1/SvJ * C57BL/6)	abnormal granulocyte differentiation	J:66501
	abnormal immune system organ morphology	J:66501
	abnormal leukocyte cell number	J:66501
	enlarged lymph nodes	J:66501
	enlarged spleen	J:66501
	increased B cell number	J:66501
	increased plasmacytoid dendritic cell number	J:66501
	increased spleen red pulp amount	J:66501
	increased spleen white pulp amount	J:66501
	increased T cell number	J:66501
	lymph node hyperplasia	J:66501
Ptprc^tm1Weis/Ptprc^tm1Weis (B6.129X1-Ptprc^tm1Weis)	abnormal double-positive T cell morphology	J:147129
	abnormal T cell subpopulation ratio	J:147129
	decreased follicular B cell number	J:147129
	enlarged lymph nodes	J:147129
	increased memory T cell number	J:147129
	increased plasma cell number	J:147129
	increased transitional stage B cell number	J:147129
Ptprcap^tm1Svn/Ptprcap^tm1Svn (involves: C57BL/6)	enlarged lymph nodes	J:58712
Ptprcap^tm1Svn/Ptprcap^tm1Svn (involves: C57BL/6)	lymphoid hyperplasia	J:58712
Ptprd^{tm2a(KOMP)Wtsi}/Ptprd^{tm2a(KOMP)Wtsi} (C57BL/6N-Ptprd^{tm2a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Ptpre^tm1Ael/Ptpre^tm1Ael (involves: 129S6/SvEvTac * C57BL/6)	abnormal osteoclast differentiation	J:90031
Ptprj^tm1.2Weis/Ptprj^tm1.2Weis (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	abnormal B cell differentiation	J:131736
	abnormal splenic cell ratio	J:131736
	increased B-2 B cell number	J:131736
	increased marginal zone B cell number	J:131736
Ptprz1^{em1(IMPC)Ccpcz}/Ptprz1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ptprz1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Ptrh2^tm1.1Eruo/Ptrh2^tm1.1Eruo (C57BL/6-Ptrh2^tm1.1Eruo)	decreased neutrophil cell number	J:131853
Pts^{tm1b(EUCOMM)Wtsi}/Pts⁺ (C57BL/6N-Pts^{tm1b(EUCOMM)Wtsi}/H)	increased large unstained cell number	J:211773
Pttg1^{tm1b(EUCOMM)Wtsi}/Pttg1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Pttg1^{tm1b(EUCOMM)Wtsi}/Tcp)	small spleen	J:211773
Pttg1^tm1Sme/Pttg1^tm1Sme (involves: 129S4/SvJae * C57BL/6)	abnormal immune system organ morphology	J:72267
	decreased spleen weight	J:72267
	increased T cell number	J:72267
	thymus hyperplasia	J:72267
Puf60^tm1.1Kmtsu/Puf60⁺ Trp53^tm1Sia/Trp53^tm1Sia (involves: C57BL/6NCrlj * C57BL/6NCrSlc * CBA/JNCrlj)	increased leukocyte cell number	J:233347
	increased spleen weight	J:233347
	increased T cell derived lymphoma incidence	J:233347
	increased thymus weight	J:233347
Pura^tm1Kkh/Pura^tm1Kkh (involves: 129)	abnormal spleen morphology	J:85759
	abnormal thymus morphology	J:85759
	decreased spleen weight	J:85759
	small spleen	J:85759
Pvrig^em1(IMPC)Mbp/Pvrig^em1(IMPC)Mbp (C57BL/6N-Pvrig^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Pwwp3a^em1(IMPC)Tcp/Pwwp3a^em1(IMPC)Tcp (C57BL/6NCrl-Pwwp3a^em1(IMPC)Tcp/Tcp)	small thymus	J:211773
Pycard^tm1Flv/Pycard^tm1Flv (involves: 129S5/SvEvBrd * C57BL/6)	decreased NK cell number	J:158969
Pycard^tm1Flv/Pycard^tm1Flv (B6.129S5-Pycard^tm1Flv)	enlarged Peyer's patches	J:173245
Pycr2^m1J/Pycr2^m1J (involves: C3H/HeJ * C57BL/6J)	decreased basophil cell number	J:308336
	decreased leukocyte cell number	J:308336
	decreased lymphocyte cell number	J:308336
Pycr2^{tm1a(EUCOMM)Wtsi}/Pycr2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Pycr2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased Ly6C low monocyte number	J:211773
	decreased monocyte cell number	J:211773
Qpct^tm1.1Gne/Qpct^tm1.1Gne Qpctl^tm1.1Gne/Qpctl^tm1.1Gne (C57BL/6N-Qpctl^tm1.1Gne Qpct^tm1.1Gne)	decreased monocyte cell number	J:324112
Qpctl^tm1.1Gne/Qpctl^tm1.1Gne (C57BL/6N-Qpctl^tm1.1Gne)	decreased monocyte cell number	J:324112
Qpctl^tm1.1Gne/Qpctl^tm1.1Gne (C57BL/6N-Qpctl^tm1.1Gne)	increased monocyte cell number	J:324112
Qprt^{Gt(OST337946)Lex}/Qprt^{Gt(OST337946)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal macrophage morphology	J:282516
Qrich1^b2b2404Clo/Qrich1^b2b2404Clo (C57BL/6J-Qrich1^b2b2404Clo)	thymus hypoplasia	J:175213
Qsox1^b2b2673Clo/Qsox1^b2b2673Clo (C57BL/6J-Qsox1^b2b2673Clo)	spleen hypoplasia	J:175213
Rab2a^em2(IMPC)Tcp/Rab2a⁺ (C57BL/6NCrl-Rab2a^em2(IMPC)Tcp/Tcp)	increased spleen weight	J:211773
Rab7^tm1.1Ale/Rab7^tm1.1Ale Tg(Cd4-cre)1Cwi/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell morphology	J:211733
	abnormal T cell subpopulation ratio	J:211733
	decreased CD4-positive, alpha-beta T cell number	J:211733
	decreased CD8-positive, alpha-beta T cell number	J:211733
	decreased T cell number	J:211733
Rab11fip2^em1(IMPC)Mbp/Rab11fip2^em1(IMPC)Mbp (C57BL/6NCrl-Rab11fip2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Rab13^tm1.1Ktg/Rab13^tm1.1Ktg (involves: C57BL/6)	decreased lymphocyte cell number	J:259093
	lymphoid hypoplasia	J:259093
	small inguinal lymph nodes	J:259093
	small spleen	J:259093
Rab19^{tm1b(EUCOMM)Hmgu}/Rab19^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rab19^{tm1b(EUCOMM)Hmgu}/Ics)	decreased large unstained cell number	J:211773
	increased eosinophil cell number	J:211773
Rab27a^ash/Rab27a^ash (B6.C3Sn-Rab27a^ash)	decreased leukocyte cell number	J:193137
Rab27a^ash/Rab27a^ash (B6.C3Sn-Rab27a^ash)	decreased neutrophil cell number	J:193137
Rab32^{tm1c(KOMP)Wtsi}/Rab32^{tm1c(KOMP)Wtsi} Tg(Itgax-cre)1-1Reiz/0 (involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * CBA)	increased neutrophil cell number	J:267497
Rab33b^em1Rmr/Rab33b⁺ (involves: C57BL/6)	abnormal osteoclast differentiation	J:338833
	abnormal osteoclast morphology	J:338833
	increased osteoclast cell number	J:338833
Rab33b^em1Rmr/Rab33b^em1Rmr (involves: C57BL/6)	abnormal osteoclast morphology	J:338833
Rab33b^em1Rmr/Rab33b^em1Rmr (involves: C57BL/6)	increased osteoclast cell number	J:338833
Rab39b^em1(IMPC)Tcp/Y (C57BL/6NCrl-Rab39b^em1(IMPC)Tcp/Tcp)	decreased spleen weight	J:211773
Rabgap1^{tm1b(EUCOMM)Hmgu}/Rabgap1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rabgap1^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased effector memory T-helper cell number	J:211773
	enlarged spleen	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	small spleen	J:211773
Rabgef1^tm1Glli/Rabgef1^tm1Glli (either: (involves: 129P2/OlaHsd * 129S/SvEv) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal mast cell morphology	J:91790
	cutaneous mastocytosis	J:91790
Rabggta^{tm1.1(KOMP)Vlcg}/Rabggta⁺ (C57BL/6N-Rabggta^{tm1.1(KOMP)Vlcg}/Nju)	decreased neutrophil cell number	J:211773
Rabl3^xm/Rabl3^em1Btlr (C57BL/6J-Rabl3^xm Rabl3^em1Btlr)	decreased leukocyte cell number	J:287198
	decreased lymphocyte cell number	J:287198
	spleen hypoplasia	J:287198
	thymus hypoplasia	J:287198
Rabl3^xm/Rabl3^xm (C57BL/6J-Rabl3^xm)	abnormal T cell morphology	J:287198
Rabl3^xm/Rabl3^xm (C57BL/6J-Rabl3^xm)	abnormal T cell number	J:287198
Rac1^em1(IMPC)Mbp/Rac1⁺ (C57BL/6N-Rac1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Rac1^tm1Djk/Rac1^tm1.1Djk Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	decreased leukocyte cell number	J:83457
	decreased neutrophil cell number	J:83457
Rac2^em1Shl/Rac2⁺ (involves: C57BL/6)	abnormal neutrophil morphology	J:276213
	decreased alpha-beta T cell number	J:276213
	decreased CD4-positive, alpha-beta T cell number	J:276213
	decreased CD8-positive, alpha-beta T cell number	J:276213
	decreased leukocyte cell number	J:276213
	decreased lymphocyte cell number	J:276213
	decreased T cell number	J:276213
	increased neutrophil cell number	J:276213
Rac2^M2Btlr/Rac2⁺ (C57BL/6J-Rac2^M2Btlr)	decreased B-1 B cell number	J:231801
	decreased B-1a cell number	J:231801
	increased B-1b cell number	J:231801
Rac2^M2Btlr/Rac2^M2Btlr (C57BL/6J-Rac2^M2Btlr)	decreased B-1 B cell number	J:231801
	decreased B-1a cell number	J:231801
	increased B-1b cell number	J:231801
Rac2^m3Btlr/Rac2⁺ (C57BL/6J-Rac2^m3Btlr)	decreased B-1a cell number	J:236680
Rac2^m3Btlr/Rac2⁺ (C57BL/6J-Rac2^m3Btlr)	increased B-1 B cell number	J:236680
Rac2^m3Btlr/Rac2^m3Btlr (C57BL/6J-Rac2^m3Btlr)	decreased B cell number	J:236680
	decreased B-1a cell number	J:236680
	increased B-1b cell number	J:236680
	increased neutrophil cell number	J:236680
Rac2^M4Btlr/Rac2⁺ (C57BL/6J-Rac2^M4Btlr)	decreased alpha-beta T cell number	J:255273
	decreased CD4-positive, alpha-beta T cell number	J:255273
	decreased CD8-positive, alpha-beta T cell number	J:255273
	decreased CD8-positive, naive alpha-beta T cell number	J:255273
	increased alpha-beta T cell number	J:255273
	increased CD8-positive, alpha-beta T cell number	J:255273
	increased central memory CD8 positive, alpha-beta T cell number	J:255273
	increased effector memory CD4-positive, alpha-beta T cell number	J:255273
	increased effector memory CD8-positive, alpha-beta T cell number	J:255273
Rac2^M4Btlr/Rac2^M4Btlr (C57BL/6J-Rac2^M4Btlr)	decreased alpha-beta T cell number	J:255273
	decreased CD4-positive, alpha-beta T cell number	J:255273
	decreased CD8-positive, alpha-beta T cell number	J:255273
	decreased CD8-positive, naive alpha-beta T cell number	J:255273
	increased alpha-beta T cell number	J:255273
	increased CD8-positive, alpha-beta T cell number	J:255273
	increased central memory CD4-positive, alpha-beta T cell number	J:255273
	increased central memory CD8 positive, alpha-beta T cell number	J:255273
	increased effector memory CD4-positive, alpha-beta T cell number	J:255273
	increased effector memory CD8-positive, alpha-beta T cell number	J:255273
Rac2^M5Btlr/Rac2⁺ (C57BL/6J-Rac2^M5Btlr)	increased CD8-positive, alpha-beta T cell number	J:255283
Rac2^M5Btlr/Rac2^M5Btlr (C57BL/6J-Rac2^M5Btlr)	decreased B-1a cell number	J:255283
	increased B-1b cell number	J:255283
	increased CD8-positive, alpha-beta T cell number	J:255283
Rac2^tm1Mddw/Rac2^tm1Mddw (involves: 129S/SvEv * C57BL/6)	abnormal granulocyte differentiation	J:53362
	decreased leukocyte cell number	J:53362
	decreased neutrophil cell number	J:53362
	increased leukocyte cell number	J:53362
	increased neutrophil cell number	J:53362
Racgap1^tm1Mahi/Racgap1^tm1Mahi Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal B cell differentiation	J:137760
	abnormal myelopoiesis	J:137760
	decreased pro-B cell number	J:137760
	decreased transitional stage B cell number	J:137760
Rad21^tm1.1Mmk/Rad21^tm1.1Mmk Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:175827
	abnormal T cell differentiation	J:175827
	decreased CD4-positive, alpha-beta T cell number	J:175827
	decreased CD8-positive, alpha-beta T cell number	J:175827
	decreased double-positive T cell number	J:175827
Rad50^tm2.1Flv/Rad50^tm2.2Flv Tg(Cd4-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:165055
Rad50^tm2Jpt/Rad50^tm2Jpt (either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))	abnormal immune system cell morphology	J:78820
	abnormal immune system organ morphology	J:78820
	abnormal spleen morphology	J:78820
	abnormal thymus morphology	J:78820
	decreased B cell number	J:78820
	decreased immature B cell number	J:78820
	decreased pre-B cell number	J:78820
	decreased T cell number	J:78820
	increased late pro-B cell number	J:78820
	increased macrophage cell number	J:78820
	increased T cell derived lymphoma incidence	J:78820
	spleen hyperplasia	J:78820
Rad50^tm2Jpt/Rad50^tm2Jpt (involves: 129S7/SvEvBrd * C57BL/6)	decreased double-negative T cell number	J:103922
	decreased macrophage cell number	J:103922
	decreased pro-B cell number	J:103922
Rad50^tm2Jpt/Rad50^tm2Jpt Smc1a^tm1Mbk/Smc1a^tm1Mbk (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)	abnormal pro-B cell morphology	J:103922
	decreased double-negative T cell number	J:103922
	decreased macrophage cell number	J:103922
Rad50^tm2Jpt/Rad50^tm2Jpt Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)	increased T cell derived lymphoma incidence	J:78820
Radil^em1(IMPC)Tcp/Radil^em1(IMPC)Tcp (C57BL/6NCrl-Radil^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Raf1^tm1.1Bgn/Raf1⁺ (involves: 129S6/SvEvTac * C57BL/6NCr)	enlarged spleen	J:172034
	increased leukocyte cell number	J:172034
	increased monocyte cell number	J:172034
	increased neutrophil cell number	J:172034
Rag1/Rag2^tm1Mnz/Rag1/Rag2^tm1Mnz (involves: 129P2/OlaHsd * C57BL/6)	abnormal double-negative T cell morphology	J:90487
	abnormal double-positive T cell morphology	J:90487
	abnormal T cell morphology	J:90487
	decreased T cell number	J:90487
Rag1/Rag2^tm1Mnz/Rag1/Rag2^tm1Mnz (involves: 129P2/OlaHsd * C57BL/6)	abnormal double-negative T cell morphology	J:90487
	abnormal double-positive T cell morphology	J:90487
	abnormal T cell morphology	J:90487
	decreased T cell number	J:90487
Rag1^coln/Rag1^coln (C57BL/6JAnu-Rag1^coln/AnuApb)	absent B cells	J:104190
Rag1^coln/Rag1^coln (C57BL/6JAnu-Rag1^coln/AnuApb)	absent T cells	J:104190
Rag1^em2Mvw/Rag1^em2Mvw (A/J-Rag1^em2Mvw/MvwJ)	absent B cells	J:332675
	absent T cells	J:332675
	arrested B cell differentiation	J:332675
	arrested T cell differentiation	J:332675
Rag1^em3Mvw/Rag1^em3Mvw (129S1/SvImJ-Rag1^em3Mvw/MvwJ)	absent B cells	J:332675
	absent T cells	J:332675
	arrested B cell differentiation	J:332675
	arrested T cell differentiation	J:332675
Rag1^m1Anu/Rag1^m1Anu (C57BL/6NCrlAnu-Rag1^m1Anu)	decreased lymphocyte cell number	J:104190
Rag1^m1Btlr/Rag1^m1Btlr (C57BL/6J-Rag1^m1Btlr)	absent late pro-B cells	J:150635
	decreased CD4-positive, alpha-beta T cell number	J:150635
	decreased CD8-positive, alpha-beta T cell number	J:150635
Rag1^m2Btlr/Rag1^m2Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased B cell number	J:185495
	decreased T cell number	J:185495
Rag1^m3Btlr/Rag1^m3Btlr (C57BL/6J-Rag1^m3Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:272858
Rag1^m4Btlr/Rag1^m4Btlr (C57BL/6J-Rag1^m4Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272094
	abnormal T cell differentiation	J:272094
	decreased B cell number	J:272094
	decreased CD8-positive, naive alpha-beta T cell number	J:272094
	increased alpha-beta T cell number	J:272094
	increased CD8-positive, alpha-beta T cell number	J:272094
	increased central memory CD8 positive, alpha-beta T cell number	J:272094
Rag1^tm1(cre)Thr/Rag1^tm1(cre)Thr (Not Specified)	abnormal lymphopoiesis	J:86869
Rag1^tm1(cre)Thr/Rag1^tm1(cre)Thr (Not Specified)	absent lymphocyte	J:86869
Rag1^tm1(GFP)Imku/? Zfp335^blt/Zfp335^blt (involves: C57BL/6 * CBA)	abnormal CD4-positive T cell differentiation	J:214793
Rag1^tm1(GFP)Imku/Rag1^tm1(GFP)Imku (involves: C57BL/6 * CBA)	abnormal immunoglobulin V(D)J recombination	J:79416
Rag1^tm1.1Sadu/Rag1^tm1.1Sadu (involves: BALB/c)	arrested B cell differentiation	J:155473
Rag1^tm1.1Sadu/Rag1^tm1.1Sadu Trdc^tm1Mal/Trdc^tm1Mal Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺ (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	absent gamma-delta T cells	J:187400
	decreased gamma-delta T cell number	J:187400
	increased gamma-delta T cell number	J:187400
	small thymus	J:187400
Rag1^tm1Bal/Rag1^tm1Bal Tg(TcraTcrb)1100Mjb/? (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:133645
	decreased CD4-positive, alpha-beta T cell number	J:133645
	increased CD8-positive, alpha-beta T cell number	J:133645
Rag1^tm1Bal/Rag1^tm1Bal Vav1^tm2Tyb/Vav1^tm2Tyb (involves: 129S4/SvJae * 129S8/SvEv)	arrested T cell differentiation	J:113270
Rag1^tm1Bal/Rag1^tm1Bal Vav1^tm2Tyb/Vav1^tm2Tyb Tg(TcrAND)53Hed/0 (involves: 129S4/SvJae * 129S8/SvEv * C57BL/6 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:113270
Rag1^tm1Fwa/Rag1^tm1Fwa (involves: 129)	abnormal B cell differentiation	J:86464
	abnormal T cell differentiation	J:86464
	decreased B cell number	J:86464
	increased double-negative T cell number	J:86464
	thymus hypoplasia	J:86464
Rag1^tm1Jsek/Rag1⁺ (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:146912
	abnormal immunoglobulin heavy chain V(D)J recombination	J:146912
	abnormal T cell differentiation	J:146912
	abnormal T cell receptor beta chain V(D)J recombination	J:146912
	decreased double-positive T cell number	J:146912
Rag1^tm1Jsek/Rag1^tm1Jsek (involves: 129S6/SvEvTac)	abnormal immunoglobulin heavy chain V(D)J recombination	J:146912
	abnormal lymphopoiesis	J:146912
	abnormal T cell receptor beta chain V(D)J recombination	J:146912
	abnormal T cell receptor V(D)J recombination	J:146912
	absent immature B cells	J:146912
	absent mature B cells	J:146912
	arrested B cell differentiation	J:146912
	arrested T cell differentiation	J:146912
	decreased CD4-positive, alpha-beta T cell number	J:146912
	decreased CD8-positive, alpha-beta T cell number	J:146912
	decreased double-positive T cell number	J:146912
	decreased gamma-delta T cell number	J:146912
	increased double-negative T cell number	J:146912
	increased pro-B cell number	J:146912
	thymus hypoplasia	J:146912
Rag1^tm1Jsek/Rag1^tm1Jsek Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * 129S6/SvEvTac)	increased T cell derived lymphoma incidence	J:146912
Rag1^tm1Mom/Rag1⁺ Tg(LPV-TAg1135)11Tvd/0 (involves: 129/Sv * C57BL/6 * DBA/2)	increased T cell derived lymphoma incidence	J:47667
Rag1^tm1Mom/Rag1⁺ Tg(LPV-TAg1135)11Tvd/0 Tg(TcrLCMV)327Sdz/0 (involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)	increased T cell derived lymphoma incidence	J:47667
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * CD-1)	abnormal B cell differentiation	J:1934
	abnormal immunoglobulin V(D)J recombination	J:1934
	abnormal inguinal lymph node morphology	J:1934
	abnormal T cell differentiation	J:1934
	abnormal T cell morphology	J:1934
	abnormal T cell receptor V(D)J recombination	J:1934
	absent mature B cells	J:1934
	spleen hypoplasia	J:1934
	thymus hypoplasia	J:1934
Rag1^tm1Mom/Rag1^tm1Mom (B6.129S7-Rag1^tm1Mom)	increased eosinophil cell number	J:111828
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)	decreased lymphocyte cell number	J:111874
	small thymus	J:111874
Rag1^tm1Mom/Rag1^tm1Mom (NOD.129S7(B6)-Rag1^tm1Mom)	decreased CD4-positive, alpha-beta T cell number	J:109843
	decreased CD8-positive, alpha-beta T cell number	J:109843
	decreased mature B cell number	J:109843
	increased granulocyte number	J:109843
	increased immature B cell number	J:109843
	increased macrophage cell number	J:109843
	increased NK cell number	J:109843
	spleen hypoplasia	J:109843
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * C57BL/6)	abnormal lymphatic vessel morphology	J:119344
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd * C57BL/6)	decreased neutrophil cell number	J:119344
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd)	abnormal double-negative T cell morphology	J:112990
Rag1^tm1Mom/Rag1^tm1Mom (involves: 129S7/SvEvBrd)	abnormal thymus epithelium morphology	J:125864
Rag1^tm1Mom/Rag1^tm1Mom Prf1^tm1Sdz/Prf1^tm1Sdz (NOD.Cg-Rag1^tm1Mom Prf1^tm1Sdz/Sz)	abnormal lymph node cortex morphology	J:109843
	abnormal spleen white pulp morphology	J:109843
	abnormal thymus cortex morphology	J:109843
	decreased CD4-positive, alpha-beta T cell number	J:109843
	decreased CD8-positive, alpha-beta T cell number	J:109843
	decreased mature B cell number	J:109843
	increased granulocyte number	J:109843
	increased immature B cell number	J:109843
	increased macrophage cell number	J:109843
	increased NK cell number	J:109843
	increased T cell derived lymphoma incidence	J:109843
	spleen hypoplasia	J:109843
	thymus hypoplasia	J:109843
Rag1^tm1Mom/Rag1^tm1Mom Rasa3^scat/Rasa3^scat (involves: 129S7/SvEvBrd * BALB/cBy)	abnormal immune system morphology	J:186485
Rag1^tm1Mom/Rag1^tm1Mom Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro (involves: 129S4/SvJae * 129S7/SvEvBrd * BALB/cJ * C57BL/6J)	abnormal osteoclast differentiation	J:117880
Rag1^tm1Mom/Rag1^tm1Mom Slc46a2^tm1Moki/Slc46a2⁺ Tg(TcraB12,TcrbB12)1Rest/0 (involves: 129 * C57BL/6)	arrested T cell differentiation	J:140121
	decreased double-positive T cell number	J:140121
	thymus hypoplasia	J:140121
Rag1^tm1Mom/Rag1^tm1Mom Tg(Lck-Akt1E40K)E-3Pnt/0 (involves: 129S7/SvEvBrd C3H/He * C57BL/6)	increased double-positive T cell number	J:135903
	increased thymocyte number	J:135903
Rag1^tm1Mom/Rag1^tm1Mom Tg(LPV-TAg1135)11Tvd/0 (involves: 129/Sv * C57BL/6 * DBA/2)	abnormal T cell receptor V(D)J recombination	J:47667
	increased T cell derived lymphoma incidence	J:47667
Rag1^tm1Mom/Rag1^tm1Mom Tg(LPV-TAg1135)11Tvd/0 Tg(TcrLCMV)327Sdz/0 (involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)	increased T cell derived lymphoma incidence	J:47667
Rag1^tm1Mom/Rag1^tm1Mom Tg(Tcra,Tcrb)HRCAll/0 (B6.Cg-Rag1^tm1Mom Tg(Tcra,Tcrb)HRCAll)	abnormal T cell differentiation	J:131347
	abnormal T cell subpopulation ratio	J:131347
	absent CD4-positive, alpha-beta T cells	J:131347
	increased CD8-positive, alpha-beta T cell number	J:131347
Rag1^tm1Mom/Rag1^tm1Mom Tg(TcraBDC12-4.1)10Jos/0 Tg(TcrbBDC12-4.1)82Gse/0 (involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)	decreased CD4-positive, alpha-beta T cell number	J:111874
	decreased lymphocyte cell number	J:111874
	decreased thymus weight	J:111874
	increased double-positive T cell number	J:111874
Rag1^tm1Mom/Rag1^tm1Mom Tnfrsf25^tm1Mjo/Tnfrsf25^tm1Mjo (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	abnormal T cell differentiation	J:84536
Rag1^tm1Mom/Rag1^tm1Mom Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)	decreased osteoclast cell number	J:294030
Rag1^tm1Mom/Rag1^tm1Mom Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S7/SvEvBrd * C57BL)	increased T cell derived lymphoma incidence	J:141515
Rag1^tm1Mom/Rag1^tm1Mom Trp53^tm1Brd/Trp53^tm1Brd Xrcc5^tm1Dbr/Xrcc5^tm1Dbr (involves: 129S7/SvEvBrd * C57BL)	increased T cell derived lymphoma incidence	J:141515
Rag1^tm1Mom/Rag1^tm1Mom Vtcn1^tm1Lpc/Vtcn1^tm1Lpc (involves: 129S/SvEvBrd * 129S7/SvEvBrd * C57BL/6)	abnormal neutrophil differentiation	J:145712
	increased neutrophil cell number	J:145712
	increased spleen weight	J:145712
Rag2^m1Btlr/Rag2^m1Btlr (C57BL/6J-Rag2^m1Btlr)	decreased B cell number	J:203045
Rag2^m1Btlr/Rag2^m1Btlr (C57BL/6J-Rag2^m1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:203045
Rag2^tm1.1Cgn/Rag2^tm1.1Cgn (C57BL/6-Rag2^tm1.1Cgn)	arrested B cell differentiation	J:72214
Rag2^tm1.1Cgn/Rag2^tm1.1Cgn (C57BL/6-Rag2^tm1.1Cgn)	arrested T cell differentiation	J:72214
Rag2^tm1.1Desi/Rag2^tm1.1Desi (involves: 129X1/SvJ * C57BL/6)	abnormal immunoglobulin V(D)J recombination	J:168974
Rag2^tm1.1Desi/Rag2^tm1.1Desi Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	increased T cell derived lymphoma incidence	J:168974
Rag2^tm1.1Mss/Rag2^tm1.1Mss (involves: 129S6/SvEvTac)	abnormal lymphopoiesis	J:171970
	abnormal pre-B cell morphology	J:171970
	decreased pre-B cell number	J:171970
	increased DN3 thymocyte number	J:171970
Rag2^tm1.1Mss/Rag2^tm1.1Mss Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * 129S6/SvEvTac)	increased T cell derived lymphoma incidence	J:170462
Rag2^tm1Avla/Rag2^tm1Avla (involves: 129/Sv * C57BL/6)	abnormal immune system cell morphology	J:122108
	abnormal immune system organ morphology	J:122108
	abnormal lymph node morphology	J:122108
	abnormal spleen morphology	J:122108
	abnormal thymus morphology	J:122108
	absent Hassall's corpuscle	J:122108
	absent Peyer's patches	J:122108
	arrested B cell differentiation	J:122108
	arrested T cell differentiation	J:122108
	decreased double-positive T cell number	J:122108
	decreased lymphocyte cell number	J:122108
	decreased NK T cell number	J:122108
	decreased spleen white pulp amount	J:122108
	small cervical lymph nodes	J:122108
	small inguinal lymph nodes	J:122108
	small lymph nodes	J:122108
	small spleen	J:122108
Rag2^tm1Cgn/Rag2^tm1.1Cgn Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	absent immature B cells	J:72214
	absent pre-B cells	J:72214
	arrested B cell differentiation	J:72214
	arrested T cell differentiation	J:72214
	decreased follicular B cell number	J:72214
	decreased marginal zone B cell number	J:72214
	decreased mature B cell number	J:72214
	increased plasma cell number	J:72214
Rag2^tm1Cgn/Rag2^tm1Cgn Xrcc4^tm1Fwa/Xrcc4^tm2Fwa Tg(Cr2-cre)3Cgn/? (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)	abnormal class switch recombination	J:150339
Rag2^tm1Fwa/Rag2⁺ Tg(LPV-TAg1135)11Tvd/0 (involves: 129S/SvEv * C57BL/6 * DBA/2)	increased T cell derived lymphoma incidence	J:47667
Rag2^tm1Fwa/Rag2⁺ Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S/SvEv * 129S2/SvPas * C57BL/6J)	increased T cell derived lymphoma incidence	J:47667
Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * MF1)	abnormal effector T cell morphology	J:1935
	abnormal immunoglobulin V(D)J recombination	J:1935
	abnormal spleen morphology	J:1935
	abnormal T cell receptor V(D)J recombination	J:1935
	absent mature B cells	J:1935
	arrested B cell differentiation	J:1935
	arrested T cell differentiation	J:1935
	decreased CD4-positive, alpha-beta T cell number	J:1935
	decreased CD8-positive, alpha-beta T cell number	J:1935
	decreased double-positive T cell number	J:1935
	increased granulocyte number	J:1935
	increased macrophage cell number	J:1935
	lymph node hypoplasia	J:1935
	spleen hypoplasia	J:1935
	thymus hypoplasia	J:1935
Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv)	decreased thymocyte number	J:114561
Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * C57BL/6)	abnormal B cell morphology	J:81133
	arrested T cell differentiation	J:91542
	decreased double-negative T cell number	J:81133, J:91542
	increased double-negative T cell number	J:91542
Rag2^tm1Fwa/Rag2^tm1Fwa Cd47^tm1Fpl/Cd47^tm1Fpl Il2rg^tm1Cgn/Y (involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6)	absent peripheral lymph nodes	J:203904
	decreased CD4-positive, alpha-beta T cell number	J:203904
	decreased lymphocyte cell number	J:203904
	increased activated T cell number	J:203904
	increased CD8-positive, alpha-beta T cell number	J:203904
Rag2^tm1Fwa/Rag2^tm1Fwa Rr299391^tm1.1Fwa/Rr299391^tm1.1Fwa (involves: 129P2/OlaHsd * 129S/SvEv)	abnormal T cell receptor delta chain V(D)J recombination	J:149413
Rag2^tm1Fwa/Rag2^tm1Fwa Sos1^tm1.1Les/Sos1^tm1.1Les Tg(Lck-cre)1Cwi/0 (involves: 129S/SvEv * C57BL/6)	abnormal T cell differentiation	J:174536
Rag2^tm1Fwa/Rag2^tm1Fwa Tbata^tm1Faf/Tbata^tm1Faf (involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)	abnormal T cell differentiation	J:166065
	increased thymocyte number	J:166065
Rag2^tm1Fwa/Rag2^tm1Fwa Tcra^Ln3Jae/Tcra⁺ Tcrb^Ln3Jae/Tcrb⁺ (involves: 129S/SvEv * 129S4/SvJae * C57BL/6)	abnormal double-negative T cell morphology	J:143006
	absent gamma-delta T cells	J:143006
	decreased CD4-positive, alpha-beta T cell number	J:143006
	increased CD8-positive, alpha-beta T cell number	J:143006
Rag2^tm1Fwa/Rag2^tm1Fwa Tcrb^Ln3Jae/Tcrb⁺ (involves: 129S/SvEv * 129S4/SvJae * C57BL/6)	abnormal double-negative T cell morphology	J:143006
	absent gamma-delta T cells	J:143006
	decreased CD4-positive, alpha-beta T cell number	J:143006
	increased double-positive T cell number	J:143006
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Cd4-NPM/ALK)N1Ingh/0 (involves: 129S/SvEv * C57BL/6 * Swiss Webster)	increased DN3 thymocyte number	J:235890
	increased T cell derived lymphoma incidence	J:235890
	increased thymus tumor incidence	J:235890
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(EmuSR-tTa)83Bop/0 Tg(tetO-Nfatct1)1Grc/0 (involves: 129S/SvEv C57BL/6J * CBA/J * FVB/N)	abnormal double-positive T cell morphology	J:141917
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Igh-Pim1)1Brn/0 (involves: 129S/SvEv * C57BL/6LiA * CBA)	decreased thymocyte number	J:114561
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Lck-Akt1)M-1Pnt/0 (involves: 129S/SvEv C3H/He * C57BL/6)	absent CD4-positive, alpha-beta T cells	J:135903
	absent CD8-positive, alpha-beta T cells	J:135903
	increased double-positive T cell number	J:135903
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(LPV-TAg1135)11Tvd/0 (involves: 129S/SvEv * C57BL/6 * DBA/2)	increased T cell derived lymphoma incidence	J:47667
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Tcra5CC7,Tcrb5CC7)IWep/? Themis^5AT161/Themis^5AT161 (involves: 129S/SvEv * C57BL/6)	arrested T cell differentiation	J:151076
	increased double-positive T cell number	J:151076
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0 (involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA/2)	abnormal CD4-positive T cell differentiation	J:125548
	abnormal positive T cell selection	J:125548
	decreased CD4-positive, alpha-beta T cell number	J:125548
	increased double-positive T cell number	J:125548
	thymus hyperplasia	J:125548
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S/SvEv * C57BL/6J * DBA/2J)	abnormal CD8-positive, alpha beta T cell morphology	J:125259
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcraH-Y,TcrbH-Y)71Vbo/? Themis^5AT161/Themis^5AT161 (involves: 129S/SvEv * C57BL/6 * DBA/2)	decreased single-positive T cell number	J:151076
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcrHEL3A9)1Mmd/0 (involves: 129S/SvEv * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	abnormal double-positive T cell morphology	J:78309
	abnormal thymus cell ratio	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
Rag2^tm1Fwa/Rag2^tm1Fwa Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0 (involves: 129S/SvEv * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
	decreased double-positive T cell number	J:78309
Rag2^tm1Fwa/Rag2^tm1Fwa Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S/SvEv * 129S2/SvPas * C57BL/6J)	increased T cell derived lymphoma incidence	J:47667
Rag2^tm1Fwa/Rag2^tm1Mao (involves: 129S/SvEv * C57BL/6)	abnormal B cell number	J:81837
	abnormal gamma-delta T cell differentiation	J:81837
	arrested B cell differentiation	J:81837
	arrested T cell differentiation	J:81837
	decreased double-negative T cell number	J:81837
	decreased immature B cell number	J:81837
	decreased mature B cell number	J:81837
	decreased pre-B cell number	J:81837
	increased immature B cell number	J:81837
	thymus hypoplasia	J:81837
Rag2^tm1Libo/Rag2^tm1Libo (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	abnormal B cell differentiation	J:84563
	decreased B cell number	J:84563
	decreased monocyte cell number	J:84563
	decreased pre-B cell number	J:84563
Rag2^tm1Mao/Rag2^tm1Mao (involves: 129S6/SvEvTac * C57BL/6)	abnormal immune system cell morphology	J:81837
Rag2^tm1Mao/Rag2^tm1Mao (involves: 129 * C57BL/6)	abnormal B cell number	J:81837
	abnormal gamma-delta T cell differentiation	J:81837
	arrested B cell differentiation	J:81837
	arrested T cell differentiation	J:81837
	decreased double-negative T cell number	J:81837
	decreased immature B cell number	J:81837
	decreased mature B cell number	J:81837
	decreased pre-B cell number	J:81837
	increased immature B cell number	J:81837
	thymus hypoplasia	J:81837
Rag2^tm1Tgi/Rag2^tm1Tgi (involves: 129S1/Sv * 129X1/SvJ)	abnormal Peyer's patch morphology	J:113641
	arrested B cell differentiation	J:113641
	arrested T cell differentiation	J:113641
	decreased B cell number	J:113641
	decreased double-positive T cell number	J:113641
	decreased thymocyte number	J:113641
Rag2^tm2.1Desi/Rag2^tm2.1Desi Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)	increased T cell derived lymphoma incidence	J:168974
Ralb^{tm1a(EUCOMM)Wtsi}/Ralb^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Ralb^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Ramp1^{tm1b(EUCOMM)Wtsi}/Ramp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ramp1^{tm1b(EUCOMM)Wtsi}/H)	increased basophil cell number	J:211773
Ramp2^tm1Kmca/Ramp2^tm1Kmca (involves: 129S6/SvEvTac * C57BL/6)	abnormal lymph organ development	J:130930
	abnormal lymphatic vessel morphology	J:130930
Ranbp17^em1(IMPC)Tcp/Ranbp17^em1(IMPC)Tcp (C57BL/6N-Ranbp17^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Rap1gap^em1(IMPC)H/Rap1gap^em1(IMPC)H (C57BL/6NTac-Rap1gap^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Rap1gds1^tm1Ytk/Rap1gds1^tm1Ytk (involves: 129X1/SvJ * C57BL/6 * DBA)	abnormal thymus morphology	J:62244
	decreased thymocyte number	J:62244
	small thymus	J:62244
Rapgef6^tm1.1Tkat/Rapgef6^tm1.1Tkat (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:126164
Rapgef6^tm1.1Tkat/Rapgef6^tm1.1Tkat (involves: 129P2/OlaHsd)	enlarged spleen	J:218581
Rara^tm1.1Ybe/Rara^tm1.1Ybe (involves: C57BL/6N)	abnormal lymphopoiesis	J:207485
Rara^tm1Ipc/Rara^tm1Ipc Rarb^tm1Ipc/Rarb^tm1Ipc (involves: 129S2/SvPas)	persistent cervical thymus	J:21034
Rara^tm1Ipc/Rara^tm1Ipc Rarb^tm1Mma/Rarb^tm1Mma (involves: 129S2/SvPas * C57BL/6)	abnormal thymus morphology	J:43344
	persistent cervical thymus	J:43344
Rara^tm1Ipc/Rara^tm1Ipc Rarg^tm1Ipc/Rarg^tm1Ipc (involves: 129S2/SvPas)	persistent cervical thymus	J:21034
Rara^tm1Ipc/Rara^tm1Ipc Rarg^tm2Ipc/Rarg^tm2Ipc (involves: 129S2/SvPas)	ectopic thymus	J:42773
Rarres1^tm1.2Mhl/Rarres1^tm1.2Mhl (involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss)	abnormal B cell differentiation	J:324270
	abnormal plasma cell differentiation	J:324270
	decreased spleen germinal center number	J:324270
Rarres2^tm1Yktk/Rarres2^tm1Yktk (B6.Cg-Rarres2^tm1Yktk)	decreased macrophage cell number	J:206120
Rasa3^hlb381/Rasa3^hlb381 (C57BL/6J-Rasa3^hlb381/J)	decreased leukocyte cell number	J:301035, J:221899
	enlarged spleen	J:221899
	increased spleen weight	J:301035
Rasa3^scat/Rasa3^scat (involves: BALB/cBy)	abnormal spleen morphology	J:186485
	decreased B cell number	J:186485
	decreased CD4-positive, alpha-beta T cell number	J:186485
	decreased CD8-positive, alpha-beta T cell number	J:186485
	decreased leukocyte cell number	J:186485
	decreased T cell number	J:186485
	enlarged spleen	J:186485
	increased spleen red pulp amount	J:186485
	pale spleen	J:186485
Rasa3^scat/Rasa3^scat (involves: BALB/cBy * BALB/cByJ)	decreased leukocyte cell number	J:301035
Rasa3^scat/Rasa3^scat (involves: BALB/cBy * BALB/cByJ)	increased spleen weight	J:301035
Rasa3^tm1.1Llp/Rasa3^tm1.1Llp Tg(Mx1-cre)1Cgn/? (involves: 129S1/SvImJ * C57BL/6J * CBA/J)	bone marrow failure	J:301035
	decreased leukocyte cell number	J:301035
	increased spleen weight	J:301035
Rasal3^tm1.1Fuj/Rasal3^tm1.1Fuj (involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)	decreased NK T cell number	J:229641
	increased granulocyte number	J:229641
Rasal3^{tm1b(EUCOMM)Hmgu}/Rasal3^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rasal3^{tm1b(EUCOMM)Hmgu}/Orl)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Rasgrp1^lag/Rasgrp1^lag (involves: 129 * C57BL/6)	abnormal lymph node morphology	J:85189
	abnormal positive T cell selection	J:85189
	enlarged lymph nodes	J:85189
	enlarged spleen	J:85189
	increased B cell number	J:85189
	increased T cell number	J:85189
Rasgrp1^m1Anu/Rasgrp1^m1Anu (C57BL/6JSfdAnu-Rasgrp1^m1Anu)	abnormal T cell differentiation	J:104190
Rasgrp1^m1Anu/Rasgrp1^m1Anu (involves: C57BL/6JSfdAnu * CBA/J)	abnormal CD4-positive, alpha beta T cell morphology	J:207898
	increased effector memory CD4-positive, alpha-beta T cell number	J:207898
Rasgrp1^m1Btlr/Rasgrp1^m1Btlr (C57BL/6J-Rasgrp1^m1Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:265163
	decreased CD8-positive, naive alpha-beta T cell number	J:265163
	increased CD8-positive, alpha-beta memory T cell number	J:265163
	increased effector memory CD4-positive, alpha-beta T cell number	J:265163
	increased NK cell number	J:265163
Rasgrp1^m2Btlr/Rasgrp1^m2Btlr (C57BL/6J-Rasgrp1^m2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265163
	decreased CD8-positive, alpha-beta T cell number	J:265163
	decreased CD8-positive, naive alpha-beta T cell number	J:265163
	decreased single-positive T cell number	J:265163
	decreased T cell number	J:265163
	increased central memory CD4-positive, alpha-beta T cell number	J:265163
	increased central memory CD8 positive, alpha-beta T cell number	J:265163
	increased effector memory CD4-positive, alpha-beta T cell number	J:265163
	increased effector memory CD8-positive, alpha-beta T cell number	J:265163
	increased NK cell number	J:265163
Rasgrp1^m3Btlr/Rasgrp1^m3Btlr (C57BL/6J-Rasgrp1^m3Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265255
	decreased CD8-positive, alpha-beta T cell number	J:265255
	decreased CD8-positive, naive alpha-beta T cell number	J:265255
	decreased single-positive T cell number	J:265255
	decreased T cell number	J:265255
	increased B cell number	J:265255
	increased B-1b cell number	J:265255
	increased central memory CD8 positive, alpha-beta T cell number	J:265255
	increased effector memory CD4-positive, alpha-beta T cell number	J:265255
	increased effector memory CD8-positive, alpha-beta T cell number	J:265255
	increased neutrophil cell number	J:265255
	increased NK cell number	J:265255
Rasgrp1^M4Btlr/Rasgrp1^M4Btlr (C57BL/6J-Rasgrp1^M4Btlr)	abnormal T cell morphology	J:267490
Rasgrp1^m5Btlr/Rasgrp1^m5Btlr (C57BL/6J-Rasgrp1^m5Btlr)	increased NK cell number	J:272846
Rasgrp1^tm1.1Wz/Rasgrp1^tm1.1Wz (B6.Cg-Rasgrp1^tm1.1Wz)	abnormal CD4-positive T cell differentiation	J:225109
	abnormal CD8-positive, alpha-beta T cell differentiation	J:225109
	abnormal immune system cell morphology	J:225109
	abnormal immune system organ morphology	J:225109
	abnormal T cell differentiation	J:225109
	decreased single-positive T cell number	J:225109
	enlarged spleen	J:225109
	increased CD4-positive, alpha-beta memory T cell number	J:225109
	increased single-positive T cell number	J:225109
	increased spleen weight	J:225109
Rasgrp1^tm1.1Wz/Rasgrp1^tm1.1Wz Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6J * DBA/2J)	decreased single-positive T cell number	J:225109
	increased double-positive T cell number	J:225109
Rasgrp1^tm1.1Wz/Rasgrp1^tm1.1Wz Tg(TcraTcrb)425Cbn/? (involves: C57BL/6 * BALB/c)	abnormal CD4-positive T cell differentiation	J:225109
Rasgrp1^tm1Jstn/Rasgrp1^tm1Jstn (involves: 129P3/J * C57BL/6J)	decreased B cell number	J:108677
	decreased thymocyte number	J:108677
	enlarged spleen	J:108677
	increased plasma cell number	J:108677
Rasgrp1^tm1Jstn/Rasgrp1^tm1Jstn (involves: 129P3/J)	abnormal CD4-positive, alpha beta T cell morphology	J:207898
	abnormal double-positive T cell morphology	J:207898
	decreased CD4-positive, alpha-beta T cell number	J:207898
	decreased CD8-positive, alpha-beta T cell number	J:207898
Rasgrp1^tm1Jstn/Rasgrp1^tm1Jstn Rasgrp3^tm1Jstn/Rasgrp3^tm1Jstn (involves: 129P3/J * C57BL/6J)	decreased B cell number	J:108677
	decreased plasma cell number	J:108677
Rasgrp3^{em1(IMPC)Wtsi}/Rasgrp3^{em1(IMPC)Wtsi} (C57BL/6N-Rasgrp3^{em1(IMPC)Wtsi}/Wtsi)	increased CD8-positive, naive alpha-beta T cell number	J:211773
Rasgrp3^tm1Jstn/Rasgrp3^tm1Jstn (involves: 129P3/J * C57BL/6J)	decreased B cell number	J:108677
Rassf2^tm1Dlim/Rassf2^tm1Dlim (B6.Cg-Rassf2^tm1Dlim)	abnormal myeloid leukocyte morphology	J:181952
	abnormal osteoclast differentiation	J:181952
	abnormal spleen red pulp morphology	J:181952
	abnormal thymus epithelium morphology	J:181952
	decreased B cell number	J:181952
	decreased CD4-positive, alpha-beta T cell number	J:181952
	decreased CD8-positive, alpha-beta T cell number	J:181952
	decreased leukocyte cell number	J:181952
	decreased osteoclast cell number	J:181952
	decreased spleen weight	J:181952
	decreased T cell number	J:181952
	decreased thymus weight	J:181952
	spleen hypoplasia	J:181952
	thymus hypoplasia	J:181952
Rassf5^tm1Kina/Rassf5⁺ (involves: C57BL/6 * CBA * ICR)	lymphoid hypoplasia	J:92670
Rassf5^tm1Kina/Rassf5^tm1Kina (involves: C57BL/6 * CBA * ICR)	abnormal B cell differentiation	J:92670
	abnormal lymph node cell ratio	J:92670
	abnormal lymph node cortex morphology	J:92670
	abnormal spleen red pulp morphology	J:92670
	abnormal thymus cell ratio	J:92670
	abnormal thymus corticomedullary boundary morphology	J:92670
	abnormal thymus medulla morphology	J:92670
	decreased thymocyte number	J:92670
	spleen hypoplasia	J:92670
Rassf5^tm1Kina/Rassf5^tm1Kina (B6.Cg-Rassf5^tm1Kina)	enlarged lymph nodes	J:168749
	enlarged spleen	J:168749
	increased B cell number	J:168749
	increased memory T cell number	J:168749
	increased plasma cell number	J:168749
	increased T cell number	J:168749
Raver1^{em1(IMPC)Hmgu}/Raver1^{em1(IMPC)Hmgu} (C57BL/6NCrl-Raver1^{em1(IMPC)Hmgu}/Ieg)	increased spleen weight	J:211773
Rb1^tm1Dwg/Rb1^tm1Dwg (involves: 129/Sv * C57BL/6)	abnormal macrophage morphology	J:105548
Rb1^tm1Mlh/Rb1^tm1Mlh (either: 129P2/OlaHsd-Rb1^tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N))	abnormal myelopoiesis	J:2498
Rb1^tm1Tyj/Rb1^tm1Tyj (involves: 129S2/SvPas)	abnormal macrophage differentiation	J:105548
Rb1^tm2Mlh/Rb1^tm2Mlh (either: 129P2/OlaHsd-Rb1^tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N))	abnormal myelopoiesis	J:2498
Rb1cc1^tm1.1Guan/Rb1cc1^tm1.1Guan Tg(BEST1-cre)1Jdun/0 (involves: 129P2/OlaHsd * C57BL/6)	microgliosis	J:282249
Rb1cc1^tm1.1Guan/Rb1cc1^tm1.1Guan Tg(Tek-cre)12Flv/0 (B6.Cg-Rb1cc1^tm1.1Guan Tg(Tek-cre)12Flv)	abnormal myelopoiesis	J:167258
	increased neutrophil cell number	J:167258
Rbbp4^em1(IMPC)Mbp/Rbbp4⁺ (C57BL/6NCrl-Rbbp4^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Rbl1^tm1Mru/Rbl1^tm1Mru (involves: 129S4/SvJae * BALB/cJ)	abnormal spleen red pulp morphology	J:51060
Rbm7^em1Aki/Rbm7^em1Aki (B6.Cg-Rbm7^em1Aki)	decreased monocyte cell number	J:288329
Rbm10^em1(IMPC)Mbp/Y (C57BL/6NCrl-Rbm10^em1(IMPC)Mbp/MbpMmucd)	enlarged lymph nodes	J:211773
Rbm10^em1(IMPC)Mbp/Rbm10⁺ (C57BL/6NCrl-Rbm10^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Rbm15^tm1Dgg/Rbm15^tm1.1Dgg Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C57BL/6 * CBA * FVB/N)	abnormal B cell differentiation	J:120321
	decreased B cell number	J:120321
	decreased pre-B cell number	J:120321
	increased spleen red pulp amount	J:120321
Rbm15^tm1Swm/Rbm15^tm1Swm Tg(Mx1-cre)1Cgn/0 (involves: 129X1/SvJ * C57BL/6 * CBA)	decreased leukocyte cell number	J:152262
	decreased lymphocyte cell number	J:152262
	decreased neutrophil cell number	J:152262
	increased spleen red pulp amount	J:152262
Rbm20^em1(IMPC)Mbp/Rbm20^em1(IMPC)Mbp (C57BL/6N-Rbm20^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Rbm22^em1(IMPC)Mbp/Rbm22⁺ (C57BL/6NCrl-Rbm22^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
Rbm38^tm1.1Xch/Rbm38^tm1.1Xch (involves: C57BL/6 * FVB/N)	enlarged spleen	J:216929
Rbm38^tm1.1Xch/Rbm38^tm1.1Xch (involves: C57BL/6 * FVB/N)	increased spleen white pulp amount	J:216929
Rbm38^tm1.1Xch/Rbm38^tm1.1Xch Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C57BL/6 * FVB/N)	abnormal spleen B cell follicle morphology	J:216929
Rbp1^tm1Ipc/Rbp1^tm1Ipc (involves: 129S2/SvPas)	increased granulocyte number	J:67762
Rbp1^tm1Ipc/Rbp1^tm1Ipc (involves: 129S2/SvPas)	increased neutrophil cell number	J:67762
Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA)	abnormal T-helper 2 cell differentiation	J:90018
Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Itgax-cre)1-1Reiz/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	decreased dendritic cell number	J:125869
Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Lck-cre)19Hhan/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA)	abnormal CD4-positive helper T cell morphology	J:168475
	increased macrophage cell number	J:168475
	increased single-positive T cell number	J:168475
	increased splenocyte number	J:168475
	increased T cell number	J:168475
Rbpj^tm1Hon/Rbpj^tm1Hon Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal B cell differentiation	J:99747
	abnormal lymphopoiesis	J:99747
	arrested T cell differentiation	J:125869, J:99747
	decreased dendritic cell number	J:125869
	decreased double-positive T cell number	J:99747
	decreased follicular dendritic cell number	J:125869
	decreased marginal zone B cell number	J:76240, J:99747
	decreased single-positive T cell number	J:99747
	decreased thymocyte number	J:99747
	increased B cell number	J:125869, J:99747
	increased double-negative T cell number	J:99747
	increased follicular B cell number	J:99747
	increased macrophage cell number	J:125869
	increased monocyte cell number	J:125869
	increased plasmacytoid dendritic cell number	J:125869
	small thymus	J:99747
Rc3h1^san/Rc3h1⁺ (involves: C57BL/6JSfdAnu)	abnormal lymph node germinal center morphology	J:189087
	abnormal lymph node morphology	J:189087
	enlarged lymph nodes	J:189087
	increased spleen weight	J:189087
	increased T cell derived lymphoma incidence	J:189087
	increased T follicular helper cell number	J:189087
Rc3h1^san/Rc3h1^san (either: C57BL/6JSfdAnu-Rc3h1^san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca))	abnormal T cell differentiation	J:98938
	enlarged lymph nodes	J:98938
Rc3h1^san/Rc3h1^san (involves: C57BL/6JSfdAnu)	abnormal effector T cell morphology	J:199407
	abnormal intraepithelial T cell number	J:199407
	enlarged spleen	J:199407
	increased activated T cell number	J:199407
	increased CD4-positive, alpha-beta T cell number	J:199407
	lymphoid hyperplasia	J:199407
Rc3h1^san/Rc3h1^san Rc3h2^tm1.2Cgv/Rc3h2^tm1.2Cgv (involves: C57BL/6 * C57BL/6JSfdAnu)	increased T follicular helper cell number	J:196137
Rc3h1^tm1.1Mass/Rc3h1^tm1.1Mass Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6 * NZB * SJL)	abnormal effector T cell morphology	J:177784
	enlarged spleen	J:177784
	increased B cell number	J:177784
	increased eosinophil cell number	J:177784
	increased regulatory T cell number	J:177784
	increased spleen weight	J:177784
Rc3h1^tm1.1Mass/Rc3h1^tm1.1Mass Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca * NZB * SJL)	abnormal B cell differentiation	J:177784
	abnormal effector T cell morphology	J:177784
	abnormal spleen B cell follicle morphology	J:177784
	decreased B cell number	J:177784
	decreased immature B cell number	J:177784
	enlarged spleen	J:177784
	increased eosinophil cell number	J:177784
	increased macrophage cell number	J:177784
	increased regulatory T cell number	J:177784
	increased spleen weight	J:177784
	increased splenocyte number	J:177784
	spleen hyperplasia	J:177784
Rc3h1^tm1.1Mass/Rc3h1^tm1.1Mass Rc3h2^{tm1c(KOMP)Wtsi}/Rc3h2^{tm1c(KOMP)Wtsi} Tg(Cd4-cre)1Cwi/? (involves: C57BL/6N * DBA/2)	abnormal B cell number	J:196136
	abnormal immune system cell morphology	J:196136
	abnormal immune system organ morphology	J:196136
	abnormal spleen B cell follicle morphology	J:196136
	abnormal spleen morphology	J:196136
	abnormal spleen periarteriolar lymphoid sheath morphology	J:196136
	decreased CD4-positive, alpha-beta T cell number	J:196136
	decreased CD8-positive, alpha-beta T cell number	J:196136
	decreased T cell number	J:196136
	enlarged lymph nodes	J:196136
	enlarged spleen	J:196136
	increased germinal center B cell number	J:196136
	increased T follicular helper cell number	J:196136
Rc3h1^tm1.1Mass/Rc3h1^tm1.1Mass Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * NZB * SJL)	increased CD8-positive, alpha-beta T cell number	J:177784
	increased eosinophil cell number	J:177784
	increased macrophage cell number	J:177784
Rc3h1^tm1.2Cgv/Rc3h1^san (involves: C57BL/6 * C57BL/6JSfdAnu)	increased CD4-positive, alpha-beta T cell number	J:196137
	increased T follicular helper cell number	J:196137
Rc3h1^tm1.2Mass/Rc3h1^tm1.2Mass (involves: C57BL/6 * CBA * NZB * SJL)	abnormal thymus development	J:177784
Rc3h1^tm1.2Mass/Rc3h1^tm1.2Mass (involves: C57BL/6 * CBA * CD-1 * NZB * SJL)	abnormal effector T cell morphology	J:177784
	enlarged spleen	J:177784
	increased spleen weight	J:177784
Rcan1^tm1Jmol/Rcan1^tm1Jmol Rcan2^tm1Jmol/Rcan2^tm1Jmol Ppp3cb^tm1Jmk/Ppp3cb^tm1Jmk (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:109586
	abnormal CD8-positive, alpha beta T cell morphology	J:109586
Rcbtb2^tm1.1Xyw/Rcbtb2⁺ (involves: C57BL/6 * CBA)	enlarged mesenteric lymph nodes	J:282928
Rcbtb2^tm1.1Xyw/Rcbtb2⁺ (involves: C57BL/6 * CBA)	enlarged spleen	J:282928
Rcbtb2^tm1.1Xyw/Rcbtb2^tm1.1Xyw (involves: C57BL/6 * CBA)	enlarged mesenteric lymph nodes	J:282928
Rcbtb2^tm1.1Xyw/Rcbtb2^tm1.1Xyw (involves: C57BL/6 * CBA)	enlarged spleen	J:282928
Rdh7^{tm1c(KOMP)Wtsi}/Rdh7^{tm1c(KOMP)Wtsi} Tg(RARE-Hspa1b/lacZ)12Jrt/0 Tg(Vil1-cre)997Gum/0 (involves: C57BL/6J * C57BL/6N * CD-1 * SJL)	decreased lymphocyte cell number	J:279231
Recql4^tm1Abe/Recql4^tm1Abe (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal thymus corticomedullary boundary morphology	J:85574
	decreased spleen white pulp amount	J:85574
	small thymus	J:85574
Reep3^em1(IMPC)Tcp/Reep3^em1(IMPC)Tcp (C57BL/6NCrl-Reep3^em1(IMPC)Tcp/Cmmr)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Reg3g^tm1.1Lvh/Reg3g^tm1.1Lvh (B6.129-Reg3g^tm1.1Lvh)	increased T-helper 1 cell number	J:177506
Rel^M1Btlr/Rel⁺ (C57BL/6J-Rel^M1Btlr)	increased CD4-positive, alpha-beta T cell number	J:236682
Rel^M1Btlr/Rel⁺ (C57BL/6J-Rel^M1Btlr)	increased T cell number	J:236682
Rel^M1Btlr/Rel^M1Btlr (C57BL/6J-Rel^M1Btlr)	decreased B-1 B cell number	J:236682
	decreased CD4-positive, alpha-beta T cell number	J:236682
	decreased CD8-positive, alpha-beta T cell number	J:236682
	increased CD4-positive, alpha-beta T cell number	J:236682
	increased CD8-positive, alpha-beta T cell number	J:236682
	increased effector memory CD4-positive, alpha-beta T cell number	J:236682
	increased T cell number	J:236682
Rel^M2Btlr/Rel^M2Btlr (C57BL/6J-Rel^M2Btlr)	abnormal CD4-positive T cell differentiation	J:272778
	abnormal T cell differentiation	J:272778
	decreased alpha-beta T cell number	J:272778
	decreased B-1 B cell number	J:272778
	decreased CD4-positive, alpha-beta T cell number	J:272778
	decreased central memory CD4-positive, alpha-beta T cell number	J:272778
	decreased effector memory CD4-positive, alpha-beta T cell number	J:272778
Rel^{tm1b(EUCOMM)Wtsi}/Rel^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rel^{tm1b(EUCOMM)Wtsi}/H)	decreased monocyte cell number	J:211773
Rel^tm1Brv/Rel^tm1Brv (involves: 129S1/Sv)	abnormal macrophage morphology	J:46911
	abnormal spleen morphology	J:46911
	abnormal splenic cell ratio	J:46911
	decreased spleen germinal center number	J:46911
	enlarged lymph nodes	J:46911
	enlarged spleen	J:46911
	increased spleen B cell follicle size	J:46911
Rel^tm1Grd/Rel^tm1Grd Rela^tm1Bal/Rela^tm1Bal (B6.129S-Rel^tm1Grd Rela^tm1Bal)	abnormal monocyte differentiation	J:111325
	increased granulocyte number	J:111325
Rel^tm1Hcl/Rel^tm1Hcl (involves: 129S4/SvJae * C57BL/6)	abnormal memory B cell number	J:75621
	abnormal T-helper 1 cell differentiation	J:79107
	increased eosinophil cell number	J:58987
Rela^tm1Bal/Rela^tm1Bal (involves: 129S4/SvJae)	decreased marginal zone B cell number	J:65246
Rela^tm1Bal/Rela^tm1Bal Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (involves: 129S4/SvJae * C57BL/6)	abnormal spleen germinal center morphology	J:60742
	abnormal thymus morphology	J:60742
	decreased spleen white pulp amount	J:60742
Rela^tm1Rsch/Rela^tm1Rsch Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal gamma-delta T cell morphology	J:169863
Rela^tm1Rsch/Rela^tm1Rsch Tg(Lck-cre)I57Jxm/0 (involves: ICR)	abnormal gamma-delta T cell morphology	J:169863
Rela^tm1Yuo/Rela^tm1Yuo (involves: 129S/SvEv)	decreased double-positive T cell number	J:63099
Rela^tm2.1Gho/Rela^tm2.1Gho (involves: 129S6/SvEvTac * C57BL/6)	abnormal spleen morphology	J:163663
	increased neutrophil cell number	J:163663
Relb^{Tg(H2-K1/GH1)106Bri}/Relb⁺ (involves: C57BL/6)	decreased NK T cell number	J:120659
	decreased Peyer's patch number	J:120659
	small Peyer's patches	J:120659
Relb^{Tg(H2-K1/GH1)106Bri}/Relb^{Tg(H2-K1/GH1)106Bri} (C57BL/6-Relb^{Tg(H2-K1/GH1)106Bri})	abnormal lymph node morphology	J:76450
	abnormal Peyer's patch morphology	J:76450
	absent thymus medulla	J:23081, J:76450
	decreased B cell number	J:76450
	decreased pre-B cell number	J:76450
	decreased T cell number	J:76450
	enlarged spleen	J:76450
	increased granulocyte number	J:23081, J:76450
	increased macrophage cell number	J:23081, J:76450
Relb^{Tg(H2-K1/GH1)106Bri}/Relb^{Tg(H2-K1/GH1)106Bri} (involves: C57BL/6)	absent lymph nodes	J:120659
	absent Peyer's patches	J:120659
	decreased NK T cell number	J:120659
Relb^tm1.1Fwei/Relb^tm1.1Fwei Tg(Lck-cre)I57Jxm/0 (involves: ICR)	abnormal gamma-delta T cell morphology	J:169863
Relb^tm1Brv/Relb^tm1Brv (involves: 129S2/SvPas * C57BL/6)	abnormal immune system organ morphology	J:22675
	abnormal lymph node morphology	J:22675
	abnormal mesenteric lymph node morphology	J:22675
	decreased dendritic cell number	J:22675
	decreased spleen white pulp amount	J:22675
	decreased T cell number	J:22675
	increased spleen red pulp amount	J:22675
	increased spleen weight	J:22675
	myeloid hyperplasia	J:22675
	thymus atrophy	J:22675
	thymus hypoplasia	J:22675
Relb^tm1Brv/Relb^tm1Brv (either: (involves: 129S2/SvPas) or (involves: C57BL/6) or (involves: 129S2/SvPas * C57BL/6))	increased eosinophil cell number	J:63950
Relb^tm1Brv/Relb^tm1Brv (involves: 129S2/SvPas)	abnormal gamma-delta T cell morphology	J:169863
	decreased dendritic cell number	J:85808
	spleen hyperplasia	J:85808
Reln^em1(IMPC)Mbp/Reln⁺ (C57BL/6N-Reln^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Relt^tm1Hlee/Relt^tm1Hlee (Not Specified)	abnormal T cell morphology	J:266480
Retnlb^tm1Lex/Retnlb^tm1Lex (FVB.129S5-Retnlb^tm1Lex)	increased neutrophil cell number	J:235058
Retreg2^{em2(IMPC)Ccpcz}/Retreg2^{em2(IMPC)Ccpcz} (C57BL/6N-Retreg2^{em2(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased leukocyte cell number	J:211773
Rev1^tm1.1Jow/Rev1^tm1.1Jow (involves: C57BL/6)	abnormal somatic hypermutation frequency	J:151700
Rev1^tm1Ndew/Rev1^tm1Ndew (involves: 129P2/OlaHsd * C57BL/6)	abnormal somatic hypermutation frequency	J:119176
	lymphoid hypoplasia	J:119176
Rev3l^tm1.1Kunk/Rev3l^tm1.1Kunk (involves: C57BL/6)	abnormal somatic hypermutation frequency	J:188723
Rev3l^tm1Rsky/Rev3l^tm1.1Rsky Tg(Cr2-cre)3Cgn/? (involves: C57BL/6)	abnormal class switch recombination	J:146453
	abnormal somatic hypermutation frequency	J:146453
	decreased germinal center B cell number	J:146453
Rev3l^tm1Rwd/Rev3l^tm2.1Rwd Trp53^tm1Brd/Trp53^tm1Brd Tg(MMTV-cre)1Mam/0 (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N)	increased T cell derived lymphoma incidence	J:158922
Rexo2^{tm1b(EUCOMM)Wtsi}/Rexo2⁺ (C57BL/6N-Rexo2^{tm1b(EUCOMM)Wtsi}/H)	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Rffl^{em1(IMPC)Ccpcz}/Rffl^{em1(IMPC)Ccpcz} (C57BL/6N-Rffl^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Rfk^em1(IMPC)Mbp/Rfk⁺ (C57BL/6NCrl-Rfk^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Rft1^{tm1b(KOMP)Wtsi}/Rft1⁺ (C57BL/6N-Rft1^{tm1b(KOMP)Wtsi}/Bay)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased monocyte cell number	J:211773
Rftn1^tm1Ayos/Rftn1^tm1Ayos (B6.Cg-Rftn1^tm1Ayos)	abnormal CD4-positive T cell differentiation	J:150299
Rftn1^tm1Ayos/Rftn1^tm1Ayos (B6.Cg-Rftn1^tm1Ayos)	decreased splenocyte number	J:150299
Rfx5^tm1.1Ifo/Rfx5^tm1.1Ifo (involves: 129 * C57BL/6)	abnormal dendritic cell morphology	J:67941
	abnormal Kupffer cell morphology	J:67941
	abnormal thymus cortex morphology	J:67941
	decreased CD4-positive, alpha-beta T cell number	J:67941
	decreased single-positive T cell number	J:67941
Rfx7^tm1.1Ggaur/Rfx7^tm1.1Ggaur Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal NK cell morphology	J:282535
	decreased NK cell number	J:282535
	small spleen	J:282535
Rfx7^tm1.1Ggaur/Rfx7^tm1.1Ggaur Ncr1^{tm1.1(icre)Viv}/Ncr1⁺ (involves: C57BL/6)	decreased NK cell number	J:282535
Rfx7^tm1.1Ggaur/Rfx7^tm1.1Ggaur Rptor^tm1.1Dmsa/Rptor⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S/SvEv * C57BL/10 * CBA/Ca)	abnormal NK cell morphology	J:282535
	decreased NK cell number	J:282535
	small spleen	J:282535
Rgl1^em1(IMPC)Mbp/Rgl1⁺ (C57BL/6N-Rgl1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Rgs1^tm1Jhk/Rgs1^tm1Jhk (B6.129P2-Rgs1^tm1Jhk)	abnormal spleen germinal center morphology	J:90780
	decreased plasma cell number	J:90780
	increased marginal zone B cell number	J:90780
	small Peyer's patches	J:90780
Rgs2^em1(IMPC)H/Rgs2⁺ (C57BL/6NTac-Rgs2^em1(IMPC)H/H)	increased large unstained cell number	J:211773
Rgs2^em1(IMPC)H/Rgs2^em1(IMPC)H (C57BL/6NTac-Rgs2^em1(IMPC)H/H)	enlarged spleen	J:211773
Rgs3^tm1Ndul/Rgs3^tm1Ndul (B6.129-Rgs3^tm1Ndul)	abnormal lymph node morphology	J:210195
	increased B cell number	J:210195
	increased CD4-positive, alpha-beta T cell number	J:210195
	increased CD8-positive, alpha-beta T cell number	J:210195
Rgs4^em1(IMPC)H/Rgs4^em1(IMPC)H (C57BL/6N-Rgs4^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased spleen weight	J:211773
Rgs5^tm1Jhk/Rgs5^tm1Jhk (involves: 129S/SvEv * C57BL/6)	decreased lymphocyte cell number	J:133897
Rgs10^tm1Ypl/Rgs10^tm1Ypl (involves: 129S4/SvJae * C57BL/6J)	abnormal osteoclast differentiation	J:123167
	decreased osteoclast cell number	J:123167
Rgs12^tm1.1Syy/Rgs12^tm1.1Syy Tg(Mx1-cre)1Cgn/0 (involves: 129 * C57BL/6 * CBA)	decreased osteoclast cell number	J:194057
Rgs13^tm1.1Jhk/Rgs13^tm1.1Jhk (involves: C57BL/6)	abnormal B cell differentiation	J:199530
	abnormal spleen morphology	J:199530
	decreased B cell number	J:199530
	increased B cell number	J:199530
	increased germinal center B cell number	J:199530
	increased spleen germinal center number	J:199530
	increased spleen germinal center size	J:199530
Rgsc14/Rgsc14⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased leukocyte cell number	J:133634
Rgsc14/Rgsc14⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased lymphocyte cell number	J:133634
Rgsc15/Rgsc15⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased leukocyte cell number	J:133634
Rgsc15/Rgsc15⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased lymphocyte cell number	J:133634
Rgsc17/Rgsc17⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased leukocyte cell number	J:133634
Rgsc17/Rgsc17⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	decreased lymphocyte cell number	J:133634
Rgsc142/Rgsc142⁺ (involves: C57BL/6JJcl * DBA/2JJcl)	increased T cell derived lymphoma incidence	J:133634
Rhag^{em1(IMPC)Ccpcz}/Rhag^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Rhag^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Rhbdd3^tm1Caox/Rhbdd3^tm1Caox (B6.129S6-Rhbdd3^tm1Caox)	increased NK cell number	J:197348
Rhbdf1^tm1.1Mfm/Rhbdf1^tm1.1Mfm (involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6J)	small spleen	J:203951
	small thymus	J:203951
Rho^tm2.1Kpal/Rho^tm2.1Kpal (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)	microgliosis	J:194158
Rhoa^tm1.1Tpal/Rhoa⁺ Tg(Cd4-cre/ERT2)11Gnri/0 (involves: C57BL/6)	increased regulatory T cell number	J:257764
	increased T follicular helper cell number	J:257764
Rhobtb1^{em2(IMPC)Ccpcz}/Rhobtb1^{em2(IMPC)Ccpcz} (C57BL/6N-Rhobtb1^{em2(IMPC)Ccpcz}/Ccpcz)	increased Ly6C-positive NK T cell number	J:211773
Rhobtb3^{tm1a(KOMP)Wtsi}/Rhobtb3^{tm1a(KOMP)Wtsi} (involves: C57BL/6N)	decreased spleen weight	J:226884
Rhof^tm1.2Dash/Rhof^tm1.2Dash (involves: 129)	abnormal spleen marginal zone morphology	J:303076
Rhof^tm1.2Dash/Rhof^tm1.2Dash (involves: 129)	decreased marginal zone B cell number	J:303076
Rhoh^tm1Brak/Rhoh^tm1Brak (involves: 129/Sv * C57BL/6)	abnormal double-negative T cell morphology	J:143161
	abnormal immune system organ morphology	J:143161
	abnormal lymphocyte cell number	J:143161
	abnormal splenic cell ratio	J:143161
	decreased CD4-positive, alpha-beta T cell number	J:143161
	decreased CD8-positive, alpha-beta T cell number	J:143161
	decreased double-positive T cell number	J:143161
	decreased single-positive T cell number	J:143161
	decreased T cell number	J:143161
	increased double-negative T cell number	J:143161
	increased gamma-delta T cell number	J:143161
	increased NK cell number	J:143161
	increased NK T cell number	J:143161
	increased T cell number	J:143161
	spleen hypoplasia	J:143161
	thymus hypoplasia	J:143161
Rhoh^tm1Brak/Rhoh^tm1Brak Itgb2^tm2Bay/Itgb2^tm2Bay (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:143161
	decreased CD8-positive, alpha-beta T cell number	J:143161
	decreased double-positive T cell number	J:143161
	decreased single-positive T cell number	J:143161
	increased double-negative T cell number	J:143161
Rhoh^tm1Brak/Rhoh^tm1Brak Tg(TcraTcrb)425Cbn/? (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:143161
Rhoh^tm1Daw/Rhoh^tm1Daw (involves: 129 * C57BL/6)	arrested T cell differentiation	J:113565
	decreased double-positive T cell number	J:113565
	decreased T cell number	J:113565
	thymus hypoplasia	J:113565
Ric1^{tm1a(EUCOMM)Hmgu}/Ric1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Ric1^{tm1a(EUCOMM)Hmgu}/H)	decreased B cell number	J:165965
	decreased leukocyte cell number	J:165965
	decreased mature B cell number	J:165965
Ric8b^{tm1b(EUCOMM)Hmgu}/Ric8b⁺ (C57BL/6N-Ric8b^{tm1b(EUCOMM)Hmgu}/Cnrm)	increased basophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Rictor^tm1.1Klg/Rictor^tm1.1Klg Tg(Mx1-cre)1Cgn/0 (B6.Cg-Rictor^tm1.1Klg Tg(Mx1-cre)1Cgn)	abnormal double-negative T cell morphology	J:189736
	decreased DN1 thymic pro-T cell number	J:189736
	decreased DN2 thymocyte number	J:189736
	decreased DN3 thymocyte number	J:189736
	decreased DN4 thymocyte number	J:189736
	decreased double-positive T cell number	J:189736
	decreased single-positive T cell number	J:189736
	decreased thymus weight	J:189736
	increased double-negative T cell number	J:189736
	thymus hypoplasia	J:189736
Rictor^tm1.1Mnh/Rictor^tm1.1Mnh Tg(Fabp4-cre)1Rev/0 (B6.Cg-Rictor^tm1.1Mnh Tg(Fabp4-cre)1Rev)	increased spleen weight	J:150064
Rif1^{Gt(XT0278)Wtsi}/Rif1^{Gt(XT0278)Wtsi} (involves: 129P2/OlaHsd * CD-1 * MF1)	abnormal class switch recombination	J:195061
Rigi^tm1Zgwg/Rigi^tm1Zgwg (involves: 129S1/Sv)	abnormal B cell differentiation	J:139016
	abnormal granulocyte morphology	J:139016
	decreased Peyer's patch number	J:139868
	decreased T cell number	J:139868
	enlarged spleen	J:139016
	increased activated T cell number	J:139868
	increased granulocyte number	J:139016
	increased memory T cell number	J:139868
	small Peyer's patches	J:139868
Rin3^{tm1.1(KOMP)Vlcg}/Rin3^{tm1.1(KOMP)Vlcg} (involves: 129P2/OlaHsd * C57BL/6N)	abnormal osteoclast morphology	J:358899
Rinl^tm1.1Boun/Rinl^tm1.1Boun (B6.Cg-Rinl^tm1.1Boun)	enlarged spleen	J:346452
	increased B cell number	J:346452
	increased CD4-positive, alpha-beta T cell number	J:346452
	increased germinal center B cell number	J:346452
	increased splenocyte number	J:346452
	increased T follicular helper cell number	J:346452
Rinl^tm1.1Boun/Rinl^tm1.1Boun Tg(TcraTcrb)425Cbn/0 (involves: C57BL/6)	abnormal T follicular helper cell differentiation	J:346452
	increased CD4-positive, alpha-beta T cell number	J:346452
	increased T follicular helper cell number	J:346452
Riok2^{tm1c(KOMP)Wtsi}/Riok2⁺ Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6N * C57BL/10 * CBA/Ca)	abnormal CD4-positive, alpha beta T cell morphology	J:305794
	abnormal immune system morphology	J:305794
	decreased neutrophil cell number	J:305794
	increased monocyte cell number	J:305794
	increased NK T cell number	J:305794
Riox1^tm1Qch/Riox1^tm1Qch Tg(Prrx1-cre)1Cjt/0 (involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl * SJL/J)	decreased osteoclast cell number	J:224562
Riox2^tm1Mtsun/Riox2^tm1Mtsun (B6CrSlc.Cg-Riox2^tm1Mtsun)	decreased eosinophil cell number	J:201871
	decreased macrophage cell number	J:201871
	decreased neutrophil cell number	J:201871
Ripk1^tm1Led/Ripk1^tm1Led (involves: 129S6/SvEvTac)	abnormal immune system organ morphology	J:46522
	abnormal leukocyte cell number	J:46522
	abnormal lymph node morphology	J:46522
	abnormal thymus morphology	J:46522
	decreased thymocyte number	J:46522
	increased spleen red pulp amount	J:46522
	lymph node necrosis	J:46522
Ripk2^tm1Flv/Ripk2^tm1Flv Tnip1^tm1.1Pcoh/Tnip1^tm1.1Pcoh (involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)	enlarged lymph nodes	J:176826
	enlarged spleen	J:176826
Ripply3^tm1Sjt/Ripply3^tm1Sjt (involves: 129S1/Sv * C57BL/6)	abnormal thymus development	J:167713
	ectopic thymus	J:167713
	small thymus	J:167713
Rit1^tm1.1Tumg/Rit1⁺ (B6.Cg-Rit1^tm1.1Tumg)	enlarged spleen	J:277548
Rlim^{em1(IMPC)Rbrc}/Rlim⁺ (C57BL/6NJcl-Rlim^{em1(IMPC)Rbrc}/Rbrc)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Rmrp^{em1(IMPC)Ccpcz}/Rmrp⁺ (C57BL/6NCrl-Rmrp^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	increased lymphocyte cell number	J:211773
Rnase6^em1(IMPC)Tcp/Rnase6^em1(IMPC)Tcp (C57BL/6N-Rnase6^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
Rnase11^em1(IMPC)Mbp/Rnase11^em1(IMPC)Mbp (C57BL/6N-Rnase11^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	increased lymphocyte cell number	J:211773
	small spleen	J:211773
Rnase12^em1(IMPC)Mbp/Rnase12^em1(IMPC)Mbp (C57BL/6N-Rnase12^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Rnaseh2a^em1(IMPC)Tcp/Rnaseh2a⁺ (C57BL/6NCrl-Rnaseh2a^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
	increased spleen weight	J:211773
Rnaseh2b^em1Anu/Rnaseh2b⁺ Tlr7^em2Anu/Tlr7⁺ (C57BL/6NCrl-Rnaseh2b^em1Anu Tlr7^em2Anu)	abnormal immune system morphology	J:324448
	abnormal mature B cell morphology	J:324448
	increased CD4-positive, alpha-beta T cell number	J:324448
	increased germinal center B cell number	J:324448
	increased plasma cell number	J:324448
	increased T follicular helper cell number	J:324448
Rnaseh2b^{tm1a(EUCOMM)Wtsi}/Rnaseh2b^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	thymus hypoplasia	J:186986
Rnasel^tm1Slvm/Rnasel^tm1Slvm (involves: 129P2/OlaHsd)	abnormal thymus morphology	J:44292
	enlarged thymus	J:44292
	thymus hyperplasia	J:44292
Rnaset2b^{tm1b(EUCOMM)Hmgu}/Rnaset2b^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rnaset2b^{tm1b(EUCOMM)Hmgu}/H)	enlarged spleen	J:211773
Rnd2^em1(IMPC)Mbp/Rnd2^em1(IMPC)Mbp (C57BL/6NCrl-Rnd2^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Rnd3^{tm1b(EUCOMM)Hmgu}/Rnd3⁺ (C57BL/6N-Rnd3^{tm1b(EUCOMM)Hmgu}/H)	increased large unstained cell number	J:211773
Rnf2^tm1Mvi/Rnf2^tm1Mvi Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10 * CBA)	abnormal B cell differentiation	J:130397
	decreased B cell number	J:130397
	decreased monocyte cell number	J:130397
Rnf5^{tm1.1(KOMP)Vlcg}/Rnf5⁺ (C57BL/6N-Rnf5^{tm1.1(KOMP)Vlcg}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Rnf5^{tm1.1(KOMP)Vlcg}/Rnf5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rnf5^{tm1.1(KOMP)Vlcg}/Ccpcz)	abnormal spleen morphology	J:211773
Rnf8^{Gt(AS0574)Wtsi}/Rnf8⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:161240
Rnf8^{Gt(AS0574)Wtsi}/Rnf8^{Gt(AS0574)Wtsi} (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:161240
	decreased B cell number	J:161240
	decreased CD4-positive, alpha-beta T cell number	J:161240
	decreased CD8-positive, alpha-beta T cell number	J:161240
	decreased double-negative T cell number	J:161240
	decreased double-positive T cell number	J:161240
	decreased immature B cell number	J:161240
	decreased pre-B cell number	J:161240
	decreased pro-B cell number	J:161240
	decreased splenocyte number	J:161240
	decreased T cell number	J:161240
	decreased thymocyte number	J:161240
	increased T cell derived lymphoma incidence	J:161240
Rnf8^{Gt(RRR260)Byg}/Rnf8^{Gt(RRR260)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:161240
	decreased B cell number	J:161240
	decreased CD4-positive, alpha-beta T cell number	J:161240
	decreased CD8-positive, alpha-beta T cell number	J:161240
	decreased double-negative T cell number	J:161240
	decreased double-positive T cell number	J:161240
	decreased immature B cell number	J:161240
	decreased pre-B cell number	J:161240
	decreased pro-B cell number	J:161240
	decreased splenocyte number	J:161240
	decreased T cell number	J:161240
	decreased thymocyte number	J:161240
	increased T cell derived lymphoma incidence	J:161240
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/Ics)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/H)	increased large unstained cell number	J:211773
Rnf10^{tm1b(KOMP)Wtsi}/Rnf10^{tm1b(KOMP)Wtsi} (C57BL/6N-Rnf10^{tm1b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Rnf19b^{em1(IMPC)Ccpcz}/Rnf19b⁺ (C57BL/6N-Rnf19b^{em1(IMPC)Ccpcz}/Ccpcz)	increased eosinophil cell number	J:211773
Rnf20^{Gt(RRJ249)Byg}/Rnf20⁺ (involves: 129P2/OlaHsd)	enlarged spleen	J:268221
Rnf20^{Gt(RRJ249)Byg}/Rnf20⁺ (involves: 129P2/OlaHsd)	increased spleen weight	J:268221
Rnf31^tm1.1Kiwa/Rnf31^tm1.1Kiwa Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6NCrlj * CBA/JNCrlj)	abnormal B-1 B cell morphology	J:201885
	decreased B-1a cell number	J:201885
	decreased B-1b cell number	J:201885
Rnf43^em1(IMPC)Tcp/Rnf43^em1(IMPC)Tcp (C57BL/6NCrl-Rnf43^em1(IMPC)Tcp/Tcp)	enlarged spleen	J:211773
Rnf115^em1(IMPC)H/Rnf115^em1(IMPC)H (C57BL/6N-Rnf115^em1(IMPC)H/H)	increased spleen weight	J:211773
Rnf128^{tm1.1(KOMP)Vlcg}/Y (C57BL/6N-Rnf128^{tm1.1(KOMP)Vlcg}/Ccpcz)	increased effector memory T-helper cell number	J:211773
Rnf128^tm1Cdon/Rnf128^tm1Cdon (involves: 129 * C57BL/6)	enlarged mesenteric lymph nodes	J:160681
Rnf128^tm1Cdon/Rnf128^tm1Cdon (involves: 129 * C57BL/6)	enlarged spleen	J:160681
Rnf135^em1(IMPC)Tcp/Rnf135^em1(IMPC)Tcp (C57BL/6NCrl-Rnf135^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Rnf146^tm1.1Rtpl/Rnf146^tm1.1Rtpl Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	abnormal osteoclast differentiation	J:243612
	increased osteoclast cell number	J:243612
Rnf148^{em1(IMPC)Ccpcz}/Rnf148^{em1(IMPC)Ccpcz} (C57BL/6N-Rnf148^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Rnf149^em1Staa/Rnf149^em1Staa (involves: BALB/c * C57BL/6)	increased leukocyte cell number	J:335358
	increased lymphocyte cell number	J:335358
	increased monocyte cell number	J:335358
	increased neutrophil cell number	J:335358
Rnf168^{Gt(156B6)Cmhd}/Rnf168^{Gt(156B6)Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:198260
	abnormal T cell receptor delta chain V(D)J recombination	J:198260
	decreased gamma-delta T cell number	J:198260
	increased DN3 thymocyte number	J:198260
	increased double-negative T cell number	J:198260
Rnf168^{Gt(405F11)Cmhd}/Rnf168^{Gt(405F11)Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:198260
	abnormal T cell receptor delta chain V(D)J recombination	J:198260
	decreased gamma-delta T cell number	J:198260
	increased DN3 thymocyte number	J:198260
	increased double-negative T cell number	J:198260
Rnf168^{tm2b(EUCOMM)Hmgu}/Rnf168^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Rnf168^{tm2b(EUCOMM)Hmgu}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
Rnf169^{tm1a(EUCOMM)Hmgu}/Rnf169^{tm1a(EUCOMM)Hmgu} (B6NTac;B6N-Rnf169^{tm1a(EUCOMM)Hmgu}/H)	increased monocyte cell number	J:165965
Rnf208^{em1(IMPC)Ccpcz}/Rnf208^{em1(IMPC)Ccpcz} (C57BL/6N-Rnf208^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
Rnf216^{tm1b(EUCOMM)Wtsi}/Rnf216^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Rnf216^{tm1b(EUCOMM)Wtsi}/Tcp)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Rnf223^{em1(IMPC)Ccpcz}/Rnf223^{em1(IMPC)Ccpcz} (C57BL/6N-Rnf223^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Rnft2^{tm1b(EUCOMM)Hmgu}/Rnft2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Rnft2^{tm1b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Rnpepl1^em1(IMPC)Mbp/Rnpepl1^em1(IMPC)Mbp (C57BL/6N-Rnpepl1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Ror1^{em1(IMPC)Ccpcz}/Ror1⁺ (C57BL/6NCrl-Ror1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Rora^sg/Rora^sg (involves: C57BL/6)	abnormal immune system organ morphology	J:2228
	spleen atrophy	J:2228
	thymus atrophy	J:2228
Rorc^m1Btlr/Rorc^m1Btlr (C57BL/6J-Rorc^m1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:203039
Rorc^m1Btlr/Rorc^m1Btlr (C57BL/6J-Rorc^m1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:203039
Rorc^m3Btlr/Rorc^m3Btlr (C57BL/6J-Rorc^m3Btlr)	abnormal CD4-positive, alpha beta T cell morphology	J:234257
	decreased B-2 B cell number	J:234257
	decreased CD4-positive, alpha-beta T cell number	J:234257
	decreased CD8-positive, naive alpha-beta T cell number	J:234257
	increased B-1a cell number	J:234257
	increased B-1b cell number	J:234257
	increased CD8-positive, alpha-beta T cell number	J:234257
	increased effector memory CD4-positive, alpha-beta T cell number	J:234257
	increased effector memory CD8-positive, alpha-beta T cell number	J:234257
Rorc^tm1.1Zsun/Rorc^tm1.1Zsun (B6(129S4)-Rorc^tm1.1Zsun)	abnormal T-helper 17 cell differentiation	J:248565
	absent Peyer's patches	J:248565
	small inguinal lymph nodes	J:248565
Rorc^tm1Amj/Rorc^tm1Amj (either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * DBA/2))	abnormal lymph organ development	J:64381
	abnormal splenic cell ratio	J:64381
	absent lymph nodes	J:64381
	absent Peyer's patches	J:64381
	decreased CD4-positive, alpha-beta T cell number	J:64381
	decreased CD8-positive, alpha-beta T cell number	J:64381
	decreased double-positive T cell number	J:64381
	decreased T cell number	J:64381
	decreased thymus weight	J:64381
	enlarged spleen	J:64381
	increased double-negative T cell number	J:64381
	thymus hypoplasia	J:64381
Rorc^tm1Litt/Rorc^tm1Litt (involves: 129P2/OlaHsd)	abnormal CD8-positive, alpha-beta T cell differentiation	J:248565
	abnormal T cell differentiation	J:128344, J:248565
	abnormal T cell morphology	J:248565
	abnormal T-helper 17 cell differentiation	J:248565
	absent lymph nodes	J:248565
	decreased CD4-positive, alpha-beta T cell number	J:248565
	decreased double-positive T cell number	J:248565
	decreased thymocyte number	J:248565
Rorc^tm1Litt/Rorc^tm1Litt Tcra-J^tm3.1Krg/Tcra-J^tm3.1Krg (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal T cell differentiation	J:128344
Rorc^tm2Litt/Rorc^tm2Litt (involves: 129P2/OlaHsd)	abnormal CD4-positive, alpha-beta intraepithelial T cell morphology	J:91566
	abnormal CD8 positive, alpha-beta intraepithelial T cell morphology	J:91566
	abnormal gut-associated lymphoid tissue morphology	J:87395, J:91566
	abnormal lymph organ development	J:87395
	absent lymph nodes	J:87395
	absent Peyer's patches	J:87395
	decreased double-negative T cell number	J:91566
	decreased double-positive T cell number	J:87395
	decreased NK cell number	J:142654
Rpa1^tm1Wed/Rpa1⁺ (involves: 129/Sv * C57BL/6J * SJL)	increased lymphocyte cell number	J:99303
Rpap3^em1(IMPC)Mbp/Rpap3⁺ (C57BL/6N-Rpap3^em1(IMPC)Mbp/Ucd)	abnormal thymus morphology	J:211773
Rpap3^em1(IMPC)Mbp/Rpap3⁺ (C57BL/6N-Rpap3^em1(IMPC)Mbp/Ucd)	enlarged thymus	J:211773
Rpe65^{tm1a(EUCOMM)Hmgu}/Rpe65^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Rpe65^{tm1a(EUCOMM)Hmgu}/H)	decreased leukocyte cell number	J:165965
	increased leukocyte cell number	J:165965
Rpe^em1(IMPC)Mbp/Rpe⁺ (C57BL/6NCrl-Rpe^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
Rpe^em1(IMPC)Mbp/Rpe⁺ (C57BL/6NCrl-Rpe^em1(IMPC)Mbp/Mmucd)	enlarged spleen	J:211773
Rpgrip1l^{tm1a(EUCOMM)Wtsi}/Rpgrip1l^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Rpgrip1l^{tm1a(EUCOMM)Wtsi}/Wtsi)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
	absent spleen	J:239583
	spleen hypoplasia	J:239583
Rpl12^em1(IMPC)Mbp/Rpl12⁺ (C57BL/6NCrl-Rpl12^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Rpl22^{Gt(GST000137)Lex}/Rpl22^{Gt(GST000137)Lex} (involves: 129S5/SvEvBrd)	abnormal T cell differentiation	J:123569
	abnormal T cell number	J:123569
	arrested T cell differentiation	J:123569
	decreased CD4-positive, alpha-beta T cell number	J:123569
	decreased CD8-positive, alpha-beta T cell number	J:123569
	decreased double-negative T cell number	J:123569
	decreased T cell number	J:123569
	thymus hypoplasia	J:123569
Rpl22^{Gt(YHB332)Byg}/Rpl22^{Gt(YHB332)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus development	J:201164
	decreased B cell number	J:201164
	decreased T cell number	J:201164
Rpl27a^Sfa/Rpl27a⁺ (C57BL/6J-Rpl27a^Sfa)	decreased leukocyte cell number	J:174216
	small spleen	J:174216
	small thymus	J:174216
Rplp1^tm1.1Melt/Rplp1^tm1.2Melt (Not Specified)	small thymus	J:218949
Rps6ka4^tm1Jsca/Rps6ka4^tm1Jsca Rps6ka5^tm1Jsca/Rps6ka5^tm1Jsca (Not Specified)	spleen hypoplasia	J:124301
Rps9^tm1.1Geno/Rps9^tm1.1Geno (involves: C57BL/6)	decreased leukocyte cell number	J:329922
Rps9^tm1.1Geno/Rps9^tm1.1Geno (involves: C57BL/6)	increased monocyte cell number	J:329922
Rps12^em1.1Nbakr/Rps12⁺ (involves: C57BL/6J * FVB/N)	decreased leukocyte cell number	J:338970
Rps12^em1.1Nbakr/Rps12⁺ (involves: C57BL/6J * FVB/N)	decreased spleen weight	J:338970
Rps14^tm1.1Ble/Rps14⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6NTac * CBA/J)	enlarged spleen	J:233322
Rps19bp1^{tm1.1(KOMP)Wtsi}/Rps19bp1⁺ (C57BL/6N-Rps19bp1^{tm1.1(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Rps27l^{Gt(IST11658B7)Tigm}/Rps27l^{Gt(IST11658B7)Tigm} (C57BL/6-Rps27l^{Gt(IST11658B7)Tigm})	decreased spleen weight	J:223276
	decreased thymus weight	J:223276
	thymus cortex hypoplasia	J:223276
Rps27l^{Gt(IST11658B7)Tigm}/Rps27l^{Gt(IST11658B7)Tigm} (involves: 129 * C57BL/6N)	spleen hypoplasia	J:223276
	thymus hypoplasia	J:223276
Rps27l^{Gt(IST11658B7)Tigm}/Rps27l^{Gt(IST11658B7)Tigm} Trp53^tm1Tyj/Trp53⁺ (involves: 129S2/SvPas * C57BL/6N)	enlarged lymph nodes	J:223276
	enlarged spleen	J:223276
	increased T cell derived lymphoma incidence	J:223276
Rptor^tm1Ahir/Rptor^tm1Ahir Tg(Itgax-cre)1-1Reiz/0 (B6.Cg-Rptor^tm1Ahir Tg(Itgax-cre)1-1Reiz)	increased dendritic cell number	J:188676
Rpusd2^{tm1b(KOMP)Wtsi}/Rpusd2^{tm1b(KOMP)Wtsi} (C57BL/6N-Rpusd2^{tm1b(KOMP)Wtsi}/Bay)	increased spleen weight	J:211773
Rr7^tm1.1Kio/Rr7^tm1.1Kio (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:179326, J:164573
Rr7^tm2.1Kio/Rr7^tm2.1Kio (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:164573
Rr7^tm3.1Kio/Rr7⁺ (B6.129S4-Rr7^tm3.1Kio)	abnormal CD4-positive, alpha beta T cell morphology	J:179326
Rr7^tm3.1Kio/Rr7⁺ Tg(Lck-cre)#Nik/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:179326
Rr7^tm4.1Kio/Rr7^tm4.1Kio (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:179326
Rr38^tm1.2Aafo/Rr38⁺ (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)	decreased thymocyte number	J:227747
Rr38^tm1.2Aafo/Rr38^tm1.2Aafo (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:227747
	decreased CD8-positive, alpha-beta T cell number	J:227747
	decreased double-positive T cell number	J:227747
	decreased single-positive T cell number	J:227747
	decreased thymocyte number	J:227747
	decreased thymus weight	J:227747
	increased DN3 thymocyte number	J:227747
	small thymus	J:227747
	thymus hypoplasia	J:227747
Rr39^em1Ched/Rr39^em1Ched (C57BL/6-Rr39^em1Ched)	decreased Ly6C low monocyte number	J:239509
Rr79^em2Rtew/Rr79^em2Rtew (C57BL/6J-Rr79^em2Rtew/J)	abnormal T cell subpopulation ratio	J:332957
Rr94^tm3.1Litt/Rr94⁺ Tg(Cd4-cre)1Cwi/0 Rr112^tm4.1Litt/Rr112⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)	abnormal T cell differentiation	J:158962
	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
Rr94^tm3.1Litt/Rr94^tm3.1Litt Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)	abnormal T cell differentiation	J:158962
	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	decreased double-positive T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
Rr94^tm3.2Litt/Rr94⁺ Rr112^tm4.1Litt/Rr112⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)	abnormal T cell differentiation	J:158962
	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
Rr94^tm3.2Litt/Rr94^tm3.2Litt (involves: 129P2/OlaHsd * FVB/N)	abnormal CD4-positive, alpha beta T cell morphology	J:158962
	abnormal double-positive T cell morphology	J:158962
	abnormal T cell differentiation	J:158962
	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	decreased double-positive T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
Rr94^tm3.2Litt/Rr94^tm3.2Litt H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)	abnormal T cell subpopulation ratio	J:158962
	decreased CD4-positive, alpha-beta T cell number	J:158962
	increased CD8-positive, alpha-beta T cell number	J:158962
Rr96^tm1.1Tich/Rr96⁺ Gt(ROSA)26Sor^{tm1(cre/ERT2)Thl}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129 129S4/SvJae * C57BL/6)	abnormal T cell differentiation	J:191711
Rr96^tm1.1Tich/Rr96⁺ Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor⁺ (involves: 129 129S4/SvJae * C57BL/6)	abnormal CD4-positive T cell differentiation	J:191711
Rr96^tm1.1Tich/Rr96^tm1.1Tich Gt(ROSA)26Sor^{tm1(rtTAM2)Jae}/Gt(ROSA)26Sor^{tm1(rtTAM2)Jae} (involves: 129 * 129S4/SvJae * C57BL/6)	abnormal T cell differentiation	J:191711
Rr96^tm1.1Tich/Rr96^tm1.1Tich Tg(ACTB-tTS)1Mllo/? (involves: 129 * C57BL/6)	decreased double-positive T cell number	J:191711
Rr96^tm1.1Yzo/Rr96^tm1.1Yzo (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:130559
	increased CD4-positive, alpha-beta T cell number	J:130559
	increased double-positive T cell number	J:130559
Rr96^tm1.1Yzo/Rr96^tm1.1Yzo H2-Ab1^b-tm1Gru/H2-Ab1^b-tm1Gru (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal T cell differentiation	J:130559
Rr96^tm1Yzo/Rr96^tm1Yzo Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:130559
	increased double-positive T cell number	J:130559
Rr96^tm1Yzo/Rr96^tm1Yzo Tg(Cd8a-cre,-GFP)1Yzo/? (involves: 129P2/OlaHsd)	increased double-positive T cell number	J:130559
Rr96^tm2Litt/Rr96⁺ Zbtb7b^tm1.1Tani/Zbtb7b^tm1.1Tani (involves: 129 * 129P2/OlaHsd * C57BL/6)	increased double-negative T cell number	J:141142
Rr96^tm2Litt/Rr96⁺ Zbtb7b^tm1Itan/Zbtb7b^tm1.1Tani (involves: 129 * 129P2/OlaHsd * C57BL/6)	abnormal double-negative T cell morphology	J:141142
	decreased CD8-positive, alpha-beta T cell number	J:141142
Rr96^tm2Litt/Rr96^tm2Litt (involves: 129P2/OlaHsd)	abnormal CD8-positive, alpha beta T cell morphology	J:80690
Rr96^tm2Litt/Rr96^tm2Litt Tfap4^tm1.1Litt/Tfap4^tm1.1Litt (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal T cell differentiation	J:176461
Rr97^tm3Welm/Rr97^tm3Welm (involves: 129 * C57BL/6)	abnormal CD4-positive T cell differentiation	J:126027
	abnormal CD8-positive, alpha-beta T cell differentiation	J:126027
	abnormal dendritic cell morphology	J:126027
	abnormal double-positive T cell morphology	J:126027
	abnormal gamma-delta intraepithelial T cell morphology	J:126027
	abnormal T cell differentiation	J:126027
Rr99^tm1Litt/Rr99^tm1Litt (either: (involves: 129P2/OlaHsd * AKR) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal CD8-positive, alpha beta T cell morphology	J:50624
Rr100^tm2.1Welm/Rr100⁺ (involves: 129P2/OlaHsd * AKR.1 * C57BL/6)	abnormal T cell differentiation	J:113136
Rr100^tm2.1Welm/Rr100^tm2.1Welm (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:113136
	abnormal T cell subpopulation ratio	J:113136
	decreased CD8-positive, alpha-beta T cell number	J:113136
	decreased double-positive T cell number	J:113136
	increased CD4-positive, alpha-beta T cell number	J:113136
Rr100^tm2.1Welm/Rr100^tm2.1Welm (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:158947
	decreased CD8-positive, alpha-beta T cell number	J:158947
	decreased double-positive T cell number	J:158947
	increased CD4-positive, alpha-beta T cell number	J:158947
Rr100^tm2.1Welm/Rr100^tm2.1Welm Tcra^tm1Mom/Tcra^tm1Mom (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal T cell morphology	J:113136
Rr104^tm1.2Mym/Rr104^tm1.2Mym Tg(Epo)458Mym/0 (involves: C57BL/6 DBA/2)	abnormal spleen morphology	J:231255
Rr123^tm1.1Vbo/Rr123^tm1.1Vbo (involves: 129S4/SvJae * C57BL/6 * FVB/N)	abnormal regulatory T cell morphology	J:191815
	increased regulatory T cell number	J:191815
Rr148^tm1.1Fwa/Rr148^tm1.1Fwa (involves: 129S6/SvEvTac)	abnormal B cell differentiation	J:101400
	arrested B cell differentiation	J:101400
	decreased immature B cell number	J:101400
	small spleen	J:101400
	spleen hypoplasia	J:101400
Rr148^tm1.1Fwa/Rr148^tm1.1Fwa Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * 129S6/SvEvTac)	abnormal B cell differentiation	J:101400
Rr148^tm1Anbo/Rr148^tm1Anbo (involves: 129/Sv * C57BL/6 * FVB/N)	abnormal immunoglobulin heavy chain V(D)J recombination	J:136307
	decreased immature B cell number	J:136307
	decreased mature B cell number	J:136307
	decreased pre-B cell number	J:136307
Rr148^tm1Fwa/Rr148^tm1Fwa (129S6/SvEvTac-Rr148^tm1Fwa)	abnormal immature B cell morphology	J:101400
	absent B cells	J:101400
	absent Peyer's patches	J:101400
	arrested B cell differentiation	J:101400
	small spleen	J:101400
	spleen hypoplasia	J:101400
Rr148^tm1Fwa/Rr148^tm1Fwa Rag2^tm1Fwa/Rag2^tm1Fwa (involves: 129S/SvEv * 129S6/SvEvTac)	abnormal B cell differentiation	J:101400
Rr148^tm2Anbo/Rr148^tm2Anbo (involves: 129/Sv * C57BL/6 * FVB/N)	abnormal immunoglobulin heavy chain V(D)J recombination	J:136307
	decreased immature B cell number	J:136307
	decreased mature B cell number	J:136307
	decreased pre-B cell number	J:136307
Rr152^tm2Cog/Rr152^tm2Cog (involves: 129S2/SvPas * C57BL/6)	increased pre-B cell number	J:90548
Rr152^tm3.1Cog/Rr152^tm3.1Cog (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal class switch recombination	J:71300
Rr152^tm3Cog/Rr152^tm3Cog (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:71300
	abnormal class switch recombination	J:71300
Rr152^tm5.1Cog/Rr152^tm5.1Cog (involves: 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:164513
	abnormal somatic hypermutation frequency	J:164513, J:333348
Rr156^tm6.1Cog/Rr156^tm6.1Cog (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:165617
Rr156^tm6Cog/Rr156^tm6Cog (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:165617
Rr158^tm1(Igh)Xu/Rr158^tm1(Igh)Xu (Not Specified)	abnormal immune system morphology	J:124407
	decreased B cell number	J:124407
	decreased immature B cell number	J:124407
	increased pre-B cell number	J:124407
Rr158^tm1Cgn/Rr158^tm1Cgn (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))	abnormal B cell differentiation	J:12574, J:64287
	decreased mature B cell number	J:64287
	increased mature B cell number	J:64287
	spleen hypoplasia	J:64287
Rr158^tm2Cgn/Rr158^tm2Cgn (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))	abnormal B cell differentiation	J:12574
Rr158^tm2Xu/Rr158^tm2Xu (Not Specified)	decreased B cell number	J:124407
Rr159^tm1.1Fwa/Rr159⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:113715
Rr159^tm1.1Fwa/Rr159^tm1.1Fwa (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:113715
	decreased B cell number	J:113715
Rr159^tm1Fwa/Rr159⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased B cell number	J:113715
Rr159^tm1Fwa/Rr159^tm1Fwa (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:113715
	decreased B cell number	J:113715
Rr160^tm1Wtg/Rr160^tm1Wtg (involves: 129S6/SvEvTac * C57BL/6)	abnormal mature B cell morphology	J:134885
	abnormal somatic hypermutation frequency	J:134885
	decreased follicular B cell number	J:134885
	increased transitional stage B cell number	J:134885
Rr161^tm2.2Wtg/Rr161^tm2.2Wtg (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)	abnormal B cell differentiation	J:167472
	abnormal immunoglobulin V(D)J recombination	J:167472
	decreased B cell number	J:167472
	decreased pro-B cell number	J:167472
	increased pre-B cell number	J:167472
Rr162^tm3.1Wtg/Rr162^tm3.1Wtg (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)	abnormal immunoglobulin V(D)J recombination	J:172855
Rr166^tm4.1Wtg/Rr166^tm4.1Wtg (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)	abnormal B cell differentiation	J:193015
	abnormal immunoglobulin light chain V-J recombination	J:193015
	abnormal pre-B cell morphology	J:193015
Rr169^tm2Rao/Rr169⁺ (involves: 129S6/SvEvTac * C57BL/6J)	abnormal T-helper 1 cell differentiation	J:94039
Rr169^tm2Rao/Rr169^tm2Rao (involves: 129S6/SvEvTac * C57BL/6J)	abnormal T-helper 1 cell differentiation	J:94039
Rr170^tm1.1Iku/Rr170^tm1.1Iku (B6.Cg-Rr170^tm1.1Iku)	decreased T cell number	J:333539
Rr172^em1Kmm/Rr172^em1Kmm Rr253^em6Kmm/Rr253^em6Kmm (C57BL/6J-Rr253^em6Kmm Rr172^em1Kmm)	decreased dendritic cell number	J:334296
	decreased monocyte cell number	J:334296
	increased dendritic cell number	J:334296
Rr253^em1Kmm/Rr253^em1Kmm (C57BL/6-Rr253^em1Kmm)	abnormal class switch recombination	J:316113
	abnormal effector T cell number	J:316113
	abnormal peritoneal macrophage morphology	J:316113
	abnormal spleen B cell follicle morphology	J:316113
	decreased B cell number	J:316113
	decreased mature NK cell number	J:316113
	decreased monocyte cell number	J:316113
	decreased plasmacytoid dendritic cell number	J:316113
	decreased spleen B cell follicle number	J:316113
	decreased spleen B cell follicle size	J:316113
	increased dendritic cell number	J:316113
	increased lymphocyte cell number	J:316113
	increased neutrophil cell number	J:316113
	increased NK cell number	J:316113
	increased T cell number	J:316113
	spleen hypoplasia	J:316113
Rr253^em3Kmm/Rr253^em3Kmm (C57BL/6J-Rr253^em3Kmm)	decreased dendritic cell number	J:334296
Rr253^em5Kmm/Rr253^em5Kmm (C57BL/6J-Rr253^em5Kmm)	decreased dendritic cell number	J:334296
Rr253^em5Kmm/Rr253^em5Kmm (C57BL/6J-Rr253^em5Kmm)	increased dendritic cell number	J:334296
Rr253^em6Kmm/Rr253^em6Kmm (C57BL/6J-Rr253^em6Kmm)	decreased dendritic cell number	J:334296
	decreased monocyte cell number	J:334296
	decreased plasmacytoid dendritic cell number	J:334296
	increased dendritic cell number	J:334296
Rr270^em1Mgn/Rr270^em1Mgn (involves: CD-1)	abnormal embryonic lymph sac morphology	J:328045
Rr308^tm1.1Fwa/Rr308^tm1.1Fwa (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:82616, J:82395
Rr308^tm1.1Fwa/Rr308^tm1.1Fwa (involves: 129P2/OlaHsd)	abnormal T cell receptor alpha chain V-J recombination	J:82616
Rr308^tm1Fwa/Rr308^tm1Fwa (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:82616
Rr308^tm1Fwa/Rr308^tm1Fwa (involves: 129P2/OlaHsd)	abnormal T cell receptor alpha chain V-J recombination	J:82616
Rr308^tm2Fwa/Rr308^tm2Fwa (Not Specified)	abnormal T cell differentiation	J:82395
Rr338^em1Jeng/Rr338^em1Jeng (Not Specified)	abnormal T cell differentiation	J:232438
	abnormal T cell number	J:232438
	decreased CD4-positive, alpha-beta T cell number	J:232438
Rr347^em1Prdns/Rr347^em1Prdns (CBA/Ca-Rr347^em1Prdns)	absent Langerhans cell	J:281171
	decreased macrophage cell number	J:281171
	decreased microglial cell number	J:281171
	increased Ly6C low monocyte number	J:281171
Rr364^tm1.1Aak/Rr364^tm1.1Aak (129.129S2(Cg)-Rr364^tm1.1Aak)	abnormal class switch recombination	J:242276
Rr381^em1Kap/Rr381^em1Kap (involves: C57BL/6)	absent CD8-positive, alpha-beta T cells	J:333471
Rr381^em4Kap/Rr381^em4Kap (involves: C57BL/6)	absent CD8-positive, alpha-beta T cells	J:333471
Rr381^em5Kap/Rr381^em5Kap (involves: C57BL/6)	absent CD8-positive, alpha-beta T cells	J:333471
Rr381^tm1.1Tani/Rr381⁺ (Not Specified)	decreased CD8-positive, alpha-beta T cell number	J:131081
Rr383^tm1Caob/Rr383^tm1Caob (B6.Cg-Rr383^tm1Caob)	decreased osteoclast cell number	J:131132
Rr394^em1Bhao/Rr394^em1Bhao (Not Specified)	abnormal T cell receptor alpha chain V-J recombination	J:333961
	decreased thymocyte number	J:333961
	increased DN3 thymocyte number	J:333961
Rr395^em1Bhao/Rr395^em1Bhao (Not Specified)	decreased double-positive T cell number	J:333961
	decreased thymocyte number	J:333961
	increased DN4 thymocyte number	J:333961
Rr149356^tm1.1Pf/Rr149356^tm1.1Pf (either: 129P2/OlaHsd-Rr149356^tm1.1Pf or (involves: 129P2/OlaHsd * BALB/c))	abnormal T cell differentiation	J:34311
	abnormal thymus cortex morphology	J:34311
	abnormal thymus medulla morphology	J:34311
	abnormal thymus morphology	J:34311
	arrested T cell differentiation	J:34311
	decreased double-positive T cell number	J:34311
	decreased single-positive T cell number	J:34311
	decreased T cell number	J:34311
	decreased thymocyte number	J:34311
	increased double-negative T cell number	J:34311
	increased gamma-delta T cell number	J:34311
	lymph node hypoplasia	J:34311
Rr149356^tm1Abnd/Rr149356^tm1Abnd (involves: 129S1/Sv * 129X1/SvJ)	abnormal T cell differentiation	J:137580
	abnormal thymus morphology	J:137580
	arrested T cell differentiation	J:137580
	decreased double-positive T cell number	J:137580
	decreased single-positive T cell number	J:137580
	decreased T cell number	J:137580
	increased double-negative T cell number	J:137580
	increased gamma-delta T cell number	J:137580
	thymus hypoplasia	J:137580
Rr149356^tm1Che/Rr149356^tm1Che (involves: 129S4/SvJae * C57BL/6)	abnormal double-negative T cell morphology	J:106246, J:107306
	abnormal double-positive T cell morphology	J:106246, J:107306
Rr149356^tm1Che/Rr149356^tm1Che Tcrd^tm1Mom/Tcrd^tm1Mom Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6)	abnormal double-negative T cell morphology	J:106246
	increased T cell derived lymphoma incidence	J:106246
Rr149356^tm1Che/Rr149356^tm1Che Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	abnormal double-negative T cell morphology	J:106246
	abnormal double-positive T cell morphology	J:106246
	increased T cell derived lymphoma incidence	J:106246
Rr275254^tm2.1Dhr/Rr275254^tm2.1Dhr (involves: 129S4/SvJae * C57BL/6)	abnormal gamma-delta T cell differentiation	J:75624
	abnormal T cell receptor gamma chain V-J recombination	J:75624
Rr275254^tm2Dhr/Rr275254^tm2Dhr (involves: 129S4/SvJae)	abnormal gamma-delta T cell differentiation	J:75624
Rr275254^tm2Dhr/Rr275254^tm2Dhr (involves: 129S4/SvJae)	abnormal T cell receptor gamma chain V-J recombination	J:75624
Rr282726^tm1Dhr/Rr282726^tm1Dhr (involves: 129S4/SvJae * C57BL/6)	abnormal gamma-delta T cell differentiation	J:75624
	abnormal T cell receptor gamma chain V-J recombination	J:75624
Rr282729^tm1.1Iku/Rr282729^tm1.1Iku (C57BL/6J-Rr316^tm1.1Iku)	abnormal T cell receptor gamma chain V-J recombination	J:288442
	decreased gamma-delta T cell number	J:288442
Rr299391^tm1.1Fwa/Rr299391⁺ (involves: 129P2/OlaHsd * FVB/N)	decreased T cell number	J:55401
	decreased thymocyte number	J:55401
Rr299391^tm1.1Fwa/Rr299391^tm1.1Fwa (involves: 129P2/OlaHsd * FVB/N)	decreased T cell number	J:55401
	decreased thymocyte number	J:55401
Rragc^em1Efe/Rragc⁺ (Not Specified)	abnormal class switch recombination	J:320567
	decreased germinal center B cell number	J:320567
	decreased plasma cell number	J:320567
	decreased spleen germinal center size	J:320567
Rragc^em1Efe/Rragc⁺ Tg(Vav-BCL2)69Jad/0 (Not Specified)	decreased germinal center B cell number	J:320567
Rragc^em1Efe/Rragc⁺ Tg(Vav-BCL2)69Jad/0 (Not Specified)	decreased spleen germinal center size	J:320567
Rras2^{em1(IMPC)Ccpcz}/Rras2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Rras2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased NK cell number	J:211773
Rras2^{Gt(OST361011)Lex}/Rras2⁺ (involves: 129S5/SvEvBrd)	decreased B cell number	J:151653
	decreased follicular B cell number	J:151653
	decreased marginal zone B cell number	J:151653
	decreased memory T cell number	J:151653
	decreased spleen B cell follicle size	J:151653
	decreased spleen weight	J:151653
	decreased T cell number	J:151653
	spleen hypoplasia	J:151653
Rras2^{Gt(OST361011)Lex}/Rras2^{Gt(OST361011)Lex} (involves: 129S5/SvEvBrd)	abnormal lymph node germinal center morphology	J:151653
	decreased B cell number	J:151653
	decreased follicular B cell number	J:151653
	decreased marginal zone B cell number	J:151653
	decreased memory T cell number	J:151653
	decreased spleen B cell follicle size	J:151653
	decreased spleen weight	J:151653
	decreased T cell number	J:151653
	spleen hypoplasia	J:151653
Rras2^{Gt(OST361011)Lex}/Rras2^{Gt(OST361011)Lex} (B6.129S5-Rras2^{Gt(OST361011)Lex})	decreased B cell number	J:151653
	decreased memory T cell number	J:151653
	decreased T cell number	J:151653
Rras^{Gt(OST24882)Lex}/Rras^{Gt(OST24882)Lex} (B6;129S5-Rras^{Gt(OST24882)Lex}/Ieg)	decreased B cell number	J:82809
	increased CD4-positive, alpha-beta T cell number	J:82809
	increased CD8-positive, alpha-beta T cell number	J:82809
Rras^tm1Itl/Rras^tm1Itl (involves: 129S6/SvEvTac * C57BL/6)	abnormal dendritic cell morphology	J:181730
Rreb1^{tm1b(EUCOMM)Wtsi}/Rreb1⁺ (C57BL/6N-Rreb1^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Rrm2b^{Gt(OST85254)Lex}/Rrm2b^{Gt(OST85254)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	spleen atrophy	J:186071
	thymus atrophy	J:186071
Rrm2b^tm1Ynak/Rrm2b^tm1Ynak (involves: 129 * C57BL/6J)	abnormal mesenteric lymph node morphology	J:84841
	decreased spleen white pulp amount	J:84841
	thymus cortex hypoplasia	J:84841
Rsad1^{tm1.1(KOMP)Vlcg}/Rsad1⁺ (C57BL/6N-Rsad1^{tm1.1(KOMP)Vlcg}/Ucd)	enlarged lymph nodes	J:211773
	small thymus	J:211773
Rsad1^{tm1.1(KOMP)Vlcg}/Rsad1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rsad1^{tm1.1(KOMP)Vlcg}/Ucd)	enlarged lymph nodes	J:211773
Rsad2^tm1Kchc/Rsad2^tm1Kchc (B6.129-Rsad2^tm1Kchc)	abnormal T-helper 2 cell differentiation	J:148305
Rsph9^em1Jwji/Rsph9^em1Jwji (B6.Cg-Rsph9^em1Jwji)	microgliosis	J:294184
Rspo1^{tm2b(KOMP)Wtsi}/Rspo1^{tm2b(KOMP)Wtsi} (C57BL/6N-Rspo1^{tm2b(KOMP)Wtsi}/Ics)	increased lymphocyte cell number	J:211773
Rtcb^{tm1c(KOMP)Wtsi}/Rtcb^{tm1c(KOMP)Wtsi} Tg(Fcer2a-cre)5Mbu/0 (involves: C57BL/6 * CBA * SJL)	abnormal B cell number	J:216740
	abnormal plasma cell morphology	J:216740
Rthyd1^NOD/MrkTac/? (involves: B10.Br/SgSnJ * NOD-H2^k)	abnormal T cell clonal deletion	J:94684
Rthyd2^B10.Br/SgSnJ/? (involves: B10.Br/SgSnJ * NOD-H2^k)	abnormal T cell clonal deletion	J:94684
Rthyd3^B10.Br/SgSnJ/? (involves: B10.Br/SgSnJ * NOD-H2^k)	abnormal T cell clonal deletion	J:94684
Rthyd5^NOD/MrkTac/? (involves: B10.Br/SgSnJ * NOD-H2^k)	abnormal T cell clonal deletion	J:94684
Rtraf^{tm1b(EUCOMM)Hmgu}/Rtraf⁺ (C57BL/6N-Rtraf^{tm1b(EUCOMM)Hmgu}/H)	increased eosinophil cell number	J:211773
Rttn^em1(IMPC)Tcp/Rttn⁺ (C57BL/6NCrl-Rttn^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Rubcn^em1Dgre/Rubcn^em1Dgre (involves: C57BL/6 * C57BL/6N)	abnormal spleen morphology	J:235399
	increased CD8-positive, alpha-beta T cell number	J:235399
	increased lymphocyte cell number	J:235399
	increased monocyte cell number	J:235399
	increased neutrophil cell number	J:235399
Rubcn^em1Dgre/Rubcn^em1Dgre Tg(CAG-EGFP/Map1lc3b)53Nmz/0 (involves: C57BL/6 * C57BL/6J * C57BL/6N * C57BL/6NCrlj * DBA/2)	abnormal macrophage morphology	J:261225
Runx1^{tm1(RUNX1)Gcg}/Runx1^{tm1(RUNX1)Gcg} Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal granulocyte differentiation	J:106800
	abnormal myelopoiesis	J:106801
	abnormal T cell differentiation	J:106800
	decreased CD4-positive, alpha-beta T cell number	J:106800
	decreased double-positive T cell number	J:106800
	increased CD8-positive, alpha-beta T cell number	J:106800
	increased T cell derived lymphoma incidence	J:106800
Runx1^{tm1(RUNX1/EVI1)Kmit}/Runx1⁺ (involves: C57BL/6 * CBA)	abnormal myelopoiesis	J:118892
Runx1^tm1Soga/Runx1^tm1.1Soga Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal B cell differentiation	J:88511
	abnormal T cell differentiation	J:88511
Runx1^tm1Soga/Runx1^tm1Soga Stag2^tm1.1Soga/Y Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	decreased leukocyte cell number	J:289000
Runx1^tm1Spe/Runx1⁺ (either: (involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA/Ca) or (involves: 129S4/SvJae * C57BL/6 * CBA/Ca))	increased T cell derived lymphoma incidence	J:80829
Runx1^tm1Spe/Runx1⁺ (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	decreased CD4-positive, alpha-beta T cell number	J:120100
Runx1^tm1Spe/Runx1^tm1Spe (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	impaired myelopoiesis	J:35115
Runx1^tm1Tani/Runx1^tm1Tani Runx3^tm1Itan/Runx3^tm1Itan Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:125959
Runx1^tm1Tani/Runx1^tm1Tani Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal CD4-positive T cell differentiation	J:125959
	abnormal CD8-positive, alpha-beta T cell differentiation	J:125959
	abnormal double-positive T cell morphology	J:125959
	decreased CD4-positive, alpha-beta T cell number	J:125959
Runx1^tm1Tani/Runx1^tm1Tani Tg(Lck-cre)1Cwi/? (involves: 129P2/OlaHsd)	arrested T cell differentiation	J:125959
	decreased double-positive T cell number	J:125959
	decreased thymocyte number	J:125959
	increased double-negative T cell number	J:125959
Runx1^tm1Toku/Runx1⁺ Runx3^tm1Itan/Runx3^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:131081
Runx1^tm1Toku/Runx1^tm1Toku (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell subpopulation ratio	J:87697
	increased CD4-positive, alpha-beta T cell number	J:87697
	small thymus	J:87697
	thymus hypoplasia	J:87697
Runx1^tm1Toku/Runx1^tm1Toku Runx3^tm1Itan/Runx3⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:131081
	decreased CD8-positive, alpha-beta T cell number	J:131081
Runx1^tm1Toku/Runx1^tm1Toku Runx3^tm1Itan/Runx3^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:131081
	decreased CD8-positive, alpha-beta T cell number	J:131081
Runx1^tm1Toku/Runx1^tm1Toku Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:131081
Runx1^tm1Yg/Runx1^tm1Yg (either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))	abnormal leukopoiesis	J:125830
	abnormal T cell differentiation	J:125830
	abnormal thymus corticomedullary boundary morphology	J:125830
	abnormal thymus lobule morphology	J:125830
	decreased single-positive T cell number	J:125830
	decreased thymocyte number	J:125830
	increased double-positive T cell number	J:125830
	small thymus	J:125830
	thymus cyst	J:125830
	thymus hypoplasia	J:125830
Runx1^tm1Yg/Runx1^tm1Yg Tg(Lck-cre)1Jtak/? (either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))	decreased T cell number	J:125830
Runx1^{tm2(Runx1)Toku}/Runx1^{tm2(Runx1)Toku} (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell subpopulation ratio	J:87697
Runx1^tm2.1Gss/Runx1^tm2.1Gss (involves: 129S4/SvJae * C57BL/6)	abnormal leukocyte morphology	J:214025
	abnormal spleen white pulp morphology	J:214025
	decreased CD8-positive, alpha-beta T cell number	J:214025
	decreased immature B cell number	J:214025
	decreased pre-pro B cell number	J:214025
	enlarged spleen	J:214025
	increased granulocyte number	J:214025
	increased macrophage cell number	J:214025
	increased mature B cell number	J:214025
	increased monocyte cell number	J:214025
	increased pro-B cell number	J:214025
	myeloid hyperplasia	J:214025
Runx1^tm2Buch/Runx1^tm2Buch Tg(Mx1-cre)1Cgn/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal immune system organ morphology	J:105709
	abnormal leukocyte morphology	J:105709
	abnormal lymph node size	J:105709
	abnormal thymus lobule morphology	J:105709
	decreased CD4-positive, alpha-beta T cell number	J:105709
	decreased CD8-positive, alpha-beta T cell number	J:105709
	decreased double-positive T cell number	J:105709
	decreased lymphocyte cell number	J:105709
	decreased mature B cell number	J:105709
	decreased spleen white pulp amount	J:105709
	decreased T cell number	J:105709
	decreased thymus weight	J:105709
	impaired myelopoiesis	J:105709
	increased mast cell number	J:105709
	increased monocyte cell number	J:105709
	increased neutrophil cell number	J:105709
	increased spleen red pulp amount	J:105709
	increased spleen weight	J:105709
	increased T cell derived lymphoma incidence	J:105709
	small Peyer's patches	J:105709
Runx1^{tm3(Runx3)Toku}/Runx1^{tm3(Runx3)Toku} (involves: 129P2/OlaHsd)	abnormal thymus medulla morphology	J:98965
	decreased leukocyte cell number	J:98965
	decreased lymphocyte cell number	J:98965
	decreased thymocyte number	J:98965
	small spleen	J:98965
	small thymus	J:98965
	thymus hypoplasia	J:98965
Runx1^tm3Dow/Runx1⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	increased T cell derived lymphoma incidence	J:77129
Runx1^tm3Itan/Runx1^tm3Itan (involves: 129P2/OlaHsd * C57BL/6)	decreased leukocyte cell number	J:160791
Runx1^tm3Itan/Runx1^tm3Itan (involves: 129P2/OlaHsd)	abnormal axillary lymph node morphology	J:168918
	abnormal inguinal lymph node morphology	J:168918
	abnormal lymph organ development	J:168918
	abnormal Peyer's patch morphology	J:168918
	decreased CD4-positive, alpha-beta T cell number	J:168918
	decreased Peyer's patch number	J:168918
	decreased thymocyte number	J:168918
	small Peyer's patches	J:168918
Runx1^tm3Spe/Runx1^tm3Spe Spi1^tm2.1Dgt/Spi1^tm2.1Dgt Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	decreased B cell number	J:131217
	decreased thymus weight	J:131217
	increased granulocyte number	J:131217
	increased spleen weight	J:131217
Runx1^tm3Spe/Runx1^tm3Spe Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	arrested T cell differentiation	J:131217
	decreased B cell number	J:151639
	decreased double-negative T cell number	J:131217
	decreased thymus weight	J:131217
	increased double-negative T cell number	J:131217
	increased spleen weight	J:131217
Runx1^tm3Spe/Runx1^tm3Spe Tg(VAV1-cre)1Graf/0 (involves: 129S4/SvJae)	decreased B cell number	J:145700
	decreased double-positive T cell number	J:145700
	decreased lymphocyte cell number	J:145700
	decreased thymocyte number	J:145700
	increased granulocyte number	J:145700
	increased monocyte cell number	J:145700
Runx1^{tm4(Runx2)Toku}/Runx1^{tm4(Runx2)Toku} (involves: 129P2/OlaHsd)	decreased leukocyte cell number	J:98965
Runx1^tm4Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:120100
Runx1^tm4Spe/Runx1^tm4Spe (involves: 129/Sv * C57BL/6)	decreased leukocyte cell number	J:120100
	decreased lymphocyte cell number	J:120100
	increased monocyte cell number	J:120100
Runx1^tm5Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:120100
Runx1^tm6Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:120100
Runx1^tm7Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:120100
Runx1^tm8Spe/Runx1⁺ (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:120100
Runx2^tm1Kish/Runx2⁺ (involves: 129P2/OlaHsd * C57BL/6)	enlarged thymus	J:162258
Runx2^tm1Kish/Runx2^tm1Kish (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:59821, J:40783
	abnormal splenic cell ratio	J:53069
	decreased B cell number	J:53069
	decreased thymocyte number	J:40783
	enlarged spleen	J:53069
	increased granulocyte number	J:53069
Runx3^tm1Itan/Runx3^tm1Itan Tg(Cd4-cre)1Cwi/0 (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	abnormal CD8-positive, alpha beta T cell morphology	J:125953
	abnormal CD8-positive, alpha-beta T cell differentiation	J:125953
	decreased CD8-positive, alpha-beta T cell number	J:131081
Runx3^tm1Litt/Runx3^tm1Litt (involves: 129P2/OlaHsd)	abnormal CD8-positive, alpha-beta T cell differentiation	J:141144
Runx3^tm1Litt/Runx3^tm1Litt (involves: 129P2/OlaHsd)	abnormal double-positive T cell morphology	J:141144
Runx3^tm1Yg/Runx3^tm1Yg (either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))	abnormal dendritic cell differentiation	J:88424
	abnormal dendritic cell morphology	J:88424
	abnormal mesenteric lymph node morphology	J:93240
	absent Langerhans cell	J:88424
	increased dendritic cell number	J:88424, J:100348
Runx3^tm1Yg/Runx3^tm1Yg (involves: 129S1/Sv * 129X1/SvJ)	abnormal CD8-positive, alpha beta T cell morphology	J:109584
Runx3^tm2Yg/Runx3^tm2Yg (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * ICR)	abnormal CD8-positive, alpha beta T cell morphology	J:109584
	abnormal dendritic cell differentiation	J:109584
Runx3^tm3.1Yg/Runx3^tm3.1Yg (Not Specified)	absent Langerhans cell	J:224898
Ruvbl1^tm1.1Oxbk/Ruvbl1^tm1.1Oxbk Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA/J * SJL)	bone marrow failure	J:220926
Ruvbl2^M1Btlr/Ruvbl2⁺ (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	decreased CD4-positive, alpha-beta T cell number	J:185495
	decreased CD8-positive, alpha-beta T cell number	J:185495
	decreased double-positive T cell number	J:185495
	decreased T cell number	J:185495
	increased thymocyte number	J:185495
Rwdd1^{tm1b(KOMP)Wtsi}/Rwdd1^{tm1b(KOMP)Wtsi} (C57BL/6N-Rwdd1^{tm1b(KOMP)Wtsi}/Wtsi)	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased regulatory T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased memory-marker gamma-delta T cell number	J:211773
Rwdd2a^em1(IMPC)J/Rwdd2a^em1(IMPC)J (C57BL/6NJ-Rwdd2a^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Rxfp2^{tm1a(EUCOMM)Wtsi}/Rxfp2^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Rxfp2^{tm1a(EUCOMM)Wtsi}/Ieg)	increased monocyte cell number	J:165965
Rxfp4^{tm1.1(KOMP)Vlcg}/Rxfp4^{tm1.1(KOMP)Vlcg} (C57BL/6N-Rxfp4^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Rxra^pke/Rxra^pke (C57BL/6J-Rxra^pke)	abnormal T-helper 2 cell morphology	J:103186
Rxra^tm1Krc/Rxra^tm1Krc Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)	abnormal peritoneal macrophage morphology	J:168799
Rxra^tm2Ipc/Rxra^tm4Ipc Tg(KRT14-cre)1Ipc/0 (involves: 129S2/SvPas * C57BL/6 * SJL)	abnormal Langerhans cell morphology	J:67149
Rxra^tm4Ipc/Rxra^tm4Ipc Rxrb^tm1Pcn/Rxrb^tm1Pcn Tg(KRT14-cre/ERT2)1Ipc/0 (involves: 129S2/SvPas)	enlarged cervical lymph nodes	J:102470
	enlarged spleen	J:102470
	increased leukocyte cell number	J:102470
	lymph node hyperplasia	J:102470
Ryk^em1(IMPC)Mbp/Ryk⁺ (C57BL/6NCrl-Ryk^em1(IMPC)Mbp/MbpMmucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
Ryr1^{tm1b(EUCOMM)Hmgu}/Ryr1⁺ (C57BL/6N-Ryr1^{tm1b(EUCOMM)Hmgu}/H)	increased spleen weight	J:211773
Ryr2^tm1.1Hnis/Ryr2^tm1.1Hnis (involves: C57BL/6)	abnormal mesenteric lymph node morphology	J:228787
	abnormal spleen white pulp morphology	J:228787
	enlarged mesenteric lymph nodes	J:228787
	increased spleen weight	J:228787
	increased thymus weight	J:228787
	large lymphoid organs	J:228787
	thymus cortex hyperplasia	J:228787
S1pr1^tm1.1Cys/S1pr1^tm1.1Cys (involves: 129P2/OlaHsd * C3H * C57BL/6)	decreased B cell number	J:176118
S1pr1^tm1.1Thla/S1pr1^tm1.1Thla (B6.Cg-S1pr1^tm1.1Thla)	increased CD4-positive, alpha-beta T cell number	J:163389
S1pr1^tm1.1Thla/S1pr1^tm1.1Thla (B6.Cg-S1pr1^tm1.1Thla)	increased CD8-positive, alpha-beta T cell number	J:163389
S1pr1^tm1Cys/S1pr1^tm1Cys (involves: 129P2/OlaHsd * C57BL/6)	decreased B cell number	J:176118
S1pr1^tm1Rlp/S1pr1^tm1Rlp (involves: 129S6/SvEvTac)	abnormal NK cell differentiation	J:154069
S1pr1^tm1Rlp/S1pr1^tm1Rlp (involves: 129S6/SvEvTac)	decreased NK cell number	J:154069
S1pr2^tm1Ajml/S1pr2^tm1Ajml (involves: 129S5/SvEvBrd * C57BL/6)	abnormal spleen marginal zone morphology	J:154439
	increased germinal center B cell number	J:154439
	increased spleen germinal center number	J:154439
	increased spleen germinal center size	J:154439
	increased T cell number	J:154439
S1pr2^tm1Rlp/S1pr2^tm1Rlp (involves: 129S6/SvEvTac * C57BL/6)	abnormal spleen germinal center morphology	J:174313
	increased B cell number	J:174313
	increased germinal center B cell number	J:174313
	increased T cell number	J:174313
S1pr3^tm1Jch/S1pr3^tm1Jch (involves: 129S1/Sv * 129X1/SvJ)	enlarged mesenteric lymph nodes	J:133917
S1pr4^tm1Lipp/S1pr4^tm1Lipp (involves: 129X1/SvJ * C57BL/6J)	abnormal thrombopoiesis	J:179199
S1pr5^tm1Club/S1pr5^tm1Club (B6.129P2-S1pr5^tm1Club)	abnormal NK cell morphology	J:178789
S1pr5^tm1Club/S1pr5^tm1Club (B6.129P2-S1pr5^tm1Club)	decreased NK cell number	J:178789
S1pr5^tm1Jch/S1pr5^tm1Jch (involves: 129P2/OlaHsd * C57BL/6)	abnormal NK cell differentiation	J:154069
S100a3^em1(IMPC)Mbp/S100a3^em1(IMPC)Mbp (C57BL/6NCrl-S100a3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
S100a9^tm1Hogg/S100a9^tm1Hogg (involves: 129P2/OlaHsd * C57BL/6)	abnormal neutrophil morphology	J:82513
Sac3d1^tm1Hnaka/Sac3d1^tm1Hnaka (involves: 129P2/OlaHsd)	spleen hyperplasia	J:144601
Sac3d1^tm1Hnaka/Sac3d1^tm1Hnaka (involves: 129P2/OlaHsd)	thymus hyperplasia	J:144601
Sacs^em1(IMPC)Tcp/Sacs^em1(IMPC)Tcp (C57BL/6NCrl-Sacs^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
Sall3^{tm1.1(KOMP)Mbp}/Sall3⁺ (C57BL/6NCrl-Sall3^{tm1.1(KOMP)Mbp}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Samd3^{tm1.1(HBEGF)Wfkr}/Samd3⁺ (C57BL/6J-Samd3^{tm1.1(HBEGF)Wfkr})	abnormal NK cell differentiation	J:322359
	decreased memory T cell number	J:322359
	decreased NK cell number	J:322359
Samd3^{tm1.1(HBEGF)Wfkr}/Samd3^{tm1.1(HBEGF)Wfkr} (C57BL/6J-Samd3^{tm1.1(HBEGF)Wfkr})	decreased CD8-positive, alpha-beta memory T cell number	J:322359
Samd9l^tm1Homy/Samd9l⁺ (involves: 129P2/OlaHsd)	abnormal myelopoiesis	J:202604
	abnormal neutrophil morphology	J:202604
	decreased neutrophil cell number	J:202604
	enlarged spleen	J:202604
	increased leukocyte cell number	J:202604
Samd9l^tm1Homy/Samd9l^tm1Homy (involves: 129P2/OlaHsd)	abnormal myelopoiesis	J:202604
	abnormal neutrophil morphology	J:202604
	decreased neutrophil cell number	J:202604
	enlarged spleen	J:202604
	increased leukocyte cell number	J:202604
Samsn1^tm1Xyw/Samsn1^tm1Xyw (B6.129P2-Samsn1^tm1Xyw)	increased B-1a cell number	J:158032
Sap130^{tm1a(KOMP)Mbp}/Sap130⁺ (C57BL/6N-Sap130^{tm1a(KOMP)Mbp}/Wtsi)	decreased leukocyte cell number	J:211773
Sash3^tm1Hlz/Sash3^tm1Hlz (B6.129P2-Sash3^tm1Hlz)	abnormal B cell morphology	J:102171
	abnormal CD4-positive T cell differentiation	J:102171
	abnormal CD8-positive, alpha-beta T cell differentiation	J:102171
	abnormal immune system organ morphology	J:102171
	abnormal T cell morphology	J:102171
	decreased double-positive T cell number	J:102171
	decreased marginal zone B cell number	J:102171
	decreased Peyer's patch number	J:102171
	lymphoid hypoplasia	J:102171
Satb1^m1Anu/Satb1⁺ (C57L/6JAnu-Satb1^m1Anu)	abnormal CD4-positive, alpha beta T cell morphology	J:104190
Satb1^m1Anu/Satb1⁺ (C57L/6JAnu-Satb1^m1Anu)	abnormal CD8-positive, alpha beta T cell morphology	J:104190
Satb1^m1Anu/Satb1^m1Anu (C57L/6JAnu-Satb1^m1Anu)	abnormal CD4-positive, alpha beta T cell morphology	J:104190
Satb1^m1Anu/Satb1^m1Anu (C57L/6JAnu-Satb1^m1Anu)	abnormal CD8-positive, alpha beta T cell morphology	J:104190
Satb1^tm1Kos/Satb1^tm1Kos (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:61085
	arrested T cell differentiation	J:61085
	decreased thymocyte number	J:61085
	small lymph nodes	J:61085
	small spleen	J:61085
	small thymus	J:61085
Satb1^tm2Kos/Satb1^tm2Kos Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	absent regulatory T cells	J:252606
Satb2^{tm1b(KOMP)Wtsi}/Satb2⁺ (C57BL/6N-Satb2^{tm1b(KOMP)Wtsi}/Ucd)	enlarged lymph nodes	J:211773
Saxo1^{tm1b(EUCOMM)Hmgu}/Saxo1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Saxo1^{tm1b(EUCOMM)Hmgu}/Ics)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Saysd1^em1(IMPC)J/Saysd1^em1(IMPC)J (C57BL/6NJ-Saysd1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Sbds^tm1Dats/Sbds^tm1Dats Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: C57BL/6 * CD-1)	abnormal myeloid leukocyte morphology	J:158901
	abnormal neutrophil morphology	J:158901
	decreased B cell number	J:158901
	decreased leukocyte cell number	J:158901
	decreased lymphocyte cell number	J:158901
Sbf1^em1(IMPC)Mbp/Sbf1^em1(IMPC)Mbp (C57BL/6N-Sbf1^em1(IMPC)Mbp/MbpMmucd)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Sbno1^{tm1b(EUCOMM)Hmgu}/Sbno1⁺ (C57BL/6N-Sbno1^{tm1b(EUCOMM)Hmgu}/H)	increased leukocyte cell number	J:211773
Sbno2^tm1.1Aki/Sbno2^tm1.1Aki (involves: 129 * C57BL/6)	abnormal osteoclast morphology	J:202853
Sbw1^NZB/BlScr/Sbw1^NZB/BlScr (involves: NZB/BlScr * NZW/LacScr)	enlarged spleen	J:20991
Sbw2^NZB/BlScr/Sbw2^NZB/BlScr (involves: NZB * NZW)	enlarged spleen	J:20991
Sbw2^NZB/BlScr/Sbw2^NZW/LacScr (involves: NZB * NZW)	enlarged spleen	J:20991
Scarb1^{tm1b(EUCOMM)Wtsi}/Scarb1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Scarb1^{tm1b(EUCOMM)Wtsi}/Bay)	enlarged spleen	J:211773
	increased spleen weight	J:211773
Scarb2^em2(IMPC)Tcp/Scarb2^em2(IMPC)Tcp (C57BL/6NCrl-Scarb2^em2(IMPC)Tcp/Tcp)	decreased monocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Scarb2^tm1Psa/Scarb2^tm1Psa (involves: 129P2/OlaHsd * C57BL/6N)	microgliosis	J:216676
Scarf1^tm1Tkms/Scarf1^tm1Tkms (involves: C57BL/6)	abnormal spleen morphology	J:208237
	enlarged spleen	J:208237
	increased B cell number	J:208237
	increased CD4-positive, alpha-beta T cell number	J:208237
	increased lymphocyte cell number	J:208237
	increased spleen germinal center size	J:208237
	increased T follicular helper cell number	J:208237
Scel^{em1(IMPC)Ccpcz}/Scel^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Scel^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Scg5^em1(IMPC)Mbp/Scg5^em1(IMPC)Mbp (C57BL/6NCrl-Scg5^em1(IMPC)Mbp/MbpMmucd)	increased monocyte cell number	J:211773
Scg5^tm1Led/Scg5^tm1Led (either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6))	spleen atrophy	J:53349
Scin^tm1Glog/Scin^tm1Glog Tg(Acp5-cre)4Rda/0 (either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * CBA))	abnormal osteoclast differentiation	J:223220
	abnormal osteoclast morphology	J:223220
Scmh1^tm1Yota/Scmh1^tm1Yota (involves: 129X1/SvJ * C57BL/6)	decreased B cell number	J:194424
	decreased T cell number	J:194424
	myeloid hyperplasia	J:194424
Scml4^em1(IMPC)J/Scml4^em1(IMPC)J (C57BL/6NJ-Scml4^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Scn8a^em1(IMPC)Bay/Scn8a⁺ (C57BL/6N-Scn8a^em1(IMPC)Bay/BayMmucd)	increased spleen weight	J:211773
Sco1^{tm1c(KOMP)Wtsi}/Sco1^{tm1c(KOMP)Wtsi} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6N * DBA)	decreased leukocyte cell number	J:222036
	decreased spleen white pulp amount	J:222036
	increased spleen iron level	J:222036
	spleen atrophy	J:222036
Scr/Scr (involves: 101/H * C3H/HeH)	small thymus	J:3458
Sctr^tm1Bkcc/Sctr^tm1Bkcc (B6.129S7-Sctr^tm1Bkcc)	increased macrophage cell number	J:121376
Scyl1^tm1.1Spel/Scyl1^tm1.1Spel (involves: 129S6/SvEvTac * C57BL/6J)	microgliosis	J:192445
Scyl1^tm1Spel/Scyl1^tm1Spel Tg(Nes-cre)1Kln/0 (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)	microgliosis	J:192445
Scyl2^tm1.1Spel/Scyl2^tm1.1Spel Tg(Nes-cre)1Kln/0 (involves: 129S6/SvEvTac * C57BL/6 * SJL)	microgliosis	J:225808
Sdc4^{tm2b(KOMP)Wtsi}/Sdc4^{tm2b(KOMP)Wtsi} (C57BL/6N-Sdc4^{tm2b(KOMP)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Sdhb^{tm1b(EUCOMM)Hmgu}/Sdhb⁺ (C57BL/6N-Sdhb^{tm1b(EUCOMM)Hmgu}/Ieg)	decreased neutrophil cell number	J:211773
seb/seb (Him:OF1)	lymph node hyperplasia	J:20987
Sec24b^em1(IMPC)Tcp/Sec24b⁺ (C57BL/6NCrl-Sec24b^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Sec63^{tm1b(EUCOMM)Hmgu}/Sec63⁺ (C57BL/6N-Sec63^{tm1b(EUCOMM)Hmgu}/Bay)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Secisbp2^{tm1a(EUCOMM)Wtsi}/Secisbp2⁺ (Not Specified)	increased NK cell number	J:165965
Secisbp2^{tm1c(EUCOMM)Wtsi}/Secisbp2^{tm1c(EUCOMM)Wtsi} (C57BL/6N-Secisbp2^{tm1a(EUCOMM)Wtsi}/H)	increased leukocyte cell number	J:211773
Sele^tm1Alb/Sele^tm1Alb (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal spleen morphology	J:101979
Sele^tm1Alb/Sele^tm1Alb (involves: 129S7/SvEvBrd * C57BL/6)	increased neutrophil cell number	J:112286
Sele^tm1Hyn/Sele^tm1Hyn Sell^tm1Hyn/Sell^tm1Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	increased eosinophil cell number	J:57973
	increased leukocyte cell number	J:57973
	increased monocyte cell number	J:57973
	increased neutrophil cell number	J:57973
Sele^tm1Hyn/Sele^tm1Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas)	abnormal granulocyte differentiation	J:31626
	abnormal myelopoiesis	J:31626
	increased eosinophil cell number	J:31626
	increased leukocyte cell number	J:31626
	increased lymphocyte cell number	J:31626
	increased monocyte cell number	J:31626
	increased neutrophil cell number	J:31626
	increased spleen red pulp amount	J:31626
	increased spleen weight	J:31626
	spleen hyperplasia	J:31626
Sele^tm1Hyn/Sele^tm1Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	increased eosinophil cell number	J:57973
	increased leukocyte cell number	J:57973
	increased monocyte cell number	J:57973
	increased neutrophil cell number	J:57973
Sele^tm2Alb/Sele^tm2Alb Sell^tm2Alb/Sell^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	abnormal cervical lymph node morphology	J:70682
	abnormal spleen B cell follicle morphology	J:70682
	abnormal spleen B cell follicle shape	J:106550
	abnormal spleen morphology	J:70682
	decreased spleen B cell follicle number	J:106550
	enlarged lymph nodes	J:70682
	increased eosinophil cell number	J:70682
	increased leukocyte cell number	J:70682
	increased monocyte cell number	J:70682
	increased neutrophil cell number	J:106550, J:70682
Sele^tm2Alb/Sele^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal leukocyte cell number	J:101979
	increased neutrophil cell number	J:101979
Sele^tm2Alb/Sele^tm2Alb Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	abnormal lymph node germinal center morphology	J:70682
	abnormal lymph node secondary follicle morphology	J:70682
	abnormal spleen B cell follicle morphology	J:70682
	decreased spleen B cell follicle number	J:70682
	enlarged lymph nodes	J:70682
	increased eosinophil cell number	J:70682
	increased leukocyte cell number	J:70682
	increased monocyte cell number	J:70682
	increased neutrophil cell number	J:70682, J:112286
Sele^tm2Hyn/Sele^tm2Hyn (B6.129S2-Sele^tm2Hyn)	decreased mast cell number	J:121083
Sele^tm2Hyn/Sele^tm2Hyn (B6.129S2-Sele^tm2Hyn)	increased mast cell number	J:121083
Selenbp1^tm1Hyama/Selenbp1^tm1Hyama (C57BL/6-Selenbp1^tm1Hyama)	decreased spleen weight	J:202420
	increased thymus weight	J:202420
Selenow^em#Hwl/Selenow^em#Hwl (C57BL/6-Selenow^em#Hwl)	abnormal osteoclast differentiation	J:317012
Selenow^em#Hwl/Selenow^em#Hwl (C57BL/6-Selenow^em#Hwl)	decreased osteoclast cell number	J:317012
Sell^m1Btlr/Sell^m1Btlr (C57BL/6J-Sell^m1Btlr)	decreased single-positive T cell number	J:217794
Sell^m2Btlr/Sell^m2Btlr (C57BL/6J-Sell^m2Btlr)	decreased single-positive T cell number	J:231806
Sell^tm1Alb/Sell^tm1Alb (involves: 129S7/SvEvBrd * C57BL/6)	intermingled spleen red and white pulp	J:70682
Sell^{tm1b(EUCOMM)Hmgu}/Sell^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sell^{tm1b(EUCOMM)Hmgu}/H)	increased spleen weight	J:211773
Sell^tm1Flv/Sell^tm1Flv (involves: 129S2/SvPas * C57BL/6)	decreased activated T cell number	J:89253
Sell^tm1Pest/Sell^tm1Pest (involves: 129S4/SvJae * C57BL/6)	abnormal splenic cell ratio	J:112550
	enlarged spleen	J:112550
	lymph node hypoplasia	J:112550
	small popliteal lymph nodes	J:112550
Sell^tm1Tft/Sell^tm1Tft (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:25005
Sell^tm1Tft/Sell^tm1Tft (B6.129P2-Sell^tm1Tft)	abnormal regulatory T cell number	J:141931
	increased monocyte cell number	J:48271, J:142184
	lymph node hypoplasia	J:141931, J:142184
	spleen hyperplasia	J:141931
Sell^tm2.1Tft/Sell^tm2.1Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	spleen hyperplasia	J:142184
Sell^tm2Hyn/Sell^tm2Hyn (involves: 129S2/SvPas * C57BL/6)	decreased monocyte cell number	J:57973
Sell^tm2Tft/Sell^tm2.1Tft (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal regulatory T cell number	J:141931
Sell^tm2Tft/Sell^tm2Tft (involves: 129S1/Sv * 129X1/SvJ)	lymph node hypoplasia	J:142184
Sell^tm2Tft/Sell^tm2Tft (involves: 129S1/Sv * 129X1/SvJ)	spleen hyperplasia	J:142184
Sell^tm3Hyn/Sell^tm3Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	increased eosinophil cell number	J:57973
	increased leukocyte cell number	J:57973
	increased neutrophil cell number	J:57973
Sell^tm4Hyn/Sell^tm4Hyn Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	increased eosinophil cell number	J:57973
Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal spleen morphology	J:101979
	increased leukocyte cell number	J:101979
	increased neutrophil cell number	J:101979, J:24239
Selp^tm1Bay/Selp^tm1Bay (either: B6.129S7-Selp^tm1Bay or (involves: 129S7/SvEvBrd * C57BL/6))	increased leukocyte cell number	J:31374
Selp^tm1Bay/Selp^tm1Bay (involves: 129S7/SvEvBrd * C57BL/6)	increased neutrophil cell number	J:112286
Selp^tm1Bay/Selp^tm1Bay (B6.129S7-Selp^tm1Bay)	decreased mast cell number	J:121083
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6J)	increased neutrophil cell number	J:77329
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas)	increased neutrophil cell number	J:29814
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	increased eosinophil cell number	J:57973
Selp^tm1Hyn/Selp^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	increased neutrophil cell number	J:57973
Selplg^tm1Fur/Selplg^tm1Fur (involves: 129/Sv * C57BL/6J * SJL)	increased eosinophil cell number	J:75412
	increased neutrophil cell number	J:75412
Selplg^tm1Rpmc/Selplg^tm1Rpmc (involves: 129S1/Sv * C57BL/6J)	increased eosinophil cell number	J:75829
	increased leukocyte cell number	J:75829
	increased lymphocyte cell number	J:75829
	increased neutrophil cell number	J:75829
Sema3f^tm1.2Ddg/Sema3f^tm1.2Ddg (Not Specified)	abnormal lymphatic vessel endothelial cell morphology	J:226501
Sema3f^tm1.2Ddg/Sema3f^tm1.2Ddg (Not Specified)	abnormal lymphatic vessel morphology	J:226501
Sema3f^tm1.2Ddg/Sema3f^tm1.2Ddg Sema3g^{tm1(KOMP)Vlcg}/Sema3g^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal lymphatic vessel endothelial cell morphology	J:226501
	abnormal lymphatic vessel morphology	J:226501
	lymphatic vessel hyperplasia	J:226501
Sema3g^{tm1(KOMP)Vlcg}/Sema3g^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal lymphatic vessel morphology	J:226501
Sema4a^tm1Kik/Sema4a^tm1Kik (either: B6.Cg-Sema4a^tm1Kik or C.Cg-Sema4a^tm1Kik)	abnormal T-helper 1 cell differentiation	J:97027
Sema4d^{tm1b(EUCOMM)Wtsi}/Sema4d^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sema4d^{tm1b(EUCOMM)Wtsi}/H)	enlarged spleen	J:211773
Sema4d^tm1Kik/Sema4d^tm1Kik (involves: 129P2/OlaHsd * C57BL/6)	abnormal B-1 B cell morphology	J:66033
	decreased B-1a cell number	J:66033
	decreased CD4-positive, alpha-beta T cell number	J:66033
	decreased spleen germinal center size	J:66033
	decreased T cell number	J:66033
	increased B cell number	J:66033
Sema4f^em1(IMPC)J/Sema4f^em1(IMPC)J (C57BL/6NJ-Sema4f^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Sema5b^{tm1a(EUCOMM)Wtsi}/Sema5b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Sema5b^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased T cell number	J:165965
Senp1^tm1.1Wami/Senp1^tm1.1Wami (involves: 129 * C57BL/6)	abnormal granulocyte differentiation	J:163428
Senp1^tm1.1Wami/Senp1^tm1.1Wami (involves: 129 * C57BL/6)	abnormal monocyte differentiation	J:163428
Septin2^em1(IMPC)Tcp/Septin2⁺ (C57BL/6NCrl-Septin2^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
Septin5^{tm1b(EUCOMM)Hmgu}/Septin5⁺ (C57BL/6N-Septin5^{tm1b(EUCOMM)Hmgu}/Rbrc)	small spleen	J:211773
Septin9^tm2.1Emfu/Septin9^tm2.1Emfu Tg(Lck-cre)548Jxm/0 (involves: C57BL/6 * CBA)	abnormal T cell differentiation	J:205027
	decreased CD4-positive, alpha-beta memory T cell number	J:205027
	decreased CD4-positive, alpha-beta T cell number	J:205027
	decreased CD8-positive, alpha-beta memory T cell number	J:205027
	decreased CD8-positive, alpha-beta T cell number	J:205027
	decreased DN4 thymocyte number	J:205027
	decreased regulatory T cell number	J:205027
	decreased single-positive T cell number	J:205027
	decreased T cell number	J:205027
	increased CD8-positive, alpha-beta memory T cell number	J:205027
	increased DN3 thymocyte number	J:205027
	increased double-negative T cell number	J:205027
Septin9^tm2.1Emfu/Septin9^tm2.1Emfu Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	decreased CD8-positive, alpha-beta T cell number	J:205027
Serac1^em1(IMPC)Tcp/Serac1^em1(IMPC)Tcp (C57BL/6NCrl-Serac1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Serf1^{tm1a(EUCOMM)Hmgu}/Serf1^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Serf1^{tm1a(EUCOMM)Hmgu}/H)	decreased CD8-positive, alpha-beta T cell number	J:165965
	decreased T cell number	J:165965
Serpina3g^tm1.1Arp/Serpina3g^tm1.1Arp (involves: C57BL/6)	abnormal memory T cell morphology	J:189782
Serpina3g^tm1.1Arp/Serpina3g^tm1.1Arp (involves: C57BL/6)	decreased CD8-positive, alpha-beta memory T cell number	J:189782
Serpina3i^em1(IMPC)J/Serpina3i^em1(IMPC)J (C57BL/6NJ-Serpina3i^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Serpinb1a^tm1.1Cben/Serpinb1a^tm1.1Cben (129S6/SvEvTac-Serpinb1a^tm1.1Cben)	decreased neutrophil cell number	J:125918
Serpinb2^tm1Dgi/Serpinb2^tm1Dgi (involves: 129S2/SvPas * C57BL/6J * DBA/2J)	abnormal leukocyte cell number	J:52283
	decreased lymphocyte cell number	J:52283
	decreased monocyte cell number	J:52283
	decreased neutrophil cell number	J:52283
Serpinb2^tm2Dgi/Serpinb2^tm2Dgi (involves: 129S2/SvPas * C57BL/6J * DBA/2J)	abnormal leukocyte cell number	J:52283
	decreased lymphocyte cell number	J:52283
	decreased monocyte cell number	J:52283
	decreased neutrophil cell number	J:52283
Serpinb9^{em1(IMPC)Ccpcz}/Serpinb9^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Serpinb9^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased effector memory T-helper cell number	J:211773
Serpinb9^tm1.1Pib/Serpinb9^tm1.1Pib (involves: BALB/cJ * C57BL/6J)	abnormal immune system morphology	J:252016
Serpinb9^tm1Arp/Serpinb9^tm1Arp (involves: C57BL/6)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:113349
Serpinb10^em1(IMPC)Mbp/Serpinb10^em1(IMPC)Mbp (C57BL/6NCrl-Serpinb10^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
Serpinc1^tm1Dwr/Serpinc1^tm1Dwr (involves: 129S1/Sv * 129X1/SvJ)	enlarged spleen	J:115658
Serpine1^em1(IMPC)Tcp/Serpine1^em1(IMPC)Tcp (C57BL/6N-Serpine1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Serpine1^tm1Mlg/Serpine1^tm1Mlg (involves: 129S2/SvPas * C57BL/6)	increased granulocyte number	J:133227
Serpinf1^{tm1e.1(KOMP)Wtsi}/Serpinf1^{tm1e.1(KOMP)Wtsi} (C57BL/6N-Serpinf1^{tm1e.1(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Serpini2^pq/Serpini2^pq (involves: C57BL/6J)	abnormal B cell differentiation	J:115744
	abnormal pre-B cell morphology	J:115744
	abnormal pro-B cell morphology	J:115744
	decreased B cell number	J:115744
	decreased immature B cell number	J:115744
	decreased lymphocyte cell number	J:115744
	decreased pre-B cell number	J:115744
	decreased pro-B cell number	J:115744
	decreased T cell number	J:115744
	decreased thymocyte number	J:115744
	small spleen	J:115744
	small thymus	J:115744
	spleen hypoplasia	J:115744
	thymus hypoplasia	J:115744
Sesn1^{tm1a(EUCOMM)Wtsi}/Sesn1^{tm1a(EUCOMM)Wtsi} (involves: C57BL/6N)	abnormal class switch recombination	J:240602
	abnormal effector T cell number	J:240602
	decreased B cell number	J:240602
	enlarged spleen	J:240602
	increased NK T cell number	J:240602
	increased single-positive T cell number	J:240602
	increased splenocyte number	J:240602
Setd1a^{tm1a(EUCOMM)Wtsi}/Setd1a⁺ (C57BL/6N-Setd1a^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Setd2^{tm1c(NCOM)Mfgc}/Setd2^{tm1c(NCOM)Mfgc} Tg(Lck-cre)#Zhu/0 (involves: C57BL/6 * SJL/J)	increased gamma-delta T cell number	J:243973
Setd3^{tm1.1(NCOM)Mfgc}/Setd3^{tm1.1(NCOM)Mfgc} (C57BL/6N-Setd3^{tm1.1(NCOM)Mfgc}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Setd5^{tm1a(EUCOMM)Wtsi}/Setd5⁺ (C57BL/6N-Setd5^{tm1a(EUCOMM)Wtsi}/Wtsi)	abnormal thymus morphology	J:239583
	enlarged lymphatic vessel	J:239583
	increased monocyte cell number	J:211773
	increased regulatory T cell number	J:211773
	small thymus	J:239583
Setdb2^tm1Desr/Setdb2^tm1Desr (B6.Cg-Setdb2^tm1Desr)	increased neutrophil cell number	J:222611
Setx^{tm1b(EUCOMM)Wtsi}/Setx^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Setx^{tm1b(EUCOMM)Wtsi}/Ics)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased NK cell number	J:211773
sevr/sevr (C3H/HeJ-sevr/GrsrJ)	thymus atrophy	J:109437
Sf3b1^tm1.1Mdf/Sf3b1⁺ Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(Mx1-cre)1Cgn/? (involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA/J)	abnormal myelopoiesis	J:234976
	decreased B cell number	J:234976
	enlarged spleen	J:234976
	increased granulocyte number	J:234976
Sf3b1^tm1.1Mdf/Sf3b1⁺ Tg(Mx1-cre)1Cgn/? (involves: 129S4/SvJae * C57BL/6 * CBA/J)	abnormal myelopoiesis	J:234976
Sf3b1^tm1Hko/Sf3b1⁺ (Not Specified)	increased spleen red pulp amount	J:324276
Sfmbt2^em1(IMPC)Mbp/Sfmbt2⁺ (C57BL/6NCrl-Sfmbt2^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Sfn^tm1Mak/Sfn^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:168328
	abnormal spleen B cell follicle morphology	J:168328
	abnormal spleen morphology	J:168328
	absent spleen marginal zone	J:168328
	decreased B cell number	J:168328
	decreased B-1a cell number	J:168328
	decreased follicular B cell number	J:168328
	decreased marginal zone B cell number	J:168328
Sfrp1^tm1Bsk/Sfrp1^tm1Bsk (involves: 129S5/SvEvBrd * C57BL/6)	decreased leukocyte cell number	J:89547
	decreased lymphocyte cell number	J:89547
	decreased neutrophil cell number	J:89547
Sfrp4^tm1.1Blan/Sfrp4^tm1.1Blan (Not Specified)	increased osteoclast cell number	J:234467
Sfrp4^tm1.1Lex/Sfrp4^tm1.1Lex (Not Specified)	increased osteoclast cell number	J:234467
Sftpa1^tm2Haw/Sftpa1^tm2Haw Sftpd^tm2Haw/Sftpd^tm2Haw (involves: C57BL/6J * CD-1)	abnormal alveolar macrophage morphology	J:86022
	increased monocyte cell number	J:86022
Sftpd^tm1Haw/Sftpd^tm1Haw (involves: C57BL/6J * CD-1)	abnormal alveolar macrophage morphology	J:98220, J:50147
Sftpd^tm1Jhf/Sftpd^tm1Jhf (involves: 129P2/OlaHsd * Black Swiss)	abnormal alveolar macrophage morphology	J:50436
	abnormal macrophage morphology	J:62282, J:50436
	increased macrophage cell number	J:62282, J:50436
	increased neutrophil cell number	J:72681
Sfxn4^{tm1b(KOMP)Wtsi}/Sfxn4^{tm1b(KOMP)Wtsi} (C57BL/6N-Sfxn4^{tm1b(KOMP)Wtsi}/J)	decreased leukocyte cell number	J:211773
Sgce^em1(IMPC)H/Sgce^em1(IMPC)H (C57BL/6N-Sgce^em1(IMPC)H/H)	increased eosinophil cell number	J:211773
sgl/sgl (involves: C3H * C57BL/6J)	abnormal lymph node morphology	J:56826
Sgms2^tm1Jia/Sgms2^tm1Jia (involves: 129 * C57BL/6)	abnormal macrophage morphology	J:162226
Sgpl1^{Gt(OST58278)Lex}/Sgpl1^{Gt(OST58278)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal lymph node morphology	J:145159
	abnormal lymphopoiesis	J:145159
	abnormal osteoclast morphology	J:145159
	abnormal spleen periarteriolar lymphoid sheath morphology	J:145159
	decreased B cell number	J:145159
	decreased double-positive T cell number	J:145159
	decreased lymphocyte cell number	J:145159
	decreased neutrophil cell number	J:145159
	decreased pre-B cell number	J:145159
	decreased T cell number	J:145159
	increased CD4-positive, alpha-beta T cell number	J:145159
	increased CD8-positive, alpha-beta T cell number	J:145159
	increased granulocyte number	J:145159
	increased monocyte cell number	J:145159
	increased osteoclast cell number	J:145159
	lymph node hypoplasia	J:145159
	lymphoid hypoplasia	J:145159
	spleen hypoplasia	J:145159
	thymus cortex hypoplasia	J:145159
	thymus hypoplasia	J:145159
	thymus medulla hyperplasia	J:145159
Sgpl1^{Gt(OST58278)Lex}/Sgpl1^{tm1(SGPL1)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal immune system organ morphology	J:145159
	abnormal osteoclast morphology	J:145159
	decreased T cell number	J:145159
	thymus cortex hypoplasia	J:145159
	thymus medulla hyperplasia	J:145159
Sgpl1^{Gt(ROSA)78Sor}/Sgpl1^{Gt(ROSA)78Sor} (involves: 129S4/SvJaeSor * C57BL/6)	decreased lymphocyte cell number	J:187619
Sgpl1^{tm1(SGPL1)Lex}/Sgpl1^{tm1(SGPL1)Lex} (involves: 129S4/SvJae * 129S5/SvEvBrd * C57BL/6J)	abnormal immune system organ morphology	J:145159
	abnormal lymph node morphology	J:145159
	abnormal thymus lobule morphology	J:145159
	decreased B cell number	J:145159
	decreased CD4-positive, alpha-beta T cell number	J:145159
	decreased CD8-positive, alpha-beta T cell number	J:145159
	decreased lymphocyte cell number	J:145159
	decreased T cell number	J:145159
	increased single-positive T cell number	J:145159
Sgpl1^tm1.2Npa/Sgpl1^tm1.2Npa (involves: BALB/cJ * C57BL/6)	spleen hypoplasia	J:199525
Sgsh^mps3a/Sgsh^mps3a (involves: 129X1/SvJ * CD-1 * C57BL/6 * SJL)	enlarged spleen	J:72142
Sgsm1^{tm1b(EUCOMM)Wtsi}/Sgsm1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sgsm1^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
Sh2b2^tm1Yeb/Sh2b2^tm1Yeb (involves: C57BL/6)	abnormal B cell differentiation	J:88527
Sh2b2^tm1Yeb/Sh2b2^tm1Yeb (involves: C57BL/6)	increased B-1 B cell number	J:88527
Sh2b3^tm1Paw/Sh2b3^tm1Paw (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal granulocyte differentiation	J:77248
	abnormal leukocyte cell number	J:77248
	abnormal monocyte differentiation	J:77248
	enlarged lymph nodes	J:77248
	enlarged spleen	J:77248
	increased B cell number	J:77248
	spleen fibrosis	J:77248
Sh2b3^tm1Paw/Sh2b3^tm1Paw (B6.129-Sh2b3^tm1Paw)	spleen hyperplasia	J:107464
Sh2b3^tm1Paw/Sh2b3^tm1Paw (involves: 129S1/Sv * 129X1/SvJ)	decreased B cell number	J:161643
	enlarged spleen	J:161643
	increased granulocyte number	J:161643
	increased leukocyte cell number	J:161643
	increased lymphocyte cell number	J:161643
	increased monocyte cell number	J:161643
	increased neutrophil cell number	J:161643
	myeloid hyperplasia	J:161643
Sh2d1a^tm1Cpt/Y (involves: 129S4/SvJae * C57BL/6)	decreased NK T cell number	J:189126
Sh2d1a^tm1Cpt/Y (involves: 129S4/SvJae * BALB/c)	abnormal germinal center B cell morphology	J:189126
	decreased germinal center B cell number	J:189126
	decreased NK T cell number	J:189126
Sh2d1a^tm1Cpt/Y Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)	decreased germinal center B cell number	J:189126
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (B6.129S4-Sh2d1a^tm1Cpt)	absent NK T cells	J:97690
	decreased NK T cell number	J:97690
	decreased transitional stage B cell number	J:97690
	increased B cell number	J:97388
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (C.129S4-Sh2d1a^tm1Cpt)	decreased spleen germinal center number	J:97388
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (involves: 129S4/SvJae * C57BL/6)	decreased NK T cell number	J:189126
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt (involves: 129S4/SvJae * BALB/c)	abnormal germinal center B cell morphology	J:189126
	decreased germinal center B cell number	J:189126
	decreased NK T cell number	J:189126
Sh2d1a^tm1Cpt/Sh2d1a^tm1Cpt Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)	decreased germinal center B cell number	J:189126
Sh2d1a^tm1Lyin/Y (involves: 129S2/SvPas * C57BL/6)	increased CD8-positive, alpha-beta T cell number	J:97346
Sh2d1a^tm1Lyin/Sh2d1a^tm1Lyin (involves: 129S2/SvPas * C57BL/6)	increased CD8-positive, alpha-beta T cell number	J:97346
Sh2d1a^tm1Pls/Y (involves: 129S6/SvEvTac)	abnormal long lived plasma cell morphology	J:157915
	abnormal NK T cell morphology	J:196692
	decreased CD4-positive, alpha-beta T cell number	J:157915
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls (either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6))	abnormal lymphocyte cell number	J:70032
	abnormal T-helper 1 cell morphology	J:70032
	abnormal T-helper 2 cell morphology	J:70032
Sh2d1a^tm1Pls/Sh2d1a^tm1Pls (involves: 129S6/SvEvTac)	abnormal long lived plasma cell morphology	J:157915
	abnormal NK T cell morphology	J:196692
	decreased CD4-positive, alpha-beta T cell number	J:157915
Sh2d1a^tm2.1Vei/Sh2d1a^tm2.1Vei (involves: C57BL/6)	decreased germinal center B cell number	J:131618
Sh2d1a^tm2.1Vei/Sh2d1a^tm2.1Vei (involves: C57BL/6)	decreased NK T cell number	J:131618
Sh2d1a^tm2Vei/Sh2d1a^tm2Vei Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased germinal center B cell number	J:131618
	decreased NK T cell number	J:131618
Sh2d1a^tm2Vei/Sh2d1a^tm2Vei Tg(Lck-cre)1Cwi/0 (involves: C57BL/6)	decreased germinal center B cell number	J:131618
	decreased NK T cell number	J:131618
Sh2d3c^tm1Lex/Sh2d3c^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	decreased marginal zone B cell number	J:161448
Sh3bp2^tm1.1Ics/Sh3bp2^tm1.1Ics (involves: 129S2/SvPas * C57BL/6)	enlarged lymph nodes	J:221901
	increased monocyte cell number	J:221901
Sh3bp2^tm1Bjro/Sh3bp2⁺ (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	abnormal osteoclast differentiation	J:117880
	increased osteoclast cell number	J:117880
Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	abnormal B cell number	J:117880
	abnormal immune system organ morphology	J:117880
	abnormal osteoclast differentiation	J:117880
	enlarged lymph nodes	J:117880
	increased osteoclast cell number	J:117880
	increased spleen red pulp amount	J:117880
Sh3bp2^tm1Bjro/Sh3bp2^tm1Bjro Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129S/SvEv * 129S4/SvJae * BALB/cJ * C57BL/6J)	abnormal osteoclast differentiation	J:117880
Sh3bp2^tm1Geha/Sh3bp2^tm1Geha (Not Specified)	abnormal B cell number	J:110319
Sh3bp2^tm1Geha/Sh3bp2^tm1Geha (Not Specified)	increased pre-B cell number	J:110319
Sh3bp2^tm1Rtpl/Sh3bp2^tm1Rtpl (B6.129P2-Sh3bp2^tm1Rtpl)	abnormal B cell number	J:121380
	abnormal spleen marginal zone morphology	J:121380
	decreased B-1 B cell number	J:121380
	decreased pro-B cell number	J:121380
	decreased transitional stage B cell number	J:121380
	increased marginal zone B cell number	J:121380
Sh3kbp1^tm1Kuro/Sh3kbp1^tm1Kuro Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6 * NZB)	abnormal lymphocyte cell number	J:176805
	decreased B cell number	J:176805
	decreased B-1a cell number	J:176805
	decreased follicular B cell number	J:176805
	decreased immature B cell number	J:176805
	decreased transitional stage T2 B cell number	J:176805
	decreased transitional stage T3 B cell number	J:176805
Sh3kbp1^tm1Kuro/Sh3kbp1^tm1Kuro Cd79a^tm1(cre)Reth/Cd79a⁺ Gt(ROSA)26Sor^{tm4(Ikbkb)Rsky}/? (involves: BALB/c * C57BL/6 * NZB)	decreased B-1a cell number	J:176805
Sh3pxd2a^{tm1b(EUCOMM)Wtsi}/Sh3pxd2a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sh3pxd2a^{tm1b(EUCOMM)Wtsi}/Wtsi)	abnormal lymphatic vessel morphology	J:239583
	abnormal thymus topology	J:239583
	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Sh3tc1^{tm1b(EUCOMM)Hmgu}/Sh3tc1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sh3tc1^{tm1b(EUCOMM)Hmgu}/Orl)	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Sh3yl1^em1(IMPC)Mbp/Sh3yl1^em1(IMPC)Mbp (C57BL/6NCrl-Sh3yl1^em1(IMPC)Mbp/MbpMmucd)	increased monocyte cell number	J:211773
Sharpin^cpdm-Dem/Sharpin^cpdm-Dem (CBy.OcB3-Sharpin^cpdm-Dem)	abnormal immune system organ morphology	J:121810
Sharpin^cpdm/Sharpin^cpdm (C57BL/KaLawRij-Sharpin^cpdm)	abnormal immune system organ morphology	J:14539
	abnormal lymph node morphology	J:14539
	abnormal mesenteric lymph node morphology	J:53575
	abnormal peripheral lymph node morphology	J:53575
	abnormal spleen morphology	J:53575
	abnormal spleen white pulp morphology	J:31745, J:53575
	absent Peyer's patches	J:53575
	absent spleen B cell follicles	J:53575
	absent spleen germinal center	J:53575
	absent spleen marginal zone	J:53575
	cutaneous mastocytosis	J:31745, J:14539
	decreased B cell number	J:53575
	decreased CD4-positive, alpha-beta T cell number	J:53575
	decreased T cell number	J:53575
	enlarged spleen	J:14539, J:53575
	increased eosinophil cell number	J:31745, J:14539
	large lymphoid organs	J:31745
Sharpin^cpdm/Sharpin^cpdm (involves: C57BL/KaLawRij * FVB/NJ)	absent Peyer's patches	J:121810
	absent spleen B cell follicles	J:121810
	absent spleen germinal center	J:121810
Shc1^tm1Ravi/Shc1^tm1Ravi Tg(Lck-cre)1Cwi/? (involves: 129 * C57BL/6)	abnormal double-negative T cell morphology	J:78180
	decreased double-positive T cell number	J:78180
	decreased single-positive T cell number	J:78180
	thymus hypoplasia	J:78180
Shcbp1^{tm1d(EUCOMM)Wtsi}/Shcbp1^{tm1d(EUCOMM)Wtsi} (involves: C57BL/6N * FVB/N)	decreased B cell number	J:212898
	decreased CD4-positive, alpha-beta T cell number	J:212898
	decreased macrophage cell number	J:212898
	decreased T cell number	J:212898
Shisa6^em1(IMPC)Tcp/Shisa6^em1(IMPC)Tcp (C57BL/6N-Shisa6^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Shisal1^{em1(IMPC)Ccpcz}/Shisal1^{em1(IMPC)Ccpcz} (C57BL/6N-Shisal1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Shld1^em1(IMPC)Mbp/Shld1^em1(IMPC)Mbp (C57BL/6NCrl-Shld1^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Shld1^em1Nus/Shld1^em1Nus (involves: C57BL/6NCrl)	abnormal class switch recombination	J:307190
Shmt2^em1(IMPC)Bay/Shmt2⁺ (C57BL/6N-Shmt2^em1(IMPC)Bay/Bay)	increased spleen weight	J:211773
sho/sho (Not Specified)	small thymus	J:255
Shprh^em1(IMPC)Tcp/Shprh^em1(IMPC)Tcp (C57BL/6NCrl-Shprh^em1(IMPC)Tcp/Tcp)	enlarged thymus	J:211773
Sidt1^{tm1.1(KOMP)Vlcg}/Sidt1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Sidt1^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal lymph node morphology	J:211773
Siglec1^{tm1(HBEGF)Mtka}/Siglec1^{tm1(HBEGF)Mtka} 1700016L21Rik^{Tg(Itgax-HBEGF/EGFP)57Lan}/? (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	abnormal metallophilic macrophage morphology	J:123958
	abnormal spleen marginal zone macrophage morphology	J:123958
Siglec1^tm1Croc/Siglec1^tm1Croc (B6.129-Siglec1^tm1Croc)	abnormal B cell number	J:105546
	abnormal T cell subpopulation ratio	J:105546
	decreased follicular B cell number	J:105546
	increased CD8-positive, alpha-beta T cell number	J:105546
	increased marginal zone B cell number	J:105546
Siglec15^tm1Yohi/Siglec15^tm1Yohi (B6.129S6-Siglec15^tm1Yohi)	abnormal osteoclast differentiation	J:193852
Siglecf^tm1.2Avrk/Siglecf^tm1.2Avrk (B6.129(FVB)-Siglecf^tm1.2Avrk)	abnormal eosinophil differentiation	J:204811
	increased eosinophil cell number	J:204811
Siglecg^M1Btlr/Siglecg^M1Btlr (C57BL/6J-Siglecg^M1Btlr)	increased B-1 B cell number	J:265179
Siglecg^m2Btlr/Siglecg^m2Btlr (C57BL/6J-Siglecg^m2Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:265183
	increased B-1 B cell number	J:265183
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:265183
Siglecg^M3Btlr/Siglecg^M3Btlr (C57BL/6J-Siglecg^M3Btlr)	decreased B-2 B cell number	J:265185
	increased B-1 B cell number	J:265185
	increased B-1a cell number	J:265185
Siglecg^M4Btlr/Siglecg^M4Btlr (C57BL/6J-Siglecg^M4Btlr)	increased B-1 B cell number	J:272021
Siglecg^M5Btlr/Siglecg^M5Btlr (C57BL/6J-Siglecg^M5Btlr)	increased B-1a cell number	J:272022
Siglecg^tm1Lnit/Siglecg^tm1Lnit (involves: BALB/c)	abnormal plasma cell differentiation	J:123353
	increased B-1 B cell number	J:123353
	increased B-1a cell number	J:123353
	increased B-1b cell number	J:123353
Siglecg^tm1Yliu/Siglecg^tm1Yliu (C57BL/6-Siglecg^tm1Yliu)	increased B-1a cell number	J:130017
Siglecg^tm1Yliu/Siglecg^tm1Yliu (C57BL/6-Siglecg^tm1Yliu)	increased pre-B cell number	J:130017
Siglech^tm1.1Cln/Siglech⁺ Tg(CLEC4C-HBEGF)956Cln/0 (involves: C57BL/6)	decreased plasmacytoid dendritic cell number	J:166504
Siglech^tm1.1Ksat/Siglech^tm1.1Ksat (B6.Cg-Siglech^tm1.1Ksat)	abnormal regulatory T cell morphology	J:179283
	decreased plasmacytoid dendritic cell number	J:179283
	decreased T-helper 17 cell number	J:179283
	increased T-helper 17 cell number	J:179283
Sik3^{tm1a(EUCOMM)Hmgu}/Sik3^{tm1a(EUCOMM)Hmgu} (C57BL/6N-Sik3^{tm1a(EUCOMM)Hmgu}/Wtsi)	decreased alpha-beta T cell number	J:211773
	decreased CD4-positive NK T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased CD5-positive gamma-delta T cell number	J:211773
	decreased early germinal center B cell number	J:211773
	decreased effector memory T-helper cell number	J:211773
	decreased gamma-delta T cell number	J:211773
	decreased germinal center B cell number	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	decreased KLRG1-positive T-helper cell number	J:211773
	decreased Ly6C-positive mature NK cell number	J:211773
	decreased memory-marker CD4-negative NK T cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	decreased NK cell number	J:211773
	decreased NK T cell number	J:211773
	decreased regulatory T cell number	J:211773
	decreased T cell number	J:211773
	decreased T-helper cell number	J:211773
	increased CD4-negative NK T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased eosinophil cell number	J:211773
	increased follicular B cell number	J:211773
	increased granulocyte number	J:211773
	increased KLRG1+ CD8 alpha-beta T cell number	J:211773
	increased KLRG1-positive CD4-negative NK T cell number	J:211773
	increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased KLRG1-positive T-helper cell number	J:211773
	increased Ly6C-positive NK T cell number	J:211773
	increased memory-marker gamma-delta T cell number	J:211773
	increased memory-marker NK cell number	J:211773
	increased NK cell number	J:211773
	increased plasmacytoid dendritic cell number	J:211773
Sin3b^tm1.2Rdp/Sin3b^tm1.2Rdp (involves: 129 * C57BL/6 * FVB/N * SJL)	abnormal granulocyte differentiation	J:154855
	decreased granulocyte number	J:154855
Sinhcaf^tm1.2Hmd/Sinhcaf^tm1.2Hmd (involves: 129 * C57BL/6)	spleen hypoplasia	J:313620
Sipa1^tm1Nm/Sipa1⁺ (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:97239
Sipa1^tm1Nm/Sipa1⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased leukocyte cell number	J:97239
Sipa1^tm1Nm/Sipa1^tm1Nm (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:97239
	increased granulocyte number	J:97239
	increased leukocyte cell number	J:97239
	spleen hyperplasia	J:97239
Sirpa^{tm1b(EUCOMM)Hmgu}/Sirpa^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sirpa^{tm1b(EUCOMM)Hmgu}/Bay)	enlarged spleen	J:211773
	increased spleen weight	J:211773
Sirpa^tm1Nog/Sirpa^tm1Nog (involves: 129P2/OlaHsd * C57BL/6)	decreased T cell number	J:79592
Sirt1^{tm1b(EUCOMM)Wtsi}/Sirt1⁺ (C57BL/6N-Sirt1^{tm1b(EUCOMM)Wtsi}/H)	increased basophil cell number	J:211773
Sirt1^tm1Mcby/Sirt1^tm1Mcby (involves: 129)	decreased CD8-positive, alpha-beta T cell number	J:81010
Sirt1^tm1Mcby/Sirt1^tm1Mcby (involves: 129S1/Sv * 129X1/SvJ * CD-1)	decreased CD8-positive, alpha-beta T cell number	J:81010
Sirt1^tm2.1Mcby/Sirt1^tm2.1Mcby (involves: 129S1/Sv * 129X1/SvJ * CD-1)	enlarged spleen	J:180628
Sirt6^tm1Fwa/Sirt6^tm1Fwa (involves: 129S6/SvEvTac * 129X1/SvJ)	abnormal B cell differentiation	J:112817
	abnormal lymphopoiesis	J:112817
	decreased double-positive T cell number	J:112817
	decreased leukocyte cell number	J:112817
	spleen hypoplasia	J:112817
Sirt7^tm1Evbo/Sirt7^tm1Evbo (involves: 129/Sv * C57BL/6)	increased granulocyte number	J:147652
Sirt7^tm1Fwa/Sirt7^tm1Fwa (involves: 129S1/Sv)	increased macrophage cell number	J:205529
Sit1^tm1Lsmn/Sit1^tm1Lsmn (B6.Cg-Sit1^tm1Lsmn)	abnormal lymphocyte cell number	J:100408
	abnormal T cell differentiation	J:100408
	abnormal T-helper 1 cell differentiation	J:100408
	decreased CD4-positive, alpha-beta T cell number	J:100408
	decreased CD8-positive, alpha-beta T cell number	J:100408
	increased double-positive T cell number	J:100408
	increased mature gamma-delta T cell number	J:100408
	lymph node hypoplasia	J:100408
	thymus hyperplasia	J:100408
Sit1^tm1Lsmn/Sit1^tm1Lsmn Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6 * C57BL/6J * DBA/2J)	abnormal CD8-positive, alpha beta T cell morphology	J:100408
	abnormal positive T cell selection	J:100408
	abnormal T cell differentiation	J:100408
Sit1^tm1Lsmn/Sit1^tm1Lsmn Tg(TcrLCMV)327Sdz/0 (involves: C57BL/6)	abnormal positive T cell selection	J:100408
	abnormal T cell selection	J:100408
	thymus hypoplasia	J:100408
Six1^em1(IMPC)Mbp/Six1⁺ (C57BL/6N-Six1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased leukocyte cell number	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Six1^tm1Kwk/Six1^tm1Kwk (involves: 129P2/OlaHsd * C57BL/6)	athymia	J:104488
Six1^tm1Mair/Six1^tm1Mair (involves: 129S2/SvPas)	athymia	J:84417
Skic8^em1(IMPC)Tcp/Skic8⁺ (C57BL/6NCrl-Skic8^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	increased monocyte cell number	J:211773
Skida1^{tm1.1(KOMP)Wtsi}/Skida1⁺ (C57BL/6N-Skida1^{tm1.1(KOMP)Wtsi}/Ucd)	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Skida1^{tm1.1(KOMP)Wtsi}/Skida1^{tm1.1(KOMP)Wtsi} (C57BL/6N-Skida1^{tm1.1(KOMP)Wtsi}/Ucd)	enlarged thymus	J:211773
	small spleen	J:211773
Skil^tm1Sis/Skil⁺ (involves: C57BL/6 * CBA)	increased T cell derived lymphoma incidence	J:62174
Skil^tm1Spw/Skil^tm1Spw (either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))	abnormal immune system cell morphology	J:84554
	abnormal immune system organ morphology	J:84554
	enlarged spleen	J:84554
Skint1^m1Tac/Skint1^m1Tac (FVB/NTac)	abnormal T cell differentiation	J:139711
Skint1^m1Tac/Skint1^m1Tac (FVB/NTac)	abnormal T cell morphology	J:139711
Skint2^em2Htaka/Skint2^em2Htaka (C57BL/6-Skint2^em2Htaka)	decreased dendritic epidermal T cell number	J:291989
skp/skp (CXB5/ByJ-skp/GrsrJ)	thymus atrophy	J:153578
Skp2^tm1Kin/Skp2^tm1Kin (involves: 129P2/OlaHsd)	abnormal immunoglobulin V(D)J recombination	J:168974
Sla2^{em1(IMPC)Ccpcz}/Sla2^{em1(IMPC)Ccpcz} (C57BL/6N-Sla2^{em1(IMPC)Ccpcz}/Ccpcz)	decreased NK cell number	J:211773
Sla^tm1Weis/Sla^tm1Weis (involves: 129 * C57BL/6)	abnormal double-positive T cell morphology	J:71804
Sla^tm1Weis/Sla^tm1Weis Sla2^tm1Amch/Sla2^tm1Amch (involves: 129)	abnormal dendritic cell differentiation	J:169170
Sla^tm1Weis/Sla^tm1Weis Tg(DO11.10)10Dlo/0 (involves: 129 * BALB/c * C3H * C57BL/6)	abnormal positive T cell selection	J:71804
	abnormal T cell differentiation	J:71804
Sla^tm1Weis/Sla^tm1Weis Zap70^tm1Weis/Zap70^tm1Weis (involves: 129 * 129X1/SvJ * C57BL/6)	abnormal T cell differentiation	J:71804
	decreased CD4-positive, alpha-beta T cell number	J:71804
Slamf9^em1Isha/Slamf9^em1Isha (involves: C57BL/6)	increased plasmacytoid dendritic cell number	J:279164
Slc1a5^tm1Tac/Slc1a5^tm1Tac (involves: 129S/SvEv * C57BL/6)	abnormal T-helper 1 cell differentiation	J:254980
	abnormal T-helper 2 cell differentiation	J:254980
	abnormal T-helper 17 cell differentiation	J:254980
	decreased B cell number	J:254980
	decreased CD4-positive, alpha-beta memory T cell number	J:254980
	decreased T helper 1 cell number	J:254980
	decreased T-helper 17 cell number	J:254980
	increased CD4-positive, alpha-beta T cell number	J:254980
Slc2a5^{tm1b(EUCOMM)Wtsi}/Slc2a5^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Slc2a5^{tm1b(EUCOMM)Wtsi}/Ieg)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Slc2a10^G128E/Slc2a10^G128E (C3HeB/FeJ-Slc2a10^G128E)	abnormal spleen morphology	J:161835
Slc3a1^{tm1.1(KOMP)Vlcg}/Slc3a1^{tm1.1(KOMP)Vlcg} (C57BL/6N-Slc3a1^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased eosinophil cell number	J:211773
	increased spleen weight	J:211773
Slc3a2^tm1.1Yait/Slc3a2^tm1.1Yait Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6NCrSlc)	abnormal macrophage differentiation	J:188365
	abnormal macrophage morphology	J:188365
Slc4a1^tm1Ahc/Slc4a1^tm1Ahc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	abnormal immune system organ morphology	J:35637
	enlarged spleen	J:35637
Slc4a1^tm1Dmb/Slc4a1^tm1Dmb (involves: 129S6/SvEvTac)	abnormal splenic cell ratio	J:145243
Slc4a1^tm1Llp/Slc4a1^tm1Llp (involves: 129S4/SvJae * C57BL/6J)	enlarged spleen	J:35487
Slc4a1^tm1Phsl/Slc4a1^tm1Phsl (involves: 129 * 129S6/SvEvTac * Black Swiss)	enlarged spleen	J:152245
Slc4a2^tm1Ges/Slc4a2^tm1Ges (involves: 129S6/SvEvTac)	abnormal osteoclast morphology	J:193823
Slc4a2^tm2Ges/Slc4a2^tm2Ges Ctsk^tm1(cre)Ska/Ctsk⁺ (involves: C57BL/6NCrlj * CBA/JNCrlj)	abnormal osteoclast morphology	J:193823
Slc4a2^tm2Ges/Slc4a2^tm2Ges Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal osteoclast morphology	J:193823
Slc4a4^tm1.1Slin/Slc4a4^tm1.1Slin (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	enlarged spleen	J:186877
	increased spleen weight	J:186877
Slc4a4^tm1Ges/Slc4a4^tm1Ges (involves: 129S6/SvEvTac * Black Swiss)	decreased lymphocyte cell number	J:120867
	disorganized spleen B cell follicle	J:120867
	enlarged spleen	J:120867
	increased spleen red pulp amount	J:120867
	increased spleen white pulp amount	J:120867
Slc4a10^{tm1b(KOMP)Wtsi}/Slc4a10^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc4a10^{tm1b(KOMP)Wtsi}/H)	small spleen	J:211773
Slc6a6^em1(IMPC)Mbp/Slc6a6^em1(IMPC)Mbp (C57BL/6N-Slc6a6^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
	increased monocyte cell number	J:211773
Slc6a8^tm1.2Lbar/Y (involves: 129 * 129S1/Sv * C57BL/6J * C57BL/6N)	microgliosis	J:238578
Slc7a5^em1(IMPC)H/Slc7a5⁺ (C57BL/6NTac-Slc7a5^em1(IMPC)H/H)	increased basophil cell number	J:211773
Slc7a7^em1Lbu/Slc7a7^em1Lbu (involves: 129/SvEv * C57BL/6)	abnormal spleen germinal center morphology	J:293773
	decreased lymphocyte cell number	J:293773
	decreased spleen weight	J:293773
	increased neutrophil cell number	J:293773
	increased spleen red pulp amount	J:293773
Slc7a7^{Gt(OST41878)Lex}/Slc7a7^{Gt(OST41878)Lex} (B6.129S-Slc7a7^{Gt(OST41878)Lex})	increased spleen weight	J:125847
Slc9a6^tm1Dgen/Y (B6.129P2-Slc9a6^tm1Dgen/J)	microgliosis	J:262453
Slc9b1^em1(IMPC)Mbp/Slc9b1^em1(IMPC)Mbp (C57BL/6N-Slc9b1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Slc11a1^em1(IMPC)Mbp/Slc11a1^em1(IMPC)Mbp (C57BL/6N-Slc11a1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Slc11a2^mk/Slc11a2^mk (MK/ReJ)	increased spleen weight	J:5167
Slc11a2^mk/Slc11a2^mk (SEC.Cg-Slc11a2^mk)	increased spleen weight	J:5167
Slc11a2^tm2Nca/Slc11a2^tm2Nca Tg(Vil1-cre)20Syr/? (involves: 129S6.129S4-Slc11a2^tm2Nca * C57BL/6 * DBA/2)	abnormal spleen morphology	J:98088
	decreased spleen iron level	J:98088
	enlarged spleen	J:98088
	increased spleen red pulp amount	J:98088
Slc12a2^em1Dlp/Slc12a2^em1Dlp (involves: C57BL/6J * DBA/2J)	increased lymphocyte cell number	J:285398
Slc12a5^em1(IMPC)Mbp/Slc12a5⁺ (C57BL/6N-Slc12a5^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Slc13a3^{tm1b(KOMP)Wtsi}/Slc13a3^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc13a3^{tm1b(KOMP)Wtsi}/Ucd)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Slc13a5^{tm1b(EUCOMM)Hmgu}/Slc13a5^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Slc13a5^{tm1b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Slc14a1^tm1Ask/Slc14a1^tm1Ask (involves: C57BL/6J * CD-1)	decreased spleen weight	J:125840
Slc15a3^{tm1a(KOMP)Wtsi}/Slc15a3^{tm1a(KOMP)Wtsi} (C57BL/6N-Slc15a3^{tm1a(KOMP)Wtsi})	abnormal myeloid dendritic cell morphology	J:210445
Slc15a3^{tm1b(KOMP)Wtsi}/Slc15a3^{tm1b(KOMP)Wtsi} (C57BL/6N-Slc15a3^{tm1b(KOMP)Wtsi}/H)	increased monocyte cell number	J:211773
Slc17a1^em1(IMPC)J/Slc17a1^em1(IMPC)J (C57BL/6NJ-Slc17a1^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Slc17a8^em1(IMPC)Mbp/Slc17a8^em1(IMPC)Mbp (C57BL/6N-Slc17a8^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Slc19a1^tm1Gold/Slc19a1^tm1Gold (involves: 129/Sv * C57BL/6 * SJL)	abnormal lymphopoiesis	J:68666
	decreased lymphocyte cell number	J:68666
	small spleen	J:68666
	small thymus	J:68666
Slc19a2^tm1Gelb/Slc19a2^tm1Gelb (involves: 129X1/SvJ)	abnormal myelopoiesis	J:79974
Slc20a1^tm1.1Lbek/Slc20a1^tm1.1Lbek Tg(Mx1-cre)1Cgn/0 (involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)	enlarged spleen	J:194198
	increased leukocyte cell number	J:194198
	intermingled spleen red and white pulp	J:194198
	spleen hyperplasia	J:194198
Slc20a1^tm1Lbek/Slc20a1^tm1Lbek (involves: 129S2/SvPas * C57BL/6J)	abnormal spleen morphology	J:194198
	enlarged spleen	J:194198
	increased spleen weight	J:157997
Slc20a2^{tm1a(EUCOMM)Wtsi}/Slc20a2^{tm1a(EUCOMM)Wtsi} (C57BL/6NTac-Slc20a2^{tm1a(EUCOMM)Wtsi}/Ieg)	microgliosis	J:223197
Slc22a6^tm1Dgen/Slc22a6^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased thymus weight	J:101679
Slc22a7^em1(IMPC)Tcp/Slc22a7^em1(IMPC)Tcp (C57BL/6NCrl-Slc22a7^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Slc22a29^em1(IMPC)Mbp/Slc22a29^em1(IMPC)Mbp (C57BL/6N-Slc22a29^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Slc23a4^{tm1a(KOMP)Wtsi}/Slc23a4^{tm1a(KOMP)Wtsi} (C57BL/6N-2010107G12Rik^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Slc24a4^{tm1b(KOMP)Wtsi}/Slc24a4⁺ (C57BL/6N-Slc24a4^{tm1b(KOMP)Wtsi}/H)	enlarged thymus	J:211773
Slc25a17^Gt(XB686)Byg/Slc25a17^Gt(XB686)Byg (involves: 129P2/OlaHsd * C57BL/6 * Swiss Webster)	abnormal Kupffer cell morphology	J:291257
Slc25a37^tm1.1Kapl/Slc25a37^tm1.2Kapl Speer6-ps1^{Tg(Alb-cre)21Mgn}/? (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * DBA)	enlarged spleen	J:173284
Slc25a37^tm1.1Kapl/Slc25a37^tm1.2Kapl Tg(Mx1-cre)1Cgn/? (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * CBA)	abnormal B cell morphology	J:173284
	abnormal lymphocyte morphology	J:173284
	abnormal spleen morphology	J:173284
	abnormal T cell morphology	J:173284
	enlarged spleen	J:173284
Slc25a42^em1(IMPC)J/Slc25a42⁺ (C57BL/6NJ-Slc25a42^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Slc25a46^atc/Slc25a46^atc (B6.Cg-Slc25a46^atc)	decreased spleen weight	J:242350
	decreased thymus weight	J:242350
	microgliosis	J:242350
	spleen hypoplasia	J:242350
	thymus hypoplasia	J:242350
Slc28a3^em1(IMPC)H/Slc28a3^em1(IMPC)H (C57BL/6N-Slc28a3^em1(IMPC)H/H)	increased large unstained cell number	J:211773
	increased monocyte cell number	J:211773
Slc29a3^em1(IMPC)Mbp/Slc29a3^em1(IMPC)Mbp (C57BL/6NCrl-Slc29a3^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased spleen weight	J:211773
	small thymus	J:211773
Slc29a3^{em1(IMPC)Wtsi}/Slc29a3^{em1(IMPC)Wtsi} (C57BL/6N-Slc29a3^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Slc29a3^tm1Lex/Slc29a3^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal macrophage morphology	J:179286
	enlarged lymph nodes	J:179286
	enlarged spleen	J:179286
	increased macrophage cell number	J:179286
	myeloid hyperplasia	J:179286
Slc30a4^em1(IMPC)Tcp/Slc30a4^em1(IMPC)Tcp (C57BL/6NCrl-Slc30a4^em1(IMPC)Tcp/Tcp)	small thymus	J:211773
Slc31a1^tm2Djt/Slc31a1^tm2Djt Tg(Vil1-cre)997Gum/0 (involves: 129 * C57BL/6 * FVB/N * SJL)	decreased spleen weight	J:129741
Slc33a1^tm1.1Lpu/Slc33a1⁺ (involves: 129S7/SvEvBrd * C57BL/6)	decreased B cell number	J:211266
	increased B cell number	J:211266
	increased neutrophil cell number	J:211266
	microgliosis	J:211266
Slc35c1^tm1Cknr/Slc35c1^tm1Cknr (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal lymph node primary follicle morphology	J:121151
	increased eosinophil cell number	J:121151
	increased leukocyte cell number	J:121151
	increased lymphocyte cell number	J:121151
	increased monocyte cell number	J:121151
	increased neutrophil cell number	J:121151
	lymph node hypoplasia	J:121151
Slc37a2^em1(IMPC)Mbp/Slc37a2^em1(IMPC)Mbp (C57BL/6NCrl-Slc37a2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
Slc37a4^tm1Jyc/Slc37a4^tm1Jyc (involves: 129S4/SvJae * C57BL/6)	abnormal myelopoiesis	J:86005
	abnormal spleen morphology	J:86005
	absent spleen white pulp	J:86005
	decreased lymphocyte cell number	J:86005
	decreased neutrophil cell number	J:86005
	small spleen	J:86005
Slc38a2^{tm1a(KOMP)Wtsi}/Slc38a2⁺ (C57BL/6N-Slc38a2^{tm1a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Slc38a7^{em1(IMPC)Ccpcz}/Slc38a7^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Slc38a7^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Slc39a3^tm1Gka/Slc39a3^tm1Gka (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:99161
	decreased double-positive T cell number	J:99161
	increased CD4-positive, alpha-beta T cell number	J:99161
Slc39a10^tm1.1Tfk/Slc39a10^tm1.1Tfk Tg(Foxn1-cre)8Ghr/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)	thymus hypoplasia	J:254216
Slc40a1^Pcm/Slc40a1⁺ (A.Cg-Slc40a1^Pcm)	abnormal spleen development	J:98335
	decreased spleen iron level	J:98335
	small spleen	J:98335
Slc40a1^Pcm/Slc40a1^Pcm (A.Cg-Slc40a1^Pcm)	abnormal spleen development	J:98335
	decreased spleen iron level	J:98335
	small spleen	J:98335
Slc40a1^tm1.1Mmfe/Slc40a1⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased spleen iron level	J:215585
Slc40a1^tm1.1Mmfe/Slc40a1^tm1.1Mmfe (involves: 129P2/OlaHsd * C57BL/6)	decreased spleen iron level	J:215585
Slc40a1^tm1Nca/Slc40a1⁺ (involves: 129S4/SvJae * 129S6/SvEvTac)	increased spleen iron level	J:129846
Slc40a1^tm2Nca/Slc40a1^tm2Nca Tg(Vil1-cre/ERT2)23Syr/0 (involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2)	decreased spleen iron level	J:129846
Slc46a2^tm1Moki/Slc46a2^tm1Moki (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	thymus hypoplasia	J:140121
Slc48a1^em1Ih/Slc48a1^em1Ih (involves: 129 * C57BL/6J)	abnormal macrophage morphology	J:282829
	dark spleen	J:282829
	decreased macrophage cell number	J:282829
	enlarged spleen	J:282829
	increased spleen iron level	J:282829
Slc51b^em1(IMPC)Mbp/Slc51b^em1(IMPC)Mbp (C57BL/6NCrl-Slc51b^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Slc52a2^{tm1.1(KOMP)Vlcg}/Slc52a2⁺ (C57BL/6N-Slc52a2^{tm1.1(KOMP)Vlcg}/Ucd)	enlarged lymph nodes	J:211773
Slco1a5^tm1Lex/Slco1a5^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	abnormal CD8-positive, alpha beta T cell morphology	J:103485
	increased B cell number	J:103485
Sle1^NZM2410/Aeg/Sle1^NZM2410/Aeg Sle3^NZM2410/Aeg/Sle3^NZM2410/Aeg (B6;NZM-Sle1^NZM2410/Aeg Sle2^NZM2410/Aeg Sle3^NZM2410/Aeg/LmoJ)	increased marginal zone B cell number	J:138314
Sle1^NZW/Sle1^NZW Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6 * DBA/2J * NZW)	increased B cell number	J:134128
	increased marginal zone B cell number	J:134128
Sle10^BXSB/J/Sle10^BXSB/J (involves: BXSB/J * C57BL/10Ola)	enlarged lymph nodes	J:60445
Slfn2^m1Btlr/Slfn2^m1Btlr (C57BL/6J-Slfn2^m1Btlr)	decreased CD4-positive, alpha-beta T cell number	J:158985
	decreased CD8-positive, alpha-beta T cell number	J:158985
	decreased monocyte cell number	J:158985
	increased neutrophil cell number	J:158985
Slfn4^{tm1c(EUCOMM)Wtsi}/Slfn4^{tm1c(EUCOMM)Wtsi} Gli1^{tm3(cre/ERT2)Alj}/Gli1⁺ (involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * Swiss Webster)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:337060
Slfn14^em1Nvm/Slfn14⁺ (C57BL/6J-Slfn14^em1Nvm)	enlarged spleen	J:325381
Slfn14^em1Nvm/Slfn14⁺ (C57BL/6J-Slfn14^em1Nvm)	increased spleen weight	J:325381
Slitrk5^em1(IMPC)Mbp/Slitrk5^em1(IMPC)Mbp (C57BL/6N-Slitrk5^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
Slu7^{tm1a(KOMP)Wtsi}/Slu7⁺ (C57BL/6N-Slu7^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Slx4^{tm1a(EUCOMM)Wtsi}/Slx4^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Slx4^{tm1a(EUCOMM)Wtsi})	abnormal lymphopoiesis	J:168567
	decreased leukocyte cell number	J:168567
Smad3^em1(IMPC)H/Smad3⁺ (C57BL/6NTac-Smad3^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
Smad3^tm1Cxd/Smad3^tm1Cxd (either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))	abnormal immune system morphology	J:53510
	enlarged lymph nodes	J:53510
	enlarged mesenteric lymph nodes	J:53510
	increased leukocyte cell number	J:53510
	increased monocyte cell number	J:53510
	increased neutrophil cell number	J:53510
	small spleen	J:53510
	spleen hypoplasia	J:53510
	thymus hypoplasia	J:53510
Smad3^tm1Cxd/Smad3^tm1Cxd (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive T cell differentiation	J:136955
Smad4^tm2.1Cxd/Smad4^tm2.1Cxd Tg(Foxn1-cre)8Ghr/0 (B6.Cg-Smad4^tm2.1Cxd Tg(Foxn1-cre)8Ghr)	small thymus	J:138837
Smad4^tm2.1Cxd/Smad4^tm2.1Cxd Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S6/SvEvTac * C57BL/6J * CD-1)	decreased osteoclast cell number	J:211171
Smad7^{Gt(YHC053)Byg}/Smad7^{Gt(YHC053)Byg} (involves: 129P2/OlaHsd * C57BL/6J)	abnormal thymus morphology	J:212881
	thymus hypoplasia	J:212881
Smad7^tm1.1Ink/Smad7^tm1.1Ink Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal T-helper 1 cell differentiation	J:184670
	decreased activated T cell number	J:184670
Smad7^tm1Rheu/Smad7^tm1Rheu (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal class switch recombination	J:120714
Smap1^tm1.1Sata/Smap1^tm1.1Sata (B6.Cg-Smap1^tm1.1Sata)	abnormal myelopoiesis	J:196385
	abnormal neutrophil morphology	J:196385
	enlarged spleen	J:196385
	increased neutrophil cell number	J:196385
Smarca4^tm1.2Pcn/Smarca4^tm1.2Pcn Tg(Lck-cre)1Cwi/0 (Not Specified)	abnormal T cell morphology	J:144072
	decreased double-negative T cell number	J:144072
Smarca4^tm1.2Pcn/Smarca4^tm1.2Pcn Tg(Lck-cre)1Cwi/0 Tg(LCKprBCL2L1)12Sjk/0 (Not Specified)	abnormal T cell morphology	J:144072
	decreased double-positive T cell number	J:144072
	increased double-negative T cell number	J:144072
	increased thymocyte number	J:144072
Smarca4^tm1.2Pcn/Smarca4^tm1Mag Tg(Lck-cre)1Cwi/? (involves: 129S/Sv * C57BL/6 * DBA/2)	abnormal T cell differentiation	J:85191
	absent CD8-positive, alpha-beta T cells	J:85191
	arrested T cell differentiation	J:85191
	decreased CD4-positive, alpha-beta T cell number	J:85191
	decreased double-negative T cell number	J:85191
	decreased double-positive T cell number	J:85191
	thymus hypoplasia	J:85191
Smarca4^tm1.2Pcn/Smarca4^tm1Mag Tg(Lck-cre)1Cwi/? Tg(LCKprBCL2)36Sjk/? (involves: 129S/Sv * C57BL/6 * DBA/2)	arrested T cell differentiation	J:85191
Smarca4^tm1.2Pcn/Smarca4^tm1Tich Tg(Lck-cre)1Cwi/0 (involves: 129)	abnormal T cell morphology	J:144072
	decreased double-negative T cell number	J:144072
	decreased thymocyte number	J:144072
Smarca4^tm1.2Pcn/Smarca4^tm1Tich Tg(Lck-cre)1Cwi/0 Tg(LCKprBCL2L1)12Sjk/0 (involves: 129)	abnormal T cell morphology	J:144072
	decreased double-positive T cell number	J:144072
	increased double-negative T cell number	J:144072
	increased thymocyte number	J:144072
Smarca4^tm1Tich/Smarca4⁺ Tg(Lck-cre)1Cwi/0 (involves: 129)	decreased double-negative T cell number	J:144072
	decreased double-positive T cell number	J:144072
	decreased single-positive T cell number	J:144072
	decreased thymocyte number	J:144072
Smarcal1^tm1.1Cfbo/Smarcal1^tm1.1Cfbo (either: B6.129-Smarcal1^tm1.1Cfbo or (involves: 129 * C57BL/6))	decreased B cell number	J:183899
Smarcb1^tm1Sho/Smarcb1^tm3Sho Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA)	abnormal lymph node morphology	J:80224
	abnormal spleen morphology	J:80224
	enlarged lymph nodes	J:80224
	enlarged spleen	J:80224
	increased eosinophil cell number	J:80224
	increased T cell derived lymphoma incidence	J:80224
Smarcc1^tm2.1Rhs/Smarcc1^tm2.1Rhs Tg(Mx1-cre)1Cgn/0 (involves: BALB/c * C57BL/6 * CBA)	abnormal immature B cell morphology	J:184060
	abnormal immunoglobulin heavy chain V(D)J recombination	J:184060
	abnormal pre-B cell morphology	J:184060
	abnormal pro-B cell morphology	J:184060
	arrested B cell differentiation	J:184060
	decreased B cell number	J:184060
	decreased early pro-B cell number	J:184060
	decreased follicular B cell number	J:184060
	decreased late pro-B cell number	J:184060
	decreased pro-B cell number	J:184060
Smc3^{tm1a(EUCOMM)Wtsi}/Smc3⁺ (involves: C57BL/6N)	increased T cell number	J:200082
Smc5^{tm1b(KOMP)Wtsi}/Smc5⁺ (C57BL/6N-Smc5^{tm1b(KOMP)Wtsi}/Ics)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Smc6^tm1.1Arln/Smc6^tm1.1Arln (involves: 129P2/OlaHsd * C57BL/6 * FVB)	increased leukocyte cell number	J:220422
Smcr8^em1Btlr/Smcr8^em1Btlr (C57BL/6J-Smcr8^em1Btlr)	enlarged lymph nodes	J:268243
	enlarged spleen	J:268243
	increased CD4-positive, alpha-beta T cell number	J:268243
	increased CD8-positive, alpha-beta T cell number	J:268243
Smcr8^em2Btlr/Smcr8^em2Btlr (C57BL/6J-Smcr8^em2Btlr)	enlarged lymph nodes	J:268243
	enlarged spleen	J:268243
	increased CD4-positive, alpha-beta T cell number	J:268243
	increased CD8-positive, alpha-beta T cell number	J:268243
Smg1^{Gt(AG0297)Wtsi}/Smg1⁺ (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:193626
Smg6^em1(IMPC)Mbp/Smg6⁺ (C57BL/6NCrl-Smg6^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Smg9^{tm1b(EUCOMM)Wtsi}/Smg9^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Smg9^{tm1b(EUCOMM)Wtsi}/Wtsi)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Smim3^tm1Anjm/Smim3⁺ Cd74^tm1Anjm/Cd74⁺ Lmo2^tm2(cre)Thr/Lmo2⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal mast cell morphology	J:155870
	decreased granulocyte number	J:155870
	decreased monocyte cell number	J:155870
Smim23^em1(IMPC)Mbp/Smim23^em1(IMPC)Mbp (C57BL/6N-Smim23^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Smoc1^{tm1b(EUCOMM)Wtsi}/Smoc1⁺ (C57BL/6N-Smoc1^{tm1b(EUCOMM)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased neutrophil cell number	J:211773
Smoc1^{tm1b(EUCOMM)Wtsi}/Smoc1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Smoc1^{tm1b(EUCOMM)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Smpd1^tm1Esc/Smpd1⁺ (involves: 129S1/Sv * C57BL/6J)	abnormal immune system cell morphology	J:70489
Smpd1^tm1Esc/Smpd1^tm1Esc (involves: 129S1/Sv * C57BL/6J)	increased macrophage derived foam cell number	J:81982
Smpd1^tm1Wst/Smpd1^tm1Wst (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:26748
	hepatosplenomegaly	J:26748
	increased macrophage derived foam cell number	J:26748
Smpdl3b^{tm1a(EUCOMM)Wtsi}/Smpdl3b^{tm1a(EUCOMM)Wtsi} (C57BL/6-Smpdl3b^{tm1a(EUCOMM)Wtsi})	abnormal macrophage morphology	J:224870
	increased neutrophil cell number	J:224870
Sms^{tm1a(EUCOMM)Wtsi}/Y (involves: C57BL/6 * C57BL/6N)	increased NK cell number	J:213427
Sms^{tm1a(EUCOMM)Wtsi}/Y (involves: C57BL/6 * C57BL/6N)	increased NK T cell number	J:213427
Smurf2^{Gt(RRA098)Byg}/Smurf2^{Gt(RRA098)Byg} (involves: 129P2/OlaHsd * C57BL/6)	enlarged spleen	J:189320
Snai2^tm2Grid/Snai2⁺ Snai3^tm1.2Jhws/Snai3^tm1.2Jhws (involves: 129/Sv * 129S1/Sv * C57BL/6)	abnormal thymus cortex morphology	J:204710
	abnormal thymus medulla morphology	J:204710
	decreased B cell number	J:204710
	disorganized spleen B cell follicle	J:204710
Snai2^tm2Grid/Snai2^tm2Grid (involves: 129S1/Sv)	abnormal T cell differentiation	J:78323
	decreased leukocyte cell number	J:78323
	small thymus	J:78323
Snai2^tm2Grid/Snai2^tm2Grid Snai3^tm1.2Jhws/Snai3⁺ (involves: 129/Sv * 129S1/Sv * C57BL/6)	abnormal thymus cortex morphology	J:204710
	abnormal thymus medulla morphology	J:204710
	decreased B cell number	J:204710
	disorganized spleen B cell follicle	J:204710
	increased macrophage cell number	J:204710
	increased neutrophil cell number	J:204710
Snai2^tm2Grid/Snai2^tm2Grid Snai3^tm1.2Jhws/Snai3^tm1.2Jhws (involves: 129/Sv * 129S1/Sv * C57BL/6)	abnormal thymus cortex morphology	J:204710
	abnormal thymus medulla morphology	J:204710
	decreased B cell number	J:204710
	decreased double-positive T cell number	J:204710
	disorganized spleen B cell follicle	J:204710
	increased macrophage cell number	J:204710
	increased neutrophil cell number	J:204710
	increased single-positive T cell number	J:204710
	small spleen	J:204710
	small thymus	J:204710
	thymus fibrosis	J:204710
Snca^em1(IMPC)H/Snca^em1(IMPC)H (C57BL/6NTac-Snca^em1(IMPC)H/H)	increased spleen weight	J:211773
Snd1^em1(IMPC)Tcp/Snd1⁺ (C57BL/6NCrl-Snd1^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	decreased spleen weight	J:211773
	increased neutrophil cell number	J:211773
	small thymus	J:211773
Snord50a/Snord50b^tm1.1Soen/Snord50a/Snord50b^tm1.1Soen (B6.129P2-Snord50a/Snord50b^tm1.1Soen)	enlarged lymph nodes	J:206419
	enlarged spleen	J:206419
Snord50a/Snord50b^tm1.1Soen/Snord50a/Snord50b^tm1.1Soen (B6.129P2-Snord50a/Snord50b^tm1.1Soen)	enlarged lymph nodes	J:206419
	enlarged spleen	J:206419
Snrnp40^em1Btlr/Snrnp40^swp (C57BL/6J-Snrnp40^em1Btlr/Snrnp40^swp)	abnormal thymus development	J:282417
	decreased B cell number	J:282417
	decreased CD4-positive, alpha-beta T cell number	J:282417
	decreased CD8-positive, alpha-beta T cell number	J:282417
	decreased DN1 thymic pro-T cell number	J:282417
	decreased DN4 thymocyte number	J:282417
	decreased lymphocyte cell number	J:282417
	decreased monocyte cell number	J:282417
	decreased NK cell number	J:282417
	decreased T cell number	J:282417
	increased central memory CD8 positive, alpha-beta T cell number	J:282417
	increased effector memory CD8-positive, alpha-beta T cell number	J:282417
	small thymus	J:282417
	thymus hypoplasia	J:282417
Snrnp200^{tm1b(KOMP)Mbp}/Snrnp200⁺ (C57BL/6N-Snrnp200^{tm1b(KOMP)Mbp}/H)	increased monocyte cell number	J:211773
Snx8^{tm2a(EUCOMM)Hmgu}/Snx8^{tm2a(EUCOMM)Hmgu} (C57BL/6N-Snx8^{tm2a(EUCOMM)Hmgu}/Wtsi)	increased leukocyte cell number	J:211773
Snx10^em1Ael/Snx10^em1Ael (involves: 129 * C57BL/6J * C57BL/6JOlaHsd)	abnormal osteoclast morphology	J:289051
	decreased osteoclast cell number	J:289051
Snx10^em2Ael/Snx10^em2Ael (involves: 129 * C57BL/6J * C57BL/6JOlaHsd)	abnormal osteoclast morphology	J:289051
	decreased osteoclast cell number	J:289051
Snx13^{tm1b(EUCOMM)Hmgu}/Snx13⁺ (C57BL/6N-Snx13^{tm1b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Snx15^{tm1.1(KOMP)Vlcg}/Snx15^{tm1.1(KOMP)Vlcg} (C57BL/6N-Snx15^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Snx27^tm1Lslo/Snx27^tm1Lslo (involves: 129P2/OlaHsd)	small spleen	J:171001
Soat1^ald/Soat1^ald (AKR/O)	thymus hyperplasia	J:12157
Soat1^tm1Far/Soat1^tm1Far (involves: 129S4/SvJae * C57BL/6)	abnormal macrophage morphology	J:37049
Socs1^tm1.1Ayr/Socs1^tm1.1Ayr (involves: C57BL/6)	decreased effector memory T-helper cell number	J:226678
Socs1^tm1Ayos/Socs1^tm1Ayos Foxp3^{tm4(YFP/icre)Ayr}/Foxp3⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	increased regulatory T cell number	J:167922
Socs1^tm1Ayos/Socs1^tm1Ayos Tg(Lck-cre)1Jtak/0 (involves: 129S4/SvJae * C57BL/6)	abnormal CD4-positive T cell differentiation	J:132905
Socs1^tm1Ayos/Socs1^tm1Ayos Tg(Tek-cre)1Ywa/0 (involves: 129S4/SvJae * C57BL/6 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:132905
	increased CD8-positive, alpha-beta T cell number	J:132905
Socs1^tm1Jni/Socs1^tm1Jni (Not Specified)	abnormal T cell differentiation	J:57475
	decreased B cell number	J:57475
	decreased thymocyte number	J:57475
Socs1^tm1Kish/Socs1^tm1Kish (involves: 129P2/OlaHsd * C57BL/6J)	abnormal spleen morphology	J:51685
	abnormal spleen white pulp morphology	J:51685
	absent thymus corticomedullary boundary	J:51685
	decreased lymphocyte cell number	J:51685
Socs1^tm1Kish/Socs1^tm1Kish (B6.129P2-Socs1^tm1Kish)	increased activated T cell number	J:69472
	increased NK T cell number	J:69472
	thymus atrophy	J:69472
Socs1^tm1Kish/Socs1^tm1Kish Stat1^tm1Rds/Stat1^tm1Rds (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	increased activated T cell number	J:69472
	thymus atrophy	J:69472
Socs1^tm1Kish/Socs1^tm1Kish Stat6^tm1Aki/Stat6^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	increased activated T cell number	J:69472
	thymus atrophy	J:69472
Socs1^tm1Wehi/Socs1^tm1Wehi (involves: 129S1/Sv * C57BL/6)	abnormal follicular B cell morphology	J:51281
	abnormal lymph node B cell domain morphology	J:51281
	abnormal mature B cell morphology	J:51281
	abnormal Peyer's patch morphology	J:51281
	abnormal spleen white pulp morphology	J:57474
	decreased B cell number	J:51281
	decreased eosinophil cell number	J:51281
	decreased leukocyte cell number	J:57474
	decreased lymphocyte cell number	J:51281
	decreased pre-B cell number	J:51281
	increased spleen red pulp amount	J:51281
	small thymus	J:51281
	thymus cortex atrophy	J:57474, J:51281
Socs1^tm1Wehi/Socs1^tm3Wehi Tg(Lck-cre)I57Jxm/0 (involves: 129P2/OlaHsd * C57BL/6 * ICR)	abnormal CD4-positive, alpha beta T cell morphology	J:83009
	abnormal CD8-positive, alpha beta T cell morphology	J:83009
	abnormal T cell differentiation	J:83009
	abnormal T cell subpopulation ratio	J:83009
	decreased B cell number	J:83009
	enlarged lymph nodes	J:83009
	enlarged thymus medulla	J:83009
	increased CD4-positive, alpha-beta T cell number	J:83009
	increased CD8-positive, alpha-beta T cell number	J:83009
	lymph node hyperplasia	J:83009
	thymus hyperplasia	J:83009
Socs1^tm2Wehi/Socs1^tm2Wehi (C57BL/6-Socs1^tm2Wehi)	absent spleen germinal center	J:72528
Socs1^tm2Wehi/Socs1^tm2Wehi (C57BL/6-Socs1^tm2Wehi)	thymus atrophy	J:72528
Socs3^tm1Robb/Socs3^tm1Robb (involves: C57BL/6)	enlarged spleen	J:145513
Socs3^tm1Robb/Socs3^tm1Robb (involves: C57BL/6)	increased neutrophil cell number	J:145513
Socs3^tm1Wsa/Socs3^tm2Wsa Tg(Vav1-cre)1Awr/0 (involves: C57BL/6)	abnormal granulocyte differentiation	J:89785
	abnormal myelopoiesis	J:89785
	enlarged spleen	J:89785
	increased neutrophil cell number	J:89785
Socs4^m1Nch/Socs4^m1Nch (C.C3Fe-Socs4^m1Nch)	decreased T cell number	J:241977
Socs4^m1Nch/Socs4^m1Nch (C.C3Fe-Socs4^m1Nch)	increased T cell number	J:241977
Sod1^m1H/Sod1^m1H (involves: C3H/HeH * C57BL/6J)	microgliosis	J:219360
Sod2^tm1Leb/Sod2^tm1Leb (B6.129S7-Sod2^tm1Leb/J)	impaired myelopoiesis	J:36148
Son^em1.1Bcgen/Son⁺ (B6(Cg)-Son^em1.1Bcgen)	abnormal B cell differentiation	J:347709
	abnormal naive B cell morphology	J:347709
	abnormal transitional stage B cell morphology	J:347709
	decreased follicular B cell number	J:347709
	decreased leukocyte cell number	J:347709
	decreased lymphocyte cell number	J:347709
	decreased monocyte cell number	J:347709
	decreased neutrophil cell number	J:347709
	decreased transitional stage T2 B cell number	J:347709
	increased marginal zone B cell number	J:347709
	increased pre-B cell number	J:347709
	increased transitional stage T1 B cell number	J:347709
Sorbs1^tm1Krc/Sorbs1^tm1Krc (B6.129-Sorbs1^tm1Krc)	decreased leukocyte cell number	J:121762
	decreased lymphocyte cell number	J:121762
	decreased monocyte cell number	J:121762
Sord^{em1(IMPC)Ccpcz}/Sord^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Sord^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Sos1^tm1.1Les/Sos1^tm1.1Les Tg(Lck-cre)1Cwi/0 (involves: 129 * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:174536
	decreased CD8-positive, alpha-beta T cell number	J:174536
	decreased DN4 thymocyte number	J:174536
	decreased double-negative T cell number	J:174536
	decreased double-positive T cell number	J:174536
	decreased gamma-delta T cell number	J:174536
	decreased thymocyte number	J:174536
Sos1^tm1.2Rak/Sos1⁺ (involves: 129S/Sv * C57BL/6 * FVB/N * SJL)	enlarged spleen	J:171873
	increased leukocyte cell number	J:171873
	increased neutrophil cell number	J:171873
	increased spleen red pulp amount	J:171873
Sostdc1^tm1Snd/Sostdc1^tm1Snd (involves: C57BL/6)	decreased osteoclast cell number	J:216098
Sox4^Igt4/Del(13)36H (involves: 101/H * C3H/HeH * C57BL/6)	thymus hypoplasia	J:141688
Sox4^tm1Cle/Sox4^tm1Cle (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:32741
	absent pre-B cells	J:32741
	decreased pro-B cell number	J:32741
Sox4^tm2Cle/Sox4^tm2Cle (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:32741
	absent pre-B cells	J:32741
	decreased pro-B cell number	J:32741
Sox9^{em1(cre/ERT2)Smoc}/Sox9⁺ Tnfsf18^em1Pwan/Tnfsf18^em1Pwan (involves: C57BL/6J)	decreased CD8-positive, alpha-beta T cell number	J:346395
Sox11^tm1.2Vlf/Sox11⁺ Sox4^tm1.1Vlf/Sox4⁺ (involves: 129 * C57BL/6 * FVB/N)	small spleen	J:175338
Sox11^tm1.2Vlf/Sox11⁺ Sox12^tm1.1Vlf/Sox12^tm1.1Vlf Sox4^tm1.1Vlf/Sox4⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)	small spleen	J:175338
Sox11^tm1.2Vlf/Sox11^tm1.2Vlf (involves: 129 * C57BL/6)	absent spleen	J:175338
Sox11^tm1Weg/Sox11^tm1Weg (involves: 129S1/Sv * 129X1/SvJ)	absent spleen	J:92251
Sox13^tm1Jskg/Sox13⁺ (involves: C57BL/6)	decreased gamma-delta T cell number	J:117301
Sox13^tm1Jskg/Sox13^tm1Jskg (involves: C57BL/6)	decreased gamma-delta T cell number	J:117301
Sox14^{em1(IMPC)Ccpcz}/Sox14⁺ (C57BL/6N-Sox14^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Sox14^{em1(IMPC)Ccpcz}/Sox14^{em1(IMPC)Ccpcz} (C57BL/6N-Sox14^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
Sox17^tm1Sjm/Sox17^tm2Sjm Tg(Mx1-cre)1Cgn/0 (involves: 129/Sv * C3H * C57BL/6 * C57BL/Ka * CBA)	decreased leukocyte cell number	J:123050
	spleen hypoplasia	J:123050
	thymus hypoplasia	J:123050
Sox18^Ra-Op/Sox18^Ra-Op (B6D2-Sox18^Ra-Op/J)	abnormal lymphatic vessel morphology	J:143564
Sox18^tm1Koop/Sox18^tm1Koop (B6.129-Sox18^tm1Koop)	abnormal lymphatic vessel morphology	J:143564
Sox21^em1(IMPC)Mbp/Sox21^em1(IMPC)Mbp (C57BL/6NCrl-Sox21^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Sp3^tm1Sus/Sp3^tm1Sus (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:84837
	decreased CD4-positive, alpha-beta T cell number	J:84837
	small thymus	J:84837
Sp4^tm1Sus/Sp4^tm1Sus (involves: 129P2/OlaHsd * C57BL/6)	spleen hypoplasia	J:77894
Sp4^tm1Sus/Sp4^tm1Sus (involves: 129P2/OlaHsd * C57BL/6)	thymus hypoplasia	J:77894
Spag11a^em1(IMPC)Mbp/Spag11a^em1(IMPC)Mbp (C57BL/6NCrl-Spag11a^em1(IMPC)Mbp/Mmucd)	increased monocyte cell number	J:211773
Sparc^tm1Hwe/Sparc^tm1Hwe (involves: 129S/SvEv * C57BL/6J)	abnormal osteoclast morphology	J:61480
Sparc^tm1Hwe/Sparc^tm1Hwe (involves: 129S/SvEv * C57BL/6J)	decreased osteoclast cell number	J:61480
Spata2^{tm1.1(KOMP)Vlcg}/Spata2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Spata2^{tm1.1(KOMP)Vlcg}/Ucd)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Spata24^{tm1b(EUCOMM)Wtsi}/Spata24^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Spata24^{tm1b(EUCOMM)Wtsi}/BayMmucd)	decreased neutrophil cell number	J:211773
Spata31f3^{em1(IMPC)Ccpcz}/Spata31f3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Spata31f3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged thymus	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
Spdye4b^{tm3b(EUCOMM)Wtsi}/Spdye4b^{tm3b(EUCOMM)Wtsi} (C57BL/6N-Spdye4b^{tm3b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Speg^{tm1b(KOMP)Wtsi}/Speg⁺ (C57BL/6N-Speg^{tm1b(KOMP)Wtsi}/Nju)	increased basophil cell number	J:211773
Spen^tm1Hon/Spen^tm1Hon (involves: 129P2/OlaHsd * C57BL/6J)	abnormal B cell differentiation	J:82332
Spg11^em1(IMPC)J/Spg11^em1(IMPC)J (C57BL/6NJ-Spg11^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Sphk1^tm1.1Cgh/Sphk1^tm2Cgh Sphk2^tm1.1Cgh/Sphk2^tm1.1Cgh Tg(Mx1-cre)1Cgn/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal NK cell differentiation	J:154069
	abnormal T cell differentiation	J:120783
	abnormal thymus cell ratio	J:120783
	decreased B cell number	J:120783
	decreased NK cell number	J:154069
	decreased T cell number	J:120783
	increased NK cell number	J:154069
Sphk1^tm1Npa/Sphk1^tm1Npa (BALB/c-Sphk1^tm1Npa)	increased B cell number	J:129314
Sphk1^tm1Rlp/Sphk1^tm1Rlp (involves: 129S6/SvEvTac)	enlarged mesenteric lymph nodes	J:133917
Sphk2^tm1Npa/Sphk2^tm1Npa (BALB/c-Sphk2^tm1Npa)	increased B cell number	J:129314
Spi1^tm1.1Dgt/Spi1^tm1.1Dgt (involves: 129S1/Sv * 129X1/SvJ)	abnormal spleen morphology	J:90331
	decreased B cell number	J:90331
	enlarged spleen	J:90331
	increased T cell derived lymphoma incidence	J:90331
	spleen hyperplasia	J:90331
Spi1^tm1.2Nutt/Spi1^tm1.2Nutt Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal granulocyte differentiation	J:98188
	abnormal spleen morphology	J:98188
	decreased B cell number	J:98188
	increased granulocyte number	J:98188
Spi1^tm1.3Dgt/Spi1^tm1.3Dgt (involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)	abnormal double-negative T cell morphology	J:106040
	abnormal T cell subpopulation ratio	J:106040
	arrested B cell differentiation	J:106040
	decreased B-1a cell number	J:106040
	decreased granulocyte number	J:106040
	decreased mature B cell number	J:106040
	decreased pre-B cell number	J:106040
	decreased pro-B cell number	J:106040
	decreased T cell number	J:106040
	decreased thymocyte number	J:106040
	increased B-1 B cell number	J:106040
	increased B-1b cell number	J:106040
	increased lymphocyte cell number	J:106040
	increased T cell derived lymphoma incidence	J:106040
	increased T cell number	J:106040
	small thymus	J:106040
Spi1^tm1.3Dgt/Spi1^tm1.3Dgt (involves: 129 * BALB/c * C57BL/6)	abnormal spleen morphology	J:90331
	decreased B cell number	J:90331
	enlarged spleen	J:90331
	increased neutrophil cell number	J:90331
	increased spleen weight	J:90331
	increased T cell derived lymphoma incidence	J:90331
	spleen hyperplasia	J:90331
Spi1^tm1Kast/Spi1^tm1Kast (B6.129S2-Spi1^tm1Kast)	absent B cells	J:90543
Spi1^tm1Kast/Spi1^tm1Kast (B6.129S2-Spi1^tm1Kast)	failure of myelopoiesis	J:90543
Spi1^tm1Ram/Spi1^tm1Ram (involves: 129S2/SvPas)	decreased macrophage cell number	J:101493
Spi1^tm1Ram/Spi1^tm1Ram (involves: 129S2/SvPas * C57BL/6)	abnormal B cell number	J:36473
	abnormal macrophage differentiation	J:36473
	abnormal microglial cell morphology	J:116087
	abnormal neutrophil differentiation	J:36473
	abnormal T cell differentiation	J:36473
	abnormal T cell number	J:36473
	absent mature B cells	J:36473
	decreased CD4-positive, alpha-beta T cell number	J:36473
	decreased CD8-positive, alpha-beta T cell number	J:36473
	decreased double-positive T cell number	J:36473
	decreased macrophage cell number	J:36473
	decreased neutrophil cell number	J:36473
	decreased spleen red pulp amount	J:36473
	decreased thymocyte number	J:36473
Spi1^tm1Rpd/Spi1^tm1Rpd (involves: 129/Sv * C57BL/6 * Black Swiss)	abnormal myelopoiesis	J:123079
	arrested B cell differentiation	J:123079
	enlarged spleen	J:123079
	impaired myelopoiesis	J:123079
Spi1^tm1Sing/Spi1⁺ Spib^tm1Mcs/Spib⁺ (involves: 129S/SvEv * 129X1/SvJ)	abnormal spleen germinal center morphology	J:88257
Spi1^tm1Sing/Spi1⁺ Spib^tm1Mcs/Spib^tm1Mcs (involves: 129S/SvEv * 129X1/SvJ)	abnormal B cell differentiation	J:88257
	abnormal immature B cell morphology	J:88257
	absent spleen germinal center	J:88257
	decreased B cell number	J:88257
Spi1^tm1Sing/Spi1^tm1Sing (involves: 129S/SvEv)	abnormal B cell differentiation	J:20348
	abnormal granulocyte morphology	J:20348
	abnormal leukopoiesis	J:20348
	abnormal monocyte morphology	J:20348
	abnormal T cell differentiation	J:20348
Spi1^tm3Dgt/Spi1^tm3Dgt (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased B cell number	J:131217
	decreased double-negative T cell number	J:131217
	increased double-negative T cell number	J:131217
	increased granulocyte number	J:131217
Spib^tm1Ksho/Spib^tm1Ksho (involves: C57BL/6J)	abnormal Peyer's patch morphology	J:187649
Spib^tm1Mcs/Spib^tm1Mcs (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal immature B cell morphology	J:88257
Spib^tm1Mcs/Spib^tm1Mcs (involves: 129S1/Sv * 129X1/SvJ)	abnormal spleen B cell follicle morphology	J:45245
	abnormal spleen germinal center morphology	J:45245
	abnormal spleen white pulp morphology	J:45245
Spic^tm1.1Kmm/Spic^tm1.1Kmm (involves: 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:143900
	increased spleen iron level	J:143900
	increased spleen weight	J:143900
Spic^tm1Kmm/Spic^tm1Kmm (involves: 129S6/SvEvTac * C57BL/6)	abnormal macrophage morphology	J:143900
	increased spleen iron level	J:143900
	increased spleen weight	J:143900
Spin4^em1Jbn/Y (involves: C57BL/6J)	increased spleen weight	J:347154
Spin4^em2Jbn/Y (involves: C57BL/6J)	increased spleen weight	J:347154
Spink1^tm1Kymm/Spink1^tm1Kymm (involves: C57BL/6NCrlj * CBA/JNCrlj)	small spleen	J:104647
Spink2^{tm1.1(KOMP)Vlcg}/Spink2^{tm1.1(KOMP)Vlcg} (C57BL/6N-Spink2^{tm1.1(KOMP)Vlcg}/Ucd)	increased basophil cell number	J:211773
Spink5^m1Btlr/Spink5^m1Btlr (involves: C57BL/6J)	increased neutrophil cell number	J:183755
Spink6^{em1(IMPC)Ccpcz}/Spink6^{em1(IMPC)Ccpcz} (C57BL/6N-Spink6^{em1(IMPC)Ccpcz}/Ccpcz)	decreased Ly6C-positive immature NK cell number	J:211773
	decreased macrophage cell number	J:211773
	increased Ly6C-positive mature NK cell number	J:211773
	increased monocyte cell number	J:211773
Spink13^{em1(IMPC)Ccpcz}/Spink13^{em1(IMPC)Ccpcz} (C57BL/6N-Spink13^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Spink14^{tm1e(KOMP)Wtsi}/Spink14^{tm1e(KOMP)Wtsi} (C57BL/6N-Spink14^{tm1e(KOMP)Wtsi}/Wtsi)	decreased immature NK cell number	J:211773
	decreased macrophage cell number	J:211773
	decreased mature NK cell number	J:211773
	decreased NK cell number	J:211773
	increased memory-marker NK cell number	J:211773
Splq1^L6/Splq1^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq1^L6/Splq1^M16i (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq2^L6/Splq2^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq2^L6/Splq2^M16i (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq3^L6/Splq3^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq4^L6/Splq4^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq4^L6/Splq4^M16i (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq5^L6/Splq5^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq5^L6/Splq5^M16i (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq6^L6/Splq6^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq6^L6/Splq6^M16i (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq7^L6/Splq7^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq8^L6/Splq8^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq8^L6/Splq8^M16i (involves: L6 * M16i)	decreased spleen weight	J:87793
Splq9^L6/Splq9^L6 (involves: L6 * M16i)	decreased spleen weight	J:87793
Splwt1^LG/J/? (involves: LG/J * SM/J)	increased spleen weight	J:94605
Spm1^C57BL/6/? (involves: C57BL/6 * NZB)	abnormal immune system organ morphology	J:59427
Spmip2^{tm1b(EUCOMM)Hmgu}/Spmip2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Spmip2^{tm1b(EUCOMM)Hmgu}/Bay)	abnormal spleen morphology	J:211773
Spns2^tm1.1Nmoc/Spns2^tm1.1Nmoc Tg(Tek-cre)1Ywa/0 (involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL)	abnormal effector T cell morphology	J:184558
	decreased CD4-positive, alpha-beta T cell number	J:184558
	decreased CD8-positive, alpha-beta T cell number	J:184558
	decreased mature B cell number	J:184558
	increased CD4-positive, alpha-beta T cell number	J:184558
	increased CD8-positive, alpha-beta T cell number	J:184558
Spns2^tm1.2Nmoc/Spns2^tm1.2Nmoc (involves: C57BL/6NCrlj * CBA/JNCrlj)	decreased B-1 B cell number	J:184558
	decreased CD4-positive, alpha-beta T cell number	J:184558
	decreased CD8-positive, alpha-beta T cell number	J:184558
	decreased follicular B cell number	J:184558
	decreased immature B cell number	J:184558
	decreased leukocyte cell number	J:184558
	decreased mature B cell number	J:184558
	decreased transitional stage T1 B cell number	J:184558
	increased CD4-positive, alpha-beta T cell number	J:184558
	increased CD8-positive, alpha-beta T cell number	J:184558
	increased single-positive T cell number	J:184558
Spns2^{tm1a(KOMP)Wtsi}/Spns2^{tm1a(KOMP)Wtsi} (B6JTyr;B6N-Spns2^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:165965
Spns2^{tm1a(KOMP)Wtsi}/Spns2^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased B cell number	J:188933, J:213427
	decreased B-1 B cell number	J:188933
	decreased CD4-positive, alpha-beta T cell number	J:188933, J:213427
	decreased CD8-positive, alpha-beta T cell number	J:188933, J:213427
	decreased follicular B cell number	J:188933
	decreased leukocyte cell number	J:188933, J:213427
	decreased mature B cell number	J:213427
	decreased T cell number	J:213427
	increased CD4-positive, alpha-beta T cell number	J:188933
	increased CD8-positive, alpha-beta T cell number	J:188933
	increased granulocyte number	J:213427
	increased monocyte cell number	J:213427
	increased NK cell number	J:213427
	increased NK T cell number	J:213427
Spns2^{tm1b(KOMP)Wtsi}/Spns2^{tm1b(KOMP)Wtsi} (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6N)	decreased B cell number	J:188933
	decreased CD4-positive, alpha-beta T cell number	J:188933
	decreased CD8-positive, alpha-beta T cell number	J:188933
	increased CD4-positive, alpha-beta T cell number	J:188933
	increased CD8-positive, alpha-beta T cell number	J:188933
Spns2^{tm1b(KOMP)Wtsi}/Spns2^{tm1b(KOMP)Wtsi} (B6Brd;B6Dnk;B6N-Tyr^c-Brd Spns2^{tm1b(KOMP)Wtsi}/WtsiH)	decreased leukocyte cell number	J:211773
Spns2^tm1Tni/Spns2^tm1Tni (B6.Cg-Spns2^tm1Tni)	abnormal leukocyte cell number	J:225108
	abnormal mature B cell number	J:225108
	abnormal thymus morphology	J:225108
	decreased leukocyte cell number	J:225108
	decreased lymphocyte cell number	J:225108
	decreased monocyte cell number	J:225108
	decreased single-positive T cell number	J:225108
	decreased thymocyte number	J:225108
Spns3^em1(IMPC)Tcp/Spns3^em1(IMPC)Tcp (C57BL/6NCrl-Spns3^em1(IMPC)Tcp/Tcp)	increased eosinophil cell number	J:211773
Spnw1^DBA/2/Spnw1^DBA/2 Spnw4^DU6i/Spnw4^DU6i (involves: DBA/2 * DU6i)	increased spleen weight	J:101006
Spo11^{tm2b(KOMP)Wtsi}/Spo11^{tm2b(KOMP)Wtsi} (C57BL/6N-Spo11^{tm2b(KOMP)Wtsi}/Bay)	abnormal spleen morphology	J:211773
	increased spleen weight	J:211773
Spop^{tm1b(KOMP)Wtsi}/Spop⁺ (C57BL/6N-Spop^{tm1b(KOMP)Wtsi}/Tcp)	enlarged lymph nodes	J:211773
	small thymus	J:211773
Spp1^Ric-r/Spp1⁺ (C3H/Rv)	increased macrophage cell number	J:7240
Spp1^tm1.1Dhd/Spp1^tm1.1Dhd (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage morphology	J:237104
	decreased osteoclast cell number	J:237104
Spp1^tm1Blh/Spp1^tm1Blh (involves: 129S6/SvEvTac * Black Swiss)	decreased leukocyte cell number	J:86531
	decreased macrophage cell number	J:127389
	increased lymphocyte cell number	J:103050
Spp1^tm1Blh/Spp1^tm1Blh (B6.129S6-Spp1^tm1Blh)	abnormal microglial cell morphology	J:118432
Spp1^tm1Blh/Spp1^tm1Blh (involves: 129S6/SvEvTac * C57BL/6)	decreased dendritic cell number	J:119298
Spp1^tm1Rit/Spp1^tm1Rit (involves: 129S7/SvEvBrd * C57BL/6)	decreased osteoclast cell number	J:115395
Spp1^tm1Rit/Spp1^tm1Rit (involves: 129S7/SvEvBrd * C57BL/6)	increased osteoclast cell number	J:56353, J:56535
Sppl2a^chompB/Sppl2a^chompB (involves: C57BL/6)	abnormal class switch recombination	J:194595
	decreased follicular B cell number	J:194595
	decreased marginal zone B cell number	J:194595
	decreased mature B cell number	J:194595
	decreased myeloid dendritic cell number	J:194595
	decreased plasmacytoid dendritic cell number	J:194595
	decreased transitional stage T2 B cell number	J:194595
Sppl2a^m1Anu/Sppl2a^m1Anu (involves: C57BL/6JAnu)	abnormal mature B cell morphology	J:194663
	abnormal transitional stage B cell morphology	J:194663
	decreased marginal zone B cell number	J:194663
	decreased transitional stage T2 B cell number	J:194663
	decreased transitional stage T3 B cell number	J:194663
Sppl2a^m1Anu/Sppl2a^m1Anu Tg(Vav-BCL2)69Jad/? (involves: C57BL/6JAnu)	abnormal T cell number	J:194663
	decreased CD4-positive, alpha-beta T cell number	J:194663
	decreased double-negative T cell number	J:194663
	increased mature B cell number	J:194663
	increased plasmacytoid dendritic cell number	J:194663
Sppl2a^tm1Basc/Sppl2a^tm1Basc (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)	arrested B cell differentiation	J:194664
	decreased B cell number	J:194664
	decreased B-1 B cell number	J:194664
	decreased B-2 B cell number	J:194664
	decreased follicular B cell number	J:194664
	decreased marginal zone B cell number	J:194664
	decreased mature B cell number	J:194664
	decreased Peyer's patch number	J:194664
	decreased T cell number	J:194664
	decreased transitional stage T2 B cell number	J:194664
	small Peyer's patches	J:194664
	small spleen	J:194664
Sppl2a^tm1Basc/Sppl2a^tm1Basc Sppl2b^{Gt(Ayu21-T160)Imeg}/Sppl2b^{Gt(Ayu21-T160)Imeg} (B6N.Cg-Sppl2a^tm1Basc Sppl2b^{Gt(Ayu21-T160)Imeg})	abnormal mature B cell morphology	J:213519
	decreased B cell number	J:213519
Sppl2a^tm1Dgen/Sppl2a^tm1Dgen (B6.129P2-Sppl2a^tm1Dgen)	decreased B cell number	J:194595
	decreased B-1 B cell number	J:194595
	decreased follicular B cell number	J:194595
	decreased myeloid dendritic cell number	J:194595
	decreased transitional stage T2 B cell number	J:194595
Sppl3^tm1Itl/Sppl3^em1Pomz Ncr1^{tm1.1(icre)Viv}/Ncr1⁺ (involves: 129S/SvEv * C57BL/6 * C57BL/6J)	abnormal NK cell differentiation	J:280182
	decreased mature NK cell number	J:280182
	decreased NK cell number	J:280182
	increased immature NK cell number	J:280182
Sppl3^tm1Itl/Sppl3^tm1Itl Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S/SvEv * C57BL/6 * C57BL/10 * CBA/Ca)	abnormal NK cell differentiation	J:280182
	decreased mature NK cell number	J:280182
	decreased NK cell number	J:280182
	increased immature NK cell number	J:280182
Sppl3^tm1Itl/Sppl3^tm1Itl Ncr1^{tm1.1(icre)Viv}/Ncr1⁺ (involves: 129S/SvEv * C57BL/6)	abnormal NK cell differentiation	J:280182
	decreased mature NK cell number	J:280182
	decreased NK cell number	J:280182
	increased immature NK cell number	J:280182
Spr^em1(IMPC)H/Spr⁺ (C57BL/6N-Spr^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Spred1^{em1(IMPC)Ccpcz}/Spred1^{em1(IMPC)Ccpcz} (C57BL/6N-Spred1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased CD4-positive NK T cell number	J:211773
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased effector memory T-helper cell number	J:211773
	increased memory-marker CD4-positive NK T cell number	J:211773
	increased neutrophil cell number	J:211773
	increased NK T cell number	J:211773
	increased spleen weight	J:211773
Spred1^tm1.1Ayos/Spred1^tm1.1Ayos (involves: 129 * C57BL/6 * SJL)	increased mast cell number	J:186742
Spred1^tm1Hiin/Spred1^tm1Hiin (involves: C57BL/6)	increased eosinophil cell number	J:95263
Spred2^em1(IMPC)Mbp/Spred2^em1(IMPC)Mbp (C57BL/6N-Spred2^em1(IMPC)Mbp/MbpMmucd)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Spred3^em1(IMPC)Tcp/Spred3⁺ (C57BL/6NCrl-Spred3^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Sprol1^STS/A/? (involves: B10.O20/Dem * O20/A)	increased lymphocyte cell number	J:56029
Spryd4^{em1(IMPC)Ccpcz}/Spryd4^{em1(IMPC)Ccpcz} (C57BL/6N-Spryd4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Spta1^ihj/Spta1^ihj (involves: HRS/J * LAH)	abnormal spleen morphology	J:105409
Spta1^ihj/Spta1^ihj (involves: HRS/J * LAH)	enlarged spleen	J:105409
Spta1^sph-2Bc/Spta1^sph-2Bc (involves: SELH)	dark spleen	J:7048
	enlarged spleen	J:7048
	increased leukocyte cell number	J:7048
Spta1^sph-3J/Spta1^sph-3J (NOD.Cg-H2^b Spta1^sph-3J)	decreased spleen iron level	J:157766
	enlarged spleen	J:157766
	increased spleen weight	J:157766
Spta1^sph-4J/Spta1^sph-4J (C57BL/6J-Spta1^sph-4J/Llp)	enlarged spleen	J:157766
Spta1^sph-4J/Spta1^sph-4J (C57BL/6J-Spta1^sph-4J/Llp)	increased spleen weight	J:157766
Spta1^sph-Dem/Spta1^sph-Dem (CcS3/Dem-Spta1^sph-Dem)	enlarged spleen	J:66966
Spta1^sph-ha/Spta1^sph-ha (involves: DBA/1J)	enlarged spleen	J:30699, J:14946
Spta1^sph-ha/Spta1^sph-ha (either: (B6.D1-Spta1^sph-ha x WB.D1-Spta1^sph-ha)F1 or (WB.D1-Spta1^sph-ha x B6.D1-Spta1^sph-ha)F1)	abnormal lymph node cell ratio	J:1967
	abnormal spleen morphology	J:6695
	abnormal splenic cell ratio	J:1967
	enlarged spleen	J:6695
	increased B cell number	J:1967
	increased CD4-positive, alpha-beta T cell number	J:1967
	increased CD8-positive, alpha-beta T cell number	J:1967
	increased leukocyte cell number	J:12830
	increased lymphocyte cell number	J:12830, J:1967
	increased monocyte cell number	J:12830
	increased neutrophil cell number	J:12830
	increased T cell number	J:1967
	lymph node hyperplasia	J:12830, J:1967
Spta1^sph-ha/Spta1^sph-ha ((WB.D1-Spta1^sph-ha/Brk x B6.D1-Spta1^sph-ha/Brk)F1)	enlarged spleen	J:162532
Spta1^sph/Spta1^sph (either: (B6.C3-Spta1^sph x WB.C3-Spta1^sph)F1 or (WB.C3-Spta1^sph x B6.C3-Spta1^sph)F1)	abnormal spleen morphology	J:6695
	enlarged spleen	J:6695
Spta1^sph/Spta1^sph ((WB.C3-Spta1^sph x B6.C3-Spta1^sph)F1)	enlarged spleen	J:162532, J:44313
Sptb^ja/Sptb^ja (129/Sv-Sptb^ja)	enlarged spleen	J:305
Sptb^ja/Sptb^ja ((WB.129-Sptb^ja/J x B6.129-Sptb^ja/J)F1)	enlarged spleen	J:162532, J:44313
Sptb^ja/Sptb^ja ((WB.129-Sptb^ja/J x B6.129-Sptb^ja/J)F1)	increased spleen red pulp amount	J:44313
Sptb^m1Jus/Sptb^m1Jus (involves: 129S6/SvEvTac * C57BL/6)	enlarged spleen	J:159750
Sptlc2^tm1Yhir/Sptlc2^tm1Yhir Gt(ROSA)26Sor^{tm9(cre/ESR1)Arte}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6NTac)	abnormal spleen morphology	J:202954
	abnormal thymus morphology	J:202954
	decreased lymphocyte cell number	J:202954
	decreased spleen weight	J:202954
	decreased thymus weight	J:202954
	increased neutrophil cell number	J:202954
Sptlc2^tm1Yhir/Sptlc2^tm1Yhir Tg(KRT5-cre)1Tak/0 (involves: C3H * C57BL/6)	abnormal dendritic epidermal T cell morphology	J:202388
	abnormal Langerhans cell morphology	J:202388
	increased dendritic cell number	J:202388
	increased gamma-delta T cell number	J:202388
	increased T-helper 17 cell number	J:202388
Spw1^SWR/J/Spw1^SWR/J Tg(CTSG-PML/RARA)135Ley/0 (involves: C3H/HeJ * C57BL/6J * SWR/J)	decreased spleen weight	J:139159
Spw2^SWR/J/? Tg(CTSG-PML/RARA)135Ley/0 (involves: C3H/HeJ * C57BL/6J * SWR/J)	decreased spleen weight	J:139159
Spw3^SWR/J/Spw3^SWR/J Tg(CTSG-PML/RARA)135Ley/0 (involves: C3H/HeJ * C57BL/6J * SWR/J)	increased spleen weight	J:139159
Spw4^SWR/J/Spw4^SWR/J Tg(CTSG-PML/RARA)135Ley/0 (involves: C3H/HeJ * C57BL/6J * SWR/J)	decreased spleen weight	J:139159
Spw5^SWR/J/Spw5^SWR/J Tg(CTSG-PML/RARA)135Ley/0 (involves: C3H/HeJ * C57BL/6J * SWR/J)	decreased spleen weight	J:139159
	increased spleen weight	J:139159
Spz1^em1(IMPC)Mbp/Spz1^em1(IMPC)Mbp (C57BL/6N-Spz1^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Sqstm1^tm1.1Sral/Sqstm1⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:173755
	increased osteoclast cell number	J:173755
Sqstm1^tm1.1Sral/Sqstm1^tm1.1Sral (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:173755
	abnormal osteoclast morphology	J:173755
	increased osteoclast cell number	J:173755
Sqstm1^tm1Jjw/Sqstm1^tm1Jjw (involves: 129 * C57BL/6)	abnormal osteoclast differentiation	J:141179
Sqstm1^tm1Jmos/Sqstm1^tm1Jmos (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal osteoclast differentiation	J:90010
	decreased osteoclast cell number	J:90010
Sqstm1^tm1Keta/Sqstm1^tm1Keta (involves: 129 * C57BL/6N)	abnormal osteoclast differentiation	J:264183
Srd5a2^em1(IMPC)Mbp/Srd5a2^em1(IMPC)Mbp (C57BL/6N-Srd5a2^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Srf^tm1Rmn/Srf^tm1Rmn H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S6/SvEvTac * C57BL/6J * CBA/J)	athymia	J:144862
Srf^tm2Nor/Srf^tm2Nor Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd)	abnormal mature B cell morphology	J:124767
	absent marginal zone B cells	J:124767
	decreased B cell number	J:124767
	decreased B-1 B cell number	J:124767
Srf^tm2Nor/Srf^tm2Nor Tg(Cd4-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6 * DBA/2)	decreased CD4-positive, alpha-beta T cell number	J:124767
	decreased CD8-positive, alpha-beta T cell number	J:124767
	decreased T cell number	J:124767
	decreased thymocyte number	J:124767
Srfbp1^em1(IMPC)J/Srfbp1⁺ (C57BL/6NJ-Srfbp1^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Srgn^tm1Mabr/Srgn^tm1Mabr (involves: 129X1/SvJ)	abnormal mast cell morphology	J:93338
Srgn^tm1Mabr/Srgn^tm1Mabr (involves: 129X1/SvJ)	decreased mast cell number	J:93338
Srpk3^{tm1b(KOMP)Wtsi}/Y (C57BL/6N-Srpk3^{tm1b(KOMP)Wtsi}/Ucd)	increased monocyte cell number	J:211773
Srpx^tm1Hzi/Srpx^tm1Hzi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymphocyte morphology	J:119999
	enlarged spleen	J:119999
	increased T cell derived lymphoma incidence	J:119999
Srsf2^tm1.1Oaw/Srsf2⁺ Tg(Mx1-cre)1Cgn/? (B6.Cg-Tg(Mx1-cre)1Cgn Srsf2^tm1.1Oaw)	abnormal myelopoiesis	J:221404
	abnormal neutrophil morphology	J:221404
	decreased B cell number	J:221404
	failure of myelopoiesis	J:221404
Srsf2^tm1Xdfu/Srsf2⁺ Tg(Lck-cre)I57Jxm/? (involves: 129S4/SvJae * 129X1/SvJ * ICR)	decreased thymocyte number	J:88668
	decreased thymus weight	J:88668
Srsf2^tm1Xdfu/Srsf2^tm1Xdfu Tg(Lck-cre)I57Jxm/? (involves: 129S4/SvJae * 129X1/SvJ * ICR)	abnormal spleen white pulp morphology	J:88668
	abnormal T cell differentiation	J:88668
	absent thymus corticomedullary boundary	J:88668
	decreased double-positive T cell number	J:88668
	decreased T cell number	J:88668
	decreased thymocyte number	J:88668
	increased double-negative T cell number	J:88668
	small thymus	J:88668
Srsf2^tm1Xdfu/Srsf2^tm1Xdfu Tg(Mx1-cre)1Cgn/? (involves: 129S4/SvJae * C57BL/6J * CBA/J)	bone marrow failure	J:221404
Srsf3^tm1Pjln/Srsf3^tm1Pjln Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129P2/OlaHsd * BALB/c)	decreased B cell number	J:113645
	decreased pre-B cell number	J:113645
	decreased pro-B cell number	J:113645
Srsf3^tm1Pjln/Srsf3^tm1Pjln Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: BALB/c * C57BL/6 * DBA)	abnormal thymus development	J:205756
Srsf5^em1Nju/Srsf5^em1Nju (C57BL/6JGpt-Srsf5^em1Nju)	small spleen	J:311867
Ssb^tm1Rjma/Ssb^tm2.1Rjma Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: 129S/SvEv * BALB/c)	arrested B cell differentiation	J:207687
	decreased B cell number	J:207687
	decreased spleen weight	J:207687
	small spleen	J:207687
Ssbp2^tm1Lana/Ssbp2^tm1Lana (involves: 129S/SvEv * C57BL/6)	decreased lymphocyte cell number	J:162035
Ssbp2^tm1Lana/Ssbp2^tm1Lana (involves: 129S/SvEv * C57BL/6)	increased pre-B cell number	J:162035
Ssbp2^tm1Lana/Ssbp2^tm1Lana Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S/SvEv * 129S2/SvPas * BALB/c * C57BL/6)	increased T cell derived lymphoma incidence	J:162035
	thymus hypoplasia	J:162035
Ssh2^em1(IMPC)J/Ssh2^em1(IMPC)J (C57BL/6NJ-Ssh2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Sspn^{tm1b(EUCOMM)Hmgu}/Sspn^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sspn^{tm1b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Ssr2^{tm1b(EUCOMM)Wtsi}/Ssr2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ssr2^{tm1b(EUCOMM)Wtsi}/Wtsi)	abnormal thymus morphology	J:239583
Sstr2^em1(IMPC)Mbp/Sstr2^em1(IMPC)Mbp (C57BL/6N-Sstr2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Sstr4^tm1Szo/Sstr4^tm1Szo (B6.129P2-Sstr4^tm1Szo)	abnormal granulocyte morphology	J:152015
Ssu2^{em1(IMPC)Ccpcz}/Ssu2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ssu2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
St3gal2^tm1Jxm/St3gal2^tm1Jxm (Not Specified)	increased spleen germinal center size	J:217719
St3gal2^tm1Jxm/St3gal2^tm1Jxm (Not Specified)	increased T cell number	J:217719
St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ)	decreased lymphocyte cell number	J:189086
St3gal4^tm1.1Jxm/St3gal4^tm1.1Jxm St3gal6^tm1.1Jxm/St3gal6^tm1.1Jxm (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased lymphocyte cell number	J:189086
	increased leukocyte cell number	J:189086
	increased neutrophil cell number	J:189086
St6gal1^tm1Jlau/St6gal1^tm1Jlau (B6.129S4-St6gal1^tm1Jlau)	abnormal myelopoiesis	J:140547
St6gal1^tm1Jlau/St6gal1^tm1Jlau (B6.129S4-St6gal1^tm1Jlau)	increased neutrophil cell number	J:140547
St6gal1^tm1Jxm/St6gal1^tm1Jxm (involves: 129S1/Sv * 129X1/SvJ)	decreased marginal zone B cell number	J:132991
	decreased transitional stage B cell number	J:132991
	increased neutrophil cell number	J:140547
St6galnac2^tm1.1Cfg/St6galnac2^tm1.1Cfg (involves: 129S1/Sv * 129X1/SvJ)	increased pre-B cell number	J:217719
	increased spleen germinal center size	J:217719
St8sia1^tm1Kfk/St8sia1^tm1Kfk (Not Specified)	decreased CD8-positive, alpha-beta T cell number	J:73818
St8sia6^em1(IMPC)Mbp/St8sia6^em1(IMPC)Mbp (C57BL/6N-St8sia6^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
St14^tm1Bug/St14^tm1Bug (involves: 129P2/OlaHsd * Black Swiss)	decreased double-positive T cell number	J:87125
St14^tm2Bug/St14^tm3Bug Tg(MMTV-cre)4Mam/0 (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * N:Black Swiss)	decreased CD4-positive, alpha-beta T cell number	J:213072
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:213072
	decreased CD8-positive, alpha-beta T cell number	J:213072
	decreased regulatory T cell number	J:213072
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:213072
	increased effector memory CD4-positive, alpha-beta T cell number	J:213072
	increased effector memory CD8-positive, alpha-beta T cell number	J:213072
Stag1^em1(IMPC)Mbp/Stag1⁺ (C57BL/6N-Stag1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Stag2^tm1.1Soga/Y Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6J * C57BL/6N * CBA/J)	decreased B cell number	J:289000
	decreased leukocyte cell number	J:289000
	enlarged spleen	J:289000
	increased granulocyte number	J:289000
	increased monocyte cell number	J:289000
Stam^tm2Sug/Stam^tm2Sug Stam2^tm1Sug/Stam2^tm1Sug Tg(Lck-cre)I57Jxm/0 (involves: 129S4/SvJae * C57BL/6 * ICR)	decreased T cell number	J:80617
Stard7^{tm1a(EUCOMM)Wtsi}/Stard7⁺ (involves: C57BL/6N)	increased CD11b-high dendritic cell number	J:242746
Stard13^{tm1a(KOMP)Wtsi}/Stard13^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	lymphoid hyperplasia	J:213427
Stat1^m4Btlr/Stat1^m4Btlr (C57BL/6J-Stat1^m4Btlr)	abnormal CD8-positive, naive alpha-beta T cell number	J:264800
	decreased B cell number	J:264800
	decreased B-1 B cell number	J:264800
	decreased CD8-positive, alpha-beta T cell number	J:264800
	decreased NK cell number	J:264800
	decreased single-positive T cell number	J:264800
	increased CD4-positive, alpha-beta T cell number	J:264800
	increased effector memory CD8-positive, alpha-beta T cell number	J:264800
	increased NK T cell number	J:264800
Stat1^m5Btlr/Stat1^m5Btlr (C57BL/6J-Stat1^m5Btlr)	abnormal CD4-positive T cell differentiation	J:274938
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274938
	abnormal T cell differentiation	J:274938
	decreased CD8-positive, naive alpha-beta T cell number	J:274938
	increased CD4-positive, alpha-beta T cell number	J:274938
	increased effector memory CD4-positive, alpha-beta T cell number	J:274938
	increased effector memory CD8-positive, alpha-beta T cell number	J:274938
	increased T cell number	J:274938
Stat1^tm1Rds/Stat1^tm1Rds (129S6/SvEv-Stat1^tm1Rds/Tac)	abnormal osteoclast differentiation	J:131353
Stat1^tm1Rds/Stat1^tm1Rds (129S6/SvEv-Stat1^tm1Rds/Tac)	increased NK T cell number	J:122801
Stat1^tm1Rds/Stat1^tm1Rds (B6.129-Stat1^tm1Rds)	increased osteoclast cell number	J:84894
Stat1^tm1Rds/Stat1^tm1Rds Stat3^tm2Aki/Stat3^tm2Aki Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129/Sv * 129P2/OlaHsd * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:83280
Stat1^{tm2b(EUCOMM)Wtsi}/Stat1^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Stat1^{tm2b(EUCOMM)Wtsi}/Orl)	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Stat2^m1Btlr/Stat2^m1Btlr (C57BL/6J-Stat2^m1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:265265
	decreased central memory CD8 positive, alpha-beta T cell number	J:265265
	decreased single-positive T cell number	J:265265
Stat2^p117/Stat2^p117 (C57BL/6J-Stat2^P117)	decreased dendritic cell number	J:164049
Stat2^p117/Stat2^p117 (C57BL/6J-Stat2^P117)	decreased plasmacytoid dendritic cell number	J:164049
Stat2^tm1Shnd/Stat2^tm1Shnd (involves: 129S1/Sv * 129X1/SvJ)	abnormal T cell differentiation	J:66564
Stat3^tm1Dlv/Stat3^tm1Dlv Tg(Cd4-cre)1Cwi/? (involves: 129 * C57BL/6 * DBA/2)	abnormal CD4-positive T cell differentiation	J:124293
	abnormal gut-associated lymphoid tissue morphology	J:124293
Stat3^tm1Dlv/Stat3^tm1Dlv Tg(Csf1r-icre)1Jwp/0 (involves: 129P2/OlaHsd * C57BL/6 * FVB)	increased granulocyte number	J:156593
	increased macrophage cell number	J:156593
	increased T cell number	J:156593
Stat3^tm1Dlv/Stat3^tm1Dlv Tg(MMTV-cre)4Mam/0 (involves: 129P2/OlaHsd * C57BL/6J * FVB)	decreased T-helper 17 cell number	J:120176
Stat3^tm1Dnl/Stat3^tm1Dlv (involves: C57BL/6)	decreased thymocyte number	J:87599
Stat3^tm1Flv/Stat3^tm1Flv Tg(Tek-cre)12Flv/0 (involves: 129 * C3H * C57BL/6)	increased leukocyte cell number	J:81973
Stat3^tm1Xyfu/Stat3^tm1.1Xyfu Tg(Ttr-cre)10-3Xyfu/? (involves: 129S1/Sv * C57BL/6)	increased monocyte cell number	J:128719
	increased neutrophil cell number	J:128719
Stat3^tm2Aki/Stat3^tm2Aki Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:83280
	increased dendritic cell number	J:83280
	increased macrophage cell number	J:83280
Stat4^tm1Gru/Stat4^tm1Gru (C.129S2-Stat4^tm1Gru)	abnormal CD4-positive T cell differentiation	J:143729
Stat5a^tm1.1Wjl/Stat5a^tm1.1Wjl Stat5b^tm2.1Wjl/Stat5b^tm2.1Wjl (involves: 129S6/SvEvTac * C57BL/6J * FVB/N)	abnormal leukocyte morphology	J:187325
	abnormal T cell subpopulation ratio	J:187325
	decreased CD8-positive, alpha-beta T cell number	J:187325
	decreased NK cell number	J:187325
Stat5a^tm1Jni/Stat5a^tm1Jni Stat5b^tm2Jni/Stat5b^tm2Jni (either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ))	abnormal myelopoiesis	J:77412
	decreased leukocyte cell number	J:77412
	decreased T cell number	J:77412
	increased neutrophil cell number	J:77412
Stat5a^tm1Jni/Stat5a^tm1Jni Stat5b^tm2Jni/Stat5b^tm2Jni (involves: 129 * C57BL/6)	abnormal mast cell differentiation	J:84889
	absent mast cells	J:84889
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:122463
Stat5a^tm1Mam/Stat5a^tm1Mam (C.129S6-Stat5a^tm1Mam)	abnormal mast cell differentiation	J:101855
	abnormal mast cell morphology	J:101855
	decreased mast cell number	J:101855
Stat5a^tm1Mam/Stat5a^tm1Mam (involves: 129S6/SvEvTac * C57BL/6)	decreased NK cell number	J:112035
	decreased splenocyte number	J:112035
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b⁺ (involves: 129S6/SvEvTac)	abnormal lymphopoiesis	J:258967
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Lck-cre)I57Jxm/0 (involves: 129 * 129S6/SvEvTac * C57BL/6 * ICR)	abnormal T cell subpopulation ratio	J:122463
	decreased CD8-positive, alpha-beta T cell number	J:122463
	enlarged spleen	J:122463
Stat5a^tm2Mam/Stat5a^tm2Mam Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal leukopoiesis	J:155489
	abnormal neutrophil differentiation	J:155489
	decreased leukocyte cell number	J:155489
	decreased lymphocyte cell number	J:155489
	decreased monocyte cell number	J:155489
	decreased neutrophil cell number	J:155489
Stat5b^tm1Hwd/Stat5b^tm1Hwd (involves: C57BL/6)	abnormal double-negative T cell morphology	J:112035
	abnormal lymphocyte cell number	J:112035
	abnormal lymphocyte morphology	J:112035
	decreased CD8-positive, alpha-beta T cell number	J:112035
	decreased NK cell number	J:112035
	decreased splenocyte number	J:112035
	decreased thymocyte number	J:112035
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Lck-cre)I57Jxm/0 (involves: 129 * 129S6/SvEvTac * C57BL/6 * ICR)	abnormal T cell subpopulation ratio	J:122463
	decreased CD8-positive, alpha-beta T cell number	J:122463
	enlarged spleen	J:122463
Stat5b^tm1Mam/Stat5b^tm1Mam Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	abnormal leukopoiesis	J:155489
	abnormal neutrophil differentiation	J:155489
	decreased leukocyte cell number	J:155489
	decreased lymphocyte cell number	J:155489
	decreased monocyte cell number	J:155489
	decreased neutrophil cell number	J:155489
Stat6^tm1Aki/Stat6^tm1Aki (involves: 129P2/OlaHsd)	decreased T-helper 2 cell number	J:172134
Stat6^tm1Gru/Stat6^tm1Gru (C.129S2-Stat6^tm1Gru/J)	abnormal CD4-positive T cell differentiation	J:204829
Stat6^tm1Gru/Stat6^tm1Gru (C.129S2-Stat6^tm1Gru/J)	abnormal CD8-positive, alpha beta T cell morphology	J:125259
Stat6^tm1Gru/Stat6^tm1Gru (129S2/SvPas-Stat6^tm1Gru)	abnormal T-helper 2 cell differentiation	J:31932
Stat6^tm1Jni/Stat6^tm1Jni (involves: 129S/SvEv)	abnormal class switch recombination	J:32607
	abnormal T-helper 1 cell differentiation	J:32607
	abnormal T-helper 2 cell differentiation	J:32607
Stat6^tm1Jni/Stat6^tm1Jni (involves: 129S/SvEv * C57BL/6)	abnormal mast cell morphology	J:110429
Stat6^tm1Jni/Stat6^tm1Jni (involves: 129S/SvEv * C57BL/6)	abnormal T-helper 1 cell differentiation	J:51096
Stau2^em1(IMPC)Mbp/Stau2^em1(IMPC)Mbp (C57BL/6N-Stau2^em1(IMPC)Mbp/MbpMmucd)	increased monocyte cell number	J:211773
Steap3^fred/Steap3^fred (C57BL/6-Steap3^fred)	enlarged spleen	J:145194
Steap3^tm1.1Atel/Steap3^tm1.1Atel (involves: C57BL/6)	abnormal spleen morphology	J:154356
	abnormal spleen red pulp morphology	J:154356
	increased spleen weight	J:154356
	increased spleen white pulp amount	J:154356
Steap4^tm1Dgen/Steap4^tm1Dgen (involves: 129P2/OlaHsd)	increased macrophage cell number	J:187736
Stim1^em1(IMPC)Mbp/Stim1⁺ (C57BL/6N-Stim1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Stim1^Sax/Stim1⁺ (involves: C3HeB/FeJ * C57BL/6)	abnormal thrombopoiesis	J:127381
	enlarged spleen	J:127381
	increased spleen red pulp amount	J:127381
Stim1^tm1.1Pg/Stim1⁺ (involves: C57BL/6)	decreased Ly6C low monocyte number	J:285187
	decreased NK cell number	J:285187
	enlarged spleen	J:285187
	increased Ly6C high monocyte number	J:285187
Stim1^tm1Kuro/Stim1^tm1Kuro Stim2^tm1.1Kuro/Stim2^tm1.1Kuro Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:172608
	increased CD8-positive, alpha-beta T cell number	J:172608
	increased regulatory T cell number	J:172608
Stim1^tm1Rao/Stim1^tm1Rao Stim2^tm1Rao/Stim2^tm1Rao Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	abnormal B cell differentiation	J:133262
	abnormal granulocyte morphology	J:133262
	abnormal immune system morphology	J:133262
	abnormal lymph organ size	J:133262
	abnormal T cell differentiation	J:133262
	decreased regulatory T cell number	J:133262
	enlarged lymph nodes	J:133262
	enlarged spleen	J:133262
	increased germinal center B cell number	J:133262
	increased lymphocyte cell number	J:133262
	increased spleen germinal center number	J:133262
Stim1^tm1Rao/Stim1^tm1Rao Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2 * SJL)	increased lymphocyte cell number	J:133262
Stim1^tm3Ics/Stim1⁺ (involves: C57BL/6N)	decreased lymphocyte cell number	J:277842
	decreased NK T cell number	J:277842
	decreased regulatory T cell number	J:277842
	increased monocyte cell number	J:277842
	increased neutrophil cell number	J:277842
	increased spleen weight	J:277842
Sting1^em1Jmin/Sting1⁺ (involves: C57BL/6N)	abnormal spleen morphology	J:251372
	decreased single-positive T cell number	J:251372
	enlarged spleen	J:251372
Stk3^tm1.1Yy/Stk3^tm1Yy Stk4^tm1.1Yy/Stk4^tm1.1Yy Tg(CAG-cre/Esr1)5Amc/0 (involves: C57BL/6 CBA)	enlarged spleen	J:156541
Stk4^{Gt(AJ0315)Wtsi}/Stk4^{Gt(AJ0315)Wtsi} (B6.129P2-Stk4^{Gt(AJ0315)Wtsi})	abnormal memory T cell number	J:142674
	abnormal T cell differentiation	J:142674
	decreased CD4-positive, alpha-beta T cell number	J:142674
	decreased CD8-positive, alpha-beta T cell number	J:142674
	decreased spleen white pulp amount	J:142674
Stk4^m1Btlr/Stk4^m1Btlr (C57BL/6J-Stk4^m1Btlr)	decreased B cell number	J:265233
	decreased CD4-positive, alpha-beta T cell number	J:265233
	decreased CD8-positive, alpha-beta T cell number	J:265233
	decreased single-positive T cell number	J:265233
	decreased T cell number	J:265233
	increased macrophage cell number	J:265233
	increased neutrophil cell number	J:265233
	increased NK cell number	J:265233
Stk4^m2Btlr/Stk4^m2Btlr (C57BL/6J-Stk4^m2Btlr)	decreased B-1 B cell number	J:265237
	decreased B-2 B cell number	J:265237
	decreased CD4-positive, alpha-beta T cell number	J:265237
	decreased CD8-positive, alpha-beta T cell number	J:265237
	decreased CD8-positive, naive alpha-beta T cell number	J:265237
	decreased single-positive T cell number	J:265237
	decreased T cell number	J:265237
	increased B-1b cell number	J:265237
	increased central memory CD4-positive, alpha-beta T cell number	J:265237
	increased central memory CD8 positive, alpha-beta T cell number	J:265237
	increased dendritic cell number	J:265237
	increased effector memory CD4-positive, alpha-beta T cell number	J:265237
	increased effector memory CD8-positive, alpha-beta T cell number	J:265237
	increased macrophage cell number	J:265237
	increased neutrophil cell number	J:265237
	increased NK cell number	J:265237
Stk4^m3Btlr/Stk4^m3Btlr (C57BL/6J-Stk4^m3Btlr)	decreased CD4-positive, alpha-beta T cell number	J:265245
	decreased CD8-positive, alpha-beta T cell number	J:265245
	decreased single-positive T cell number	J:265245
	decreased T cell number	J:265245
Stk4^m4Btlr/Stk4^m4Btlr (C57BL/6J-Stk4^m4Btlr)	decreased CD11b-high dendritic cell number	J:272536
	increased B-1b cell number	J:272536
	increased dendritic cell number	J:272536
Stk4^m5Btlr/Stk4^m5Btlr (C57BL/6J-Stk4^m5Btlr)	abnormal CD4-positive T cell differentiation	J:272743
	abnormal T cell differentiation	J:272743
	decreased CD4-positive, alpha-beta T cell number	J:272743
	increased central memory CD4-positive, alpha-beta T cell number	J:272743
Stk4^tm1.1Kina/Stk4^tm1.1Kina (involves: C57BL/6)	abnormal immune system organ morphology	J:148791
	abnormal marginal zone B cell morphology	J:148791
	abnormal Peyer's patch germinal center morphology	J:148791
	abnormal Peyer's patch T cell area morphology	J:148791
	abnormal spleen B cell follicle morphology	J:148791
	decreased B cell number	J:148791
	decreased lymphocyte cell number	J:148791
	decreased marginal zone B cell number	J:148791
	decreased myeloid dendritic cell number	J:148791
	decreased spleen B cell follicle size	J:148791
	decreased T cell number	J:148791
	increased single-positive T cell number	J:148791
	thymus hyperplasia	J:148791
Stk4^tm1.1Wtao/Stk4^tm1.2Wtao Tg(Lck-cre)#Zhu/0 (involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * SJL/J)	decreased CD4-positive, alpha-beta T cell number	J:152323
	decreased CD8-positive, alpha-beta T cell number	J:152323
	decreased T cell number	J:152323
	increased single-positive T cell number	J:152323
	increased thymocyte number	J:152323
Stk4^tm1.2Wtao/Stk4^tm1.2Wtao (involves: 129S4/SvJaeSor * 129S6/SvEvTac)	decreased B cell number	J:152323
	decreased CD4-positive, alpha-beta T cell number	J:152323
	decreased CD8-positive, alpha-beta T cell number	J:152323
	decreased lymphocyte cell number	J:152323
	increased single-positive T cell number	J:152323
	increased thymocyte number	J:152323
Stk4^tm1Dlim/Stk4^tm1Dlim (Not Specified)	decreased T cell number	J:155001
Stk11^tm1.1Mlfr/Stk11⁺ (involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J)	enlarged spleen	J:104347
Stk11^tm1.1Sjm/Stk11^tm1.1Sjm Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA * SJL)	decreased leukocyte cell number	J:165090
	thymus hypoplasia	J:165090
Stk17b^tm1Hed/Stk17b^tm1Hed (B6.129X1-Stk17b^tm1Hed)	decreased double-positive T cell number	J:94685
	increased CD4-positive, alpha-beta T cell number	J:94685
	increased memory T cell number	J:94685
Stk24^{Gt(AM0826)Wtsi}/Stk24^{Gt(AM0826)Wtsi} (B6.129P2-Stk24^{Gt(AM0826)Wtsi})	abnormal neutrophil morphology	J:256076
Stk26^{tm1b(EUCOMM)Hmgu}/Y (C57BL/6N-Stk26^{tm1b(EUCOMM)Hmgu}/Ccpcz)	increased NK T cell number	J:211773
Stk26^{tm1b(EUCOMM)Hmgu}/Stk26^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Stk26^{tm1b(EUCOMM)Hmgu}/Ccpcz)	decreased monocyte cell number	J:211773
Stk36^tm1Fjs/Stk36^tm1Fjs (involves: 129S1/Sv * C57BL/6)	spleen atrophy	J:116391
Stk36^tm1Fjs/Stk36^tm1Fjs (involves: 129S1/Sv * C57BL/6)	thymus atrophy	J:116391
Stk38^{tm1b(KOMP)Wtsi}/Stk38⁺ (C57BL/6N-Stk38^{tm1b(KOMP)Wtsi}/J)	increased leukocyte cell number	J:211773
Stk38^tm1Hem/Stk38⁺ (involves: 129P2/Ola * C57BL/6)	increased T cell derived lymphoma incidence	J:185408
Stk38^tm1Hem/Stk38^tm1Hem (involves: 129P2/Ola * C57BL/6)	increased T cell derived lymphoma incidence	J:185408
Stoml1^em1(IMPC)Tcp/Stoml1^em1(IMPC)Tcp (C57BL/6N-Stoml1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Stra6l^{tm1b(KOMP)Wtsi}/Stra6l^{tm1b(KOMP)Wtsi} (C57BL/6N-Stra6l^{tm1b(KOMP)Wtsi}/Ucd)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased neutrophil cell number	J:211773
Stub1^tm1Cpat/Stub1^tm1Cpat (involves: 129S/SvEv * C57BL/6)	thymus atrophy	J:86213
Stub1^tm1Cpat/Stub1^tm1Cpat (involves: 129S/SvEv * C57BL/6)	thymus hypoplasia	J:86213
Stx7^{em1(IMPC)Rbrc}/Stx7^{em1(IMPC)Rbrc} (C57BL/6NJcl-Stx7^{em1(IMPC)Rbrc}/Rbrc)	abnormal thymus morphology	J:211773
	decreased large unstained cell number	J:211773
	small thymus	J:211773
Stx11^em1(IMPC)Mbp/Stx11^em1(IMPC)Mbp (C57BL/6N-Stx11^em1(IMPC)Mbp/MbpMmucd)	increased lymphocyte cell number	J:211773
Stx11^tm1.2Ics/Stx11^tm1.2Ics (involves: C57BL/6NTac)	decreased leukocyte cell number	J:193137
Stx11^tm1.2Ics/Stx11^tm1.2Ics (involves: C57BL/6NTac)	decreased neutrophil cell number	J:193137
sty/sty (Not Specified)	small thymus	J:3675
Styxl2^em1(IMPC)Mbp/Styxl2^em1(IMPC)Mbp (C57BL/6N-Styxl2^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
Suco^{Gt(KST050)Byg}/Suco^{Gt(KST050)Byg} (involves: 129P2/OlaHsd * C57BL/6 * CD-1)	decreased osteoclast cell number	J:159823
Sufu^{tm1b(KOMP)Wtsi}/Sufu⁺ (C57BL/6N-Sufu^{tm1b(KOMP)Wtsi}/Ucd)	enlarged lymph nodes	J:211773
Sugct^tm1.2Kald/Sugct^tm1.2Kald (B6.Cg-Sugct^tm1.2Kald)	increased macrophage cell number	J:293423
Sugp1^em1(IMPC)Mbp/Sugp1⁺ (C57BL/6NCrl-Sugp1^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Sult1a1^{em1(IMPC)Ccpcz}/Sult1a1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Sult1a1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Sumf1^{Gt(RST760)Byg}/Sumf1^{Gt(RST760)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal macrophage morphology	J:120146
	abnormal microglial cell morphology	J:120146
	increased macrophage cell number	J:120146
Sun1^{tm1b(EUCOMM)Wtsi}/Sun1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Sun1^{tm1b(EUCOMM)Wtsi}/Orl)	decreased lymphocyte cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Sun2^{tm1b(EUCOMM)Hmgu}/Sun2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Sun2^{tm1b(EUCOMM)Hmgu}/Bay)	increased large unstained cell number	J:211773
Sun5^em1(IMPC)Mbp/Sun5^em1(IMPC)Mbp (C57BL/6N-Sun5^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Supv3l1^tm2.1Jkl/Supv3l1^tm2.2Jkl Tg(CAG-cre/Esr1)5Amc/0 (involves: 129P2/OlaHsd 129S4/SvJaeSor * C57BL/6 * FVB/N)	abnormal T cell differentiation	J:144991
	decreased CD4-positive, alpha-beta T cell number	J:144991
	decreased CD8-positive, alpha-beta T cell number	J:144991
	decreased double-negative T cell number	J:144991
	decreased double-positive T cell number	J:144991
	increased macrophage derived foam cell number	J:144991
	thymus atrophy	J:144991
	thymus hypoplasia	J:144991
Supv3l1^tm2Jkl/Supv3l1^tm2Jkl Tg(CAG-cre/Esr1)5Amc/0 (involves: 129P2/OlaHsd C57BL/6)	abnormal T cell differentiation	J:144991
	decreased CD4-positive, alpha-beta T cell number	J:144991
	decreased CD8-positive, alpha-beta T cell number	J:144991
	decreased double-negative T cell number	J:144991
	decreased double-positive T cell number	J:144991
	increased macrophage derived foam cell number	J:144991
	thymus atrophy	J:144991
	thymus hypoplasia	J:144991
Supv3l1^tm2Jkl/Supv3l1^tm2Jkl Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	increased macrophage derived foam cell number	J:144991
	increased plasma cell number	J:144991
Susd4^tm1Lex/Susd4^tm1Lex (B6.129S5-Susd4^tm1Lex)	abnormal microglial cell morphology	J:306852
Susd6^{tm1b(KOMP)Wtsi}/Susd6^{tm1b(KOMP)Wtsi} (C57BL/6N-Susd6^{tm1b(KOMP)Wtsi}/Bay)	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	enlarged spleen	J:211773
	increased lymphocyte cell number	J:211773
Suz12^Plt8/Suz12⁺ (involves: 129 * C57BL/6)	increased leukocyte cell number	J:136262
Suz12^Plt8/Suz12⁺ (involves: 129 * C57BL/6)	increased lymphocyte cell number	J:136262
Svep1^{tm1a(EUCOMM)Hmgu}/Svep1^{tm1a(EUCOMM)Hmgu} (involves: C57BL/6N)	abnormal lymphangiogenesis	J:244466
	abnormal lymphatic vessel morphology	J:244466
Swap70^tm1Jess/Swap70^tm1Jess (involves: 129T2/SvEms * 129X1/SvJ)	abnormal class switch recombination	J:71160
Swq6^C57BL/6J/Swq6^CAST/EiJ (involves: C57BL/6J * CAST/EiJ)	increased spleen weight	J:117545
Swq6^CAST/EiJ/Swq6^CAST/EiJ (involves: C57BL/6J * CAST/EiJ)	increased spleen weight	J:117545
Swqnd1^NMRI8/Fbn/? (involves: DBA/2OlaHsd * NMRI8/Fbn)	decreased spleen weight	J:122125
Swqnd2^NMRI8/Fbn/? (involves: DBA/2OlaHsd * NMRI8/Fbn)	decreased spleen weight	J:122125
Swsap1^em1(IMPC)Mbp/Swsap1^em1(IMPC)Mbp (C57BL/6NCrl-Swsap1^em1(IMPC)Mbp/MbpMmucd)	increased monocyte cell number	J:211773
Swt1^em1(IMPC)J/Swt1^em1(IMPC)J (C57BL/6NJ-Swt1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Syk^m1Btlr/Syk^m1Btlr (involves: C57BL/6J)	decreased B cell number	J:199281
Syk^m1Btlr/Syk^m1Btlr (involves: C57BL/6J)	increased neutrophil cell number	J:199281
Syk^M2Btlr/Syk⁺ (C57BL/6J-Syk^M2Btlr)	abnormal NK cell differentiation	J:231803
Syk^M2Btlr/Syk^M2Btlr (C57BL/6J-Syk^M2Btlr)	abnormal NK cell differentiation	J:231803
Syk^{tm1.1(cre)Fkfr}/Syk^{tm1.1(cre)Fkfr} Gt(ROSA)26Sor^tm1(EYFP)Cos/Gt(ROSA)26Sor^tm1(EYFP)Cos (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphangiogenesis	J:159112
	decreased leukocyte cell number	J:159112
	increased leukocyte cell number	J:159112
Syk^tm1.1Nns/Syk^tm1.1Nns Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/10 * CBA/Ca)	abnormal lymphatic vessel morphology	J:181715
Syk^tm1.1Nns/Syk^tm1.1Nns Tg(Pf4-icre)Q3Rsko/0 (involves: C57BL/6)	abnormal lymphatic vessel endothelial cell morphology	J:181715
	abnormal lymphatic vessel morphology	J:181715
Syk^tm1.1Nns/Syk^tm1.1Nns Tg(Tie1-cre)9Ref/0 Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * CBA/Ca)	abnormal lymphatic vessel morphology	J:181715
Syk^tm1.1Tara/Syk^tm1.1Tara (involves: 129P2/OlaHsd * C57BL/6)	arrested B cell differentiation	J:115080
Syk^tm1.2Tara/Syk^tm1.2Tara Tg(Cr2-cre)3Cgn/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:208904
Syk^tm1Kuro/Syk^tm1Kuro Zap70^tm1Dlo/Zap70^tm1Dlo Cd79a^tm1(cre)Reth/? (involves: 129P2/OlaHsd * BALB/c * C57BL/6)	abnormal pro-B cell differentiation	J:134528
Syk^tm1Paw/Syk^tm1Paw (involves: 129S1/Sv * 129X1/SvJ)	abnormal B cell differentiation	J:29797
	abnormal lymphangiogenesis	J:159112
	abnormal lymphatic vessel endothelium morphology	J:159112
	abnormal lymphatic vessel morphology	J:159112
	absent pre-B cells	J:29797
	decreased late pro-B cell number	J:29797
	enlarged lymphatic vessel	J:159112
	lymphatic vessel hyperplasia	J:159112
Syk^tm1Tyb/Syk^tm1Tyb (involves: 129S2/SvPas * C57BL/6 * DBA/2)	abnormal T cell number	J:29796
	arrested B cell differentiation	J:29796
Syk^tm1Tyb/Syk^tm1Tyb (involves: 129S2/SvPas * C57BL/6)	abnormal osteoclast differentiation	J:89583
Syk^tm1Tyb/Syk^tm1Tyb (involves: 129S2/SvPas * C57BL/6J)	abnormal lymphatic vessel morphology	J:181715
Syk^tm1Tyb/Syk^tm1Tyb (involves: 129S2/SvPas * C57BL/6J)	decreased lymphatic vessel endothelial cell number	J:181715
Syk^{tm2.1(ZAP70)Fkfr}/Syk^{tm2.1(ZAP70)Fkfr} (B6.129-Syk^{tm2.1(ZAP70)Fkfr})	arrested B cell differentiation	J:188422
	decreased B cell number	J:188422
	decreased DN1 thymic pro-T cell number	J:188422
	decreased marginal zone B cell number	J:188422
	decreased mature B cell number	J:188422
	decreased transitional stage B cell number	J:188422
	decreased transitional stage T1 B cell number	J:188422
	decreased transitional stage T2 B cell number	J:188422
	increased CD4-positive, alpha-beta memory T cell number	J:188422
	increased CD4-positive, alpha-beta T cell number	J:188422
	increased CD8-positive, alpha-beta memory T cell number	J:188422
	increased CD8-positive, alpha-beta T cell number	J:188422
	increased DN3 thymocyte number	J:188422
Syngr1^{em1(IMPC)Ccpcz}/Syngr1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Syngr1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Syngr3^em1Pave/Syngr3⁺ Tg(Prnp-MAPTP301S)PS19Vle/0 (involves: C3H C57BL/6)	microgliosis	J:303506
Synj1^{tm1b(EUCOMM)Wtsi}/Synj1⁺ (C57BL/6N-Synj1^{tm1b(EUCOMM)Wtsi}/H)	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased lymphocyte cell number	J:211773
Synpo2^{tm1b(EUCOMM)Wtsi}/Synpo2⁺ (C57BL/6N-Synpo2^{tm1b(EUCOMM)Wtsi}/Ics)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Sytl1^{tm1a(KOMP)Wtsi}/Sytl1^{tm1a(KOMP)Wtsi} (involves: C57BL/6 * C57BL/6N)	decreased CD4-positive, alpha-beta T cell number	J:213427
	decreased mature B cell number	J:213427
	decreased T cell number	J:213427
	increased regulatory T cell number	J:213427
t^AE5/t^AE5 (Not Specified)	abnormal spleen morphology	J:83862
	abnormal thymus cortex morphology	J:83862
	abnormal thymus morphology	J:83862
	decreased spleen white pulp amount	J:83862
	increased mast cell number	J:83862
	thymus cortex hypoplasia	J:83862
Tab2^tm2.1Aki/Tab2^tm2.1Aki Tab3^tm1Aki/Tab3^tm1Aki Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased B-1a cell number	J:195289
	decreased mature B cell number	J:195289
	decreased plasma cell number	J:195289
Tac4^tm1Albe/Tac4^tm1Albe (B6.129P2-Tac4^tm1Albe)	increased pro-B cell number	J:166471
Tacc3^tm1Jni/Tacc3^tm1Jni (involves: 129P2/OlaHsd * C57BL/6)	decreased thymocyte number	J:74762
	small thymus	J:74762
Taf7^tm1.1Dss/Taf7^tm1.2Dss Tg(Cd8a*-cre)B8Asin/0 (involves: C57BL/6)	abnormal T cell differentiation	J:185745
	decreased CD4-positive, alpha-beta T cell number	J:185745
	decreased CD8-positive, alpha-beta T cell number	J:185745
	decreased double-positive T cell number	J:185745
	decreased single-positive T cell number	J:185745
	decreased T cell number	J:185745
	decreased thymocyte number	J:185745
Taf7^tm1.1Dss/Taf7^tm1.2Dss Tg(Lck-cre)1Cwi/0 (involves: C57BL/6)	abnormal T cell differentiation	J:185745
	decreased CD4-positive, alpha-beta T cell number	J:185745
	decreased CD8-positive, alpha-beta T cell number	J:185745
	decreased double-positive T cell number	J:185745
	decreased thymocyte number	J:185745
	increased double-negative T cell number	J:185745
	small thymus	J:185745
Taf15^em1(IMPC)Mbp/Taf15^em1(IMPC)Mbp (C57BL/6NCrl-Taf15^em1(IMPC)Mbp/MbpMmucd)	increased lymphocyte cell number	J:211773
Tagap1^em1(IMPC)Tcp/Tagap1⁺ (C57BL/6N-Tagap1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Tagln2^em1(IMPC)Tcp/Tagln2^em1(IMPC)Tcp (C57BL/6N-Tagln2^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	enlarged spleen	J:211773
	increased neutrophil cell number	J:211773
Tal1^Hpt/Tal1⁺ (HPT/Le)	decreased leukocyte cell number	J:1780
Tal1^tm1Por/Tal1^tm1Por (involves: 129P2/OlaHsd)	increased spleen weight	J:139179
Tal1^tm3Wehi/Tal1^tm2Wehi Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal splenic cell ratio	J:81826
Tank^tm1Aki/Tank^tm1Aki (involves: 129/Sv * C57BL/6)	increased mature B cell number	J:151757
	increased plasma cell number	J:151757
	lymph node hyperplasia	J:151757
	spleen hyperplasia	J:151757
Tap1^m1Btlr/Tap1^m1Btlr (C57BL/6J-Tap1^m1Btlr)	decreased CD8-positive, alpha-beta memory T cell number	J:254888
Tap1^m1Btlr/Tap1^m1Btlr (C57BL/6J-Tap1^m1Btlr)	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254888
Tap1^m2Btlr/Tap1^m2Btlr (C57BL/6J-Tap1^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:236697
Tap1^rose/Tap1^rose (C57BL/6JAnu-Tap1^rose/AnuApb)	decreased CD8-positive, alpha-beta T cell number	J:166104
Tap1^tm1Arp/Tap1^tm1Arp (involves: 129S2/SvPas * C57BL/6)	absent CD8-positive, alpha-beta T cells	J:3524
Tap1^tm1Arp/Tap1^tm1Arp (involves: 129S2/SvPas * C57BL/6)	decreased double-negative T cell number	J:3524
Tap1^tm1Arp/Tap1^tm1Arp (involves: 129S2/SvPas)	decreased CD8-positive, alpha-beta T cell number	J:64177, J:64349
Tap1^tm1Arp/Tap1^tm1Arp (B6.129S2-Tap1^tm1Arp/J)	decreased CD8-positive, alpha-beta T cell number	J:123934
Tap1^tm1Arp/Tap1^tm1Arp (B6.129S2-Tap1^tm1Arp/J)	increased T-helper 1 cell number	J:123934
Tap2^jas/Tap2^jas (C57BL/6JSfdAnu-Tap2^jas/AnuApb)	absent CD8-positive, alpha-beta T cells	J:104190
Tap2^jas/Tap2^jas (C57BL/6JSfdAnu-Tap2^jas/AnuApb)	decreased CD8-positive, alpha-beta T cell number	J:166104
Tap2^m1Btlr/Tap2^m1Btlr (C57BL/6J-Tap2^m1Btlr)	absent CD8-positive, alpha-beta T cells	J:159355
Tap2^m2Btlr/Tap2^m2Btlr (C57BL/6J-Tap2^m2Btlr)	decreased CD8-positive, alpha-beta T cell number	J:217145
Tap2^m2Btlr/Tap2^m2Btlr (C57BL/6J-Tap2^m2Btlr)	increased CD4-positive, alpha-beta T cell number	J:217145
Tap2^m3Btlr/Tap2^m3Btlr (C57BL/6J-Tap2^m3Btlr)	decreased CD8-positive, alpha-beta T cell number	J:254929
	decreased CD8-positive, naive alpha-beta T cell number	J:254929
	decreased effector memory CD4-positive, alpha-beta T cell number	J:254929
	decreased NK T cell number	J:254929
	increased CD4-positive, alpha-beta T cell number	J:254929
	increased central memory CD8 positive, alpha-beta T cell number	J:254929
Tap2^M4Btlr/Tap2^M4Btlr (C57BL/6J-Tap2^M4Btlr)	increased CD4-positive, alpha-beta T cell number	J:272847
Tapbp^tm1Gjh/Tapbp^tm1Gjh (involves: 129S2/SvPas)	decreased T cell number	J:64349
Tapbp^tm1Luc/Tapbp^tm1Luc (involves: 129S6/SvEvTac)	decreased CD8-positive, alpha-beta T cell number	J:64177
Tapbp^tm1Luc/Tapbp^tm1Luc Tg(TcraTcrb)1100Mjb/? (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:64177
	abnormal CD8-positive, alpha beta T cell morphology	J:64177
	abnormal negative T cell selection	J:64177
	abnormal positive T cell selection	J:64177
Tardbp^tm1.1Neas/Tardbp^tm1.1Neas (B6(C3)-Tardbp^tm1.1Neas)	microgliosis	J:283769
Tardbp^tm2.1Neas/Tardbp^tm2.1Neas (B6(C3)-Tardbp^tm2.1Neas)	microgliosis	J:283769
Tarm1^tm1Yiw/Tarm1^tm1Yiw (involves: C57BL/6 * C57BL/6NSlc)	abnormal dendritic cell differentiation	J:301164
	decreased B cell number	J:301164
	decreased CD4-positive, alpha-beta T cell number	J:301164
	decreased dendritic cell number	J:301164
Tars3^em1(IMPC)J/Tars3^em1(IMPC)J (C57BL/6NJ-Tars3^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Tas2r131^em1(IMPC)Bay/Tas2r131^em1(IMPC)Bay (C57BL/6N-Tas2r131^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Tas2r139^em1(IMPC)Mbp/Tas2r139^em1(IMPC)Mbp (C57BL/6NCrl-Tas2r139^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Tasp1^tm1Jjdh/Tasp1^tm1Jjdh Tg(Mx1-cre)1Cgn/? (involves: 129X1/SvJ * C57BL/6 * CBA)	decreased double-positive T cell number	J:112159
	decreased thymocyte number	J:112159
	decreased thymus weight	J:112159
Tbata^tm1Faf/Tbata^tm1Faf (involves: 129P2/OlaHsd * C57BL/6)	abnormal thymus epithelium morphology	J:166065
	enlarged thymus	J:166065
	increased double-negative T cell number	J:166065
	increased thymocyte number	J:166065
	thymus hyperplasia	J:166065
Tbc1d4^tm1.1Arte/Tbc1d4^tm1.1Arte (involves: C57BL/6)	decreased spleen weight	J:169477
Tbc1d4^{tm1b(EUCOMM)Hmgu}/Tbc1d4^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tbc1d4^{tm1b(EUCOMM)Hmgu}/J)	decreased leukocyte cell number	J:211773
Tbc1d8b^em1(IMPC)Bay/Y (C57BL/6N-Tbc1d8b^em1(IMPC)Bay/BayMmucd)	decreased spleen weight	J:211773
Tbc1d25^em1(IMPC)Tcp/Tbc1d25^em1(IMPC)Tcp (C57BL/6NCrl-Tbc1d25^em1(IMPC)Tcp/Tcp)	increased neutrophil cell number	J:211773
Tbc1d32^b2b2284Clo/Tbc1d32^b2b2284Clo (C57BL/6J-Tbc1d32^b2b2284Clo)	spleen hypoplasia	J:175213
Tbk1^tm1.1Lex/Tbk1⁺ (involves: 129S4/SvJae * 129S5/SvEvBrd)	decreased basophil cell number	J:166476
Tbk1^tm1.1Lex/Tbk1⁺ (involves: 129S4/SvJae * 129S5/SvEvBrd)	decreased eosinophil cell number	J:166476
Tbk1^tm1.1Lex/Tbk1^tm1.1Lex (involves: 129S4/SvJae * 129S5/SvEvBrd)	decreased NK T cell number	J:166476
	increased monocyte cell number	J:166476
	increased NK T cell number	J:166476
	increased spleen weight	J:166476
	lymphoid hyperplasia	J:166476
Tbk1^tm1Arte/Tbk1^tm1Arte Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)	abnormal class switch recombination	J:188560
	increased mature B cell number	J:188560
Tbk1^tm1Arte/Tbk1^tm1Arte Map3k14^tm1Rds/Map3k14^tm1Rds Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:188560
Tbkbp1^{tm1b(EUCOMM)Wtsi}/Tbkbp1^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tbkbp1^{tm1b(EUCOMM)Wtsi}/H)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Tbrg1^{tm1a(KOMP)Wtsi}/Tbrg1^{tm1a(KOMP)Wtsi} (C57BL/6N-Tbrg1^{tm1a(KOMP)Wtsi})	enlarged spleen	J:225146
	increased marginal zone B cell number	J:225146
	increased spleen white pulp amount	J:225146
Tbx1^m1H/Tbx1^m1H (involves: C3H/HeH * C57BL/6J)	small thymus	J:169366
Tbx1^m1Jlk/Tbx1^m1Jlk (129/Sv-Tbx1^m1Jlk)	athymia	J:146769
Tbx1^m1Jlk/Tbx1^tm1Bld (involves: 129)	athymia	J:146769
Tbx1^tm1.1Dsr/Tbx1^tm1.1Dsr (either: 129/Sv or (involves: 129/Sv * C57BL/6))	athymia	J:93588
Tbx1^tm1Bem/Tbx1^tm1Bem (FVB.Cg-Tbx1^tm1Bem)	athymia	J:91664
Tbx1^tm1Bem/Tbx1^tm1Bem (FVB.Cg-Tbx1^tm1Bem)	thymus hypoplasia	J:91664
Tbx1^tm1Bld/Tbx1^tm1Bld (involves: 129S7/SvEvBrd)	abnormal lymphangiogenesis	J:159824
	abnormal lymphatic vessel morphology	J:159824
	athymia	J:146769
	lymphangiectasis	J:159824
Tbx1^tm1Bld/Tbx1^tm2.1Bem Tfap2a^tm1(cre)Moon/Tfap2a⁺ (either: (involves: 129/Sv * C57BL/6 * SJL) or (involves: 129/Sv * C57BL/6J * CBA * SJL))	athymia	J:154590
	thymus hypoplasia	J:154590
Tbx1^tm1Bld/Tbx1^tm3Bld Tg(CAG-cre/Esr1)5Amc/0 (involves: 129S7/SvEvBrd C57BL/6 * CBA)	abnormal lymphangiogenesis	J:159824
	abnormal lymphatic vessel morphology	J:159824
Tbx1^tm1Bld/Tbx1^tm3Bld Tg(Tek-cre)1Ywa/0 (involves: 129S7/SvEvBrd * C57BL/6 * SJL)	abnormal lymphangiogenesis	J:159824
	abnormal lymphatic vessel morphology	J:159824
Tbx1^tm1Bld/Tbx1^tm5Bld (involves: 129S7/SvEvBrd * C57BL/6)	athymia	J:112457
Tbx1^tm1Dsr/Tbx1^tm1Dsr (either: 129/Sv or (involves: 129/Sv * C57BL/6))	athymia	J:93588
Tbx1^tm1Pa/Tbx1^tm1Pa (either: (involves: 129) or (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * Swiss Webster))	abnormal thymus development	J:70730
	athymia	J:70730
Tbx1^tm2.1Bem/Tbx1^tm2.2Bem Foxg1^tm1(cre)Skm/Foxg1⁺ (involves: 129 * C57BL/6J * SJL * Swiss Webster)	athymia	J:105980
Tbx3^em1(IMPC)Mbp/Tbx3⁺ (C57BL/6NCrl-Tbx3^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
Tbx20^em1(IMPC)Mbp/Tbx20⁺ (C57BL/6N-Tbx20^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Tbx21^duane/Tbx21^duane (C57BL/6-Tbx21^duane)	abnormal NK cell differentiation	J:154069
	absent NK T cells	J:154069
	decreased NK cell number	J:154069
	increased NK cell number	J:154069
Tbx21^m1Btlr/Tbx21^m1Btlr (C57BL/6J-Tbx21^m1Btlr)	increased CD8-positive, alpha-beta T cell number	J:267478
Tbx21^m1Btlr/Tbx21^m1Btlr (C57BL/6J-Tbx21^m1Btlr)	increased effector memory CD8-positive, alpha-beta T cell number	J:267478
Tbx21^tm1Glm/Tbx21⁺ (involves: 129S6/SvEvTac * C57BL/6)	decreased T helper 1 cell number	J:73833
Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:73833
	abnormal T-helper 1 cell differentiation	J:73833
	decreased T helper 1 cell number	J:73833
	increased T-helper 2 cell number	J:73833
Tbx21^tm1Glm/Tbx21^tm1Glm (B6.129S6-Tbx21^tm1Glm)	abnormal CD4-positive T cell differentiation	J:143729
Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac)	decreased CD4-positive, alpha-beta T cell number	J:163822
Tbx21^tm1Glm/Tbx21^tm1Glm (involves: 129S6/SvEvTac)	decreased memory T cell number	J:163822
Tbx21^tm1Srnr/Tbx21⁺ (involves: C57BL/6)	absent NK T cells	J:112679
Tbx21^tm1Srnr/Tbx21⁺ (involves: C57BL/6)	decreased NK cell number	J:112679
Tbx21^tm1Srnr/Tbx21^tm1Srnr (involves: C57BL/6)	abnormal T-helper 1 cell morphology	J:112679
Tbx21^tm1Srnr/Tbx21^tm1Srnr (involves: C57BL/6)	decreased NK T cell number	J:112679
Tbx21^tm2Srnr/Tbx21⁺ Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:174315
Tbx21^tm2Srnr/Tbx21^tm2Srnr Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:174315
Tbxa2r^tm1Sna/Tbxa2r^tm1Sna (either: (involves: 129/Ola * BALB/c) or (involves: 129/Ola * C57BL/6))	abnormal cervical lymph node morphology	J:84085
	abnormal immune system organ morphology	J:84085
	abnormal lymph node morphology	J:84085
	enlarged lymph nodes	J:84085
	enlarged spleen	J:84085
Tcaf2^{em1(IMPC)Ccpcz}/Tcaf2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tcaf2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Tcaim^{tm1b(EUCOMM)Wtsi}/Tcaim^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tcaim^{tm1b(EUCOMM)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Tcdel1^C57BL/6/Tcdel1^NOD/ShiLtDoi (involves: C57BL/6 * NOD/ShLtDoi * SJL)	decreased double-negative T cell number	J:97046
	increased double-positive T cell number	J:97046
Tcdel1^NOD/ShiLtDoi/Tcdel1^NOD/ShiLtDoi (involves: C57BL/6 * NOD/ShLtDoi * SJL)	decreased double-negative T cell number	J:97046
	increased double-positive T cell number	J:97046
Tcdel2^C57BL/6/Tcdel2^NOD/ShiLtDoi (involves: C57BL/6 * NOD/ShLtDoi * SJL)	decreased double-negative T cell number	J:97046
	increased double-positive T cell number	J:97046
Tcdel2^NOD/ShiLtDoi/Tcdel2^NOD/ShiLtDoi (involves: C57BL/6 * NOD/ShLtDoi * SJL)	decreased double-negative T cell number	J:97046
	increased double-positive T cell number	J:97046
Tcea2^em1(IMPC)J/Tcea2^em1(IMPC)J (C57BL/6NJ-Tcea2^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Tceal3^em1(IMPC)Tcp/Y (C57BL/6NCrl-Tceal3^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Tcf3^tm1(PBX1)Mlc/Tcf3⁺ Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal pro-B cell differentiation	J:226241
	abnormal pro-B cell morphology	J:226241
	arrested B cell differentiation	J:226241
	decreased B cell number	J:226241
	decreased immature B cell number	J:226241
	enlarged lymph nodes	J:226241
	enlarged spleen	J:226241
	increased leukocyte cell number	J:226241
Tcf3^tm1(PBX1)Mlc/Tcf3⁺ Cd79a^tm1(cre)Reth/Cd79a⁺ (involves: BALB/c * C57BL/6)	arrested B cell differentiation	J:226241
	decreased B cell number	J:226241
	decreased immature B cell number	J:226241
	enlarged lymph nodes	J:226241
	enlarged spleen	J:226241
	increased leukocyte cell number	J:226241
Tcf3^tm1(PBX1)Mlc/Tcf3⁺ Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * C57BL/6J * CBA/J)	arrested B cell differentiation	J:226241
	decreased B cell number	J:226241
	decreased immature B cell number	J:226241
	enlarged lymph nodes	J:226241
	enlarged spleen	J:226241
	increased leukocyte cell number	J:226241
Tcf3^{tm1(TCF3/HLF)Homy}/Tcf3⁺ Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal B cell differentiation	J:160392
	increased B cell number	J:160392
Tcf3^tm1.1Mbu/Tcf3⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:137719
Tcf3^tm1Cmu/Tcf3⁺ (either: 129P2/OlaHsd-Tcf3^tm1Cmu or (involves: 129P2/OlaHsd * FVB/N))	decreased B cell number	J:67011
Tcf3^tm1Cmu/Tcf3^tm1Cmu (either: 129P2/OlaHsd-Tcf3^tm1Cmu or (involves: 129P2/OlaHsd * FVB/N))	abnormal immunoglobulin heavy chain V(D)J recombination	J:67011
	abnormal immunoglobulin V(D)J recombination	J:67011
	abnormal T cell subpopulation ratio	J:67011
	decreased B cell number	J:67011
	decreased lymphocyte cell number	J:67011
Tcf3^tm1Mbu/Tcf3^tm1.2Mbu Tg(Aicda-cre)9Mbu/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL)	abnormal germinal center B cell morphology	J:137719
	decreased B cell number	J:137719
	decreased germinal center B cell number	J:137719
Tcf3^tm1Mbu/Tcf3^tm1.2Mbu Tg(Fcer2a-cre)5Mbu/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL)	abnormal germinal center B cell morphology	J:137719
	decreased B cell number	J:137719
	decreased germinal center B cell number	J:137719
	increased marginal zone B cell number	J:137719
Tcf3^tm1Mbu/Tcf3^tm1Mbu Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca)	decreased pro-B cell number	J:137719
Tcf3^tm1Wein/Tcf3⁺ (either: (involves: 129/Sv * 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6J))	decreased B cell number	J:22134
Tcf3^tm1Wein/Tcf3⁺ (involves: 129S4/SvJaeSor)	abnormal B cell number	J:91042
Tcf3^tm1Wein/Tcf3⁺ (involves: 129S4/SvJaeSor)	decreased pre-B cell number	J:91042
Tcf3^tm1Wein/Tcf3^tm1Wein (either: (involves: 129 * 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6J))	abnormal B cell number	J:22134
	abnormal lymphocyte cell number	J:22134
	spleen atrophy	J:22134
Tcf3^tm1Wein/Tcf3^tm1Wein (involves: 129S4/SvJaeSor * C57BL/6)	enlarged thymus	J:44278
	increased T cell derived lymphoma incidence	J:44278
Tcf3^tm1Wein/Tcf3^tm3Zhu (involves: 129/Sv * 129S4/SvJaeSor * C57BL/6)	decreased pro-B cell number	J:47671
Tcf3^tm1Xhsu/Tcf3^tm1Xhsu (B6.129X1-Tcf3^tm1Xhsu)	increased B cell number	J:132669
Tcf3^tm1Zhu/Tcf3^tm1Zhu (involves: 129)	decreased B cell number	J:47671
Tcf3^tm1Zhu/Tcf3^tm1Zhu (involves: 129 * C57BL/6J)	decreased double-positive T cell number	J:136143
	increased double-negative T cell number	J:136143
	increased single-positive T cell number	J:136143
	thymus hypoplasia	J:136143
Tcf3^tm1Zhu/Tcf3^tm2Zhu (involves: 129 * C57BL/6)	decreased B cell number	J:47671
Tcf3^tm2Cmu/Tcf3^tm2Cmu (involves: 129P2/OlaHsd)	abnormal lymphopoiesis	J:118827
	absent pre-B cells	J:118827
	absent pro-B cells	J:118827
	decreased dendritic cell number	J:118827
	decreased NK cell number	J:118827
Tcf3^tm2Wein/Tcf3^tm2Wein (Not Specified)	abnormal immune system morphology	J:47671
Tcf3^tm2Wein/Tcf3^tm2Wein (Not Specified)	increased T cell derived lymphoma incidence	J:47671
Tcf3^tm2Zhu/Tcf3^tm2Zhu (involves: 129 * C57BL/6)	decreased pre-B cell number	J:47671
Tcf3^tm2Zhu/Tcf3^tm2Zhu (involves: 129 * C57BL/6)	decreased pro-B cell number	J:47671
Tcf3^tm3.1Cmu/Tcf3^tm3.1Cmu (involves: 129S/SvEv * FVB/N)	abnormal B cell differentiation	J:153423
	abnormal immunoglobulin light chain V-J recombination	J:153423
	decreased pre-B cell number	J:153423
Tcf3^tm3Zhu/Tcf3^tm3Zhu (involves: 129/Sv * C57BL/6)	decreased B cell number	J:47671
Tcf3^tm4.1Cmu/Tcf3^tm4.1Cmu (involves: 129S/SvEv * FVB/N)	abnormal immunoglobulin light chain V-J recombination	J:153423
	absent B cells	J:153423
	arrested B cell differentiation	J:153423
	decreased pro-B cell number	J:153423
Tcf3^{tm6(Esr1)Zhu}/Tcf3^{tm6(Esr1)Zhu} (involves: 129/Sv * C57BL/6)	abnormal immunoglobulin heavy chain V(D)J recombination	J:154788
	arrested B cell differentiation	J:154788
Tcf4^tm1.1Hmb/Tcf4⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased double-negative T cell number	J:136143
Tcf4^tm1.1Hmb/Tcf4^tm1.1Hmb (involves: 129P2/OlaHsd * C57BL/6J)	abnormal T cell differentiation	J:136143
	increased double-negative T cell number	J:136143
Tcf4^tm1Hmb/Tcf4^tm1Zhu Tg(Kit-cre)143Hmb/? (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal B cell differentiation	J:65236
	decreased double-positive T cell number	J:65236
	decreased thymocyte number	J:65236
	spleen hypoplasia	J:65236
Tcf4^tm1Zhu/Tcf4⁺ Tcf3^tm1Wein/Tcf3⁺ (involves: 129P2/OlaHsd)	decreased pro-B cell number	J:43324
Tcf4^tm1Zhu/Tcf4^tm1Zhu (involves: 129P2/OlaHsd * C57BL/6)	decreased pro-B cell number	J:43324
Tcf7^{tm1a(EUCOMM)Wtsi}/Tcf7^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tcf7^{tm1a(EUCOMM)Wtsi}/Ics)	decreased CD4-positive, alpha-beta T cell number	J:165965
	decreased T cell number	J:165965
	increased B cell number	J:165965
Tcf7^tm1Cle/Tcf7^tm1Cle (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:23255
	decreased CD8-positive, alpha-beta T cell number	J:189838
	decreased double-positive T cell number	J:23255
	decreased single-positive T cell number	J:23255
	decreased T cell number	J:23255
	increased osteoclast cell number	J:98430
	thymus cortex hypoplasia	J:23255
	thymus hypoplasia	J:23255
Tcf7^tm2Cle/Tcf7^tm2Cle (involves: 129P2/OlaHsd)	decreased double-positive T cell number	J:23255
	decreased single-positive T cell number	J:23255
	thymus hypoplasia	J:23255
Tcf12^m1Btlr/Tcf12^m1Btlr (C57BL/6J-Tcf12^M1Btlr)	increased CD8-positive, alpha-beta T cell number	J:267564
Tcf12^M2Btlr/Tcf12^M2Btlr (C57BL/6J-Tcf12^M2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:267666
	increased CD8-positive, alpha-beta T cell number	J:267666
	increased effector memory CD4-positive, alpha-beta T cell number	J:267666
Tcf12^M3Btlr/Tcf12^M3Btlr (C57BL/6J-Tcf12^M3Btlr)	decreased B cell number	J:271971
	decreased CD4-positive, alpha-beta T cell number	J:271971
	increased CD8-positive, alpha-beta T cell number	J:271971
Tcf12^m4Btlr/Tcf12^m4Btlr (C57BL/6J-Tcf12^m4Btlr)	abnormal B cell morphology	J:271972
	abnormal T cell morphology	J:271972
	decreased CD4-positive, alpha-beta T cell number	J:271972
	increased CD8-positive, alpha-beta T cell number	J:271972
Tcf12^tm1Zhu/Tcf12⁺ Tcf3^tm1Wein/Tcf3⁺ (involves: 129S4/SvJaeSor)	decreased pro-B cell number	J:43324
Tcf12^tm1Zhu/Tcf12⁺ Tcf3^tm4Zhu/Tcf3^tm4Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6 * SJL)	abnormal T cell differentiation	J:75746
	increased double-negative T cell number	J:75746
	increased single-positive T cell number	J:75746
Tcf12^tm1Zhu/Tcf12⁺ Tcf4^tm1Zhu/Tcf4⁺ (involves: 129P2/OlaHsd * 129S7/SvEvBrd)	decreased pro-B cell number	J:43324
Tcf12^tm1Zhu/Tcf12^tm1Zhu (involves: 129/Sv * C57BL/6)	decreased pro-B cell number	J:43324
Tcf12^tm1Zhu/Tcf12^tm1Zhu (involves: 129S7/SvEvBrd)	arrested T cell differentiation	J:120411
Tcf12^tm1Zhu/Tcf12^tm1Zhu (involves: 129S7/SvEvBrd)	decreased thymocyte number	J:120411
Tcf12^tm1Zhu/Tcf12^tm1Zhu (involves: 129S7/SvEvBrd * C57BL/6J)	decreased double-positive T cell number	J:136143
	increased CD8-positive, alpha-beta T cell number	J:136143
	increased double-negative T cell number	J:136143
	thymus hypoplasia	J:136143
Tcf12^tm1Zhu/Tcf12^tm2Zhu (involves: 129S7/SvEvBrd)	arrested T cell differentiation	J:120411
Tcf12^tm2Zhu/Tcf12^tm2Zhu (Not Specified)	abnormal B cell differentiation	J:120411
	abnormal T cell differentiation	J:120411
	absent T cells	J:120411
	arrested T cell differentiation	J:120411
	decreased double-positive T cell number	J:120411
	decreased immature B cell number	J:120411
	decreased pre-B cell number	J:120411
	decreased pro-B cell number	J:120411
	decreased thymocyte number	J:120411
	increased double-negative T cell number	J:120411
	thymus hypoplasia	J:120411
Tcf12^tm2Zhu/Tcf12^tm2Zhu Tg(TcrAND)53Hed/0 (involves: C57BL/6 * SJL)	abnormal CD4-positive, alpha beta T cell morphology	J:120411
	abnormal T cell subpopulation ratio	J:120411
	arrested T cell differentiation	J:120411
	increased T cell number	J:120411
Tcf12^tm3Zhu/Tcf12^tm3Zhu Tcf3^tm4Zhu/Tcf3^tm4Zhu Tg(Cd4-cre)1Cwi/0 (involves: 129S4/SvJae * C57BL/6 * DBA/2)	abnormal CD8-positive, alpha beta T cell morphology	J:129171
	abnormal T cell differentiation	J:129171
	decreased CD4-positive, alpha-beta T cell number	J:129171
	increased CD8-positive, alpha-beta T cell number	J:129171
Tcf12^tm3Zhu/Tcf12^tm3Zhu Tcf3^tm4Zhu/Tcf3^tm4Zhu Tg(Lck-cre)#Zhu/0 (involves: 129S4/SvJae * C57BL/6 * SJL/J)	decreased double-positive T cell number	J:129570
	decreased T cell number	J:129570
	increased double-negative T cell number	J:129570
	thymus hypoplasia	J:129570
Tcf12^tm3Zhu/Tcf12^tm3Zhu Tg(Lck-cre)#Zhu/0 (involves: C57BL/6 * SJL/J)	decreased thymocyte number	J:129570
	increased CD8-positive, alpha-beta T cell number	J:129570
Tcf21^em1(IMPC)Mbp/Tcf21⁺ (C57BL/6NCrl-Tcf21^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Tcf21^tm1Eno/Tcf21^tm1Eno (involves: 129 * Black Swiss)	abnormal spleen development	J:64068
Tcf21^tm1Eno/Tcf21^tm1Eno (involves: 129 * Black Swiss)	absent spleen	J:64068
Tcf21^tm2Eno/Tcf21^tm2Eno (involves: 129 * Black Swiss)	abnormal spleen development	J:64068
Tcf21^tm2Eno/Tcf21^tm2Eno (involves: 129 * Black Swiss)	absent spleen	J:64068
Tcim^tm1Icle/Tcim^tm1Icle (B6.129-Tcim^tm1Icle)	abnormal mononuclear cell morphology	J:217318
	increased eosinophil cell number	J:217318
	increased leukocyte cell number	J:217318
	increased lymphocyte cell number	J:217318
	increased monocyte cell number	J:217318
	increased neutrophil cell number	J:217318
	lymphoid hyperplasia	J:217318
	myeloid hyperplasia	J:217318
Tcirg1^M1Jeau/Tcirg1⁺ (either: (involves: C3H/HeJ * C57BL/6) or (involves: C3H/HeJ * C57BL/6 * FVB/N))	abnormal osteoclast morphology	J:196503
	increased osteoclast cell number	J:196503
Tcirg1^oc/Tcirg1^oc (B6C3Fe a/a-Tcirg1^oc/J)	abnormal osteoclast morphology	J:7870
Tcirg1^tm1Utku/Tcirg1^tm1Utku (involves: 129X1/SvJ * C57BL/6)	abnormal mesenteric lymph node morphology	J:92730
	abnormal peripheral lymph node morphology	J:92730
	abnormal Peyer's patch morphology	J:92730
	abnormal spleen B cell corona morphology	J:92730
	abnormal spleen morphology	J:92730
	abnormal spleen periarteriolar lymphoid sheath morphology	J:92730
	abnormal spleen red pulp morphology	J:92730
	abnormal spleen white pulp morphology	J:92730
	decreased B cell number	J:92730
	decreased lymphocyte cell number	J:92730
	decreased spleen B cell follicle size	J:92730
	decreased T cell number	J:92730
	increased granulocyte number	J:92730
	increased spleen germinal center number	J:92730
	thymus atrophy	J:92730
Tcpm1^BALB/c/Tcpm1^BALB/c (involves: BALB/c * C57BL/10)	abnormal effector T cell morphology	J:36255
Tcpm1^BALB/c/Tcpm1^C57BL/10Sn (involves: BALB/c * C57BL/10)	abnormal effector T cell morphology	J:36255
Tcra-J^tm1Jpdv/Tcra-J^tm1Jpdv (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:77518
Tcra-J^tm1Kgwa/Tcra-J^tm1Kgwa Tg(Tcrb2B4)1Mmd/0 (involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J)	abnormal T cell differentiation	J:50143
	increased double-positive T cell number	J:50143
Tcra-J^tm1Slek/Tcra-J^tm1Slek (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:101398
	decreased double-positive T cell number	J:101398
	decreased single-positive T cell number	J:101398
	increased double-negative T cell number	J:101398
	increased thymocyte number	J:101398
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (B6.129-Tcra-J^tm1Tgi)	decreased activated T cell number	J:99107
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (B6.129-Tcra-J^tm1Tgi)	decreased B cell number	J:99107
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129X1/SvJ * BALB/c)	abnormal eosinophil cell number	J:84720
Tcra-J^tm1Tgi/Tcra-J^tm1Tgi (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	decreased NK T cell number	J:89695
Tcra-J^tm2.3Krg/Tcra-J^tm2.3Krg (involves: 129S/SvEv * C57BL/6)	abnormal T cell receptor alpha chain V-J recombination	J:147326
Tcra-J^tm3.1Krg/Tcra-J^tm3.1Krg (involves: 129S6/SvEvTac)	abnormal T cell differentiation	J:128344
Tcra-J^tm4.1Krg/Tcra-J^tm4.1Krg (involves: 129S6/SvEvTac)	abnormal T cell receptor alpha chain V-J recombination	J:147326
Tcra-J^tm5Krg/Tcra-J^tm5Krg (involves: 129S6/SvEvTac)	abnormal T cell receptor alpha chain V-J recombination	J:147326
Tcra^Ln1Ogu/Tcra⁺ (involves: 129/Sv * C57BL/6)	abnormal NK T cell morphology	J:152041
	abnormal T cell subpopulation ratio	J:152041
	decreased splenocyte number	J:152041
	decreased thymocyte number	J:152041
	increased NK T cell number	J:152041
Tcra^Ln1Ogu/Tcra⁺ Tcrb^Ln1Ogu/Tcrb⁺ (involves: 129/Sv * C57BL/6)	abnormal T cell morphology	J:152069
Tcra^Ln2Ogu/Tcra⁺ Tcrb^Ln2Ogu/Tcrb⁺ (involves: 129/Sv * C57BL/6)	abnormal T cell morphology	J:152069
Tcra^Ln3Jae/Tcra⁺ (B6.Cg-Tcra^Ln3Jae)	abnormal double-negative T cell morphology	J:143006
	decreased CD4-positive, alpha-beta T cell number	J:143006
	decreased double-positive T cell number	J:143006
	increased CD8-positive, alpha-beta T cell number	J:143006
	thymus hypoplasia	J:143006
Tcra^Ln3Jae/Tcra⁺ Tcrb^Ln3Jae/Tcrb⁺ (B6.Cg-Tcrb^Ln3Jae Tcra^Ln3Jae)	abnormal double-negative T cell morphology	J:143006
	abnormal T cell differentiation	J:143006
	absent gamma-delta T cells	J:143006
	decreased CD4-positive, alpha-beta T cell number	J:143006
	decreased double-positive T cell number	J:143006
	increased CD8-positive, alpha-beta T cell number	J:143006
	thymus hypoplasia	J:143006
Tcra^tm1Cgn/Tcra^tm1Cgn Tg(Mx1-cre)1Cgn/0 (involves: 129S7/SvEvBrd * C57BL/6 * CBA)	abnormal CD4-positive, alpha beta T cell morphology	J:79298
	abnormal CD8-positive, alpha beta T cell morphology	J:79298
	abnormal memory T cell morphology	J:79298
	abnormal T cell morphology	J:79298
Tcra^tm1Cgn/Tcra^tm1Mass Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	increased T cell number	J:201417
Tcra^tm1Mass/Tcra⁺ Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	abnormal NK T cell morphology	J:201417
	decreased NK cell number	J:201417
	increased NK T cell number	J:201417
Tcra^tm1Mass/Tcra⁺ Tg(Nes-cre)Wme/0 (involves: C57BL/6 * CBA)	abnormal positive T cell selection	J:201417
	decreased NK T cell number	J:201417
	decreased thymocyte number	J:201417
	increased double-negative T cell number	J:201417
Tcra^tm1Mass/Tcra^tm1Mass (involves: C57BL/6)	arrested T cell differentiation	J:201417
Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd * BALB/c)	abnormal immune system organ morphology	J:1292
	abnormal splenic cell ratio	J:1292
	abnormal T cell morphology	J:1292
	abnormal thymus cortex morphology	J:1292
	absent thymus medulla	J:1292
	enlarged thymus cortex	J:1292
	increased activated T cell number	J:111129
	increased B cell number	J:111129
	small Peyer's patches	J:1292
Tcra^tm1Mjo/Tcra^tm1Mjo (NOD.129P2-Tcra^tm1Mjo)	increased activated T cell number	J:52940
Tcra^tm1Mjo/Tcra^tm1Mjo (involves: 129P2/OlaHsd)	enlarged mesenteric lymph nodes	J:110898
	enlarged spleen	J:110898
	increased activated T cell number	J:110898
	increased gamma-delta T cell number	J:110898
	increased T cell number	J:110898
	spleen hyperplasia	J:110898
Tcra^tm1Mom/Tcra/Tcrd^{tm1.1(Tcra)Rsky} H2^b/H2^b Tg(Tcrb)93Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal double-negative T cell morphology	J:131357
	abnormal double-positive T cell morphology	J:81564
	abnormal negative T cell selection	J:81564
	abnormal T cell differentiation	J:81564
	decreased double-positive T cell number	J:131357
	decreased thymocyte number	J:131357
Tcra^tm1Mom/Tcra/Tcrd^{tm1.1(Tcra)Rsky} H2^d/H2^d Ptcra^tm1Vbo/Ptcra^tm1Vbo Tg(Tcrb)93Vbo/? (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:131357
	decreased thymocyte number	J:131357
Tcra^tm1Mom/Tcra^tm1Mom (involves: 129S2/SvPas)	absent T cells	J:88620
Tcra^tm1Mom/Tcra^tm1Mom (B6.129S2-Tcra^tm1Mom)	increased mature gamma-delta T cell number	J:135597
Tcra^tm1Mom/Tcra^tm1Mom (involves: 129S2/SvPas * C57BL/6)	arrested T cell differentiation	J:3206
	decreased CD4-positive, alpha-beta T cell number	J:3206
	decreased CD8-positive, alpha-beta T cell number	J:3206
	increased gamma-delta intraepithelial T cell number	J:15221
Tcra^tm1Mom/Tcra^tm1Mom Tcra-J^tm1Kgwa/Tcra-J^tm1Kgwa (involves: 129P2/OlaHsd * 129S2/SvPas * C3H/HeJ * C57BL/6J)	increased double-negative T cell number	J:50143
Tcra^tm1Mom/Tcra^tm1Mom Tcrb^tm1Mom/Tcrb^tm1Mom (involves: 129 * BALB/c * C57BL/6)	arrested T cell differentiation	J:3206
	decreased double-positive T cell number	J:3206
	thymus hypoplasia	J:3206
Tcra^tm1Mom/Tcra^tm1Mom Tcrg^tm1.1Hish/Tcrg^tm1.1Hish (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	absent gamma-delta T cells	J:135597
Tcra^tm1Mom/Tcra^tm1Mom Tg(CD19-Tnfsf7)#Rvl/0 (involves: 129P2/OlaHsd * C57BL/6)	absent T cells	J:88620
Tcra^tm1Mom/Tcra^tm1Mom Tg(Lck-Akt1E40K)E-3Pnt/0 (involves: 129S2/SvPas C3H/He * C57BL/6)	arrested T cell differentiation	J:135903
Tcra^tm1Mom/Tcra^tm1Mom Tg(TcraAV19AJ33)1Shima/? (involves: 129S2/SvPas * C57BL/6)	abnormal NK T cell morphology	J:140924
Tcrb^Ln3Jae/Tcrb⁺ (B6.Cg-Tcrb^Ln3Jae)	abnormal double-negative T cell morphology	J:143006
Tcrb^Ln3Jae/Tcrb⁺ (B6.Cg-Tcrb^Ln3Jae)	absent gamma-delta T cells	J:143006
Tcrb^tm1(Tcrb)Chb/Tcrb^tm1(Tcrb)Chb (Not Specified)	abnormal double-negative T cell morphology	J:147947
	abnormal T cell morphology	J:147947
	decreased CD8-positive, alpha-beta T cell number	J:147947
	increased single-positive T cell number	J:147947
Tcrb^tm1(Tcrb)Chb/Tcrb^tm1Slek (Not Specified)	abnormal double-negative T cell morphology	J:147947
	abnormal T cell morphology	J:147947
	abnormal T cell receptor beta chain V(D)J recombination	J:147947
	decreased CD8-positive, alpha-beta T cell number	J:147947
	increased single-positive T cell number	J:147947
Tcrb^tm1(Tcrb)Fwa/Tcrb^tm1(Tcrb)Fwa (involves: 129)	abnormal T cell receptor beta chain V(D)J recombination	J:131995
Tcrb^tm1Mom/Tcrb^tm1Mom (involves: 129P2/OlaHsd * BALB/c)	arrested T cell differentiation	J:3206
	decreased CD4-positive, alpha-beta T cell number	J:3206
	decreased CD8-positive, alpha-beta T cell number	J:3206
	decreased double-positive T cell number	J:3206
	thymus hypoplasia	J:3206
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (B6.129P2-Tcrb^tm1Mom Tcrd^tm1Mom/J)	abnormal transitional stage B cell morphology	J:187766
	decreased plasma cell number	J:187766
	decreased T cell number	J:187766
	increased B cell number	J:187766
	increased follicular B cell number	J:187766
	increased immature B cell number	J:187766
	increased marginal zone B cell number	J:187766
	increased mature B cell number	J:187766
	increased transitional stage T2 B cell number	J:187766
	increased transitional stage T3 B cell number	J:187766
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (involves: 129 * BALB/c * C57BL/6)	absent CD4-positive, alpha-beta T cells	J:3206
	absent CD8-positive, alpha-beta T cells	J:3206
	arrested T cell differentiation	J:3206
	decreased double-positive T cell number	J:3206
	thymus hypoplasia	J:3206
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom (involves: 129P2/OlaHsd)	decreased lymphocyte cell number	J:97824
	increased T cell number	J:97824
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom Igh-J^{tm2(3H9-VDJ)Mwg}/Igh-J⁺ (B6.129P2-Tcrb^tm1Mom Igh-J^{tm2(3H9-VDJ)Mwg} Tcrd^tm1Mom)	increased marginal zone B cell number	J:142389
	spleen hypoplasia	J:142389
Tcrb^tm1Mom/Tcrb^tm1Mom Tcrd^tm1Mom/Tcrd^tm1Mom Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (B6.129-Tcrb^tm1Mom Traf3ip2^tm1.1Lix Tcrd^tm1Mom)	abnormal transitional stage B cell morphology	J:187766
	decreased T cell number	J:187766
	increased immature B cell number	J:187766
	increased marginal zone B cell number	J:187766
Tcrb^tm1Mom/Tcrb^tm1Mom Tg(H2-K-Cd86)7All/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal B cell differentiation	J:112475
	abnormal B cell morphology	J:112475
	decreased B cell number	J:112475
Tcrb^tm1Slek/Tcrb^tm5Slek (Not Specified)	abnormal T cell receptor beta chain V(D)J recombination	J:143738
Tcrb^tm1Slek/Tcrb^tm6Slek (Not Specified)	abnormal T cell receptor beta chain V(D)J recombination	J:143738
Tcrb^tm2(Tcrb)Fwa/Tcrb^tm3Slek (involves: 129)	abnormal T cell receptor beta chain V(D)J recombination	J:132446
Tcrb^tm2Slek/Tcrb^tm2Slek (Not Specified)	arrested T cell differentiation	J:119552
Tcrb^tm2Slek/Tcrb^tm2Slek (Not Specified)	decreased T cell number	J:119552
Tcrb^tm2Slek/Tcrb^tm2Slek Trbv13-2^tm1(CD2)Zhu/Trbv13-2^tm1(CD2)Zhu (involves: 129 * C57BL/6)	abnormal T cell differentiation	J:121608
Tcrb^tm3Slek/Tcrb^tm3Slek (Not Specified)	arrested T cell differentiation	J:119552
Tcrb^tm3Slek/Tcrb^tm3Slek (Not Specified)	decreased T cell number	J:119552
Tcrb^tm5Slek/Tcrb^tm5Slek (Not Specified)	abnormal T cell receptor beta chain V(D)J recombination	J:143738
Tcrb^tm6Slek/Tcrb^tm6Slek (Not Specified)	abnormal T cell receptor beta chain V(D)J recombination	J:143738
Tcrb^tm7Slek/Tcrb^tm7Slek (Not Specified)	abnormal T cell receptor beta chain V(D)J recombination	J:143738
Tcrd-V1^tm1Kjk/Tcrd-V1^tm1Kjk (involves: 129P2/OlaHsd * C57BL/6)	abnormal gamma-delta T cell differentiation	J:64863
	abnormal mature gamma-delta T cell morphology	J:64863
	abnormal T cell receptor delta chain V(D)J recombination	J:64863
	decreased gamma-delta intraepithelial T cell number	J:64863
Tcrd-V1^tm1Kjk/Tcrd-V1^tm1Kjk (B6.129P2-Tcrd-V1^tm1Kjk)	abnormal T cell receptor delta chain V(D)J recombination	J:128525
Tcrd-V1^tm1Kjk/Tcrd-V1^tm1Kjk (B6.129P2-Tcrd-V1^tm1Kjk)	decreased gamma-delta intraepithelial T cell number	J:128525
Tcrd^tm1Mom/Tcrd^tm1Mom (either: (involves: 129P2/OlaHsd * BALB/cJ) or (involves: 129P2/OlaHsd * C57BL/6))	abnormal gamma-delta T cell differentiation	J:3865
	absent gamma-delta T cells	J:3865
Tcrd^tm1Mom/Tcrd^tm1Mom Tcrg^tm2.1Dhr/Tcrg^tm2.1Dhr (involves: 129 * C57BL/6)	abnormal T cell receptor gamma chain V-J recombination	J:75624
Tcrg^tm1.1Dhr/Tcrg^tm1.1Dhr (involves: 129)	abnormal T cell receptor gamma chain V-J recombination	J:133974
Tcrg^tm1.1Hish/Tcrg^tm1.1Hish (involves: 129P2/OlaHsd * C57BL/6)	absent gamma-delta T cells	J:135597
Tcrg^tm1Dhr/Tcrg^tm1Dhr (involves: 129)	abnormal T cell receptor gamma chain V-J recombination	J:133974
Tcrg^tm1Scar/Tcrg^tm1Scar (B6.Cg-Tcrg^tm1Scar)	abnormal immune system organ morphology	J:105477
	enlarged spleen	J:105477
	enlarged thymus	J:105477
	increased macrophage cell number	J:105477
	increased T cell number	J:105477
	spleen hyperplasia	J:105477
	thymus hyperplasia	J:105477
Tcrg^tm2.1Dhr/Tcrg^tm2.1Dhr (involves: 129S4/SvJae * C57BL/6)	abnormal gamma-delta T cell differentiation	J:75624
	abnormal T cell receptor gamma chain V-J recombination	J:75624
Tdp1^em1(IMPC)Tcp/Tdp1^em1(IMPC)Tcp (C57BL/6NCrl-Tdp1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Tdp2^tm1.1Huy/Tdp2^tm1.1Huy (involves: 129P2/OlaHsd * CD-1)	abnormal immature B cell morphology	J:195301
	abnormal immune system organ morphology	J:195301
	abnormal lymphopoiesis	J:195301
	decreased double-positive T cell number	J:195301
	spleen atrophy	J:195301
	thymus atrophy	J:195301
Tdrd3^{Gt(RRK474)Byg}/Tdrd3^{Gt(RRK474)Byg} (involves: 129P2/OlaHsd)	abnormal B cell differentiation	J:210647
Tedc1^em1(IMPC)Tcp/Tedc1⁺ (C57BL/6NCrl-Tedc1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Teddm1a^em1(IMPC)Tcp/Teddm1a^em1(IMPC)Tcp (C57BL/6N-Teddm1a^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
Tekt1^{em1(IMPC)Ccpcz}/Tekt1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tekt1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	small lymph nodes	J:211773
Tenm4^em1(IMPC)Tcp/Tenm4^em1(IMPC)Tcp (C57BL/6NCrl-Tenm4^em1(IMPC)Tcp/Tcp)	decreased spleen weight	J:211773
Tent4a^{tm1b(EUCOMM)Hmgu}/Tent4a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tent4a^{tm1b(EUCOMM)Hmgu}/Ccpcz)	increased lymphocyte cell number	J:211773
Tent5a^{em1(IMPC)Ccpcz}/Tent5a^{em1(IMPC)Ccpcz} (C57BL/6N-Tent5a^{em1(IMPC)Ccpcz}/Ccpcz)	decreased Ly6C-positive mature NK cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased granulocyte number	J:211773
	increased leukocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Tent5c^{tm1b(KOMP)Wtsi}/Tent5c^{tm1b(KOMP)Wtsi} (C57BL/6N-Tent5c^{tm1b(KOMP)Wtsi}/Wtsi)	absent connection between subcutaneous lymph vessels and lymph sac	J:239583
Terb1^{tm1b(KOMP)Mbp}/Terb1⁺ (C57BL/6N-Terb1^{tm1b(KOMP)Mbp}/Ucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Terc^tm1Rdp/Terc^tm1Rdp (involves: 129/Sv * C57BL/6J * SJL)	decreased spleen B cell follicle number	J:60223
Terc^tm1Rdp/Terc^tm1Rdp (involves: 129/Sv * C57BL/6J * SJL)	decreased spleen germinal center number	J:60223
Tert^tm2.1Rdp/Tert^tm2.1Rdp (involves: C57BL/6)	decreased spleen weight	J:167227
Tert^tm2.1Rdp/Tert^tm2.1Rdp (involves: C57BL/6)	spleen atrophy	J:167227
Tespa1^tm1Smoc/Tespa1^tm1Smoc (B6.129-Tespa1^tmSmoc)	abnormal T cell differentiation	J:186446
	abnormal thymus morphology	J:186446
	decreased CD4-positive, alpha-beta T cell number	J:186446
	decreased CD8-positive, alpha-beta T cell number	J:186446
	decreased regulatory T cell number	J:186446
	decreased T cell number	J:186446
	increased memory T cell number	J:186446
	small thymus medulla	J:186446
Tespa1^tm1Smoc/Tespa1^tm1Smoc Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129 * C57BL/6 * DBA/2J)	decreased CD8-positive, alpha-beta T cell number	J:186446
Tespa1^tm1Smoc/Tespa1^tm1Smoc Tg(TcraTcrb)425Cbn/0 (B6.Cg-Tespa1^tm1Smoc Tg(TcraTcrb)425Cbn)	abnormal T cell differentiation	J:186446
	decreased CD4-positive, alpha-beta T cell number	J:186446
	decreased CD8-positive, alpha-beta T cell number	J:186446
Tespa1^tm1Smoc/Tespa1^tm1Smoc Tg(TcraTcrb)1100Mjb/0 (B6.Cg-Tespa1^tm1Smoc Tg(TcraTcrb)1100Mjb)	abnormal T cell differentiation	J:186446
	decreased CD4-positive, alpha-beta T cell number	J:186446
	decreased CD8-positive, alpha-beta T cell number	J:186446
Tet1^tm1.1Gxu/Tet1^tm1.1Gxu (involves: 129 * 129P2/OlaHsd * C57BL/6J)	decreased spleen iron level	J:315675
Tet1^tm1.1Jae/Tet1^tm1.1Jae (involves: 129S4/SvJae * C57BL/6)	decreased neutrophil cell number	J:175858
Tet1^tm1.2Jae/Tet1^tm1.2Jae Tet2^tm1.1Iaai/Tet2⁺ Tet3^tm1.1Yzhg/Tet3^tm1.1Yzhg Tg(Rorc-cre)1Litt/0 (involves: 129 * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB)	decreased effector memory T-helper cell number	J:333574
Tet1^tm1.2Jae/Tet1^tm1.2Jae Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tet3^tm1.1Yzhg/Tet3^tm1.1Yzhg Tg(Rorc-cre)1Litt/0 (involves: 129 * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB)	enlarged lymph nodes	J:333574
	enlarged spleen	J:333574
Tet2^{Gt(AN0709)Wtsi}/Tet2⁺ (B6.129P2-Tet2^{Gt(AN0709)Wtsi})	abnormal monocyte differentiation	J:174052
	abnormal spleen morphology	J:174052
	enlarged spleen	J:174052
	increased B cell number	J:174052
	increased leukocyte cell number	J:174052
	increased monocyte cell number	J:174052
Tet2^{Gt(AN0709)Wtsi}/Tet2^{Gt(AN0709)Wtsi} (B6.129P2-Tet2^{Gt(AN0709)Wtsi})	abnormal monocyte differentiation	J:174052
	abnormal spleen morphology	J:174052
	decreased pre-B cell number	J:174052
	decreased pro-B cell number	J:174052
	enlarged spleen	J:174052
	increased B cell number	J:174052
	increased DN1 thymic pro-T cell number	J:174052
	increased double-negative T cell number	J:174052
	increased leukocyte cell number	J:174052
	increased monocyte cell number	J:174052
Tet2^tm1.1Iaai/Tet2⁺ Tg(VAV1-cre)1Graf/0 (involves: 129S/SvEv * C57BL/6)	increased leukocyte cell number	J:174053
	increased monocyte cell number	J:174053
Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(Mx1-cre)1Cgn/0 (involves: 129S/SvEv * C57BL/6 * CBA)	abnormal myelopoiesis	J:234976
	decreased B cell number	J:234976
	enlarged spleen	J:234976
	increased granulocyte number	J:234976
Tet2^tm1.1Iaai/Tet2^tm1.1Iaai Tg(VAV1-cre)1Graf/0 (involves: 129S/SvEv * C57BL/6)	abnormal myeloid leukocyte morphology	J:174053
	enlarged spleen	J:174053
	increased leukocyte cell number	J:174053
	increased monocyte cell number	J:174053
	increased spleen weight	J:174053
	myeloid hyperplasia	J:174053
Tet2^tm1.1Mjxu/Tet2⁺ (involves: 129 * C57BL/6)	enlarged spleen	J:178415
	increased leukocyte cell number	J:178415
	increased monocyte cell number	J:178415
	myeloid hyperplasia	J:178415
Tet2^tm1.1Mjxu/Tet2^tm1.1Mjxu (involves: 129 * C57BL/6)	enlarged spleen	J:178415
	increased leukocyte cell number	J:178415
	increased monocyte cell number	J:178415
	increased neutrophil cell number	J:178415
	myeloid hyperplasia	J:178415
Tet2^tm1.2Rao/Tet2^tm1.2Rao (involves: C57BL/6NTac)	abnormal myelopoiesis	J:175222
Tet2^tm1.2Rao/Tet2^tm1.2Rao (involves: C57BL/6NTac)	increased splenocyte number	J:175222
Tet2^tm1Ics/Tet2^tm1Ics Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 * CBA)	abnormal spleen morphology	J:174052
	decreased pre-B cell number	J:174052
	decreased pro-B cell number	J:174052
	enlarged spleen	J:174052
	increased B cell number	J:174052
	increased DN1 thymic pro-T cell number	J:174052
	increased double-negative T cell number	J:174052
	increased leukocyte cell number	J:174052
	increased monocyte cell number	J:174052
	increased spleen red pulp amount	J:174052
Tex2^{tm1.1(KOMP)Vlcg}/Tex2⁺ (C57BL/6N-Tex2^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Tex29^{tm1.1(KOMP)Vlcg}/Tex29^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tex29^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Tex261^{tm1b(EUCOMM)Wtsi}/Tex261^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tex261^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Tfap4^tm1.1Litt/Tfap4^tm1.1Litt (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	abnormal T cell differentiation	J:176461
Tfr2^tm1.1Anro/Tfr2^tm1.1Anro (129.Cg-Tfr2^tm1.1Anro)	increased spleen iron level	J:160785
Tfr2^tm1.1Nsub/Tfr2^tm1.1Nsub (involves: 129T2/SvEms * C57BL/6)	decreased spleen iron level	J:114330
Tfr2^tm1.1Nsub/Tfr2^tm1.1Nsub (involves: 129T2/SvEms)	increased spleen iron level	J:160785
Tfr2^tm1Slu/Tfr2^tm1Slu (involves: 129X1/SvJ * C57BL/6J)	decreased spleen iron level	J:78360
Tfrc^em1(IMPC)H/Tfrc⁺ (C57BL/6N-Tfrc^em1(IMPC)H/H)	increased large unstained cell number	J:211773
Tfrc^tm1Nca/Tfrc⁺ (either: (involves: 129S4/SvJae * 129S6/SvEvTac) or (involves: 129S4/SvJae * C57BL/6))	decreased spleen iron level	J:54107
Tg(Ace2-ACE2)1Cqin/0 (involves: ICR)	lymph node necrosis	J:287631
Tg(Acp5-Adam8)#Rood/0 (involves: BALB/c * C57BL/6)	abnormal osteoclast differentiation	J:172936
	abnormal osteoclast morphology	J:172936
	increased osteoclast cell number	J:172936
Tg(Acp5-Selenow)#Djeo/0 (involves: FVB/N)	abnormal osteoclast differentiation	J:317012
Tg(Acp5-Selenow)#Djeo/0 (involves: FVB/N)	increased osteoclast cell number	J:317012
Tg(ACTB-Mgat3)2Nta/0 (involves: C57BL/6 * DBA/2)	decreased leukocyte cell number	J:80227
	decreased lymphocyte cell number	J:80227
	decreased neutrophil cell number	J:80227
	decreased spleen B cell follicle number	J:80227
	spleen atrophy	J:80227
Tg(ACTB-TNFRSF6B)754Jwu/? (B6.Cg-Tg(Actb-TNFRSF6B)754Jwu)	abnormal CD4-positive, alpha beta T cell morphology	J:148162
	decreased leukocyte cell number	J:148162
	enlarged lymph nodes	J:148162
	enlarged spleen	J:148162
	increased B-1a cell number	J:148162
Tg(Alb1-GP33/H2-K^b)1Hpi/0 Tg(TcrLCMV)318Sdz/0 (involves: C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:162605
Tg(Alb1-Myc)#Sst/0 Tg(MtTGFA)Lmb/0 (involves: C57BL/6 * CBA * CD-1)	decreased NK cell number	J:176432
	increased NK T cell number	J:176432
Tg(Alb-PDGFC)#Jcam/0 (involves: C57BL/6)	enlarged spleen	J:211984
Tg(ANX6)2Agh/0 (FVB/N-Tg(ANX6)2Agh)	thymus cortex hypoplasia	J:92579
Tg(aP2-SREBF1c)9884Reh/0 (involves: C57BL/6J * SJL)	abnormal abdominal lymph node morphology	J:50770
Tg(aP2-SREBF1c)9884Reh/0 (involves: C57BL/6J * SJL)	enlarged spleen	J:50770
Tg(APCS-Tnfsf11)#aKhs/0 (C57BL/6J-Tg(APCS-Tnfsf11)#aKhs)	abnormal osteoclast morphology	J:264357
	enlarged thymus medulla	J:264357
	increased osteoclast cell number	J:264357
Tg(APOA1)1Rub/Tg(APOA1)1Rub (C57BL/6-Tg(APOA1)1Rub/J)	abnormal spleen weight	J:190966
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh (C57BL/6-Tg(APOC1)1Lmh)	enlarged spleen	J:65036
Tg(APOE-FGF23R176Q)#Ack/0 (involves: C57BL/6J CBA)	decreased osteoclast cell number	J:93981
Tg(APP695)3Dbo/0 Tg(PSEN1dE9)S9Dbo/0 (Not Specified)	abnormal microglial cell morphology	J:139070
Tg(APPSWE)2576Kha/0 (involves: C57BL/6 * SJL)	microgliosis	J:159623
Tg(APPswe,PSEN1dE9)85Dbo/0 (D2.Cg-Tg(APPswe,PSEN1dE9)85Dbo)	microgliosis	J:227541
Tg(B19-RNAi:Il3)241Ckn/? (involves: BALB/cJ * C57BL/6J * FVB/N)	abnormal B cell differentiation	J:107618
	enlarged lymph nodes	J:107618
	enlarged spleen	J:107618
	increased pre-B cell number	J:107618
Tg(BCL2)22Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	abnormal B cell differentiation	J:93111
Tg(BCL2)22Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	increased B cell number	J:93111
Tg(BCL2)22Wehi/0 (involves: C57BL/6J * C57BL/6JWehi)	increased B cell number	J:88565
Tg(BCL2)22Wehi/0 Tg(IghMyc)22Bri/0 (involves: C57BL/6 * C57BL/6JWehi * SJL/J * SJL/JWehi)	abnormal B cell morphology	J:69571
	abnormal pre-B cell morphology	J:69571
	enlarged lymph nodes	J:69571
	enlarged spleen	J:69571
	enlarged thymus	J:69571
	increased B cell number	J:69571
	increased leukocyte cell number	J:69571
	increased pre-B cell number	J:69571
Tg(BCL2)25Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	abnormal B cell differentiation	J:131912
	abnormal plasma cell differentiation	J:131912
	increased T cell number	J:93111
Tg(BCL2)36Wehi/0 (involves: C57BL/6JWehi * SJL/JWehi)	increased B cell number	J:93111
	increased T cell derived lymphoma incidence	J:93111
	increased T cell number	J:93111
Tg(BCL2/IGH)1Tjd/? (involves: C3H/He * C57BL/6)	abnormal lymph node morphology	J:81147
	abnormal mononuclear cell differentiation	J:81147
	enlarged lymph nodes	J:81147
	enlarged spleen	J:81147
	increased B cell number	J:81147
	increased spleen white pulp amount	J:81147
	spleen hyperplasia	J:81147
Tg(BCL2/IGH)#Jcre/0 Tg(H2-K/Igh-Traf2)#Ywc/0 (involves: BALB/c C57BL/6 * CBA/J * FVB/N * SJL/J * SWR/J)	abnormal spleen marginal zone morphology	J:94116
	enlarged lymph nodes	J:94116
	enlarged spleen	J:94116
	increased B cell number	J:94116
	increased B-1a cell number	J:94116
	increased B-1b cell number	J:94116
	increased marginal zone B cell number	J:94116
	increased spleen weight	J:94116
Tg(BCL2/IGH)M23Tjd/? (involves: C3H/He * C57BL/6)	abnormal lymph node morphology	J:81147
	abnormal mononuclear cell differentiation	J:81147
	enlarged lymph nodes	J:81147
	enlarged spleen	J:81147
	increased B cell number	J:81147
	increased spleen white pulp amount	J:81147
	spleen hyperplasia	J:81147
Tg(C9orf72)500Lpwr/0 (FVB/NJ-Tg(C9orf72)500Lpwr)	microgliosis	J:239579
Tg(CAG-Bgeo,-Hras1,-EGFP)#Ichi/0 Tg(Flt4-cre)44Ichi/0 (involves: 129P2/OlaHsd * C57BL/6J)	lymphatic vessel hyperplasia	J:159024
Tg(CAG-Bgeo,-Hras1,-EGFP)#Ichi/0 Tg(Tek-cre)12Flv/0 (involves: 129P2/OlaHsd * C3H * C57BL/6)	lymphatic vessel hyperplasia	J:159024
Tg(CAG-Btc)2Ewo/0 (FVB/N-Tg(CAG-Btc)2Ewo)	increased spleen weight	J:103364
Tg(CAG-Btc)4Ewo/0 (FVB/N-Tg(CAG-Btc)4Ewo)	increased spleen weight	J:103364
Tg(CAG-cre/Esr1)5Amc/0 Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm (involves: 129S6/SvEvTac C57BL/6 * CBA)	microgliosis	J:221181
Tg(CAG-DPP4)4Yuzh/0 (C57BL/6-Tg(CAG-DPP4)4Yuzh)	abnormal spleen morphology	J:286175
Tg(CAG-DPP4)52Ctkt/0 (involves: C3H/HeJ * C57BL/6J)	abnormal mononuclear cell morphology	J:227925
Tg(CAG-dsRed2/RNAi:Tardbp)6Zxu/0 (involves: C57BL/6 * C57BL/6J * FVB/NJ * SJL)	microgliosis	J:207750
Tg(CAG-Has2)99Nita/0 Tg(MMTV-cre)4Mam/0 Tg(MMTVneu)202Mul/0 (FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTV-cre)4Mam Tg(MMTVneu)202Mul)	abnormal lymphatic vessel morphology	J:130531
	increased macrophage cell number	J:164205
Tg(CAG-Has2)99Nita/0 Tg(MMTVneu)202Mul/0 (FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTVneu)202Mul)	abnormal lymphatic vessel morphology	J:130531
Tg(CAG-Ncoa6)71Hwl/0 (involves: FVB)	spleen atrophy	J:80609
Tg(CAG-Ncoa6)71Hwl/0 (involves: FVB)	thymus atrophy	J:80609
Tg(CAG-Ncoa6)87Hwl/0 (involves: FVB)	spleen atrophy	J:80609
Tg(CAG-Ncoa6)87Hwl/0 (involves: FVB)	thymus atrophy	J:80609
Tg(CAG-Ncoa6)104Hwl/0 (involves: FVB)	spleen atrophy	J:80609
Tg(CAG-Ncoa6)104Hwl/0 (involves: FVB)	thymus atrophy	J:80609
Tg(CAG-PGDS)1Groy/0 (involves: FVB/N)	abnormal lymph node morphology	J:107651
Tg(CAG-Ptafr)1Tksh/0 (B6;D2-Tg(CAG-Ptafr)1Tksh/TkshRbrc)	increased mast cell number	J:38639
Tg(CAG-SPTLC1C133W)8EAmcc/0 (involves: C3H C57BL/6)	microgliosis	J:155748
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-APPSwInd)Dbo/0 (involves: C3H/HeJ * C57BL/6J)	microgliosis	J:236737
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-LRRK2)C77Cai/0 Tg(tetO-SNCA*A53T)E2Cai/0 (involves: C57BL/6)	microgliosis	J:156512
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-LRRK2)C7874Cai/0 Tg(tetO-SNCA*A53T)E2Cai/0 (involves: C57BL/6)	microgliosis	J:156512
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-LRRK2G2019S)E3Cai/0 Tg(tetO-SNCAA53T)E2Cai/0 (involves: C57BL/6)	microgliosis	J:156512
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-Mtor)#Atai/0 (involves: C57BL/6 DBA/2 * ICR)	microgliosis	J:211789
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-SNCA*A53T)E2Cai/0 (involves: C57BL/6)	microgliosis	J:156512
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-TARDBP)12Vle/0 (involves: C3H/HeJ * C57BL/6J)	microgliosis	J:170756
Tg(CD2-Ccdc86)1Hfuj/? (B6.FVB-Tg(CD2-Ccdc86)1Hfuj)	abnormal T cell morphology	J:151722
Tg(CD2-Ceacam1*4L)1Rsb/0 (involves: C57BL/6)	decreased T cell number	J:116136
Tg(CD2-Foxj1)#Stlp/0 (C57BL/6-Tg(CD2-Foxj1)#Stlp)	decreased CD4-positive, alpha-beta T cell number	J:122222
	decreased CD8-positive, alpha-beta T cell number	J:122222
	increased single-positive T cell number	J:122222
	lymphoid hypoplasia	J:122222
Tg(CD2-Ifngr2)1Pbro/? (B6.Cg-Tg(CD2-Ifngr2)1Pbro)	abnormal T-helper 1 cell differentiation	J:134448
Tg(CD2-Ifngr2)2Pbro/? (B6.Cg-Tg(CD2-Ifngr2)2Pbro)	abnormal T-helper 1 cell differentiation	J:134448
Tg(CD2-Ifngr2)2Pbro/? (NOD.Cg-Tg(CD2-Ifngr2)2Pbro)	abnormal splenic cell ratio	J:81981
Tg(CD2-Lmo2)#Thr/0 (involves: C57BL/6 * CBA)	enlarged spleen	J:102058
Tg(CD2-Lmo2)#Thr/0 (involves: C57BL/6 * CBA)	enlarged thymus	J:102058
Tg(CD2-Mir181d)38Oers/0 (involves: C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:212571
	decreased double-positive T cell number	J:212571
	decreased T cell number	J:212571
	thymus atrophy	J:212571
Tg(CD2-Mir181d)38Oers/0 Tg(TcraTcrb)425Cbn/0 (involves: C3H * C57BL/6)	decreased T cell number	J:212571
Tg(CD2-Myb/en)2Kmw/? (involves: C57BL/10 * CBA)	abnormal single-positive T cell number	J:126456
	decreased T cell number	J:126456
	increased double-negative T cell number	J:126456
Tg(CD2-Myb/en)2Kmw/Tg(CD2-Myb/en)2Kmw (involves: C57BL/10 * CBA)	decreased double-positive T cell number	J:126456
	decreased T cell number	J:126456
	increased double-negative T cell number	J:126456
	small spleen	J:126456
	small thymus	J:126456
Tg(CD2-Nfat5)1Snh/0 (involves: BALB/c * C57BL/6)	abnormal T cell differentiation	J:80066
	decreased CD4-positive, alpha-beta T cell number	J:80066
	decreased CD8-positive, alpha-beta T cell number	J:80066
	decreased T cell number	J:80066
	spleen hypoplasia	J:80066
	thymus hypoplasia	J:80066
Tg(CD2-Ppp2ca)#Gct/0 (involves: C57BL/6J)	abnormal T cell subpopulation ratio	J:184067
	enlarged lymph nodes	J:184067
	enlarged spleen	J:184067
	increased germinal center B cell number	J:184067
	increased neutrophil cell number	J:184067
Tg(CD2-Rorc)#Staka/0 (involves: C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:236222
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:230700
	decreased CD8-positive, alpha-beta T cell number	J:236222
	increased effector memory CD4-positive, alpha-beta T cell number	J:230700
Tg(CD2-S1PR1)1Ejg/? (involves: C57BL/6 * DBA/2)	decreased activated T cell number	J:96558
	increased activated T cell number	J:96558
	increased T cell number	J:96558
Tg(Cd2-Smad7)#Chbe/0 (involves: C57BL/6)	abnormal T-helper 1 cell differentiation	J:184670
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 (involves: C57BL/10)	abnormal positive T cell selection	J:113713
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 (involves: C57BL/10)	increased CD8-positive, alpha-beta T cell number	J:113713
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 (involves: C57BL/10 * CBA/Ca)	decreased CD8-positive, alpha-beta T cell number	J:113713
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 (involves: BALB/c * C57BL/10)	decreased CD8-positive, alpha-beta T cell number	J:113713
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * FVB/N)	abnormal positive T cell selection	J:126026
	decreased CD4-positive, alpha-beta T cell number	J:126026
	increased CD8-positive, alpha-beta T cell number	J:126026
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 Tg(Cd4-BCL2G101AD102AD103A)AWnt/0 (involves: C57BL/6 C57BL/10)	abnormal T cell clonal deletion	J:217939
	enlarged lymph nodes	J:217939
	increased T cell number	J:217939
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 Tg(LCKprBCL2)36Sjk/0 (involves: C57BL/6 * C57BL/10)	abnormal T cell clonal deletion	J:217939
Tg(CD2-Tgfbr2)1Grs/0 (C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)	enlarged lymph nodes	J:97523
Tg(CD2-Tgfbr2)1Grs/0 (C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)	enlarged spleen	J:97523
Tg(CD2-Tgfbr2)1Grs/? (C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)	abnormal CD8-positive, alpha beta T cell morphology	J:93665
Tg(CD2-Tgfbr2)1Grs/? (C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)	increased T cell derived lymphoma incidence	J:93665
Tg(CD2-Zbtb7b)C8Rbo/? (involves: C57BL/6)	absent CD8-positive, alpha-beta T cells	J:97610
Tg(CD2-Zbtb7b)C8Rbo/? (involves: C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:97610
Tg(CD2-Zbtb7b)C8Rbo/? Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6 * DBA/2J)	abnormal T cell differentiation	J:97610
Tg(CD2-Zbtb7b)C8Rbo/? Tg(TcrLCMV)327Sdz/? (involves: C57BL/6 * DBA/2J)	abnormal T cell differentiation	J:97610
Tg(CD2-Zbtb7b)C8Rbo/? Themis^tm1Lov/Themis^tm1Lov (involves: 129)	abnormal T cell differentiation	J:151075
Tg(Cd3d-Il5)NJ.1638Nal/? (involves: C57BL/6J * CBA/J)	abnormal eosinophil differentiation	J:123440
	abnormal spleen morphology	J:123440
	abnormal T cell number	J:123440
	enlarged lymph nodes	J:123440
	increased eosinophil cell number	J:123440
	increased leukocyte cell number	J:123440
	increased mature B cell number	J:123440
	increased monocyte cell number	J:123440
	increased neutrophil cell number	J:123440
	increased spleen weight	J:123440
Tg(CD3E)26Cpt/Tg(CD3E)26Cpt (involves: C57BL/6J * CBA/J)	abnormal thymus corticomedullary boundary morphology	J:81711
	absent NK cells	J:81711
	arrested T cell differentiation	J:81711
	decreased double-positive T cell number	J:54756
	decreased T cell number	J:54756
	decreased thymocyte number	J:81711
	decreased uterine NK cell number	J:134589
	thymus hypoplasia	J:54756
Tg(Cd4-BCL2G101AD102A*D103A)AWnt/0 (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell number	J:217939
	abnormal mesenteric lymph node morphology	J:217939
	abnormal splenic cell ratio	J:217939
	abnormal T cell clonal deletion	J:217939
	abnormal T cell subpopulation ratio	J:217939
	decreased double-positive T cell number	J:217939
	enlarged lymph nodes	J:217939
	enlarged spleen	J:217939
	increased activated T cell number	J:217939
	increased B cell number	J:217939
	increased central memory CD8 positive, alpha-beta T cell number	J:217939
	increased regulatory T cell number	J:217939
	increased single-positive T cell number	J:217939
	increased T cell number	J:217939
	lymphoid hyperplasia	J:217939
Tg(Cd4-BCL2G101AD102AD103A)AWnt/0 (involves: C57BL/6 CBA/J)	abnormal T cell clonal deletion	J:217939
Tg(Cd4-BCL2G101AD102AD103A)AWnt/0 Tg(Nr4a1-EGFP/cre)820Khog/0 (involves: C57BL/6 C57BL/6J)	abnormal T cell clonal deletion	J:217939
Tg(Cd4-BCL2G101AD102AD103A)AWnt/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6 C57BL/6J * DBA/2J)	abnormal T cell clonal deletion	J:217939
Tg(CD4-CIITA)357Ccum/? (involves: C57BL/6 * C57BL/6J * SJL)	increased osteoclast cell number	J:233241
Tg(Cd4-cre)1Cwi/0 Trmt6^em1Hbgl/Trmt6^em1Hbgl (involves: C57BL/6 * DBA/2J)	decreased CD4-positive, alpha-beta T cell number	J:336736
Tg(Cd4-cre)1Cwi/0 Trmt61a^em1Hbgl/Trmt61a^em1Hbgl (involves: C57BL/6 * DBA/2J)	abnormal CD4-positive T cell differentiation	J:336736
	decreased CD4-positive, alpha-beta T cell number	J:336736
	decreased CD8-positive, alpha-beta T cell number	J:336736
	increased CD4-positive, alpha-beta T cell number	J:336736
	increased CD8-positive, alpha-beta T cell number	J:336736
Tg(CD4-HIV)F21380Pjo/0 (involves: C3H * C57BL/6)	lymph node atrophy	J:78756
	spleen atrophy	J:78756
	thymus atrophy	J:78756
Tg(CD4-HIV)F21388Pjo/0 (involves: C3H * C57BL/6)	lymph node atrophy	J:78756
	spleen atrophy	J:78756
	thymus atrophy	J:78756
Tg(CD4-HIV)F21407Pjo/0 (involves: C3H * C57BL/6)	lymph node atrophy	J:78756
	spleen atrophy	J:78756
	thymus atrophy	J:78756
Tg(CD4-HIV)F26605Pjo/0 (involves: C3H * C57BL/6)	lymph node atrophy	J:78756
	spleen atrophy	J:78756
	thymus atrophy	J:78756
Tg(CD4-HIV)F26622Pjo/0 (involves: C3H * C57BL/6)	lymph node atrophy	J:78756
	spleen atrophy	J:78756
	thymus atrophy	J:78756
Tg(CD4-HIV)F26990Pjo/0 (involves: C3H * C57BL/6)	lymph node atrophy	J:78756
	spleen atrophy	J:78756
	thymus atrophy	J:78756
Tg(CD4-HIV)F27011Pjo/0 (involves: C3H * C57BL/6)	lymph node atrophy	J:78756
	spleen atrophy	J:78756
	thymus atrophy	J:78756
Tg(CD4-HIV)F27367Pjo/0 (involves: C3H * C57BL/6)	lymph node atrophy	J:78756
	spleen atrophy	J:78756
	thymus atrophy	J:78756
Tg(Cd4-Il17rb)#Cdon/? (involves: C57BL/6)	abnormal T cell differentiation	J:158594
Tg(Cd4-Il17rb)#Cdon/? (involves: C57BL/6)	increased eosinophil cell number	J:158594
Tg(Cd4-NPM/ALK)N1Ingh/0 (either: (involves: BALB/c * Swiss Webster) or (involves: C57BL/6 * Swiss Webster))	increased lymphoblastic lymphoma incidence	J:82127
Tg(Cd4-NPM/ALK)N1Ingh/0 (involves: C57BL/6 * Swiss Webster)	abnormal T cell differentiation	J:235890
	abnormal T cell morphology	J:235890
	increased DN3 thymocyte number	J:235890
	increased thymus tumor incidence	J:235890
Tg(Cd4-NPM/ALK)N1Ingh/0 Tg(TcraTcrb)1100Mjb/0 (involves: C57BL/6 * Swiss Webster)	abnormal double-negative T cell morphology	J:235890
	abnormal thymus morphology	J:235890
	increased T cell derived lymphoma incidence	J:235890
Tg(Cd4-TGFBR2)16Flv/? (involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd)	decreased B cell number	J:97554
	increased memory T cell number	J:97554
	lymph node hyperplasia	J:97554
	spleen hyperplasia	J:97554
Tg(Cd4-TGFBR2)16Flv/? (involves: C3H * C57BL/6)	abnormal CD8-positive, alpha-beta regulatory T cell morphology	J:134473
Tg(Cd4-Zbtb16)1797Aben/? (C57BL/6-Tg(Cd4-Zbtb16)1797Aben)	decreased CD4-positive, alpha-beta T cell number	J:139690
	increased CD4-positive, alpha-beta memory T cell number	J:139690
	increased T-helper 2 cell number	J:139690
Tg(Cd8aCd8b)3Erob/0 (involves: C57BL/6 * DBA/2)	abnormal CD8-positive, alpha-beta T cell differentiation	J:93004
	abnormal double-positive T cell morphology	J:93004
	decreased CD4-positive, alpha-beta T cell number	J:93004
	decreased double-negative T cell number	J:93004
	increased CD8-positive, alpha-beta T cell number	J:93004
Tg(Cd8aCd8b)3Erob/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6 * DBA/2)	abnormal CD4-positive, alpha beta T cell morphology	J:93004
	abnormal CD8-positive, alpha-beta T cell differentiation	J:93004
	increased CD8-positive, alpha-beta T cell number	J:93004
Tg(CD8aCD8b)57Scr/? (B6;SJL-Tg(CD8aCD8b)57Scr/J)	abnormal effector T cell morphology	J:92994
Tg(Cd8b1)46Erob/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal T cell subpopulation ratio	J:110916
	decreased T cell number	J:110916
	decreased thymocyte number	J:110916
Tg(CD19)1Tft/0 (involves: C57BL/6 * C57BL/6J * SJL)	decreased B cell number	J:27236
Tg(CD19)1Tft/Tg(CD19)1Tft (involves: C57BL/6 * C57BL/6J * SJL)	decreased B cell number	J:27236
	decreased immature B cell number	J:27236
Tg(CD19-Tnfsf7)#Rvl/0 (involves: C57BL/6)	abnormal metallophilic macrophage morphology	J:88620
	abnormal spleen marginal zone macrophage morphology	J:88620
	abnormal spleen marginal zone morphology	J:88620
	decreased B cell number	J:88620
	decreased mature B cell number	J:88620
	decreased transitional stage B cell number	J:88620
Tg(Cd68-BCL2)533Medz/0 (involves: 129 * C57BL/6)	abnormal immune system cell morphology	J:82809
Tg(Cd68-BCL2)535Medz/0 (involves: 129 * C57BL/6)	enlarged lymph nodes	J:82809
Tg(Cd68-BCL2)535Medz/0 (involves: 129 * C57BL/6)	enlarged spleen	J:82809
Tg(Cd74-Nlrc4*)1Kyas/0 (involves: C57BL/6N)	abnormal spleen morphology	J:219652
	enlarged spleen	J:219652
	increased neutrophil cell number	J:219652
	increased splenocyte number	J:219652
	increased T cell number	J:219652
Tg(Cd79b-TCL1A)BKTeit/0 (involves: C3H * C57BL/6)	abnormal lymph node morphology	J:79703
	abnormal spleen morphology	J:79703
	abnormal thymus morphology	J:79703
	enlarged lymph nodes	J:79703
	enlarged spleen	J:79703
	increased lymphocyte cell number	J:79703
Tg(CD207-Dta)312Dhka/? (FVB-Tg(CD207-Dta)312Dhka)	absent Langerhans cell	J:113309
Tg(CLEC4C-HBEGF)956Cln/0 (C57BL/6-Tg(CLEC4C-HBEGF)956Cln)	decreased CD8-positive, alpha-beta T cell number	J:166504
	decreased plasmacytoid dendritic cell number	J:166504
	decreased splenocyte number	J:166504
	small spleen	J:166504
Tg(Cma1-cre)ARoer/0 Tg(Kit*D814V)1Roer/0 (involves: C57BL/6)	increased mast cell number	J:169611
Tg(Cma1-cre)ARoer/0 Tg(Kit*D814V)3Roer/0 (involves: C57BL/6)	increased mast cell number	J:169611
Tg(CMV-cre)1Cgn/0 Tg(KitD814V)1Roer/0 (involves: BALB/cJ C57BL/6)	increased mast cell number	J:169611
Tg(CMV-cre)1Cgn/0 Tg(KitD814V)3Roer/0 (involves: BALB/cJ C57BL/6)	increased mast cell number	J:169611
Tg(CMV-cre)1Cgn/0 Trp53^tm4Att/Trp53⁺ (involves: 129S4/SvJae * BALB/cJ * C57BL/6J)	small thymus	J:217080
Tg(CMV-IghvaD11)CCat/0 Tg(CMV-IgkvaD11)BCat/0 (involves: C57BL/6 * SJL)	abnormal splenic cell ratio	J:79946
Tg(CMV-IghvaD11)DCat/0 Tg(CMV-IgkvaD11)ACat/0 (involves: C57BL/6 * SJL)	abnormal splenic cell ratio	J:79946
Tg(CMV-SALL4_iB)#Chai/? (Not Specified)	abnormal leukocyte morphology	J:115037
	abnormal myelopoiesis	J:115037
	abnormal neutrophil morphology	J:115037
	decreased leukocyte cell number	J:115037
	decreased neutrophil cell number	J:115037
	myeloid hyperplasia	J:115037
Tg(CMV-tTA)3Bjd/0 Tg(tetO-Prkar1ax2as)1Stra/0 (involves: C57BL/6 NMRI * SJL)	abnormal lymph node morphology	J:94953
Tg(Cnp-EGFR)10Nrat/0 (involves: C57BL/6 * SJL)	increased mast cell number	J:95933
Tg(Cnp-Gpr17)1Qrlu/0 (Not Specified)	microgliosis	J:154602
Tg(Col1a1-cre)1Kry/0 Vdr^tm2Ska/Vdr^tm2Ska (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj * FVB/N)	abnormal osteoclast differentiation	J:196471
	decreased osteoclast cell number	J:196471
Tg(Col1a1-Dkk1)1Hmk/? (B6.FVB-Tg(Col1a1-Dkk1)1Hmk)	increased osteoclast cell number	J:158620
Tg(Col1a1-FGF2,-Sapphire)203Mmh/Tg(Col1a1-FGF2,-Sapphire)203Mmh (involves: FVB/N)	increased osteoclast cell number	J:159949
Tg(Col1a1-Runx2)#Pmt/0 (involves: BALB/c * C57BL/6)	increased osteoclast cell number	J:167992
Tg(Col1a1-TK*)#Rowe/0 (involves: CD-1)	decreased osteoclast cell number	J:112520, J:217781
Tg(Col1a1-TK*)#Rowe/0 (involves: CD-1)	increased spleen weight	J:112520
Tg(Col1a1-tTA)139Niss/0 Tg(tetO-HTR4D100A)7Niss/0 (FVB/N-Tg(Col1a1-tTA)139Niss Tg(tetO-HTR4D100A)7Niss)	increased osteoclast cell number	J:131617
Tg(Col2a1-Fgfr3/GH)BDor/0 (FVB/N-Tg(Col2a1-Fgfr3/GH)BDor)	abnormal osteoclast differentiation	J:50292
Tg(Col10a1-Tg*L2263P)1Rpbh/0 (Not Specified)	decreased osteoclast cell number	J:154052
Tg(Col10a1-TgL2263P)1Rpbh/Tg(Col10a1-TgL2263P)1Rpbh (Not Specified)	decreased osteoclast cell number	J:154052
Tg(Cr2-cre)3Cgn/? Xrcc4^tm1Fwa/Xrcc4^tm2Fwa (involves: 129P2/OlaHsd * 129S6/SvEvTac)	abnormal class switch recombination	J:150339
Tg(Crh)227.1Pbl/0 (involves: C57BL/6 * SJL)	decreased spleen weight	J:92996
Tg(Crh)227.1Pbl/0 (involves: C57BL/6 * SJL)	decreased thymus weight	J:92996
Tg(CSTG-NPM1/RARA)#Sjch/0 (involves: C57BL/6)	enlarged spleen	J:55196
Tg(CSTG-NPM1/RARA)#Sjch/0 (involves: C57BL/6)	increased spleen red pulp amount	J:55196
Tg(CTSG-NUMA1/RARA)#Skr/0 (involves: C57BL/6)	abnormal spleen morphology	J:88103
	abnormal spleen red pulp morphology	J:88103
	enlarged spleen	J:88103
	increased granulocyte number	J:88103
	increased leukocyte cell number	J:88103
	increased neutrophil cell number	J:88103
	increased spleen germinal center size	J:88103
	increased spleen white pulp amount	J:88103
Tg(CTSG-PML/RARA)135Ley/? (Not Specified)	abnormal leukocyte cell number	J:77881
	abnormal spleen red pulp morphology	J:77881
	enlarged spleen	J:77881
	spleen hyperplasia	J:77881
Tg(CTSG-PML/RARA)135Ley/? (involves: C3H * C57BL/6)	abnormal spleen red pulp morphology	J:59080
	enlarged spleen	J:59080
	increased leukocyte cell number	J:59080
Tg(CTSG-PML/RARA)135Ley/0 Tg(CTSG-RARA/PML)#Ley/0 (involves: C3H * C57BL/6)	abnormal spleen red pulp morphology	J:59080
	enlarged spleen	J:59080
	increased leukocyte cell number	J:59080
Tg(CTSG-PML/RARA)135Ley/0 Wbcc1^SWR/J/? (involves: C3H/HeJ * C57BL/6J * SWR/J)	decreased leukocyte cell number	J:139159
Tg(CTSG-PML/RARA)135Ley/0 Wbcc2^SWR/J/? (involves: C3H/HeJ * C57BL/6J * SWR/J)	increased leukocyte cell number	J:139159
Tg(CTSG-PML/RARA)135Ley/0 Wbcc3^SWR/J/? (involves: C3H/HeJ * C57BL/6J * SWR/J)	increased leukocyte cell number	J:139159
Tg(CTSG-PML/RARA)6179Ppp/0 (Not Specified)	abnormal myelopoiesis	J:40373
	increased granulocyte number	J:40373
	increased leukocyte cell number	J:40373
Tg(CTSG-PML/RARA)#Ppp/0 (Not Specified)	abnormal myelopoiesis	J:78201, J:40373
	increased granulocyte number	J:40373
	increased leukocyte cell number	J:40373
Tg(CTSG-RARA/ZBTB16)#Ppp/0 (Not Specified)	abnormal myelopoiesis	J:65878
	enlarged spleen	J:65878
	myeloid hyperplasia	J:65878
Tg(CTSG-RARA/ZBTB16)#Ppp/0 Tg(CTSG-ZBTB16/RARA)#Ppp/0 (Not Specified)	abnormal myelopoiesis	J:65878
	increased leukocyte cell number	J:65878
Tg(CTSG-ZBTB16/RARA)#Ppp/0 (Not Specified)	abnormal myelopoiesis	J:78201
Tg(CTSG-ZBTB16/RARA)#Ppp/0 (Not Specified)	increased leukocyte cell number	J:65878, J:78201
Tg(CTSG-ZBTB16/RARA)#Sjch/0 (involves: C57BL/6)	abnormal myelopoiesis	J:55196
	abnormal spleen morphology	J:55196
	abnormal spleen red pulp morphology	J:55196
	enlarged spleen	J:55196
	increased leukocyte cell number	J:55196
	myeloid hyperplasia	J:55196
Tg(Dct-Grm1)ESzc/0 (involves: C57BL/6J)	enlarged inguinal lymph nodes	J:83183
Tg(Dct-Grm1)ESzc/0 (involves: C57BL/6J)	enlarged submandibular lymph nodes	J:83183
Tg(DMD-APP)7Neve/0 (involves: C57BL/6 SJL)	abnormal microglial cell morphology	J:100978
Tg(DMD-APP)18Neve/0 (involves: C57BL/6 SJL)	abnormal microglial cell morphology	J:100978
Tg(DO11.10)10Dlo/? (involves: BALB/c * C3H * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:70572
Tg(DO11.10)10Dlo/? (involves: BALB/c * C3H * C57BL/6)	decreased double-positive T cell number	J:70572
Tg(DO11.10)10Dlo/? Tox^tm1.1Kay/Tox^tm1.1Kay (involves: 129S/Sv * BALB/c * C3H * C57BL/6)	arrested T cell differentiation	J:131287
	decreased T cell number	J:131287
Tg(ED-L2-IL1RN/IL1B)#Tcw/? (B6.Cg-Tg(ED-L2-IL1RN/IL1B)#Tcw)	enlarged spleen	J:180282
Tg(EEF1A1-SHC1)1Ravi/? Tg(Lck-cre)1Cwi/? (involves: 129 C57BL/6)	abnormal double-negative T cell morphology	J:78180
	decreased double-positive T cell number	J:78180
	decreased single-positive T cell number	J:78180
	thymus hypoplasia	J:78180
Tg(EIF1AX-Il31ra)1Jagr/0 (involves: C3H * C57BL/6)	abnormal leukopoiesis	J:91124
	cutaneous mastocytosis	J:91124
	decreased T cell number	J:91124
	enlarged lymph nodes	J:91124
	increased activated T cell number	J:91124
	increased B cell number	J:91124
	increased memory T cell number	J:91124
Tg(Ela-KRASG12D)9Eps/0 (involves: C57BL/6 FVB)	increased regulatory T cell number	J:231759
Tg(Ela-KRASG12D)9Eps/0 Tg(Mt1-TGFBR2)AM3Epb/0 (involves: C57BL/6 * FVB)	increased regulatory T cell number	J:231759
Tg(Ela-KRASG12D)9Eps/0 Tgfbr1^tm1Bopa/Tgfbr1⁺ (involves: 129S1/SvImJ C57BL/6 * FVB)	increased CD8-positive, alpha-beta T cell number	J:231759
Tg(Emu-FGFR3)A5Wmk/0 (FVB/N-Tg(Emu-FGFR3)A5Wmk)	lymphoid hyperplasia	J:160845
Tg(Emu-FGFR3)D3Wmk/0 (FVB/N-Tg(Emu-FGFR3)D3Wmk)	lymphoid hyperplasia	J:160845
Tg(Emu-Pim1)64aBrn/0 (involves: C57BL/6LiA * CBA)	enlarged lymph nodes	J:79624
	enlarged spleen	J:79624
	enlarged thymus	J:79624
	increased T cell derived lymphoma incidence	J:79624
Tg(Emu-TXLNA)1Amjr/0 (B6.Cg-Tg(Emu-TXLNA)1Amjr)	enlarged spleen	J:117018
	increased B cell number	J:117018
	increased B-1 B cell number	J:117018
	increased B-2 B cell number	J:117018
	increased germinal center B cell number	J:117018
	increased marginal zone B cell number	J:117018
	increased plasma cell number	J:117018
	lymphoid hyperplasia	J:117018
Tg(Emu-Zfp521)1Homy/0 (Not Specified)	abnormal B cell differentiation	J:160392
Tg(Emu-Zfp521)1Homy/0 (Not Specified)	increased B cell number	J:160392
Tg(EmuSR-HDAC9)1468Kpet/0 (involves: C57BL/6 * CBA)	abnormal spleen marginal zone morphology	J:237420
	enlarged spleen	J:237420
	increased B cell number	J:237420
Tg(EmuSR-tTa)83Bop/0 Tg(IghMyc)22Bri/0 Tg(tetO-RNAi:Trp53)ASlowe/0 (involves: C57BL * C57BL/6 * FVB/N * SJL)	enlarged spleen	J:123006
Tg(EmuSR-tTa)83Bop/Tg(EmuSR-tTa)83Bop Tg(tetO-NPM1/ALK,-luc)2Gde/0 (involves: FVB/N)	enlarged lymph nodes	J:160236
	enlarged spleen	J:160236
Tg(EmuSR-tTa)83Bop/Tg(EmuSR-tTa)83Bop Tg(tetO-TPM3/ALK,-luc)2Gde/0 (involves: FVB/N)	enlarged lymph nodes	J:160236
	enlarged spleen	J:160236
Tg(Eno2-Hgf)1Tnak/0 Tg(SOD1G93A)^dl1Gur/0 (involves: C57BL/6 C57BL/6J * SJL/J)	microgliosis	J:128738
Tg(Eno2-Hmox1)2Main/Tg(Eno2-Hmox1)2Main (involves: C57BL/6J)	enlarged spleen	J:120240
Tg(EPO33)72Ptc/0 (involves: C57BL/6J * SJL/J)	enlarged spleen	J:92650
Tg(Fabp2-Arg1)1Wla/Tg(Fabp2-Arg1)1Wla (involves: FVB)	abnormal B cell differentiation	J:80204
	abnormal Peyer's patch morphology	J:80204, J:80556
	decreased B cell number	J:80204
	decreased Peyer's patch number	J:80556
	decreased pre-B cell number	J:80204
	decreased spleen B cell follicle number	J:80204
	decreased spleen weight	J:80556
	decreased transitional stage B cell number	J:80204
	small Peyer's patches	J:80556
	small spleen	J:80204
Tg(Fabp4-Phb*Y114F)#Smis/0 (Not Specified)	abnormal lymph node morphology	J:227976
	abnormal spleen morphology	J:227976
	enlarged lymph nodes	J:227976
	enlarged spleen	J:227976
	increased lymphocyte cell number	J:227976
Tg(Fli1)1Ber/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)	increased thymocyte number	J:33052
Tg(FOXJ1-ACE2)1Rba/0 (involves: C3H * C57BL/6)	decreased lymphocyte cell number	J:288386
Tg(Foxp3-HBEGF/EGFP)23.2Spar/0 (involves: C57BL/6NCrl)	decreased regulatory T cell number	J:125295
	enlarged lymph nodes	J:125295
	enlarged spleen	J:125295
	increased spleen red pulp amount	J:125295
	increased spleen white pulp amount	J:125295
	lymph node hyperplasia	J:125295
Tg(Gfap-gp120)2Lms/0 (involves: C57BL/6 * SJL)	abnormal microglial cell morphology	J:146427
Tg(Gfap-gp120)2Lms/0 (involves: C57BL/6 * SJL)	microgliosis	J:146427
Tg(Gfap-gp120)10Lms/0 (involves: C57BL/6 * SJL)	microgliosis	J:146427
Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan/0 (involves: C57BL/6)	abnormal microglial cell morphology	J:132679
Tg(Gfap-TK)7.1Mvs/0 (involves: C57BL/10 * CBA * CFLP)	increased neutrophil cell number	J:104241
Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem/0 (either: FVB-Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem or (involves: C57BL/6 * FVB))	abnormal thymus development	J:67796
	abnormal thymus lobule morphology	J:67796
	decreased thymocyte number	J:67796
	thymus hypoplasia	J:67796
Tg(H2-D-Il15)3304Clgr/? (FVB/N-Tg(H2-D-Il15)3304Clgr)	abnormal T cell morphology	J:67478
	abnormal T cell subpopulation ratio	J:67478
	enlarged lymph nodes	J:67478
	enlarged spleen	J:67478
	increased lymphocyte cell number	J:67478
	increased memory T cell number	J:67478
	increased NK cell number	J:67478
	increased spleen white pulp amount	J:67478
Tg(H2-Ea-G6pc2)69Tkay/? (NOD-Tg(H2-Ea-G6pc2)69Tkay)	abnormal CD8-positive, alpha beta T cell morphology	J:117352
Tg(H2-Ea-HA)HACIIAjca/0 Tg(Tcra/Tcrb)1Vbo/0 (C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo)	abnormal CD4-positive, alpha beta T cell morphology	J:209872
Tg(H2-Ea-HA)HACIIAjca/0 Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0 (C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)	abnormal CD4-positive, alpha beta T cell morphology	J:209872
	enlarged lymph nodes	J:209872
Tg(H2-Ea-Il7)10Rhdr/0 (involves: C57BL/6)	abnormal B cell morphology	J:81133
Tg(H2-Ea-Il7)10Rhdr/0 (involves: C57BL/6)	abnormal double-negative T cell morphology	J:81133
Tg(H2-Ea-Il7)10Rhdr/0 (involves: C57BL/6 * DBA/2)	increased pre-B cell number	J:171924
Tg(H2-Ea-Il7)10Rhdr/0 (involves: C57BL/6 * DBA/2)	increased pro-B cell number	J:171924
Tg(H2-Ea-Ins2)1Wehi/Tg(H2-Ea-Ins2)1Wehi (NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)	abnormal CD8-positive, alpha beta T cell morphology	J:117352
Tg(H2-Ea-LACK)1Ngkh/0 (C.Cg-Tg(H2-Ea-LACK)1Ngkh)	decreased T-helper 2 cell number	J:181384
Tg(H2-Ea-LACK)1Ngkh/0 (C.Cg-Tg(H2-Ea-LACK)1Ngkh)	increased T-helper 1 cell number	J:181384
Tg(H2-Ea-Tnfsf9)16Lpc/0 (involves: C57BL/6)	abnormal lymph node B cell domain morphology	J:132372
	decreased B cell number	J:132372
	decreased spleen B cell follicle number	J:132372
	enlarged spleen	J:132372
	increased granulocyte number	J:132372
	increased lymphocyte cell number	J:132372
	increased macrophage cell number	J:132372
	increased memory T cell number	J:145439
	increased NK cell number	J:132372
	spleen hyperplasia	J:132372
Tg(H2-K-BCL2)1Josd/0 (involves: C57BL/6 * C57BL/Ka * C3H)	abnormal lymph organ size	J:80894
	enlarged lymph nodes	J:80894
	enlarged spleen	J:80894
	enlarged thymus	J:80894
	increased leukocyte cell number	J:80894
Tg(H2-K-Cd86)7All/0 (involves: C57BL/6J * CBA)	abnormal B cell differentiation	J:112475
	decreased B cell number	J:112475
	increased CD4-positive, alpha-beta T cell number	J:112475
	increased CD8-positive, alpha-beta T cell number	J:112475
Tg(H2-K-Cd86)7All/0 (B6.Cg-Tg(H2-K-Cd86)7All)	decreased B cell number	J:112266
	decreased CD4-positive, alpha-beta T cell number	J:112266
	increased CD8-positive, alpha-beta T cell number	J:112266
	increased T cell number	J:112266
	lymph node hyperplasia	J:112266
	lymphoid hyperplasia	J:112266
Tg(H2-K-Cd86)7All/0 (involves: BALB/c * C57BL/6 * CBA)	increased splenocyte number	J:112266
	lymph node hyperplasia	J:112266
	spleen hyperplasia	J:112266
Tg(H2-K-Cd86)27All/0 (involves: C57BL/6J * CBA)	abnormal B cell differentiation	J:112475
Tg(H2-K-Cd86)27All/0 (involves: C57BL/6J * CBA)	decreased B cell number	J:112475
Tg(H2-K-Cd86)31All/0 (involves: C57BL/6J * CBA)	increased CD4-positive, alpha-beta T cell number	J:112475
Tg(H2-K-Cd86)31All/0 (involves: C57BL/6J * CBA)	increased CD8-positive, alpha-beta T cell number	J:112475
Tg(H2-K-DUSP5)21Wjl/0 (involves: C57BL/6J * CBA)	abnormal T cell number	J:138077
	decreased single-positive T cell number	J:138077
	increased CD4-positive, alpha-beta T cell number	J:138077
	increased CD8-positive, alpha-beta T cell number	J:138077
	increased double-positive T cell number	J:138077
	increased plasma cell number	J:138077
	increased single-positive T cell number	J:138077
Tg(H2-K-Fosl1)1Wag/0 (involves: C57BL/6 * CBA)	enlarged spleen	J:64494
Tg(H2-K-Fosl2,-EGFP)13Wag/0 (either: 129.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag or B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag)	thymus fibrosis	J:139032
Tg(H2-K-Hmga1)#Lmsr/0 (involves: C57BL/6 * SJL)	increased leukocyte cell number	J:90252
Tg(H2-K-IL6)2Srj/0 (B6.Cg-Tg(H2-K-IL6)2Srj)	abnormal granulocyte morphology	J:185153
	abnormal lymph node germinal center morphology	J:185153
	abnormal lymph node morphology	J:185153
	abnormal spleen germinal center morphology	J:185153
	abnormal spleen red pulp morphology	J:185153
	enlarged lymph nodes	J:185153
	enlarged spleen	J:185153
	increased plasma cell number	J:185153
Tg(H2-K-MC159/EGFP)13Fkmc/0 (involves: C57BL/6)	abnormal lymphopoiesis	J:138050
	enlarged spleen	J:138050
	increased follicular B cell number	J:138050
Tg(H2-K-MC159/EGFP)13Fkmc/Tg(H2-K-MC159/EGFP)13Fkmc (involves: C57BL/6)	increased double-negative T cell number	J:138050
	increased T cell number	J:138050
Tg(H2-K-TcrbP14)128Mak/? (involves: C57BL/6 * C57L * DBA/2)	abnormal CD8-positive, alpha-beta T cell differentiation	J:111265
	abnormal T cell clonal deletion	J:111265
	abnormal T cell differentiation	J:111265
	increased CD8-positive, alpha-beta T cell number	J:111265
Tg(H2-K^b-IL21)5Wjl/0 (involves: 129)	abnormal B cell differentiation	J:93740
	abnormal class switch recombination	J:93740
	decreased follicular B cell number	J:93740
	decreased marginal zone B cell number	J:93740
	decreased mature B cell number	J:93740
	decreased transitional stage T2 B cell number	J:93740
	increased immature B cell number	J:93740
	increased transitional stage T1 B cell number	J:93740
Tg(H2-K^b-Jak2V617F)2Shmd/0 (involves: C57BL/6 DBA/2)	abnormal spleen morphology	J:130189
	enlarged spleen	J:130189
	increased leukocyte cell number	J:130189
	increased neutrophil cell number	J:130189
	increased spleen red pulp amount	J:130189
	increased spleen weight	J:130189
	myeloid hyperplasia	J:130189
	spleen fibrosis	J:130189
Tg(H2-K^b-Tcra,-Tcrb)1640Kurs/0 (SJL.FVB-Tg(H2-K^b-Tcra,-Tcrb)1640Kurs)	increased T-helper 1 cell number	J:149511
	increased T-helper 17 cell number	J:149511
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish (C57BL/6-Tg(H2-L-IL6)1Kish)	abnormal myelopoiesis	J:128016
	enlarged lymph nodes	J:128016, J:138762
	enlarged spleen	J:128016, J:138762
	increased monocyte cell number	J:128016
	increased neutrophil cell number	J:128016
	increased plasma cell number	J:128016, J:138762
Tg(H2-L-IL6)40Csk/0 (involves: C57BL/6)	enlarged lymph nodes	J:207264
	enlarged spleen	J:207264
	increased spleen weight	J:207264
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish (C57BL/6-Tg(H2-L-IL6)46Kish)	enlarged axillary lymph nodes	J:40405
	enlarged mesenteric lymph nodes	J:40405
	increased plasma cell number	J:40405
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish (involves: BALB/c * C57BL/6)	abnormal immune system organ morphology	J:40405
	abnormal lymph node morphology	J:40405
	enlarged mesenteric lymph nodes	J:40405
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish (C.B6-Tg(H2-L-IL6)46Kish)	abnormal spleen trabecular artery morphology	J:177820
	abnormal spleen trabecular vein morphology	J:177820
	enlarged spleen	J:177820
Tg(H2KePCC)2403Stoe/? Tg(TcraTcrbAD10)1Hed/? (involves: C57BL/6 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:92997
Tg(H2KmPCC)2939Stoe/0 Tg(Tcra2B4)1Mmd/0 Tg(Tcrb2B4)1Mmd/0 (involves: C3H/HeJ * C57BL/6 * SJL)	abnormal T cell differentiation	J:50143
	decreased thymocyte number	J:50143
Tg(H2KmPCC)2939Stoe/? Tg(TcrAND)53Hed/? (involves: C57BL/6 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:92997
Tg(H2KmPCC)2939Stoe/? Tg(TcraTcrbAD10)1Hed/? (involves: C57BL/6 * SJL)	decreased CD4-positive, alpha-beta T cell number	J:92997
Tg(HBB-Myc)#Cos/0 (involves: C57BL/6J * CBA/J)	abnormal immune system organ morphology	J:276641
Tg(HBVX,-Myc)#Skp/Tg(HBVX,-Myc)#Skp (Not Specified)	increased macrophage cell number	J:81098
Tg(Igh3H9)41Mwg/? (involves: C57BL/6 * SJL)	abnormal B cell differentiation	J:119625
Tg(Igh*-Mir125b-1)5Toki/0 (Not Specified)	enlarged spleen	J:178816
Tg(Igh*-Mir125b-1)116Toki/0 (Not Specified)	enlarged spleen	J:178816
	increased B cell number	J:178816
	increased T cell derived lymphoma incidence	J:178816
Tg(Igh-3/Igh-6VD93)1241Ust/? (C57BL/6-Tg(Igh-3/Igh-6VD93)1241Ust)	abnormal B cell morphology	J:135209
	decreased pre-B cell number	J:135209
Tg(Igh-3VD93)343Ust/? (involves: C57BL/6 * SJL)	abnormal B cell morphology	J:135209
Tg(Igh-3VD93)343Ust/? (involves: C57BL/6 * SJL)	decreased pre-B cell number	J:135209
Tg(Igh-6-Cd80)1Gjf/0 (involves: FVB)	decreased B cell number	J:44271
Tg(Igh-6-Cd80)1Gjf/0 (B6.Cg-Tg(Igh-6-Cd80)1Gjf)	abnormal T cell number	J:112266
Tg(Igh-6-Cd80)1Gjf/0 (NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ)	decreased B cell number	J:131077
	decreased B-2 B cell number	J:131077
	decreased follicular B cell number	J:131077
	decreased immature B cell number	J:131077
	decreased mature B cell number	J:131077
Tg(Igh-6-Cd86)1Akab/0 (involves: FVB)	decreased B cell number	J:44271
Tg(Igh-6/Igh-V125)2Jwt/0 Tg(Igk-C/Igk-V125)1Jwt/0 (NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)	abnormal B cell number	J:91865
Tg(Igh-Abl1)40Sco/0 (involves: C57BL/6JWehi * SJL/JWehi)	abnormal peripheral lymph node morphology	J:78204
	enlarged mesenteric lymph nodes	J:78204
	enlarged spleen	J:78204
Tg(Igh-Abl1)40Sco/0 Tg(IghMyc)22Bri/0 (involves: C57BL/6 * C57BL/6JWehi * SJL/J * SJL/JWehi)	enlarged mesenteric lymph nodes	J:78204
Tg(Igh-HMGA2)#Cro/0 (FVB/N-Tg(Igh-HMGA2)#Cro)	abnormal splenic cell ratio	J:233225
	decreased B cell number	J:233225
	decreased T cell number	J:233225
	enlarged lymph nodes	J:233225
	enlarged spleen	J:233225
	increased T cell number	J:233225
Tg(Igh-HOX11)11Idd/0 (CD-1)	abnormal immunoglobulin V(D)J recombination	J:52782
	increased leukocyte cell number	J:52782
	myeloid hyperplasia	J:52782
	spleen hyperplasia	J:52782
Tg(Igh-Lmp2a)ERlon/0 (involves: C57BL/6 * SJL)	decreased B cell number	J:129571
Tg(Igh-Maf)68Staka/0 (C57BL/6-Tg(Igh-Maf)68Staka)	abnormal spleen morphology	J:168074
	enlarged spleen	J:168074
	increased plasma cell number	J:168074
Tg(Igh-Maf)524Staka/0 (involves: C57BL/6 * C57BL/6J * DBA/2)	abnormal spleen morphology	J:168074
	enlarged spleen	J:168074
	increased plasma cell number	J:168074
Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0 (FVB/N-Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro)	abnormal lymphopoiesis	J:162077
	abnormal spleen morphology	J:162077
	enlarged spleen	J:162077
	increased B-1a cell number	J:162077
	spleen hyperplasia	J:162077
Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0 Tg(Igh-V186.2-TCL1A)3Cro/0 (involves: C3H * C57BL/6 * FVB/N)	increased B-1a cell number	J:162077
	spleen hyperplasia	J:162077
Tg(Igh-Mir155)8Cro/0 (involves: FVB/N)	abnormal lymphopoiesis	J:109591
	abnormal spleen B cell follicle morphology	J:109591
	decreased leukocyte cell number	J:109591
	decreased spleen white pulp amount	J:109591
	enlarged spleen	J:109591
	increased B cell number	J:109591
	increased lymphoblastic lymphoma incidence	J:109591
	increased pre-B cell number	J:109591
	increased spleen white pulp amount	J:109591
	intermingled spleen red and white pulp	J:109591
Tg(Igh-Mir155)10Cro/0 (involves: FVB/N)	enlarged spleen	J:109591
Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs (B6.Cg-Tg(Igh-Mir210)#aKgcs)	abnormal class switch recombination	J:205868
	abnormal spleen marginal zone morphology	J:205868
	decreased marginal zone B cell number	J:205868
	decreased mature B cell number	J:205868
	decreased pre-B cell number	J:205868
	decreased pro-B cell number	J:205868
	increased B-1a cell number	J:205868
Tg(Igh-Pim1)1Brn/0 (involves: C57BL/6LiA * CBA)	enlarged lymph nodes	J:79624
	enlarged spleen	J:79624
	enlarged thymus	J:79624
	increased T cell derived lymphoma incidence	J:79624
Tg(Igh-ROR1)1Kip/0 (C57BL/6-Tg(Igh-ROR1)1Kip)	enlarged spleen	J:206368
	increased lymphocyte cell number	J:206368
	increased mature B cell number	J:206368
Tg(Igh-ROR1)1Kip/0 Tg(Igh-V186.2-TCL1A)3Cro/0 (B6.Cg-Tg(Igh-ROR1)1Kip Tg(Igh-V186.2-TCL1A)3Cro)	enlarged spleen	J:206368
	increased lymphocyte cell number	J:206368
	increased mature B cell number	J:206368
Tg(Igh-TCL1A)1Ypek/0 (FVB/N-Tg(Igh-TCL1A)1Ypek)	enlarged spleen	J:160184
Tg(Igh-V186.2-TCL1A)3Cro/0 (involves: C3H * C57BL/6)	abnormal B cell morphology	J:76574
	increased marginal zone B cell number	J:76574
	spleen hyperplasia	J:76574
Tg(Igh-V-CD40lg)#Tsub/0 (involves: C57BL/6)	abnormal bronchus-associated lymphoid tissue morphology	J:89855
	enlarged lymph nodes	J:89855
	enlarged spleen	J:89855
	increased splenocyte number	J:89855
Tg(IGH@)SALed/0 (involves: C57BL/6 CD-1)	abnormal mature B cell morphology	J:131938
Tg(IGH@yH1)2BJkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:23827
Tg(IGH@yH1)2BJkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin heavy chain V(D)J recombination	J:23827
Tg(IGH@yH1)2BJkbv/0 Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:23827
Tg(IghelMD4)4Ccg/0 (involves: C3H/HeJ * C57BL/6)	decreased pre-B cell number	J:115059
Tg(IghelMD4)4Ccg/0 (involves: C3H/HeJ * C57BL/6)	decreased pro-B cell number	J:115059
Tg(IghelMD4)4Ccg/0 (involves: C57BL/6)	decreased pre-B cell number	J:115059
Tg(IghelMD4)4Ccg/0 (involves: C57BL/6)	decreased pro-B cell number	J:115059
Tg(IghelMD4)4Ccg/0 (C57BL/6-Tg(IghelMD4)4Ccg)	abnormal B cell morphology	J:78308, J:109923, J:132538
	abnormal B-2 B cell morphology	J:132538
	abnormal germinal center B cell morphology	J:109923
	abnormal immature B cell morphology	J:109923
	abnormal mature B cell morphology	J:89156, J:109923
	abnormal plasma cell morphology	J:109923
	abnormal pro-B cell morphology	J:109923
	increased immature B cell number	J:78308, J:132538
Tg(IghelMD4)4Ccg/0 Tg(KLK4mHEL)6Ccg/0 (NOD.B6-Tg(IghelMD4)4Ccg Tg(KLK4mHEL)6Ccg/Dvs)	decreased B cell number	J:89156
Tg(IghelMD4)4Ccg/0 Tg(KLK4mHEL)6Ccg/0 (C57BL/6-Tg(IghelMD4)4Ccg Tg(KLK4mHEL)6Ccg)	decreased B cell number	J:89156
Tg(IghelMD4)4Ccg/? Tg(KLK4mHEL)6Ccg/? (involves: C57BL/6)	arrested B cell differentiation	J:78307
	decreased mature B cell number	J:78307
	increased immature B cell number	J:78307
Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (NOD.B6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg/Dvs)	abnormal B cell clonal deletion	J:89156
	abnormal B cell morphology	J:89156
Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (C57BL/6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg)	abnormal germinal center B cell morphology	J:109923
	abnormal immature B cell morphology	J:109923
	abnormal mature B cell morphology	J:109923
	abnormal plasma cell morphology	J:109923
	abnormal pro-B cell morphology	J:109923
	abnormal spleen B cell follicle morphology	J:109923
	decreased B cell number	J:89156
Tg(IghelMD4)4Ccg/0 Tg(ML5sHEL)5Ccg/0 (involves: C57BL/6)	abnormal spleen primary B follicle morphology	J:76134
	decreased B cell number	J:76134
	decreased marginal zone B cell number	J:132538
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg (NOD.B6-Tg(IghelMD4)4Ccg/DvsJ)	abnormal mature B cell morphology	J:80859, J:89156
	decreased CD8-positive, alpha-beta T cell number	J:80859
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg (involves: C57BL/6)	decreased pre-B cell number	J:171924
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg (involves: C57BL/6)	decreased pro-B cell number	J:171924
Tg(IghMyc)22Bri/? (involves: C57BL * C57BL/6 * SJL)	enlarged spleen	J:121564
Tg(IghMyc)22Bri/? (involves: C57BL * C57BL/6 * SJL)	increased lymphocyte cell number	J:121564
Tg(IghMyc)22Bri/0 (involves: C57BL/6 * SJL)	abnormal lymphopoiesis	J:78177
	enlarged lymph nodes	J:78177
	enlarged spleen	J:78177
	enlarged thymus	J:78177
	increased leukocyte cell number	J:186117
	increased pre-B cell number	J:223213
Tg(IghMyc)22Bri/0 (B6.Cg-Tg(IghMyc)22Bri/J)	enlarged lymph nodes	J:354285, J:164200
Tg(IghMyc)22Bri/0 (B6.Cg-Tg(IghMyc)22Bri/J)	spleen hyperplasia	J:164200
Tg(IghMyc)22Bri/0 Tg(Igk-V21-Bax)1967Bvn/0 (involves: C57BL/6 * FVB/N)	enlarged spleen	J:89049
	increased transitional stage B cell number	J:89049
Tg(IghMyc)22Bri/0 Xiap^tm1Hs/Xiap^tm1Hs (B6.Cg-Xiap^tm1Hs Tg(IghMyc)22Bri)	decreased leukocyte cell number	J:138979
Tg(Igk-Lta/Ltb)4Cys/0 (involves: C57BL/6J * DBA/2J)	abnormal B cell morphology	J:73100
Tg(Igk-Lta/Ltb)10Cys/0 (involves: C57BL/6J * DBA/2J)	abnormal B cell morphology	J:73100
Tg(Igk-V21-Bax)1967Bvn/0 (involves: FVB/N)	abnormal plasma cell morphology	J:89049
Tg(Igk-V21-Bax)1967Bvn/0 (involves: FVB/N)	increased transitional stage B cell number	J:89049
Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal B cell morphology	J:23827
Tg(IGK@yK1)9.2CJkbv/0 (involves: 129P2/OlaHsd)	abnormal immunoglobulin light chain V-J recombination	J:23827
Tg(Igkv3-5-MYC)24Plbe/0 (C57BL/6J-Tg(Igkv3-5-MYC)DLoxP4Plbe/PlbeMmmh)	abnormal plasma cell differentiation	J:131912
	increased plasma cell number	J:131912
Tg(Igl-2MOPC315)1275Ust/? (C57BL/6-Tg(Igl-2MOPC315)1275Ust)	abnormal B cell morphology	J:134666
Tg(Igl-2MOPC315)1275Ust/? (C57BL/6-Tg(Igl-2MOPC315)1275Ust)	decreased immature B cell number	J:134666
Tg(IGL-MYC)3Hm/0 (C57BL/6N-Tg(IGL-MYC)3Hm/Nci)	enlarged lymph nodes	J:65245
Tg(ILK3mHEL)3Ccg/0 Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6JSfd * C57BL/10Sg * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
Tg(Ins2-Ccl19)2Cys/0 (involves: C57BL/6 * DBA/2)	abnormal lymph organ development	J:77238
Tg(Ins2-Ccl21b)2Cys/0 (involves: C57BL/6 * DBA/2)	abnormal lymph organ development	J:77238
Tg(Ins2-Cxcl13)1Cys/0 (involves: C57BL/6 * DBA/2)	abnormal lymph organ development	J:110548
Tg(Ins2-GP)#Psoh/0 Tg(TcrLCMV)327Sdz/0 (involves: C57BL/6 * DBA/2)	abnormal B cell selection	J:81285
Tg(Ins2-TFRC/OVA)296Wehi/0 (involves: C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:98589
Tg(Ins2-TFRC/OVA)296Wehi/0 Tg(TcraTcrb)425Cbn/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:135154
	increased double-positive T cell number	J:135154
Tg(Ins2-Tnf)17Flv/0 (involves: C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:93555
Tg(Ins2-Tnf)17Flv/0 (involves: C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:93555
Tg(ITGAL-Hhex)2Hro/0 (C3HeB/FeJ-Tg(ITGAL-Hhex)2Hro)	abnormal double-negative T cell morphology	J:80777
	abnormal thymus corticomedullary boundary morphology	J:80777
	decreased double-positive T cell number	J:80777
	decreased leukocyte cell number	J:80777
	decreased lymphocyte cell number	J:80777
	decreased T cell number	J:80777
	increased CD8-positive, alpha-beta T cell number	J:80777
	thymus hypoplasia	J:80777
Tg(ITGAL-Ptprc^a)FRasch/Tg(ITGAL-Ptprc^a)FRasch (involves: BALB/c * C57BL/6)	abnormal T cell differentiation	J:158876
Tg(ITGAM-HBEGF/EGFP)34Lan/0 (involves: FVB/N)	abnormal macrophage morphology	J:95141
	decreased macrophage cell number	J:95141
	increased neutrophil cell number	J:95141
Tg(ITGAM-HBEGF/EGFP)34Lan/0 (NOD.FVB-Tg(ITGAM-HBEGF/EGFP)34Lan/Jdk)	decreased macrophage cell number	J:137009
Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh/0 (C57BL/6-Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh)	increased monocyte cell number	J:194800
	increased neutrophil cell number	J:194800
Tg(Itgax-HBEGF/OVA/EGFP)1Garbi/0 (C57BL/6-Tg(Itgax-HBEGF/OVA/EGFP)1Garbi)	decreased dendritic cell number	J:194800
	increased neutrophil cell number	J:194800
Tg(Itgax-TGFBR2)1Flv/0 (C.Cg-Tg(Itgax-TGFBR2)1Flv)	abnormal NK cell differentiation	J:98953
Tg(Itgax-TGFBR2)1Flv/0 (C.Cg-Tg(Itgax-TGFBR2)1Flv)	increased NK cell number	J:98953
Tg(IVL-KLK5)#Hov/0 (involves: C57BL/6 * CBA)	abnormal inguinal lymph node morphology	J:210758
	enlarged lymph nodes	J:210758
	enlarged spleen	J:210758
	increased activated T cell number	J:210758
Tg(JAK2V617F)FF1Rsko/0 Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 C57BL/10 * CBA/Ca)	abnormal myelopoiesis	J:134364
	abnormal spleen morphology	J:134364
	decreased B cell number	J:134364
	decreased T cell number	J:134364
	enlarged spleen	J:134364
	increased neutrophil cell number	J:134364
	spleen fibrosis	J:134364
Tg(JAK2V617F)FF1Rsko/0 Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	abnormal myelopoiesis	J:134364
	abnormal spleen morphology	J:134364
	decreased B cell number	J:134364
	decreased T cell number	J:134364
	enlarged spleen	J:134364
	increased neutrophil cell number	J:134364
	spleen fibrosis	J:134364
Tg(JAK2V617F)FF1Rsko/0 Tg(Tek-cre)1Arnd/0 (involves: C57BL/6 CBA * DBA/2)	decreased T cell number	J:206659
	enlarged spleen	J:206659
	increased neutrophil cell number	J:206659
Tg(K18-ACE2)2Prlmn/0 (B6.Cg-Tg(K18-ACE2)2Prlmn/J)	increased leukocyte cell number	J:294084
	increased lymphocyte cell number	J:302313
	increased macrophage cell number	J:294084, J:302313
	increased neutrophil cell number	J:294084, J:300960, J:302313
	increased T cell number	J:300960
	microgliosis	J:294084
Tg(KitD814V)1Roer/0 Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	abnormal mast cell morphology	J:169611
	enlarged spleen	J:169611
	increased mast cell number	J:169611
Tg(KitD814V)2Roer/0 Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	abnormal mast cell morphology	J:169611
	increased mast cell number	J:169611
Tg(KitD814V)3Roer/0 Tg(Mx1-cre)1Cgn/0 (involves: C57BL/6 CBA)	abnormal mast cell morphology	J:169611
	enlarged spleen	J:169611
	increased mast cell number	J:169611
Tg(KLK4mHEL)6Ccg/0 Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6 * C57BL/10 * C57BR/cd)	decreased CD4-positive, alpha-beta T cell number	J:78309
	decreased double-positive T cell number	J:78309
Tg(KRT5-IKBKB)2Armz/0 (involves: C57BL/6 * DBA/2)	abnormal melanophage morphology	J:160072
Tg(KRT5-rtTA)1Glk/0 Tg(tetO/CMV-Tslp)#Sfz/0 (involves: C3H * C57BL/6 * FVB/N)	abnormal lymph node morphology	J:100506
	enlarged lymph nodes	J:100506
	enlarged spleen	J:100506
	increased CD4-positive, alpha-beta T cell number	J:100506
Tg(KRT5-rtTA)#Glk/0 Tg(tetO-cre)1Jaw/0 Wls^tm1.1Lan/Wls^tm1.1Lan (involves: 129S6/SvEvTac * C57BL/6 * FVB/N)	cutaneous mastocytosis	J:204142
Tg(KRT5-TGFB1)F2020Xjw/0 (involves: C57BL/6 * DBA/2 * ICR)	abnormal Langerhans cell morphology	J:90118
	cutaneous mastocytosis	J:90118
	decreased Langerhans cell number	J:90118
Tg(KRT5-tTA)1216Glk/0 Tg(tetO-Il13)1Tazh/0 (B6.Cg-Tg(KRT5-tTA)1216Glk Tg(tetO-Il13)1Tazh)	cutaneous mastocytosis	J:150232
Tg(KRT14-CASP1)1Miz/0 (involves: C57BL/6)	decreased T cell number	J:78602
Tg(KRT14-CASP1)1Miz/0 (involves: C57BL/6)	increased neutrophil cell number	J:78602
Tg(KRT14-FIGF)2Ali/0 (involves: FVB/N)	lymphatic vessel hyperplasia	J:137909, J:68138
Tg(KRT14-FLT4/IGHG1)#Ali/0 (either: (involves: FVB/N) or (involves: BALB/c * DBA))	abnormal lymphatic vessel morphology	J:201429
	abnormal mononuclear phagocyte morphology	J:201429
Tg(Krt14-Ifnk)#Cya/0 (C57BL/6N-Tg(Krt14-Ifnk)#Cya)	enlarged spleen	J:322130
Tg(KRT14-Il18)#Knak/0 (C57BL/6-Tg(KRT14-Il18)#Knak)	decreased T cell number	J:78602
Tg(KRT14-Il18)#Knak/0 (C57BL/6-Tg(KRT14-Il18)#Knak)	increased neutrophil cell number	J:78602
Tg(KRT14-Tslp)1Pcn/0 (involves: C57BL/6 * SJL)	enlarged spleen	J:102470
Tg(KRT14-Tslp)1Pcn/0 (involves: C57BL/6 * SJL)	lymph node hyperplasia	J:102470
Tg(KRT14-Vegfa)3Dtm/0 (FVB/N-Tg(KRT14-Vegfa)3Dtm)	abnormal lymphatic vessel morphology	J:111924
	enlarged lymph nodes	J:92643
	enlarged lymphatic vessel	J:92643
	increased macrophage cell number	J:111924
	increased mast cell number	J:104245
Tg(KRT14-VEGFC*)1Ali/0 (involves: FVB/N)	lymphatic vessel hyperplasia	J:68138
Tg(KRT14-Vegfd)1Ali/0 Vegfc^tm1Ali/Vegfc⁺ (involves: 129S1/Sv * 129X1/SvJ * FVB)	abnormal lymphatic vessel morphology	J:137909
Tg(KRT14-VP16/NR1I2)13Sdub/? (involves: C57BL/6)	abnormal CD4-positive, alpha-beta T cell number	J:258435
	abnormal CD8-positive, alpha beta T cell morphology	J:258435
	enlarged lymph nodes	J:258435
	increased dendritic cell number	J:258435
	increased effector memory T-helper cell number	J:258435
	increased gamma-delta T cell number	J:258435
	increased leukocyte cell number	J:258435
Tg(KRT18-DPP4)3Pbmj/0 (involves: C57BL/6J * SJL/J)	abnormal mononuclear cell morphology	J:286231
Tg(KRT18-DPP4)3Pbmj/0 (involves: C57BL/6J * SJL/J)	increased lymphocyte cell number	J:286231
Tg(LANA,vFLIP,vCYC)801Dtmr/? (involves: C57BL/6)	abnormal B cell differentiation	J:196403
	abnormal marginal zone B cell morphology	J:196403
	abnormal spleen morphology	J:196403
	enlarged spleen	J:196403
	increased germinal center B cell number	J:196403
	increased marginal zone B cell number	J:196403
	increased mature B cell number	J:196403
	increased plasma cell number	J:196403
Tg(Lck)4220Rmp/0 (involves: C57BL/6J * DBA/2)	increased T cell derived lymphoma incidence	J:88120
Tg(Lck-Akt1)M-1Pnt/0 (involves: C3H/He C57BL/6)	decreased thymocyte number	J:73487
	enlarged spleen	J:73487
	increased double-negative T cell number	J:135903
	increased single-positive T cell number	J:135903
	increased T cell derived lymphoma incidence	J:73487
Tg(Lck-Akt1E40K)E-3Pnt/0 (involves: C3H/He C57BL/6)	decreased thymocyte number	J:73487
	enlarged spleen	J:73487
	increased T cell derived lymphoma incidence	J:73487
Tg(Lck-Akt1*E40K)E-3Pnt/0 (Not Specified)	abnormal T cell differentiation	J:144975
Tg(Lck-Akt1*E40K)E-3Pnt/0 (Not Specified)	increased T cell derived lymphoma incidence	J:144975
Tg(Lck-Akt2*)#Test/0 (Not Specified)	increased T cell derived lymphoma incidence	J:153923
Tg(Lck-Bcl2l1)1Cant/? (B6.Cg-Tg(Lck-Bcl2l1)1Cant)	increased memory T cell number	J:77507
Tg(Lck-cre)1Cwi/0 (involves: C57BL/6 * DBA/2)	decreased thymocyte number	J:226234
Tg(Lck-cre)548Jxm/? Tgfb1^tm2.1Doe/Tgfb1^tm2.1Doe (involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA)	abnormal immune system organ morphology	J:150024
	abnormal T cell subpopulation ratio	J:150024
	decreased spleen weight	J:150024
	decreased thymus weight	J:150024
	spleen hypoplasia	J:150024
	thymus hypoplasia	J:150024
Tg(Lck-cre)548Jxm/? Upf2^tm1Btp/Upf2^tm1Btp (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal T cell receptor beta chain V(D)J recombination	J:134765
	decreased CD4-positive, alpha-beta T cell number	J:134765
	decreased CD8-positive, alpha-beta T cell number	J:134765
	decreased double-positive T cell number	J:134765
	thymus hypoplasia	J:134765
Tg(Lck-cre)I57Jxm/? Traf2^tm1Rbr/Traf2^tm1Rbr (involves: C57BL/6 * ICR)	absent follicular B cells	J:132877
	absent marginal zone B cells	J:132877
	decreased mature B cell number	J:132877
Tg(Lck-cre)I57Jxm/? Traf3^tm1Rbr/Traf3^tm1Rbr (involves: C57BL/6 * ICR * SJL)	decreased CD4-positive, alpha-beta T cell number	J:132877
	decreased CD8-positive, alpha-beta T cell number	J:132877
Tg(Lck-FADD)1Hed/0 (involves: BALB/c * C57BL/6)	arrested T cell differentiation	J:100451
	decreased T cell number	J:100451
	decreased thymocyte number	J:100451
Tg(Lck-FADD)1Hed/Tg(Lck-FADD)1Hed (involves: BALB/c * C57BL/6)	abnormal T cell differentiation	J:100451
	decreased T cell number	J:100451
	decreased thymocyte number	J:100451
Tg(Lck-Hhex)1Hro/0 (C3HeB/FeJ-Tg(Lck-Hhex)1Hro)	abnormal double-negative T cell morphology	J:80777
	decreased double-positive T cell number	J:80777
	decreased leukocyte cell number	J:80777
	decreased lymphocyte cell number	J:80777
	decreased T cell number	J:80777
	increased CD8-positive, alpha-beta T cell number	J:80777
	thymus hyperplasia	J:80777
Tg(Lck-Id1)28Xhsu/0 (Not Specified)	increased T cell derived lymphoma incidence	J:58607
Tg(Lck-Il31)1Jagr/0 (involves: C3H * C57BL/6)	abnormal leukopoiesis	J:91124
	cutaneous mastocytosis	J:91124
	decreased T cell number	J:91124
	enlarged lymph nodes	J:91124
	increased activated T cell number	J:91124
	increased B cell number	J:91124
	increased memory T cell number	J:91124
Tg(Lck-LMO1)11Sjk/0 Tg(STIL-TAL1)A5.3Alpa/0 (involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros)	enlarged lymph nodes	J:40868
	enlarged spleen	J:40868
	enlarged thymus	J:40868
	increased leukocyte cell number	J:40868
	increased T cell derived lymphoma incidence	J:40868
Tg(Lck-Map3k8)3456Ngc/? (involves: C3H/HeJ * C57BL/6J)	increased T cell derived lymphoma incidence	J:39450
Tg(LCK-NFKBIA)5Dwb/0 (involves: C57BL/6 * DBA/2)	abnormal CD8-positive, alpha-beta T cell differentiation	J:93003
	decreased CD4-positive, alpha-beta T cell number	J:93003
	decreased CD8-positive, alpha-beta T cell number	J:93003
Tg(Lck-Notch3)#Issc/0 (involves: C57BL/6 * DBA/2)	abnormal T cell differentiation	J:63300
	enlarged lymph nodes	J:63300
	enlarged spleen	J:63300
	increased double-negative T cell number	J:63300
	increased lymphoblastic lymphoma incidence	J:63300
	increased T cell derived lymphoma incidence	J:96010
	increased thymocyte number	J:63300
	thymus hyperplasia	J:63300
Tg(Lck-Socs3)1Kubo/0 (Not Specified)	abnormal CD4-positive T cell differentiation	J:132905
	decreased T cell number	J:128797
	decreased thymocyte number	J:128797
Tg(Lck-Sox13)#Jskg/0 (involves: C57BL/6)	decreased double-positive T cell number	J:117301
Tg(Lck-Sox13)#Jskg/0 (involves: C57BL/6)	decreased thymocyte number	J:117301
Tg(Lck-Stat5b*)1Mafa/0 (Not Specified)	decreased mature B cell number	J:132669
Tg(Lck-Stk17b)26.1Wals/? (B6.Cg-Tg(Lck-Stk17b)26.1Wals)	decreased CD4-positive, alpha-beta T cell number	J:149973
	decreased CD8-positive, alpha-beta T cell number	J:149973
	decreased single-positive T cell number	J:149973
	decreased thymocyte number	J:149973
	enlarged spleen	J:149973
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:149973
	increased double-positive T cell number	J:149973
	increased spleen weight	J:149973
	spleen hyperplasia	J:149973
Tg(Lck-Stk17b)26.1Wals/? Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6 * C57BL/10)	abnormal T cell differentiation	J:149973
	decreased CD8-positive, alpha-beta T cell number	J:149973
	decreased thymocyte number	J:149973
	increased CD8-positive, alpha-beta T cell number	J:149973
Tg(Lck-Tal1)4709Led/0 (FVB/N-Tg(Lck-Tal1)4709Led)	abnormal thymus morphology	J:36076
	enlarged spleen	J:36076
	increased lymphoblastic lymphoma incidence	J:36076
Tg(Lck-Tax)53Hall/0 (involves: C57BL/6)	enlarged lymph nodes	J:129531
	enlarged spleen	J:129531
	hepatosplenomegaly	J:129531
	increased T cell derived lymphoma incidence	J:129531
Tg(Lck-Tnfsf4)1Nish/0 (B6.Cg-Tg(Lck-Tnfsf4)1Nish)	abnormal T cell subpopulation ratio	J:194882
	increased CD4-positive, alpha-beta T cell number	J:194882
	increased regulatory T cell number	J:194882
Tg(Lck-Tnfsf4)1Nish/0 (C.Cg-Tg(Lck-Tnfsf4)1Nish)	increased CD4-positive, alpha-beta T cell number	J:194882
Tg(Lck-Tnfsf4)1Nish/0 (C.Cg-Tg(Lck-Tnfsf4)1Nish)	increased regulatory T cell number	J:194882
Tg(Lck-TNFSF13)3919Mhah/0 (B6.Cg-Tg(Lck-TNFSF13)3919Mhah)	abnormal immune system organ morphology	J:94628
	abnormal mesenteric lymph node morphology	J:94628
	abnormal spleen morphology	J:94628
	enlarged mesenteric lymph nodes	J:94628
	enlarged Peyer's patches	J:94628
	increased B cell number	J:94628
	increased B-1 B cell number	J:94628
	increased CD4-positive, alpha-beta T cell number	J:94628
	increased CD8-positive, alpha-beta T cell number	J:94628
	intermingled spleen red and white pulp	J:94628
	spleen hyperplasia	J:94628
Tg(Lck-Tnfsf14)24Yxf/? (C57BL/6-Tg(Lck-Tnfsf14)24Yxf)	abnormal lymph node cell ratio	J:129951
	increased spleen weight	J:129951
	lymph node hyperplasia	J:129951
	spleen hyperplasia	J:129951
Tg(Lck-Tnfsf15,-EGFP)#Targ/0 (involves: C57BL/6)	increased CD4-positive, alpha-beta memory T cell number	J:169462
Tg(Lck-Tnfsf15,-EGFP)#Targ/0 (involves: C57BL/6)	increased CD8-positive, alpha-beta memory T cell number	J:169462
Tg(Lck-Tslp)1Chea/0 (B6.Cg-Tg(Lck-Tslp)1Chea)	enlarged lymph nodes	J:72982
	enlarged spleen	J:72982
	increased spleen weight	J:72982
Tg(Lck-VIPR2)1Ejg/0 (C57BL/6-Tg(Lck-VIPR2)1Ejg)	increased eosinophil cell number	J:127974
Tg(LckIl4)1315Dbl/0 (involves: C57BL/6J * DBA/2J)	abnormal T cell differentiation	J:92453
	abnormal T cell number	J:92453
	abnormal thymus cell ratio	J:92453
	abnormal thymus morphology	J:92453
	absent CD8-positive, alpha-beta T cells	J:92453
	decreased CD4-positive, alpha-beta T cell number	J:92453
	decreased double-positive T cell number	J:92453
	increased CD4-positive, alpha-beta T cell number	J:92453
	increased CD8-positive, alpha-beta T cell number	J:92453
	increased double-negative T cell number	J:92453
	thymus cortex hypoplasia	J:92453
	thymus hypoplasia	J:92453
Tg(LckNotch1)9Erob/? (involves: C57BL/6 * CBA/J)	abnormal CD8-positive, alpha-beta T cell differentiation	J:93005
	abnormal thymus cell ratio	J:93005
	decreased CD4-positive, alpha-beta T cell number	J:93005
	increased CD8-positive, alpha-beta T cell number	J:93005
	increased T cell derived lymphoma incidence	J:93005
Tg(LCKprBCL2)36Sjk/? (involves: C3H * C57BL/6)	abnormal T cell number	J:28635
	abnormal T cell subpopulation ratio	J:11548
	abnormal thymus cell ratio	J:11548
	increased CD8-positive, alpha-beta T cell number	J:11548
	increased T cell derived lymphoma incidence	J:28635
	increased T cell number	J:11548
Tg(LCKprBCL2)36Sjk/0 (B6.Cg-Tg(LCKprBCL2)36Sjk)	abnormal CD4-positive, alpha-beta T cell number	J:217939
	abnormal T cell subpopulation ratio	J:217939
	increased regulatory T cell number	J:217939
Tg(LCKprBCL2)36Sjk/0 (involves: C57BL/6 * CBA/J)	abnormal T cell clonal deletion	J:217939
Tg(LCKprBCL2)36Sjk/0 Tg(Nr4a1-EGFP/cre)820Khog/0 (involves: C57BL/6 * C57BL/6J)	abnormal T cell clonal deletion	J:217939
Tg(LCKprBCL2)36Sjk/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: C57BL/6 * C57BL/6J * DBA/2J)	abnormal T cell clonal deletion	J:217939
Tg(LCR-HBA2,LCR-HBB)1Cos/0 (involves: C57BL/6J CBA/J)	enlarged spleen	J:94193
Tg(Ly6a-BCR/ABL1)IS1AIsg/0 (involves: C57BL/6J * CBA)	abnormal lymph node morphology	J:144382
	abnormal spleen morphology	J:144382
	increased leukocyte cell number	J:144382
	increased neutrophil cell number	J:144382
	increased spleen red pulp amount	J:144382
	increased spleen weight	J:144382
Tg(Ly6a-BCR/ABL1)IS1BIsg/0 (involves: C57BL/6J * CBA)	abnormal lymph node morphology	J:144382
	abnormal spleen morphology	J:144382
	increased leukocyte cell number	J:144382
	increased neutrophil cell number	J:144382
	increased spleen red pulp amount	J:144382
	increased spleen weight	J:144382
Tg(Ly6a-GCSAM)102AIsg/0 (involves: C57BL/6J * CBA)	abnormal spleen morphology	J:221238
	decreased B-1 B cell number	J:221238
	enlarged Peyer's patches	J:221238
	enlarged spleen	J:221238
	increased B-1 B cell number	J:221238
	increased spleen white pulp amount	J:221238
	lymphoid hyperplasia	J:221238
Tg(Ly6a-SET/NUP214)2969Gcg/0 (involves: FVB/NJ)	abnormal B cell differentiation	J:142938
	decreased leukocyte cell number	J:142938
	decreased lymphocyte cell number	J:142938
	decreased pre-B cell number	J:142938
	decreased pro-B cell number	J:142938
Tg(Ly6a-TK,-BCR/ABL1)IS9AIsg/0 (involves: C57BL/6J * CBA)	increased leukocyte cell number	J:144382
Tg(Ly6a-TK,-BCR/ABL1)IS9AIsg/0 (involves: C57BL/6J * CBA)	increased neutrophil cell number	J:144382
Tg(Ly6e-MALT1)#Isg/0 (involves: C57BL/6 * CBA)	increased mature B cell number	J:185590
	increased pre-B cell number	J:185590
	increased pro-B cell number	J:185590
Tg(MCL1)8Caig/0 (involves: C57BL/6 * SJL)	abnormal immature B cell morphology	J:50604
	abnormal mast cell differentiation	J:50604
	abnormal monocyte differentiation	J:50604
	increased spleen white pulp amount	J:50604
	increased T cell derived lymphoma incidence	J:69755
	increased thymocyte number	J:50604
	spleen hyperplasia	J:50604
Tg(Mcpt8-cre)1Voeh/0 (involves: C57BL/6)	decreased basophil cell number	J:164432
Tg(ML5sHEL)5Ccg/0 Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6 * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
	decreased double-positive T cell number	J:78309
Tg(ML5sHEL)5Ccg/0 Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0 (involves: C57BL/6JSfd * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
	decreased double-positive T cell number	J:78309
Tg(MMTV-Erbb2)9Pjo/0 (involves: BALB/c * C3H * C57BL/6)	enlarged spleen	J:72129
Tg(MMTV-Erbb2)9Pjo/0 (involves: BALB/c * C3H * C57BL/6)	increased spleen red pulp amount	J:72129
Tg(MMTV-Erbb2)10Pjo/0 (involves: BALB/c * C3H * C57BL/6)	enlarged spleen	J:72129
Tg(MMTV-Erbb2)10Pjo/0 (involves: BALB/c * C3H * C57BL/6)	increased spleen red pulp amount	J:72129
Tg(MMTV-Erbb2)12Pjo/0 (involves: BALB/c * C3H * C57BL/6)	enlarged spleen	J:72129
Tg(MMTV-Erbb2)12Pjo/0 (involves: BALB/c * C3H * C57BL/6)	increased spleen red pulp amount	J:72129
Tg(MMTV-Erbb2)17Pjo/0 (involves: BALB/c * C3H * C57BL/6)	enlarged spleen	J:72129
Tg(MMTV-Erbb2)17Pjo/0 (involves: BALB/c * C3H * C57BL/6)	increased spleen red pulp amount	J:72129
Tg(MMTV-PyVT)#Mul/0 (B6.FVB-Tg(MMTV-PyVT)#Mul)	abnormal lymph node cell ratio	J:147923
	abnormal lymph node morphology	J:147923
	abnormal splenic cell ratio	J:147923
	enlarged spleen	J:147923
	increased regulatory T cell number	J:147923
	increased splenocyte number	J:147923
Tg(Mpz-RAF1/ESR1)A668Ayld/0 (involves: C57BL/6J * CBA/J)	increased macrophage cell number	J:182703
	increased mast cell number	J:182703
	increased neutrophil cell number	J:182703
	increased T cell number	J:182703
Tg(Msmb-TAg)183-2Xuan/0 (involves: C57BL/6 * CBA)	enlarged lymph nodes	J:80313
Tg(Mt1-IL6)28Gci/0 (involves: C57BL/6 * DBA/2)	abnormal spleen morphology	J:18424
	enlarged lymph nodes	J:18424
	enlarged spleen	J:177825, J:18424
	increased granulocyte number	J:177825
	increased leukocyte cell number	J:18424
	increased neutrophil cell number	J:18424
	increased plasma cell number	J:177825, J:18424
	increased plasmacytoid dendritic cell number	J:177825
Tg(Mx1-cre)1Cgn/0 Tg(Tal1-tTA)19Dgt/0 Tg(tetO-BCR/ABL1)2Dgt/0 TgTn(pb-sb-GrOnc)#aGsva/0 (involves: C57BL/6 * CBA/J * DBA/2 * FVB/N)	increased granulocyte number	J:227558
	increased leukocyte cell number	J:227558
Tg(Mx1-cre)1Cgn/0 Thoc5^tm1Tate/Thoc5^tm1Tate (involves: C57BL/6 * CBA)	abnormal lymphopoiesis	J:169944
	decreased leukocyte cell number	J:169944
	decreased spleen weight	J:169944
Tg(Mx1-cre)1Cgn/0 Tnfrsf13c^tm2.1Mass/Tnfrsf13c^tm2.1Mass (involves: C57BL/6 * CBA)	increased immature B cell number	J:170519
	increased pre-B cell number	J:170519
	increased pro-B cell number	J:170519
Tg(Mx1-cre)1Cgn/0 Traf2^tm1Rbr/Traf2^tm1Rbr (involves: C57BL/6 * CBA)	abnormal spleen marginal zone morphology	J:93890
	abnormal spleen morphology	J:93890
	enlarged lymph nodes	J:93890
	enlarged spleen	J:93890
	increased B cell number	J:93890
	increased marginal zone B cell number	J:93890
Tg(Mx1-cre)1Cgn/0 U2af1^tm1.1Hev/U2af1⁺ (involves: 129S6/SvEvTac * BALB/c * C57BL/6 * C57BL/6J * CBA/J)	decreased leukocyte cell number	J:267082
Tg(Mx1-cre)1Cgn/0 U2af1^tm1Mohi/U2af1^tm1Mohi (involves: C57BL/6J * CBA/J)	bone marrow failure	J:308564
	decreased leukocyte cell number	J:308564
	decreased neutrophil cell number	J:308564
Tg(Mx1-cre)1Cgn/0 Zmiz1^{tm1c(EUCOMM)Hmgu}/Zmiz1^{tm1c(EUCOMM)Hmgu} (involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA/J)	decreased B cell number	J:234445
	decreased NK cell number	J:234445
	decreased T cell number	J:234445
	thymus hypoplasia	J:234445
Tg(Myh6-IGF1)34Pia/0 (FVB/N-Tg(Myh6-IGF1)34Pia)	increased spleen weight	J:35215
Tg(PF4-tTA/VP16)42Kra/0 Tg(tetO-Aurkb,lacZ)41Kra/0 (FVB/NJ-Tg(tetO-Aurkb,lacZ)41Kra Tg(PF4-tTA/VP16)42Kra)	abnormal thrombopoiesis	J:104239
Tg(PF4MER)6Kra/? (FVB/N-Tg(PF4MER)6Kra)	enlarged spleen	J:35507
Tg(Pgk1-HA)1.1Vbo/? Tg(Tcra/Tcrb)1Vbo/? (involves: 129 * BALB/c * C57BL/6J * DBA/2J)	decreased CD4-positive, alpha-beta T cell number	J:125750
	increased double-positive T cell number	J:125750
	increased regulatory T cell number	J:125750
Tg(Pgk1-HA)1.1Vbo/? Tg(Tcra/Tcrb)1Vbo/? (C.Cg-Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)	increased regulatory T cell number	J:112603
Tg(PGK1-KITLG220)441Daw/Tg(PGK1-KITLG220)441Daw (C3H/HeJ-Tg(PGK1-KITLG*220)441Daw)	abnormal thymus morphology	J:32600
Tg(Pim1-Il9)5Jcrd/0 (involves: FVB/N)	increased T cell derived lymphoma incidence	J:17848
Tg(Pklr-HRASG12V)21Ak/0 (involves: C57BL/6 DBA/2)	abnormal thymus morphology	J:44803
Tg(Pklr-HRASG12V)21Ak/0 (involves: C57BL/6 DBA/2)	enlarged thymus	J:44803
Tg(Pklr-Myc)73Ak/0 (B6.Cg-Tg(Pklr-Myc)73Ak)	decreased NK T cell number	J:184496
Tg(Plp1-LMNB1)1108Qsp/0 (involves: FVB/N)	microgliosis	J:226169
Tg(Plp1-SNCA)1Haa/0 (involves: C57BL/6 * DBA/2)	microgliosis	J:96778
Tg(PML-RARA)556Kog/? (involves: FVB/N)	abnormal neutrophil differentiation	J:39327
Tg(PML-RARA)556Kog/0 (FVB/N-Tg(PML-RARA)556Kog)	enlarged spleen	J:262172
Tg(PML-RARA)556Kog/0 (FVB/N-Tg(PML-RARA)556Kog)	increased leukocyte cell number	J:262172
Tg(PMP22)C61Clh/0 (B6.Cg-Tg(PMP22)C61Clh)	increased macrophage cell number	J:158350
Tg(Prnp-APP)1Hmor/0 (B6.Cg-Tg(Prnp-APP)1Hmor)	microgliosis	J:159623
Tg(Prnp-FUS)WT3Cshw/0 (involves: C57BL/6 * Crl:CD-1(ICR))	microgliosis	J:189360
Tg(Prnp-FUS)WT3Cshw/Tg(Prnp-FUS)WT3Cshw (involves: C57BL/6 * Crl:CD-1(ICR))	microgliosis	J:189360
Tg(Prnp-ITM2B)7Jckr/0 (C57BL/6-Tg(Prnp-ITM2B)7Jckr)	microgliosis	J:159279
Tg(Prnp-MAPTR406W)21807Dwst/? (FVB/N-Tg(Prnp-MAPTR406W)21807Dwst)	microgliosis	J:95971
Tg(Prnp-PFN1C71G)22Zxu/0 Tg(Thy1-PFN1C71G)67Zxu/Tg(Thy1-PFN1*C71G)67Zxu (involves: FVB/N)	microgliosis	J:235427
Tg(Prnp-TARDBP)96Dwc/0 Tg(Prnp-TARDBPQ331K)31Dwc/0 (involves: C3H C57BL/6)	microgliosis	J:239141
Tg(Prnp-TARDBPQ331K)31Dwc/? (involves: C3H C57BL/6)	microgliosis	J:239141
Tg(Prox1-EGFP)KY221Gsat/0 (involves: FVB/NTac)	abnormal lymphangiogenesis	J:235778
Tg(Prox1-EGFP)KY221Gsat/0 (involves: FVB/NTac)	abnormal lymphatic vessel endothelial cell morphology	J:235778
Tg(Psp-Rbbp4)1Yoha/0 (involves: C57BL/6)	increased marginal zone B cell number	J:141378
Tg(PTH-CCND1)PC2Anar/0 (FVB/N-Tg(PTH-CCND1)PC2Anar)	increased osteoclast cell number	J:69423
Tg(Rr158-H2-Ea^d)1Flv/0 Tg(Tcra1H3.1,Tcrb1H3.1)1Vire/0 (involves: C57BL/6 * SJL)	decreased double-positive T cell number	J:124574
	thymus hypoplasia	J:124574
Tg(rv-CYCLIN)29Dlh/0 (involves: C57BL/6 * SJL)	lymphoid hyperplasia	J:62478
Tg(rv-CYCLIN)29Dlh/0 (involves: C57BL/6 * SJL)	spleen hyperplasia	J:62478
Tg(Scgb1a1-rtTA)1Jaw/0 Tg(tetO-Aimp1)29872Mcla/0 (involves: 129 * C57BL/6)	increased macrophage cell number	J:173904
Tg(Scgb1a1-rtTA,-tTS,tetO-CHI3L1)1Eli/0 (Not Specified)	abnormal macrophage morphology	J:148490
Tg(Scgb1a1-rtTA,-tTS,tetO-CHI3L1)1Eli/0 (Not Specified)	increased T-helper 2 cell number	J:148490
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0 (involves: C57BL/6 * CBA)	increased lymphocyte cell number	J:100854
	increased macrophage cell number	J:100854
	increased neutrophil cell number	J:100854
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0 (involves: C57BL/6 * CBA)	increased T-helper 2 cell number	J:148490
Tg(SERPINA1-IGHG1/Il1rl1)423Zbz/? (involves: C3H * C57BL/6)	increased eosinophil cell number	J:63507
X/Tg(SERPINC1-SV40)BPbr (involves: C57BL/6 * DBA/2)	increased macrophage cell number	J:84204
Tg(SFTPC-Il18)AThos/0 (B6N.Cg-Tg(SFTPC-Il18)AThos)	abnormal spleen morphology	J:147547
Tg(SFTPC-Il18)AThos/0 (B6N.Cg-Tg(SFTPC-Il18)AThos)	enlarged spleen	J:147547
Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0 (involves: C57BL/6 * SJL)	abnormal B cell morphology	J:97297
	abnormal bronchus-associated lymphoid tissue morphology	J:97297
	abnormal CD4-positive, alpha beta T cell morphology	J:97297
	abnormal dendritic cell morphology	J:97297
	abnormal T cell morphology	J:97297
	increased CD8-positive, alpha-beta T cell number	J:97297
	increased lymphocyte cell number	J:97297
	increased neutrophil cell number	J:97297
Tg(SOD1G93A)1Gur/0 (B6.Cg-Tg(SOD1G93A)1Gur/J)	abnormal spleen morphology	J:138237
	decreased spleen weight	J:138237
	decreased splenocyte number	J:138237
Tg(SOD1G93A)1Gur/0 (B6SJL-Tg(SOD1G93A)1Gur/J)	abnormal lymphocyte morphology	J:129215
	abnormal microglial cell morphology	J:165019, J:143173
	abnormal spleen morphology	J:138237
	abnormal splenic cell ratio	J:138237
	abnormal splenocyte morphology	J:138237
	decreased eosinophil cell number	J:129215
	decreased leukocyte cell number	J:129215
	decreased lymphocyte cell number	J:129215
	decreased monocyte cell number	J:129215
	decreased spleen weight	J:138237
	increased basophil cell number	J:129215
	microgliosis	J:146652, J:165019, J:110437, J:143173
	small spleen	J:138237
Tg(SOD1G93A)^dl1Gur/0 (involves: C57BL/6 C57BL/6J * SJL/J)	microgliosis	J:128738
Tg(SOD1H46R)LAra/0 (involves: C57BL/6 DBA/2)	microgliosis	J:221350
Tg(SOD1H46RC111S)PAra/0 (involves: C57BL/6 * DBA/2)	microgliosis	J:221350
Tg(SOD1H46RC111S)PAra/Tg(SOD1H46RC111S)PAra (involves: C57BL/6 * DBA/2)	microgliosis	J:221350
Tg(SOD1H46RC111S)QAra/0 (involves: C57BL/6 * DBA/2)	microgliosis	J:221350
Tg(SOD1L126Z)45Dbo/0 (involves: C3H/HeJ C57BL/6J)	microgliosis	J:219482
Tg(Stat3*)9199Alau/0 (involves: C57BL/6)	abnormal T-helper 17 cell differentiation	J:210877
Tg(Stat3*)9199Alau/0 (involves: C57BL/6)	increased neutrophil cell number	J:210877
Tg(SV40-Ahr)1Poe/0 (involves: C57BL/6 * CBA)	absent B-1a cells	J:82428
	decreased B-1 B cell number	J:82428
	decreased thymus weight	J:77977
	increased B-2 B cell number	J:82428
	increased mature B cell number	J:82428
	increased pre-B cell number	J:82428
	increased pro-B cell number	J:82428
Tg(SV40-Igh-64C8)H3Hon/0 Tg(SV40-Igk4C8)L1Hon/0 (involves: C57BL/6)	abnormal B cell clonal deletion	J:139864
	abnormal B cell number	J:139864
Tg(SV40-NRAS*G12D)1Sco/? (Not Specified)	increased T cell derived lymphoma incidence	J:125150
Tg(SV)419Bri/Tg(SV)419Bri (C57BL/6J-Tg(SV)419Bri)	increased T cell derived lymphoma incidence	J:147031
Tg(SV)427Bri/0 (C57BL/6J-Tg(SV)427Bri)	enlarged thymus	J:79096
Tg(TARDBP)#Jpj/0 (involves: C3H * C57BL/6)	microgliosis	J:195184
Tg(TARDBPA315T)#Jpj/0 (involves: C3H C57BL/6)	microgliosis	J:195184
Tg(TARDBPG348C)#Jpj/0 (involves: C3H C57BL/6)	microgliosis	J:195184
Tg(TCF3/HLF)1Mlc/0 (involves: FVB/N)	abnormal CD4-positive, alpha beta T cell morphology	J:55022
	arrested T cell differentiation	J:55022
	decreased CD4-positive, alpha-beta T cell number	J:55022
	decreased CD8-positive, alpha-beta T cell number	J:55022
	decreased double-positive T cell number	J:55022
	decreased T cell number	J:55022
	decreased thymocyte number	J:55022
	increased T cell derived lymphoma incidence	J:55022
	thymus hypoplasia	J:55022
Tg(Tcra2B4)1Mmd/? (involves: C3H/HeJ * C57BL/6)	abnormal thymus cell ratio	J:92992
	decreased CD4-positive, alpha-beta T cell number	J:92992
	decreased double-positive T cell number	J:92992
	decreased thymocyte number	J:92992
	increased double-negative T cell number	J:92992
Tg(Tcra2C,Tcrb2C)1Dlo/? (involves: C57BL/6 * SJL)	abnormal CD8-positive, alpha beta T cell morphology	J:125259
Tg(Tcra2C,Tcrb2C)1Dlo/? (involves: C57L * DBA/2 * SJL)	decreased lymphocyte cell number	J:95380
	decreased thymocyte number	J:95380
	increased CD4-positive, alpha-beta T cell number	J:95380
Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:83278
Tg(Tcra2D2,Tcrb2D2)1Kuch/0 (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 1 cell number	J:189919
	decreased T-helper 2 cell number	J:189919
	decreased T-helper 17 cell number	J:189919
Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0 (involves: C57BL/6 * DBA/2)	abnormal positive T cell selection	J:125548
Tg(Tcra,Tcrb)3Ayr/0 (involves: C57BL/6 * DBA/2)	abnormal positive T cell selection	J:125548
Tg(Tcra,Tcrb)24Efro/0 (D1.Cg-Tg(Tcra,Tcrb)24Efro)	abnormal T cell differentiation	J:104243
Tg(Tcra,Tcrb)24Efro/0 (D1.Cg-Tg(Tcra,Tcrb)24Efro)	increased memory T cell number	J:104243
Tg(Tcra,Tcrb)HRCAll/0 (B6.Cg-Tg(Tcra,Tcrb)HRCAll)	abnormal T cell subpopulation ratio	J:131347
	decreased CD4-positive, alpha-beta T cell number	J:131347
	increased CD8-positive, alpha-beta T cell number	J:131347
Tg(Tcra,Tcrb)HRVAll/0 (B6.Cg-Tg(Tcra,Tcrb)HRVAll)	abnormal T cell subpopulation ratio	J:131347
	decreased CD4-positive, alpha-beta T cell number	J:131347
	increased CD8-positive, alpha-beta T cell number	J:131347
Tg(TcraAI4)1Dvs/0 (NOD-Tg(TcraAI4)1Dvs)	abnormal CD4-positive, alpha beta T cell morphology	J:93553
Tg(TcraAI4)1Dvs/0 Tg(TcrbAI4)1Dvs/0 (NOD-Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)	abnormal CD4-positive, alpha beta T cell morphology	J:93553
	abnormal CD8-positive, alpha beta T cell morphology	J:94192
Tg(TcraAV19AJ33)1Shima/? (involves: 129S4/SvJae * C57BL/6)	abnormal NK T cell morphology	J:112657
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (NOD.Cg-Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)	increased activated T cell number	J:52940
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: C57BL/6 * NOD * SJL)	decreased dendritic cell number	J:137009
Tg(TcraCl1,TcrbCl1)1Shrm/0 (B10.Cg-Thy1^a H2^d Tg(TcraCl1,TcrbCl1)1Shrm)	abnormal T cell subpopulation ratio	J:97745
Tg(TcraCl4,TcrbCl4)1Shrm/? (B10.Cg-H2^d Tg(TcraCl4,TcrbCl4)1Shrm)	abnormal CD8-positive, alpha-beta T cell differentiation	J:99756
	abnormal T cell subpopulation ratio	J:99756
Tg(TcraDN32D3)#Alhn/0 (involves: NOD)	decreased NK cell number	J:201417
	decreased thymocyte number	J:201417
	increased double-negative T cell number	J:201417
Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6J * C57L/J * DBA/2J)	abnormal double-negative T cell morphology	J:79738
	abnormal T cell differentiation	J:79738, J:90776
	decreased thymocyte number	J:79738
	thymus hypoplasia	J:79738
Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: C57BL/6 * DBA/2J)	abnormal T cell differentiation	J:97610
Tg(TcraH-Y,TcrbH-Y)71Vbo/? Themis^tm1Gasc/Themis^tm1Gasc (involves: 129S6/SvEvTac * C57BL/6 * DBA/2)	abnormal negative T cell selection	J:151074
	abnormal positive T cell selection	J:151074
Tg(TcraH-Y,TcrbH-Y)71Vbo/? Themis^tm1Lov/Themis^tm1Lov (involves: 129 * C57BL/6 * DBA/2)	abnormal negative T cell selection	J:151075
	abnormal positive T cell selection	J:151075
	decreased single-positive T cell number	J:151075
	increased double-positive T cell number	J:151075
Tg(TcraH-Y,TcrbH-Y)71Vbo/0 Tnfrsf25^tm1Mjo/Tnfrsf25^tm1Mjo (involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)	abnormal negative T cell selection	J:84536
	abnormal thymus morphology	J:84536
	increased thymocyte number	J:84536
Tg(TcrAND)53Hed/? (involves: A/WySnSg * C57BL/6 * C57BL/10SnSg * SJL)	abnormal positive T cell selection	J:85777
	abnormal T cell differentiation	J:85777
	abnormal T cell subpopulation ratio	J:85777
	decreased CD8-positive, alpha-beta T cell number	J:85777
	decreased double-positive T cell number	J:85777
	increased CD4-positive, alpha-beta T cell number	J:85777
Tg(TcrAND)53Hed/? (involves: C57BL/6 * SJL)	abnormal lymph node cell ratio	J:124701
Tg(TcrAND)53Hed/? (involves: C57BL/6 * SJL)	increased CD4-positive, alpha-beta T cell number	J:124701
Tg(TcrAND)53Hed/? Themis^tm1Gasc/Themis^tm1Gasc (involves: 129S6/SvEvTac * C57BL/6 * SJL)	abnormal positive T cell selection	J:151074
	decreased CD4-positive, alpha-beta T cell number	J:151074
	decreased CD8-positive, alpha-beta T cell number	J:151074
	increased double-positive T cell number	J:151074
Tg(TcrAND)53Hed/? Themis^tm1Lov/Themis^tm1Lov (involves: 129 * C57BL/6 * SJL)	abnormal positive T cell selection	J:151075
	decreased single-positive T cell number	J:151075
	increased double-positive T cell number	J:151075
Tg(TcrAND)53Hed/? Zbtb7b^tm1.1Rbo/Zbtb7b^tm1.1Rbo (involves: C57BL/6 * SJL)	abnormal T cell differentiation	J:141145
Tg(TcraR28,TcrbR28)KRNDim/0 (involves: C57BL/6 * NOD * SJL)	abnormal lymphocyte cell number	J:36815
	abnormal T cell clonal deletion	J:36815
	decreased CD4-positive, alpha-beta T cell number	J:36815
	decreased CD8-positive, alpha-beta T cell number	J:36815
	enlarged spleen	J:36815
	increased B cell number	J:36815
Tg(TcraTcrb)8Rest/? (C57BL/6-Tg(TcraTcrb)8Rest)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:85058
Tg(TcraTcrb)425Cbn/0 (involves: BALB/c * C57BL/6)	abnormal positive T cell selection	J:125548
Tg(TcraTcrb)425Cbn/? (involves: BALB/c * C57BL/6)	abnormal positive T cell selection	J:87876
Tg(TcraTcrb)425Cbn/? (involves: BALB/c * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:87876
Tg(TcraTcrb)425Cbn/0 Trip10^tm1.1Geha/Trip10^tm1.1Geha (B6.Cg-Trip10^tm1.1Geha Tg(TcraTcrb)425Cbn)	abnormal effector T cell morphology	J:164363
	decreased CD4-positive, alpha-beta T cell number	J:164363
Tg(TcraTcrb)1100Mjb/? (involves: C57BL/6)	abnormal CD8-positive, alpha beta T cell morphology	J:92867
	abnormal positive T cell selection	J:92867, J:133645
	abnormal T cell clonal deletion	J:92867
	abnormal T cell subpopulation ratio	J:92867, J:133645
	decreased CD4-positive, alpha-beta T cell number	J:133645
	increased CD8-positive, alpha-beta T cell number	J:92867, J:133645
Tg(TcraTcrb)1100Mjb/? Themis^tm1Gasc/Themis^tm1Gasc (involves: 129S6/SvEvTac * C57BL/6)	abnormal positive T cell selection	J:151074
	decreased CD8-positive, alpha-beta T cell number	J:151074
	increased double-positive T cell number	J:151074
Tg(Tcrb)93Vbo/0 (involves: C57BL/LiA * CBA/BrA)	abnormal T cell morphology	J:93247
Tg(Tcrb)93Vbo/0 (involves: C57BL/LiA * CBA/BrA)	abnormal T cell receptor beta chain V(D)J recombination	J:93247
Tg(Tcrb)93Vbo/0 (involves: C57BL/6 * C57BL/LiA * CBA/BrA)	abnormal CD8-positive, alpha-beta T cell differentiation	J:66565
Tg(Tcrb)93Vbo/0 (involves: C57BL/6 * C57BL/LiA * CBA/BrA)	abnormal T cell clonal deletion	J:66565
Tg(Tcrb-TCF3/PBX1)19Gusa/0 (involves: C3H * C57BL/6 * C57BL/6J)	decreased thymocyte number	J:95693
Tg(Tcrb-TCF3/PBX1)23Gusa/0 (involves: C3H * C57BL/6 * C57BL/6J)	decreased thymocyte number	J:95693
Tg(TcrbAI4)1Dvs/0 (NOD-Tg(TcrbAI4)1Dvs)	abnormal CD4-positive, alpha beta T cell morphology	J:93553
Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:73608
Tg(TcrHEL3A9)1Mmd/0 (involves: C57BL/6 * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	abnormal double-positive T cell morphology	J:78309
	abnormal thymus cell ratio	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0 (involves: C57BL/6 * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:78309
	decreased CD4-positive, alpha-beta T cell number	J:78309
	decreased double-positive T cell number	J:78309
Tg(TcrLCMV)1Aox/? (C57BL/6-Tg(TcrLCMV)1Aox)	decreased CD8-positive, alpha-beta T cell number	J:92228
	decreased double-positive T cell number	J:92228
	increased CD4-positive, alpha-beta T cell number	J:92228
	increased double-negative T cell number	J:92228
Tg(TcrLCMV)2Aox/? (C57BL/6-Tg(TcrLCMV)2Aox)	decreased CD8-positive, alpha-beta T cell number	J:92228
	decreased double-positive T cell number	J:92228
	increased CD4-positive, alpha-beta T cell number	J:92228
	increased double-negative T cell number	J:92228
Tg(TcrLCMV)327Sdz/0 (involves: C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:77696
	decreased double-positive T cell number	J:77696
	thymus hypoplasia	J:77696
Tg(TcrLCMV)327Sdz/? (involves: C57BL/6 * DBA/2J)	abnormal T cell differentiation	J:97610
Tg(TcrLCMV)327Sdz/? (involves: C57BL/6 * DBA/2J)	decreased CD4-positive, alpha-beta T cell number	J:97610
Tg(Tek-cre)1Ywa/0 Thbd^tm2Rdr/Thbd^tm2Wlr (involves: 129S2/SvPas * C57BL/6 * SJL)	increased spleen weight	J:71269
Tg(Tek-cre)1Ywa/0 Trp53^tm1Brn/Trp53^tm1Brn (involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL)	increased T cell derived lymphoma incidence	J:263520
Tg(Tek-tTA)1Dmt/0 Tg(tetO-Tek)1Dmt/0 (involves: CD-1)	abnormal spleen red pulp morphology	J:137745
	abnormal spleen white pulp morphology	J:137745
	enlarged spleen	J:137745
	increased eosinophil cell number	J:137745
	increased T cell number	J:137745
Tg(tetO-BCR/ABL1)2Dgt/0 Tg(MMTVtTA)1Mam/0 (involves: C57BL/6 * FVB/N * SJL)	enlarged lymph nodes	J:72377
	enlarged spleen	J:72377
	increased leukocyte cell number	J:72377
Tg(tetO-BCR/ABL1)2Dgt/0 Tg(Tal1-tTA)19Dgt/0 (involves: C57BL/6 * DBA/2 * FVB/N)	abnormal lymph node morphology	J:96511
	abnormal lymphopoiesis	J:96511
	abnormal spleen red pulp morphology	J:96511
	abnormal splenic cell ratio	J:96511
	enlarged spleen	J:96511
	increased leukocyte cell number	J:96511
	increased neutrophil cell number	J:96511
Tg(tetO-BCR/ABL1)27Dgt/0 Tg(MMTVtTA)1Mam/0 (involves: C57BL/6 * FVB/N * SJL)	enlarged lymph nodes	J:72377
	enlarged spleen	J:72377
	increased leukocyte cell number	J:72377
Tg(TG-SV40)#Cled/0 (involves: C57BL/6J * DBA/2J)	spleen hypoplasia	J:209788
Tg(TG-SV40)#Cled/0 (involves: C57BL/6J * DBA/2J)	thymus hypoplasia	J:209788
Tg(Thy1-APP)3Somm/0 (involves: C57BL/6J * DBA/2)	microgliosis	J:134832
Tg(Thy1-AppR609DK612E)2Vln/0 (involves: C57BL * CBA/J)	abnormal microglial cell morphology	J:32213
Tg(Thy1-AppR609DK612E)4Vln/0 (involves: FVB)	abnormal microglial cell morphology	J:32213
Tg(Thy1-AppR609DK612E)6Vln/0 (involves: FVB)	abnormal microglial cell morphology	J:32213
Tg(Thy1-APPDutch)#Jckr/0 (involves: C57BL/6J)	microgliosis	J:92796
Tg(Thy1-APPSw)10Jiri/0 (involves: C3H * C57BL/6)	microgliosis	J:128647
Tg(Thy1-APPSw)10Jiri/0 Tg(Thy1-PSEN1M146V)#Jiri/0 (B6.Cg-Tg(Thy1-APPSw)10Jiri Tg(Thy1-PSEN1M146V)#Jiri)	microgliosis	J:156577
Tg(Thy1-APPSweLon)41Ema/0 (involves: C57BL/6 * DBA/2)	microgliosis	J:162842
Tg(Thy1-cmyc)6Kio/0 (Not Specified)	increased T cell derived lymphoma incidence	J:129440
Tg(Thy1-cmyc)6LKio/0 (Not Specified)	increased T cell derived lymphoma incidence	J:129440
Tg(Thy1-Fcer2a)2431Putt/? (involves: BALB/c * C57BL/6)	increased eosinophil cell number	J:20421
Tg(Thy1-FUS)1Dit/0 (B6.Cg-Tg(Thy1-FUS)1Dit)	microgliosis	J:287782
Tg(Thy1-FUS)1Dit/0 Tg(Thy1-TARDBP)4Singh/0 (involves: C57BL/6J DBA/2J * SJL/J)	microgliosis	J:287782
Tg(Thy1-FUS)19Vlb/0 (B6.Cg-Tg(Thy1-FUS)19Vlb)	microgliosis	J:203550
Tg(Thy1-MAPT)1Avil/Tg(Thy1-MAPT)1Avil (involves: C57BL/6 * CBA)	microgliosis	J:201700
Tg(Thy1-PSEN1M146V,-APPSwe)10Arte/Tg(Thy1-PSEN1M146V,-APPSwe)10Arte (involves: C57BL/6 * CBA)	microgliosis	J:155410
Tg(Thy1-Snca)1S13Putt/? (involves: C57BL/6)	microgliosis	J:177661
Tg(Thy1-SNCA)61Ema/0 (involves: C57BL/6 * DBA/2)	abnormal microglial cell morphology	J:238066
Tg(Thy1-Sncg)HvP36Putt/? (C57BL/6-Tg(Thy1-Sncg)HvP36Putt)	microgliosis	J:185793
Tg(Thy1-TARDBP)4Singh/0 (involves: C57BL/6J * SJL/J)	microgliosis	J:157550
Tg(Thy1-TARDBP)4Singh/Tg(Thy1-TARDBP)4Singh (involves: C57BL/6J * SJL/J)	microgliosis	J:157550
Tg(Thy1-TARDBP)6Singh/Tg(Thy1-TARDBP)6Singh (involves: C57BL/6 * C57BL/6J * SJL)	microgliosis	J:157550
Tg(Thy1/THY1)T6Gsv/0 (involves: C57BL/10 * CBA)	abnormal mononuclear cell morphology	J:294621
	increased macrophage derived foam cell number	J:294621
	increased neutrophil cell number	J:294621
Tg(Tlr7)1Boll/0 (involves: C57BL/6)	abnormal dendritic cell morphology	J:127600
	abnormal spleen morphology	J:127600
	decreased spleen white pulp amount	J:127600
	enlarged spleen	J:127600
X/Tg(Tlr7)6Boll (involves: C57BL/6)	abnormal B cell morphology	J:127600
	abnormal dendritic cell morphology	J:127600
	decreased marginal zone B cell number	J:127600
	enlarged spleen	J:127600
	increased mature B cell number	J:127600
Tg(TNF)197Gkl/0 (involves: C57BL/6 * CBA)	abnormal osteoclast differentiation	J:97992
Tg(TNF)197Gkl/0 (involves: C57BL/6 * CBA)	increased osteoclast cell number	J:97992
Tg(Tnf)6074Gkl/0 (involves: C57BL/6 * CBA)	abnormal microglial cell morphology	J:106592
Tg(TNFSF11)5516Edou/0 Tnfsf11^tles/Tnfsf11^tles (involves: 129S6/SvEvTac * C57BL/6J * CBA/J)	absent lymph nodes	J:233240
Tg(TNFSF11)5519Edou/0 (involves: C57BL/6J * CBA/J)	increased osteoclast cell number	J:233240
Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6 * DBA/2J)	abnormal B cell morphology	J:58798
	abnormal spleen follicular dendritic cell network	J:58798
	abnormal spleen morphology	J:58798
	abnormal spleen periarteriolar lymphoid sheath morphology	J:58798
	abnormal T cell number	J:58798
	abnormal T cell subpopulation ratio	J:58798
	enlarged lymph nodes	J:58798
	enlarged Peyer's patches	J:58798
	enlarged spleen	J:58798
	increased B cell number	J:58798
	increased lymphocyte cell number	J:58798
	increased marginal zone B cell number	J:58798
	increased mature B cell number	J:58798
	increased plasma cell number	J:58798
	increased spleen B cell follicle size	J:58798
	increased spleen germinal center size	J:58798
	increased T cell number	J:58798
Tg(Tnfsf13b)1Fma/0 (B6.Cg-Tg(Tnfsf13b)1Fma)	abnormal B cell differentiation	J:73711
	abnormal B-1 B cell morphology	J:114782
	abnormal spleen germinal center morphology	J:114782
	abnormal spleen marginal zone morphology	J:114782
	increased B cell number	J:114782
	increased B-1a cell number	J:114782
	increased B-1b cell number	J:114782
	increased plasma cell number	J:114782
Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6J * DBA/2J)	abnormal B cell differentiation	J:115788
Tg(Tnfsf13b)1Fma/0 (involves: C57BL/6J * DBA/2J)	abnormal B-1 B cell morphology	J:115788
Tg(Tnfsf13b)1Fma/? (B6.Cg-Tg(Tnfsf13b)1Fma)	abnormal spleen marginal zone morphology	J:113556
	increased B cell number	J:113556
	increased marginal zone B cell number	J:113556
	increased transitional stage B cell number	J:113556
Tg(Tnfsf13b)1Fma/? Tnfrsf13b^tm1Rjb/Tnfrsf13b^tm1Rjb (B6.Cg-Tnfrsf13b^tm1Rjb Tg(Tnfsf13b)1Fma)	abnormal class switch recombination	J:113556
Tg(Tnfsf13b)1Fma/? Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (B6.Cg-Tnfrsf13c^tm1Mass Tg(Tnfsf13b)1Fma)	abnormal class switch recombination	J:113556
Tg(Tnfsf13b)1Fma/0 Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)	abnormal spleen germinal center morphology	J:114782
	abnormal spleen marginal zone morphology	J:114782
	increased B cell number	J:114782
	increased plasma cell number	J:114782
Tg(Tnfsf13b)1Fma/Tg(Tnfsf13b)1Fma (involves: C57BL/6 * DBA/2)	increased B cell number	J:178227
	increased marginal zone B cell number	J:178227
	increased transitional stage T2 B cell number	J:178227
Tg(Tox)1Kay/? Tox^tm1.1Kay/Tox^tm1.1Kay (involves: 129S6/SvEvTac * C57BL/6)	abnormal T cell number	J:131287
Tg(Trp53A135V)L3Ber/0 (involves: C57BL/6 * CD-1)	decreased spleen weight	J:73757
Tg(Ttr-IGF1)1Sykr/0 (FVB/N-Tg(Ttr-IGF1)1Sykr)	increased spleen weight	J:157350
Tg(UBC-scFv)2Nemz/0 (involves: C57BL/6 * DBA/2)	abnormal B cell differentiation	J:96759
	abnormal B cell morphology	J:96759
	abnormal B cell receptor editing	J:96759
	abnormal B-1 B cell morphology	J:96759
	abnormal mature B cell morphology	J:96759
	decreased mature B cell number	J:96759
	decreased splenocyte number	J:96759
	spleen hypoplasia	J:96759
Tg(Vav1-Asxl1Y588X)#Fcy/0 (C57BL/6-Tg(Vav1-Asxl1Y588X)#Fcy)	abnormal neutrophil morphology	J:257690
	abnormal spleen morphology	J:257690
	decreased leukocyte cell number	J:257690
	decreased lymphocyte cell number	J:257690
	enlarged spleen	J:257690
	hepatosplenomegaly	J:257690
	increased leukocyte cell number	J:257690
	increased monocyte cell number	J:257690
	increased neutrophil cell number	J:257690
Tg(Vav1-ERG)#Jpim/0 (involves: C57BL/6)	abnormal thymus morphology	J:174808
	enlarged spleen	J:174808
	enlarged thymus	J:174808
Tg(Vav1-JAK2V617F)AZjz/0 (involves: C57BL/6 DBA/2)	enlarged spleen	J:135993
	increased granulocyte number	J:135993
	increased leukocyte cell number	J:135993
	increased spleen weight	J:135993
	spleen fibrosis	J:135993
Tg(Vav1-Lin28b)C3Apla/0 (involves: C57BL/6)	abnormal T cell differentiation	J:189197
	abnormal thymus cell ratio	J:189197
	abnormal thymus cortex morphology	J:189197
	abnormal thymus corticomedullary boundary morphology	J:189197
	decreased CD4-positive, alpha-beta T cell number	J:189197
	decreased CD8-positive, alpha-beta T cell number	J:189197
	decreased double-positive T cell number	J:189197
	decreased leukocyte cell number	J:189197
	decreased lymphocyte cell number	J:189197
	decreased thymocyte number	J:189197
	enlarged lymph nodes	J:189197
	enlarged spleen	J:189197
	enlarged thymus medulla	J:189197
	increased CD8-positive, alpha-beta T cell number	J:189197
	increased effector memory CD4-positive, alpha-beta T cell number	J:189197
	increased effector memory CD8-positive, alpha-beta T cell number	J:189197
	increased eosinophil cell number	J:189197
	increased neutrophil cell number	J:189197
	increased T cell derived lymphoma incidence	J:189197
Tg(Vav1-NUP98/HOXD13)C1Apla/0 (FVB/N-Tg(Vav1-NUP98/HOXD13)C1Apla)	abnormal neutrophil morphology	J:107446
	decreased leukocyte cell number	J:107446
Tg(Vav1-NUP98/HOXD13)G2Apla/0 (C57BL/6-Tg(Vav1-NUP98/HOXD13)G2Apla)	abnormal neutrophil morphology	J:107446
	decreased leukocyte cell number	J:107446
	decreased lymphocyte cell number	J:107446
	decreased neutrophil cell number	J:107446
Tg(Vav1-STAT5BN642H)726Biat/0 (C57BL/6NCrl-Tg(Vav1-STAT5BN642H)726Biat)	abnormal effector T cell number	J:257519
	abnormal lymph node morphology	J:257519
	abnormal spleen morphology	J:257519
	enlarged spleen	J:257519
	increased CD4-positive, alpha-beta T cell number	J:257519
	increased CD8-positive, alpha-beta T cell number	J:257519
	increased leukocyte cell number	J:257519
Tg(Vav-BCL2)69Jad/0 (involves: C57BL/6J)	abnormal class switch recombination	J:88565
	abnormal lymphocyte cell number	J:88565
	abnormal somatic hypermutation frequency	J:88565
	abnormal spleen germinal center morphology	J:88565
	enlarged lymph nodes	J:88565
	enlarged spleen	J:88565
	increased B cell number	J:88565
	increased CD4-positive, alpha-beta T cell number	J:88565
	increased CD8-positive, alpha-beta T cell number	J:88565
	increased spleen germinal center number	J:88565
	increased spleen germinal center size	J:88565
	increased T cell derived lymphoma incidence	J:88565
	increased T cell number	J:88565
Tg(Vil1-cre)997Gum/? Tlr5^tm1.1Gewr/Tlr5^tm1.1Gewr (involves: C57BL/6J * C57BL/6NTac * SJL/J)	enlarged spleen	J:229155
Tg(Vil1-cre)997Gum/0 Tnfrsf11a^tm1.1Irw/Tnfrsf11a^tm1.1Irw (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * SJL)	abnormal Peyer's patch epithelium morphology	J:219915, J:226603
	abnormal Peyer's patch follicle morphology	J:226603
	abnormal Peyer's patch germinal center morphology	J:226603
	abnormal Peyer's patch morphology	J:226603
	abnormal Peyer's patch T cell area morphology	J:226603
	decreased plasma cell number	J:226603
Tg(VIM-Tag)3Pau/0 (involves: C57BL/6 * SJL/J)	enlarged thymus	J:91542
	increased double-negative T cell number	J:91542
	thymus hyperplasia	J:91542
Tg(Wnt1)1Hev/0 Zfp451^em1Ssli/Zfp451^em1Ssli (involves: C57BL/6 * SJL)	abnormal macrophage morphology	J:338905
Tg^m3Btlr/Tg^m3Btlr (C57BL/6J-Tg^m3Btlr)	decreased B cell number	J:265197
Tg^m4Btlr/Tg^m4Btlr (C57BL/6J-Tg^m4Btlr)	decreased B cell number	J:272522
	decreased B-2 B cell number	J:272522
	increased alpha-beta T cell number	J:272522
	increased B-1a cell number	J:272522
	increased CD4-positive, alpha-beta T cell number	J:272522
	increased CD8-positive, alpha-beta T cell number	J:272522
	increased central memory CD4-positive, alpha-beta T cell number	J:272522
	increased macrophage cell number	J:272522
Tg^M5Btlr/Tg^M5Btlr (C57BL/6J-Tg^M5Btlr)	increased central memory CD4-positive, alpha-beta T cell number	J:272523
Tg^m6Btlr/Tg^m6Btlr (C57BL/6J-Tg^m6Btlr)	increased alpha-beta T cell number	J:272525
tga/tga (C57BL/6J-tga)	thymus hypoplasia	J:94456
Tgfb1^{tm1(Tgfb3)Kul}/Tgfb1^{tm1(Tgfb3)Kul} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal T cell morphology	J:204892
	increased monocyte cell number	J:204892
	increased regulatory T cell number	J:204892
Tgfb1^tm1Doe/Tgfb1^tm1Doe (involves: 129S2/SvPas * CF-1)	abnormal Peyer's patch germinal center morphology	J:2892
	decreased Peyer's patch number	J:2892
	enlarged lymph nodes	J:2892
	increased leukocyte cell number	J:2892
	small spleen	J:2892
Tgfb1^tm1Doe/Tgfb1^tm1Doe (C.129S2-Tgfb1^tm1Doe)	decreased CD4-positive, alpha-beta T cell number	J:69346
	increased CD4-positive, alpha-beta T cell number	J:69346
	increased T-helper 1 cell number	J:69346
Tgfb1^tm1Jmu/Tgfb1^tm1Jmu (involves: 129S6/SvEvTac * C57BL/6)	absent Langerhans cell	J:120085
Tgfb1^tm1Jmu/Tgfb1^tm1Jmu (involves: 129S6/SvEvTac * C57BL/6 * Swiss Webster)	absent Langerhans cell	J:120085
Tgfb1^tm1N/Tgfb1^tm1N (involves: 129S/SvEv)	absent Langerhans cell	J:120085
Tgfb1^tm1Rif/Tgfb1^tm1Rif (either: (involves: 129) or (involves: 129S/SvEv * C57BL/6))	absent Langerhans cell	J:142353
Tgfb1^tm2Flv/B9d2/Tgfb1^tm1Flv Tg(CD207-cre)1Dhka/? (involves: 129S6/SvEvTac * C57BL/6J * SJL/J)	decreased Langerhans cell number	J:126147
Tgfb1^tm3.1Flv/Tgfb1^tm3.1Flv Tg(Cd4-cre)1Cwi/0 (involves: 129 * C57BL/6 * DBA/2 * NOD)	increased regulatory T cell number	J:196160
	increased T-helper 1 cell number	J:196160
Tgfb1^tm3.1Flv/Tgfb1^tm3.1Flv Tg(Cd4-cre)1Cwi/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)	increased regulatory T cell number	J:196160
	increased T-helper 1 cell number	J:196160
Tgfb3^{tm1.1(KOMP)Vlcg}/Tgfb3⁺ (C57BL/6N-Tgfb3^{tm1.1(KOMP)Vlcg}/Tcp)	enlarged lymph nodes	J:211773
Tgfbi^tm1Zhao/Tgfbi^tm1Zhao (involves: 129 * C57BL/6J)	enlarged spleen	J:143036
Tgfbi^tm1Zhao/Tgfbi^tm1Zhao (involves: 129 * C57BL/6J)	increased B cell number	J:143036
Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Tg(Cd4-cre)1Cwi/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: 129 * C57BL/6 * DBA/2 * NOD * SJL)	abnormal abdominal lymph node morphology	J:196160
	abnormal immune system morphology	J:196160
	abnormal immune system organ morphology	J:196160
	abnormal spleen morphology	J:196160
	decreased regulatory T cell number	J:196160
	increased regulatory T cell number	J:196160
Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Tg(CD207-cre)1Dhka/? (involves: 129S6/SvEvTac * C57BL/6J * SJL/J)	decreased Langerhans cell number	J:126147
Tgfbr2^tm1.2Hlm/Tgfbr2^tm1.2Hlm Tg(Foxp3-EGFP/cre)1cJbs/0 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0 (involves: 129S6/SvEvTac * C57BL/6 * NOD * SJL)	increased regulatory T cell number	J:196160
Tgfbr2^tm1Karl/Tgfbr2^tm1Karl H2az2^{Tg(Wnt1-cre)11Rth}/H2az2⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	small thymus	J:96359
Tgfbr2^tm1Karl/Tgfbr2^tm1Karl Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)	small thymus	J:77844
Tgfbr3^tm1Stv/Tgfbr3^tm1Stv (involves: 129/Sv * C57BL/6)	abnormal spleen morphology	J:83727
Tgfbr3^tm1Stv/Tgfbr3^tm1Stv (involves: 129/Sv * C57BL/6)	decreased spleen white pulp amount	J:83727
Tgm2^tm1Gml/Tgm2^tm1Gml (involves: C57BL/6)	increased macrophage cell number	J:131975
Tgm2^tm1Gml/Tgm2^tm1Gml (involves: C57BL/6 * DBA/1LacJ)	abnormal thymus morphology	J:132254
TgTn(pb-CAG-Gm40600)#Rew/0 (C57BL/6-TgTn(pb-CAG-Gm40600)#Rew)	abnormal plasmablast number	J:311878
	decreased B cell number	J:311878
	decreased plasma cell number	J:311878
	increased B cell number	J:311878
	increased plasma cell number	J:311878
Thap4^em1Nvl/Thap4^em1Nvl (C57BL/6JJcl-Thap4^em1Nvl)	increased thymus weight	J:350810
Thbd^tm1Wlr/Thbd^tm1Wlr (B6.129S2-Thbd^tm1Wlr)	abnormal spleen morphology	J:111502
Thbd^tm1Wlr/Thbd^tm2Rdr (involves: 129S2/SvPas * C57BL/6)	abnormal spleen morphology	J:111502, J:47676
Thbs1^tm1Hyn/Thbs1^tm1Hyn (either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6))	increased eosinophil cell number	J:46182
	increased leukocyte cell number	J:46182
	increased lymphocyte cell number	J:46182
	increased monocyte cell number	J:46182
	increased neutrophil cell number	J:46182
Thbs1^tm1Hyn/Thbs1^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	decreased regulatory T cell number	J:153126
Thbs1^tm1Hyn/Thbs1^tm1Hyn (involves: 129S2/SvPas * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:153126
Thbs2^em1(IMPC)Mbp/Thbs2^em1(IMPC)Mbp (C57BL/6NCrl-Thbs2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Thbs4^tm1Dgen/Thbs4^tm1Dgen (involves: 129P2/OlaHsd * C57BL/6)	increased macrophage cell number	J:301049
Thbs4^tm1Olsa/Thbs4^tm1Olsa (C57BL/6J-Thbs4^tm1Olsa)	decreased macrophage cell number	J:301049
Themis^5AT161/Themis^5AT161 (involves: C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:151076
	decreased CD8-positive, alpha-beta T cell number	J:151076
	decreased regulatory T cell number	J:151076
	decreased single-positive T cell number	J:151076
Themis^m1Btlr/Themis^m1Btlr (C57BL/6J-Themis^m1Btlr)	abnormal lymphocyte morphology	J:211400
	decreased B-1a cell number	J:211400
	decreased CD4-positive, alpha-beta T cell number	J:211400
	decreased CD8-positive, alpha-beta T cell number	J:211400
Themis^m2Btlr/Themis^m2Btlr (C57BL/6J-Themis^m2Btlr)	decreased CD4-positive, alpha-beta T cell number	J:236691
	decreased T cell number	J:236691
	increased CD8-positive, alpha-beta T cell number	J:236691
	increased effector memory CD4-positive, alpha-beta T cell number	J:236691
Themis^m3Btlr/Themis^m3Btlr (C57BL/6J-Themis^m3Btlr)	abnormal CD8-positive, alpha-beta cytotoxic T cell morphology	J:254834
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254834
	decreased CD8-positive, alpha-beta memory T cell number	J:254834
	decreased CD8-positive, naive alpha-beta T cell number	J:254834
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254834
	increased CD8-positive, alpha-beta memory T cell number	J:254834
	increased central memory CD4-positive, alpha-beta T cell number	J:254834
	increased central memory CD8 positive, alpha-beta T cell number	J:254834
	increased effector memory CD4-positive, alpha-beta T cell number	J:254834
Themis^M4Btlr/Themis^M4Btlr (C57BL/6J-Themis^M4Btlr)	decreased CD4-positive, alpha-beta T cell number	J:272849
Themis^m5Btlr/Themis^m5Btlr (C57BL/6J-Themis^m5Btlr)	abnormal CD4-positive T cell differentiation	J:274716
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274716
	abnormal T cell differentiation	J:274716
	decreased alpha-beta T cell number	J:274716
	decreased CD4-positive, alpha-beta T cell number	J:274716
	decreased CD8-positive, alpha-beta T cell number	J:274716
	decreased CD8-positive, naive alpha-beta T cell number	J:274716
	increased CD8-positive, alpha-beta memory T cell number	J:274716
	increased central memory CD4-positive, alpha-beta T cell number	J:274716
	increased central memory CD8 positive, alpha-beta T cell number	J:274716
	increased effector memory CD4-positive, alpha-beta T cell number	J:274716
	increased effector memory CD8-positive, alpha-beta T cell number	J:274716
	increased NK T cell number	J:274716
Themis^Spotr/Themis⁺ (C57BL/6-Themis^Spotr)	decreased CD4-positive, alpha-beta T cell number	J:152601
Themis^Spotr/Themis⁺ (C57BL/6-Themis^Spotr)	decreased CD8-positive, alpha-beta T cell number	J:152601
Themis^Spotr/Themis^Spotr (C57BL/6-Themis^Spotr)	abnormal T cell differentiation	J:152601
	decreased CD4-positive, alpha-beta T cell number	J:152601
	decreased CD8-positive, alpha-beta T cell number	J:152601
	small thymus medulla	J:152601
Themis^tm1.1Hko/Themis⁺ (Not Specified)	decreased CD4-positive, alpha-beta T cell number	J:152601
Themis^tm1.1Hko/Themis⁺ (Not Specified)	decreased CD8-positive, alpha-beta T cell number	J:152601
Themis^tm1.1Hko/Themis^tm1.1Hko (Not Specified)	decreased CD4-positive, alpha-beta T cell number	J:152601
	decreased CD8-positive, alpha-beta T cell number	J:152601
	decreased single-positive T cell number	J:152601
Themis^tm1Gasc/Themis^tm1Gasc (B6.129S-Themis^tm1Gasc)	abnormal memory T cell morphology	J:151074
	abnormal positive T cell selection	J:151074
	abnormal regulatory T cell morphology	J:151074
	abnormal thymus medulla morphology	J:151074
	decreased CD4-positive, alpha-beta T cell number	J:151074
	decreased CD8-positive, alpha-beta T cell number	J:151074
	decreased thymocyte number	J:151074
	increased double-positive T cell number	J:151074
Themis^tm1Hasu/Themis⁺ (involves: C57BL/6 * CBA)	decreased CD4-positive, alpha-beta T cell number	J:153235
Themis^tm1Hasu/Themis⁺ (involves: C57BL/6 * CBA)	decreased CD8-positive, alpha-beta T cell number	J:153235
Themis^tm1Hasu/Themis^tm1Hasu (involves: C57BL/6 * CBA)	abnormal T cell differentiation	J:153235
	decreased CD4-positive, alpha-beta T cell number	J:153235
	decreased CD8-positive, alpha-beta T cell number	J:153235
	decreased splenocyte number	J:153235
	decreased thymocyte number	J:153235
	increased memory T cell number	J:153235
Themis^tm1Lov/Themis^tm1Lov (involves: 129)	abnormal negative T cell selection	J:151075
	abnormal T cell differentiation	J:151075
	decreased CD4-positive, alpha-beta T cell number	J:151075
	decreased CD8-positive, alpha-beta T cell number	J:151075
	decreased regulatory T cell number	J:151075
	decreased single-positive T cell number	J:151075
	increased memory T cell number	J:151075
Thim^{Tg(Myh6-TGFB1)1Ljf}/Thim⁺ (involves: C3HeB/FeJ)	increased T cell derived lymphoma incidence	J:59903
Thnsl2^em1(IMPC)Tcp/Thnsl2^em1(IMPC)Tcp (C57BL/6NCrl-Thnsl2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Thoc1^{em1(IMPC)Ccpcz}/Thoc1⁺ (C57BL/6NCrl-Thoc1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Thoc6^em5(IMPC)Tcp/Thoc6⁺ (C57BL/6NCrl-Thoc6^em5(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Thop1^em1(IMPC)Mbp/Thop1^em1(IMPC)Mbp (C57BL/6NCrl-Thop1^em1(IMPC)Mbp/MbpMmucd)	decreased leukocyte cell number	J:211773
Thop1^{Gt(CSG163)Byg}/Thop1^{Gt(CSG163)Byg} (B6.129P2-Thop1^{Gt(CSG163)Byg})	decreased lymphocyte cell number	J:290567
	increased granulocyte number	J:290567
	increased monocyte cell number	J:290567
Thra^tm1Ffla/Thra⁺ Tg(Sycp1-cre)4Min/? (involves: 129/Sv * C57BL/6 * DBA/2)	decreased spleen weight	J:125353
Thra^tm1Syc/Thra⁺ (involves: 129S6/SvEvTac * C57BL/6J * NIH Black Swiss)	decreased osteoclast cell number	J:217018
Thra^tm2Jas/Thra^tm2Jas (involves: 129)	decreased osteoclast cell number	J:120899
Thrb^tm1Olc/Thrb^tm1Olc (involves: 129)	increased osteoclast cell number	J:120899
Thyct1^C57BL/6J/Thyct1^C57BL/6J Thyct2^C57BL/6J/Thyct2^C57BL/6J (involves: C57BL/6J * DBA/2J)	thymus hyperplasia	J:85261
Thyct1^DBA/2J/Thyct1^DBA/2J Thyct2^DBA/2J/Thyct2^DBA/2J (involves: C57BL/6J * DBA/2J)	thymus hypoplasia	J:85261
Thyls2^MSM/Thyls2^MSM (involves: BALB/c * MSM)	increased T cell derived lymphoma incidence	J:87704
Tia1^tm1Andp/Tia1^tm1Andp Zfp36^tm1Pjb/Zfp36^tm1Pjb (B6.Cg-Tia1^tm1Andp Zfp36^tm1Pjb)	increased neutrophil cell number	J:88443
Ticam1^Lps2/Ticam1^Lps2 (C57BL/6J-Ticam1^Lps2/J)	decreased CD8-positive, alpha-beta T cell number	J:288471
	decreased Ly6C low monocyte number	J:288471
	increased Ly6C high monocyte number	J:288471
	increased macrophage cell number	J:288471
	increased neutrophil cell number	J:288471
	increased plasmacytoid dendritic cell number	J:288471
Ticam1^tm1Aki/Ticam1^tm1Aki (involves: 129P2/OlaHsd * C57BL/6)	decreased CD8-positive, alpha-beta T cell number	J:130954
Tie1^tm1.1Scba/Tie1^tm1.1Scba (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal lymphangiogenesis	J:158668
	abnormal lymphatic vessel morphology	J:158668
	lymphatic vessel hyperplasia	J:158668
Tie1^tm1Geno/Tie1^tm1Geno (involves: ICR)	abnormal lymphangiogenesis	J:159507
Tie1^tm1Jpa/Tie1^tm1Jpa (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal lymphangiogenesis	J:159507
Tie1^tm1Scba/Tie1^tm1Scba (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal lymphangiogenesis	J:158668
	abnormal lymphatic vessel morphology	J:158668
	lymphatic vessel hyperplasia	J:158668
Tifab^em1(IMPC)J/Tifab^em1(IMPC)J (C57BL/6NJ-Tifab^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Tifab^tm1.1Dsta/Tifab⁺ (involves: 129 * C57BL/6 * C57BL/6J)	enlarged spleen	J:229024
Tifab^tm1.1Dsta/Tifab^tm1.1Dsta (involves: 129 * C57BL/6 * C57BL/6J)	abnormal neutrophil morphology	J:229024
	decreased leukocyte cell number	J:229024
	decreased lymphocyte cell number	J:229024
	decreased monocyte cell number	J:229024
	decreased neutrophil cell number	J:229024
	enlarged spleen	J:229024
Timd2^{tm1(GAL4)Pdre}/Timd2^{tm1(GAL4)Pdre} (C.129S4-Timd2^{tm1(GAL4)Pdre})	increased eosinophil cell number	J:125054
	increased lymphocyte cell number	J:125054
Timd4^tm1Wouy/Timd4^tm1Wouy (involves: 129)	increased leukocyte cell number	J:160304
Timd4^tm1Wouy/Timd4^tm1Wouy (involves: 129)	increased lymphocyte cell number	J:160304
Timd6^{tm1b(KOMP)Wtsi}/Timd6⁺ (C57BL/6N-Timd6^{tm1b(KOMP)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Timm13^em1(IMPC)Tcp/Timm13⁺ (C57BL/6NCrl-Timm13^em1(IMPC)Tcp/Tcp)	abnormal spleen morphology	J:211773
	enlarged thymus	J:211773
Timmdc1^{Gt(OST407011)Lex}/Timmdc1⁺ (B6;129S5-Timmdc1^{Gt(OST407011)Lex}/Mmucd)	increased CD4-positive, alpha-beta T cell number	J:171883
Timp1^tm1Pds/Timp1^tm1Pds (involves: 129S4/SvJae * C57BL/6)	increased neutrophil cell number	J:112941
Timp2^{em1(IMPC)Hmgu}/Timp2^{em1(IMPC)Hmgu} (C57BL/6N-Timp2^{em1(IMPC)Hmgu}/Ieg)	increased follicular B cell number	J:211773
Timp2^tm1Pds/Timp2^tm1Pds (involves: 129S4/SvJae * C57BL/6)	increased neutrophil cell number	J:112941
Timp3^tm1Rkho/Timp3^tm1Rkho Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129 * 129S/SvEv * C57BL/6)	increased neutrophil cell number	J:112033
Timp4^em1(IMPC)Mbp/Timp4^em1(IMPC)Mbp (C57BL/6N-Timp4^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Tincr^{em1(IMPC)Ccpcz}/Tincr^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tincr^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Tinf2^tm2.2Tdl/Tinf2⁺ (involves: BALB/cJ * C57BL/6)	lymphoid hyperplasia	J:207367
Tinf2^tm2.2Tdl/Tinf2⁺ (involves: BALB/cJ * C57BL/6)	myeloid hyperplasia	J:207367
Tiparp^{tm1b(EUCOMM)Wtsi}/Tiparp^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tiparp^{tm1b(EUCOMM)Wtsi}/Tcp)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tk1^tm1Vnd/Tk1^tm1Vnd (involves: 129P2/OlaHsd * C57BL/6)	lymph node atrophy	J:101669
	small spleen	J:101669
	spleen hypoplasia	J:101669
Tkfc^{em1(IMPC)Ccpcz}/Tkfc^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tkfc^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Tlag2^AKR/J/Tlag2^C57L/J (involves: AKR/J * C57L/J)	increased T cell derived lymphoma incidence	J:74369
Tlag2^AKR/J/Tlag2^C57L/J Tlag1^AKR/J/Tlag1^AKR/J (involves: AKR/J * C57L/J)	increased T cell derived lymphoma incidence	J:74369
Tle3^em1(IMPC)Mbp/Tle3^em1(IMPC)Mbp (C57BL/6N-Tle3^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Tle4^em1(IMPC)Mbp/Tle4^em1(IMPC)Mbp (C57BL/6NCrl-Tle4^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Tle4^tm1.2Dasw/Tle4^tm1.2Dasw (B6.129S6(Cg)-Tle4^tm1.2Dasw)	abnormal lymphopoiesis	J:219243
	abnormal thymus morphology	J:219243
	decreased B cell number	J:219243
	decreased DN2 thymocyte number	J:219243
	decreased double-positive T cell number	J:219243
	decreased follicular B cell number	J:219243
	decreased leukocyte cell number	J:219243
	decreased lymphocyte cell number	J:219243
	decreased pre-pro B cell number	J:219243
	decreased spleen B cell follicle number	J:219243
	increased NK T cell number	J:219243
	spleen hypoplasia	J:219243
	thymus atrophy	J:219243
	thymus hypoplasia	J:219243
Tlf2^NOD/Smrf/? (involves: NOD/Smrf * NON/Lt)	increased CD8-positive, alpha-beta T cell number	J:49676
Tlf^NOD/Smrf/? (involves: NOD/Smrf * NON/Lt)	increased CD4-positive, alpha-beta T cell number	J:49676
Tll1^b2b2476Clo/Tll1^b2b2476Clo (C57BL/6J-Tll1^b2b2476Clo)	thymus hypoplasia	J:175213
Tlr2^tm1Aki/Tlr2^tm1Aki (B6.129P2-Tlr2^tm1Aki)	increased T cell number	J:118954
Tlr4^lps-5Btlr/Tlr4^lps-5Btlr (C57BL/6J-Tlr4^lps-5Btlr)	decreased B cell number	J:224666
Tlr4^lps-5Btlr/Tlr4^lps-5Btlr (C57BL/6J-Tlr4^lps-5Btlr)	decreased memory B cell number	J:224666
Tlr4^Lps-d/Tlr4^Lps-d (involves: C3H/HeJ)	abnormal osteoclast differentiation	J:131353
Tlr4^Lps-d/Tlr4^Lps-d (C3H/HeJ-Tlr4^Lps-d)	abnormal phagocyte morphology	J:125179
Tlr4^Lps-d/Tlr4^Lps-d (C3H/HeJ-Tlr4^Lps-d)	abnormal spleen weight	J:37271
Tlr4^Lps-d/Tlr4^Lps-d Tg(IghelMD4)4Ccg/0 Tg(KLK4mHEL)6Ccg/0 (involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6)	decreased B cell number	J:115059
	increased B-1 B cell number	J:115059
Tlr4^lps-del/Tlr4^lps-del (C57BL/10ScN)	increased spleen weight	J:37271
Tlr4^lps-n/Tlr4^lps-n (C3H/HeN)	increased spleen weight	J:37271
Tlr4^tm1Aki/Tlr4^tm1Aki (involves: 129P2/OlaHsd * C57BL/6J)	enlarged mesenteric lymph nodes	J:98224
Tlr5^tm1Aki/Tlr5^tm1Aki (involves: 129P2/OlaHsd)	enlarged spleen	J:229155
Tlr5^tm1Flv/Tlr5^tm1Flv (involves: 129S1/Sv * C57BL/6)	decreased neutrophil cell number	J:111778
Tlr7^em2Anu/Y (C57BL/6NCrl-Tlr7^em2Anu)	abnormal Peyer's patch morphology	J:324448
	enlarged spleen	J:324448
	increased CD4-positive, alpha-beta T cell number	J:324448
	increased effector memory CD4-positive, alpha-beta T cell number	J:324448
	increased T follicular helper cell number	J:324448
Tlr7^em2Anu/Tlr7⁺ (C57BL/6NCrl-Tlr7^em2Anu)	abnormal mature B cell morphology	J:324448
	decreased marginal zone B cell number	J:324448
	enlarged spleen	J:324448
	increased B cell number	J:324448
	increased CD4-positive, alpha-beta T cell number	J:324448
	increased germinal center B cell number	J:324448
	increased plasma cell number	J:324448
	increased spleen germinal center number	J:324448
	increased T follicular helper cell number	J:324448
	spleen hyperplasia	J:324448
Tlr7^em2Anu/Tlr7^em2Anu (C57BL/6NCrl-Tlr7^em2Anu)	abnormal mature B cell morphology	J:324448
	abnormal Peyer's patch morphology	J:324448
	decreased leukocyte cell number	J:324448
	decreased marginal zone B cell number	J:324448
	enlarged spleen	J:324448
	increased B cell number	J:324448
	increased CD4-positive, alpha-beta T cell number	J:324448
	increased effector memory CD4-positive, alpha-beta T cell number	J:324448
	increased germinal center B cell number	J:324448
	increased plasma cell number	J:324448
	increased spleen germinal center number	J:324448
	increased T follicular helper cell number	J:324448
	spleen hyperplasia	J:324448
Tlr7^tm1Flv/Y (B6.129S1-Tlr7^tm1Flv)	increased marginal zone B cell number	J:127600
Tlr8/Tlr7^tm1Vlcg/Tlr8/Tlr7^tm1Vlcg (B6.Cg-Tlr8/Tlr7^tm1Vlcg)	decreased follicular B cell number	J:165267
	increased marginal zone B cell number	J:165267
Tlr8/Tlr7^tm1Vlcg/Tlr7⁺ Tlr8/Tlr7^tm1Vlcg/Tlr8^tm1Vlcg (B6.Cg-Tlr8/Tlr7^tm1Vlcg Tlr8^tm1Vlcg)	abnormal spleen marginal zone morphology	J:165267
	decreased marginal zone B cell number	J:165267
	increased marginal zone B cell number	J:165267
Tlr8/Tlr7^tm1Vlcg/Tlr8/Tlr7^tm1Vlcg (B6.Cg-Tlr8/Tlr7^tm1Vlcg Tlr8^tm1Vlcg)	decreased follicular B cell number	J:165267
	increased marginal zone B cell number	J:165267
Tlr8^tm1Vlcg/Tlr8^tm1Vlcg (B6.129S1-Tlr8^tm1Vlcg)	abnormal spleen marginal zone morphology	J:165267
	decreased B-1a cell number	J:165267
	decreased B-1b cell number	J:165267
	decreased dendritic cell number	J:165267
	decreased marginal zone B cell number	J:165267
	enlarged spleen	J:165267
	increased B-2 B cell number	J:165267
	increased spleen weight	J:165267
Tlr9^tm1Aki/Tlr9^tm1Aki Tg(IghelMD4)4Ccg/0 Tg(KLK4mHEL)6Ccg/0 (involves: 129P2/OlaHsd * C57BL/6)	decreased mature B cell number	J:115059
	increased B-1 B cell number	J:115059
Tlsm1^AKR/JMs/Tlsm1^AKR/JMs (involves: AKR/JMs * SL/Kh)	increased T cell derived lymphoma incidence	J:21741, J:41197, J:33016
Tlsm1^AKR/JMs/Tlsm1^SL/Kh (involves: AKR/JMs * SL/Kh)	increased T cell derived lymphoma incidence	J:21741, J:41197, J:33016
tlss/tlss (Not Specified)	enlarged mesenteric lymph nodes	J:169366
	enlarged spleen	J:169366
	enlarged thymus	J:169366
Tlx1^{tm1.1(cre/ERT2)Rygo}/Tlx1^{tm1.1(cre/ERT2)Rygo} (involves: C57BL/6 * C57BL/6JJcl * C57BL/6NSlc)	absent spleen	J:217489
Tlx1^tm1Sjk/Tlx1^tm1Sjk (involves: 129S2/SvPas)	abnormal spleen development	J:17695
	abnormal spleen mesenchyme morphology	J:17695
	absent spleen	J:17695
	increased leukocyte cell number	J:17695
	increased lymphocyte cell number	J:17695
	increased neutrophil cell number	J:17695
Tlx1^tm1Thr/Tlx1^tm1Thr (involves: 129P2/OlaHsd * MF1)	abnormal spleen development	J:28700
Tlx1^tm1Thr/Tlx1^tm1Thr (involves: 129P2/OlaHsd * MF1)	absent spleen	J:28700
Tm4sf19^em1Sjkm/Tm4sf19^em1Sjkm (C57BL/6J-Tm4sf19^em1Sjkm)	abnormal osteoclast differentiation	J:343322
Tm4sf19^em2Sjkm/Tm4sf19^em2Sjkm (C57BL/6J-Tm4sf19^em2Sjkm)	abnormal osteoclast differentiation	J:343322
Tm4sf20^em1(IMPC)Bay/Tm4sf20^em1(IMPC)Bay (C57BL/6N-Tm4sf20^em1(IMPC)Bay/BayMmucd)	decreased spleen weight	J:211773
Tm7sf2^{tm1b(KOMP)Wtsi}/Tm7sf2^{tm1b(KOMP)Wtsi} (C57BL/6N-Tm7sf2^{tm1b(KOMP)Wtsi}/Orl)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Tm9sf2^em1(IMPC)Tcp/Tm9sf2⁺ (C57BL/6N-Tm9sf2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Tmc6^tm1.1Les/Tmc6^tm1.1Les (B6.129S6(Cg)-Tmc6^tm1.1Les)	decreased CD4-positive, alpha-beta T cell number	J:300461
Tmc6^tm1.1Les/Tmc6^tm1.1Les (B6.129S6(Cg)-Tmc6^tm1.1Les)	decreased CD8-positive, alpha-beta T cell number	J:300461
Tmc7^em1(IMPC)Mbp/Tmc7^em1(IMPC)Mbp (C57BL/6NCrl-Tmc7^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tmc8^tm1.1Les/Tmc8^tm1.1Les (B6.129S6(Cg)-Tmc8^tm1.1Les)	decreased CD4-positive, alpha-beta T cell number	J:300461
Tmc8^tm1.1Les/Tmc8^tm1.1Les (B6.129S6(Cg)-Tmc8^tm1.1Les)	decreased CD8-positive, alpha-beta T cell number	J:300461
Tmcc2^em1(IMPC)Mbp/Tmcc2⁺ (C57BL/6N-Tmcc2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tmco1^em1(IMPC)J/Tmco1⁺ (C57BL/6NJ-Tmco1^em1(IMPC)J/J)	increased leukocyte cell number	J:211773
Tmem8b^em1(IMPC)Tcp/Tmem8b⁺ (C57BL/6N-Tmem8b^em1(IMPC)Tcp/Tcp)	increased basophil cell number	J:211773
Tmem35a^{tm1.1(KOMP)Vlcg}/Y (B6(FVB)-Tmem35a^{tm1.1(KOMP)Vlcg})	spleen hyperplasia	J:244268
Tmem45a^em1(IMPC)Mbp/Tmem45a^em1(IMPC)Mbp (C57BL/6N-Tmem45a^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Tmem60^{em1(IMPC)Ccpcz}/Tmem60^{em1(IMPC)Ccpcz} (C57BL/6N-Tmem60^{em1(IMPC)Ccpcz}/Ccpcz)	decreased effector memory T-helper cell number	J:211773
Tmem64^{Gt(SYA242)Byg}/Tmem64^{Gt(SYA242)Byg} (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:198051
	decreased osteoclast cell number	J:198051
Tmem74^em1(IMPC)Tcp/Tmem74^em1(IMPC)Tcp (C57BL/6NCrl-Tmem74^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	small thymus	J:211773
Tmem86a^{tm1b(KOMP)Mbp}/Tmem86a^{tm1b(KOMP)Mbp} (C57BL/6N-Tmem86a^{tm1b(KOMP)Mbp}/Kmpc)	abnormal lymph node morphology	J:211773
Tmem100^{tm1e.1(KOMP)Wtsi}/Tmem100⁺ (C57BL/6N-Tmem100^{tm1e.1(KOMP)Wtsi}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Tmem116^{tm1b(EUCOMM)Hmgu}/Tmem116^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tmem116^{tm1b(EUCOMM)Hmgu}/Ieg)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Tmem121b^em1(IMPC)Tcp/Tmem121b^em1(IMPC)Tcp (C57BL/6NCrl-Tmem121b^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Tmem126a^{tm1a(EUCOMM)Wtsi}/Tmem126a^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tmem126a^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased alpha-beta T cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased T-helper cell number	J:211773
Tmem127^{tm1(KOMP)Wtsi}/Tmem127^{tm1(KOMP)Wtsi} (C57BL/6N-Tmem127^{tm1(KOMP)Wtsi}/Wtsi)	decreased B cell number	J:211773
	decreased B-2 B cell number	J:211773
	decreased CD4-positive, alpha-beta T cell number	J:211773
	decreased effector memory CD8-positive, alpha-beta T cell number	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	decreased KLRG1-positive T-helper cell number	J:211773
	decreased Ly6C high monocyte number	J:211773
	decreased memory-marker NK cell number	J:211773
	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	decreased NK cell number	J:211773
	decreased plasmacytoid dendritic cell number	J:211773
	increased alpha-beta T cell number	J:211773
	increased CD4-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, alpha-beta T cell number	J:211773
	increased CD8-positive, naive alpha-beta T cell number	J:211773
	increased KLRG1-positive NK cell number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased memory-marker NK cell number	J:211773
	increased T cell number	J:211773
Tmem138^{tm1b(EUCOMM)Wtsi}/Tmem138^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tmem138^{tm1b(EUCOMM)Wtsi}/BayMmucd)	increased spleen weight	J:211773
Tmem150b^{em1(IMPC)Ccpcz}/Tmem150b^{em1(IMPC)Ccpcz} (C57BL/6N-Tmem150b^{em1(IMPC)Ccpcz}/Ccpcz)	decreased eosinophil cell number	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
Tmem178^tm1Lex/Tmem178^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	abnormal osteoclast differentiation	J:228311
	increased osteoclast cell number	J:228311
Tmem184b^{tm1.1(KOMP)Vlcg}/Tmem184b^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tmem184b^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal lymph node morphology	J:211773
Tmem204^tm1.1Ali/Tmem204^tm1.1Ali (involves: BALB/c * C57BL/6)	abnormal lymphatic vessel smooth muscle morphology	J:159519
	enlarged lymphatic vessel	J:159519
Tmem204^tm1Ali/Tmem204^tm1Ali Tg(Tie1-cre)9Ref/0 (involves: 129S1/Sv * 129X1/SvJ)	enlarged lymphatic vessel	J:159519
Tmem209^em1(IMPC)Tcp/Tmem209⁺ (C57BL/6NCrl-Tmem209^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Tmem219^{tm1(KOMP)Vlcg}/Tmem219^{tm1(KOMP)Vlcg} (B6J.B6N-Tmem219^{tm1(KOMP)Vlcg})	increased eosinophil cell number	J:236976
Tmem225^em1(IMPC)Mbp/Tmem225^em1(IMPC)Mbp (C57BL/6N-Tmem225^em1(IMPC)Mbp/MbpMmucd)	small spleen	J:211773
Tmem237^{tm1b(EUCOMM)Hmgu}/Tmem237⁺ (C57BL/6N-Tmem237^{tm1b(EUCOMM)Hmgu}/Ccpcz)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Tmem248^{tm1.1(KOMP)Vlcg}/Tmem248^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tmem248^{tm1.1(KOMP)Vlcg}/Ucd)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased thymus weight	J:211773
	increased monocyte cell number	J:211773
	small spleen	J:211773
	small thymus	J:211773
Tmem256^{tm1.1(KOMP)Vlcg}/Tmem256^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tmem256^{tm1.1(KOMP)Vlcg}/Ucd)	increased monocyte cell number	J:211773
Tmem263^em1Gww/Tmem263^em1Gww (C57BL/6J-Tmem263^em1Gww)	decreased spleen weight	J:345905
Tmem268^em1Cheyy/Tmem268^em1Cheyy (involves: C57BL/6)	abnormal monocyte cell number	J:350812
	abnormal neutrophil cell number	J:350812
	decreased macrophage cell number	J:350812
Tmprss2^{em1(IMPC)Ccpcz}/Tmprss2^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tmprss2^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Tmprss6^msk/Tmprss6^msk (C57BL/6J-Tmprss6^msk)	decreased spleen iron level	J:134446
Tmprss6^{tm1b(EUCOMM)Wtsi}/Tmprss6^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Tmprss6^{tm1b(EUCOMM)Wtsi}/Ics)	decreased CD8-positive, alpha-beta T cell number	J:211773
	decreased NK cell number	J:211773
	increased CD11b-high dendritic cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased Ly6C-positive mature NK cell number	J:211773
Tmprss6^tm1Dgen/Tmprss6⁺ (B6.129P2-Tmprss6^tm1Dgen/Crl)	decreased spleen iron level	J:160248
Tmprss6^tm1Dgen/Tmprss6^tm1Dgen (B6.129P2-Tmprss6^tm1Dgen/Crl)	decreased spleen iron level	J:160248
	increased spleen weight	J:160248
Tmprss15^{tm1a(KOMP)Wtsi}/Tmprss15^{tm1a(KOMP)Wtsi} (C57BL/6N-Tmprss15^{tm1a(KOMP)Wtsi}/Wtsi)	increased leukocyte cell number	J:175295
Tmub1^tm1Lex/Tmub1^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	increased monocyte cell number	J:171883
Tmub2^{tm1b(KOMP)Wtsi}/Tmub2^{tm1b(KOMP)Wtsi} (C57BL/6N-Tmub2^{tm1b(KOMP)Wtsi}/Tcp)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Tnf^M1Btlr/Tnf⁺ (C57BL/6J-Tnf^M1Btlr)	decreased follicular dendritic cell number	J:124642
Tnf^M1Btlr/Tnf^M1Btlr (C57BL/6J-Tnf^M1Btlr)	decreased follicular dendritic cell number	J:124642
Tnf^tm1.2Sned/Tnf^tm1.2Sned (involves: 129/Sv * C57BL/6)	absent Peyer's patches	J:97783
Tnf^tm1.2Sned/Tnf^tm1.2Sned (involves: 129/Sv * C57BL/6)	increased leukocyte cell number	J:97783
Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129S/SvEv * C57BL/6)	abnormal lymph node B cell domain morphology	J:40970
	abnormal mesenteric lymph node morphology	J:114740
	abnormal Peyer's patch follicle morphology	J:40970
	abnormal Peyer's patch morphology	J:40970
	abnormal spleen follicular dendritic cell network	J:42579
	abnormal spleen primary B follicle morphology	J:47673
	absent follicular dendritic cells	J:40970
	absent spleen germinal center	J:47673, J:114740
	decreased Peyer's patch number	J:40970
Tnf^tm1Gkl/Tnf^tm1Gkl (either: B6.129-Tnf^tm1Gkl or (involves: 129 * C57BL/6))	decreased Peyer's patch number	J:97783
	increased leukocyte cell number	J:97783
	increased lymphocyte cell number	J:97783
	increased neutrophil cell number	J:97783
	small Peyer's patches	J:97783
Tnf^tm1Gkl/Tnf^tm1Gkl (involves: 129S/SvEv * C57BL/6J)	abnormal metallophilic macrophage morphology	J:124642
	abnormal Peyer's patch follicle morphology	J:124642
	abnormal Peyer's patch germinal center morphology	J:124642
	abnormal Peyer's patch morphology	J:124642
	abnormal Peyer's patch T cell area morphology	J:124642
	abnormal spleen follicular dendritic cell network	J:124642
	abnormal spleen marginal sinus morphology	J:124642
	abnormal spleen primary B follicle morphology	J:124642
	absent spleen germinal center	J:124642
	decreased Peyer's patch number	J:124642
Tnf^tm1Jods/Tnf^tm1Jods (involves: C57BL/6)	abnormal lymph node primary follicle morphology	J:98591
	abnormal metallophilic macrophage morphology	J:98591
	abnormal Peyer's patch follicle morphology	J:43602
	abnormal Peyer's patch morphology	J:43602, J:98591
	abnormal spleen marginal sinus morphology	J:43602
	abnormal spleen primary B follicle morphology	J:43602, J:98591
	abnormal spleen white pulp morphology	J:43602, J:98591
	absent spleen germinal center	J:98591
	decreased follicular dendritic cell number	J:43602
	decreased Peyer's patch number	J:43602
	increased leukocyte cell number	J:43602
	small Peyer's patches	J:43602
Tnf^tm1Jods/Tnf^tm1Jods (C57BL/6-Lta^tm1Jods)	abnormal spleen B cell follicle morphology	J:78229
Tnf^tm1Ljo/Tnf^tm1Ljo (involves: 129S1/Sv)	absent spleen germinal center	J:80616, J:41992
	decreased spleen B cell follicle number	J:95684
	decreased spleen white pulp amount	J:80616
Tnf^tm1Ljo/Tnf^tm1Ljo (either: B6.129-Tnf^tm1Ljo or (involves: 129 * C57BL/6))	abnormal Peyer's patch follicle morphology	J:97783
	abnormal Peyer's patch germinal center morphology	J:97783
	abnormal Peyer's patch T cell area morphology	J:97783
	absent follicular dendritic cells	J:97783
	decreased Peyer's patch number	J:97783
	increased leukocyte cell number	J:97783
	increased lymphocyte cell number	J:97783
	increased neutrophil cell number	J:97783
	small Peyer's patches	J:97783
Tnf^tm1Ljo/Tnf^tm1Ljo (involves: 129S1/Sv * C57BL/6)	abnormal lymph node cell ratio	J:127028
	increased neutrophil cell number	J:127028
	lymph node hypoplasia	J:127028
Tnf^tm1Sek/Tnf^tm1Sek (B6.Cg-Tnf^tm1Sek)	abnormal mesenteric lymph node morphology	J:44841
	abnormal Peyer's patch germinal center morphology	J:44841
	absent lymph node germinal center	J:44841
	absent spleen germinal center	J:44841
Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * C57BL/6)	abnormal alpha-beta intraepithelial T cell morphology	J:136667
	abnormal CD8-positive, alpha beta T cell morphology	J:136667
	abnormal T cell subpopulation ratio	J:136667
	increased dendritic cell number	J:204922
Tnf^tm2Gkl/Tnf⁺ (involves: 129S/SvEv * C57BL/6J)	abnormal myelopoiesis	J:108572
	enlarged spleen	J:108572
	increased CD8-positive, alpha-beta T cell number	J:108572
Tnf^tm2Gkl/Tnf⁺ (B6.129S-Tnf^tm2Gkl/Jarn)	abnormal CD8-positive, alpha beta T cell morphology	J:131978
	increased CD4-positive, alpha-beta memory T cell number	J:145626
	increased CD4-positive, alpha-beta T cell number	J:145626
Tnf^tm2Gkl/Tnf^tm2Gkl (involves: 129S/SvEv * C57BL/6)	thymus hypoplasia	J:54056
Tnf^tm2Jods/Tnf^tm2Jods (involves: C57BL/6)	abnormal lymph node cell ratio	J:127028
Tnf^tm2Jods/Tnf^tm2Jods (C57BL/6-Tnf^tm2Jods)	abnormal lymph node primary follicle morphology	J:98591
	abnormal metallophilic macrophage morphology	J:98591
	abnormal Peyer's patch follicle morphology	J:98591
	abnormal spleen follicular dendritic cell network	J:98591
	abnormal spleen primary B follicle morphology	J:98591
	abnormal spleen white pulp morphology	J:98591
	decreased spleen germinal center number	J:98591
	decreased spleen germinal center size	J:98591
Tnf^tm3Gkl/Tnf^tm3Gkl (involves: 129S/SvEv * C57BL/6)	abnormal lymph node B cell domain morphology	J:114740
	abnormal mesenteric lymph node morphology	J:114740
	abnormal spleen primary B follicle morphology	J:114740
	absent follicular dendritic cells	J:114740
	absent spleen germinal center	J:114740
Tnf^tm3Gkl/Tnf^tm3Gkl Zfp36^tm1Pjb/Zfp36^tm1Pjb (involves: 129S/SvEv * C57BL/6)	myeloid hyperplasia	J:114740
Tnfaip3^m1Apb/Tnfaip3^m1Apb (C57BL/6-Tnfaip3^m1Apb)	enlarged lymph nodes	J:324062
	increased effector memory T-helper cell number	J:324062
	increased macrophage cell number	J:324062
Tnfaip3^tm1.1Gho/Tnfaip3^tm1.1Gho (involves: C57BL/6J)	enlarged spleen	J:217021
Tnfaip3^tm1Ama/Tnfaip3^tm1Ama (Not Specified)	increased granulocyte number	J:92931
	increased lymphocyte cell number	J:92931
	increased macrophage cell number	J:92931
Tnfaip3^tm1Homy/Tnfaip3^tm1Homy Tg(Mx1-cre)1Cgn/? (involves: 129S6/SvEvTac * C57BL/6J * CBA/J)	abnormal B cell number	J:212681
	abnormal myelopoiesis	J:212681
	abnormal spleen morphology	J:212681
	enlarged lymph nodes	J:212681
Tnfaip3^tm2Ama/Tnfaip3^tm2Ama Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell morphology	J:163917
	abnormal B-1a B cell morphology	J:163917
	decreased B cell number	J:163917
	increased B cell number	J:163917
	increased germinal center B cell number	J:163917
	increased immature B cell number	J:163917
	increased plasma cell number	J:163917
	increased T cell number	J:163917
Tnfaip3^tm3.1Ama/Tnfaip3^tm3.1Ama (C57BL/6J-Tnfaip3^tm3.1Ama)	enlarged spleen	J:203160
	increased B cell number	J:203160
	increased CD4-positive, alpha-beta T cell number	J:203160
	increased CD8-positive, alpha-beta T cell number	J:203160
	myeloid hyperplasia	J:203160
Tnfaip3^tm4.1Ama/Tnfaip3^tm4.1Ama (C57BL/6J-Tnfaip3^tm4.1Ama)	enlarged spleen	J:203160
	increased B cell number	J:203160
	increased CD4-positive, alpha-beta T cell number	J:203160
	increased CD8-positive, alpha-beta T cell number	J:203160
	myeloid hyperplasia	J:203160
Tnfaip8^{Gt(IST13629C1)Tigm}/Tnfaip8^{Gt(IST13629C1)Tigm} (involves: C57BL/6N)	increased neutrophil cell number	J:223320
	small spleen	J:223320
Tnfaip8^{Gt(IST13629C1)Tigm}/Tnfaip8^{Gt(IST13629C1)Tigm} Tnfaip8l1^em1Huwa/Tnfaip8l1^em1Huwa (involves: C57BL/6 * C57BL/6N)	decreased spleen weight	J:342074
	increased leukocyte cell number	J:342074
	increased T-helper 17 cell number	J:342074
Tnfaip8l1^em1(IMPC)Mbp/Tnfaip8l1^em1(IMPC)Mbp (C57BL/6N-Tnfaip8l1^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Tnfaip8l2^tm1Yhcn/Tnfaip8l2^tm1Yhcn (129S6/SvEvTac-Tnfaip8l2^tm1Yhcn)	abnormal leukocyte morphology	J:139785
	abnormal myeloid dendritic cell morphology	J:139785
	abnormal spleen morphology	J:139785
	enlarged spleen	J:139785
	increased B cell number	J:139785
	increased spleen white pulp amount	J:139785
	increased T cell number	J:139785
	spleen hyperplasia	J:139785
Tnfrsf1a^{em1(IMPC)Ccpcz}/Tnfrsf1a^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tnfrsf1a^{em1(IMPC)Ccpcz}/Ccpcz)	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
	increased neutrophil cell number	J:211773
	increased NK cell number	J:211773
Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt (involves: 129P2/OlaHsd * C57BL/6)	abnormal lymph node B cell domain morphology	J:40970
	abnormal Peyer's patch follicle morphology	J:40970
	abnormal Peyer's patch morphology	J:40970
	absent follicular dendritic cells	J:40970
	decreased Peyer's patch number	J:40970
Tnfrsf1a^tm1Blt/Tnfrsf1a^tm1Blt Tnfrsf1b^tm1Mwm/Tnfrsf1b^tm1Mwm (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	abnormal lymph node cortex morphology	J:119206
	abnormal lymph node primary follicle morphology	J:119206
	abnormal lymph node secondary follicle morphology	J:119206
	absent lymph node germinal center	J:119206
	absent spleen germinal center	J:119206
	small Peyer's patches	J:119206
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (C57BL/6-Tnfrsf1a^tm1Imx)	decreased microglial cell number	J:112713
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx (C57BL/6-Tnfrsf1a^tm1Imx/J)	abnormal follicular dendritic cell morphology	J:160543
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx Tg(Ins2-Cxcl13)1Cys/0 (involves: C57BL/6 * DBA/2)	abnormal lymph organ development	J:110548
Tnfrsf1a^tm1Imx/Tnfrsf1a^tm1Imx Tg(Thy1-APP)3Somm/0 (involves: C57BL/6 * C57BL/6J * DBA/2)	microgliosis	J:134832
Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak (involves: 129S2/SvPas)	abnormal spleen germinal center morphology	J:139030
Tnfrsf1a^tm1Mak/Tnfrsf1a^tm1Mak Tnip1^{Gt(E059E05)Wrst}/Tnip1^{Gt(E059E05)Wrst} (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)	increased neutrophil cell number	J:180054
	spleen hyperplasia	J:180054
Tnfrsf1a^tm1Rsie/Tnfrsf1a^tm1Rsie (B6.Cg-Tnfrsf1a^tm1Rsie)	abnormal follicular dendritic cell morphology	J:160543
Tnfrsf1a^{tm2b(EUCOMM)Wtsi}/Tnfrsf1a^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Tnfrsf1a^{tm2b(EUCOMM)Wtsi}/H)	decreased monocyte cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Tnfrsf1b^{tm1a(EUCOMM)Wtsi}/Tnfrsf1b^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Tnfrsf1b^{tm1a(EUCOMM)Wtsi}/Ics)	decreased T cell number	J:165965
Tnfrsf1b^tm1Imx/Tnfrsf1b^tm1Imx (involves: 129S7/SvEvBrd * C57BL/6)	microgliosis	J:112713
Tnfrsf8^tm1Mak/Tnfrsf8^tm1Mak (involves: 129P2/OlaHsd * C57BL/6)	enlarged thymus	J:62854
	increased thymocyte number	J:62854
Tnfrsf9^m1Btlr/Tnfrsf9^m1Btlr (C57BL/6J-Tnfrsf9^m1Btlr)	decreased CD8-positive, alpha-beta T cell number	J:265260
	decreased CD8-positive, naive alpha-beta T cell number	J:265260
	decreased single-positive T cell number	J:265260
	increased B cell number	J:265260
	increased effector memory CD4-positive, alpha-beta T cell number	J:265260
	increased effector memory CD8-positive, alpha-beta T cell number	J:265260
Tnfrsf10b^tm1Wnt/Tnfrsf10b^tm1Wnt (involves: 129S6/SvEvTac * C57BL/6)	increased NK cell number	J:94681
Tnfrsf10b^tm1Wsed/Tnfrsf10b^tm1Wsed (involves: 129P2/OlaHsd)	enlarged thymus	J:96816
Tnfrsf11a^del8/Tnfrsf11a^del8 (involves: 129)	abnormal mesenteric lymph node morphology	J:111512
	decreased osteoclast cell number	J:111512
	enlarged spleen	J:111512
Tnfrsf11a^tm1.1Sral/Tnfrsf11a⁺ (B6.129P2(Cg)-Tnfrsf11a^tm1.1Sral)	abnormal osteoclast differentiation	J:312215
	increased osteoclast cell number	J:312215
Tnfrsf11a^tm1.1Sral/Tnfrsf11a^tm1.1Sral (B6.129P2(Cg)-Tnfrsf11a^tm1.1Sral)	abnormal osteoclast differentiation	J:312215
	decreased osteoclast cell number	J:312215
Tnfrsf11a^tm1.2Pngr/Tnfrsf11a^tm1.2Pngr (B6.Cg-Tnfrsf11a^tm1.2Pngr)	absent lymph nodes	J:155398
	decreased osteoclast cell number	J:155398
Tnfrsf11a^tm1Imx/Tnfrsf11a^tm1Imx (involves: 129 * C57BL/6)	abnormal osteoclast differentiation	J:57899
	absent lymph nodes	J:57899
	decreased B cell number	J:57899
	decreased mature B cell number	J:57899
	decreased osteoclast cell number	J:57899
	decreased Peyer's patch number	J:57899
	decreased spleen germinal center size	J:57899
	increased granulocyte number	J:57899
	increased neutrophil cell number	J:57899
	small Peyer's patches	J:57899
	spleen hyperplasia	J:57899
Tnfrsf11a^tm1Imx/Tnfrsf11a^tm1Imx (involves: 129)	abnormal negative T cell selection	J:125864
Tnfrsf11a^tm1Imx/Tnfrsf11a^tm1Imx (involves: 129)	abnormal thymus epithelium morphology	J:125864
Tnfrsf11b^em1(IMPC)Mbp/Tnfrsf11b^em1(IMPC)Mbp (C57BL/6N-Tnfrsf11b^em1(IMPC)Mbp/MbpMmucd)	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Tnfrsf11b^tm1Eac/Tnfrsf11b^tm1Eac (involves: 129S4/SvJaeSor)	abnormal immune system morphology	J:67105
	abnormal pro-B cell differentiation	J:67105
	increased B cell number	J:67105
	increased immature B cell number	J:67105
	increased pro-B cell number	J:67105
Tnfrsf11b^tm1Khs/Tnfrsf11b^tm1Khs (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:111153, J:48325
	increased osteoclast cell number	J:80503
Tnfrsf11b^tm1Wss/Tnfrsf11b^tm1Wss (either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * Black Swiss))	abnormal osteoclast morphology	J:47602
Tnfrsf13b^tm1Cmac/Tnfrsf13b^tm1Cmac (Not Specified)	enlarged spleen	J:91914
Tnfrsf13b^tm1Cmac/Tnfrsf13b^tm1Cmac (Not Specified)	increased B cell number	J:91914
Tnfrsf13b^tm1Rjb/Tnfrsf13b^tm1Rjb (involves: 129X1/SvJ * C57BL/6)	increased B cell number	J:69474
	increased spleen weight	J:69474
Tnfrsf13b^tm1Rjb/Tnfrsf13b^tm1Rjb (involves: 129X1/SvJ)	abnormal class switch recombination	J:95288
Tnfrsf13b^tm1Vmd/Tnfrsf13b^tm1Vmd (involves: C57BL/6)	abnormal lymph node primary follicle morphology	J:70172, J:82331
	abnormal Peyer's patch follicle morphology	J:70172
	abnormal spleen morphology	J:70172
	abnormal spleen periarteriolar lymphoid sheath morphology	J:70172, J:82331
	abnormal spleen primary B follicle morphology	J:70172
	enlarged lymph nodes	J:70172, J:82331
	enlarged spleen	J:70172, J:82331
	increased B cell number	J:70172, J:82331
	increased follicular B cell number	J:70172
	increased marginal zone B cell number	J:70172
	increased mature B cell number	J:70172
	increased spleen germinal center size	J:70172
	increased spleen white pulp amount	J:70172
	increased transitional stage B cell number	J:70172
Tnfrsf13c^m1Btlr/Tnfrsf13c^m1Btlr (C57BL/6J-Tnfrsf13c^m1Btlr)	decreased B cell number	J:265247
Tnfrsf13c^M2Btlr/Tnfrsf13c^M2Btlr (C57BL/6J-Tnfrsf13c^M2Btlr)	decreased B cell number	J:265247
Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (C57BL/6-Tnfrsf13c^tm1Mass)	absent marginal zone B cells	J:92732
	arrested B cell differentiation	J:92732
	decreased B-2 B cell number	J:92732
	decreased mature B cell number	J:92732
Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (involves: C57BL/6)	decreased lymphocyte cell number	J:139293
Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass (involves: C57BL/6)	decreased mature B cell number	J:139293
Tnfrsf13c^tm1Mass/Tnfrsf13c^tm1Mass Traf2^tm1Rbr/Traf2^tm1Rbr (involves: C57BL/6)	decreased germinal center B cell number	J:172843
	decreased spleen germinal center size	J:172843
Tnfrsf13c^tm1Msc/Tnfrsf13c^tm1Msc (involves: 129P2/OlaHsd * C57BL/6)	absent marginal zone B cells	J:92676
	absent transitional stage B cells	J:92676
	decreased B cell number	J:92676
	decreased B-2 B cell number	J:92676
Tnfrsf17^tm1Kplm/Tnfrsf17^tm1Kplm (involves: 129P2/OlaHsd * C57BL/6)	decreased plasma cell number	J:124543
Tnfrsf21^tm1Ddy/Tnfrsf21^tm1Ddy (involves: 129S1/Sv * 129X1/SvJ)	increased spleen germinal center size	J:109341
Tnfrsf21^tm1Vmd/Tnfrsf21^tm1Vmd (involves: C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:72761
	increased CD8-positive, alpha-beta T cell number	J:72761
	increased T cell number	J:72761
Tnfrsf25^tm1Mjo/Tnfrsf25^tm1Mjo (involves: 129P2/OlaHsd)	abnormal negative T cell selection	J:84536
	enlarged thymus	J:84536
	increased thymocyte number	J:84536
Tnfsf10^tm1Mjs/Tnfsf10^tm1Mjs (C.129-Tnfsf10^tm1Mjs)	abnormal negative T cell selection	J:82145
Tnfsf10^tm1Mjs/Tnfsf10^tm1Mjs (C.129-Tnfsf10^tm1Mjs)	thymus hyperplasia	J:84838, J:82145
Tnfsf10^tm1Mjs/Tnfsf10^tm1Mjs (B6.129-Tnfsf10^tm1Mjs)	abnormal negative T cell selection	J:82145
Tnfsf10^tm1Mjs/Tnfsf10^tm1Mjs (B6.129-Tnfsf10^tm1Mjs)	thymus hyperplasia	J:82145
Tnfsf11^tles/Tnfsf11^tles (involves: 129S6/SvEvTac * C57BL/6J)	absent lymph nodes	J:179743
	decreased osteoclast cell number	J:179743
	enlarged spleen	J:179743
	thymus hypoplasia	J:179743
Tnfsf11^tles/Tnfsf11^tm1Pngr (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)	decreased osteoclast cell number	J:179743
Tnfsf11^{tm1(TNFSF11)Kost}/Tnfsf11^{tm1(TNFSF11)Kost} (involves: 129/Sv * Black Swiss)	abnormal osteoclast morphology	J:166279
Tnfsf11^tm1.1Caob/Tnfsf11^tm1.1Caob Tg(Dmp1-cre)1Jqfe/0 (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB)	abnormal osteoclast cell number	J:177558
	decreased osteoclast cell number	J:177558
Tnfsf11^tm1.1Caob/Tnfsf11^tm1.1Caob Tg(Prrx1-cre)1Cjt/0 (involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)	decreased osteoclast cell number	J:177558
Tnfsf11^tm1.1Htaka/Tnfsf11^tm1.2Htaka Tg(Dmp1-cre)1Jqfe/0 (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * FVB/N)	decreased osteoclast cell number	J:177557
Tnfsf11^tm1.2Htaka/Tnfsf11⁺ (B6.Cg-Tnfsf11^tm1.2Htaka)	decreased osteoclast cell number	J:177557
Tnfsf11^tm1.2Htaka/Tnfsf11^tm1.2Htaka (B6.Cg-Tnfsf11^tm1.2Htaka)	decreased osteoclast cell number	J:177557
	increased spleen weight	J:177557
Tnfsf11^tm1Pngr/Tnfsf11^tm1Pngr (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune system morphology	J:52369
	abnormal pro-B cell differentiation	J:52369
	absent mesenteric lymph nodes	J:52369
	absent peripheral lymph nodes	J:52369
	arrested T cell differentiation	J:52369
	decreased immature B cell number	J:52369
	decreased mature B cell number	J:52369
	decreased osteoclast cell number	J:52369
	decreased thymus weight	J:52369
	increased spleen weight	J:52369
	small Peyer's patches	J:52369
	thymus hypoplasia	J:52369
Tnfsf11^tm1Pngr/Tnfsf11^tm1Pngr (involves: 129P2/OlaHsd)	abnormal thymus epithelium morphology	J:173115
Tnfsf11^tm1Ywc/Tnfsf11⁺ (involves: 129P2/OlaHsd)	absent peripheral lymph nodes	J:65888
Tnfsf11^tm1Ywc/Tnfsf11^tm1Ywc (involves: 129P2/OlaHsd)	abnormal cervical lymph node morphology	J:65888
	abnormal spleen B cell follicle morphology	J:65888
	abnormal spleen marginal zone morphology	J:65888
	abnormal spleen morphology	J:65888
	abnormal splenic cell ratio	J:233265
	abnormal thymus cell ratio	J:233265
	absent cervical lymph nodes	J:65888
	absent mesenteric lymph nodes	J:65888
	absent peripheral lymph nodes	J:65888
	decreased Langerhans cell number	J:137471
	decreased osteoclast cell number	J:65888, J:64737
	decreased Peyer's patch number	J:233265
	decreased spleen white pulp amount	J:233265
	increased spleen red pulp amount	J:233265
	small Peyer's patches	J:233265
	small thymus medulla	J:233265
Tnfsf12^tm1Ash/Tnfsf12^tm1Ash (B6.129-Tnfsf12^tm1Ash)	abnormal immune system organ morphology	J:104801
	abnormal leukocyte morphology	J:104801
	enlarged lymph nodes	J:104801
	enlarged spleen	J:104801
	increased double-positive T cell number	J:104801
	increased memory T cell number	J:104801
	increased NK cell number	J:104801
	increased T-helper 1 cell number	J:104801
Tnfsf13^tm1Geha/Tnfsf13^tm1Geha (involves: 129S4/SvJae)	abnormal class switch recombination	J:88910
	increased memory T cell number	J:88910
	increased spleen germinal center number	J:88910
	increased spleen germinal center size	J:88910
Tnfsf13b^m1Anu/Tnfsf13b^m1Anu (C57BL/6JAnu-Tnfsf13b^m1Anu/AnuApb)	abnormal B cell differentiation	J:104190
	decreased mature B cell number	J:104190
	increased immature B cell number	J:104190
Tnfsf13b^M1Btlr/Tnfsf13b⁺ (C57BL/6J-Tnfsf13b^M1Btlr)	decreased B cell number	J:220069
	increased single-positive T cell number	J:220069
	increased T cell number	J:220069
Tnfsf13b^M1Btlr/Tnfsf13b^M1Btlr (C57BL/6J-Tnfsf13b^M1Btlr)	decreased B cell number	J:220069
	increased single-positive T cell number	J:220069
	increased T cell number	J:220069
Tnfsf13b^m2Btlr/Tnfsf13b^m2Btlr (C57BL/6J-Tnfsf13b^m2Btlr)	decreased B cell number	J:220070
Tnfsf13b^m3Btlr/Tnfsf13b^m3Btlr (C57BL/6J-Tnfsf13b^m3Btlr)	abnormal lymphocyte morphology	J:272850
Tnfsf13b^m3Btlr/Tnfsf13b^m3Btlr (C57BL/6J-Tnfsf13b^m3Btlr)	decreased B cell number	J:272850
Tnfsf13b^tm1Cleg/Tnfsf13b^tm1Cleg (involves: 129S5/SvEvBrd)	abnormal B cell differentiation	J:71301
	abnormal leukocyte morphology	J:71301
	abnormal lymph organ size	J:71301
	decreased follicular B cell number	J:71301
	decreased mature B cell number	J:71301
	decreased memory T cell number	J:71301
	increased T cell number	J:71301
	lymph node hypoplasia	J:71301
	spleen hypoplasia	J:71301
Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc (involves: 129S2/SvPas * C57BL/6)	abnormal B cell differentiation	J:71681
	abnormal lymph node B cell domain morphology	J:71681
	arrested B cell differentiation	J:71681
	decreased B cell number	J:71681
	decreased follicular B cell number	J:71681
	decreased marginal zone B cell number	J:71681
	decreased spleen weight	J:71681
Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc (involves: 129S2/SvPas)	decreased B cell number	J:138560
	decreased follicular B cell number	J:138560
	decreased transitional stage B cell number	J:138560
Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc Traf2^tm1Rbr/Traf2^tm1Rbr (involves: 129S2/SvPas * C57BL/6)	absent follicular B cells	J:132877
	absent marginal zone B cells	J:132877
	decreased mature B cell number	J:132877
Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell subpopulation ratio	J:77250
Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (involves: 129P2/OlaHsd)	abnormal gamma-delta T cell morphology	J:169863
Tnfsf14^tm1Kpf/Tnfsf14^tm1Kpf (B6.129P2-Tnfsf14^tm1Kpf)	abnormal osteoclast differentiation	J:294030
Tnfsf15^tm1Cdon/Tnfsf15^tm1Cdon (B6.129-Tnfsf15^tm1Cdon)	abnormal dendritic cell differentiation	J:136280
Tnfsf15^tm1Hluo/Tnfsf15^tm1Hluo (D1LacJ.129(B6)-Tnfsf15^tm1Hluo)	decreased B cell number	J:207029
	decreased germinal center B cell number	J:207029
	decreased plasma cell number	J:207029
	decreased T cell number	J:207029
	decreased T follicular helper cell number	J:207029
	lymph node hypoplasia	J:207029
Tnfsf15^tm1Lex/Tnfsf15^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6)	increased NK cell number	J:82809
Tnip1^{Gt(E059E05)Wrst}/Tnip1^{Gt(E059E05)Wrst} (involves: 129P2/OlaHsd * C57BL/6)	enlarged lymph nodes	J:180054
	enlarged spleen	J:180054
	increased neutrophil cell number	J:180054
	lymph node hyperplasia	J:180054
	spleen hyperplasia	J:180054
Tnip1^m1Btlr/Tnip1^m1Btlr (C57BL/6J-Tnip1^m1Btlr)	decreased B cell number	J:265175
	decreased B-2 B cell number	J:265175
	increased B-1a cell number	J:265175
	increased B-1b cell number	J:265175
	increased dendritic cell number	J:265175
	increased macrophage cell number	J:265175
Tnip1^tm1.1Pcoh/Tnip1^tm1.1Pcoh (involves: 129P2/OlaHsd * C57BL/6)	abnormal effector T cell morphology	J:176826
	abnormal immune system morphology	J:176826
	abnormal Peyer's patch morphology	J:176826
	abnormal plasma cell morphology	J:176826
	abnormal spleen germinal center morphology	J:176826
	enlarged lymph nodes	J:176826
	enlarged spleen	J:176826
	increased B cell number	J:176826
	increased germinal center B cell number	J:176826
	increased granulocyte number	J:176826
	increased monocyte cell number	J:176826
	increased plasma cell number	J:176826
	increased spleen red pulp amount	J:176826
	increased spleen weight	J:176826
	increased spleen white pulp amount	J:176826
	increased T follicular helper cell number	J:176826
Tnip1^tm1.2Ama/Tnip1^tm1.2Ama Tg(Itgax-cre)1-1Reiz/0 (involves: C57BL/6 * C57BL/6J * CBA)	abnormal leukocyte morphology	J:205446
	enlarged lymph nodes	J:205446
	enlarged spleen	J:205446
	increased memory T cell number	J:205446
	increased plasmacytoid dendritic cell number	J:205446
Tnip1^tm1.2Pcoh/Tnip1^tm1.2Pcoh (involves: 129P2/OlaHsd * C57BL/6)	abnormal immune system morphology	J:176826
Tnip1^{tm1b(EUCOMM)Hmgu}/Tnip1^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tnip1^{tm1b(EUCOMM)Hmgu}/H)	decreased lymphocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased large unstained cell number	J:211773
	increased monocyte cell number	J:211773
	increased spleen weight	J:211773
Tnk2^em1(IMPC)Tcp/Tnk2^em1(IMPC)Tcp (C57BL/6N-Tnk2^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Tnk2^tm1.2Npma/Tnk2^tm1.2Npma (B6(Cg)-Tnk2^tm1.2Npma)	abnormal regulatory T cell number	J:341740
	increased activated T cell number	J:341740
	increased effector memory CD8-positive, alpha-beta T cell number	J:341740
Tnr^{em1(IMPC)Rbrc}/Tnr^{em1(IMPC)Rbrc} (C57BL/6NJcl-Tnr^{em1(IMPC)Rbrc}/Rbrc)	increased spleen weight	J:211773
Tns2^nph/Tns2^nph (involves: ICR)	enlarged lymph nodes	J:24698
Tns3^Gt(XK294)Byg/Tns3^Gt(XK294)Byg (involves: 129P2/OlaHsd * C57BL/6)	small spleen	J:96666
Tnxb^{tm1b(EUCOMM)Hmgu}/Tnxb^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tnxb^{tm1b(EUCOMM)Hmgu}/H)	enlarged spleen	J:211773
Tob2^tm1Tya/Tob2^tm1Tya (involves: 129S4/SvJae * C57BL/6)	abnormal osteoclast differentiation	J:134287
Tob2^tm1Tya/Tob2^tm1Tya (involves: 129S4/SvJae * C57BL/6)	increased osteoclast cell number	J:134287
Tom1l2^Gt(XG909)Byg/Tom1l2⁺ (involves: 129P2/OlaHsd * C57BL/6J)	enlarged spleen	J:133892
Tom1l2^Gt(XG909)Byg/Tom1l2^Gt(XG909)Byg (involves: 129P2/OlaHsd * C57BL/6J)	abnormal lymph node cell ratio	J:133892
	abnormal spleen B cell follicle morphology	J:133892
	abnormal spleen morphology	J:133892
	abnormal spleen periarteriolar lymphoid sheath morphology	J:133892
	abnormal splenic cell ratio	J:133892
	dark spleen	J:133892
	enlarged spleen	J:133892
	increased B cell number	J:133892
	increased CD4-positive, alpha-beta T cell number	J:133892
	increased CD8-positive, alpha-beta T cell number	J:133892
	increased leukocyte cell number	J:133892
	increased spleen white pulp amount	J:133892
	increased T cell number	J:133892
	lymphoid hyperplasia	J:133892
Tomm5^{Gt(OST44663)Lex}/Tomm5^{Gt(OST44663)Lex} (involves: 129S5/SvEvBrd * C57BL/6)	increased eosinophil cell number	J:186382
	thymus atrophy	J:186382
Tomm6^{tm1a(KOMP)Wtsi}/Tomm6⁺ (C57BL/6N-Tomm6^{tm1a(KOMP)Wtsi}/Wtsi)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Tomm20^em1(IMPC)J/Tomm20⁺ (C57BL/6NJ-Tomm20^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Top2a^em2(IMPC)Tcp/Top2a⁺ (C57BL/6NCrl-Top2a^em2(IMPC)Tcp/Tcp)	small spleen	J:211773
	small thymus	J:211773
Top2b^em1(IMPC)Mbp/Top2b⁺ (C57BL/6NCrl-Top2b^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Top3b^tm1Jcw/Top3b^tm1Jcw (involves: 129S6/SvEvTac * C57BL/6)	enlarged axillary lymph nodes	J:69405
	enlarged spleen	J:69405
	enlarged submandibular lymph nodes	J:69405
Tor1b^em1(IMPC)Mbp/Tor1b^em1(IMPC)Mbp (C57BL/6NCrl-Tor1b^em1(IMPC)Mbp/MbpMmucd)	increased basophil cell number	J:211773
Tox2^em1Cdon/Tox2^em1Cdon (C57BL/6J-Tox2^em1Cdon)	abnormal T follicular helper cell differentiation	J:290926
Tox2^em1Cdon/Tox2^em1Cdon (C57BL/6J-Tox2^em1Cdon)	decreased germinal center B cell number	J:290926
Tox^tm1.1Kay/Tox^tm1.1Kay (involves: 129S6/SvEvTac)	abnormal CD4-positive T cell differentiation	J:131287
	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:131287
	abnormal CD8-positive, alpha beta T cell morphology	J:131287
	decreased CD4-positive, alpha-beta T cell number	J:131287
	decreased NK T cell number	J:131287
Tox^tm1.1Kay/Tox^tm1.1Kay (involves: 129S6/SvEvTac * C57BL/6)	abnormal positive T cell selection	J:164687
	abnormal spleen morphology	J:164687
	absent axillary lymph nodes	J:164687
	absent inguinal lymph nodes	J:164687
	absent mesenteric lymph nodes	J:164687
	absent popliteal lymph nodes	J:164687
	decreased NK cell number	J:164687
	decreased Peyer's patch number	J:164687
	small Peyer's patches	J:164687
Tox^{tm1b(KOMP)Wtsi}/Tox^{tm1b(KOMP)Wtsi} (C57BL/6N-Tox^{tm1b(KOMP)Wtsi}/Tcp)	increased spleen weight	J:211773
Tox^tm1Kay/Tox^tm1Kay Tg(Lck-cre)1Cwi/0 (involves: 129S6/SvEvTac * C57BL/6)	abnormal CD4-positive T cell differentiation	J:164687
Tpcn2^{tm1b(EUCOMM)Hmgu}/Tpcn2^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Tpcn2^{tm1b(EUCOMM)Hmgu}/H)	increased eosinophil cell number	J:211773
Tph2^em1(IMPC)Mbp/Tph2^em1(IMPC)Mbp (C57BL/6N-Tph2^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	increased eosinophil cell number	J:211773
Tpi1^a-m6Neu/Tpi1^a-m6Neu (involves: 101/El * C3H/El)	increased spleen weight	J:163223
Tpi1^rbc19/Tpi1^rbc19 (SJL-Tpi1^rbc19)	abnormal spleen red pulp morphology	J:263104
Tpi1^rbc19/Tpi1^rbc19 (SJL-Tpi1^rbc19)	enlarged spleen	J:263104
Tpo^R479C/Tpo^R479C (involves: ICR)	small spleen	J:112930
Tpp2^tm1.1Gnie/Tpp2^tm1.1Gnie (involves: 129S6/SvEvTac * C57BL/6)	abnormal immune system cell morphology	J:133572
	abnormal immune system organ morphology	J:133572
	abnormal spleen morphology	J:133572
	abnormal splenic cell ratio	J:133572
	decreased CD8-positive, alpha-beta T cell number	J:133572
	decreased double-positive T cell number	J:133572
	decreased T cell number	J:133572
	enlarged spleen	J:133572
	increased double-negative T cell number	J:133572
	increased single-positive T cell number	J:133572
	increased spleen red pulp amount	J:133572
	increased T cell number	J:133572
	thymus atrophy	J:133572
Tpp2^tm1.1Gnie/Tpp2^tm1.1Gnie (involves: 129S6/SvEvTac)	abnormal CD4-positive T cell differentiation	J:221205
	abnormal CD8-positive, alpha-beta T cell differentiation	J:221205
	decreased leukocyte cell number	J:221205
	enlarged lymph nodes	J:221205
	enlarged spleen	J:221205
	increased B cell number	J:221205
	increased memory T cell number	J:221205
Tppp3^{em1(IMPC)Ccpcz}/Tppp3⁺ (C57BL/6NCrl-Tppp3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased CD4-positive NK T cell number	J:211773
	increased memory-marker CD4-positive NK T cell number	J:211773
	increased NK T cell number	J:211773
Tpsab1^m1/Tpsab1^m1 (involves: C57BL/6J)	abnormal mast cell differentiation	J:142880
Tpsab1^m1/Tpsab1^m1 Tpsb2^tm1(cre)Adch/Tpsb2^tm1(cre)Adch (B6.Cg-Tpsb2^tm1(cre)Adch Tpsab1^m1)	abnormal mast cell differentiation	J:142880
Tpsb2^tm1.1Mfg/Tpsb2^tm1.1Mfg (B6.129-Tpsb2^tm1.1Mfg)	abnormal mast cell differentiation	J:142880
Tpx2^{Gt(D028B03)Wrst}/Tpx2⁺ (involves: 129S2/SvPas * C57BL/6J)	abnormal splenocyte morphology	J:184948
Tra2a^{tm2b(EUCOMM)Hmgu}/Tra2a⁺ (C57BL/6N-Tra2a^{tm2b(EUCOMM)Hmgu}/Bay)	increased basophil cell number	J:211773
Trabd2b^{em2(IMPC)Ccpcz}/Trabd2b^{em2(IMPC)Ccpcz} (C57BL/6N-Trabd2b^{em2(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Tradd^tm1.1Mak/Tradd^tm1.1Mak (either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))	abnormal spleen follicular dendritic cell network	J:138824
	absent spleen germinal center	J:138824
Tradd^tm1.1Mpa/Tradd^tm1.1Mpa (involves: BALB/cJ * C57BL/6)	abnormal spleen germinal center morphology	J:139030
Traf1^tm1Tsi/Traf1^tm1Tsi (involves: 129S4/SvJae * C57BL/6)	abnormal lymph node cell ratio	J:72327
Traf1^tm1Tsi/Traf1^tm1Tsi (involves: 129S4/SvJae * C57BL/6)	increased lymphocyte cell number	J:72327
Traf2^{tm1a(EUCOMM)Wtsi}/Traf2⁺ (C57BL/6N-Traf2^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased alpha-beta T cell number	J:211773
	decreased CD8-positive, alpha-beta T cell number	J:211773
Traf2^tm1Mak/Traf2^tm1Mak (either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))	absent lymph node germinal center	J:44360
	absent spleen germinal center	J:44360
	decreased double-positive T cell number	J:44360
	decreased immature B cell number	J:44360
	decreased lymphocyte cell number	J:44360
	decreased thymocyte number	J:44360
	increased granulocyte number	J:44360
	lymphoid hypoplasia	J:44360
	spleen atrophy	J:44360
	thymus atrophy	J:44360
Traf3^m1Btlr/Traf3^m1Btlr (C57BL/6J-Traf3^m1Btlr)	decreased mature B cell number	J:212064
Traf3^tm1Bal/Traf3^tm1Bal (involves: 129S4/SvJae * C57BL/6J)	abnormal B cell differentiation	J:37065
	decreased double-positive T cell number	J:37065
	decreased leukocyte cell number	J:37065
	decreased thymocyte number	J:37065
	spleen hypoplasia	J:37065
Traf3^tm1Bshp/Traf3^tm1Bshp Cd19^tm1(cre)Cgn/Cd19⁺ (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)	abnormal immune system organ morphology	J:124329
	abnormal leukocyte morphology	J:124329
	abnormal lymph node B cell domain morphology	J:124329
	abnormal spleen germinal center morphology	J:124329
	decreased T cell number	J:124329
	enlarged lymph nodes	J:124329
	enlarged spleen	J:124329
	increased B cell number	J:124329
	increased follicular B cell number	J:124329
	increased marginal zone B cell number	J:124329
	increased spleen white pulp amount	J:124329
	increased transitional stage B cell number	J:124329
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (involves: 129/Sv * BALB/c)	abnormal immune system morphology	J:93923
	abnormal spleen B cell corona morphology	J:93923
	enlarged lymph nodes	J:93923
	enlarged spleen	J:93923
	increased B cell number	J:93923
	increased dendritic cell number	J:93923
	lymphoid hyperplasia	J:93923
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (C.129-Traf3ip2^tm1.1Lix)	enlarged submandibular lymph nodes	J:138560
	increased follicular B cell number	J:138560
	increased marginal zone B cell number	J:138560
	increased transitional stage B cell number	J:138560
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix (B6.129-Traf3ip2^tm1.1Lix)	abnormal transitional stage B cell morphology	J:187766
	enlarged cervical lymph nodes	J:187766
	enlarged spleen	J:187766
	increased B cell number	J:187766
	increased immature B cell number	J:187766
	increased marginal zone B cell number	J:187766
	increased spleen weight	J:187766
	lymph node hyperplasia	J:187766
	spleen hyperplasia	J:187766
Traf3ip2^tm1.1Lix/Traf3ip2^tm1.1Lix Tnfsf13b^tm1Msc/Tnfsf13b^tm1Msc (involves: 129 * 129S2/SvPas * BALB/c)	decreased B cell number	J:138560
	decreased follicular B cell number	J:138560
	decreased mature B cell number	J:138560
	decreased transitional stage B cell number	J:138560
	enlarged lymph nodes	J:93923
	enlarged spleen	J:93923
Traf3ip2^tm1Lix/Traf3ip2^tm1.1Lix Tg(CD19-cre/ERT2)1Cgn/0 (involves: 129/Sv * BALB/c)	enlarged lymph nodes	J:93923
	enlarged spleen	J:93923
	increased B cell number	J:93923
	increased dendritic cell number	J:93923
Traf3ip3^{tm1a(KOMP)Wtsi}/Traf3ip3^{tm1a(KOMP)Wtsi} (C57BL/6N-Traf3ip3^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:175295
Traf3ip3^{tm1b(KOMP)Wtsi}/Traf3ip3^{tm1b(KOMP)Wtsi} (involves: BALB/cJ * C57BL/6N)	abnormal T cell differentiation	J:226431
	decreased CD4-positive, alpha-beta memory T cell number	J:226431
	decreased CD8-positive, alpha-beta memory T cell number	J:226431
	decreased regulatory T cell number	J:226431
	decreased T cell number	J:226431
	decreased thymocyte number	J:226431
	increased double-positive T cell number	J:226431
	increased gamma-delta T cell number	J:226431
Traf6^tm1Jino/Traf6^tm1Jino (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:77453
	decreased immature B cell number	J:77453
	decreased lymph node number	J:77453
Traf6^tm1Mak/Traf6^tm1Mak (involves: 129P3/J)	abnormal osteoclast morphology	J:54467
Traf6^tm1Mak/Traf6^tm1Mak (involves: 129P3/J)	enlarged spleen	J:54467
Traf6^tm1Ywc/Traf6^tm1Ywc (Not Specified)	abnormal dendritic cell differentiation	J:85808
	abnormal lymph node morphology	J:85808
	abnormal spleen morphology	J:85808
	absent spleen white pulp	J:85808
	decreased dendritic cell number	J:85808
	enlarged spleen	J:85808
	thymus atrophy	J:85808
Traf6^tm2Ywc/Traf6^tm2Ywc Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	increased activated T cell number	J:130882
	increased memory T cell number	J:130882
Traf7^em1(IMPC)Tcp/Traf7⁺ (C57BL/6NCrl-Traf7^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Traj18^em1Hwata/Traj18^em1Hwata (C57BL/6-Traj18^em1Hwata)	absent NK T cells	J:256533
Traj18^em1Hwata/Traj18^em1Hwata (C.B6-Traj18^em1Hwata)	absent NK T cells	J:256533
Traj18^tm1.1Kro/Traj18^tm1.1Kro (involves: C57BL/6NTac)	absent NK T cells	J:232957
Traj33^em#Dig/Traj33^em#Dig (involves: C57BL/6)	decreased T cell number	J:276912
Trak1^{em1(IMPC)Ccpcz}/Trak1⁺ (C57BL/6NCrl-Trak1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Trak2^em1(IMPC)Mbp/Trak2^em1(IMPC)Mbp (C57BL/6N-Trak2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Trap1^em1(IMPC)Mbp/Trap1^em1(IMPC)Mbp (C57BL/6N-Trap1^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	decreased monocyte cell number	J:211773
Trap1^{Gt(E150H04)Wrst}/Trap1^{Gt(E150H04)Wrst} (involves: 129P2/OlaHsd * C57BL/6)	spleen hyperplasia	J:226880
Trappc1^em1(IMPC)Mbp/Trappc1⁺ (C57BL/6NCrl-Trappc1^em1(IMPC)Mbp/Mmucd)	enlarged spleen	J:211773
Trappc2l^em1(IMPC)Mbp/Trappc2l^em1(IMPC)Mbp (C57BL/6N-Trappc2l^em1(IMPC)Mbp/Ucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Trappc8^em1(IMPC)Tcp/Trappc8⁺ (C57BL/6NCrl-Trappc8^em1(IMPC)Tcp/Tcp)	increased eosinophil cell number	J:211773
Trappc9^{tm1a(EUCOMM)Wtsi}/Trappc9^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Trappc9^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased CD11b-low dendritic cell number	J:211773
	decreased gamma-delta T cell number	J:211773
	decreased KLRG1-positive NK cell number	J:211773
	increased CD11b-high dendritic cell number	J:211773
	increased Ly6C high monocyte number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased monocyte cell number	J:211773
Trappc10^b2b2416Clo/Trappc10^b2b2416Clo (Trappc10^b2b2416Clo)	thymus hypoplasia	J:175213
Trat1^tm1Lsmn/Trat1^tm1Lsmn (B6.129X1-Trat1^tm1Lsmn)	lymph node hypoplasia	J:108406
	spleen hypoplasia	J:108406
	thymus hypoplasia	J:108406
Trbv13-2^tm1(CD2)Zhu/Trbv13-2^tm1(CD2)Zhu (involves: 129 * C57BL/6)	abnormal T cell differentiation	J:121608
Trbv13-2^tm1(CD2)Zhu/Trbv13-2^tm1(CD2)Zhu (involves: 129 * C57BL/6 * SJL)	abnormal T cell differentiation	J:121608
Trbv14^tm1Che/Trbv14^tm1Che (involves: 129S4/SvJae)	decreased T cell number	J:92288
Trbv14^tm2Che/Trbv14^tm2Che (involves: 129S4/SvJae)	decreased T cell number	J:92288
Trdmt1^{Gt(OST19279)Lex}/Trdmt1^{Gt(OST19279)Lex} (involves: 129S5/SvEvBrd * C57BL/6J)	decreased NK cell number	J:103485
Treh^em1(IMPC)H/Treh^em1(IMPC)H (C57BL/6N-Treh^em1(IMPC)H/H)	increased eosinophil cell number	J:211773
Trem1^tm1.1Ahoru/Trem1^tm1.1Ahoru (C57BL/6-Trem1^tm1.1Ahoru)	decreased monocyte cell number	J:191035
	decreased neutrophil cell number	J:191035
Trem2^em2Bwef/Trem2⁺ (involves: C57BL/6J * DBA/2J * FVB/N)	decreased macrophage cell number	J:242126
Trem2^em2Bwef/Trem2^em2Bwef (involves: C57BL/6J * DBA/2J * FVB/N)	decreased macrophage cell number	J:242126
Trex1^{em1(IMPC)Ccpcz}/Trex1⁺ (C57BL/6NCrl-Trex1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Trex1^{em1(IMPC)Ccpcz}/Trex1^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Trex1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased lymphocyte cell number	J:211773
	decreased NK cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased effector memory T-helper cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Trex1^em3Gpt/Trex1^em3Gpt (C57BL/6JGpt-Trex1^em3Gpt)	enlarged spleen	J:330879
Trex1^em3Gpt/Trex1^em3Gpt (C57BL/6JGpt-Trex1^em3Gpt)	increased spleen weight	J:330879
Trex1^tm1.1Fwpe/Trex1⁺ (involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)	increased CD4-positive, alpha-beta T cell number	J:220965
Trex1^tm1.1Fwpe/Trex1^tm1.1Fwpe (involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)	abnormal immune system organ morphology	J:220965
	enlarged lymph nodes	J:220965
	enlarged spleen	J:220965
	increased B cell number	J:220965
	increased CD4-positive, alpha-beta T cell number	J:220965
	increased plasma cell number	J:220965
	increased regulatory T cell number	J:220965
	increased spleen weight	J:220965
	increased splenocyte number	J:220965
	lymphoid hyperplasia	J:220965
Trex1^tm1Tld/Trex1^tm1Tld (involves: 129P2/OlaHsd)	abnormal spleen marginal zone morphology	J:92264
	enlarged lymph nodes	J:92264
	enlarged spleen	J:92264
	increased spleen B cell follicle size	J:92264
	thymus cortex hypoplasia	J:92264
Trf^{em1(IMPC)Rbrc}/Trf⁺ (C57BL/6NJcl-Trf^{em1(IMPC)Rbrc}/Rbrc)	increased large unstained cell number	J:211773
Trgc1^tm1.2Dhr/Trgc1^tm1.2Dhr (either: 129S4/SvJae or (involves: 129S4/SvJae * C57BL/6))	decreased gamma-delta T cell number	J:91304
Trib1^tm1Aki/Trib1^tm1Aki (involves: 129P2/OlaHsd)	abnormal spleen red pulp morphology	J:196449
	decreased eosinophil cell number	J:196449
	decreased macrophage cell number	J:196449
	decreased spleen iron level	J:196449
	increased neutrophil cell number	J:196449
Trib2^{Tg(Thy1-Trh/APP)2.1Ingm}/Trib2⁺ Tg(Thy1-APP)2.2Ingm/0 (involves: C57BL/6 * DBA/1)	microgliosis	J:176575
Trib2^{Tg(Thy1-Trh/APP)2.1Ingm}/Trib2^{Tg(Thy1-Trh/APP)2.1Ingm} (involves: C57BL/6 * DBA/1)	microgliosis	J:176575
Trib2^tm1Lex/Trib2^tm1Lex (involves: 129S5/SvEvBrd * C57BL/6J)	decreased B cell number	J:82809
	increased CD8-positive, alpha-beta T cell number	J:82809
Trim9^{em1(IMPC)Ccpcz}/Trim9^{em1(IMPC)Ccpcz} (C57BL/6N-Trim9^{em1(IMPC)Ccpcz}/Ccpcz)	decreased effector memory T-helper cell number	J:211773
	decreased spleen weight	J:211773
Trim13^em1(IMPC)Tcp/Trim13^em1(IMPC)Tcp (C57BL/6N-Trim13^em1(IMPC)Tcp/Tcp)	enlarged thymus	J:211773
Trim21^tm1Mwah/Trim21^tm1Mwah (C57BL/6-Trim21^tm1Mwah)	enlarged lymph nodes	J:151775
Trim21^tm1Mwah/Trim21^tm1Mwah (C57BL/6-Trim21^tm1Mwah)	enlarged spleen	J:151775
Trim30a^tm1Yjk/Trim30a^tm1Yjk (B6.129P2-Trim30a^tm1Yjk)	abnormal T cell subpopulation ratio	J:215171
Trim30a^tm1Yjk/Trim30a^tm1Yjk (B6.129P2-Trim30a^tm1Yjk)	increased CD4-positive, alpha-beta T cell number	J:215171
Trim31^em1Cya/Trim31^em1Cya (involves: C57BL/6)	increased Ly6C high monocyte number	J:243237
Trim31^em1Cya/Trim31^em1Cya (involves: C57BL/6)	increased neutrophil cell number	J:243237
Trim33^em1(IMPC)Tcp/Trim33⁺ (C57BL/6N-Trim33^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Trim37^{Gt(RRO307)Byg}/Trim37^{Gt(RRO307)Byg} (B6J.129P2-Trim37^{Gt(RRO307)Byg})	enlarged spleen	J:232482
Trim39^{tm1b(EUCOMM)Hmgu}/Trim39^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Trim39^{tm1b(EUCOMM)Hmgu}/H)	increased lymphocyte cell number	J:211773
Trim46^em1(IMPC)J/Trim46^em1(IMPC)J (C57BL/6NJ-Trim46^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Trim50^{tm1b(KOMP)Wtsi}/Trim50^{tm1b(KOMP)Wtsi} (C57BL/6N-Trim50^{tm1b(KOMP)Wtsi}/BayMmucd)	decreased spleen weight	J:211773
Trim56^{tm1a(EUCOMM)Wtsi}/Trim56^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Trim56^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased regulatory T cell number	J:211773
Trim58^em1(IMPC)Mbp/Trim58^em1(IMPC)Mbp (C57BL/6N-Trim58^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
Trio^em1(IMPC)H/Trio⁺ (C57BL/6NTac-Trio^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Trip6^{tm1b(EUCOMM)Hmgu}/Trip6⁺ (C57BL/6N-Trip6^{tm1b(EUCOMM)Hmgu}/Bay)	enlarged spleen	J:211773
Trip10^tm1.1Geha/Trip10^tm1.1Geha (B6.129S1-Trip10^tm1.1Geha)	abnormal spleen germinal center morphology	J:164363
	decreased spleen germinal center number	J:164363
	decreased spleen germinal center size	J:164363
Trip13^{tm1.1(KOMP)Vlcg}/Trip13^{tm1.1(KOMP)Vlcg} (C57BL/6N-Trip13^{tm1.1(KOMP)Vlcg}/Ucd)	increased leukocyte cell number	J:211773
Trmq1^C57BL/6J/Trmq1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal CD4-positive, alpha beta T cell morphology	J:77603
Trmq1^DBA/2J/Trmq1^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal CD4-positive, alpha beta T cell morphology	J:77603
Trmq2^C57BL/6J/Trmq2^C57BL/6J (involves: C57BL/6J * DBA/2J)	abnormal CD4-positive, alpha beta T cell morphology	J:77603
Trmq2^C57BL/6J/Trmq2^DBA/2J (involves: C57BL/6J * DBA/2J)	abnormal CD4-positive, alpha beta T cell morphology	J:77603
Trmq3^DBA/1J/Trmq3^FVB/N (involves: DBA/1J * FVB/N)	abnormal CD4-positive, alpha beta T cell morphology	J:116665
Trmq3^FVB/N/? (involves: DBA/1J * FVB/N)	abnormal CD4-positive, alpha beta T cell morphology	J:94347
Trmq3^FVB/N/Trmq3^FVB/N (involves: DBA/1J * FVB/N)	abnormal CD4-positive, alpha beta T cell morphology	J:116665
Trmq4^RIIIS/J/Trmq4^RIIIS/J Trmq5^RIIIS/J/Trmq5^RIIIS/J (involves: B10.RIII * RIIIS/J)	abnormal CD4-positive, alpha beta T cell morphology	J:95848
Trmt2a^{tm2b(EUCOMM)Wtsi}/Trmt2a^{tm2b(EUCOMM)Wtsi} (C57BL/6N-Trmt2a^{tm2b(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Trp53^Bbl/Trp53⁺ (C57BL/6JSfdAnu-Trp53^Bbl/Anu)	increased T cell derived lymphoma incidence	J:104190
Trp53^bhy/Trp53⁺ (C57BL/6JSfdAnu-Trp53^bhy/Anu)	increased T cell derived lymphoma incidence	J:104190
Trp53^tm1.1Awbr/Trp53^tm1.1Awbr (involves: C57BL/6)	increased pro-B cell number	J:169434
Trp53^tm1.1Awbr/Trp53^tm1.1Awbr (involves: C57BL/6)	increased T cell derived lymphoma incidence	J:173271
Trp53^tm1.1Manf/Trp53^tm1.1Manf (Not Specified)	abnormal abdominal lymph node morphology	J:201153
	abnormal spleen morphology	J:201153
	abnormal spleen white pulp morphology	J:201153
	abnormal thymus morphology	J:201153
	decreased neutrophil cell number	J:201153
	small spleen	J:201153
	small thymus	J:201153
Trp53^tm1.1Manf/Trp53^tm1.1Manf (involves: C57BL/6J)	abnormal abdominal lymph node morphology	J:201153
	abnormal spleen morphology	J:201153
	abnormal spleen white pulp morphology	J:201153
	abnormal thymus morphology	J:201153
	decreased neutrophil cell number	J:201153
	small spleen	J:201153
	small thymus	J:201153
Trp53^tm1.1Thst/Trp53⁺ (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	spleen hyperplasia	J:198482
Trp53^tm1.1Thst/Trp53^tm1.1Thst (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	increased T cell derived lymphoma incidence	J:198482
	spleen hyperplasia	J:198482
Trp53^tm1.1Umol/Trp53^tm1.1Umol (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	increased T cell derived lymphoma incidence	J:228632
Trp53^tm1.2Awbr/Trp53⁺ (involves: C57BL/6)	abnormal lymphocyte morphology	J:173271
Trp53^tm1.2Awbr/Trp53⁺ (involves: C57BL/6)	abnormal Peyer's patch morphology	J:173271
Trp53^tm1.2Awbr/Trp53^tm1.2Awbr (involves: C57BL/6)	abnormal lymphocyte morphology	J:173271
	abnormal Peyer's patch morphology	J:173271
	enlarged spleen	J:173271
	increased T cell derived lymphoma incidence	J:173271
Trp53^tm1Brd/Trp53^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6)	increased T cell derived lymphoma incidence	J:126497
Trp53^tm1Brd/Trp53^tm1Brd Tg(Lck-cre)1Cwi/0 (involves: 129S7/SvEvBrd)	increased T cell derived lymphoma incidence	J:157041
Trp53^tm1Brd/Trp53^tm1Brd Tg(Nes-cre)1Kln/0 (involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * SJL)	increased T cell derived lymphoma incidence	J:109585
Trp53^tm1Brd/Trp53^tm1Ldo (involves: 129S7/SvEvBrd * C57BL/6)	increased T cell derived lymphoma incidence	J:73757
Trp53^tm1Brd/Trp53^tm8Xu (involves: 129S7/SvEvBrd)	decreased leukocyte cell number	J:170216
Trp53^tm1Gev/Trp53^tm1Gev (involves: 129P2/OlaHsd * C57BL/6)	increased T cell derived lymphoma incidence	J:99305
Trp53^tm1Glo/Trp53^tm1Glo (involves: 129S7/SvEvBrd * C57BL/6)	increased T cell derived lymphoma incidence	J:61683
Trp53^tm1Glo/Trp53^tm4Glo (involves: 129S7/SvEvBrd * C57BL/6)	increased T cell derived lymphoma incidence	J:171821
Trp53^tm1Ldo/Trp53⁺ (involves: 129S7/SvEvBrd * C57BL/6)	decreased spleen weight	J:73757
Trp53^tm1Ldo/Trp53⁺ (involves: 129S7/SvEvBrd * C57BL/6)	spleen hypoplasia	J:73757
Trp53^tm1Sia/Trp53^tm1Sia (involves: C57BL/6 * CBA)	increased T cell derived lymphoma incidence	J:36762
Trp53^tm1Sia/Trp53^tm1Sia (involves: C57BL/6NCrlj * CBA/JNCrlj)	increased leukocyte cell number	J:233347
	increased spleen weight	J:233347
	increased T cell derived lymphoma incidence	J:233347
	increased thymus weight	J:233347
Trp53^tm1Thst/Trp53⁺ (involves: 129S1/Sv * 129X1/SvJ)	spleen hyperplasia	J:198482
Trp53^tm1Thst/Trp53^tm1.1Thst (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	spleen hyperplasia	J:198482
Trp53^tm1Thst/Trp53^tm1Thst (involves: 129S1/Sv * 129X1/SvJ)	increased T cell derived lymphoma incidence	J:198482
Trp53^tm1Tyj/Trp53⁺ Trp63^tm1Fmc/Trp63⁺ (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	increased T cell derived lymphoma incidence	J:98958
Trp53^tm1Tyj/Trp53⁺ Trp73^tm1Fmc/Trp73⁺ (involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)	increased T cell derived lymphoma incidence	J:98958
Trp53^tm1Tyj/Trp53⁺ Xrcc2^tm1Pmc/Xrcc2^tm1Pmc (involves: 129S1/Sv * 129S2/SvPas * C57BL/6)	increased T cell derived lymphoma incidence	J:111068
Trp53^tm1Tyj/Trp53^tm1.1Umol (involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	increased T cell derived lymphoma incidence	J:228632
Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas * C57BL/6)	increased T cell derived lymphoma incidence	J:87501, J:17728
Trp53^tm1Tyj/Trp53^tm1Tyj (involves: 129S2/SvPas)	increased T cell derived lymphoma incidence	J:251434, J:221224, J:88120, J:95316
Trp53^tm1Tyj/Trp53^tm1Tyj Xrcc2^tm1Pmc/Xrcc2^tm1Pmc (involves: 129S1/Sv * 129S2/SvPas * C57BL/6)	increased T cell derived lymphoma incidence	J:111068
Trp53^tm1Tyj/Trp53^tm1Tyj Xrcc4^tm1Fwa/Xrcc4^tm1Fwa (involves: 129P2/OlaHsd * 129S2/SvPas)	abnormal lymphopoiesis	J:61973
Trp53^tm1Tyj/Trp53^tm2.1Tyj (involves: 129S2/SvPas * 129S4/SvJae)	increased T cell derived lymphoma incidence	J:95316
Trp53^tm1Tyj/Trp53^tm2.1Umol (involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	increased T cell derived lymphoma incidence	J:228632
Trp53^tm1Tyj/Trp53^tm3.1Tyj (involves: 129S2/SvPas * 129S4/SvJae)	increased T cell derived lymphoma incidence	J:95316
Trp53^tm1Yjc/Trp53^tm1Yjc (B6.129S1-Trp53^tm1Yjc)	abnormal spleen marginal zone morphology	J:195018
	abnormal spleen white pulp morphology	J:195018
	enlarged spleen	J:195018
Trp53^tm2.1Thst/Trp53^tm2.1Thst (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	increased T cell derived lymphoma incidence	J:282255
Trp53^tm2.1Umol/Trp53^tm2.1Umol (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)	increased T cell derived lymphoma incidence	J:228632
Trp53^tm2Thst/Trp53^tm2.1Thst (involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)	increased T cell derived lymphoma incidence	J:282255
Trp53^tm2Wahl/Trp53^tm2Wahl (involves: 129S4/SvJae * C57BL/6)	decreased leukocyte cell number	J:174375
	decreased spleen red pulp amount	J:174375
Trp53^tm3.1Glo/Trp53⁺ (B6.129S7-Trp53^tm3.1Glo)	hepatosplenomegaly	J:317504
	increased leukocyte cell number	J:317504
	increased T cell derived lymphoma incidence	J:317504
Trp53^tm4Glo/Trp53^tm4Glo (involves: 129S7/SvEvBrd * C57BL/6)	increased T cell derived lymphoma incidence	J:171821
Trp53^tm4Xu/Trp53^tm4Xu (Not Specified)	increased T cell derived lymphoma incidence	J:126497
Trp53^tm6Xu/Trp53^tm6Xu Tg(Lck-cre)1Cwi/0 (involves: 129S4/SvJae)	increased T cell derived lymphoma incidence	J:157041
Trp53bp1^{Gt(OST94324)Lex}/Trp53bp1^{Gt(OST94324)Lex} (involves: 129S5/SvEvBrd)	abnormal T cell differentiation	J:83164
	decreased mature B cell number	J:83164
	decreased T cell number	J:83164
	small thymus	J:83164
	thymus hypoplasia	J:83164
Trp53bp1^m2Btlr/Trp53bp1^m2Btlr (C57BL/6J-Trp53bp1^m2Btlr)	decreased B cell number	J:254841
	decreased CD8-positive, naive alpha-beta T cell number	J:254841
	increased central memory CD4-positive, alpha-beta T cell number	J:254841
Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129 * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:82512
	increased double-negative T cell number	J:82512
	increased T cell derived lymphoma incidence	J:82512
	thymus hypoplasia	J:82512
Trp53bp1^tm1Jc/Trp53bp1^tm1Jc (involves: 129)	abnormal class switch recombination	J:194603, J:231089, J:307190
Trp53bp2^tm1Cdlo/Trp53bp2⁺ Tg(EmuSR-tTa)83Bop/0 Tg(tetO-MYC)36aBop/0 (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	increased T cell derived lymphoma incidence	J:146764
Trp53bp2^tm1Xlu/Trp53bp2⁺ (involves: 129S6/SvEvTac * C57BL/6J)	increased T cell derived lymphoma incidence	J:108701
Trp53bp2^tm1Xlu/Trp53bp2^tm1Xlu (C.129S6-Trp53bp2^tm1Xlu)	small thymus	J:240594
Trp53inp2^em1(IMPC)Mbp/Trp53inp2^em1(IMPC)Mbp (C57BL/6N-Trp53inp2^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Trp63^tm1Fmc/Trp63⁺ Trp73^tm1Fmc/Trp73⁺ (involves: 129S4/SvJae * C57BL/6)	increased T cell derived lymphoma incidence	J:98958
Trp63^tm2Brd/Trp63⁺ (involves: 129S7/SvEvBrd)	enlarged lymph nodes	J:100483
Trp73^em1(IMPC)H/Trp73⁺ (C57BL/6NTac-Trp73^em1(IMPC)H/H)	decreased spleen weight	J:211773
Trp73^tm1Fmc/Trp73⁺ (involves: 129S4/SvJae * C57BL/6)	increased T cell derived lymphoma incidence	J:98958
Trp73^tm1Mak/Trp73⁺ (involves: 129P2/OlaHsd * C57BL/6J)	increased T cell derived lymphoma incidence	J:142848
Trp73^tm1Mak/Trp73^tm1Mak (involves: 129P2/OlaHsd * C57BL/6J)	increased T cell derived lymphoma incidence	J:142848
Trpc1^em1(IMPC)H/Trpc1^em1(IMPC)H (C57BL/6N-Trpc1^em1(IMPC)H/H)	increased spleen weight	J:211773
Trpm2^tm1Lhj/Trpm2^tm1Lhj (Not Specified)	abnormal macrophage morphology	J:202791
Trpm4^tm1.1Knt/Trpm4^tm1.1Knt (Not Specified)	decreased dendritic cell number	J:140991
Trpm4^tm1.1Knt/Trpm4^tm1.1Knt Trpm5^tm1Csz/Trpm5^tm1Csz (involves: 129S1/Sv * 129X1/SvJ)	decreased dendritic cell number	J:140991
Trpm7^tm1Clph/Trpm7^tm1.1Clph Tg(Lck-cre)548Jxm/0 (involves: 129S4/SvJae * C57BL/6 * CBA)	abnormal T cell differentiation	J:140630
	abnormal thymus cell ratio	J:140630
	abnormal thymus corticomedullary boundary morphology	J:140630
	abnormal thymus medulla morphology	J:140630
	abnormal thymus morphology	J:140630
	decreased T cell number	J:140630
	decreased thymocyte number	J:140630
Trpv5^tm1Bind/Trpv5^tm1Bind (involves: 129 * C57BL/6)	increased osteoclast cell number	J:86949
Try10^em1(IMPC)J/Try10^em1(IMPC)J (C57BL/6NJ-Try10^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Ts(16C-tel)1Cje/0 (involves: C57BL/6J * Rb(11.16)2H * Rb(16.17)32Lub)	abnormal spleen B cell follicle morphology	J:174270
	abnormal spleen B cell follicle shape	J:241597
	abnormal spleen red pulp morphology	J:174270
	increased spleen B cell follicle size	J:241597
Ts(17¹⁶)65Dn/0 (involves: C3H/HeJ * C57BL/6J * DBA/2J)	abnormal spleen B cell follicle morphology	J:174270
	abnormal spleen B cell follicle shape	J:174270
	abnormal spleen red pulp morphology	J:174270
	increased spleen B cell follicle size	J:174270
Tsc1^{em1(IMPC)Ccpcz}/Tsc1⁺ (C57BL/6NCrl-Tsc1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Tsc22d3^tm1.2Efmd/Y (Not Specified)	abnormal T cell subpopulation ratio	J:201728
Tsc22d3^tm1.2Hum/Y (involves: 129S1/SvImJ)	abnormal thymus cell ratio	J:223992
	decreased DN3 thymocyte number	J:223992
	decreased thymus weight	J:223992
	increased DN4 thymocyte number	J:223992
Tshr^hyt/Tshr^hyt (CBy.RF-Tshr^hyt/J)	decreased B cell number	J:111014
Tshr^hyt/Tshr^hyt (CBy.RF-Tshr^hyt/J)	increased pro-B cell number	J:111014
Tsil^{Tg(Myc)12ALvn}/Tsil^{Tg(Myc)12ALvn} (involves: C57BL/6 * SJL/J)	increased double-positive T cell number	J:33857
Tslp^{tm1(KOMP)Vlcg}/Tslp^{tm1(KOMP)Vlcg} (involves: C57BL/6 * C57BL/6NTac)	abnormal T-helper 2 cell differentiation	J:187770
Tslp^tm1.1Pcn/Tslp^tm1.1Pcn Tg(KRT14-cre)1Ipc/0 (involves: 129 * C57BL/6 * SJL)	decreased eosinophil cell number	J:146511
	decreased lymphocyte cell number	J:146511
Tspan2^tm1Hbw/Tspan2^tm1Hbw (C57BL/6-Tspan2^tm1Hbw)	microgliosis	J:201143
Tspan9^em1Tshu/Tspan9^em1Tshu (C57BL/6-Tspan9^em1Tshu)	abnormal macrophage morphology	J:307067
	abnormal neutrophil morphology	J:307067
	decreased neutrophil cell number	J:307067
Tspan32^em1(IMPC)Mbp/Tspan32^em1(IMPC)Mbp (C57BL/6N-Tspan32^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Tspan33^tm1Stsa/Tspan33^tm1Stsa (involves: 129S1/Sv * 129X1/SvJ)	abnormal spleen morphology	J:143158
	abnormal splenic cell ratio	J:143158
	enlarged spleen	J:143158
	increased monocyte cell number	J:143158
Tspo^tm1.1Guwu/Tspo^tm1.1Guwu (involves: C57BL/6)	increased NK cell number	J:219189
Tssk5^{tm1.1(KOMP)Vlcg}/Tssk5^{tm1.1(KOMP)Vlcg} (C57BL/6N-Tssk5^{tm1.1(KOMP)Vlcg}/J)	decreased leukocyte cell number	J:211773
Tst^{tm1(KOMP)Vlcg}/Tst^{tm1(KOMP)Vlcg} (C57BL/6N-Tst^{tm1(KOMP)Vlcg}/Ucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Tstd1^em1(IMPC)J/Tstd1^em1(IMPC)J (C57BL/6NJ-Tstd1^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ttc7^fsn-Jic/Ttc7^fsn-Jic (C3.INT-Ttc7^fsn-Jic)	decreased spleen white pulp amount	J:115742
	decreased thymus weight	J:115742
	increased spleen red pulp amount	J:115742
	increased spleen weight	J:115742
Ttc7^fsn/Ttc7^fsn (CByJ.A-Ttc7^fsn)	enlarged spleen	J:29200, J:30519
	small thymus	J:29200
	thymus cortex hypoplasia	J:29200
Ttc7^fsn/Ttc7^fsn (involves: A/J * BALB/cByJ)	increased dendritic epidermal T cell number	J:14506
Ttc7^fsn/Ttc7^fsn (involves: A/J * BALB/cByJ)	increased Langerhans cell number	J:14506
Ttc7^hea/Ttc7^hea (CFO)	enlarged spleen	J:7515
Ttc7^hea/Ttc7^hea (CFO)	increased leukocyte cell number	J:7515
Ttc9^tm1Vcl/Ttc9⁺ (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	thymus hyperplasia	J:241703
Ttc9^tm1Vcl/Ttc9^tm1Vcl (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)	increased spleen weight	J:241703
	increased thymus weight	J:241703
	thymus hyperplasia	J:241703
Ttc28^{tm1b(EUCOMM)Hmgu}/Ttc28^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ttc28^{tm1b(EUCOMM)Hmgu}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Tti1^em1(IMPC)J/Tti1⁺ (C57BL/6NJ-Tti1^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Tti2^{tm1b(KOMP)Wtsi}/Tti2⁺ (C57BL/6N-Tti2^{tm1b(KOMP)Wtsi}/Ics)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Ttk^em1(IMPC)J/Ttk⁺ (C57BL/6NJ-Ttk^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Ttll11^{em1(IMPC)Ccpcz}/Ttll11^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Ttll11^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Tubal3^em1(IMPC)J/Tubal3^em1(IMPC)J (C57BL/6NJ-Tubal3^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Tulp4^{tm1a(KOMP)Wtsi}/Tulp4⁺ (involves: C57BL/6N * C57BL/6NRj)	absent connection between subcutaneous lymph vessels and lymph sac	J:344151
Tulp4^{tm1a(KOMP)Wtsi}/Tulp4^{tm1a(KOMP)Wtsi} (involves: C57BL/6N * C57BL/6NRj)	abnormal thymus topology	J:344151
Tusc2^tm1Avi/Tusc2^tm1Avi (involves: 129S1/Sv * C57BL/6J)	abnormal NK cell differentiation	J:119985
	decreased NK cell number	J:119985
	increased leukocyte cell number	J:119985
Tusc2^tm1Avi/Tusc2^tm1Avi (involves: 129S1/Sv)	decreased thymocyte number	J:309768
	increased macrophage cell number	J:309768
	increased monocyte cell number	J:309768
Twist2^tm1(cre)Dor/Twist2^tm1(cre)Dor (involves: 129/Sv * 129X1/SvJ)	abnormal spleen morphology	J:81485
	abnormal spleen white pulp morphology	J:81485
	abnormal thymus cortex morphology	J:81485
	abnormal thymus medulla morphology	J:81485
	abnormal thymus morphology	J:81485
	thymus atrophy	J:81485
Twsg1^tm1Nosa/Twsg1^tm1Nosa (involves: 129P2/OlaHsd * C57BL/6)	abnormal B cell differentiation	J:82738
	abnormal spleen development	J:82738
	abnormal thymus development	J:82738
	decreased double-positive T cell number	J:82738
	decreased immature B cell number	J:82738
	decreased lymphocyte cell number	J:82738
	decreased pre-B cell number	J:82738
	decreased pro-B cell number	J:82738
	decreased spleen white pulp amount	J:82738
	decreased splenocyte number	J:82738
	decreased thymocyte number	J:82738
	increased granulocyte number	J:82738
	increased monocyte cell number	J:82738
	increased single-positive T cell number	J:82738
	thymus atrophy	J:82738
Txlna^{tm1b(EUCOMM)Hmgu}/Txlna⁺ (C57BL/6N-Txlna^{tm1b(EUCOMM)Hmgu}/H)	increased large unstained cell number	J:211773
Txlna^{tm1b(EUCOMM)Hmgu}/Txlna^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Txlna^{tm1b(EUCOMM)Hmgu}/H)	increased large unstained cell number	J:211773
	increased lymphocyte cell number	J:211773
Txnip^tm1Yu/Txnip^tm1Yu (involves: 129)	abnormal mesenteric lymph node morphology	J:96677
	abnormal NK cell morphology	J:96677
	decreased CD8-positive, alpha-beta T cell number	J:96677
	decreased NK cell number	J:96677
	decreased NK T cell number	J:96677
	increased lymphocyte cell number	J:96677
	increased regulatory T cell number	J:96677
Txnl1^em1(IMPC)Tcp/Txnl1^em1(IMPC)Tcp (C57BL/6NCrl-Txnl1^em1(IMPC)Tcp/Tcp)	increased monocyte cell number	J:211773
Tyk2^tm1Shmd/Tyk2^tm1Shmd (involves: 129P2/OlaHsd)	abnormal T cell differentiation	J:65409
Tyk2^{tm2b(EUCOMM)Hmgu}/Tyk2^{tm2b(EUCOMM)Hmgu} (C57BL/6N-Tyk2^{tm2b(EUCOMM)Hmgu}/Ieg)	decreased plasmacytoid dendritic cell number	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Tyro3^{em1(IMPC)Ccpcz}/Tyro3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Tyro3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
	increased eosinophil cell number	J:211773
Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (involves: 129P2/OlaHsd * C57BL/6)	decreased uterine NK cell number	J:100668
Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)	increased dendritic cell number	J:64764
Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (B6.129P2-Tyrobp^tm1.1Viv)	abnormal microglial cell morphology	J:95232
Tyrobp^tm1.1Viv/Tyrobp^tm1.1Viv (B6.129P2-Tyrobp^tm1.1Viv)	abnormal myelopoiesis	J:95232
Tyrobp^tm1Lll/Tyrobp^tm1Lll (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast differentiation	J:89583
	increased dendritic cell number	J:64763
Tyrobp^tm1Ttk/Tyrobp^tm1Ttk (involves: 129P2/OlaHsd * C57BL/6)	abnormal osteoclast morphology	J:81823
Tyrobp^tm1Ttk/Tyrobp^tm1Ttk (B6.129P2-Tyrobp^tm1Ttk)	increased germinal center B cell number	J:177613
	increased spleen germinal center number	J:177613
	increased spleen germinal center size	J:177613
U2af2^em1(IMPC)J/U2af2⁺ (C57BL/6NJ-U2af2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Uaca^tm1Kiy/Uaca^tm1Kiy (B6.129P2-Uaca^tm1Kiy)	abnormal Kupffer cell morphology	J:157049
Uaca^tm1Kiy/Uaca^tm1Kiy (B6.129P2-Uaca^tm1Kiy)	decreased dendritic cell number	J:157049
Ubash3b^tm1Jni/Ubash3b^tm1Jni Ubash3a^tm1Jni/Ubash3a^tm1Jni (Not Specified)	increased mature B cell number	J:89761
	increased splenocyte number	J:89761
Ubd^{tm1b(EUCOMM)Wtsi}/Ubd^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Ubd^{tm1b(EUCOMM)Wtsi}/Ccpcz)	abnormal thymus morphology	J:211773
	decreased memory-marker CD4-positive NK T cell number	J:211773
	increased CD4-positive, CD25-positive NK T cell number	J:211773
	small thymus	J:211773
Ube2b^{tm1b(EUCOMM)Wtsi}/Ube2b⁺ (C57BL/6N-Ube2b^{tm1b(EUCOMM)Wtsi}/Ics)	decreased basophil cell number	J:211773
	decreased neutrophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Ube2i^em1(IMPC)J/Ube2i⁺ (C57BL/6NJ-Ube2i^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Ube2j2^{em1(IMPC)Rbrc}/Ube2j2^{em1(IMPC)Rbrc} (C57BL/6NJcl-Ube2j2^{em1(IMPC)Rbrc}/Rbrc)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
Ube2n^{em1(IMPC)Ccpcz}/Ube2n⁺ (C57BL/6N-Ube2n^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Ube2u^{tm1e.1(KOMP)Wtsi}/Ube2u^{tm1e.1(KOMP)Wtsi} (C57BL/6N-Ube2u^{tm1e.1(KOMP)Wtsi}/H)	increased basophil cell number	J:211773
Ube2w^{tm1d(EUCOMM)Wtsi}/Ube2w^{tm1d(EUCOMM)Wtsi} (involves: 129 * C57BL/6N)	increased neutrophil cell number	J:230053
Ube3b^{Gt(RRJ142)Byg}/Ube3b^{Gt(RRJ142)Byg} (involves: 129P2/OlaHsd * CBA/Ca)	lymphangiectasis	J:203652
Ube3c^{tm1b(EUCOMM)Hmgu}/Ube3c^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ube3c^{tm1b(EUCOMM)Hmgu}/Rbrc)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Ube3c^{tm1b(EUCOMM)Hmgu}/Ube3c^{tm1b(EUCOMM)Hmgu} (C57BL/6NCrl-Ube3c^{tm1b(EUCOMM)Hmgu}/Rbrc)	decreased CD4-negative NK T cell number	J:211773
	decreased CD5-positive Ly6C-positive T cell number	J:211773
	decreased Ly6C-positive immature NK cell number	J:211773
	decreased Ly6C-positive NK T cell number	J:211773
	increased effector memory CD8-positive, alpha-beta T cell number	J:211773
Ube4a^em1(IMPC)Tcp/Ube4a^em1(IMPC)Tcp (C57BL/6N-Ube4a^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Ubl4b^{em1(IMPC)Ccpcz}/Ubl4b^{em1(IMPC)Ccpcz} (C57BL/6N-Ubl4b^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ubox5^{tm1b(EUCOMM)Hmgu}/Ubox5^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Ubox5^{tm1b(EUCOMM)Hmgu}/Tcp)	increased neutrophil cell number	J:211773
Ubqln4^em1(IMPC)Mbp/Ubqln4^em1(IMPC)Mbp (C57BL/6NCrl-Ubqln4^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Ubr7^em1(IMPC)Tcp/Ubr7^em1(IMPC)Tcp (C57BL/6NCrl-Ubr7^em1(IMPC)Tcp/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Ubtf^em1(IMPC)Mbp/Ubtf⁺ (C57BL/6NCrl-Ubtf^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Ubxn11^em1(IMPC)J/Ubxn11^em1(IMPC)J (C57BL/6NJ-Ubxn11^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Uevld^{tm1a(EUCOMM)Wtsi}/Uevld^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Uevld^{tm1a(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Ufl1^{tm1c(EUCOMM)Wtsi}/Ufl1^{tm1c(EUCOMM)Wtsi} Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/6N)	decreased granulocyte number	J:238253
	decreased leukocyte cell number	J:238253
	decreased lymphocyte cell number	J:238253
	decreased monocyte cell number	J:238253
Ugcg^em1(IMPC)H/Ugcg⁺ (C57BL/6NTac-Ugcg^em1(IMPC)H/H)	decreased lymphocyte cell number	J:211773
Ugcg^em1(IMPC)H/Ugcg⁺ (C57BL/6NTac-Ugcg^em1(IMPC)H/H)	increased neutrophil cell number	J:211773
Uhrf1^{tm1a(EUCOMM)Wtsi}/Uhrf1⁺ (Not Specified)	increased NK cell number	J:165965
Uhrf2^{tm1b(EUCOMM)Wtsi}/Uhrf2^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Uhrf2^{tm1b(EUCOMM)Wtsi}/Tcp)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Uimc1^tm1.2Amj/Uimc1^tm1.2Amj (involves: BALB/cJ * C57BL/6)	increased T cell derived lymphoma incidence	J:191827
Ulk1^tm1.1Thsn/Ulk1^tm1.1Thsn (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	increased spleen weight	J:139213
Ulk3^em2(IMPC)Tcp/Ulk3^em2(IMPC)Tcp (C57BL/6NCrl-Ulk3^em2(IMPC)Tcp/Tcp)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
Unc13d^Jinx/Unc13d^Jinx (C57BL/6J-Unc13d^Jinx/Mmucd)	absent lymph node germinal center	J:119974
	enlarged spleen	J:119974
	increased CD8-positive, alpha-beta T cell number	J:119974
	increased monocyte cell number	J:119974
	increased neutrophil cell number	J:119974
Unc80^em1(IMPC)Tcp/Unc80⁺ (C57BL/6N-Unc80^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Unc93b1^3d/Unc93b1^3d (C57BL/6-Unc93b1^3d)	abnormal dendritic cell morphology	J:159599
Unc93b1^{tm1(KOMP)Vlcg}/Unc93b1^{tm1(KOMP)Vlcg} (involves: C57BL/6NTac)	abnormal dendritic cell morphology	J:211069
Unc93b1^tm1.1Kmiy/Unc93b1^tm1.1Kmiy (involves: 129P2/OlaHsd * C57BL/6)	abnormal T-helper 1 cell differentiation	J:174308
	abnormal T-helper 17 cell differentiation	J:174308
	decreased marginal zone B cell number	J:174308
	enlarged spleen	J:174308
	increased B cell number	J:174308
	increased CD4-positive, alpha-beta memory T cell number	J:174308
	increased memory T cell number	J:174308
	increased spleen weight	J:174308
	increased T-helper 1 cell number	J:174308
	increased T-helper 17 cell number	J:174308
Ung^tm1Tld/Ung^tm1Tld (Not Specified)	abnormal class switch recombination	J:79590
	enlarged lymph nodes	J:85353
	enlarged spleen	J:85353
	enlarged thymus	J:85353
	lymphoid hyperplasia	J:85353
	spleen hyperplasia	J:85353
Ung^tm1Tld/Ung^tm1Tld (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:306598
Ung^tm1Tld/Ung^tm1Tld (involves: 129P2/OlaHsd)	abnormal somatic hypermutation frequency	J:155454
Upf2^tm1Btp/Upf2^tm1Btp Tg(Mx1-cre)1Cgn/0 (involves: 129P2/OlaHsd * C57BL/6 * CBA)	abnormal B cell number	J:134765
	decreased granulocyte number	J:134765
Upf3b^em1(IMPC)Tcp/Y (C57BL/6NCrl-Upf3b^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	small thymus	J:211773
Upf3b^em1(IMPC)Tcp/Upf3b^em1(IMPC)Tcp (C57BL/6NCrl-Upf3b^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	small thymus	J:211773
Uqcrb^{tm1b(EUCOMM)Wtsi}/Uqcrb⁺ (C57BL/6N-Uqcrb^{tm1b(EUCOMM)Wtsi}/Ieg)	increased leukocyte cell number	J:211773
Urah^plt2/Urah^plt2 (C57BL/6-Urah^plt2)	abnormal NK cell morphology	J:267227
Urah^plt2/Urah^plt2 (C57BL/6-Urah^plt2)	decreased CD8-positive, alpha-beta T cell number	J:267227
Uros^tm1Cged/Uros^tm1Cged (involves: 129S2/SvPas)	enlarged spleen	J:105776
Uros^tm1Cged/Uros^tm1Cged (involves: 129S2/SvPas)	increased spleen red pulp amount	J:105776
Uros^tm2Rjde/Uros^tm3Rjde (involves: 129S6/SvEvTac * C57BL/6)	enlarged spleen	J:132542
	increased spleen iron level	J:132542
Usp5^{tm1a(EUCOMM)Hmgu}/Usp5⁺ (C57BL/6N-Usp5^{tm1a(EUCOMM)Hmgu}/Wtsi)	decreased leukocyte cell number	J:211773
Usp12^{tm1a(EUCOMM)Hmgu}/Usp12^{tm1a(EUCOMM)Hmgu} (Not Specified)	decreased CD8-positive, alpha-beta T cell number	J:165965
Usp15^{tm1b(EUCOMM)Wtsi}/Usp15^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Usp15^{tm1b(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Usp16^{tm1b(EUCOMM)Hmgu}/Usp16⁺ (C57BL/6N-Usp16^{tm1b(EUCOMM)Hmgu}/Nju)	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
Usp17lc^tm1Khb/Usp17lc⁺ (either: 129-Usp17lc^tm1Khb or (involves: 129S/SvEv * C57BL/6J))	decreased regulatory T cell number	J:191761
	increased B cell number	J:191761
	increased CD4-positive, alpha-beta T cell number	J:191761
	increased CD8-positive, alpha-beta T cell number	J:191761
	increased thymus weight	J:191761
Usp18^ity9/Usp18^ity9 (involves: 129S1/SvImJ * C57BL/6)	abnormal lymphocyte morphology	J:163843
Usp18^ity9/Usp18^ity9 (involves: 129S1/SvImJ * C57BL/6)	decreased leukocyte cell number	J:163843
Usp21^tm1.1Jhy/Usp21^tm1.1Jhy (B6.129S7(Cg)-Usp21^tm1.1Jhy)	enlarged spleen	J:208320
	increased macrophage cell number	J:208320
	increased neutrophil cell number	J:208320
	increased spleen weight	J:208320
	increased splenocyte number	J:208320
Usp21^{tm1a(EUCOMM)Wtsi}/Usp21^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Usp21^{tm1a(EUCOMM)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Usp22^{tm1b(KOMP)Wtsi}/Usp22⁺ (C57BL/6N-Usp22^{tm1b(KOMP)Wtsi}/Wtsi)	increased monocyte cell number	J:211773
Usp25^{Gt(RRS805)Byg}/Usp25^{Gt(RRS805)Byg} (involves: 129P2/OlaHsd)	increased neutrophil cell number	J:188557
Usp28^{Gt(EUCE0037g10)Hmgu}/Usp28^{Gt(EUCE0037g10)Hmgu} (involves: 129P2/OlaHsd * C57BL/6J)	decreased spleen weight	J:215354
	decreased splenocyte number	J:215354
Usp32^{em1(IMPC)Mhzh}/Usp32⁺ (C57BL/6N-Usp32^{em1(IMPC)Mhzh}/Mhzh)	decreased neutrophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Usp42^{tm2a(EUCOMM)Wtsi}/Usp42^{tm2a(EUCOMM)Wtsi} (involves: C57BL/6 * C57BL/6N)	increased CD4-positive, alpha-beta T cell number	J:213427
	increased T cell number	J:213427
Usp45^em1(IMPC)H/Usp45^em1(IMPC)H (C57BL/6NTac-Usp45^em1(IMPC)H/H)	decreased neutrophil cell number	J:211773
Usp54^{tm1b(KOMP)Wtsi}/Usp54^{tm1b(KOMP)Wtsi} (C57BL/6N-Usp54^{tm1b(KOMP)Wtsi}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Utp4^em1(IMPC)J/Utp4⁺ (C57BL/6NJ-Utp4^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Vamp4^{em1(IMPC)Ccpcz}/Vamp4^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Vamp4^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Vav1^m1Anu/Vav1^m1Anu (C57BL/6JAnu-Vav1^m1Anu)	increased T cell number	J:104190
Vav1^m1Btlr/Vav1^m1Btlr (C57BL/6J-Vav1^m1Btlr)	decreased B-1 B cell number	J:265128
	decreased CD4-positive, alpha-beta T cell number	J:265128
	decreased CD8-positive, alpha-beta T cell number	J:265128
	decreased CD8-positive, naive alpha-beta T cell number	J:265128
	decreased single-positive T cell number	J:265128
	decreased T cell number	J:265128
	increased central memory CD4-positive, alpha-beta T cell number	J:265128
	increased central memory CD8 positive, alpha-beta T cell number	J:265128
	increased effector memory CD4-positive, alpha-beta T cell number	J:265128
Vav1^m2Btlr/Vav1^m2Btlr (C57BL/6J-Vav1^m2Btlr)	decreased B-1 B cell number	J:265130
Vav1^M4Btlr/Vav1^M4Btlr (C57BL/6J-Vav1^M4Btlr)	abnormal CD4-positive T cell differentiation	J:272528
	abnormal CD8-positive, alpha-beta T cell differentiation	J:272528
	abnormal T cell differentiation	J:272528
	decreased B-1 B cell number	J:272528
	decreased CD4-positive, alpha-beta T cell number	J:272528
	decreased CD8-positive, naive alpha-beta T cell number	J:272528
	increased central memory CD4-positive, alpha-beta T cell number	J:272528
	increased central memory CD8 positive, alpha-beta T cell number	J:272528
	increased effector memory CD4-positive, alpha-beta T cell number	J:272528
	increased effector memory CD8-positive, alpha-beta T cell number	J:272528
Vav1^M5Btlr/Vav1^M5Btlr (C57BL/6J-Vav1^M5Btlr)	decreased CD8-positive, alpha-beta T cell number	J:272529
Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S2/SvPas * 129S8/SvEv)	decreased CD4-positive, alpha-beta T cell number	J:113270
	decreased double-negative T cell number	J:113270
Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:113270
	abnormal negative T cell selection	J:113270
Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S2/SvPas)	abnormal double-negative T cell morphology	J:79323
	decreased double-positive T cell number	J:79323
	decreased mature B cell number	J:86654
	decreased single-positive T cell number	J:79323
	decreased thymocyte number	J:86654
	thymus hypoplasia	J:79323
Vav1^tm1Tyb/Vav1^tm1Tyb (C.129S2-Vav1^tm1Tyb)	abnormal negative T cell selection	J:79323
Vav1^tm1Tyb/Vav1^tm1Tyb (involves: 129S2/SvPas * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:79323
Vav1^tm1Tyb/Vav1^tm1Tyb (either: (involves: 129S4/SvJae * 129S8/SvEv) or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))	abnormal lymphocyte cell number	J:190087
	abnormal T cell number	J:190087
	decreased double-positive T cell number	J:190087
	increased DN2 thymocyte number	J:190087
	increased DN3 thymocyte number	J:190087
	increased double-negative T cell number	J:190087
Vav1^tm1Tyb/Vav1^tm1Tyb Vav2^tm1Kdf/Vav2^tm1Kdf (involves: 129S1/Sv * 129S2/SvPas)	decreased double-negative T cell number	J:86654
	decreased double-positive T cell number	J:86654
	decreased mature B cell number	J:86654
	decreased single-positive T cell number	J:86654
	decreased T cell number	J:86654
	decreased thymocyte number	J:86654
Vav1^tm1Tyb/Vav1^tm1Tyb Vav2^tm1Kdf/Vav2^tm1Kdf Vav3^tm1Swat/Vav3^tm1Swat (involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)	arrested B cell differentiation	J:86654
	arrested T cell differentiation	J:86654
	decreased double-positive T cell number	J:86654
	decreased follicular B cell number	J:86654
	decreased marginal zone B cell number	J:86654
	decreased mature B cell number	J:86654
	decreased single-positive T cell number	J:86654
	decreased T cell number	J:86654
	decreased thymocyte number	J:86654
	decreased transitional stage T2 B cell number	J:86654
	increased immature B cell number	J:86654
	increased transitional stage T1 B cell number	J:86654
Vav1^tm1Tyb/Vav1^tm1Tyb Vav2^tm1Tnr/Vav2^tm1Tnr (involves: 129P2/OlaHsd * 129S2/SvPas)	decreased B cell number	J:69807
	decreased CD4-positive, alpha-beta T cell number	J:69807
	decreased CD8-positive, alpha-beta T cell number	J:69807
	decreased follicular B cell number	J:69807
	decreased immature B cell number	J:69807
	decreased mature B cell number	J:69807
Vav1^tm1Tyb/Vav1^tm1Tyb Vav3^tm1Swat/Vav3^tm1Swat (involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)	decreased double-negative T cell number	J:86654
	decreased double-positive T cell number	J:86654
	decreased mature B cell number	J:86654
	decreased single-positive T cell number	J:86654
	decreased T cell number	J:86654
Vav1^tm2Bbd/Vav1^tm2Bbd (involves: 129S1/Sv * 129X1/SvJ * CD-1)	abnormal T cell differentiation	J:47596
	decreased B-1 B cell number	J:47596
	decreased CD4-positive, alpha-beta T cell number	J:47596
	decreased CD8-positive, alpha-beta T cell number	J:47596
	thymus hypoplasia	J:47596
Vav1^tm2Bbd/Vav1^tm2Bbd (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell number	J:55647
	abnormal lymph node cell ratio	J:69806
	abnormal splenic cell ratio	J:69806
	abnormal T cell differentiation	J:47596
	abnormal T cell number	J:47596
	decreased B-1 B cell number	J:55647
	decreased CD4-positive, alpha-beta T cell number	J:47596
	decreased CD8-positive, alpha-beta T cell number	J:47596
	increased double-negative T cell number	J:47596
	increased transitional stage B cell number	J:69806
Vav1^tm2Bbd/Vav1^tm2Bbd (B6.129-Vav1^tm2Bbd)	abnormal CD4-positive T cell differentiation	J:141390
	abnormal positive T cell selection	J:141390
	decreased double-positive T cell number	J:141390
	decreased NK T cell number	J:71161
	decreased T cell number	J:141390
Vav1^tm2Bbd/Vav1^tm2Bbd Vav2^tm1Kdf/Vav2^tm1Kdf (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal B cell differentiation	J:69806
	abnormal lymph node cell ratio	J:69806
	abnormal splenic cell ratio	J:69806
	abnormal T cell differentiation	J:69806
	decreased B cell number	J:69806
	decreased B-1 B cell number	J:69806
	decreased CD8-positive, alpha-beta T cell number	J:69806
	decreased mature B cell number	J:69806
	decreased T cell number	J:69806
	thymus hypoplasia	J:69806
Vav1^tm2Tyb/Vav1^tm2Tyb (involves: 129S4/SvJae * 129S8/SvEv)	decreased CD4-positive, alpha-beta T cell number	J:113270
	decreased double-negative T cell number	J:113270
Vav1^tm2Tyb/Vav1^tm2Tyb (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)	abnormal CD4-positive, alpha beta T cell morphology	J:113270
	abnormal negative T cell selection	J:113270
Vav1^tm4Tyb/Vav1^tm4Tyb (either: 129S8.129S4-Vav1^tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))	abnormal lymphocyte cell number	J:190087
	abnormal T cell number	J:190087
	increased DN2 thymocyte number	J:190087
	increased DN3 thymocyte number	J:190087
Vav2^tm1Kdf/Vav2^tm1Kdf (involves: 129S1/Sv * C57BL/6)	decreased mature B cell number	J:69806
Vav2^tm1Tnr/Vav2^tm1Tnr (involves: 129P2/OlaHsd)	abnormal class switch recombination	J:69807
	decreased B cell number	J:69807
	decreased spleen germinal center number	J:69807
Vcam1^tm1Dmil/Vcam1^tm1Dmil (either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))	increased monocyte cell number	J:69597
Vcam1^tm1Dmil/Vcam1^tm1Dmil (C.129S4-Vcam1^tm1Dmil)	increased B cell number	J:69597
	increased leukocyte cell number	J:69597
	increased monocyte cell number	J:69597
	increased T cell number	J:69597
Vcam1^tm2Flv/Vcam1^tm3Flv Tg(Tek-cre)12Flv/0 (involves: 129S1/Sv * C3H * C57BL/6)	abnormal splenic cell ratio	J:107447
	decreased B cell number	J:68147
	decreased CD4-positive, alpha-beta T cell number	J:68147
	decreased CD8-positive, alpha-beta T cell number	J:68147
	decreased immature B cell number	J:68147
	increased immature B cell number	J:68147
	increased leukocyte cell number	J:107447, J:68147
	spleen hyperplasia	J:107447
Vcam1^tm2Roml/Vcam1^tm2Roml Tg(Mx1-cre)1Cgn/? (involves: 129S1/Sv * C57BL/6 * CBA)	decreased B cell number	J:68148
	decreased mature B cell number	J:68148
	decreased transitional stage B cell number	J:68148
	increased B cell number	J:68148
	increased immature B cell number	J:68148
	increased mature B cell number	J:68148
	increased transitional stage B cell number	J:68148
Vcan^em2(IMPC)Mbp/Vcan⁺ (C57BL/6NCrl-Vcan^em2(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Vcp^tm1Itl/Vcp⁺ (B6.129S-Vcp^tm1Itl)	abnormal osteoclast differentiation	J:166230
Vcp^tm1Itl/Vcp⁺ (B6.129S-Vcp^tm1Itl)	increased osteoclast cell number	J:166230
Vdac2^tm1.1Ehyc/Vdac2^tm1.1Ehyc Bax^tm2Sjk/Bax^tm2Sjk Tg(Lck-cre)1Cwi/? (involves: 129X1/SvJ * C57BL/6 * DBA/2)	decreased thymocyte number	J:220951
	small thymus	J:220951
Vdac2^tm1.1Ehyc/Vdac2^tm1.1Ehyc Tg(Lck-cre)1Cwi/? (involves: 129X1/SvJ * C57BL/6 * DBA/2)	decreased thymocyte number	J:220951
	small thymus	J:220951
Vdr^{em1(IMPC)Hmgu}/Vdr^{em1(IMPC)Hmgu} (C57BL/6NCrl-Vdr^{em1(IMPC)Hmgu}/Ieg)	increased neutrophil cell number	J:211773
Vdr^tm1Gcm/Vdr^tm1Gcm Tg(Col2a1-cre)1Bhr/? (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)	decreased osteoclast cell number	J:117377
Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129S4/SvJae * C57BL/6)	increased thymus weight	J:107077
Vdr^tm1Mbd/Vdr^tm1Mbd (involves: 129S4/SvJae * C57BL/6)	thymus hyperplasia	J:107077
Vdr^tm1Ska/Vdr^tm1Ska (NOD.Cg-Vdr^tm1Ska/CmatJ)	abnormal dendritic cell differentiation	J:127787
	abnormal T cell number	J:127787
	decreased regulatory T cell number	J:127787
Vegfa^tm1.1Nagy/Vegfa^tm1.1Nagy (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphatic vessel morphology	J:64090
Vegfa^tm1Pec/Vegfa^tm1Pec (involves: 129S1/Sv * 129X1/SvJ)	abnormal thymus morphology	J:81698
	athymia	J:81698
	decreased lymphocyte cell number	J:81698
	ectopic thymus	J:81698
	thymus hypoplasia	J:81698
Vegfc^tm1Ali/Vegfc⁺ (involves: 129S1/Sv * 129X1/SvJ * ICR)	lymphatic vessel hypoplasia	J:87394
Vegfc^tm1Ali/Vegfc⁺ (involves: 129S1/Sv * 129X1/SvJ)	lymphatic vessel hypoplasia	J:137909
Vegfc^tm1Ali/Vegfc⁺ Tg(KRT14-FIGF)2Ali/0 (involves: 129S1/Sv * 129X1/SvJ * FVB/N)	lymphatic vessel hyperplasia	J:137909
Vegfc^tm1Ali/Vegfc^tm1Ali (involves: 129S1/Sv * 129X1/SvJ * ICR)	absent lymphatic vessels	J:87394
Vegfc^tm1Ali/Vegfc^tm1Ali (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphangiogenesis	J:137909
Vegfc^tm1Ali/Vegfc^tm1Ali (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphatic vessel morphology	J:137909
Vegfd^{em1(IMPC)Ccpcz}/Vegfd^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Vegfd^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Vegfd^tm1Mach/Vegfd^tm1Mach Vegfc^tm1Ali/Vegfc^tm1Ali (involves: 129S1/Sv * 129X1/SvJ)	abnormal lymphangiogenesis	J:137909
	abnormal lymphatic vessel morphology	J:137909
Vezf1^tm1Stmn/Vezf1⁺ (B6.129-Vezf1^tm1Stmn)	abnormal lymphatic vessel morphology	J:99326
Vhl^tm1Jae/Vhl^tm1Jae Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0 (involves: 129S4/SvJae * CD-1)	decreased lymphocyte cell number	J:186085
	enlarged spleen	J:186085
Vhl^tm1Mcs/Vhl^tm1Mcs (involves: 129S4/SvJae * C57BL/6 * FVB/N)	dark spleen	J:130780
	decreased spleen white pulp amount	J:130780
	increased leukocyte cell number	J:130780
	increased spleen red pulp amount	J:130780
	increased spleen weight	J:130780
Vkorc1l1^em1(IMPC)J/Vkorc1l1^em1(IMPC)J (C57BL/6NJ-Vkorc1l1^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Vldlr^em1(IMPC)Mbp/Vldlr^em1(IMPC)Mbp (C57BL/6N-Vldlr^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
Vnn3^{em1(IMPC)Ccpcz}/Vnn3^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Vnn3^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Vpreb1a^tm1Ilm/Vpreb1a^tm1Ilm (involves: 129P2/OlaHsd * C57BL/6)	abnormal pre-B cell morphology	J:53512
	arrested B cell differentiation	J:53512
Vpreb1a^tm1Ilm/Vpreb1a^tm1Ilm (B6.129P2-Vpreb1a^tm1Ilm)	decreased pre-B cell number	J:104211
Vpreb1a^tm1Ilm/Vpreb1a^tm1Ilm (B6.129P2-Vpreb1a^tm1Ilm)	increased pre-B cell number	J:104211
Vpreb1a^tm1Ilm/Vpreb1a^tm1Ilm Vpreb1b^tm1Ilm/Vpreb1b⁺ (involves: 129P2/OlaHsd * C57BL/6)	decreased mature B cell number	J:104211
	decreased pre-B cell number	J:104211
	increased pre-B cell number	J:104211
Vpreb1a^tm1Ilm/Vpreb1a^tm1Ilm Vpreb1b^tm1Ilm/Vpreb1b^tm1Ilm (B6.129P2-Vpreb1a^tm1Ilm Vpreb1b^tm1Ilm)	abnormal B cell differentiation	J:67609
	abnormal immature B cell morphology	J:67609
	abnormal splenic cell ratio	J:67609
	decreased B-1a cell number	J:67609
	decreased mature B cell number	J:67609
	decreased pre-B cell number	J:67609
	increased pre-B cell number	J:67609
Vps4a^{tm1b(EUCOMM)Hmgu}/Vps4a⁺ (C57BL/6N-Vps4a^{tm1b(EUCOMM)Hmgu}/Bay)	enlarged spleen	J:211773
	increased spleen weight	J:211773
Vps13a^{tm1b(EUCOMM)Wtsi}/Vps13a^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Vps13a^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased plasmacytoid dendritic cell number	J:211773
	decreased T-helper cell number	J:211773
Vps13b^em1(IMPC)Tcp/Vps13b^em1(IMPC)Tcp (C57BL/6N-Vps13b^em1(IMPC)Tcp/Tcp)	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	small spleen	J:211773
Vps33a^em2(IMPC)Tcp/Vps33a⁺ (C57BL/6NCrl-Vps33a^em2(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
	increased spleen weight	J:211773
Vps33b^tm1.1Arte/Vps33b^tm1.1Arte Gt(ROSA)26Sor^{tm1(cre/ERT2)Tyj}/Gt(ROSA)26Sor⁺ (involves: C57BL/6 * C57BL/6J)	decreased dendritic cell number	J:222766
	decreased lymphocyte cell number	J:222766
	enlarged spleen	J:222766
	increased macrophage cell number	J:222766
	increased monocyte cell number	J:222766
	increased neutrophil cell number	J:222766
Vps35^tm1.1Mjff/Vps35^tm1.1Mjff (B6.Cg-Vps35^tm1.1Mjff)	microgliosis	J:303283
Vrk3^em1(IMPC)Mbp/Vrk3^em1(IMPC)Mbp (C57BL/6NCrl-Vrk3^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Vsig4^tm1Gne/Vsig4^tm1Gne (C57BL/6-Vsig4^tm1Gne)	increased T-helper 1 cell number	J:281762
Vsig4^tm1Gne/Vsig4^tm1Gne (C57BL/6-Vsig4^tm1Gne)	increased T-helper 17 cell number	J:281762
Vsig10^{em1(IMPC)Wtsi}/Vsig10^{em1(IMPC)Wtsi} (C57BL/6N-Vsig10^{em1(IMPC)Wtsi}/Wtsi)	increased leukocyte cell number	J:211773
Vtcn1^tm1Lpc/Vtcn1^tm1Lpc (B6.129S-Vtcn1^tm1Lpc)	abnormal myelopoiesis	J:145712
Vtcn1^tm1Lpc/Vtcn1^tm1Lpc (B6.129S-Vtcn1^tm1Lpc)	increased neutrophil cell number	J:145712
Vtcn1^tm1Xxz/Vtcn1^tm1Xxz (involves: 129S4/SvJae * BALB/c * C57BL/6)	increased CD4-positive, alpha-beta T cell number	J:177612
	increased T-helper 1 cell number	J:177612
	increased T-helper 17 cell number	J:177612
Wac^{tm2b(EUCOMM)Wtsi}/Wac⁺ (C57BL/6N-Wac^{tm2b(EUCOMM)Wtsi}/Wtsi)	decreased eosinophil cell number	J:211773
	increased Ly6C low monocyte number	J:211773
	increased monocyte cell number	J:211773
Was^tm1Itl/Y (Not Specified)	abnormal dendritic cell morphology	J:153247
	abnormal lymphocyte morphology	J:153247
	decreased NK cell number	J:153247
	decreased T cell number	J:153247
	increased B cell number	J:153247
	increased follicular B cell number	J:153247
	increased leukocyte cell number	J:153247
	increased splenocyte number	J:153247
	spleen hyperplasia	J:153247
Was^tm1Itl/Was^tm1Itl (Not Specified)	abnormal dendritic cell morphology	J:153247
	abnormal lymphocyte morphology	J:153247
	decreased NK cell number	J:153247
	decreased T cell number	J:153247
	increased B cell number	J:153247
	increased follicular B cell number	J:153247
	increased leukocyte cell number	J:153247
	increased splenocyte number	J:153247
	spleen hyperplasia	J:153247
Was^tm1Kas/Was^tm1Kas (involves: 129/Sv * C57BL/6)	decreased B cell number	J:87875
	decreased double-positive T cell number	J:87875
	decreased lymphocyte cell number	J:87875
	decreased T cell number	J:87875
	lymphoid hypoplasia	J:87875
	thymus hypoplasia	J:87875
Was^tm1Sbs/Y (involves: 129S6/SvEvTac)	abnormal dendritic cell morphology	J:153247
	abnormal lymphocyte morphology	J:153247
	decreased NK cell number	J:153247
	decreased T cell number	J:153247
	increased B cell number	J:153247
	increased follicular B cell number	J:153247
	increased leukocyte cell number	J:153247
	increased monocyte cell number	J:153247
	increased splenocyte number	J:153247
	spleen hyperplasia	J:153247
Was^tm1Sbs/Y (involves: 129S6/SvEvTac * C57BL/6)	decreased marginal zone B cell number	J:182528
	decreased mature B cell number	J:182528
	increased germinal center B cell number	J:182528
	increased plasma cell number	J:182528
Was^tm1Sbs/Was^tm1Sbs (either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))	decreased B cell number	J:48836
	decreased lymphocyte cell number	J:48836
	decreased T cell number	J:48836
	increased neutrophil cell number	J:48836
Was^tm1Sbs/Was^tm1Sbs (involves: 129S/SvEv)	abnormal mast cell morphology	J:86835
Was^tm1Sbs/Was^tm1Sbs (involves: 129S/SvEv)	abnormal osteoclast differentiation	J:90542
Was^tm1Sbs/Was^tm1Sbs (involves: 129S6/SvEvTac)	abnormal dendritic cell morphology	J:153247
	abnormal double-negative T cell morphology	J:125309
	abnormal double-positive T cell morphology	J:125309
	abnormal lymphocyte morphology	J:153247
	decreased NK cell number	J:153247
	decreased T cell number	J:153247
	increased B cell number	J:153247
	increased follicular B cell number	J:153247
	increased leukocyte cell number	J:153247
	increased monocyte cell number	J:153247
	increased splenocyte number	J:153247
	spleen hyperplasia	J:153247
Was^tm1Sbs/Was^tm1Sbs (involves: 129S6/SvEvTac * C57BL/6)	decreased marginal zone B cell number	J:182528
	decreased mature B cell number	J:182528
	increased germinal center B cell number	J:182528
	increased plasma cell number	J:182528
Was^tm1Sbs/Was^tm1Sbs Wasl^tm2Sbs/Wasl^tm2Sbs Tg(Lck-cre)1Cwi/? (involves: 129S6/SvEvTac * C57BL/6)	abnormal double-negative T cell morphology	J:125309
	abnormal double-positive T cell morphology	J:125309
	decreased regulatory T cell number	J:125309
	decreased single-positive T cell number	J:125309
	decreased T cell number	J:125309
	decreased thymocyte number	J:125309
	increased single-positive T cell number	J:125309
Was^tm2Itl/Y (Not Specified)	abnormal dendritic cell morphology	J:153247
	abnormal lymphocyte morphology	J:153247
	decreased NK cell number	J:153247
	decreased T cell number	J:153247
	increased B cell number	J:153247
	increased follicular B cell number	J:153247
	increased leukocyte cell number	J:153247
	increased splenocyte number	J:153247
Was^tm2Itl/Was^tm2Itl (Not Specified)	abnormal dendritic cell morphology	J:153247
	abnormal lymphocyte morphology	J:153247
	decreased NK cell number	J:153247
	decreased T cell number	J:153247
	increased B cell number	J:153247
	increased follicular B cell number	J:153247
	increased leukocyte cell number	J:153247
	increased splenocyte number	J:153247
Wbcq1^C57BLKS/J/Wbcq1^C57BLKS/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq1^C57BLKS/J/Wbcq1^SM/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq2^C57BLKS/J/Wbcq2^SM/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq2^C57BLKS/J/Wbcq2^SM/J Wbcq3^C57BLKS/J/Wbcq3^C57BLKS/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq2^SM/J/Wbcq2^SM/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq2^SM/J/Wbcq2^SM/J Wbcq3^C57BLKS/J/Wbcq3^C57BLKS/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq3^C57BLKS/J/Wbcq3^SM/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq3^SM/J/Wbcq3^SM/J (involves: C57BLKS/J * SM/J)	increased leukocyte cell number	J:102636
Wbcq4^NZW/LacJ/Wbcq4^NZW/LacJ (involves: NZW/LacJ * SM/J)	increased leukocyte cell number	J:102636
Wbcq4^NZW/LacJ/Wbcq4^SM/J (involves: NZW/LacJ * SM/J)	increased leukocyte cell number	J:102636
Wbcq5^NZW/LacJ/Wbcq5^NZW/LacJ (involves: NZW/LacJ * SM/J)	increased leukocyte cell number	J:102636
Wbcq6^NZW/LacJ/Wbcq6^NZW/LacJ (involves: NZW/LacJ * SM/J)	increased leukocyte cell number	J:102636
Wbcq6^SM/J/Wbcq6^SM/J (involves: NZW/LacJ * SM/J)	increased leukocyte cell number	J:102636
Wbp1l^{tm2a(EUCOMM)Hmgu}/Wbp1l^{tm2a(EUCOMM)Hmgu} (involves: C57BL/6N)	abnormal pre-B cell morphology	J:284781
	decreased B cell number	J:284781
	decreased B-1 B cell number	J:284781
	decreased pre-B cell number	J:284781
	decreased pro-B cell number	J:284781
	increased dendritic cell number	J:284781
	increased marginal zone B cell number	J:284781
Wbp2^{tm2a(EUCOMM)Wtsi}/Wbp2^{tm2a(EUCOMM)Wtsi} (C57BL/6N-Wbp2^{tm2a(EUCOMM)Wtsi}/Cnrm)	increased leukocyte cell number	J:165965
Wbp11^em1Gcha/Wbp11⁺ (involves: C57BL/6J * FVB/N)	ectopic thymus	J:300837
Wdfy3^em1(IMPC)Mbp/Wdfy3⁺ (C57BL/6N-Wdfy3^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Wdfy4^em1Jkln/Wdfy4^em1Jkln (C57BL/6J-Wdfy4^em1Jkln)	decreased dendritic cell number	J:326216
Wdr1^rede/Wdr1^rede (C57BL/6-Wdr1^rede)	abnormal myelopoiesis	J:134092
	abnormal thrombopoiesis	J:134092
	increased neutrophil cell number	J:134092
	increased osteoclast cell number	J:134092
Wdr27^{em1(IMPC)Ccpcz}/Wdr27^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Wdr27^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Wdr37^{tm1a(KOMP)Wtsi}/Wdr37^{tm1a(KOMP)Wtsi} (C57BL/6N-Wdr37^{tm1a(KOMP)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Wdr41^m1Btlr/Wdr41^m1Btlr (C57BL/6J-Wdr41^m1Btlr)	increased CD4-positive, alpha-beta T cell number	J:268243
Wdr41^m1Btlr/Wdr41^m1Btlr (C57BL/6J-Wdr41^m1Btlr)	increased CD8-positive, alpha-beta T cell number	J:268243
Wdr41^m2Btlr/Wdr41^m2Btlr (C57BL/6J-Wdr41^m2Btlr)	increased CD4-positive, alpha-beta T cell number	J:268243
Wdr41^m2Btlr/Wdr41^m2Btlr (C57BL/6J-Wdr41^m2Btlr)	increased CD8-positive, alpha-beta T cell number	J:268243
Wdr45^em1Wrst/Y (involves: C57BL/6N * FVB)	increased leukocyte cell number	J:307284
Wdr59^{tm1b(EUCOMM)Wtsi}/Wdr59⁺ (C57BL/6N-Wdr59^{tm1b(EUCOMM)Wtsi}/Wtsi)	decreased leukocyte cell number	J:211773
Wdr62^em1(IMPC)Tcp/Wdr62^em1(IMPC)Tcp (C57BL/6NCrl-Wdr62^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Wfdc2^em1(IMPC)H/Wfdc2⁺ (C57BL/6NTac-Wfdc2^em1(IMPC)H/H)	decreased eosinophil cell number	J:211773
Whrn^wi/Whrn^wi (involves: C57BL/6J * STOCK a Tyrp1^b Myo5a^d Oca2^p Ednrb^s)	decreased leukocyte cell number	J:5538
	decreased thymus weight	J:5037
Wipf1^tm1Geha/Wipf1^tm1Geha (involves: 129S6/SvEvTac)	decreased thymocyte number	J:74719
Wipf1^tm1Geha/Wipf1^tm1Geha (involves: 129S6/SvEvTac)	thymus hypoplasia	J:74719
Wipf1^tm1Geha/Wipf1^tm1Geha (involves: 129S6/SvEvTac * C57BL/6)	abnormal alpha-beta T cell morphology	J:116168
	abnormal lymph node B cell domain morphology	J:116168
	abnormal lymphopoiesis	J:116168
	abnormal Peyer's patch T cell area morphology	J:116168
	abnormal spleen morphology	J:116168
	abnormal thymus morphology	J:116168
	decreased B cell number	J:116168
	decreased follicular B cell number	J:116168
	decreased lymphocyte cell number	J:116168
	decreased marginal zone B cell number	J:116168
	decreased spleen white pulp amount	J:116168
	decreased thymus weight	J:116168
	enlarged spleen	J:116168
	increased granulocyte number	J:116168
	increased monocyte cell number	J:116168
	increased spleen red pulp amount	J:116168
Wls^tm1.1Arte/Wls^tm1.1Arte Krt14^tm1(cre)Wbm/Krt14⁺ (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:202499
	abnormal T cell subpopulation ratio	J:202499
	cutaneous mastocytosis	J:202499
	decreased double-positive T cell number	J:202499
	decreased gamma-delta T cell number	J:202499
	decreased T cell number	J:202499
	decreased thymus weight	J:202499
	increased double-negative T cell number	J:202499
	increased macrophage cell number	J:202499
	increased neutrophil cell number	J:202499
	small thymus medulla	J:202499
	thymus atrophy	J:202499
	thymus hypoplasia	J:202499
Wnt1^tm1Brd/Wnt1^tm1Brd (involves: 129S7/SvEvBrd * C57BL/6J)	decreased thymocyte number	J:75999
Wnt1^tm1Brd/Wnt1^tm1Brd Wnt4^tm1Amc/Wnt4^tm1Amc (involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6J)	decreased thymocyte number	J:75999
Wnt2b^{tm1b(EUCOMM)Wtsi}/Wnt2b^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Wnt2b^{tm1b(EUCOMM)Wtsi}/Tcp)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
	small spleen	J:211773
Wnt3a^{em1(IMPC)Ccpcz}/Wnt3a⁺ (C57BL/6NCrl-Wnt3a^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	increased lymphocyte cell number	J:211773
Wnt4^tm1Amc/Wnt4^tm1Amc (involves: 129S1/Sv)	decreased thymocyte number	J:75999
Wnt5a^b2b3077.1Clo/Wnt5a^b2b3077.1Clo (C57BL/6J-Wnt5a^b2b3077.1Clo)	thymus hypoplasia	J:175213
Wrn^b2b3121.1Clo/Wrn^b2b3121.1Clo (C57BL/6J-Wrn^b2b3121.1Clo)	thymus hypoplasia	J:175213
Wrn^{em1(IMPC)Ccpcz}/Wrn^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Wrn^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Wrn^tm1Lgu/Wrn^tm1Lgu (B6J.Cg-Wrn^tm1Lgu)	increased osteoclast cell number	J:213181
Wrnip1^{tm1a(EUCOMM)Wtsi}/Wrnip1^{tm1a(EUCOMM)Wtsi} (C57BL/6N-Wrnip1^{tm1a(EUCOMM)Wtsi}/Cnrm)	decreased T cell number	J:165965
Wt1^tm1Jae/Wt1^tm1Jae (involves: 129S4/SvJae * C57BL/6 * MF1)	abnormal spleen development	J:56651
	absent spleen	J:56651
Wwox^em1Mald/Wwox^em1Mald (FVB/N-Wwox^em1Mald)	microgliosis	J:339564
Wwox^tm1.1Mald/Wwox^tm1.1Mald (involves: C57BL/6 * FVB/N)	abnormal thymus cortex morphology	J:155406
	decreased leukocyte cell number	J:155406
	decreased spleen weight	J:155406
	decreased thymus weight	J:155406
	small spleen	J:155406
	spleen atrophy	J:155406
Wwox^tm1Ria/Wwox⁺ (involves: 129X1/SvJ * C57BL/6)	enlarged spleen	J:120064
Xbp1^{tm1a(EUCOMM)Wtsi}/Xbp1⁺ (C57BL/6N-Xbp1^{tm1a(EUCOMM)Wtsi}/Ics)	decreased T cell number	J:165965
Xbp1^{tm1b(EUCOMM)Wtsi}/Xbp1⁺ (C57BL/6N-Xbp1^{tm1b(EUCOMM)Wtsi}/Ics)	decreased large unstained cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Xcl1^tm1.1Dnax/Xcl1^tm1.1Dnax (either: (involves: 129/Sv * BALB/c) or (involves: 129/Sv * C57BL/6))	abnormal immune system morphology	J:176844
	decreased dendritic cell number	J:176844
	decreased regulatory T cell number	J:176844
	increased dendritic cell number	J:176844
Xcl1^tm1Rakr/Xcl1^tm1Rakr Tg(TcraTcrb)1100Mjb/0 (involves: 129/Sv * C57BL/6)	decreased T cell number	J:155297
Xcr1^{tm2(HBEGF/Venus)Ksho}/Xcr1⁺ (involves: C57BL/6 * C57BL/6J)	decreased dendritic cell number	J:204851
Xdh^tm1.1Takni/Xdh^tm1.1Takni (involves: C57BL/6)	abnormal peritoneal macrophage morphology	J:281671
Xpa^tm1Tnka/Xpa^tm1Tnka (involves: C57BL/6 * CBA)	increased NK cell number	J:55739
Xpnpep1^{tm1a(KOMP)Wtsi}/Xpnpep1^{tm1a(KOMP)Wtsi} (C57BL/6N-Xpnpep1^{tm1a(KOMP)Wtsi}/Wtsi)	abnormal thymus morphology	J:239583
	increased gamma-delta T cell number	J:211773
	increased NK cell number	J:211773
Xpo5^em1(IMPC)Mbp/Xpo5⁺ (C57BL/6NCrl-Xpo5^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Xrcc4^tm1Fwa/Xrcc4^tm1Fwa (involves: 129P2/OlaHsd * C57BL/6)	thymus hypoplasia	J:65218
Xrcc5^{em1(IMPC)Ccpcz}/Xrcc5^{em1(IMPC)Ccpcz} (C57BL/6NCrl-Xrcc5^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	decreased leukocyte cell number	J:211773
	small spleen	J:211773
	small thymus	J:211773
Xrcc5^m1Btlr/Xrcc5^m1Btlr (C57BL/6J-Xrcc5^m1Btlr)	abnormal B cell differentiation	J:274736
	abnormal CD8-positive, alpha-beta T cell differentiation	J:274736
	abnormal T cell differentiation	J:274736
	decreased B-2 B cell number	J:274736
	decreased CD4-positive, alpha-beta T cell number	J:274736
	decreased CD8-positive, alpha-beta T cell number	J:274736
	decreased CD8-positive, naive alpha-beta T cell number	J:274736
	decreased T cell number	J:274736
	increased B-1a cell number	J:274736
	increased B-1b cell number	J:274736
	increased CD4-positive, alpha-beta T cell number	J:274736
	increased dendritic cell number	J:274736
	increased effector memory CD4-positive, alpha-beta T cell number	J:274736
	increased effector memory CD8-positive, alpha-beta T cell number	J:274736
	increased neutrophil cell number	J:274736
Xrcc5^tm1Dbr/Xrcc5^tm1Dbr (involves: 129S1/Sv * C57BL/6)	abnormal B cell differentiation	J:34834
	absent T cells	J:34834
	arrested B cell differentiation	J:34834
	arrested T cell differentiation	J:34834
	increased double-negative T cell number	J:34834
	lymph node hypoplasia	J:34834
	thymus hypoplasia	J:34834
Xrcc5^tm1Dbr/Xrcc5^tm1Dbr Lig4^tm1Fwa/Lig4^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6)	abnormal lymphocyte morphology	J:80467
Xrcc5^tm1Nus/Xrcc5^tm1Nus (involves: 129S1/Sv * 129X1/SvJ)	abnormal class switch recombination	J:120658
	spleen hypoplasia	J:108657
	thymus hypoplasia	J:108657
Xrcc6^avon/Xrcc6^avon (involves: C57BL/6JAnu)	decreased B cell number	J:104190
Xrcc6^avon/Xrcc6^avon (involves: C57BL/6JAnu)	decreased T cell number	J:104190
Xrcc6^tm1Fwa/Xrcc6^tm1Fwa (involves: 129S6/SvEvTac * C57BL/6J)	abnormal B cell differentiation	J:44361
	abnormal B cell morphology	J:44361
	abnormal T cell differentiation	J:44361
	abnormal T cell morphology	J:44361
	absent immature B cells	J:44361
	absent mature B cells	J:44361
	absent pre-B cells	J:44361
	arrested B cell differentiation	J:44361
	decreased single-positive T cell number	J:44361
	decreased thymocyte number	J:44361
	increased double-positive T cell number	J:44361
	increased T cell derived lymphoma incidence	J:44361
Xrcc6^tm1Gcl/Xrcc6^tm1Gcl (involves: 129S1/Sv * C57BL/6)	abnormal B cell differentiation	J:108657
	abnormal immune system organ morphology	J:108657
	absent mature B cells	J:108657
	decreased spleen white pulp amount	J:108657
	small lymph nodes	J:108657
	small spleen	J:108657
	small thymus	J:108657
	spleen hypoplasia	J:108657
	thymus hypoplasia	J:108657
Xylt1^npo/Xylt1^npo (involves: C57BL/6J * FVB/NJ)	abnormal osteoclast differentiation	J:205339
X/Yaa ((NZB x BXSB)F1)	abnormal lymph node morphology	J:6235
	enlarged lymph nodes	J:6235
	increased spleen weight	J:6235
X/Yaa ((SJL/J x BXSB)F1)	enlarged lymph nodes	J:6235
X/Yaa ((C57BL/6J x BXSB)F1)	enlarged lymph nodes	J:6235
X/Yaa (involves: BXSB * NZB)	enlarged lymph nodes	J:6235
X/Yaa (BXSB/MpJ)	abnormal B cell differentiation	J:108760
	abnormal lymph node morphology	J:6235
	abnormal spleen B cell follicle morphology	J:179430
	abnormal T cell subpopulation ratio	J:179430
	enlarged lymph nodes	J:6235
	increased monocyte cell number	J:7308
	increased plasma cell number	J:108760
	increased spleen weight	J:6235
	increased splenocyte number	J:179430
X/Yaa (BXSB/MpJScr)	decreased CD4-positive, alpha-beta T cell number	J:10973
X/Yaa (BXSB/MpJScr)	increased monocyte cell number	J:10973
X/Yaa ((NZB x B6.SB/Le-Yaa)F1)	increased monocyte cell number	J:129409
X/Yaa (B6.SB-Yaa/J)	decreased marginal zone B cell number	J:127600
Ydjc^{tm1(KOMP)Wtsi}/Ydjc^{tm1(KOMP)Wtsi} (C57BL/6N-Ydjc^{tm1(KOMP)Wtsi}/Wtsi)	increased effector memory T-helper cell number	J:211773
	increased germinal center B cell number	J:211773
Yeats4^em1Zfa/Yeats4^em1Zfa Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (involves: C57BL/6 * C57BL/10 * CBA/Ca)	abnormal gut-associated lymphoid tissue morphology	J:282740
	abnormal lymphopoiesis	J:282740
	decreased lymphocyte cell number	J:282740
	decreased Peyer's patch number	J:282740
Yipf6^em1(IMPC)Mbp/Yipf6^em1(IMPC)Mbp (C57BL/6N-Yipf6^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	increased monocyte cell number	J:211773
Ykt6^em1(IMPC)J/Ykt6⁺ (C57BL/6NJ-Ykt6^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Yod1^tm1bNarl/Yod1^tm1bNarl (C57BL/6N-Yod1^tm1bNarl/Narl)	decreased lymphocyte cell number	J:211773
Yod1^tm1bNarl/Yod1^tm1bNarl (C57BL/6N-Yod1^tm1bNarl/Narl)	increased neutrophil cell number	J:211773
Ythdf3^em1(IMPC)Mbp/Ythdf3^em1(IMPC)Mbp (C57BL/6N-Ythdf3^em1(IMPC)Mbp/MbpMmucd)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Ywhaz^{tm1b(EUCOMM)Hmgu}/Ywhaz⁺ (C57BL/6N-Ywhaz^{tm1b(EUCOMM)Hmgu}/Tcp)	enlarged lymph nodes	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Yy2^em1(IMPC)Mbp/Yy2^em1(IMPC)Mbp (C57BL/6NCrl-Yy2^em1(IMPC)Mbp/Mmucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Zap70^m1Btlr/Zap70^m1Btlr (involves: C57BL/6J)	abnormal class switch recombination	J:185495
	absent CD4-positive, alpha-beta T cells	J:167119
	absent CD8-positive, alpha-beta T cells	J:167119
	decreased T cell number	J:185495
Zap70^m1Saka/Zap70^m1Saka (involves: BALB/c)	abnormal lymph node cell ratio	J:154166
	abnormal positive T cell selection	J:154166, J:86607
	abnormal splenic cell ratio	J:154166
	abnormal T cell clonal deletion	J:154166
	abnormal T cell differentiation	J:86607
	abnormal T cell selection	J:86607
	abnormal thymus cell ratio	J:154166
	decreased CD4-positive, alpha-beta T cell number	J:154166, J:86607
	decreased CD8-positive, alpha-beta T cell number	J:154166, J:86607
	decreased regulatory T cell number	J:154166
	increased activated T cell number	J:154166
	increased B cell number	J:86607
	increased memory T cell number	J:154166
Zap70^m1Saka/Zap70^m1Saka Tg(DO11.10)10Dlo/0 (involves: BALB/c * C3H * C57BL/6)	decreased T cell number	J:86607
Zap70^m1Saka/Zap70^m1Saka Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: BALB/c * C57BL/6J * DBA/2J)	abnormal positive T cell selection	J:86607
Zap70^m1Saka/Zap70^tm2.1Weis (involves: 129S4/SvJae * BALB/c)	abnormal T cell clonal deletion	J:154166
Zap70^m2Btlr/Zap70^m2Btlr (involves: C57BL/6J)	decreased T cell number	J:174837
Zap70^m4Btlr/Zap70^m4Btlr (C57BL/6J-Zap70^m4Btlr)	decreased CD4-positive, alpha-beta T cell number	J:236698
	decreased CD8-positive, alpha-beta T cell number	J:236698
	decreased T cell number	J:236698
Zap70^m5Btlr/Zap70^m5Btlr (C57BL/6J-Zap70^m5Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254830
	decreased CD8-positive, alpha-beta T cell number	J:254830
	decreased CD8-positive, naive alpha-beta T cell number	J:254830
	increased B cell number	J:254830
	increased central memory CD4-positive, alpha-beta T cell number	J:254830
	increased central memory CD8 positive, alpha-beta T cell number	J:254830
	increased effector memory CD4-positive, alpha-beta T cell number	J:254830
Zap70^m6Btlr/Zap70^m6Btlr (C57BL/6J-Zap70^m6Btlr)	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254831
	decreased CD8-positive, alpha-beta T cell number	J:254831
	decreased CD8-positive, naive alpha-beta T cell number	J:254831
	increased B cell number	J:254831
	increased central memory CD4-positive, alpha-beta T cell number	J:254831
	increased central memory CD8 positive, alpha-beta T cell number	J:254831
	increased effector memory CD4-positive, alpha-beta T cell number	J:254831
Zap70^m6Hefl/Zap70^m6Hefl (C3HeB/FeJ-Zap70^m6Hefl)	abnormal T cell differentiation	J:137446
	decreased CD4-positive, alpha-beta T cell number	J:137446
	decreased CD8-positive, alpha-beta T cell number	J:137446
	decreased T cell number	J:137446
Zap70^m6Hefl/Zap70^tm1Weis (involves: 129X1/SvJ * C3HeB/FeJ * C57BL/10 * DBA/2)	decreased T cell number	J:137446
Zap70^m7Btlr/Zap70^m7Btlr (C57BL/6J-Zap70^m7Btlr)	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:254832
Zap70^m7Btlr/Zap70^m7Btlr (C57BL/6J-Zap70^m7Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:254832
Zap70^m8Btlr/Zap70^m8Btlr (C57BL/6J-Zap70^m8Btlr)	decreased CD8-positive, naive alpha-beta T cell number	J:272864
Zap70^m8Btlr/Zap70^m8Btlr (C57BL/6J-Zap70^m8Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:272864
Zap70^mrtle/Zap70^mrtle (C57BL/6JSfdAnu-Zap70^mrtle/Apb)	abnormal positive T cell selection	J:104190
	abnormal T cell subpopulation ratio	J:104190
	absent T cells	J:104190
	arrested T cell differentiation	J:104190
	decreased T cell number	J:104190
Zap70^mrtle/Zap70^mrtle (involves: C57BL/6JSfdAnu)	abnormal double-positive T cell morphology	J:211510
	abnormal regulatory T cell number	J:211510
	decreased CD4-positive, alpha-beta T cell number	J:211510
	decreased CD8-positive, alpha-beta T cell number	J:211510
	increased double-positive T cell number	J:211510
Zap70^mrtle/Zap70^rps (involves: C57BL/6 * C57BL/6JSfdAnu)	abnormal CD4-positive, alpha beta T cell morphology	J:211510
	abnormal double-positive T cell morphology	J:211510
	abnormal regulatory T cell number	J:211510
	decreased CD4-positive, alpha-beta T cell number	J:211510
	decreased CD8-positive, alpha-beta T cell number	J:211510
	increased double-positive T cell number	J:211510
Zap70^mur/Zap70^mur (C57BL/6Apb-Zap70^mur/ApbH)	decreased T cell number	J:104190
Zap70^st/Zap70^st (involves: C57BL/6)	arrested T cell differentiation	J:41170
	decreased T cell number	J:41170
	thymus hypoplasia	J:41170
Zap70^st/Zap70^tm1Dlo (involves: C57BL/6)	arrested T cell differentiation	J:41170
Zap70^tm1Dlo/Zap70^tm1Dlo (involves: 129P2/OlaHsd)	increased double-positive T cell number	J:97610
Zap70^tm1Weis/Zap70^tm1Weis (involves: 129X1/SvJ * C57BL/6J)	abnormal lymph node cell ratio	J:74974
	abnormal splenic cell ratio	J:74974
	abnormal T cell differentiation	J:74974
	arrested T cell differentiation	J:74974
	small lymph nodes	J:74974
Zap70^tm2.1Mmal/Zap70^tm2.1Mmal Tg(TcraH-Y,TcrbH-Y)71Vbo/0 (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6J * DBA/2J)	abnormal lymph node cell ratio	J:71099
	abnormal T cell morphology	J:71099
	abnormal thymus cell ratio	J:71099
Zap70^tm2.1Mmal/Zap70^tm2.1Mmal Tg(TcrLCMV)327Sdz/0 (involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * DBA/2)	abnormal T cell morphology	J:71099
Zap70^tm2.1Weis/Zap70^tm2.1Weis (B6.129S4-Zap70^tm2.1Weis)	abnormal CD8-positive, alpha-beta T cell differentiation	J:154166
	abnormal thymus cell ratio	J:154166
	decreased CD4-positive, alpha-beta T cell number	J:154166
	decreased CD8-positive, alpha-beta T cell number	J:154166
Zap70^tm2.1Weis/Zap70^tm2.1Weis (C.129S4-Zap70^tm2.1Weis)	abnormal lymph node cell ratio	J:154166
	abnormal positive T cell selection	J:154166
	abnormal splenic cell ratio	J:154166
	abnormal T cell clonal deletion	J:154166
	abnormal thymus cell ratio	J:154166
	decreased CD4-positive, alpha-beta T cell number	J:154166
	decreased CD8-positive, alpha-beta T cell number	J:154166
	decreased regulatory T cell number	J:154166
	increased activated T cell number	J:154166
	increased memory T cell number	J:154166
Zap70^tm2.1Weis/Zap70^tm2.1Weis Tg(DO11.10)10Dlo/? (involves: 129S4/SvJae * BALB/c * C3H * C57BL/6)	abnormal positive T cell selection	J:154166
Zap70^tm2.1Weis/Zap70^tm2.1Weis Tg(TcraH-Y,TcrbH-Y)71Vbo/? (involves: 129S4/SvJae * C57BL/6J * DBA/2J)	abnormal positive T cell selection	J:154166
	abnormal T cell clonal deletion	J:154166
Zbtb1^m1Btlr/Zbtb1^m1Btlr (involves: C3H/HeN * C57BL/6J)	abnormal B cell differentiation	J:178820
	abnormal T cell differentiation	J:178820
	abnormal thymus morphology	J:178820
	decreased B cell number	J:178820
	decreased CD4-positive, alpha-beta T cell number	J:178820
	decreased CD8-positive, alpha-beta T cell number	J:178820
	decreased DN2 thymocyte number	J:178820
	decreased DN3 thymocyte number	J:178820
	decreased DN4 thymocyte number	J:178820
	decreased double-positive T cell number	J:178820
	decreased follicular B cell number	J:178820
	decreased NK cell number	J:178820
	decreased T cell number	J:178820
	decreased transitional stage B cell number	J:178820
	increased B cell number	J:178820
	thymus hypoplasia	J:178820
Zbtb1^m2Btlr/Zbtb1^m2Btlr (C57BL/6J-Zbtb1^m2Btlr)	abnormal CD8-positive, alpha-beta T cell differentiation	J:272845
Zbtb1^m2Btlr/Zbtb1^m2Btlr (C57BL/6J-Zbtb1^m2Btlr)	increased central memory CD8 positive, alpha-beta T cell number	J:272845
Zbtb7a^tm1Ppp/Zbtb7a^tm1Ppp (B6.129S1-Zbtb7a^tm1Ppp)	abnormal lymphopoiesis	J:121576
	decreased B cell number	J:121576
	decreased pro-B cell number	J:121576
Zbtb7a^tm1Ppp/Zbtb7a^tm2Ppp Tg(Mx1-cre)1Cgn/0 (involves: 129S1/Sv * C57BL/6 * CBA)	abnormal B cell differentiation	J:121576
	abnormal double-positive T cell morphology	J:121576
	decreased B cell number	J:121576
	decreased leukocyte cell number	J:121576
Zbtb7b^hd/Zbtb7b^hd (involves: 129/Sv * BALB/c * C3H * C57BL/6)	abnormal CD4-positive T cell differentiation	J:48734
	absent CD4-positive, alpha-beta T cells	J:48734
	increased CD8-positive, alpha-beta T cell number	J:48734
Zbtb7b^hpls/Zbtb7b^hpls (involves: C57BL/6JAnu)	decreased CD4-positive, alpha-beta T cell number	J:104190
Zbtb7b^tm1.1Rbo/Zbtb7b^tm1.1Rbo (Not Specified)	abnormal CD8-positive, alpha-beta T cell number	J:141145
	abnormal T cell differentiation	J:141145
	decreased CD4-positive, alpha-beta T cell number	J:141145
Zbtb7b^tm1.1Skok/Zbtb7b^tm1.1Skok (involves: 129/Sv * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:169841
Zbtb7b^tm1.1Tani/Zbtb7b^tm1.1Tani (involves: 129 * C57BL/6)	increased double-negative T cell number	J:141142
Zbtb7b^tm1Itan/Zbtb7b^tm1.1Tani (involves: 129 * C57BL/6)	abnormal CD4-positive, alpha beta T cell morphology	J:141142
	decreased CD4-positive, alpha-beta T cell number	J:141142
	increased CD8-positive, alpha-beta T cell number	J:141142
	increased double-negative T cell number	J:141142
Zbtb7b^tm1Itan/Zbtb7b^tm2Itan (involves: 129 * C57BL/6)	decreased CD4-positive, alpha-beta T cell number	J:141142
	increased CD8-positive, alpha-beta T cell number	J:141142
	increased double-negative T cell number	J:141142
Zbtb7b^tm1Litt/Zbtb7b^tm1.2Litt (involves: C57BL/6)	abnormal double-positive T cell morphology	J:141144
	decreased CD4-positive, alpha-beta T cell number	J:141144
	increased CD8-positive, alpha-beta T cell number	J:141144
Zbtb7b^tm2Litt/Zbtb7b^tm1.2Litt (involves: 129P2/OlaHsd)	decreased CD4-positive, alpha-beta T cell number	J:141144
Zbtb7b^tm2Litt/Zbtb7b^tm1.2Litt Tg(Lck-cre)1Cwi/? (involves: 129P2/OlaHsd * C57BL/6)	abnormal T cell differentiation	J:141144
	decreased CD4-positive, alpha-beta T cell number	J:141144
Zbtb7b^tm2Litt/Zbtb7b^tm2Litt (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)	absent CD4-positive, alpha-beta T cells	J:141519
Zbtb7b^tm4.1Itan/Zbtb7b^tm4.1Itan (Not Specified)	decreased CD4-positive, alpha-beta T cell number	J:193321
Zbtb7b^tm4.1Itan/Zbtb7b^tm4.1Itan (Not Specified)	increased CD8-positive, alpha-beta T cell number	J:193321
Zbtb7b^tm6.1Itan/Zbtb7b^tm6.1Itan Tg(Cd4-cre)1Cwi/? (involves: C57BL/6 * DBA/2)	decreased CD8-positive, alpha-beta T cell number	J:195348
Zbtb7b^tm7Itan/Zbtb7b^tm7Itan (Not Specified)	decreased CD4-positive, alpha-beta T cell number	J:195348
Zbtb16^em1(IMPC)Mbp/Zbtb16^em1(IMPC)Mbp (C57BL/6NCrl-Zbtb16^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Zbtb16^lu/Zbtb16^lu (B6.C3-Zbtb16^lu/J)	decreased NK T cell number	J:139690
Zbtb17^tm1Cksn/Zbtb17^tm1Cksn Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Zbtb17^tm1Cksn Commd10^{Tg(Vav1-icre)A2Kio})	arrested T cell differentiation	J:170508
	decreased DN1 thymic pro-T cell number	J:170508
	decreased DN2 thymocyte number	J:170508
	decreased DN3 thymocyte number	J:170508
	decreased double-negative T cell number	J:170508
	decreased gamma-delta T cell number	J:170508
	decreased T cell number	J:170508
	decreased thymocyte number	J:170508
	thymus hypoplasia	J:170508
Zbtb42^em1(IMPC)Mbp/Zbtb42^em1(IMPC)Mbp (C57BL/6NCrl-Zbtb42^em1(IMPC)Mbp/Mmucd)	enlarged lymph nodes	J:211773
Zbtb46^{tm1(HBEGF)Mnz}/Zbtb46⁺ (C57BL/6-Zbtb46^{tm1(HBEGF)Mnz})	decreased dendritic cell number	J:189122
	increased monocyte cell number	J:189122
	increased neutrophil cell number	J:189122
Zbtb46^tm2.1Mnz/Zbtb46^tm2.1Mnz (involves: C57BL/6)	abnormal dendritic cell morphology	J:191314
	abnormal lymphangiogenesis	J:191314
	decreased dendritic cell number	J:191314
	enlarged lymph nodes	J:191314
	increased dendritic cell number	J:191314
	lymph node hyperplasia	J:191314
Zc2hc1c^{em1(IMPC)Ccpcz}/Zc2hc1c^{em1(IMPC)Ccpcz} (C57BL/6N-Zc2hc1c^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal thymus morphology	J:211773
	enlarged thymus	J:211773
Zc3h7b^em1(IMPC)J/Zc3h7b^em1(IMPC)J (C57BL/6NJ-Zc3h7b^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Zc3h8^{em1(IMPC)Ccpcz}/Zc3h8⁺ (C57BL/6N-Zc3h8^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	decreased CD8-positive, naive alpha-beta T cell number	J:211773
	enlarged spleen	J:211773
Zc3h11a^em1(IMPC)Mbp/Zc3h11a⁺ (C57BL/6NCrl-Zc3h11a^em1(IMPC)Mbp/Mmucd)	abnormal thymus morphology	J:211773
Zc3h12a^tm1Aki/Zc3h12a^tm1Aki (involves: 129X1/SvJ * C57BL/6)	abnormal class switch recombination	J:147868
	enlarged lymph nodes	J:147868
	enlarged spleen	J:147868
	increased leukocyte cell number	J:147868
	increased memory T cell number	J:147868
	increased plasma cell number	J:147868
Zc3h12a^{tm1c(EUCOMM)Hmgu}/Zc3h12a^{tm1c(EUCOMM)Hmgu} Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺ (involves: C57BL/6 * C57BL/6N * DBA)	enlarged spleen	J:304105
Zc3h12a^tm1Fum/Zc3h12a^tm1Fum (C57BL/6-Zc3h12a^tm1Fum)	enlarged lymph nodes	J:176866
Zc3h12a^tm1Fum/Zc3h12a^tm1Fum (C57BL/6-Zc3h12a^tm1Fum)	enlarged spleen	J:176866
Zc3h12b^em1(IMPC)Tcp/Zc3h12b^em1(IMPC)Tcp (C57BL/6NCrl-Zc3h12b^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Zc3h12c^em1(IMPC)Tcp/Zc3h12c^em1(IMPC)Tcp (C57BL/6NCrl-Zc3h12c^em1(IMPC)Tcp/Tcp)	decreased lymphocyte cell number	J:211773
	enlarged lymph nodes	J:211773
	increased neutrophil cell number	J:211773
Zc3h12c^{tm2c(EUCOMM)Hmgu}/Zc3h12c^{tm2c(EUCOMM)Hmgu} Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)	enlarged lymph nodes	J:277714
	increased B cell number	J:277714
	increased CD4-positive, alpha-beta T cell number	J:277714
	increased effector memory CD8-positive, alpha-beta T cell number	J:277714
	increased immature B cell number	J:277714
	increased marginal zone B cell number	J:277714
Zc3h12c^{tm2d(EUCOMM)Hmgu}/Zc3h12c^{tm2d(EUCOMM)Hmgu} (involves: 129S4/SvJaeSor * C57BL/6N)	abnormal lymph node cortex morphology	J:277714
	abnormal lymph node primary follicle morphology	J:277714
	decreased CD8-positive, alpha-beta T cell number	J:277714
	decreased germinal center B cell number	J:277714
	decreased macrophage cell number	J:277714
	enlarged lymph nodes	J:277714
	increased B cell number	J:277714
	increased CD4-positive, alpha-beta T cell number	J:277714
	increased effector memory CD4-positive, alpha-beta T cell number	J:277714
	increased immature B cell number	J:277714
	increased marginal zone B cell number	J:277714
	increased splenocyte number	J:277714
	increased T cell number	J:277714
Zc3h12d^{tm1b(EUCOMM)Hmgu}/Zc3h12d^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Zc3h12d^{tm1b(EUCOMM)Hmgu}/Orl)	decreased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Zc3h12d^tm1Tom/Zc3h12d^tm1Tom (B6.Cg-Zc3h12d^tm1Tom)	increased T-helper 17 cell number	J:209383
Zc3hav1l^{tm1b(EUCOMM)Wtsi}/Zc3hav1l^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Zc3hav1l^{tm1b(EUCOMM)Wtsi}/Tcp)	increased eosinophil cell number	J:211773
Zcchc17^{em1(IMPC)Hmgu}/Zcchc17^{em1(IMPC)Hmgu} (C57BL/6NCrl-Zcchc17^{em1(IMPC)Hmgu}/Ieg)	increased spleen weight	J:211773
Zcrb1^{em1(IMPC)Ccpcz}/Zcrb1⁺ (C57BL/6NCrl-Zcrb1^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
Zcwpw1^em1(IMPC)Tcp/Zcwpw1^em1(IMPC)Tcp (C57BL/6N-Zcwpw1^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Zdbf2^em1(IMPC)J/Zdbf2^em1(IMPC)J (C57BL/6NJ-Zdbf2^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Zdhhc2^em1Eko/Zdhhc2^em1Eko (C57BL/6-Zdhhc2^em1Eko)	decreased dendritic epidermal T cell number	J:303593
	decreased leukocyte cell number	J:303593
	decreased plasmacytoid dendritic cell number	J:303593
	increased alpha-beta T cell number	J:303593
	increased gamma-delta T cell number	J:303593
Zdhhc13^skc4/Zdhhc13^skc4 (involves: 129S6/SvEvTac * C3H * C57BL/6)	abnormal Kupffer cell morphology	J:161519
	decreased leukocyte cell number	J:161519
	enlarged spleen	J:161519
	increased neutrophil cell number	J:161519
Zeb1^m1Btlr/Zeb1^m1Btlr (involves: C57BL/6J)	abnormal B cell differentiation	J:185495
	abnormal class switch recombination	J:185495
	absent marginal zone B cells	J:185495
	decreased B-1 B cell number	J:185495
	decreased B-1a cell number	J:185495
	decreased B-1b cell number	J:185495
	decreased double-positive T cell number	J:185495
	decreased germinal center B cell number	J:185495
	decreased NK cell number	J:185495
	increased single-positive T cell number	J:185495
	increased thymocyte number	J:185495
Zeb1^tm1Yhi/Zeb1^tm1Yhi (B6.129P2-Zeb1^tm1Yhi)	abnormal T cell differentiation	J:39865
	abnormal T cell subpopulation ratio	J:39865
	abnormal thymus development	J:39865
	decreased CD8-positive, alpha-beta T cell number	J:39865
	decreased double-positive T cell number	J:39865
	decreased lymphocyte cell number	J:39865
	decreased splenocyte number	J:39865
	decreased T cell number	J:39865
	decreased thymocyte number	J:39865
	lymph node hypoplasia	J:39865
	small thymus	J:39865
	thymus hypoplasia	J:39865
Zeb1^tm1Yhi/Zeb1^tm1Yhi (either: (involves: 129 * C3H * C57BL/6) or (involves: 129 * C57BL/6 * ICR))	increased T cell derived lymphoma incidence	J:139194
Zeb1^tm2Yhi/Zeb1^tm2Yhi (B6.129-Zeb1^tm2Yhi)	decreased thymocyte number	J:45575
Zeb1^tm2Yhi/Zeb1^tm2Yhi (B6.129-Zeb1^tm2Yhi)	thymus hypoplasia	J:45575
Zeb1^Tw/Zeb1⁺ (B6.Cg-Zeb1^Tw)	decreased leukocyte cell number	J:177274
	decreased lymphocyte cell number	J:177274
	decreased neutrophil cell number	J:177274
	small spleen	J:177274
	small thymus	J:177274
Zfand2b^tm1Otin/Zfand2b⁺ (involves: 129S7/SvEvBrd * C57BL/6)	increased granulocyte number	J:233169
Zfand2b^tm1Otin/Zfand2b^tm1Otin (involves: 129S7/SvEvBrd * C57BL/6)	abnormal myeloid leukocyte morphology	J:233169
	decreased lymphocyte cell number	J:233169
	enlarged spleen	J:233169
	increased granulocyte number	J:233169
	increased leukocyte cell number	J:233169
	increased lymphocyte cell number	J:233169
	increased spleen weight	J:233169
Zfand3^em1(IMPC)J/Zfand3^em1(IMPC)J (C57BL/6NJ-Zfand3^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Zfand6^em1(IMPC)Mbp/Zfand6^em1(IMPC)Mbp (C57BL/6N-Zfand6^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Zfat^{em1(IMPC)Ccpcz}/Zfat⁺ (C57BL/6NCrl-Zfat^{em1(IMPC)Ccpcz}/Ccpcz)	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
Zfat^tm2.1Sawa/Zfat^tm2.1Sawa Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6JJcl * C57BL/6NCrSlc * DBA/2)	abnormal CD8-positive, alpha-beta T cell differentiation	J:187164
	decreased CD4-positive, alpha-beta T cell number	J:187164
	decreased CD8-positive, alpha-beta T cell number	J:187164
Zfp14^tm1Xch/Zfp14⁺ (involves: C57BL/6)	lymph node hyperplasia	J:331393
	spleen hyperplasia	J:331393
	thymus hyperplasia	J:331393
Zfp14^tm1Xch/Zfp14^tm1Xch (involves: C57BL/6)	lymph node hyperplasia	J:331393
	spleen hyperplasia	J:331393
	thymus hyperplasia	J:331393
Zfp35^tm1Naka/Zfp35^tm1Naka (either: B6.Cg-Zfp35^tm1Naka or C.Cg-Zfp35^tm1Naka)	abnormal T-helper 2 cell differentiation	J:153828
	increased eosinophil cell number	J:153828
Zfp36^{tm1(KOMP)Vlcg}/Zfp36⁺ (C57BL/6N-Zfp36^{tm1(KOMP)Vlcg}/Nju)	increased leukocyte cell number	J:211773
Zfp36^tm1Pjb/Zfp36^tm1Pjb (Not Specified)	abnormal thymus cortex morphology	J:33986
	abnormal thymus medulla morphology	J:33986
	enlarged lymph nodes	J:33986
	enlarged spleen	J:33986
	increased leukocyte cell number	J:33986
	spleen hyperplasia	J:33986
	thymus hypoplasia	J:33986
Zfp36^tm1Pjb/Zfp36^tm1Pjb (B6.Cg-Zfp36^tm1Pjb)	decreased lymphocyte cell number	J:214114
	increased granulocyte number	J:214114
	increased monocyte cell number	J:214114
	increased neutrophil cell number	J:214114
Zfp36^tm4.1Pjb/Zfp36^tm4.1Pjb Lyz2^tm1(cre)Ifo/Lyz2⁺ (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)	enlarged lymph nodes	J:188677
	enlarged spleen	J:188677
	increased spleen weight	J:188677
Zfp36l1^tm1.1Tnr/Zfp36l1^tm1.1Tnr Zfp36l2^tm1.1Tnr/Zfp36l2^tm1.1Tnr Tg(CD2-icre)4Kio/0 (involves: C57BL/6 * C57BL/10 * CBA/Ca * SJL)	abnormal thymus development	J:162388
	enlarged lymph nodes	J:162388
	enlarged spleen	J:162388
	increased T cell derived lymphoma incidence	J:162388
	thymus atrophy	J:162388
Zfp36l2^tm2Pjb/Zfp36l2^tm2Pjb (involves: 129S7/SvEvBrd * C57BL/6)	decreased leukocyte cell number	J:152911
	decreased neutrophil cell number	J:152911
	decreased splenocyte number	J:152911
Zfp91^em1(IMPC)Tcp/Zfp91⁺ (C57BL/6N-Zfp91^em1(IMPC)Tcp/Tcp)	enlarged lymph nodes	J:211773
Zfp106^{tm1a(KOMP)Wtsi}/Zfp106^{tm1a(KOMP)Wtsi} (involves: C57BL/6Brd * C57BL/6Dnk * C57BL/6N)	microgliosis	J:229162
Zfp119a^{tm1b(EUCOMM)Hmgu}/Zfp119a^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Zfp119a^{tm1b(EUCOMM)Hmgu}/Ieg)	increased leukocyte cell number	J:211773
Zfp131^tm1.1Mytk/Zfp131^tm1.1Mytk Tg(Cd4-cre)1Cwi/0 (involves: C57BL/6 * C57BL/6N * DBA/2)	abnormal T cell subpopulation ratio	J:271921
	decreased CD4-positive, alpha-beta T cell number	J:271921
	decreased CD8-positive, alpha-beta T cell number	J:271921
	decreased T cell number	J:271921
Zfp131^tm1.1Mytk/Zfp131^tm1.2Mytk Tg(Lck-cre)1Jtak/0 (involves: C57BL/6N * FVB/N)	abnormal double-negative T cell morphology	J:271921
	abnormal T cell differentiation	J:271921
	arrested T cell differentiation	J:271921
	decreased CD4-positive, alpha-beta T cell number	J:271921
	decreased CD8-positive, alpha-beta T cell number	J:271921
	decreased DN2 thymocyte number	J:271921
	decreased DN3 thymocyte number	J:271921
	decreased DN4 thymocyte number	J:271921
	decreased double-negative T cell number	J:271921
	decreased double-positive T cell number	J:271921
	decreased thymocyte number	J:271921
Zfp142^{tm1b(EUCOMM)Wtsi}/Zfp142^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Zfp142^{tm1b(EUCOMM)Wtsi}/Bay)	abnormal spleen morphology	J:211773
Zfp160^{tm1b(EUCOMM)Wtsi}/Zfp160^{tm1b(EUCOMM)Wtsi} (C57BL/6N-Zfp160^{tm1b(EUCOMM)Wtsi}/BayMmucd)	decreased spleen weight	J:211773
Zfp207^{tm1b(EUCOMM)Hmgu}/Zfp207⁺ (C57BL/6N-Zfp207^{tm1b(EUCOMM)Hmgu}/H)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Zfp236^em1(IMPC)Mbp/Zfp236⁺ (C57BL/6NCrl-Zfp236^em1(IMPC)Mbp/Mmucd)	abnormal spleen morphology	J:211773
	enlarged spleen	J:211773
Zfp260^{tm1b(NCOM)Mfgc}/Zfp260⁺ (C57BL/6N-Zfp260^{tm1b(NCOM)Mfgc}/Tcp)	decreased lymphocyte cell number	J:211773
	increased neutrophil cell number	J:211773
Zfp281^em1(IMPC)Mbp/Zfp281⁺ (C57BL/6N-Zfp281^em1(IMPC)Mbp/MbpMmucd)	abnormal spleen morphology	J:211773
	small spleen	J:211773
Zfp318^m1Anu/Zfp318^m1Anu (C57BL/6JAnu-Zfp318^m1Anu)	abnormal B cell number	J:104190
Zfp318^m1Anu/Zfp318^m1Anu (C57BL/6JAnu-Zfp318^m1Anu)	increased mature B cell number	J:207375
Zfp318^tm1.1Jhws/Zfp318^tm1.1Jhws Commd10^{Tg(Vav1-icre)A2Kio}/Commd10⁺ (B6.Cg-Zfp318^tm1.1Jhws Tg^Vav1-creA2Kio)	decreased transitional stage T2 B cell number	J:215815
Zfp335^blt/Zfp335^blt (involves: C57BL/6)	abnormal CD4-positive T cell differentiation	J:214793
	abnormal CD8-positive, alpha-beta T cell differentiation	J:214793
	abnormal T cell differentiation	J:214793
	decreased B cell number	J:214793
	decreased CD4-positive, alpha-beta memory T cell number	J:214793
	decreased CD4-positive, alpha-beta T cell number	J:214793
	decreased CD8-positive, alpha-beta memory T cell number	J:214793
	decreased CD8-positive, alpha-beta T cell number	J:214793
	decreased NK T cell number	J:214793
	decreased regulatory T cell number	J:214793
	decreased single-positive T cell number	J:214793
Zfp354a^em1(IMPC)Mbp/Zfp354a^em1(IMPC)Mbp (C57BL/6NCrl-Zfp354a^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Zfp366^b2b2834Clo/Zfp366^b2b2834Clo (C57BL/6J-Zfp366^b2b2834Clo)	thymus hypoplasia	J:175213
Zfp398^em1(IMPC)Mbp/Zfp398^em1(IMPC)Mbp (C57BL/6NCrl-Zfp398^em1(IMPC)Mbp/Mmucd)	increased basophil cell number	J:211773
Zfp420^{tm1b(EUCOMM)Hmgu}/Zfp420^{tm1b(EUCOMM)Hmgu} (C57BL/6N-Zfp420^{tm1b(EUCOMM)Hmgu}/Bay)	increased lymphocyte cell number	J:211773
Zfp467^{tm1.1(KOMP)Vlcg}/Zfp467^{tm1.1(KOMP)Vlcg} (B6(Cg)-Zfp467^{tm1.1(KOMP)Vlcg})	increased osteoclast cell number	J:302865
Zfp469^em1(IMPC)Mbp/Zfp469^em1(IMPC)Mbp (C57BL/6N-Zfp469^em1(IMPC)Mbp/MbpMmucd)	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
Zfp474^{em1(IMPC)Ccpcz}/Zfp474^{em1(IMPC)Ccpcz} (C57BL/6N-Zfp474^{em1(IMPC)Ccpcz}/Ccpcz)	decreased lymphocyte cell number	J:211773
	increased eosinophil cell number	J:211773
	increased neutrophil cell number	J:211773
Zfp488^em1(IMPC)Bay/Zfp488^em1(IMPC)Bay (C57BL/6N-Zfp488^em1(IMPC)Bay/Bay)	abnormal spleen morphology	J:211773
Zfp503^em1(IMPC)Mbp/Zfp503⁺ (C57BL/6N-Zfp503^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
	increased basophil cell number	J:211773
Zfp513^em1(IMPC)J/Zfp513^em1(IMPC)J (C57BL/6NJ-Zfp513^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Zfp521^tm1Nohk/Zfp521^tm1Nohk (B6J.Cg-Zfp521^tm1Nohk)	decreased spleen weight	J:214267
Zfp521^tm1Nohk/Zfp521^tm1Nohk (B6J.Cg-Zfp521^tm1Nohk)	decreased thymus weight	J:214267
Zfp574^em1Btlr/Zfp574^em1Btlr (C57BL/6J-Zfp574^em1Btlr)	abnormal class switch recombination	J:354285
	decreased B cell number	J:354285
	decreased B-1 B cell number	J:354285
	decreased leukocyte cell number	J:354285
	decreased lymphocyte cell number	J:354285
	decreased monocyte cell number	J:354285
	decreased neutrophil cell number	J:354285
	decreased T cell number	J:354285
Zfp574^em1Btlr/Zfp574^em1Btlr Tg(IghMyc)22Bri/0 (B6.Cg-Zfp574^em1Btlr Tg(IghMyc)22Bri)	decreased pre-B cell number	J:354285
Zfp574^em3Btlr/Zfp574^em3Btlr Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ (B6.Cg-Ndor1^{Tg(UBC-cre/ERT2)1Ejb} Zfp574^em3Btlr)	decreased B cell number	J:354285
Zfp574^em3Btlr/Zfp574^em3Btlr Ndor1^{Tg(UBC-cre/ERT2)1Ejb}/Ndor1⁺ Tg(IghMyc)22Bri/0 (B6.Cg-Ndor1^{Tg(UBC-cre/ERT2)1Ejb} Zfp574^em3Btlr Tg(IghMyc)22Bri)	decreased B cell number	J:354285
Zfp574^m1Btlr/Zfp574^m1Btlr (C57BL/6J-Zfp574^m1Btlr)	decreased B cell number	J:354285
Zfp593^em1(IMPC)J/Zfp593^em1(IMPC)J (C57BL/6NJ-Zfp593^em1(IMPC)J/Mmjax)	decreased leukocyte cell number	J:211773
Zfp595^{tm1b(KOMP)Wtsi}/Zfp595^{tm1b(KOMP)Wtsi} (C57BL/6N-Zfp595^{tm1b(KOMP)Wtsi}/Bay)	decreased eosinophil cell number	J:211773
	decreased leukocyte cell number	J:211773
	decreased lymphocyte cell number	J:211773
Zfp616^{tm1b(KOMP)Wtsi}/Zfp616^{tm1b(KOMP)Wtsi} (C57BL/6N-Zfp616^{tm1b(KOMP)Wtsi}/Wtsi)	increased KLRG1-positive T-helper cell number	J:211773
Zfp629^em1(IMPC)Tcp/Zfp629^em1(IMPC)Tcp (C57BL/6N-Zfp629^em1(IMPC)Tcp/Tcp)	small spleen	J:211773
Zfp638^em1(IMPC)J/Zfp638⁺ (C57BL/6NJ-Zfp638^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Zfp683^{Gt(OST314703)Lex}/Zfp683^{Gt(OST314703)Lex} (B6.129S5-Zfp683^{Gt(OST314703)Lex})	abnormal NK T cell morphology	J:187727
	decreased NK T cell number	J:187727
Zfp871^{tm1a(EUCOMM)Wtsi}/Zfp871⁺ (C57BL/6N-Zfp871^{tm1a(EUCOMM)Wtsi}/BayMmucd)	spleen hyperplasia	J:317166
	thymus hyperplasia	J:317166
Zfpm1^tm1.1Esv/Zfpm1^tm1.1Esv (involves: 129S6/SvEvTac * C57BL/6)	abnormal spleen morphology	J:156475
	increased granulocyte number	J:156475
	increased neutrophil cell number	J:156475
	increased spleen red pulp amount	J:156475
	increased spleen weight	J:156475
Zfpm1^tm1.1Geab/Zfpm1^tm1.1Geab (Not Specified)	decreased spleen white pulp amount	J:156393
	enlarged spleen	J:156393
	increased monocyte cell number	J:156393
	increased neutrophil cell number	J:156393
	increased spleen weight	J:156393
	spleen hypoplasia	J:156393
Zftraf1^em1(IMPC)H/Zftraf1^em1(IMPC)H (C57BL/6NTac-Zftraf1^em1(IMPC)H/H)	decreased eosinophil cell number	J:211773
Zfx^tm1.1Reiz/Y Tg(Mx1-cre)1Cgn/0 (involves: 129S6/SvEvTac * C57BL/6 * CBA)	decreased lymphocyte cell number	J:149654
Zfx^tm1.1Reiz/Y Tg(Tek-cre)12Flv/0 (involves: 129S6/SvEvTac * C3H * C57BL/6)	decreased mature B cell number	J:149654
	decreased T cell number	J:149654
Zfyve16^{tm2a(KOMP)Wtsi}/Zfyve16^{tm2a(KOMP)Wtsi} (C57BL/6N-Zfyve16^{tm2a(KOMP)Wtsi})	decreased B cell number	J:302014
	increased T cell number	J:302014
Zic2^iso/Zic2^iso (involves: C3H/HeH * C57BL/6)	abnormal spleen morphology	J:268103
	abnormal spleen size	J:268103
	absent spleen	J:268103
Zic3^tm1Bca/Y (involves: 129S7/SvEvBrd * C57BL/6)	spleen hypoplasia	J:75951
Zic3^tm1Bca/Zic3⁺ (involves: 129S7/SvEvBrd * C57BL/6)	spleen hypoplasia	J:75951
Zic3^tm1Bca/Zic3^tm1Bca (involves: 129S7/SvEvBrd * C57BL/6)	spleen hypoplasia	J:75951
Zkscan7^em1(IMPC)Mbp/Zkscan7^em1(IMPC)Mbp (C57BL/6N-Zkscan7^em1(IMPC)Mbp/MbpMmucd)	abnormal lymph node morphology	J:211773
	abnormal spleen morphology	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
Zmpste24^tm1Otin/Zmpste24^tm1Otin (involves: 129P2/Ola * C57BL/6)	abnormal thymus corticomedullary boundary morphology	J:76209
	thymus hypoplasia	J:76209
Zmym2^em1(IMPC)J/Zmym2⁺ (C57BL/6NJ-Zmym2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Zmynd12^em1(IMPC)J/Zmynd12^em1(IMPC)J (C57BL/6NJ-Zmynd12^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Znhit2^em1(IMPC)J/Znhit2⁺ (C57BL/6NJ-Znhit2^em1(IMPC)J/Mmjax)	increased leukocyte cell number	J:211773
Znhit6^em1(IMPC)Mbp/Znhit6⁺ (C57BL/6N-Znhit6^em1(IMPC)Mbp/Ucd)	abnormal lymph node morphology	J:211773
	enlarged lymph nodes	J:211773
Zranb1^{tm1c(EUCOMM)Hmgu}/Zranb1^{tm1c(EUCOMM)Hmgu} Tg(Itgax-cre)1-1Reiz/0 (involves: 129S4/SvJaeSor * C57BL/6N * CBA)	decreased T helper 1 cell number	J:235701
	decreased T-helper 17 cell number	J:235701
Zranb1^{tm1d(EUCOMM)Hmgu}/Zranb1^{tm1d(EUCOMM)Hmgu} (involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)	decreased CD4-positive, alpha-beta T cell number	J:235701
	decreased T helper 1 cell number	J:235701
	decreased T-helper 17 cell number	J:235701
Zrsr2^em1(IMPC)Mbp/Y (C57BL/6N-Zrsr2^em1(IMPC)Mbp/MbpMmucd)	decreased lymphocyte cell number	J:211773
Zrsr2^em1(IMPC)Mbp/Y (C57BL/6N-Zrsr2^em1(IMPC)Mbp/MbpMmucd)	increased neutrophil cell number	J:211773
Zscan10^{Gt(285B6)1.1Cmhd}/Zscan10^{Gt(285B6)1.1Cmhd} (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)	abnormal T cell subpopulation ratio	J:221010
	decreased spleen weight	J:221010
	decreased T cell number	J:221010
	increased B cell number	J:221010
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:221010
	increased mature NK cell number	J:221010
Zswim1^{tm1b(KOMP)Mbp}/Zswim1^{tm1b(KOMP)Mbp} (C57BL/6N-Zswim1^{tm1b(KOMP)Mbp}/Nju)	decreased lymphocyte cell number	J:211773
	decreased monocyte cell number	J:211773
	increased basophil cell number	J:211773
	increased eosinophil cell number	J:211773
	increased leukocyte cell number	J:211773
	increased lymphocyte cell number	J:211773
	increased monocyte cell number	J:211773
	increased neutrophil cell number	J:211773

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 03/25/2025 MGI 6.24